PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lechauve, C; Jager, M; Laguerre, L; Kiger, L; Correc, G; Leroux, C; Vinogradov, S; Czjzek, M; Marden, MC; Bailly, X				Lechauve, Christophe; Jager, Muriel; Laguerre, Laurent; Kiger, Laurent; Correc, Gaelle; Leroux, Cedric; Vinogradov, Serge; Czjzek, Mirjam; Marden, Michael C.; Bailly, Xavier			Neuroglobins, Pivotal Proteins Associated with Emerging Neural Systems and Precursors of Metazoan Globin Diversity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE SUPERFAMILY; NERVOUS-SYSTEM; STEM-CELLS; EVOLUTION; DIVERSIFICATION; HEMOGLOBINS; EXPRESSION; GENOME; NEUROGENESIS; CYTOGLOBIN	Neuroglobins, previously thought to be restricted to vertebrate neurons, were detected in the brain of a photosymbiotic acoel, Symsagittifera roscoffensis, and in neurosensory cells of the jellyfish Clytia hemisphaerica. For the neuroglobin of S. roscoffensis, a member of a lineage that originated either at the base of the bilateria or of the deuterostome clade, we report the ligand binding properties, crystal structure at 2.3 (A) over circle, and brain immunocytochemical pattern. We also describe in situ hybridizations of two neuroglobins specifically expressed in differentiating nematocytes (neurosensory cells) and in statocytes (ciliated mechanosensory cells) of C. hemisphaerica, a member of the early branching animal phylum cnidaria. In silico searches using these neuroglobins as queries revealed the presence of previously unidentified neuroglobin-like sequences in most metazoan lineages. Because neural systems are almost ubiquitous in metazoa, the constitutive expression of neuroglobin-like proteins strongly supports the notion of an intimate association of neuroglobins with the evolution of animal neural systems and hints at the preservation of a vitally important function. Neuroglobins were probably recruited in the first protoneurons in early metazoans from globin precursors. Neuroglobins were identified in choanoflagellates, sponges, and placozoans and were conserved during nervous system evolution. Because the origin of neuroglobins predates the other metazoan globins, it is likely that neuroglobin gene duplication followed by co-option and subfunctionalization led to the emergence of globin families in protostomes and deuterostomes (i.e. convergent evolution).	[Lechauve, Christophe] Univ Paris 06, Ctr Hosp Natl Ophtalmol Quinze Vingts, Inst Vis, INSERM,UMR S 968,CNRS,Unite Mixte Rech UMR 7210, F-75012 Paris, France; [Jager, Muriel] Univ Paris 06, UMR CNRS UPMC Museum Natl Hist Nat IRD 7138, F-75005 Paris, France; [Laguerre, Laurent; Leroux, Cedric; Czjzek, Mirjam; Bailly, Xavier] UPMC CNRS, FR2424, Stn Biol Roscoff, F-29680 Roscoff, France; [Kiger, Laurent; Marden, Michael C.] Univ Paris 11, INSERM, U779, F-94275 Le Kremlin Bicetre, France; [Correc, Gaelle; Czjzek, Mirjam] UPMC CNRS, Stn Biol Roscoff, UMR Marine Plants & Biomol 7139, F-29680 Roscoff, France; [Vinogradov, Serge] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Wayne State University	Bailly, X (corresponding author), UPMC CNRS, FR2424, Stn Biol Roscoff, F-29680 Roscoff, France.	xavier.bailly@sb-roscoff.fr	Marden, Michael/AAA-5923-2020; Lechauve, Christophe/AAH-8873-2019; Kiger, Laurent/Q-1686-2018	LEROUX, Cedric/0000-0001-9225-1234	Region Bretagne; Centre National de la Recherche Scientifique; Universite Pierre et Marie Curie, Paris	Region Bretagne(Region Bretagne); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie, Paris	Crystal structure determination was performed at the crystallography platform of the Station Biologique de Roscoff, supported by the Region Bretagne, the Centre National de la Recherche Scientifique, and Universite Pierre et Marie Curie, Paris 06. We are indebted to the staff of the European Synchrotron Radiation Facilities (ESRF, Grenoble, France), beamline ID23-I and BM30A, for technical support during data collection and treatment. Confocal microscopy was performed in the imaging facility platform Merimage at the Station Biologique de Roscoff. Spectroscopic studies were supported by INSERM and the University Paris 11. We thank Ian Probert from the Marine Resource Center of the Station Biologique de Roscoff for discussions and critical reading of the manuscript.	Bailly X., 2009, CAH BIOL MAR, V50, P106; Bailly Xavier, 2008, V9, P191; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bery A, 2010, DEV GENES EVOL, V220, P61, DOI 10.1007/s00427-010-0328-2; Blank M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025292; Brittain T, 2010, IUBMB LIFE, V62, P878, DOI 10.1002/iub.405; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2007, ADV EXP MED BIOL, V618, P169; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Cheng CHC, 2009, IUBMB LIFE, V61, P184, DOI 10.1002/iub.138; Chevalier S, 2006, DEV GENES EVOL, V216, P709, DOI 10.1007/s00427-006-0103-6; Chiori R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004231; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; DOELLER JE, 1988, BIOL BULL, V174, P67, DOI 10.2307/1541760; Droge J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-54; Ertas B, 2011, J BIOL CHEM, V286, P3185, DOI 10.1074/jbc.M110.160341; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; Galliot B, 2011, KEY TRANSITIONS IN ANIMAL EVOLUTION, P127; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Ganfornina MD, 1999, BIOESSAYS, V21, P432, DOI 10.1002/(SICI)1521-1878(199905)21:5<432::AID-BIES10>3.0.CO;2-T; Geuens E, 2004, IUBMB LIFE, V56, P653, DOI 10.1080/15216540500037471; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P1735, DOI 10.1093/molbev/mss018; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P303, DOI 10.1093/molbev/msr207; Hoffmann FG, 2010, P NATL ACAD SCI USA, V107, P14274, DOI 10.1073/pnas.1006756107; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Houliston E, 2010, TRENDS GENET, V26, P159, DOI 10.1016/j.tig.2010.01.008; Hundahl C, 2006, FEBS J, V273, P1323, DOI 10.1111/j.1742-4658.2006.05158.x; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Jager M, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-12; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; KRAUS DW, 1986, SCIENCE, V232, P90, DOI 10.1126/science.232.4746.90; Lechauve C, 2012, BBA-MOL CELL RES, V1823, P2261, DOI 10.1016/j.bbamcr.2012.09.009; Li WG, 2011, PROTEINS, V79, P115, DOI 10.1002/prot.22863; Lowe CJ, 2011, CURR BIOL, V21, pR151, DOI 10.1016/j.cub.2010.12.017; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; Miljkovic-Licina M, 2004, BIOSYSTEMS, V76, P75, DOI 10.1016/j.biosystems.2004.05.030; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nosengo N, 2011, NATURE, V470, P444, DOI 10.1038/470444a; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Roesner A, 2005, MOL BIOL EVOL, V22, P12, DOI 10.1093/molbev/msh258; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Semmler H, 2010, DEV GROWTH DIFFER, V52, P701, DOI 10.1111/j.1440-169X.2010.01207.x; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Storz JF, 2011, IUBMB LIFE, V63, P313, DOI 10.1002/iub.482; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Vallone B, 2004, PROTEINS, V56, P85, DOI 10.1002/prot.20113; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; WITTENBERG BA, 1965, BIOCHEM J, V96, P363, DOI 10.1042/bj0960363; Ye SQ, 2009, ACTA PHARMACOL SIN, V30, P913, DOI 10.1038/aps.2009.70; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	64	27	28	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6957	6967		10.1074/jbc.M112.407601	http://dx.doi.org/10.1074/jbc.M112.407601			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23288852	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000316002400018
J	Gosalia, N; Leir, SH; Harris, A				Gosalia, Nehal; Leir, Shih-Hsing; Harris, Ann			Coordinate Regulation of the Gel-forming Mucin Genes at Chromosome 11p15.5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULATOR PROTEIN CTCF; DEVELOPMENTAL EXPRESSION; DNA METHYLATION; UP-REGULATION; CELL LINE; MUC5AC; IDENTIFICATION; ORGANIZATION; CARCINOMA; SEQUENCE	Four of the genes that encode gel-forming mucins, which are major components of the mucus layer protecting many epithelial surfaces, are clustered at chromosome 11p15.5 and show both cell-and tissue-specific expression patterns. We aimed to determine whether the individual genes were coordinately regulated by mechanisms involving higher order chromatin structure. CCCTC-binding factor (CTCF) sites were predicted in silico and CTCF occupancy then evaluated by chromatin immunoprecipitation. CTCF was found at many sites across the gene cluster, and its binding was correlated with mucin gene expression. Next, siRNA-mediated depletion of CTCF was shown to increase MUC2 expression in A549 lung carcinoma cells and both MUC6 and MUC5AC expression in LS180 colon carcinoma cells. These changes correlated with loss of CTCF binding at multiple sites, although others retained occupancy. In cells actively expressing the mucins, the gene cluster was shown by chromosome conformation capture to form looped three-dimensional structures with direct interactions between the MUC2 promoter region, regions 30 kb 5' to it, close to the MUC6 promoter and others near the 3' end of MUC5AC, >170 kb away. Finally, to demonstrate the importance of CTCF binding to mucin gene expression, Calu-3 lung carcinoma cells were exposed to lipopolysaccharide (LPS). LPS increased the expression of MUC2 and MUC5AC and reduced MUC5B. CTCF occupancy was concurrently depleted at specific binding sites close to these genes. These data suggest that CTCF binding and cell type-specific long-range interactions across the 11p15.5 gene cluster are critical mechanisms for coordinating gel-forming mucin gene expression.	[Gosalia, Nehal; Leir, Shih-Hsing; Harris, Ann] Northwestern Univ, Human Mol Genet Program, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60614 USA; [Gosalia, Nehal; Leir, Shih-Hsing; Harris, Ann] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60614 USA; [Harris, Ann] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60614 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Harris, A (corresponding author), Northwestern Univ, Human Mol Genet Program, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60614 USA.	ann-harris@northwestern.edu	Leir, Shih-Hsing/AAG-1086-2019; Leir, Shih-Hsing/O-6739-2019	Leir, Shih-Hsing/0000-0001-9524-3379; Gosalia, Nehal/0000-0002-1444-5786	National Institutes of Health [R01 HL094585, R01 HD068901]; Cystic Fibrosis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068901] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health Grants R01 HL094585 and R01 HD068901 and the Cystic Fibrosis Foundation.	BALAGUE C, 1995, GASTROENTEROLOGY, V109, P953, DOI 10.1016/0016-5085(95)90406-9; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Blackledge NP, 2009, NUCLEIC ACIDS RES, V37, P1086, DOI 10.1093/nar/gkn1056; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Copin MC, 2000, INT J CANCER, V86, P162, DOI 10.1002/(SICI)1097-0215(20000415)86:2<162::AID-IJC3>3.3.CO;2-I; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Desseyn JL, 2000, MOL BIOL EVOL, V17, P1175, DOI 10.1093/oxfordjournals.molbev.a026400; Dohrman A, 1998, BBA-MOL BASIS DIS, V1406, P251, DOI 10.1016/S0925-4439(98)00010-6; DUPERAT VG, 1995, BIOCHEM J, V305, P211, DOI 10.1042/bj3050211; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GUM JR, 1989, J BIOL CHEM, V264, P6480; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hauber HP, 2007, AM J RESP CELL MOL, V37, P606, DOI 10.1165/rcmb.2006-0404OC; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Krivega I, 2012, CURR OPIN GENET DEV, V22, P79, DOI 10.1016/j.gde.2011.11.001; Leir SH, 2011, EXP CELL RES, V317, P2408, DOI 10.1016/j.yexcr.2011.07.021; LESUFFLEUR T, 1995, J BIOL CHEM, V270, P13665, DOI 10.1074/jbc.270.23.13665; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Li T, 2008, MOL CELL BIOL, V28, P6473, DOI 10.1128/MCB.00204-08; Lidell ME, 2003, BIOCHEM J, V372, P335, DOI 10.1042/BJ20030003; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lutz M, 2000, NUCLEIC ACIDS RES, V28, P1707, DOI 10.1093/nar/28.8.1707; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Majumder P, 2010, MOL CELL BIOL, V30, P4211, DOI 10.1128/MCB.00327-10; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ott CJ, 2009, P NATL ACAD SCI USA, V106, P19934, DOI 10.1073/pnas.0900946106; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pigny P, 1996, GENOMICS, V38, P340, DOI 10.1006/geno.1996.0637; PORCHET N, 1991, AM REV RESPIR DIS, V144, pS15, DOI 10.1164/ajrccm/144.3_pt_2.S15; Reid CJ, 1998, GUT, V42, P220, DOI 10.1136/gut.42.2.220; Reid CJ, 1997, AM J RESP CELL MOL, V17, P592, DOI 10.1165/ajrcmb.17.5.2798; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Roy MG, 2011, AM J RESP CELL MOL, V44, P755, DOI 10.1165/rcmb.2010-0020OC; Shen B. Q., 1994, AM J PHYSIOL, V266, pL439; Smirnova MG, 2003, CELL IMMUNOL, V221, P42, DOI 10.1016/S0008-8749(03)00059-5; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; TORIBARA NW, 1993, J BIOL CHEM, V268, P5879; Van Seuningen I, 2001, FRONT BIOSCI-LANDMRK, V6, pD1216; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Vincent A, 2007, ONCOGENE, V26, P6566, DOI 10.1038/sj.onc.1210479; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yamada N, 2006, INT J CANCER, V119, P1850, DOI 10.1002/ijc.22047; Yamada N, 2011, CLIN EPIGENETICS, V2, P85, DOI 10.1007/s13148-011-0037-3	57	14	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6717	6725		10.1074/jbc.M112.437400	http://dx.doi.org/10.1074/jbc.M112.437400			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23303185	Green Published, hybrid			2022-12-28	WOS:000315820700069
J	van Sorge, NM; Beasley, FC; Gusarov, I; Gonzalez, DJ; von Kockritz-Blickwede, M; Anik, S; Borkowski, AW; Dorrestein, PC; Nudler, E; Nizet, V				van Sorge, Nina M.; Beasley, Federico C.; Gusarov, Ivan; Gonzalez, David J.; von Koeckritz-Blickwede, Maren; Anik, Sabina; Borkowski, Andrew W.; Dorrestein, Pieter C.; Nudler, Evgeny; Nizet, Victor			Methicillin-resistant Staphylococcus aureus Bacterial Nitric-oxide Synthase Affects Antibiotic Sensitivity and Skin Abscess Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDE LL-37; SOFT-TISSUE INFECTIONS; BACILLUS-SUBTILIS; SUPEROXIDE-DISMUTASE; INNATE IMMUNITY; HOST-DEFENSE; VIRULENCE; PROTEIN; STRESS; IRON	Staphylococcus aureus infections present an enormous global health concern complicated by an alarming increase in antibiotic resistance. S. aureus is among the few bacterial species that express nitric-oxide synthase(bNOS) and thus can catalyze NO production from L-arginine. Here we generate an isogenic bNOS-deficient mutant in the epidemic community-acquired methicillin-resistant S. aureus (MRSA) USA300 clone to study its contribution to virulence and antibiotic susceptibility. Loss of bNOS increased MRSA susceptibility to reactive oxygen species and host cathelicidin antimicrobial peptides, which correlated with increased MRSA killing by human neutrophils and within neutrophil extracellular traps. bNOS also promoted resistance to the pharmaceutical antibiotics that act on the cell envelope such as vancomycin and daptomycin. Surprisingly, bNOS-deficient strains gained resistance to aminoglycosides, suggesting that the role of bNOS in antibiotic susceptibility is more complex than previously observed in Bacillus species. Finally, the MRSA bNOS mutant showed reduced virulence with decreased survival and smaller abscess generation in a mouse subcutaneous infection model. Together, these data indicate that bNOS contributes to MRSA innate immune and antibiotic resistance phenotypes. Future development of specific bNOS inhibitors could be an attractive option to simultaneously reduce MRSA pathology and enhance its susceptibility to commonly used antibiotics.	[van Sorge, Nina M.; Beasley, Federico C.; Gonzalez, David J.; von Koeckritz-Blickwede, Maren; Anik, Sabina; Borkowski, Andrew W.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Gonzalez, David J.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.; Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gusarov, Ivan; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; New York University	Nizet, V (corresponding author), Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr,Mail Code 0687, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Gusarov, Ivan/AAJ-6282-2020; Dorrestein, Pieter/ABF-2930-2020; Nizet, Victor/AAF-3190-2019; van Sorge, Nina/E-3290-2017	van Sorge, Nina/0000-0002-2695-5863; Nudler, Evgeny/0000-0002-8811-3071; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health [AI077780, HD071600, AI057153]; National Institutes of Health; National Institutes of Health/UCSD Immunology Training Grant [5T32AI060536]; A.P. Giannini Foundation Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD071600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052453, T32AI060536, R37AI052453, U54AI057153, R01AI093451, R01AI077780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/UCSD Immunology Training Grant; A.P. Giannini Foundation Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077780, HD071600, and AI057153 (to V. N.). This work was also supported by a National Institutes of Health Director's Pioneer award (to E. N.).; Supported National Institutes of Health/UCSD Immunology Training Grant 5T32AI060536.; Recipient of an A.P. Giannini Foundation Postdoctoral Fellowship.	Alalwani SM, 2010, EUR J IMMUNOL, V40, P1118, DOI 10.1002/eji.200939275; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BEST GK, 1965, ARCH BIOCHEM BIOPHYS, V111, P685, DOI 10.1016/0003-9861(65)90250-X; Bird LE, 2002, STRUCTURE, V10, P1687, DOI 10.1016/S0969-2126(02)00911-5; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Chakravortty D, 2003, MICROBES INFECT, V5, P621, DOI 10.1016/S1286-4579(03)00096-0; CHAMBERS HF, 1984, J INFECT DIS, V149, P894, DOI 10.1093/infdis/149.6.894; Choi WS, 1997, BIOCHEM BIOPH RES CO, V237, P554, DOI 10.1006/bbrc.1997.7189; Clarke SR, 2007, CELL HOST MICROBE, V1, P199, DOI 10.1016/j.chom.2007.04.005; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Eckman C, 2010, EUR J MED RES, V15, P554; Escaich S, 2010, EXPERT OPIN THER PAT, V20, P1401, DOI 10.1517/13543776.2010.511176; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Hachmann AB, 2009, ANTIMICROB AGENTS CH, V53, P1598, DOI 10.1128/AAC.01329-08; Hochgrafe F, 2008, J BACTERIOL, V190, P4997, DOI 10.1128/JB.01846-07; Hong IS, 2003, FEMS MICROBIOL LETT, V222, P177, DOI 10.1016/S0378-1097(03)00254-4; Jin T, 2004, J IMMUNOL, V172, P1169, DOI 10.4049/jimmunol.172.2.1169; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Kohler J, 2011, MICROBES INFECT, V13, P914, DOI 10.1016/j.micinf.2011.05.004; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kristian SA, 2003, J INFECT DIS, V188, P414, DOI 10.1086/376533; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; Lemaire S, 2009, ANTIMICROB AGENTS CH, V53, P2289, DOI 10.1128/AAC.01135-08; Lim MH, 2006, INORG CHEM, V45, P8980, DOI 10.1021/ic0609913; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; MANDELL GL, 1975, J CLIN INVEST, V55, P561, DOI 10.1172/JCI107963; McCollister BD, 2011, ANTIMICROB AGENTS CH, V55, P2189, DOI 10.1128/AAC.01203-10; Moet GJ, 2007, DIAGN MICR INFEC DIS, V57, P7, DOI 10.1016/j.diagmicrobio.2006.05.009; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nizet V, 2003, SCAND J INFECT DIS, V35, P670, DOI 10.1080/00365540310015629; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Ouhara K, 2008, J ANTIMICROB CHEMOTH, V61, P1266, DOI 10.1093/jac/dkn106; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; Park B, 2008, J BACTERIOL, V190, P2275, DOI 10.1128/JB.00006-08; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; REPINE JE, 1981, J BIOL CHEM, V256, P7094; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Robertson CM, 2008, J SURG RES, V150, P278, DOI 10.1016/j.jss.2008.02.009; Salard I, 2006, J INORG BIOCHEM, V100, P2024, DOI 10.1016/j.jinorgbio.2006.09.017; Sasaki S, 1998, INFECT IMMUN, V66, P1017, DOI 10.1128/IAI.66.3.1017-1022.1998; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Soehnlein O, 2009, J MOL MED-JMM, V87, P1157, DOI 10.1007/s00109-009-0508-6; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Yeom J, 2010, J BIOL CHEM, V285, P22689, DOI 10.1074/jbc.M110.127456; Zheng Y, 2007, BRIT J DERMATOL, V157, P1124, DOI 10.1111/j.1365-2133.2007.08196.x	66	73	74	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6417	6426		10.1074/jbc.M112.448738	http://dx.doi.org/10.1074/jbc.M112.448738			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322784	Green Published, hybrid			2022-12-28	WOS:000315820700036
J	Frangini, M; Franzolin, E; Chemello, F; Laveder, P; Romualdi, C; Bianchi, V; Rampazzo, C				Frangini, Miriam; Franzolin, Elisa; Chemello, Francesco; Laveder, Paolo; Romualdi, Chiara; Bianchi, Vera; Rampazzo, Chiara			Synthesis of Mitochondrial DNA Precursors during Myogenesis, an Analysis in Purified C2C12 Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIDINE TRIPHOSPHATE POOLS; RIBONUCLEOTIDE REDUCTION; DEOXYNUCLEOTIDE POOLS; CELL-CYCLE; KINASE; EXPRESSION; GENE; SPECIFICITY; FIBROBLASTS; SUBSTRATE	During myogenesis, myoblasts fuse into multinucleated myotubes that acquire the contractile fibrils and accessory structures typical of striated skeletal muscle fibers. To support the high energy requirements of muscle contraction, myogenesis entails an increase in mitochondrial (mt) mass with stimulation of mtDNA synthesis and consumption of DNA precursors (dNTPs). Myotubes are quiescent cells and as such down-regulate dNTP production despite a high demand for dNTPs. Although myogenesis has been studied extensively, changes in dNTP metabolism have not been examined specifically. In differentiating cultures of C2C12 myoblasts and purified myotubes, we analyzed expression and activities of enzymes of dNTP biosynthesis, dNTP pools, and the expansion of mtDNA. Myotubes exibited pronounced post-mitotic modifications of dNTP synthesis with a particularly marked down-regulation of de novo thymidylate synthesis. Expression profiling revealed the same pattern of enzyme down-regulation in adult murine muscles. The mtDNA increased steadily after myoblast fusion, turning over rapidly, as revealed after treatment with ethidium bromide. We individually down-regulated p53R2 ribonucleotide reductase, thymidine kinase 2, and deoxyguanosine kinase by siRNA transfection to examine how a further reduction of these synthetic enzymes impacted myotube development. Silencing of p53R2 had little effect, but silencing of either mt kinase caused 50% mtDNA depletion and an unexpected decrease of all four dNTP pools independently of the kinase specificity. We suggest that during development of myotubes the shortage of even a single dNTP may affect all four pools through dysregulation of ribonucleotide reduction and/or dissipation of the non-limiting dNTPs during unproductive elongation of new DNA chains.	[Frangini, Miriam; Franzolin, Elisa; Chemello, Francesco; Laveder, Paolo; Romualdi, Chiara; Bianchi, Vera; Rampazzo, Chiara] Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Padua	Bianchi, V (corresponding author), Dipartimento Biol, Via Ugo Bassi 58B, I-35131 Padua, Italy.	vbianchi@bio.unipd.it; rampazzo@bio.unipd.it	Chemello, Francesco/ABB-3801-2020; Romualdi, Chiara/K-1132-2016; Frangini, Miriam/I-3532-2013	Romualdi, Chiara/0000-0003-4792-9047; Chemello, Francesco/0000-0002-3877-527X	Italian Telethon Grant [GGP09019]; Associazione Italiana per la Ricerca sul Cancro [1091]; University of Padova (Progetti Strategici); University of Padova (Progetto di Ateneo) [CPDA099940]	Italian Telethon Grant(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); University of Padova (Progetti Strategici); University of Padova (Progetto di Ateneo)	This work was supported by Italian Telethon Grant GGP09019, Associazione Italiana per la Ricerca sul Cancro (1091), and the University of Padova (Progetti Strategici 2008) (to V. B.), and from the University of Padova (Progetto di Ateneo CPDA099940) (to P. L.).	Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Barbieri Elena, 2011, J Aging Res, V2011, P845379, DOI 10.4061/2011/845379; BIANCHI V, 1987, MOL CELL BIOL, V7, P4218, DOI 10.1128/MCB.7.12.4218; BIANCHI V, 1990, TOXICOL IN VITRO, V4, P9, DOI 10.1016/0887-2333(90)90003-C; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453; ENGSTROM Y, 1988, EMBO J, V7, P1615, DOI 10.1002/j.1460-2075.1988.tb02987.x; Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Frangini M, 2009, FEBS J, V276, P1104, DOI 10.1111/j.1742-4658.2008.06853.x; Franzolin E, 2006, BIOCHEM BIOPH RES CO, V344, P30, DOI 10.1016/j.bbrc.2006.03.147; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hirano M, 2005, GENE, V354, P152, DOI 10.1016/j.gene.2005.04.041; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; KAUFFMAN MG, 1991, MOL CELL BIOL, V11, P2538, DOI 10.1128/MCB.11.5.2538; Ke PY, 2004, MOL CELL BIOL, V24, P514, DOI 10.1128/MCB.24.2.514-526.2004; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Kislinger T, 2005, MOL CELL PROTEOMICS, V4, P887, DOI 10.1074/mcp.M400182-MCP200; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; Leanza L, 2008, J BIOL CHEM, V283, P16437, DOI 10.1074/jbc.M801572200; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2012, CELL CYCLE, V11, P4099, DOI 10.4161/cc.22324; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Pontarin G, 2011, J BIOL CHEM, V286, P11132, DOI 10.1074/jbc.M110.202283; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Pronicka E, 2011, J APPL GENET, V52, P61, DOI 10.1007/s13353-010-0008-y; Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029; Saada A, 2004, DNA CELL BIOL, V23, P797; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tannu NS, 2004, MOL CELL PROTEOMICS, V3, P1065, DOI 10.1074/mcp.M400020-MCP200; Toy G, 2010, P NATL ACAD SCI USA, V107, P5551, DOI 10.1073/pnas.0913900107; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Wang LY, 1996, FEBS LETT, V390, P39, DOI 10.1016/0014-5793(96)00623-0; Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547; Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133	58	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5624	5635		10.1074/jbc.M112.441147	http://dx.doi.org/10.1074/jbc.M112.441147			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297407	Green Published, hybrid			2022-12-28	WOS:000315342500036
J	Kuno, A; Hori, YS; Hosoda, R; Tanno, M; Miura, T; Shimamoto, K; Horio, Y				Kuno, Atsushi; Hori, Yusuke S.; Hosoda, Ryusuke; Tanno, Masaya; Miura, Tetsuji; Shimamoto, Kazuaki; Horio, Yoshiyuki			Resveratrol Improves Cardiomyopathy in Dystrophin-deficient Mice through SIRT1 Protein-mediated Modulation of p300 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COACTIVATOR; ACETYLATION; DEGRADATION; ACTIVATION; SIRTUINS; SURVIVAL; GROWTH; DOMAIN	Cardiomyopathy is the main cause of death in Duchenne muscular dystrophy. Here, we show that oral administration of resveratrol, which leads to activation of an NAD(+)-dependent protein deacetylase SIRT1, suppresses cardiac hypertrophy and fibrosis and restores cardiac diastolic function in dystrophin-deficient mdx mice. The pro-hypertrophic co-activator p300 protein but not p300 mRNA was up-regulated in the mdx heart, and resveratrol administration down-regulated the p300 protein level. In cultured cardiomyocytes, cardiomyocyte hypertrophy induced by the alpha(1)-agonist phenylephrine was inhibited by the overexpression of SIRT1 as well as resveratrol, both of which down-regulated p300 protein levels but not p300 mRNA levels. In addition, activation of atrial natriuretic peptide promoter by p300 was inhibited by SIRT1. We found that SIRT1 induced p300 down-regulation via the ubiquitin-proteasome pathway by deacetylation of lysine residues for ubiquitination. These findings indicate the pathological significance of p300 up-regulation in the dystrophic heart and indicate that SIRT1 activation has therapeutic potential for dystrophic cardiomyopathy.	[Kuno, Atsushi; Hori, Yusuke S.; Hosoda, Ryusuke; Horio, Yoshiyuki] Sapporo Med Univ, Sch Med, Dept Pharmacol, Sapporo, Hokkaido 0608556, Japan; [Kuno, Atsushi; Tanno, Masaya; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Internal Med 2, Sapporo, Hokkaido 0608556, Japan; [Shimamoto, Kazuaki] Sapporo Med Univ, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Horio, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Pharmacol, Sapporo, Hokkaido 0608556, Japan.	horio@sapmed.ac.jp		Horio, Yoshiyuki/0000-0002-5021-5929; Hori, Yusuke S./0000-0001-9921-6810; KUNO, ATSUSHI/0000-0001-6873-1297; Hori, Yusuke S./0000-0002-8195-8979	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22590245]; National Project of Knowledge Cluster Initiative of Second Stage, Sapporo Biocluster Bio-S; Regional R&D Proposal-based Program from the Northern Advancement Center for Science and Technology of Hokkaido; Tubasa Foundation; Hokkaido Heart Association grant for research; Fukuda Foundation for Medical Technology; Akiyama Life Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Project of Knowledge Cluster Initiative of Second Stage, Sapporo Biocluster Bio-S; Regional R&D Proposal-based Program from the Northern Advancement Center for Science and Technology of Hokkaido; Tubasa Foundation; Hokkaido Heart Association grant for research; Fukuda Foundation for Medical Technology(Fukuda Foundation for Medical Technology); Akiyama Life Science Foundation	This work was supported in part by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid 22590245 (to Y.H.), the National Project of Knowledge Cluster Initiative of Second Stage, Sapporo Biocluster Bio-S (to Y.H.), the Regional R&D Proposal-based Program from the Northern Advancement Center for Science and Technology of Hokkaido (to Y.H.), the Tubasa Foundation (to Y.H.), the Hokkaido Heart Association grant for research (to A.K.), and research grants from the Fukuda Foundation for Medical Technology and the Akiyama Life Science Foundation (to A.K.).	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bish LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010230; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Chen JH, 2007, EPIGENETICS-US, V2, P92, DOI 10.4161/epi.2.2.4326; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Ghosh AK, 2007, J CELL PHYSIOL, V213, P663, DOI 10.1002/jcp.21162; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Gusterson R, 2002, J BIOL CHEM, V277, P2517, DOI 10.1074/jbc.M104626200; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Hori YS, 2011, J PHARMACOL EXP THER, V338, P784, DOI 10.1124/jpet.111.183210; Horio Y, 2011, CLIN SCI, V121, P191, DOI 10.1042/CS20100587; Hosoda R, 2013, J PHARMACOL EXP THER, V344, P124, DOI 10.1124/jpet.112.198937; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; McNally EM, 2007, ANNU REV MED, V58, P75, DOI 10.1146/annurev.med.58.011706.144703; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Shin JH, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-132; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Wei JQ, 2008, CIRCULATION, V118, P934, DOI 10.1161/CIRCULATIONAHA.107.760488; Yanazume T, 2003, MOL CELL BIOL, V23, P3593, DOI 10.1128/MCB.23.10.3593-3606.2003	30	67	73	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5963	5972		10.1074/jbc.M112.392050	http://dx.doi.org/10.1074/jbc.M112.392050			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297412	Green Published, hybrid			2022-12-28	WOS:000315342500064
J	Mao, W; Miyagishima, KJ; Yao, Y; Soreghan, B; Sampath, AP; Chen, JE				Mao, Wen; Miyagishima, K. J.; Yao, Yun; Soreghan, Brian; Sampath, Alapakkam P.; Chen, Jeannie			Functional Comparison of Rod and Cone G alpha(t) on the Regulation of Light Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSDUCIN ALPHA-SUBUNIT; HETEROTRIMERIC G-PROTEIN; BETA-GAMMA-COMPLEX; VISUAL PIGMENT; PHOTORECEPTOR SIGNALS; DRIVEN TRANSLOCATION; EXPRESSION LEVELS; TRANSGENIC MICE; MOUSE RETINA; 2.0 ANGSTROM	The signaling cascades mediated byGprotein-coupled receptors (GPCRs) exhibit a wide spectrum of spatial and temporal response properties to fulfill diverse physiological demands. However, the mechanisms that shape the signaling response of the GPCR are not well understood. In this study, we replaced cone transducin alpha (cT alpha) for rod transducin alpha (rT alpha) in rod photoreceptors of transgenic mice, which also express S opsin, to evaluate the role of G alpha subtype on signal amplification from different GPCRs in the same cell; such analysis may explain functional differences between retinal rod and cone photoreceptors. We showed that ectopically expressed cT alpha 1) forms a heterotrimeric complex with rod G beta(1)gamma(1), 2) substitutes equally for rT alpha in generating photoresponses initiated by either rhodopsin or S-cone opsin, and 3) exhibited similar light-activated translocation as endogenous rT alpha in rods and endogenous cT alpha in cones. Thus, rT alpha and cT alpha appear functionally interchangeable. Interestingly, light sensitivity appeared to correlate with the concentration of cT alpha when expression is reduced below 35% of normal. However, quantification of endogenous cT alpha concentration in cones showed a higher level to rT alpha in rods. Thus, reduced sensitivity in cones cannot be explained by reduced coupling efficiency between the GPCR and G protein or a lower concentration of G protein in cones versus rods.	[Mao, Wen; Yao, Yun; Soreghan, Brian; Chen, Jeannie] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Miyagishima, K. J.; Sampath, Alapakkam P.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Biophys, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Chen, JE (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, 1501 San Pablo St,Rm 227, Los Angeles, CA 90033 USA.	jeannie@usc.edu		Miyagishima, Kiyoharu/0000-0002-9744-3152	National Institutes of Health [RO1 EY12155, RO1 EY17606]; Doheny Eye Institute [EY03040]; Beckman Initiative for Macular Research; Karl Kirchgessner Foundation; McKnight Endowment Fund for Neurosciences; NATIONAL EYE INSTITUTE [R01EY017606, R01EY012155, P30EY003040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doheny Eye Institute; Beckman Initiative for Macular Research; Karl Kirchgessner Foundation; McKnight Endowment Fund for Neurosciences; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants RO1 EY12155 (to J. C.) and RO1 EY17606 (to A. P. S.); a Vision Core grant to Doheny Eye Institute (EY03040); the Beckman Initiative for Macular Research (to J. C.); the Karl Kirchgessner Foundation (to A. P. S.); and the McKnight Endowment Fund for Neurosciences (to A. P. S.).	BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1987, INVEST OPHTH VIS SCI, V28, P34; Betke KM, 2012, PROG NEUROBIOL, V96, P304, DOI 10.1016/j.pneurobio.2012.01.009; BIGAY J, 1994, BIOCHEMISTRY-US, V33, P14081, DOI 10.1021/bi00251a017; BLANKS JC, 1984, INVEST OPHTH VIS SCI, V25, P546; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen CK, 2010, J PHYSIOL-LONDON, V588, P3231, DOI 10.1113/jphysiol.2010.191221; Chen CK, 1996, P NATL ACAD SCI USA, V93, P12885, DOI 10.1073/pnas.93.23.12885; Chen J, 1996, P NATL ACAD SCI USA, V93, P7042, DOI 10.1073/pnas.93.14.7042; Chen JY, 2006, J NEUROSCI, V26, P11929, DOI 10.1523/JNEUROSCI.3212-06.2006; Chen JP, 2007, INVEST OPHTH VIS SCI, V48, P3350, DOI 10.1167/iovs.07-0126; Concepcion F, 2002, VISION RES, V42, P417, DOI 10.1016/S0042-6989(01)00195-X; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; DARTNALL HJ, 1968, VISION RES, V8, P339, DOI 10.1016/0042-6989(68)90104-1; Deng WT, 2009, P NATL ACAD SCI USA, V106, P17681, DOI 10.1073/pnas.0901382106; Driessen CAGG, 2000, MOL CELL BIOL, V20, P4275, DOI 10.1128/MCB.20.12.4275-4287.2000; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Herrmann R, 2010, J NEUROSCI, V30, P3239, DOI 10.1523/JNEUROSCI.4775-09.2010; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Joseph RM, 1996, INVEST OPHTH VIS SCI, V37, P2434; Kassai H, 2005, NEURON, V47, P529, DOI 10.1016/j.neuron.2005.07.025; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Kerov V, 2005, J BIOL CHEM, V280, P41069, DOI 10.1074/jbc.M508849200; Kerov V, 2007, J NEUROSCI, V27, P10270, DOI 10.1523/JNEUROSCI.2494-07.2007; Kerov V, 2011, MOL CELL NEUROSCI, V46, P340, DOI 10.1016/j.mcn.2010.10.006; Kolesnikov AV, 2011, J NEUROSCI, V31, P8067, DOI 10.1523/JNEUROSCI.0174-11.2011; Kosloff M, 2008, J BIOL CHEM, V283, P31197, DOI 10.1074/jbc.M803799200; Krispel CM, 2007, J GEN PHYSIOL, V130, P303, DOI 10.1085/jgp.200709812; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Lobanova ES, 2007, J NEUROSCI, V27, P1151, DOI 10.1523/JNEUROSCI.5010-06.2007; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; Lomonosova E, 2012, INVEST OPHTH VIS SCI, V53, P1225, DOI 10.1167/iovs.11-9350; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; Mazzoni MR, 1996, J BIOL CHEM, V271, P30034, DOI 10.1074/jbc.271.47.30034; NAVON SE, 1987, J BIOL CHEM, V262, P15746; NEUBERT TA, 1992, J BIOL CHEM, V267, P18274; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; NORMANN RA, 1979, J PHYSIOL-LONDON, V286, P491, DOI 10.1113/jphysiol.1979.sp012633; Okawa H, 2010, J PHYSIOL-LONDON, V588, P1947, DOI 10.1113/jphysiol.2010.188573; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; PENG YW, 1992, P NATL ACAD SCI USA, V89, P10882, DOI 10.1073/pnas.89.22.10882; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Starace DM, 1997, J BIOL CHEM, V272, P1095, DOI 10.1074/jbc.272.2.1095; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wang Q, 2008, J BIOL CHEM, V283, P30015, DOI 10.1074/jbc.M803953200; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; Zhang HB, 2003, MOL VIS, V9, P231; Zhang X, 2003, J NEUROSCI, V23, P1287, DOI 10.1523/JNEUROSCI.23-04-01287.2003	67	16	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5257	5267		10.1074/jbc.M112.430058	http://dx.doi.org/10.1074/jbc.M112.430058			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288843	Green Published, hybrid			2022-12-28	WOS:000315342500001
J	Quint, P; Ruan, M; Pederson, L; Kassem, M; Westendorf, JJ; Khosla, S; Oursler, MJ				Quint, Patrick; Ruan, Ming; Pederson, Larry; Kassem, Moustapha; Westendorf, Jennifer J.; Khosla, Sundeep; Oursler, Merry Jo			Sphingosine 1-Phosphate (S1P) Receptors 1 and 2 Coordinately Induce Mesenchymal Cell Migration through S1P Activation of Complementary Kinase Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; THERAPEUTIC TARGETS; BONE-RESORPTION; TNF-ALPHA; JAK-STAT; CANCER; GROWTH; SPHINGOSINE-1-PHOSPHATE; PROLIFERATION; CARCINOMA	Normal bone turnover requires tight coupling of bone resorption and bone formation to preserve bone quantity and structure. With aging and during several pathological conditions, this coupling breaks down, leading to either net bone loss or excess bone formation. To preserve or restore normal bone metabolism, it is crucial to determine the mechanisms by which osteoclasts and osteoblast precursors interact and contribute to coupling. We showed that osteoclasts produce the chemokine sphingosine 1-phosphate (S1P), which stimulates osteoblast migration. Thus, osteoclast-derived S1P may recruit osteoblasts to sites of bone resorption as an initial step in replacing lost bone. In this study we investigated the mechanisms by which S1P stimulates mesenchymal (skeletal) cell chemotaxis. S1P treatment of mesenchymal (skeletal) cells activated RhoA GTPase, but this small G protein did not contribute to migration. Rather, two S1P receptors, S1PR1 and S1PR2, coordinately promoted migration through activation of the JAK/STAT3 and FAK/PI3K/AKT signaling pathways, respectively. These data demonstrate that the chemokine S1P couples bone formation to bone resorption through activation of kinase signaling pathways.	[Quint, Patrick; Ruan, Ming; Pederson, Larry; Khosla, Sundeep; Oursler, Merry Jo] Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA; [Quint, Patrick; Ruan, Ming; Pederson, Larry; Khosla, Sundeep; Oursler, Merry Jo] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA; [Westendorf, Jennifer J.] Mayo Clin, Div Orthoped Res, Rochester, MN 55905 USA; [Westendorf, Jennifer J.; Oursler, Merry Jo] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Kassem, Moustapha] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark; [Kassem, Moustapha] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11451, Saudi Arabia	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Southern Denmark; Odense University Hospital; King Saud University	Quint, P (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	quint.patrick@mayo.edu	Kassem, Moustapha/O-3819-2019; Kassem, Moustapha/J-7688-2013; Khosla, Sundeep/AAE-6170-2020	Kassem, Moustapha/0000-0003-1557-0869; Kassem, Moustapha/0000-0003-1557-0869; Khosla, Sundeep/0000-0002-2936-4372	National Institutes of Health [P01 AG004875]; NATIONAL INSTITUTE ON AGING [P01AG004875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 AG004875 through the NIA.	Ader I, 2009, CANCER RES, V69, P3723, DOI 10.1158/0008-5472.CAN-09-0389; Andl CD, 2004, AM J PHYSIOL-GASTR L, V287, pG1227, DOI 10.1152/ajpgi.00253.2004; Badgwell DB, 2012, ONCOGENE, V31, P68, DOI 10.1038/onc.2011.213; Baumruker T, 2007, EXPERT OPIN INV DRUG, V16, P283, DOI 10.1517/13543784.16.3.283; Beccari S, 2002, MECH DEVELOP, V111, P115, DOI 10.1016/S0925-4773(01)00615-3; Belvitch P, 2012, MICROVASC RES, V83, P22, DOI 10.1016/j.mvr.2011.08.012; Bergelin N, 2010, ENDOCRINOLOGY, V151, P2994, DOI [10.1210/en.2009-1387, 10.1210//en.2009-1387]; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; Bonacchi A, 2001, J BIOL CHEM, V276, P9945, DOI 10.1074/jbc.M010303200; Brocklyn James R Van, 2010, World J Biol Chem, V1, P307, DOI 10.4331/wjbc.v1.i10.307; Brown S, 2006, DEV DYNAM, V235, P958, DOI 10.1002/dvdy.20709; Cuvillier O, 2007, ANTI-CANCER DRUG, V18, P105, DOI 10.1097/CAD.0b013e328011334d; Delehedde M, 2001, EUR J BIOCHEM, V268, P4423, DOI 10.1046/j.1432-1327.2001.02363.x; Facchinetti MM, 2010, CELLS TISSUES ORGANS, V192, P314, DOI 10.1159/000318173; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; Garcia-Bernal D, 2013, J PATHOL, V229, P36, DOI 10.1002/path.4066; Guan HY, 2011, MOL ENDOCRINOL, V25, P1858, DOI 10.1210/me.2011-1048; Harvey KA, 2010, MOL CELL BIOCHEM, V342, P7, DOI 10.1007/s11010-010-0461-2; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Howard C, 2010, J ENDODONT, V36, P1963, DOI 10.1016/j.joen.2010.08.046; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jin ZQ, 2007, CARDIOVASC RES, V76, P41, DOI 10.1016/j.cardiores.2007.05.029; Johnson CE, 2012, BREAST CANCER RES TR, V133, P889, DOI 10.1007/s10549-011-1835-1; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lai WQ, 2012, FUTURE MED CHEM, V4, P727, DOI [10.4155/FMC.12.28, 10.4155/fmc.12.28]; Lai WQ, 2008, J IMMUNOL, V181, P8010, DOI 10.4049/jimmunol.181.11.8010; Lamana A, 2011, J INVEST DERMATOL, V131, P1503, DOI 10.1038/jid.2011.54; Lee SH, 2012, J CLIN ENDOCR METAB, V97, pE1421, DOI 10.1210/jc.2012-1044; Li MH, 2009, CANCER LETT, V276, P171, DOI 10.1016/j.canlet.2008.11.025; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Lynch Kevin R, 2012, Biochem J, V444, pe1, DOI 10.1042/BJ20120567; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Matsuyuki H, 2006, CELL MOL IMMUNOL, V3, P429; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Nagiec MM, 1998, J BIOL CHEM, V273, P19437, DOI 10.1074/jbc.273.31.19437; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Oskeritzian CA, 2008, BLOOD, V111, P4193, DOI 10.1182/blood-2007-09-115451; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Sato C, 2012, BIOCHEM BIOPH RES CO, V423, P200, DOI 10.1016/j.bbrc.2012.05.130; Schwalm S, 2010, BRIT J PHARMACOL, V160, P1641, DOI 10.1111/j.1476-5381.2010.00818.x; Sekine Y, 2011, PROSTATE, V71, P690, DOI 10.1002/pros.21285; Seo YJ, 2011, CYTOKINE GROWTH F R, V22, P55, DOI 10.1016/j.cytogfr.2010.12.001; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Soede RDM, 2001, J IMMUNOL, V166, P4293, DOI 10.4049/jimmunol.166.7.4293; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Wang SY, 2011, ANTI-CANCER AGENT ME, V11, P993, DOI 10.2174/187152011797927661; Wu WC, 2004, MOL CELL BIOL, V24, P7359, DOI 10.1128/MCB.24.17.7359-7369.2004; Wu YP, 2008, HUM MOL GENET, V17, P2257, DOI 10.1093/hmg/ddn126; Yamada O, 2012, MOL CANCER THER, V11, P1112, DOI 10.1158/1535-7163.MCT-11-0850; Zeng HY, 2002, J BIOL CHEM, V277, P46791, DOI 10.1074/jbc.M206133200; Zheng DQ, 2000, J BIOL CHEM, V275, P24565, DOI 10.1074/jbc.M002646200	66	55	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5398	5406		10.1074/jbc.M112.413583	http://dx.doi.org/10.1074/jbc.M112.413583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23300082	hybrid, Green Published			2022-12-28	WOS:000315342500015
J	Arshad, N; Ballal, S; Visweswariah, SS				Arshad, Najla; Ballal, Suhas; Visweswariah, Sandhya S.			Site-specific N-Linked Glycosylation of Receptor Guanylyl Cyclase C Regulates Ligand Binding, Ligand-mediated Activation and Interaction with Vesicular Integral Membrane Protein 36, VIP36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-STABLE ENTEROTOXIN; NATRIURETIC-PEPTIDE RECEPTOR; ESCHERICHIA-COLI; QUALITY-CONTROL; ION-TRANSPORT; DOMAIN; EXPRESSION; GLYCOPROTEINS; SECRETION; EVOLUTION	Guanylyl cyclase C (GC-C) is a multidomain, membrane-associated receptor guanylyl cyclase. GC-C is primarily expressed in the gastrointestinal tract, where it mediates fluid-ion homeostasis, intestinal inflammation, and cell proliferation in a cGMP-dependent manner, following activation by its ligands guanylin, uroguanylin, or the heat-stable enterotoxin peptide (ST). GC-C is also expressed in neurons, where it plays a role in satiation and attention deficiency/hyperactive behavior. GC-C is glycosylated in the extracellular domain, and differentially glycosylated forms that are resident in the endoplasmic reticulum (130 kDa) and the plasma membrane (145 kDa) bind the ST peptide with equal affinity. When glycosylation of human GC-C was prevented, either by pharmacological intervention or by mutation of all of the 10 predicted glycosylation sites, ST binding and surface localization was abolished. Systematic mutagenesis of each of the 10 sites of glycosylation in GC-C, either singly or in combination, identified two sites that were critical for ligand binding and two that regulated ST-mediated activation. We also show that GC-C is the first identified receptor client of the lectin chaperone vesicular integral membrane protein, VIP36. Interaction with VIP36 is dependent on glycosylation at the same sites that allow GC-C to fold and bind ligand. Because glycosylation of proteins is altered in many diseases and in a tissue-dependent manner, the activity and/or glycan-mediated interactions of GC-C may have a crucial role to play in its functions in different cell types.	[Arshad, Najla; Ballal, Suhas; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Arshad, Najla/H-9453-2019; Visweswariah, Sandhya/Q-7500-2019; Ballal, Suhas/AAD-5449-2021; Ballal, Suhas/ABA-2862-2021	Arshad, Najla/0000-0001-5553-311X; Visweswariah, Sandhya/0000-0003-2786-7344; Ballal, Suhas/0000-0002-6041-8332; 	Department of Science and Technology (India)	Department of Science and Technology (India)(Department of Science & Technology (India))	This work was supported by the Department of Science and Technology (India).	Albano F, 2001, BIOCHEM BIOPH RES CO, V284, P331, DOI 10.1006/bbrc.2001.4973; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Bakre MM, 2000, EUR J BIOCHEM, V267, P179, DOI 10.1046/j.1432-1327.2000.00986.x; Balog CIA, 2012, MOL CELL PROTEOMICS, V11, P571, DOI 10.1074/mcp.M111.011601; Basu N, 2010, MOL CELL BIOCHEM, V334, P67, DOI 10.1007/s11010-009-0324-x; Basu N, 2009, MOL CELL BIOL, V29, P5277, DOI 10.1128/MCB.00001-09; Benoit I, 2006, FEBS LETT, V580, P5815, DOI 10.1016/j.febslet.2006.09.039; Bhandari R, 2001, BIOCHEMISTRY-US, V40, P9196, DOI 10.1021/bi002595g; Boyer MZ, 2003, ARCH PEDIATRIE, V10, P590, DOI 10.1016/S0929-693X(03)00278-1; Brown KH, 2003, J NUTR, V133, p328S, DOI 10.1093/jn/133.1.328S; Campbell B, 2001, SMITHSONIAN, V32, P18; Crane JK, 1996, MOL CELL BIOCHEM, V165, P111; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; DEJONGE HR, 1975, FEBS LETT, V53, P237, DOI 10.1016/0014-5793(75)80028-7; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Delos SE, 2002, VIROLOGY, V294, P354, DOI 10.1006/viro.2001.1339; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Fenrick R, 1997, MOL CELL BIOCHEM, V173, P25, DOI 10.1023/A:1006855522272; FIELD M, 1978, P NATL ACAD SCI USA, V75, P2800, DOI 10.1073/pnas.75.6.2800; Fiskerstrand T, 2012, NEW ENGL J MED, V366, P1586, DOI 10.1056/NEJMoa1110132; FORTE LR, 1993, J CLIN INVEST, V91, P2423, DOI 10.1172/JCI116476; Ghanekar Y, 2004, BIOCHEM J, V379, P653, DOI 10.1042/BJ20040001; Ghanekar Y, 2003, EUR J BIOCHEM, V270, P3848, DOI 10.1046/j.1432-1033.2003.03779.x; Gong R, 2011, SCIENCE, V333, P1642, DOI 10.1126/science.1207675; HAMRA FK, 1993, P NATL ACAD SCI USA, V90, P10464, DOI 10.1073/pnas.90.22.10464; Hara-Kuge S, 2004, GLYCOBIOLOGY, V14, P739, DOI 10.1093/glycob/cwh082; Hara-Kuge S, 2002, J BIOL CHEM, V277, P16332, DOI 10.1074/jbc.M112188200; Hasegawa M, 1999, EUR J BIOCHEM, V263, P338, DOI 10.1046/j.1432-1327.1999.00488.x; Hayes CA, 2012, BIOINFORMATICS, V28, P1669, DOI 10.1093/bioinformatics/bts242; He XL, 2001, SCIENCE, V293, P1657, DOI 10.1126/science.1062246; Hodson CA, 2006, TRAFFIC, V7, P456, DOI 10.1111/j.1600-0854.2006.00398.x; Jaleel M, 2006, BIOCHEMISTRY-US, V45, P1888, DOI 10.1021/bi052089x; Jaleel M, 2002, BIOL REPROD, V67, P1975, DOI 10.1095/biolreprod.102.006445; Kaczur V, 2003, MOL GENET METAB, V78, P275, DOI 10.1016/S1096-7192(03)00036-2; Kawasaki N, 2007, J BIOCHEM, V141, P221, DOI 10.1093/jh/mvm024; Kazerounian S, 2005, J PHARMACOL EXP THER, V314, P1013, DOI 10.1124/jpet.105.089052; KOCH KW, 1994, EUR J BIOCHEM, V222, P589, DOI 10.1111/j.1432-1033.1994.tb18901.x; Kopic S, 2010, TOXINS, V2, P2132, DOI 10.3390/toxins2082132; Lanctot PM, 2005, BIOCHEM J, V390, P367, DOI 10.1042/BJ20050189; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lauber T, 2009, PROTEIN ENG DES SEL, V22, P1, DOI 10.1093/protein/gzn062; Lin JE, 2010, GASTROENTEROLOGY, V138, P241, DOI 10.1053/j.gastro.2009.08.064; Mann EA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-86; Mialet-Perez J, 2004, J BIOL CHEM, V279, P38603, DOI 10.1074/jbc.M403708200; Miyagi M, 2000, EUR J BIOCHEM, V267, P5758, DOI 10.1046/j.1432-1327.2000.01647.x; Nandi A, 1996, PROTEIN EXPRES PURIF, V8, P151, DOI 10.1006/prep.1996.0087; Nawa D, 2007, GLYCOBIOLOGY, V17, P913, DOI 10.1093/glycob/cwm067; PAREKH RB, 1987, EMBO J, V6, P1233, DOI 10.1002/j.1460-2075.1987.tb02359.x; Pitari GM, 2003, P NATL ACAD SCI USA, V100, P2695, DOI 10.1073/pnas.0434905100; Pitari GM, 2001, P NATL ACAD SCI USA, V98, P7846, DOI 10.1073/pnas.141124698; Reiterer V, 2010, TRAFFIC, V11, P1044, DOI 10.1111/j.1600-0854.2010.01078.x; Romi H, 2012, AM J HUM GENET, V90, P893, DOI 10.1016/j.ajhg.2012.03.022; Saha S, 2009, J BIOL CHEM, V284, P27135, DOI 10.1074/jbc.M109.020032; Schulz S, 1997, J CLIN INVEST, V100, P1590, DOI 10.1172/JCI119683; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Scott RO, 2002, J BIOL CHEM, V277, P22934, DOI 10.1074/jbc.M202434200; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shi XH, 2004, J VIROL, V78, P5414, DOI 10.1128/JVI.78.10.5414-5422.2004; Shirakabe K, 2011, J BIOL CHEM, V286, P43154, DOI 10.1074/jbc.M111.275586; SINGH S, 1991, BIOCHEM BIOPH RES CO, V179, P1455, DOI 10.1016/0006-291X(91)91736-V; Stein RA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-79; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Valentino MA, 2011, J CLIN INVEST, V121, P3578, DOI 10.1172/JCI57925; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; van den Akker F, 2001, J MOL BIOL, V311, P923, DOI 10.1006/jmbi.2001.4922; VISWESWARIAH SS, 1994, EUR J BIOCHEM, V219, P727, DOI 10.1111/j.1432-1033.1994.tb18551.x; Yamashita K, 1999, BBA-GEN SUBJECTS, V1473, P147, DOI 10.1016/S0304-4165(99)00175-0; Zhao XC, 2010, MOL BIOL REP, V37, P2301, DOI 10.1007/s11033-009-9724-y	68	11	12	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3907	3917		10.1074/jbc.M112.413906	http://dx.doi.org/10.1074/jbc.M112.413906			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23269669	hybrid, Green Published			2022-12-28	WOS:000314845000021
J	Jiang, CT; Kim, JH; Li, F; Qu, AJ; Gavrilova, O; Shah, YM; Gonzalez, FJ				Jiang, Changtao; Kim, Jung-Hwan; Li, Fei; Qu, Aijuan; Gavrilova, Oksana; Shah, Yatrik M.; Gonzalez, Frank J.			Hypoxia-inducible Factor 1 alpha Regulates a SOCS3-STAT3-Adiponectin Signal Transduction Pathway in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; GENE-EXPRESSION; DSBA-L; ADIPONECTIN; OBESITY; SECRETION; FIBROSIS; CELL; ARNT/HIF1-BETA	Obesity has been identified as a major risk factor for type 2 diabetes, characterized by insulin resistance in insulin target tissues. Hypoxia-inducible factor 1 alpha (HIF1 alpha) regulates pathways in energy metabolism that become dysregulated in obesity. Earlier studies revealed that HIF1 alpha in adipose tissue is markedly elevated in high-fat diet-fed mice that are obese and insulin-resistant. Genetic ablation of HIF1 alpha in adipose tissue decreased insulin resistance and obesity, accompanied by increased serum adiponectin levels. However, the exact mechanism whereby HIF1 alpha regulates adiponectin remains unclear. Here, acriflavine (ACF), an inhibitor of HIF1 alpha, induced the expression of adiponectin and reduced the expression of SOCS3 in cultured 3T3-L1 adipocytes. Mechanistic studies revealed that HIF1 alpha suppressed the expression of adiponectin through a SOCS3-STAT3 pathway. Socs3 was identified as a novel HIF1 alpha target gene based on chromatin immunoprecipitation and luciferase assays. STAT3 directly regulated adiponectin in vitro in cultured 3T3-L1 adipocytes. ACF was found to prevent diet-induced obesity and insulin resistance. In vivo, ACF also regulated the SOCS3-STAT3-adiponectin pathway, and inhibition of HIF1 alpha in adipose tissue was essential for ACF to improve the SOCS3-STAT3-adiponectin pathway to counteract insulin resistance. This study provides evidence for a novel target gene and signal transduction pathway in adipocytes and indicates that inhibitors of HIF1 alpha have potential utility for the treatment of obesity and type 2 diabetes.	[Jiang, Changtao; Kim, Jung-Hwan; Li, Fei; Qu, Aijuan; Shah, Yatrik M.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, NIH, Bethesda, MD 20892 USA; [Shah, Yatrik M.] Univ Michigan, Div Gastroenterol, Sch Med, Dept Mol & Integrat Physiol & Internal Med, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Michigan System; University of Michigan	Gonzalez, FJ (corresponding author), NCI, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA.	gonzalef@mail.nih.gov	Li, Fei/F-6849-2013	Kim, Jung Hwan/0000-0002-2975-4899; Jiang, Changtao/0000-0002-5206-2372	NCI; NIDDK; National Institutes of Health [CA148828]; NATIONAL CANCER INSTITUTE [R01CA148828, ZIABC005708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, ZICDK070002] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the NCI and NIDDK Intramural Research Programs and National Institutes of Health Grant CA148828 (to Y. M. S.).	Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Girgis CM, 2012, TRENDS ENDOCRIN MET, V23, P372, DOI 10.1016/j.tem.2012.05.003; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Ii H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008089; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Jiang CT, 2009, AM J PHYSIOL-CELL PH, V297, pC1466, DOI 10.1152/ajpcell.00304.2009; Jiang Y., 2012, CELL, V150; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kanatani Y, 2007, DIABETES, V56, P795, DOI 10.2337/db06-1039; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Lee KY, 2011, CELL METAB, V14, P491, DOI 10.1016/j.cmet.2011.08.006; Lee SH, 2012, J BIOL CHEM, V287, P14760, DOI 10.1074/jbc.M112.340232; Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Michailidou Z, 2012, J BIOL CHEM, V287, P4188, DOI 10.1074/jbc.M111.259325; Miyamoto L, 2012, J BIOL CHEM, V287, P40441, DOI 10.1074/jbc.M112.384545; Moh A, 2008, DIABETES, V57, P1227, DOI 10.2337/db06-1582; Olefsky JM, 2009, CELL, V138, P834, DOI 10.1016/j.cell.2009.08.018; Palsgaard J, 2012, J BIOL CHEM, V287, P12016, DOI 10.1074/jbc.M111.337048; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Saltiel AR, 2012, CELL METAB, V15, P798, DOI 10.1016/j.cmet.2012.03.001; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; STEPHENS JM, 1992, J BIOL CHEM, V267, P13580; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tennant DA, 2011, CELL, V145, P647, DOI 10.1016/j.cell.2011.05.009; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Wang XL, 2009, CELL METAB, V9, P428, DOI 10.1016/j.cmet.2009.04.001; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Wang ZV, 2008, P NATL ACAD SCI USA, V105, P18077, DOI 10.1073/pnas.0810027105; Xie LL, 2006, J BIOL CHEM, V281, P7253, DOI 10.1074/jbc.M511313200; Yang SJ, 2010, MOL CELL BIOCHEM, V345, P45, DOI 10.1007/s11010-010-0558-7; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yoshimura Akihiko, 2011, Nihon Rinsho, V69 Suppl 1, P782; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908; Zhang H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001112; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412	52	54	58	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3844	3857		10.1074/jbc.M112.426338	http://dx.doi.org/10.1074/jbc.M112.426338			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23255598	hybrid, Green Published			2022-12-28	WOS:000314845000016
J	Gheiratmand, L; Brasseur, A; Zhou, Q; He, CY				Gheiratmand, Ladan; Brasseur, Anais; Zhou, Qing; He, Cynthia Y.			Biochemical Characterization of the Bi-lobe Reveals a Continuous Structural Network Linking the Bi-lobe to Other Single-copied Organelles in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASAL BODY MOVEMENTS; CELL-CYCLE; MONOCLONAL-ANTIBODIES; GENOME SEGREGATION; PARAFLAGELLAR ROD; MITOCHONDRIAL-DNA; GOLGI DUPLICATION; FLAGELLAR POCKET; DIVISION; PROTEIN	Trypanosoma brucei, a unicellular parasite, contains several single-copied organelles that duplicate and segregate in a highly coordinated fashion during the cell cycle. In the procyclic stage, a bi-lobed structure is found adjacent to the single ER exit site and Golgi apparatus, forming both stable and dynamic association with other cytoskeletal components including the basal bodies that seed the flagellum and the flagellar pocket collar that is critical for flagellar pocket biogenesis. To further understand the bi-lobe and its association with adjacent organelles, we performed proteomic analyses on the immunoisolated bi-lobe complex. Candidate proteins were localized to the flagellar pocket, the basal bodies, a tripartite attachment complex linking the basal bodies to the kinetoplast, and a segment of microtubule quartet linking the flagellar pocket collar and bi-lobe to the basal bodies. These results supported an extensive connection among the single-copied organelles in T. brucei, a strategy employed by the parasite for orderly organelle assembly and inheritance during the cell cycle.	[Gheiratmand, Ladan; Brasseur, Anais; Zhou, Qing; He, Cynthia Y.] Natl Univ Singapore, Ctr BioImaging Sci, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore	He, CY (corresponding author), Natl Univ Singapore, Ctr BioImaging Sci, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbshyc@nus.edu.sg	He, Cynthia/H-9789-2012; Zhou, Qing/A-8296-2019; Zhou, Qing/I-6223-2019	Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960	Singapore National Research Foundation; A*STAR SINGA fellowship	Singapore National Research Foundation(National Research Foundation, Singapore); A*STAR SINGA fellowship(Agency for Science Technology & Research (A*STAR))	This work was supported by the Singapore National Research Foundation.; A recipient of the A*STAR SINGA fellowship.	Absalon S, 2008, J CELL SCI, V121, P3704, DOI 10.1242/jcs.035626; Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Bangs JD, 2011, MOL MICROBIOL, V82, P1433, DOI 10.1111/j.1365-2958.2011.07900.x; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chan SW, 2005, GENE, V353, P189, DOI 10.1016/j.gene.2005.04.025; Dougherty GW, 2005, CELL MOTIL CYTOSKEL, V62, P141, DOI 10.1002/cm.20093; Esson HJ, 2012, EUKARYOT CELL, V11, P761, DOI 10.1128/EC.05287-11; Fagarasanu A, 2007, CURR OPIN MICROBIOL, V10, P528, DOI 10.1016/j.mib.2007.10.002; Fagarasanu A, 2010, NAT REV MOL CELL BIO, V11, P644, DOI 10.1038/nrm2960; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Ikeda KN, 2012, J CELL SCI, V125, P3173, DOI 10.1242/jcs.101162; Imoto Y, 2011, J ELECTRON MICROSC, V60, pS117, DOI 10.1093/jmicro/dfr034; ISMACH R, 1989, J PROTOZOOL, V36, P617, DOI 10.1111/j.1550-7408.1989.tb01105.x; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Lacomble S, 2010, J CELL SCI, V123, P2884, DOI 10.1242/jcs.074161; Lowe M, 2007, NAT REV MOL CELL BIO, V8, P429, DOI 10.1038/nrm2179; Morriswood B, 2009, MOL BIOCHEM PARASIT, V167, P95, DOI 10.1016/j.molbiopara.2009.05.001; Nolan DP, 2008, MOL BIOCHEM PARASIT, V157, P233, DOI 10.1016/j.molbiopara.2007.10.006; Ochsenreiter T, 2008, MOL CELL BIOL, V28, P5595, DOI 10.1128/MCB.00637-08; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Portman N, 2012, PARASITOLOGY, V139, P1168, DOI 10.1017/S0031182012000443; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; SCHLAEPPI K, 1989, J CELL BIOL, V109, P1695, DOI 10.1083/jcb.109.4.1695; Sheahan MB, 2007, J INTEGR PLANT BIOL, V49, P1208, DOI 10.1111/j.1672-9072.2007.00523.x; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Shi J, 2008, J CELL SCI, V121, P3062, DOI 10.1242/jcs.030643; Stephan A, 2007, TRAFFIC, V8, P1323, DOI 10.1111/j.1600-0854.2007.00611.x; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; VICKERMAN K, 1969, J CELL SCI, V5, P163; Wang ZF, 2002, EMBO J, V21, P4998, DOI 10.1093/emboj/cdf482; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1989, J CELL SCI, V93, P491; Zhao Z, 2008, EMBO J, V27, P143, DOI 10.1038/sj.emboj.7601956; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676; Zhou Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009660	45	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3489	3499		10.1074/jbc.M112.417428	http://dx.doi.org/10.1074/jbc.M112.417428			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235159	Green Published, hybrid			2022-12-28	WOS:000314397900054
J	Jadav, RS; Chanduri, MVL; Sengupta, S; Bhandari, R				Jadav, Rathan S.; Chanduri, Manasa V. L.; Sengupta, Sagar; Bhandari, Rashna			Inositol Pyrophosphate Synthesis by Inositol Hexakisphosphate Kinase 1 Is Required for Homologous Recombination Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX PROTEIN DBP5; GENE DELETION; HISTONE H2AX; PYROPHOSPHORYLATION; PHOSPHORYLATION; PHOSPHATE; BINDING; FORKS; GLE1	Inositol pyrophosphates, such as diphosphoinositol pentakisphosphate (IP7), are water-soluble inositol phosphates that contain high energy diphosphate moieties on the inositol ring. Inositol hexakisphosphate kinase 1 (IP6K1) participates in inositol pyrophosphate synthesis, converting inositol hexakisphosphate (IP6) to IP7. In the present study, we show that mouse embryonic fibroblasts (MEFs) lacking IP6K1 exhibit impaired DNA damage repair via homologous recombination (HR). IP6K1 knock-out MEFs show decreased viability and reduced recovery after induction of DNA damage by the replication stress inducer, hydroxyurea, or the radiomimetic antibiotic, neocarzinostatin. Cells lacking IP6K1 arrest after genotoxic stress, and markers associated with DNA repair are recruited to DNA damage sites, indicating that HR repair is initiated in these cells. However, repair does not proceed to completion because these markers persist as nuclear foci long after drug removal. A fraction of IP6K1-deficient MEFs continues to proliferate despite the persistence of DNA damage, rendering the cells more susceptible to chromosomal aberrations. Expression of catalytically active but not inactive IP6K1 can restore the repair process in knock-out MEFs, implying that inositol pyrophosphates are required for HR-mediated repair. Our study there fore highlights inositol pyrophosphates as novel small molecule regulators of HR signaling in mammals.	[Jadav, Rathan S.; Chanduri, Manasa V. L.; Bhandari, Rashna] Ctr DNA Fingerprinting & Diagnost, Lab Cell Signalling, Hyderabad 500001, Andhra Pradesh, India; [Sengupta, Sagar] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Bhandari, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Lab Cell Signalling, Bldg 7 Gurhakalpa,5-4-399-B Nampally, Hyderabad 500001, Andhra Pradesh, India.	rashna@cdfd.org.in	Sengupta, Sagar/AGR-1063-2022	Sengupta, Sagar/0000-0002-6365-1770; Bhandari, Rashna/0000-0003-3101-0204	Wellcome Trust/Department of Biotechnology India Alliance [500020/Z/09/Z]; Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India; Council of Scientific and Industrial Research; National Institute of Immunology; Department of Biotechnology (DBT), India [BT/PR11258/BRB/10/645/2008]; Department of Science and Technology (DST), India [SR/SO/BB-08/2010]; Indo-French Centre for the Promotion of Advanced Research (IFCPAR) [IFC/4603-A/2011/1250]; Council of Scientific and Industrial Research (CSIR), India [37(1541)/12/EMR-II]; Wellcome Trust/DBT India Alliance [500020/Z/09/Z]; DBT Innovative Young Biotechnologist Award [BT/BI/12/045/2008]	Wellcome Trust/Department of Biotechnology India Alliance(Wellcome Trust DBT India Alliance); Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); National Institute of Immunology; Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), India(Department of Science & Technology (India)); Indo-French Centre for the Promotion of Advanced Research (IFCPAR)(Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Wellcome Trust/DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance); DBT Innovative Young Biotechnologist Award	This work was supported by the Wellcome Trust/Department of Biotechnology India Alliance (500020/Z/09/Z (to R.B.)) and core funds from the Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India.; Recipients of Junior and Senior Research Fellowships of the Council of Scientific and Industrial Research toward the pursuit of a Ph. D. degree of the Manipal University.; Supported by National Institute of Immunology core funds; the Department of Biotechnology (DBT), India (Grant BT/PR11258/BRB/10/645/2008); the Department of Science and Technology (DST), India (Grant SR/SO/BB-08/2010); the Indo-French Centre for the Promotion of Advanced Research (IFCPAR) (Grant IFC/4603-A/2011/1250); and the Council of Scientific and Industrial Research (CSIR), India (Grant 37(1541)/12/EMR-II).; Supported by a Senior Fellowship from the Wellcome Trust/DBT India Alliance (500020/Z/09/Z); and the DBT Innovative Young Biotechnologist Award (Grant BT/BI/12/045/2008). To whom correspondence should be addressed: Laboratory of Cell Signalling, Centre for DNA Fingerprinting and Diagnostics, Bldg. 7 Gurhakalpa, 5-4-399/B Nampally, Hyderabad 500001, India. Tel.: 91-40-24749430; Fax: 91-40-24749448; E-mail: rashna@cdfd.org.in.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; Azevedo C, 2011, ADV ENZYME REGUL, V51, P74, DOI 10.1016/j.advenzreg.2010.08.003; Azevedo C, 2009, P NATL ACAD SCI USA, V106, P21161, DOI 10.1073/pnas.0909176106; Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Chakraborty A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001958; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HUANG KN, 1995, GENETICS, V141, P1275; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Lee YS, 2008, NAT CHEM BIOL, V4, P25, DOI 10.1038/nchembio.2007.52; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Morrison BH, 2009, ONCOGENE, V28, P2383, DOI 10.1038/onc.2009.113; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nagata E, 2005, J BIOL CHEM, V280, P1634, DOI 10.1074/jbc.M409416200; Onnebo SMN, 2009, BIOCHEM J, V423, P109, DOI 10.1042/BJ20090241; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Prasad A, 2011, NAT IMMUNOL, V12, P752, DOI 10.1038/ni.2052; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Scully R, 2000, ONCOGENE, V19, P6176, DOI 10.1038/sj.onc.1203971; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Shears SB, 2011, ADV ENZYME REGUL, V51, P13, DOI 10.1016/j.advenzreg.2010.09.008; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Tikoo Shweta, 2010, Genome Integr, V1, P14, DOI 10.1186/2041-9414-1-14; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Yoshihara T, 2004, EMBO J, V23, P670, DOI 10.1038/sj.emboj.7600087; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	44	33	36	0	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3312	3321		10.1074/jbc.M112.396556	http://dx.doi.org/10.1074/jbc.M112.396556			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255604	Green Published, hybrid			2022-12-28	WOS:000314397900037
J	Park, JH; Yoon, DS; Choi, HJ; Hahm, DH; Oh, SM				Park, Jung-Hwan; Yoon, Dae-Sung; Choi, Hye-Jin; Hahm, Dae-Hyun; Oh, Sang-Muk			Phosphorylation of I kappa B alpha at Serine 32 by T-lymphokine-activated Killer Cell-originated Protein Kinase Is Essential for Chemoresistance against Doxorubicin in Cervical Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ-BINDING KINASE; DNA-DAMAGE; MITOTIC KINASE; TOPK PHOSPHORYLATION; INDUCED APOPTOSIS; BREAST-CANCER; C-DELTA; EXPRESSION; INHIBITION; PATHWAY	T-lymphokine-activated killer cell-originated protein kinase (TOPK) is known to be up-regulated in cancer cells and appears to contribute to cancer cell proliferation and survival. However, the molecular mechanism by which TOPK regulates cancer cell survival still remains elusive. Here we show that TOPK directly interacted with and phosphorylated I kappa B alpha at Ser-32, leading to p65 nuclear translocation and NF-kappa B activation. We also revealed that doxorubicin promoted the interaction between nonphosphorylated or phosphorylated TOPK and I kappa B alpha and that TOPK-mediated I kappa B alpha phosphorylation was enhanced in response to doxorubicin. Also, exogenously overexpressed TOPK augmented transcriptional activity driven by either NF-kappa B or inhibitor of apoptosis protein 2 (cIAP2) promoters. On the other hand, NF-kappa B activity including I kappa B alpha phosphorylation and p65 nuclear translocation, as well as cIAP2 gene expression, was markedly diminished in TOPK knockdown HeLa cervical cancer cells. Moreover, doxorubicin-mediated apoptosis was noticeably increased in TOPK knockdown HeLa cells, compared with control cells, which resulted from caspase-dependent signaling pathways. These results demonstrate that TOPK is a molecular target of doxorubicin and mediates doxorubicin chemoresistance of HeLa cells, suggesting a novel mechanism for TOPK barrier of doxorubicin-mediated cervical cancer cell apoptosis.	[Park, Jung-Hwan; Choi, Hye-Jin; Oh, Sang-Muk] Konyang Univ, Dept Biochem, Coll Med, Taejon 302718, South Korea; [Yoon, Dae-Sung] Konyang Univ, Dept Surg, Coll Med, Konyang Hosp, Taejon 302718, South Korea; [Hahm, Dae-Hyun] Kyung Hee Univ, Coll Oriental Med, Acupuncture & Meridian Sci Res Ctr, Seoul 130701, South Korea	Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Kyung Hee University	Oh, SM (corresponding author), Konyang Univ, Dept Biochem, Coll Med, 685 Gasuwon Dong, Taejon 302718, South Korea.	sangmuk_oh@konyang.ac.kr		Park, Jung-hwan/0000-0002-8880-1149	Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0005899]; Konyang University Myunggok Research Fund	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Konyang University Myunggok Research Fund	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant 2010-0005899. This work was supported in part by Konyang University Myunggok Research Fund of 2009.	Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; Abe Y, 2007, J MOL BIOL, V370, P231, DOI 10.1016/j.jmb.2007.04.067; Bednarski BK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006992; Binaschi M, 1997, MOL PHARMACOL, V51, P1053, DOI 10.1124/mol.51.6.1053; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Christiansen S, 2006, EUR J CARDIO-THORAC, V30, P611, DOI 10.1016/j.ejcts.2006.06.024; Ehrhardt H, 2011, CLIN CANCER RES, V17, P7605, DOI 10.1158/1078-0432.CCR-11-0513; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; HENDERSON IC, 1979, NEW ENGL J MED, V300, P310, DOI 10.1056/NEJM197902083000610; Hu F, 2010, ONCOGENE, V29, P5464, DOI 10.1038/onc.2010.275; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Jimenez-Lara AM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-15; Juliger S, 2007, CANCER RES, V67, P10984, DOI 10.1158/0008-5472.CAN-07-0519; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; Kinsella AR, 1997, BRIT J CANCER, V75, P935, DOI 10.1038/bjc.1997.164; Kwon HR, 2010, BIOCHEM BIOPH RES CO, V391, P830, DOI 10.1016/j.bbrc.2009.11.147; Lee SA, 2007, J BIOL CHEM, V282, P15271, DOI 10.1074/jbc.M701362200; Li SQ, 2011, J BIOL CHEM, V286, P29601, DOI 10.1074/jbc.M111.225813; Li W, 2012, ONCOGENE, V31, P2412, DOI 10.1038/onc.2011.426; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Manna SK, 2011, J BIOL CHEM, V286, P7339, DOI 10.1074/jbc.M110.191916; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Nandi A, 2004, BLOOD CELL MOL DIS, V32, P240, DOI 10.1016/j.bcmd.2003.10.004; Oh SM, 2007, CANCER RES, V67, P5186, DOI 10.1158/0008-5472.CAN-06-4506; Panaretakis T, 2005, MOL BIOL CELL, V16, P3821, DOI 10.1091/mbc.E04-10-0862; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Sen GS, 2011, J BIOL CHEM, V286, P42232, DOI 10.1074/jbc.M111.262295; Simons-Evelyn M, 2001, BLOOD CELL MOL DIS, V27, P825, DOI 10.1006/bcmd.2001.0452; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Tapia MA, 2007, CELL CYCLE, V6, P2284, DOI 10.4161/cc.6.18.4721; Thoms HC, 2007, CANCER RES, V67, P1660, DOI 10.1158/0008-5472.CAN-06-1038; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10; Yoda A, 2008, J BIOL CHEM, V283, P18969, DOI 10.1074/jbc.M800560200; Zhao SH, 2001, INT J BIOCHEM CELL B, V33, P631, DOI 10.1016/S1357-2725(01)00005-X; Zhu F, 2007, GASTROENTEROLOGY, V133, P219, DOI 10.1053/j.gastro.2007.04.048; Zykova TA, 2010, J BIOL CHEM, V285, P29138, DOI 10.1074/jbc.M110.135905	40	23	24	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3585	3593		10.1074/jbc.M112.422170	http://dx.doi.org/10.1074/jbc.M112.422170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250755	hybrid, Green Published			2022-12-28	WOS:000314397900063
J	Mendelson, K; Zygmunt, T; Torres-Vazquez, J; Evans, T; Hla, T				Mendelson, Karen; Zygmunt, Tomasz; Torres-Vazquez, Jesus; Evans, Todd; Hla, Timothy			Sphingosine 1-Phosphate Receptor Signaling Regulates Proper Embryonic Vascular Patterning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; GENOME DUPLICATION; PROGENITOR CELLS; SPHINGOSINE-1-PHOSPHATE; ZEBRAFISH; MIGRATION; ANGIOGENESIS; METABOLISM; CADHERIN; BLOOD	Sphingosine 1-phosphate (S1P) binds G-protein-coupled receptors (S1P(1-5)) to regulate a multitude of physiological effects, especially those in the vascular and immune systems. S1P receptors in the vascular system have been characterized primarily in mammals. Here, we report that the S1P receptors and metabolic enzymes are conserved in the genome of zebrafish Danio rerio. Bioinformatic analysis identified seven S1P receptor-like sequences in the zebrafish genome, including duplicated orthologs of receptors 3 and 5. Sphingolipidomic analysis detected erythrocyte and plasma S1P as well as high plasma ceramides and sphingosine. Morpholino-mediated knockdown of s1pr1 causes global and pericardial edema, loss of blood circulation, and vascular defects characterized by both reduced vascularization in intersegmental vessels, decreased proliferation of intersegmental and axial vessels, and hypersprouting in the caudal vein plexus. The s1pr2 gene was previously characterized as a regulator of cell migration and heart development, but its role in angiogenesis is not known. However, when expression of both s1pr1 and s1pr2 is suppressed, severely reduced vascular development of the intersegmental vessels was observed with doses of the s1pr1 morpholino that alone did not cause any discernible vascular defects, suggesting that s1pr1 and s1pr2 function cooperatively to regulate vascular development in zebrafish. Similarly, the S1P transporter, spns2, also cooperated with s1pr1. We propose that extracellular S1P acts through vascular S1P receptors to regulate vascular development.	[Mendelson, Karen; Hla, Timothy] Cornell Univ, Weill Cornell Med Coll, Ctr Vasc Biol, Dept Pathol & Lab Med, New York, NY 10021 USA; [Evans, Todd] Cornell Univ, Dept Surg, Weill Cornell Med Coll, New York, NY 10021 USA; [Zygmunt, Tomasz; Torres-Vazquez, Jesus] NYU, Sch Med, Dept Cell Biol,Skirball Inst, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA	Cornell University; Cornell University; New York University	Evans, T (corresponding author), Cornell Univ, Dept Surg, Weill Cornell Med Coll, 1300 York Ave, New York, NY 10021 USA.	tre2003@med.cornell.edu; tih2002@med.cornell.edu	; Hla, Timothy/G-5873-2012	Torres-Vazquez, Jesus/0000-0002-3808-3978; Hla, Timothy/0000-0001-8355-4065	National Institutes of Health from the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; National Institutes of Health COBRE Grant from the Lipidomics Core, South Carolina Lipidomics and Pathobiology [P20 RR017677]; National Institutes of Health from NHLBI [T32HL083824, HL092263-01A1, HL056182, HL111400, HL67330, HL89934, HL70694]; Office of the Director of the National Institutes of Health through NCRR [C06 RR018823]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677, C06RR018823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083824, R01HL089934, R37HL067330, R37HL056182, P01HL070694, R01HL067330, R01HL056182, R01HL111400, R01HL092263] Funding Source: NIH RePORTER	National Institutes of Health from the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina; National Institutes of Health COBRE Grant from the Lipidomics Core, South Carolina Lipidomics and Pathobiology; National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of the Director of the National Institutes of Health through NCRR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Sphingolipid measurements were supported by National Institutes of Health Grant P30 CA138313 from the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina and by National Institutes of Health COBRE Grant P20 RR017677 from the Lipidomics Core, South Carolina Lipidomics and Pathobiology.; This work was supported, in whole or in part, by National Institutes of Health Grants T32HL083824 (to K. M.), HL092263-01A1 (to J. T.-V.), HL056182, and HL111400 (to T. E.), and HL67330, HL89934, and HL70694 (to T. H.) from NHLBI and Grant C06 RR018823 from Office of the Director of the National Institutes of Health through NCRR.	Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.3.CO;2-T; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Choi J, 2011, DEVELOPMENT, V138, P1173, DOI 10.1242/dev.054049; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Graler MH, 1998, GENOMICS, V53, P164, DOI 10.1006/geno.1998.5491; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hla T, 2005, PROSTAG OTH LIPID M, V77, P197, DOI 10.1016/j.prostaglandins.2005.06.008; HLA T, 1990, J BIOL CHEM, V265, P9308; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Im DS, 2001, BIOCHEMISTRY-US, V40, P14053, DOI 10.1021/bi011606i; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Kai M, 2008, DEVELOPMENT, V135, P3043, DOI 10.1242/dev.020396; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Kono M, 2007, J BIOL CHEM, V282, P10690, DOI 10.1074/jbc.M700370200; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liu CH, 1997, GENOMICS, V43, P15, DOI 10.1006/geno.1997.4759; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Malek RL, 2001, J BIOL CHEM, V276, P5692, DOI 10.1074/jbc.M003964200; Matsui Takaaki, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS77, DOI 10.1038/ncpcardio0764; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pedroso GL, 2012, JOVE-J VIS EXP, DOI 10.3791/3865; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; SCHMELZ EM, 1994, J NUTR, V124, P702, DOI 10.1093/jn/124.5.702; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tobia C, 2012, ARTERIOSCL THROM VAS, V32, pE104, DOI 10.1161/ATVBAHA.112.250035; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007	42	58	60	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2143	2156		10.1074/jbc.M112.427344	http://dx.doi.org/10.1074/jbc.M112.427344			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229546	Green Published, hybrid			2022-12-28	WOS:000314211500005
J	Arlinghaus, FT; Eble, JA				Arlinghaus, Franziska T.; Eble, Johannes A.			The Collagen-binding Integrin alpha 2 beta 1 Is a Novel Interaction Partner of the Trimeresurus flavoviridis Venom Protein Flavocetin-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; HIGH-MOLECULAR-MASS; VONWILLEBRAND-FACTOR; PLATELET-ADHESION; RHODOCETIN; GPIB; PURIFICATION; INHIBITOR; ECHICETIN; TARGET	Many snake venoms are known for their antithrombotic activity. They contain components that specifically target different platelet-activating receptors such as the collagen-binding integrin alpha 2 beta 1 and the von Willebrand factor receptor GPIb. In a search for an alpha 2 beta 1 integrin-blocking component from the venom of the habu snake (Trimeresurus flavoviridis), we employed two independent purification protocols. First, we used the integrin alpha 2A domain, a major collagen-binding domain, as bait for affinity purification of an alpha 2 beta 1 integrin-binding toxin from the crude venom. Second, in parallel, we used classical protein separation protocols and tested for alpha 2 beta 1 integrin-inhibiting capabilities by ELISA. Using both approaches, we identified flavocetin-A as an inhibitor of alpha 2 beta 1 integrin. Hitherto, flavocetin-A has been reported as a GPIb inhibitor. However, flavocetin-A inhibited collagen-induced platelet aggregation even after GPIb was blocked with other inhibitors. Moreover, flavocetin-A antagonized alpha 2 beta 1 integrin-mediated adhesion and migration of HT1080 human fibrosarcoma cells, which lack any GPIb, on collagen. Protein chemical analyses proved that flavocetin-A binds to alpha 2 beta 1 integrin and its alpha 2A domain with high affinity and in a cooperative manner, which most likely is due to its quaternary structure. Kinetic measurements confirmed the formation of a strong complex between integrin and flavocetin-A, which dissociates very slowly. This study proves that flavocetin-A, which has long been known as a GPIb inhibitor, efficiently targets alpha 2 beta 1 integrin and thus blocks collagen-induced platelet activation. Moreover, our findings suggest that the separation of GPIb-and alpha 2 beta 1 integrin-blocking members within the C-type lectin-related protein family is less strict than previously assumed.	[Arlinghaus, Franziska T.; Eble, Johannes A.] Frankfurt Univ Hosp, Dept Vasc Matrix Biol, Ctr Mol Med, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Eble, JA (corresponding author), Frankfurt Univ Hosp, Dept Vasc Matrix Biol, Ctr Mol Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	eble@med.uni-frankfurt.de						ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8317, DOI 10.1021/bi00447a009; Arlinghaus FT, 2012, TOXICON, V60, P512, DOI 10.1016/j.toxicon.2012.03.001; CANFIELD VA, 1987, BIOCHEM BIOPH RES CO, V147, P526, DOI 10.1016/0006-291X(87)90963-6; Clemetson KJ, 2008, THROMB HAEMOSTASIS, V99, P473, DOI 10.1160/TH07-12-0718; Clemetson KJ, 2010, TOXICON, V56, P1236, DOI 10.1016/j.toxicon.2010.03.011; Clemetson KJ, 2001, HAEMOSTASIS, V31, P148; Du XY, 2001, THROMB HAEMOSTASIS, V86, P1277, DOI 10.1055/s-0037-1616062; Eble JA, 2005, CURR PHARM DESIGN, V11, P867, DOI 10.2174/1381612053381738; Eble JA, 2002, MATRIX BIOL, V21, P547, DOI 10.1016/S0945-053X(02)00068-9; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; Eble JA, 2009, FASEB J, V23, P2917, DOI 10.1096/fj.08-126763; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Fukuda K, 2000, BIOCHEMISTRY-US, V39, P1915, DOI 10.1021/bi992134z; Fukuda K, 1999, ACTA CRYSTALLOGR D, V55, P1911, DOI 10.1107/S0907444999009622; Hamako J, 1996, BIOCHEM BIOPH RES CO, V226, P273, DOI 10.1006/bbrc.1996.1345; Marcinkiewicz C, 2000, BIOCHEMISTRY-US, V39, P9859, DOI 10.1021/bi000428a; Morita T, 2005, TOXICON, V45, P1099, DOI 10.1016/j.toxicon.2005.02.021; Navdaev A, 2001, BLOOD, V97, P2333, DOI 10.1182/blood.V97.8.2333; Nuyttens BP, 2011, THROMB RES, V127, pS26, DOI 10.1016/S0049-3848(10)70151-1; PENG ML, 1991, BIOCHEMISTRY-US, V30, P11529, DOI 10.1021/bi00113a007; PENG ML, 1993, BLOOD, V81, P2321; SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0; Staniszewska I, 2009, CANCER BIOL THER, V8, P1507, DOI 10.4161/cbt.8.15.8999; TANIUCHI Y, 1995, BBA-GEN SUBJECTS, V1244, P331, DOI 10.1016/0304-4165(95)00052-D; Taniuchi Y, 2000, THROMB RES, V97, P69, DOI 10.1016/S0049-3848(99)00143-7	25	11	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					947	955		10.1074/jbc.M112.399618	http://dx.doi.org/10.1074/jbc.M112.399618			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23204528	hybrid, Green Published			2022-12-28	WOS:000313570300019
J	Quy, PN; Kuma, A; Pierre, P; Mizushima, N				Pham Nguyen Quy; Kuma, Akiko; Pierre, Philippe; Mizushima, Noboru			Proteasome-dependent Activation of Mammalian Target of Rapamycin Complex 1 (mTORC1) Is Essential for Autophagy Suppression and Muscle Remodeling Following Denervation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; AMINO-ACIDS; PROTEIN; GROWTH; DEGRADATION; METABOLISM; PATHWAY; HYPERTROPHY; INHIBITION; GLUTAMINE	Drastic protein degradation occurs during muscle atrophy induced by denervation, fasting, immobility, and various systemic diseases. Although the ubiquitin-proteasome system is highly up-regulated in denervated muscles, the involvement of autophagy and protein synthesis has been controversial. Here, we report that autophagy is rather suppressed in denervated muscles even under autophagy-inducible starvation conditions. This is due to a constitutive activation of mammalian target of rapamycin complex 1 (mTORC1). We further reveal that denervation-induced mTORC1 activation is dependent on the proteasome, which is likely mediated by amino acids generated from proteasomal degradation. Protein synthesis and ribosome biogenesis are paradoxically increased in denervated muscles in an mTORC1-dependent manner, and mTORC1 activation plays an anabolic role against denervation-induced muscle atrophy. These results suggest that denervation induces not only muscle degradation but also adaptive muscle response in a proteasome- and mTORC1-dependent manner.	[Pham Nguyen Quy; Kuma, Akiko; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Pierre, Philippe] Aix Marseille Univ, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Pierre, Philippe] INSERM, U1104, F-13288 Marseille, France; [Pierre, Philippe] CNRS, UMR 7280, F-13288 Marseille, France; [Mizushima, Noboru] Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Bunkyo Ku, Tokyo 1130033, Japan; [Mizushima, Noboru] Univ Tokyo, Fac Med, Tokyo 1130033, Japan	Tokyo Medical & Dental University (TMDU); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Tokyo; University of Tokyo	Mizushima, N (corresponding author), Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nmizu@m.u-tokyo.ac.jp	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; pierre, philippe/0000-0003-0863-8255	Ministry of Education, Culture, Sports, Science and Technology, Japan; Funding Program for Next Generation World-Leading Researchers	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the Funding Program for Next Generation World-Leading Researchers (to N. M.).	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Argadine HM, 2011, AM J PHYSIOL-CELL PH, V300, pC318, DOI 10.1152/ajpcell.00172.2010; Argadine HM, 2009, J APPL PHYSIOL, V107, P438, DOI 10.1152/japplphysiol.91247.2008; Batt J, 2005, FASEB J, V19, P115, DOI 10.1096/fj.04-3640fje; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; CHANG TW, 1978, J BIOL CHEM, V253, P3685; DAVIS TA, 1988, BIOCHEM J, V254, P667, DOI 10.1042/bj2540667; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; FURUNO K, 1990, J BIOL CHEM, V265, P8550; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; GOLDSPINK DF, 1976, BIOCHEM J, V156, P71, DOI 10.1042/bj1560071; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Hornberger TA, 2001, AM J PHYSIOL-CELL PH, V281, pC179, DOI 10.1152/ajpcell.2001.281.1.C179; Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; KING PA, 1983, BIOCHEM J, V216, P523, DOI 10.1042/bj2160523; Kostrominova TY, 2005, PHYSIOL GENOMICS, V22, P227, DOI 10.1152/physiolgenomics.00210.2004; Koyama S, 2008, J MOL BIOL, V376, P1224, DOI 10.1016/j.jmb.2007.11.049; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Machida M, 2012, J CELL PHYSIOL, V227, P1569, DOI 10.1002/jcp.22871; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Murakami M, 2008, DEV GROWTH DIFFER, V50, P121, DOI [10.1111/j.1440-169x.2007.00982.x, 10.1111/j.1440-169X.2007.00982.x]; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sadiq F, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-23; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sun HL, 2012, MOL CELL BIOCHEM, V364, P193, DOI 10.1007/s11010-011-1218-2; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; TANAKA K, 1986, J BIOL CHEM, V261, P5197; TURINSKY J, 1990, AM J PHYSIOL, V258, pE485, DOI 10.1152/ajpendo.1990.258.3.E485; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	76	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1125	1134		10.1074/jbc.M112.399949	http://dx.doi.org/10.1074/jbc.M112.399949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23209294	Green Published, hybrid			2022-12-28	WOS:000313570300035
J	Longstaff, C; Varju, I; Sotonyi, P; Szabo, L; Krumrey, M; Hoell, A; Bota, A; Varga, Z; Komorowicz, E; Kolev, K				Longstaff, Colin; Varju, Imre; Sotonyi, Peter; Szabo, Laszlo; Krumrey, Michael; Hoell, Armin; Bota, Attila; Varga, Zoltan; Komorowicz, Erzsebet; Kolev, Krasimir			Mechanical Stability and Fibrinolytic Resistance of Clots Containing Fibrin, DNA, and Histones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; DEEP-VEIN THROMBOSIS; INNATE IMMUNITY; PLASMINOGEN; PLATELET; GENERATION; RELEASE; LYSIS	Neutrophil extracellular traps are networks of DNA and associated proteins produced by nucleosome release from activated neutrophils in response to infection stimuli and have recently been identified as key mediators between innate immunity, inflammation, and hemostasis. The interaction of DNA and histones with a number of hemostatic factors has been shown to promote clotting and is associated with increased thrombosis, but little is known about the effects of DNA and histones on the regulation of fibrin stability and fibrinolysis. Here we demonstrate that the addition of histone-DNA complexes to fibrin results in thicker fibers (increase in median diameter from 84 to 123 nm according to scanning electron microscopy data) accompanied by improved stability and rigidity (the critical shear stress causing loss of fibrin viscosity increases from 150 to 376 Pa whereas the storage modulus of the gel increases from 62 to 82 pascals according to oscillation rheometric data). The effects of DNA and histones alone are subtle and suggest that histones affect clot structure whereas DNA changes the way clots are lysed. The combination of histones + DNA significantly prolongs clot lysis. Isothermal titration and confocal microscopy studies suggest that histones and DNA bind large fibrin degradation products with 191 and 136 nM dissociation constants, respectively, interactions that inhibit clot lysis. Heparin, which is known to interfere with the formation of neutrophil extracellular traps, appears to prolong lysis time at a concentration favoring ternary histone-DNA-heparin complex formation, and DNase effectively promotes clot lysis in combination with tissue plasminogen activator.	[Longstaff, Colin] Natl Inst Biol Stand & Controls, Haemostasis Sect, Potters Bar EN6 3QG, Herts, England; [Varju, Imre; Komorowicz, Erzsebet; Kolev, Krasimir] Semmelweis Univ, Dept Med Biochem, H-1094 Budapest, Hungary; [Sotonyi, Peter] Semmelweis Univ, Dept Vasc Surg, H-1122 Budapest, Hungary; [Szabo, Laszlo] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Mat & Environm Chem, H-1025 Budapest, Hungary; [Bota, Attila; Varga, Zoltan] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Mol Pharmacol, Dept Biol Nanochem, H-1025 Budapest, Hungary; [Krumrey, Michael] PTB, D-10587 Berlin, Germany; [Hoell, Armin] HZB, D-14109 Berlin, Germany	National Institute for Biological Standards & Control; Semmelweis University; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Physikalisch-Technische Bundesanstalt (PTB); Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Longstaff, C (corresponding author), Natl Inst Biol Stand & Controls, Biotherapeut Grp, S Mimms EN6 3QG, Herts, England.	colin.longstaff@nibsc.hpa.org.uk	Longstaff, Colin/D-2413-2013; Kolev, Krasimir/J-7648-2019; Krumrey, Michael/G-6295-2011; Kolev, Krasimir/A-3517-2008; Varga, Zoltan/C-5215-2008	Longstaff, Colin/0000-0001-7608-208X; Kolev, Krasimir/0000-0002-5612-004X; Krumrey, Michael/0000-0001-9591-5462; Kolev, Krasimir/0000-0002-5612-004X; Hoell, Armin/0000-0002-7080-8393; Varga, Zoltan/0000-0002-5741-2669	Wellcome Trust [083174]; Hungarian Scientific Research Fund [OTKA 75430, 83023]; German Academic Exchange Service [DAAD A/12/01760]	Wellcome Trust(Wellcome TrustEuropean Commission); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Wellcome Trust Grant 083174, Hungarian Scientific Research Fund Grants OTKA 75430 and 83023, and German Academic Exchange Service Grant DAAD A/12/01760.	Ammollo CT, 2011, J THROMB HAEMOST, V9, P1795, DOI 10.1111/j.1538-7836.2011.04422.x; Aziz RK, 2004, MOL MICROBIOL, V54, P184, DOI 10.1111/j.1365-2958.2004.04255.x; Borissoff JI, 2011, J THROMB HAEMOST, V9, P1791, DOI 10.1111/j.1538-7836.2011.04425.x; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Esmon CT, 2011, J THROMB HAEMOST, V9, P182, DOI 10.1111/j.1538-7836.2011.04323.x; Esmon CT, 2009, BLOOD REV, V23, P225, DOI 10.1016/j.blre.2009.07.002; Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gleber G, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012027; Guthold M, 2004, BIOPHYS J, V87, P4226, DOI 10.1529/biophysj.104.042333; Komissarov AA, 2011, J BIOL CHEM, V286, P41949, DOI 10.1074/jbc.M111.301218; Komorowicz E, 1998, BIOCHEMISTRY-US, V37, P9112, DOI 10.1021/bi980180d; Longstaff C, 2004, J THROMB HAEMOST, V2, P1416, DOI 10.1111/j.1538-7836.2004.00816.x; Longstaff C, 2011, BLOOD, V117, P661, DOI 10.1182/blood-2010-06-290338; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; R Development Core Team, 2011, R PROGR STAT COMP; Rabai G, 2010, THROMB RES, V126, pE94, DOI 10.1016/j.thromres.2010.05.007; RACZ Z, 1993, BIOMED TECH, V38, P266; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Ruf W, 2010, NAT MED, V16, P851, DOI 10.1038/nm0810-851; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Saha P, 2011, ARTERIOSCL THROM VAS, V31, P506, DOI 10.1161/ATVBAHA.110.213405; Sands D, 2002, THROMB HAEMOSTASIS, V88, P294; SCRUTTON MC, 1994, BLOOD COAGUL FIBRIN, V5, P719, DOI 10.1097/00001721-199410000-00007; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Silva MMCG, 2012, J THROMB HAEMOST, V10, P2354, DOI 10.1111/j.1538-7836.2012.04925.x; Smeeth L, 2006, LANCET, V367, P1075, DOI 10.1016/S0140-6736(06)68474-2; Tenekedjiev K., 2012, THEORY APPL MONTE CA; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Weisel J. W., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P161, DOI 10.2174/187152508784871963; WEISEL JW, 1986, J ULTRA MOL STRUCT R, V96, P176, DOI 10.1016/0889-1605(86)90019-4; Wohner N, 2010, J THROMB HAEMOST, V8, P1624, DOI 10.1111/j.1538-7836.2010.03890.x; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yang Z, 2000, P NATL ACAD SCI USA, V97, P14156, DOI 10.1073/pnas.97.26.14156; Yeromonahos C, 2010, BIOPHYS J, V99, P2018, DOI 10.1016/j.bpj.2010.04.059	37	162	164	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6946	6956		10.1074/jbc.M112.404301	http://dx.doi.org/10.1074/jbc.M112.404301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23293023	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000316002400017
J	Santosa, V; Martha, S; Hirose, N; Tanaka, K				Santosa, Venny; Martha, Sabrina; Hirose, Noriaki; Tanaka, Katsunori			The Fission Yeast Minichromosome Maintenance (MCM)-binding Protein (MCM-BP), Mcb1, Regulates MCM Function during Prereplicative Complex Formation in DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE; CELL-CYCLE; GENE; IDENTIFICATION; CHECKPOINT; ORIGINS; LOCALIZATION; INITIATION; PROMOTES; FAMILY	The minichromosome maintenance (MCM) complex is a replicative helicase, which is essential for chromosome DNA replication. In recent years, the identification of a novel MCM-binding protein (MCM-BP) in most eukaryotes has led to numerous studies investigating its function and its relationship to the MCM complex. However, the mechanisms by which MCM-BP functions and associates with MCM complexes are not well understood; in addition, the functional role of MCM-BP remains controversial and may vary between model organisms. The present study aims to elucidate the nature and biological function of the MCM-BP ortholog, Mcb1, in fission yeast. The Mcb1 protein continuously interacts with MCM proteins during the cell cycle in vivo and can interact with any individual MCM subunit in vitro. To understand the detailed characteristics of mcb1(+), two temperature-sensitive mcb1 gene mutants (mcb1(ts)) were isolated. Extensive genetic analysis showed that the mcb1(ts) mutants were suppressed by a mcm5(+) multicopy plasmid and displayed synthetic defects with many S-phase-related gene mutants. Moreover, cyclin-dependent kinase modulation by Cig2 repression or Rum1 overproduction suppressed the mcb1(ts) mutants, suggesting the involvement of Mcb1 in pre-RC formation during DNA replication. These data are consistent with the observation that Mcm7 loading onto replication origins is reduced and S-phase progression is delayed in mcb1(ts) mutants. Furthermore, the mcb1(ts) mutation led to the redistribution of MCM subunits to the cytoplasm, and this redistribution was dependent on an active nuclear export system. These results strongly suggest that Mcb1 promotes efficient pre-RC formation during DNA replication by regulating the MCM complex.	[Santosa, Venny; Martha, Sabrina; Hirose, Noriaki; Tanaka, Katsunori] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Hyogo 6691337, Japan; [Santosa, Venny; Tanaka, Katsunori] Kwansei Gakuin Univ, Sch Sci & Technol, Res Ctr Environm Biosci, Sanda, Hyogo 6691337, Japan	Kwansei Gakuin University; Kwansei Gakuin University	Tanaka, K (corresponding author), Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	katsunori@kwansei.ac.jp	Tanaka, Katsunori/F-8086-2010	Tanaka, Katsunori/0000-0001-9692-0968	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science and the Support Project to Assist Private Universities in Developing Bases for Research by the Ministry of Education, Culture, Sports, Science, and Technology (to K. T.).	Bailis JM, 2008, MOL CELL BIOL, V28, P1724, DOI 10.1128/MCB.01717-07; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Benito J, 1998, EMBO J, V17, P482, DOI 10.1093/emboj/17.2.482; Bochman ML, 2010, NUCLEIC ACIDS RES, V38, P6078, DOI 10.1093/nar/gkq422; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Ding L, 2011, J BIOL CHEM, V286, P32918, DOI 10.1074/jbc.M111.282541; Ferguson RL, 2010, J CELL SCI, V123, P2743, DOI 10.1242/jcs.073098; Forbes KC, 1998, GENETICS, V150, P1361; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Fukuura M, 2011, MOL BIOL CELL, V22, P2620, DOI 10.1091/mbc.E10-12-0995; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Grallert B, 2000, J CELL SCI, V113, P1447; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Jagannathan M, 2012, J CELL SCI, V125, P133, DOI 10.1242/jcs.089938; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Johnson EM, 2003, NUCLEIC ACIDS RES, V31, P2915, DOI 10.1093/nar/gkg395; Kanter DM, 2008, J BIOL CHEM, V283, P31172, DOI 10.1074/jbc.M804686200; Kato H, 2008, CELL CYCLE, V7, P1085; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; Kawamukai M, 1999, BBA-GENE STRUCT EXPR, V1446, P93, DOI 10.1016/S0167-4781(99)00071-8; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Kumada K, 1996, MOL GEN GENET, V250, P59, DOI 10.1007/s004380050051; Kunnev D, 2010, ONCOGENE, V29, P3630, DOI 10.1038/onc.2010.125; LABIB K, 1995, J CELL SCI, V108, P3285; Li JJ, 2011, FEBS LETT, V585, P3850, DOI 10.1016/j.febslet.2011.10.033; Liang DT, 1999, J CELL SCI, V112, P559; Lopez-Girona A, 1998, MOL BIOL CELL, V9, P63, DOI 10.1091/mbc.9.1.63; Lutzmann M, 2005, GENE, V362, P51, DOI 10.1016/j.gene.2005.07.031; Lutzmann M, 2012, MOL CELL, V47, P523, DOI 10.1016/j.molcel.2012.05.048; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Maki K, 2011, J BIOL CHEM, V286, P41701, DOI 10.1074/jbc.M111.285619; Martin-Castellanos C, 1996, Prog Cell Cycle Res, V2, P29; Mondesert O, 1996, MOL CELL BIOL, V16, P1527; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakajima R, 2002, MOL BIOL CELL, V13, P1462, DOI 10.1091/mbc.02-01-0006; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Nishimura K, 2012, MOL CELL, V47, P511, DOI 10.1016/j.molcel.2012.05.047; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Nitani N, 2006, GENETICS, V174, P155, DOI 10.1534/genetics.106.060053; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Pasion SG, 1999, MOL BIOL CELL, V10, P4043, DOI 10.1091/mbc.10.12.4043; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sakwe AM, 2007, MOL CELL BIOL, V27, P3044, DOI 10.1128/MCB.02384-06; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; SAZER S, 1990, J CELL SCI, V97, P509; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; Takahashi N, 2008, EMBO J, V27, P1840, DOI 10.1038/emboj.2008.107; Takahashi N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000817; Takeda T, 1999, MOL CELL BIOL, V19, P5535; Nguyen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035931; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; WOODS A, 1989, J CELL SCI, V93, P491; Yamada Y, 2004, MOL BIOL CELL, V15, P3740, DOI 10.1091/mbc.E04-04-0292; Yoshida K, 2005, BIOCHEM BIOPH RES CO, V331, P669, DOI 10.1016/j.bbrc.2005.03.222	65	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6864	6880		10.1074/jbc.M112.432393	http://dx.doi.org/10.1074/jbc.M112.432393			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23322785	Green Published, hybrid			2022-12-28	WOS:000316002400008
J	Cheriyan, M; Pedamallu, CS; Tori, K; Perler, F				Cheriyan, Manoj; Pedamallu, Chandra Sekhar; Tori, Kazuo; Perler, Francine			Faster Protein Splicing with the Nostoc punctiforme DnaE Intein Using Non-native Extein Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL CLEAVAGE ACTIVITY; TUBERCULOSIS-RECA INTEIN; SPLIT INTEINS; MYCOBACTERIUM-TUBERCULOSIS; HIGHLY EFFICIENT; SYSTEM; COMMON	Inteins are naturally occurring intervening sequences that catalyze a protein splicing reaction resulting in intein excision and concatenation of the flanking polypeptides (exteins) with a native peptide bond. Inteins display a diversity of catalytic mechanisms within a highly conserved fold that is shared with hedgehog autoprocessing proteins. The unusual chemistry of inteins has afforded powerful biotechnology tools for controlling enzyme function upon splicing and allowing peptides of different origins to be coupled in a specific, time-defined manner. The extein sequences immediately flanking the intein affect splicing and can be defined as the intein substrate. Because of the enormous potential complexity of all possible flanking sequences, studying intein substrate specificity has been difficult. Therefore, we developed a genetic selection for splicing-dependent kanamycin resistance with no significant bias when six amino acids that immediately flanked the intein insertion site were randomized. We applied this selection to examine the sequence space of residues flanking the Nostoc punctiforme Npu DnaE intein and found that this intein efficiently splices a much wider range of sequences than previously thought, with little N-extein specificity and only two important C-extein positions. The novel selected extein sequences were sufficient to promote splicing in three unrelated proteins, confirming the generalizable nature of the specificity data and defining new potential insertion sites for any target. Kinetic analysis showed splicing rates with the selected exteins that were as fast or faster than the native extein, refuting past assumptions that the naturally selected flanking extein sequences are optimal for splicing.	[Cheriyan, Manoj; Pedamallu, Chandra Sekhar; Tori, Kazuo; Perler, Francine] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Perler, F (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	pcs.murali@gmail.com; hiris5211@yahoo.co.jp; perler@neb.com	Pedamallu, Chandra Sekhar/AAV-6745-2020; Pedamallu, Chandra Sekhar/AAV-6723-2020					Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Appleby-Tagoe JH, 2011, J BIOL CHEM, V286, P34440, DOI 10.1074/jbc.M111.277350; Carvajal-Vallejos P, 2012, J BIOL CHEM, V287, P28686, DOI 10.1074/jbc.M112.372680; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalgaard JZ, 1997, J COMPUT BIOL, V4, P193, DOI 10.1089/cmb.1997.4.193; Daugelat S, 1999, PROTEIN SCI, V8, P644; Flavell RR, 2009, ACCOUNTS CHEM RES, V42, P107, DOI 10.1021/ar800129c; Fong BA, 2010, TRENDS BIOTECHNOL, V28, P272, DOI 10.1016/j.tibtech.2010.02.003; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gangopadhyay JP, 2003, BBA-GEN SUBJECTS, V1619, P193, DOI 10.1016/S0304-4165(02)00495-6; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Lew BM, 2002, GENE, V282, P169, DOI 10.1016/S0378-1119(01)00836-8; Lockless SW, 2009, P NATL ACAD SCI USA, V106, P10999, DOI 10.1073/pnas.0902964106; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Oeemig JS, 2012, J MOL BIOL, V421, P85, DOI 10.1016/j.jmb.2012.04.029; Oeemig JS, 2009, FEBS LETT, V583, P1451, DOI 10.1016/j.febslet.2009.03.058; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Shah NH, 2012, J AM CHEM SOC, V134, P11338, DOI 10.1021/ja303226x; Shemella PT, 2011, BIOPHYS J, V100, P2217, DOI 10.1016/j.bpj.2011.02.037; Shi JX, 2005, J AM CHEM SOC, V127, P6198, DOI 10.1021/ja042287w; Tori K, 2012, BIOCHEMISTRY-US, V51, P2496, DOI 10.1021/bi201840k; Tori K, 2010, J BIOL CHEM, V285, P2515, DOI 10.1074/jbc.M109.069567; Volkmann G, 2010, MOL BIOSYST, V6, P2110, DOI 10.1039/c0mb00034e; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003	28	73	79	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6202	6211		10.1074/jbc.M112.433094	http://dx.doi.org/10.1074/jbc.M112.433094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23306197	hybrid, Green Published			2022-12-28	WOS:000315820700016
J	van de Kooij, B; Verbrugge, I; de Vries, E; Gijsen, M; Montserrat, V; Maas, C; Neefjes, J; Borst, J				van de Kooij, Bert; Verbrugge, Inge; de Vries, Evert; Gijsen, Merel; Montserrat, Veronica; Maas, Chiel; Neefjes, Jacques; Borst, Jannie			Ubiquitination by the Membrane-associated RING-CH-8 (MARCH-8) Ligase Controls Steady-state Cell Surface Expression of Tumor Necrosis Factor-related Apoptosis Inducing Ligand (TRAIL) Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; DENDRITIC CELLS; DOWN-REGULATION; PROTEASOMAL ACTIVITY; E3 LIGASES; C-MIR; DEGRADATION; ENDOCYTOSIS; ACTIVATION; PROTEINS	The eleven members of the membrane-associated RING-CH (MARCH) ubiquitin ligase family are relatively unexplored. Upon exogenous (over) expression, a number of these ligases can affect the trafficking of membrane molecules. However, only for MARCH-1 endogenous functions have been demonstrated. For the other endogenous MARCH proteins, no functions or substrates are known. We report here that TRAIL-R1 is a physiological substrate of the endogenous MARCH-8 ligase. Human TRAIL-R1 and R2 play a role in immunosurveillance and are targets for cancer therapy, because they selectively induce apoptosis in tumor cells. We demonstrate that TRAIL-R1 is down-regulated from the cell surface, with great preference over TRAIL-R2, by exogenous expression of MARCH ligases that are implicated in endosomal trafficking, such as MARCH-1 and -8. MARCH-8 attenuated TRAIL-R1 cell surface expression and apoptosis signaling by virtue of its ligase activity. This suggested that ubiquitination of TRAIL-R1 was instrumental in its down-regulation by MARCH-8. Indeed, in cells with endogenous MARCH expression, TRAIL-R1 was ubiquitinated at steady-state, with the conserved membrane proximal lysine 273 as one of the potential acceptor sites. This residue was also essential for the interaction of TRAIL-R1 with MARCH-1 and MARCH-8 and its down-regulation by these ligases. Gene silencing identified MARCH-8 as the endogenous ligase that ubiquitinates TRAIL-R1 and attenuates its cell surface expression. These findings reveal that endogenous MARCH-8 regulates the steady-state cell surface expression of TRAIL-R1.	[van de Kooij, Bert; Verbrugge, Inge; de Vries, Evert; Gijsen, Merel; Maas, Chiel; Borst, Jannie] Netherlands Canc Inst Antoni van Leeuwenhoek, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Montserrat, Veronica; Neefjes, Jacques] Netherlands Canc Inst Antoni van Leeuwenhoek, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Borst, J (corresponding author), Netherlands Canc Inst Antoni van Leeuwenhoek, Div Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.borst@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Borst, Jannie/0000-0002-8043-5009	Dutch Cancer Society [NKI 2004-3079, NKI 2008-4110]; Netherlands Organization for Scientific Research [ECHO 700.57.008]	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Grants NKI 2004-3079 and NKI 2008-4110 from the Dutch Cancer Society and Grant ECHO 700.57.008 from the Netherlands Organization for Scientific Research (to J. B.).	Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Austin CD, 2006, P NATL ACAD SCI USA, V103, P10283, DOI 10.1073/pnas.0604044103; Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bartee E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015132; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen R, 2012, P NATL ACAD SCI USA, V109, P14128, DOI 10.1073/pnas.1205246109; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Ganten TM, 2004, CELL DEATH DIFFER, V11, pS86, DOI 10.1038/sj.cdd.4401437; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Goto E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001490; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Herr RA, 2009, TRAFFIC, V10, P1301, DOI 10.1111/j.1600-0854.2009.00946.x; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Jahnke M, 2012, J BIOL CHEM, V287, P28779, DOI 10.1074/jbc.M112.381541; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Kranenburg O, 1999, J BIOL CHEM, V274, P35301, DOI 10.1074/jbc.274.50.35301; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Maas C, 2010, CELL DEATH DIFFER, V17, P1613, DOI 10.1038/cdd.2010.39; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Morokuma Y, 2007, J BIOL CHEM, V282, P24806, DOI 10.1074/jbc.M700414200; Nathan JA, 2009, EXP CELL RES, V315, P1593, DOI 10.1016/j.yexcr.2008.10.026; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; Verbrugge I, 2008, ONCOGENE, V27, P574, DOI 10.1038/sj.onc.1210696; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2008, SEMIN CANCER BIOL, V18, P441, DOI 10.1016/j.semcancer.2008.09.002	51	57	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6617	6628		10.1074/jbc.M112.448209	http://dx.doi.org/10.1074/jbc.M112.448209			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300075	Green Published, hybrid			2022-12-28	WOS:000315820700061
J	Zhang, T; Zhu, QQ; Xie, ZH; Chen, YF; Qiao, YB; Li, LY; Jing, NH				Zhang, Ting; Zhu, Qingqing; Xie, Zhihui; Chen, Yongfeng; Qiao, Yunbo; Li, Lingyu; Jing, Naihe			The Zinc Finger Transcription Factor Ovol2 Acts Downstream of the Bone Morphogenetic Protein Pathway to Regulate the Cell Fate Decision between Neuroectoderm and Mesendoderm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; IN-SITU HYBRIDIZATION; NEURAL PLATE; DROSOPHILA-OVO; GENE-EXPRESSION; AXIS FORMATION; CHICK-EMBRYOS; AVIAN EMBRYOS; MOUSE HOMOLOG; NESTIN GENE	During early embryonic development, bone morphogenetic protein (BMP) signaling is essential for neural/non-neural cell fate decisions. BMP signaling inhibits precocious neural differentiation and allows for proper differentiation of mesoderm, endoderm, and epidermis. However, the mechanisms underlying the BMP pathway-mediated cell fate decision remain largely unknown. Here, we show that the expression of Ovol2, which encodes an evolutionarily conserved zinc finger transcription factor, is down-regulated during neural differentiation of mouse embryonic stem cells. Knockdown of Ovol2 in embryonic stem cells facilitates neural conversion and inhibits mesendodermal differentiation, whereas Ovol2 overexpression gives rise to the opposite phenotype. Moreover, Ovol2 knockdown partially rescues the neural inhibition and mesendodermal induction by BMP4. Mechanistic studies further show that BMP4 directly regulates Ovol2 expression through the binding of Smad1/5/8 to the second intron of the Ovol2 gene. In the chick embryo, cOvol2 expression is specifically excluded from neural territory and is up-regulated by BMP4. In addition, ectopic expression of cOvol2 in the prospective neural plate represses the expression of the definitive neural plate marker cSox2. Taken together, these results indicate that Ovol2 acts downstream of the BMP pathway in the cell fate decision between neuroectoderm and mesendoderm to ensure proper germ layer development.	[Zhang, Ting; Zhu, Qingqing; Xie, Zhihui; Chen, Yongfeng; Qiao, Yunbo; Li, Lingyu; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jing, NH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	njing@sibcb.ac.cn		Zhang, Ting/0000-0001-6330-8473	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01010201]; National Key Basic Research and Development Program of China [2009CB941100]; National Natural Science Foundation of China [30830034, 90919046, 91219303]; Council of Shanghai Municipal Government for Science and Technology [11ZR1443200]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Council of Shanghai Municipal Government for Science and Technology	This work was supported in part by Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01010201; National Key Basic Research and Development Program of China Grant 2009CB941100; National Natural Science Foundation of China Grants 30830034, 90919046, and 91219303; and Council of Shanghai Municipal Government for Science and Technology Grant 11ZR1443200.	Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Dai X, 1998, GENE DEV, V12, P3452, DOI 10.1101/gad.12.21.3452; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Feledy JA, 1999, DEV BIOL, V212, P455, DOI 10.1006/dbio.1999.9374; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Ishimura A, 2000, DEV GROWTH DIFFER, V42, P307; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; Johnson AD, 2001, DEVELOPMENT, V128, P2857; Kimelman D, 2000, CURR OPIN GENET DEV, V10, P350, DOI 10.1016/S0959-437X(00)00095-2; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Levi G, 2006, MECH DEVELOP, V123, P3, DOI 10.1016/j.mod.2005.10.007; Li B, 2002, GENOMICS, V80, P319, DOI 10.1006/geno.2002.6831; Li BA, 2002, P NATL ACAD SCI USA, V99, P6064, DOI 10.1073/pnas.092137099; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Mackay DR, 2006, DEV BIOL, V291, P38, DOI 10.1016/j.ydbio.2005.12.003; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MEVELNINIO M, 1991, EMBO J, V10, P2259, DOI 10.1002/j.1460-2075.1991.tb07762.x; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; OLIVER B, 1987, GENE DEV, V1, P913, DOI 10.1101/gad.1.9.913; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Patthey C, 2009, DEVELOPMENT, V136, P73, DOI 10.1242/dev.025890; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Pearson S, 2008, DEVELOPMENT, V135, P1525, DOI 10.1242/dev.011767; Pera E, 1999, DEVELOPMENT, V126, P63; Qiao YB, 2012, CELL RES, V22, P1546, DOI 10.1038/cr.2012.122; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Rodaway A, 2001, CELL, V105, P169, DOI 10.1016/S0092-8674(01)00307-5; Schroeder IS, 2006, NAT PROTOC, V1, P495, DOI 10.1038/nprot.2006.71; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; Streit A, 1998, DEVELOPMENT, V125, P507; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; Streit A, 2001, METHODS, V23, P339, DOI 10.1006/meth.2000.1146; Suzuki A, 1997, DEVELOPMENT, V124, P3037; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tang SJ, 1998, DEVELOPMENT, V125, P1877; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Unezaki S, 2004, GENE, V336, P47, DOI 10.1016/j.gene.2004.03.013; Unezaki S, 2007, GENES CELLS, V12, P773, DOI 10.1111/j.1365-2443.2007.01084.x; Voiculescu O, 2008, NAT PROTOC, V3, P419, DOI 10.1038/nprot.2008.10; Wang C, 2006, MOL BIOL CELL, V17, P3075, DOI 10.1091/mbc.E05-11-1087; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yang L, 1998, J NEUROSCI, V18, P8322; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494	63	24	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6166	6177		10.1074/jbc.M112.418376	http://dx.doi.org/10.1074/jbc.M112.418376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319585	Green Published, hybrid			2022-12-28	WOS:000315820700013
J	Dahl, JU; Radon, C; Buhning, M; Nimtz, M; Leichert, LI; Denis, Y; Jourlin-Castelli, C; Iobbi-Nivol, C; Mejean, V; Leimkuhler, S				Dahl, Jan-Ulrik; Radon, Christin; Buehning, Martin; Nimtz, Manfred; Leichert, Lars I.; Denis, Yann; Jourlin-Castelli, Cecile; Iobbi-Nivol, Chantal; Mejean, Vincent; Leimkuehler, Silke			The Sulfur Carrier Protein TusA Has a Pleiotropic Role in Escherichia coli That Also Affects Molybdenum Cofactor Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; MOLYBDOPTERIN SYNTHASE; CONVERTING FACTOR; SULFITE OXIDASE; EXPRESSION; GENE; IDENTIFICATION; FNR; REDUCTASE; PATHWAYS	The Escherichia coli L-cysteine desulfurase IscS mobilizes sulfur from L-cysteine for the synthesis of several biomolecules such as iron-sulfur (FeS) clusters, molybdopterin, thiamin, lipoic acid, biotin, and the thiolation of tRNAs. The sulfur transfer from IscS to various biomolecules is mediated by different interaction partners (e.g. TusA for thiomodification of tRNAs, IscU for FeS cluster biogenesis, and ThiI for thiamine biosynthesis/tRNA thiolation), which bind at different sites of IscS. Transcriptomic and proteomic studies of a Delta tusA strain showed that the expression of genes of the moaABCDE operon coding for proteins involved in molybdenum cofactor biosynthesis is increased under aerobic and anaerobic conditions. Additionally, under anaerobic conditions the expression of genes encoding hydrogenase 3 and several molybdoenzymes such as nitrate reductase were also increased. On the contrary, the activity of all molydoenzymes analyzed was significantly reduced in the Delta tusA mutant. Characterization of the Delta tusA strain under aerobic conditions showed an overall low molybdopterin content and an accumulation of cyclic pyranopterin monophosphate. Under anaerobic conditions the activity of nitrate reductase was reduced by only 50%, showing that TusA is not essential for molybdenum cofactor biosynthesis. We present a model in which we propose that the direction of sulfur transfer for each sulfur-containing biomolecule is regulated by the availability of the interaction partner of IscS. We propose that in the absence of TusA, more IscS is available for FeS cluster biosynthesis and that the overproduction of FeS clusters leads to a modified expression of several genes.	[Dahl, Jan-Ulrik; Radon, Christin; Buehning, Martin; Leimkuehler, Silke] Univ Potsdam, Dept Mol Enzymol, Inst Biochem & Biol, D-14476 Golm, Germany; [Nimtz, Manfred] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Leichert, Lars I.] Ruhr Univ Bochum, Med Proteom Ctr, Redox Prote Grp, D-44780 Bochum, Germany; [Denis, Yann] Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee FR3479, F-13402 Marseille 20, France; [Jourlin-Castelli, Cecile; Iobbi-Nivol, Chantal; Mejean, Vincent] Aix Marseille Univ, CNRS, Lab Chim Bacterienne UMR7283, F-13402 Marseille 20, France	University of Potsdam; Helmholtz Association; Helmholtz-Center for Infection Research; Ruhr University Bochum; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Leimkuhler, S (corresponding author), Univ Potsdam, Dept Mol Enzymol, Inst Biochem & Biol, D-14476 Golm, Germany.	sleim@uni-potsdam.de	Dahl, Jan-Ulrik/J-1893-2019; Leichert, Lars I./B-4762-2009; Dahl, Jan-Ulrik/J-4970-2017	Dahl, Jan-Ulrik/0000-0001-8597-7416; Leichert, Lars I./0000-0002-5666-9681; Dahl, Jan-Ulrik/0000-0002-4164-6129; Leimkuhler, Silke/0000-0003-3238-2122; Mejean, Vincent/0000-0001-6533-5846; Jourlin-Castelli, Cecile/0000-0001-8581-2590	Deutsche Forschungsgemeinschaft [LE1171/5-3]; DAAD (German Academic Exchange Program)-PROCOPE program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD (German Academic Exchange Program)-PROCOPE program(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Deutsche Forschungsgemeinschaft Grant LE1171/5-3 (to S.L.). The exchange of researchers among the laboratories involved in the work was funded by the DAAD (German Academic Exchange Program)-PROCOPE program (to C.I.-N. and S.L.).	Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Dahl JU, 2011, J BIOL CHEM, V286, P35801, DOI 10.1074/jbc.M111.282368; Dietzel U, 2009, J BIOL CHEM, V284, P8759, DOI 10.1074/jbc.M808114200; Dos Santos PC, 2007, J BACTERIOL, V189, P2854, DOI 10.1128/JB.01734-06; ERASO JM, 1992, J BACTERIOL, V174, P5101, DOI 10.1128/JB.174.15.5101-5109.1992; Flint DH, 1996, J BIOL CHEM, V271, P16068; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Garrett RM, 1996, J BIOL CHEM, V271, P7387, DOI 10.1074/jbc.271.13.7387; Genest O, 2006, FEMS MICROBIOL LETT, V265, P51, DOI 10.1111/j.1574-6968.2006.00468.x; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hidese R, 2011, APPL MICROBIOL BIOT, V91, P47, DOI 10.1007/s00253-011-3336-x; Hilton JC, 1996, ARCH BIOCHEM BIOPHYS, V325, P139, DOI 10.1006/abbi.1996.0017; Iannuzzi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021992; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; IobbiNivol C, 1996, BBA-PROTEIN STRUCT M, V1294, P77, DOI 10.1016/0167-4838(95)00271-5; Ishii Y, 2000, BIOSCI BIOTECH BIOCH, V64, P799, DOI 10.1271/bbb.64.799; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Katoh E, 2000, J MOL BIOL, V304, P219, DOI 10.1006/jmbi.2000.4170; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Maynard ND, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.101; Moore LJ, 2001, J BIOL CHEM, V276, P45744, DOI 10.1074/jbc.M106569200; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Neumann M, 2007, BIOCHEMISTRY-US, V46, P9586, DOI 10.1021/bi700630p; Neumann M, 2009, J BIOL CHEM, V284, P21891, DOI 10.1074/jbc.M109.008565; Neumann M, 2009, FEBS J, V276, P2762, DOI 10.1111/j.1742-4658.2009.07000.x; PITTERLE DM, 1989, J BACTERIOL, V171, P3373, DOI 10.1128/jb.171.6.3373-3378.1989; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rajagopalan KV, 1996, ESCHERICHIA COLI SAL, P674; Reinhart F, 2008, J BACTERIOL, V190, P879, DOI 10.1128/JB.01374-07; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schmitz J, 2007, BIOCHEMISTRY-US, V46, P909, DOI 10.1021/bi062011w; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; SYLVERS LA, 1993, BIOCHEMISTRY-US, V32, P3836, DOI 10.1021/bi00066a002; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; UNDEN G, 1995, ARCH MICROBIOL, V164, P81; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Yamashino T, 1998, J BACTERIOL, V180, P2257, DOI 10.1128/JB.180.8.2257-2261.1998; YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172	54	46	48	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5426	5442		10.1074/jbc.M112.431569	http://dx.doi.org/10.1074/jbc.M112.431569			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23281480	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000315342500018
J	McGee-Lawrence, ME; Li, XD; Bledsoe, KL; Wu, H; Hawse, JR; Subramaniam, M; Razidlo, DF; Stensgard, BA; Stein, GS; van Wijnen, AJ; Lian, JB; Hsu, W; Westendorf, JJ				McGee-Lawrence, Meghan E.; Li, Xiaodong; Bledsoe, Krista L.; Wu, Hai; Hawse, John R.; Subramaniam, Malayannan; Razidlo, David F.; Stensgard, Bridget A.; Stein, Gary S.; van Wijnen, Andre J.; Lian, Jane B.; Hsu, Wei; Westendorf, Jennifer J.			Runx2 Protein Represses Axin2 Expression in Osteoblasts and Is Required for Craniosynostosis in Axin2-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEIDOCRANIAL DYSPLASIA; BETA-CATENIN; SUTURE CRANIOSYNOSTOSIS; CALVARIAL MORPHOGENESIS; COLORECTAL-CANCER; PREMATURE FUSION; BONE-FORMATION; DNA-BINDING; DIFFERENTIATION; TRANSCRIPTION	Runx2 and Axin2 regulate craniofacial development and skeletal maintenance. Runx2 is essential for calvarial bone development, as Runx2 haploinsufficiency causes cleidocranial dysplasia. In contrast, Axin2-deficient mice develop craniosynostosis because of high beta-catenin activity. Axin2 levels are elevated in Runx2(-/-) calvarial cells, and Runx2 represses transcription of Axin2 mRNA, suggesting a direct relationship between these factors in vivo. Here we demonstrate that Runx2 binds several regions of the Axin2 promoter and that Runx2-mediated repression of Axin2 transcription depends on Hdac3. To determine whether Runx2 contributes to the etiology of Axin2 deficiency-induced craniosynostosis, we generated Axin2(-/-):Runx2(-/-) mice. These double mutant mice had longer skulls than Axin2(-/-) mice, indicating that Runx2 haploinsufficiency rescued the craniosynostosis phenotype of Axin2(-/-) mice. Together, these studies identify a key mechanistic pathway for regulating intramembranous bone development within the skull that involves Runx2- and Hdac3-mediated suppression of Axin2 to prevent the untimely closure of the calvarial sutures.	[McGee-Lawrence, Meghan E.; Li, Xiaodong; Bledsoe, Krista L.; Hawse, John R.; Subramaniam, Malayannan; Razidlo, David F.; Stensgard, Bridget A.; van Wijnen, Andre J.; Westendorf, Jennifer J.] Mayo Clin, Rochester, MN 55905 USA; [Wu, Hai; Stein, Gary S.; Lian, Jane B.] Univ Vermont, Burlington, VT 05405 USA; [Hsu, Wei] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	Mayo Clinic; University of Vermont; University of Rochester	Westendorf, JJ (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu	van Wijnen, Andre J./AAG-3578-2019; Hsu, Wei/ABG-6856-2021	van Wijnen, Andre J./0000-0002-4458-0946; Hsu, Wei/0000-0001-6738-6030; McGee-Lawrence, Meghan/0000-0002-2728-5849	National Institutes of Health [R01 AR48147, R01 DE020194, T32 AR056950, T32 CA148073, F32 AR60140]; NATIONAL CANCER INSTITUTE [T32CA148073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048147, T32AR056950, F32AR060140, R01AR049069, R01AR039588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528, R01DE020194, R01DE015654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR48147, R01 DE020194, T32 AR056950, T32 CA148073, and F32 AR60140.	Behr B, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00037; Beshiri Michael L, 2010, J Vis Exp, DOI 10.3791/2101; Boulet SL, 2008, AM J MED GENET A, V146A, P984, DOI 10.1002/ajmg.a.32208; Bradley JP, 1996, PLAST RECONSTR SURG, V98, P1039, DOI 10.1097/00006534-199611000-00018; Carver EA, 2002, ANAT REC, V268, P90, DOI 10.1002/ar.10124; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Godman CA, 2008, CANCER BIOL THER, V7, P1570, DOI 10.4161/cbt.7.10.6561; Hawse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019429; Hesse E, 2010, J CELL BIOL, V191, P1271, DOI 10.1083/jcb.201009107; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Li X, 2009, J CELL BIOCHEM, V108, P378, DOI 10.1002/jcb.22263; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Maeno T, 2011, BONE, V49, P673, DOI 10.1016/j.bone.2011.07.023; Martinez-Abadias N, 2010, DEV DYNAM, V239, P3058, DOI 10.1002/dvdy.22414; Maruyama T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000727; McGee-Lawrence ME, 2013, BONE, V52, P296, DOI 10.1016/j.bone.2012.10.015; McGee-Lawrence ME, 2011, BONE, V48, P1117, DOI 10.1016/j.bone.2011.01.007; Mefford HC, 2010, AM J MED GENET A, V152A, P2203, DOI 10.1002/ajmg.a.33557; Meyers S, 1996, ONCOGENE, V13, P303; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Mirando AJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-116; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park J, 2012, J CELL BIOCHEM, V113, P457, DOI 10.1002/jcb.23368; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Pratap J, 2003, CANCER RES, V63, P5357; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Rice DPC, 2010, HUM MOL GENET, V19, P3457, DOI 10.1093/hmg/ddq258; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Shevde NK, 2001, CLEFT PALATE-CRAN J, V38, P606, DOI 10.1597/1545-1569(2001)038<0606:EAOODF>2.0.CO;2; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Tanimoto Y, 2012, J BIOL CHEM, V287, P21429, DOI 10.1074/jbc.M112.362145; VILLANUEVA AR, 1977, AM J MED TECHNOL, V43, P536; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wilkie AOM, 2010, PEDIATRICS, V126, pE391, DOI 10.1542/peds.2009-3491; Wu R, 2001, CANCER RES, V61, P8247; Yan Y, 2009, J CELL SCI, V122, P3566, DOI 10.1242/jcs.051904; Yoon WJ, 2008, J BIOL CHEM, V283, P32751, DOI 10.1074/jbc.M803183200; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	58	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5291	5302		10.1074/jbc.M112.414995	http://dx.doi.org/10.1074/jbc.M112.414995			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23300083	hybrid, Green Published			2022-12-28	WOS:000315342500004
J	Tai, LM; Bilousova, T; Jungbauer, L; Roeske, SK; Youmans, KL; Yu, CJ; Poon, WW; Cornwell, LB; Miller, CA; Vinters, HV; Van Eldik, LJ; Fardo, DW; Estus, S; Bu, GJ; Gylys, KH; LaDu, MJ				Tai, Leon M.; Bilousova, Tina; Jungbauer, Lisa; Roeske, Stephen K.; Youmans, Katherine L.; Yu, Chunjiang; Poon, Wayne W.; Cornwell, Lindsey B.; Miller, Carol A.; Vinters, Harry V.; Van Eldik, Linda J.; Fardo, David W.; Estus, Steve; Bu, Guojun; Gylys, Karen Hoppens; LaDu, Mary Jo			Levels of Soluble Apolipoprotein E/Amyloid-beta (A beta) Complex Are Reduced and Oligomeric A beta Increased with APOE4 and Alzheimer Disease in a Transgenic Mouse Model and Human Samples	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOFORM-SPECIFIC BINDING; AMYLOID-BETA; IN-VITRO; PEPTIDE; PROTEIN; BRAIN; DEGRADATION; CLEARANCE; NEURODEGENERATION; COLOCALIZATION	Human apolipoprotein E (apoE) isoforms may differentially modulate amyloid-beta (A beta) levels. Evidence suggests physical interactions between apoE and A beta are partially responsible for these functional effects. However, the apoE/A beta complex is not a single static structure; rather, it is defined by detection methods. Thus, literature results are inconsistent and difficult to interpret. An ELISA was developed to measure soluble apoE/A beta in a single, quantitative method and was used to address the hypothesis that reduced levels of soluble apoE/A beta and an increase in soluble A beta, specifically oligomeric A beta (oA beta), are associated with APOE4 and AD. Previously, soluble A beta 42 and oA beta levels were greater with APOE4 compared with APOE2/APOE3 in hippocampal homogenates from EFAD transgenic mice (expressing five familial AD mutations and human apoE isoforms). In this study, soluble apoE/A beta levels were lower in E4FAD mice compared with E2FAD and E3FAD mice, thus providing evidence that apoE/A beta levels isoform-specifically modulate soluble oA beta clearance. Similar results were observed in soluble preparations of human cortical synaptosomes; apoE/A beta levels were lower in AD patients compared with controls and lower with APOE4 in the AD cohort. In human CSF, apoE/A beta levels were also lower in AD patients and with APOE4 in the AD cohort. Importantly, although total A beta 42 levels decreased in AD patients compared with controls, oA beta levels increased and were greater with APOE4 in the AD cohort. Overall, apoE isoform-specific formation of soluble apoE/A beta modulates oA beta levels, suggesting a basis for APOE4-induced AD risk and a mechanistic approach to AD biomarkers.	[Tai, Leon M.; Jungbauer, Lisa; Roeske, Stephen K.; Youmans, Katherine L.; Yu, Chunjiang; LaDu, Mary Jo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Bilousova, Tina; Gylys, Karen Hoppens] UCLA Sch Nursing, Los Angeles, CA 90095 USA; [Bilousova, Tina; Gylys, Karen Hoppens] Mary S Easton Ctr Alzheimers Res, Los Angeles, CA 90095 USA; [Poon, Wayne W.; Cornwell, Lindsey B.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA; [Miller, Carol A.] Keck Univ Southern Calif, Sch Med, Dept Pathol, Los Angeles, CA 90089 USA; [Miller, Carol A.] Keck Univ Southern Calif, Sch Med, Dept Neurol, Los Angeles, CA 90089 USA; [Miller, Carol A.] Keck Univ Southern Calif, Sch Med, Program Neurosci, Los Angeles, CA 90089 USA; [Vinters, Harry V.] UCLA Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Van Eldik, Linda J.; Fardo, David W.; Estus, Steve] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Van Eldik, Linda J.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Fardo, David W.] Univ Kentucky, Dept Biostat, Lexington, KY 40536 USA; [Estus, Steve] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Mayo Clinic	LaDu, MJ (corresponding author), Univ Illinois, Dept Anat & Cell Biol, 808 S Wood St,M-C 512, Chicago, IL 60612 USA.	mladu@uic.edu		Jungbauer Nikolas, Lisa/0000-0002-5429-3393; Poon, Wayne/0000-0003-0625-3968; LaDu, Mary Jo/0000-0003-2141-1450; Fardo, David/0000-0002-7207-4696	National Institutes of Health from NIA [P01AG030128, AG27465, G18879, 050 AG05142, P50 AG 16970, P50 AG016573, P30 AG028383]; Alzheimer's Association Grant [ZEN-08-899000]; University of Illinois at Chicago Center for Clinical and Translational Science Grant [UL1RR029879]; Alzheimer's Drug Discovery Foundation Grant; Daljit S. and Elaine Sarkaria Chair in Diagnostic Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028383, P50AG005142, R56AG027465, P50AG016573, R01AG046205, P01AG030128, R01AG027465, R01AG027924, RF1AG046205] Funding Source: NIH RePORTER	National Institutes of Health from NIA; Alzheimer's Association Grant(Alzheimer's Association); University of Illinois at Chicago Center for Clinical and Translational Science Grant; Alzheimer's Drug Discovery Foundation Grant; Daljit S. and Elaine Sarkaria Chair in Diagnostic Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AG030128 from NIA (to M. J. L. and S. E.), AG27465 (to K. H. G.), and G18879 (to C. A. M.). This work was also supported by Alzheimer's Association Grant ZEN-08-899000 (to M. J. L.), University of Illinois at Chicago Center for Clinical and Translational Science Grant UL1RR029879 (to M. J. L.), and an Alzheimer's Drug Discovery Foundation Grant (to M. J. L. and S. E.).; Supported by the Daljit S. and Elaine Sarkaria Chair in Diagnostic Medicine.; Human post-mortem samples were obtained from the Alzheimer's Disease Research Center Neuropathology Cores of the University of Southern California (supported by National Institutes of Health Grant 050 AG05142 from NIA), UCLA (supported by National Institutes of Health Grant P50 AG 16970 from NIA), and University of California at Irvine (supported by National Institutes of Health Grant P50 AG016573 from NIA). Human CSF samples were obtained from the University of Kentucky Alzheimer's Disease Research Center (supported by National Institutes of Health Grant P30 AG028383 from NIA). We also gratefully acknowledge Maria Corrada and Claudia Kawas and the 90+ Study for providing tissue (University of California at Irvine).	Aleshkov S, 1997, BIOCHEMISTRY-US, V36, P10571, DOI 10.1021/bi9626362; Arold S, 2012, ACTA NEUROPATHOL, V123, P39, DOI 10.1007/s00401-011-0892-1; Bachmeier C, 2013, J MOL NEUROSCI, V49, P270, DOI 10.1007/s12031-012-9866-6; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Basak JM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-14; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Bentley NM, 2002, BIOCHEM J, V366, P273, DOI 10.1042/BJ20020207; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Drzezga A, 2009, NEUROLOGY, V72, P1487, DOI 10.1212/WNL.0b013e3181a2e8d0; Fein JA, 2008, AM J PATHOL, V172, P1683, DOI 10.2353/ajpath.2008.070829; Findlay JWA, 2007, AAPS J, V9, pE260, DOI 10.1208/aapsj0902029; GOLABEK A, 1995, NEUROSCI LETT, V191, P79, DOI 10.1016/0304-3940(95)11565-7; Golabek AA, 1996, J BIOL CHEM, V271, P10602, DOI 10.1074/jbc.271.18.10602; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; Grimmer T, 2010, BIOL PSYCHIAT, V68, P879, DOI 10.1016/j.biopsych.2010.05.013; Gylys KH, 2007, NEUROBIOL AGING, V28, P8, DOI 10.1016/j.neurobiolaging.2005.10.018; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; Hawkes CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041636; Henkins KM, 2012, BRAIN PATHOL, V22, P826, DOI 10.1111/j.1750-3639.2012.00598.x; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Hong SY, 2011, J NEUROSCI, V31, P15861, DOI 10.1523/JNEUROSCI.3272-11.2011; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Jones PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014586; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kuo YM, 1996, J BIOL CHEM, V271, P4077; LaDu MJ, 2012, BBA-MOL CELL BIOL L, V1821, P295, DOI 10.1016/j.bbalip.2011.11.005; LaDu MJ, 1997, J NEUROSCI RES, V49, P9, DOI 10.1002/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H; LaDu MJ, 2006, BIOCHEMISTRY-US, V45, P381, DOI 10.1021/bi051765s; LADU MJ, 1994, J BIOL CHEM, V269, P23403; LADU MJ, 1995, J BIOL CHEM, V270, P9039, DOI 10.1074/jbc.270.16.9039; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lefterov I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-20; Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224; Mahley RW, 2012, J MED CHEM, V55, P8997, DOI 10.1021/jm3008618; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; Moore BD, 2009, BIOCHEMISTRY-US, V48, P11796, DOI 10.1021/bi901571t; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Morris JC, 2011, NEUROBIOL AGING, V32, pS1, DOI 10.1016/j.neurobiolaging.2011.09.005; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Munson GW, 2000, BIOCHEMISTRY-US, V39, P16119, DOI 10.1021/bi0017475; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Petrlova J, 2011, PROTEINS, V79, P402, DOI 10.1002/prot.22891; Pillot T, 1997, EUR J BIOCHEM, V243, P650, DOI 10.1111/j.1432-1033.1997.00650.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Russo C, 1998, P NATL ACAD SCI USA, V95, P15598, DOI 10.1073/pnas.95.26.15598; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Shoji M, 2011, INT J ALZHEIMERS DIS; Sokolow S, 2012, NEUROBIOL AGING, V33, P1545, DOI 10.1016/j.neurobiolaging.2011.05.011; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Wirths O, 2012, LIFE SCI, V91, P1148, DOI 10.1016/j.lfs.2012.02.001; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Yamauchi K, 2000, J NEUROSCI RES, V62, P608, DOI 10.1002/1097-4547(20001115)62:4<608::AID-JNR16>3.0.CO;2-4; Yang DS, 1997, J NEUROCHEM, V68, P721; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957; Youmans KL, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-8; Youmans KL, 2011, J NEUROSCI METH, V196, P51, DOI 10.1016/j.jneumeth.2010.12.025; Zhou ZM, 1996, MOL MED, V2, P175, DOI 10.1007/BF03401614; Zhou ZM, 2002, MOL MED, V8, P376, DOI 10.1007/BF03402018	87	118	120	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5914	5926		10.1074/jbc.M112.442103	http://dx.doi.org/10.1074/jbc.M112.442103			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23293020	Green Published, hybrid			2022-12-28	WOS:000315342500060
J	Kummarapurugu, AB; Fischer, BM; Zheng, S; Milne, GL; Ghio, AJ; Potts-Kant, EN; Foster, WM; Soderblom, EJ; Dubois, LG; Moseley, MA; Thompson, JW; Voynow, JA				Kummarapurugu, Apparao B.; Fischer, Bernard M.; Zheng, Shuo; Milne, Ginger L.; Ghio, Andrew J.; Potts-Kant, Erin N.; Foster, W. Michael; Soderblom, Erik J.; Dubois, Laura G.; Moseley, M. Arthur; Thompson, J. Will; Voynow, Judith A.			NADPH: Quinone Oxidoreductase 1 Regulates Host Susceptibility to Ozone via Isoprostane Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BRONCHIAL EPITHELIAL-CELLS; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; IN-VITRO; IL-8 EXPRESSION; ALPHA KINASE; CYSTEINE 179; TNF-ALPHA; IKK-BETA	NADPH: quinone oxidoreductase 1 (NQO1) is recognized as a major susceptibility gene for ozone-induced pulmonary toxicity. In the absence of NQO1 as can occur by genetic mutation, the human airway is protected from harmful effects of ozone. We recently reported that NQO1-null mice are protected from airway hyperresponsiveness and pulmonary inflammation following ozone exposure. However, NQO1 regenerates intracellular antioxidants and therefore should protect the individual from oxidative stress. To explain this paradox, we tested whether in the absence of NQO1 ozone exposure results in increased generation of A(2)-isoprostane, a cyclopentenone isoprostane that blunts inflammation. Using GC-MS, we found that NQO1-null mice had greater lung tissue levels of D-2- and E-2-isoprostanes, the precursors of J(2)- and A(2)-isoprostanes, both at base line and following ozone exposure compared with congenic wild-type mice. We confirmed in primary cultures of normal human bronchial epithelial cells that A(2)-isoprostane inhibited ozone-induced NF-kappa B activation and IL-8 regulation. Furthermore, we determined that A(2)-isoprostane covalently modified the active Cys(179) domain in inhibitory kappa B kinase in the presence of ozone in vitro, thus establishing the biochemical basis for A(2)-isoprostane inhibition of NF-kappa B. Our results demonstrate that host factors may regulate pulmonary susceptibility to ozone by regulating the generation of A(2)-isoprostanes in the lung. These observations provide the biochemical basis for the epidemiologic observation that NQO1 regulates pulmonary susceptibility to ozone.	[Kummarapurugu, Apparao B.; Fischer, Bernard M.; Zheng, Shuo; Voynow, Judith A.] Duke Univ, Med Ctr, Dept Pediat, Div Pediat Pulm & Sleep Med, Durham, NC 27710 USA; [Potts-Kant, Erin N.; Foster, W. Michael] Duke Univ, Med Ctr, Div Pulm Med, Dept Med, Durham, NC 27710 USA; [Soderblom, Erik J.; Dubois, Laura G.; Moseley, M. Arthur; Thompson, J. Will] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Milne, Ginger L.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Milne, Ginger L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Ghio, Andrew J.] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA	Duke University; Duke University; Duke University; Vanderbilt University; Vanderbilt University; United States Environmental Protection Agency	Voynow, JA (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Pediat Pulm & Sleep Med, Box 102360, Durham, NC 27710 USA.	voyno001@mc.duke.edu	Milne, Ginger/D-7648-2014	Milne, Ginger/0000-0003-3890-151X	National Institutes of Health [R01 ES016836]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 ES016836.	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; [Anonymous], 1996, Am J Respir Crit Care Med, V153, P477; AWAD JA, 1993, J BIOL CHEM, V268, P4161; Bayram H, 2001, J ALLERGY CLIN IMMUN, V107, P287, DOI 10.1067/mai.2001.111141; Bergamaschi E, 2001, AM J RESP CRIT CARE, V163, P1426, DOI 10.1164/ajrccm.163.6.2006056; Chen C, 2007, EUR RESPIR J, V30, P677, DOI 10.1183/09031936.00160806; Corradi M, 2002, TOXICOL LETT, V134, P219, DOI 10.1016/S0378-4274(02)00169-8; David GL, 2003, AM J RESP CRIT CARE, V168, P1199, DOI 10.1164/rccm.200305-684OC; DEVLIN RB, 1994, AM J PHYSIOL, V266, pL612, DOI 10.1152/ajplung.1994.266.6.L612; Fakhrzadeh L, 2004, AM J PHYSIOL-LUNG C, V287, pL279, DOI 10.1152/ajplung.00348.2003; Farias SE, 2008, J LIPID RES, V49, P1990, DOI 10.1194/jlr.M800200-JLR200; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Foster WM, 2000, J APPL PHYSIOL, V89, P1804, DOI 10.1152/jappl.2000.89.5.1804; Gupta SC, 2010, J BIOL CHEM, V285, P35406, DOI 10.1074/jbc.M110.161984; Harikumar KB, 2009, BLOOD, V113, P2003, DOI 10.1182/blood-2008-04-151944; Janssen LJ, 2001, AM J PHYSIOL-LUNG C, V280, pL1067, DOI 10.1152/ajplung.2001.280.6.L1067; Janssen LJ, 2005, ANTIOXID REDOX SIGN, V7, P244, DOI 10.1089/ars.2005.7.244; Janssen-Heininger Yvonne M W, 2009, Proc Am Thorac Soc, V6, P249, DOI 10.1513/pats.200806-054RM; Jaspers I, 1997, AM J PHYSIOL-LUNG C, V272, pL504, DOI 10.1152/ajplung.1997.272.3.L504; Kafoury RM, 2007, ENVIRON TOXICOL, V22, P159, DOI 10.1002/tox.20246; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Krunkosky TM, 2003, FREE RADICAL BIO MED, V35, P1158, DOI 10.1016/S0891-5849(03)00498-2; Lappas M, 2007, FREE RADICAL BIO MED, V42, P1791, DOI 10.1016/j.freeradbiomed.2007.03.009; LEIKAUF GD, 1995, ENVIRON HEALTH PERSP, V103, P91, DOI 10.2307/3432455; Milne GL, 2005, BIOMARKERS, V10, pS10, DOI 10.1080/13547500500216546; Milne GL, 2005, ANTIOXID REDOX SIGN, V7, P210, DOI 10.1089/ars.2005.7.210; Morrow JD, 1998, ARCH BIOCHEM BIOPHYS, V353, P160, DOI 10.1006/abbi.1998.0645; Musiek ES, 2005, LIPIDS, V40, P987, DOI 10.1007/s11745-005-1460-7; Musiek ES, 2005, J BIOL CHEM, V280, P35562, DOI 10.1074/jbc.M504785200; Nichols BG, 2001, TOXICOL SCI, V60, P356, DOI 10.1093/toxsci/60.2.356; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Peden DB, 2005, J ALLERGY CLIN IMMUN, V115, P213, DOI 10.1016/j.jaci.2004.12.003; PRYOR WA, 1995, FREE RADICAL BIO MED, V19, P935, DOI 10.1016/0891-5849(95)02033-7; Reich EE, 2001, AM J PATHOL, V158, P293, DOI 10.1016/S0002-9440(10)63968-5; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Ross D, 2004, METHOD ENZYMOL, V382, P115; Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rusznak C, 1996, EUR RESPIR J, V9, P2298, DOI 10.1183/09031936.96.09112298; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Siegel D, 1998, CLIN CANCER RES, V4, P2065; Son PS, 2010, CARCINOGENESIS, V31, P1442, DOI 10.1093/carcin/bgq099; Trasande L, 2005, J ALLERGY CLIN IMMUN, V115, P689, DOI 10.1016/j.jaci.2005.01.056; Valacchi G, 2005, ANTIOXID REDOX SIGN, V7, P25, DOI 10.1089/ars.2005.7.25; Voynow JA, 2004, AM J PHYSIOL-LUNG C, V287, pL1293, DOI 10.1152/ajplung.00140.2004; Voynow JA, 2009, AM J RESP CELL MOL, V41, P107, DOI 10.1165/rcmb.2008-0381OC; Zheng S, 2007, FREE RADICAL BIO MED, V42, P1398, DOI 10.1016/j.freeradbiomed.2007.01.040	47	5	5	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4681	4691		10.1074/jbc.M112.438440	http://dx.doi.org/10.1074/jbc.M112.438440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23275341	hybrid, Green Published			2022-12-28	WOS:000315340400017
J	Le, BV; Nguyen, JB; Logarajah, S; Wang, B; Marcus, J; Williams, HP; Catteruccia, F; Baxter, RHG				Le, Binh V.; Nguyen, Jennifer B.; Logarajah, Shankar; Wang, Bo; Marcus, Jacob; Williams, Hazel P.; Catteruccia, Flaminia; Baxter, Richard H. G.			Characterization of Anopheles gambiae Transglutaminase 3 (AgTG3) and Its Native Substrate Plugin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG LIVER TRANSGLUTAMINASE; COAGULATION-FACTOR-XIII; CALCIUM-IONS; BINDING SITE; FIELD; IDENTIFICATION; PURIFICATION; MECHANISM; RELEASE; SYSTEMS	Male Anopheles mosquitoes coagulate their seminal fluids via cross-linking of a substrate, called Plugin, by the seminal transglutaminase AgTG3. Formation of the "mating plug" by cross-linking Plugin is necessary for efficient sperm storage by females. AgTG3 has a similar degree of sequence identity (similar to 30%) to both human Factor XIII (FXIII) and tissue transglutaminase 2 (hTG2). Here we report the solution structure and in vitro activity for the cross-linking reaction of AgTG3 and Plugin. AgTG3 is a dimer in solution and exhibits Ca2+-dependent nonproteolytic activation analogous to cytoplasmic FXIII. The C-terminal domain of Plugin is predominantly alpha-helical with extended tertiary structure and oligomerizes in solution. The specific activity of AgTG3 was measured as 4.25 x 10(-2) units mg(-1). AgTG3 is less active than hTG2 assayed using the general substrate TVQQEL but has 8-10 x higher relative activity when Plugin is the substrate. Mass spectrometric analysis of cross-linked Plugin detects specific peptides including a predicted consensus motif for cross-linking by AgTG3. These results support the development of AgTG3 inhibitors as specific and effective chemosterilants for A. gambiae.	[Le, Binh V.; Logarajah, Shankar; Wang, Bo; Marcus, Jacob; Baxter, Richard H. G.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Nguyen, Jennifer B.; Baxter, Richard H. G.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Williams, Hazel P.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Catteruccia, Flaminia] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Catteruccia, Flaminia] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, I-06123 Perugia, Italy	Yale University; Yale University; Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; University of Perugia	Baxter, RHG (corresponding author), POB 208107, New Haven, CT 06520 USA.	richard.baxter@yale.edu	Nguyen, Jennifer/GVS-4347-2022; Baxter, Richard/F-3027-2013	Baxter, Richard/0000-0001-5140-1726; Catteruccia, Flaminia/0000-0003-3295-6683	National Institutes of Health Career Development Award from NIAID [K22AI085112-01]; European Research Council [260897]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI085112] Funding Source: NIH RePORTER	National Institutes of Health Career Development Award from NIAID; European Research Council(European Research Council (ERC)European Commission); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Career Development Award K22AI085112-01 from the NIAID (to R. H. G. B.). This work was also supported by European Research Council FP7 ERC Starting Grant Project "Anorep" Grant 260897 (to F. C.). Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; Ahvazi B, 2003, J BIOL CHEM, V278, P23834, DOI 10.1074/jbc.M301162200; ASMAN SM, 1981, ANNU REV ENTOMOL, V26, P289, DOI 10.1146/annurev.en.26.010181.001445; BUSHLAND RC, 1955, SCIENCE, V122, P287, DOI 10.1126/science.122.3163.287; Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; El Sayed BB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S3; FOLK JE, 1983, ADV ENZYMOL RAMB, V54, P1; Fox BA, 1999, J BIOL CHEM, V274, P4917, DOI 10.1074/jbc.274.8.4917; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Helinski MEH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-65; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kratky O., 1982, SMALL ANGLE XRAY SCA, P361; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristiansen GK, 2011, J BIOL CHEM, V286, P9833, DOI 10.1074/jbc.M110.174128; LAI TS, 1994, PROTEIN EXPRES PURIF, V5, P125, DOI 10.1006/prep.1994.1019; Leblanc A, 1999, PROTEIN EXPRES PURIF, V17, P89, DOI 10.1006/prep.1999.1107; Lehane MJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001495; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lung O, 2001, INSECT BIOCHEM MOLEC, V31, P543, DOI 10.1016/S0965-1748(00)00154-5; Noguchi K, 2001, J BIOL CHEM, V276, P12055, DOI 10.1074/jbc.M009862200; Palopoli MF, 2008, NATURE, V454, P1019, DOI 10.1038/nature07171; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shibata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013477; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tseng HC, 2012, AMINO ACIDS, V42, P951, DOI 10.1007/s00726-011-1009-9; Tsurupa G, 2012, BIOCHEMISTRY-US, V51, P2526, DOI 10.1021/bi2017848; Tsurupa G, 2011, BIOCHEMISTRY-US, V50, P8028, DOI 10.1021/bi2008189; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Williams-Ashman H G, 1980, Adv Enzyme Regul, V18, P239, DOI 10.1016/0065-2571(80)90018-7; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yuval B, 2006, ANNU REV ENTOMOL, V51, P413, DOI 10.1146/annurev.ento.51.110104.151058	42	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4844	4853		10.1074/jbc.M112.435347	http://dx.doi.org/10.1074/jbc.M112.435347			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288850	Green Published, hybrid			2022-12-28	WOS:000315340400033
J	Chechenova, MB; Bryantsev, AL; Cripps, RM				Chechenova, Maria B.; Bryantsev, Anton L.; Cripps, Richard M.			The Drosophila Z-disc Protein Z(210) Is an Adult Muscle Isoform of Zasp52, Which Is Required for Normal Myofibril Organization in Indirect Flight Muscles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCULAR-DYSTROPHY; CYPHER; PDZ; EXPRESSION; MUTATIONS; MEMBER; MOTIF; FORM	The Z-disc is a critical anchoring point for thin filaments as they slide during muscle contraction. Therefore, identifying components of the Z-disc is critical for fully comprehending how myofibrils assemble and function. In the adult Drosophila musculature, the fibrillar indirect flight muscles accumulate a > 200 kDa Z-disc protein termed Z(210), the identity of which has to date been unknown. Here, we use mass spectrometry and gene specific knockdown studies, to identify Z(210) as an adult isoform of the Z-disc protein Zasp52. The Zasp52 primary transcript is extensively alternatively spliced, and we describe its splicing pattern in the flight muscles, identifying a new Zasp52 isoform, which is the one recognized by the Z(210) antibody. We also demonstrate that Zasp52 is required for the association of alpha-actinin with the flight muscle Z-disc, and for normal sarcomere structure. These studies expand our knowledge of Zasp isoforms and their functions in muscle. Given the role of Zasp proteins in mammalian muscle development and disease, our results have relevance to mammalian muscle biology.	[Chechenova, Maria B.; Bryantsev, Anton L.; Cripps, Richard M.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Cripps, RM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	rcripps@unm.edu		Bryantsev, Anton/0000-0003-2775-7110	University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource; National Institutes of Health from the Institute Development Award (IDeA) Program of the National Center for Research Resources [1P20RR18754]; National Institutes of Health [GM061738]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061738] Funding Source: NIH RePORTER	University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource; National Institutes of Health from the Institute Development Award (IDeA) Program of the National Center for Research Resources; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Judith Saide for the anti-Z(210) antibody and Dr. Kathleen Clark for anti-Mlp84B. Confocal images were generated in the University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource, funded as detailed on hsc.unm.edu/crtc/microscopy/acknowledgment.shtml. We acknowledge technical support from the Dept. of Biology's Molecular Biology Facility, supported by National Institutes of Health Grant Number 1P20RR18754 from the Institute Development Award (IDeA) Program of the National Center for Research Resources.; This work was supported, in whole or in part, by Grant GM061738 (to R. M. C.) from the National Institutes of Health.	Anant S, 1998, DEVELOPMENT, V125, P1361; [Anonymous], 2009, SKELETAL MUSCLE STRU; Benna C, 2009, CELL TISSUE RES, V337, P463, DOI 10.1007/s00441-009-0813-y; Bonnemann CG, 2004, CURR OPIN NEUROL, V17, P529; Bryantsev AL, 2012, DEV BIOL, V361, P191, DOI 10.1016/j.ydbio.2011.09.031; Champagne MB, 2000, J MOL BIOL, V300, P759, DOI 10.1006/jmbi.2000.3802; COLLIER VL, 1990, GENE DEV, V4, P885, DOI 10.1101/gad.4.6.885; CRIPPS RM, 1992, BIOCHEM GENET, V30, P159, DOI 10.1007/BF02399706; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hauser MA, 2000, HUM MOL GENET, V9, P2141, DOI 10.1093/hmg/9.14.2141; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Katzemich A, 2011, GENE EXPR PATTERNS, V11, P484, DOI 10.1016/j.gep.2011.08.004; Klaavuniemi T, 2006, EXP CELL RES, V312, P1299, DOI 10.1016/j.yexcr.2005.12.036; Luther PK, 2009, J MUSCLE RES CELL M, V30, P171, DOI 10.1007/s10974-009-9189-6; Morriss GR, 2012, METHODS MOL BIOL, V798, P127, DOI 10.1007/978-1-61779-343-1_8; ODONNELL PT, 1988, J CELL BIOL, V107, P2601, DOI 10.1083/jcb.107.6.2601; Patel SR, 2005, J MUSCLE RES CELL M, V26, P213, DOI 10.1007/s10974-005-9012-y; Rui YN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001208; SAIDE JD, 1989, J CELL BIOL, V109, P2157, DOI 10.1083/jcb.109.5.2157; Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376; Sheikh F, 2007, TRENDS CARDIOVAS MED, V17, P258, DOI 10.1016/j.tcm.2007.09.002; Stronach BE, 1999, MOL BIOL CELL, V10, P2329, DOI 10.1091/mbc.10.7.2329; van der Meer DLM, 2006, DEV BIOL, V299, P356, DOI 10.1016/j.ydbio.2006.07.032; VIGOREAUX JO, 1991, J MUSCLE RES CELL M, V12, P340, DOI 10.1007/BF01738589; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	29	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3718	3726		10.1074/jbc.M112.401794	http://dx.doi.org/10.1074/jbc.M112.401794			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23271733	Green Published, hybrid			2022-12-28	WOS:000314845000004
J	Sinha, C; Ren, AX; Arora, K; Moon, CS; Yarlagadda, S; Zhang, WQ; Cheepala, SB; Schuetz, JD; Naren, AP				Sinha, Chandrima; Ren, Aixia; Arora, Kavisha; Moon, Chang-Suk; Yarlagadda, Sunitha; Zhang, Weiqiang; Cheepala, Satish B.; Schuetz, John D.; Naren, Anjaparavanda P.			Multi-drug Resistance Protein 4 (MRP4)-mediated Regulation of Fibroblast Cell Migration Reflects a Dichotomous Role of Intracellular Cyclic Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP; MRP4; ACTIVATION; KINASE; TRANSPORTER; INHIBITION; ADHESION; CFTR	It has long been known that cyclic nucleotides and cyclic nucleotide-dependent signaling molecules control cell migration. However, the concept that it is not just the absence or presence of cyclic nucleotides, but a highly coordinated balance between these molecules that regulates cell migration, is new and revolutionary. In this study, we used multidrug resistance protein 4 (MRP4)-expressing cell lines and MRP4 knock-out mice as model systems and wound healing assays as the experimental system to explore this unique and emerging concept. MRP4, a member of a large family of ATP binding cassette transporter proteins, localizes to the plasma membrane and functions as a nucleotide efflux transporter and thus plays a role in the regulation of intracellular cyclic nucleotide levels. Here, we demonstrate that mouse embryonic fibroblasts (MEFs) isolated from Mrp4(-/-) mice have higher intracellular cyclic nucleotide levels and migrate faster compared with MEFs from Mrp4(-/-) mice. Using FRET-based cAMP and cGMP sensors, we show that inhibition of MRP4 with MK571 increases both cAMP and cGMP levels, which results in increased migration. In contrast to these moderate increases in cAMP and cGMP levels seen in the absence of MRP4, a robust increase in cAMP levels was observed following treatment with forskolin and isobutylmethylxanthine, which decreases fibroblast migration. In response to externally added cell-permeant cyclic nucleotides (cpt-cAMP and cpt-cGMP), MEF migration appears to be biphasic. Altogether, our studies provide the first experimental evidence supporting the novel concept that balance between cyclic nucleotides is critical for cell migration.	[Sinha, Chandrima; Ren, Aixia; Arora, Kavisha; Moon, Chang-Suk; Yarlagadda, Sunitha; Zhang, Weiqiang; Naren, Anjaparavanda P.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Cheepala, Satish B.; Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Naren, AP (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave,426 Nash Res Bldg, Memphis, TN 38163 USA.	anaren@uthsc.edu	Schuetz, John D/N-2692-2018		National Institutes of Health [RO1-DK080834, RO1-DK093045, RO1-GM60904]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093045, R01DK080834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK080834, RO1-DK093045 (to A.P.N.), and RO1-GM60904 (to J.D.S).	Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chen L, 2008, J BIOL CHEM, V283, P13799, DOI 10.1074/jbc.M800555200; Copsel S, 2011, J BIOL CHEM, V286, P6979, DOI 10.1074/jbc.M110.166868; ELFERINK JGR, 1993, EUR J PHARM-MOLEC PH, V246, P157, DOI 10.1016/0922-4106(93)90093-O; Elferink JGR, 1996, GEN PHARMACOL-VASC S, V27, P387, DOI 10.1016/0306-3623(95)00070-4; Ghosh MC, 2012, AM J PHYSIOL-LUNG C, V302, pL846, DOI 10.1152/ajplung.00321.2011; Guo DG, 2007, CELL, V128, P341, DOI 10.1016/j.cell.2006.11.048; Hara Y, 2011, J CLIN INVEST, V121, P2888, DOI 10.1172/JCI45023; Honda A, 2001, P NATL ACAD SCI USA, V98, P2437, DOI 10.1073/pnas.051631298; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Kopecki Z, 2009, J INVEST DERMATOL, V129, P2031, DOI 10.1038/jid.2008.461; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lin ZP, 2008, MOL PHARMACOL, V73, P243, DOI 10.1124/mol.107.039594; Liu LL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-154; Mazzalupo S, 2002, J INVEST DERMATOL, V118, P866, DOI 10.1046/j.1523-1747.2002.01736.x; Negash S, 2009, AM J PHYSIOL-HEART C, V297, pH304, DOI 10.1152/ajpheart.00077.2008; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Sellers ZM, 2012, EUR J PHARMACOL, V681, P80, DOI 10.1016/j.ejphar.2012.02.018; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Tagami M, 2010, BIOCHEM BIOPH RES CO, V400, P593, DOI 10.1016/j.bbrc.2010.08.109; van de Ven R, 2008, BLOOD, V112, P2353, DOI 10.1182/blood-2008-03-147850	32	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3786	3794		10.1074/jbc.M112.435925	http://dx.doi.org/10.1074/jbc.M112.435925			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264633	Green Published, hybrid			2022-12-28	WOS:000314845000010
J	Jung, M; Lord, MS; Cheng, B; Lyons, JG; Alkhouri, H; Hughes, JM; McCarthy, SJ; Iozzo, RV; Whitelock, JM				Jung, MoonSun; Lord, Megan S.; Cheng, Bill; Lyons, J. Guy; Alkhouri, Hatem; Hughes, J. Margaret; McCarthy, Simon J.; Iozzo, Renato V.; Whitelock, John M.			Mast Cells Produce Novel Shorter Forms of Perlecan That Contain Functional Endorepellin A ROLE IN ANGIOGENESIS AND WOUND HEALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; CHONDROITIN SULFATE-E; HEPARAN-SULFATE; SERGLYCIN PROTEOGLYCAN; MONOCLONAL-ANTIBODY; ANGIOSTATIC MODULE; CORE PROTEIN; DOMAIN V; FRAGMENT; GENE	Mast cells are derived from hematopoietic progenitors that are known to migrate to and reside within connective and mucosal tissues, where they differentiate and respond to various stimuli by releasing pro-inflammatory mediators, including histamine, growth factors, and proteases. This study demonstrated that primary human mast cells as well as the rat and human mast cell lines, RBL-2H3 and HMC-1, produce the heparan sulfate proteoglycan, perlecan, with a molecular mass of 640 kDa as well as smaller molecular mass species of 300 and 130 kDa. Utilizing domain-specific antibodies coupled with N-terminal sequencing, it was confirmed that both forms contained the C-terminal module of the protein core known as endorepellin, which were generated by mast cell-derived proteases. Domain-specific RT-PCR experiments demonstrated that transcripts corresponding to domains I and V, including endorepellin, were present; however, mRNA transcripts corresponding to regions of domain III were not present, suggesting that these cells were capable of producing spliced forms of the protein core. Fractions from mast cell cultures that were enriched for these fragments were shown to bind endothelial cells via the alpha(2)beta(1) integrin and stimulate the migration of cells in "scratch assays," both activities of which were inhibited by incubation with either anti-endorepellin or anti-perlecan antibodies. This study shows for the first time that mast cells secrete and process the extracellular proteoglycan perlecan into fragments containing the endorepellin C-terminal region that regulate angiogenesis and matrix turnover, which are both key events in wound healing.	[Whitelock, John M.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia; [Lyons, J. Guy] Univ Sydney, Discipline Dermatol, Bosch Inst, Sydney Canc Ctr, Sydney, NSW 2006, Australia; [Alkhouri, Hatem; Hughes, J. Margaret] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [McCarthy, Simon J.] HemCon Med Technol Inc, Portland, OR 97223 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	University of New South Wales Sydney; University of Sydney; University of Sydney; Jefferson University; Jefferson University	Whitelock, JM (corresponding author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.	j.whitelock@unsw.edu.au	Lyons, Guy/B-1319-2012; Cheng, Bill/M-8387-2013; Alkhouri, Hatem/AAG-3390-2021; Lord, Megan/D-4673-2013; Iozzo, Renato/AAS-1980-2020	Lyons, Guy/0000-0002-4835-4663; Alkhouri, Hatem/0000-0002-5569-704X; Lord, Megan/0000-0002-0506-9811; Whitelock, John/0000-0003-1835-802X; Cheng, Bill/0000-0002-0692-4349; Iozzo, Renato/0000-0002-5908-5112	Australian Research Council under the Linkage Project [LP0776293]; NATIONAL CANCER INSTITUTE [R01CA039481, R01CA047282] Funding Source: NIH RePORTER	Australian Research Council under the Linkage Project(Australian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by partial funding from the Australian Research Council under the Linkage Project (Grant LP0776293).	Alkhouri H, 2011, ALLERGY, V66, P1231, DOI 10.1111/j.1398-9995.2011.02616.x; Artuc M, 1999, EXP DERMATOL, V8, P1, DOI 10.1111/j.1600-0625.1999.tb00342.x; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2007, BLOOD, V109, P3745, DOI 10.1182/blood-2006-08-039925; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Cailhier JF, 2008, J BIOL CHEM, V283, P27220, DOI 10.1074/jbc.M801164200; CATERSON B, 1983, J BIOL CHEM, V258, P8848; Chang JW, 2008, PROTEOM CLIN APPL, V2, P23, DOI 10.1002/prca.200780049; Chuang CY, 2010, BIOCHEMISTRY-US, V49, P5524, DOI 10.1021/bi1005199; COHEN IR, 1993, P NATL ACAD SCI USA, V90, P10404, DOI 10.1073/pnas.90.21.10404; COUCHMAN JR, 1995, J HISTOCHEM CYTOCHEM, V43, P955, DOI 10.1177/43.9.7543915; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Duelli A, 2009, J IMMUNOL, V183, P7073, DOI 10.4049/jimmunol.0900309; GILEAD L, 1987, IMMUNOLOGY, V62, P23; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; GOTO T, 1984, AM REV RESPIR DIS, V130, P797; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; HAWKINS RA, 1985, ANN INTERN MED, V102, P182, DOI 10.7326/0003-4819-102-2-182; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; Joseph SJ, 1996, DEVELOPMENT, V122, P3443; KATZ HR, 1986, J BIOL CHEM, V261, P3393; Knox S, 2001, PROTEOMICS, V1, P1534, DOI 10.1002/1615-9861(200111)1:12<1534::AID-PROT1534>3.0.CO;2-A; Knox S, 2002, J BIOL CHEM, V277, P14657, DOI 10.1074/jbc.M111826200; Laplante P, 2006, J BIOL CHEM, V281, P30383, DOI 10.1074/jbc.M606412200; Lee B, 2011, J CLIN INVEST, V121, P3005, DOI 10.1172/JCI46358; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; Lundquist EA, 1996, DEVELOPMENT, V122, P1601; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; Melrose J, 2006, J BIOL CHEM, V281, P36905, DOI 10.1074/jbc.M608462200; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; Mullen GP, 1999, MOL BIOL CELL, V10, P3205, DOI 10.1091/mbc.10.10.3205; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; Ng MFY, 2010, INT WOUND J, V7, P55, DOI 10.1111/j.1742-481X.2009.00651.x; NILSSON G, 1994, SCAND J IMMUNOL, V39, P489, DOI 10.1111/j.1365-3083.1994.tb03404.x; Oda O, 1996, CLIN CHIM ACTA, V255, P119, DOI 10.1016/0009-8981(96)06395-4; Parker TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033714; Passante E, 2009, INFLAMM RES, V58, P611, DOI [10.1007/s00011-009-0028-4, 10.1007/s00011-009-0644-z]; Patel VN, 2007, DEVELOPMENT, V134, P4177, DOI 10.1242/dev.011171; Samoszuk M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-121; SELDIN DC, 1985, J BIOL CHEM, V260, P1131; Skold CM, 2001, INFLAMMATION, V25, P47, DOI 10.1023/A:1007075628316; Smith SML, 2007, ARCH BIOCHEM BIOPHYS, V468, P244, DOI 10.1016/j.abb.2007.10.006; Soulez M, 2012, CIRC RES, V110, P94, DOI 10.1161/CIRCRESAHA.111.250431; Soulez M, 2010, STEM CELLS, V28, P810, DOI 10.1002/stem.403; Spartz AK, 2004, MOL CELL BIOL, V24, P6811, DOI 10.1128/MCB.24.15.6811-6823.2004; Spike CA, 2001, MOL CELL BIOL, V21, P4985, DOI 10.1128/MCB.21.15.4985-4995.2001; STEVENS RL, 1988, J BIOL CHEM, V263, P7287; Tapanadechopone P, 1999, BIOCHEM BIOPH RES CO, V265, P680, DOI 10.1006/bbrc.1999.1714; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; THOMPSON HL, 1988, J IMMUNOL, V140, P2708; THOMPSON HL, 1991, J CLIN INVEST, V87, P619, DOI 10.1172/JCI115038; West L, 2006, J ORTHOP RES, V24, P1317, DOI 10.1002/jor.20160; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200	59	51	51	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3289	3304		10.1074/jbc.M112.387811	http://dx.doi.org/10.1074/jbc.M112.387811			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235151	Green Published, hybrid			2022-12-28	WOS:000314397900035
J	Pan, JA; Fan, YJ; Gandhirajan, RK; Madesh, M; Zong, WX				Pan, Ji-An; Fan, Yongjun; Gandhirajan, Rajesh Kumar; Madesh, Muniswamy; Zong, Wei-Xing			Hyperactivation of the Mammalian Degenerin MDEG Promotes Caspase-8 Activation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CAENORHABDITIS-ELEGANS; CELL-DEATH; C-ELEGANS; NEURONAL DEGENERATION; 26S PROTEASOME; CYTOCHROME-C; NA+ CHANNEL; AUTOPHAGY; CALCIUM	Intracellular calcium overload plays a critical role in numerous pathological syndromes such as heart failure, brain ischemia, and stroke. Hyperactivation of the acid-sensing ion channels including degenerin/epithelial amiloride-sensitive sodium (DEG/ENaC) channels has been shown to elevate intracellular calcium and cause subsequent neuronal cell death that is independent of the canonical Egl-1/Ced-9/Ced-4/Ced-3 apoptotic pathway in Caenorhabditis elegans. In mammalian cells, hyperactivation of the DEG/ENaC channels can also lead to cell death, although the underlying mechanism remains largely unknown. Here, we use a tetracycline-inducible system to express the hyperactivation mutant of a mammalian DEG/ENaC channel protein, MDEG G430F, in murine kidney epithelial cells deficient in the key mitochondrial apoptotic proteins Bax and Bak. Remarkably, expression of MDEG G430F induces increased intracellular calcium, reactive oxygen species (ROS) production, and cell death. The MDEG G430F-induced cell death is blocked by the intracellular calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (acetoxymethyl ester), ROS scavengers, and the caspase inhibitor z-VAD-fmk (where z and fmk are benzyloxycarbonyl and fluoromethyl ketone). Mechanistically, the intracellular calcium overload and ROS increase lead to the inhibition of proteasomal and autophagic protein degradation, which promotes the accumulation of protein aggregates containing caspase-8 and subsequent caspase-8 activation. As protein aggregation upon the inhibition of proteasomal and autophagic degradation pathways is mediated by the ubiquitin-binding protein SQSTM1/p62 and the autophagy-related protein LC3, silencing of p62 and LC3 protects cells from MDEG G430F-induced cell death. Our results uncover a new mechanism of caspase-8-mediated apoptosis induced by intracellular calcium overload that is dependent on the autophagy-related proteins LC3 and p62 upon hyperactivation of DEG/ENaC channels.	[Pan, Ji-An; Fan, Yongjun; Zong, Wei-Xing] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Gandhirajan, Rajesh Kumar; Madesh, Muniswamy] Temple Univ, Dept Biochem, Philadelphia, PA 19140 USA; [Gandhirajan, Rajesh Kumar; Madesh, Muniswamy] Temple Univ, Ctr Translat Med, Philadelphia, PA 19140 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Zong, WX (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	wzong@notes.cc.sunysb.edu		Gandhirajan, Rajesh/0000-0002-0039-771X	National Institutes of Health [CA129536, GM097355, HL086699]; NATIONAL CANCER INSTITUTE [R01CA129536] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA129536 and GM097355 (to W. X. Z) and HL086699 (to M. M.).	Ausserlechner MJ, 2006, MOL CANCER THER, V5, P1927, DOI 10.1158/1535-7163.MCT-05-0500; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dou ZX, 2010, J CELL BIOL, V191, P827, DOI 10.1083/jcb.201006056; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Harr MW, 2010, AUTOPHAGY, V6, P912, DOI 10.4161/auto.6.7.13290; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; KAWAHARA H, 1994, DEV BIOL, V166, P623, DOI 10.1006/dbio.1994.1342; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lam D, 2008, MOL BIOL CELL, V19, P691, DOI 10.1091/mbc.E07-08-0823; Li Minghua, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P156; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Qadri YJ, 2012, AM J PHYSIOL-CELL PH, V302, pC943, DOI 10.1152/ajpcell.00019.2012; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Toth ML, 2007, J CELL SCI, V120, P1134, DOI 10.1242/jcs.03401; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Ullman E, 2011, MOL CELL BIOL, V31, P2902, DOI 10.1128/MCB.05452-11; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Wei MC, 2000, GENE DEV, V14, P2060; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Young MM, 2012, J BIOL CHEM, V287, P12455, DOI 10.1074/jbc.M111.309104; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	42	24	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2952	2963		10.1074/jbc.M112.441063	http://dx.doi.org/10.1074/jbc.M112.441063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23239879	Green Published, hybrid			2022-12-28	WOS:000314397900006
J	Vellano, CP; Brown, NE; Blumer, JB; Hepler, JR				Vellano, Christopher P.; Brown, Nicole E.; Blumer, Joe B.; Hepler, John R.			Assembly and Function of the Regulator of G protein Signaling 14 (RGS14)center dot H-Ras Signaling Complex in Live Cells Are Regulated by G alpha(i1) and G alpha(i)-linked G Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; AIRWAY SMOOTH-MUSCLE; SYNAPTIC PLASTICITY; EXPRESSION ANALYSIS; SURFACE EXPRESSION; EGF RECEPTOR; H-RAS; RGS14; ALPHA; ACTIVATION	Regulator of G protein signaling 14 (RGS14) is a multifunctional scaffolding protein that integrates heterotrimeric G protein and H-Ras signaling pathways. RGS14 possesses an RGS domain that binds active G alpha(i/o)-GTP subunits to promote GTP hydrolysis and a G protein regulatory (GPR) motif that selectively binds inactive G alpha(i1/3)-GDP subunits to form a stable heterodimer at cellular membranes. RGS14 also contains two tandem Ras/Rap binding domains (RBDs) that bind H-Ras. Here we show that RGS14 preferentially binds activated H-Ras-GTP in live cells to enhance H-Ras cellular actions and that this interaction is regulated by inactive G alpha(i1)-GDP and Gprotein-coupled receptors (GPCRs). Using bioluminescence resonance energy transfer (BRET) in live cells, we show that RGS14-Luciferase and active H-Ras(G/V)-Venus exhibit a robust BRET signal at the plasma membrane that is markedly enhanced in the presence of inactive G alpha(i1)-GDP but not active G alpha(i1)-GTP. Active H-Ras(G/V) interacts with a native RGS14.G alpha(i1) complex in brain lysates, and co-expression of RGS14 and G alpha(i1) in PC12 cells greatly enhances H-Ras(G/V) stimulatory effects on neurite outgrowth. Stimulation of the G alpha(i)-linked alpha(2A)-adrenergic receptor induces a conformational change in the G alpha(i1).RGS14.H-Ras(G/V) complex that may allow subsequent regulation of the complex by other binding partners. Together, these findings indicate that inactive G alpha(i1)-GDP enhances the affinity of RGS14 for H-Ras-GTP in live cells, resulting in a ternary signaling complex that is further regulated by GPCRs.	[Vellano, Christopher P.; Brown, Nicole E.; Hepler, John R.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Blumer, Joe B.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA	Emory University; Medical University of South Carolina	Hepler, JR (corresponding author), Emory Univ, Sch Med, Rollins Res Ctr G206, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	jhepler@emory.edu		Blumer, Joe/0000-0002-0020-3815; Brown, Nicole/0000-0002-3184-0550	National Institutes of Health [R01NS049195, R01NS037112, GM086510]; Microscopy Core of the Emory Neuroscience NINDS Core Facilities Grant [P30NS055077]; PhRMA Foundation Pre-doctoral Pharmacology/Toxicology Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086510, T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037112, R01NS049195, P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microscopy Core of the Emory Neuroscience NINDS Core Facilities Grant; PhRMA Foundation Pre-doctoral Pharmacology/Toxicology Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS049195 and R01NS037112 (to J. R. H.) and GM086510 (to J. B. B.) and by Microscopy Core of the Emory Neuroscience NINDS Core Facilities Grant P30NS055077. This work was also supported by a PhRMA Foundation Pre-doctoral Pharmacology/Toxicology Fellowship (to C. P. V).	Alderton F, 2001, J BIOL CHEM, V276, P28578, DOI 10.1074/jbc.M102771200; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Cho HS, 2005, J BIOL CHEM, V280, P805, DOI 10.1074/jbc.M408163200; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Conway AM, 1999, BIOCHEM J, V337, P171, DOI 10.1042/0264-6021:3370171; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DESCHENES RJ, 1989, J BIOL CHEM, V264, P11865; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; DUZIC E, 1992, J BIOL CHEM, V267, P9844; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hampoelz B, 2004, CELL, V119, P453, DOI 10.1016/j.cell.2004.10.025; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollinger S, 2003, BIOCHEMISTRY-US, V42, P811, DOI 10.1021/bi026664y; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Khafizov K, 2009, J MOL MODEL, V15, P1491, DOI 10.1007/s00894-009-0516-z; Kiel C, 2005, J MOL BIOL, V348, P759, DOI 10.1016/j.jmb.2005.02.046; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Manabe T, 2000, J NEUROSCI, V20, P2504; Mittal V, 2004, J BIOL CHEM, V279, P46772, DOI 10.1074/jbc.M407409200; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Pineda VV, 2004, NEURON, V41, P153, DOI 10.1016/S0896-6273(03)00813-4; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Rakhit S, 2000, MOL PHARMACOL, V58, P413, DOI 10.1124/mol.58.2.413; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schade MA, 2005, GENETICS, V169, P631, DOI 10.1534/genetics.104.032334; Schmidt WK, 1998, P NATL ACAD SCI USA, V95, P11175, DOI 10.1073/pnas.95.19.11175; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Snow BE, 1997, BIOCHEM BIOPH RES CO, V233, P770, DOI 10.1006/bbrc.1997.6537; Tonissoo T, 2006, BEHAV BRAIN RES, V167, P42, DOI 10.1016/j.bbr.2005.08.025; Tonissoo T, 2003, GENE EXPR PATTERNS, V3, P591, DOI 10.1016/S1567-133X(03)00119-4; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Vellano CP, 2011, TRENDS PHARMACOL SCI, V32, P666, DOI 10.1016/j.tips.2011.07.005; Vellano CP, 2011, BIOCHEMISTRY-US, V50, P752, DOI 10.1021/bi101910n; Willard FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004884; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	59	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3620	3631		10.1074/jbc.M112.440057	http://dx.doi.org/10.1074/jbc.M112.440057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250758	Green Published, hybrid			2022-12-28	WOS:000314397900066
J	Strathern, J; Malagon, F; Irvin, J; Gotte, D; Shafer, B; Kireeva, M; Lubkowska, L; Jin, DJ; Kashlev, M				Strathern, Jeffrey; Malagon, Francisco; Irvin, Jordan; Gotte, Deanna; Shafer, Brenda; Kireeva, Maria; Lubkowska, Lucyna; Jin, Ding Jun; Kashlev, Mikhail			The Fidelity of Transcription RPB1 (RPO21) MUTATIONS THAT INCREASE TRANSCRIPTIONAL SLIPPAGE IN S. CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; READING-FRAME RESTORATION; GENE-EXPRESSION; ELONGATION; BACTERIAL; YEAST; COMPLEXES; SEQUENCE; COLI	The fidelity of RNA synthesis depends on both accurate template-mediated nucleotide selection and proper maintenance of register between template and RNA. Loss of register, or transcriptional slippage, is particularly likely on homopolymeric runs in the template. Transcriptional slippage can alter the coding capacity of mRNAs and is used as a regulatory mechanism. Here we describe mutations in the largest subunit of Saccharomyces cerevisiae RNA polymerase II that substantially increase the level of transcriptional slippage. Alleles of RPB1 (RPO21) with elevated slippage rates were identified among 6-azauracil-sensitive mutants and were also isolated using a slippage-dependent reporter gene. Biochemical characterization of polymerase II isolated from these mutants confirms elevated levels of transcriptional slippage.	[Strathern, Jeffrey] NCI, Gene Regulat & Chromosome Biol Lab, Ctr Canc Res, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Strathern, J (corresponding author), NCI, Gene Regulat & Chromosome Biol Lab, Ctr Canc Res, Frederick Natl Lab Canc Res, POB B, Frederick, MD 21702 USA.	strathej@mail.nih.gov	Kireeva, Maria/B-4391-2018	Kireeva, Maria/0000-0003-0527-3182; Irvin, Jordan/0000-0001-8504-5985	National Institutes of Health; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010992, ZIABC010795, ZIABC010632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program. This work was also supported by the National Cancer Institute and the Center for Cancer Research.	Amberg DC., 2005, METHODS YEAST GENETI; Anikin M, 2010, NUCLEIC ACIDS MOL BI, V24, P409, DOI 10.1007/978-0-387-89382-2_19; Baranov PV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r25; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Fox Jeffrey D, 2003, Methods Mol Biol, V205, P99; Kaplan C, 2008, NATION, V286, P30; Kireeva ML, 2008, MOL CELL, V30, P557, DOI 10.1016/j.molcel.2008.04.017; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Koyama H, 2003, GENES CELLS, V8, P779, DOI 10.1046/j.1365-2443.2003.00677.x; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Larsen B, 2000, P NATL ACAD SCI USA, V97, P1683, DOI 10.1073/pnas.97.4.1683; Linton MF, 1997, J BIOL CHEM, V272, P14127, DOI 10.1074/jbc.272.22.14127; LINTON MF, 1992, P NATL ACAD SCI USA, V89, P11431, DOI 10.1073/pnas.89.23.11431; Liu XQ, 2009, J BIOL CHEM, V284, P36262, DOI 10.1074/jbc.M109.056820; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Nesser NK, 2006, P NATL ACAD SCI USA, V103, P3268, DOI 10.1073/pnas.0511330103; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; Penno C, 2006, MOL MICROBIOL, V62, P1460, DOI 10.1111/j.1365-2958.2006.05456.x; Ratinier M, 2008, J GEN VIROL, V89, P1569, DOI 10.1099/vir.0.83614-0; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; Shaw RJ, 2002, J BIOL CHEM, V277, P24420, DOI 10.1074/jbc.M202059200; Strathern JN, 2012, BBA-GENE REGUL MECH, V1819, P694, DOI 10.1016/j.bbagrm.2012.02.005; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Turnbough CL, 2008, MOL MICROBIOL, V69, P10, DOI 10.1111/j.1365-2958.2008.06272.x; Turnbough CL, 2011, CURR OPIN MICROBIOL, V14, P142, DOI 10.1016/j.mib.2011.01.012; Wu JS, 1996, P NATL ACAD SCI USA, V93, P11552, DOI 10.1073/pnas.93.21.11552; XIONG XF, 1993, J MOL BIOL, V231, P569, DOI 10.1006/jmbi.1993.1310; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhou YN, 2013, J BIOL CHEM, V288, P2700, DOI 10.1074/jbc.M112.429464	35	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2689	2699		10.1074/jbc.M112.429506	http://dx.doi.org/10.1074/jbc.M112.429506			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223234	Green Published, hybrid			2022-12-28	WOS:000314211500053
J	Qiang, L; Wu, CL; Ming, M; Viollet, B; He, YY				Qiang, Lei; Wu, Chunli; Ming, Mei; Viollet, Benoit; He, Yu-Ying			Autophagy Controls p38 Activation to Promote Cell Survival under Genotoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UVB-INDUCED APOPTOSIS; PROTEIN-KINASE; AMPK PHOSPHORYLATION; MAP KINASE; DEGRADATION; INHIBITION; TUMOR; GROWTH; GENE; IRRADIATION	Deregulated cell survival under carcinogen-induced genotoxic stress is vital for cancer development. One of the cellular processes critical for cell survival under metabolic stress and energy starvation is autophagy, a catabolic process involved in capture and delivery of cytoplasmic components to lysosomes for degradation. However, the role of autophagy following carcinogen-induced genotoxic stress remains unclear. Here we show that UVB radiation, a known human skin carcinogen that operates by causing DNA damage, induced autophagy and autophagic flux through AMP kinase activation. Autophagy deficiency sensitizes cells to UVB-induced apoptosis through increasing p62-dependent activation of the stress-activated protein kinase p38. Compared with normal human skin, autophagy was activated in human squamous cell carcinomas, in association with decreased phosphorylation of p38, and increased phosphorylation of ATR and formation of gamma-H2AX, two markers of DNA damage response. Our results demonstrate that autophagy promotes cell survival through suppressing p62-mediated p38 activation and thus may facilitate tumor development under genotoxic stress. These findings suggest that autophagy plays an oncogenic role in epithelial carcinogenesis by promoting cell survival.	[Qiang, Lei; Wu, Chunli; Ming, Mei; He, Yu-Ying] Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA; [Wu, Chunli] China Med Univ, Dept Radiat Oncol, Affiliated Hosp 4, Shenyang 110001, Liaoning, Peoples R China; [Viollet, Benoit] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Viollet, Benoit] CNRS, UMR8104, F-75014 Paris, France; [Viollet, Benoit] Univ Paris 05, F-75014 Paris, France	University of Chicago; China Medical University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	He, YY (corresponding author), Univ Chicago, Dept Med, Dermatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu	Qiang, Lei/B-2763-2012; Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Qiang, Lei/0000-0002-7164-3164; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224	National Institutes of Health [ES016936, UL1RR024999]; American Cancer Society [RSG-13-078-01]; University of Chicago Comprehensive Cancer Center [P30 CA014599]; University of Chicago Friends of Dermatology Research; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); University of Chicago Comprehensive Cancer Center; University of Chicago Friends of Dermatology Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES016936 (to Y.-Y.H.) and UL1RR024999 through the Clinical and Translational Science Award (CTSA) Program. This work was also supported by American Cancer Society Grant RSG-13-078-01 (to Y.-Y.H.), University of Chicago Comprehensive Cancer Center Pilot Program Grant P30 CA014599, and the University of Chicago Friends of Dermatology Research.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Chouinard N, 2002, BIOCHEM J, V365, P133, DOI 10.1042/BJ20020072; Dang CV, 2008, J CLIN INVEST, V118, P15, DOI 10.1172/JCI34503; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Gills JJ, 2008, AUTOPHAGY, V4, P107, DOI 10.4161/auto.5224; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harhaji-Trajkovic L, 2009, J CELL MOL MED, V13, P3644, DOI 10.1111/j.1582-4934.2009.00663.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Ito H, 2005, INT J ONCOL, V26, P1401; Ivanov VN, 2000, ONCOGENE, V19, P3003, DOI 10.1038/sj.onc.1203602; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Landis M, 2007, ARCH DERMATOL RES, V299, P263, DOI 10.1007/s00403-007-0753-x; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mukherjee P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-37; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Roy S, 2010, SEMIN IMMUNOPATHOL, V32, P383, DOI 10.1007/s00281-010-0213-0; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seo MR, 2007, J BIOL CHEM, V282, P24720, DOI 10.1074/jbc.M702343200; Shaw MM, 2007, J CELL MOL MED, V11, P286, DOI 10.1111/j.1582-4934.2007.00023.x; Shimizu H, 1999, J INVEST DERMATOL, V112, P769, DOI 10.1046/j.1523-1747.1999.00582.x; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sudo T, 2000, BIOCHEM BIOPH RES CO, V269, P521, DOI 10.1006/bbrc.2000.2333; Turchi L, 2008, CELL DEATH DIFFER, V15, P1472, DOI 10.1038/cdd.2008.74; Van Laethem A, 2004, FASEB J, V18, P1946, DOI 10.1096/fj.04-2285fje; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang J, 2008, MOL CARCINOGEN, V47, P974, DOI 10.1002/mc.20450	50	83	84	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1603	1611		10.1074/jbc.M112.415224	http://dx.doi.org/10.1074/jbc.M112.415224			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23212914	hybrid, Green Published			2022-12-28	WOS:000313751400016
J	Zhu, L; Zhong, XW; Chen, SRW; Banavali, N; Liu, Z				Zhu, Li; Zhong, Xiaowei; Chen, S. R. Wayne; Banavali, Nilesh; Liu, Zheng			Modeling a Ryanodine Receptor N-terminal Domain Connecting the Central Vestibule and the Corner Clamp Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; SKELETAL-MUSCLE; CRYOELECTRON MICROSCOPY; FK506-BINDING PROTEIN; DEFECTIVE REGULATION; CA2+ RELEASE; STRUCTURAL-CHARACTERIZATION; 3-DIMENSIONAL LOCALIZATION; PHOSPHORYLATION SITE; MOLECULAR-DYNAMICS	Ryanodine receptors (RyRs) form a class of intracellular calcium release channels in various excitable tissues and cells such as muscles and neurons. They are the major cellular mediators of the release of calcium ions from the sarcoplasmic reticulum, an essential step in muscle excitation-contraction coupling. Several crystal structures of skeletal muscle RyR1 peptide fragments have been solved, but these cover less than 15% of the full-length RyR1 sequence. In this study, by combining modeling techniques with sub-nanometer resolution cryo-electron microscopy (cryo-EM) maps, we obtained pseudo-atomic models for RyR fragments consisting of residues 850-1,056 in rabbit RyR1 or residues 861-1,067 in mouse RyR2. These fragments are docked into a domain that connects the central vestibule and corner clamp region of RyR, resulting in a good match of the secondary structure elements in the cryo-EM map and the pseudo-atomic models, which is also consistent with our previous mappings of GFP insertions by cryo-EM and with FRET measurements involving RyR and FK506-binding protein (FKBP). A combined model of the RyR fragment and FKBP docked into the cryo-EM map suggests that the fragment is positioned adjacent to the FKBP-binding site. Its predicted binding interface with FKBP consists primarily of electrostatic contacts and contains several disease-associated mutations. A dynamic interaction between the fragment and an RyR phosphorylation domain, characterized by FRET experiments, also supports the structural predictions of the pseudo-atomic models.	[Zhu, Li; Banavali, Nilesh; Liu, Zheng] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Zhong, Xiaowei; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Zhong, Xiaowei; Chen, S. R. Wayne] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	State University of New York (SUNY) System; Wadsworth Center; University of Calgary; University of Calgary	Liu, Z (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.	liuz@wadsworth.org		Banavali, Nilesh/0000-0003-2206-7049; Liu, Zheng/0000-0001-6952-3406	National Institutes of Health [R01HL095541]; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095541] Funding Source: NIH RePORTER; Alberta Innovates [201001238] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Alberta Innovates	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL095541 (to Z. L.). This work was also supported by a Canadian Institutes of Health Research grant (to S. R. W. C.).	Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Blunck R, 2008, P NATL ACAD SCI USA, V105, P20263, DOI 10.1073/pnas.0807056106; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; Du GG, 2005, DEV CARDIOVASC MED, V254, P9; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; HAKAMATA Y, 1992, FEBS LETT, V312, P229, DOI 10.1016/0014-5793(92)80941-9; Herren T, 2009, CLIN RES CARDIOL, V98, P141, DOI 10.1007/s00392-009-0751-4; Huang XJ, 2012, J BIOL CHEM, V287, P30328, DOI 10.1074/jbc.M112.383109; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikemoto N, 2005, DEV CARDIOVASC MED, V254, P53; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; Jeyakumar LH, 2001, BIOCHEM BIOPH RES CO, V281, P979, DOI 10.1006/bbrc.2001.4444; Jiang MT, 2002, CIRC RES, V91, P1015, DOI 10.1161/01.RES.0000043663.08689.05; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laver DR, 2010, CURR TOP MEMBR, V66, P69, DOI 10.1016/S1063-5823(10)66004-8; Lee EH, 2004, J BIOL CHEM, V279, P26481, DOI 10.1074/jbc.M309574200; Li YX, 2002, CIRC RES, V90, P309, DOI 10.1161/hh0302.105660; Liu NA, 2008, PROG CARDIOVASC DIS, V51, P23, DOI 10.1016/j.pcad.2007.10.005; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; Lobo PA, 2011, STRUCTURE, V19, P790, DOI 10.1016/j.str.2011.03.016; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Marjamaa A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-12; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Masumiya H, 2003, J BIOL CHEM, V278, P3786, DOI 10.1074/jbc.M210962200; Medeiros-Domingo A, 2009, J AM COLL CARDIOL, V54, P2065, DOI 10.1016/j.jacc.2009.08.022; Meissner G, 2010, CURR TOP MEMBR, V66, P91, DOI 10.1016/S1063-5823(10)66005-X; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; Meng X, 2009, J MOL BIOL, V387, P320, DOI 10.1016/j.jmb.2009.01.059; Oda T, 2005, CIRCULATION, V111, P3400, DOI 10.1161/CIRCULATIONAHA.104.507921; OTSU K, 1990, J BIOL CHEM, V265, P13472; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rusu M, 2012, J STRUCT BIOL, V177, P410, DOI 10.1016/j.jsb.2011.11.029; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 1999, J CELL BIOL, V146, P493, DOI 10.1083/jcb.146.2.493; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Sharma MR, 2000, J BIOL CHEM, V275, P9485, DOI 10.1074/jbc.275.13.9485; Sharma MR, 2006, BIOPHYS J, V90, P164, DOI 10.1529/biophysj.105.063503; Sharma MR, 1998, J BIOL CHEM, V273, P18429, DOI 10.1074/jbc.273.29.18429; Sharma P, 2012, FEBS J, V279, P3952, DOI 10.1111/j.1742-4658.2012.08755.x; Stange M, 2003, J BIOL CHEM, V278, P51693, DOI 10.1074/jbc.M310406200; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; Wang RW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194316; Wehrens XDHT, 2005, DEV CARDIOVASC MED, V254, P151; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Xiao BL, 2005, CIRC RES, V96, P847, DOI 10.1161/01.RES.0000163276.26083.e8; Xin HB, 1999, J BIOL CHEM, V274, P15315, DOI 10.1074/jbc.274.22.15315; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V291, P1102, DOI 10.1006/bbrc.2002.6569; Yang ZK, 2006, CARDIOVASC RES, V70, P475, DOI 10.1016/j.cardiores.2006.03.001; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; Zhang J, 2003, J BIOL CHEM, V278, P14211, DOI 10.1074/jbc.M213164200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou Q, 2008, BIOPHYS J, V95, P4289, DOI 10.1529/biophysj.108.137224; Zissimopoulos S, 2005, J BIOL CHEM, V280, P5475, DOI 10.1074/jbc.M412954200; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	68	10	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					903	914		10.1074/jbc.M112.429670	http://dx.doi.org/10.1074/jbc.M112.429670			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23204524	hybrid, Green Published			2022-12-28	WOS:000313570300015
J	Kapilashrami, K; Bommineni, GR; Machutta, CA; Kim, P; Lai, CT; Simmerling, C; Picart, F; Tonge, PJ				Kapilashrami, Kanishk; Bommineni, Gopal R.; Machutta, Carl A.; Kim, Pilho; Lai, Cheng-Tsung; Simmerling, Carlos; Picart, Francis; Tonge, Peter J.			Thiolactomycin-based beta-Ketoacyl-AcpM Synthase A (KasA) Inhibitors FRAGMENT-BASED INHIBITOR DISCOVERY USING TRANSIENT ONE-DIMENSIONAL NUCLEAR OVERHAUSER EFFECT NMR SPECTROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS; CONDENSING ENZYMES; NOE EXPERIMENTS; BIOSYNTHESIS; NMR; IDENTIFICATION; ANTIMALARIAL; DERIVATIVES; ANALOGS	Thiolactomycin (TLM) is a natural product inhibitor of KasA, the beta-ketoacyl synthase A from Mycobacterium tuberculosis. To improve the affinity of TLM for KasA, a series of TLM analogs have been synthesized based on interligand NOEs between TLM and a pantetheine analog when both are bound simultaneously to the enzyme. Kinetic binding data reveal that position 3 of the thiolactone ring is a suitable position for elaboration of the TLM scaffold, and the structure-activity relationship studies provide information on the molecular features that govern time-dependent inhibition in this enzyme system. These experiments also exemplify the utility of transient one-dimensional NOE spectroscopy for obtaining interligand NOEs compared with traditional steady state two-dimensional NOESY spectroscopy.	[Kapilashrami, Kanishk; Bommineni, Gopal R.; Machutta, Carl A.; Lai, Cheng-Tsung; Simmerling, Carlos; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Kapilashrami, Kanishk; Bommineni, Gopal R.; Picart, Francis; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Lai, Cheng-Tsung; Simmerling, Carlos] SUNY Stony Brook, Dept Biochem, Biochem & Struct Biol Grad Program, Stony Brook, NY 11794 USA; [Simmerling, Carlos] SUNY Stony Brook, Laufer Ctr Phys & Quantitat Biol, Stony Brook, NY 11794 USA; [Kim, Pilho] Korea Res Inst Chem Technol, Ctr Canc & Infect Dis, Bioorgan Sci Div, Taejon 305600, South Korea	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Korea Research Institute of Chemical Technology (KRICT)	Picart, F (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.	francis.picart@sunysb.edu; peter.tonge@sunysb.edu	Lai, Cheng-Tsung/H-6728-2013; Tonge, Peter J/A-7443-2009	Lai, Cheng-Tsung/0000-0002-1192-2815; Tonge, Peter J/0000-0003-1606-3471	National Institutes of Health [GM102864, AI044639]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044639, R21AI044639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM102864 and AI044639 (to P. J. T.).	Al-Balas Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005617; Becattini B, 2006, CHEM-EUR J, V12, P2658, DOI 10.1002/chem.200500636; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Brown MS, 2003, J AM CHEM SOC, V125, P10166, DOI 10.1021/ja034540i; Chen JH, 2007, ACS CHEM BIOL, V2, P329, DOI 10.1021/cb700025j; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; DeLano W.L, PYMOL MOL GRAPHICS S; EDZES HT, 1977, NATURE, V265, P521, DOI 10.1038/265521a0; Hu HT, 2006, J MAGN RESON, V182, P173, DOI 10.1016/j.jmr.2006.06.009; Jones AL, 2000, BIOCHEM J, V347, P205, DOI 10.1042/0264-6021:3470205; Jones SM, 2004, BIOORGAN MED CHEM, V12, P683, DOI 10.1016/j.bmc.2003.11.023; Kim P, 2006, J MED CHEM, V49, P159, DOI 10.1021/jm050825p; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Lee PJ, 2009, J MED CHEM, V52, P952, DOI 10.1021/jm8008103; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; Luckner SR, 2009, STRUCTURE, V17, P1004, DOI 10.1016/j.str.2009.04.012; Machutta CA, 2010, J BIOL CHEM, V285, P6161, DOI 10.1074/jbc.M109.077909; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; McFadden JM, 2005, J MED CHEM, V48, P946, DOI 10.1021/jm049389h; MIYAKAWA S, 1982, J ANTIBIOT, V35, P411, DOI 10.7164/antibiotics.35.411; Mukherjee S, 2010, J CHEM INF MODEL, V50, P1986, DOI 10.1021/ci1001982; NOTO T, 1982, J ANTIBIOT, V35, P401, DOI 10.7164/antibiotics.35.401; Omura S, 1981, Methods Enzymol, V72, P520; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; SASAKI H, 1982, J ANTIBIOT, V35, P396, DOI 10.7164/antibiotics.35.396; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Singh S, 2008, EUR J MED CHEM, V43, P1071, DOI 10.1016/j.ejmech.2007.06.018; Spry C, 2005, ANTIMICROB AGENTS CH, V49, P4649, DOI 10.1128/AAC.49.11.4649-4657.2005; STOTT K, 1995, J AM CHEM SOC, V117, P4199, DOI 10.1021/ja00119a048; Stott K, 1997, J MAGN RESON, V125, P302, DOI 10.1006/jmre.1997.1110; Swinney DC, 2004, NAT REV DRUG DISCOV, V3, P801, DOI 10.1038/nrd1500; Szabo A, 1999, TETRAHEDRON-ASYMMETR, V10, P61, DOI 10.1016/S0957-4166(98)00499-6; WANG CLJ, 1984, TETRAHEDRON LETT, V25, P5243; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Witkowski A, 1999, BIOCHEMISTRY-US, V38, P11643, DOI 10.1021/bi990993h	36	26	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6045	6052		10.1074/jbc.M112.414516	http://dx.doi.org/10.1074/jbc.M112.414516			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23306195	hybrid, Green Published			2022-12-28	WOS:000315820700002
J	Siebert, AP; Ma, ZM; Grevet, JD; Demuro, A; Parker, I; Foskett, JK				Siebert, Adam P.; Ma, Zhongming; Grevet, Jeremy D.; Demuro, Angelo; Parker, Ian; Foskett, J. Kevin			Structural and Functional Similarities of Calcium Homeostasis Modulator 1 (CALHM1) Ion Channel with Connexins, Pannexins, and Innexins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNELS; BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; ORGANIC CATIONS; TOPOLOGY PREDICTION; MOLECULAR-BASIS; SODIUM-CHANNEL; ORAI3 CHANNELS; PERMEABILITY; FAMILY	CALHM1 (calcium homeostasis modulator 1) forms a plasma membrane ion channel that mediates neuronal excitability in response to changes in extracellular Ca2+ concentration. Six human CALHM homologs exist with no homology to other proteins, although CALHM1 is conserved across >20 species. Here we demonstrate that CALHM1 shares functional and quaternary and secondary structural similarities with connexins and evolutionarily distinct innexins and their vertebrate pannexin homologs. A CALHM1 channel is a hexamer, comprised of six monomers, each of which possesses four transmembrane domains, cytoplasmic amino and carboxyl termini, an aminoterminal helix, and conserved extracellular cysteines. The estimated pore diameter of the CALHM1 channel is similar to 14 angstrom, enabling permeation of large charged molecules. Thus, CALHMs, connexins, and pannexins and innexins are structurally related protein families with shared and distinct functional properties.	[Siebert, Adam P.; Ma, Zhongming; Grevet, Jeremy D.; Foskett, J. Kevin] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Demuro, Angelo; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Irvine	Foskett, JK (corresponding author), Univ Penn, Dept Physiol, 726 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu	Foskett, Kevin/R-2549-2019	Foskett, J. Kevin/0000-0002-8854-0268	National Institutes of Health [MH059937, GM056328, GM048071]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056328, R01GM048071, R01GM056328, R37GM048071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH059937 and GM056328 (to J. K. F.) and GM048071 (to I. P.).	ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Bahima L, 2006, J CELL PHYSIOL, V206, P95, DOI 10.1002/jcp.20440; BALASUBRAMANIAN S, 1995, J MEMBRANE BIOL, V146, P177; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; BARNES TM, 1994, TRENDS GENET, V10, P303, DOI 10.1016/0168-9525(94)90023-X; Beblo DA, 1997, J GEN PHYSIOL, V109, P509, DOI 10.1085/jgp.109.4.509; BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Common JEA, 2002, BIOCHEM BIOPH RES CO, V298, P651, DOI 10.1016/S0006-291X(02)02517-2; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; DAHL G, 1994, BIOPHYS J, V67, P1816, DOI 10.1016/S0006-3495(94)80663-0; DANI JA, 1989, J NEUROSCI, V9, P884; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; Demuro A, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1846074; Demuro A, 2011, P NATL ACAD SCI USA, V108, P17832, DOI 10.1073/pnas.1114814108; Ding H, 2009, BIOPHYS J, V97, P912, DOI 10.1016/j.bpj.2009.05.035; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; Ebihara L, 2003, NEWS PHYSIOL SCI, V18, P100, DOI 10.1152/nips.01431.2002; Ebihara L, 1996, BIOPHYS J, V71, P742, DOI 10.1016/S0006-3495(96)79273-1; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Eskandari S, 2002, J MEMBRANE BIOL, V185, P93, DOI 10.1007/s00232-001-0115-0; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Fushiki D, 2010, BIOMED RES-TOKYO, V31, P133, DOI 10.2220/biomedres.31.133; Gallego-Sandin S, 2011, BIOCHEM J, V437, P469, DOI 10.1042/BJ20110479; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hamer W. J., 1972, J PHYS CHEM REF DATA, V1, P1047, DOI DOI 10.1063/1.3253108; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hua VB, 2003, J MEMBRANE BIOL, V194, P59, DOI 10.1007/s00232-003-2026-8; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lambert JC, 2007, PSYCHONEUROENDOCRINO, V32, pS62, DOI 10.1016/j.psyneuen.2007.05.015; Landesman Y, 1999, J CELL SCI, V112, P2391; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Ma ZM, 2012, P NATL ACAD SCI USA, V109, pE1963, DOI 10.1073/pnas.1204023109; Maeda S, 2011, CELL MOL LIFE SCI, V68, P1115, DOI 10.1007/s00018-010-0551-z; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Martinez-Wittinghan FJ, 2006, J MEMBRANE BIOL, V211, P163, DOI 10.1007/s00232-006-0021-6; MCCLESKEY EW, 1985, P NATL ACAD SCI USA, V82, P7149, DOI 10.1073/pnas.82.20.7149; Meuser D, 1999, FEBS LETT, V462, P447, DOI 10.1016/S0014-5793(99)01579-3; Moreno-Ortega AJ, 2010, BIOCHEM BIOPH RES CO, V391, P722, DOI 10.1016/j.bbrc.2009.11.127; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; NIGHTINGALE ER, 1959, J PHYS CHEM-US, V63, P1381, DOI 10.1021/j150579a011; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Oh S, 1997, NEURON, V19, P927, DOI 10.1016/S0896-6273(00)80973-3; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Phelan P, 1998, TRENDS GENET, V14, P348, DOI 10.1016/S0168-9525(98)01547-9; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sitaram A, 2009, MOL BIOL CELL, V20, P1464, DOI 10.1091/mbc.E08-07-0710; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Srinivas M, 2006, J GEN PHYSIOL, V127, P67, DOI 10.1085/jgp.200509397; Srinivas M, 2001, P NATL ACAD SCI USA, V98, P10942, DOI 10.1073/pnas.191206198; Starich TA, 1996, J CELL BIOL, V134, P537, DOI 10.1083/jcb.134.2.537; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; VEENSTRA RD, 1994, BIOPHYS J, V66, P1915, DOI 10.1016/S0006-3495(94)80985-3; Verselis VK, 2008, J GEN PHYSIOL, V132, P315, DOI 10.1085/jgp.200810029; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wang HZ, 1997, J GEN PHYSIOL, V109, P491, DOI 10.1085/jgp.109.4.491; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; White TW, 1999, EUR J NEUROSCI, V11, P1883, DOI 10.1046/j.1460-9568.1999.00607.x; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yen MR, 2007, PROG BIOPHYS MOL BIO, V94, P5, DOI 10.1016/j.pbiomolbio.2007.03.006; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; ZAREI MM, 1995, J NEUROSCI, V15, P1446	90	82	83	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6140	6153		10.1074/jbc.M112.409789	http://dx.doi.org/10.1074/jbc.M112.409789			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300080	Green Published, hybrid			2022-12-28	WOS:000315820700011
J	Yang, FC; Tan, BCM; Chen, WH; Lin, YH; Huang, JY; Chang, HY; Sun, HY; Hsu, PH; Liou, GG; Shen, J; Chang, CJ; Han, CC; Tsai, MD; Lee, SC				Yang, Fu-Chia; Tan, Bertrand Chin-Ming; Chen, Wei-Hao; Lin, Ya-Huei; Huang, Jing-Yi; Chang, Hsin-Yun; Sun, Hui-Yu; Hsu, Pang-Hung; Liou, Gunn-Guang; Shen, James; Chang, Ching-Jin; Han, Chau-Chung; Tsai, Ming-Daw; Lee, Sheng-Chung			Reversible Acetylation Regulates Salt-inducible Kinase (SIK2) and Its Function in Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; EXPRESSION; TDP-43; POLYGLUTAMINE; INVOLVEMENT; INHIBITION; EXPANSIONS; DISEASE; CAMP	Salt-inducible kinase 2 (SIK2) is a serine/threonine protein kinase belonging to the AMP-activated protein kinase (AMPK) family. SIK2 has been shown to function in the insulin-signaling pathway during adipocyte differentiation and to modulate CREB-mediated gene expression in response to hormones and nutrients. However, molecular mechanisms underlying the regulation of SIK2 kinase activity remains largely elusive. Here we report a dynamic, post-translational regulation of its kinase activity that is coordinated by an acetylation-deaceytlation switch, p300/CBP-mediated Lys-53 acetylation inhibits SIK2 kinase activity, whereas HDAC6-mediated deacetylation restores the activity. Interestingly, overexpression of acetylation-mimetic mutant of SIK2 (SIK2-K53Q), but not the nonacetylatable K53R variant, resulted in accumulation of autophagosomes. Further consistent with a role in autophagy, knockdown of SIK2 abrogated autophagosome and lysosome fusion. Consequently, SIK2 and its kinase activity are indispensable for the removal of TDP-43 Delta inclusion bodies. Our findings uncover SIK2 as a critical determinant in autophagy progression and further suggest a mechanism in which the interplay among kinase and deacetylase activities contributes to cellular protein pool homeostasis.	[Yang, Fu-Chia; Chen, Wei-Hao; Lin, Ya-Huei; Huang, Jing-Yi; Chang, Hsin-Yun; Sun, Hui-Yu; Lee, Sheng-Chung] Natl Taiwan Univ, Inst Mol Med, Taipei 100, Taiwan; [Yang, Fu-Chia; Chang, Ching-Jin] Natl Taiwan Univ, Inst Biochem Sci, Taipei 100, Taiwan; [Lee, Sheng-Chung] Natl Taiwan Univ, Inst Clin Med, Taipei 100, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Dept Biomed Sci, Tao Yuan 33302, Taiwan; [Yang, Fu-Chia] Acad Sinica, Inst Biol Chem, Taiwan Int Grad Program, Chem Biol & Mol Biophys Program, Taipei 11529, Taiwan; [Hsu, Pang-Hung; Tsai, Ming-Daw] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Shen, James] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Chang, Ching-Jin; Tsai, Ming-Daw; Lee, Sheng-Chung] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Han, Chau-Chung] Acad Sinica, Inst Mol & Atom Sci, Taipei 11529, Taiwan; [Liou, Gunn-Guang] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli 35053, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Chang Gung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan	Lee, SC (corresponding author), Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10051, Taiwan.	slee@ntu.edu.tw	shen, Che-Kun James/L-1343-2015; Liou, Gunn‐Guang/AAI-9787-2020; Chang, Ching-Jin/G-4511-2019; Hsu, Pang-Hung/C-5587-2018; Tsai, Ming-Daw/G-4689-2019; Han, Chau-Chung/F-7930-2012; Liou, Gan-Guang/E-3976-2010	Hsu, Pang-Hung/0000-0001-6873-6434; Tsai, Ming-Daw/0000-0003-1374-0414; Chang, Ching-Jin/0000-0001-7129-8092; Tan, Bertrand/0000-0002-2218-7115; Liou, Gan-Guang/0000-0002-2619-8516	National Science Council [NSC96-2321-B-002-008, NSC100-2320-B-002-008, NSC99-2632-B-182-011-MY3, NSC101-2320-B-182-036-MY3, NSC101-2321-B-182-009]; Academia Sinica; Institute of Biological Chemistry, Academia Sinica; Department of Medical Research, National Taiwan University Hospital	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); Institute of Biological Chemistry, Academia Sinica(Academia Sinica - Taiwan); Department of Medical Research, National Taiwan University Hospital	This work was supported by National Science Council Grants NSC96-2321-B-002-008 and NSC100-2320-B-002-008 (to S.-C. L.), NSC99-2632-B-182-011-MY3, NSC101-2320-B-182-036-MY3, and NSC101-2321-B-182-009 (to B. C-M. T.), and grants from the Academia Sinica (to M.-D. T.) and the Institute of Biological Chemistry, Academia Sinica (to S.-C. L).; We thank Drs. Tso-Pang Yao for HDAC6 and Mitsuhiro Okamoto for SIK2 and GST-Syntide plasmids. We are indebted to Dr. Yeu-Kuang Hwu of Academia Sinica and the National Synchrotron Radiation Research Center for kindly providing a Jeol 2100F EM, to the Institute of Molecular Biology, Academia Sinica, for the FEI Tecnai G<SUP>2</SUP> EM service, and Hsiao-Hsuian Shen, Shu-Ping Tsai, Wen-Li Peng, Sue-Ping Lee, and Yi-Yun Chen for EM technical assistance. We appreciate Yi-Li Liu and I-Ching Huang for their technical expertise on DNA sequencing, supported in part by the Department of Medical Research, National Taiwan University Hospital.	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Henriksson E, 2012, BIOCHEM J, V444, P503, DOI 10.1042/BJ20111932; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Huang JY, 2006, NUCLEIC ACIDS RES, V34, P2398, DOI 10.1093/nar/gkl241; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Kumagai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026148; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Liu Y, 2012, ENDOCRINOLOGY, V153, P223, DOI 10.1210/en.2011-1404; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rohn TT, 2008, BRAIN RES, V1228, P189, DOI 10.1016/j.brainres.2008.06.094; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tsay YG, 2000, ANAL BIOCHEM, V287, P55, DOI 10.1006/abio.2000.4837; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Yi C, 2012, AUTOPHAGY, V8, P1529, DOI 10.4161/auto.21156; Yi C, 2012, SCIENCE, V336, P474, DOI 10.1126/science.1216990; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	31	26	34	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6227	6237		10.1074/jbc.M112.431239	http://dx.doi.org/10.1074/jbc.M112.431239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322770	Green Published, hybrid			2022-12-28	WOS:000315820700018
J	Adu-Gyamfi, E; Soni, SP; Xue, Y; Digman, MA; Gratton, E; Stahelin, RV				Adu-Gyamfi, Emmanuel; Soni, Smita P.; Xue, Yi; Digman, Michelle A.; Gratton, Enrico; Stahelin, Robert V.			The Ebola Virus Matrix Protein Penetrates into the Plasma Membrane A KEY STEP IN VIRAL PROTEIN 40 (VP40) OLIGOMERIZATION AND VIRAL EGRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MEMBRANES; AMINO-ACIDS; DOMAINS; BINDING; BRIGHTNESS; MARBURG; NUMBER; IDENTIFICATION; LOCALIZATION; MECHANISMS	Ebola, a fatal virus in humans and non-human primates, has no Food and Drug Administration-approved vaccines or therapeutics. The virus from the Filoviridae family causes hemorrhagic fever, which rapidly progresses and in some cases has a fatality rate near 90%. The Ebola genome encodes seven genes, the most abundantly expressed of which is viral protein 40 (VP40), the major Ebola matrix protein that regulates assembly and egress of the virus. It is well established that VP40 assembles on the inner leaflet of the plasma membrane; however, the mechanistic details of plasma membrane association by VP40 are not well understood. In this study, we used an array of biophysical experiments and cellular assays along with mutagenesis of VP40 to investigate the role of membrane penetration in VP40 assembly and egress. Here we demonstrate that VP40 is able to penetrate specifically into the plasma membrane through an interface enriched in hydrophobic residues in its C-terminal domain. Mutagenesis of this hydrophobic region consisting of Leu(213), Ile(293), Leu(295), and Val(298) demonstrated that membrane penetration is critical to plasma membrane localization, VP40 oligomerization, and viral particle egress. Taken together, VP40 membrane penetration is an important step in the plasma membrane localization of the matrix protein where oligomerization and budding are defective in the absence of key hydrophobic interactions with the membrane.	[Soni, Smita P.; Xue, Yi; Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Eck Inst Global Hlth, South Bend, IN 46556 USA; [Stahelin, Robert V.] Univ Notre Dame, Ctr Rare & Neglected Dis, South Bend, IN 46556 USA; [Digman, Michelle A.; Gratton, Enrico; Stahelin, Robert V.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA	Indiana University System; Indiana University South Bend; University of Notre Dame; University of Notre Dame; University of California System; University of California Irvine	Stahelin, RV (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 143 Raclin Carmichael Hall,1234 Notre Dame Ave, South Bend, IN 46617 USA.	rstaheli@iupui.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863; , Michelle/0000-0003-4611-7100	National Institutes of Health [AI081077, P41-RRO3155, P50-GM076516]; Notre Dame Center for Rare and Neglected Diseases; Indiana University School of Medicine-South Bend Imaging and Flow Cytometry Core Facility; Notre Dame Integrated Imaging Facility; Eck Institute for Global Health; Keck Foundation [44769549507]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notre Dame Center for Rare and Neglected Diseases; Indiana University School of Medicine-South Bend Imaging and Flow Cytometry Core Facility; Notre Dame Integrated Imaging Facility; Eck Institute for Global Health; Keck Foundation(W.M. Keck Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI081077 (to R. V. S.) and P41-RRO3155 and P50-GM076516 (to E. G. and M. A. D.). This work was also supported by the Notre Dame Center for Rare and Neglected Diseases, the Indiana University School of Medicine-South Bend Imaging and Flow Cytometry Core Facility, and the Notre Dame Integrated Imaging Facility (to R. V. S.).; Supported by a fellowship from the Eck Institute for Global Health.; Supported by Keck Foundation Grant 44769549507.	Adu-Gyamfi E, 2012, BIOPHYS J, V103, pL41, DOI 10.1016/j.bpj.2012.09.026; Adu-Gyamfi E, 2012, BIOPHYS J, V102, P2517, DOI 10.1016/j.bpj.2012.04.022; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Dessen A, 2000, EMBO J, V19, P4228, DOI 10.1093/emboj/19.16.4228; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; ELLIOTT LH, 1985, VIROLOGY, V147, P169, DOI 10.1016/0042-6822(85)90236-3; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Feldmann H, 1999, ARCH VIROL, P159; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; Gomis-Roth FX, 2003, STRUCTURE, V11, P423, DOI 10.1016/S0969-2126(03)00050-9; Han ZY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-92; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 2009, ANTIVIR RES, V81, P189, DOI 10.1016/j.antiviral.2008.12.003; Hoenen T, 2005, J VIROL, V79, P1898, DOI 10.1128/JVI.79.3.1898-1905.2005; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; JOHNSON KM, 1977, LANCET, V1, P569; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Liu YL, 2010, J VIROL, V84, P2294, DOI 10.1128/JVI.02034-09; Makino A, 2011, J INFECT DIS, V204, pS871, DOI 10.1093/infdis/jir309; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; McCarthy SE, 2007, J VIROL, V81, P11452, DOI 10.1128/JVI.00853-07; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Neumann G, 2005, J VIROL, V79, P10300, DOI 10.1128/JVI.79.16.10300-10307.2005; Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099; Olejnik J, 2011, VIRUSES-BASEL, V3, P1501, DOI 10.3390/v3081501; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; Reynard O, 2011, J INFECT DIS, V204, pS884, DOI 10.1093/infdis/jir359; Ross JA, 2011, BIOPHYS J, V100, pL15, DOI 10.1016/j.bpj.2010.12.3703; Scianimanico S, 2000, EMBO J, V19, P6732, DOI 10.1093/emboj/19.24.6732; Scott JL, 2012, INTEGR BIOL-UK, V4, P247, DOI 10.1039/c2ib00143h; Silva LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039978; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Timmins J, 2003, VIROLOGY, V312, P359, DOI 10.1016/S0042-6822(03)00260-5; Yamayoshi S, 2008, CELL HOST MICROBE, V3, P168, DOI 10.1016/j.chom.2008.02.001	40	61	63	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5779	5789		10.1074/jbc.M112.443960	http://dx.doi.org/10.1074/jbc.M112.443960			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297401	Green Published, hybrid			2022-12-28	WOS:000315342500049
J	Pacheco-Quinto, J; Eckman, EA				Pacheco-Quinto, Javier; Eckman, Elizabeth A.			Endothelin-converting Enzymes Degrade Intracellular beta-Amyloid Produced within the Endosomal/Lysosomal Pathway and Autophagosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; NONPEPTIDIC INHIBITORS; CELLULAR UPTAKE; PEPTIDE; PROTEIN; PHOSPHORAMIDON; ACCUMULATION; ENDOSOMES; METALLOPROTEASE; PHARMACOLOGY	Impairments in A beta removal are increasingly being considered as a possible cause for the abnormal A beta build-up typical of Alzheimer disease. Of particular interest is a pool of A beta that accumulates intraneuronally and may contribute to neuronal toxicity. The mechanism for intraneuronal accumulation, however, is not well understood and is commonly attributed to impaired removal of extracellular A beta by neurons. Based on the intracellular distribution of the well established A beta degrading enzymes, ECE-1 and ECE-2, we tested whether impairments in their catalytic activity could lead to intracellular A beta accumulation. Using SH-SY5Y cells overexpressing wild-type amyloid precursor protein and pharmacological inhibition of endogenous ECE activity, we found that ECEs participate in the degradation of at least two distinct pools of A beta; one destined for secretion and the other being produced and degraded within the endosomal-autophagic-lysosomal pathways. Although ECE-1 regulates both pools of A beta, ECE-2 regulates mainly the intracellular pool of the peptide. Consistent with this result, ECE-2 was found to co-localize with markers of the endosomal/lysosomal pathway but not with a trans-Golgi network marker. Furthermore, ECE-2 was detected in autophagic vesicles in cells treated with chloroquine. Under these conditions, ECE inhibition produced significantly higher elevations in intracellular A beta than chloroquine treatment alone. This study highlights the existence of A beta clearance mechanisms by ECEs at intracellular sites of production. Alterations in ECE activity may be considered as a cause for increased intraneuronal A beta in Alzheimer disease.	[Pacheco-Quinto, Javier; Eckman, Elizabeth A.] MidAtlantic Neonatol Associates, Biomed Res Inst New Jersey, Morristown, NJ 07960 USA; Atlantic Hlth Sys, Morristown, NJ 07960 USA	Atlantic Health System	Eckman, EA (corresponding author), Biomed Res Inst New Jersey, 140 E Hanover Ave, Cedar Knolls, NJ 07927 USA.	elizabeth.eckman@atlantichealth.org	Eckman, Elizabeth/AAL-7316-2021	Eckman, Elizabeth/0000-0002-5391-4960	NINDS, National Institutes of Health Grant [R01 NS073512]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073512] Funding Source: NIH RePORTER	NINDS, National Institutes of Health Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grant R01 NS073512 (to E. A. E.).	Abramowski D, 2012, J NEUROSCI, V32, P1273, DOI 10.1523/JNEUROSCI.4586-11.2012; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Cattaruzza F, 2009, BRIT J PHARMACOL, V156, P730, DOI 10.1111/j.1476-5381.2008.00039.x; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; De Lombaert S, 2000, J MED CHEM, V43, P488, DOI 10.1021/jm990507o; DELOMBAERT S, 1995, BIOORG MED CHEM LETT, V5, P151, DOI 10.1016/0960-894X(94)00475-U; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; EMOTO N, 1995, J BIOL CHEM, V270, P15262, DOI 10.1074/jbc.270.25.15262; Fauq AH, 2004, SYNTHETIC COMMUN, V34, P775, DOI 10.1081/SCC-120028350; FULLER SJ, 1995, BIOCHEMISTRY-US, V34, P8091, DOI 10.1021/bi00025a015; Glenner G G, 1984, Appl Pathol, V2, P357; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; GRUNDKEIQBAL I, 1989, P NATL ACAD SCI USA, V86, P2853, DOI 10.1073/pnas.86.8.2853; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Haugabook SJ, 2001, J NEUROSCI METH, V108, P171, DOI 10.1016/S0165-0270(01)00388-0; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Ida N, 1996, FEBS LETT, V394, P174, DOI 10.1016/0014-5793(96)00948-9; Ikeda S, 2002, BIOCHEM BIOPH RES CO, V293, P421, DOI 10.1016/S0006-291X(02)00252-8; Jeng AY, 2000, J CARDIOVASC PHARM, V36, pS36; KUKKOLA PJ, 1995, J CARDIOVASC PHARM, V26, pS65; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lunemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115; Muller L, 2003, J BIOL CHEM, V278, P545, DOI 10.1074/jbc.M208949200; Nixon Ralph A, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a008839; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Pacheco-Quinto J., 2012, J ALZHEIMERS DIS; Pasternak SH, 2004, J ALZHEIMERS DIS, V6, P53; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Steinerman JR, 2008, ARCH NEUROL-CHICAGO, V65, P906, DOI 10.1001/archneur.65.7.906; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Turner AJ, 1996, BIOCHEM PHARMACOL, V51, P91, DOI 10.1016/0006-2952(95)02036-5; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082	47	67	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5606	5615		10.1074/jbc.M112.422964	http://dx.doi.org/10.1074/jbc.M112.422964			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23283972	hybrid, Green Published			2022-12-28	WOS:000315342500034
J	Teo, AKK; Windmueller, R; Johansson, BB; Dirice, E; Njolstad, PR; Tjora, E; Raeder, H; Kulkarni, RN				Teo, Adrian K. K.; Windmueller, Rebecca; Johansson, Bente B.; Dirice, Ercument; Njolstad, Pal R.; Tjora, Erling; Raeder, Helge; Kulkarni, Rohit N.			Derivation of Human Induced Pluripotent Stem Cells from Patients with Maturity Onset Diabetes of the Young	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFINED FACTORS	Maturity onset diabetes of the young (MODY) is an autosomal dominant disease. Despite extensive research, the mechanism by which a mutant MODY gene results in monogenic diabetes is not yet clear due to the inaccessibility of patient samples. Induced pluripotency and directed differentiation toward the pancreatic lineage are now viable and attractive methods to uncover the molecular mechanisms underlying MODY. Here we report, for the first time, the derivation of human induced pluripotent stem cells (hiPSCs) from patients with five types of MODY: MODY1 (HNF4A), MODY2 (GCK), MODY3 (HNF1A), MODY5 (HNF1B), and MODY8 (CEL) with a polycistronic lentiviral vector expressing a Cre-excisable human "stem cell cassette" containing the four reprogramming factors OCT4, KLF4, SOX2, and CMYC. These MODY-hiPSCs morphologically resemble human pluripotent stem cells (hPSCs), express pluripotency markers OCT4, SOX2, NANOG, SSEA-4, and TRA-1-60, give rise to derivatives of the three germ layers in a teratoma assay, and are karyotypically normal. Overall, our MODYhiPSCs serve as invaluable tools to dissect the role of MODY genes in the development of pancreas and islet cells and to evaluate their significance in regulating beta cell function. This knowledge will aid future attempts aimed at deriving functional mature beta cells from hPSCs.	[Teo, Adrian K. K.; Windmueller, Rebecca; Dirice, Ercument; Kulkarni, Rohit N.] Brigham & Womens Hosp, Dept Med, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Teo, Adrian K. K.; Windmueller, Rebecca; Dirice, Ercument; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Njolstad, Pal R.; Tjora, Erling; Raeder, Helge] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Johansson, Bente B.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Johansson, Bente B.; Njolstad, Pal R.; Raeder, Helge] Univ Bergen, Dept Med 2, KG Jebsen Ctr Diabet Res, N-5021 Bergen, Norway	Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Kulkarni, RN (corresponding author), Brigham & Womens Hosp, Dept Med, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, 1 Joslin Pl, Boston, MA 02215 USA.	rohit.kulkarni@joslin.harvard.edu	Raeder, Helge/ABE-3601-2020; Raeder, Helge/AFQ-6279-2022; Dirice, Ercument/B-2825-2017; Johansson, Bente Berg/AAE-7666-2022; Teo, Adrian Kee Keong/A-4009-2013	Teo, Adrian Kee Keong/0000-0001-5901-7075; Johansson, Bente Berg/0000-0001-8893-1915; Dirice, Ercument/0000-0003-2792-7204	Harvard Stem Cell Institute [SG-0078-12-00]; National Institutes of Health [RO1 DK 67536]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067536] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant from the Harvard Stem Cell Institute Agreement SG-0078-12-00 (to R.N.K.) and in part by National Institutes of Health Grant RO1 DK 67536 (to R.N.K.).	Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lombardo D, 2001, BBA-MOL CELL BIOL L, V1533, P1, DOI 10.1016/S1388-1981(01)00130-5; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park In-Hyun, 2009, Curr Protoc Stem Cell Biol, VChapter 4, DOI 10.1002/9780470151808.sc04a01s8; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Steck AK, 2011, CURR OPIN ENDOCRINOL, V18, P252, DOI 10.1097/MED.0b013e3283488275; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019	11	85	89	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5353	5356		10.1074/jbc.C112.428979	http://dx.doi.org/10.1074/jbc.C112.428979			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23306198	Green Published, hybrid			2022-12-28	WOS:000315342500009
J	Walkinshaw, DR; Weist, R; Xiao, L; Yan, KZ; Kim, GW; Yang, XJ				Walkinshaw, Donald R.; Weist, Ryan; Xiao, Lin; Yan, Kezhi; Kim, Go-Woon; Yang, Xiang-Jiao			Dephosphorylation at a Conserved SP Motif Governs cAMP Sensitivity and Nuclear Localization of Class IIa Histone Deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; CARDIAC-HYPERTROPHY; LYSINE ACETYLATION; PHOSPHORYLATION; HDAC4; GENE; EXPRESSION; EXPORT	Histone deacetylase 4 (HDAC4) and its paralogs, HDAC5, -7, and -9 (all members of class IIa), possess multiple phosphorylation sites crucial for 14-3-3 binding and subsequent nuclear export. cAMP signaling stimulates nuclear import of HDAC4 and HDAC5, but the underlying mechanisms remain to be elucidated. Here we show that cAMP potentiates nuclear localization of HDAC9. Mutation of an SP motif conserved in HDAC4, -5, and -9 prevents cAMP-stimulated nuclear localization. Unexpectedly, this treatment inhibits phosphorylation at the SP motif, indicating an inverse relationship between the phosphorylation event and nuclear import. Consistent with this, leptomycin B-induced nuclear import and adrenocorticotropic hormone (ACTH) treatment result in the dephosphorylation at the motif. Moreover, the modification synergizes with phosphorylation at a nearby site, and similar kinetics was observed for both phosphorylation events during myoblast and adipocyte differentiation. These results thus unravel a previously unrecognized mechanism whereby cAMP promotes dephosphorylation and differentially regulates multisite phosphorylation and the nuclear localization of class IIa HDACs.	[Walkinshaw, Donald R.; Weist, Ryan; Xiao, Lin; Yan, Kezhi; Kim, Go-Woon; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Walkinshaw, Donald R.; Weist, Ryan; Xiao, Lin; Yan, Kezhi; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A3, Canada; [Kim, Go-Woon; Yang, Xiang-Jiao] McGill Univ, Deparment Anat & Cell Biol, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-Jiao] McGill Univ, Deparment Biochem, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University; McGill University	Yang, XJ (corresponding author), McGill Univ, Ctr Hlth, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca			Canadian Institutes of Health Research; Canadian Cancer Society; Banting and Best Canada Graduate Scholarship from the CIHR; Rolande and Marcel Gosselin studentship; Canderel studentship from the Goodman Cancer Research Centre; McGill University Health Centre studentship; Cole Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Banting and Best Canada Graduate Scholarship from the CIHR(Canadian Institutes of Health Research (CIHR)); Rolande and Marcel Gosselin studentship; Canderel studentship from the Goodman Cancer Research Centre; McGill University Health Centre studentship; Cole Foundation	This project was supported by operating grants from the Canadian Institutes of Health Research and the Canadian Cancer Society (to X. J. Y.).; Supported in part by a Banting and Best Canada Graduate Scholarship from the CIHR, a Rolande and Marcel Gosselin studentship, and a Canderel studentship from the Goodman Cancer Research Centre as well as a McGill University Health Centre studentship.; Supported in part by a Cole Foundation studentship.	Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Baillie GS, 2005, FEBS LETT, V579, P3264, DOI 10.1016/j.febslet.2005.03.089; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; Borghi S, 2001, J CELL SCI, V114, P4477; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Choi RCY, 2000, NEUROREPORT, V11, P801, DOI 10.1097/00001756-200003200-00029; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Deng XB, 2005, J BIOL CHEM, V280, P4894, DOI 10.1074/jbc.M411894200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Garren L D, 1971, Recent Prog Horm Res, V27, P433; Greco TM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004317; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Ha CH, 2008, ARTERIOSCL THROM VAS, V28, P1782, DOI 10.1161/ATVBAHA.108.172528; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Ha CH, 2010, P NATL ACAD SCI USA, V107, P15467, DOI 10.1073/pnas.1000462107; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Harrison BC, 2010, FEBS LETT, V584, P1103, DOI 10.1016/j.febslet.2010.02.057; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Illi B, 2008, CIRC RES, V102, P51, DOI 10.1161/CIRCRESAHA.107.157305; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kim MS, 2008, MOL CELL BIOL, V28, P3600, DOI 10.1128/MCB.00189-08; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Liu YW, 2009, J PHYSIOL-LONDON, V587, P1101, DOI 10.1113/jphysiol.2008.164566; Magun R, 1998, INT J OBESITY, V22, P567, DOI 10.1038/sj.ijo.0800626; Majdzadeh N, 2008, FRONT BIOSCI-LANDMRK, V13, P1072, DOI 10.2741/2745; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Parra M, 2007, GENE DEV, V21, P638, DOI 10.1101/gad.1513107; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896; Szyf M, 2000, ENDOCR RES, V26, P921, DOI 10.3109/07435800009048618; Taniguchi M, 2012, NEURON, V73, P108, DOI 10.1016/j.neuron.2011.10.032; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Verdel A, 1999, J BIOL CHEM, V274, P2440, DOI 10.1074/jbc.274.4.2440; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Williams S, 2010, BRIT DENT J, V208, P4, DOI 10.1038/sj.bdj.2010.7; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; WOOD HN, 1973, P NATL ACAD SCI USA, V70, P447, DOI 10.1073/pnas.70.2.447; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yuan ZG, 2010, J BIOL CHEM, V285, P39329, DOI 10.1074/jbc.M110.179333; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098; Zhu GZ, 2005, J BIOL CHEM, V280, P10743, DOI 10.1074/jbc.M413159200	87	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5591	5605		10.1074/jbc.M112.445668	http://dx.doi.org/10.1074/jbc.M112.445668			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297420	Green Published, hybrid			2022-12-28	WOS:000315342500033
J	Amacher, JF; Cushing, PR; Bahl, CD; Beck, T; Madden, DR				Amacher, Jeanine F.; Cushing, Patrick R.; Bahl, Christopher D.; Beck, Tobias; Madden, Dean R.			Stereochemical Determinants of C-terminal Specificity in PDZ Peptide-binding Domains A NOVEL CONTRIBUTION OF THE CARBOXYLATE- BINDING LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; STRUCTURAL BASIS; WIDE PREDICTION; RECOGNITION; AFFINITY; NETWORKS; PARTNERS; FEATURES; COMPLEX; MOTIFS	PDZ (PSD-95/Dlg/ZO-1) binding domains often serve as cellular traffic engineers, controlling the localization and activity of a wide variety of binding partners. As a result, they play important roles in both physiological and pathological processes. However, PDZ binding specificities overlap, allowing multiple PDZ proteins to mediate distinct effects on shared binding partners. For example, several PDZ domains bind the cystic fibrosis (CF) transmembrane conductance regulator (CFTR), an epithelial ion channel mutated in CF. Among these binding partners, the CFTR-associated ligand (CAL) facilitates post-maturational degradation of the channel and is thus a potential therapeutic target. Using iterative optimization, we previously developed a selective CAL inhibitor peptide (iCAL36). Here, we investigate the stereochemical basis of iCAL36 specificity. The crystal structure of iCAL36 in complex with the CAL PDZ domain reveals stereochemical interactions distributed along the peptide-binding cleft, despite the apparent degeneracy of the CAL binding motif. A critical selectivity determinant that distinguishes CAL from other CFTR-binding PDZ domains is the accommodation of an isoleucine residue at the C-terminal position (P-0), a characteristic shared with the Tax-interacting protein-1. Comparison of the structures of these two PDZ domains in complex with ligands containing P-0 Leu or Ile residues reveals two distinct modes of accommodation for beta-branched C-terminal side chains. Access to each mode is controlled by distinct residues in the carboxylate-binding loop. These studies provide new insights into the primary sequence determinants of binding motifs, which in turn control the scope and evolution of PDZ interactomes.	Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Beck, Tobias] Univ Gottingen, Dept Struct Chem, D-37077 Gottingen, Germany	Dartmouth College; University of Gottingen	Madden, DR (corresponding author), 7200 Vail Bldg, Hanover, NH 03755 USA.	drm0001@dartmouth.edu	Beck, Tobias/K-3738-2014; Bahl, Christopher D/B-9410-2016	Beck, Tobias/0000-0001-7398-3982; Bahl, Christopher D/0000-0002-3652-3693	National Institutes of Health [R01-DK075309, T32-GM008704, T32-DK007301, P20-RR018787, P20-GM103413]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075309, T32DK007301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704, P20GM103413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK075309 (to D. R. M.) and Training Grants T32-GM008704 (to J. F. A.) and T32-DK007301 (to P. R. C.), Institutional Development Awards P20-RR018787 and P20-GM103413 to the Dartmouth Lung Biology Center of Biomedical Research Excellence, Cystic Fibrosis Foundation Grant RDP STANTO11R0, and a Hitchcock Foundation Program Project Grant.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alewine C, 2006, MOL BIOL CELL, V17, P4200, DOI 10.1091/mbc.E06-02-0129; Amacher JF, 2011, ACTA CRYSTALLOGR F, V67, P600, DOI 10.1107/S1744309111009985; Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Babault N, 2011, STRUCTURE, V19, P1518, DOI 10.1016/j.str.2011.07.007; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Beck T, 2008, ACTA CRYSTALLOGR E, V64, pO1286, DOI 10.1107/S1600536808017741; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chimura T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-300; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Edwards RJ, 2012, MOL BIOSYST, V8, P282, DOI 10.1039/c1mb05212h; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000416; Feng J, 1998, PDB VALIDATION SERVE; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Gianni S, 2011, J BIOL CHEM, V286, P27167, DOI 10.1074/jbc.M111.239541; Grandy D, 2009, J BIOL CHEM, V284, P16256, DOI 10.1074/jbc.M109.009647; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko T, 2011, TRENDS BIOCHEM SCI, V36, P183, DOI 10.1016/j.tibs.2010.12.001; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Kaufmann K, 2011, J MOL MODEL, V17, P315, DOI 10.1007/s00894-010-0725-5; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002510; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lee HJ, 2009, ANGEW CHEM INT EDIT, V48, P6448, DOI 10.1002/anie.200902981; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025528; Li X, 2006, PROTEIN SCI, V15, P2149, DOI 10.1110/ps.062087506; Madden D. R., 1992, THESIS HARVARD U CAM; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obenauer John C, 2004, Methods Mol Biol, V261, P445; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Piserchio A, 2005, BIOCHEMISTRY-US, V44, P16158, DOI 10.1021/bi0516475; Piserchio A, 2004, CHEM BIOL, V11, P469, DOI 10.1016/j.chembiol.2004.03.013; Politzer P, 2010, PHYS CHEM CHEM PHYS, V12, P7748, DOI 10.1039/c004189k; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P102, DOI 10.1016/S0968-0004(00)88973-2; Ponting CP, 1997, PROTEIN SCI, V6, P464; Roberts KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002477; Sakarya O, 2010, MOL BIOL EVOL, V27, P1058, DOI 10.1093/molbev/msp311; SHELDRICK G, 1991, XPREP SPACE GROUP DE; Sheldrick G. M., 2004, SADABS; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shepherd TR, 2010, J MOL BIOL, V398, P730, DOI 10.1016/j.jmb.2010.03.047; Shoulders MD, 2010, P NATL ACAD SCI USA, V107, P559, DOI 10.1073/pnas.0909592107; Smith CA, 2010, J MOL BIOL, V402, P460, DOI 10.1016/j.jmb.2010.07.032; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Thomas J, 2009, PROTEINS, V76, P911, DOI 10.1002/prot.22398; Thorsen TS, 2010, P NATL ACAD SCI USA, V107, P413, DOI 10.1073/pnas.0902225107; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vouilleme L, 2010, ANGEW CHEM INT EDIT, V49, P9912, DOI 10.1002/anie.201005575; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Yaffe Michael B, 2006, Sci STKE, V2006, ppe28, DOI 10.1126/stke.3402006pe28; Yan XJ, 2009, J MOL BIOL, V392, P967, DOI 10.1016/j.jmb.2009.07.060; Zaslavsky E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012787; Zhang JX, 2008, J MOL BIOL, V384, P255, DOI 10.1016/j.jmb.2008.09.034	73	22	23	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5114	5126		10.1074/jbc.M112.401588	http://dx.doi.org/10.1074/jbc.M112.401588			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23243314	hybrid, Green Published			2022-12-28	WOS:000315340400059
J	Hernandez-Ortega, S; Bru, S; Ricco, N; Ramirez, S; Casals, N; Jimenez, J; Isasa, M; Crosas, B; Clotet, J				Hernandez-Ortega, Sara; Bru, Samuel; Ricco, Natalia; Ramirez, Sara; Casals, Nuria; Jimenez, Javier; Isasa, Marta; Crosas, Bernat; Clotet, Josep			Defective in Mitotic Arrest 1 (Dma1) Ubiquitin Ligase Controls G(1) Cyclin Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUDDING YEAST; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; DEPENDENT DEGRADATION; PROTEASOME PATHWAY; RAPID DEGRADATION; PROTEIN-KINASE; DNA-DAMAGE; G1 CYCLINS; S-PHASE	Progression through the G(1) phase of the cell cycle is controlled by diverse cyclin-dependent kinases (CDKs) that might be associated to numerous cyclin isoforms. Given such complexity, regulation of cyclin degradation should be crucial for coordinating progression through the cell cycle. In Saccharomyces cerevisiae, SCF is the only E3 ligase known to date to be involved in G(1) cyclin degradation. Here, we report the design of a genetic screening that uncovered Dma1 as another E3 ligase that targets G(1) cyclins in yeast. We show that the cyclin Pcl1 is ubiquitinated in vitro and in vivo by Dma1, and accordingly, is stabilized in dma1 mutants. We demonstrate that Pcl1 must be phosphorylated by its own CDK to efficiently interact with Dma1 and undergo degradation. A nonphosphorylatable version of Pcl1 accumulates throughout the cell cycle, demonstrating the physiological relevance of the proposed mechanism. Finally, we present evidence that the levels of Pcl1 and Cln2 are independently controlled in response to nutrient availability. This new previously unknown mechanism for G(1) cyclin degradation that we report here could help elucidate the specific roles of the redundant CDK-cyclin complexes in G(1).	[Hernandez-Ortega, Sara; Bru, Samuel; Ricco, Natalia; Ramirez, Sara; Casals, Nuria; Jimenez, Javier; Clotet, Josep] Univ Int Catalunya, Dept Ciencies Basiques, Barcelona 08017, Spain; [Isasa, Marta; Crosas, Bernat] CSIC, Inst Biol Mol Barcelona, Dept Cellular Biol, E-08028 Barcelona, Spain	Universitat Internacional de Catalunya (UIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Clotet, J (corresponding author), Univ Int Catalunya, Dept Ciencies Basiques, Barcelona 08017, Spain.	jclotet@uic.es	Clotet, Josep/AAF-2618-2019; Ramírez, Sara/AAE-4400-2022; Jiménez, Javier/ABE-1795-2020; Clotet, Josep/ABC-8727-2020; Casals, Nuria/L-3378-2014	Jiménez, Javier/0000-0002-0402-4427; Clotet, Josep/0000-0001-5462-8598; Casals, Nuria/0000-0002-6719-4300; Ramirez Flores, Sara/0000-0002-2072-2495	Ministry of Economy and Competitiveness [BFU 2009-09278]; Universitat Internacional de Catalunya; l'Obra Social la Caixa	Ministry of Economy and Competitiveness; Universitat Internacional de Catalunya; l'Obra Social la Caixa(La Caixa Foundation)	This work was supported by Spanish Ministry of Science and Innovation Grant BFU 2009-09278, now known as the Ministry of Economy and Competitiveness.; Supported by a post-graduate Junior Faculty fellowship from the Universitat Internacional de Catalunya and l'Obra Social la Caixa.	Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; Benanti JA, 2007, NAT CELL BIOL, V9, P1184, DOI 10.1038/ncb1639; Berset G, 2002, MOL CELL BIOL, V22, P4463, DOI 10.1128/MCB.22.13.4463-4476.2002; Bieganowski P, 2004, J BIOL CHEM, V279, P44656, DOI 10.1074/jbc.M406151200; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chin CF, 2010, MOL CELL BIOL, V30, P22, DOI 10.1128/MCB.00687-09; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fraschini R, 2004, MOL BIOL CELL, V15, P3796, DOI 10.1091/mbc.E04-02-0094; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gopinathan L, 2011, RESULTS PROBL CELL D, V53, P365, DOI 10.1007/978-3-642-19065-0_16; Guertin DA, 2002, DEV CELL, V3, P779, DOI 10.1016/S1534-5807(02)00367-2; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Huang K, 2007, MOL CELL, V28, P614, DOI 10.1016/j.molcel.2007.09.013; Irniger S, 1997, J CELL SCI, V110, P1523; Jackson LP, 2006, MOL CELL BIOL, V26, P2456, DOI 10.1128/MCB.26.6.2456-2466.2006; Jacobson MD, 2000, MOL CELL BIOL, V20, P4483, DOI 10.1128/MCB.20.13.4483-4493.2000; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Johnson AE, 2011, EMBO J, V30, P341, DOI 10.1038/emboj.2010.317; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; Li WJ, 2006, MOL MICROBIOL, V62, P212, DOI 10.1111/j.1365-2958.2006.05361.x; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Loring GL, 2008, CELL CYCLE, V7, P96, DOI 10.4161/cc.7.1.5113; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Moffat J, 2004, NAT CELL BIOL, V6, P59, DOI 10.1038/ncb1078; NAKAMURA T, 1995, EXP CELL RES, V221, P534, DOI 10.1006/excr.1995.1406; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Palecek SP, 2000, GENETICS, V156, P1005; Raspelli E, 2011, MOL BIOL CELL, V22, P2185, DOI 10.1091/mbc.E11-02-0127; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Sanbhnani S, 2012, CELL MOL LIFE SCI, V69, P1669, DOI 10.1007/s00018-011-0892-2; Schneider BL, 1998, NATURE, V395, P86, DOI 10.1038/25774; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Wysocki R, 2006, NAT STRUCT MOL BIOL, V13, P908, DOI 10.1038/nsmb1139; YAGLOM J, 1995, MOL CELL BIOL, V15, P731; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	50	4	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4704	4714		10.1074/jbc.M112.426593	http://dx.doi.org/10.1074/jbc.M112.426593			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264631	Green Published, hybrid			2022-12-28	WOS:000315340400019
J	Anower-E-Khuda, MF; Habuchi, H; Nagai, N; Habuchi, O; Yokochi, T; Kimata, K				Anower-E-Khuda, Md. Ferdous; Habuchi, Hiroko; Nagai, Naoko; Habuchi, Osami; Yokochi, Takashi; Kimata, Koji			Heparan Sulfate 6-O-Sulfotransferase Isoform-dependent Regulatory Effects of Heparin on the Activities of Various Proteases in Mast Cells and the Biosynthesis of 6-O-Sulfated Heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL PEPTIDASE I; CHONDROITIN SULFATE; MICE DEFICIENT; CARBOXYPEPTIDASE-A; CONNECTIVE-TISSUE; TRICHINELLA-SPIRALIS; STRUCTURAL-ANALYSIS; SECRETORY GRANULE; TRYPTASE MMCP-6; INNATE IMMUNITY	Heparan sulfate 6-O-sulfotransferase (HS6ST) is an enzyme involved in heparan sulfate (HS) biosynthesis that transfers a sulfate residue to position 6 of the GlcNAc/GlcNSO(3) residues of HS, and it consists of three isoforms. Heparin, the highly sulfated form of HS, resides in connective tissue mast cells and is involved in the storage of mast cell proteases (MCPs). However, it is not well understood which isoform(s) of HS6ST participates in 6-O-sulfation of heparin and how the 6-O-sulfate residues in heparin affect MCPs. To investigate these issues, we prepared fetal skin-derived mast cells (FSMCs) from wild type (WT) and HS6ST-deficient mice (HS6ST-1(-/-), HS6ST-2(-/-), and HS6ST-1(-/-)/HS6ST-2(-/-)) and determined the structure of heparin, the protease activity, and the mRNA expression of each MCP in cultured FSMCs. The activities of tryptase and carboxypeptidase-A were decreased in HS6ST-2(-/-)-FSMCs in which 6-O-sulfation of heparin was decreased at 50% of WT-FSMCs and almost lost in HS6ST-1(-/-)/HS6ST-2(-/-)-FSMCs, which lacked the 6-O-sulfation in heparin nearly completely. In contrast, chymase activity was retained even in HS6ST-1(-/-)/HS6ST-2(-/-) FSMCs. Each MCP mRNA was not decreased in any of the mutant FSMCs. Western blot analysis showed that tryptase (mMCP-6) was almost absent from HS6ST-1(-/-)/HS6ST-2(-/-) FSMCs indicating degradation/secretion of the enzyme protein. These observations suggest that both HS6ST-1 and HS6ST-2 are involved in 6-O-sulfation of heparin and that the proper packaging and storage of tryptase, carboxypeptidase-A, and chymase may be regulated differently by the 6-O-sulfate residues in heparin. It is thus likely that 6-O-sulfation of heparin plays important roles in regulating MCP functions.	[Nagai, Naoko] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan; [Anower-E-Khuda, Md. Ferdous; Yokochi, Takashi] Aichi Med Univ, Dept Microbiol & Immunol, Nagakute, Aichi 4801195, Japan	Aichi Medical University; Aichi Medical University	Kimata, K (corresponding author), 1-1 Yazako, Nagakute, Aichi 4801195, Japan.	kimata@aichi-med-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [20570113, 22590296, 23570148, 14082206, S1101027]; Strategic Research Foundation; Grants-in-Aid for Scientific Research [22590296] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research C 20570113 (to H. H.), 22590296 (to N. N. and K. K.), and 23570148 (to K. K.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, Grant-in-aid for Scientific Research on Priority Areas 14082206 (to K. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and in part by Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (2011-2015), S1101027.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bink RJ, 2003, J BIOL CHEM, V278, P31118, DOI 10.1074/jbc.M213124200; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Chen E, 2005, DEV BIOL, V284, P364, DOI 10.1016/j.ydbio.2005.05.032; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Dragonetti A, 2000, J CELL SCI, V113, P3289; ENERBACK L, 1985, BIOCHEM J, V227, P661, DOI 10.1042/bj2270661; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Feyerabend TB, 2006, NAT CHEM BIOL, V2, P195, DOI 10.1038/nchembio777; Feyerabend TB, 2005, MOL CELL BIOL, V25, P6199, DOI 10.1128/MCB.25.14.6199-6210.2005; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; Habuchi H, 2003, BIOCHEM J, V371, P131, DOI 10.1042/BJ20021259; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; Habuchi H, 2010, PROG MOL BIOL TRANSL, V93, P79, DOI [10.1016/S1877-1173(10)93005-6, 10.1010/S1877-1173(10)93005-6]; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; Hallgren J, 2000, BIOCHEMISTRY-US, V39, P13068, DOI 10.1021/bi000973b; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Henningsson F, 2005, J CELL SCI, V118, P2035, DOI 10.1242/jcs.02333; Henningsson F, 2002, BIOL CHEM, V383, P793, DOI 10.1515/BC.2002.083; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; HUANG RY, 1991, EUR J IMMUNOL, V21, P1611, DOI 10.1002/eji.1830210706; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; Izvolsky KI, 2008, GENESIS, V46, P8, DOI 10.1002/dvg.20355; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Kobayashi T, 2010, DEV GROWTH DIFFER, V52, P146, DOI 10.1111/j.1440-169X.2009.01148.x; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; LIDHOLT K, 1995, BIOCHEM J, V311, P233, DOI 10.1042/bj3110233; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Miller HRP, 2002, IMMUNOLOGY, V105, P375, DOI 10.1046/j.1365-2567.2002.01375.x; Ohtake-Niimi S, 2010, J BIOL CHEM, V285, P20793, DOI 10.1074/jbc.M109.084749; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pejler G, 2009, TRENDS IMMUNOL, V30, P401, DOI 10.1016/j.it.2009.04.008; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Pratt T, 2006, J NEUROSCI, V26, P6911, DOI 10.1523/JNEUROSCI.0505-06.2006; Prieto-Garcia A, 2012, J BIOL CHEM, V287, P7834, DOI 10.1074/jbc.M111.325712; RAZIN E, 1982, J BIOL CHEM, V257, P7229; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; Sakai K, 1996, J CLIN INVEST, V97, P988, DOI 10.1172/JCI118523; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; STEVENS RL, 1988, P NATL ACAD SCI USA, V85, P2284, DOI 10.1073/pnas.85.7.2284; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Sun JS, 2009, CIRCULATION, V120, P973, DOI 10.1161/CIRCULATIONAHA.109.849679; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; THOMPSON HL, 1988, J IMMUNOL, V140, P2708; Tornberg J, 2011, P NATL ACAD SCI USA, V108, P11524, DOI 10.1073/pnas.1102284108; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; Welle M, 1997, J LEUKOCYTE BIOL, V61, P233, DOI 10.1002/jlb.61.3.233; Wolters PJ, 2000, AM J RESP CELL MOL, V22, P183, DOI 10.1165/ajrcmb.22.2.3767; Xing W, 2011, P NATL ACAD SCI USA, V108, P14210, DOI 10.1073/pnas.1111048108; Yamada N, 2003, J INVEST DERMATOL, V121, P1425, DOI 10.1046/j.1523-1747.2003.12613.x	68	18	19	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3705	3717		10.1074/jbc.M112.416651	http://dx.doi.org/10.1074/jbc.M112.416651			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23223449	Green Published, hybrid			2022-12-28	WOS:000314845000003
J	Hebron, ML; Lonskaya, I; Sharpe, K; Weerasinghe, PPK; Algarzae, NK; Shekoyan, AR; Moussa, CEH				Hebron, Michaeline L.; Lonskaya, Irina; Sharpe, Kaydee; Weerasinghe, Puwakdandawe P. K.; Algarzae, Norah K.; Shekoyan, Ashot R.; Moussa, Charbel E. -H.			Parkin Ubiquitinates Tar-DNA Binding Protein-43 (TDP-43) and Promotes Its Cytosolic Accumulation via Interaction with Histone Deacetylase 6 (HDAC6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; PATHOLOGICAL TDP-43; DEMENTIA COMPLEX; DISEASE; PHOSPHORYLATION; MUTATIONS; INCLUSIONS; COMPONENT; DROSOPHILA-PINK1	The importance of E3 ubiquitin ligases, involved in the degradation of misfolded proteins or promotion of protein-protein interaction, is increasingly recognized in neurodegeneration. TDP-43 is a predominantly nuclear protein, which regulates the transcription of thousands of genes and binds to mRNA of the E3 ubiquitin ligase Parkin to regulate its expression. Wild type and mutated TDP-43 are detected in ubiquitinated forms within the cytosol in several neurodegenerative diseases. We elucidated the mechanisms of TDP-43 interaction with Parkin using transgenic A315T mutant TDP-43(TDP43-Tg) mice, lentiviral wild type TDP-43, and Parkin gene transfer rat models. TDP-43 expression increased Parkin mRNA and protein levels. Lentiviral TDP-43 increased the levels of nuclear and cytosolic protein, whereas Parkin co-expression mediated Lys-48 and Lys-63-linked ubiquitin to TDP-43 and led to cytosolic co-localization of Parkin with ubiquitinated TDP-43. Parkin and TDP-43 formed a multiprotein complex with HDAC6, perhaps to mediate TDP-43 translocation. In conclusion, Parkin ubiquitinates TDP-43 and facilitates its cytosolic accumulation through a multiprotein complex with HDAC6.	[Hebron, Michaeline L.; Lonskaya, Irina; Sharpe, Kaydee; Weerasinghe, Puwakdandawe P. K.; Algarzae, Norah K.; Shekoyan, Ashot R.; Moussa, Charbel E. -H.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA	Georgetown University	Moussa, CEH (corresponding author), Georgetown Univ, Sch Med, Dept Neurosci, Lab Dementia & Parkinsonism,TRB, 3970 Reservoir Rd NW,Rm WP09B, Washington, DC 20057 USA.	cem46@georgetown.edu		Weerasinghe, Puwakdandawe/0000-0002-1382-301X	National Institutes of Health Grant [AG30378]; Georgetown University Funding; NATIONAL INSTITUTE ON AGING [K01AG030378] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgetown University Funding; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG30378. This work was also supported by Georgetown University Funding (to C. E.-H. M.).	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Avraham E, 2007, J BIOL CHEM, V282, P12842, DOI 10.1074/jbc.M608243200; Burns MP, 2009, HUM MOL GENET, V18, P3206, DOI 10.1093/hmg/ddp258; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Dickins RA, 2002, MOL CELL BIOL, V22, P2294, DOI 10.1128/MCB.22.7.2294-2303.2002; Dickson DW, 2007, ACTA NEUROPATHOL, V114, P71, DOI 10.1007/s00401-007-0234-5; Fiesel FC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-64; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Geser F, 2008, ACTA NEUROPATHOL, V115, P133, DOI 10.1007/s00401-007-0257-y; Geser F, 2010, ARCH NEUROL-CHICAGO, V67, P1238, DOI 10.1001/archneurol.2010.254; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hasegawa M, 2007, BRAIN, V130, P1386, DOI 10.1093/brain/awm065; Herman AM, 2012, EXP NEUROL, V235, P297, DOI 10.1016/j.expneurol.2012.02.011; Herman AM, 2011, BRAIN RES, V1386, P191, DOI 10.1016/j.brainres.2011.02.052; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; Hu G, 1999, MOL CELL BIOL, V19, P724; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; Jiang Q, 2008, J NEUROSCI, V28, P12993, DOI 10.1523/JNEUROSCI.2860-08.2008; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kawahara K, 2008, J BIOL CHEM, V283, P6979, DOI 10.1074/jbc.M710418200; Khandelwal PJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-47; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; LEIGH PN, 1991, BRAIN, V114, P775, DOI 10.1093/brain/114.2.775; Lonskaya I, 2013, J ALZHEIMERS DIS, V33, P231, DOI 10.3233/JAD-2012-121141; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; McCluskey LF, 2009, ARCH NEUROL-CHICAGO, V66, P121, DOI 10.1001/archneur.66.1.121; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Mizuno Y, 2001, CURR OPIN NEUROL, V14, P477, DOI 10.1097/00019052-200108000-00008; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Qi JF, 2010, ONCOTARGET, V1, P379, DOI 10.18632/oncotarget.171; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Riley BE, 2010, J CELL BIOL, V191, P537, DOI 10.1083/jcb.201005012; Rodriguez-Navarro JA, 2008, HUM MOL GENET, V17, P3128, DOI 10.1093/hmg/ddn210; Rosen KM, 2010, J NEUROSCI RES, V88, P167, DOI 10.1002/jnr.22178; Rubio de la Torre E, 2009, HUM MOL GENET, V18, P809, DOI 10.1093/hmg/ddn407; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Yokota O, 2010, ACTA NEUROPATHOL, V120, P55, DOI 10.1007/s00401-010-0702-1; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	77	91	91	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4103	4115		10.1074/jbc.M112.419945	http://dx.doi.org/10.1074/jbc.M112.419945			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258539	hybrid, Green Published			2022-12-28	WOS:000314845000039
J	Errami, Y; Naura, AS; Kim, H; Ju, JH; Suzuki, Y; El-Bahrawy, AH; Ghonim, MA; Hemeida, RA; Mansy, MS; Zhang, JH; Xu, M; Smulson, ME; Brim, H; Boulares, AH				Errami, Youssef; Naura, Amarjit S.; Kim, Hogyoung; Ju, Jihang; Suzuki, Yasuhiro; El-Bahrawy, Ali H.; Ghonim, Mohamed A.; Hemeida, Ramadan A.; Mansy, Moselhy S.; Zhang, Jianhua; Xu, Ming; Smulson, Mark E.; Brim, Hassan; Boulares, A. Hamid			Apoptotic DNA Fragmentation May Be a Cooperative Activity between Caspase-activated Deoxyribonuclease and the Poly(ADP-ribose) Polymerase-regulated DNAS1L3, an Endoplasmic Reticulum-localized Endonuclease That Translocates to the Nucleus during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN CONDENSATION; CELLS; ROLES; THYMOCYTES; CLEAVAGE; IDENTIFICATION; DFF40/CAD; PROTEASES; DNASE1L3; CA2+	Caspase-activated DNase (CAD) is the most favorable candidate for chromatin degradation during apoptosis. Ca2+-dependent endonucleases are equally important in internucleosomal DNA fragmentation (INDF), including the PARP-1-regulated DNAS1L3. Despite the elaborate work on these endonucleases, the question of whether these enzymes cooperate during INDF was not addressed. Here, we show a lack of correlation between INDF and CAD expression levels and inactivation by cleavage of its inhibitor (ICAD) during apoptosis. The cells that failed to induce INDF accumulated large amounts of 50-kb breaks, which is suggestive of incomplete chromatin processing. Similarly, INDF was blocked by Ca2+ chelation without a block in ICAD cleavage or caspase-3 activation, which is consistent with the involvement of CAD in 50-kb DNA fragmentation and its Ca2+ independence. However, DNAS1L3 expression in INDF-deficient cells promoted INDF during apoptosis and was blocked by Ca2+ chelation. Interestingly, expression of DNAS1L3 in ICAD-deficient cells failed to promote tumor necrosis factor alpha-induced INDF but required the coexpression of ICAD. These results suggest a cooperative activity between CAD and DNAS1L3 to accomplish INDF. In HT-29 cells, endogenous DNAS1L3 localized to the endoplasmic reticulum (ER) and translocated to the nucleus upon apoptosis induction but prior to INDF manifestation, making it the first reported Ca2+-dependent endonuclease to migrate from the ER to the nucleus. The nuclear accumulation of DNAS1L3, but not its exit out of the ER, required the activity of cysteine and serine proteases. Interestingly, the endonuclease accumulated in the cytosol upon inhibition of serine, but not cysteine, proteases. These results exemplify the complexity of chromatin degradation during apoptosis.	[Errami, Youssef; Naura, Amarjit S.; Kim, Hogyoung; Ju, Jihang; El-Bahrawy, Ali H.; Ghonim, Mohamed A.; Boulares, A. Hamid] Louisiana State Univ, Hlth Sci Ctr, Stanley Scott Canc Ctr, New Orleans, LA 70112 USA; [Errami, Youssef; Suzuki, Yasuhiro; Boulares, A. Hamid] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Naura, Amarjit S.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA; [El-Bahrawy, Ali H.; Hemeida, Ramadan A.] Al Azhar Univ, Dept Pharmacol & Toxicol, Assiut 71515, Egypt; [Ghonim, Mohamed A.; Mansy, Moselhy S.] Al Azhar Univ, Fac Pharm, Cairo 11787, Egypt; [Zhang, Jianhua] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Xu, Ming] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA; [Smulson, Mark E.] Georgetown Univ, Sch Med, Dept Biochem, Washington, DC 20057 USA; [Brim, Hassan] Howard Univ, Dept Pathol, Washington, DC 20059 USA; [Brim, Hassan] Howard Univ, Ctr Canc, Washington, DC 20059 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); Al Azhar University; University of Alabama System; University of Alabama Birmingham; University of Chicago; Georgetown University; Howard University; Howard University	Boulares, AH (corresponding author), 533 Bolivar St, New Orleans, LA 70112 USA.	hboulr@lsuhsc.edu	Ghonim, Mohamed A./AAT-3339-2021; Ghonim, Mohamed A./L-4757-2016	Ghonim, Mohamed A./0000-0001-9404-2698; Ghonim, Mohamed A./0000-0001-9404-2698; Zhang, Jianhua/0000-0002-2128-9574; Errami, Youssef/0000-0002-0432-4331; El-Bahrawy, Ali/0000-0001-6116-0428	National Institutes of Health Grant [HL072889]; American Cancer Society Grant [RSG-116608]; Louisiana Cancer Research Consortium (New Orleans, LA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103501] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Grant(American Cancer Society); Louisiana Cancer Research Consortium (New Orleans, LA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL072889. This work was also supported by American Cancer Society Grant RSG-116608 and by funds from the Louisiana Cancer Research Consortium (New Orleans, LA) (to H. B.).	Boulares AH, 2004, BASIC CLIN PHARMACOL, V94, P19; Boulares AH, 2002, CANCER RES, V62, P4439; Boulares AH, 2002, BIOCHEM BIOPH RES CO, V290, P796, DOI 10.1006/bbrc.2001.6280; Boulares AH, 2002, J BIOL CHEM, V277, P372, DOI 10.1074/jbc.M107738200; Boulares AH, 2001, J BIOL CHEM, V276, P38185; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Kitazumi I, 2011, FEBS J, V278, P427, DOI 10.1111/j.1742-4658.2010.07975.x; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu QY, 1998, BIOCHEMISTRY-US, V37, P10134, DOI 10.1021/bi9800597; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Los M, 2000, BIOCHEMISTRY-US, V39, P7365, DOI 10.1021/bi000158w; Moffitt KL, 2007, BIOCHEM SOC T, V35, P559, DOI 10.1042/BST0350559; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Napirei M, 2005, BIOCHEM J, V389, P355, DOI 10.1042/BJ20042124; Napirei M, 2009, FEBS J, V276, P1059, DOI 10.1111/j.1742-4658.2008.06849.x; O'Connell AR, 2006, BIOCHEM BIOPH RES CO, V345, P608, DOI 10.1016/j.bbrc.2006.04.147; Shiokawa D, 2005, BIOCHEM J, V392, P511, DOI 10.1042/BJ20051114; Shiokawa D, 2003, BIOCHEM J, V376, P377, DOI 10.1042/BJ20030820; SHIOKAWA D, 1994, EUR J BIOCHEM, V226, P23, DOI 10.1111/j.1432-1033.1994.tb20022.x; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; Takahashi K, 1999, INT J RADIAT BIOL, V75, P1099, DOI 10.1080/095530099139566; Trbovich AM, 1998, CELL DEATH DIFFER, V5, P38, DOI 10.1038/sj.cdd.4400299; Urbano A, 1998, J BIOL CHEM, V273, P34820, DOI 10.1074/jbc.273.52.34820; WALKER PR, 1991, CANCER RES, V51, P1078; Widlak P, 2001, MOL CELL BIOCHEM, V218, P125, DOI 10.1023/A:1007231822086; Widlak P, 2000, ACTA BIOCHIM POL, V47, P1037; Yakovlev AG, 2000, J BIOL CHEM, V275, P21302, DOI 10.1074/jbc.M001087200; Yakovlev AG, 2001, MOL MED, V7, P205, DOI 10.1007/BF03401955; Yakovlev AG, 1999, NUCLEIC ACIDS RES, V27, P1999, DOI 10.1093/nar/27.9.1999; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zhang JH, 2000, BIOCHEM BIOPH RES CO, V274, P225, DOI 10.1006/bbrc.2000.3122; Zhang M, 2001, APOPTOSIS, V6, P291, DOI 10.1023/A:1011387509290	35	51	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3460	3468		10.1074/jbc.M112.423061	http://dx.doi.org/10.1074/jbc.M112.423061			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23229555	Green Published, hybrid			2022-12-28	WOS:000314397900050
J	Hong, S; Kim, HY; Kim, J; Ha, HT; Kim, YM; Bae, E; Kim, TH; Lee, KC; Kim, SJ				Hong, Suntaek; Kim, Hye-Youn; Kim, Jooyoung; Huyen Trang Ha; Kim, Young-Mi; Bae, Eunjin; Kim, Tae Hyung; Lee, Kang Choon; Kim, Seong-Jin			Smad7 Protein Induces Interferon Regulatory Factor 1-dependent Transcriptional Activation of Caspase 8 to Restore Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TRAIL-INDUCED APOPTOSIS; FACTOR-KAPPA-B; TGF-BETA; GENE-EXPRESSION; NEUROBLASTOMA-CELLS; CRYSTAL-STRUCTURE; UP-REGULATION; MH1 DOMAIN; IN-VIVO	Smad7 has been known as a negative regulator for the transforming growth factor-beta (TGF-beta) signaling pathway through feedback regulation. However, Smad7 has been suspected to have other biological roles through the regulation of gene transcription. By screening differentially regulated genes, we found that the caspase 8 gene was highly up-regulated in Smad7-expressing cells. Smad7 was able to activate the caspase 8 promoter through recruitment of the interferon regulatory factor 1 (IRF1) transcription factor to the interferon-stimulated response element (ISRE) site. Interaction of Smad7 on the caspase 8 promoter was confirmed with electrophoretic mobility shift assay and chromatin immunoprecipitation experiment. Interestingly, Smad7 did not directly interact with the ISRE site, but it increased the binding activity of IRF1 with ISRE. These results support that Smad7 recruits IRF1 protein on the caspase 8 promoter and functions as a transcriptional coactivator. To confirm the biological significance of caspase 8 up-regulation, we tested tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated cell death assay in breast cancer cells. Smad7 in apoptosis-resistant MCF7 cells markedly sensitized the cells to TRAIL-induced cell death by restoring the caspase cascade. Furthermore, restoration of caspase 8-mediated apoptosis pathway repressed the tumor growth in the xenograft model. In conclusion, we suggest a novel role for Smad7 as a transcriptional coactivator for caspase 8 through the interaction with IRF1 in regulation of the cell death pathway.	[Hong, Suntaek; Kim, Hye-Youn; Kim, Jooyoung; Huyen Trang Ha; Kim, Young-Mi; Bae, Eunjin] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Dept Mol Med, Inchon 406840, South Korea; [Bae, Eunjin; Kim, Seong-Jin] Cha Univ, Cha Canc Inst, Seoul 135081, South Korea; [Kim, Tae Hyung] Sungkyunkwan Univ, Coll Pharm, Suwon 440746, South Korea	Gachon University; Pochon Cha University; Sungkyunkwan University (SKKU)	Hong, S (corresponding author), Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Dept Mol Med, Inchon 406840, South Korea.	sthong@gachon.ac.kr; kimsj@cha.ac.kr	Ha, Trang/AAD-6717-2019; Kim, Hye Youn/K-3590-2016	Ha, Trang/0000-0002-5238-7599; 	World Class University program; Ministry of Education, Science and Technology through the National Research Foundation of Korea [R32-10215, 2009-0081756]; Bio & Medical Technology Development Program	World Class University program; Ministry of Education, Science and Technology through the National Research Foundation of Korea; Bio & Medical Technology Development Program	Supported by World Class University program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea Grant R32-10215. To whom correspondence may be addressed: Dept. of Molecular Medicine, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, 7-45 Songdo-dong Yeonsu-gu Incheon, 406-840, Republic of Korea. Tel.: 82-32-899-6311; Fax: 82-32-899-6039; E-mail: sthong@gachon.ac.kr.; Supported by Bio & Medical Technology Development Program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea Grant 2009-0081756. To whom correspondence may be addressed: Cha Cancer Institute, Cha University, 650-9 Yeok-sam-1-dong Kangnam-gu Seoul, 135-081, Republic of Korea. Tel.: 82-2-3468-2646; Fax: 82-2-3468- 2651; E-mail: kimsj@cha.ac.kr.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Bai ST, 2002, J BIOL CHEM, V277, P4176, DOI 10.1074/jbc.M105105200; Casciano I, 2004, ANN NY ACAD SCI, V1028, P157, DOI 10.1196/annals.1322.017; Chae SY, 2010, MOL CANCER THER, V9, P1719, DOI 10.1158/1535-7163.MCT-09-1076; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Cook JA, 2010, CANCER LETT, V289, P119, DOI 10.1016/j.canlet.2009.08.009; De Ambrosis A, 2007, INT J CANCER, V120, P39, DOI 10.1002/ijc.22173; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Finlay D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013375; Frontini M, 2009, NUCLEIC ACIDS RES, V37, P1073, DOI 10.1093/nar/gkn1051; Fulda S, 2006, ONCOGENE, V25, P5125, DOI 10.1038/sj.onc.1209518; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Geiger K, 2012, MOL BIOL CELL, V23, P2226, DOI 10.1091/mbc.E11-06-0535; Grocott T, 2007, NUCLEIC ACIDS RES, V35, P890, DOI 10.1093/nar/gkl1105; Hong S, 2007, CANCER RES, V67, P9577, DOI 10.1158/0008-5472.CAN-07-1179; Hong S, 2007, NAT IMMUNOL, V8, P504, DOI 10.1038/ni1451; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Johnsen JI, 2004, INT J ONCOL, V25, P1849; Kennedy BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022606; Kim BC, 2004, MOL CELL BIOL, V24, P2251, DOI 10.1128/MCB.24.6.2251-2262.2004; Kim YS, 2002, HEPATOLOGY, V36, P1498, DOI 10.1053/jhep.2002.36942; Komata T, 2005, INT J ONCOL, V26, P1345; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Lalaoui N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019679; Lallemand F, 2001, ONCOGENE, V20, P879, DOI 10.1038/sj.onc.1204167; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lin X, 2003, MOL CELL BIOL, V23, P9081, DOI 10.1128/MCB.23.24.9081-9093.2003; Lissat A, 2007, AM J PATHOL, V170, P1917, DOI 10.2353/ajpath.2007.060993; Liu XG, 2005, CANCER RES, V65, P9169, DOI 10.1158/0008-5472.CAN-05-0939; Menke C, 2011, CANCER RES, V71, P1883, DOI 10.1158/0008-5472.CAN-10-2252; Monteleone G, 2004, GASTROENTEROLOGY, V126, P674, DOI 10.1053/j.gastro.2003.11.048; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Muhlethaler-Mottet A, 2003, ANN NY ACAD SCI, V1010, P195, DOI 10.1196/annals.1299.033; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Qing J, 2004, MOL CELL BIOL, V24, P1411, DOI 10.1128/MCB.24.3.1411-1425.2004; Rizzo A, 2011, CANCER RES, V71, P7423, DOI 10.1158/0008-5472.CAN-11-1895; Ruiz-Ruiz C, 2004, J BIOL CHEM, V279, P19712, DOI 10.1074/jbc.M313023200; Sanlioglu AD, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-54; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Simonsson M, 2005, J BIOL CHEM, V280, P21797, DOI 10.1074/jbc.M503134200; Singh TR, 2003, CANCER RES, V63, P5390; Spector I, 2010, PANCREAS, V39, P1008, DOI 10.1097/MPA.0b013e3181da8aa3; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Weng HL, 2007, J HEPATOL, V46, P295, DOI 10.1016/j.jhep.2006.09.014; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu YY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-32; Xavier S, 2004, J BIOL CHEM, V279, P15167, DOI 10.1074/jbc.M309798200; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhang YH, 2011, INT J ORAL SCI, V3, P1, DOI 10.4248/IJOS11003; Zhou B, 2008, BBA-PROTEINS PROTEOM, V1784, P747, DOI 10.1016/j.bbapap.2008.01.021	63	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3560	3570		10.1074/jbc.M112.400408	http://dx.doi.org/10.1074/jbc.M112.400408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255602	hybrid, Green Published			2022-12-28	WOS:000314397900061
J	Ripple, MO; Kim, N; Springett, R				Ripple, Maureen O.; Kim, Namjoon; Springett, Roger			Acute Mitochondrial Inhibition by Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (MEK) 1/2 Inhibitors Regulates Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURVIVAL; COMPLEX-I; CANCER; PATHWAY; GROWTH; RAS; DIFFERENTIATION; EXPRESSION; NADH; PHOSPHORYLATION	The Ras-MEK1/2-ERK1/2 kinase signaling pathway regulates proliferation, survival, and differentiation and, because it is often aberrant in tumors, is a popular target for small molecule inhibition. A novel metabolic analysis that measures the real-time oxidation state of NAD(H) and the hemes of the electron transport chain and oxygen consumption within intact, living cells found that structurally distinct MEK1/2 inhibitors had an immediate, dose-dependent effect on mitochondrial metabolism. The inhibitors U0126, MIIC and PD98059 caused NAD(H) reduction, heme oxidation, and decreased oxygen consumption, characteristic of complex I inhibition. PD198306, an orally active MEK1/2 inhibitor, acted as an uncoupler. Each MEK1/2 inhibitor depleted phosphorylated ERK1/2 and inhibited proliferation, but the most robust antiproliferative effects always correlated with the metabolic failure which followed mitochondrial inhibition rather than inhibition of MEK1/2. This warrants rethinking the role of ERK1/2 in proliferation and emphasizes the importance of mitochondrial function in this process.	[Ripple, Maureen O.; Kim, Namjoon; Springett, Roger] Geisel Sch Med Dartmouth, Dept Radiol, Hanover, NH 03755 USA	Dartmouth College	Ripple, MO (corresponding author), Geisel Sch Med Dartmouth, Dept Radiol, HB 7786, Hanover, NH 03755 USA.	maureen.ripple@dartmouth.edu	Springett, Roger/P-2274-2019		National Institutes of Health [5R21RR25803, R01NS054298]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R21RR25803 and R01NS054298.	Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Beloueche-Babari M, 2005, CANCER RES, V65, P3356, DOI 10.1158/0008-5472.CAN-03-2981; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Bost F, 1997, J BIOL CHEM, V272, P33422, DOI 10.1074/jbc.272.52.33422; Brose MS, 2002, CANCER RES, V62, P6997; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; COLLINS SJ, 1987, BLOOD, V70, P1233; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Dokladda K, 2005, FEBS LETT, V579, P236, DOI 10.1016/j.febslet.2004.11.084; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fremin C, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-8; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; HALLER T, 1994, ANAL BIOCHEM, V218, P338, DOI 10.1006/abio.1994.1188; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hollis VS, 2003, BBA-BIOENERGETICS, V1607, P191, DOI 10.1016/j.bbabio.2003.09.012; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Kim N, 2012, BIOPHYS J, V102, P1194, DOI 10.1016/j.bpj.2012.02.003; Kim N, 2011, BBA-BIOENERGETICS, V1807, P779, DOI 10.1016/j.bbabio.2011.03.008; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Morgan MA, 2001, BLOOD, V97, P1823, DOI 10.1182/blood.V97.6.1823; Newbern JM, 2011, NEURON, V69, P91, DOI 10.1016/j.neuron.2010.12.003; Nowak G, 2006, AM J PHYSIOL-RENAL, V291, pF840, DOI 10.1152/ajprenal.00219.2005; Osborne JK, 2012, CELL RES, V22, P14, DOI 10.1038/cr.2011.193; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Papa S, 2002, J BIOENERG BIOMEMBR, V34, P1, DOI 10.1023/A:1013863018115; Paz C, 2009, METHOD ENZYMOL, V457, P169, DOI 10.1016/S0076-6879(09)05010-1; Ripple MO, 2005, BREAST CANCER RES TR, V93, P177, DOI 10.1007/s10549-005-4794-6; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schilling B, 2005, MOL CELL PROTEOMICS, V4, P84, DOI 10.1074/mcp.M400143-MCP200; Sebolt-Leopold JS, 2008, CLIN CANCER RES, V14, P3651, DOI 10.1158/1078-0432.CCR-08-0333; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; SteinlechnerMaran R, 1996, AM J PHYSIOL-CELL PH, V271, pC2053, DOI 10.1152/ajpcell.1996.271.6.C2053; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; YU L, 1987, J BIOL CHEM, V262, P1137	41	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2933	2940		10.1074/jbc.M112.430082	http://dx.doi.org/10.1074/jbc.M112.430082			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235157	Green Published, hybrid			2022-12-28	WOS:000314397900004
J	Freewan, M; Rees, MD; Plaza, TSS; Glaros, E; Lim, YJ; Wang, XS; Yeung, AWS; Witting, PK; Terentis, AC; Thomas, SR				Freewan, Mohammed; Rees, Martin D.; Plaza, Tito S. Sempertegui; Glaros, Elias; Lim, Yean J.; Wang, Xiao Suo; Yeung, Amanda W. S.; Witting, Paul K.; Terentis, Andrew C.; Thomas, Shane R.			Human Indoleamine 2,3-Dioxygenase Is a Catalyst of Physiological Heme Peroxidase Reactions IMPLICATIONS FOR THE INHIBITION OF DIOXYGENASE ACTIVITY BY HYDROGEN PEROXIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOCHLOROUS ACID PRODUCTION; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; TRYPTOPHAN 2,3-DIOXYGENASE; NITRIC-OXIDE; N-FORMYLKYNURENINE; POSTTRANSLATIONAL REGULATION; STRUCTURAL-PROPERTIES; LIPID-PEROXIDATION; TYROSINE NITRATION	The heme enzyme indoleamine 2,3-dioxygenase (IDO) is a key regulator of immune responses through catalyzing L-tryptophan (L-Trp) oxidation. Here, we show that hydrogen peroxide (H2O2) activates the peroxidase function of IDO to induce protein oxidation and inhibit dioxygenase activity. Exposure of IDO-expressing cells or recombinant human IDO (rIDO) to H2O2 inhibited dioxygenase activity in a manner abrogated by L-Trp. Dioxygenase inhibition correlated with IDO-catalyzed H2O2 consumption, compound I-mediated formation of protein-centered radicals, altered protein secondary structure, and opening of the distal heme pocket to promote nonproductive substrate binding; these changes were inhibited by L-Trp, the heme ligand cyanide, or free radical scavengers. Protection by L-Trp coincided with its oxidation into oxindolylalanine and kynurenine and the formation of a compound II-type ferryl-oxo heme. Physiological peroxidase substrates, ascorbate or tyrosine, enhanced rIDO-mediated H2O2 consumption and attenuated H2O2-induced protein oxidation and dioxygenase inhibition. In the presence of H2O2, rIDO catalytically consumed nitric oxide (NO) and utilized nitrite to promote 3-nitrotyrosine formation on IDO. The promotion of H2O2 consumption by peroxidase substrates, NO consumption, and IDO nitration was inhibited by L-Trp. This study identifies IDO as a heme peroxidase that, in the absence of substrates, self-inactivates dioxygenase activity via compound I-initiated protein oxidation. L-Trp protects against dioxygenase inactivation by reacting with compound I and retarding compound II reduction to suppress peroxidase turnover. Peroxidase-mediated dioxygenase inactivation, NO consumption, or protein nitration may modulate the biological actions of IDO expressed in inflammatory tissues where the levels of H2O2 and NO are elevated and L-Trp is low.	[Freewan, Mohammed; Rees, Martin D.; Glaros, Elias; Lim, Yean J.; Yeung, Amanda W. S.; Thomas, Shane R.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; [Freewan, Mohammed; Rees, Martin D.; Glaros, Elias; Lim, Yean J.; Yeung, Amanda W. S.; Thomas, Shane R.] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Plaza, Tito S. Sempertegui; Terentis, Andrew C.] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA; [Wang, Xiao Suo; Witting, Paul K.] Univ Sydney, Discipline Pathol, Sydney Med Sch, Bosch Inst, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of New South Wales Sydney; State University System of Florida; Florida Atlantic University; University of Sydney	Terentis, AC (corresponding author), Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA.	terentis@fau.edu; shane.thomas@unsw.edu.au	Witting, Paul/ABD-2053-2020; Terentis, Andrew/N-9188-2019; Witting, Paul/L-9786-2019	Witting, Paul/0000-0003-2237-7004; Terentis, Andrew/0000-0001-6137-8275; Lim, Yean Jin/0000-0003-1874-2662; Sempertegui Plaza, Tito/0000-0003-0958-1780; Wang, Xiao Suo/0000-0003-3487-4614; Rees, Martin/0000-0002-3564-5736	Australian National Health and Medical Research Council [568774]; American Chemical Society [46549-G4]; Australian Research Council [DP0878559]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); American Chemical Society(American Chemical Society); Australian Research Council(Australian Research Council)	This work was supported in part by Australian National Health and Medical Research Council Project Grant 568774 (to S. R. T.), American Chemical Society Petroleum Research Fund Grant 46549-G4 (to A. C. T.), and Australian Research Council Discovery Grant DP0878559 (to P. K. W.).	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Austin C, 2009, AMINO ACIDS, V36, P99, DOI 10.1007/s00726-008-0037-6; Basran J, 2008, BIOCHEMISTRY-US, V47, P4752, DOI 10.1021/bi702393b; Basran J, 2011, J AM CHEM SOC, V133, P16251, DOI 10.1021/ja207066z; Bove PF, 2008, J BIOL CHEM, V283, P17919, DOI 10.1074/jbc.M709914200; Bove PF, 2006, FREE RADICAL BIO MED, V41, P515, DOI 10.1016/j.freeradbiomed.2006.05.011; Burner U, 2000, J BIOL CHEM, V275, P20597, DOI 10.1074/jbc.M000181200; Capece L, 2012, J PHYS CHEM B, V116, P1401, DOI 10.1021/jp2082825; Capece L, 2010, J BIOL INORG CHEM, V15, P811, DOI 10.1007/s00775-010-0646-x; Chauhan N, 2008, BIOCHEMISTRY-US, V47, P4761, DOI 10.1021/bi702405a; Chung LW, 2010, J AM CHEM SOC, V132, P11993, DOI 10.1021/ja103530v; CORNFORTH JW, 1951, BIOCHEM J, V48, P598, DOI 10.1042/bj0480598; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; De Marinis E, 2009, IUBMB LIFE, V61, P62, DOI 10.1002/iub.149; DeGray JA, 1997, J BIOL CHEM, V272, P2359; Efimov I, 2011, BIOCHEMISTRY-US, V50, P2717, DOI 10.1021/bi101732n; Ehrenshaft M, 2009, FREE RADICAL BIO MED, V46, P1260, DOI 10.1016/j.freeradbiomed.2009.01.020; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Ferry G, 2005, BIOCHEM J, V388, P205, DOI 10.1042/BJ20042075; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Fu R, 2011, J BIOL CHEM, V286, P26541, DOI 10.1074/jbc.M111.253237; Galijasevic S, 2008, FREE RADICAL BIO MED, V44, P1570, DOI 10.1016/j.freeradbiomed.2008.01.003; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Gen JF, 2012, J AM CHEM SOC, V134, P12209, DOI 10.1021/ja304164b; Giessauf A, 1996, FEBS LETT, V389, P136; Glover RE, 1999, NITRIC OXIDE-BIOL CH, V3, P439, DOI 10.1006/niox.1999.0256; Herold S, 2001, J BIOL INORG CHEM, V6, P543, DOI 10.1007/s007750100231; Holt S, 1999, LANCET, V353, P1241, DOI 10.1016/S0140-6736(98)05768-7; Hsuanyu Y, 1999, ARCH BIOCHEM BIOPHYS, V368, P413, DOI 10.1006/abbi.1999.1328; Irwin JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P94, DOI 10.1006/abbi.1998.0987; ITAKURA K, 1994, CHEM RES TOXICOL, V7, P185, DOI 10.1021/tx00038a011; Kettle AJ, 2000, REDOX REP, V5, P179, DOI 10.1179/135100000101535726; Kettle AJ, 2001, BIOCHEMISTRY-US, V40, P10204, DOI 10.1021/bi010940b; Kettle AJ, 2007, BIOCHEMISTRY-US, V46, P4888, DOI 10.1021/bi602587k; Kilinc K, 2001, BIOCHEM BIOPH RES CO, V285, P273, DOI 10.1006/bbrc.2001.5168; King NJC, 2007, INT J BIOCHEM CELL B, V39, P2167, DOI 10.1016/j.biocel.2007.01.004; Kuo HH, 2012, P NATL ACAD SCI USA, V109, P13966, DOI 10.1073/pnas.1207191109; LABROO RB, 1990, J ORG CHEM, V55, P4901, DOI 10.1021/jo00303a027; Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106; Littlejohn TK, 2003, J BIOL CHEM, V278, P29525, DOI 10.1074/jbc.M301700200; Liu XP, 2001, FREE RADICAL BIO MED, V31, P894, DOI 10.1016/S0891-5849(01)00665-7; Lu CY, 2011, J BIOL CHEM, V286, P21220, DOI 10.1074/jbc.M111.221507; MARQUEZ LA, 1994, BIOCHEMISTRY-US, V33, P1447, DOI 10.1021/bi00172a022; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; MASKOS Z, 1992, ARCH BIOCHEM BIOPHYS, V296, P514, DOI 10.1016/0003-9861(92)90605-V; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; Matsui T, 1999, J AM CHEM SOC, V121, P9952, DOI 10.1021/ja9914846; MAYO SL, 1986, SCIENCE, V233, P948, DOI 10.1126/science.3016897; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Moore KP, 1998, J BIOL CHEM, V273, P31731, DOI 10.1074/jbc.273.48.31731; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200; Poljak A, 2006, ARCH BIOCHEM BIOPHYS, V450, P9, DOI 10.1016/j.abb.2006.03.003; Poulos TL, 2010, ARCH BIOCHEM BIOPHYS, V500, P3, DOI 10.1016/j.abb.2010.02.008; Prendergast GC, 2010, AM J PATHOL, V176, P2082, DOI 10.2353/ajpath.2010.091173; Queiroz RF, 2011, BIOCHEM J, V439, P423, DOI 10.1042/BJ20110555; Rafice SA, 2009, BIOCHEM SOC T, V37, P408, DOI 10.1042/BST0370408; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Rees MD, 2009, BIOCHEM J, V421, P79, DOI 10.1042/BJ20090309; Rosell FI, 2011, J BIOL CHEM, V286, P29273, DOI 10.1074/jbc.M111.262139; Sampson JB, 1998, ARCH BIOCHEM BIOPHYS, V356, P207, DOI 10.1006/abbi.1998.0772; Simat TJ, 1998, J AGR FOOD CHEM, V46, P490, DOI 10.1021/jf970818c; SONO M, 1980, J BIOL CHEM, V255, P1339; SONO M, 1989, J BIOL CHEM, V264, P1616; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; TAKIKAWA O, 1983, J BIOL CHEM, V258, P6808; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Terentis AC, 2002, J BIOL CHEM, V277, P15788, DOI 10.1074/jbc.M200457200; Terentis AC, 2010, BIOCHEMISTRY-US, V49, P591, DOI 10.1021/bi901546e; Thomas SR, 2007, J BIOL CHEM, V282, P23778, DOI 10.1074/jbc.M700669200; Thomas SR, 2001, J IMMUNOL, V166, P6332, DOI 10.4049/jimmunol.166.10.6332; Thomas SR, 1999, REDOX REP, V4, P199, DOI 10.1179/135100099101534927; van Dalen CJ, 2000, J BIOL CHEM, V275, P11638, DOI 10.1074/jbc.275.16.11638; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; Vetter SW, 2009, J BIOL INORG CHEM, V14, P179, DOI 10.1007/s00775-008-0436-x; Vlasits J, 2010, ARCH BIOCHEM BIOPHYS, V500, P74, DOI 10.1016/j.abb.2010.04.018; Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6; Witting PK, 1999, CHEM RES TOXICOL, V12, P1173, DOI 10.1021/tx9900472; Yanagisawa S, 2011, FARADAY DISCUSS, V148, P239, DOI 10.1039/c004552g; Yanagisawa S, 2010, BIOCHEMISTRY-US, V49, P10081, DOI 10.1021/bi1009997; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007; Zhang Y, 2007, BIOCHEMISTRY-US, V46, P145, DOI 10.1021/bi0620095	88	39	39	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1548	1567		10.1074/jbc.M112.410993	http://dx.doi.org/10.1074/jbc.M112.410993			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23209301	hybrid, Green Published			2022-12-28	WOS:000313751400012
J	Rai, AK; Paul, K; Chattopadhyay, K				Rai, Anand Kumar; Paul, Karan; Chattopadhyay, Kausik			Functional Mapping of the Lectin Activity Site on the beta-Prism Domain of Vibrio cholerae Cytolysin IMPLICATIONS FOR THE MEMBRANE PORE-FORMATION MECHANISM OF THE TOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOTYPE EL-TOR; HEPTAMERIC TRANSMEMBRANE PORE; CRYSTAL-STRUCTURE; FORMING TOXINS; HEMOLYSIN; COMPLEX; BINDING; MODE; O1; PURIFICATION	Vibrio cholerae cytolysin (VCC) is a prominent member in the family of beta-barrel pore-forming toxins. It induces lysis of target eukaryotic cells by forming transmembrane oligomeric beta-barrel channels. VCC also exhibits prominent lectin-like activity in interacting with beta 1-galactosyl-terminated glycoconjugates. Apart from the cytolysin domain, VCC harbors two lectin-like domains: the beta-Trefoil and the beta-Prism domains; however, precise contribution of these domains in the lectin property of VCC is not known. Also, role(s) of these lectin-like domains in the mode of action of VCC remain obscure. In the present study, we show that the beta-Prism domain of VCC acts as the structural scaffold to determine the lectin activity of the protein toward beta 1-galactosyl-terminated glycoconjugates. Toward exploring the physiological implication of the beta-Prism domain, we demonstrate that the presence of the beta-Prism domain-mediated lectin activity is crucial for an efficient interaction of the toxin toward the target cells. Our results also suggest that such lectin activity may act to regulate the oligomerization ability of the membrane-bound VCC toxin. Based on the data presented here, and also consistent with the existing structural information, we propose a novel mechanism of regulation imposed by the beta-Prism domain's lectin activity, implicated in the process of membrane pore formation by VCC.	[Rai, Anand Kumar; Paul, Karan; Chattopadhyay, Kausik] IISER, Dept Biol Sci, Manauli 140306, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Chattopadhyay, K (corresponding author), IISER, Dept Biol Sci, Sect 81, Manauli 140306, Punjab, India.	kausik@iisermohali.ac.in	Chattopadhyay, Kausik/H-5044-2015; Paul, Karan/GZK-9033-2022	Chattopadhyay, Kausik/0000-0001-8529-9475; Paul, Karan/0000-0002-4921-6799	Department of Biotechnology (DBT), India [BT/PR13350/BRB/10/751/2009]; IISER Mohali	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); IISER Mohali	This work was supported by a grant from the Department of Biotechnology (DBT), India (DBT Grant No. BT/PR13350/BRB/10/751/2009) and IISER Mohali.	Alouf J., 2006, COMPREHENSIVE SOURCE; Chattopadhyay K, 2003, J BIOL CHEM, V278, P38470, DOI 10.1074/jbc.M305965200; Chattopadhyay K, 2002, EUR J BIOCHEM, V269, P4351, DOI 10.1046/j.1432-1033.2002.03137.x; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; GOLDBERG SL, 1984, J BACTERIOL, V160, P239, DOI 10.1128/JB.160.1.239-244.1984; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; HONDA T, 1979, INFECT IMMUN, V26, P1020, DOI 10.1128/IAI.26.3.1020-1027.1979; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; Ikigai H, 1996, INFECT IMMUN, V64, P2968, DOI 10.1128/IAI.64.8.2968-2973.1996; KRASILNIKOV OV, 1992, BIOCHIM BIOPHYS ACTA, V1111, P7, DOI 10.1016/0005-2736(92)90268-Q; Lee X, 1998, J BIOL CHEM, V273, P6312, DOI 10.1074/jbc.273.11.6312; Mazumdar B, 2011, INDIAN J MED RES, V133, P131; Menzl K, 1996, EUR J BIOCHEM, V240, P646, DOI 10.1111/j.1432-1033.1996.0646h.x; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Paul K, 2012, FEBS J, V279, P4039, DOI 10.1111/j.1742-4658.2012.08809.x; Paul K, 2011, BIOCHEMISTRY-US, V50, P3936, DOI 10.1021/bi200332g; Saha N, 1997, J BIOL CHEM, V272, P162, DOI 10.1074/jbc.272.1.162; Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; YAMAMOTO K, 1990, INFECT IMMUN, V58, P4106, DOI 10.1128/IAI.58.12.4106-4116.1990; YAMAMOTO K, 1984, INFECT IMMUN, V45, P192, DOI 10.1128/IAI.45.1.192-196.1984; Yuldasheva LN, 2001, BBA-BIOMEMBRANES, V1512, P53, DOI 10.1016/S0005-2736(01)00302-9; ZITZER A, 1995, MED MICROBIOL IMMUN, V184, P37, DOI 10.1007/BF00216788; Zitzer A, 1997, EUR J BIOCHEM, V247, P209, DOI 10.1111/j.1432-1033.1997.00209.x	31	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1665	1673		10.1074/jbc.M112.430181	http://dx.doi.org/10.1074/jbc.M112.430181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23209283	hybrid, Green Published			2022-12-28	WOS:000313751400022
J	Tamarit, B; Bugault, F; Pillet, AH; Lavergne, V; Bochet, P; Garin, N; Schwarz, U; Theze, J; Rose, T				Tamarit, Blanche; Bugault, Florence; Pillet, Anne-Helene; Lavergne, Vincent; Bochet, Pascal; Garin, Nathalie; Schwarz, Ulf; Theze, Jacques; Rose, Thierry			Membrane Microdomains and Cytoskeleton Organization Shape and Regulate the IL-7 Receptor Signalosome in Human CD4 T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; INTERLEUKIN-7; ACTIVATION; CYTOKINES; COMPLEX; CLONING; RAFT; EXPRESSION; MICROSCOPY; TRANSPORT	Interleukin (IL)-7 is the main homeostatic regulator of CD4 T-lymphocytes (helper) at both central and peripheral levels. Upon activation by IL-7, several signaling pathways, mainly JAK/STAT, PI3K/Akt and MAPK, induce the expression of genes involved in T-cell differentiation, activation, and proliferation. We have analyzed the early events of CD4 T-cell activation by IL-7. We have shown that IL-7 in the first few min induces the formation of cholesterol-enriched membrane microdomains that compartmentalize its activated receptor and initiate its anchoring to the cytoskeleton, supporting the formation of the signaling complex, the signalosome, on the IL-7 receptor cytoplasmic domains. Here we describe by stimulated emission depletion microscopy the key roles played by membrane microdomains and cytoskeleton transient organization in the IL-7-regulated JAK/STAT signaling pathway. We image phospho-STAT5 and cytoskeleton components along IL-7 activation kinetics using appropriate inhibitors. We show that lipid raft inhibitors delay and reduce IL-7-induced JAK1 and JAK3 phosphorylation. Drug-induced disassembly of the cytoskeleton inhibits phospho-STAT5 formation, transport, and translocation into the nucleus that controls the transcription of genes involved in T-cell activation and proliferation. We fit together the results of these quantitative analyses and propose the following mechanism. Activated IL-7 receptors embedded in membrane microdomains induce actin-microfilament meshwork formation, anchoring microtubules that grow radially from rafted receptors to the nuclear membrane. STAT5 phosphorylated by signalosomes are loaded on kinesins and glide along the microtubules across the cytoplasm to reach the nucleus 2 min after IL-7 stimulation. Radial microtubules disappear 15 min later, while transversal microtubules, independent of phospho-STAT5 transport, begin to bud from the microtubule organization center.	[Tamarit, Blanche; Bugault, Florence; Pillet, Anne-Helene; Lavergne, Vincent; Bochet, Pascal; Theze, Jacques; Rose, Thierry] Inst Pasteur, Dept Immunol, Dept Infect & Epidemiol, Unite Immunogenet Cellulaire, F-75724 Paris 15, France; [Tamarit, Blanche; Pillet, Anne-Helene] Univ Paris 06, Cellule Pasteur UPMC, F-75015 Paris, France; [Bochet, Pascal] CNRS, UMR3525, F-75015 Paris, France; [Garin, Nathalie] Leica Microsyst AG, CH-9435 Heerbrugg, Switzerland; [Schwarz, Ulf] Leica Microsyst CMS GmbH, D-68165 Mannheim, Germany	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rose, T (corresponding author), Inst Pasteur, Dept Immunol, Dept Infect & Epidemiol, Unite Immunogenet Cellulaire, 25 Rue Dr Roux, F-75724 Paris 15, France.	rose@pasteur.fr		ROSE, Thierry/0000-0001-8863-0207	Institut Pasteur [PTR 424]; Ministere de l'Education Nationale et de la Recherche	Institut Pasteur(European Commission); Ministere de l'Education Nationale et de la Recherche	This work was supported in part by Institut Pasteur and its Transversal Research Program (PTR 424).; Supported by fellowships from the Ministere de l'Education Nationale et de la Recherche.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Alves NL, 2008, J IMMUNOL, V180, P5201, DOI 10.4049/jimmunol.180.8.5201; Cangiani A, 2010, J THEOR BIOL, V267, P614, DOI 10.1016/j.jtbi.2010.08.017; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Colle JH, 2007, AIDS, V21, P101, DOI 10.1097/QAD.0b013e3280115b6a; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302; Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029; He HT, 2011, ANNU REV PHYS CHEM, V62, P417, DOI 10.1146/annurev-physchem-032210-103402; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Jiang K, 2011, CURR OPIN CELL BIOL, V23, P94, DOI 10.1016/j.ceb.2010.08.008; Kitazawa H, 1997, J IMMUNOL, V159, P2259; Lasserre R, 2010, FEBS LETT, V584, P4845, DOI 10.1016/j.febslet.2010.09.001; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Leonard WJ, 1999, COLD SPRING HARB SYM, V64, P417, DOI 10.1101/sqb.1999.64.417; Lopez-Perez M, 2006, INT J BIOCHEM CELL B, V38, P1716, DOI 10.1016/j.biocel.2006.04.001; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; McElroy CA, 2012, P NATL ACAD SCI USA, V109, P2503, DOI 10.1073/pnas.1116582109; Melen K, 2001, J BIOL CHEM, V276, P16447, DOI 10.1074/jbc.M008821200; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pillet AH, 2010, J MOL BIOL, V403, P671, DOI 10.1016/j.jmb.2010.08.056; Pillet AH, 2009, J IMMUNOL, V182, P6267, DOI 10.4049/jimmunol.0801933; Pillet AH, 2008, EUR CYTOKINE NETW, V19, P49, DOI 10.1684/ecn.2008.0120; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rose T, 2010, J BIOL CHEM, V285, P14898, DOI 10.1074/jbc.M110.104232; Rose T, 2009, J IMMUNOL, V182, P7389, DOI 10.4049/jimmunol.0900190; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Walsh STR, 2012, IMMUNOL REV, V250, P303, DOI 10.1111/j.1600-065X.2012.01160.x; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Zoubiane GS, 2004, J CELL SCI, V117, P271, DOI 10.1242/jcs.00855	37	22	22	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8691	8701		10.1074/jbc.M113.449918	http://dx.doi.org/10.1074/jbc.M113.449918			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23329834	hybrid, Green Published			2022-12-28	WOS:000316564500069
J	Bojja, RS; Andrake, MD; Merkel, G; Weigand, S; Dunbrack, RL; Skalka, AM				Bojja, Ravi Shankar; Andrake, Mark D.; Merkel, George; Weigand, Steven; Dunbrack, Roland L., Jr.; Skalka, Anna Marie			Architecture and Assembly of HIV Integrase Multimers in the Absence of DNA Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 INTEGRASE; VIRAL-DNA; PROTEIN; DOMAIN; MODEL; OLIGOMERIZATION; CONFORMATIONS; INTASOME; MONOMER; BINDING	We have applied small angle x-ray scattering and protein cross-linking coupled with mass spectrometry to determine the architectures of full-length HIV integrase (IN) dimers in solution. By blocking interactions that stabilize either a core-core domain interface or N-terminal domain intermolecular contacts, we show that full-length HIV IN can form two dimer types. One is an expected dimer, characterized by interactions between two catalytic core domains. The other dimer is stabilized by interactions of the N-terminal domain of one monomer with the C-terminal domain and catalytic core domain of the second monomer as well as direct interactions between the two C-terminal domains. This organization is similar to the "reaching dimer" previously described for wild type ASV apoIN and resembles the inner, substrate binding dimer in the crystal structure of the PFV intasome. Results from our small angle x-ray scattering and modeling studies indicate that in the absence of its DNA substrate, the HIV IN tetramer assembles as two stacked reaching dimers that are stabilized by core-core interactions. These models of full-length HIV IN provide new insight into multimer assembly and suggest additional approaches for enzyme inhibition.	[Bojja, Ravi Shankar; Andrake, Mark D.; Merkel, George; Weigand, Steven; Dunbrack, Roland L., Jr.; Skalka, Anna Marie] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Skalka, AM (corresponding author), 333 Cottman Ave, Philadelphia, PA 19111 USA.	AM_Skalka@fccc.edu	Dunbrack, Roland/ABG-7141-2020; Weigand, Steven/G-6181-2015	Weigand, Steven/0000-0003-3137-0672; Dunbrack, Roland/0000-0001-7674-6667	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; National Institutes of Health [AI40385, CA71515, CA006927]; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA071515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084453] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our colleagues Drs. Richard A. Katz, Eileen Jaffe, and Heinrich Roder for helpful comments regarding the experiments reported in this manuscript and Marie Estes for assistance in its preparation. Use of Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences (DE-AC02-06CH11357) under general user proposal access. Our studies also benefited from access to the following shared Cancer Center Support Grant facilities: Molecular Modeling, Organic synthesis, DNA sequencing, and Cell Culture. Dr. Anthony Young generously provided access to his mass spectrometry suite, and Dr. Hong Chen assisted with CD spectral analysis.; This work was supported, in whole or in part, by National Institutes of Health Grants AI40385, CA71515, and CA006927.	Al-Mawsawi LQ, 2008, VIROLOGY, V377, P353, DOI 10.1016/j.virol.2008.04.030; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asante-Appiah E, 1998, J BIOL CHEM, V273, P35078, DOI 10.1074/jbc.273.52.35078; AsanteAppiah E, 1997, J BIOL CHEM, V272, P16196, DOI 10.1074/jbc.272.26.16196; Bojja RS, 2011, J BIOL CHEM, V286, P17047, DOI 10.1074/jbc.M110.212571; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; CRAIGIE R, 1991, NUCLEIC ACIDS RES, V19, P2729, DOI 10.1093/nar/19.10.2729; Craigie R, 2012, FUTURE VIROL, V7, P679, DOI 10.2217/FVL.12.56; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Gupta K, 2012, STRUCTURE, V20, P1918, DOI 10.1016/j.str.2012.08.023; Gupta K, 2010, J BIOL CHEM, V285, P20303, DOI 10.1074/jbc.M110.114413; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Ilavsky J, 2009, J APPL CRYSTALLOGR, V42, P347, DOI 10.1107/S0021889809002222; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; LevyMintz P, 1996, J VIROL, V70, P8821, DOI 10.1128/JVI.70.12.8821-8832.1996; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Lutzke RAP, 1998, J VIROL, V72, P4841, DOI 10.1128/JVI.72.6.4841-4848.1998; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Merkel G, 2009, METHODS, V47, P243, DOI 10.1016/j.ymeth.2008.10.024; Pandey KK, 2011, BIOCHEMISTRY-US, V50, P9788, DOI 10.1021/bi201247f; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Powers ET, 2003, BIOPHYS J, V85, P3587, DOI 10.1016/S0006-3495(03)74777-8; Selwood T, 2012, ARCH BIOCHEM BIOPHYS, V519, P131, DOI 10.1016/j.abb.2011.11.020; Serrao E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045177; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Taltynov O., 2012, MOL BIOL INT; Tintori C, 2012, BIOORG MED CHEM LETT, V22, P3109, DOI 10.1016/j.bmcl.2012.03.064; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Xu QF, 2011, NUCLEIC ACIDS RES, V39, pD761, DOI 10.1093/nar/gkq1059	44	23	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7373	7386		10.1074/jbc.M112.434431	http://dx.doi.org/10.1074/jbc.M112.434431			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23322775	hybrid, Green Published			2022-12-28	WOS:000316002400056
J	Demissie, ZA; Erland, LAE; Rheault, MR; Mahmoud, SS				Demissie, Zerihun A.; Erland, Lauren A. E.; Rheault, Mark R.; Mahmoud, Soheil S.			The Biosynthetic Origin of Irregular Monoterpenes in Lavandula ISOLATION AND BIOCHEMICAL CHARACTERIZATION OF A NOVEL cis-PRENYL DIPHOSPHATE SYNTHASE GENE, LAVANDULYL DIPHOSPHATE SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERANYL DIPHOSPHATE; CHRYSANTHEMUM-CINERARIAEFOLIUM; FUNCTIONAL-CHARACTERIZATION; SOPHORA-FLAVESCENS; TERPENE SYNTHASES; CLONING; PYROPHOSPHATE; PRENYLTRANSFERASES; CONSTITUENTS; EXPRESSION	Lavender essential oils are constituted predominantly of regular monoterpenes, for example linalool, 1,8-cineole, and camphor. However, they also contain irregular monoterpenes including lavandulol and lavandulyl acetate. Although the majority of genes responsible for the production of regular monoterpenes in lavenders are now known, enzymes (including lavandulyl diphosphate synthase (LPPS)) catalyzing the biosynthesis of irregular monoterpenes in these plants have not been described. Here, we report the isolation and functional characterization of a novel cis-prenyl diphosphate synthase cDNA, termed Lavandula x intermedia lavandulyl diphosphate synthase (LiLPPS), through a homology-based cloning strategy. The LiLPPS ORF, encoding for a 305-amino acid long protein, was expressed in Escherichia coli, and the recombinant protein was purified by nickel-nitrilotriacetic acid affinity chromatography. The approximately 34.5-kDa bacterially produced protein specifically catalyzed the head-to-middle condensation of two dimethylallyl diphosphate units to LPP in vitro with apparent K-m and k(cat) values of 208 +/- 12 mu M and 0.1 s(-1), respectively. LiLPPS is a homodimeric enzyme with a sigmoidal saturation curve and Hill coefficient of 2.7, suggesting a positive co-operative interaction among its catalytic sites. LiLPPS could be used to modulate the production of lavandulol and its derivatives in plants through metabolic engineering.	[Demissie, Zerihun A.; Erland, Lauren A. E.; Rheault, Mark R.; Mahmoud, Soheil S.] Univ British Columbia, Dept Biol, Kelowna, BC V1V 1V7, Canada	University of British Columbia	Mahmoud, SS (corresponding author), Univ British Columbia, Dept Biol, 3333 Univ Way, Kelowna, BC V1V 1V7, Canada.	soheil.mahmoud@ubc.ca	Rheault, Mark/K-6252-2012; Erland, Lauren/I-8415-2019	Rheault, Mark/0000-0002-7290-4565; Erland, Lauren/0000-0003-3157-0535	University of British Columbia Okanagan; Investment Agriculture Foundation of British Columbia; National Research Council Plant Biotechnology Institute through the NAPGEN program; Genome British Columbia; Natural Sciences and Engineering Research Council of Canada; British Columbia through the Ministry of Advanced Education	University of British Columbia Okanagan; Investment Agriculture Foundation of British Columbia; National Research Council Plant Biotechnology Institute through the NAPGEN program; Genome British Columbia; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); British Columbia through the Ministry of Advanced Education	This work was supported through grants or in-kind contributions by the University of British Columbia Okanagan, Investment Agriculture Foundation of British Columbia, National Research Council Plant Biotechnology Institute through the NAPGEN program, and Genome British Columbia (to S. S. M.) and by the Natural Sciences and Engineering Research Council of Canada (to S. S. M. and M. R. R.).; Supported by the Pacific Century Graduate Scholarships from the province of British Columbia through the Ministry of Advanced Education.	Bouvier F, 2000, PLANT J, V24, P241, DOI 10.1046/j.1365-313x.2000.00875.x; Burke C, 2002, ARCH BIOCHEM BIOPHYS, V405, P130, DOI 10.1016/S0003-9861(02)00335-1; Burke CC, 1999, P NATL ACAD SCI USA, V96, P13062, DOI 10.1073/pnas.96.23.13062; Chang TH, 2010, PLANT CELL, V22, P454, DOI 10.1105/tpc.109.071738; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Christianson DW, 2008, CURR OPIN CHEM BIOL, V12, P141, DOI 10.1016/j.cbpa.2007.12.008; CROTEAU R, 1979, ARCH BIOCHEM BIOPHYS, V198, P512, DOI 10.1016/0003-9861(79)90526-5; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Demissie ZA, 2012, PLANT MOL BIOL, V79, P393, DOI 10.1007/s11103-012-9920-3; Demissie ZA, 2011, PLANTA, V233, P685, DOI 10.1007/s00425-010-1332-5; Dewick P.M., 2009, MED NATURAL PRODUCTS; EPSTEIN WW, 1991, J ORG CHEM, V56, P4451, DOI 10.1021/jo00014a023; Falk L, 2009, J ESSENT OIL RES, V21, P225, DOI 10.1080/10412905.2009.9700154; Franco JC, 2009, BIORATIONAL CONTROL OF ARTHROPOD PESTS: APPLICATION AND RESISTANCE MANAGEMENT, P233, DOI 10.1007/978-90-481-2316-2_10; Gao Y, 2012, NAT PROD REP, V29, P1153, DOI 10.1039/c2np20059g; Haug-Schifferdecker E, 2010, J BIOL CHEM, V285, P16487, DOI 10.1074/jbc.M110.113720; Hemmerlin A, 2003, J BIOL CHEM, V278, P32132, DOI 10.1074/jbc.M213045200; Kharel Y, 2003, NAT PROD REP, V20, P111, DOI 10.1039/b108934j; Ko WG, 2000, TOXICOL IN VITRO, V14, P429, DOI 10.1016/S0887-2333(00)00041-2; Landmann C, 2007, ARCH BIOCHEM BIOPHYS, V465, P417, DOI 10.1016/j.abb.2007.06.011; Lane A., 2010, LAVENDER GENUS LAVEN, P117; Lee HS, 1997, PLANTA MED, V63, P266, DOI 10.1055/s-2006-957670; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Lis-Balchin M., 2002, LAVENDER, P117, DOI [10.1201/9780203216521-16, DOI 10.1201/9780203216521-16]; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Matsuda K, 2005, PHYTOCHEMISTRY, V66, P1529, DOI 10.1016/j.phytochem.2005.05.005; Matsuda K, 2012, TOP CURR CHEM, V314, P73, DOI 10.1007/128_2011_271; Rivera SB, 2001, P NATL ACAD SCI USA, V98, P4373, DOI 10.1073/pnas.071543598; Sallaud C, 2009, PLANT CELL, V21, P301, DOI 10.1105/tpc.107.057885; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106; Schmidt A, 2008, PHYTOCHEMISTRY, V69, P49, DOI 10.1016/j.phytochem.2007.06.022; Sugiyama A, 2011, METAB ENG, V13, P629, DOI 10.1016/j.ymben.2011.07.003; Tholl D, 2004, PLANT CELL, V16, P977, DOI 10.1105/tpc.020156; Thulasiram HV, 2008, J AM CHEM SOC, V130, P1966, DOI 10.1021/ja0771282; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; Walsh CT, 2007, ACS CHEM BIOL, V2, P296, DOI 10.1021/cb700094s; Walton VM, 2006, J ECON ENTOMOL, V99, P1280, DOI 10.1603/0022-0493-99.4.1280; Wang GD, 2009, P NATL ACAD SCI USA, V106, P9914, DOI 10.1073/pnas.0904069106; Woronuk G, 2011, PLANTA MED, V77, P7, DOI 10.1055/s-0030-1250136; Zhao P, 2003, PLANT PHYSIOL, V133, P1306, DOI 10.1104/pp.103.025213	41	63	64	1	67	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6333	6341		10.1074/jbc.M112.431171	http://dx.doi.org/10.1074/jbc.M112.431171			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23306202	hybrid, Green Published			2022-12-28	WOS:000315820700028
J	Kurata, HT; Akrouh, A; Li, JBW; Marton, LJ; Nichols, CG				Kurata, Harley T.; Akrouh, Alejandro; Li, Jenny B. W.; Marton, Laurence J.; Nichols, Colin G.			Scanning the Topography of Polyamine Blocker Binding in an Inwardly Rectifying Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CHANNELS; CRYSTAL-STRUCTURE; CYTOPLASMIC POLYAMINES; VOLTAGE SENSITIVITY; SPERMINE BINDING; KIR2.1 CHANNELS; MOLECULAR-BASIS; RECTIFICATION; PORE; MECHANISM	Steeply voltage-dependent inward rectification of Kir (inwardly rectifying potassium) channels arises from blockade by cytoplasmic polyamines. These polycationic blockers traverse a long (> 70 angstrom) pore, displacing multiple permeant ions, en route to a high affinity binding site that remains loosely defined. We have scanned the effects of cysteine modification at multiple pore-lining positions on the blocking properties of a library of polyamine analogs, demonstrating that the effects of cysteine modification are position-and blocker-dependent. Specifically, introduction of positively charged adducts results in two distinct phenotypes: either disruption of blocker binding or generation of a barrier to blocker migration, in a consistent pattern that depends on both the length of the polyamine blocker and the position of the modified cysteine. These findings reveal important details about the chemical basis and specific location of high affinity polyamine binding.	[Kurata, Harley T.; Li, Jenny B. W.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Akrouh, Alejandro; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Akrouh, Alejandro; Nichols, Colin G.] Washington Univ, Sch Med, CIMED, St Louis, MO 63110 USA; [Marton, Laurence J.] Univ Calif San Francisco, Dept Lab Med, Palo Alto, CA 94306 USA	University of British Columbia; Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California San Francisco	Kurata, HT (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, 2176 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	harley.kurata@ubc.ca		Kurata, Harley/0000-0003-4357-4189	National Institutes of Health [HL54171, HL53268]; Canadian Institutes for Health Research (CIHR) [MOP-97998]; Natural Sciences and Engineering Research Council (NSERC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL54171 (to C. G. N.) and HL53268 (to H. T. K.). This work was also supported by Canadian Institutes for Health Research (CIHR) Operating Grant MOP-97998 (to H. T. K.) and a Natural Sciences and Engineering Research Council (NSERC) Discovery grant (to H. T. K.).	Bushman JD, 2010, J BIOL CHEM, V285, P6012, DOI 10.1074/jbc.M109.085860; Cerrone M, 2006, J INTERN MED, V259, P24, DOI 10.1111/j.1365-2796.2005.01582.x; Chang HK, 2003, J PHYSIOL-LONDON, V553, P101, DOI 10.1113/jphysiol.2003.052845; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; HAGIWARA S, 1976, J GEN PHYSIOL, V67, P621, DOI 10.1085/jgp.67.6.621; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2008, BIOPHYS J, V95, P3827, DOI 10.1529/biophysj.108.133256; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; Kurata HT, 2010, J GEN PHYSIOL, V135, P495, DOI 10.1085/jgp.200910253; Kurata HT, 2006, J GEN PHYSIOL, V127, P467, DOI 10.1085/jgp.200509467; Kurata HT, 2004, J GEN PHYSIOL, V124, P541, DOI 10.1085/jgp.200409159; Lopatin AN, 1996, J GEN PHYSIOL, V108, P105, DOI 10.1085/jgp.108.2.105; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Loussouarn G, 2005, MOL PHARMACOL, V68, P298, DOI 10.1124/mol.105.012377; Loussouarn G, 2001, P NATL ACAD SCI USA, V98, P4227, DOI 10.1073/pnas.061452698; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; MAVRI J, 1994, PROTEINS, V18, P381, DOI 10.1002/prot.340180408; Mitchell JLA, 2002, BIOCHEM J, V366, P663, DOI 10.1042/BJ20011612; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Robertson JL, 2008, J GEN PHYSIOL, V132, P613, DOI 10.1085/jgp.200810068; Shin HG, 2005, J GEN PHYSIOL, V125, P413, DOI 10.1085/jgp.200409242; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Valasinas A, 2001, J MED CHEM, V44, P390, DOI 10.1021/jm000309t; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; Xu YP, 2009, NAT STRUCT MOL BIOL, V16, P1252, DOI 10.1038/nsmb.1717; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7	38	14	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6591	6601		10.1074/jbc.M112.383794	http://dx.doi.org/10.1074/jbc.M112.383794			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300089	hybrid, Green Published			2022-12-28	WOS:000315820700059
J	Otani, J; Arita, K; Kato, T; Kinoshita, M; Kimura, H; Suetake, I; Tajima, S; Ariyoshi, M; Shirakawa, M				Otani, Junji; Arita, Kyohei; Kato, Tsuyoshi; Kinoshita, Mariko; Kimura, Hironobu; Suetake, Isao; Tajima, Shoji; Ariyoshi, Mariko; Shirakawa, Masahiro			Structural Basis of the Versatile DNA Recognition Ability of the Methyl-CpG Binding Domain of Methyl-CpG Binding Domain Protein 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-DEMETHYLATION; GLYCOSYLASE MBD4; THYMINE; REPLICATION; 5-CARBOXYLCYTOSINE; 5-METHYLCYTOSINE; DEAMINATION; EXCISION; PRODUCT; ERASURE	The methyl-CpG binding domain (MBD) protein MBD4 participates in DNA repair as a glycosylase that excises mismatched thymine bases in CpG sites and also functions in transcriptional repression. Unlike other MBD proteins, MBD4 recognizes not only methylated CpG dinucleotides ((5m)CG/(5m)CG) but also T/G mismatched sites generated by spontaneous deamination of 5-methylcytosine ((5m)CG/TG). The glycosylase activity of MBD4 is also implicated in active DNA demethylation initiated by the deaminase-catalyzed conversion of 5-methylcytosine to thymine. Here, we report the crystal structures of the MBD of MBD4(MBDMBD4) complexed with (5m)CG/(5m)CG and (5m)CG/TG. The crystal structures show that the DNA interface of MBD4 has flexible structural features and harbors an extensive water network that supports its dual base specificities. Combined with the results of biochemical analyses, the crystal structure of MBD4 bound to 5-hydroxymethylcytosine further demonstrates that MBDMBD4 is able to recognize a wide range of 5-methylcytosine modifications through the unique water network. The versatile base recognition ability of MBDMBD4 implies multifunctional roles for MBD4 in the regulation of dynamic DNA methylation patterns coupled with deamination and/or oxidation of 5-methylcytosine.	[Otani, Junji; Arita, Kyohei; Kato, Tsuyoshi; Kinoshita, Mariko; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan; [Kimura, Hironobu; Suetake, Isao; Tajima, Shoji] Inst Prot Res, Suita, Osaka 5650871, Japan; [Ariyoshi, Mariko] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6158501, Japan; [Ariyoshi, Mariko] JST, PREST, Kawaguchi, Saitama 3320012, Japan; [Shirakawa, Masahiro] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Shirakawa, Masahiro] RIKEN, Yokohama Inst, Kanagawa 2300045, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); RIKEN	Ariyoshi, M (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6158501, Japan.	ariyoshi@moleng.kyoto-u.ac.jp; shirakawa@moleng.kyoto-u.ac.jp	Kimura, Hironobu/B-3731-2010; Suetake, Isao/G-3144-2013; Arita, Kyohei/AAJ-6402-2020; Suetake, Isao/D-4326-2009	Arita, Kyohei/0000-0002-9762-8405; Suetake, Isao/0000-0002-1246-8474	Ministry of Education, Culture, Sports, Science and Technology; Japan Science and Technology Agency (MEXT); JST, PRESTO; Global COE Program "International Center for Integrated Research and Advanced Education in Materials Science" of MEXT of Japan [B-09]; Grants-in-Aid for Scientific Research [24113711, 24570153, 24116515] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (MEXT); JST, PRESTO(Japan Science & Technology Agency (JST)); Global COE Program "International Center for Integrated Research and Advanced Education in Materials Science" of MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology and the Japan Science and Technology Agency (MEXT) (to M. S.) and by JST, PRESTO (to M. A.) and the Global COE Program "International Center for Integrated Research and Advanced Education in Materials Science" (No. B-09) of MEXT of Japan, administered by the Japan Society for the Promotion of Science.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aziz MA, 2009, CANCER BIOL THER, V8, P1156, DOI 10.4161/cbt.8.12.8536; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; HUNTER WN, 1987, J BIOL CHEM, V262, P9962; Inomata K, 2008, BIOCHEMISTRY-US, V47, P3266, DOI 10.1021/bi7019029; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kondo E, 2005, MOL CELL BIOL, V25, P4388, DOI 10.1128/MCB.25.11.4388-4396.2005; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Liu PF, 2003, DNA REPAIR, V2, P199, DOI 10.1016/S1568-7864(02)00198-2; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Manvilla BA, 2012, J MOL BIOL, V420, P164, DOI 10.1016/j.jmb.2012.04.028; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morera S, 2012, NUCLEIC ACIDS RES, V40, P9917, DOI 10.1093/nar/gks714; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Olson WK, 2001, J MOL BIOL, V313, P229, DOI 10.1006/jmbi.2001.4987; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Riccio A, 1999, NAT GENET, V23, P266, DOI 10.1038/15443; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	42	53	53	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6351	6362		10.1074/jbc.M112.431098	http://dx.doi.org/10.1074/jbc.M112.431098			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23316048	Green Published, hybrid			2022-12-28	WOS:000315820700030
J	Sabat, J; Egawa, T; Lu, CY; Stuehr, DJ; Gerfen, GJ; Rousseau, DL; Yeh, SR				Sabat, Joseph; Egawa, Tsuyoshi; Lu, Changyuan; Stuehr, Dennis J.; Gerfen, Gary J.; Rousseau, Denis L.; Yeh, Syun-Ru			Catalytic Intermediates of Inducible Nitric-oxide Synthase Stabilized by the W188H Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; LIGAND-PROTEIN INTERACTIONS; FE-S BOND; COMPOUND-I; CYTOCHROME P450CAM; HEME DOMAIN; NO-SYNTHASE; RAMAN-SPECTROSCOPY; L-ARGININE; 2ND STEP	Nitric-oxide synthase (NOS) catalyzes nitric oxide (NO) synthesis via a two-step process: L-arginine (L-Arg)-> N-hydroxy-L-arginine -> citrulline + NO. In the active site the heme is coordinated by a thiolate ligand, which accepts a H-bond from a nearby tryptophan residue, Trp-188. Mutation of Trp-188 to histidine in murine inducible NOS was shown to retard NO synthesis and allow for transient accumulation of a new intermediate with a Soret maximum at 420 nm during the L-Arg hydroxylation reaction (Tejero, J., Biswas, A., Wang, Z. Q., Page, R. C., Haque, M. M., Hemann, C., Zweier, J. L., Misra, S., and Stuehr, D. J. (2008) J. Biol. Chem. 283, 33498-33507). However, crystallographic data showed that the mutation did not perturb the overall structure of the enzyme. To understand how the proximal mutation affects the oxygen chemistry, we carried out biophysical studies of the W188H mutant. Our stopped-flow data showed that the 420-nm intermediate was not only populated during the L-Arg reaction but also during the N-hydroxy-L-arginine reaction. Spectroscopic data and structural analysis demonstrated that the 420-nm intermediate is a hydroxide-bound ferric heme species that is stabilized by an out-of-plane distortion of the heme macrocycle and a cation radical centered on the tetrahydrobiopterin cofactor. The current data add important new insights into the previously proposed catalytic mechanism of NOS (Li, D., Kabir, M., Stuehr, D. J., Rousseau, D. L., and Yeh, S. R. (2007) J. Am. Chem. Soc. 129, 6943-6951).	[Sabat, Joseph; Egawa, Tsuyoshi; Lu, Changyuan; Gerfen, Gary J.; Rousseau, Denis L.; Yeh, Syun-Ru] Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA	Yeshiva University; Albert Einstein College of Medicine; Cleveland Clinic Foundation	Yeh, SR (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA.	syun-ru.yeh@einstein.yu.edu		Yeh, Syun-Ru/0000-0002-9858-386X	National Institutes of Health [GM54806, F31GM078679, CA53914, GM51491, HL76491]; National Science Foundation [NSF1026788, NSF0956358]; NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098799, R01GM051491, R01GM054806, T32GM007288, F31GM078679, R01GM086482] Funding Source: NIH RePORTER; Division Of Chemistry [1026788] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54806 (to D. L. R.), F31GM078679 (to J. S.), and CA53914, GM51491, and HL76491 (to D. J. S.). This work was also supported by National Science Foundation Grants NSF1026788 (to D. L. R.) and NSF0956358 (to S.-R. Y.).	Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 2001, J INORG BIOCHEM, V83, P301, DOI 10.1016/S0162-0134(00)00176-8; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Baka E, 2008, J PHARMACEUT BIOMED, V46, P335, DOI 10.1016/j.jpba.2007.10.030; Bec N, 2000, J INORG BIOCHEM, V81, P207, DOI 10.1016/S0162-0134(00)00104-5; CHAMPION PM, 1982, J AM CHEM SOC, V104, P5469, DOI 10.1021/ja00384a037; Cho KB, 2009, J PHYS CHEM B, V113, P336, DOI 10.1021/jp8073199; Couture M, 2001, J BIOL CHEM, V276, P38280; Czernuszewicz RS, 1996, INORG CHEM, V35, P199, DOI 10.1021/ic950749o; CZERNUSZEWICZ RS, 1989, J AM CHEM SOC, V111, P7024, DOI 10.1021/ja00200a019; Davydov R, 2002, BIOCHEMISTRY-US, V41, P10375, DOI 10.1021/bi0260637; Davydov R, 2009, J AM CHEM SOC, V131, P14493, DOI 10.1021/ja906133h; Denisov IG, 2008, J PHYS CHEM A, V112, P13172, DOI 10.1021/jp8017875; Egawa T, 2005, J INORG BIOCHEM, V99, P72, DOI 10.1016/j.jinorgbio.2004.10.017; Egawa T, 2001, J BIOL INORG CHEM, V6, P46, DOI 10.1007/s007750000181; EGAWA T, 1994, BIOCHEM BIOPH RES CO, V201, P1464, DOI 10.1006/bbrc.1994.1868; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Giroud C, 2010, J BIOL CHEM, V285, P7233, DOI 10.1074/jbc.M109.038240; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Hurshman AR, 2002, BIOCHEMISTRY-US, V41, P3439, DOI 10.1021/bi012002h; Jentzen W, 1998, BIOPHYS J, V74, P753, DOI 10.1016/S0006-3495(98)74000-7; Jung C, 2005, MAGN RESON CHEM, V43, pS84, DOI 10.1002/mrc.1694; Kabir M, 2008, BIOCHEMISTRY-US, V47, P12389, DOI 10.1021/bi801491e; Krymov V, 2003, J MAGN RESON, V162, P466, DOI 10.1016/S1090-7807(03)00109-5; Lang J, 2011, BIOCHEMISTRY-US, V50, P10069, DOI 10.1021/bi200965e; Li D, 2004, J BIOL CHEM, V279, P26489, DOI 10.1074/jbc.M400968200; Li D, 2007, J AM CHEM SOC, V129, P6943, DOI 10.1021/ja070683j; Lin Y, 2003, ANAL CHEM, V75, P5381, DOI 10.1021/ac0346205; Martin NI, 2007, J AM CHEM SOC, V129, P12563, DOI 10.1021/ja0746159; Mathieu D, 2004, CHEM COMMUN, P54, DOI 10.1039/b312441j; MITCHELL R, 1994, BBA-BIOENERGETICS, V1186, P19, DOI 10.1016/0005-2728(94)90130-9; Newcomb M, 2006, J AM CHEM SOC, V128, P4580, DOI 10.1021/ja060048y; Olea C, 2010, J AM CHEM SOC, V132, P12794, DOI 10.1021/ja106252b; Ranguelova K, 2007, J BIOL CHEM, V282, P6255, DOI 10.1074/jbc.M607309200; Rousseau DL, 2005, J INORG BIOCHEM, V99, P306, DOI 10.1016/j.jinorgbio.2004.11.007; RUTTER R, 1984, BIOCHEMISTRY-US, V23, P6809, DOI 10.1021/bi00321a082; Santolini J, 2001, J BIOL CHEM, V276, P48887, DOI 10.1074/jbc.M108666200; Santolini M, 2006, BIOCHEMISTRY-US, V45, P1480, DOI 10.1021/bi051710q; Schelvis JPM, 2002, BIOCHEMISTRY-US, V41, P5695, DOI 10.1021/bi0118456; SCHULZ CE, 1984, BIOCHEMISTRY-US, V23, P4743, DOI 10.1021/bi00315a033; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Spolitak T, 2005, J BIOL CHEM, V280, P20300, DOI 10.1074/jbc.M501761200; Spolitak T, 2008, J BIOL INORG CHEM, V13, P599, DOI 10.1007/s00775-008-0348-9; Stoll S, 2010, J AM CHEM SOC, V132, P11812, DOI 10.1021/ja105372s; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Takahashi S, 1997, NAT STRUCT BIOL, V4, P44, DOI 10.1038/nsb0197-44; Tejero JS, 2008, J BIOL CHEM, V283, P33498, DOI 10.1074/jbc.M806122200; Wei CC, 2003, J BIOL CHEM, V278, P46668, DOI 10.1074/jbc.M307682200; Wei CC, 2001, J BIOL CHEM, V276, P315, DOI 10.1074/jbc.M008441200; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Wilson DJ, 2001, BIOCHEM BIOPH RES CO, V287, P126, DOI 10.1006/bbrc.2001.5559; Woodward JJ, 2010, J AM CHEM SOC, V132, P5105, DOI 10.1021/ja909378n; Woodward JJ, 2009, J AM CHEM SOC, V131, P297, DOI 10.1021/ja807299t; Yoshioka S, 2000, J INORG BIOCHEM, V81, P141, DOI 10.1016/S0162-0134(00)00097-0	55	13	13	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6095	6106		10.1074/jbc.M112.403238	http://dx.doi.org/10.1074/jbc.M112.403238			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23269673	Green Published, hybrid			2022-12-28	WOS:000315820700007
J	Verissimo, AF; Mohtar, MA; Daldal, F				Verissimo, Andreia F.; Mohtar, Mohamad A.; Daldal, Fevzi			The Heme Chaperone ApoCcmE Forms a Ternary Complex with CcmI and Apocytochrome c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; RHODOBACTER-CAPSULATUS; RHODOPSEUDOMONAS-CAPSULATA; LIGATION COMPLEX; MATURATION; BIOGENESIS; PROTEINS; BIOSYNTHESIS; MITOCHONDRIA; TRAFFICKING	Cytochrome c maturation (Ccm) is a post-translational process that occurs after translocation of apocytochromes c to the positive (p) side of energy-transducing membranes. Ccm is responsible for the formation of covalent bonds between the thiol groups of two cysteines residues at the heme-binding sites of the apocytochromes and the vinyl groups of heme b (protoporphyrin IX-Fe). Among the proteins (CcmABCDEFGHI and CcdA) required for this process, CcmABCD are involved in loading heme b to apoCcmE. The holoCcmE thus formed provides heme b to the apocytochromes. Catalysis of the thioether bonds between the apocytochromes c and heme b is mediated by the heme ligation core complex, which in Rhodobacter capsulatus contains at least the CcmF, CcmH, and CcmI components. In this work we show that the heme chaperone apoCcmE binds to the apocytochrome c and the apocytochrome c chaperone CcmI to yield stable binary and ternary complexes in the absence of heme in vitro. We found that during these protein-protein interactions, apoCcmE favors the presence of a disulfide bond at the apocytochrome c heme-binding site. We also establish using detergent-dispersed membranes that apoCcmE interacts directly with CcmI and CcmH of the heme ligation core complex CcmFHI. Implications of these findings are discussed with respect to heme transfer from CcmE to the apocytochromes c during heme ligation assisted by the core complex CcmFHI.	[Verissimo, Andreia F.; Mohtar, Mohamad A.; Daldal, Fevzi] Univ Penn, Dept Biol, Philadelphia, PA 19014 USA	University of Pennsylvania	Daldal, F (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19014 USA.	fdaldal@sas.upenn.edu	Mohtar, M. Aiman/ABB-8253-2020; Mohtar, M. Aiman/B-8129-2018	Mohtar, M. Aiman/0000-0002-9015-9802; Mohtar, M. Aiman/0000-0002-9015-9802	National Institutes of Health [GM 38237]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-91ER20052]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 38237 (to F.D.). This work was also supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy through Grant DE-FG02-91ER20052 for the production, purification, and assay of the proteins and their mutant variants (to F.D.).	Ahuja U, 2005, J BIOL CHEM, V280, P236, DOI 10.1074/jbc.M410912200; Ahuja U, 2003, J BIOL CHEM, V278, P52061, DOI 10.1074/jbc.M310077200; AMBLER RP, 1991, BIOCHIM BIOPHYS ACTA, V1058, P42, DOI 10.1016/S0005-2728(05)80266-X; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Arnesano F, 2002, BIOCHEMISTRY-US, V41, P13587, DOI 10.1021/bi026362w; BENNING MM, 1991, J MOL BIOL, V220, P673, DOI 10.1016/0022-2836(91)90109-J; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; BHAGWAT AS, 1986, J BACTERIOL, V166, P751, DOI 10.1128/jb.166.3.751-755.1986; Bowman SEJ, 2008, NAT PROD REP, V25, P1118, DOI 10.1039/b717196j; Christensen O, 2007, FEBS J, V274, P2322, DOI 10.1111/j.1742-4658.2007.05769.x; DALDAL F, 1986, P NATL ACAD SCI USA, V83, P2012, DOI 10.1073/pnas.83.7.2012; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P7872, DOI 10.1073/pnas.132259099; Deshmukh M, 2000, MOL MICROBIOL, V35, P123, DOI 10.1046/j.1365-2958.2000.01683.x; Deshmukh M, 2002, MOL MICROBIOL, V46, P1069, DOI 10.1046/j.1365-2958.2002.03212.x; Di Matteo A, 2007, J BIOL CHEM, V282, P27012, DOI 10.1074/jbc.M702702200; Enggist E, 2002, STRUCTURE, V10, P1551, DOI 10.1016/S0969-2126(02)00885-7; Feissner RE, 2006, MOL MICROBIOL, V61, P219, DOI 10.1111/j.1365-2958.2006.05221.x; Francisco BS, 2011, BIOCHEMISTRY-US, V50, P10974, DOI 10.1021/bi201508t; Giege P, 2004, FEBS LETT, V563, P165, DOI 10.1016/S0014-5793(04)00291-1; Goldman BS, 1997, J MOL BIOL, V268, P724, DOI 10.1006/jmbi.1997.0992; Hasegawa J, 1998, BIOCHEMISTRY-US, V37, P9641, DOI 10.1021/bi9803067; HOLDEN HM, 1987, J MOL BIOL, V195, P229, DOI 10.1016/0022-2836(87)90341-X; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang SE, 1996, J BACTERIOL, V178, P5279, DOI 10.1128/jb.178.17.5279-5290.1996; Lee DH, 2005, J AM CHEM SOC, V127, P3716, DOI 10.1021/ja044658e; Lee JH, 2007, BBA-BIOMEMBRANES, V1768, P2164, DOI 10.1016/j.bbamem.2007.04.022; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Marino SM, 2010, J MOL BIOL, V404, P902, DOI 10.1016/j.jmb.2010.09.027; Mavridou DAI, 2012, J BIOL CHEM, V287, P2342, DOI 10.1074/jbc.M111.313692; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Rayapuram N, 2008, J BIOL CHEM, V283, P25200, DOI 10.1074/jbc.M802621200; Ren Q, 2002, J BIOL CHEM, V277, P7657, DOI 10.1074/jbc.M110979200; Ren Q, 2001, J BIOL CHEM, V276, P32591, DOI 10.1074/jbc.M103058200; Richard-Fogal C, 2010, J MOL BIOL, V401, P350, DOI 10.1016/j.jmb.2010.06.041; Richard-Fogal CL, 2008, J BACTERIOL, V190, P3489, DOI 10.1128/JB.00146-08; Richard-Fogal CL, 2009, EMBO J, V28, P2349, DOI 10.1038/emboj.2009.189; Roos G, 2013, ANTIOXID REDOX SIGN, V18, P94, DOI 10.1089/ars.2012.4521; Sambongi Y, 2002, EUR J BIOCHEM, V269, P3355, DOI 10.1046/j.1432-1033.2002.03045.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanders C, 2005, J BACTERIOL, V187, P4245, DOI 10.1128/JB.187.12.4245-4256.2005; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Sanders C, 2007, J BACTERIOL, V189, P789, DOI 10.1128/JB.01441-06; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Schulz H, 2000, J BACTERIOL, V182, P6831, DOI 10.1128/JB.182.23.6831-6833.2000; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Thony-Meyer L, 2003, BIOCHEMISTRY-US, V42, P13099, DOI 10.1021/bi035598c; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x; Verissimo AF, 2011, J BIOL CHEM, V286, P40452, DOI 10.1074/jbc.M111.277764	50	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6272	6283		10.1074/jbc.M112.440024	http://dx.doi.org/10.1074/jbc.M112.440024			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319598	Green Published, hybrid			2022-12-28	WOS:000315820700022
J	Garcia-Yague, AJ; Rada, P; Rojo, AI; Lastres-Becker, I; Cuadrado, A				Juan Garcia-Yaguee, Angel; Rada, Patricia; Rojo, Ana I.; Lastres-Becker, Isabel; Cuadrado, Antonio			Nuclear Import and Export Signals Control the Subcellular Localization of Nurr1 Protein in Response to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; DOPAMINERGIC-NEURONS; NGFI-B; GENE-EXPRESSION; NR4A2; IDENTIFICATION; PHENOTYPE; TRANSPORT; PATHWAY; HETERODIMERIZATION	Orphan receptor Nurr1 participates in the acquisition and maintenance of the dopaminergic cell phenotype, modulation of inflammation, and cytoprotection, but little is known about its regulation. In this study, we report that Nurr1 contains a bipartite nuclear localization signal (NLS) within its DNA binding domain and two leucine-rich nuclear export signals (NES) in its ligand binding domain. Together, these signals regulate Nurr1 shuttling in and out of the nucleus. Immunofluorescence and immunoblot analysis revealed that Nurr1 is mostly nuclear. A Nurr1 mutant lacking the NLS failed to enter the nucleus. The Nurr1 NLS sequence, when fused to green fluorescent protein, led to nuclear accumulation of this chimeric protein, indicating that this sequence was sufficient to direct nuclear localization of Nurr1. Furthermore, two NES were characterized in the ligand binding domain, whose deletion caused Nurr1 to accumulate predominantly in the nucleus. The Nurr1 NES was sensitive to CRM1 and could function as an independent export signal when fused to green fluorescent protein. Sodium arsenite, an agent that induces oxidative stress, promoted nuclear export of ectopically expressed Nurr1 in HEK293T cells, and the antioxidant N-acetylcysteine rescued from this effect. Similarly, in dopaminergic MN9D cells, arsenite induced the export of endogenous Nurr1, resulting in the loss of expression of Nurr1-dependent genes. This study illustrates that Nurr1 shuttling between the cytosol and nucleus is controlled by specific nuclear import and export signals and that oxidative stress can unbalance the distribution of Nurr1 to favor its cytosolic accumulation.	[Juan Garcia-Yaguee, Angel; Rada, Patricia; Rojo, Ana I.; Lastres-Becker, Isabel; Cuadrado, Antonio] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Juan Garcia-Yaguee, Angel; Rada, Patricia; Lastres-Becker, Isabel; Cuadrado, Antonio] CSIC, Dept Quim, Madrid, Spain; [Juan Garcia-Yaguee, Angel; Rada, Patricia; Lastres-Becker, Isabel; Cuadrado, Antonio] CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Juan Garcia-Yaguee, Angel; Rada, Patricia; Lastres-Becker, Isabel; Cuadrado, Antonio] Univ Autonoma Madrid, CSIC UAM, Madrid, Spain; [Juan Garcia-Yaguee, Angel; Rada, Patricia; Lastres-Becker, Isabel; Cuadrado, Antonio] Inst Invest Sanitaria La Paz IDIPAZ, Madrid, Spain; [Rojo, Ana I.] Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol, Madrid, Spain	CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Complutense University of Madrid	Lastres-Becker, I (corresponding author), UAM CSIC, Inst Invest Biomed Alberto Sols, C Arturo Duperier 4, Madrid 28029, Spain.	ilbecker@iib.uam.es; antonio.cuadrado@uam.es	Rada, Patricia/G-7300-2015; García Yagüe, Ángel Juan/AER-0203-2022; Lastres-Becker, Isabel/R-3403-2018; Becker, Isabel Lastres/AAB-6788-2019; Rojo, Ana I/AAA-5203-2019	Rada, Patricia/0000-0002-6731-2098; García Yagüe, Ángel Juan/0000-0002-7876-0638; Lastres-Becker, Isabel/0000-0002-4968-2175; Becker, Isabel Lastres/0000-0002-4968-2175; Cuadrado, Antonio/0000-0002-3444-9012; Rojo, Ana I/0000-0002-0312-5867; Cuadrado, Antonio/0000-0002-4039-7140	Spanish Ministry of Science and Innovation [SAF2010-172218]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported in part by Grant SAF2010-172218 from the Spanish Ministry of Science and Innovation.; Recipient of a Ramon y Cajal Contract provided by the Spanish Ministry of Science and Innovation. To whom correspondence may be addressed: Instituto de Investigaciones Biomedicas "Alberto Sols" UAM-CSIC, c/Arturo Duperier 4, 28029 Madrid, Spain. Tel.: 34-915854383; Fax: 34-915854401; E-mail: ilbecker@ iib.uam.es.	Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; Alavian KN, 2008, MOVEMENT DISORD, V23, P319, DOI 10.1002/mds.21640; Arenas E, 2005, ANN NY ACAD SCI, V1049, P51, DOI 10.1196/annals.1334.007; Bassett MH, 2004, MOL ENDOCRINOL, V18, P279, DOI 10.1210/me.2003-0005; Bensinger SJ, 2009, CELL, V137, P26, DOI 10.1016/j.cell.2009.03.024; Buervenich S, 2000, AM J MED GENET, V96, P808, DOI 10.1002/1096-8628(20001204)96:6<808::AID-AJMG23>3.0.CO;2-E; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Carpentier R, 2008, J NEUROCHEM, V104, P777, DOI 10.1111/j.1471-4159.2007.05055.x; Codina A, 2004, J BIOL CHEM, V279, P53338, DOI 10.1074/jbc.M409096200; Debernard KAB, 2012, NEUROCHEM INT, V61, P79, DOI 10.1016/j.neuint.2012.04.002; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grimes DA, 2006, MOVEMENT DISORD, V21, P906, DOI 10.1002/mds.20820; Guttler T, 2011, EMBO J, V30, P3457, DOI 10.1038/emboj.2011.287; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Holla VR, 2011, J BIOL CHEM, V286, P30003, DOI 10.1074/jbc.M110.184697; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Inamoto T, 2010, CANCER-AM CANCER SOC, V116, P340, DOI 10.1002/cncr.24737; Jacobsen KX, 2008, NEUROBIOL DIS, V29, P117, DOI 10.1016/j.nbd.2007.08.003; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Jo AY, 2009, STEM CELLS, V27, P2238, DOI 10.1002/stem.146; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; Ke N, 2004, CANCER RES, V64, P8208, DOI 10.1158/0008-5472.CAN-04-2134; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Lammi J, 2007, BIOCHEM BIOPH RES CO, V359, P391, DOI 10.1016/j.bbrc.2007.05.122; Lastres-Becker I, 2012, HUM MOL GENET, V21, P3173, DOI 10.1093/hmg/dds143; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Li WG, 2006, J BIOL CHEM, V281, P27251, DOI 10.1074/jbc.M602746200; Li XL, 2009, CARCINOGENESIS, V30, P1606, DOI 10.1093/carcin/bgp161; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; No H, 2010, NEUROCHEM INT, V56, P620, DOI 10.1016/j.neuint.2010.01.005; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; Pirih FQ, 2004, J BIOL CHEM, V279, P53167, DOI 10.1074/jbc.M405677200; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Sacchetti P, 2002, J BIOL CHEM, V277, P35088, DOI 10.1074/jbc.M205816200; Sacchetti P, 2006, NUCLEIC ACIDS RES, V34, P5515, DOI 10.1093/nar/gkl712; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sun Z, 2012, ONCOGENE, V31, P2653, DOI 10.1038/onc.2011.448; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Watanabe T., 2012, ARCH TOXICOL, V85, P577; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Wingate AD, 2006, BIOCHEM SOC T, V34, P1107, DOI 10.1042/BST0341107; Wu YM, 2005, ENDOCRINOLOGY, V146, P237, DOI 10.1210/en.2004-0889; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhang T, 2007, NEUROSCI LETT, V423, P118, DOI 10.1016/j.neulet.2007.06.041; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	51	50	52	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5506	5517		10.1074/jbc.M112.439190	http://dx.doi.org/10.1074/jbc.M112.439190			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23283970	Green Published, hybrid			2022-12-28	WOS:000315342500025
J	Bunn, HF				Bunn, H. Franklin			Practicing Biochemistry without a License	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONENZYMATIC GLYCOSYLATION; ERYTHROPOIETIN GENE; HEMOGLOBIN-FUNCTION; BETA-CHAIN; HIF-ALPHA; 2,3-DIPHOSPHOGLYCERATE; PROTEINS; IDENTIFICATION; DISSOCIATION; EXPRESSION		Harvard Univ, Brigham & Womens Hosp, Dept Med, Hematol Div,Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bunn, HF (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Med, Hematol Div,Med Sch, Boston, MA 02115 USA.	hfbunn@rics.bwh.harvard.edu						ARNONE A, 1972, NATURE, V237, P146, DOI 10.1038/237146a0; BLANCHARD KL, 1992, MOL CELL BIOL, V12, P5373, DOI 10.1128/MCB.12.12.5373; BOISSEL JP, 1985, P NATL ACAD SCI USA, V82, P8448, DOI 10.1073/pnas.82.24.8448; BOISSEL JP, 1988, J BIOL CHEM, V263, P8443; BOISSEL JP, 1993, J BIOL CHEM, V268, P15983; BOOKCHIN RM, 1968, BIOCHEM BIOPH RES CO, V32, P86, DOI 10.1016/0006-291X(68)90430-0; BROWNLEE M, 1981, ANNU REV BIOCHEM, V50, P385, DOI 10.1146/annurev.bi.50.070181.002125; BRUGNARA C, 1985, J CLIN INVEST, V75, P1608, DOI 10.1172/JCI111867; BRUGNARA C, 1986, SCIENCE, V232, P388, DOI 10.1126/science.3961486; Bunn H. F., 1973, COMP BIOCH PHYSL A, V62, P95; BUNN HF, 1974, BIOCHEMISTRY-US, V13, P988, DOI 10.1021/bi00702a024; BUNN HF, 1974, ANN NY ACAD SCI, V241, P498, DOI 10.1111/j.1749-6632.1974.tb21906.x; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; BUNN HF, 1971, SCIENCE, V172, P1049, DOI 10.1126/science.172.3987.1049; BUNN HF, 1982, P NATL ACAD SCI-BIOL, V79, P7527, DOI 10.1073/pnas.79.23.7527; BUNN HF, 1970, J CLIN INVEST, V49, P1088, DOI 10.1172/JCI106324; BUNN HF, 1976, J CLIN INVEST, V57, P1652, DOI 10.1172/JCI108436; BUNN HF, 1983, NATURE, V306, P498, DOI 10.1038/306498a0; BUNN HF, 1981, SCIENCE, V213, P222, DOI 10.1126/science.12192669; BUNN HF, 1969, J CLIN INVEST, V48, P126, DOI 10.1172/JCI105961; BUNN HF, 1974, J BIOL CHEM, V249, P7402; BUNN HF, 1969, J EXP MED, V129, P909, DOI 10.1084/jem.129.5.909; BUNN HF, 1975, P NATL ACAD SCI USA, V72, P3609, DOI 10.1073/pnas.72.9.3609; BUNN HF, 1973, BLOOD, V42, P471, DOI 10.1182/blood.V42.3.471.471; BUNN HF, 1970, NATURE, V227, P839, DOI 10.1038/227839a0; BUNN HF, 1975, BIOCHEM BIOPH RES CO, V67, P103, DOI 10.1016/0006-291X(75)90289-2; BUNN HF, 1969, J CLIN INVEST, V48, P311, DOI 10.1172/JCI105987; Bunn HF, 1986, HEMOGLOBIN MOL GENET; CHIOU SH, 1981, J BIOL CHEM, V256, P5176; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FORGET BG, 1975, P NATL ACAD SCI USA, V72, P3614, DOI 10.1073/pnas.72.9.3614; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; GARLICK RL, 1988, DIABETES, V37, P1144, DOI 10.2337/diabetes.37.8.1144; GOLDBERG MA, 1977, J BIOL CHEM, V252, P3414; GOLDBERG MA, 1987, P NATL ACAD SCI USA, V84, P7972, DOI 10.1073/pnas.84.22.7972; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; GUIDOTTI G, 1967, J BIOL CHEM, V242, P3685; GUIDOTTI G, 1967, J BIOL CHEM, V242, P3694; HIGGINS PJ, 1981, J BIOL CHEM, V256, P5204; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; MCDONALD MJ, 1987, J BIOL CHEM, V262, P5951; MILLER JA, 1980, J CLIN INVEST, V65, P896, DOI 10.1172/JCI109743; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; MRABET NT, 1986, J BIOL CHEM, V261, P5222; NIENHUIS AW, 1974, SCIENCE, V185, P946, DOI 10.1126/science.185.4155.946; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; RAHBAR S, 1968, CLIN CHIM ACTA, V22, P296, DOI 10.1016/0009-8981(68)90372-0; SHAEFFER JR, 1978, NATURE, V276, P631, DOI 10.1038/276631a0; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; SIMON SR, 1966, P NATL ACAD SCI USA, V56, P749, DOI 10.1073/pnas.56.2.749; TSUNASAWA S, 1985, J BIOL CHEM, V260, P5382; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WEN DY, 1994, J BIOL CHEM, V269, P22839; Xie JX, 2004, P NATL ACAD SCI USA, V101, P10750, DOI 10.1073/pnas.0404044101; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhu H, 2004, J BIOL CHEM, V279, P30316, DOI 10.1074/jbc.M402664200; Zhu H, 1999, P NATL ACAD SCI USA, V96, P14742, DOI 10.1073/pnas.96.26.14742	61	1	1	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5062	5071		10.1074/jbc.X113.451591	http://dx.doi.org/10.1074/jbc.X113.451591			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23300076	Green Published, hybrid			2022-12-28	WOS:000315340400054
J	Karunakaran, D; Kockx, M; Owen, DM; Burnett, JR; Jessup, W; Kritharides, L				Karunakaran, Denuja; Kockx, Maaike; Owen, Dylan M.; Burnett, John R.; Jessup, Wendy; Kritharides, Leonard			Protein Kinase C Controls Vesicular Transport and Secretion of Apolipoprotein E from Primary Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-DERIVED MACROPHAGES; HIGH-DENSITY-LIPOPROTEIN; PHORBOL ESTER; MOUSE MACROPHAGES; APOE EXPRESSION; MUCIN SECRETION; MARCKS PROTEIN; PKC ACTIVATION; DEFICIENT MICE; CHOLESTEROL	Macrophage-specific apolipoprotein E (apoE) secretion plays an important protective role in atherosclerosis. However, the precise signaling mechanisms regulating apoE secretion from primary human monocyte-derived macrophages (HMDMs) remain unclear. Here we investigate the role of protein kinase C (PKC) in regulating basal and stimulated apoE secretion from HMDMs. Treatment of HMDMs with structurally distinct pan-PKC inhibitors (calphostin C, Ro-31-8220, Go6976) and a PKC inhibitory peptide all significantly decreased apoE secretion without significantly affecting apoE mRNA or apoE protein levels. The PKC activator phorbol 12-myristate 13-acetate (PMA) stimulated apoE secretion, and both PMA-induced and apoAI-induced apoE secretion were inhibited by PKC inhibitors. PKC regulation of apoE secretion was found to be independent of the ATP binding cassette transporter ABCA1. Live cell imaging demonstrated that PKC inhibitors inhibited vesicular transport of apoE to the plasma membrane. Pharmacological or peptide inhibitor and knockdown studies indicate that classical isoforms PKC alpha/beta and not PKC delta, -epsilon, -theta, or -iota/zeta isoforms regulate apoE secretion from HMDMs. The activity of myristoylated alanine-rich protein kinase C substrate (MARCKS) correlated with modulation of PKC activity in these cells, and direct peptide inhibition of MARCKS inhibited apoE secretion, implicating MARCKS as a downstream effector of PKC in apoE secretion. Comparison with other secreted proteins indicated that PKC similarly regulated secretion of matrix metalloproteinase 9 and chitinase-3-like-1 protein but differentially affected the secretion of other proteins. In conclusion, PKC regulates the secretion of apoE from primary human macrophages.	[Karunakaran, Denuja; Kockx, Maaike; Jessup, Wendy; Kritharides, Leonard] Univ New S Wales, Sch Med Sci, Ctr Vasc Res, Macrophage Biol Grp, Sydney, NSW, Australia; [Owen, Dylan M.] Univ New S Wales, Sch Med Sci, Ctr Vasc Res, Cellular Membrane Biol Grp, Sydney, NSW, Australia; [Burnett, John R.] Univ Western Australia, Royal Perth Hosp, Dept Core Clin Pathol & Biochem, Perth, WA 6009, Australia; [Kritharides, Leonard] Univ Sydney, Concord Repatriat Gen Hosp, Dept Cardiol, Concord, NSW 2139, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Royal Perth Hospital; University of Western Australia; Concord Repatriation General Hospital; University of Sydney	Kritharides, L (corresponding author), Concord Repatriat Gen Hosp, Dept Cardiol, Concord, NSW 2139, Australia.	leonard.kritharides@sydney.edu.au	Karunakaran, Denuja/G-2275-2010; Kritharides, Leonard/AAQ-2720-2020	Karunakaran, Denuja/0000-0002-4789-8634; 	National Health and Medical Research Council, Australia [222722]; National Heart Foundation, Australia [PF 10S 5362]; Royal Perth Hospital Medical Research Foundation;  [ExNCR: B7A-AY-V003]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation, Australia(National Heart Foundation of Australia); Royal Perth Hospital Medical Research Foundation; 	This work was supported by a Program Grant 222722 (to L. K and W. J) from the National Health and Medical Research Council, Australia, a Heart Foundation Postdoctoral Fellowship PF 10S 5362 (to D. K) from the National Heart Foundation, Australia, and a Practitioner Fellowship (to J. R. B.) from the Royal Perth Hospital Medical Research Foundation. Eli Lilly Australia provided the LY379196 compound as part of their grant (ExNCR: B7A-AY-V003).	ALITALO K, 1980, J EXP MED, V151, P602, DOI 10.1084/jem.151.3.602; Allan LL, 2009, BLOOD, V114, P2411, DOI 10.1182/blood-2009-04-211417; Arici M, 2002, NEPHROL DIAL TRANSPL, V17, P1751, DOI 10.1093/ndt/17.10.1751; BASHEERUDDIN K, 1992, J BIOL CHEM, V267, P1219; BASU SK, 1981, P NATL ACAD SCI-BIOL, V78, P7545, DOI 10.1073/pnas.78.12.7545; BASU SK, 1983, SCIENCE, V219, P871, DOI 10.1126/science.6823554; BASU SK, 1982, J BIOL CHEM, V257, P9788; Bielicki JK, 1999, J LIPID RES, V40, P85; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Chattopadhyay N, 2002, MOL BRAIN RES, V102, P73, DOI 10.1016/S0169-328X(02)00215-2; COFFEY ET, 1994, J NEUROCHEM, V63, P1303; Coffman F, 2008, CRIT REV CL LAB SCI, V45, P531, DOI [10.1080/10408360802334743, 10.1080/10408360802334743 ]; Damera G, 2010, EXP LUNG RES, V36, P75, DOI 10.3109/01902140903131200; Danis RP, 2009, EXPERT OPIN PHARMACO, V10, P2913, DOI 10.1517/14656560903401620; De Marinis YZ, 2010, DIABETOLOGIA, V53, P717, DOI 10.1007/s00125-009-1635-x; Deeg MA, 1997, ARTERIOSCL THROM VAS, V17, P1667, DOI 10.1161/01.ATV.17.9.1667; Deeney JT, 1996, J BIOL CHEM, V271, P18154, DOI 10.1074/jbc.271.30.18154; DENG JT, 1995, J LIPID RES, V36, P2129; DORY L, 1993, BIOCHEM J, V292, P105, DOI 10.1042/bj2920105; DORY L, 1991, J LIPID RES, V32, P783; Efanov AM, 1997, P NATL ACAD SCI USA, V94, P4435, DOI 10.1073/pnas.94.9.4435; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Fazio S, 1999, J BIOL CHEM, V274, P8247, DOI 10.1074/jbc.274.12.8247; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Garver WS, 1997, ARTERIOSCL THROM VAS, V17, P2698, DOI 10.1161/01.ATV.17.11.2698; Goodall AR, 1997, J NEUROCHEM, V68, P392; Green TD, 2011, BBA-GEN SUBJECTS, V1810, P1110, DOI 10.1016/j.bbagen.2011.01.009; Greenow K, 2005, J MOL MED, V83, P329, DOI 10.1007/s00109-004-0631-3; Ha H, 2001, KIDNEY INT, V59, P463, DOI 10.1046/j.1523-1755.2001.059002463.x; Hasty AH, 2005, J LIPID RES, V46, P1433, DOI 10.1194/jlr.M400418-JLR200; Helal R, 2010, IN VITRO CELL DEV-AN, V46, P492, DOI 10.1007/s11626-010-9273-7; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; Hong DH, 1997, AM J PHYSIOL-GASTR L, V272, pG31, DOI 10.1152/ajpgi.1997.272.1.G31; Hooper AJ, 2009, CLIN CHIM ACTA, V409, P136, DOI 10.1016/j.cca.2009.08.017; Huang ZH, 2001, ARTERIOSCL THROM VAS, V21, P2019, DOI 10.1161/hq1201.100242; Huang ZH, 2013, J LIPID RES, V54, P202, DOI 10.1194/jlr.M031906; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kanda Y, 1998, MOL CELL ENDOCRINOL, V143, P125, DOI 10.1016/S0303-7207(98)00125-7; KAYDEN HJ, 1985, ARCH BIOCHEM BIOPHYS, V239, P388, DOI 10.1016/0003-9861(85)90704-0; Kockx M, 2004, J BIOL CHEM, V279, P25966, DOI 10.1074/jbc.M401177200; Kockx M, 2008, ARTERIOSCL THROM VAS, V28, P1060, DOI 10.1161/ATVBAHA.108.164350; Kockx M, 2007, CIRC RES, V101, P607, DOI 10.1161/CIRCRESAHA.107.157198; Kockx M, 2009, J BIOL CHEM, V284, P24144, DOI 10.1074/jbc.M109.032615; KRITHARIDES L, 1995, ARTERIOSCL THROM VAS, V15, P276, DOI 10.1161/01.ATV.15.2.276; Lee Y, 2010, MOL CELL PROTEOMICS, V9, P1968, DOI 10.1074/mcp.M900430-MCP200; Li YH, 2001, J BIOL CHEM, V276, P40982, DOI 10.1074/jbc.M105614200; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Liu JF, 2002, BIOCHEM BIOPH RES CO, V293, P1174, DOI 10.1016/S0006-291X(02)00350-9; Ludowyke RI, 1996, J IMMUNOL, V157, P5130; Ma HT, 2006, BIOCHEM BIOPH RES CO, V349, P214, DOI 10.1016/j.bbrc.2006.08.018; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Maioli E, 2006, CELL MOL LIFE SCI, V63, P637, DOI 10.1007/s00018-005-5541-1; MAKOWSKE M, 1988, J BIOL CHEM, V263, P3402; MAZZONE T, 1987, J BIOL CHEM, V262, P11657; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Mooijaart SP, 2006, PLOS MED, V3, P874, DOI 10.1371/journal.pmed.0030176; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Osto E, 2008, CIRCULATION, V118, P2174, DOI 10.1161/CIRCULATIONAHA.108.789537; Park J, 2008, AM J RESP CELL MOL, V39, P68, DOI 10.1165/rcmb.2007-0139OC; Park MJ, 2003, INT J ONCOL, V22, P137; Pollack IF, 1997, J NEURO-ONCOL, V31, P255, DOI 10.1023/A:1005729626354; Raufman JP, 1997, J CELL BIOCHEM, V64, P514; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rees D, 1999, J BIOL CHEM, V274, P27925, DOI 10.1074/jbc.274.39.27925; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; ROUIS M, 1990, EUR J BIOCHEM, V189, P447, DOI 10.1111/j.1432-1033.1990.tb15509.x; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Singer M, 2004, NAT MED, V10, P193, DOI 10.1038/nm983; Skvara H, 2008, J CLIN INVEST, V118, P3151, DOI 10.1172/JCI35636; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; TAKEMURA R, 1984, AM J PHYSIOL, V246, pC1, DOI 10.1152/ajpcell.1984.246.1.C1; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Turner NA, 1996, J NEUROCHEM, V66, P2381; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Vaughan PFT, 1998, MOL NEUROBIOL, V18, P125, DOI 10.1007/BF02914269; Von Eckardstein A, 2001, FASEB J, V15, P1555, DOI 10.1096/fj.00-0798com; Ward RA, 2000, J BIOL CHEM, V275, P36713, DOI 10.1074/jbc.M003017200; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; WERB Z, 1986, CIBA F SYMP, V118, P155, DOI 10.1002/9780470720998.ch11; Yancey PG, 2007, ARTERIOSCL THROM VAS, V27, P1123, DOI 10.1161/ATVBAHA.107.139592; ZANNIS VI, 1984, J BIOL CHEM, V259, P5495; ZAWALICH W, 1983, BIOCHEM BIOPH RES CO, V117, P448, DOI 10.1016/0006-291X(83)91221-4; Zhang WY, 1996, J BIOL CHEM, V271, P28641, DOI 10.1074/jbc.271.45.28641; Zhao YW, 2002, J BIOL CHEM, V277, P29477, DOI 10.1074/jbc.M200219200	88	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5186	5197		10.1074/jbc.M112.428961	http://dx.doi.org/10.1074/jbc.M112.428961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288845	Green Published, hybrid			2022-12-28	WOS:000315340400066
J	Lee, JO; Lee, SK; Kim, N; Kim, JH; You, GY; Moon, JW; Jie, S; Kim, SJ; Lee, YW; Kang, HJ; Lim, Y; Park, SH; Kim, HS				Lee, Jung Ok; Lee, Soo Kyung; Kim, Nami; Kim, Ji Hae; You, Ga Young; Moon, Ji Wook; Jie, Sha; Kim, Su Jin; Lee, Yong Woo; Kang, Ho Jin; Lim, Yongchul; Park, Sun Hwa; Kim, Hyeon Soo			E3 Ubiquitin Ligase, WWP1, Interacts with AMPK alpha 2 and Down-regulates Its Expression in Skeletal Muscle C2C12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GLUCOSE-TRANSPORT; FATTY-ACID; GLUT4 TRANSLOCATION; UP-REGULATION; AMP KINASE; FIBER-TYPE; INCREASES; INSULIN; RAT	It is known that the activity of AMP-activated protein kinase (AMPK alpha 2) was depressed under high glucose conditions. However, whether protein expression of AMPK alpha 2 is also down-regulated or not remains unclear. In this study, we showed that the expression of AMPK alpha 2 was down-regulated in cells cultured under high glucose conditions. Treatment of proteasome inhibitor, MG132, blocked high glucose-induced AMPK alpha 2 downregulation. Endogenous AMPK alpha 2 ubiquitination was detected by immunoprecipitation of AMPK alpha 2 followed by immunoblotting detection of ubiquitin. The yeast-two hybrid (YTH) approach identified WWP1, an E3 ubiquitin ligase, as the AMPK alpha 2-interacting protein in skeletal muscle cells. Interaction between AMPK alpha 2 and WWP1 was validated by co-immunoprecipitation. Knockdown of WWP1 blocked high glucose-induced AMPK alpha 2 down-regulation. The overexpression of WWP1 down-regulated AMPK alpha 2. In addition, the expression of WWP1 is increased under high glucose culture conditions in both mRNA and protein levels. The level of AMPK alpha 2 was downregulated in the quadriceps muscle of diabetic animal model db/db mice. Expression of WWP1 blocked metformin-induced glucose uptake. Taken together, our results demonstrated that WWP1 down-regulated AMPK alpha 2 under high glucose culture conditions via the ubiquitin-proteasome pathway.	[Lee, Jung Ok; Lee, Soo Kyung; Kim, Nami; Kim, Ji Hae; You, Ga Young; Moon, Ji Wook; Jie, Sha; Kim, Su Jin; Lee, Yong Woo; Kang, Ho Jin; Lim, Yongchul; Park, Sun Hwa; Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Kim, HS (corresponding author), Korea Univ, Coll Med, Dept Anat, 126-1,Anam Dong 5 Ga, Seoul 136705, South Korea.	anatomykim@korea.ac.kr			National Research Foundation of Korea; Korean government [2010-0011053]	National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government)	This study was supported by the National Research Foundation of Korea funded by the Korean government (2010-0011053).	Ai H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1291, DOI 10.1152/ajpendo.00167.2001; Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Joly E, 2009, J DIABETES, V1, P263, DOI 10.1111/j.1753-0407.2009.00043.x; Karlsson HKR, 2009, DIABETES, V58, P847, DOI 10.2337/db08-1539; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Lee WJ, 2005, BIOCHEM BIOPH RES CO, V332, P885, DOI 10.1016/j.bbrc.2005.05.035; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Makinde AO, 1997, CIRC RES, V80, P482, DOI 10.1161/01.RES.80.4.482; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Moreno D, 2009, INT J BIOCHEM CELL B, V41, P2431, DOI 10.1016/j.biocel.2009.07.002; Nishino Y, 2004, CARDIOVASC RES, V61, P610, DOI 10.1016/j.cardiores.2003.10.022; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870; Shi LH, 2011, DIABETES RES CLIN PR, V92, pE41, DOI 10.1016/j.diabres.2011.02.009; Song HY, 2010, BIOCHEM BIOPH RES CO, V396, P961, DOI 10.1016/j.bbrc.2010.05.033; Thomson David M, 2008, Biochem J, V411, pe9, DOI 10.1042/BJ20080459; Yamaguchi S, 2005, AM J PHYSIOL-ENDOC M, V289, pE643, DOI 10.1152/ajpendo.00456.2004; Yang J, 2005, J BIOL CHEM, V280, P4070, DOI 10.1074/jbc.M410213200; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599; Zungu M, 2011, AM J PATHOL, V178, P4, DOI 10.1016/j.ajpath.2010.11.030	31	22	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4673	4680		10.1074/jbc.M112.406009	http://dx.doi.org/10.1074/jbc.M112.406009			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23293026	Green Published, hybrid			2022-12-28	WOS:000315340400016
J	Tabares, LC; Un, S				Tabares, Leandro C.; Un, Sun			In Situ Determination of Manganese(II) Speciation in Deinococcus radiodurans by High Magnetic Field EPR DETECTION OF HIGH LEVELS OF Mn(II) BOUND TO PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS RESISTANCE; SUPEROXIDE DISMUTASES; BINDING; RESONANCE; MN(II)	High magnetic field high frequency electron paramagnetic resonance techniques were used to measure in situ Mn(II) speciation in Deinococcus radiodurans, a radiation-resistant bacteria capable of accumulating high concentrations of Mn(II). It was possible to identify and quantify the evolution of Mn(II) species in intact cells at various stages of growth. Aside from water, 95-GHz high field electron nuclear double resonance showed that the Mn(II) ions are bound to histidines and phosphate groups, mostly from fructose-1,6-bisphosphate but also inorganic phosphates and nucleotides. During stationary growth phase, 285-GHz continuous wave EPR measurements showed that histidine is the most common ligand to Mn(II) and that significant amounts of cellular Mn(II) in D. radiodurans are bound to peptides and proteins. As much as 40% of the total Mn(II) was in manganese superoxide dismutase, and it is this protein and not smaller manganese complexes, as has been suggested recently, that is probably the primary defense against superoxide.	[Tabares, Leandro C.; Un, Sun] CEA Saclay, Inst Biol & Technol Saclay, Serv Bioenerget Biol Struct & Mecanismes, CNRS,UMR 8221, F-91191 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Tabares, LC (corresponding author), CEA Saclay, Inst Biol & Technol Saclay, Serv Bioenerget Biol Struct & Mecanismes, CNRS,UMR 8221, F-91191 Gif Sur Yvette, France.	leandro.tabares@cea.fr; sun.un@cea.fr	Tabares, Leandro C/A-6368-2009	Tabares, Leandro C/0000-0002-8906-6430	Agence Nationale de la Recherche [2011 BSV5 013 01]; CNRS; Region Ile-de-France; CEA	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Ile-de-France(Region Ile-de-France); CEA(French Atomic Energy Commission)	This work was partially financed by the Agence Nationale de la Recherche it has been possible to measure Mn(II) speciation in situ at (Contract Number 2011 BSV5 013 01) and CNRS (Programme "Interface PCB") and the spectrometers were funded by the Region Ile-de-France (Programme Sesame), CEA, and CNRS.	ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n; Barnese K, 2012, P NATL ACAD SCI USA, V109, P6892, DOI 10.1073/pnas.1203051109; Bennati M, 2005, REP PROG PHYS, V68, P411, DOI 10.1088/0034-4885/68/2/R05; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BERLETT BS, 1990, P NATL ACAD SCI USA, V87, P389, DOI 10.1073/pnas.87.1.389; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Chen HA, 2010, BIOCHEM BIOPH RES CO, V396, P413, DOI 10.1016/j.bbrc.2010.04.106; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Davey CA, 2002, P NATL ACAD SCI USA, V99, P11169, DOI 10.1073/pnas.172271399; DAVIES ER, 1974, PHYS LETT A, VA 47, P1, DOI 10.1016/0375-9601(74)90078-4; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Kruger A, 2011, ANTIOXID REDOX SIGN, V15, P311, DOI 10.1089/ars.2010.3797; LEIBOWITZ PJ, 1976, PHOTOCHEM PHOTOBIOL, V23, P45; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; McNaughton RL, 2010, P NATL ACAD SCI USA, V107, P15335, DOI 10.1073/pnas.1009648107; Millonig H, 2009, J INORG BIOCHEM, V103, P876, DOI 10.1016/j.jinorgbio.2009.03.004; MIMS WB, 1965, PROC R SOC LON SER-A, V283, P452, DOI 10.1098/rspa.1965.0034; Mounicou S, 2009, CHEM SOC REV, V38, P1119, DOI 10.1039/b713633c; Potapov A, 2006, APPL MAGN RESON, V30, P461, DOI 10.1007/BF03166212; Robinson CK, 2011, J BACTERIOL, V193, P1653, DOI 10.1128/JB.01310-10; Schiemann O, 2007, APPL MAGN RESON, V31, P543, DOI 10.1007/BF03166601; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Sun HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035057; Tabares LC, 2010, BBA-PROTEINS PROTEOM, V1804, P308, DOI 10.1016/j.bbapap.2009.09.027; Tabares LC, 2009, J PHYS CHEM B, V113, P9016, DOI 10.1021/jp9021807; Un S, 2004, J AM CHEM SOC, V126, P2720, DOI 10.1021/ja036503x; Un S, 2001, APPL MAGN RESON, V21, P341, DOI 10.1007/BF03162413; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126	36	32	33	1	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5050	5055		10.1074/jbc.C112.444992	http://dx.doi.org/10.1074/jbc.C112.444992			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23303180	Green Published, hybrid			2022-12-28	WOS:000315340400052
J	Velez, N; Brautigam, CA; Phillips, MA				Velez, Nahir; Brautigam, Chad A.; Phillips, Margaret A.			Trypanosoma brucei S-Adenosylmethionine Decarboxylase N Terminus Is Essential for Allosteric Activation by the Regulatory Subunit Prozyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; POLYAMINE METABOLISM; PUTRESCINE ACTIVATION; SEDIMENTATION; INHIBITORS; KINASE; ULTRACENTRIFUGATION; TRYPANOTHIONE; COMPLEX; TARGET	Human African trypanosomiasis is caused by a single-celled protozoan parasite, Trypanosoma brucei. Polyamine biosynthesis is a clinically validated target for the treatment of human African trypanosomiasis. Metabolic differences between the parasite and thehumanpolyamine pathway are thought to contribute to species selectivity of pathway inhibitors. S- adenosylmethionine decarboxylase ( AdoMetDC) catalyzes a key step in the production of the polyamine spermidine. We previously showed that trypanosomatid AdoMetDC differs from other eukaryotic enzymes in that it is regulated by heterodimer formation with a catalytically dead paralog, designated prozyme, which binds with high affinity to the enzyme and increases its activity by up to 103- fold. Herein, we examine the role of specific residues involved in AdoMetDC activation by prozyme through deletion and site- directed mutagenesis. Results indicate that 12 key amino acids at the N terminus of AdoMetDC are essential for prozyme- mediated activation with Leu- 8, Leu- 10, Met- 11, and Met- 13 identified as the key residues. These N- terminal residues are fully conserved in the trypanosomatids but are absent from other eukaryotic homologs lacking the prozyme mechanism, suggesting co- evolution of these residues with the prozyme mechanism. Heterodimer formation between AdoMetDC and prozyme was not impaired by mutation of Leu- 8 and Leu- 10 to Ala, suggesting that these residues are involved in a conformational change that is essential for activation. Ourfindings provide the first insight into the mechanisms that influence catalytic regulation ofAdoMetDCandmayhave potential implications for the development of new inhibitors against this enzyme.	[Velez, Nahir; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Brautigam, Chad A.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Phillips, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	margaret.phillips@UTSouthwestern.edu		Brautigam, Chad/0000-0001-6563-1338	National Institutes of Health [R01 AI34432, R37AI034432]; Welch Foundation [I-1257]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034432, R01AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI34432 and R37AI034432 (to M. A. P.). This work was also supported by Welch Foundation Grant I-1257 (to M. A. P.).	BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; BACCHI CJ, 1992, ANTIMICROB AGENTS CH, V36, P2736, DOI 10.1128/AAC.36.12.2736; Bale S, 2010, AMINO ACIDS, V38, P451, DOI 10.1007/s00726-009-0404-y; Bale S, 2008, BIOCHEMISTRY-US, V47, P13404, DOI 10.1021/bi801732m; Barker RH, 2009, ANTIMICROB AGENTS CH, V53, P2052, DOI 10.1128/AAC.01674-08; Barrett MP, 2011, FUTURE MICROBIOL, V6, P1037, DOI [10.2217/FMB.11.88, 10.2217/fmb.11.88]; Bevington PR., 2002, DATA REDUCTION ERROR; Brautigam CA, 2011, METHODS, V54, P4, DOI 10.1016/j.ymeth.2010.12.029; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Brun R, 2011, FUTURE MICROBIOL, V6, P677, DOI [10.2217/FMB.11.44, 10.2217/fmb.11.44]; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Cherry M, 2004, CURR MED CHEM, V11, P663, DOI 10.2174/0929867043455792; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Clyne T, 2002, BIOCHEMISTRY-US, V41, P13207, DOI 10.1021/bi026541d; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; DeLano W.L, PYMOL MOL GRAPHICS S; Ekstrom JL, 1999, STRUCTURE, V7, P583, DOI 10.1016/S0969-2126(99)80074-4; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; GILBERT GA, 1956, NATURE, V177, P853, DOI 10.1038/177853a0; Hanfrey C, 2005, J BIOL CHEM, V280, P39229, DOI 10.1074/jbc.M509340200; Jacobs RT, 2011, CURR TOP MED CHEM, V11, P1255; JOHNSON ML, 1992, ANAL BIOCHEM, V206, P215, DOI 10.1016/0003-2697(92)90356-C; Kennedy PGE, 2008, ANN NEUROL, V64, P116, DOI 10.1002/ana.21429; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Nagar B, 2002, CANCER RES, V62, P4236; OSTERMAN A, 1994, BIOCHEMISTRY-US, V33, P13662, DOI 10.1021/bi00250a016; Pegg AE, 1998, BIOCHEM SOC T, V26, P580, DOI 10.1042/bst0260580; PEGG AE, 1983, METHOD ENZYMOL, V94, P234; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pegg AE, 2009, ESSAYS BIOCHEM, V46, P25, DOI [10.1042/BSE0460003, 10.1042/bse0460003]; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Phillips MA, 2012, MOL MICROBIOL, V86, P10, DOI 10.1111/mmi.12001; Regan J, 2002, J MED CHEM, V45, P2994, DOI 10.1021/jm020057r; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Spinks D, 2012, CHEMMEDCHEM, V7, P95, DOI 10.1002/cmdc.201100420; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tolbert WD, 2003, BIOCHEMISTRY-US, V42, P2386, DOI 10.1021/bi0268854; Willert E, 2012, TRENDS PARASITOL, V28, P66, DOI 10.1016/j.pt.2011.11.001; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Willert EK, 2009, MOL BIOCHEM PARASIT, V168, P1, DOI 10.1016/j.molbiopara.2009.05.009; Willert EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000183; Yun O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000720	48	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5232	5240		10.1074/jbc.M112.442475	http://dx.doi.org/10.1074/jbc.M112.442475			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288847	Green Published, hybrid			2022-12-28	WOS:000315340400070
J	Basu, M; Roy, SS				Basu, Moitri; Roy, Sib Sankar			Wnt/beta-Catenin Pathway Is Regulated by PITX2 Homeodomain Protein and Thus Contributes to the Proliferation of Human Ovarian Adenocarcinoma Cell, SKOV-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT-SIGNALING PATHWAY; BETA-CATENIN; DIFFERENTIAL EXPRESSION; GROWTH-FACTOR; GENE; MUTATIONS; RECEPTOR; IDENTIFICATION; TRANSCRIPTION; ISOFORMS	Pituitary homeobox-2 (PITX2) plays a substantial role in the development of pituitary, heart, and brain. Although the role of PITX2 isoforms in embryonic development has been extensively studied, its possible involvement in regulating the Wnt signaling pathway has not been reported. Because the Wnt pathway is strongly involved in ovarian development and cancer, we focused on the possible association between PITX2 and Wnt pathway in ovarian carcinoma cells. Remarkably, we found that PITX2 interacts and regulates WNT2/5A/9A/6/2B genes of the canonical, noncanonical, or other pathways in the human ovarian cancer cell SKOV-3. Chromatin immunoprecipitation and promoter-reporter assays further indicated the significant association of PITX2 with WNT2 and WNT5A promoters. Detailed study further reveals that the PITX2 isoform specifically activates the canonical Wnt signaling pathway either directly or through Wnt ligands. Thus, the activated Wnt pathway subsequently enhances cell proliferation. Moreover, we found the activation of Wnt pathway reduces the expression of different FZD receptors that limit further Wnt activation, demonstrating the existence of an auto-regulatory feedback loop. In contrast, PITX2 could not activate the noncanonical pathway as the Wnt5A-specific ROR2 receptor does not express in SKOV-3 cells. Collectively, our findings demonstrated that, despite being a target of the canonical Wnt signaling pathway, PITX2 itself induces the same, thus leading to the activation of the cell cycle regulating genes as well as the proliferation of SKOV-3 cells. Collectively, we highlighted that the PITX2 and Wnt pathway exerts a positive feedback regulation, whereas frizzled receptors generate a negative feedback in this pathway. Our findings will help to understand the molecular mechanism of proliferation in ovarian cancer cells.	[Basu, Moitri; Roy, Sib Sankar] Indian Inst Chem Biol, Council Sci & Ind Res, Cell Biol & Physiol Div, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Roy, SS (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Cell Biol & Physiol Div, 4 Raja Subodh Chandra Mullick Rd, Kolkata 700032, India.	sibsankar@iicb.res.in			Council of Scientific and Industrial Research, Government of India [BSC 0101, 10-2(5)/2007(II)-E.UII]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Council of Scientific and Industrial Research, Government of India, Grant BSC 0101.; Recipient of Fellowship Award 10-2(5)/2007(II)-E.UII from the Council of Scientific and Industrial Research, Government of India.	Ai D, 2007, MOL CELL BIOL, V27, P5765, DOI 10.1128/MCB.01848-06; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Barbolina MV, 2011, BIOCHEM J, V437, P1, DOI 10.1042/BJ20110112; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Cui J, 2003, J GASTROEN HEPATOL, V18, P280, DOI 10.1046/j.1440-1746.2003.02973.x; Espinoza HM, 2002, HUM MOL GENET, V11, P743, DOI 10.1093/hmg/11.7.743; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Ghosh S, 2012, J BIOL CHEM, V287, P15001, DOI 10.1074/jbc.M111.284034; Hirose H, 2011, ANN SURG ONCOL, V18, P3005, DOI 10.1245/s10434-011-1653-z; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Karasawa T, 2002, J BIOL CHEM, V277, P37479, DOI 10.1074/jbc.M205658200; Karbova E, 2002, INT J SURG PATHOL, V10, P175, DOI 10.1177/106689690201000302; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lee AY, 2004, ONCOGENE, V23, P6672, DOI 10.1038/sj.onc.1207881; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu CY, 2002, DEVELOPMENT, V129, P5081; Liu CY, 2001, DEVELOPMENT, V128, P2039; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; McWhirter JR, 1999, P NATL ACAD SCI USA, V96, P11464, DOI 10.1073/pnas.96.20.11464; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Nallasamy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002500; Nimmrich I, 2008, BREAST CANCER RES TR, V111, P429, DOI 10.1007/s10549-007-9800-8; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Palacios J, 1998, CANCER RES, V58, P1344; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Roy SS, 2003, ENDOCRINOLOGY, V144, P1585, DOI 10.1210/en.2002-220350; Sagae S, 1999, JPN J CANCER RES, V90, P510, DOI 10.1111/j.1349-7006.1999.tb00777.x; Saha SK, 2005, ENDOCRINOLOGY, V146, P2963, DOI 10.1210/en.2004-1440; Schweickert A, 2000, MECH DEVELOP, V90, P41, DOI 10.1016/S0925-4773(99)00227-0; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Venugopalan SR, 2008, HUM MOL GENET, V17, P3643, DOI 10.1093/hmg/ddn258; Vinarskaja A., 2011, UROL ONCOL IN PRESS; Wang HX, 2009, MOL HUM REPROD, V15, P11, DOI 10.1093/molehr/gan070; Wright K, 1999, INT J CANCER, V82, P625, DOI 10.1002/(SICI)1097-0215(19990827)82:5<625::AID-IJC1>3.0.CO;2-2; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010; Yu XY, 2001, DEVELOPMENT, V128, P1005; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	51	54	57	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4355	4367		10.1074/jbc.M112.409102	http://dx.doi.org/10.1074/jbc.M112.409102			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23250740	Green Published, hybrid			2022-12-28	WOS:000314845000063
J	Frischmann, A; Neudl, S; Gaderer, R; Bonazza, K; Zach, S; Gruber, S; Spadiut, O; Friedbacher, G; Grothe, H; Seidl-Seiboth, V				Frischmann, Alexa; Neudl, Susanna; Gaderer, Romana; Bonazza, Klaus; Zach, Simone; Gruber, Sabine; Spadiut, Oliver; Friedbacher, Gernot; Grothe, Hinrich; Seidl-Seiboth, Verena			Self-assembly at Air/Water Interfaces and Carbohydrate Binding Properties of the Small Secreted Protein EPL1 from the fungus Trichoderma atroviride	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-SP PLATANI; CERATO-PLATANIN; SYSTEMIC RESISTANCE; COCCIDIOIDES-IMMITIS; CELL-WALLS; EXPRESSION; FAMILY; REESEI; GENE; TRANSFORMATION	The protein EPL1 from the fungus Trichoderma atroviride belongs to the cerato-platanin protein family. These proteins occur only in filamentous fungi and are associated with the induction of defense responses in plants and allergic reactions in humans. However, fungi with other lifestyles also express cerato-platanin proteins, and the primary function of this protein family has not yet been elucidated. In this study, we investigated the biochemical properties of the cerato-platanin protein EPL1 from T. atroviride. Our results showed that EPL1 readily self-assembles at air/water interfaces and forms protein layers that can be redissolved in water. These properties are reminiscent of hydrophobins, which are amphiphilic fungal proteins that accumulate at interfaces. Atomic force microscopy imaging showed that EPL1 assembles into irregular meshwork-like substructures. Furthermore, surface activity measurements with EPL1 revealed that, in contrast to hydrophobins, EPL1 increases the polarity of aqueous solutions and surfaces. In addition, EPL1 was found to bind to various forms of polymeric chitin. The T. atroviride genome contains three epl genes. epl1 was predominantly expressed during hyphal growth, whereas epl2 was mainly expressed during spore formation, suggesting that the respective proteins are involved in different biological processes. For epl3, no gene expression was detected under most growth conditions. Single and double gene knock-out strains of epl1 and epl2 did not reveal a detectable phenotype, showing that these proteins are not essential for fungal growth and development despite their abundant expression.	[Frischmann, Alexa; Gaderer, Romana; Zach, Simone; Gruber, Sabine; Seidl-Seiboth, Verena] Vienna Univ Technol, Res Area Biotechnol & Microbiol, Inst Chem Engn, A-1060 Vienna, Austria; [Spadiut, Oliver] Vienna Univ Technol, Res Area Biochem Engn, Inst Chem Engn, A-1060 Vienna, Austria; [Neudl, Susanna; Grothe, Hinrich] Vienna Univ Technol, Inst Mat Chem, A-1060 Vienna, Austria; [Bonazza, Klaus; Friedbacher, Gernot] Vienna Univ Technol, Inst Chem Technol & Analyt, A-1060 Vienna, Austria	Technische Universitat Wien; Technische Universitat Wien; Technische Universitat Wien; Technische Universitat Wien	Seidl-Seiboth, V (corresponding author), Vienna Univ Technol, Res Area Biotechnol & Microbiol, Inst Chem Engn, Gumpendorfer Str 1A, A-1060 Vienna, Austria.	verena.seidl@tuwien.ac.at	Grothe, Hinrich/D-8097-2013; Gruber, Sabine/AAD-5734-2021	Grothe, Hinrich/0000-0002-2715-1429; Gruber, Sabine/0000-0001-6232-763X	Austrian Science Fund (FWF) [T390]; OMV AG	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); OMV AG	This work was supported by Austrian Science Fund (FWF) Grant T390 (to V. S.-S.).; We thank OMV AG for its financial support in funding of the contact angle measurement device DSA 100. Field emission gun scanning electron microscopy imaging was carried out using facilities at the University Service Centre for Transmission Electron Microscopy (USTEM), Vienna University of Technology, Austria.	Askohn S, 2005, FEMS MICROBIOL LETT, V253, P281, DOI 10.1016/j.femsle.2005.09.047; Baccelli I, 2012, FEMS MICROBIOL LETT, V327, P155, DOI 10.1111/j.1574-6968.2011.02475.x; Boddi S, 2004, FEMS MICROBIOL LETT, V233, P341, DOI [10.1016/j.femsle.2004.03.001, 10.1111/j.1574-6968.2004.tb09501.x]; Catalano V, 2011, CURR GENET, V57, P13, DOI 10.1007/s00294-010-0322-2; COLE GT, 1989, INFECT IMMUN, V57, P1524, DOI 10.1128/IAI.57.5.1524-1534.1989; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Djonovic S, 2007, PLANT PHYSIOL, V145, P875, DOI 10.1104/pp.107.103689; Djonovic S, 2006, MOL PLANT MICROBE IN, V19, P838, DOI 10.1094/MPMI-19-0838.02006; Gruber S, 2011, GLYCOBIOLOGY, V21, P122, DOI 10.1093/glycob/cwq142; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Kurup VP, 2000, CLIN EXP ALLERGY, V30, P988, DOI 10.1046/j.1365-2222.2000.00837.x; Limon MC, 2004, APPL MICROBIOL BIOT, V64, P675, DOI 10.1007/s00253-003-1538-6; Lopez-Mondejar R, 2009, FEBS J, V276, P5137, DOI 10.1111/j.1742-4658.2009.07211.x; MACH RL, 1994, CURR GENET, V25, P567, DOI 10.1007/BF00351679; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; PAN SC, 1995, INFECT IMMUN, V63, P3994, DOI 10.1128/IAI.63.10.3994-4002.1995; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; PENTTILA M, 1987, GENE, V61, P155, DOI 10.1016/0378-1119(87)90110-7; Ruiz-Herrera J., 1991, FUNGAL CELL WALL STR, P92; SAMBROOK J, 2001, MOL CLONING LAB MANU, P74; Scala A, 2004, J PLANT PATHOL, V86, P27; Seidl V, 2005, FEBS J, V272, P5923, DOI 10.1111/j.1742-4658.2005.04994.x; Seidl V, 2004, FUNGAL GENET BIOL, V41, P1132, DOI 10.1016/j.fgb.2004.09.002; Seidl V, 2006, FEBS J, V273, P4346, DOI 10.1111/j.1742-4658.2006.05435.x; Shang JY, 2010, COLLOID SURFACE A, V353, P1, DOI 10.1016/j.colsurfa.2009.10.013; Sharen A. L., 1970, PHYTOPATHOLOGY, V60, P1480; Vargas WA, 2008, J BIOL CHEM, V283, P19804, DOI 10.1074/jbc.M802724200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilson LM, 2002, MOL PLANT PATHOL, V3, P487, DOI 10.1046/j.1364-3703.2002.00144.x; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; Yang D, 2010, COLLOID SURFACE A, V367, P174, DOI 10.1016/j.colsurfa.2010.07.008; Yang YY, 2009, PLANT BIOTECHNOL J, V7, P763, DOI 10.1111/j.1467-7652.2009.00442.x	34	64	65	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4278	4287		10.1074/jbc.M112.427633	http://dx.doi.org/10.1074/jbc.M112.427633			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23250741	Green Published, hybrid			2022-12-28	WOS:000314845000056
J	Li, TT; Wang, HH; Sun, YM; Zhao, LN; Gang, Y; Guo, XG; Huang, R; Yang, ZP; Pan, YL; Wu, KC; Xu, L; Liu, ZG; Fan, DM				Li, Tingting; Wang, Honghong; Sun, Yimin; Zhao, Lina; Gang, Yi; Guo, Xuegang; Huang, Rei; Yang, Zhiping; Pan, Yanglin; Wu, Kaichun; Xu, Li; Liu, Zhiguo; Fan, Daiming			Transcription Factor CUTL1 Is a Negative Regulator of Drug Resistance in Gastric Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE; CELLS; PROTEIN; CUX1; ACTIVATION; APOPTOSIS; GENE; PROLIFERATION; CHEMOTHERAPY; MOTILITY	Gastric cancer is one of the leading causes of malignancy-related mortality worldwide, and drug resistance hampered the clinical efficacy of chemotherapy. To better understand the molecular mechanism causing drug resistance, we previously established an isogenic pair of doxorubicin-sensitive and -resistant gastric cancer cell lines, SGC7901 and SGC7901/ADR cells. Here, we investigated how modulation of CUTL1 activity affects the response of gastric cancer to frequently used chemotherapeutic agents. In this study, we demonstrated that CUTL1 transcription activity was significantly reduced in doxorubicin-resistant cells. Furthermore, decreased CUTL1 expression was strongly associated with intrinsic drug resistance in human gastric cancer tissues and could be used as a poor prognosis biomarker. Both gain-of-function (by overexpression of active CUTL1) and loss-of-function (by CUTL1-specific shRNA knockdown) studies showed that increased CUTL1 activity significantly enhanced cell sensitivity to drugs and led to increased apoptosis, whereas decreased CUTL1 expression dramatically reduced cell sensitivity to drugs and thus fewer apoptoses. Importantly, modulation of CUTL1 activity resulted in altered sensitivity to multiple drugs. In vivo mouse studies indicated that overexpression of active CUTL1 significantly resulted in increased cancer tissue response to chemotherapy and therefore inhibited growth, whereas knockdown of CUTL1 conferred resistance to chemotherapy. Taken together, our results strongly indicate that CUTL1 activity is inversely associated with drug resistance and thus is an attractive therapeutic target to modulate multidrug resistance in gastric cancer.	[Li, Tingting; Wang, Honghong; Zhao, Lina; Gang, Yi; Guo, Xuegang; Huang, Rei; Yang, Zhiping; Pan, Yanglin; Wu, Kaichun; Xu, Li; Liu, Zhiguo; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Li, Tingting] Chinese Peoples Liberat Army Gen Hosp, Dept Gerontal Gastroenterol, Beijing 100853, Peoples R China; [Wang, Honghong] Chinese Peoples Liberat Army, Hosp 518, Xian 710043, Peoples R China; [Sun, Yimin] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Sun, Yimin] Natl Engn Res Ctr Beijing Biochip Technol, Beijing 100084, Peoples R China	Air Force Military Medical University; Chinese People's Liberation Army General Hospital; Tsinghua University	Xu, L (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, 15 W Changle Rd, Xian 710032, Peoples R China.	xuli@fmmu.edu.cn; liuzhiguo@fmmu.edu.cn; fandaim@fmmu.edu.cn	Zhao, Lina/GVR-7716-2022	liu, zhiguo/0000-0002-8485-7356	National Natural Scientific Foundation of China [30400541, 81172096, 30801349, 30672369, 81070350, 30901785, 81030044]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Scientific Foundation of China Grants 30400541, 81172096, 30801349, 30672369, 81070350, 30901785, and 81030044.	Chen GK, 2004, MOL PHARMACOL, V65, P906, DOI 10.1124/mol.65.4.906; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; Du JP, 2005, INT J CANCER, V113, P213, DOI 10.1002/ijc.20570; Gingras N, 2005, GENE, V344, P273, DOI 10.1016/j.gene.2004.11.008; Hong L, 2006, BIOCHEM CELL BIOL, V84, P199, DOI 10.1139/O05-173; Jin HF, 2007, NEOPLASIA, V9, P471, DOI 10.1593/neo.07175; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kodera Yasuhiro, 2006, Int J Clin Oncol, V11, P449, DOI 10.1007/s10147-006-0618-x; Kohno K, 2005, EUR J CANCER, V41, P2577, DOI 10.1016/j.ejca.2005.08.007; Li XH, 2007, BIOCHEM CELL BIOL, V85, P741, DOI 10.1139/O07-141; Liang J, 2009, FEBS J, V276, P685, DOI 10.1111/j.1742-4658.2008.06816.x; Liu H, 2008, ONCOL REP, V20, P963, DOI 10.3892/or_00000097; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Michl P, 2006, J BIOL CHEM, V281, P15138, DOI 10.1074/jbc.M600908200; Ning HB, 2006, CANCER BIOL THER, V5, P950, DOI 10.4161/cbt.5.8.2877; Qiao JY, 2008, J PROTEOME RES, V7, P2769, DOI 10.1021/pr700883t; Ripka S, 2010, NEOPLASIA, V12, P659, DOI 10.1593/neo.10486; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Shah MA, 2010, JAMA-J AM MED ASSOC, V303, P1753, DOI 10.1001/jama.2010.553; Shao W, 2005, J PROTEOME RES, V4, P1451, DOI 10.1021/pr050053l; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; Sun YM, 2008, J PROTEOME RES, V7, P4455, DOI 10.1021/pr800417e; Suttana W, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-99; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Truscott M, 2003, MOL CELL BIOL, V23, P3013, DOI 10.1128/MCB.23.8.3013-3028.2003; Truscott M, 2008, MOL CELL BIOL, V28, P3127, DOI 10.1128/MCB.02089-07; Truscott M, 2007, J BIOL CHEM, V282, P30216, DOI 10.1074/jbc.M702328200; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yamamoto K, 2009, ANTICANCER RES, V29, P4211; Zhao L, 2009, J BIOL CHEM, V284, P26273, DOI 10.1074/jbc.M109.028068; Zhao YQ, 2002, CANCER LETT, V185, P211, DOI 10.1016/S0304-3835(02)00264-1	31	18	21	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4135	4147		10.1074/jbc.M112.345942	http://dx.doi.org/10.1074/jbc.M112.345942			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23255599	Green Published, hybrid			2022-12-28	WOS:000314845000042
J	Buschmann, J; Moritz, B; Jeske, M; Lilie, H; Schierhorn, A; Wahle, E				Buschmann, Juliane; Moritz, Bodo; Jeske, Mandy; Lilie, Hauke; Schierhorn, Angelika; Wahle, Elmar			Identification of Drosophila and Human 7-Methyl GMP-specific Nucleotidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; PYRIMIDINE 5'-NUCLEOTIDASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; CYTOSOLIC 5'-NUCLEOTIDASE-II; DNA GLYCOSYLASE; RIBOSOMAL-RNA; PROTEIN; MECHANISM; DCPS	Turnover of mRNA releases, in addition to the four regular nucleoside monophosphates, the methylated cap nucleotide in the form of 7-methylguanosine monophosphate (m(7)GMP) or diphosphate (m(7)GDP). The existence of pathways to eliminate the modified nucleotide seems likely, as its incorporation into nucleic acids is undesirable. Here we describe a novel 5' nucleotidase from Drosophila that cleaves m(7)GMP to 7-methylguanosine and inorganic phosphate. The enzyme, encoded by the predicted gene CG3362, also efficiently dephosphorylates CMP, although with lower apparent affinity; UMP and the purine nucleotides are poor substrates. The enzyme is inhibited by elevated concentrations of AMP and also cleaves m(7)GDP to the nucleoside and two inorganic phosphates, albeit less efficiently. CG3362 has equivalent sequence similarity to two human enzymes, cytosolic nucleotidase III (cNIII) and the previously uncharacterized cytosolic nucleotidase III-like (cNIII-like). We show that cNIII-like also displays 5' nucleotidase activity with a high affinity for m(7)GMP. CMP is a slightly better substrate but again with a higher K-m. The activity of cNIII-like is stimulated by phosphate. In contrast to cNIII-like, cNIII and human cytosolic nucleotidase II do not accept m(7)GMP as a substrate. We suggest that the m(7)G-specific nucleotidases protect cells against undesired salvage of m(7)GMP and its incorporation into nucleic acids.	[Buschmann, Juliane; Moritz, Bodo; Jeske, Mandy; Lilie, Hauke; Schierhorn, Angelika; Wahle, Elmar] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06099 Halle, Germany	Martin Luther University Halle Wittenberg	Wahle, E (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06099 Halle, Germany.	ewahle@biochemtech.uni-halle.de		Jeske, Mandy/0000-0002-1107-9442; Wahle, Elmar/0000-0003-2504-0677	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (to E. W.).	Allegrin S, 2001, J BIOL CHEM, V276, P33526, DOI 10.1074/jbc.M104088200; Allegrini S, 2004, EUR J BIOCHEM, V271, P4881, DOI 10.1111/j.1432-1033.2004.04457.x; Alseth I, 2006, MOL MICROBIOL, V59, P1602, DOI 10.1111/j.1365-2958.2006.05044.x; Amici A, 2002, ARCH BIOCHEM BIOPHYS, V397, P184, DOI 10.1006/abbi.2001.2676; Asaeda A, 2000, BIOCHEMISTRY-US, V39, P1959, DOI 10.1021/bi9917075; Bitto E, 2006, J BIOL CHEM, V281, P20521, DOI 10.1074/jbc.M602000200; BOITEUX S, 1990, J BIOL CHEM, V265, P3916; Bosse-Doenecke E, 2008, PROTEIN EXPRES PURIF, V58, P114, DOI 10.1016/j.pep.2007.10.012; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Chekanova JA, 2000, J BIOL CHEM, V275, P33158, DOI 10.1074/jbc.M005493200; Chen N, 2005, J MOL BIOL, V347, P707, DOI 10.1016/j.jmb.2005.01.062; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; Cohen LS, 2004, RNA, V10, P1609, DOI 10.1261/rna.7690504; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; FISHER DK, 1994, PHARMACEUT RES, V11, P759, DOI 10.1023/A:1018996817529; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Gates KS, 2004, CHEM RES TOXICOL, V17, P839, DOI 10.1021/tx049965c; Ghosh T, 2004, MOL CELL, V13, P817, DOI 10.1016/S1097-2765(04)00127-3; Grobosky CL, 2012, J MOL BIOL, V423, P540, DOI 10.1016/j.jmb.2012.08.014; HENDLER S, 1970, BIOCHEMISTRY-US, V9, P4141, DOI 10.1021/bi00823a017; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Jeske M, 2006, J BIOL CHEM, V281, P25124, DOI 10.1074/jbc.M604802200; Jeske M, 2011, EMBO J, V30, P90, DOI 10.1038/emboj.2010.283; Jeske M, 2008, METHOD ENZYMOL, V448, P107, DOI 10.1016/S0076-6879(08)02606-2; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Lin MD, 2006, DEV CELL, V10, P601, DOI 10.1016/j.devcel.2006.02.021; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; Malys N, 2006, J MOL BIOL, V363, P370, DOI 10.1016/j.jmb.2006.08.015; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; O'Brien PJ, 2004, J BIOL CHEM, V279, P26876, DOI 10.1074/jbc.M403860200; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Reichard P, 2010, BIOCHEM BIOPH RES CO, V396, P19, DOI 10.1016/j.bbrc.2010.02.108; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; Rubinson EH, 2010, NATURE, V468, P406, DOI 10.1038/nature09428; Sambrook J., 2001, MOL CLONING LAB MANU; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Song MG, 2010, MOL CELL, V40, P423, DOI 10.1016/j.molcel.2010.10.010; Steiger M, 2003, RNA, V9, P231, DOI 10.1261/rna.2151403; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; Temme C, 2009, J BIOL CHEM, V284, P8337, DOI 10.1074/jbc.M808319200; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; VALENTINE WN, 1974, J CLIN INVEST, V54, P866, DOI 10.1172/JCI107826; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; van Dijk E, 2003, P NATL ACAD SCI USA, V100, P12081, DOI 10.1073/pnas.1635192100; Wallden K, 2007, J BIOL CHEM, V282, P17828, DOI 10.1074/jbc.M700917200; Walser CB, 2011, CURR OPIN GENET DEV, V21, P431, DOI 10.1016/j.gde.2011.03.003; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Wypijewska A, 2012, BIOCHEMISTRY-US, V51, P8003, DOI 10.1021/bi300781g; Zanella A, 2006, BRIT J HAEMATOL, V133, P113, DOI 10.1111/j.1365-2141.2006.05992.x	55	23	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2441	2451		10.1074/jbc.M112.426700	http://dx.doi.org/10.1074/jbc.M112.426700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223233	Green Published, hybrid			2022-12-28	WOS:000314211500031
J	Flach, RJR; Matevossian, A; Akie, TE; Negrin, KA; Paul, MT; Czech, MP				Flach, Rachel J. Roth; Matevossian, Anouch; Akie, Thomas E.; Negrin, Kimberly A.; Paul, Marina T.; Czech, Michael P.			beta(3)-Adrenergic Receptor Stimulation Induces E-Selectin-mediated Adipose Tissue Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; P-SELECTIN; ENDOTHELIAL-CELLS; DEFICIENT MICE; INSULIN; OBESITY; ACTIVATION; AGONIST; PROTEIN; WHITE	Inflammation induced by wound healing or infection activates local vascular endothelial cells to mediate leukocyte rolling, adhesion, and extravasation by up-regulation of leukocyte adhesion molecules such as E-selectin and P-selectin. Obesity-associated adipose tissue inflammation has been suggested to cause insulin resistance, but weight loss and lipolysis also promote adipose tissue immune responses. While leukocyte-endothelial interactions are required for obesity-induced inflammation of adipose tissue, it is not known whether lipolysis-induced inflammation requires activation of endothelial cells. Here, we show that beta(3)-adrenergic receptor stimulation by CL 316,243 promotes adipose tissue neutrophil infiltration in wild type and P-selectin-null mice but not in E-selectin-null mice. Increased expression of adipose tissue cytokines IL-1 beta, CCL2, and TNF-alpha in response to CL 316,243 administration is also dependent upon E-selectin but not P-selectin. In contrast, fasting increases adipose-resident macrophages but not neutrophils, and does not activate adipose-resident endothelium. Thus, two models of lipolysis-induced inflammation induce distinct immune cell populations within adipose tissue and exhibit distinct dependences on endothelial activation. Importantly, our results indicate that beta(3)-adrenergic stimulation acts through up-regulation of E-selectin in adipose tissue endothelial cells to induce neutrophil infiltration.	[Flach, Rachel J. Roth; Matevossian, Anouch; Akie, Thomas E.; Negrin, Kimberly A.; Paul, Marina T.; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Suite 100, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu			National Institutes of Health [DK030898]; International Research Alliance at Novo Nordisk Foundation Center for Metabolic Research; NIH [5T32HD007312-25]; American Heart Association [AHA 11POST704009]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Research Alliance at Novo Nordisk Foundation Center for Metabolic Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant DK030898 and a grant from the International Research Alliance at Novo Nordisk Foundation Center for Metabolic Research (to M. P. C.), NIH Training Grant 5T32HD007312-25, and American Heart Association postdoctoral fellowship AHA 11POST704009 (to R. J. R. F.), and support for core facilities by the UMASS Diabetes and Endocrinology Research Center (DK032520).	Ahima RS, 2008, MOL ENDOCRINOL, V22, P1023, DOI 10.1210/me.2007-0529; Asterholm IW, 2012, J LIPID RES, V53, P1254, DOI 10.1194/jlr.M021725; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; deSouza CJ, 1997, DIABETES, V46, P1257, DOI 10.2337/diabetes.46.8.1257; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Giri H, 2012, ARTERIOSCL THROM VAS, V32, P1943, DOI 10.1161/ATVBAHA.111.239251; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Grujic D, 1997, J BIOL CHEM, V272, P17686, DOI 10.1074/jbc.272.28.17686; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Jung U, 1999, J IMMUNOL, V162, P6755; Karmann K, 1996, J EXP MED, V184, P173, DOI 10.1084/jem.184.1.173; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; Ley K, 1998, CIRC RES, V83, P287, DOI 10.1161/01.RES.83.3.287; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li GL, 2009, ENDOCRINOLOGY, V150, P3475, DOI 10.1210/en.2009-0172; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Mottillo EP, 2010, BBA-MOL CELL BIOL L, V1801, P1048, DOI 10.1016/j.bbalip.2010.04.012; Nishimura S, 2008, J CLIN INVEST, V118, P710, DOI 10.1172/JCI33328; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Ringseis R, 2010, PROSTAG LEUKOTR ESS, V82, P189, DOI 10.1016/j.plefa.2010.02.022; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Russo HM, 2010, CIRC RES, V107, P388, DOI 10.1161/CIRCRESAHA.110.218651; Sato C, 2011, DIABETES, V60, P189, DOI 10.2337/db09-1894; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sengenes C, 2007, J INTERN MED, V262, P415, DOI 10.1111/j.1365-2796.2007.01853.x; STRALFORS P, 1983, J BIOL CHEM, V258, P5146; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 1998, DIABETES, V47, P1555, DOI 10.2337/diabetes.47.10.1555; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	48	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2882	2892		10.1074/jbc.M112.412346	http://dx.doi.org/10.1074/jbc.M112.412346			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23235150	Green Published, hybrid			2022-12-28	WOS:000314211500070
J	Nyarko, A; Song, YJ; Novacek, J; Zidek, L; Barbar, E				Nyarko, Afua; Song, Yujuan; Novacek, Jiri; Zidek, Lukas; Barbar, Elisar			Multiple Recognition Motifs in Nucleoporin Nup159 Provide a Stable and Rigid Nup159-Dyn2 Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN LIGHT-CHAIN; NUCLEAR-PORE COMPLEX; INTERMEDIATE CHAIN; FUNCTIONAL INTERACTION; BINDING REGIONS; TERMINAL DOMAIN; MOLECULAR-BASIS; HIGH-THROUGHPUT; DISORDER; LC8	Dyn2 is the yeast ortholog of the molecular hub LC8, which binds disordered proteins and promotes their self-association and higher order assembly. Dyn2 is proposed to dimerize and stabilize the Nup82-Nsp1-Nup159 complex of the nuclear pore assembly through its interaction with nucleoporin Nup159. Nup159 has six LC8 recognition motifs separated by short linkers. NMR experiments reported here show that the Dyn2 binding domain of Nup159 is intrinsically disordered and that binding of one equivalent of Dyn2 dimer aligns two Nup159 chains along the full Dyn2 binding domain to form a bivalent scaffold that promotes binding of other Dyn2 dimers. Isothermal titration calorimetry of Dyn2 binding to Nup constructs of increasing lengths determine that the third LC8 recognition motifs does not bind Dyn2. A new approach to identifying active LC8 recognition motifs based on NMR-detected beta-sheet propensities is presented. Isothermal titration calorimetry experiments also show that, due to unfavorable entropy changes, a Nup-Dyn2 complex with three Dyn2 dimers is more stable than the wildtype complex with five Dyn2 dimers. The calorimetric results argue that, from a thermodynamics perspective, only three Dyn2 dimers are needed for optimal stability and suggest that the evolutionary adaptation of multiple tandem LC8 recognition motifs imparts to the complex other properties such as rigidity and a kink in the rod-like structure. These findings extend the repertoire of functions of intrinsically disordered protein to fine-tuning and versatile assembly of higher order macromolecular complexes.	[Nyarko, Afua; Song, Yujuan; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Novacek, Jiri; Zidek, Lukas] Masaryk Univ, Fac Sci, Natl Ctr Biomed Res, Brno 62500, Czech Republic; [Novacek, Jiri; Zidek, Lukas] Masaryk Univ, Cent European Inst Technol, Brno 62500, Czech Republic	Oregon State University; Masaryk University Brno; Masaryk University Brno	Barbar, E (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	barbare@science.oregonstate.edu	Zidek, Lukas/AAB-6109-2020; Nyarko, Afua/R-9872-2019; Novacek, Jiri/D-8551-2012; Zidek, Lukas/D-7112-2012; Novacek, Jiri/AAQ-4739-2021	Zidek, Lukas/0000-0002-8013-0336; Novacek, Jiri/0000-0003-4013-3898; Zidek, Lukas/0000-0002-8013-0336; Novacek, Jiri/0000-0003-4013-3898; Barbar, Elisar/0000-0003-4892-5259	National Institutes of Health [GM 084276]; European Community (EAST-NMR) [228461]; Czech Science Foundation [P206/11/0758]; National Institutes of Health, NIEHS [00210]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community (EAST-NMR); Czech Science Foundation(Grant Agency of the Czech Republic); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 084276 (to A. N., Y. S., and E. B.). This work was also supported by the Access to Research Infrastructures activity in the 7th Framework Programme of the European Community (Grant 228461, EAST-NMR) (to E. B. and A. N.) and Czech Science Foundation Grant P206/11/0758 (to J. N. and L. Z.).; We acknowledge the support of the nucleic acid and protein core and mass spectrometry facilities and services core in the Oregon State University Environmental Health Sciences Center (supported by National Institutes of Health, NIEHS Grant 00210). We thank Professor Clare Woodward for valuable suggestions and Professor RNDr Vladimir Sklenao and Dr. Radovan Fiala of the National Center for Biomedical Research, (Faculty of Science) Masaryk University, for access to NMR facilities.	Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; Cavanagh J, 2006, PROTEIN NMR SPECTROS, P391; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Flemming D, 2010, NAT STRUCT MOL BIOL, V17, P775, DOI 10.1038/nsmb.1811; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; Goddard TD., SPARKY VERSION 3; Gupta A, 2012, J CELL BIOL, V198, P115, DOI 10.1083/jcb.201111041; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Hayakawa A, 2012, J CELL BIOL, V196, P19, DOI 10.1083/jcb.201108124; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Kazimierczuk K, 2006, J BIOMOL NMR, V36, P157, DOI 10.1007/s10858-006-9077-y; Kazimierczuk K, 2010, J MAGN RESON, V205, P286, DOI 10.1016/j.jmr.2010.05.012; Kazimierczuk K, 2009, J MAGN RESON, V197, P219, DOI 10.1016/j.jmr.2009.01.003; KRAEMER DM, 1995, J BIOL CHEM, V270, P19017, DOI 10.1074/jbc.270.32.19017; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Motackova V, 2010, J BIOMOL NMR, V48, P169, DOI 10.1007/s10858-010-9447-3; Novacek J, 2011, J BIOMOL NMR, V50, P1, DOI 10.1007/s10858-011-9496-2; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Nyarko A, 2012, HANDBOOK OF DYNEIN, P285; Nyarko A, 2011, BIOPHYS CHEM, V159, P41, DOI 10.1016/j.bpc.2011.05.001; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Rapali P, 2011, BIOCHEM BIOPH RES CO, V414, P493, DOI 10.1016/j.bbrc.2011.09.093; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Rapali P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018818; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Romes EM, 2012, J BIOL CHEM, V287, P15862, DOI 10.1074/jbc.M111.336172; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Stelter P, 2012, MOL CELL, V47, P788, DOI 10.1016/j.molcel.2012.06.015; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Stuchell-Brereton MD, 2011, MOL BIOL CELL, V22, P2690, DOI 10.1091/mbc.E11-01-0075; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003	47	25	25	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2614	2622		10.1074/jbc.M112.432831	http://dx.doi.org/10.1074/jbc.M112.432831			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223634	Green Published, hybrid			2022-12-28	WOS:000314211500046
J	Salcedo-Sicilia, L; Granell, S; Jovic, M; Sicart, A; Mato, E; Johannes, L; Balla, T; Egea, G				Salcedo-Sicilia, Laia; Granell, Susana; Jovic, Marko; Sicart, Adria; Mato, Eugenia; Johannes, Ludger; Balla, Tamas; Egea, Gustavo			beta III Spectrin Regulates the Structural Integrity and the Secretory Protein Transport of the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; ATAXIA TYPE 5; RETROGRADE TRANSPORT; MEMBRANE SKELETON; ANKYRIN; IDENTIFICATION; BINDING; DYNEIN; PHOSPHOINOSITIDES; TRAFFICKING	A spectrin-based cytoskeleton is associated with endomembranes, including the Golgi complex and cytoplasmic vesicles, but its role remains poorly understood. Using new generated antibodies to specific peptide sequences of the human beta III spectrin, we here show its distribution in the Golgi complex, where it is enriched in the trans-Golgi and trans-Golgi network. The use of a drug-inducible enzymatic assay that depletes the Golgi-associated pool of PI4P as well as the expression of PH domains of Golgi proteins that specifically recognize this phosphoinositide both displaced beta III spectrin from the Golgi. However, the interference with actin dynamics using actin toxins did not affect the localization of beta III spectrin to Golgi membranes. Depletion of beta III spectrin using siRNA technology and the microinjection of anti-beta III spectrin antibodies into the cytoplasm lead to the fragmentation of the Golgi. At ultrastructural level, Golgi fragments showed swollen distal Golgi cisternae and vesicular structures. Using a variety of protein transport assays, we show that the endoplasmic reticulum-to-Golgi and post-Golgi protein transports were impaired in beta III spectrin-depleted cells. However, the internalization of the Shiga toxin subunit B to the endoplasmic reticulum was unaffected. We state that beta III spectrin constitutes a major skeletal component of distal Golgi compartments, where it is necessary to maintain its structural integrity and secretory activity, and unlike actin, PI4P appears to be highly relevant for the association of beta III spectrin the Golgi complex.	[Salcedo-Sicilia, Laia; Granell, Susana; Sicart, Adria; Mato, Eugenia; Egea, Gustavo] Univ Barcelona, Fac Med, Dept Biol Cel Lular Immunol & Neurociencies, Barcelona 08036, Spain; [Jovic, Marko; Balla, Tamas] NICHD, Sect Mol Signal Transduct, Program Dev Neurosci, NIH, Bethesda, MD USA; [Johannes, Ludger] Inst Curie, Ctr Rech, Traff Signaling & Delivery Grp, F-75005 Paris, France; [Johannes, Ludger] CNRS, UMR144, F-75700 Paris, France; [Mato, Eugenia] Hosp Santa Creu & Sant Pau, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Barcelona 08025, Spain; [Egea, Gustavo] Inst Invest Biomed August Pi & Sunyer Nanociencia, Barcelona 08036, Spain	University of Barcelona; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Hospital of Santa Creu i Sant Pau; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Egea, G (corresponding author), Univ Barcelona, Fac Med, Dept Biol Cel Lular Immunol & Neurociencies, C Casanova 143, Barcelona 08036, Spain.	gegea@ub.edu	Egea, Gustavo/I-2394-2014; Johannes, Ludger/M-9778-2017; Johannes, Ludger/W-8593-2019	Egea, Gustavo/0000-0001-5242-150X; Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; Balla, Tamas/0000-0002-9077-3335; Jovic, Marko/0000-0002-0310-7730	intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health; Ministry of Science and Innovation; University of Barcelona; Generalitat de Catalunya;  [BFU2009-07186]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER	intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of Barcelona; Generalitat de Catalunya(Generalitat de Catalunya); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant BFU2009-07186 (to G. E,) and by the intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (to M. J. and T. B.); Recipient of a FPI predoctoral fellowship from Ministry of Science and Innovation.; Recipient of a fellowship from the University of Barcelona.; Recipient of a Beatriu de Pinos postdoctoral contract from the Generalitat de Catalunya.	Bard F, 2003, J BIOL CHEM, V278, P46601, DOI 10.1074/jbc.M302221200; Beck KA, 1998, BBA-MOL CELL RES, V1404, P153, DOI 10.1016/S0167-4889(98)00054-8; BECK KA, 1994, J CELL BIOL, V127, P707, DOI 10.1083/jcb.127.3.707; Beck KA, 1997, J CELL SCI, V110, P1239; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Clarkson YL, 2010, HUM MOL GENET, V19, P3634, DOI 10.1093/hmg/ddq279; Colon-Franco JM, 2011, J CELL SCI, V124, P3118, DOI 10.1242/jcs.083725; D'Angelo Giovanni, 2012, Subcell Biochem, V59, P255, DOI 10.1007/978-94-007-3015-1_8; De Matteis MA, 1998, CURR OPIN CELL BIOL, V10, P542, DOI 10.1016/S0955-0674(98)80071-9; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; De Matteis MA, 2000, J CELL SCI, V113, P2331; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; Devarajan P, 1997, P NATL ACAD SCI USA, V94, P10711, DOI 10.1073/pnas.94.20.10711; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Holappa K, 2004, FEBS LETT, V564, P97, DOI 10.1016/S0014-5793(04)00315-1; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Holleran EA, 1998, INT REV CYTOL, V182, P69, DOI 10.1016/S0074-7696(08)62168-3; Holleran EA, 1998, TRENDS CELL BIOL, V8, P26, DOI 10.1016/S0962-8924(97)01195-1; Hui N., 1998, CELL BIOL LAB HDB, V2; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kang QZ, 2009, J CELL SCI, V122, P1091, DOI 10.1242/jcs.039644; Kepes F, 2005, INT REV CYTOL, V242, P55; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lorenzo DN, 2010, J CELL BIOL, V189, P143, DOI 10.1083/jcb.200905158; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Percival JM, 2004, MOL BIOL CELL, V15, P268, DOI 10.1091/mbc.e03-03-0176; Perkins EM, 2010, J NEUROSCI, V30, P4857, DOI 10.1523/JNEUROSCI.6065-09.2010; Siddhanta A, 2003, J BIOL CHEM, V278, P1957, DOI 10.1074/jbc.M209137200; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; Stankewich MC, 2010, P NATL ACAD SCI USA, V107, P6022, DOI 10.1073/pnas.1001522107; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Watabe H, 2008, J INVEST DERMATOL, V128, P162, DOI 10.1038/sj.jid.5701019; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063	48	17	18	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2157	2166		10.1074/jbc.M112.406462	http://dx.doi.org/10.1074/jbc.M112.406462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233669	Green Published, hybrid			2022-12-28	WOS:000314211500006
J	Bauer, R; Plieschnig, JA; Finkes, T; Riegler, B; Hermann, M; Schneider, WJ				Bauer, Raimund; Plieschnig, Julia A.; Finkes, Thomas; Riegler, Barbara; Hermann, Marcela; Schneider, Wolfgang J.			The Developing Chicken Yolk Sac Acquires Nutrient Transport Competence by an Orchestrated Differentiation Process of Its Endodermal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; ENDOTHELIAL TUBE FORMATION; IN-SITU HYBRIDIZATION; APOLIPOPROTEIN-A-V; VISCERAL-ENDODERM; EXTRAEMBRYONIC TISSUES; LIPOPROTEIN RECEPTORS; DENSITY-LIPOPROTEIN; AMNIONLESS GENE; OOCYTE GROWTH	During chicken yolk sac (YS) growth, mesodermal cells in the area vasculosa follow the migrating endodermal epithelial cell (EEC) layer in the area vitellina. Ultimately, these cells form the vascularized YS that functions in nutrient transfer to the embryo. How and when EECs, with their apical aspect directly contacting the oocytic yolk, acquire the ability to take up yolk macromolecules during the vitellina-to-vasculosa transition has not been investigated. In addressing these questions, we found that with progressive vascularization, the expression level in EECs of the nutrient receptor triad, LRP2-cubilin-amnionless, changes significantly. The receptor complex, competent for uptake of yolk proteins, is produced by EECs in the area vasculosa but not in the area vitellina. Yolk components endocytosed by LRP2-cubilin-amnionless, preformed and newly formed lipid droplets, and yolk-derived very low density lipoprotein, shown to be efficiently endocytosed and lysosomally processed by EECs, probably provide substrates for resynthesis and secretion of nutrients, such as lipoproteins. In fact, as directly demonstrated by pulse-chase experiments, EECs in the vascularized, but not in the avascular, region efficiently produce and secrete lipoproteins containing apolipoprotein A-I (apoA-I), apoB, and/or apoA-V. In contrast, perilipin 2, a lipid droplet-stabilizing protein, is produced exclusively by the EECs of the area vitellina. These data suggest a differentiation process that orchestrates the vascularization of the developing YS with the induction of yolk uptake and lipoprotein secretion by EECs to ensure embryo nutrition.	[Bauer, Raimund; Plieschnig, Julia A.; Finkes, Thomas; Riegler, Barbara; Hermann, Marcela; Schneider, Wolfgang J.] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Schneider, WJ (corresponding author), Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria.	wolfgang.schneider@meduniwien.ac.at		Hermann, Marcela/0000-0003-2298-4269; Oberle, Raimund/0000-0001-6701-4130	Austrian Science Fund (FWF) [P20218-B11, P19680-B11]; Austrian Ministry of Science and Research GEN-AU Grant GOLD-Genomics of Lipid-associated Disorders; DOC-fFORTE-fellowship of the Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 20218] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Ministry of Science and Research GEN-AU Grant GOLD-Genomics of Lipid-associated Disorders; DOC-fFORTE-fellowship of the Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Grants P20218-B11 (to W. J. S.) and P19680-B11 (to M. H.), by the Austrian Ministry of Science and Research GEN-AU Grant GOLD-Genomics of Lipid-associated Disorders (to W. J. S.), and by a DOC-fFORTE-fellowship of the Austrian Academy of Sciences (to J. A. P.).	Acloque H, 2008, METHOD CELL BIOL, V87, P169, DOI 10.1016/S0091-679X(08)00209-4; Ahuja R, 2008, BIOCHEM J, V410, P301, DOI 10.1042/BJ20070919; Artus J, 2012, DEV BIOL, V361, P245, DOI 10.1016/j.ydbio.2011.10.015; Assemat E, 2005, BIOL REPROD, V72, P1079, DOI 10.1095/biolreprod.104.036913; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; BARAKAT HA, 1985, J LIPID RES, V26, P1252; BELLAIRS R, 1963, J EMBRYOL EXP MORPH, V11, P201; BENSADOUN A, 1972, P SOC EXP BIOL MED, V141, P814, DOI 10.3181/00379727-141-36878; BROWN EM, 1990, J CHROMATOGR, V512, P203, DOI 10.1016/S0021-9673(01)89486-3; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Coudroy G, 2005, J AM SOC NEPHROL, V16, P2330, DOI 10.1681/ASN.2004110925; DASTON GP, 1991, TERATOLOGY, V43, P253, DOI 10.1002/tera.1420430309; DAWSON PA, 1986, J BIOL CHEM, V261, P5681; Dichlberger A, 2007, J LIPID RES, V48, P1451, DOI 10.1194/jlr.C600026-JLR200; Dunn NR, 2001, NAT GENET, V27, P351, DOI 10.1038/86829; Farese RV, 1996, J LIPID RES, V37, P347; Fisher CE, 2006, DEV BIOL, V296, P279, DOI 10.1016/j.ydbio.2006.06.007; FRASER R, 1986, BRIT J EXP PATHOL, V67, P783; Gerhartz B, 1997, COMP BIOCHEM PHYS B, V118, P159, DOI 10.1016/S0305-0491(97)00034-5; Hermann M, 2000, J BIOL CHEM, V275, P16837, DOI 10.1074/jbc.M000163200; Hermann M, 1997, J LIPID RES, V38, P1308; HERMIER D, 1985, BIOCHIM BIOPHYS ACTA, V836, P105, DOI 10.1016/0005-2760(85)90226-7; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Hummel S, 2003, J LIPID RES, V44, P1633, DOI 10.1194/jlr.M300014-JLR200; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P572, DOI 10.1097/MOL.0b013e328312707c; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Kalantry S, 2001, NAT GENET, V27, P412, DOI 10.1038/86912; Kanai M, 1996, MICROSC RES TECHNIQ, V35, P340, DOI 10.1002/(SICI)1097-0029(19961101)35:4<340::AID-JEMT5>3.0.CO;2-Q; Kozyraki R, 2007, CURR PHARM DESIGN, V13, P3038, DOI 10.2174/138161207782110507; Kwon GS, 2006, DEV DYNAM, V235, P2549, DOI 10.1002/dvdy.20843; LAEMMLI UK, 1974, VIROLOGY, V62, P483, DOI 10.1016/0042-6822(74)90409-7; LAMBSON RO, 1970, AM J ANAT, V129, P1, DOI 10.1002/aja.1001290102; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; MACLACHLAN I, 1994, J BIOL CHEM, V269, P24127; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; MATO M, 1964, EXP CELL RES, V35, P426, DOI 10.1016/0014-4827(64)90111-9; MOBBS IG, 1981, AM J ANAT, V160, P285, DOI 10.1002/aja.1001600307; MOBBS IG, 1979, AM J ANAT, V155, P287, DOI 10.1002/aja.1001550302; Nakazawa F, 2011, DEV DYNAM, V240, P2002, DOI 10.1002/dvdy.22690; Nilsson SK, 2011, ATHEROSCLEROSIS, V219, P15, DOI 10.1016/j.atherosclerosis.2011.07.019; Paca A, 2012, DEV BIOL, V361, P90, DOI 10.1016/j.ydbio.2011.10.013; PALIS J, 1995, BLOOD, V86, P156, DOI 10.1182/blood.V86.1.156.bloodjournal861156; PARDANAUD L, 1989, DEVELOPMENT, V105, P473; Plieschnig JA, 2012, GENE, V508, P49, DOI 10.1016/j.gene.2012.07.041; RAJAVASHISTH TB, 1987, J BIOL CHEM, V262, P7058; RETZEK H, 1992, DNA CELL BIOL, V11, P661, DOI 10.1089/dna.1992.11.661; Schneider WJ, 1998, BIOL CHEM, V379, P965; Schneider WJ, 2009, GEN COMP ENDOCR, V163, P18, DOI 10.1016/j.ygcen.2008.11.032; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; Shelness GS, 2005, CURR OPIN LIPIDOL, V16, P325, DOI 10.1097/01.mol.0000169353.12772.eb; SHEN XY, 1993, CELL TISSUE RES, V272, P459, DOI 10.1007/BF00318552; Sheng GJ, 2012, ANN NY ACAD SCI, V1271, P97, DOI 10.1111/j.1749-6632.2012.06726.x; Sheng GJ, 2010, INT J DEV BIOL, V54, P1033, DOI 10.1387/ijdb.103105gs; Stern CD, 2012, DEVELOPMENT, V139, P1059, DOI 10.1242/dev.070730; STIFANI S, 1988, BIOCHEM J, V250, P467, DOI 10.1042/bj2500467; STIFANI S, 1990, P NATL ACAD SCI USA, V87, P1955, DOI 10.1073/pnas.87.5.1955; Streit A, 2001, METHODS, V23, P339, DOI 10.1006/meth.2000.1146; van Greevenbroek MMJ, 1998, ATHEROSCLEROSIS, V141, pS9; VIEIRA AV, 1993, BIOCHIM BIOPHYS ACTA, V1169, P250, DOI 10.1016/0005-2760(93)90248-8; VIEIRA PM, 1995, J LIPID RES, V36, P601; Vokes SA, 2004, DEVELOPMENT, V131, P4371, DOI 10.1242/dev.01304; Vokes SA, 2002, DEVELOPMENT, V129, P775; Walzem RL, 1999, J NUTR, V129, p467S, DOI 10.1093/jn/129.2.467S; WETTERAU JR, 1992, SCIENCE, V258, P999; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; WILT FH, 1965, SCIENCE, V147, P1588, DOI 10.1126/science.147.3665.1588; Yoshizaki N, 2004, DEV GROWTH DIFFER, V46, P229, DOI 10.1111/j.1440-169X.2004.00740.x; Zohn IE, 2010, BIRTH DEFECTS RES A, V88, P593, DOI 10.1002/bdra.20705	68	51	51	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1088	1098		10.1074/jbc.M112.393090	http://dx.doi.org/10.1074/jbc.M112.393090			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23209291	hybrid, Green Published			2022-12-28	WOS:000313570300032
J	Jain, M; Rivera, S; Monclus, EA; Synenki, L; Zirk, A; Eisenbart, J; Feghali-Bostwick, C; Mutlu, GM; Budinger, GRS; Chandel, NS				Jain, Manu; Rivera, Stephanie; Monclus, Elena A.; Synenki, Lauren; Zirk, Aaron; Eisenbart, James; Feghali-Bostwick, Carol; Mutlu, Gokhan M.; Budinger, G. R. Scott; Chandel, Navdeep S.			Mitochondrial Reactive Oxygen Species Regulate Transforming Growth Factor-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; HUMAN LUNG FIBROBLASTS; TGF-BETA; ACTIVATION; EXPRESSION; DIFFERENTIATION; MYOFIBROBLAST; ROS; GENERATION; APOPTOSIS	TGF-beta signaling is required for normal tissue repair; however, excessive TGF-beta signaling can lead to robust profibrotic gene expression in fibroblasts, resulting in tissue fibrosis. TGF-beta binds to cell-surface receptors, resulting in the phosphorylation of the Smad family of transcription factors to initiate gene expression. TGF-beta also initiates Smad-independent pathways, which augment gene expression. Here, we report that mitochondrial reactive oxygen species (ROS) generated at complex III are required for TGF-beta-induced gene expression in primary normal human lung fibroblasts. TGF-beta-induced ROS could be detected in both the mitochondrial matrix and cytosol. Mitochondrially targeted antioxidants markedly attenuated TGF-beta-induced gene expression without affecting Smad phosphorylation or nuclear translocation. Genetically disrupting mitochondrial complex III-generated ROS production attenuated TGF-beta-induced profibrotic gene expression. Furthermore, inhibiting mitochondrial ROS generation attenuated NOX4 (NADPH oxidase 4) expression, which is required for TGF-beta induced myofibroblast differentiation. Lung fibroblasts from patients with pulmonary fibrosis generated more mitochondrial ROS than normal human lung fibroblasts, and mitochondrially targeted antioxidants attenuated profibrotic gene expression in both normal and fibrotic lung fibroblasts. Collectively, our results indicate that mitochondrial ROS are essential for normal TGF-beta-mediated gene expression and that targeting mitochondrial ROS might be beneficial in diseases associated with excessive fibrosis.	[Jain, Manu; Rivera, Stephanie; Monclus, Elena A.; Synenki, Lauren; Zirk, Aaron; Eisenbart, James; Mutlu, Gokhan M.; Budinger, G. R. Scott; Chandel, Navdeep S.] Northwestern Univ, Sch Med, Dept Med, Div Pulm & Crit Care, Chicago, IL 60611 USA; [Chandel, Navdeep S.] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Feghali-Bostwick, Carol] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Feghali-Bostwick, Carol] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA	Northwestern University; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jain, M (corresponding author), Northwestern Univ, Sch Med, Dept Med, Div Pulm & Crit Care, McGaw M-332,240 E Huron Ave, Chicago, IL 60611 USA.	m-jain@northwestern.edu	Mutlu, Gokhan/HIR-2545-2022; Rivera, Eleanor/K-1127-2019	Rivera, Eleanor/0000-0002-3111-0611	NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013995] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000150] Funding Source: Medline; NCI NIH HHS [P30 CA060553] Funding Source: Medline; NIEHS NIH HHS [R01 ES013995] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bhattacharyya S, 2005, ARTHRITIS RHEUM-US, V52, P1248, DOI 10.1002/art.20996; Black D, 2007, BIOCHIMIE, V89, P1464, DOI 10.1016/j.biochi.2007.09.001; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Emerling BM, 2005, MOL CELL BIOL, V25, P4853, DOI 10.1128/MCB.25.12.4853-4862.2005; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Heneberg P, 2005, CURR MED CHEM, V12, P1859, DOI 10.2174/0929867054546636; Jennings MT, 1998, J NEURO-ONCOL, V36, P123, DOI 10.1023/A:1005863419880; Michaeloudes C, 2011, AM J PHYSIOL-LUNG C, V300, pL295, DOI 10.1152/ajplung.00134.2010; Mishra R, 2007, AM J PHYSIOL-CELL PH, V292, pC1361, DOI 10.1152/ajpcell.00370.2006; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107	24	237	244	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					770	777		10.1074/jbc.M112.431973	http://dx.doi.org/10.1074/jbc.M112.431973			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23204521	Green Published, hybrid			2022-12-28	WOS:000313570300002
J	Bader, HL; Lambert, E; Guiraud, A; Malbouyres, M; Driever, W; Koch, M; Ruggiero, F				Bader, Hannah L.; Lambert, Elise; Guiraud, Alexandre; Malbouyres, Marilyne; Driever, Wolfgang; Koch, Manuel; Ruggiero, Florence			Zebrafish Collagen XIV Is Transiently Expressed in Epithelia and Is Required for Proper Function of Certain Basement Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; EXTRACELLULAR-MATRIX; BINDING-PROPERTIES; GROWTH; EMPHASIS; UNDULIN; PROTEIN; FORM	We found that zebrafish has two differentially expressed col14a1 paralogs. col14a1a expression peaked between 18-somite stage and 24 hours postfertilization (hpf), whereas col14a1b was first expressed at 32 hpf. To uncover functions of collagen XIV (COLXIV) during early embryogenesis, we focused our study on col14a1a. We characterized the alpha 1 (XIV-A) chain as a collagenase-sensitive 200-kDa protein that formed dimer that could be reduced at high pH. As observed for the transcript, COLXIV-A protein expression peaked between 24 and 48 hpf. Using antisense probes and polyclonal antibodies, we show that col14a1a and its protein product COLXIV-A are transiently expressed in several epithelia, including epithelia undergoing shape changes, such as the fin folds. In contrast, anti-COLXII antibodies stained only connective tissues. COLXIV-A was also detected in the basement membrane (BM), where it co-localized with COLXII. At later developmental stages, COLXIV-A was not expressed in epithelia anymore but persisted in the BM. Morpholino knockdown of COLXIV-A provoked a skin detachment phenotype. Electron microscopy analysis revealed that morpholino-injected embryos lacked a lamina densa and lamina lucida at 24 hpf, and BM defects, such as gaps in the adepidermal granules, were still detected at 48 hpf. These BM defects were accompanied by a rupture of the dermis and detachment of the epidermis. Taken together, these data suggest an unexpected role of COLXIV-A in undifferentiated epithelia and in the formation of embryonic basement membranes.	[Bader, Hannah L.; Lambert, Elise; Guiraud, Alexandre; Malbouyres, Marilyne; Ruggiero, Florence] Univ Lyon 1, Ecole Normale Super Lyon, UMR CNRS 5242, Inst Genom Fonct Lyon, F-69364 Lyon 07, France; [Driever, Wolfgang] Univ Freiburg, Inst Biol 1, Dept Dev Biol, D-79104 Freiburg, Germany; [Bader, Hannah L.; Koch, Manuel] Univ Cologne, Fac Med, Ctr Mol Med Cologne, Inst Dent Res & Musculoskeletal Biol,Ctr Biochem, D-50931 Cologne, Germany	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Freiburg; University of Cologne	Ruggiero, F (corresponding author), ENS Lyon, Inst Genom Fonct Lyon, 46 Allee Italie, F-69364 Lyon 07, France.	florence.ruggiero@ens-lyon.fr	Koch, Manuel/AAG-9914-2021	Koch, Manuel/0000-0002-2962-7814; RUGGIERO, Florence/0000-0003-2915-5359; Driever, Wolfgang/0000-0002-9551-9141; Guiraud, Alexandre/0000-0002-7636-9205; LAMBERT, Elise/0000-0003-1192-0112	Agence Nationale de la Recherche [10BLAN121901]; Emergence Research Program (Region Rhone-Alpes); University Lyon 1 (Bonus Qualite Recherche); University Lyon1; German Academic Exchange Service	Agence Nationale de la Recherche(French National Research Agency (ANR)); Emergence Research Program (Region Rhone-Alpes)(Region Auvergne-Rhone-Alpes); University Lyon 1 (Bonus Qualite Recherche); University Lyon1; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Agence Nationale de la Recherche Grant 10BLAN121901 and grants from the Emergence Research Program (Region Rhone-Alpes) and from the University Lyon 1 (Bonus Qualite Recherche). Recipient of a doctoral fellowship from the University Lyon1 and the German Academic Exchange Service. Present address: Boston University School of Medicine, Dept. of Medicine, Evans Biomedical Research Bldg. X-440, Boston, MA 022118.	Agarwal P, 2012, J BIOL CHEM, V287, P22549, DOI 10.1074/jbc.M111.335935; Ansorge HL, 2009, J BIOL CHEM, V284, P8427, DOI 10.1074/jbc.M805582200; AUBERTFOUCHER E, 1992, J BIOL CHEM, V267, P15759; Bader HL, 2009, MATRIX BIOL, V28, P32, DOI 10.1016/j.matbio.2008.09.580; Bauer M, 1997, BBA-GENE STRUCT EXPR, V1354, P183, DOI 10.1016/S0167-4781(97)00131-0; BROWN JC, 1993, J CELL BIOL, V120, P557, DOI 10.1083/jcb.120.2.557; CASTAGNOLA P, 1992, EUR J CELL BIOL, V59, P340; Charvet B, 2011, CELL TISSUE RES, V346, P439, DOI 10.1007/s00441-011-1266-7; Dahm R, 2007, EXP EYE RES, V85, P74, DOI 10.1016/j.exer.2007.02.015; Ehnis T, 1996, EXP CELL RES, V229, P388, DOI 10.1006/excr.1996.0384; Furthauer M., 2001, R01RR15402 NIH; Gordon MK, 1996, DEV DYNAM, V206, P49, DOI 10.1002/(SICI)1097-0177(199605)206:1<49::AID-AJA5>3.3.CO;2-T; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; HANSEN A, 1993, J COMP NEUROL, V333, P289, DOI 10.1002/cne.903330213; Hauptmann G, 2000, METH MOL B, V137, P139; Imhof M, 2001, J BIOL CHEM, V276, P9141, DOI 10.1074/jbc.M009148200; Izu Y, 2011, J CELL BIOL, V193, P1115, DOI 10.1083/jcb.201010010; KEENE DR, 1991, J CELL BIOL, V113, P971, DOI 10.1083/jcb.113.4.971; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klein G, 1998, MATRIX BIOL, V16, P307, DOI 10.1016/S0945-053X(98)90002-6; KOCH M, 1992, EUR J BIOCHEM, V207, P847, DOI 10.1111/j.1432-1033.1992.tb17116.x; Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388; Maguen E, 1997, CORNEA, V16, P675; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; SCHNITTGER S, 1995, CYTOGENET CELL GENET, V68, P233, DOI 10.1159/000133920; SCHUPPAN D, 1990, J BIOL CHEM, V265, P8823; Tao G, 2012, J MOL CELL CARDIOL, V53, P626, DOI 10.1016/j.yjmcc.2012.08.002; Tomte LT, 2004, J MOL HISTOL, V35, P803, DOI 10.1007/s10735-004-1132-y; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; WALCHLI C, 1994, J CELL SCI, V107, P669; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Webb AE, 2007, DEV BIOL, V311, P369, DOI 10.1016/j.ydbio.2007.08.034; Westerfield M, 2007, ZEBRAFISH BOOK GUIDE; Young BB, 2000, DEV DYNAM, V217, P430, DOI 10.1002/(SICI)1097-0177(200004)217:4<430::AID-DVDY10>3.0.CO;2-5	35	21	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6777	6787		10.1074/jbc.M112.430637	http://dx.doi.org/10.1074/jbc.M112.430637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23325806	Green Published, hybrid			2022-12-28	WOS:000316002400001
J	Zheng, ZQ; Li, AM; Holmes, BB; Marasa, JC; Diamond, MI				Zheng, Zhiqiang; Li, Aimin; Holmes, Brandon B.; Marasa, Jayne C.; Diamond, Marc I.			An N-terminal Nuclear Export Signal Regulates Trafficking and Aggregation of Huntingtin (Htt) Protein Exon 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; MUTANT HUNTINGTIN; POLYGLUTAMINE AGGREGATION; SUBCELLULAR-LOCALIZATION; ANDROGEN RECEPTOR; REDUCES TOXICITY; CASPASE CLEAVAGE; DISEASE; FRAGMENTS; MODULATE	Huntington disease is a dominantly inherited neurodegenerative condition caused by polyglutamine expansion in the N terminus of the huntingtin protein (Htt). The first 17 amino acids (N17) of Htt play a key role in regulating its toxicity and aggregation. Both nuclear export and cytoplasm retention functions have been ascribed to N17. We have determined that N17 acts as a nuclear export sequence (NES) within Htt exon and when fused to yellow fluorescent protein. We have defined amino acids within N17 that constitute the nuclear export sequence (NES). Mutation of any of the conserved residues increases nuclear accumulation of Htt exon 1. Nuclear export of Htt is sensitive to leptomycin B and is reduced by knockdown of exportin 1. In HEK293 cells, NES mutations decrease overall Htt aggregation but increase the fraction of cells with nuclear inclusions. In primary cultured neurons, NES mutations increase nuclear accumulation and increase overall aggregation. This work defines a bona fide nuclear export sequence within N17 and links it to effects on protein aggregation. This may help explain the important role of N17 in controlling Htt toxicity.	[Zheng, Zhiqiang; Li, Aimin; Holmes, Brandon B.; Diamond, Marc I.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Marasa, Jayne C.] Washington Univ, Dept Radiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Diamond, MI (corresponding author), Washington Univ, Sch Med, Dept Neurol, Box 8111,660 S Euclid Ave, St Louis, MO 63110 USA.	diamondm@neuro.wustl.edu		Holmes, Brandon/0000-0002-1153-840X	National Institutes of Health through the NINDS [R21NS076116]; Hope Center for Neurological Disorders; National Institutes of Health predoctoral fellowship through the NINDS; Molecular Imaging Center [P50 CA94056]; Siteman Cancer Center at Washington University School of Medicine [P30 CA091842]; NATIONAL CANCER INSTITUTE [P30CA091842, P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS079039, R21NS076116] Funding Source: NIH RePORTER	National Institutes of Health through the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hope Center for Neurological Disorders; National Institutes of Health predoctoral fellowship through the NINDS; Molecular Imaging Center; Siteman Cancer Center at Washington University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21NS076116 through the NINDS. This work was also supported by Hope Center for Neurological Disorders (to M. I. D.); a National Institutes of Health predoctoral fellowship through the NINDS (to B. B. H.), Molecular Imaging Center Grant P50 CA94056, the Siteman Cancer Center at Washington University School of Medicine Grant P30 CA091842, and an Anheuser-Busch/Emerson challenge gift (High Throughput Screening Core).	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Angeli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009053; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Ben-Efraim I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-74; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DeRooij KE, 1996, HUM MOL GENET, V5, P1093, DOI 10.1093/hmg/5.8.1093; Desai UA, 2006, HUM MOL GENET, V15, P2114, DOI 10.1093/hmg/ddl135; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Havel LS, 2011, HUM MOL GENET, V20, P1424, DOI 10.1093/hmg/ddr023; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Li SH, 1998, HUM MOL GENET, V7, P777, DOI 10.1093/hmg/7.5.777; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shao J, 2008, FEBS LETT, V582, P1637, DOI 10.1016/j.febslet.2008.04.009; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tao T, 2001, TRAFFIC, V2, P385, DOI 10.1034/j.1600-0854.2001.002006385.x; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156	40	53	55	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6063	6071		10.1074/jbc.M112.413575	http://dx.doi.org/10.1074/jbc.M112.413575			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319588	Green Published, hybrid			2022-12-28	WOS:000315820700004
J	Lee, SJ; Cho, SC; Lee, EJ; Kim, S; Lee, SB; Lim, JH; Choi, YH; Kim, WJ; Moon, SK				Lee, Se-Jung; Cho, Seok-Cheol; Lee, Eo-Jin; Kim, Sangtae; Lee, Soo-Bok; Lim, Jung-Hyurk; Choi, Yung Hyun; Kim, Wun-Jae; Moon, Sung-Kwon			Interleukin-20 Promotes Migration of Bladder Cancer Cells through Extracellular Signal-regulated Kinase (ERK)-mediated MMP-9 Protein Expression Leading to Nuclear Factor (NF-kappa B) Activation by Inducing the Up-regulation of p21(WAF1) Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGENASE GENE; MATRIX METALLOPROTEINASES; TRANSCRIPTION FACTOR; TUMOR PROGRESSION; CYCLE REGULATORS; BREAST-CANCER; INFLAMMATORY CYTOKINES; URINARY-BLADDER; CDK INHIBITORS; GROWTH-FACTOR	The role of inflammatory cytokine interleukin-20 (IL-20) has not yet been studied in cancer biology. Here, we demonstrated up-regulation of both IL-20 and IL-20R1 in muscle-invasive bladder cancer patients. The expressions of IL-20 and IL-20R1 were observed in bladder cancer 5637 and T-24 cells. We found that IL-20 significantly increased the expression of matrix metalloproteinase (MMP)-9 via binding activity of NF-kappa B and AP-1 in bladder cancer cells and stimulated the activation of ERK1/2, JNK, p38 MAPK, and JAK-STAT signaling. Among the pathways examined, only ERK1/2 inhibitor U0126 significantly inhibited IL-20-induced migration and invasion. Moreover, siRNA knockdown of IL-20R1 suppressed migration, invasion, ERK1/2 activation, and NF-kappa B-mediated MMP-9 expression induced by IL-20. Unexpectedly, the cell cycle inhibitor p21(WAF1) was induced by IL-20 treatment without altering cell cycle progression. Blockade of p21(WAF1) function by siRNA reversed migration, invasion, activation of ERK signaling, MMP-9 expression, and activation of NF-kappa B in IL-20-treated cells. In addition, IL-20 induced the activation of I kappa B kinase, the degradation and phosphorylation of I kappa B alpha, and NF-kappa B p65 nuclear translocation, which was regulated by ERK1/2. IL-20 stimulated the recruitment of p65 to the MMP-9 promoter region. Finally, the IL-20-induced migration and invasion of cells was confirmed by IL-20 gene transfection and by addition of anti-IL-20 antibody. This is the first report that p21(WAF1) is involved in ERK1/2-mediated MMP-9 expression via increased binding activity of NF-kappa B, which resulted in the induction of migration in IL-20/IL-20R1 dyad-induced bladder cancer cells. These unexpected results might provide a critical new target for the treatment of bladder cancer.	[Lee, Se-Jung; Lee, Eo-Jin; Kim, Sangtae; Moon, Sung-Kwon] Chungju Natl Univ, Dept Biotechnol, Chungju 380702, Chungbuk, South Korea; [Cho, Seok-Cheol] Seowon Univ, Dept Food & Nutr, Cheongju 3773, Chungbuk, South Korea; [Lee, Soo-Bok] Yonsei Univ, Dept Food & Nutr, Brain Korea Project 21, Seoul 120749, South Korea; [Lim, Jung-Hyurk] Chungju Natl Univ, Dept Polymer Sci & Engn, Chungju 380702, Chungbuk, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Coll Oriental Med, Dept Biochem, Pusan 614052, South Korea; [Lee, Se-Jung; Lee, Eo-Jin; Kim, Wun-Jae; Moon, Sung-Kwon] Chungbuk Natl Univ, Dept Urol, Personalized Tumor Engn Res Ctr, Cheongju 361763, Chungbuk, South Korea	Seowon University; Yonsei University; Dong-Eui University; Chungbuk National University	Moon, SK (corresponding author), Chung Ang Univ, Sch Food Sci & Technol, Ansung 456756, South Korea.	sumoon66@dreamwiz.com			National Research Foundation of Korea Grant [2012-0000482]; MEST, Rural Development Administration, Republic of Korea; Next-Generation BioGreen 21 Program Grant, Rural Development Administration, Republic of Korea [PJ0081952011]	National Research Foundation of Korea Grant(National Research Foundation of Korea); MEST, Rural Development Administration, Republic of Korea; Next-Generation BioGreen 21 Program Grant, Rural Development Administration, Republic of Korea	This work was supported by National Research Foundation of Korea Grant 2012-0000482 funded by MEST and by Next-Generation BioGreen 21 Program Grant PJ0081952011, Rural Development Administration, Republic of Korea.	Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Baldi Alfonso, 2011, Patholog Res Int, V2011, P605042, DOI 10.4061/2011/605042; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Black PC, 2007, CANCER METAST REV, V26, P623, DOI 10.1007/s10555-007-9084-9; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Chen WY, 2009, J IMMUNOL, V182, P5003, DOI 10.4049/jimmunol.0803653; CORDONCARDO C, 1995, AM J PATHOL, V147, P545; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DAVIES B, 1993, CANCER RES, V53, P5365; Di Carlo A, 2006, ONCOL REP, V15, P1321; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; ESRIG D, 1994, NEW ENGL J MED, V331, P1259, DOI 10.1056/NEJM199411103311903; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goswami B, 2008, INT J GYNECOL CANCER, V18, P591, DOI 10.1111/j.1525-1438.2007.01089.x; Hsieh MY, 2006, GENES IMMUN, V7, P234, DOI 10.1038/sj.gene.6364291; Hsu YH, 2012, J IMMUNOL, V188, P1981, DOI 10.4049/jimmunol.1102843; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Inoue K, 2000, CANCER RES, V60, P2290; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Juan G, 2001, CANCER RES, V61, P1220; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Kumar B, 2010, CANCER RES, V70, P832, DOI 10.1158/0008-5472.CAN-09-2918; Lee SJ, 2008, ONCOL REP, V19, P1007; LIOTTA LA, 1986, CANCER RES, V46, P1; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Metts MC, 2000, J NATL MED ASSOC, V92, P285; Moses MA, 1998, CANCER RES, V58, P1395; Nutt JE, 2003, BJU INT, V91, P99, DOI 10.1046/j.1464-410X.2003.04020.x; Okamoto M, 1997, INT J CANCER, V72, P149, DOI 10.1002/(SICI)1097-0215(19970703)72:1<149::AID-IJC21>3.0.CO;2-D; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; SARKIS AS, 1993, J NATL CANCER I, V85, P53, DOI 10.1093/jnci/85.1.53; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1993, ONCOGENE, V8, P395; Shariat SF, 2003, UROLOGY, V61, P1140, DOI 10.1016/S0090-4295(03)00236-X; Shen ZC, 2008, PHARM RES-DORDR, V25, P1500, DOI 10.1007/s11095-008-9566-7; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sier CFM, 2000, CLIN CANCER RES, V6, P2333; So MK, 2006, NAT PROTOC, V1, P1160, DOI 10.1038/nprot.2006.162; Stein JP, 1998, J NATL CANCER I, V90, P1072, DOI 10.1093/jnci/90.14.1072; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wegenka UM, 2010, CYTOKINE GROWTH F R, V21, P353, DOI 10.1016/j.cytogfr.2010.08.001; Xu WF, 2004, INT IMMUNOPHARMACOL, V4, P627, DOI 10.1016/j.intimp.2004.01.006; Yoon TJ, 2006, SMALL, V2, P209, DOI [10.1002/smll.200500360, 10.1002/511111.200500360]; Zaravinos A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018255	51	68	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5539	5552		10.1074/jbc.M112.410233	http://dx.doi.org/10.1074/jbc.M112.410233			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23271730	Green Published, hybrid			2022-12-28	WOS:000315342500028
J	Nanda, JS; Saini, AK; Munoz, AM; Hinnebusch, AG; Lorsch, JR				Nanda, Jagpreet S.; Saini, Adesh K.; Munoz, Antonio M.; Hinnebusch, Alan G.; Lorsch, Jon R.			Coordinated Movements of Eukaryotic Translation Initiation Factors eIF1, eIF1A, and eIF5 Trigger Phosphate Release from eIF2 in Response to Start Codon Recognition by the Ribosomal Preinitiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; SELECTION IN-VIVO; SITE SELECTION; MULTIFACTOR COMPLEX; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; AUG SELECTION; SUBUNIT; REVEALS; BINDING	Accurate recognition of the start codon in an mRNA by the eukaryotic translation preinitiation complex (PIC) is essential for proper gene expression. The process is mediated by eukaryotic translation initiation factors (eIFs) in conjunction with the 40 S ribosomal subunit and (initiator) tRNA(i). Here, we provide evidence that the C-terminal tail (CTT) of eIF1A, which we previously implicated in start codon recognition, moves closer to the N-terminal domain of eIF5 when the PIC encounters an AUG codon. Importantly, this movement is coupled to dissociation of eIF1 from the PIC, a critical event in start codon recognition, and is dependent on the scanning enhancer elements in the eIF1A CTT. The data further indicate that eIF1 dissociation must be accompanied by the movement of the eIF1A CTT toward eIF5 in order to trigger release of phosphate from eIF2, which converts the latter to its GDP-bound state. Our results also suggest that release of eIF1 from the PIC and movement of the CTT of eIF1A are triggered by the same event, most likely accommodation of tRNA(i) in the P site of the 40 S subunit driven by base pairing between the start codon in the mRNA and the anticodon in tRNA(i). Finally, we show that the C-terminal domain of eIF5 is responsible for the factor's activity in antagonizing eIF1 binding to the PIC. Together, our data provide a more complete picture of the chain of molecular events that is triggered when the scanning PIC encounters an AUG start codon in the mRNA.	[Nanda, Jagpreet S.; Munoz, Antonio M.; Lorsch, Jon R.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Saini, Adesh K.; Hinnebusch, Alan G.] Eunice K Shriver NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lorsch, JR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	jlorsch@jhmi.edu	Saini, Adesh/AAY-6016-2020	Saini, Adesh/0000-0002-5445-5786; Nanda, Jagpreet/0000-0002-6629-4641; Lorsch, Jon/0000-0002-4521-4999	National Institutes of Health [GM 62128]; National Institutes of Health Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 62128 (to J.R.L.) and by the National Institutes of Health Intramural Research Program (to A.G.H.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Alone PV, 2008, MOL CELL BIOL, V28, P6877, DOI 10.1128/MCB.01147-08; Alone PV, 2006, J BIOL CHEM, V281, P12636, DOI 10.1074/jbc.M511700200; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Conte MR, 2006, BIOCHEMISTRY-US, V45, P4550, DOI 10.1021/bi052387u; Das S, 2001, J BIOL CHEM, V276, P6720, DOI 10.1074/jbc.M008863200; Fekete CA, 2005, EMBO J, V24, P3588, DOI 10.1038/sj.emboj.7600821; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Hashimoto NN, 2002, BIOCHEM J, V367, P359, DOI 10.1042/BJ20020556; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kolitz SE, 2009, RNA, V15, P138, DOI 10.1261/rna.1318509; Lakowicz JR, 1999, PRINCIPLES FLUORESCE, P353; Laurino JP, 1999, MOL CELL BIOL, V19, P173; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Loughran G, 2012, NUCLEIC ACIDS RES, V40, P2898, DOI 10.1093/nar/gkr1192; Luna RE, 2012, CELL REPORTS, V1, P689, DOI 10.1016/j.celrep.2012.04.007; Maag D, 2006, J MOL BIOL, V356, P724, DOI 10.1016/j.jmb.2005.11.083; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Martin-Marcos P, 2011, MOL CELL BIOL, V31, P4814, DOI 10.1128/MCB.05819-11; Nanda J., 2011, METHODS NAVIGATOR; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Shih WM, 2000, CELL, V102, P683, DOI 10.1016/S0092-8674(00)00090-8; Singh CR, 2005, MOL CELL BIOL, V25, P5480, DOI 10.1128/MCB.25.13.5480-5491.2005; Singh CR, 2004, J BIOL CHEM, V279, P31910, DOI 10.1074/jbc.M313940200; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; Wei ZY, 2006, J MOL BIOL, V359, P1, DOI 10.1016/j.jmb.2006.03.037; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102; Yatime L, 2007, P NATL ACAD SCI USA, V104, P18445, DOI 10.1073/pnas.0706784104; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	43	58	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5316	5329		10.1074/jbc.M112.440693	http://dx.doi.org/10.1074/jbc.M112.440693			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23293029	hybrid, Green Published			2022-12-28	WOS:000315342500006
J	Panjarian, S; Iacob, RE; Chen, SG; Engen, JR; Smithgall, TE				Panjarian, Shoghag; Iacob, Roxana E.; Chen, Shugui; Engen, John R.; Smithgall, Thomas E.			Structure and Dynamic Regulation of Abl Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SRC-FAMILY KINASES; C-ABL; TYROSINE KINASE; BCR-ABL; OLIGOMERIZATION DOMAIN; TRANSFORMING ACTIVITY; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; LEUKEMIA-CELLS; SH3 DOMAINS	The c-abl proto-oncogene encodes a unique protein-tyrosine kinase (Abl) distinct from c-Src, c-Fes, and other cytoplasmic tyrosine kinases. In normal cells, Abl plays prominent roles in cellular responses to genotoxic stress as well as in the regulation of the actin cytoskeleton. Abl is also well known in the context of Bcr-Abl, the oncogenic fusion protein characteristic of chronic myelogenous leukemia. Selective inhibitors of Bcr-Abl, of which imatinib is the prototype, have had a tremendous impact on clinical outcomes in chronic myelogenous leukemia and revolutionized the field of targeted cancer therapy. In this minireview, we focus on the structural organization and dynamics of Abl kinases and how these features influence inhibitor sensitivity.	[Panjarian, Shoghag; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Iacob, Roxana E.; Chen, Shugui; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northeastern University	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.	tsmithga@pitt.edu		Engen, John R./0000-0002-6918-9476	National Institutes of Health [CA169962, CA101828, GM086507, GM101135]; Waters Corporation; NATIONAL CANCER INSTITUTE [R21CA169962, R01CA101828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101135, R01GM086507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waters Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA169962 and CA101828 (to T.E.S.) and GM086507 and GM101135 (to J.R.E.) and by a research collaboration with the Waters Corporation (to J.R.E).	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Brier S, 2008, MASS SPECTROMETRY AN, P11; Cao XQ, 2008, J BIOL CHEM, V283, P31401, DOI 10.1074/jbc.M804002200; Chen S, 2008, J MOL BIOL, V383, P414, DOI 10.1016/j.jmb.2008.08.040; Chen SG, 2008, BIOCHEMISTRY-US, V47, P5795, DOI 10.1021/bi800446b; Chen SG, 2007, PROTEIN SCI, V16, P572, DOI 10.1110/ps.062631007; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Engen JR, 2013, INT REV PHYS CHEM, V32, P96, DOI 10.1080/0144235X.2012.751175; Engen JR, 2009, ANAL CHEM, V81, P7870, DOI 10.1021/ac901154s; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; Glover RT, 2000, J BIOL CHEM, V275, P12725, DOI 10.1074/jbc.275.17.12725; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Grebien F, 2011, CELL, V147, P306, DOI 10.1016/j.cell.2011.08.046; Guo XYD, 1998, ONCOGENE, V17, P825, DOI 10.1038/sj.onc.1201999; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hochrein JM, 2006, PROTEIN SCI, V15, P65, DOI 10.1110/ps.051782206; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Iacob RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015929; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Li YZ, 2007, J CELL SCI, V120, P1436, DOI 10.1242/jcs.03430; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Marcsisin SR, 2010, ANAL BIOANAL CHEM, V397, P967, DOI 10.1007/s00216-010-3556-4; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Panjarian S, 2013, J BIOL CHEM, V288, P6116, DOI 10.1074/jbc.M112.431312; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Pene-Dumitrescu T, 2010, J BIOL CHEM, V285, P21446, DOI 10.1074/jbc.M109.090043; Pisabarro MT, 1998, J MOL BIOL, V281, P513, DOI 10.1006/jmbi.1998.1932; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Smith KM, 2001, J BIOL CHEM, V276, P24372, DOI 10.1074/jbc.M100786200; Sun X, 2008, LEUKEMIA, V22, P1053, DOI 10.1038/sj.leu.2404990; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; Wales TE, 2006, J MOL BIOL, V357, P1592, DOI 10.1016/j.jmb.2006.01.075; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Xiong XL, 2008, BBA-MOL CELL RES, V1783, P737, DOI 10.1016/j.bbamcr.2008.01.028; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Yang SC, 2010, P NATL ACAD SCI USA, V107, P15757, DOI 10.1073/pnas.1004569107; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhao X, 2002, NAT STRUCT BIOL, V9, P117; Zhuang CM, 2011, J BIOL CHEM, V286, P38614, DOI 10.1074/jbc.M111.281139	70	71	74	1	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5443	5450		10.1074/jbc.R112.438382	http://dx.doi.org/10.1074/jbc.R112.438382			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23316053	Green Published, hybrid			2022-12-28	WOS:000315342500019
J	Zhang, H; Zhang, H; Gao, ZQ; Wang, WJ; Liu, GF; Xu, JH; Su, XD; Dong, YH				Zhang, Heng; Zhang, Heng; Gao, Zeng-Qiang; Wang, Wen-Jia; Liu, Guang-Feng; Xu, Jian-Hua; Su, Xiao-Dong; Dong, Yu-Hui			Structure of the Type VI Effector-Immunity Complex (Tae4-Tai4) Provides Novel Insights into the Inhibition Mechanism of the Effector by Its Immunity Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; SECRETION SYSTEM; PEPTIDOGLYCAN; BACTERIAL; AMIDASE; DOMAIN; MACROMOLECULES; RECOGNITION	The type VI secretion system (T6SS), a multisubunit needle-like apparatus, has recently been found to play a role in interspecies interactions. The Gram-negative bacteria harboring T6SS (donor) deliver the effectors into their neighboring cells (recipient) to kill them. Meanwhile, the cognate immunity proteins were employed to protect the donor cells against the toxic effectors. Tae4 (type VI amidase effector 4) and Tai4 (type VI amidase immunity 4) are newly identified T6SS effector-immunity pairs. Here, we report the crystal structures of Tae4 from Enterobacter cloacae and Tae4-Tai4 complexes from both E. cloacae and Salmonella typhimurium. Tae4 acts as a DL-endopeptidase and displays a typical N1pC/P60 domain. Unlike Tsi1 (type VI secretion immunity 1), Tai4 is an all-helical protein and forms a dimer in solution. The small angle x-ray scattering study combined with the analytical ultracentrifugation reveal that the Tae4-Tai4 complex is a compact heterotetramer that consists of a Tai4 dimer and two Tae4 molecules in solution. Structure-based mutational analysis of the Tae4-Tai4 interface shows that a helix (alpha 3) of one subunit in dimeric Tai4 plays a major role in binding of Tae4, whereas a protruding loop (L4) in the other subunit is mainly responsible for inhibiting Tae4 activity. The inhibition process requires collaboration between the Tai4 dimer. These results reveal a novel and unique inhibition mechanism in effector-immunity pairs and suggest a new strategy to develop antipathogen drugs.	[Zhang, Heng; Su, Xiao-Dong] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Zhang, Heng; Gao, Zeng-Qiang; Wang, Wen-Jia; Liu, Guang-Feng; Xu, Jian-Hua; Dong, Yu-Hui] Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China	Peking University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Su, XD (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, 5 Yiheyuan Rd, Beijing 100871, Peoples R China.	xdsu@pku.edu.cn; dongyh@ihep.ac.cn	zhang, heng/O-2665-2013	zhang, heng/0000-0003-1112-7149; Dong, Yuhui/0000-0002-4422-4685; Zhang, Heng/0000-0003-3208-6489; Gao, Zengqiang/0000-0002-9100-9929	National Basic Research Program of China [2012CB917203]; National Natural Science Foundation of China [10979005, 31200552]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2012CB917203 and National Natural Science Foundation of China Grants 10979005 and 31200552.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Benz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040453; Cambronne ED, 2006, TRAFFIC, V7, P929, DOI 10.1111/j.1600-0854.2006.00446.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Ding JJ, 2012, J BIOL CHEM, V287, P26911, DOI 10.1074/jbc.M112.368043; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Li M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002613; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Zhang H, 2012, FEBS LETT, V586, P3193, DOI 10.1016/j.febslet.2012.06.036; Zhang H, 2012, FEBS LETT, V586, P1147, DOI 10.1016/j.febslet.2012.03.029; Zou TT, 2012, J MOL BIOL, V417, P351, DOI 10.1016/j.jmb.2012.01.040	36	46	47	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5928	5939		10.1074/jbc.M112.434357	http://dx.doi.org/10.1074/jbc.M112.434357			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288853	hybrid, Green Published			2022-12-28	WOS:000315342500061
J	Magupalli, VG; Mochida, S; Yan, J; Jiang, X; Westenbroek, RE; Nairn, AC; Scheuer, T; Catterall, WA				Magupalli, Venkat G.; Mochida, Sumiko; Yan, Jin; Jiang, Xin; Westenbroek, Ruth E.; Nairn, Angus C.; Scheuer, Todd; Catterall, William A.			Ca2+-independent Activation of Ca2+/Calmodulin-dependent Protein Kinase II Bound to the C-terminal Domain of Ca(V)2.1 Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUID GIANT SYNAPSE; CA2+ CHANNELS; PRESYNAPTIC PLASTICITY; TRANSMITTER RELEASE; INTERACTION SITE; N-TYPE; CAMKII; PHOSPHORYLATION; BRAIN; NEURONS	Ca2+/calmodulin-dependent protein kinase II (CaMKII) forms a major component of the postsynaptic density where its functions in synaptic plasticity are well established, but its presynaptic actions are poorly defined. Here we show that CaMKII binds directly to the C-terminal domain of Ca(V)2.1 channels. Binding is enhanced by autophosphorylation, and the kinase-channel signaling complex persists after dephosphorylation and removal of the Ca2+/CaM stimulus. Autophosphorylated CaMKII can bind the Ca(V)2.1 channel and synapsin-1 simultaneously. CaMKII binding to Ca(V)2.1 channels induces Ca2+-independent activity of the kinase, which phosphorylates the enzyme itself as well as the neuronal substrate synapsin-1. Facilitation and inactivation of Ca(V)2.1 channels by binding of Ca2+/CaM mediates short term synaptic plasticity in transfected superior cervical ganglion neurons, and these regulatory effects are prevented by a competing peptide and the endogenous brain inhibitor CaMKIIN, which blocks binding of CaMKII to Ca(V)2.1 channels. These results define the functional properties of a signaling complex of CaMKII and Ca(V)2.1 channels in which both binding partners are persistently activated by their association, and they further suggest that this complex is important in presynaptic terminals in regulating protein phosphorylation and short term synaptic plasticity.	[Magupalli, Venkat G.; Yan, Jin; Jiang, Xin; Westenbroek, Ruth E.; Scheuer, Todd; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Mochida, Sumiko] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan; [Nairn, Angus C.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA	University of Washington; University of Washington Seattle; Tokyo Medical University; Yale University	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Mailstop 357280, Seattle, WA 98195 USA.	wcatt@uw.edu		Magupalli, Venkat/0000-0003-4638-3062; Nairn, Angus/0000-0002-7075-0195	National Institutes of Health [R01 NS22625]; National Institute on Drug Abuse [DA10044]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS22625 (to W. A. C.) and National Institute on Drug Abuse Grant DA10044 (to A. C. N.).	Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BENFENATI F, 1992, NEURON, V8, P377, DOI 10.1016/0896-6273(92)90303-U; BENNETT AF, 1992, EUR J BIOCHEM, V206, P783, DOI 10.1111/j.1432-1033.1992.tb16985.x; BRICKEY DA, 1990, BIOCHEM BIOPH RES CO, V173, P578, DOI 10.1016/S0006-291X(05)80074-9; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; Colbran RJ, 2004, J NEUROSCI, V24, P8404, DOI 10.1523/JNEUROSCI.3602-04.2004; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Grueter CE, 2008, BIOCHEMISTRY-US, V47, P1760, DOI 10.1021/bi701755q; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; HEMMINGS HC, 1989, FASEB J, V3, P1583, DOI 10.1096/fasebj.3.5.2493406; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; Hojjati MR, 2007, NAT NEUROSCI, V10, P1125, DOI 10.1038/nn1946; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Jiang X, 2008, P NATL ACAD SCI USA, V105, P341, DOI 10.1073/pnas.0710213105; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee JS, 2012, P NATL ACAD SCI USA, V109, pE765, DOI 10.1073/pnas.1114072109; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; Lu FM, 2006, P NATL ACAD SCI USA, V103, P4264, DOI 10.1073/pnas.0508162103; Luk CC, 2011, EUR J NEUROSCI, V34, P569, DOI 10.1111/j.1460-9568.2011.07784.x; Magupalli VG, 2008, J NEUROSCI, V28, P7954, DOI 10.1523/JNEUROSCI.1964-08.2008; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Ohyama A, 2002, J NEUROSCI, V22, P3342; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sakaba T, 2003, J NEUROSCI, V23, P837; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; Stefani G, 1997, J PHYSIOL-LONDON, V504, P501, DOI 10.1111/j.1469-7793.1997.501bd.x; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wu LG, 1999, J NEUROSCI, V19, P726; Yokoyama CT, 2005, MOL CELL NEUROSCI, V28, P1, DOI 10.1016/j.mcn.2004.08.019	60	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4637	4648		10.1074/jbc.M112.369058	http://dx.doi.org/10.1074/jbc.M112.369058			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23255606	Green Published, hybrid			2022-12-28	WOS:000315340400013
J	Dixit, M; Kim, S; Matthews, GF; Erreger, K; Galli, A; Cobb, CE; Hustedt, EJ; Beth, AH				Dixit, Mrinalini; Kim, Sunghoon; Matthews, Gage F.; Erreger, Kevin; Galli, Aurelio; Cobb, Charles E.; Hustedt, Eric J.; Beth, Albert H.			Structural Arrangement of the Intracellular Ca2+ Binding Domains of the Cardiac Na+/Ca2+ Exchanger (NCX1.1) EFFECTS OF Ca2+ BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOLEMMAL NA+-CA2+ EXCHANGER; HUMAN VENTRICULAR MYOCYTES; SODIUM-CALCIUM EXCHANGE; CYTOPLASMIC DOMAIN; SPIN-LABELS; ELECTROSTATIC SWITCH; CA2+-BINDING DOMAIN; ERYTHROCYTE BAND-3; DYNAMIC PROPERTIES; GLOBAL ANALYSIS	The cardiac Na+/Ca2+ exchanger (NCX1.1) serves as the primary means of Ca2+ extrusion across the plasma membrane of cardiomyocytes after the rise in intracellular Ca2+ during contraction. The exchanger is regulated by binding of Ca2+ to its intracellular domain, which contains two structurally homologous Ca2+ binding domains denoted as CBD1 and CBD2. NMR and x-ray crystallographic studies have provided structures for the isolated CBD1 and CBD2 domains and have shown how Ca2+ binding affects their structures and motional dynamics. However, structural information on the entire Ca2+ binding domain, denoted CBD12, and how binding of Ca2+ alters its structure and dynamics is more limited. Site-directed spin labeling has been employed in this work to address these questions. Electron paramagnetic resonance measurements on singly labeled constructs of CBD12 have identified the regions that undergo changes in dynamics as a result of Ca2+ binding. Double electron-electron resonance (DEER) measurements on doubly labeled constructs of CBD12 have shown that the beta-sandwich regions of the CBD1 and CBD2 domains are largely insensitive to Ca2+ binding and that these two domains are widely separated at their N and C termini. Interdomain distances measured by DEER have been employed to construct structural models for CBD12 in the presence and absence of Ca2+. These models show that there is not a major change in the relative orientation of the two Ca2+ binding domains as a result of Ca2+ binding in the NCX1.1 isoform. Additional measurements have shown that there are significant changes in the dynamics of the F-G loop region of CBD2 that merit further characterization with regard to their possible involvement in regulation of NCX1.1 activity.	[Dixit, Mrinalini; Kim, Sunghoon; Matthews, Gage F.; Erreger, Kevin; Galli, Aurelio; Cobb, Charles E.; Hustedt, Eric J.; Beth, Albert H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Beth, AH (corresponding author), Vanderbilt Univ, Sch Med, 727 Light Hall, Nashville, TN 37232 USA.	al.beth@vanderbilt.edu		Matthews, Gage/0000-0002-8695-9727; kim, sunghoon/0000-0002-1570-3230	National Institutes of Health [RR019120]; NATIONAL CANCER INSTITUTE [DP1CA174419] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We greatly appreciate receiving the cDNA encoding NCX1.1 from Dr.J.Lytton, University of Calgary. Funding for the DEER instrument was provided by National Institutes of Health Grant RR019120.	Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Brandon S, 2012, J MAGN RESON, V218, P93, DOI 10.1016/j.jmr.2012.03.006; Breukels V, 2010, PROTEINS, V78, P1813, DOI 10.1002/prot.22695; Dong H, 2002, BIOPHYS J, V82, P1943, DOI 10.1016/S0006-3495(02)75543-4; Dong H, 2001, J BIOL CHEM, V276, P25919, DOI 10.1074/jbc.M103401200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; Hustedt EJ, 1997, BIOPHYS J, V72, P1861, DOI 10.1016/S0006-3495(97)78832-5; Hustedt EJ, 2006, BIOPHYS J, V90, P340, DOI 10.1529/biophysj.105.068544; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; Kang TM, 2004, NATURE, V427, P544, DOI 10.1038/nature02271; Kim S, 2011, J BIOL CHEM, V286, P20746, DOI 10.1074/jbc.M111.230326; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; Matsuoka S, 1997, J GEN PHYSIOL, V109, P273, DOI 10.1085/jgp.109.2.273; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Pogwizd SM, 1999, CIRC RES, V85, P1009; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Ren XY, 2006, J BIOL CHEM, V281, P22808, DOI 10.1074/jbc.M604753200; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Salinas RK, 2011, J BIOL CHEM, V286, P32123, DOI 10.1074/jbc.M111.249268; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Weisser-Thomas J, 2003, CARDIOVASC RES, V57, P974, DOI 10.1016/S0008-6363(02)00732-0; Wu MS, 2011, STRUCTURE, V19, P1509, DOI 10.1016/j.str.2011.07.008; Zhou Z, 2005, BIOCHEMISTRY-US, V44, P15115, DOI 10.1021/bi050931t; Zhou Z, 2007, BIOCHEMISTRY-US, V46, P10248, DOI 10.1021/bi700948p	35	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4194	4207		10.1074/jbc.M112.423293	http://dx.doi.org/10.1074/jbc.M112.423293			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23233681	Green Published, hybrid			2022-12-28	WOS:000314845000046
J	Elimam, H; Papillon, J; Takano, T; Cybulsky, AV				Elimam, Hanan; Papillon, Joan; Takano, Tomoko; Cybulsky, Andrey V.			Complement-mediated Activation of Calcium-independent Phospholipase A(2)gamma ROLE OF PROTEIN KINASES AND PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; GLOMERULAR EPITHELIAL-CELLS; ENDOPLASMIC-RETICULUM; A(2); INHIBITION; EXPRESSION; MEMBRANE; IPLA(2)GAMMA; MITOCHONDRIAL; GROWTH	In experimental membranous nephropathy, complement C5b-9-induces glomerular epithelial cell (GEC) injury and proteinuria. The effects of C5b-9 are mediated via signaling pathways, including calcium-independent phospholipase A(2)gamma (iPLA(2)gamma), and mitogen-activated protein kinases (MAPKs) such as extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. The iPLA(2)gamma pathway is cytoprotective. This study addresses the mechanisms of iPLA(2)gamma activation. iPLA(2)gamma activity was monitored by quantifying prostaglandin E-2 (PGE(2)) production. In GECs, iPLA(2)gamma localized at the endoplasmic reticulum and mitochondria. Complement-mediated production of PGE2 was amplified in GECs that overexpress iPLA(2)gamma, compared with control cells, and was blocked by the iPLA(2)gamma inhibitor bromoenol lactone in both iPLA(2)gamma-overexpressing and control GECs. In GECs that overexpress iPLA(2)gamma, complement-mediated PGE2 production was reduced by inhibitors of MAP/ERK kinase 1 (MEK1) and p38 but not JNK. In COS-1 cells that overexpress iPLA(2)gamma and cyclooxygenase-1, PGE2 production was induced by co-expression of constitutively active MEK1 or MAPK-interacting kinase 1 (MNK1) as well as by stimulation with epidermal growth factor (EGF) + ionomycin. Complement-and EGF + ionomycin-stimulated iPLA(2)gamma activity was attenuated by the S511A/S515A double mutation. Moreover, complement and EGF + ionomycin enhanced phosphorylation of Ser-511. Thus, complement-mediated activation of iPLA(2)gamma is mediated via ERK and p38 pathways, and phosphorylation of Ser-511 and/or Ser-515 plays a key role in the catalytic activity and signaling of iPLA(2)gamma. Defining the mechanisms by which complement activates iPLA(2)gamma provides opportunities for development of novel therapeutic approaches to GEC injury and proteinuria.	[Elimam, Hanan; Papillon, Joan; Takano, Tomoko; Cybulsky, Andrey V.] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ H3A 1A1, Canada	McGill University	Takano, T (corresponding author), McGill Univ, Div Nephrol, 3775 Univ St,Rm 236, Montreal, PQ H3A 2B4, Canada.	tomoko.takano@mcgill.ca; andrey.cybulsky@mcgill.ca	Elimam, Hanan/H-5858-2017; Cybulsky, Andrey V./AAG-8238-2020	Elimam, Hanan/0000-0003-2585-9957; Cybulsky, Andrey V./0000-0003-4348-2348	Canadian Institutes of Health Research [MOP-53264, MOP-53335]; Kidney Foundation of Canada; Catherine McLaughlin Hakim Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Catherine McLaughlin Hakim Chair	This work was supported by Canadian Institutes of Health Research Grants MOP-53264 (to A. V. C.) and MOP-53335 (to T. T.). This work was also supported by the Kidney Foundation of Canada (to A. V. C.).; Supported by the Catherine McLaughlin Hakim Chair. To whom correspondence may be addressed: Division of Nephrology, Royal Victoria Hospital, 687 Pine Ave. West, Montreal, Quebec H3A 1A1, Canada. Tel.: 514-398-8148; Fax: 514-843-2815. E-mail: andrey.cybulsky@mcgill.ca.	Aoto M, 2009, FEBS LETT, V583, P1611, DOI 10.1016/j.febslet.2009.04.028; Aoudjit L, 2006, AM J PHYSIOL-RENAL, V290, pF1534, DOI 10.1152/ajprenal.00267.2005; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Beckett CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1350, DOI 10.1152/ajpcell.00487.2005; Bonventre JV, 1999, J AM SOC NEPHROL, V10, P404; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P28766, DOI 10.1074/jbc.273.44.28766; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chilton F, 1996, J CLIN INVEST, V97, P2161, DOI 10.1172/JCI118654; Coers W, 1996, EXP NEPHROL, V4, P184; Cohen D, 2008, AM J PHYSIOL-RENAL, V294, pF469, DOI 10.1152/ajprenal.00372.2007; Cummings BS, 2002, AM J PHYSIOL-RENAL, V283, pF492, DOI 10.1152/ajprenal.00022.2002; Cummings BS, 2000, J PHARMACOL EXP THER, V294, P793; Cybulsky AV, 2011, CONTRIB NEPHROL, V169, P107, DOI 10.1159/000313948; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF660, DOI 10.1152/ajprenal.00437.2004; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF593, DOI 10.1152/ajprenal.00066.2005; Cybulsky AV, 2002, J BIOL CHEM, V277, P41342, DOI 10.1074/jbc.M204694200; Cybulsky AV, 1998, KIDNEY INT, V54, P360, DOI 10.1046/j.1523-1755.1998.00013.x; Deng N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000117; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Kuwata H, 2007, J BIOL CHEM, V282, P20124, DOI 10.1074/jbc.M611883200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Liu JH, 2001, BIOCHEM J, V353, P79, DOI 10.1042/bj3530079; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; McHowat J, 2001, BIOCHEMISTRY-US, V40, P14921, DOI 10.1021/bi0156153; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Panesar M, 1997, J IMMUNOL, V159, P3584; Pattabiraman PP, 2012, AM J PHYSIOL-CELL PH, V302, pC979, DOI 10.1152/ajpcell.00396.2011; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Perez R, 2004, J BIOL CHEM, V279, P40385, DOI 10.1074/jbc.M402562200; Portilla D, 1999, CURR OPIN NEPHROL HY, V8, P473, DOI 10.1097/00041552-199907000-00012; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; Roshak AK, 2000, J BIOL CHEM, V275, P35692, DOI 10.1074/jbc.M002273200; Saavedra G, 2006, J PHARMACOL EXP THER, V318, P1211, DOI 10.1124/jpet.106.105650; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Sun B, 2008, J PHARMACOL EXP THER, V326, P59, DOI 10.1124/jpet.108.138958; Takahashi S, 2001, J PHARMACOL EXP THER, V296, P48; Takano T, 2000, AM J PATHOL, V156, P2091, DOI 10.1016/S0002-9440(10)65080-8; Takano T, 2003, J PHARMACOL EXP THER, V305, P240, DOI 10.1124/jpet.102.043604; Tanaka H, 2000, BIOCHEM BIOPH RES CO, V272, P320, DOI 10.1006/bbrc.2000.2776; Tanaka H, 2004, BIOCHEM BIOPH RES CO, V320, P1284, DOI 10.1016/j.bbrc.2004.05.225; Tran K, 2000, J BIOL CHEM, V275, P25023, DOI 10.1074/jbc.M908971199; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Yang JY, 2003, FEBS LETT, V546, P247, DOI 10.1016/S0014-5793(03)00581-7; Yellaturu CR, 2003, J BIOL CHEM, V278, P43831, DOI 10.1074/jbc.M301472200; Zhang XH, 2006, J CELL SCI, V119, P1005, DOI 10.1242/jcs.02821	61	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3871	3885		10.1074/jbc.M112.396614	http://dx.doi.org/10.1074/jbc.M112.396614			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258543	Green Published, hybrid			2022-12-28	WOS:000314845000018
J	Hunter, CS; Stein, R				Hunter, Chad S.; Stein, Roland			Characterization of an Apparently Novel beta-Cell Line-enriched 80-88 kDa Transcriptional Activator of the MafA and Pdx1 Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR 3-BETA; EMBRYONIC STEM-CELLS; FACTOR-BINDING SITES; INSULIN GENE; IN-VIVO; CONSERVED SEQUENCES; PANCREATIC EXOCRINE; DIABETES-MELLITUS; REGULATORY REGION; ENDOCRINE-CELLS	MafA and Pdx1 represent critical transcriptional regulators required for the maintenance of pancreatic islet beta-cell function. The in vivo beta-cell-enriched expression pattern of these genes is principally directed by islet transcription factors binding within conserved Region 3 (base pairs (bp) -8118/-7750) of MafA and Area II (bp -2153/-1923) of the Pdx1 gene. Comprehensive mutational analysis of conserved MafA Region 3 revealed two new beta-cell line-specific cis-activation elements, termed Site 4 (bp -7997 to -7988) and Site 12 (bp -7835 to -7826). Gel mobility and antibody super-shift analysis identified Pdx1 as the Site 4 binding factor, while an 80-88 kilodalton (kDa) beta-cell line-enriched protein complex bound Site 12 and similar aligned nucleotides within Pdx1 Area II. The 80-88 kDa activator was also found in adult mouse islet extract. Strikingly, the molecular weight, DNA binding, and antibody recognition properties of this activator were unique when compared with all other key islet transcription factors tested, including Prox1 (83 kDa), Hnf1 alpha (67 kDa), FoxA2 (48 kDa), MafA (46 kDa), Isl1 (44 kDa), Pdx1 (42 kDa), and Nkx2.2 (30 kDa). Collectively, these data define an apparently novel MafA Region 3 and Pdx1 Area II activator contributing to expression in beta-cells.	[Hunter, Chad S.; Stein, Roland] Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University	Stein, R (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, 723 Light Hall, Nashville, TN 37232 USA.	Roland.Stein@vanderbilt.edu		Hunter, Chad/0000-0002-1644-447X	National Institutes of Health [DK050203]; NIDDK NRSA Postdoctoral Fellowship from the National Institutes of Health [F32 DK083160]; National Institutes of Health (Public Health Service) [P60 DK20593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, R01DK090570, R01DK050203, R56DK050203, F32DK083160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NRSA Postdoctoral Fellowship from the National Institutes of Health; National Institutes of Health (Public Health Service)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants DK050203 (to R. S.), NIDDK NRSA Postdoctoral Fellowship F32 DK083160 (to C. S. H.) from the National Institutes of Health.; We thank Min Guo (Vanderbilt University), Brian McKenna (Vanderbilt), Dr. Shuangli Guo (Vanderbilt) for technical assistance, and Dr. Richard O'Brien (Vanderbilt) for the kind use of liver nuclear extract. The pFox-Luc reporter plasmid was provided by Dr. Raghavendra Mirmira (Indiana University), and the Pdx1 and Prox1 antibodies were generously provided by Drs. Chris Wright (Vanderbilt) and Beatriz Sosa-Pineda (St. Jude Children's Research Hospital), respectively. Other antibodies utilized in this study (e. g. Isl1 and Hb9) were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. Partial support was provided to the Vanderbilt University Medical Molecular Biology Laboratory by our National Institutes of Health-funded Diabetes Research and Training Center (Public Health Service Grant P60 DK20593).	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; Cui WW, 2004, J BIOL CHEM, V279, P11088, DOI 10.1074/jbc.M312414200; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dai C, 2012, DIABETOLOGIA, V55, P707, DOI 10.1007/s00125-011-2369-0; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gerrish K, 2004, MOL ENDOCRINOL, V18, P533, DOI 10.1210/me.2003-0371; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; GUZ Y, 1995, DEVELOPMENT, V121, P11; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; Hunter CS, 2011, MOL ENDOCRINOL, V25, P339, DOI 10.1210/me.2010-0362; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Khoo C, 2012, MOL ENDOCRINOL, V26, P521, DOI 10.1210/me.2011-1231; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Locker J, 2002, NUCLEIC ACIDS RES, V30, P3809, DOI 10.1093/nar/gkf484; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Offield MF, 1996, DEVELOPMENT, V122, P983; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Petrovic V, 2008, J BIOL CHEM, V283, P453, DOI 10.1074/jbc.M705792200; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Raum JC, 2010, MOL CELL BIOL, V30, P4234, DOI 10.1128/MCB.01396-09; Samaras SE, 2003, J BIOL CHEM, V278, P12263, DOI 10.1074/jbc.M210801200; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; STEIN R, 1993, TRENDS ENDOCRIN MET, V4, P96, DOI 10.1016/1043-2760(93)90086-T; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Van Velkinburgh JC, 2005, J BIOL CHEM, V280, P38438, DOI 10.1074/jbc.M508594200; Vanhoose AM, 2008, J BIOL CHEM, V283, P22612, DOI 10.1074/jbc.M802902200; Wiebe PO, 2007, MOL CELL BIOL, V27, P4093, DOI 10.1128/MCB.01978-06; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Yang YP, 2011, GENE DEV, V25, P1680, DOI 10.1101/gad.16875711; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	42	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3795	3803		10.1074/jbc.M112.434282	http://dx.doi.org/10.1074/jbc.M112.434282			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23269676	hybrid, Green Published			2022-12-28	WOS:000314845000011
J	Kuo, CJ; Ptak, CP; Hsieh, CL; Akey, BL; Chang, YF				Kuo, Chih-Jung; Ptak, Christopher P.; Hsieh, Ching-Lin; Akey, Bruce L.; Chang, Yung-Fu			Elastin, a Novel Extracellular Matrix Protein Adhering to Mycobacterial Antigen 85 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; IMMUNOGLOBULIN-LIKE PROTEIN; STAPHYLOCOCCUS-AUREUS; ATTACHMENT PROTEIN; PROTECTIVE EFFICACY; CRYSTAL-STRUCTURES; CALCIUM BINDS; TUBERCULOSIS; MOTIF; TROPOELASTIN	The antigen 85 complex (Ag85) consists of three predominantly secreted proteins (Ag85A, Ag85B, and Ag85C), which play a key role in the mycobacterial pathogenesis and also possess enzymatic mycolyltransferase activity involved in cell wall synthesis. Ag85 is not only considered to be a virulence factor because its expression is essential for intracellular survival within macrophages, but also because it contributes to adherence, invasion, and dissemination of mycobacteria in host cells. In this study, we report that the extracellular matrix components, elastin and its precursor (tropoelastin) derived from human aorta, lung, and skin, serve as binding partners of Ag85 from Mycobacterium tuberculosis. The binding affinity of M. tuberculosis Ag85 to human tropoelastin was characterized (K-D = 0.13 +/- 0.006 mu M), and a novel Ag85-binding motif, AAA-KAA(K/Q)(Y/F), on multiple tropoelastin modules was identified. In addition, the negatively charged Glu-258 of Ag85 was demonstrated to participate in an electrostatic interaction with human tropoelastin. Moreover, binding of Ag85 on elastin siRNA-transfected Caco-2 cells was significantly reduced (34.3%), implying that elastin acts as an important ligand contributing to mycobacterial invasion.	[Kuo, Chih-Jung; Hsieh, Ching-Lin; Akey, Bruce L.; Chang, Yung-Fu] Cornell Univ, Dept Populat Med, Coll Vet Med, Ithaca, NY 14853 USA; [Kuo, Chih-Jung; Hsieh, Ching-Lin; Akey, Bruce L.; Chang, Yung-Fu] Cornell Univ, Dept Diagnost Sci, Coll Vet Med, Ithaca, NY 14853 USA; [Ptak, Christopher P.] Cornell Univ, Dept Mol Med, Coll Vet Med, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Chang, YF (corresponding author), Cornell Univ, Dept Populat Med, Coll Vet Med, Ithaca, NY 14853 USA.	yc42@cornell.edu	Hsieh, Ching-Lin/ABA-6461-2021; Ptak, Christopher/I-3126-2012; Ptak, Christopher/AAP-7763-2021; Hsieh, Ching-Lin/K-4139-2018; HSIEH, CHING-LIN/G-6057-2011	Ptak, Christopher/0000-0003-2752-0367; Ptak, Christopher/0000-0003-2752-0367; HSIEH, CHING-LIN/0000-0001-9468-9969; Kuo, Chih-Jung/0000-0002-4988-5124; Hsieh, Ching-Lin/0000-0002-3665-5717	Agriculture and Food Research Initiative [2008-35204-04626, 2009-65119-05993, 2008-55620-18710, 4535-CU-USDA-8710, 3954-CU-USDA-8710]; Animal Formula Fund [NY-478455, NY-478437]; Biotechnology Research and Development Corp.	Agriculture and Food Research Initiative; Animal Formula Fund; Biotechnology Research and Development Corp.	This work was supported by the Agriculture and Food Research Initiative Competitive Grants 2008-35204-04626, 2009-65119-05993, 2008-55620-18710, 4535-CU-USDA-8710, and 3954-CU-USDA-8710, Animal Formula Fund Grant NY-478455 and NY-478437, and the Biotechnology Research and Development Corp.	Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108; Baldwin S. L., 1999, Tubercle and Lung Disease, V79, P251, DOI 10.1054/tuld.1998.0196; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Castro-Garza J, 2002, FEMS MICROBIOL LETT, V212, P145, DOI 10.1111/j.1574-6968.2002.tb11258.x; Denis O, 1997, INFECT IMMUN, V65, P676, DOI 10.1128/IAI.65.2.676-684.1997; Graf R, 1996, CELL TISSUE RES, V283, P133; GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; JANICKI BW, 1971, AM REV RESPIR DIS, V104, P602; Janvilisri T, 2010, J INFECT DIS, V202, P282, DOI 10.1086/653484; Kamath AT, 1999, INFECT IMMUN, V67, P1702; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Keane FM, 2007, BIOCHEMISTRY-US, V46, P7226, DOI 10.1021/bi700454x; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Kuo CJ, 2012, J BIOL CHEM, V287, P1892, DOI 10.1074/jbc.M111.298687; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2011, J BIOL CHEM, V286, P3957, DOI 10.1074/jbc.M110.184523; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Mamat B, 2002, PROTEIN SCI, V11, P2168, DOI 10.1110/ps.0211002; Middleton AM, 2002, TUBERCULOSIS, V82, P69, DOI 10.1054/tube.2002.0324; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Naito M, 1998, J BIOL CHEM, V273, P2905, DOI 10.1074/jbc.273.5.2905; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; RATLIFF TL, 1993, INFECT IMMUN, V61, P1889, DOI 10.1128/IAI.61.5.1889-1894.1993; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Santos R, 2001, MOL PLANT MICROBE IN, V14, P758, DOI 10.1094/MPMI.2001.14.6.758; Sato F, 2007, J MOL BIOL, V369, P841, DOI 10.1016/j.jmb.2007.03.060; SCHOREY JS, 1995, INFECT IMMUN, V63, P2652, DOI 10.1128/IAI.63.7.2652-2657.1995; Schorey JS, 1996, MOL MICROBIOL, V21, P321, DOI 10.1046/j.1365-2958.1996.6381353.x; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Secott TE, 2001, INFECT IMMUN, V69, P2075, DOI 10.1128/IAI.69.4.2075-2082.2001; Shima S, 2000, J MOL BIOL, V300, P935, DOI 10.1006/jmbi.2000.3909; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; STARCHER BC, 1986, THORAX, V41, P577, DOI 10.1136/thx.41.8.577; Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i; Tiruviluamala P, 2002, ANNU REV PUBL HEALTH, V23, P403, DOI 10.1146/annurev.publhealth.23.100901.140519; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; Vannberg FO, 2011, IMMUNOL REV, V240, P105, DOI 10.1111/j.1600-065X.2010.00996.x; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; Verly RM, 2009, BIOPHYS J, V96, P2194, DOI 10.1016/j.bpj.2008.11.063; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Zhao WC, 1999, J BIOL CHEM, V274, P4521, DOI 10.1074/jbc.274.8.4521	58	28	32	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3886	3896		10.1074/jbc.M112.415679	http://dx.doi.org/10.1074/jbc.M112.415679			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23250738	hybrid, Green Published			2022-12-28	WOS:000314845000019
J	Lowry, JL; Brovkovych, V; Zhang, YK; Skidgel, RA				Lowry, Jessica L.; Brovkovych, Viktor; Zhang, Yongkang; Skidgel, Randal A.			Endothelial Nitric-oxide Synthase Activation Generates an Inducible Nitric-oxide Synthase-like Output of Nitric Oxide in Inflamed Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; HETEROTRIMERIC G-PROTEINS; CELL-MIGRATION; POSTTRANSLATIONAL ACTIVATION; DEPENDENT ACTIVATION; CARBOXYPEPTIDASE-M; S-NITROSYLATION; CONTROL ELEMENT; BRADYKININ B-1; KININASE-I	High levels of NO generated in the vasculature under inflammatory conditions are usually attributed to inducible nitric-oxide synthase (iNOS), but the role of the constitutively expressed endothelial NOS (eNOS) is unclear. In normal human lung microvascular endothelial cells (HLMVEC), bradykinin (BK) activates kinin B2 receptor (B2R) signaling that results in Ca2+ dependent activation of eNOS and transient NO. In inflamed HLMVEC(pretreated with interleukin-1 beta and interferon-gamma), we found enhanced binding of eNOS to calcium-calmodulin at basal Ca2+ levels, thereby increasing its basal activity that was dependent on extracellular L-Arg. Furthermore, B2R stimulation generated prolonged high output eNOS-derived NO that is independent of increased intracellular Ca2+ and is mediated by a novel G alpha(i)-, MEK1/2-, and JNK1/2-dependent pathway. This high output NO stimulated with BK was blocked with a B2R antagonist, eNOS siRNA, or eNOS inhibitor but not iNOS inhibitor. Moreover, B2R-mediated NO production and JNK phosphorylation were inhibited with MEK1/2 and JNK inhibitors or MEK1/2 and JNK1/2 siRNA but not with ERK1/2 inhibitor. BK induced Ca2+-dependent eNOS phosphorylation at Ser(1177), Thr(495), and Ser(114) in cytokine-treated HLMVEC, but these modifications were not dependent on JNK1/2 activation and were not responsible for prolonged NO output. Cytokine treatment did not alter the expression of B2R, G alpha(q/11), G(alpha i1,2), JNK, or eNOS. B2R activation in control endothelial cells enhanced migration, but in cytokine-treated HLMVEC it reduced migration. Both responses were NO-dependent. Understanding how JNK regulates prolonged eNOS-derived NO may provide new therapeutic targets for the treatment of disorders involving vascular inflammation.	[Lowry, Jessica L.; Brovkovych, Viktor; Zhang, Yongkang; Skidgel, Randal A.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Skidgel, Randal A.] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Skidgel, RA (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol Mc 868, 835 S Wolcott, Chicago, IL 60612 USA.	rskidgel@uic.edu			National Institutes of Health [PO1 HL60678, T32 HL072742, RO1 HL36473]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072742, R01HL036473, T32HL007829, P01HL060678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL60678, T32 HL072742, and RO1 HL36473.; Recipient of a predoctoral fellowship from the American Heart Association.	Adler V, 2005, BIOCHEMISTRY-US, V44, P10784, DOI 10.1021/bi050619j; Adomeit A, 1999, MOL CELL BIOL, V19, P5289; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Albrecht EWJA, 2003, J PATHOL, V199, P8, DOI 10.1002/path.1250; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bachetti T, 2004, J MOL CELL CARDIOL, V37, P939, DOI 10.1016/j.yjmcc.2004.07.006; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bellamy TC, 2002, J BIOL CHEM, V277, P31801, DOI 10.1074/jbc.M205936200; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Blaukat A, 2000, MOL CELL BIOL, V20, P6837, DOI 10.1128/MCB.20.18.6837-6848.2000; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Brovkovych V, 1999, J PHARMACEUT BIOMED, V19, P135, DOI 10.1016/S0731-7085(98)00090-9; Brovkovych V, 2011, J CELL MOL MED, V15, P258, DOI 10.1111/j.1582-4934.2009.00992.x; Casanello P, 2009, PLACENTA, V30, P625, DOI 10.1016/j.placenta.2009.04.010; Chan GC, 2005, J IMMUNOL, V175, P3846, DOI 10.4049/jimmunol.175.6.3846; Chatterjee A, 2008, VASC PHARMACOL, V49, P134, DOI 10.1016/j.vph.2008.06.008; Chen PF, 2003, J BIOL CHEM, V278, P52392, DOI 10.1074/jbc.M305469200; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Cirino G, 2003, TRENDS PHARMACOL SCI, V24, P91, DOI 10.1016/S0165-6147(02)00049-4; Closs EI, 2000, MOL PHARMACOL, V57, P68; Closs EI, 2002, CURR OPIN NEPHROL HY, V11, P99, DOI 10.1097/00041552-200201000-00015; Cooke JP, 1997, CIRCULATION, V96, P379; Coso OA, 1996, J BIOL CHEM, V271, P3963; DRAPEAU G, 1988, EUR J PHARMACOL, V155, P193, DOI 10.1016/0014-2999(88)90423-2; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Engstrom W, 2010, CELL PROLIFERAT, V43, P56, DOI 10.1111/j.1365-2184.2009.00654.x; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 2008, CIRC RES, V102, P497, DOI 10.1161/CIRCRESAHA.107.162933; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Griffiths C, 2001, J PHYSIOL-LONDON, V536, P855, DOI 10.1111/j.1469-7793.2001.00855.x; Gross ND, 2007, CLIN CANCER RES, V13, P5910, DOI 10.1158/1078-0432.CCR-07-0352; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Hill BG, 2010, J BIOL CHEM, V285, P19699, DOI 10.1074/jbc.R110.101618; Ignjatovic T., 2001, MOL PHARM, V66, P1310; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Knudsen GM, 2003, J BIOL CHEM, V278, P31814, DOI 10.1074/jbc.M303267200; Koika V, 2010, VASC PHARMACOL, V53, P215, DOI 10.1016/j.vph.2010.08.004; Kubes Pal, 1995, Microcirculation (New York), V2, P235, DOI 10.3109/10739689509146769; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; Kuhr FK, 2010, FASEB J, V24, P2475, DOI 10.1096/fj.09-148783; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lancaster JR, 2006, CHEM RES TOXICOL, V19, P1160, DOI 10.1021/tx060061w; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liesmaa I, 2009, J CELL PHYSIOL, V221, P359, DOI 10.1002/jcp.21861; Luhrs H, 2002, RESP PHYSIOL, V129, P367, DOI 10.1016/S0034-5687(01)00323-1; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005; Morais C, 2012, AM J PATHOL, V180, P1702, DOI 10.1016/j.ajpath.2011.12.018; Neumann P, 2006, AM J PHYSIOL-LUNG C, V290, pL674, DOI 10.1152/ajplung.00391.2005; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Papapetropoulos A, 1999, CARDIOVASC RES, V43, P509, DOI 10.1016/S0008-6363(99)00161-3; Park JH, 2012, BIOCHEM BIOPH RES CO, V417, P340, DOI 10.1016/j.bbrc.2011.11.112; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Ramadoss J, 2012, HYPERTENSION, V59, P1052, DOI 10.1161/HYPERTENSIONAHA.111.189498; Ruan L, 2011, ARTERIOSCL THROM VAS, V31, P392, DOI 10.1161/ATVBAHA.110.213181; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; Sangsree S, 2003, AM J PHYSIOL-HEART C, V284, pH1959, DOI 10.1152/ajpheart.00036.2003; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Siddiqui MR, 2011, J CELL BIOL, V193, P841, DOI 10.1083/jcb.201012129; Skidgel RA, 2002, AM J PHYSIOL-LUNG C, V282, pL1179, DOI 10.1152/ajplung.00045.2002; Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361; Soneja A, 2005, PHARMACOL REP, V57, P108; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Ussar S, 2004, J BIOL CHEM, V279, P43861, DOI 10.1074/jbc.M406240200; Venema RC, 2002, INT IMMUNOPHARMACOL, V2, P1755, DOI 10.1016/S1567-5769(02)00185-6; Villanueva C, 2010, FREE RADICAL BIO MED, V49, P307, DOI 10.1016/j.freeradbiomed.2010.04.004; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; Wu F, 2009, CARDIOVASC RES, V81, P38, DOI 10.1093/cvr/cvn246; Xiao ZH, 2011, J BIOL CHEM, V286, P20100, DOI 10.1074/jbc.M111.220236; Yamauchi J, 2000, J BIOL CHEM, V275, P7633, DOI 10.1074/jbc.275.11.7633; Yuan SY, 2000, MICROCIRCULATION, V7, P395; Zamora R, 2000, MOL MED, V6, P347, DOI 10.1007/BF03401781; Zhang XM, 2008, J BIOL CHEM, V283, P7994, DOI 10.1074/jbc.M709837200; Zhang XM, 2011, J BIOL CHEM, V286, P18547, DOI 10.1074/jbc.M110.214940; Zhang YP, 2007, AM J RESP CELL MOL, V36, P697, DOI 10.1165/rcmb.2005-0369OC; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200; Zimmerman B, 2011, CELL SIGNAL, V23, P648, DOI 10.1016/j.cellsig.2010.11.016	91	40	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4174	4193		10.1074/jbc.M112.436022	http://dx.doi.org/10.1074/jbc.M112.436022			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23255592	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000314845000045
J	Ozyamak, E; Kollman, J; Agard, DA; Komeili, A				Ozyamak, Ertan; Kollman, Justin; Agard, David A.; Komeili, Arash			The Bacterial Actin MamK IN VITRO ASSEMBLY BEHAVIOR AND FILAMENT ARCHITECTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DYNAMIC INSTABILITY; BACILLUS-SUBTILIS; MAGNETOSOME FORMATION; MOLECULAR-MECHANISMS; ELECTRON-MICROSCOPY; HELICAL FILAMENTS; UPTAKE SYSTEM; PROTEIN MAMK; CELL-SHAPE	It is now recognized that actin-like proteins are widespread in bacteria and, in contrast to eukaryotic actins, are highly diverse in sequence and function. The bacterial actin, MamK, represents a clade, primarily found in magnetotactic bacteria, that is involved in the proper organization of subcellular organelles, termed magnetosomes. We have previously shown that MamK from Magnetospirillum magneticum AMB-1 (AMB-1) forms dynamic filaments in vivo. To gain further insights into the molecular mechanisms that underlie MamK dynamics and function, we have now studied the in vitro properties of MamK. We demonstrate that MamK is an ATPase that, in the presence of ATP, assembles rapidly into filaments that disassemble once ATP is depleted. The mutation of a conserved active site residue (E143A) abolishes ATPase activity of MamK but not its ability to form filaments. Filament disassembly depends on both ATPase activity and potassium levels, the latter of which results in the organization of MamK filaments into bundles. These data are consistent with observations indicating that accessory factors are required to promote filament disassembly and for spatial organization of filaments in vivo. We also used cryo-electron microscopy to obtain a high resolution structure of MamK filaments. MamK adopts a two-stranded helical filament architecture, but unlike eukaryotic actin and other actin-like filaments, subunits in MamK strands are unstaggered giving rise to a unique filament architecture. Beyond extending our knowledge of the properties and function of MamK in magnetotactic bacteria, this study emphasizes the functional and structural diversity of bacterial actins in general.	[Ozyamak, Ertan; Komeili, Arash] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Kollman, Justin] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; McGill University; University of California System; University of California San Francisco	Komeili, A (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 261 Koshland Hall, Berkeley, CA 94720 USA.	komeili@berkeley.edu		Ozyamak, Ertan/0000-0002-4081-1268	National Institutes of Health [R01GM084122, GM031627]; Howard Hughes Medical Institute grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084122, R01GM031627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute grant(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM084122 (to A. K.) and GM031627 (to D. A. A.). This work was also supported by a Howard Hughes Medical Institute grant (to D. A. A.).	ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Bean GJ, 2008, BIOCHEMISTRY-US, V47, P826, DOI 10.1021/bi701538e; Behrmann E, 2012, J STRUCT BIOL, V177, P302, DOI 10.1016/j.jsb.2011.12.020; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Draper O, 2011, MOL MICROBIOL, V82, P342, DOI 10.1111/j.1365-2958.2011.07815.x; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; EPSTEIN W, 1965, J GEN PHYSIOL, V49, P221, DOI 10.1085/jgp.49.2.221; Esue O, 2006, J BACTERIOL, V188, P968, DOI 10.1128/JB.188.3.968-976.2006; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frank J., 1996, 3 DIMENSIONAL ELECT, P1; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Galkin VE, 2009, STRUCTURE, V17, P1253, DOI 10.1016/j.str.2009.07.008; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Ingerson-Mahar M, 2012, FEMS MICROBIOL REV, V36, P256, DOI 10.1111/j.1574-6976.2011.00316.x; JAHNS T, 1994, ARCH MICROBIOL, V161, P207, DOI 10.1007/s002030050043; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katzmann E, 2011, MOL MICROBIOL, V82, P1316, DOI 10.1111/j.1365-2958.2011.07874.x; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Komeili A, 2012, FEMS MICROBIOL REV, V36, P232, DOI 10.1111/j.1574-6976.2011.00315.x; KROLL RG, 1983, BIOCHEM J, V216, P709, DOI 10.1042/bj2160709; Lopez D, 2009, P NATL ACAD SCI USA, V106, P280, DOI 10.1073/pnas.0810940106; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; LUSK JE, 1968, J BIOL CHEM, V243, P2618; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; MICHELS M, 1987, J BACTERIOL, V169, P4335, DOI 10.1128/jb.169.9.4335-4341.1987; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; NISHIDA E, 1983, J BIOCHEM-TOKYO, V93, P1011, DOI 10.1093/oxfordjournals.jbchem.a134224; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Popp D, 2012, J BIOL CHEM, V287, P21121, DOI 10.1074/jbc.M112.341016; Popp D, 2010, J BIOL CHEM, V285, P10130, DOI 10.1074/jbc.M109.071613; Rioux JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009151; Rivera CR, 2011, J BIOL CHEM, V286, P14282, DOI 10.1074/jbc.M110.203828; Roe AJ, 2000, MOL MICROBIOL, V35, P1235, DOI 10.1046/j.1365-2958.2000.01793.x; Roeben A, 2006, J MOL BIOL, V358, P145, DOI 10.1016/j.jmb.2006.01.096; Rosen B. P., 1987, ION TRANSPORT PROKAR, P85; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Salje J, 2010, NAT REV MICROBIOL, V8, P683, DOI 10.1038/nrmicro2425; Shaevitz JW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000364; SHETERLINE P, 1995, PROTEIN PROFILE, V2, P1; Sonkaria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034189; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Taoka A, 2007, J BACTERIOL, V189, P8737, DOI 10.1128/JB.00899-07; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wen KK, 2002, J BIOL CHEM, V277, P41101, DOI 10.1074/jbc.M204025200; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2521, DOI 10.1099/00221287-136-12-2521	70	48	49	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4265	4277		10.1074/jbc.M112.417030	http://dx.doi.org/10.1074/jbc.M112.417030			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23204522	hybrid, Green Published			2022-12-28	WOS:000314845000055
J	Dou, ZC; Coppens, I; Carruthers, VB				Dou, Zhicheng; Coppens, Isabelle; Carruthers, Vern B.			Non-canonical Maturation of Two Papain-family Proteases in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL CYSTEINE PROTEASES; PLASMODIUM-FALCIPARUM; CATHEPSIN-B; MALARIA PARASITES; PROCATHEPSIN-B; PROTEINASE-INHIBITORS; PROTEOMIC ANALYSIS; CELL INVASION; SECRETION; DEGRADATION	Proteases regulate key events during infection by the pervasive intracellular parasite Toxoplasma gondii. Understanding how parasite proteases mature from an inactive zymogen to an active enzyme is expected to inform new strategies for blocking their actions. Herein, we show that T. gondii cathepsin B protease (TgCPB) does not undergo self-maturation but instead requires the expression of a second papain-family cathepsin protease, TgCPL. Using recombinant enzymes we also show that TgCPL is capable of partially maturing TgCPB in vitro. Consistent with this interrelationship, antibodies with validated specificity detected TgCPB in the lysosome-like vacuolar compartment along with TgCPL. Our findings also establish that TgCPB does not localize to the rhoptries as previously reported. Accordingly, rhoptry morphology and rhoptry protein maturation are normal in TgCPB knock-out parasites. Finally, we show that although maturation of TgCPL is independent of TgCPB, it may involve an additional protease(s) in conjunction with self-maturation.	[Dou, Zhicheng; Carruthers, Vern B.] Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USA; [Coppens, Isabelle] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Coppens, Isabelle] Malaria Res Inst, Baltimore, MD 21205 USA	University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Carruthers, VB (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Sch Med, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	vcarruth@umich.edu		Carruthers, Vern/0000-0001-6859-8895	National Institutes of Health [AI063263]; American Heart Association Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI063263 (to V. B. C.). This work was also supported by an American Heart Association Postdoctoral Fellowship (to Z. D.).	BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Brydges SD, 2008, BIOL CELL, V100, P253, DOI 10.1042/BC20070076; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; DLUZEWSKI AR, 1986, EXP PARASITOL, V62, P416, DOI 10.1016/0014-4894(86)90050-0; Donnelly S, 2011, ADV EXP MED BIOL, V712, P192, DOI 10.1007/978-1-4419-8414-2_12; Dou ZC, 2011, ADV EXP MED BIOL, V712, P49, DOI 10.1007/978-1-4419-8414-2_4; Eksi S, 2004, MOL MICROBIOL, V53, P243, DOI 10.1111/j.1365-2958.2004.04108.x; Fachado A, 1997, MEM I OSWALDO CRUZ, V92, P589, DOI 10.1590/S0074-02761997000500005; Fagarasanu A, 2007, CURR OPIN MICROBIOL, V10, P528, DOI 10.1016/j.mib.2007.10.002; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kasper LH, 1998, PARASITOL TODAY, V14, P150, DOI 10.1016/S0169-4758(97)01212-X; Kirschke H, 1998, LYSOSOMAL CYSTEINE P, P131; Larson ET, 2009, J BIOL CHEM, V284, P26839, DOI 10.1074/jbc.M109.003780; MACH L, 1993, BIOCHEM J, V293, P437, DOI 10.1042/bj2930437; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; O'Brien TC, 2008, J BIOL CHEM, V283, P28934, DOI 10.1074/jbc.M805824200; Parussini F, 2010, MOL MICROBIOL, V76, P1340, DOI 10.1111/j.1365-2958.2010.07181.x; PFEFFERKORN ER, 1976, EXP PARASITOL, V36, P365, DOI 10.1016/0014-4894(76)90040-0; Pungercar JR, 2009, FEBS J, V276, P660, DOI 10.1111/j.1742-4658.2008.06815.x; Que XC, 2004, INFECT IMMUN, V72, P2915, DOI 10.1128/IAI.72.5.2915-2921.2004; Que XC, 2002, J BIOL CHEM, V277, P25791, DOI 10.1074/jbc.M202659200; Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3; ROSENTHAL PJ, 1995, EXP PARASITOL, V80, P272, DOI 10.1006/expr.1995.1033; ROSENTHAL PJ, 1989, MOL BIOCHEM PARASIT, V35, P177, DOI 10.1016/0166-6851(89)90120-5; Rosenthal PJ, 1996, ANTIMICROB AGENTS CH, V40, P1600, DOI 10.1128/AAC.40.7.1600; ROSENTHAL PJ, 1991, J CLIN INVEST, V88, P1467, DOI 10.1172/JCI115456; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; ROWAN AD, 1992, J BIOL CHEM, V267, P15993; Sabin AB, 1941, J AMER MED ASSOC, V116, P801, DOI 10.1001/jama.1941.02820090001001; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P8721, DOI 10.1073/pnas.0402738101; Teo CF, 2007, ANTIMICROB AGENTS CH, V51, P679, DOI 10.1128/AAC.01059-06; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; Zhou XW, 2004, MOL CELL PROTEOMICS, V3, P565, DOI 10.1074/mcp.M300123-MCP200	44	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3523	3534		10.1074/jbc.M112.443697	http://dx.doi.org/10.1074/jbc.M112.443697			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250753	hybrid, Green Published			2022-12-28	WOS:000314397900057
J	Hachiro, T; Yamamoto, T; Nakano, K; Tanaka, K				Hachiro, Takeru; Yamamoto, Takaharu; Nakano, Kenji; Tanaka, Kazuma			Phospholipid Flippases Lem3p-Dnf1p and Lem3p-Dnf2p Are Involved in the Sorting of the Tryptophan Permease Tat2p in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; P-TYPE ATPASES; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; AMINOPHOSPHOLIPID FLIPPASES; PREVACUOLAR COMPARTMENT; ACTIN CYTOSKELETON; SECRETORY VESICLES; POLARIZED GROWTH; BINDING-PROTEINS	The type 4 P-type ATPases are flippases that generate phospholipid asymmetry in membranes. In budding yeast, heteromeric flippases, including Lem3p-Dnf1p and Lem3p-Dnf2p, translocate phospholipids to the cytoplasmic leaflet of membranes. Here, we report that Lem3p-Dnf1/2p are involved in transport of the tryptophan permease Tat2p to the plasma membrane. The lem3 Delta mutant exhibited a tryptophan requirement due to the mislocalization of Tat2p to intracellular membranes. Tat2p was relocalized to the plasma membrane when trans-Golgi network (TGN)-to-endosome transport was inhibited. Inhibition of ubiquitination by mutations in ubiquitination machinery also rerouted Tat2p to the plasma membrane. Lem3p-Dnf1/2p are localized to endosomal/TGN membranes in addition to the plasma membrane. Endocytosis mutants, in which Lem3p-Dnf1/2p are sequestered to the plasma membrane, also exhibited the ubiquitination-dependent missorting of Tat2p. These results suggest that Tat2p is ubiquitinated at the TGN and missorted to the vacuolar pathway in the lem3 Delta mutant. The NH2-terminal cytoplasmic region of Tat2p containing ubiquitination acceptor lysines interacted with liposomes containing acidic phospholipids, including phosphatidylserine. This interaction was abrogated by alanine substitution mutations in the basic amino acids downstream of the ubiquitination sites. Interestingly, a mutant Tat2p containing these substitutions was missorted in a ubiquitination-dependent manner. We propose the following model based on these results; Tat2p is not ubiquitinated when the NH2-terminal region is bound to membrane phospholipids, but if it dissociates from the membrane due to a low level of phosphatidylserine caused by perturbation of phospholipid asymmetry in the lem3 Delta mutant, Tat2p is ubiquitinated and then transported from the TGN to the vacuole.	[Hachiro, Takeru; Yamamoto, Takaharu; Nakano, Kenji; Tanaka, Kazuma] Hokkaido Univ, Div Mol Interact, Inst Med Genet, Grad Sch Life Sci,Kita Ku, Sapporo, Hokkaido 0600815, Japan	Hokkaido University	Tanaka, K (corresponding author), Hokkaido Univ, Div Mol Interact, Inst Med Genet, Grad Sch Life Sci,Kita Ku, N15 W7, Sapporo, Hokkaido 0600815, Japan.	k-tanaka@igm.hokudai.ac.jp	Tanaka, Kazuma/A-4240-2012		Japan Society for the Promotion of Science KAKENHI [21570192, 21370085]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 21570192 and 21370085.	Abe F, 2000, MOL CELL BIOL, V20, P8093, DOI 10.1128/MCB.20.21.8093-8102.2000; Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bauer BE, 2003, EUR J BIOCHEM, V270, P3189, DOI 10.1046/j.1432-1033.2003.03701.x; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Bensen ES, 2000, GENETICS, V154, P83; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Brachmann CB, 1998, YEAST, V14, P115; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Das A, 2012, NAT CELL BIOL, V14, P304, DOI 10.1038/ncb2444; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gerrard SR, 2000, TRAFFIC, V1, P259, DOI 10.1034/j.1600-0854.2000.010308.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Guo Y, 2010, J BIOL CHEM, V285, P39564, DOI 10.1074/jbc.M110.177055; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; HEITMAN J, 1993, MOL CELL BIOL, V13, P5010, DOI 10.1128/MCB.13.8.5010; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jacquot A, 2012, J BIOL CHEM, V287, P13249, DOI 10.1074/jbc.M111.313916; JONES EW, 1982, GENETICS, V102, P665; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kikyo M, 1999, ONCOGENE, V18, P7046, DOI 10.1038/sj.onc.1203184; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Liu K, 2007, MOL BIOL CELL, V18, P487, DOI 10.1091/mbc.E06-07-0592; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Misu K, 2003, MOL BIOL CELL, V14, P730, DOI 10.1091/mbc.E02-06-0314; Mochida J, 2002, GENETICS, V160, P923; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Nagayama A, 2004, EXTREMOPHILES, V8, P143, DOI 10.1007/s00792-003-0373-0; Nakamura H, 2000, BIOSCI BIOTECH BIOCH, V64, P167, DOI 10.1271/bbb.64.167; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; NOTHWEHR SF, 1995, J CELL BIOL, V129, P35, DOI 10.1083/jcb.129.1.35; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Risinger AL, 2008, MOL BIOL CELL, V19, P2962, DOI 10.1091/mbc.E07-06-0627; Rodriguez-Vargas S, 2007, APPL ENVIRON MICROB, V73, P110, DOI 10.1128/AEM.01360-06; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Saito K, 2007, DEV CELL, V13, P743, DOI 10.1016/j.devcel.2007.09.014; SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Stevens HC, 2008, J BIOL CHEM, V283, P35060, DOI 10.1074/jbc.M802379200; Surma MA, 2012, BBA-MOL CELL BIOL L, V1821, P1059, DOI 10.1016/j.bbalip.2011.12.008; Takagi K, 2012, BIOCHEM BIOPH RES CO, V417, P490, DOI 10.1016/j.bbrc.2011.11.147; Takahashi Y, 2011, J BIOCHEM, V149, P423, DOI 10.1093/jb/mvq155; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tang HY, 1997, MOL CELL BIOL, V17, P4294, DOI 10.1128/MCB.17.8.4294; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; Vaduva G, 1997, J CELL BIOL, V139, P1821, DOI 10.1083/jcb.139.7.1821; Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; ZUBENKO GS, 1982, GENETICS, V102, P679; [No title captured]	78	29	30	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3594	3608		10.1074/jbc.M112.416263	http://dx.doi.org/10.1074/jbc.M112.416263			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250744	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000314397900064
J	Jin, ES; Sherry, AD; Malloy, CR				Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.			Evidence for Transaldolase Activity in the Isolated Heart Supplied with [U-C-13(3)]Glycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTOSE-PHOSPHATE PATHWAY; WORKING RAT-HEART; EXTRACELLULAR GLYCEROL; OXIDATIVE STRESS; PLASMA-GLUCOSE; ACID CYCLE; GLUCONEOGENESIS; FAILURE; FLUX; METABOLISM	Studies of glycerol metabolism in the heart have largely emphasized its role in triglyceride synthesis. However, glycerol may also be oxidized in the citric acid cycle, and glycogen synthesis from glycerol has been reported in the nonmammalian myocardium. The intent of this study was to test the hypothesis that glycerol may be metabolized to glycogen in mammalian heart. Isolated rat hearts were supplied with a mixture of substrates including glucose, lactate, pyruvate, octanoate, [U-C-13(3)]glycerol, and (H2O)-H-2 to probe various metabolic pathways including glycerol oxidation, glycolysis, the pentose phosphate pathway, and carbon sources of stored glycogen. NMR analysis confirmed that glycogen production from the level of the citric acid cycle did not occur and that the glycerol contribution to oxidation in the citric acid cycle was negligible in the presence of alternative substrates. Quite unexpectedly, C-13 from [U-C-13(3)]glycerol appeared in glycogen in carbon positions 4-6 of glucosyl units but none in positions 1-3. The extent of [4,5,6-C-13(3)]glucosyl unit enrichment in glycogen was enhanced by insulin but decreased by H2O2. Given that triose phosphate isomerase is generally assumed to fully equilibrate carbon tracers in the triose pool, the marked C-13 asymmetry in glycogen can only be attributed to conversion of [U-C-13(3)]glycerol to [U-C-13(3)]dihydroxyacetone phosphate and [U-C-13(3)]glyceraldehyde 3-phosphate followed by rearrangements in the nonoxidative branch of the pentose phosphate pathway involving transaldolase that places this C-13-enriched 3-carbon unit only in the bottom half of hexose phosphate molecules contributing to glycogen.	[Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Jin, Eunsook S.; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Sherry, A. Dean; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Sherry, A. Dean] Univ Texas Dallas, Dept Chem, Richardson, TX 75080 USA; [Malloy, Craig R.] Vet Affairs N Texas Hlth Care Syst, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Jin, ES (corresponding author), Adv Imaging Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eunsook.jin@utsouthwestern.edu	Sherry, Dean/P-2348-2018	Sherry, Dean/0000-0001-7150-8301; Malloy, Craig/0000-0001-5077-0642	National Institutes of Health [K01-DK078933, RR-02584, HL-34557]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034557, R37HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078933, P01DK058398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported, in whole or in part, by National Institutes of Health Grants K01-DK078933 (to E. S. J.), RR-02584 (to C. R. M.), and HL-34557 (to A. D. S.).	Banki K, 1996, J BIOL CHEM, V271, P32994, DOI 10.1074/jbc.271.51.32994; Basu R, 2009, DIABETES, V58, P1539, DOI 10.2337/db08-1300; BELCH JJF, 1991, BRIT HEART J, V65, P245; Bock G, 2008, DIABETES, V57, P50, DOI 10.2337/db07-0694; Brito NA, 2008, AM J PHYSIOL-REG I, V294, pR1445, DOI 10.1152/ajpregu.00068.2008; BURNS AH, 1977, AM J PHYSIOL, V232, pE570, DOI 10.1152/ajpendo.1977.232.6.E570; Chandramouli V, 1999, AM J PHYSIOL-ENDOC M, V277, pE717, DOI 10.1152/ajpendo.1999.277.4.E717; Davis SN, 2000, J CLIN ENDOCR METAB, V85, P224, DOI 10.1210/jc.85.1.224; DRAKE AJ, 1980, CARDIOVASC RES, V14, P65, DOI 10.1093/cvr/14.2.65; Gambert S, 2005, BBA-MOL CELL BIOL L, V1736, P152, DOI 10.1016/j.bbalip.2005.08.004; Gambert S, 2007, AM J PHYSIOL-HEART C, V292, pH1600, DOI 10.1152/ajpheart.00563.2006; Goodwin GW, 2001, AM J PHYSIOL-ENDOC M, V280, pE502, DOI 10.1152/ajpendo.2001.280.3.E502; Hill MF, 1996, AM J PATHOL, V148, P291; James H M, 1985, Int J Vitam Nutr Res Suppl, V28, P29; Jin ES, 2005, AM J PHYSIOL-ENDOC M, V288, pE654, DOI 10.1152/ajpendo.00365.2004; Jin ES, 2009, AM J PHYSIOL-ENDOC M, V296, pE748, DOI 10.1152/ajpendo.90935.2008; Jones JG, 2000, ANAL BIOCHEM, V277, P121, DOI 10.1006/abio.1999.4391; Jones JG, 2008, MAGN RESON MED, V59, P423, DOI 10.1002/mrm.21451; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; LJUNGDAHL L, 1961, J BIOL CHEM, V236, P1622; MALAISSE WJ, 1990, MOL CELL BIOCHEM, V93, P153; Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536; MALLOY CR, 1988, J BIOL CHEM, V263, P6964; Massicotte D, 2006, EUR J APPL PHYSIOL, V96, P322, DOI 10.1007/s00421-005-0058-8; Perl A, 2011, TRENDS MOL MED, V17, P395, DOI 10.1016/j.molmed.2011.01.014; PFEIFER R, 1986, BIOL CHEM H-S, V367, P1061, DOI 10.1515/bchm3.1986.367.2.1061; REMESY C, 1983, ANN NUTR METAB, V27, P57, DOI 10.1159/000176624; ROBINSON J, 1969, BIOCHEM J, V112, P449, DOI 10.1042/bj1120449; SAVINA MV, 1977, COMP BIOCHEM PHYS B, V57, P185, DOI 10.1016/0305-0491(77)90141-9; TAEGTMEYER H, 1984, BASIC RES CARDIOL, V79, P322, DOI 10.1007/BF01908033; van der Merwe MT, 2001, J CLIN ENDOCR METAB, V86, P3296, DOI 10.1210/jc.86.7.3296; van Rosendal SP, 2009, NUTR REV, V67, P690, DOI 10.1111/j.1753-4887.2009.00254.x; Verhoeven NM, 2005, J INHERIT METAB DIS, V28, P169, DOI 10.1007/s10545-005-5261-6	34	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2914	2922		10.1074/jbc.M112.409441	http://dx.doi.org/10.1074/jbc.M112.409441			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235149	hybrid, Green Published			2022-12-28	WOS:000314397900002
J	Scaringi, R; Piccoli, M; Papini, N; Cirillo, F; Conforti, E; Bergante, S; Tringali, C; Garatti, A; Gelfi, C; Venerando, B; Menicanti, L; Tettamanti, G; Anastasia, L				Scaringi, Raffaella; Piccoli, Marco; Papini, Nadia; Cirillo, Federica; Conforti, Erika; Bergante, Sonia; Tringali, Cristina; Garatti, Andrea; Gelfi, Cecilia; Venerando, Bruno; Menicanti, Lorenzo; Tettamanti, Guido; Anastasia, Luigi			NEU3 Sialidase Is Activated under Hypoxia and Protects Skeletal Muscle Cells from Apoptosis through the Activation of the Epidermal Growth Factor Receptor Signaling Pathway and the Hypoxia-inducible Factor (HIF)-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; GANGLIOSIDE SIALIDASE; TRANSCRIPTION FACTORS; MOLECULAR-CLONING; EGF RECEPTOR; DIFFERENTIATION; EXPRESSION; THERAPY; CANCER; OXYGEN	NEU3 sialidase, a key enzyme in ganglioside metabolism, is activated under hypoxic conditions in cultured skeletal muscle cells (C2C12). NEU3 up-regulation stimulates the EGF receptor signaling pathway, which in turn activates the hypoxia-inducible factor (HIF-1 alpha), resulting in a final increase of cell survival and proliferation. In the same cells, stable overexpression of sialidase NEU3 significantly enhances cell resistance to hypoxia, whereas stable silencing of the enzyme renders cells more susceptible to apoptosis. These data support the working hypothesis of a physiological role played by NEU3 sialidase in protecting cells from hypoxic stress and may suggest new directions in the development of therapeutic strategies against ischemic diseases, particularly of the cerebro-cardiovascular system.	[Scaringi, Raffaella; Papini, Nadia; Bergante, Sonia; Tringali, Cristina; Gelfi, Cecilia; Venerando, Bruno; Anastasia, Luigi] Univ Milan, Dept Biomed Sci Hlth, I-20090 Milan, Italy; [Scaringi, Raffaella; Piccoli, Marco; Papini, Nadia; Cirillo, Federica; Conforti, Erika; Bergante, Sonia; Tringali, Cristina; Garatti, Andrea; Venerando, Bruno; Menicanti, Lorenzo; Tettamanti, Guido; Anastasia, Luigi] Ist Ricovero & Cura Carattere Sci Policlin San Do, Lab Stem Cells Tissue Engn, I-20097 Milan, Italy	University of Milan	Anastasia, L (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Via Flli Cervi 93, I-20090 Milan, Italy.	luigi.anastasia@unimi.it	bergante, sonia/AAI-1215-2019; Gelfi, Cecilia/L-1490-2016; Anastasia, Luigi/AAN-1964-2020; Piccoli, Marco/S-3731-2019; menicanti, lorenzo/K-5649-2018; Cirillo, Federica/ABE-3480-2020; Garatti, Andrea/K-3105-2016; Tringali, Cristina Alessandra/Q-7259-2017; papini, nadia/M-2425-2017	Gelfi, Cecilia/0000-0002-2996-6912; Anastasia, Luigi/0000-0002-0712-2161; Piccoli, Marco/0000-0002-9461-2715; menicanti, lorenzo/0000-0001-8530-6284; Cirillo, Federica/0000-0002-0196-5977; Garatti, Andrea/0000-0002-6744-1850; Tringali, Cristina Alessandra/0000-0002-0632-6197; papini, nadia/0000-0003-4066-4955; Bergante, Sonia/0000-0001-8986-0004				Anastasia L, 2008, J BIOL CHEM, V283, P36265, DOI 10.1074/jbc.M805755200; Bennewith KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-504; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Haga Y, 2008, BBA-GEN SUBJECTS, V1780, P393, DOI 10.1016/j.bbagen.2007.10.018; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Huang M, 2011, CIRCULATION, V124, pS46, DOI 10.1161/CIRCULATIONAHA.110.014019; Kanwar JR, 2011, DRUG DISCOV TODAY, V16, P485, DOI 10.1016/j.drudis.2011.04.001; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Miljan Erik A, 2002, Sci STKE, V2002, pre15, DOI 10.1126/stke.2002.160.re15; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Miyata T, 2011, AM J PHYSIOL-CELL PH, V300, pC226, DOI 10.1152/ajpcell.00430.2010; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Papini N, 2012, J CELL BIOCHEM, V113, P2967, DOI 10.1002/jcb.24174; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; Ronkainen VP, 2007, FASEB J, V21, P1821, DOI 10.1096/fj.06-7294com; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Semenza GL, 2011, AM J PHYSIOL-CELL PH, V301, pC550, DOI 10.1152/ajpcell.00176.2011; Yamaguchi K, 2010, BIOCHEM J, V430, P107, DOI 10.1042/BJ20100350; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zanchetti G, 2007, BIOCHEM J, V408, P211, DOI 10.1042/BJ20070503	26	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3153	3162		10.1074/jbc.M112.404327	http://dx.doi.org/10.1074/jbc.M112.404327			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23209287	Green Published, hybrid			2022-12-28	WOS:000314397900023
J	Barcellos, KSA; Bigarella, CL; Wagner, MV; Vieira, KP; Lazarini, M; Langford, PR; Machado-Neto, JA; Call, SG; Staley, DM; Chung, JY; Hansen, MD; Saad, STO				Barcellos, Karin S. A.; Bigarella, Carolina L.; Wagner, Mark V.; Vieira, Karla P.; Lazarini, Mariana; Langford, Peter R.; Machado-Neto, Joao A.; Call, Steven G.; Staley, Davis M.; Chung, Jarom Y.; Hansen, Marc D.; Saad, Sara T. O.			ARHGAP21 Protein, a New Partner of alpha-Tubulin Involved in Cell-Cell Adhesion Formation and Essential for Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-FAMILY GTPASES; E-CADHERIN; CATENIN EXPRESSION; BETA-CATENIN; MICROTUBULE; MIGRATION; MECHANISMS; SIGNALS; COMPLEX; GROWTH	Cell-cell adhesions and the cytoskeletons play important and coordinated roles in cell biology, including cell differentiation, development, and migration. Adhesion and cytoskeletal dynamics are regulated by Rho-GTPases. ARHGAP21 is a negative regulator of Rho-GTPases, particularly Cdc42. Here we assess the function ofARHGAP21in cell-cell adhesion, cell migration, and scattering. We find that ARHGAP21 is localized in the nucleus, cytoplasm, or perinuclear region but is transiently redistributed to cell-cell junctions 4 h after initiation of cell-cell adhesion. ARHGAP21 interacts with Cdc42, and decreased Cdc42 activity coincides with the appearance of ARHGAP21 at the cell-cell junctions. Cells lacking ARHGAP21 expression show weaker cell-cell adhesions, increased cell migration, and a diminished ability to undergo hepatocyte growth factor-induced epithelial-mesenchymal transition (EMT). In addition, ARHGAP21 interacts with alpha-tubulin, and it is essential for alpha-tubulin acetylation in EMT. Our findings indicate that ARHGAP21 is a Rho-GAP involved in cell-cell junction remodeling and that ARHGAP21 affects migration and EMT through alpha-tubulin interaction and acetylation.	[Barcellos, Karin S. A.; Bigarella, Carolina L.; Vieira, Karla P.; Lazarini, Mariana; Machado-Neto, Joao A.; Saad, Sara T. O.] Univ Estadual Campinas, Hemoctr, UNICAMP,Hematol & Hemotherapy Ctr, Inst Nacl Ciencia & Tecnol Sangue, Campinas, SP, Brazil; [Wagner, Mark V.; Call, Steven G.; Staley, Davis M.; Chung, Jarom Y.; Hansen, Marc D.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA	Universidade Estadual de Campinas; Brigham Young University	Saad, STO (corresponding author), Univ Estadual Campinas UNICAMP, Ctr Hematol & Hemoterapia, Hemoctr, Rua Carlos Chagas,480 Cidade Univ Zeferino Vaz, BR-13083970 Campinas, SP, Brazil.	sara@unicamp.br	Machado-Neto, João Agostinho/L-8975-2016	Machado-Neto, João Agostinho/0000-0002-2937-8109; Lazarini, Mariana/0000-0002-5030-7583	Instituto Nacional de Ciencia e Tecnologia do Sangue (INCT); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brigham Young University Cancer Research Center	Instituto Nacional de Ciencia e Tecnologia do Sangue (INCT); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brigham Young University Cancer Research Center	This work was supported by Instituto Nacional de Ciencia e Tecnologia do Sangue (INCT), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Fundacao de Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).; Supported by a Summer Undergraduate Research Fellowship from the Brigham Young University Cancer Research Center.	Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Bagutti C, 1998, J PATHOL, V186, P8, DOI 10.1002/(SICI)1096-9896(199809)186:1<8::AID-PATH156>3.0.CO;2-H; Basseres DS, 2002, BIOCHEM BIOPH RES CO, V294, P579; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Bigarella CL, 2009, BBA-MOL CELL RES, V1793, P806, DOI 10.1016/j.bbamcr.2009.02.010; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; El-Bahrawy M, 2002, LAB INVEST, V82, P1167, DOI 10.1097/01.LAB.0000028821.41246.6A; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; HARTMANN G, 1994, J BIOL CHEM, V269, P21936; Hehnly H, 2009, MOL BIOL CELL, V20, P4303, DOI 10.1091/mbc.E09-02-0155; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kumper S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011801; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Peck J, 2002, FEBS LETT, V528, P27, DOI 10.1016/S0014-5793(02)03331-8; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Raich WB, 1999, CURR BIOL, V9, P1139, DOI 10.1016/S0960-9822(00)80015-9; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; SHIOZAKI H, 1994, AM J PATHOL, V144, P667; Sousa S, 2005, NAT CELL BIOL, V7, P954, DOI 10.1038/ncb1308; Sperry RB, 2010, J CELL PHYSIOL, V222, P612, DOI 10.1002/jcp.21977; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; van Leenders G, 2002, PROSTATE, V51, P98, DOI 10.1002/pros.10073; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wang S, 2012, J BIOL CHEM, V287, P9804, DOI 10.1074/jbc.M111.312959; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Wynshaw-Boris A, 2009, CELL, V136, P393, DOI 10.1016/j.cell.2009.01.024	44	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2179	2189		10.1074/jbc.M112.432716	http://dx.doi.org/10.1074/jbc.M112.432716			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23235160	Green Published, hybrid			2022-12-28	WOS:000314211500008
J	Haataja, L; Snapp, E; Wright, J; Liu, M; Hardy, AB; Wheeler, MB; Markwardt, ML; Rizzo, M; Arvan, P				Haataja, Leena; Snapp, Erik; Wright, Jordan; Liu, Ming; Hardy, Alexandre B.; Wheeler, Michael B.; Markwardt, Michele L.; Rizzo, Mark; Arvan, Peter			Proinsulin Intermolecular Interactions during Secretory Trafficking in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE POLARIZATION MICROSCOPY; ZINC TRANSPORTER ZNT8; ENDOPLASMIC-RETICULUM; GLUCOSE-HOMEOSTASIS; INSULIN-SECRETION; MESSENGER-RNA; B-CELLS; PROTEIN; PATHWAY; MATURATION	Classically, exit from the endoplasmic reticulum (ER) is rate-limiting for secretory protein trafficking because protein folding/assembly occurs there. In this study, we have exploited "hPro-CpepSfGFP," a human proinsulin bearing "superfolder" green fluorescent C-peptide expressed in pancreatic beta cells where it is processed to human insulin and CpepSfGFP. Remarkably, steady-state accumulation of hPro-CpepSfGFP and endogenous proinsulin is in the Golgi region, as if final stages of protein folding/assembly were occurring there. The Golgi regional distribution of proinsulin is dynamic, influenced by fasting/refeeding, and increased with beta cell zinc deficiency. However, coexpression of ER-entrapped mutant proinsulin-C(A7) Y shifts the steady-state distribution of wild-type proinsulin to the ER. Endogenous proinsulin coprecipitates with hPro-CpepSfGFP and even more so with hProC(A7) Y-CpepSfGFP. Using Cerulean and Venus-tagged proinsulins, we find that both WT-WT and WT-mutant proinsulin pairs exhibit FRET. The data demonstrate that wild-type proinsulin dimerizes within the ER but accumulates at a poorly recognized slow step within the Golgi region, reflecting either slow kinetics of proinsulin hexamerization, steps in formation of nascent secretory granules, or other unknown molecular events. However, in the presence of ongoing misfolding of a subpopulation of proinsulin in beta cells, the rate-limiting step in transport of the remaining proinsulin shifts to the ER.	[Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabetes, Sch Med, Brehm Ctr 5112, Ann Arbor, MI 48105 USA; [Snapp, Erik] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Hardy, Alexandre B.; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Markwardt, Michele L.; Rizzo, Mark] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA	University of Michigan System; University of Michigan; Yeshiva University; Albert Einstein College of Medicine; University of Toronto; University System of Maryland; University of Maryland Baltimore	Arvan, P (corresponding author), Univ Michigan, Div Metab Endocrinol & Diabetes, Sch Med, Brehm Ctr 5112, 1000 Wall St, Ann Arbor, MI 48105 USA.	parvan@umich.edu	Wright, Jordan/AAO-4376-2021	Wright, Jordan/0000-0002-2043-0150; Wheeler, Michael B./0000-0002-7480-7267; Snapp, Erik/0000-0001-9482-2272	National Institutes of Health [R01-DK48280, R01-DK077140, R01-GM086530, R01-DK088856]; CIHR [MOP-102588]; Morphology and Image Analysis Core of the National Institutes of Health [NIH P60-DK20572]; Molecular Biology and DNA Sequencing Core of the National Institutes of Health [NIH P60-DK20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088856, R01DK048280, P60DK020572, P30DK020572, R01DK077140, F30DK095504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086530, T32GM008322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Morphology and Image Analysis Core of the National Institutes of Health; Molecular Biology and DNA Sequencing Core of the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK48280 (to P. A.), R01-DK077140 (to M. A. R.), R01-GM086530 (to E. S.), R01-DK088856 (to M. L), and CIHR MOP-102588 (to M. B. W.).; We thank ALPCO for supplying the proinsulin-specific antibody used for immunocytochemistry, Ms. Lindsey Costantini for creation of the SfVenus and SfCerulean cDNAs, and Mr. Paul Gianella for creating hPro-CpepSfGFP-KDEL. We also thank the laboratory of Dr. C. Newgard (Duke University, Durham NC) for supplying INS832/13 cells, the Morphology and Image Analysis Core and the Molecular Biology and DNA Sequencing Core of the National Institutes of Health-funded Diabetes Research Center (NIH P60-DK20572) for assistance, and Bill and Dee Brehm for helping to create the Brehm Center for Diabetes Research at the University of Michigan and their support of the Brehm Coalition.	Aronson DE, 2011, TRAFFIC, V12, P543, DOI 10.1111/j.1600-0854.2011.01168.x; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; CASTLE AM, 1992, J BIOL CHEM, V267, P13093; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; FRANK BH, 1968, BIOCHEM BIOPH RES CO, V32, P155, DOI 10.1016/0006-291X(68)90362-8; FRANK BH, 1970, BIOCHEM BIOPH RES CO, V38, P284, DOI 10.1016/0006-291X(70)90710-2; Gething M J, 1990, Semin Cell Biol, V1, P65; GIDDINGS SJ, 1981, J CLIN INVEST, V67, P952, DOI 10.1172/JCI110145; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Hodish I, 2011, DIABETES, V60, P2092, DOI 10.2337/db10-1671; Hodish I, 2010, J BIOL CHEM, V285, P685, DOI 10.1074/jbc.M109.038042; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Jain RK, 2001, BIOCHEM J, V360, P645, DOI 10.1042/0264-6021:3600645; Khoo C, 2011, ENDOCRINOLOGY, V152, P2599, DOI 10.1210/en.2010-1420; Kuliawat R, 1997, J CELL BIOL, V137, P595, DOI 10.1083/jcb.137.3.595; KULIAWAT R, 1994, J CELL BIOL, V126, P77, DOI 10.1083/jcb.126.1.77; KULIAWAT R, 1992, J CELL BIOL, V118, P521, DOI 10.1083/jcb.118.3.521; Lara-Lemus R, 2006, J CELL SCI, V119, P1833, DOI 10.1242/jcs.02905; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2012, DIABETES, V61, P828, DOI 10.2337/db11-0878; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; LODISH HF, 1988, J BIOL CHEM, V263, P2107; MALIDE D, 1995, J HISTOCHEM CYTOCHEM, V43, P11, DOI 10.1177/43.1.7822759; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; MICHAEL J, 1987, J BIOL CHEM, V262, P16531; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; ORCI L, 1985, CELL, V42, P671, DOI 10.1016/0092-8674(85)90124-2; ORCI L, 1986, J CELL BIOL, V103, P2273, DOI 10.1083/jcb.103.6.2273; ORCI L, 1984, P NATL ACAD SCI-BIOL, V81, P6743, DOI 10.1073/pnas.81.21.6743; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; Piston DW, 2008, METHOD CELL BIOL, V85, P415, DOI 10.1016/S0091-679X(08)85018-2; Rajan S, 2010, AM J PHYSIOL-ENDOC M, V298, pE403, DOI 10.1152/ajpendo.00592.2009; Rajpal G, 2012, J BIOL CHEM, V287, P43, DOI 10.1074/jbc.C111.279927; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; ROTH J, 1989, VIRCHOWS ARCH B, V56, P287; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Sempoux C, 2001, DIABETES, V50, pS172, DOI 10.2337/diabetes.50.2007.S172; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Watkins S, 2002, TRAFFIC, V3, P461, DOI 10.1034/j.1600-0854.2002.30703.x; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10299, DOI 10.1073/pnas.162352799; Zhu YL, 2004, ENDOCRINOLOGY, V145, P3840, DOI 10.1210/en.2003-1512; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	55	55	58	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1896	1906		10.1074/jbc.M112.420018	http://dx.doi.org/10.1074/jbc.M112.420018			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23223446	Green Published, hybrid			2022-12-28	WOS:000313751400043
J	Demmer, U; Warkentin, E; Srivastava, A; Kockelkorn, D; Potter, M; Marx, A; Fuchs, G; Ermler, U				Demmer, Ulrike; Warkentin, Eberhard; Srivastava, Ankita; Kockelkorn, Daniel; Poetter, Markus; Marx, Achim; Fuchs, Georg; Ermler, Ulrich			Structural Basis for a Bispecific NADP(+) and CoA Binding Site in an Archaeal Malonyl-Coenzyme A Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SEMIALDEHYDE DEHYDROGENASE; AUTOTROPHIC CARBON FIXATION; 3-HYDROXYPROPIONATE CYCLE; CHLOROFLEXUS-AURANTIACUS; ESCHERICHIA-COLI; CATALYTIC CYCLE; A REDUCTASE; SULFOLOBUS; CARBOXYLASE; INTERMEDIATE	Autotrophic members of the Sulfolobales (crenarchaeota) use the 3-hydroxypropionate/4-hydroxybutyrate cycle to assimilate CO2 into cell material. The product of the initial acetyl-CoA carboxylation with CO2, malonyl-CoA, is further reduced to malonic semialdehyde by an NADPH-dependent malonyl-CoA reductase (MCR); the enzyme also catalyzes the reduction of succinyl-CoA to succinic semialdehyde onwards in the cycle. Here, we present the crystal structure of Sulfolobus tokodaii malonyl-CoA reductase in the substrate-free state and in complex with NADP(+) and CoA. Structural analysis revealed an unexpected reaction cycle in which NADP(+) and CoA successively occupy identical binding sites. Both coenzymes are pressed into an S-shaped, nearly superimposable structure imposed by a fixed and preformed binding site. The template-governed cofactor shaping implicates the same binding site for the 3'- and 2'-ribose phosphate group of CoA and NADP(+), respectively, but a different one for the common ADP part: the beta-phosphate of CoA aligns with the alpha-phosphate of NADP(+). Evolution from an NADP(+) to a bispecific NADP(+) and CoA binding site involves many amino acid exchanges within a complex process by which constraints of the CoA structure also influence NADP(+) binding. Based on the paralogous aspartate-beta-semialdehyde dehydrogenase structurally characterized with a covalent Cys-aspartyl adduct, a malonyl/succinyl group can be reliably modeled into MCR and discussed regarding its binding mode, the malonyl/succinyl specificity, and the catalyzed reaction. The modified polypeptide surrounding around the absent ammonium group in malonate/succinate compared with aspartate provides the structural basis for engineering a methylmalonyl-CoA reductase applied for biotechnical polyester building block synthesis.	[Demmer, Ulrike; Warkentin, Eberhard; Srivastava, Ankita; Ermler, Ulrich] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Kockelkorn, Daniel; Fuchs, Georg] Univ Freiburg, Mikrobiol Inst Biol 2, D-79104 Freiburg, Germany; [Poetter, Markus; Marx, Achim] Evon Ind AG, D-45128 Essen, Germany	Max Planck Society; University of Freiburg	Ermler, U (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	ulrich.ermler@biophys.mpg.de			Deutsche Forschungsgemeinschaft [Fu 118/15-4]; Evonik Industries AG	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Evonik Industries AG	This work was supported by Deutsche Forschungsgemeinschaft (Fu 118/15-4) and Evonik Industries AG.	Alber B, 2006, J BACTERIOL, V188, P8551, DOI 10.1128/JB.00987-06; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Blanco J, 2003, P NATL ACAD SCI USA, V100, P12613, DOI 10.1073/pnas.1634958100; Burton NP, 1999, ARCH MICROBIOL, V172, P349, DOI 10.1007/s002030050771; Chuakrut S, 2003, J BACTERIOL, V185, P938, DOI 10.1128/JB.185.3.938-947.2003; Ciesla J, 2006, ACTA BIOCHIM POL, V53, P11; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evguenieva-Hackenberg E, 2002, J BIOL CHEM, V277, P46145, DOI 10.1074/jbc.M208717200; Faehnle CR, 2006, J BIOL CHEM, V281, P31031, DOI 10.1074/jbc.M605926200; Faehnle CR, 2005, J MOL BIOL, V353, P1055, DOI 10.1016/j.jmb.2005.09.027; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Hugler M, 2002, J BACTERIOL, V184, P2404, DOI 10.1128/JB.184.9.2404-2410.2002; Ishii M, 1996, ARCH MICROBIOL, V166, P368, DOI 10.1007/BF01682981; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawarabayasi Y, 2001, DNA RES, V8, P123, DOI 10.1093/dnares/8.4.123; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kockelkorn D, 2009, J BACTERIOL, V191, P6352, DOI 10.1128/JB.00794-09; Lei Y, 2008, BIOCHEMISTRY-US, V47, P6870, DOI 10.1021/bi800349k; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; Menendez C, 1999, J BACTERIOL, V181, P1088, DOI 10.1128/JB.181.4.1088-1098.1999; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NORRIS P, 1989, FEMS SYMP, V49, P24; Pejchal R, 2005, BIOCHEMISTRY-US, V44, P11447, DOI 10.1021/bi050533q; Ricagno S, 2003, EMBO J, V22, P3210, DOI 10.1093/emboj/cdg333; SKARZYNSKI T, 1987, J MOL BIOL, V193, P171, DOI 10.1016/0022-2836(87)90635-8; SMITH LT, 1980, ARCH BIOCHEM BIOPHYS, V203, P663, DOI 10.1016/0003-9861(80)90224-6; STORER AC, 1994, METHOD ENZYMOL, V244, P486; Suzuki T, 2002, EXTREMOPHILES, V6, P39, DOI 10.1007/s007920100221; Viola R. E., 2011, AMINO ACIDS, V2011; WOLODKO WT, 1994, J BIOL CHEM, V269, P10883; Zarzycki J, 2011, APPL ENVIRON MICROB, V77, P6181, DOI 10.1128/AEM.00705-11	31	15	20	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6363	6370		10.1074/jbc.M112.421263	http://dx.doi.org/10.1074/jbc.M112.421263			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23325803	hybrid, Green Published			2022-12-28	WOS:000315820700031
J	Nguyen, HM; Galea, CA; Schmunk, G; Smith, BJ; Edwards, RA; Norton, RS; Chandy, KG				Nguyen, Hai M.; Galea, Charles A.; Schmunk, Galina; Smith, Brian J.; Edwards, Robert A.; Norton, Raymond S.; Chandy, K. George			Intracellular Trafficking of the K(V)1.3 Potassium Channel Is Regulated by the Prodomain of a Matrix Metalloprotease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION PROFILE; GATED K+ CHANNELS; CYSTEINE ARRAY; FORCE-FIELD; PROTEIN; IDENTIFICATION; SUBUNIT; TISSUE; TOXIN; KV1.3	Matrix metalloproteases (MMPs) are endopeptidases that regulate diverse biological processes. Synthesized as zymogens, MMPs become active after removal of their prodomains. Much is known about the metalloprotease activity of these enzymes, but noncanonical functions are poorly defined, and functions of the prodomains have been largely ignored. Here we report a novel metalloprotease-independent, channel-modulating function for the prodomain of MMP23 (MMP23-PD). Whole-cell patch clamping and confocal microscopy, coupled with deletion analysis, demonstrate that MMP23-PD suppresses the voltage-gated potassium channel K(V)1.3, but not the closely related K(V)1.2 channel, by trapping the channel intracellularly. Studies with K(V)1.2-1.3 chimeras suggest that MMP23-PD requires the presence of the K(V)1.3 region from the S5 trans-membrane segment to the C terminus to modulate K(V)1.3 channel function. NMR studies of MMP23-PD reveal a single, kinked trans-membrane alpha-helix, joined by a short linker to a juxtamembrane alpha-helix, which is associated with the surface of the membrane and protected from exchange with the solvent. The topological similarity of MMP23-PD to KCNE1, KCNE2, and KCNE4 proteins that trap K(V)1.3, K(V)1.4, K(V)3.3, and K(V)3.4 channels early in the secretory pathway suggests a shared mechanism of channel regulation. MMP23 and K(V)1.3 expression is enhanced and overlap-ping in colorectal cancers where the interaction of the two proteins could affect cell function.	[Nguyen, Hai M.; Schmunk, Galina; Chandy, K. George] Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, Irvine, CA 92697 USA; [Edwards, Robert A.] Univ Calif Irvine, Dept Pathol, Sch Med, Irvine, CA 92697 USA; [Galea, Charles A.; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Program Med Chem, Parkville, Vic 3052, Australia; [Smith, Brian J.] La Trobe Univ, Dept Chem, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia	University of California System; University of California Irvine; University of California System; University of California Irvine; Monash University; La Trobe University	Norton, RS (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Program Med Chem, Parkville, Vic 3052, Australia.	ray.norton@monash.edu; gchandy@uci.edu	Galea, Charles/O-8800-2014; Smith, Brian J/F-8282-2011	Galea, Charles/0000-0003-2730-1105; Smith, Brian J/0000-0003-0498-1910; Norton, Raymond/0000-0001-8893-0584	National Institutes of Health [NS48252]; Australian Research Council [DP1093909]; National Institutes of Health through the NCI [P30CA062203]; Australian National Health and Medical Research Council; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS48252 (to K. G. C.). This work was also supported by the Australian Research Council (Grant DP1093909 to R. S. N., B. J. S., and K. G. C.). Colorectal cancer tissue procurement was supported by Award Number P30CA062203 from the National Institutes of Health through the NCI.; Recipient of fellowship support from the Australian National Health and Medical Research Council.	Abdul M, 2002, ONCOL REP, V9, P961; Baeza-Delgado C, 2013, EUR BIOPHYS J BIOPHY, V42, P199, DOI 10.1007/s00249-012-0813-9; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Beswick V, 1998, BIOCHIMIE, V80, P451, DOI 10.1016/S0300-9084(00)80012-7; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Clancy BM, 2003, BONE, V33, P46, DOI 10.1016/S8756-3282(03)00116-9; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Davidson RK, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2013; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fortunato SJ, 2002, J ASSIST REPROD GEN, V19, P483, DOI 10.1023/A:1020362519981; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Golubkov VS, 2011, J BIOL CHEM, V286, P34215, DOI 10.1074/jbc.M111.264036; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Grunnet M, 2003, BBA-BIOMEMBRANES, V1616, P85, DOI 10.1016/S0005-2736(03)00198-6; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hegedus L, 2008, J CELL PHYSIOL, V216, P480, DOI 10.1002/jcp.21417; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kanda VA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00231; Kanda VA, 2011, BIOPHYS J, V101, P1354, DOI 10.1016/j.bpj.2011.08.015; Kanda VA, 2011, BIOPHYS J, V101, P1364, DOI 10.1016/j.bpj.2011.08.014; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Klammt C, 2012, NAT METHODS, V9, P834, DOI [10.1038/NMETH.2033, 10.1038/nmeth.2033]; Krogsgaard M, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.8541; Langelaan DN, 2010, J CHEM INF MODEL, V50, P2213, DOI 10.1021/ci100324n; Lin DH, 2002, J BIOMOL NMR, V23, P317, DOI 10.1023/A:1020225206644; Mannello F, 2012, PROG HISTOCHEM CYTO, V47, P27, DOI 10.1016/j.proghi.2011.12.002; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Ohnishi J, 2001, MOL ENDOCRINOL, V15, P747, DOI 10.1210/me.15.5.747; Okada Aiko, 2009, Clin Calcium, V19, P1593, DOI CliCa091115931601; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pei DQ, 2000, J BIOL CHEM, V275, P33988, DOI 10.1074/jbc.M006493200; Pei DQ, 1999, FEBS LETT, V457, P262, DOI 10.1016/S0014-5793(99)01046-7; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Rangaraju S, 2010, J BIOL CHEM, V285, P9124, DOI 10.1074/jbc.M109.071266; Riddick ACP, 2005, BRIT J CANCER, V92, P2171, DOI 10.1038/sj.bjc.6602630; Rovnyak D, 2004, J MAGN RESON, V170, P15, DOI 10.1016/j.jmr.2004.05.016; Scrideli CA, 2008, J NEURO-ONCOL, V88, P281, DOI 10.1007/s11060-008-9579-4; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shen Y, 2012, J BIOMOL NMR, V52, P211, DOI 10.1007/s10858-012-9602-0; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sole L, 2009, J CELL SCI, V122, P3738, DOI 10.1242/jcs.056689; Tapper AR, 2000, J GEN PHYSIOL, V116, P379, DOI 10.1085/jgp.116.3.379; Van Horn WD, 2011, CURR OPIN STRUC BIOL, V21, P283, DOI 10.1016/j.sbi.2011.01.001; Velasco G, 1999, J BIOL CHEM, V274, P4570, DOI 10.1074/jbc.274.8.4570; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	56	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6451	6464		10.1074/jbc.M112.421495	http://dx.doi.org/10.1074/jbc.M112.421495			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300077	Green Published, hybrid			2022-12-28	WOS:000315820700039
J	Ennemann, EC; Radhakrishnan, K; Mariappan, M; Wachs, M; Pringle, TH; Schmidt, B; Dierks, T				Ennemann, Eva C.; Radhakrishnan, Karthikeyan; Mariappan, Malaiyalam; Wachs, Michaela; Pringle, Thomas H.; Schmidt, Bernhard; Dierks, Thomas			Proprotein Convertases Process and Thereby Inactivate Formylglycine-generating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SULFATASE DEFICIENCY; ENDOPLASMIC-RETICULUM; CLEAVAGE SITES; FURIN; CELLS; GENE; SUMF1; TRAFFICKING; PREDICTION; RETENTION	Formylglycine-generating enzyme (FGE) post-translationally converts a specific cysteine in newly synthesized sulfatases to formylglycine (FGly). FGly is the key catalytic residue of the sulfatase family, comprising 17 nonredundant enzymes in human that play essential roles in development and homeostasis. FGE, a resident protein of the endoplasmic reticulum, is also secreted. A major fraction of secreted FGE is N-terminally truncated, lacking residues 34-72. Here we demonstrate that this truncated form is generated intracellularly by limited proteolysis mediated by proprotein convertase(s) (PCs) along the secretory pathway. The cleavage site is represented by the sequence RYSR72 down arrow, a motif that is conserved in higher eukaryotic FGEs, implying important functionality. Residues Arg-69 and Arg-72 are critical because their mutation abolishes FGE processing. Furthermore, residues Tyr-70 and Ser-71 confer an unusual property to the cleavage motif such that endogenous as well as overexpressed FGE is only partially processed. FGE is cleaved by furin, PACE4, and PC5a. Processing is disabled in furin-deficient cells but fully restored upon transient furin expression, indicating that furin is the major protease cleaving FGE. Processing by endogenous furin occurs mostly intracellularly, although also extracellular processing is observed in HEK293 cells. Interestingly, the truncated form of secreted FGE no longer possesses FGly-generating activity, whereas the unprocessed form of secreted FGE is active. As always both forms are secreted, we postulate that furin-mediated processing of FGE during secretion is a physiological means of higher eukaryotic cells to regulate FGE activity upon exit from the endoplasmic reticulum.	[Ennemann, Eva C.; Radhakrishnan, Karthikeyan; Wachs, Michaela; Dierks, Thomas] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany; [Radhakrishnan, Karthikeyan; Mariappan, Malaiyalam; Schmidt, Bernhard] Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany; [Pringle, Thomas H.] Sperling Fdn, Eugene, OR 97405 USA	University of Bielefeld; University of Gottingen	Dierks, T (corresponding author), Univ Bielefeld, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany.	thomas.dierks@uni-bielefeld.de	Dierks, Thomas/A-3596-2012; mariappan, malaiyalam/K-9024-2012	Dierks, Thomas/0000-0001-6426-1339; Radhakrishnan, Karthikeyan/0000-0003-1731-7410	Deutsche Forschungsgemeinschaft [DI 575/7, SCHM 830/2, SFB 860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants DI 575/7, SCHM 830/2, and SFB 860.	Annunziata Ida, 2007, Hum Mutat, V28, P928, DOI 10.1002/humu.9504; Buono M, 2010, J EXP MED, V207, P1647, DOI 10.1084/jem.20091022; Carlson BL, 2008, J BIOL CHEM, V283, P20117, DOI 10.1074/jbc.M800217200; Cosma MP, 2004, HUM MUTAT, V23, P576, DOI 10.1002/humu.20040; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Dierks T, 2009, BBA-MOL CELL RES, V1793, P710, DOI 10.1016/j.bbamcr.2008.11.015; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fey J, 2001, J BIOL CHEM, V276, P47021, DOI 10.1074/jbc.M108943200; Fraldi A, 2008, HUM MOL GENET, V17, P2610, DOI 10.1093/hmg/ddn161; GIESELMANN V, 1992, J BIOL CHEM, V267, P13262; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; Mariappan M, 2005, J BIOL CHEM, V280, P15173, DOI 10.1074/jbc.M413698200; Mariappan M, 2008, J BIOL CHEM, V283, P11556, DOI 10.1074/jbc.M707858200; Mariappan M, 2008, J BIOL CHEM, V283, P6375, DOI 10.1074/jbc.M709171200; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Plaimauer B, 2001, BIOCHEM J, V354, P689, DOI 10.1042/0264-6021:3540689; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Schlotawa Lars, 2008, Hum Mutat, V29, P205, DOI 10.1002/humu.9515; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Sun T, 2010, INT J BIOL SCI, V6, P89; Tian S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00261; von Figura K, 1998, BIOESSAYS, V20, P505, DOI 10.1002/(SICI)1521-1878(199806)20:6<505::AID-BIES9>3.0.CO;2-K; Wu P, 2009, P NATL ACAD SCI USA, V106, P3000, DOI 10.1073/pnas.0807820106; Zito E, 2007, EMBO J, V26, P2443, DOI 10.1038/sj.emboj.7601695	36	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5828	5839		10.1074/jbc.M112.405159	http://dx.doi.org/10.1074/jbc.M112.405159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288839	hybrid, Green Published			2022-12-28	WOS:000315342500053
J	Zhu, TT; Chappel, JC; Hsu, FF; Turk, J; Aurora, R; Hyrc, K; De Camilli, P; Broekelmann, TJ; Mecham, RP; Teitelbaum, SL; Zou, W				Zhu, Tingting; Chappel, Jean C.; Hsu, Fong-Fu; Turk, John; Aurora, Rajeev; Hyrc, Krzysztof; De Camilli, Pietro; Broekelmann, Thomas J.; Mecham, Robert P.; Teitelbaum, Steven L.; Zou, Wei			Type I Phosphotidylinosotol 4-Phosphate 5-Kinase gamma Regulates Osteoclasts in a Bifunctional Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTDINS(4,5)P-2 SYNTHESIS; PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASES; ACTIN CYTOSKELETON; BONE-RESORPTION; KINASE; INTEGRIN; ALPHA-V-BETA-3; LOCALIZATION; PHAGOCYTOSIS; PLC-GAMMA-2	Type 1 phosphotidylinosotol-4 phosphate 5 kinase gamma (PIP5KI gamma) is central to generation of phosphotidylinosotol (4,5)P-2 (PI(4,5)P-2). PIP5KI gamma also participates in cytoskeletal organization by delivering talin to integrins, thereby enhancing their ligand binding capacity. As the cytoskeleton is pivotal to osteoclast function, we hypothesized that absence of PIP5KI gamma would compromise their resorptive capacity. Absence of the kinase diminishes PI(4,5) abundance and desensitizes pre-cursors to RANK ligand-stimulated differentiation. Thus, PIP5KI gamma(-/-) osteoclasts are reduced in number in vitro and confirm physiological relevance in vivo. Despite reduced numbers, PIP5KI gamma(-/-) osteoclasts surprisingly have normal cytoskeletons and effectively resorb bone. PIP5KI gamma overexpression, which increases PI(4,5)P-2, also delays osteoclast differentiation and reduces cell number but in contrast to cells lacking the kinase, its excess disrupts the cytoskeleton. The cytoskeleton-disruptive effects of excess PIP5KI gamma reflect its kinase activity and are independent of talin recognition. The combined arrested differentiation and disorganized cytoskeleton of PIP5KI gamma-transduced osteoclasts compromises bone resorption. Thus, optimal PIP5KI gamma and PI(4,5)P-2 expression, by osteoclasts, are essential for skeletal homeostasis.	[Zhu, Tingting; Chappel, Jean C.; Teitelbaum, Steven L.; Zou, Wei] Washington Univ, St Louis Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Hsu, Fong-Fu; Turk, John; Teitelbaum, Steven L.] Washington Univ, St Louis Sch Med, Dept Med, St Louis, MO 63110 USA; [Broekelmann, Thomas J.; Mecham, Robert P.] Washington Univ, St Louis Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Hyrc, Krzysztof] Washington Univ, St Louis Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Aurora, Rajeev] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [De Camilli, Pietro] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [De Camilli, Pietro] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Yale University; Howard Hughes Medical Institute; Yale University	Teitelbaum, SL (corresponding author), Washington Univ, St Louis Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	teitelbs@wustl.edu; weizou@wustl.edu		Zou, Wei/0000-0001-8081-268X; Hsu, Fong-Fu/0000-0001-5368-0183; Aurora, Rajeev/0000-0002-6609-6055; Teitelbaum, Steven/0000-0002-4054-6679	National Institutes of Health [AR032788, AR046523, AR054618, AR057037, AR057235, HL53325, HL74138, NS036251, P41-RR-00954, P60-DK-20579, P30-DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL053325, R01HL074138, R01HL053325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057037, P30AR057235, R01AR046523, R37AR046523, R01AR054618, R01AR032788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK020579, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR032788, AR046523, AR054618, AR057037, and AR057235 (to S. L. T.), HL53325 and HL74138 (to R. P. M.), and NS036251 (to P. D. C.). This work was also supported by NIH Grants P41-RR-00954, P60-DK-20579, and P30-DK56341.	Biswas RS, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-19; Chellaiah MA, 2006, EUR J CELL BIOL, V85, P311, DOI 10.1016/j.ejcb.2006.01.008; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Epple H, 2008, MOL CELL BIOL, V28, P3610, DOI 10.1128/MCB.00259-08; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Faccio R, 2010, ANN NY ACAD SCI, V1192, P124, DOI 10.1111/j.1749-6632.2009.05217.x; Halstead JR, 2010, J CELL SCI, V123, P3535, DOI 10.1242/jcs.062679; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Kang H, 2010, P NATL ACAD SCI USA, V107, P12901, DOI 10.1073/pnas.1001499107; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Wang YF, 2008, J CLIN INVEST, V118, P812, DOI 10.1172/JCI34239; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Weinkove D, 2008, DEV BIOL, V313, P384, DOI 10.1016/j.ydbio.2007.10.029; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022; Zhou P, 2006, J IMMUNOL, V177, P8777, DOI 10.4049/jimmunol.177.12.8777; Zou W., 2012, MOL CELL BIOL; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	29	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5268	5277		10.1074/jbc.M112.446054	http://dx.doi.org/10.1074/jbc.M112.446054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23300084	Green Published, hybrid			2022-12-28	WOS:000315342500002
J	Chen, JD; Waltenspiel, B; Warren, WD; Wagner, EJ				Chen, Jiandong; Waltenspiel, Bernhard; Warren, William D.; Wagner, Eric J.			Functional Analysis of the Integrator Subunit 12 Identifies a Microdomain That Mediates Activation of the Drosophila Integrator Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' END FORMATION; ESCHERICHIA-COLI; SMALL NUCLEAR; MESSENGER-RNA; U1 SNRNA; GLOBAL ANALYSIS; U2 SNRNA; PROTEIN; TRANSCRIPTION; 3'-END	The Drosophila integrator complex consists of 14 subunits that associate with the C terminus of Rpb1 and catalyze the endonucleolytic cleavage of nascent snRNAs near their 3' ends. Although disruption of almost any integrator subunit causes snRNA misprocessing, very little is known about the role of the individual subunits or the network of structural and functional interactions that exist within the complex. Here we developed an RNAi rescue assay in Drosophila S2 cells to identify functional domains within integrator subunit 12 (IntS12) required for snRNA 3' end formation. Surprisingly, the defining feature of the Ints12 protein, a highly conserved and centrally located plant homeodomain finger domain, is not required for reporter snRNA 3' end cleavage. Rather, we find a small, 45-amino acid N-terminal microdomain to be both necessary and nearly sufficient for snRNA biogenesis in cells depleted of endogenous IntS12 protein. This IntS12 microdomain can function autonomously, restoring full integrator processing activity when introduced into a heterologous protein. Moreover, mutations within the microdomain not only disrupt IntS12 function but also abolish binding to other integrator subunits. Finally, the IntS12 microdomain is sufficient to interact and stabilize the putative scaffold integrator subunit, IntS1. Collectively, these results identify an unexpected interaction between the largest and smallest integrator subunits that is essential for the 3' end formation of Drosophila snRNA.	[Chen, Jiandong; Wagner, Eric J.] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chen, Jiandong; Wagner, Eric J.] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Waltenspiel, Bernhard; Warren, William D.] James Cook Univ, Sch Pharm & Mol Sci, Comparat Genom Ctr, Townsville, Qld 4811, Australia	University of Texas System; University of Texas Health Science Center Houston; James Cook University	Wagner, EJ (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, MSB 6-200,6431 Fannin, Houston, TX 77030 USA.	Eric.J.Wagner@uth.tmc.edu	Warren, William/D-4419-2009; Chen, Jiandong/H-4016-2019	Warren, William/0000-0002-3753-1871; Chen, Jiandong/0000-0002-5144-7537	National Institutes of Health [5R00GM080447]; T. C. Hsu faculty development award; Queensland Cancer Fund; National Health and Medical Research Council (NHMRC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM080447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T. C. Hsu faculty development award; Queensland Cancer Fund; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R00GM080447 (to E. J. W.). This work was also supported by the T. C. Hsu faculty development award and by the Queensland Cancer Fund (to E. J. W.), and by the National Health and Medical Research Council (NHMRC) through the Australian Drosophila Biomedical Research Support Facility.	ACH RA, 1987, MOL CELL BIOL, V7, P2070, DOI 10.1128/MCB.7.6.2070; Albrecht TR, 2012, MOL CELL BIOL, V32, P1112, DOI 10.1128/MCB.06511-11; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Boyd DC, 2000, GENE, V247, P33, DOI 10.1016/S0378-1119(00)00134-7; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Cazalla D, 2011, MOL CELL, V43, P982, DOI 10.1016/j.molcel.2011.07.025; Chandran V, 2006, J MOL BIOL, V358, P8, DOI 10.1016/j.jmb.2006.02.012; Chen JD, 2012, RNA, V18, P2148, DOI 10.1261/rna.035725.112; Chen JD, 2010, BIOCHEM SOC T, V38, P1082, DOI 10.1042/BST0381082; Colledge VL, 2011, J MOL BIOL, V411, P597, DOI 10.1016/j.jmb.2011.06.004; DEVEGVAR HEN, 1986, CELL, V47, P259; Dominski Z, 1995, RNA, V1, P915; Dominski Z, 2005, MOL CELL BIOL, V25, P1489, DOI 10.1128/MCB.25.4.1489-1500.2005; Dominski Z, 2003, P NATL ACAD SCI USA, V100, P9422, DOI 10.1073/pnas.1533509100; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Egloff S, 2010, J BIOL CHEM, V285, P20564, DOI 10.1074/jbc.M110.132530; Egloff S, 2009, MOL CELL BIOL, V29, P4002, DOI 10.1128/MCB.00189-09; Ezzeddine N, 2011, MOL CELL BIOL, V31, P328, DOI 10.1128/MCB.00943-10; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Hernandez G, 2007, NUCLEIC ACIDS RES, V35, P21, DOI 10.1093/nar/gkl982; HERNANDEZ N, 1986, CELL, V47, P249, DOI 10.1016/0092-8674(86)90447-2; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; HERNANDEZ N, 1985, EMBO J, V4, P1827, DOI 10.1002/j.1460-2075.1985.tb03857.x; Johnen G, 1997, P NATL ACAD SCI USA, V94, P13469, DOI 10.1073/pnas.94.25.13469; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Musselman CA, 2011, NUCLEIC ACIDS RES, V39, P9061, DOI 10.1093/nar/gkr613; Nurmohamed S, 2010, ACTA CRYSTALLOGR D, V66, P1036, DOI 10.1107/S0907444910030015; Pavelitz T, 2008, MOL CELL BIOL, V28, P3573, DOI 10.1128/MCB.00087-08; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Schulz JG, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp450; Stunkel W, 1997, MOL CELL BIOL, V17, P4397; Sullivan KD, 2009, MOL CELL, V34, P322, DOI 10.1016/j.molcel.2009.04.024; Zhao XY, 2001, MOL CELL, V7, P539, DOI 10.1016/S1097-2765(01)00201-5	43	20	24	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4867	4877		10.1074/jbc.M112.425892	http://dx.doi.org/10.1074/jbc.M112.425892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288851	Green Published, hybrid			2022-12-28	WOS:000315340400035
J	Deng, XD; Morris, J; Chaton, C; Schroder, GF; Davidson, WS; Thompson, TB				Deng, Xiaodi; Morris, Jamie; Chaton, Catherine; Schroeder, Gunnar F.; Davidson, W. Sean; Thompson, Thomas B.			Small-angle X-ray Scattering of Apolipoprotein A-IV Reveals the Importance of Its Termini for Structural Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; CRYSTAL-STRUCTURE; SELF-ASSOCIATION; FOOD-INTAKE; N-TERMINI; PROTEINS; MACROMOLECULES; REFINEMENT; DOMAINS; SIZE	ApoA-IV is an amphipathic protein that can emulsify lipids and has been linked to protective roles against cardiovascular disease and obesity. We previously reported an x-ray crystal structure of apoA-IV that was truncated at its N and C termini. Here, we have extended this work by demonstrating that self-associated states of apoA-IV are stable and can be structurally studied using small-angle x-ray scattering. Both the full-length monomeric and dimeric forms of apoA-IV were examined, with the dimer showing an elongated rod core with two nodes at opposing ends. The monomer is roughly half the length of the dimer with a single node. Small-angle x-ray scattering visualization of several deletion mutants revealed that removal of both termini can have substantial conformational effects throughout the molecule. Additionally, the F334A point mutation, which we previously showed increases apoA-IV lipid binding, also exhibited large conformational effects on the entire dimer. Merging this study's low-resolution structural information with the crystal structure provides insight on the conformation of apoA-IV as a monomer and as a dimer and further defines that a clasp mechanism may control lipid binding and, ultimately, protein function.	[Deng, Xiaodi; Chaton, Catherine; Thompson, Thomas B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Morris, Jamie; Davidson, W. Sean] Univ Cincinnati, Metab Dis Inst, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45215 USA; [Schroeder, Gunnar F.] Forschungszentrum Julich, Inst Complex Syst ICS 6, D-52425 Julich, Germany	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Helmholtz Association; Research Center Julich	Thompson, TB (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way,MSB 3005B, Cincinnati, OH 45267 USA.	tom.thompson@uc.edu	Schröder, Gunnar F/H-5261-2013	Schröder, Gunnar F/0000-0003-1803-5431; Thompson, Thomas/0000-0002-7041-5047; Davidson, William/0000-0003-2756-2989	National Institutes of Health [R01 GM098458, HL67093, T32 HL007382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007382, R01HL067093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM098458 (to T. B. T. and W. S. D.), Grant HL67093 (to W. S. D.), and Training Grant T32 HL007382 (to X. D.).	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Culnan DM, 2009, OBESITY, V17, P46, DOI 10.1038/oby.2008.428; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Deng XD, 2012, STRUCTURE, V20, P767, DOI 10.1016/j.str.2012.02.020; Deng XD, 2012, ACTA CRYSTALLOGR F, V68, P105, DOI [10.1107/S1744309111048706, 10.1107/S1744309111048706105]; Garai K, 2010, BIOCHEMISTRY-US, V49, P9533, DOI 10.1021/bi101407m; Ilavsky J, 2009, J APPL CRYSTALLOGR, V42, P347, DOI 10.1107/S0021889809002222; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lund-Katz S, 2010, SUBCELL BIOCHEM, V51, P183, DOI 10.1007/978-90-481-8622-8_7; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Pearson K, 2005, J BIOL CHEM, V280, P38576, DOI 10.1074/jbc.M506802200; Pearson K, 2004, BIOCHEMISTRY-US, V43, P10719, DOI 10.1021/bi048978m; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tabet F, 2009, CLIN SCI, V116, P87, DOI 10.1042/CS20080106; Tso P, 1999, J NUTR, V129, P1503, DOI 10.1093/jn/129.8.1503; Tso P, 2004, PHYSIOL BEHAV, V83, P631, DOI 10.1016/j.physbeh.2004.07.032; Tso P, 2004, AM J PHYSIOL-GASTR L, V286, pG885, DOI 10.1152/ajpgi.00511.2003; Tubb MR, 2007, J BIOL CHEM, V282, P28385, DOI 10.1074/jbc.M704070200; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; VITELLO LB, 1976, J BIOL CHEM, V251, P1131; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Wang Z, 2012, BIOPOLYMERS, V97, P687, DOI 10.1002/bip.22046; WEINBERG RB, 1985, J BIOL CHEM, V260, P4279; Weinberg RB, 2012, J LIPID RES, V53, P736, DOI 10.1194/jlr.M019992; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107	38	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4854	4866		10.1074/jbc.M112.436709	http://dx.doi.org/10.1074/jbc.M112.436709			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288849	Green Published, hybrid			2022-12-28	WOS:000315340400034
J	Yamazaki, J; Okamura, K; Uehara, K; Hatta, M				Yamazaki, Jun; Okamura, Kazuhiko; Uehara, Kiyoko; Hatta, Mitsutoki			CLCA Splicing Isoform Associated with Adhesion through beta(1)-Integrin and Its Scaffolding Protein SPECIFIC EXPRESSION IN UNDIFFERENTIATED EPITHELIAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL; BETA(1) INTEGRIN; KINASE-C; EXTRACELLULAR-MATRIX; MEMBRANE-PROTEINS; ANION TRANSPORT; RACK1; CLONING; GROWTH; GENERATION	We previously found that a rat CLCA homologue (rCLCA-f) modulates Ca2+-dependent Cl- transport in the ductal cells of the rat submandibular gland. CLCA proteins have been shown to be multifunctional, with roles in, for example, cell adhesion. Here, we describe the mRNA and protein expressions of a splicing isoform of rat rCLCA (rCLCA-t). This isoform is a 514-amino acid protein containing a C-terminal 59-amino acid that is distinct from the rCLCA-f sequence. Immunohistochemistry revealed rCLCA-t to be located in the basal cells of the rat submandibular gland excretory duct and the stratum basale of rat epidermis, whereas rCLCA-f was detected in cells during the process of differentiation. In a heterologous expression system, rCLCA-t was found to be a membrane protein present predominantly in the perinuclear region, and not to be either present on the cell surface or secreted. rCLCA-t failed to enhance ionomycin-induced Cl- conductance (unlike rCLCA-f). When compared with rCLCA-f, it weakened cell attachment to a greater extent and in a manner that was evidently modulated by intracellular Ca2+, protein kinase C, and beta(1)-integrin. rCLCA-t was found to associate with RACK1 (receptor for activated C kinase) and to reduce expression of mature beta(1)-integrin. Treatment of rat skin with rCLCA-t siRNA increased the expression of beta(1)-integrin in the stratum basale of the epidermis. These results are consistent with cell-specific splicing of rCLCA mRNA playing a role in the modulation of the adhesive potential of undifferentiated epithelial cells.	[Yamazaki, Jun] Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Sawara Ku, Fukuoka 8140193, Japan; [Okamura, Kazuhiko] Fukuoka Dent Coll, Dept Morphol Biol, Sawara Ku, Fukuoka 8140193, Japan; [Uehara, Kiyoko] Fukuoka Univ, Sch Med, Dept Cell Biol, Jonan Ku, Fukuoka 8140180, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Fukuoka University	Yamazaki, J (corresponding author), Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.	junyama@college.fdcnet.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Japan Society for the Promotion of Science	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (to J. Y.) and by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (to J. Y. and K. O).	Abdel-Ghany M, 2003, J BIOL CHEM, V278, P49406, DOI 10.1074/jbc.M309086200; Abdel-Ghany M, 2001, J BIOL CHEM, V276, P25438, DOI 10.1074/jbc.M100478200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Besson A, 2002, J BIOL CHEM, V277, P22073, DOI 10.1074/jbc.M111644200; BREZILLON S, 1995, LAB INVEST, V72, P191; Connon CJ, 2005, ACTA HISTOCHEM, V106, P421, DOI 10.1016/j.acthis.2004.08.003; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Elble RC, 2006, J BIOL CHEM, V281, P29448, DOI 10.1074/jbc.M605919200; Elble RC, 1997, J BIOL CHEM, V272, P27853, DOI 10.1074/jbc.272.44.27853; Elble RC, 2001, J BIOL CHEM, V276, P40510, DOI 10.1074/jbc.M104821200; Fuller CM, 2000, CLIN EXP PHARMACOL P, V27, P906, DOI 10.1046/j.1440-1681.2000.03359.x; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Gruber AD, 1999, BBA-GENE STRUCT EXPR, V1444, P418, DOI 10.1016/S0167-4781(99)00008-1; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; HEINO J, 1989, J BIOL CHEM, V264, P380; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Hume JR, 2000, PHYSIOL REV, V80, P31, DOI 10.1152/physrev.2000.80.1.31; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishibashi K, 2006, J DENT RES, V85, P1101, DOI 10.1177/154405910608501207; Jensen PJ, 1996, CELL DEATH DIFFER, V3, P357; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kamada F, 2004, GENES IMMUN, V5, P540, DOI 10.1038/sj.gene.6364124; Kiely PA, 2008, J BIOL CHEM, V283, P22952, DOI 10.1074/jbc.M800802200; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kunzelmann K, 2011, PFLUG ARCH EUR J PHY, V462, P195, DOI 10.1007/s00424-011-0975-9; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lee I, 2004, J BIOL CHEM, V279, P53007, DOI 10.1074/jbc.M405717200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pauli BU, 2000, CLIN EXP PHARMACOL P, V27, P901, DOI 10.1046/j.1440-1681.2000.03358.x; Ritzka M, 2004, HUM GENET, V115, P483, DOI 10.1007/s00439-004-1190-y; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Salicioni AM, 2004, J BIOL CHEM, V279, P10005, DOI 10.1074/jbc.M306625200; Shenoy PS, 2001, BIOCHEM CELL BIOL, V79, P399, DOI 10.1139/bcb-79-4-399; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; VANDEWIELVANKEMENADE E, 1992, J CELL BIOL, V117, P461, DOI 10.1083/jcb.117.2.461; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Xia Z, 2008, AM J NEPHROL, V28, P34, DOI 10.1159/000108759; Yamazaki J, 2005, BBA-BIOMEMBRANES, V1715, P132, DOI 10.1016/j.bbamem.2005.08.001; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zaslavsky A, 2005, FEBS LETT, V579, P3899, DOI 10.1016/j.febslet.2005.06.006; ZHU DZ, 1991, J HISTOCHEM CYTOCHEM, V39, P1137, DOI 10.1177/39.8.1856462; ZHU DZ, 1991, P NATL ACAD SCI USA, V88, P9568, DOI 10.1073/pnas.88.21.9568	49	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4831	4843		10.1074/jbc.M112.396481	http://dx.doi.org/10.1074/jbc.M112.396481			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23297403	hybrid, Green Published			2022-12-28	WOS:000315340400032
J	Gillette, DD; Shah, PA; Cremer, T; Gavrilin, MA; Besecker, BY; Sarkar, A; Knoell, DL; Cormet-Boyaka, E; Wewers, MD; Butchar, JP; Tridandapani, S				Gillette, Devyn D.; Shah, Prexy A.; Cremer, Thomas; Gavrilin, Mikhail A.; Besecker, Beth Y.; Sarkar, Anasuya; Knoell, Daren L.; Cormet-Boyaka, Estelle; Wewers, Mark D.; Butchar, Jonathan P.; Tridandapani, Susheela			Analysis of Human Bronchial Epithelial Cell Proinflammatory Response to Burkholderia cenocepacia Infection INABILITY TO SECRETE IL-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTIC-FIBROSIS; CIGARETTE-SMOKE; IN-VITRO; RELEASE; IL-1-BETA; INFLAMMASOME; CULTURES; KINASE	Burkholderia cenocepacia, the causative agent of cepacia syndrome, primarily affects cystic fibrosis patients, often leading to death. In the lung, epithelial cells serve as the initial barrier to airway infections, yet their responses to B. cenocepacia have not been fully investigated. Here, we examined the molecular responses of human airway epithelial cells to B. cenocepacia infection. Infection led to early signaling events such as activation of Erk, Akt, and NF-kappa B. Further, TNF alpha, IL-6, IL-8, and IL-1 beta were all significantly induced upon infection, but no IL-1 beta was detected in the supernatants. Because caspase-1 is required for IL-1 beta processing and release, we examined its expression in airway epithelial cells. Interestingly, little to no caspase-1 was detectable in airway epithelial cells. Transfection of caspase-1 into airway epithelial cells restored their ability to secrete IL-1 beta following B. cenocepacia infection, suggesting that a deficiency in caspase-1 is responsible, at least in part, for the attenuated IL-1 beta secretion.	[Gillette, Devyn D.; Tridandapani, Susheela] Ohio State Univ, Integrated Biomed Grad Program, Columbus, OH 43210 USA; [Shah, Prexy A.; Cremer, Thomas; Gavrilin, Mikhail A.; Besecker, Beth Y.; Sarkar, Anasuya; Knoell, Daren L.; Cormet-Boyaka, Estelle; Wewers, Mark D.; Butchar, Jonathan P.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Knoell, Daren L.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Butchar, JP (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	butchar.2@osu.edu; tridandapani.2@osu.edu	Cormet-Boyaka, Estelle/H-5624-2011; Tridandapani, Susheela/E-4209-2011; Besecker, Beth/E-2747-2011; Butchar, Jonathan/E-2825-2011; Wewers, Mark/AAB-6202-2021	Gavrilin, Mikhail/0000-0003-2003-768X	Cystic Fibrosis Foundation [(20020527): GILLET11H0]; National Institutes of Health [K12-CA133250]; American Cancer Society [IRG-67-003-47]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076278] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the Cystic Fibrosis Foundation (20020527): GILLET11H0.; Supported by National Institutes of Health Grant K12-CA133250 and American Cancer Society Grant IRG-67-003-47. To whom correspondence may be addressed. E-mail:butchar.2@osu.edu.	Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Boland S, 1999, AM J PHYSIOL-LUNG C, V276, pL604, DOI 10.1152/ajplung.1999.276.4.L604; Cremer TJ, 2011, J IMMUNOL, V187, P635, DOI 10.4049/jimmunol.1003034; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Mortaz E, 2011, BBA-MOL BASIS DIS, V1812, P1104, DOI 10.1016/j.bbadis.2011.06.002; Reddi K, 2003, PEDIATR RES, V54, P297, DOI 10.1203/01.PDR.0000076661.85928.1D; Rusznak C, 2000, AM J RESP CELL MOL, V23, P530, DOI 10.1165/ajrcmb.23.4.3959; Sajjan U, 2004, INFECT IMMUN, V72, P4188, DOI 10.1128/IAI.72.7.4188-4199.2004; Sajjan US, 2008, CELL MICROBIOL, V10, P188, DOI 10.1111/j.1462-5822.2007.01029.x; Shi L, 2012, AM J RESP CELL MOL, V47, P363, DOI 10.1165/rcmb.2011-0267OC	12	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3691	3695		10.1074/jbc.C112.430298	http://dx.doi.org/10.1074/jbc.C112.430298			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23269671	Green Published, hybrid			2022-12-28	WOS:000314845000001
J	Jouve, N; Despoix, N; Espeli, M; Gauthier, L; Cypowyj, S; Fallague, K; Schiff, C; Dignat-George, F; Vely, F; Leroyer, AS				Jouve, Nathalie; Despoix, Nicolas; Espeli, Marion; Gauthier, Laurent; Cypowyj, Sophie; Fallague, Karim; Schiff, Claudine; Dignat-George, Franoise; Vely, Frederic; Leroyer, Aurelie S.			The Involvement of CD146 and Its Novel Ligand Galectin-1 in Apoptotic Regulation of Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; POOR-PROGNOSIS; STROMAL CELLS; PRE-B; ADHESION; EXPRESSION; IDENTIFICATION; AFFINITY; GROWTH; GLYCOPROTEINS	CD146 is a highly glycosylated junctional adhesion molecule, expressed on human vascular endothelial cells and involved in the control of vessel integrity. Galectin-1 is a lectin produced by vascular cells that can binds N- and O-linked oligosaccharides of cell membrane glycoproteins. Because both CD146 and Galectin-1 are involved in modulation of cell apoptosis, we hypothesized that Galectin-1 could interact with CD146, leading to functional consequences in endothelial cell apoptosis. We first characterized CD146 glycosylations and showed that it is mainly composed of N-glycans able to establish interactions with Galectin-1. We demonstrated a sugar-dependent binding of recombinant CD146 to Galectin-1 using both ELISA and Bia-core assays. This interaction is direct, with a K-D of 3.10(-7) M, and specific as CD146 binds to Galectin-1 and not to Galectin-2. Moreover, co-immunoprecipitation experiments showed that Galectin-1 interacts with endogenous CD146 that is highly expressed by HUVEC. We observed a Galectin-1-induced HUVEC apoptosis in a dose-dependent manner as demonstrated by Annexin-V/7AAD staining. Interestingly, both down-regulation of CD146 cell surface expression using siRNA and antibody-mediated blockade of CD146 increase this apoptosis. Altogether, our results identify Galectin-1 as a novel ligand for CD146 and this interaction protects, in vitro, endothelial cells against apoptosis induced by Galectin-1.	[Jouve, Nathalie; Despoix, Nicolas; Cypowyj, Sophie; Fallague, Karim; Dignat-George, Franoise; Leroyer, Aurelie S.] Aix Marseille Univ, INSERM, UMR S 1076, F-13385 Marseille, France; [Espeli, Marion; Schiff, Claudine; Vely, Frederic] UM2, Aix Marseille Univ, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Gauthier, Laurent] INNATE PHARMA, F-13288 Marseille, France; [Schiff, Claudine; Vely, Frederic] INSERM, U1104, F-13288 Marseille, France; [Schiff, Claudine; Vely, Frederic] CNRS, UMR 7280, F-13288 Marseille, France; [Dignat-George, Franoise; Vely, Frederic] Hop Conception, AP HP, F-13385 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Leroyer, AS (corresponding author), Fac Pharm Marseille, INSERM, UMR S 1076, 27 Bd Jean Moulin, F-13385 Marseille 5, France.	aurelie.leroyer@univ-amu.fr	DIGNAT-GEORGE, Françoise/R-1129-2016; jouve, nathalie/D-5098-2017; Leroyer, Aurelie S./M-4400-2016; Espeli, Marion/AAH-4483-2021; Vély, Frédéric/HHM-3894-2022	DIGNAT-GEORGE, Françoise/0000-0001-7006-4462; Leroyer, Aurelie S./0000-0002-8079-7122; Espeli, Marion/0000-0001-5005-1664; Vely, Frederic/0000-0002-1682-0949	Fondation de France; Region PACA; Inserm, Region Funding	Fondation de France(Fondation de France); Region PACA(Region Provence-Alpes-Cote d'Azur); Inserm, Region Funding	This work was supported by institutional resources provided by Aix-Marseille University, INSERM and by a grant from the Fondation de France.; Recipient of Doctoral funds from the Region PACA and is supported by Inserm, Region Funding.	Adams L, 1996, BBA-MOL CELL RES, V1312, P137, DOI 10.1016/0167-4889(96)00031-6; Aldovini D, 2006, INT J CANCER, V119, P1920, DOI 10.1002/ijc.22082; Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Anfosso F, 1998, J BIOL CHEM, V273, P26852, DOI 10.1074/jbc.273.41.26852; Anfosso F, 2001, J BIOL CHEM, V276, P1564, DOI 10.1074/jbc.M007065200; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Bardin N, 2009, ARTERIOSCL THROM VAS, V29, P746, DOI 10.1161/ATVBAHA.108.183251; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; BAUM LG, 1995, GLYCOCONJUGATE J, V12, P63, DOI 10.1007/BF00731870; Blasko A, 2011, ACTA BIOL HUNG, V62, P106, DOI 10.1556/ABiol.61.2011.1.11; Braeuer RR, 2012, PIGM CELL MELANOMA R, V25, P592, DOI 10.1111/j.1755-148X.2012.01026.x; Burns JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021888; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Cedeno-Laurent F, 2012, J INVEST DERMATOL, V132, P410, DOI 10.1038/jid.2011.335; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Chan B, 2005, DEV DYNAM, V232, P232, DOI 10.1002/dvdy.20220; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Despoix N, 2008, EUR J IMMUNOL, V38, P2855, DOI 10.1002/eji.200838469; Dings RPM, 2010, BIOCONJUGATE CHEM, V21, P20, DOI 10.1021/bc900287y; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Fischer I, 2009, PLACENTA, V30, P1078, DOI 10.1016/j.placenta.2009.10.003; Flanagan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040443; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; GEORGE F, 1992, THROMB HAEMOSTASIS, V67, P147; Guezguez B, 2007, J IMMUNOL, V179, P6673, DOI 10.4049/jimmunol.179.10.6673; Harhouri K, 2010, BLOOD, V115, P3843, DOI 10.1182/blood-2009-06-229591; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Ito K, 2011, ANGIOGENESIS, V14, P293, DOI 10.1007/s10456-011-9213-5; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jiang TX, 2012, BLOOD, V120, P2330, DOI 10.1182/blood-2012-01-406108; Johnson JP, 1997, INT J CANCER, V73, P769; Kebir A, 2010, CIRC RES, V107, P66, DOI 10.1161/CIRCRESAHA.109.213827; Kristiansen G, 2003, ANAL CELL PATHOL, V25, P77, DOI 10.1155/2003/574829; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Levroney EL, 2005, J IMMUNOL, V175, P413, DOI 10.4049/jimmunol.175.1.413; Ouhtit A, 2009, BBA-REV CANCER, V1795, P130, DOI 10.1016/j.bbcan.2009.01.002; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perillo NL, 1997, J EXP MED, V185, P1851, DOI 10.1084/jem.185.10.1851; Pickl WF, 1997, J IMMUNOL, V158, P2107; Rabinovich GA, 2009, IMMUNOL REV, V230, P144, DOI 10.1111/j.1600-065X.2009.00787.x; Rossi B, 2006, J IMMUNOL, V177, P796, DOI 10.4049/jimmunol.177.2.796; Sakaguchi M, 2006, P NATL ACAD SCI USA, V103, P7112, DOI 10.1073/pnas.0508793103; Salomonsson E, 2010, BIOCHEMISTRY-US, V49, P9518, DOI 10.1021/bi1009584; Shi IM, 1999, J PATHOL, V189, P4, DOI 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P; Solovey AN, 2001, J LAB CLIN MED, V138, P322, DOI 10.1067/mlc.2001.118519; Staquicini FI, 2008, CANCER RES, V68, P8419, DOI 10.1158/0008-5472.CAN-08-1242; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2009, J BIOL CHEM, V284, P4989, DOI 10.1074/jbc.M808925200; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Vas V, 2005, STEM CELLS, V23, P279, DOI 10.1634/stemcells.2004-0084; Wu Z, 2012, TUMOR BIOL, V33, P1619, DOI 10.1007/s13277-012-0417-0; Yan XY, 2003, BLOOD, V102, P184, DOI 10.1182/blood-2002-04-1004; Yang HC, 2001, GENE, V265, P133, DOI 10.1016/S0378-1119(01)00349-3; Zabouo G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2215	59	52	58	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2571	2579		10.1074/jbc.M112.418848	http://dx.doi.org/10.1074/jbc.M112.418848			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223580	hybrid, Green Published			2022-12-28	WOS:000314211500042
J	Kim, SY; Colpitts, CC; Wiedemann, G; Jepson, C; Rahimi, M; Rothwell, JR; McInnes, AD; Hasebe, M; Reski, R; Sterenberg, BT; Suh, DY				Kim, Sun Young; Colpitts, Che C.; Wiedemann, Gertrud; Jepson, Christina; Rahimi, Mehrieh; Rothwell, Jordan R.; McInnes, Adam D.; Hasebe, Mitsuyasu; Reski, Ralf; Sterenberg, Brian T.; Suh, Dae-Yeon			Physcomitrella PpORS, Basal to Plant Type III Polyketide Synthases in Phylogenetic Trees, Is a Very Long Chain 2 '-Oxoalkylresorcinol Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHALCONE SYNTHASE; ACID SYNTHESIS; IDENTIFICATION; REVEALS; BIOSYNTHESIS; SUPERFAMILY; EVOLUTION; GENETICS; ENZYMES; PATENS	The plant type III polyketide synthases (PKSs), which produce diverse secondary metabolites with different biological activities, have successfully co-evolved with land plants. To gain insight into the roles that ancestral type III PKSs played during the early evolution of land plants, we cloned and characterized PpORS from the moss Physcomitrella. PpORS has been proposed to closely resemble the most recent common ancestor of the plant type III PKSs. PpORS condenses a very long chain fatty acyl-CoA with four molecules of malonyl-CoA and catalyzes decarboxylative aldol cyclization to yield the pentaketide 2'-oxoalkylresorcinol. Therefore, PpORS is a 2'-oxoalkylresorcinol synthase. Structure modeling and sequence alignments identified a unique set of amino acid residues (Gln(218), Val(277), and Ala(286)) at the putative PpORS active site. Substitution of the Ala(286) to Phe apparently constricted the active site cavity, and the A286F mutant instead produced triketide alkylpyrones from fatty acyl-CoA substrates with shorter chain lengths. Phylogenetic analysis and comparison of the active sites of PpORS and alkylresorcinol synthases from sorghum and rice suggested that the gramineous enzymes evolved independently from PpORS to have similar functions but with distinct active site architecture. Microarray analysis revealed that PpORS is exclusively expressed in nonprotonemal moss cells. The in planta function of PpORS, therefore, is probably related to a nonprotonemal structure, such as the cuticle.	[Kim, Sun Young; Colpitts, Che C.; Jepson, Christina; Rahimi, Mehrieh; Rothwell, Jordan R.; McInnes, Adam D.; Sterenberg, Brian T.; Suh, Dae-Yeon] Univ Regina, Dept Chem & Biochem, Regina, SK S4S 0A2, Canada; [Wiedemann, Gertrud; Reski, Ralf] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Reski, Ralf] Univ Freiburg, Freiburg Inst Adv Studies, D-79104 Freiburg, Germany; [Hasebe, Mitsuyasu] Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Hasebe, Mitsuyasu] Grad Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Hasebe, Mitsuyasu] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Okazaki, Aichi 4448585, Japan	University of Regina; University of Freiburg; University of Freiburg; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Suh, DY (corresponding author), Univ Regina, Dept Chem & Biochem, 3737 Wascana Pkwy, Regina, SK S4S 0A2, Canada.	suhdaey@uregina.ca	Colpitts, Che C./AAD-2768-2019; Suh, Dae-Yeon/AFU-3630-2022; Sterenberg, Brian/AAF-2566-2021	Colpitts, Che C./0000-0003-2474-1834; Suh, Dae-Yeon/0000-0003-4094-5132; Sterenberg, Brian/0000-0001-5579-4184; McInnes, Adam/0000-0002-9876-4011; Wiedemann, Gertrud/0000-0002-2259-1011; Reski, Ralf/0000-0002-5496-6711; Hasebe, Mitsuyasu/0000-0001-7425-8758	NSERC; Natural Sciences and Engineering Research Council, Canada	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank Matthew Endsin and Fatima Abbas for their contribution in the preparation of pET28-PpORS, and Li Li for the purification of Trx-PpORS. We also thank Dr. Nobutaka Funa (University of Tokyo) for expression plasmids of ArsB and ArsC. CGS-M postgraduate scholarship from NSERC to C. C. Colpitts is also acknowledged.; This work was supported by the Natural Sciences and Engineering Research Council, Canada, Discovery Grant (to D.-Y.S.).	Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Avsejs LA, 2002, ORG GEOCHEM, V33, P861, DOI 10.1016/S0146-6380(02)00046-3; Colpitts CC, 2011, NEW PHYTOL, V192, P855, DOI 10.1111/j.1469-8137.2011.03858.x; Cook D, 2010, PLANT CELL, V22, P867, DOI 10.1105/tpc.109.072397; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Firn RD, 2000, MOL MICROBIOL, V37, P989, DOI 10.1046/j.1365-2958.2000.02098.x; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Funa N, 2002, BIOCHEM J, V367, P781, DOI 10.1042/BJ20020953; Funa N, 2007, J BIOL CHEM, V282, P14476, DOI 10.1074/jbc.M701239200; Grienenberger E, 2010, PLANT CELL, V22, P4067, DOI 10.1105/tpc.110.080036; Gross F, 2006, ARCH MICROBIOL, V185, P28, DOI 10.1007/s00203-005-0059-3; Jez JM, 2002, P NATL ACAD SCI USA, V99, P5319, DOI 10.1073/pnas.082590499; Jiang CG, 2006, PHYTOCHEMISTRY, V67, P2531, DOI 10.1016/j.phytochem.2006.09.030; Jiang CG, 2008, MOL PHYLOGENET EVOL, V49, P691, DOI 10.1016/j.ympev.2008.09.002; Koduri PKH, 2010, PLANT MOL BIOL, V72, P247, DOI 10.1007/s11103-009-9565-z; KOZUBEK A, 1995, CHEM PHYS LIPIDS, V78, P29, DOI 10.1016/0009-3084(95)02480-7; Ligrone R, 2008, PLANT SYST EVOL, V270, P257, DOI 10.1007/s00606-007-0617-z; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MARUYAMA K, 1994, GENE, V138, P171; Matsuzawa M, 2010, PHYTOCHEMISTRY, V71, P1059, DOI 10.1016/j.phytochem.2010.02.012; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Posehn SE, 2012, CHEMBIOCHEM, V13, P2212, DOI 10.1002/cbic.201200346; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Reski R, 1998, BOT ACTA, V111, P1; Richardt S, 2010, PLANT MOL BIOL, V72, P27, DOI 10.1007/s11103-009-9550-6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross AB, 2003, J AGR FOOD CHEM, V51, P4111, DOI 10.1021/jf0340456; ROTHER S, 1994, J PLANT PHYSIOL, V143, P72, DOI 10.1016/S0176-1617(11)82099-7; Rubin-Pitel SB, 2008, CHEM BIOL, V15, P1079, DOI 10.1016/j.chembiol.2008.08.011; Sankaranarayanan R, 2004, NAT STRUCT MOL BIOL, V11, P894, DOI 10.1038/nsmb809; SEITZ LM, 1992, J AGR FOOD CHEM, V40, P1541, DOI 10.1021/jf00021a014; Seshime Y, 2010, BIOORGAN MED CHEM, V18, P4542, DOI 10.1016/j.bmc.2010.04.058; Suh DY, 2000, BIOCHEM J, V350, P229, DOI 10.1042/0264-6021:3500229; Suzuki Y, 1998, PHYTOCHEMISTRY, V47, P1247, DOI 10.1016/S0031-9422(97)00720-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wolf L, 2010, PLANT PHYSIOL, V153, P1123, DOI 10.1104/pp.110.154658; Wyatt HDM, 2008, BOTANY, V86, P385, DOI 10.1139/B08-003; Yamaguchi T, 1999, FEBS LETT, V460, P457, DOI 10.1016/S0014-5793(99)01403-9; Yamazaki Y, 2001, PLANTA, V214, P75, DOI 10.1007/s004250100586; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	42	17	17	0	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2767	2777		10.1074/jbc.M112.430686	http://dx.doi.org/10.1074/jbc.M112.430686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223578	Green Published, hybrid			2022-12-28	WOS:000314211500060
J	Rai, R; Tate, JJ; Nelson, DR; Cooper, TG				Rai, Rajendra; Tate, Jennifer J.; Nelson, David R.; Cooper, Terrance G.			gln3 Mutations Dissociate Responses to Nitrogen Limitation (Nitrogen Catabolite Repression) and Rapamycin Inhibition of TorC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE PHOSPHOPROTEOME REVEALS; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; ACTIVATORS GLN3; GENE-EXPRESSION; PROTEIN-KINASE; PHOSPHATASE; TAP42; URE2P; PHOSPHORYLATION	The GATA family transcription activator, Gln3 responds to the nitrogen requirements and environmental resources of the cell. When rapidly utilized, "good" nitrogen sources, e. g., glutamine, are plentiful, Gln3 is completely sequestered in the cytoplasm, and the transcription it mediates is minimal. In contrast, during nitrogen-limiting conditions, Gln3 quickly relocates to the nucleus and activates transcription of genes required to scavenge alternative, "poor" nitrogen sources, e. g., proline. This physiological response has been designated nitrogen catabolite repression (NCR). Because rapamycin treatment also elicits nuclear Gln3 localization, TorC1 has been thought to be responsible for NCR-sensitive Gln3 regulation. However, accumulating evidence now suggests that GATA factor regulation may occur by two separate pathways, one TorC1-dependent and the other NCR-sensitive. Therefore, the present experiments were initiated to identify Gln3 amino acid substitutions capable of dissecting the individual contributions of these pathways to overall Gln3 regulation. The rationale was that different regulatory pathways might be expected to operate through distinct Gln3 sensor residues. We found that C-terminal truncations or amino acid substitutions in a 17-amino acid Gln3 peptide with a predicted propensity to fold into an alpha-helix partially abolished the ability of the cell to sequester Gln3 in the cytoplasm of glutamine-grown cells and eliminated the rapamycin response of Gln3 localization, but did not adversely affect its response to limiting nitrogen. However, overall wild type control of intracellular Gln3 localization requires the contributions of both individual regulatory systems. We also found that Gln3 possesses at least one Tor1-interacting site in addition to the one previously reported.	[Rai, Rajendra; Tate, Jennifer J.; Nelson, David R.; Cooper, Terrance G.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Cooper, TG (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	tcooper@uthsc.edu		Cooper, Terrance G./0000-0002-7651-9963; Nelson, David/0000-0003-0583-5421	National Institutes of Health [GM-35642-22-23]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642-22-23.	[Anonymous], 2009, Nat Cell Biol, V11, P667; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2011, J BIOL CHEM, V286, P44897, DOI 10.1074/jbc.M111.290577; Georis I, 2011, MOL CELL BIOL, V31, P92, DOI 10.1128/MCB.00482-10; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; James P, 1996, GENETICS, V144, P1425; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kulkarni A, 2006, FEMS YEAST RES, V6, P218, DOI 10.1111/j.1567-1364.2006.00031.x; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; MINEHART PL, 1991, MOL CELL BIOL, V11, P6216, DOI 10.1128/MCB.11.12.6216; Puria R, 2008, P NATL ACAD SCI USA, V105, P7194, DOI 10.1073/pnas.0801087105; Scott S, 2000, J BIOL CHEM, V275, P7198, DOI 10.1074/jbc.275.10.7198; Scott S, 2000, J BIOL CHEM, V275, P30886, DOI 10.1074/jbc.M005624200; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Tate JJ, 2007, J BIOL CHEM, V282, P18467, DOI 10.1074/jbc.M609550200; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2010, J BIOL CHEM, V285, P17880, DOI 10.1074/jbc.M109.085712; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239	47	27	29	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2789	2804		10.1074/jbc.M112.421826	http://dx.doi.org/10.1074/jbc.M112.421826			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223232	Green Published, hybrid			2022-12-28	WOS:000314211500062
J	Lee, J; Lee, J				Lee, Jihyun; Lee, Junho			Hypoxia-inducible Factor-1 (HIF-1)-independent Hypoxia Response of the Small Heat Shock Protein hsp-16.1 Gene Regulated by Chromatin-remodeling Factors in the Nematode Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-2 HOMEOSTASIS; FACTOR 1-ALPHA; OXYGEN; HIF-1; NURF; ISWI; CALCIUM; DNA; PURIFICATION; CALCINEURIN	Oxygen deprivation is accompanied by the coordinated expression of numerous hypoxia-responsive genes, many of which are controlled by hypoxia-inducible factor-1 (HIF-1). However, the cellular response to hypoxia is not likely to be mediated by HIF-1 alone, and little is known about HIF-1-independent hypoxia responses. To better establish the molecular mechanisms of HIF-1-independent hypoxia responses, we sought to characterize the molecular basis of the hypoxia response of the hsp-16.1 gene in the nematode Caenorhabditis elegans; this gene has been shown to be induced by hypoxia independently of hif-1. Using affinity purification followed by LC-MS/MS, we identified HMG-1.2 as a protein that binds to a specific promoter region under hypoxic conditions. By systematic prediction followed by validation of these interactions through RNAi, we identified the chromatin modifiers isw-1 and hda-1, histone H4, and NURF-1 chromatin-remodeling factors as new components of the hif-1-independent hypoxia response. These data suggest that the modulation of nucleosome positioning at the hsp-16.1 promoter may be important for the hypoxia response. In addition, we found that calcineurin acts independently of hif-1 to modulate the cellular response to hypoxia and that calcium ions are necessary for the induction of hsp-16.1 under hypoxic conditions.	[Lee, Jihyun; Lee, Junho] Seoul Natl Univ, Dept Biol Sci, WCU Dept Biophys & Chem Biol, Inst Mol Biol & Genet,Res Ctr Cellul, Seoul 151742, South Korea	Seoul National University (SNU)	Lee, J (corresponding author), Seoul Natl Univ, Dept Biol Sci, WCU Dept Biophys & Chem Biol, Inst Mol Biol & Genet,Res Ctr Cellul, 56-1 Gwanak Gu, Seoul 151742, South Korea.	elegans@snu.ac.kr	Lee, Junho/AAO-4706-2021		World Class University Program; Research Center for Functional Cellulomics; Korea Student Aid Foundation (KOSAF) from the Korean Government [S2-2009-000-01151-1]	World Class University Program; Research Center for Functional Cellulomics; Korea Student Aid Foundation (KOSAF) from the Korean Government	This work was supported in part by the World Class University Program and the Research Center for Functional Cellulomics.; Supported by Korea Student Aid Foundation (KOSAF) Grant S2-2009-000-01151-1 from the Korean Government.	Andersen EC, 2006, DEVELOPMENT, V133, P2695, DOI 10.1242/dev.02444; Bandyopadhyay J, 2002, MOL BIOL CELL, V13, P3281, DOI 10.1091/mbc.E02-01-0005; Bonaldi T, 2002, EMBO J, V21, P6865, DOI 10.1093/emboj/cdf692; BRENNER S, 1974, GENETICS, V77, P71; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; BUCKLER KJ, 1994, J PHYSIOL-LONDON, V476, P423, DOI 10.1113/jphysiol.1994.sp020143; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Chang AJ, 2008, P NATL ACAD SCI USA, V105, P7321, DOI 10.1073/pnas.0802164105; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; DIXON DK, 1990, DNA CELL BIOL, V9, P177, DOI 10.1089/dna.1990.9.177; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gdula DA, 1998, GENE DEV, V12, P3206, DOI 10.1101/gad.12.20.3206; Georgel PT, 1997, EMBO J, V16, P4717, DOI 10.1093/emboj/16.15.4717; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Hong M, 2004, J MOL BIOL, V344, P369, DOI 10.1016/j.jmb.2004.09.077; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Jiang LI, 1999, GENE DEV, V13, P877, DOI 10.1101/gad.13.7.877; JONES D, 1989, DNA-J MOLEC CELL BIO, V8, P481, DOI 10.1089/dna.1.1989.8.481; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lee I, 2010, GENOME RES, V20, P1143, DOI 10.1101/gr.102749.109; Lehner Ben, 2008, Briefings in Functional Genomics & Proteomics, V7, P217, DOI 10.1093/bfgp/eln020; Mabon ME, 2009, GENETICS, V181, P483, DOI 10.1534/genetics.108.097188; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; Mizukami Y, 2007, CLIN CANCER RES, V13, P5670, DOI 10.1158/1078-0432.CCR-07-0111; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; STROS M, 1994, FEBS LETT, V344, P201, DOI 10.1016/0014-5793(94)00364-5; STROS M, 1990, BIOCHEM INT, V21, P891; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Treinin M, 2003, PHYSIOL GENOMICS, V14, P17, DOI 10.1152/physiolgenomics.00179.2002; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Von Stetina SE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-226; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Zhong H, 1999, CANCER RES, V59, P5830	51	15	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1582	1589		10.1074/jbc.M112.401554	http://dx.doi.org/10.1074/jbc.M112.401554			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23229554	Green Published, hybrid			2022-12-28	WOS:000313751400014
J	Theesfeld, CL; Hampton, RY				Theesfeld, Chandra L.; Hampton, Randolph Y.			Insulin-induced Gene Protein (INSIG)-dependent Sterol Regulation of Hmg2 Endoplasmic Reticulum-associated Degradation (ERAD) in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE DEGRADATION; SACCHAROMYCES-CEREVISIAE; COA REDUCTASE; MEMBRANE-PROTEIN; (HMG)-COA REDUCTASE; UBIQUITIN LIGASE; INSIG; CHOLESTEROL; SIGNAL; IDENTIFICATION	Insulin-induced gene proteins (INSIGs) function in control of cellular cholesterol. Mammalian INSIGs exert control by directly interacting with proteins containing sterol-sensing domains (SSDs) when sterol levels are elevated. Mammalian 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase (HMGR) undergoes sterol-dependent, endoplasmic-reticulum (ER)-associated degradation (ERAD) that is mediated by INSIG interaction with the HMGR SSD. The yeast HMGR isozyme Hmg2 also undergoes feedback-regulated ERAD in response to the early pathway-derived isoprene gernanylgeranyl pyrophosphate (GGPP). Hmg2 has an SSD, and its degradation is controlled by the INSIG homologue Nsg1. However, yeast Nsg1 promotes Hmg2 stabilization by inhibiting GGPP-stimulated ERAD. We have proposed that the seemingly disparate INSIG functions can be unified by viewing INSIGs as sterol-dependent chaperones of SSD clients. Accordingly, we tested the role of sterols in the Nsg1 regulation of Hmg2. We found that both Nsg1-mediated stabilization of Hmg2 and the Nsg1-Hmg2 interaction required the early sterol lanosterol. Lowering lanosterol in the cell allowed GGPP-stimulated Hmg2 ERAD. Thus, Hmg2-regulated degradation is controlled by a two-signal logic; GGPP promotes degradation, and lanosterol inhibits degradation. These data reveal that the sterol dependence of INSIG-client interaction has been preserved for over 1 billion years. We propose that the INSIGs are a class of sterol-dependent chaperones that bind to SSD clients, thus harnessing ER quality control in the homeostasis of sterols.	[Theesfeld, Chandra L.; Hampton, Randolph Y.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu			National Institutes of Health, NIGMS, National Research Service [5F32GM82195, 5R01DK051996]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051996, R37DK051996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082195] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS, National Research Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, National Research Service Award 5F32GM82195 (to C. L. T.) and Grant 5R01DK051996 (to R. Y. H.).	BASSON ME, 1986, P NATL ACAD SCI USA, V83, P5563, DOI 10.1073/pnas.83.15.5563; BROWN MS, 1980, J LIPID RES, V21, P505; Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Crowley JH, 1998, CURR GENET, V34, P93, DOI 10.1007/s002940050371; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; NEAL WD, 1977, J BACTERIOL, V129, P1375, DOI 10.1128/JB.129.3.1375-1378.1977; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Nguyen AD, 2009, J BIOL CHEM, V284, P26778, DOI 10.1074/jbc.M109.032342; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; SIKORSKI RS, 1989, GENETICS, V122, P19; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Ter Linde JJM, 2002, YEAST, V19, P825, DOI 10.1002/yea.879; Theesfeld CL, 2011, J BIOL CHEM, V286, P26298, DOI 10.1074/jbc.M111.244798; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697	36	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8519	8530		10.1074/jbc.M112.404517	http://dx.doi.org/10.1074/jbc.M112.404517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23306196	Green Published, hybrid			2022-12-28	WOS:000316564500048
J	Bae, JS; Koo, NY; Namkoong, E; Davies, AJ; Choi, SK; Shin, Y; Jin, M; Hwang, SM; Mikoshiba, K; Park, K				Bae, Jun-Seok; Koo, Na-Youn; Namkoong, Eun; Davies, Alexander J.; Choi, Seul-Ki; Shin, Yonghwan; Jin, Meihong; Hwang, Sung-Min; Mikoshiba, Katsuhiko; Park, Kyungpyo			Chaperone Stress 70 Protein (STCH) Binds and Regulates Two Acid/Base Transporters NBCe1-B and NHE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGER ISOFORM 1; NA+/H+ EXCHANGER; SALIVARY-GLANDS; ATPASE DOMAIN; PH REGULATION; COTRANSPORTER; EXPRESSION; CANCER; CALCIUM; CELLS	Regulation of intracellular pH is critical for the maintenance of cell homeostasis in response to stress. We used yeast two-hybrid screening to identify novel interacting partners of the pH-regulating transporter NBCe1-B. We identified Hsp70-like stress 70 protein chaperone (STCH) as interacting with NBCe1-B at the N-terminal (amino acids 96-440) region. Co-injection of STCH and NBCe1-B cRNA into Xenopus oocytes significantly increased surface expression of NBCe1-B and enhanced bicarbonate conductance compared with NBCe1-B cRNA alone. STCH siRNA decreased the rate of Na+-dependent pH(i) recovery from NH4+ pulse-induced acidification in an HSG (human submandibular gland ductal) cell line. We observed that in addition to NBCe1-B, Na+/H+ exchanger (NHE)-dependent pHi recovery was also impaired by STCH siRNA and further confirmed the interaction of STCH with NHE1 but not plasma membrane Ca2+ ATPase. Both NBCe1-B and NHE1 interactions were dependent on a specific 45-amino acid region of STCH. In conclusion, we identify a novel role of STCH in the regulation of pHi through site-specific interactions with NBCe1-B and NHE1 and subsequent modulation of membrane transporter expression. We propose STCH may play a role in pHi regulation at times of cellular stress by enhancing the recovery from intracellular acidification.	[Bae, Jun-Seok; Koo, Na-Youn; Namkoong, Eun; Davies, Alexander J.; Choi, Seul-Ki; Shin, Yonghwan; Jin, Meihong; Hwang, Sung-Min; Park, Kyungpyo] Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul 110749, South Korea; [Bae, Jun-Seok; Koo, Na-Youn; Namkoong, Eun; Davies, Alexander J.; Choi, Seul-Ki; Shin, Yonghwan; Jin, Meihong; Hwang, Sung-Min; Park, Kyungpyo] Dent Res Inst, Seoul 110749, South Korea; [Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan	Seoul National University (SNU); RIKEN	Park, K (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral Physiol, Yeongeon Dong 28, Seoul 110749, South Korea.	kppark@snu.ac.kr	Mikoshiba, Katsuhiko/N-7943-2015	Davies, Alexander/0000-0003-0072-1708	National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea [2011-0028231]	National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea(National Research Foundation of Korea)	This work was supported by a National Research Foundation of Korea grant through the Oromaxillofacial Dysfunction Research Center for the Elderly (2011-0028231) at Seoul National University in Korea.	Aoki M, 2005, BIOCHEM BIOPH RES CO, V335, P566, DOI 10.1016/j.bbrc.2005.07.110; Boedtkjer E, 2012, CURR PHARM DESIGN, V18, P1345, DOI 10.2174/138161212799504830; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Choi SY, 2006, J DENT RES, V85, P839, DOI 10.1177/154405910608500912; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; DYCK JRB, 1995, CARDIOVASC RES, V29, P203, DOI 10.1016/S0008-6363(96)88571-3; Groet J, 1998, GENOME RES, V8, P385, DOI 10.1101/gr.8.4.385; Han Pu, 2011, Zhonghua Yi Xue Za Zhi, V91, P2314; He PJ, 2008, J BIOL CHEM, V283, P33544, DOI 10.1074/jbc.M805534200; Heimel JA, 2008, GENES BRAIN BEHAV, V7, P915, DOI 10.1111/j.1601-183X.2008.00431.x; HOHFELD J, 1995, CELL, V83, P589; Homann V, 2006, HISTOCHEM CELL BIOL, V125, P583, DOI 10.1007/s00418-005-0100-2; Hwang SM, 2011, J BIOL CHEM, V286, P1719, DOI 10.1074/jbc.M109.090951; Iurov I Iu, 2010, Genetika, V46, P1348; Kaye FJ, 2000, FEBS LETT, V467, P348, DOI 10.1016/S0014-5793(00)01135-2; Kemp G, 2008, CHANNELS, V2, P329, DOI 10.4161/chan.2.5.6898; Kim YB, 2003, BIOCHEM BIOPH RES CO, V304, P593, DOI 10.1016/S0006-291X(03)00632-6; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Lee SK, 2012, AM J PHYSIOL-CELL PH, V302, pC518, DOI 10.1152/ajpcell.00352.2011; Li J, 2006, AM J PHYSIOL-GASTR L, V291, pG1031, DOI 10.1152/ajpgi.00483.2005; Loo SY, 2012, CURR PHARM DESIGN, V18, P1372; Matsushita M, 2011, AM J PHYSIOL-CELL PH, V301, pC280, DOI 10.1152/ajpcell.00404.2010; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; OTTERSON GA, 1994, EMBO J, V13, P1216, DOI 10.1002/j.1460-2075.1994.tb06371.x; Otterson GA, 1997, GENE, V199, P287, DOI 10.1016/S0378-1119(97)00383-1; Park K, 2002, ARCH ORAL BIOL, V47, P1, DOI 10.1016/S0003-9969(01)00098-X; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; RAO GN, 1993, AM J PHYSIOL, V264, pC1278, DOI 10.1152/ajpcell.1993.264.5.C1278; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Roussa E, 2001, HISTOCHEM J, V33, P337, DOI 10.1023/A:1012471023913; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; SILVA NLCL, 1995, BIOCHEMISTRY-US, V34, P10412, DOI 10.1021/bi00033a013; TOMBAUGH GC, 1993, J NEUROCHEM, V61, P793, DOI 10.1111/j.1471-4159.1993.tb03589.x; Wanamaker CP, 2007, J BIOL CHEM, V282, P31113, DOI 10.1074/jbc.M705369200; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Worsham MJ, 2012, J ONCOL, V2012, DOI 10.1155/2012/752860; Xue J, 2007, AM J PHYSIOL-REG I, V292, pR2406, DOI 10.1152/ajpregu.00859.2006; Yamagata N, 2008, BIOCHEM BIOPH RES CO, V376, P499, DOI 10.1016/j.bbrc.2008.09.013; Yang DK, 2011, J CLIN INVEST, V121, P956, DOI 10.1172/JCI43475; Yao H, 2004, CELL CALCIUM, V36, P247, DOI 10.1016/j.ceca.2004.02.013	41	20	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6295	6305		10.1074/jbc.M112.392001	http://dx.doi.org/10.1074/jbc.M112.392001			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23303189	Green Published, hybrid			2022-12-28	WOS:000315820700024
J	Chapman, ALP; Mocatta, TJ; Shiva, S; Seidel, A; Chen, B; Khalilova, I; Paumann-Page, ME; Jameson, GNL; Winterbourn, CC; Kettle, AJ				Chapman, Anna L. P.; Mocatta, Tessa J.; Shiva, Sruti; Seidel, Antonia; Chen, Brian; Khalilova, Irada; Paumann-Page, Martina E.; Jameson, Guy N. L.; Winterbourn, Christine C.; Kettle, Anthony J.			Ceruloplasmin Is an Endogenous Inhibitor of Myeloperoxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; CATALYZED OXIDATION; COMPOUND-I; PROTEIN; KINETICS; ASSOCIATION	Myeloperoxidase is a neutrophil enzyme that promotes oxidative stress in numerous inflammatory pathologies. It uses hydrogen peroxide to catalyze the production of strong oxidants including chlorine bleach and free radicals. A physiological defense against the inappropriate action of this enzyme has yet to be identified. We found that myeloperoxidase oxidized 75% of the ascorbate in plasma from ceruloplasmin knock-out mice, but there was no significant loss in plasma from wild type animals. When myeloperoxidase was added to human plasma it became bound to other proteins and was reversibly inhibited. Ceruloplasmin was the predominant protein associated with myeloperoxidase. When the purified proteins were mixed, they became strongly but reversibly associated. Ceruloplasmin was a potent inhibitor of purified myeloperoxidase, inhibiting production of hypochlorous acid by 50% at 25 nM. Ceruloplasmin rapidly reduced Compound I, the FeV redox intermediate of myeloperoxidase, to Compound II, which has Fe-IV in its heme prosthetic groups. It also prevented the fast reduction of Compound II by tyrosine. In the presence of chloride and hydrogen peroxide, ceruloplasmin converted myeloperoxidase to Compound II and slowed its conversion back to the ferric enzyme. Collectively, our results indicate that ceruloplasmin inhibits myeloperoxidase by reducing Compound I and then trapping the enzyme as inactive Compound II. We propose that ceruloplasmin should provide a protective shield against inadvertent oxidant production by myeloperoxidase during inflammation.	[Chapman, Anna L. P.; Mocatta, Tessa J.; Chen, Brian; Khalilova, Irada; Paumann-Page, Martina E.; Winterbourn, Christine C.; Kettle, Anthony J.] Univ Otago, Ctr Free Rad Res, Dept Pathol, Christchurch 8140, New Zealand; [Seidel, Antonia; Jameson, Guy N. L.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Shiva, Sruti] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15261 USA	University of Otago; University of Otago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kettle, AJ (corresponding author), Univ Otago, Ctr Free Rad Res, POB 4345, Christchurch 8140, New Zealand.	tony.kettle@otago.ac.nz	Jameson, Guy N. L./J-3258-2015; Khalilova, Irada/AGF-0824-2022; Khalilova, Irada/I-5103-2015	Jameson, Guy N. L./0000-0001-9416-699X; Khalilova, Irada/0000-0002-4238-3113; Kettle, Tony/0000-0002-8218-7766	Health Research Council of New Zealand; University of Otago	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago	This work was supported by the Health Research Council of New Zealand.; Supported by a University of Otago doctoral scholarship.	Auchere F, 2001, EUR J BIOCHEM, V268, P2889, DOI 10.1046/j.1432-1327.2001.02175.x; Auchere F, 1999, BIOCHEM J, V343, P603, DOI 10.1042/0264-6021:3430603; Bakhautdin B, 2013, GUT, V62, P209, DOI 10.1136/gutjnl-2011-300694; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Bielli P, 2002, CELL MOL LIFE SCI, V59, P1413, DOI 10.1007/s00018-002-8519-2; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Buss IH, 2003, PEDIATR RES, V53, P455, DOI 10.1203/01.PDR.0000050655.25689.CE; Carr AC, 2000, FEBS LETT, V487, P176, DOI 10.1016/S0014-5793(00)02227-4; CHESNEY JA, 1991, ANAL BIOCHEM, V196, P262, DOI 10.1016/0003-2697(91)90463-4; Da Costa LA, 2013, J NUTR BIOCHEM, V24, P396, DOI 10.1016/j.jnutbio.2012.08.012; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Dunford HB, 1999, BIOCHEM CELL BIOL, V77, P449, DOI 10.1139/bcb-77-5-449; Dypbukt JM, 2005, FREE RADICAL BIO MED, V39, P1468, DOI 10.1016/j.freeradbiomed.2005.07.008; EHRENWALD E, 1994, J CLIN INVEST, V93, P1493, DOI 10.1172/JCI117127; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Griffin SV, 1999, KIDNEY INT, V55, P917, DOI 10.1046/j.1523-1755.1999.055003917.x; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; GUTTERIDGE JMC, 1980, MED LAB SCI, V37, P267; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; HARRISON JE, 1980, BIOCHEM BIOPH RES CO, V94, P34, DOI 10.1016/S0006-291X(80)80183-5; Heinecke JW, 2002, TOXICOLOGY, V177, P11, DOI 10.1016/S0300-483X(02)00192-0; Jantschko W, 2005, BIOCHEM PHARMACOL, V69, P1149, DOI 10.1016/j.bcp.2005.02.006; Jennette JC, 2011, CURR OPIN NEPHROL HY, V20, P263, DOI 10.1097/MNH.0b013e3283456731; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; KETTLE AJ, 1991, BIOCHEM PHARMACOL, V41, P1485, DOI 10.1016/0006-2952(91)90565-M; KETTLE AJ, 1989, BIOCHEM J, V263, P823, DOI 10.1042/bj2630823; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; Kim IG, 1998, FEBS LETT, V431, P473, DOI 10.1016/S0014-5793(98)00817-5; Klebanoff S. J., 2013, J LEUKOC BI IN PRESS; MANTTARI M, 1994, EUR HEART J, V15, P1599; MARQUEZ LA, 1993, ARCH BIOCHEM BIOPHYS, V305, P414, DOI 10.1006/abbi.1993.1440; MARQUEZ LA, 1994, BIOCHEMISTRY-US, V33, P1447, DOI 10.1021/bi00172a022; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Meotti FC, 2008, FREE RADICAL BIO MED, V44, P109, DOI 10.1016/j.freeradbiomed.2007.09.017; Mocatta TJ, 2007, J AM COLL CARDIOL, V49, P1993, DOI 10.1016/j.jacc.2007.02.040; Naito Y, 2007, J GASTROENTEROL, V42, P787, DOI 10.1007/s00535-007-2096-y; Nicholls SJ, 2009, J LIPID RES, V50, pS346, DOI 10.1194/jlr.R800086-JLR200; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; Ochs RS, 2000, J CHEM EDUC, V77, P1453, DOI 10.1021/ed077p1453; Park YS, 2000, FREE RADICAL RES, V33, P261, DOI 10.1080/10715760000301421; Prutz WA, 2000, ARCH BIOCHEM BIOPHYS, V380, P181, DOI 10.1006/abbi.2000.1914; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; SCHRAUFSTATTER IU, 1990, J CLIN INVEST, V85, P554, DOI 10.1172/JCI114472; Segelmark M, 1997, CLIN EXP IMMUNOL, V108, P167, DOI 10.1046/j.1365-2249.1997.d01-992.x; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Sokolov AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P409, DOI 10.1134/S0006297907040074; Sokolov AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1225, DOI 10.1134/S0006297909110078; Sokolov AV, 2010, CHEM PHYS LIPIDS, V163, P347, DOI 10.1016/j.chemphyslip.2010.02.002; Sokolov AV, 2008, FREE RADICAL RES, V42, P989, DOI 10.1080/10715760802566574; Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P516, DOI 10.1161/ATVBAHA.111.237040; TAYLOR JC, 1982, AM REV RESPIR DIS, V126, P476; Thomson E, 2010, FREE RADICAL BIO MED, V49, P1354, DOI 10.1016/j.freeradbiomed.2010.07.010; Tiden AK, 2011, J BIOL CHEM, V286, P37578, DOI 10.1074/jbc.M111.266981; Tien M, 1999, ARCH BIOCHEM BIOPHYS, V367, P61, DOI 10.1006/abbi.1999.1226; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Vasilyev VB, 2010, BIOCHEM SOC T, V38, P947, DOI 10.1042/BST0380947; Vile GF, 2000, ARCH BIOCHEM BIOPHYS, V377, P122, DOI 10.1006/abbi.2000.1706; Vissers MCM, 2001, J BIOL CHEM, V276, P46835, DOI 10.1074/jbc.M107664200; WALKER FJ, 1990, J BIOL CHEM, V265, P1834; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Winterbourn CC, 2000, CRIT CARE MED, V28, P143, DOI 10.1097/00003246-200001000-00024; Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Ximenes VF, 2010, BIOCHEM J, V425, P285, DOI 10.1042/BJ20090776; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	74	86	88	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6465	6477		10.1074/jbc.M112.418970	http://dx.doi.org/10.1074/jbc.M112.418970			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23306200	Green Published, hybrid			2022-12-28	WOS:000315820700040
J	Jayakar, SS; Dailey, WP; Eckenhoff, RG; Cohen, JB				Jayakar, Selwyn S.; Dailey, William P.; Eckenhoff, Roderic G.; Cohen, Jonathan B.			Identification of Propofol Binding Sites in a Nicotinic Acetylcholine Receptor with a Photoreactive Propofol Analog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; NONCOMPETITIVE ANTAGONIST; GENERAL-ANESTHETICS; GABA(A) RECEPTOR; ETOMIDATE; POTENTIATION; DESENSITIZATION; SUBUNIT; STATE	Propofol, a widely used intravenous general anesthetic, acts at anesthetic concentrations as a positive allosteric modulator of gamma-aminobutyric acid type A receptors and at higher concentration as an inhibitor of nicotinic acetylcholine receptors (nAChRs). Here, we characterize propofol binding sites in a muscle-type nAChR by use of a photoreactive analog of propofol, 2-isopropyl-5-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenol (AziPm). Based upon radioligand binding assays, AziPm stabilized the Torpedo nAChR in the resting state, whereas propofol stabilized the desensitized state. nAChR-rich membranes were photolabeled with [H-3] AziPm, and labeled amino acids were identified by Edman degradation. [H-3] AziPm binds at three sites within the nAChR transmembrane domain: (i) an intrasubunit site in the delta subunit helix bundle, photolabeling in the nAChR desensitized state (+agonist) delta M2-18' and two residues in delta M1 (delta Phe-232 and delta Cys-236); (ii) in the ion channel, photolabeling in the nAChR resting, closed channel state (-agonist) amino acids in the M2 helices (alpha M2-6', beta M2-6' and -13', and delta M2-13') that line the channel lumen (with photolabeling reduced by >90% in the desensitized state); and (iii) at the gamma-alpha interface, photolabeling alpha M2-10'. Propofol enhanced [H-3] AziPm photolabeling at alpha M2-10'. Propofol inhibited [H-3]AziPm photolabeling within the delta subunit helix bundle at lower concentrations (IC50 = 40 mu M) than it inhibited ion channel photolabeling (IC50 = 125 mu M). These results identify for the first time a single intrasubunit propofol binding site in the nAChR transmembrane domain and suggest that this is the functionally relevant inhibitory binding site.	[Jayakar, Selwyn S.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Dailey, William P.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Eckenhoff, Roderic G.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Cohen, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu		Jayakar, Selwyn/0000-0002-5792-6408; Eckenhoff, Roderic/0000-0002-5581-746X	National Institutes of Health from the United States Public Health Service [GM-58448, GM-55876]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876, P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-58448 (to J. B. C. and K. W. M.) and GM-55876 (to R. G. E.) from the United States Public Health Service.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; Bertaccini EJ, 2010, J CHEM INF MODEL, V50, P2248, DOI 10.1021/ci100266c; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BOYD ND, 1984, BIOCHEMISTRY-US, V23, P4023, DOI 10.1021/bi00313a003; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Chiara DC, 2009, BIOCHEMISTRY-US, V48, P10066, DOI 10.1021/bi901271w; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Flood P, 1997, ANESTHESIOLOGY, V86, P859, DOI 10.1097/00000542-199704000-00016; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Garcia G, 2007, BIOCHEMISTRY-US, V46, P10296, DOI 10.1021/bi7008163; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Hamouda AK, 2011, J BIOL CHEM, V286, P20466, DOI 10.1074/jbc.M111.219071; Hamouda AK, 2008, BIOCHEMISTRY-US, V47, P12787, DOI 10.1021/bi801476j; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Middleton RE, 1999, MOL PHARMACOL, V56, P290, DOI 10.1124/mol.56.2.290; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; NEUBIG RR, 1982, BIOCHEMISTRY-US, V21, P3460, DOI 10.1021/bi00257a032; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; OSWALD RE, 1983, BIOCHEMISTRY-US, V22, P3128, DOI 10.1021/bi00282a015; Pratt MB, 2000, J BIOL CHEM, V275, P29441, DOI 10.1074/jbc.M004710200; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SIGRIST H, 1990, J PHOTOCH PHOTOBIO B, V7, P277, DOI 10.1016/1011-1344(90)85162-P; Stewart DS, 2011, J MED CHEM, V54, P8124, DOI 10.1021/jm200943f; TAYLOR P, 1983, CURR TOP MEMBR TRANS, V18, P407; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Violet JM, 1997, ANESTHESIOLOGY, V86, P866, DOI 10.1097/00000542-199704000-00017; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITE BH, 1991, J BIOL CHEM, V266, P21595; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Yamodo IH, 2010, BIOCHEMISTRY-US, V49, P156, DOI 10.1021/bi901550p; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	42	61	61	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6178	6189		10.1074/jbc.M112.435909	http://dx.doi.org/10.1074/jbc.M112.435909			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300078	Green Published, hybrid			2022-12-28	WOS:000315820700014
J	Leung, JWC; Ghosal, G; Wang, WQ; Shen, X; Wang, JD; Li, L; Chen, JJ				Leung, Justin Wai-Chung; Ghosal, Gargi; Wang, Wenqi; Shen, Xi; Wang, Jiadong; Li, Lei; Chen, Junjie			Alpha Thalassemia/Mental Retardation Syndrome X-linked Gene Product ATRX Is Required for Proper Replication Restart and Cellular Resistance to Replication Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE; MENTAL-RETARDATION; GENOMIC INTEGRITY; HISTONE CHAPERONE; S PHASE; PROTEIN; MUTATIONS; CELLS; RECOMBINATION	Alpha thalassemia/mental retardation syndrome X-linked (ATRX) is a member of the SWI/SNF protein family of DNA-dependent ATPases. It functions as a chromatin remodeler and is classified as an SNF2-like helicase. Here, we showed somatic knock-out of ATRX displayed perturbed S-phase progression as well as hypersensitivity to replication stress. ATRX is recruited to sites of DNA damage, required for efficient checkpoint activation and faithful replication restart. In addition, we identified ATRX as a binding partner of MRE11-RAD50-NBS1 (MRN) complex. Together, these results suggest a non-canonical function of ATRX in guarding genomic stability.	[Leung, Justin Wai-Chung; Ghosal, Gargi; Wang, Wenqi; Shen, Xi; Wang, Jiadong; Li, Lei; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 66, 1515 Holcombe Blvd,Room Y3-6006, Houston, TX 77030 USA.	jchen8@mdanderson.org		Wang, Wenqi/0000-0003-4053-5088; Ghosal, Gargi/0000-0001-8399-5354; Leung, Justin Wai Chung/0000-0003-4601-390X	National Institutes of Health [CA089239, CA092312]; Dept. of Defense [W81XWH-05-1-0470]; NATIONAL CANCER INSTITUTE [R01CA089239, P30CA016672, R01CA092312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grants CA089239 and CA092312 (to J. C.) from the National Institutes of Health.; Recipient of an Era of Hope Scholar award from the Dept. of Defense (W81XWH-05-1-0470) and a member of the M. D. Anderson Cancer Center (CA016672).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Baumann C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001137; Boe SO, 2006, J CELL SCI, V119, P3284, DOI 10.1242/jcs.03068; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Cardoso C, 2000, J MED GENET, V37, P746, DOI 10.1136/jmg.37.10.746; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; De La Fuente R, 2011, REPRODUCTION, V142, P221, DOI 10.1530/REP-10-0380; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Draskovic I, 2009, P NATL ACAD SCI USA, V106, P15726, DOI 10.1073/pnas.0907689106; Falbo KB, 2009, NAT STRUCT MOL BIOL, V16, P1167, DOI 10.1038/nsmb.1686; Falck J, 2012, EMBO REP, V13, P561, DOI 10.1038/embor.2012.58; Ge XQ, 2010, J CELL BIOL, V191, P1285, DOI 10.1083/jcb.201007074; Ghosal G, 2012, J BIOL CHEM, V287, P34225, DOI 10.1074/jbc.M112.400135; Gibbons RJ, 2003, NAT GENET, V34, P446, DOI 10.1038/ng1213; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Higgs DR, 2005, ANN NY ACAD SCI, V1054, P92, DOI 10.1196/annals.1345.012; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huh MS, 2012, J CLIN INVEST, V122, P4412, DOI 10.1172/JCI63765; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Leung JWC, 2012, P NATL ACAD SCI USA, V109, P4491, DOI 10.1073/pnas.1118720109; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Ma HT, 2011, METHODS MOL BIOL, V761, P151, DOI 10.1007/978-1-61779-182-6_10; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Tittel-Elmer M, 2009, EMBO J, V28, P1142, DOI 10.1038/emboj.2009.60; Weston R, 2012, GENE DEV, V26, P1558, DOI 10.1101/gad.193516.112; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	41	63	65	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6342	6350		10.1074/jbc.M112.411603	http://dx.doi.org/10.1074/jbc.M112.411603			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23329831	Green Published, hybrid			2022-12-28	WOS:000315820700029
J	Bourgeois, S; Bounoure, L; Christensen, EI; Ramakrishnan, SK; Houillier, P; Devuyst, O; Wagner, CA				Bourgeois, Soline; Bounoure, Lisa; Christensen, Erik I.; Ramakrishnan, Suresh K.; Houillier, Pascal; Devuyst, Olivier; Wagner, Carsten A.			Haploinsufficiency of the Ammonia Transporter Rhcg Predisposes to Chronic Acidosis Rhcg IS CRITICAL FOR APICAL AND BASOLATERAL AMMONIA TRANSPORT IN THE MOUSE COLLECTING DUCT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THICK ASCENDING LIMB; C GLYCOPROTEIN; B GLYCOPROTEIN; KIDNEY; NH4+; RHBG; EXPRESSION; EXCRETION; BASE; K+	Ammonia secretion by the collecting duct (CD) is critical for acid-base homeostasis and, when defective, causes distal renal tubular acidosis (dRTA). The Rhesus protein RhCG mediates NH3 transport as evident from cell-free and cellular models as well as from Rhcg-null mice. Here, we investigated in a Rhcg mouse model the metabolic effects of Rhcg haploinsufficiency, the role of Rhcg in basolateral NH3 transport, and the mechanisms of adaptation to the lack of Rhcg. Both Rhcg(+/+) and Rhcg(+/-) mice were able to handle an acute acid load, whereas Rhcg(-/-) mice developed severe metabolic acidosis with reduced ammonuria and high mortality. However, chronic acid loading revealed that Rhcg(+/-) mice did not fully recover, showing lower blood HCO3- concentration and more alkaline urine. Microperfusion studies demonstrated that transepithelial NH3 permeability was reduced by 80 and 40%, respectively, in CDs from Rhcg(-/-) and Rhcg(+/-) mice compared with controls. Basolateral membrane permeability to NH3 was reduced in CDs from Rhcg(-/-) mice consistent with basolateral Rhcg localization. Rhcg(-/-) responded to acid loading with normal expression of enzymes and transporters involved in proximal tubular ammoniagenesis but reduced abundance of the NKCC2 transporter responsible for medullary accumulation of ammonium. Consequently, tissue ammonium content was decreased. These data demonstrate a role for apical and basolateral Rhcg in transepithelial NH3 transport and uncover an incomplete dRTA pheno-type in Rhcg(+/-) mice. Haploinsufficiency or reduced expression of RhCG may underlie human forms of (in)complete dRTA.	[Bourgeois, Soline; Bounoure, Lisa; Devuyst, Olivier; Wagner, Carsten A.] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Bourgeois, Soline; Bounoure, Lisa; Devuyst, Olivier; Wagner, Carsten A.] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Christensen, Erik I.] Univ Aarhus, Dept Biomed, DK-8000 Aarhus C, Denmark; [Ramakrishnan, Suresh K.; Houillier, Pascal] Ctr Rech Cordeliers, INSERM, UMRS872, F-75270 Paris, France; [Ramakrishnan, Suresh K.] Univ Paris 06, Fac Med, F-75015 Paris, France; [Houillier, Pascal] Univ Paris 05, F-75015 Paris, France; [Houillier, Pascal] Hop Europeen Georges Pompidou, AP HP, Dept Physiol, F-75015 Paris, France	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Wagner, CA (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	Wagnerca@access.uzh.ch	Houillier, Pascal/AAD-4903-2019	Houillier, Pascal/0000-0003-4953-6917; Devuyst, Olivier/0000-0003-3744-4767	Swiss National Science Foundation [3100A0-122217, 31003A_138143]; 7th European Union Framework Project EUNEFRON; Danish Medical Research Council; The Novo Nordisk Foundation; Swiss National Centre of Competence in Research; Erasmus Mundus External Cooperation Window Lot 15, India	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 7th European Union Framework Project EUNEFRON; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Novo Nordisk Foundation(Novo Nordisk Foundation); Swiss National Centre of Competence in Research; Erasmus Mundus External Cooperation Window Lot 15, India	This work was supported in part by Grants 3100A0-122217 and 31003A_138143 from the Swiss National Science Foundation (to C. A. W.), the 7th European Union Framework Project EUNEFRON (to P. H., E. I. C., O. D., and C. A. W.), the Danish Medical Research Council, The Novo Nordisk Foundation (to E. I. C.), and the Swiss National Centre of Competence in Research (to O. D. and C. A. W.).; Supported by Erasmus Mundus External Cooperation Window Lot 15, India.	Batlle D. C., 1985, RENAL TUBULAR DISORD, P281; BERTHELOT MPE, 1959, REP CHEM APPL, V1, P284, DOI DOI 10.1056/NEJMOA1708131; Bishop JM, 2010, AM J PHYSIOL-RENAL, V299, pF1065, DOI 10.1152/ajprenal.00277.2010; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; BLEICH M, 1995, PFLUG ARCH EUR J PHY, V429, P345, DOI 10.1007/BF00374149; Brown ACN, 2009, AM J PHYSIOL-RENAL, V296, pF1279, DOI 10.1152/ajprenal.00013.2009; Chambrey R, 2005, AM J PHYSIOL-RENAL, V289, pF1281, DOI 10.1152/ajprenal.00172.2005; CHRISTENSEN EI, 1995, EUR J CELL BIOL, V66, P349; CURTHOYS NP, 1976, ARCH BIOCHEM BIOPHYS, V172, P162, DOI 10.1016/0003-9861(76)90062-X; DUBOSE TD, 1991, J AM SOC NEPHROL, V1, P1193; Eladari D, 2002, J AM SOC NEPHROL, V13, P1999, DOI 10.1097/01.ASN.0000025280.02386.9D; FLESSNER MF, 1992, AM J PHYSIOL, V262, pF1, DOI 10.1152/ajprenal.1992.262.1.F1; GOOD DW, 1994, ANNU REV PHYSIOL, V56, P623, DOI 10.1146/annurev.ph.56.030194.003203; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; Hafner P, 2008, AM J PHYSIOL-CELL PH, V295, pC1658, DOI 10.1152/ajpcell.00419.2008; Hamm LL, 2008, SELDIN GIEBISCHS KID, P1539; Han KH, 2010, AM J PHYSIOL-RENAL, V299, pF187, DOI 10.1152/ajprenal.00607.2009; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; JONES ER, 1984, J CLIN INVEST, V74, P992, DOI 10.1172/JCI111520; JORGENSEN K, 1957, SCAND J CLIN LAB INV, V9, P287, DOI 10.3109/00365515709079972; KIKERI D, 1989, NATURE, V339, P478, DOI 10.1038/339478a0; Kim H. Y., 2009, AM J PHYSIOL-RENAL, V296, pF1364; Kim HY, 2009, AM J PHYSIOL-RENAL, V296, pF543, DOI 10.1152/ajprenal.90637.2008; Lee HW, 2009, AM J PHYSIOL-RENAL, V296, pF1364, DOI 10.1152/ajprenal.90667.2008; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Milton AE, 1998, AM J PHYSIOL-RENAL, V274, pF1086, DOI 10.1152/ajprenal.1998.274.6.F1086; Mouro-Chanteloup I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008921; NUTBOURNE D, 1961, CLIN SCI, V20, P263; PACKER RK, 1991, J AM SOC NEPHROL, V2, P77; Prabhakar SS, 2004, KIDNEY INT, V66, P1742, DOI 10.1111/j.1523-1755.2004.00951.x; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SEATON B, 1984, MED LAB SCI, V41, P327; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wagner CA, 2011, KIDNEY INT, V79, P154, DOI 10.1038/ki.2010.386; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Wall SM, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134827; Wall SM, 2002, AM J PHYSIOL-RENAL, V282, pF91, DOI 10.1152/ajprenal.0141.2001; WALL SM, 1994, AM J PHYSIOL-RENAL, V267, pF660, DOI 10.1152/ajprenal.1994.267.4.F660; WATTS BA, 1994, J BIOL CHEM, V269, P20250; Weiner ID, 2011, AM J PHYSIOL-RENAL, V300, pF11, DOI 10.1152/ajprenal.00554.2010; Zhelyaskov VR, 2000, KIDNEY INT, V57, P1764, DOI 10.1046/j.1523-1755.2000.00022.x	43	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5518	5529		10.1074/jbc.M112.441782	http://dx.doi.org/10.1074/jbc.M112.441782			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23281477	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000315342500026
J	Connolly, DJ; O'Neill, LAJ; McGettrick, AF				Connolly, Dympna J.; O'Neill, Luke A. J.; McGettrick, Anne F.			The GOLD Domain-containing Protein TMED1 Is Involved in Interleukin-33 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ACCESSORY PROTEIN; SUBCELLULAR-LOCALIZATION; P24 PROTEINS; SOLUBLE ST2; IL-33; PATHWAY; FAMILY; INFLAMMATION; TRANSPORT; CLONING	The proinflammatory danger signal IL-33, which is released from damaged or dying cells, achieves its effects via the IL-1R family member ST2L. The detection of IL-33 by ST2L initiates downstream signaling pathways that result in the activation of MAPKs and NF-kappa B. Here, we show that TMED1 associates with ST2L. Using a series of mutation and deletion constructs, we demonstrate that this interaction is mediated by the GOLD domain of TMED1 and the TIR domain of ST2L. Our findings also demonstrate that TMED1 is required for optimal IL-33-induced IL-8 and IL-6 production. This discovery provides additional support to the concept that the TMED family members are important players in innate immune signaling.	[Connolly, Dympna J.; O'Neill, Luke A. J.; McGettrick, Anne F.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland	Trinity College Dublin	Connolly, DJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Pearse St, Dublin 2, Ireland.	connoldj@tcd.ie		O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland.	Anantharaman V, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-5-RESEARCH0023; Boltz KA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-212; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Bulek K, 2009, J IMMUNOL, V182, P2601, DOI 10.4049/jimmunol.0802729; Carney GE, 2004, BIOL CELL, V96, P271, DOI 10.1016/j.biolcel.2004.01.004; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Doyle SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1706; Emery G, 2000, J CELL SCI, V113, P2507; Funakoshi-Tago M, 2008, CELL SIGNAL, V20, P1679, DOI 10.1016/j.cellsig.2008.05.013; Gayle MA, 1996, J BIOL CHEM, V271, P5784, DOI 10.1074/jbc.271.10.5784; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; Jun Y, 2011, BMB REP, V44, P369, DOI 10.5483/BMBRep.2011.44.6.369; Li HJ, 2000, GENOMICS, V67, P284, DOI 10.1006/geno.2000.6269; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Mirchandani AS, 2012, TRENDS IMMUNOL, V33, P389, DOI 10.1016/j.it.2012.04.005; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Tago K, 2001, BIOCHEM BIOPH RES CO, V285, P1377, DOI 10.1006/bbrc.2001.5306; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341	28	27	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5616	5623		10.1074/jbc.M112.403899	http://dx.doi.org/10.1074/jbc.M112.403899			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23319592	Green Published, hybrid			2022-12-28	WOS:000315342500035
J	Han, KD; Ahn, DH; Lee, SA; Min, YH; Kwon, AR; Ahn, HC; Lee, BJ				Han, Kyung-Doo; Ahn, Do-Hwan; Lee, Seung-A; Min, Yu-Hong; Kwon, Ae-Ran; Ahn, Hee-Chul; Lee, Bong-Jin			Identification of Chromosomal HP0892-HP0893 Toxin-Antitoxin Proteins in Helicobacter pylori and Structural Elucidation of Their Protein-Protein Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; RIBONUCLEASE; BACTERIA; SYSTEM; YAFQ; MECHANISM; AUTOPHAGY; ALIGNMENT; RIBOSOME	Bacterial chromosomal toxin-antitoxin (TA) systems have been proposed not only to play an important role in the stress response, but also to be associated with antibiotic resistance. Here, we identified the chromosomal HP0892-HP0893 TA proteins in the gastric pathogen, Helicobacter pylori, and structurally characterized their protein-protein interaction. Previously, HP0892 protein was suggested to be a putative TA toxin based on its structural similarity to other RelE family TA toxins. In this study, we demonstrated that HP0892 binds to HP0893 strongly with a stoichiometry of 1:1, and HP0892-HP0893 interaction occurs mainly between the N-terminal secondary structure elements of HP0892 and the C-terminal region of HP0893. HP0892 cleaved mRNA in vitro, preferentially at the 5' end of A or G, and the RNase activity of HP0892 was inhibited by HP0893. In addition, heterologous expression of HP0892 in Escherichia coli cells led to cell growth arrest, and the cell toxicity of HP0892 was neutralized by co-expression with HP0893. From these results and a structural comparison with other TA toxins, it is concluded that HP0892 is a toxin with intrinsic RNase activity and HP0893 is an antitoxin against HP0892 from a TA system of H. pylori. It has been known that hp0893 gene and another TA antitoxin gene, hp0895, of H. pylori, are both genomic open reading frames that correspond to genes that are potentially expressed in response to interactions with the human gastric mucosa. Therefore, it is highly probable that TA systems of H. pylori are involved in virulence of H. pylori.	[Han, Kyung-Doo] Korea Inst Sci & Technol, Adv Anal Ctr, Seoul 136791, South Korea; [Ahn, Do-Hwan; Lee, Seung-A; Lee, Bong-Jin] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Min, Yu-Hong; Kwon, Ae-Ran] Daegu Haany Univ, Dept Herbal Skin Care, Gyongsan 712715, Gyeongsangbuk D, South Korea; [Ahn, Hee-Chul] Dongguk Univ, Coll Pharm, Dept Pharm, Goyang 410820, Geonggi, South Korea	Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Daegu Haany University; Dongguk University	Lee, BJ (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea.	lbj@nmr.snu.ac.kr	Lee, Bong-Jin/AAQ-1609-2020	Lee, Bong-Jin/0000-0001-7896-2961	National Research Foundation of Korea [20110001207, 2012R1A2A1A01003569]; Korean Government (MEST); Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A084420, A092006]; Korea Healthcare Technology RD Project; Project for Medicine, Dentistry, and Pharmacy [2011 BK21]; Korea Institute of Science and Technology [2V02900]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Healthcare Technology RD Project; Project for Medicine, Dentistry, and Pharmacy; Korea Institute of Science and Technology(Korea Institute of Science & Technology (KIST))	This work was supported by National Research Foundation of Korea Grants 20110001207 and 2012R1A2A1A01003569 funded by the Korean Government (MEST); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea Grants A084420 and A092006; 2011 BK21 Project for Medicine, Dentistry, and Pharmacy; and Korea Institute of Science and Technology Grant 2V02900.	Armalyte J, 2012, J BACTERIOL, V194, P1523, DOI 10.1128/JB.06104-11; Blower TR, 2009, J BACTERIOL, V191, P6029, DOI 10.1128/JB.00720-09; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cover T. L., 2001, PRINCIPLES BACTERIAL, P509; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Graham JE, 2002, GASTROENTEROLOGY, V123, P1637, DOI 10.1053/gast.2002.36589; Han KD, 2005, PROTEINS, V61, P1114, DOI 10.1002/prot.20691; Han KD, 2008, PROTEINS, V70, P599, DOI 10.1002/prot.21701; Han KD, 2011, J BIOL CHEM, V286, P4842, DOI 10.1074/jbc.M109.097840; Hu Ming-Xi, 2010, Int J Microbiol, V2010, P781430, DOI 10.1155/2010/781430; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Matin A, 1996, INFECT IMMUN, V64, P1434, DOI 10.1128/IAI.64.4.1434-1436.1996; Motiejunaite R, 2007, FEMS MICROBIOL LETT, V268, P112, DOI 10.1111/j.1574-6968.2006.00563.x; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pellecchia M, 2002, NAT REV DRUG DISCOV, V1, P211, DOI 10.1038/nrd748; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Rothenbacher D, 2003, MICROBES INFECT, V5, P693, DOI 10.1016/S1286-4579(03)00111-4; Sachs G, 2003, ANNU REV PHYSIOL, V65, P349, DOI 10.1146/annurev.physiol.65.092101.142156; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Scott DR, 1998, GASTROENTEROLOGY, V114, P58, DOI 10.1016/S0016-5085(98)70633-X; Sevcik J, 1996, ACTA CRYSTALLOGR D, V52, P327, DOI 10.1107/S0907444995007669; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Terry CE, 2005, INFECT IMMUN, V73, P3794, DOI 10.1128/IAI.73.6.3794-3798.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Yakovlev GI, 2003, PROTEIN SCI, V12, P2367, DOI 10.1110/ps.03176803; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x	48	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					6004	6013		10.1074/jbc.M111.322784	http://dx.doi.org/10.1074/jbc.M111.322784			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297406	hybrid, Green Published			2022-12-28	WOS:000315342500068
J	Prindle, MJ; Schmitt, MW; Parmeggiani, F; Loeb, LA				Prindle, Marc J.; Schmitt, Michael W.; Parmeggiani, Fabio; Loeb, Lawrence A.			A Substitution in the Fingers Domain of DNA Polymerase delta Reduces Fidelity by Altering Nucleotide Discrimination in the Catalytic Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROOFREADING EXONUCLEASE; MOTIF-A; REPLICATION; ANTIMUTATOR; MUTANTS; EPSILON; BACTERIOPHAGE-T4; MUTATIONS; INCREASE	DNA polymerase delta (Pol delta) is one of the major replicative DNA polymerases in eukaryotic cells, catalyzing lagging strand synthesis as well as playing a role in many DNA repair pathways. The catalytic site for polymerization consists of a palm domain and mobile fingers domain that opens and closes each catalytic cycle. We explored the effect of amino acid substitutions in a region of the highly conserved sequence motif B in the fingers domain on replication fidelity. A novel substitution, A699Q, results in a marked increase in mutation rate at the yeast CAN1 locus, and is synthetic lethal with both proofreading deficiency and mismatch repair deficiency. Modeling the A699Q mutation onto the crystal structure of Saccharomyces cerevisiae Pol delta template reveals four potential contacts for A699Q but not for A699. We substituted alanine for each of these residues and determined that an interaction with multiple residues of the N-terminal domain is responsible for the mutator phenotype. The corresponding mutation in purified human Pol delta results in a similar 30-fold increase in mutation frequency when copying gapped DNA templates. Sequence analysis indicates that the most characteristic mutation is a guanine-to-adenine (G to A) transition. The increase in deoxythymidine 5'-triphosphate-G mispairs was confirmed by performing steady state single nucleotide addition studies. Our combined data support a model in which the Ala-to-Gln substitution in the fingers domain of Pol delta results in an interaction with the N-terminal domain that affects the base selectivity of the enzyme.	[Prindle, Marc J.; Schmitt, Michael W.; Loeb, Lawrence A.] Univ Washington, Joseph Gottstein Mem Lab, Dept Pathol, Seattle, WA 98195 USA; [Parmeggiani, Fabio; Loeb, Lawrence A.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Loeb, LA (corresponding author), Univ Washington, Sch Med, Box 357705, Seattle, WA 98195 USA.	laloeb@uw.edu	Parmeggiani, Fabio/P-3661-2019; Parmeggiani, Fabio/B-9344-2016	Parmeggiani, Fabio/0000-0001-8548-1090; Parmeggiani, Fabio/0000-0001-8548-1090	National Institutes of Health [CA15802, CA102029, POLCA77852]; Human Frontier Science Program long term fellowship; NATIONAL CANCER INSTITUTE [R01CA102029, P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program long term fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA15802, CA102029, and POLCA77852.; A recipient of a Human Frontier Science Program long term fellowship.	Bebenek K, 1995, METHOD ENZYMOL, V262, P217; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; Daee DL, 2010, P NATL ACAD SCI USA, V107, P157, DOI 10.1073/pnas.0907526106; Fazlieva R, 2009, NUCLEIC ACIDS RES, V37, P2854, DOI 10.1093/nar/gkp155; Flohr T, 1999, INT J CANCER, V80, P919, DOI 10.1002/(SICI)1097-0215(19990315)80:6<919::AID-IJC19>3.0.CO;2-U; Fortune JM, 2005, J BIOL CHEM, V280, P29980, DOI 10.1074/jbc.M505236200; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Herr AJ, 2011, CRIT REV BIOCHEM MOL, V46, P548, DOI 10.3109/10409238.2011.620941; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; JOYCE CM, 1995, J BACTERIOL, V177, P6321, DOI 10.1128/jb.177.22.6321-6329.1995; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Larrea AA, 2010, P NATL ACAD SCI USA, V107, P17674, DOI 10.1073/pnas.1010178107; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Loh E, 2007, J BIOL CHEM, V282, P12201, DOI 10.1074/jbc.M611294200; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; Ogawa M, 2003, J BIOL CHEM, V278, P19071, DOI 10.1074/jbc.M208605200; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Pavlov YI, 2001, GENETICS, V159, P47; Prindle MJ, 2012, ENVIRON MOL MUTAGEN, V53, P666, DOI 10.1002/em.21745; REHAKRANTZ LJ, 1994, J BIOL CHEM, V269, P5635; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Schaaper RM, 1998, GENETICS, V148, P1579; Schmitt MW, 2009, BIOCHIMIE, V91, P1163, DOI 10.1016/j.biochi.2009.06.007; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Suzuki M, 1997, J BIOL CHEM, V272, P11228; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Venkatesan RN, 2006, J BIOL CHEM, V281, P4486, DOI 10.1074/jbc.M510245200; Yang GW, 2002, BIOCHEMISTRY-US, V41, P2526, DOI 10.1021/bi0119924	31	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5572	5580		10.1074/jbc.M112.436410	http://dx.doi.org/10.1074/jbc.M112.436410			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23283971	Green Published, hybrid			2022-12-28	WOS:000315342500031
J	Tong, X; Zhang, DQ; Buelow, K; Guha, A; Arthurs, B; Brady, HJM; Yin, L				Tong, Xin; Zhang, Deqiang; Buelow, Katie; Guha, Anirvan; Arthurs, Blake; Brady, Hugh J. M.; Yin, Lei			Recruitment of Histone Methyltransferase G9a Mediates Transcriptional Repression of Fgf21 Gene by E4BP4 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR 21; REV-ERB-ALPHA; PPAR-ALPHA; CIRCADIAN EXPRESSION; HEPATIC EXPRESSION; METABOLIC SYNDROME; CLOCK; OBESITY; METHYLATION; FIBROBLAST-GROWTH-FACTOR-21	The liver responds to fasting-refeeding cycles by reprogramming expression of metabolic genes. Fasting potently induces one of the key hepatic hormones, fibroblast growth factor 21 (FGF21), to promote lipolysis, fatty acid oxidation, and ketogenesis, whereas refeeding suppresses its expression. We previously reported that the basic leucine zipper transcription factor E4BP4 (E4 binding protein 4) represses Fgf21 expression and disrupts its circadian oscillations in cultured hepatocytes. However, the epigenetic mechanism for E4BP4-dependent suppression of Fgf21 has not yet been addressed. Here we present evidence that histone methyltransferase G9a mediates E4BP4-dependent repression of Fgf21 during refeeding by promoting repressive histone modification. We find that Fgf21 expression is up-regulated in E4bp4 knock-out mouse liver. We demonstrate that the G9a-specific inhibitor BIX01294 abolishes suppression of the Fgf21 promoter activity by E4BP4, whereas overexpression of E4bp4 leads to increased levels of dimethylation of histone 3 lysine 9 (H3K9me2) around the Fgf21 promoter region. Furthermore, we also show that E4BP4 interacts with G9a, and knockdown of G9a blocks repression of Fgf21 promoter activity and expression in cells overexpressing E4bp4. A G9a mutant lacking catalytic activity, due to deletion of the SET domain, fails to inhibit the Fgf21 promoter activity. Importantly, acute hepatic knockdown by adenoviral shRNA targeting G9a abolishes Fgf21 repression by refeeding, concomitant with decreased levels of H3K9me2 around the Fgf21 promoter region. In summary, we show that G9a mediates E4BP4-dependent suppression of hepatic Fgf21 by enhancing histone methylation (H3K9me2) of the Fgf21 promoter.	[Tong, Xin; Zhang, Deqiang; Buelow, Katie; Guha, Anirvan; Arthurs, Blake; Yin, Lei] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Brady, Hugh J. M.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Immunol & Infect Sect, London SW7 2AZ, England	University of Michigan System; University of Michigan; Imperial College London	Yin, L (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	leiyin@umich.edu	Zhang, Deqiang/J-9199-2016	TONG, XIN/0000-0002-4832-8940; Guha, Anirvan/0000-0001-6018-1438; Buelow, Katie/0000-0002-2616-1756; Brady, Hugh/0000-0002-3152-067X	National Institutes of Health [K99/R00 DK 077449]; Michigan Diabetes Research Center [P600K020572]; Michigan Obesity and Nutrition Research Center [DK089503]; MRC [G0901737] Funding Source: UKRI; Medical Research Council [G0901737] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK077449, P30DK089503, P30DK020572, P60DK020572, R25DK088752, R00DK077449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research Center; Michigan Obesity and Nutrition Research Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant K99/R00 DK 077449 (to L.Y.). Part of this work was also supported by a pilot grants (to L.Y.) from the Michigan Diabetes Research Center (P600K020572) and Michigan Obesity and Nutrition Research Center (DK089503).	Adams AC, 2010, J BIOL CHEM, V285, P14078, DOI 10.1074/jbc.C110.107375; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Cowell IG, 1996, NUCLEIC ACIDS RES, V24, P3607, DOI 10.1093/nar/24.18.3607; Cowell IG, 2002, BIOESSAYS, V24, P1023, DOI 10.1002/bies.10176; COWELL IG, 1992, MOL CELL BIOL, V12, P3070, DOI 10.1128/MCB.12.7.3070; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Esteve PO, 2005, NUCLEIC ACIDS RES, V33, P3211, DOI 10.1093/nar/gki635; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lehnertz B, 2010, J EXP MED, V207, P915, DOI 10.1084/jem.20100363; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Oishi K, 2008, FEBS LETT, V582, P3639, DOI 10.1016/j.febslet.2008.09.046; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Takahashi S, 2010, J ATHEROSCLER THROMB, V17, P73, DOI 10.5551/jat.2410; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Uebanso T, 2012, J NUTR BIOCHEM, V23, P785, DOI 10.1016/j.jnutbio.2011.03.023; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Vila-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; ZHANG W, 1995, MOL CELL BIOL, V15, P6055; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	63	28	28	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5417	5425		10.1074/jbc.M112.433482	http://dx.doi.org/10.1074/jbc.M112.433482			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23283977	hybrid, Green Published			2022-12-28	WOS:000315342500017
J	Guo, YH; Fan, YB; Zhang, JF; Chang, L; Lin, JDD; Chen, YE				Guo, Yanhong; Fan, Yanbo; Zhang, Jifeng; Chang, Lin; Lin, Jiandie D.; Chen, Y. Eugene			Peroxisome Proliferator-activated Receptor gamma Coactivator 1 beta (PGC-1 beta) Protein Attenuates Vascular Lesion Formation by Inhibition of Chromatin Loading of Minichromosome Maintenance Complex in Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; DNA-REPLICATION; MCM PROTEINS; INDUCIBLE COACTIVATOR; GROWTH-FACTOR; METFORMIN; CANCER; ALPHA; PGC-1-ALPHA; EXPRESSION	Proliferation of vascular smooth muscle cells (VSMCs) in response to vascular injury plays a critical role in vascular lesion formation. Emerging data suggest that peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1) is a key regulator of energy metabolism and other biological processes. However, the physiological role of PGC-1 beta in VSMCs remains unknown. A decrease in PGC-1 beta expression was observed in balloon-injured rat carotid arteries. PGC-1 beta overexpression substantially inhibited neointima formation in vivo and markedly inhibited VSMC proliferation and induced cell cycle arrest at the G(1)/S transition phase in vitro. Accordingly, overexpression of PGC-1 beta decreased the expression of minichromosome maintenance 4 (MCM4), which leads to a decreased loading of the MCM complex onto chromatin at the replication origins and decreased cyclin D1 levels, whereas PGC-1 beta loss of function by adenovirus containing PGC-1 beta shRNA resulted in the opposite effect. The transcription factor AP-1 was involved in the down-regulation of MCM4 expression. Furthermore, PGC-1 beta is up-regulated by metformin, and metformin-associated anti-proliferative activity in VSMCs is at least partially dependent on PGC-1 beta. Our data show that PGC-1 beta is a critical component in regulating DNA replication, VSMC proliferation, and vascular lesion formation, suggesting that PGC-1 beta may emerge as a novel therapeutic target for control of proliferative vascular diseases.	[Guo, Yanhong; Fan, Yanbo; Zhang, Jifeng; Chang, Lin; Chen, Y. Eugene] Univ Michigan, Ctr Cardiovasc, Dept Internal Med, Ann Arbor, MI 48109 USA; [Lin, Jiandie D.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Lin, Jiandie D.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chen, YE (corresponding author), Univ Michigan, Ctr Cardiovasc, MSRB 3 7200,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	echenum@umich.edu	Fan, Yanbo/AAD-4710-2020; GUO, Yanhong/B-5325-2012; Fan, Yanbo/C-6360-2013	Fan, Yanbo/0000-0002-3845-7562; Fan, Yanbo/0000-0002-3845-7562	National Institutes of Health [HL068878, HL105114, HL089544]; American Heart Association [10POST3270008, 09SDG2230270, 0835237N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089544, R01HL105114, R01HL068878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL068878, HL105114, and HL089544 (to Y. E. C.). This work was also supported by American Heart Association Grants 10POST3270008 (to Y. F.), 09SDG2230270 (to L. C.), and 0835237N (to J. Z.).	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Bailey CJ, 2008, CARDIOVASC DRUG THER, V22, P215, DOI 10.1007/s10557-008-6092-0; Barnes DM, 1998, BREAST CANCER RES TR, V52, P1, DOI 10.1023/A:1006103831990; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Blaschke F, 2004, CIRC RES, V95, pE110, DOI 10.1161/01.RES.0000150368.56660.4f; Bonta PI, 2010, CIRCULATION, V121, P2023, DOI 10.1161/CIRCULATIONAHA.109.885673; Bost F, 2012, CURR OPIN ONCOL, V24, P103, DOI 10.1097/CCO.0b013e32834d8155; Boyle JG, 2010, DIABETIC MED, V27, P1097, DOI 10.1111/j.1464-5491.2010.03098.x; Bruemmer D, 2003, EXP CELL RES, V290, P28, DOI 10.1016/S0014-4827(03)00311-2; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Delerive P, 2002, J BIOL CHEM, V277, P3913, DOI 10.1074/jbc.M109409200; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Fan YB, 2011, J BIOL CHEM, V286, P40584, DOI 10.1074/jbc.M111.232918; Fu MG, 2001, J BIOL CHEM, V276, P45888, DOI 10.1074/jbc.M105490200; Gallagher EJ, 2011, ANN NY ACAD SCI, V1243, P54, DOI 10.1111/j.1749-6632.2011.06285.x; Giaginis C, 2010, HISTOL HISTOPATHOL, V25, P351, DOI 10.14670/HH-25.351; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Gizard F, 2005, J CLIN INVEST, V115, P3228, DOI 10.1172/JCI22756; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Hemandez C, 2010, CELL METAB, V12, P411, DOI 10.1016/j.cmet.2010.09.001; Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kikuchi J, 2011, LUNG CANCER, V72, P229, DOI 10.1016/j.lungcan.2010.08.020; Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Lee JW, 2001, CELL MOL LIFE SCI, V58, P289, DOI 10.1007/PL00000856; Lei M, 2005, CURR CANCER DRUG TAR, V5, P365, DOI 10.2174/1568009054629654; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Liu BL, 2011, CELL CYCLE, V10, P2959, DOI 10.4161/cc.10.17.16359; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Mamputu JC, 2003, DIABETES METAB, V29, pS71; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qu AJ, 2009, AM J PHYSIOL-CELL PH, V297, pC645, DOI 10.1152/ajpcell.00469.2008; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; SHARMA RV, 1995, CLIN EXP HYPERTENS, V17, P913, DOI 10.3109/10641969509033643; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wu YF, 2002, J BIOL CHEM, V277, P8898, DOI 10.1074/jbc.M110761200; Xiong SQ, 2010, J BIOL CHEM, V285, P2474, DOI 10.1074/jbc.M109.065235; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Yu ST, 2007, BBA-MOL CELL BIOL L, V1771, P936, DOI 10.1016/j.bbalip.2007.01.008; Zhang JF, 2002, J BIOL CHEM, V277, P11505, DOI 10.1074/jbc.M110580200; Zhu L, 2009, IEEE PHOTONICS J, V1, P1, DOI 10.1109/JPHOT.2009.2020963	57	7	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4625	4636		10.1074/jbc.M112.407452	http://dx.doi.org/10.1074/jbc.M112.407452			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264620	Green Published, hybrid			2022-12-28	WOS:000315340400012
J	Rouhana, J; Padilla, A; Estaran, S; Bakari, S; Delbecq, S; Boublik, Y; Chopineau, J; Pugniere, M; Chavanieu, A				Rouhana, Jad; Padilla, Andre; Estaran, Sebastien; Bakari, Sana; Delbecq, Stephan; Boublik, Yvan; Chopineau, Joel; Pugniere, Martine; Chavanieu, Alain			Kinetics of Interaction between ADP-ribosylation Factor-1 (Arf1) and the Sec7 Domain of Arno Guanine Nucleotide Exchange Factor, Modulation by Allosteric Factors, and the Uncompetitive Inhibitor Brefeldin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RAS SUPERFAMILY; RHO GTPASES; FAMILY; ACTIVATION; PROTEINS; MECHANISM; ROLES; MG2+; GDP	The GDP/GTP nucleotide exchange of Arf1 is catalyzed by nucleotide exchange factors (GEF), such as Arno, which act through their catalytic Sec7 domain. This exchange is a complex mechanism that undergoes conformational changes and intermediate complex species involving several allosteric partners such as nucleotides, Mg2+, and Sec7 domains. Using a surface plasmon resonance approach, we characterized the kinetic binding parameters for various intermediate complexes. We first confirmed that both GDP and GTP counteract equivalently to the free-nucleotide binary Arf1-Arno complex stability and revealed that Mg2+ potentiates by a factor of 2 the allosteric effect of GDP. Then we explored the uncompetitive inhibitory mechanism of brefeldin A (BFA) that conducts to an abortive pentameric Arf1-Mg2+-GDP-BFA-Sec7 complex. With BFA, the association rate of the abortive complex is drastically reduced by a factor of 42, and by contrast, the 15-fold decrease of the dissociation rate concurs to stabilize the pentameric complex. These specific kinetic signatures have allowed distinguishing the level and nature as well as the fate in real time of formed complexes according to experimental conditions. Thus, we showed that in the presence of GDP, the BFA-resistant Sec7 domain of Arno can also associate to form a pentameric complex, which suggests that the uncompetitive inhibition by BFA and the nucleotide allosteric effect combine to stabilize such abortive complex.	[Rouhana, Jad; Estaran, Sebastien; Bakari, Sana; Chavanieu, Alain] Univ Montpellier I, CNRS, UMR 5247, IBMM,Fac Pharm, F-34093 Montpellier 5, France; [Rouhana, Jad; Estaran, Sebastien; Bakari, Sana; Chavanieu, Alain] Univ Montpellier 2, CNRS, UMR 5247, IBMM,Fac Pharm, F-34093 Montpellier 5, France; [Pugniere, Martine] Univ Montpellier I, INSERM, U896, CRLC Val dAurelle Paul Lamarque,IRCM, F-34298 Montpellier, France; [Padilla, Andre] CNRS, INSERM, UMR 5048, Ctr Biochim Struct,U554, F-34090 Montpellier, France; [Padilla, Andre] Univ Montpellier 1 & 2, F-34090 Montpellier, France; [Boublik, Yvan] Univ Montpellier 2, CNRS, UMR 5237, Ctr Rech Biochim Macromol, F-34293 Montpellier, France; [Boublik, Yvan] Univ Montpellier I, CNRS, UMR 5237, Ctr Rech Biochim Macromol, F-34293 Montpellier, France; [Delbecq, Stephan] Univ Montpellier I, Fac Pharm, Biol Cellulaire & Mol Lab, EA Vaccinat Antiparasitaire 4558, F-34093 Montpellier, France; [Chopineau, Joel] UM1, UM2, ENSCM, Inst Charles Gerhardt Montpellier,CNRS,UMR 5253, F-34296 Montpellier, France; [Chopineau, Joel] Univ Nimes, F-30000 Nimes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universite de Nimes	Chavanieu, A (corresponding author), Univ Montpellier I, CNRS, UMR 5247, IBMM,Fac Pharm, 15 Ave Charles Flahault,BP14491, F-34093 Montpellier 5, France.	alain.chavanieu@univ-montp1.fr	chopineau, joel/J-6674-2015; PUGNIERE, Martine/AAD-4315-2020; Pugniere, Martine/T-1355-2017	chopineau, joel/0000-0001-8307-0167; PUGNIERE, Martine/0000-0002-2049-2909; Pugniere, Martine/0000-0002-2049-2909; Delbecq, Stephane/0000-0002-2813-1219; PADILLA, ANDRE/0000-0001-9702-4612	MENRT (Ministere de l'Education Nationale, de la Recherche et de la Technologie) grant from the French government	MENRT (Ministere de l'Education Nationale, de la Recherche et de la Technologie) grant from the French government	Recipient of a MENRT (Ministere de l'Education Nationale, de la Recherche et de la Technologie) grant from the French government.	AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Ben Hamida-Rebai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009142; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Boal F, 2010, TRAFFIC, V11, P1537, DOI 10.1111/j.1600-0854.2010.01122.x; Boulay PL, 2011, ONCOGENE, V30, P3846, DOI 10.1038/onc.2011.100; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; CHANG CH, 1983, BIOCHEMISTRY-US, V22, P600, DOI 10.1021/bi00272a012; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Goody RS, 2002, EUR BIOPHYS J BIOPHY, V31, P268, DOI 10.1007/s00249-002-0225-3; GREASLEY SE, 1995, NAT STRUCT BIOL, V2, P797, DOI 10.1038/nsb0995-797; Guo Z, 2005, BIOCHEMISTRY-US, V44, P15423, DOI 10.1021/bi0518601; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heasman Sarah J, 2010, Small GTPases, V1, P174, DOI 10.4161/sgtp.1.3.14724; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jian XY, 2012, J BIOL CHEM, V287, P24273, DOI 10.1074/jbc.M112.368084; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kolanus W, 2007, IMMUNOL REV, V218, P102, DOI 10.1111/j.1600-065X.2007.00542.x; Kremer W, 2004, J BIOL CHEM, V279, P17004, DOI 10.1074/jbc.M312780200; Kumano-Kuramochi M, 2008, J BIOCHEM, V143, P229, DOI 10.1093/jb/mvm213; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Moss J, 2002, ARCH BIOCHEM BIOPHYS, V397, P156, DOI 10.1006/abbi.2001.2661; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; Ohashi Y, 2012, J BIOL CHEM, V287, P3885, DOI 10.1074/jbc.M111.316125; Okamura H, 2011, STRUCTURE, V19, P988, DOI 10.1016/j.str.2011.04.007; Pan JY, 1998, BIOESSAYS, V20, P516, DOI 10.1002/(SICI)1521-1878(199806)20:6<516::AID-BIES11>3.0.CO;2-3; Papalia G, 2010, ANAL BIOCHEM, V403, P30, DOI 10.1016/j.ab.2010.03.044; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Pommier Y, 2005, TRENDS PHARMACOL SCI, V26, P138, DOI 10.1016/j.tips.2005.01.008; Rao YJ, 2006, BIOCHEM BIOPH RES CO, V348, P908, DOI 10.1016/j.bbrc.2006.07.148; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; Smith WJ, 2005, BIOCHEMISTRY-US, V44, P13282, DOI 10.1021/bi050591b; Soundararajan M, 2008, PROTEINS, V72, P498, DOI 10.1002/prot.22017; Stalder D, 2011, J BIOL CHEM, V286, P3873, DOI 10.1074/jbc.M110.145532; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200; Zhang BL, 2005, BIOCHEMISTRY-US, V44, P2566, DOI 10.1021/bi048755w; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200	53	9	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4659	4672		10.1074/jbc.M112.391748	http://dx.doi.org/10.1074/jbc.M112.391748			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23255605	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000315340400015
J	Henderson, MJ; Richie, CT; Airavaara, M; Wang, Y; Harvey, BK				Henderson, Mark J.; Richie, Christopher T.; Airavaara, Mikko; Wang, Yun; Harvey, Brandon K.			Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) Secretion and Cell Surface Binding Are Modulated by KDEL Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM STRESS-RESPONSE; BREFELDIN-A; PROTEIN; EXPRESSION; ER; THAPSIGARGIN; CHAPERONE; ISCHEMIA; DYNAMICS; REVEALS	Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an endoplasmic reticulum (ER) stress-responsive protein with neuroprotective effects in animal models of neuro-degeneration, but the underlying mechanism is not understood. We constructed a set of lentiviral vectors that contain or lack the highly conserved final four amino acids of MANF ("RTDL"), which resemble the canonical ER retention signal ("KDEL"), to study MANF regulation in neuroblastoma cells and rat primary cortical neurons. The RTDL sequence was required for both ER retention and secretory response to ER stress. Overexpression of KDEL receptor paralogs (KDELRs) differentially reduced MANF secretion but had no effect on MANF lacking RTDL. MANF binding to the plasma membrane also required the RTDL sequence and was inhibited with a peptide known to interact with KDELRs, suggesting MANF binds KDELRs at the surface. We detected surface localization of FLAG-tagged KDELRs, with levels increasing following ER stress. Our study provides new insight into the regulation of MANF trafficking and has implications for other secreted proteins containing a KDEL-like retention signal.	[Henderson, Mark J.; Richie, Christopher T.; Airavaara, Mikko; Wang, Yun; Harvey, Brandon K.] NIDA, Intramural Res Program, Baltimore, MD 21224 USA; [Airavaara, Mikko] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; [Wang, Yun] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Helsinki; National Health Research Institutes - Taiwan	Harvey, BK (corresponding author), NIDA, Intramural Res Program, Ste 200,Rm 06A729,251 Bayview Blvd, Baltimore, MD 21224 USA.	BHarvey@intra.nida.nih.gov	Harvey, Brandon Keith/AAY-4080-2021	Harvey, Brandon Keith/0000-0002-4036-1383; Airavaara, Mikko/0000-0002-2026-1609; Henderson, Mark/0000-0001-8590-7338	National Institutes of Health Intramural Research Program, National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000443, ZICDA000555, ZIADA000576, ZIADA000461, ZIADA000429] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, National Institute on Drug Abuse.	Airavaara M, 2010, EXP NEUROL, V225, P104, DOI 10.1016/j.expneurol.2010.05.020; Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Alanen HI, 2011, J MOL BIOL, V409, P291, DOI 10.1016/j.jmb.2011.03.070; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Berger CL, 1997, INT J CANCER, V71, P1077; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; CLARK CC, 1994, J ORTHOPAED RES, V12, P601, DOI 10.1002/jor.1100120502; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Engelsberg A, 2003, J BIOL CHEM, V278, P22998, DOI 10.1074/jbc.M301361200; Giannotta M, 2012, EMBO J, V31, P2869, DOI 10.1038/emboj.2012.134; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Glembotski CC, 2011, J MOL CELL CARDIOL, V51, P512, DOI 10.1016/j.yjmcc.2010.10.008; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Hessler JL, 1997, BIOCHEMISTRY-US, V36, P14577, DOI 10.1021/bi971447w; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; HSU VW, 1992, CELL, V69, P625, DOI 10.1016/0092-8674(92)90226-3; Kim Y, 2006, BIOCHEMISTRY-US, V45, P9434, DOI 10.1021/bi060264j; LENCER WI, 1995, J CELL BIOL, V131, P951, DOI 10.1083/jcb.131.4.951; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Oh-hashi K, 2012, MOL CELL BIOCHEM, V363, P35, DOI 10.1007/s11010-011-1155-0; Palgi M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-134; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; POWELL MF, 1992, J PHARM SCI, V81, P731, DOI 10.1002/jps.2600810802; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Saudek V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030876; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Wang P, 2011, NEUROSCIENCE, V190, P43, DOI 10.1016/j.neuroscience.2011.06.008; WILSON DW, 1993, J BIOL CHEM, V268, P7465; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Yu YQ, 2010, J CEREBR BLOOD F MET, V30, P79, DOI 10.1038/jcbfm.2009.181	40	92	92	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4209	4225		10.1074/jbc.M112.400648	http://dx.doi.org/10.1074/jbc.M112.400648			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23255601	Green Published, hybrid			2022-12-28	WOS:000314845000048
J	Johnson, DT; Luong, R; Lee, SH; Peng, Y; Shaltouki, A; Lee, JT; Lin, D; Wang, YZ; Sun, ZJ				Johnson, Daniel T.; Luong, Richard; Lee, Suk Hyung; Peng, Yue; Shaltouki, Atossa; Lee, Jane T.; Lin, Dong; Wang, Yuzhuo; Sun, Zijie			Deletion of Leucine Zipper Tumor Suppressor 2 (Lzts2) Increases Susceptibility to Tumor Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIAS-LIKE PROTEIN; BETA-CATENIN; NUCLEAR EXPORT; SUBCELLULAR-LOCALIZATION; MICE; GENE; EXPRESSION; HZIMP10; LAPSER1	Using an Lzts2 knock-out mouse model, we characterized the biological role of Lzts2 in tumorigenesis. Both heterozygous and homozygous deletion of the Lzts2-targeted allele in mice shows an increased incidence in spontaneous tumor development, although Lzts2 homozygous knock-out mice show significantly higher incidences than heterozygous mice. Treatment of Lzts2-deficient mice with a carcinogen, N-butyl-N-(4-hydroxybutyl) nitrosamine, increases the susceptibility to N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder carcinoma development. Examination of human prostate cancer tissue specimens shows a reduction of LZTS2 protein expression in prostate cancer cells. Further analyses of mouse embryonic fibroblasts isolated from Lzts2 knock-out embryos show that loss of Lzts2 enhances cell growth. These data provide the first line of evidence demonstrating that deletion of Lzts2 increases susceptibility to spontaneous and carcinogen-induced tumor development.	[Johnson, Daniel T.; Lee, Suk Hyung; Peng, Yue; Shaltouki, Atossa; Lee, Jane T.; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Johnson, Daniel T.; Lee, Suk Hyung; Peng, Yue; Shaltouki, Atossa; Lee, Jane T.; Sun, Zijie] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; [Lin, Dong; Wang, Yuzhuo] British Columbia Canc Agcy, Dept Canc Endocrinol, Vancouver, BC V5Z 1L3, Canada	Stanford University; Stanford University; Stanford University; British Columbia Cancer Agency	Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, S287 Grant Bldg, Stanford, CA 94305 USA.	zsun@stanford.edu		Wang, Yuzhuo/0000-0002-9749-8591; Johnson, Daniel/0000-0003-4669-037X	Public Health Service from National Cancer Institute [CA-070297, CA-151623]; NATIONAL CANCER INSTITUTE [R29CA070297, R01CA151623, R01CA070297] Funding Source: NIH RePORTER	Public Health Service from National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service Grants CA-070297 and CA-151623 from the National Cancer Institute.	Baffa R, 2008, CARCINOGENESIS, V29, P846, DOI 10.1093/carcin/bgn006; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Cabeza-Arvelaiz Y, 2001, ONCOGENE, V20, P6707, DOI 10.1038/sj.onc.1204866; Cho HH, 2008, BBA-MOL CELL RES, V1783, P419, DOI 10.1016/j.bbamcr.2007.08.005; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eleftheriou A, 2001, J BIOL CHEM, V276, P25883, DOI 10.1074/jbc.M102656200; Farson D, 2001, HUM GENE THER, V12, P981, DOI 10.1089/104303401750195935; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Ishii H, 1999, P NATL ACAD SCI USA, V96, P3928, DOI 10.1073/pnas.96.7.3928; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Lin D, 2008, CANCER RES, V68, P4352, DOI 10.1158/0008-5472.CAN-07-5237; Lubet RA, 2005, CARCINOGENESIS, V26, P571, DOI 10.1093/carcin/bgh352; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Peng Y, 2011, J BIOL CHEM, V286, P40331, DOI 10.1074/jbc.M111.302059; Peng Y, 2010, J BIOL CHEM, V285, P11465, DOI 10.1074/jbc.M109.079327; RASHEED BKA, 1995, ONCOGENE, V10, P2243; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schmeisser MJ, 2009, J BIOL CHEM, V284, P29146, DOI 10.1074/jbc.M109.020628; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Sudo H, 2008, HUM MOL GENET, V17, P2524, DOI 10.1093/hmg/ddn153; Sudo H, 2007, FASEB J, V21, P2086, DOI 10.1096/fj.06-7254com; Teufel A, 2005, ONCOL REP, V14, P547; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Vecchione A, 2001, CLIN CANCER RES, V7, P1546; Vecchione A, 2007, CANCER CELL, V11, P275, DOI 10.1016/j.ccr.2007.01.014; Verras M, 2004, CANCER RES, V64, P8860, DOI 10.1158/0008-5472.CAN-04-2370; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Weinstein MH, 2002, MODERN PATHOL, V15, P1302, DOI 10.1097/01.MP.0000038460.95912.6E; Wiechens N, 2001, CURR BIOL, V11, P18, DOI 10.1016/S0960-9822(00)00045-2	35	15	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3727	3738		10.1074/jbc.M112.417568	http://dx.doi.org/10.1074/jbc.M112.417568			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23275340	Green Published, hybrid			2022-12-28	WOS:000314845000005
J	Almabouada, F; Diaz-Ruiz, A; Rabanal-Ruiz, Y; Peinado, JR; Vazquez-Martinez, R; Malagon, MM				Almabouada, Farid; Diaz-Ruiz, Alberto; Rabanal-Ruiz, Yoana; Peinado, Juan R.; Vazquez-Martinez, Rafael; Malagon, Maria M.			Adiponectin Receptors Form Homomers and Heteromers Exhibiting Distinct Ligand Binding and Intracellular Signaling Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; RESONANCE ENERGY-TRANSFER; AGONIST-DEPENDENT DISSOCIATION; LIVING CELLS; GABA(B) RECEPTOR; DIMERIZATION; PATHWAYS; INFLAMMATION; ACTIVATION; ADIPOSE	Adiponectin binds to two widely expressed receptors (AdipoR1 and AdipoR2) that contain seven transmembrane domains but, unlike G-protein coupled receptors, present an extracellular C terminus and a cytosolic N terminus. Recently, AdipoR1 was found to associate in high order complexes. However, it is still unknown whether AdipoR2 may also form homomers or heteromers with AdipoR1 or if such interactions may be functionally relevant. Herein, we have analyzed the oligomerization pattern of AdipoRs by FRET and immunoprecipitation and evaluated both the internalization of AdipoRs in response to various adiponectin isoforms and the effect of adiponectin binding to different AdipoR combinations on AMP-activated protein kinase phosphorylation and peroxisome proliferator-activated receptor alpha activation. Transfection of HEK293AD cells with AdipoR1 and AdipoR2 showed that both receptors colocalize at both the plasma membrane and the endoplasmic reticulum. Co-transfection with the different AdipoR pairs yielded high FRET efficiencies in non-stimulated cells, which indicates that AdipoR1 and AdipoR2 form homo- and heteromeric complexes under resting conditions. Live FRET imaging suggested that both homo-and heteromeric AdipoR complexes dissociate in response to adiponectin, but heteromers separate faster than homomers. Finally, phosphorylation of AMP-activated protein kinase in response to adiponectin was delayed in cells wherein heteromer formation was favored. In sum, our findings indicate that AdipoR1 and AdipoR2 form homo-and heteromers that present unique interaction behaviors and signaling properties. This raises the possibility that the pleiotropic, tissue-dependent functions of adiponectin depend on the expression levels of AdipoR1 and AdipoR2 and, therefore, on the steady-state proportion of homo-and heteromeric complexes.	[Almabouada, Farid; Diaz-Ruiz, Alberto; Rabanal-Ruiz, Yoana; Vazquez-Martinez, Rafael; Malagon, Maria M.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba, Univ Hosp Reina Sofia, Cordoba 14014, Spain; [Almabouada, Farid; Diaz-Ruiz, Alberto; Rabanal-Ruiz, Yoana; Vazquez-Martinez, Rafael; Malagon, Maria M.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain; [Peinado, Juan R.] Univ Castilla La Mancha, Dept Med Sci, E-13071 Ciudad Real, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Castilla-La Mancha	Vazquez-Martinez, R (corresponding author), Univ Cordoba, Dept Cell Biol Physiol & Immunol, Campus Univ Rabanales, Cordoba 14014, Spain.	bc2vamar@uco.es; bc1mapom@uco.es	Peinado, Juan R/A-3450-2011; Rabanal, Yoana/R-9471-2019; Vazquez-Martinez, Rafael/G-1243-2016; Malagon, Maria M/L-5386-2014	Peinado, Juan R/0000-0002-0004-7963; Rabanal, Yoana/0000-0003-1904-8218; Malagon, Maria M/0000-0002-2419-2727; Diaz-Ruiz, Alberto/0000-0002-0488-4216	MINECO/FEDER [BFU2010-17116]; Andalucia/FEDER [CTS-03039, CTS-6606]; CIBER Fisiopatologia de la Obesidad y Nutricion (Instituto de Salud Carlos III), Spain	MINECO/FEDER; Andalucia/FEDER; CIBER Fisiopatologia de la Obesidad y Nutricion (Instituto de Salud Carlos III), Spain	This work was supported by MINECO/FEDER (BFU2010-17116), J. Andalucia/FEDER (CTS-03039, CTS-6606), and CIBER Fisiopatologia de la Obesidad y Nutricion (Instituto de Salud Carlos III), Spain.	Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; Buechler C, 2010, FEBS LETT, V584, P4280, DOI 10.1016/j.febslet.2010.09.035; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Chen XP, 2011, MED ONCOL, V28, P1288, DOI 10.1007/s12032-010-9617-x; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Duran-Prado M, 2008, MOL CELL ENDOCRINOL, V286, P63, DOI 10.1016/j.mce.2007.12.006; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Grant M, 2004, J BIOL CHEM, V279, P36179, DOI 10.1074/jbc.M407310200; Heiker JT, 2009, CELL SIGNAL, V21, P936, DOI 10.1016/j.cellsig.2009.02.003; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kosel D, 2010, J CELL SCI, V123, P1320, DOI 10.1242/jcs.057919; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Latif R, 2002, J BIOL CHEM, V277, P45059, DOI 10.1074/jbc.M206693200; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maenhaut N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-25; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Narasimhan ML, 2005, MOL CELL, V17, P171, DOI 10.1016/j.molcel.2004.11.050; O'Dowd BF, 2011, EUR J PHARMACOL, V658, P74, DOI 10.1016/j.ejphar.2011.02.030; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Vilardaga JP, 2010, J CELL SCI, V123, P4215, DOI 10.1242/jcs.063354; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vu V, 2007, DIABETES-METAB RES, V23, P600, DOI 10.1002/dmrr.778; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xu AM, 2012, AM J PHYSIOL-HEART C, V302, pH1231, DOI 10.1152/ajpheart.00765.2011; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zeug A, 2012, BIOPHYS J, V103, P1821, DOI 10.1016/j.bpj.2012.09.031; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357	56	41	42	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3112	3125		10.1074/jbc.M112.404624	http://dx.doi.org/10.1074/jbc.M112.404624			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255609	Green Published, hybrid			2022-12-28	WOS:000314397900020
J	Tran, MN; Choi, W; Wszolek, MF; Navai, N; Lee, ILC; Nitti, G; Wen, SJ; Flores, ER; Siefker-Radtke, A; Czerniak, B; Dinney, C; Barton, M; McConkey, DJ				Tran, Mai N.; Choi, Woonyoung; Wszolek, Matthew F.; Navai, Neema; Lee, I-Ling C.; Nitti, Giovanni; Wen, Sijin; Flores, Elsa R.; Siefker-Radtke, Arlene; Czerniak, Bogdan; Dinney, Colin; Barton, Michelle; McConkey, David J.			The p63 Protein Isoform Delta Np63 alpha Inhibits Epithelial-Mesenchymal Transition in Human Bladder Cancer Cells ROLE OF MIR-205	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL HUMAN KERATINOCYTES; STEM-CELLS; E-CADHERIN; UROTHELIAL NEOPLASMS; CARCINOMA-CELLS; MIR-200 FAMILY; BREAST-CANCER; HOST GENES; P-CADHERIN; IN-VIVO	Epithelial-mesenchymal transition (EMT) is a physiological process that plays important roles in tumor metastasis, "stemness," and drug resistance. EMT is typically characterized by the loss of the epithelial marker E-cadherin and increased expression of EMT-associated transcriptional repressors, including ZEB1 and ZEB2. The miR-200 family and miR-205 prevent EMT through suppression of ZEB1/2. p53 has been implicated in the regulation of miR-200c, but the mechanisms controlling miR-205 expression remain elusive. Here we report that the p53 family member and p63 isoform, Delta Np63 alpha, promotes miR-205 transcription and controls EMT in human bladder cancer cells. Delta Np63 alpha, E-cadherin and miR-205 were coexpressed in a panel of bladder cancer cell lines (n = 28) and a cohort of primary bladder tumors (n = 98). Stable knockdown of Delta Np63 alpha in the "epithelial" bladder cancer cell line UM-UC6 decreased the expression of miR-205 and induced the expression of ZEB1/2, effects that were reversed by expression of exogenous miR-205. Conversely, overexpression of Delta Np63 alpha in the "mesenchymal" bladder cancer cell line UM-UC3 induced miR-205 and suppressed ZEB1/2. Delta Np63 alpha knockdown reduced the expression of the primary and mature forms of miR-205 and the miR-205 "host" gene (miR-205HG) and decreased binding of RNA Pol II to the miR-205HG promoter, inhibiting miR-205HG transcription. Finally, high miR-205 expression was associated with adverse clinical outcomes in bladder cancer patients. Together, our data demonstrate that Delta Np63 alpha-mediated expression of miR-205 contributes to the regulation of EMT in bladder cancer cells and identify miR-205 as a molecular marker of the lethal subset of human bladder cancers.	[Dinney, Colin; McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77054 USA; [Siefker-Radtke, Arlene] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77054 USA; [McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77054 USA; [Flores, Elsa R.; Barton, Michelle] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77054 USA; [Czerniak, Bogdan] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77054 USA; [Wen, Sijin] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77054 USA; [Tran, Mai N.; Nitti, Giovanni; Flores, Elsa R.; Barton, Michelle; McConkey, David J.] Univ Texas Grad Sch Biomed Sci GSBS Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	McConkey, DJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA.	dmcconke@mdanderson.org		Barton, Michelle/0000-0002-4042-1374; Wen, Sijin/0000-0002-6955-2917; Dinney, Colin/0000-0002-8969-711X; Siefker-Radtke, Arlene/0000-0002-6328-9599	MD Anderson Bladder SPORE Grant [P50 CA91846]; Cancer Center Support Grant [P30 016672]; Vietnam Education Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA160394, R01CA151489, P50CA091846] Funding Source: NIH RePORTER	MD Anderson Bladder SPORE Grant; Cancer Center Support Grant; Vietnam Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by MD Anderson Bladder SPORE Grant P50 CA91846 and Cancer Center Support Grant P30 016672.; We thank the Vietnam Education Foundation for fellowship support to Mai Tran. We also thank Dr. Santosh Chauhan (Cancer Biology Department, University of Texas M.D. Anderson Cancer Center) for technical help with the ChIP experiments and Dr. Russell Braeuer (Cancer Biology Department, University of Texas M.D. Anderson Cancer Center) for help with the nuclear run-on experiments.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Blanpain C, 2007, NAT CELL BIOL, V9, P731, DOI 10.1038/ncb0707-731; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Choi W, 2012, PLOS ONE, V7, P453, DOI 10.1371/journal.pone.0030206; Chow SE, 2011, CANCER CHEMOTH PHARM, V68, P835, DOI 10.1007/s00280-010-1552-1; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Gandellini P, 2012, CELL DEATH DIFFER, V19, P1750, DOI 10.1038/cdd.2012.56; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jarrard DF, 1997, CLIN CANCER RES, V3, P2121; Johansson SL, 1997, SEMIN SURG ONCOL, V13, P291; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karni-Schmidt O, 2011, AM J PATHOL, V178, P1350, DOI 10.1016/j.ajpath.2010.11.061; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Koga F, 2003, BRIT J CANCER, V88, P740, DOI 10.1038/sj.bjc.6600764; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Kurzrock EA, 2008, AM J PHYSIOL-RENAL, V294, pF1415, DOI 10.1152/ajprenal.00533.2007; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marquis L, 2012, CANCER BIOL THER, V13, P477, DOI 10.4161/cbt.19590; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Oh JE, 2011, J BIOL CHEM, V286, P38757, DOI 10.1074/jbc.M111.244939; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Piovan C, 2012, MOL ONCOL, V6, P458, DOI 10.1016/j.molonc.2012.03.003; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rieger-Christ KM, 2001, HUM PATHOL, V32, P18, DOI 10.1053/hupa.2001.21140; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Roman S, 2007, AM J PHYSIOL-GASTR L, V293, pG45, DOI 10.1152/ajpgi.00583.2006; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Sabichi A, 2006, J UROLOGY, V175, P1133, DOI 10.1016/S0022-5347(05)00323-X; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shimomura Y, 2008, DEVELOPMENT, V135, P743, DOI 10.1242/dev.006718; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Tsai J. H., CANC CELL, V22, P725; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Westfall MD, 2004, CARCINOGENESIS, V25, P857, DOI 10.1093/carcin/bgh148; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yugawa T, 2010, CANCER RES, V70, P4034, DOI 10.1158/0008-5472.CAN-09-4063	55	101	102	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3275	3288		10.1074/jbc.M112.408104	http://dx.doi.org/10.1074/jbc.M112.408104			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23239884	Green Published, hybrid			2022-12-28	WOS:000314397900034
J	Harleton, E; Besana, A; Comas, GM; Danilo, P; Rosen, TS; Argenziano, M; Rosen, MR; Robinson, RB; Feinmark, SJ				Harleton, Erin; Besana, Alessandra; Comas, George M.; Danilo, Peter, Jr.; Rosen, Tove S.; Argenziano, Michael; Rosen, Michael R.; Robinson, Richard B.; Feinmark, Steven J.			Ability to Induce Atrial Fibrillation in the Peri-operative Period Is Associated with Phosphorylation-dependent Inhibition of TWIK Protein-related Acid-sensitive Potassium Channel 1 (TASK-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; MYOCARDIAL-ISCHEMIA-REPERFUSION; K+ CHANNEL; VENTRICULAR-FIBRILLATION; PAF-ANTAGONIST; ARRHYTHMIAS; REPOLARIZATION; INFLAMMATION; NEUTROPHILS; PERFUSION	Peri-operative atrial fibrillation (peri-op AF) is a common complication following thoracic surgery. This arrhythmia is thought to be triggered by an inflammatory response and can be reproduced in various animal models. Previous work has shown that the lipid inflammatory mediator, platelet-activating factor (PAF), synthesized by activated neutrophils, can induce atrial and ventricular arrhythmias as well as repolarization abnormalities in isolated ventricular myocytes. We have previously shown that carbamylated PAF-induced repolarization abnormalities result from the protein kinase C (PKC) epsilon-dependent phosphorylation of the two-pore domain potassium channel TASK-1. We now demonstrate that canine peri-op AF is associated with the phosphorylation-dependent loss of TASK-1 current. Further studies identified threonine 383 in the C terminus of human and canine TASK-1 as the phosphorylation site required for PAF-dependent inhibition of the channel. Using a novel phosphorylation site-specific antibody targeting the phosphorylated channel, we have determined that peri-op AF is associated with the loss of TASK-1 current and increased phosphorylation of TASK-1 at this site.	[Harleton, Erin; Besana, Alessandra; Danilo, Peter, Jr.; Rosen, Michael R.; Robinson, Richard B.; Feinmark, Steven J.] Columbia Univ, Med Ctr, Dept Pharmacol, New York, NY 10032 USA; [Comas, George M.; Argenziano, Michael] Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA; [Rosen, Tove S.; Rosen, Michael R.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Rosen, Michael R.; Robinson, Richard B.; Feinmark, Steven J.] Columbia Univ, Med Ctr, Ctr Mol Therapeut, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Feinmark, SJ (corresponding author), Columbia Univ, Med Ctr, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA.	sjf1@columbia.edu			National Institutes of Health from NHLBI [R01 HL70105, HL67101]; National Center for Advancing Translational Sciences [TL1 TR000082]; PhRMA Foundation; Institut de Recherches Servier; Thoracic Surgery Foundation for Research and Education;  [TL1 RR024158]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070105, R01HL067101] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); PhRMA Foundation; Institut de Recherches Servier; Thoracic Surgery Foundation for Research and Education; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL70105 (to S. J. F.) and HL67101 (to M. R. R.) from NHLBI and Grant TL1 TR000082 from National Center for Advancing Translational Sciences (formerly NCRR) and Grant TL1 RR024158. This work was also supported by grants from the PhRMA Foundation, Institut de Recherches Servier, and a career development award from the Thoracic Surgery Foundation for Research and Education (to M. A.).	Baker KE, 2006, BRIT J PHARMACOL, V149, P269, DOI 10.1038/sj.bjp.0706846; Baker KE, 1999, J CARDIOVASC PHARM, V34, P394, DOI 10.1097/00005344-199909000-00012; Baker KE, 2004, BRIT J PHARMACOL, V142, P352, DOI 10.1038/sj.bjp.0705767; Baker WL, 2007, ANN PHARMACOTHER, V41, P587, DOI 10.1345/aph.1H594; Barbuti A, 2002, AM J PHYSIOL-HEART C, V282, pH2024, DOI 10.1152/ajpheart.00956.2001; Besana A, 2004, J BIOL CHEM, V279, P33154, DOI 10.1074/jbc.M403525200; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; CHAKRABARTY S, 1992, BRIT J PHARMACOL, V107, P705, DOI 10.1111/j.1476-5381.1992.tb14510.x; Decher N, 2011, CELL PHYSIOL BIOCHEM, V28, P77, DOI 10.1159/000331715; Dhein S, 1995, CARDIOVASC RES, V30, P881, DOI 10.1016/S0008-6363(95)00131-X; Donner BC, 2011, BASIC RES CARDIOL, V106, P75, DOI 10.1007/s00395-010-0128-x; Ehrlich JR, 2005, CARDIOVASC RES, V67, P520, DOI 10.1016/j.cardiores.2005.03.007; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; FLORES NA, 1990, BRIT J PHARMACOL, V101, P734, DOI 10.1111/j.1476-5381.1990.tb14149.x; FREEMAN LC, 1990, AM J VET RES, V51, P174; Gaspo R, 1999, CARDIOVASC RES, V42, P434, DOI 10.1016/S0008-6363(99)00036-X; Gurney A, 2009, EUR BIOPHYS J BIOPHY, V38, P305, DOI 10.1007/s00249-008-0326-8; Hoffman BF, 1997, J CARDIOVASC ELECTR, V8, P679, DOI 10.1111/j.1540-8167.1997.tb01831.x; Hoffman BF, 1996, J CARDIOVASC ELECTR, V7, P120, DOI 10.1111/j.1540-8167.1996.tb00507.x; Hogue CW, 2005, CHEST, V128, p9S, DOI 10.1378/chest.128.2_suppl.9S; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Ishii Y, 2005, CIRCULATION, V111, P2881, DOI 10.1161/CIRCULATIONAHA.104.475194; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Kim D, 2005, CURR PHARM DESIGN, V11, P2717, DOI 10.2174/1381612054546824; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Limberg SH, 2011, CELL PHYSIOL BIOCHEM, V28, P613, DOI 10.1159/000335757; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; Montrucchio G, 2000, PHYSIOL REV, V80, P1669, DOI 10.1152/physrev.2000.80.4.1669; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; Nattel S, 2009, J PHYSIOL-LONDON, V587, P1385, DOI 10.1113/jphysiol.2009.170621; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Putzke C, 2007, CARDIOVASC RES, V75, P59, DOI 10.1016/j.cardiores.2007.02.025; Qayumi AK, 1998, ANN THORAC SURG, V65, P1690, DOI 10.1016/S0003-4975(98)00275-6; Ravens U, 2008, EUROPACE, V10, P1133, DOI 10.1093/europace/eun193; Stangl V, 2002, CARDIOVASC RES, V53, P12, DOI 10.1016/S0008-6363(01)00420-5	36	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2829	2838		10.1074/jbc.M112.404095	http://dx.doi.org/10.1074/jbc.M112.404095			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229553	Green Published, hybrid			2022-12-28	WOS:000314211500065
J	Shenkman, M; Groisman, B; Ron, E; Avezov, E; Hendershot, LM; Lederkremer, GZ				Shenkman, Marina; Groisman, Bella; Ron, Efrat; Avezov, Edward; Hendershot, Linda M.; Lederkremer, Gerardo Z.			A Shared Endoplasmic Reticulum-associated Degradation Pathway Involving the EDEM1 Protein for Glycosylated and Nonglycosylated Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; UBIQUITIN LIGASE COMPLEX; MANNOSIDASE-LIKE PROTEIN; QUALITY-CONTROL; MISFOLDED PROTEINS; LIGHT-CHAINS; DISULFIDE REDUCTASE; HEAVY-CHAIN; IN-VIVO; RETENTION	Studies of misfolded protein targeting to endoplasmic reticulum-associated degradation (ERAD) have largely focused on glycoproteins, which include the bulk of the secretory proteins. Mechanisms of targeting of nonglycosylated proteins are less clear. Here, we studied three nonglycosylated proteins and analyzed their use of known glycoprotein quality control and ERAD components. Similar to an established glycosylated ERAD substrate, the uncleaved precursor of asialoglycoprotein receptor H2a, its nonglycosylated mutant, makes use of calnexin, EDEM1, and HRD1, but only glycosylated H2a is a substrate for the cytosolic SCFFbs2 E3 ubiquitin ligase with lectin activity. Two nonglycosylated BiP substrates, NS-1 kappa light chain and truncated Ig gamma heavy chain, interact with the ERAD complex lectins OS-9 and XTP3-B and require EDEM1 for degradation. EDEM1 associates through a region outside of its mannosidase-like domain with the nonglycosylated proteins. Similar to glycosylated substrates, proteasomal inhibition induced accumulation of the nonglycosylated proteins and ERAD machinery in the endoplasmic reticulum-derived quality control compartment. Our results suggest a shared ERAD pathway for glycosylated and nonglycosylated proteins composed of luminal lectin machinery components also capable of protein-protein interactions.	[Shenkman, Marina; Groisman, Bella; Ron, Efrat; Avezov, Edward; Lederkremer, Gerardo Z.] Tel Aviv Univ, George Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	Tel Aviv University; St Jude Children's Research Hospital	Lederkremer, GZ (corresponding author), Tel Aviv Univ, George Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	gerardo@post.tau.ac.il	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Lederkremer, Gerardo/0000-0002-9857-7152; Avezov, Edward/0000-0002-2894-0585	Israel Science Foundation [1070/10]; German-Israeli Project Cooperation (Deutsch-Israelische Projektkooperation) [K 5-1]	Israel Science Foundation(Israel Science Foundation); German-Israeli Project Cooperation (Deutsch-Israelische Projektkooperation)	This work was supported in part by Grant 1070/10 from the Israel Science Foundation and German-Israeli Project Cooperation (Deutsch-Israelische Projektkooperation K 5-1).	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Benyair R, 2011, WORLD J GASTROENTERO, V17, P5305, DOI 10.3748/wjg.v17.i48.5305; Benyair R, 2011, INT REV CEL MOL BIO, V292, P197, DOI 10.1016/B978-0-12-386033-0.00005-0; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Chillaron J, 2000, MOL BIOL CELL, V11, P217, DOI 10.1091/mbc.11.1.217; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; Frenkel Z, 2003, J BIOL CHEM, V278, P34119, DOI 10.1074/jbc.M305929200; Frenkel Z, 2004, MOL BIOL CELL, V15, P2133, DOI 10.1091/mbc.E03-12-0899; Groisman B, 2006, ISRAEL J CHEM, V46, P189, DOI 10.1560/2QPD-9WP9-NCYK-58X3; Groisman B, 2011, J BIOL CHEM, V286, P1292, DOI 10.1074/jbc.M110.154849; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Izawa T, 2012, MOL BIOL CELL, V23, P1283, DOI 10.1091/mbc.E11-08-0722; Jaenicke LA, 2011, MOL BIOL CELL, V22, P2937, DOI 10.1091/mbc.E10-10-0832; Jakob CA, 2001, EMBO REP, V2, P423; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; MA J, 1990, MOL IMMUNOL, V27, P623, DOI 10.1016/0161-5890(90)90004-J; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Marin MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042998; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Ron E, 2011, MOL BIOL CELL, V22, P3945, DOI 10.1091/mbc.E10-12-0944; Shenkman M, 1997, P NATL ACAD SCI USA, V94, P11363, DOI 10.1073/pnas.94.21.11363; Shenkman M, 2000, J BIOL CHEM, V275, P2845, DOI 10.1074/jbc.275.4.2845; Skowronek MH, 1998, P NATL ACAD SCI USA, V95, P1574, DOI 10.1073/pnas.95.4.1574; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Tamura T, 2011, J BIOL CHEM, V286, P24906, DOI 10.1074/jbc.M111.243998; Tolchinsky S, 1996, J BIOL CHEM, V271, P14496, DOI 10.1074/jbc.271.24.14496; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Yamaguchi Y, 2007, BIOCHEM BIOPH RES CO, V362, P712, DOI 10.1016/j.bbrc.2007.08.056; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Yoshida Y, 2005, EMBO REP, V6, P239, DOI 10.1038/sj.embor.7400351	53	42	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2167	2178		10.1074/jbc.M112.438275	http://dx.doi.org/10.1074/jbc.M112.438275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233672	hybrid, Green Published			2022-12-28	WOS:000314211500007
J	Venkataraman, S; Birks, DK; Balakrishnan, I; Alimova, I; Harris, PS; Patel, PR; Handler, MH; Dubuc, A; Taylor, MD; Foreman, NK; Vibhakar, R				Venkataraman, Sujatha; Birks, Diane K.; Balakrishnan, Ilango; Alimova, Irina; Harris, Peter S.; Patel, Purvi R.; Handler, Michael H.; Dubuc, Adrian; Taylor, Michael D.; Foreman, Nicholas K.; Vibhakar, Rajeev			MicroRNA 218 Acts as a Tumor Suppressor by Targeting Multiple Cancer Phenotype-associated Genes in Medulloblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; RNA; ONCOMIRS; MYC	Aberrant expression of microRNAs has been implicated in many cancers. We recently demonstrated differential expression of several microRNAs in medulloblastoma. In this study, the regulation and function of microRNA 218 (miR-218), which is significantly underexpressed in medulloblastoma, was evaluated. Re-expression of miR-218 resulted in a significant decrease in medulloblastoma cell growth, cell colony formation, cell migration, invasion, and tumor sphere size. We used C17.2 neural stem cells as a model to show that increased miR-218 expression results in increased cell differentiation and also decreased malignant transformation when transfected with the oncogene REST. These results suggest that miR-218 acts as a tumor suppressor in medulloblastoma. MicroRNAs function by down-regulating translation of target mRNAs. Targets are determined by imperfect base pairing of the microRNA to the 3'-UTR of the mRNA. To comprehensively identify actual miR-218 targets, medulloblastoma cells overexpressing miR-218 and control cells were subjected to high throughput sequencing of RNA isolated by cross-linking immunoprecipitation, a technique that identifies the mRNAs bound to the RNA-induced silencing complex component protein Argonaute 2. High throughput sequencing of mRNAs identified 618 genes as targets of miR-218 and included both previously validated targets and many targets not predicted computationally. Additional work further confirmed CDK6, RICTOR, and CTSB (cathepsin B) as targets of miR-218 and examined the functional role of one of these targets, CDK6, in medulloblastoma.	[Venkataraman, Sujatha; Alimova, Irina; Harris, Peter S.; Patel, Purvi R.; Foreman, Nicholas K.; Vibhakar, Rajeev] Univ Colorado, Childrens Hosp Colorado, Dept Pediat, Denver, CO 80045 USA; [Birks, Diane K.; Handler, Michael H.] Univ Colorado, Childrens Hosp Colorado, Dept Neurosurg, Denver, CO 80045 USA; [Balakrishnan, Ilango] Univ Colorado, Childrens Hosp Colorado, Dept Med Oncol, Denver, CO 80045 USA; [Dubuc, Adrian; Taylor, Michael D.] Hosp Sick Children, Program Dev & Stem Cell Biol, Div Neurosurg, Toronto, ON M5C 1X8, Canada	Children's Hospital Colorado; University of Colorado System; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Denver; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Vibhakar, R (corresponding author), Univ Colorado Denver, Dept Pediat, 12800 19th Ave,Mail Stop 4103, Aurora, CO 80045 USA.	Rajeev.Vibhakar@ucdenver.edu		Taylor, Michael/0000-0001-7009-3466; Foreman, Nicholas/0000-0003-4848-4801	National Institutes of Health, NINDS [K08NS059790]; Morgan Adams foundation; National Institutes of Health, NCRR, Colorado Clinical and Translational Services Institute [UL1 RR025780]; National Institutes of Health [P30 DK57516]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS059790] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Morgan Adams foundation; National Institutes of Health, NCRR, Colorado Clinical and Translational Services Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant K08NS059790 (to R. V.). This work was also supported by Morgan Adams foundation grants (to R. V. and N. K. F.).; We thank Dr. Jay Hesselberth for help with sequencing. We also thank Dr. Manoj Pillai for technical assistance with the HITS-CLIP method. We thank Dr. Robert Darnell for valuable input on the HITS-CLIP method. We thank Janet Parrish for help with the luciferase assay. Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advance Light Microscopy Core, supported in part by National Institutes of Health, NCRR, Colorado Clinical and Translational Services Institute Grant UL1 RR025780. Plasmid sequencing was done in the University of Colorado, Denver, Diabetes and Endocrinology Research Center Molecular Biology Core, supported by National Institutes of Health Grant P30 DK57516.	Alimova I, 2012, INT J CANCER, V131, P1800, DOI 10.1002/ijc.27455; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chiyomaru T, 2012, UROL ONCOL-SEMIN ORI, V30, P434, DOI 10.1016/j.urolonc.2010.05.008; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gao CP, 2010, CANCER-AM CANCER SOC, V116, P41, DOI 10.1002/cncr.24743; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Harris PS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-80; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang Z, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-43; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Mendrzyk F, 2005, J CLIN ONCOL, V23, P8853, DOI 10.1200/JCO.2005.02.8589; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Parker MA, 2005, EXP NEUROL, V194, P320, DOI 10.1016/j.expneurol.2005.04.018; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Provias JP, 1996, J NEURO-ONCOL, V29, P35, DOI 10.1007/BF00165516; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ribi K, 2005, NEUROPEDIATRICS, V36, P357, DOI 10.1055/s-2005-872880; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Song LB, 2010, BIOCHEM BIOPH RES CO, V402, P135, DOI 10.1016/j.bbrc.2010.10.003; Srivastava VK, 2008, CYTOM PART A, V73A, P940, DOI 10.1002/cyto.a.20633; Su XH, 2006, MOL CELL BIOL, V26, P1666, DOI 10.1128/MCB.26.5.1666-1678.2006; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368; Venkataraman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010748; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang X, 2012, ONCOGENE, V31, P187, DOI 10.1038/onc.2011.232; Whiteway SL, 2013, J NEURO-ONCOL, V111, P113, DOI 10.1007/s11060-012-1000-7; Wilbert ML, 2011, WIRES SYST BIOL MED, V3, P491, DOI 10.1002/wsbm.128; Wu DW, 2010, CANCER RES, V70, P10392, DOI 10.1158/0008-5472.CAN-10-2341; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s	43	86	90	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1918	1928		10.1074/jbc.M112.396762	http://dx.doi.org/10.1074/jbc.M112.396762			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23212916	Green Published, hybrid			2022-12-28	WOS:000313751400045
J	Cho, SW; Pirih, FQ; Koh, AJ; Michalski, M; Eber, MR; Ritchie, K; Sinder, B; Oh, S; Al-Dujaili, SA; Lee, J; Kozloff, K; Danciu, T; Wronski, TJ; McCauley, LK				Cho, Sun Wook; Pirih, Flavia Q.; Koh, Amy J.; Michalski, Megan; Eber, Matthew R.; Ritchie, Kathryn; Sinder, Benjamin; Oh, Seojin; Al-Dujaili, Saja A.; Lee, JoonHo; Kozloff, Ken; Danciu, Theodora; Wronski, Thomas J.; McCauley, Laurie K.			The Soluble Interleukin-6 Receptor Is a Mediator of Hematopoietic and Skeletal Actions of Parathyroid Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; BONE-RESORPTION; IN-VIVO; OSTEOBLASTIC DIFFERENTIATION; ANABOLIC ACTIONS; CELL-LINE; ACTIVATION; GP130; PROTEIN; IMMUNE	Both PTH and IL-6 signaling play pivotal roles in hematopoiesis and skeletal biology, but their interdependence is unclear. The purpose of this study was to evaluate the effect of IL-6 and soluble IL-6 receptor (sIL-6R) on hematopoietic and skeletal actions of PTH. In the bone microenvironment, PTH stimulated sIL-6R protein levels in primary osteoblast cultures in vitro and bone marrow in vivo in both IL-6 (+/+) and IL-6 (-/-) mice. PTH-mediated hematopoietic cell expansion was attenuated in IL-6(-/-) compared with IL-6(+/+) bone marrow, whereas sIL-6R treatment amplified PTH actions in IL-6(-/-) earlier than IL-6(+/+) marrow cultures. Blocking sIL-6R signaling with sgp130 (soluble glycoprotein 130 receptor) inhibited PTH-dependent hematopoietic cell expansion in IL-6(-/-) marrow. In the skeletal system, although intermittent PTH administration to IL-6(+/+) and IL-6(-/-) mice resulted in similar anabolic actions, blocking sIL-6R significantly attenuated PTH anabolic actions. sIL-6R showed no direct effects on osteoblast proliferation or differentiation in vitro; however, it up-regulated myeloid cell expansion and production of the mesenchymal stem cell recruiting agent, TGF-beta 1 in the bone marrow microenvironment. Collectively, sIL-6R demonstrated orphan function and mediated PTH anabolic actions in bone in association with support of myeloid lineage cells in the hematopoietic system.	[Cho, Sun Wook; Pirih, Flavia Q.; Koh, Amy J.; Michalski, Megan; Eber, Matthew R.; Ritchie, Kathryn; Oh, Seojin; Al-Dujaili, Saja A.; Lee, JoonHo; Danciu, Theodora; McCauley, Laurie K.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [McCauley, Laurie K.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Sinder, Benjamin; Kozloff, Ken] Univ Michigan, Sch Med, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; [Wronski, Thomas J.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32611 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida	McCauley, LK (corresponding author), Univ Michigan, Sch Dent, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	mccauley@umich.edu			National Institutes of Health [DK53904, PO1 CA093900]; NATIONAL CANCER INSTITUTE [P01CA093900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK53904 and PO1 CA093900 (to L. K. M.).	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Aspenberg P, 2010, J BONE MINER RES, V25, P404, DOI 10.1359/jbmr.090731; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bashutski JD, 2010, NEW ENGL J MED, V363, P2396, DOI 10.1056/NEJMoa1005361; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang JK, 2009, ARTHRITIS RHEUM-US, V60, P3049, DOI 10.1002/art.24843; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; DIAMANT M, 1994, J IMMUNOL METHODS, V173, P229, DOI 10.1016/0022-1759(94)90301-8; Ellegaard M, 2010, CALCIFIED TISSUE INT, V87, P1, DOI 10.1007/s00223-010-9360-5; Erices A, 2002, EXP CELL RES, V280, P24, DOI 10.1006/excr.2002.5627; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; GABAY C, 1995, EUR J IMMUNOL, V25, P2378, DOI 10.1002/eji.1830250838; Grey A, 1999, ENDOCRINOLOGY, V140, P4683, DOI 10.1210/en.140.10.4683; Han D, 2010, BIOCHEM J, V425, P541, DOI 10.1042/BJ20090429; Holub MC, 2002, IMMUNOL LETT, V82, P79, DOI 10.1016/S0165-2478(02)00022-6; Igaz P, 1998, CYTOKINE, V10, P620, DOI 10.1006/cyto.1997.0330; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kinjyo I, 2006, J EXP MED, V203, P1021, DOI 10.1084/jem.20052333; Kobayashi S, 2012, AUTOPHAGY, V8, P577, DOI 10.4161/auto.18980; Koh AJ, 2011, ENDOCRINOLOGY, V152, P4525, DOI 10.1210/en.2011-1515; Koh AJ, 1999, ENDOCRINOLOGY, V140, P3154, DOI 10.1210/en.140.7.3154; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; McGregor NE, 2010, CALCIFIED TISSUE INT, V86, P261, DOI 10.1007/s00223-010-9337-4; MICHALEVICZ R, 1989, SCANNING MICROSCOPY, V3, P1143; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Nishimura R, 1998, J BONE MINER RES, V13, P777, DOI 10.1359/jbmr.1998.13.5.777; ONYIA JE, 1995, BONE, V17, P479, DOI 10.1016/8756-3282(95)00332-2; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Pirih FQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013657; Pollock JH, 1996, J BONE MINER RES, V11, P754; Servet-Delprat Christine, 2002, BMC Immunol, V3, P15, DOI 10.1186/1471-2172-3-15; Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1359/JBMR.050209; Sims NA, 2004, J CLIN INVEST, V113, P379, DOI 10.1172/JCI200419872; Sui XW, 1996, J EXP MED, V183, P837, DOI 10.1084/jem.183.3.837; Taguchi Y, 1998, P ASSOC AM PHYSICIAN, V110, P559; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Terauchi M, 2009, CELL METAB, V10, P229, DOI 10.1016/j.cmet.2009.07.010; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Wu XW, 2010, CELL STEM CELL, V7, P571, DOI 10.1016/j.stem.2010.09.012; Younce CW, 2010, CARDIOVASC RES, V87, P665, DOI 10.1093/cvr/cvq102	49	29	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6814	6825		10.1074/jbc.M112.393363	http://dx.doi.org/10.1074/jbc.M112.393363			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23297399	Green Published, hybrid			2022-12-28	WOS:000316002400004
J	Raines, SM; Rane, HS; Bernardo, SM; Binder, JL; Lee, SA; Parra, KJ				Raines, Summer M.; Rane, Hallie S.; Bernardo, Stella M.; Binder, Jessica L.; Lee, Samuel A.; Parra, Karlett J.			Deletion of Vacuolar Proton-translocating ATPase V(o)a Isoforms Clarifies the Role of Vacuolar pH as a Determinant of Virulence-associated Traits in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST V-ATPASE; H+-ATPASE; AMINO-ACIDS; PHOSPHATIDYLINOSITOL 3-KINASE; ANTIFUNGAL SUSCEPTIBILITY; SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; MEMBRANE-VESICLES; GENE ENCODES; SUBUNIT	Vacuolar proton-translocating ATPase (V-ATPase) is a central regulator of cellular pH homeostasis, and inactivation of all V-ATPase function has been shown to prevent infectivity in Candida albicans. V-ATPase subunit a of the V-o domain (V(o)a) is present as two fungal isoforms: Stv1p (Golgi) and Vph1p (vacuole). To delineate the individual contribution of Stv1p and Vph1p to C. albicans physiology, we created stv1 Delta/Delta and vph1 Delta/Delta mutants and compared them to the corresponding reintegrant strains (stv1 Delta/Delta R and vph1 Delta/Delta R). V-ATPase activity, vacuolar physiology, and in vitro virulence-related phenotypes were unaffected in the stv1 Delta/Delta mutant. The vph1 Delta/Delta mutant exhibited defective V1Vo assembly and a 90% reduction in concanamycin A-sensitive ATPase activity and proton transport in purified vacuolar membranes, suggesting that the Vph1p isoform is essential for vacuolar V-ATPase activity in C. albicans. The vph1 Delta/Delta cells also had abnormal endocytosis and vacuolar morphology and an alkalinized vacuolar lumen (pH(vph1)Delta/Delta = 6.8 versus pH(vph1) Delta/Delta(R) = 5.8) in both yeast cells and hyphae. Secreted protease and lipase activities were significantly reduced, and M199-induced filamentation was impaired in the vph1 Delta/Delta mutant. However, the vph1 Delta/Delta cells remained competent for filamentation induced by Spider media and YPD, 10% FCS, and biofilm formation and macrophage killing were unaffected in vitro. These studies suggest that different virulence mechanisms differentially rely on acidified vacuoles and that the loss of both vacuolar (Vph1p) and non-vacuolar (Stv1p) V-ATPase activity is necessary to affect in vitro virulence-related phenotypes. As a determinant of C. albicans pathogenesis, vacuolar pH alone may prove less critical than originally assumed.	[Raines, Summer M.; Binder, Jessica L.; Parra, Karlett J.] Univ New Mexico, Dept Biochem & Mol Biol, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Bernardo, Stella M.; Lee, Samuel A.] Univ New Mexico, Dept Internal Med, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Rane, Hallie S.; Bernardo, Stella M.; Lee, Samuel A.; Parra, Karlett J.] New Mexico Vet Healthcare Syst, Infect Dis Sect, Albuquerque, NM 87108 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Parra, KJ (corresponding author), Univ New Mexico, Dept Biochem & Mol Biol, MSC08 4670, Albuquerque, NM 87131 USA.	kjparra@salud.unm.edu		Binder, Jessica/0000-0003-2091-3950	National Institutes of Health [5R01GM086495, K12GM088021, 5T32AI007538-13]; Department of Veterans Affairs MERIT Award; Biomedical Research Institute of New Mexico; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021, R01GM086495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs MERIT Award(US Department of Veterans Affairs); Biomedical Research Institute of New Mexico; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM086495 (to K. J. P.), K12GM088021 (to S. M. R.), and 5T32AI007538-13 (to S. M. B.). The work was also supported by a Department of Veterans Affairs MERIT Award (to S. A. L.) and a Biomedical Research Institute of New Mexico grant (to S. A. L.).	Augsten M, 2002, INFECT IMMUN, V70, P4462, DOI 10.1128/IAI.70.8.4462-4470.2002; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Bernardo SM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-133; Bruckmann A, 2000, MICROBIOL-SGM, V146, P2755, DOI 10.1099/00221287-146-11-2755; Chan CY, 2012, J BIOL CHEM, V287, P10236, DOI 10.1074/jbc.M111.321133; CRANDALL M, 1987, J GEN MICROBIOL, V133, P2817; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Davis DA, 2009, CURR OPIN MICROBIOL, V12, P365, DOI 10.1016/j.mib.2009.05.006; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Eck R, 2005, INT J MED MICROBIOL, V295, P57, DOI 10.1016/j.ijmm.2004.12.007; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Erickson T, 2001, MOL MICROBIOL, V42, P1121, DOI 10.1046/j.1365-2958.2001.02712.x; Finnigan GC, 2012, J BIOL CHEM, V287, P19487, DOI 10.1074/jbc.M112.343814; FORGAC M, 1983, P NATL ACAD SCI-BIOL, V80, P1300, DOI 10.1073/pnas.80.5.1300; Fu Y, 1997, MICROBIOL-UK, V143, P331, DOI 10.1099/00221287-143-2-331; GRAHAM LA, 1994, J BIOL CHEM, V269, P25974; Gustavsson M, 2008, MOL GENET GENOMICS, V280, P233, DOI 10.1007/s00438-008-0359-9; Hilty J, 2008, MOL MICROBIOL, V70, P127, DOI 10.1111/j.1365-2958.2008.06395.x; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Huang CJ, 2011, J BIOL CHEM, V286, P10058, DOI 10.1074/jbc.M110.197889; Ishimoto M, 2012, BIOSCI BIOTECH BIOCH, V76, P1802, DOI 10.1271/bbb.120372; Jia N, 2002, ANTIMICROB AGENTS CH, V46, P947, DOI 10.1128/AAC.46.4.947-957.2002; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Karkowska-Kuleta J, 2009, ACTA BIOCHIM POL, V56, P211; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Kretschmar M, 2002, MICROB PATHOGENESIS, V32, P61, DOI 10.1006/mpat.2001.0478; Lee SA, 2009, MYCOPATHOLOGIA, V167, P55, DOI 10.1007/s11046-008-9155-7; Lin M, 2012, EUKARYOT CELL, V11, P442, DOI 10.1128/EC.05286-11; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; MANOLSON MF, 1992, J EXP BIOL, V172, P105; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Owegi MA, 2005, J BIOL CHEM, V280, P18393, DOI 10.1074/jbc.M412567200; Owegi MA, 2006, J BIOL CHEM, V281, P30001, DOI 10.1074/jbc.M605006200; Palanisamy SKA, 2010, EUKARYOT CELL, V9, P266, DOI 10.1128/EC.00295-09; Palmer GE, 2005, EUKARYOT CELL, V4, P1677, DOI 10.1128/EC.4.10.1677-1686.2005; Palmer Glen E, 2011, Commun Integr Biol, V4, P240, DOI 10.4161/cib.4.2.14717; Palmer GE, 2010, EUKARYOT CELL, V9, P1755, DOI 10.1128/EC.00029-10; Parra K. J., 2012, EMERGING STRATEGIES, P89; Perzov N, 2002, J EXP BIOL, V205, P1209; Perzov N, 2000, J BIOL CHEM, V275, P40088, DOI 10.1074/jbc.M007011200; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Ramage G, 2005, METH MOLEC MED, V118, P71; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; SATO T, 1984, J BIOL CHEM, V259, P1505; Shoji JY, 2006, EUKARYOT CELL, V5, P411, DOI 10.1128/EC.5.2.411-421.2006; STEWART E, 1988, J GEN MICROBIOL, V134, P1079; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; Tobudic S, 2012, MYCOSES, V55, P199, DOI 10.1111/j.1439-0507.2011.02076.x; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; van de Veerdonk FL, 2010, CURR OPIN CRIT CARE, V16, P453, DOI 10.1097/MCC.0b013e32833e046e; Veses V, 2008, CURR OPIN MICROBIOL, V11, P503, DOI 10.1016/j.mib.2008.09.017; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zhang Yong-Qiang, 2010, Virulence, V1, P551, DOI 10.4161/viru.1.6.13802; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939	65	28	31	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6190	6201		10.1074/jbc.M112.426197	http://dx.doi.org/10.1074/jbc.M112.426197			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23316054	hybrid, Green Published			2022-12-28	WOS:000315820700015
J	Theis, T; Mishra, B; von der Ohe, M; Loers, G; Prondzynski, M; Pless, O; Blackshear, PJ; Schachner, M; Kleene, R				Theis, Thomas; Mishra, Bibhudatta; von der Ohe, Maren; Loers, Gabriele; Prondzynski, Maksymilian; Pless, Ole; Blackshear, Perry J.; Schachner, Melitta; Kleene, Ralf			Functional Role of the Interaction between Polysialic Acid and Myristoylated Alanine-rich C Kinase Substrate at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; MICE DEFICIENT; PSA-NCAM; PHOSPHOLIPID-MEMBRANES; CALMODULIN-BINDING; NEURITE OUTGROWTH; MARCKS DEFICIENCY; MUTANT MICE	Polysialic acid (PSA) is a homopolymeric glycan that plays crucial roles in the developing and adult nervous system. So far only a few PSA-binding proteins have been identified. Here, we identify myristoylated alanine-rich C kinase substrate (MARCKS) as novel PSA binding partner. Binding assays showed a direct interaction between PSA and a peptide comprising the effector domain of MARCKS (MARCKS-ED). Co-immunoprecipitation of PSA-carrying neural cell adhesion molecule (PSA-NCAM) with MARCKS and co-immunostaining of MARCKS and PSA at the cell membrane of hippocampal neurons confirm the interaction between PSA and MARCKS. Co-localization and an intimate interaction of PSA and MARCKS at the cell surface was seen by confocal microscopy and fluorescence resonance energy transfer (FRET) analysis after the addition of fluorescently labeled PSA or PSA-NCAM to live CHO cells or hippocampal neurons expressing MARCKS as a fusion protein with green fluorescent protein (GFP). Cross-linking experiments showed that extracellularly applied PSA or PSA-NCAM and intracellularly expressed MARCKS-GFP are in close contact, suggesting that PSA and MARCKS interact with each other at the plasma membrane from opposite sides. Insertion of PSA and MARCKS-ED peptide into lipid bilayers from opposite sides alters the electric properties of the bilayer confirming the notion that PSA and the effector domain of MARCKS interact at and/or within the plane of the membrane. The MARCKS-ED peptide abolished PSA-induced enhancement of neurite outgrowth from cultured hippocampal neurons indicating an important functional role for the interaction between MARCKS and PSA in the developing and adult nervous system.	[Theis, Thomas; Mishra, Bibhudatta; von der Ohe, Maren; Loers, Gabriele; Schachner, Melitta; Kleene, Ralf] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Shantou Univ, Ctr Neurosci, Coll Med, Shantou 515041, Peoples R China; [Blackshear, Perry J.] Duke Univ, Dept Med, Durham, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Dept Biochem, Durham, NC 27709 USA; [Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Bethesda, MD USA; [Prondzynski, Maksymilian; Pless, Ole] European Screening Port GmbH, D-22525 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Shantou University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Schachner, M (corresponding author), Shantou Univ, Ctr Neurosci, Coll Med, 22 Xin Ling Rd, Shantou 515041, Peoples R China.	schachner@stu.edu.cn	Theis, Thomas/I-4247-2019; Prondzynski, Maksymilian/AAB-5907-2021; Pless, Ole/E-8348-2016; Blackshear, Perry J./C-6206-2019	Theis, Thomas/0000-0001-5555-8501; Prondzynski, Maksymilian/0000-0002-6846-6435; Pless, Ole/0000-0002-1468-316X; Blackshear, Perry J./0000-0002-9561-8529	New Jersey Commission for Spinal Cord Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	New Jersey Commission for Spinal Cord Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the New Jersey Commission for Spinal Cord Research and a consultant at the Center for Neuroscience at Shantou University Medical College, China. To whom correspondence should be addressed: Center for Neuroscience, Shantou University Medical College, 22 Xin Ling Road, Shantou 515041, China. Tel.: 86-754-88900276; Fax: 86 754 88900236; E-mail: schachner@stu.edu.cn.	ALBERT KA, 1987, P NATL ACAD SCI USA, V84, P7046, DOI 10.1073/pnas.84.20.7046; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; BRISSON JR, 1992, BIOCHEMISTRY-US, V31, P4996, DOI 10.1021/bi00136a012; Brocco MA, 2006, FEBS LETT, V580, P4723, DOI 10.1016/j.febslet.2006.07.058; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; FigarellaBranger D, 1996, J CLIN ONCOL, V14, P2066, DOI 10.1200/JCO.1996.14.7.2066; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; GASCARD P, 1991, BIOCHIM BIOPHYS ACTA, V1069, P27, DOI 10.1016/0005-2736(91)90100-M; Gatlin JC, 2006, MOL BIOL CELL, V17, P5115, DOI 10.1091/mbc.E05-12-1183; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Hussain RJ, 2006, HIPPOCAMPUS, V16, P495, DOI 10.1002/hipo.20177; Janas T, 2001, ACTA BIOCHIM POL, V48, P163; Janas T, 2000, EUR BIOPHYS J BIOPHY, V29, P507, DOI 10.1007/s002490000097; Janas T, 2010, CHEM PHYS LIPIDS, V163, P286, DOI 10.1016/j.chemphyslip.2009.12.003; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Kwiatkowska K, 2010, CELL MOL LIFE SCI, V67, P3927, DOI 10.1007/s00018-010-0432-5; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Li HM, 2008, MOL BIOL CELL, V19, P4804, DOI 10.1091/mbc.E08-03-0294; Li J, 2011, GLYCOBIOLOGY, V21, P1010, DOI 10.1093/glycob/cwr020; LOBAUGH LA, 1990, J BIOL CHEM, V265, P18393; Loers G, 2012, J NEUROSCI, V32, P3917, DOI 10.1523/JNEUROSCI.6165-11.2012; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Markram K, 2007, NEUROSCIENCE, V144, P788, DOI 10.1016/j.neuroscience.2006.10.024; McNamara RK, 2005, HIPPOCAMPUS, V15, P675, DOI 10.1002/hipo.20089; McNamara RK, 1998, J COMP NEUROL, V397, P337; McNamara RK, 1998, P NATL ACAD SCI USA, V95, P14517, DOI 10.1073/pnas.95.24.14517; Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128; MICHON F, 1987, BIOCHEMISTRY-US, V26, P8399, DOI 10.1021/bi00399a055; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; Qin ZH, 1996, BIOCHEMISTRY-US, V35, P2917, DOI 10.1021/bi9521452; Ronn LCB, 2000, INT J DEV NEUROSCI, V18, P193, DOI 10.1016/S0736-5748(99)00088-X; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Seki T, 1998, J NEUROSCI, V18, P3757; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Senkov O, 2012, INT J BIOCHEM CELL B, V44, P591, DOI 10.1016/j.biocel.2012.01.008; Shiraishi M, 2006, J CELL PHYSIOL, V209, P1029, DOI 10.1002/jcp.20814; Solomonia RO, 2008, EXP BRAIN RES, V188, P323, DOI 10.1007/s00221-008-1428-3; Spizz G, 2001, J BIOL CHEM, V276, P32264, DOI 10.1074/jbc.M103960200; Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x; Strekalova H, 2006, NEUROBIOL AGING, V27, P1, DOI 10.1016/j.neurobiolaging.2004.11.013; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; SWIERCZYNSKI SL, 1995, J BIOL CHEM, V270, P13436, DOI 10.1074/jbc.270.22.13436; Swierczynski SL, 1996, DEV BIOL, V179, P135, DOI 10.1006/dbio.1996.0246; Timofeeva OA, 2010, BRAIN RES, V1308, P147, DOI 10.1016/j.brainres.2009.10.040; Vaithianathan T, 2004, J BIOL CHEM, V279, P47975, DOI 10.1074/jbc.M407138200; Venero C, 2006, EUR J NEUROSCI, V23, P1585, DOI 10.1111/j.1460-9568.2006.04663.x; Vergeres G, 1998, BIOCHEM J, V330, P5, DOI 10.1042/bj3300005; Victor K, 1999, BIOCHEMISTRY-US, V38, P12527, DOI 10.1021/bi990847b; Vutskits L, 2001, EUR J NEUROSCI, V13, P1391, DOI 10.1046/j.0953-816x.2001.01516.x; Watterson JM, 2002, BRAIN RES, V934, P69, DOI 10.1016/S0006-8993(02)02362-4; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yamaguchi H, 2009, J CELL PHYSIOL, V220, P748, DOI 10.1002/jcp.21822	72	33	37	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6726	6742		10.1074/jbc.M112.444034	http://dx.doi.org/10.1074/jbc.M112.444034			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23329829	Green Published, hybrid			2022-12-28	WOS:000315820700070
J	Nakano, T; Miyamoto-Matsubara, M; Shoulkamy, MI; Salem, AMH; Pack, SP; Ishimi, Y; Ide, H				Nakano, Toshiaki; Miyamoto-Matsubara, Mayumi; Shoulkamy, Mahmoud I.; Salem, Amir M. H.; Pack, Seung Pil; Ishimi, Yukio; Ide, Hiroshi			Translocation and Stability of Replicative DNA Helicases upon Encountering DNA-Protein Cross-links	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ESCHERICHIA-COLI; HEXAMERIC HELICASE; STERIC EXCLUSION; BINDING-ACTIVITY; MCM HELICASE; UNWIND DNA; DUPLEX DNA; T-ANTIGEN; MECHANISM	DNA-protein cross-links (DPCs) are formed when cells are exposed to various DNA-damaging agents. Because DPCs are extremely large, steric hindrance conferred by DPCs is likely to affect many aspects of DNA transactions. In DNA replication, DPCs are first encountered by the replicative helicase that moves at the head of the replisome. However, little is known about how replicative helicases respond to covalently immobilized protein roadblocks. In the present study we elucidated the effect of DPCs on the DNA unwinding reaction of hexameric replicative helicases in vitro using defined DPC substrates. DPCs on the translocating strand but not on the nontranslocating strand impeded the progression of the helicases including the phage T7 gene 4 protein, simian virus 40 large T antigen, Escherichia coli DnaB protein, and human minichromosome maintenance Mcm467 subcomplex. The impediment varied with the size of the cross-linked proteins, with a threshold size for clearance of 5.0-14.1 kDa. These results indicate that the central channel of the dynamically translocating hexameric ring helicases can accommodate only small proteins and that all of the helicases tested use the steric exclusion mechanism to unwind duplex DNA. These results further suggest that DPCs on the translocating and nontranslocating strands constitute helicase and polymerase blocks, respectively. The helicases stalled by DPC had limited stability and dissociated from DNA with a half-life of 15-36 min. The implications of the results are discussed in relation to the distinct stabilities of replisomes that encounter tight but reversible DNA-protein complexes and irreversible DPC roadblocks.	[Nakano, Toshiaki; Miyamoto-Matsubara, Mayumi; Shoulkamy, Mahmoud I.; Ide, Hiroshi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Salem, Amir M. H.] Natl Res Ctr, Dept Pathol, Cairo 12311, Egypt; [Pack, Seung Pil] Korea Univ, Dept Biotechnol & Bioinformat, Jochiwon 339700, Sejong, South Korea; [Ishimi, Yukio] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan	Hiroshima University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Korea University; Ibaraki University	Ide, H (corresponding author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan.	ideh@hiroshima-u.ac.jp	Shoulkamy, Mahmoud Ibrahim/AAV-9934-2020; Ide, Hiroshi/G-9042-2019; Salem, Amir/J-7562-2016	Shoulkamy, Mahmoud Ibrahim/0000-0002-4736-1212; Nakano, Toshiaki/0000-0002-5274-2909; Salem, Amir/0000-0001-5852-1501	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Marine Biomaterials Research Center grant from the Marine Biotechnology Program; Ministry of Land, Transport, and Maritime Affairs, Korea	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Marine Biomaterials Research Center grant from the Marine Biotechnology Program; Ministry of Land, Transport, and Maritime Affairs, Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea)	This work was supported in part by a grant-in-aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. I.), a grant-in-aid for Young Scientists (B) from the Japan Society for the Promotion of Science (to T. N.), and a Marine Biomaterials Research Center grant from the Marine Biotechnology Program funded by the Ministry of Land, Transport, and Maritime Affairs, Korea (to S. P. P.).	Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Chen HJC, 2008, CHEMBIOCHEM, V9, P1074, DOI 10.1002/cbic.200700686; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costa A, 2009, CRIT REV BIOCHEM MOL, V44, P326, DOI 10.1080/10409230903186012; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; ISHIMI Y, 1993, P NATL ACAD SCI USA, V90, P5399, DOI 10.1073/pnas.90.12.5399; Ishimi Y, 2003, J BIOL CHEM, V278, P24644, DOI 10.1074/jbc.M213252200; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Jiao JF, 2003, J VIROL, V77, P12720, DOI 10.1128/JVI.77.23.12720-12728.2003; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Katafuchi A, 2004, J BIOL CHEM, V279, P14464, DOI 10.1074/jbc.M400393200; Kumari A, 2010, J BIOL CHEM, V285, P21313, DOI 10.1074/jbc.M109.078964; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Labib K, 2007, EMBO REP, V8, P346, DOI 10.1038/sj.embor.7400940; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; McGlynn P, 2008, J MOL BIOL, V381, P249, DOI 10.1016/j.jmb.2008.05.053; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Nakano T, 2005, NUCLEIC ACIDS RES, V33, P2181, DOI 10.1093/nar/gki513; Nakano T, 2003, J BIOL CHEM, V278, P25264, DOI 10.1074/jbc.M212847200; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nakano T, 2012, J BIOL CHEM, V287, P6562, DOI 10.1074/jbc.M111.318410; Nakano T, 2009, J BIOL CHEM, V284, P27065, DOI 10.1074/jbc.M109.019174; Novakova O, 2003, NUCLEIC ACIDS RES, V31, P6450, DOI 10.1093/nar/gkg863; Numata Y, 2010, J BIOCHEM, V147, P917, DOI 10.1093/jb/mvq028; Pack SP, 2005, NUCLEIC ACIDS RES, V33, P5771, DOI 10.1093/nar/gki865; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Possoz C, 2006, EMBO J, V25, P2596, DOI 10.1038/sj.emboj.7601155; Salem AMH, 2009, J BACTERIOL, V191, P5657, DOI 10.1128/JB.00417-09; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Shin JH, 2007, J BIOL CHEM, V282, P4908, DOI 10.1074/jbc.M606847200; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Shoulkamy MI, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks601; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Veaute X, 2000, MUTAT RES-DNA REPAIR, V459, P19, DOI 10.1016/S0921-8777(99)00052-X; YANCEYWRONA JE, 1992, NUCLEIC ACIDS RES, V20, P6713, DOI 10.1093/nar/20.24.6713; Yong YQ, 1996, CHEM RES TOXICOL, V9, P179, DOI 10.1021/tx950112h	61	47	47	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4649	4658		10.1074/jbc.M112.419358	http://dx.doi.org/10.1074/jbc.M112.419358			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283980	Green Published, hybrid			2022-12-28	WOS:000315340400014
J	Smyth, AM; Yang, L; Martin, KJ; Hamilton, C; Lu, WP; Cousin, MA; Rickman, C; Duncan, RR				Smyth, Annya M.; Yang, Lei; Martin, Kirsty J.; Hamilton, Charlotte; Lu, Weiping; Cousin, Michael A.; Rickman, Colin; Duncan, Rory R.			Munc 18-1 Protein Molecules Move between Membrane Molecular Depots Distinct from Vesicle Docking Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL SNARE COMPLEX; CONFORMATIONAL SWITCH; SECRETORY GRANULES; SYNTAXIN 1A; FUSION; LOCALIZATION; BINDING; CELLS; EXOCYTOSIS; DYNAMICS	Four evolutionarily conserved proteins are required for mammalian regulated exocytosis: three SNARE proteins, syntaxin, SNAP-25, and synaptobrevin, and the SM protein, Munc18-1. Here, using single-molecule imaging, we measured the spatial distribution of large cohorts of single Munc18-1 molecules correlated with the positions of single secretory vesicles in a functionally rescued Munc18-1-null cellular model. Munc18-1 molecules were nonrandomly distributed across the plasma membrane in a manner not directed by mode of interaction with syntaxin1, with a small mean number of molecules observed to reside under membrane resident vesicles. Surprisingly, we found that the majority of vesicles in fully secretion-competent cells had no Munc18-1 associated within distances relevant to plasma membrane-vesicle SNARE interactions. Live cell imaging of Munc18-1 molecule dynamics revealed that the density of Munc18-1 molecules at the plasma membrane anticorrelated with molecular speed, with single Munc18-1 molecules displaying directed motion between membrane hotspots enriched in syntaxin1a. Our findings demonstrate that Munc18-1 molecules move between membrane depots distinct from vesicle morphological docking sites.	[Smyth, Annya M.; Martin, Kirsty J.; Hamilton, Charlotte; Lu, Weiping; Rickman, Colin; Duncan, Rory R.] Heriot Watt Univ, Life Phys Sci Interface Lab, Inst Biol Chem Biophys & Bioengn, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Smyth, Annya M.; Cousin, Michael A.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Yang, Lei] Philips Res Asia, Shanghai 200233, Peoples R China	Heriot Watt University; University of Edinburgh; Philips; Philips Research	Duncan, RR (corresponding author), Heriot Watt Univ, Life Phys Sci Interface Lab, Inst Biol Chem Biophys & Bioengn, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.	r.r.duncan@hw.ac.uk	Yang, Lei/H-9595-2014; Lu, Wei/AAE-2921-2022	Lu, Wei/0000-0002-4150-8674; Rickman, Colin/0000-0001-8938-524X; Martin, Kirsty/0000-0003-2899-2841; Duncan, Rory/0000-0003-0693-910X; Cousin, Michael/0000-0002-1762-160X	Medical Research Council (MRC); Wellcome Trust; Royal Society; MRC; Medical Research Council [G0901607] Funding Source: researchfish; MRC [G0901607] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by project grants from the Medical Research Council (MRC), the Wellcome Trust, and the Royal Society (to R. R. D. and C. R.) and a Ph.D. studentship award from the MRC (to R. R. D. and M. A. C.).	Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Barg S, 2010, P NATL ACAD SCI USA, V107, P20804, DOI 10.1073/pnas.1014823107; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Graham ME, 2004, J BIOL CHEM, V279, P32751, DOI 10.1074/jbc.M400827200; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Kim SA, 2010, J NEUROSCI, V30, P16409, DOI 10.1523/JNEUROSCI.3063-10.2010; Knowles MK, 2010, P NATL ACAD SCI USA, V107, P20810, DOI 10.1073/pnas.1014840107; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; McEvoy AL, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-106; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Oh E, 2012, J BIOL CHEM, V287, P25821, DOI 10.1074/jbc.M112.361501; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rickman C, 2010, J BIOL CHEM, V285, P13535, DOI 10.1074/jbc.M109.091058; Rickman C, 2010, J BIOL CHEM, V285, P3965, DOI 10.1074/jbc.M109.040402; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Rowe J, 2001, J CELL SCI, V114, P3323; Rowe J, 1999, J CELL SCI, V112, P1865; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108; Smyth AM, 2010, J BIOL CHEM, V285, P38141, DOI 10.1074/jbc.M110.164038; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Teramura Y, 2006, EMBO J, V25, P4215, DOI 10.1038/sj.emboj.7601308; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Yang L., 2012, PLOS ONE, V7; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	49	13	13	0	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5102	5113		10.1074/jbc.M112.407585	http://dx.doi.org/10.1074/jbc.M112.407585			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23223447	Green Published, hybrid			2022-12-28	WOS:000315340400058
J	Sharma, P; Lata, H; Arya, DK; Kashyap, AK; Kumar, H; Dua, M; Ali, A; Johri, AK				Sharma, Puja; Lata, Hem; Arya, Deepak Kumar; Kashyap, Arun Kumar; Kumar, Hemant; Dua, Meenakshi; Ali, Arif; Johri, Atul Kumar			Role of Pilus Proteins in Adherence and Invasion of Streptococcus agalactiae to the Lung and Cervical Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; GENOME SEQUENCE; IDENTIFICATION; VIRULENCE; VACCINE; COMPLEMENT; PATHOGEN; ANTIBODY; C5A	Streptococcus agalactiae, or group B Streptococcus (GBS), is an important opportunistic pathogen that causes pneumonia, sepsis, and meningitis in neonates and severe diseases in immunocompromised adults. We have performed comparative genomics of prevalent GBS serotypes of Indian origin (i.e. Ia, III, V, and VII). Pilus-proteins were commonly found up-regulated, and their expression was studied by using antiserum for GBS80 (backbone protein of pilus island-I), GBS67 (ancillary protein of PI-2a), and SAN1518 (backbone protein of PI-2b) by whole cell and Western blot analysis. To check the role of pilus proteins in adherence and invasion, an inhibition assay was performed. Comparative immunoblotting experiments revealed that expression of pili proteins does not differ in geographically different selected serotypes, Ia and V, of India and the United States. In the case of A549 cells, we found that GBS VII invasion and adherence was inhibited by pilus protein-specific antiserum SAN1518 significantly (p < 0.001) by 88.5 and 91%, respectively. We found that mutant strains, deficient in the pilus proteins (Delta gbs80 and Delta san1518) exhibit a significant decrease in adherence in the case of type Ia, III, and VII. In the case of type VII, we have found a 95% reduction in invasion when Delta san1518 was used with A549 cells. Because the pilus proteins were identified previously as vaccine candidates against GBS serotypes of developed countries, we also found their role in the attachment and invasion of GBS of Indian origin. Thus, the present work supports the idea of making a more effective pilus protein-based vaccine that can be used universally.	[Sharma, Puja; Lata, Hem; Arya, Deepak Kumar; Kashyap, Arun Kumar; Kumar, Hemant; Johri, Atul Kumar] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Dua, Meenakshi] Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India; [Sharma, Puja; Ali, Arif] Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Jamia Millia Islamia	Johri, AK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	akjohri14@yahoo.com	Kumar, Hemant/AAW-6086-2021; Kumar, Arun/C-9149-2009	Kumar, Arun/0000-0001-8422-0219; Kumar, Hemant/0000-0001-7698-2301	Department of Biotechnology, Government of India; University Grants Commission (UGC); Council of Scientific and Industrial Research, Government of India; Jawaharlal Nehru University; DST-Purse; UGC resource Net Working, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Jawaharlal Nehru University; DST-Purse; UGC resource Net Working, Government of India	This work was supported in part by the Department of Biotechnology, Government of India (to A. K. J.).; Recipients of Rajiv Gandhi National Fellowships from the University Grants Commission (UGC) and of research fellowships from the Council of Scientific and Industrial Research, Government of India.; Supported by the Jawaharlal Nehru University capacity build-up fund for DNA microarray work and by funds from DST-Purse and UGC resource Net Working, Government of India.	Adderson EE, 2003, INFECT IMMUN, V71, P6857, DOI 10.1128/IAI.71.12.6857-6863.2003; Baker C. J., 1991, INFECT DIS, P820; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200; BOHNSACK JF, 1991, BIOCHEM J, V273, P635, DOI 10.1042/bj2730635; Bray BA, 2009, MICROBIOL-SGM, V155, P1451, DOI 10.1099/mic.0.025213-0; Brodeur BR, 2000, INFECT IMMUN, V68, P5610, DOI 10.1128/IAI.68.10.5610-5618.2000; Cheng Q, 2001, INFECT IMMUN, V69, P2302, DOI 10.1128/IAI.69.4.2302-2308.2001; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Hensler ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002446; Hoshina K, 1997, ACTA PAEDIATR JAPON, V39, P546; Johri AK, 2003, INFECT IMMUN, V71, P6707, DOI 10.1128/IAI.71.12.6707-6711.2003; Johri AK, 2007, INFECT IMMUN, V75, P1473, DOI 10.1128/IAI.00638-06; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Lachenauer CS, 1999, J INFECT DIS, V179, P1030, DOI 10.1086/314666; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Madureira P, 2007, J IMMUNOL, V178, P1379, DOI 10.4049/jimmunol.178.3.1379; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Matsubara K, 2000, PEDIATR INFECT DIS J, V19, P359, DOI 10.1097/00006454-200004000-00022; Mikamo H, 2004, INFECT IMMUN, V72, P4716, DOI 10.1128/IAI.72.8.4716-4722.2004; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Paoletti LC, 1996, INFECT IMMUN, V64, P1220, DOI 10.1128/IAI.64.4.1220-1226.1996; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Prakobphol A, 2000, J BIOL CHEM, V275, P39860, DOI 10.1074/jbc.M006928200; RAINARD P, 1992, INFECT IMMUN, V60, P4801, DOI 10.1128/IAI.60.11.4801-4808.1992; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Spellerberg B, 1999, INFECT IMMUN, V67, P871, DOI 10.1128/IAI.67.2.871-878.1999; STALHAMMARCARLEMALM M, 1993, J EXP MED, V177, P1593, DOI 10.1084/jem.177.6.1593; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Tettelin H, 2006, EXPERT REV VACCINES, V5, P687, DOI 10.1586/14760584.5.5.687; WALSH JA, 1989, PEDIATR INFECT DIS J, V8, P271	41	31	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4023	4034		10.1074/jbc.M112.425728	http://dx.doi.org/10.1074/jbc.M112.425728			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23209289	Green Published, hybrid			2022-12-28	WOS:000314845000031
J	Goc, A; Al-Azayzih, A; Abdalla, M; Al-Husein, B; Kavuri, S; Lee, J; Moses, K; Somanath, PR				Goc, Anna; Al-Azayzih, Ahmad; Abdalla, Maha; Al-Husein, Belal; Kavuri, Sravankumar; Lee, Jeffrey; Moses, Kelvin; Somanath, Payaningal R.			P21 Activated Kinase-1 (Pak1) Promotes Prostate Tumor Growth and Microinvasion via Inhibition of Transforming Growth Factor beta Expression and Enhanced Matrix Metalloproteinase 9 Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; CELL INVASION; CANCER; KINASE; ACTIVATION; INTEGRIN; RECEPTOR; ANGIOGENESIS; AKT	P21-activated kinases (Paks) are major effectors downstream of the small Rho family of GTPases. Among the six isoforms, Pak1 is the most ubiquitous and the best characterized member. Previous studies have shown that inhibition of Pak6, which is predominantly present in the prostate compared with other tissues, inhibits prostate tumor growth in vivo. Even though Pak1 has been identified in normal prostatic epithelial cells and cancer cells, its specific role in the development of prostate cancer remains unclear. We report here that highly invasive prostate cancer cells express significantly higher levels of Pak1 protein compared with non-invasive prostate cancer cells. Furthermore, prostate tumor tissues and prostate cancer metastasized to lungs showed a higher expression of Pak1 compared with normal tissues. Interestingly, Pak6 protein expression levels did not change with the invasive/metastatic potential of the cancer cells or tumors. Although inhibition of Pak1, and not Pak6, resulted in impaired PC3 cell migration, the effects of Pak1 knockdown on transendothelial migration (microinvasion), tumor growth, and tumor angiogenesis was higher compared with Pak6 knockdown. Finally, gene array data revealed reduced expression of matrix metalloproteinase 9 with the ablation of either Pak1 or Pak6 gene expression in PC3 cells, whereas protein levels of TGF beta was elevated significantly with specific modulation of Pak1 activity or ablation of the Pak1 gene. Our observations suggest that although some level of functional redundancy exists between Pak1 and Pak6 in prostate cancer cells, targeting Pak1 is a potential option for the management of prostate tumor growth, microinvasion, and metastasis.	[Goc, Anna; Al-Azayzih, Ahmad; Abdalla, Maha; Al-Husein, Belal; Somanath, Payaningal R.] Univ Georgia, Coll Pharm, Augusta, GA USA; [Goc, Anna; Al-Azayzih, Ahmad; Abdalla, Maha; Al-Husein, Belal; Kavuri, Sravankumar; Lee, Jeffrey; Moses, Kelvin; Somanath, Payaningal R.] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA USA; [Kavuri, Sravankumar; Lee, Jeffrey; Moses, Kelvin] Georgia Hlth Sci Univ, Dept Pathol, Augusta, GA 30912 USA; [Kavuri, Sravankumar; Lee, Jeffrey; Moses, Kelvin] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA 30912 USA; [Somanath, Payaningal R.] Georgia Hlth Sci Univ, Dept Med, Augusta, GA 30912 USA; [Somanath, Payaningal R.] Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA 30912 USA	University System of Georgia; University of Georgia; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Somanath, PR (corresponding author), Georgia Hlth Sci Univ, Coll Pharm, Univ Georgia, HM1200, Augusta, GA 30912 USA.	sshenoy@georgiahealth.edu	Al_Husin, Belal/CAF-6794-2022	Rammohan Shenoy, Somanath/0000-0003-3017-0230; Al-Husein, Belal/0000-0003-4001-5058; Abdalla, Maha/0000-0002-5644-3383	National Institutes of Health [R01HL103952]; University of Georgia Research Foundation; Wilson Pharmacy Foundation; University of Georgia College of Pharmacy; American Heart Association [0830326N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Research Foundation; Wilson Pharmacy Foundation; University of Georgia College of Pharmacy; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL103952 (to P. R. S.). This work was also supported by the University of Georgia Research Foundation, by the Wilson Pharmacy Foundation, and by the University of Georgia College of Pharmacy through intramural grants (to P. R. S.) and by American Heart Association Scientist Development Grant 0830326N (to P. R. S.).	Al-Azayzih A., 2012, BIOCHEM BIOPH RES CO, V32, P1095; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bright MD, 2009, CELL SIGNAL, V21, P1738, DOI 10.1016/j.cellsig.2009.07.005; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Eswaran J, 2007, STRUCTURE, V15, P201, DOI 10.1016/j.str.2007.01.001; Eswaran J, 2012, CLIN CANCER RES, V18, P3743, DOI 10.1158/1078-0432.CCR-11-1952; Goc A, 2012, BRIT J CANCER, V107, P713, DOI 10.1038/bjc.2012.295; Goc A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040594; Goc A, 2011, INT J ONCOL, V38, P267, DOI 10.3892/ijo_00000847; Kichina JV, 2010, EXPERT OPIN THER TAR, V14, P703, DOI 10.1517/14728222.2010.492779; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Kochuparambil ST, 2011, J PHARMACOL EXP THER, V336, P496, DOI 10.1124/jpet.110.174870; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lakka SS, 2003, CANCER RES, V63, P2454; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li BY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-239; Park MH, 2013, ONCOGENE, V32, P2475, DOI 10.1038/onc.2012.255; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Richmond B., 2005, P AM ASS CANC RES, V46; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Scicchitano MS, 2009, J HISTOCHEM CYTOCHEM, V57, P849, DOI 10.1369/jhc.2009.953497; Somanath PR, 2009, ONCOGENE, V28, P2365, DOI 10.1038/onc.2009.114; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Somanath PR, 2009, J CELL PHYSIOL, V218, P394, DOI 10.1002/jcp.21612; Wen XQ, 2009, UROLOGY, V73, P1407, DOI 10.1016/j.urology.2008.09.041; Wolff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016353; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Zhang M, 2010, PROSTATE, V70, P807, DOI 10.1002/pros.21114	30	62	62	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3025	3035		10.1074/jbc.M112.424770	http://dx.doi.org/10.1074/jbc.M112.424770			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23258534	hybrid, Green Published			2022-12-28	WOS:000314397900013
J	Paonessa, F; Latifi, S; Scarongella, H; Cesca, F; Benfenati, F				Paonessa, Francesco; Latifi, Shahrzad; Scarongella, Helena; Cesca, Fabrizia; Benfenati, Fabio			Specificity Protein 1 (Sp1)-dependent Activation of the Synapsin I Gene (SYN1) Is Modulated by RE1-silencing Transcription Factor (REST) and 5 '-Cytosine-Phosphoguanine (CpG) Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; TATA-LESS; SYNAPTIC VESICLES; NEURONAL GENES; MOUSE-BRAIN; EXPRESSION; PROMOTER; SP1; REPRESSOR; BINDING	The development and function of the nervous system are directly dependent on a well defined pattern of gene expression. Indeed, perturbation of transcriptional activity or epigenetic modifications of chromatin can dramatically influence neuronal phenotypes. The phosphoprotein synapsin I (Syn I) plays a crucial role during axonogenesis and synaptogenesis as well as in synaptic transmission and plasticity of mature neurons. Abnormalities in SYN1 gene expression have been linked to important neuropsychiatric disorders, such as epilepsy and autism. SYN1 gene transcription is suppressed in non-neural tissues by the RE1-silencing transcription factor (REST); however, the molecular mechanisms that allow the constitutive expression of this genetic region in neurons have not been clarified yet. Herein we demonstrate that a conserved region of human and mouse SYN1 promoters contains cis-sites for the transcriptional activator Sp1 in close proximity to REST binding motifs. Through a series of functional assays, we demonstrate a physical interaction of Sp1 on the SYN1 promoter and show that REST directly inhibits Sp1-mediated transcription, resulting in SYN1 down-regulation. Upon differentiation of neuroblastoma Neuro2a cells, we observe a decrease in endogenous REST and a higher stability of Sp1 on target GC boxes, resulting in an increase of SYN1 transcription. Moreover, methylation of Sp1 cis-sites in the SYN1 promoter region could provide an additional level of transcriptional regulation. Our results introduce Sp1 as a fundamental activator of basal SYN1 gene expression, whose activity is modulated by the neural master regulator REST and CpG methylation.	[Paonessa, Francesco; Latifi, Shahrzad; Scarongella, Helena; Cesca, Fabrizia; Benfenati, Fabio] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Benfenati, F (corresponding author), Ist Italiano Tecnol, Via Morego 30, I-16163 Genoa, Italy.	fabio.benfenati@iit.it		Paonessa, Francesco/0000-0002-4729-0928; Cesca, Fabrizia/0000-0003-2190-6314	Italian Ministry of University and Research (PRIN); Compagnia di San Paolo, Torino, Italy; Telethon-Italy [GGP09134]	Italian Ministry of University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Compagnia di San Paolo, Torino, Italy(Compagnia di San Paolo); Telethon-Italy(Fondazione Telethon)	This study was supported by research grants from the Italian Ministry of University and Research (PRIN) and the Compagnia di San Paolo, Torino, Italy. The support of Telethon-Italy (Grant GGP09134) is also acknowledged.	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Babu H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00089; Baldelli P, 2007, J NEUROSCI, V27, P13520, DOI 10.1523/JNEUROSCI.3151-07.2007; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Bogen IL, 2009, NEUROSCIENCE, V158, P231, DOI 10.1016/j.neuroscience.2008.05.055; Butta N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-17; Cao YX, 2000, BIOCHEM J, V350, P883, DOI 10.1042/0264-6021:3500883; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chang L., 2011, MOL CANCER RES, V9, P1; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Chiappalone M, 2009, CEREB CORTEX, V19, P1422, DOI 10.1093/cercor/bhn182; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; Clinton M., 2000, GENOME BIOL, V1; Corradi A, 2008, J CELL SCI, V121, P3042, DOI 10.1242/jcs.035063; Ekici M, 2008, NEUROCHEM INT, V53, P165, DOI 10.1016/j.neuint.2008.07.006; Fassio A, 2011, HUM MOL GENET, V20, P2297, DOI 10.1093/hmg/ddr122; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HOESCHE C, 1993, J BIOL CHEM, V268, P26494; Huber R, 1998, GENE, V214, P35, DOI 10.1016/S0378-1119(98)00233-9; James AB, 2004, CELL SIGNAL, V16, P1355, DOI 10.1016/j.cellsig.2004.04.001; JUNGLING S, 1994, EUR J BIOCHEM, V226, P925, DOI 10.1111/j.1432-1033.1994.00925.x; Kitazawa S, 1999, J BIOL CHEM, V274, P28787, DOI 10.1074/jbc.274.40.28787; Kudo S, 1998, MOL CELL BIOL, V18, P5492, DOI 10.1128/MCB.18.9.5492; KUDO S, 1995, J BIOL CHEM, V270, P13298, DOI 10.1074/jbc.270.22.13298; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lietz M, 1998, BIOL CHEM, V379, P1301; Lietz M, 2003, EUR J BIOCHEM, V270, P2, DOI 10.1046/j.1432-1033.2003.03360.x; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Palm K, 1998, J NEUROSCI, V18, P1280; Park SY, 2007, J NEUROCHEM, V103, P2565, DOI 10.1111/j.1471-4159.2007.04947.x; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Plaisance V, 2005, J BIOL CHEM, V280, P401, DOI 10.1074/jbc.M411825200; Rivero S, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-52; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; SAUERWALD A, 1990, J BIOL CHEM, V265, P14932; Schoch S, 1996, J BIOL CHEM, V271, P3317, DOI 10.1074/jbc.271.6.3317; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Strathdee G, 2004, BIOCHEM SOC T, V32, P913, DOI 10.1042/BST0320913; Strathdee G, 2004, CARCINOGENESIS, V25, P693, DOI 10.1093/carcin/bgh066; Sunkin SM, 2007, HUM MOL GENET, V16, pR209, DOI 10.1093/hmg/ddm183; THIEL G, 1994, J BIOL CHEM, V269, P15294; THIEL G, 1991, P NATL ACAD SCI USA, V88, P3431, DOI 10.1073/pnas.88.8.3431; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wood IC, 2003, J MOL BIOL, V334, P863, DOI 10.1016/j.jmb.2003.10.017; Zhu Q, 2012, J MOL NEUROSCI, V46, P420, DOI 10.1007/s12031-011-9602-7; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	56	37	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3227	3239		10.1074/jbc.M112.399782	http://dx.doi.org/10.1074/jbc.M112.399782			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250796	Green Published, hybrid			2022-12-28	WOS:000314397900030
J	Yamaguchi, Y; Shao, ZF; Sharif, S; Du, XY; Myles, T; Merchant, M; Harsh, G; Glantz, M; Recht, L; Morser, J; Leung, LLK				Yamaguchi, Yasuto; Shao, Zhifei; Sharif, Shadi; Du, Xiao-Yan; Myles, Timothy; Merchant, Milton; Harsh, Griffith; Glantz, Michael; Recht, Lawrence; Morser, John; Leung, Lawrence L. K.			Thrombin-cleaved Fragments of Osteopontin Are Overexpressed in Malignant Glial Tumors and Provide a Molecular Niche with Survival Advantage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER; PROGENITOR CELLS; TISSUE FACTOR; STEM-CELLS; GLIOBLASTOMA; INTEGRIN; IDENTIFICATION; PROTEIN; GLIOMAS	Osteopontin (OPN), which is highly expressed in malignant glioblastoma (GBM), possesses inflammatory activity modulated by proteolytic cleavage by thrombin and plasma carboxypeptidase B2 (CPB2) at a highly conserved cleavage site. Full-length OPN (OPN-FL) was elevated in cerebrospinal fluid (CSF) samples from all cancer patients compared with noncancer patients. However, thrombin-cleaved OPN (OPN-R) and thrombin/CPB2-double-cleaved OPN (OPN-L) levels were markedly increased in GBM and non-GBM gliomas compared with systemic cancer and noncancer patients. Cleaved OPN constituted similar to 23 and similar to 31% of the total OPN in the GBM and non-GBM CSF samples, respectively. OPN-R was also elevated in GBM tissues. Thrombin-antithrombin levels were highly correlated with cleaved OPN, but not OPN-FL, suggesting that the cleaved OPN fragments resulted from increased thrombin and CPB2 in this extracellular compartment. Levels of VEGF and CCL4 were increased in CSF of GBM and correlated with the levels of cleaved OPN. GBM cell lines were more adherent to OPN-R and OPN-L than OPN-FL. Adhesion to OPN altered gene expression, in particular genes involved with cellular processes, cell cycle regulation, death, and inflammation. OPN and its cleaved forms promoted motility of U-87 MG cells and conferred resistance to apoptosis. Although functional mutation of the RGD motif in OPN largely abolished these functions, OPNRAA-R regained significant cell binding and signaling function, suggesting that the SVVYGLR motif in OPN-R may substitute for the RGD motif if the latter becomes inaccessible. OPN cleavage contributes to GBM development by allowing more cells to bind in niches where they acquire anti-apoptotic properties.	[Yamaguchi, Yasuto; Shao, Zhifei; Sharif, Shadi; Du, Xiao-Yan; Myles, Timothy; Morser, John; Leung, Lawrence L. K.] Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Merchant, Milton; Recht, Lawrence] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Harsh, Griffith] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Glantz, Michael] Penn State Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Yamaguchi, Yasuto; Shao, Zhifei; Morser, John; Leung, Lawrence L. K.] Vet Affairs Palo Alto Hlth Care Syst, Med Serv, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Morser, J (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, 3801 Miranda Ave,Bldg 4,Room A236I, Palo Alto, CA 94304 USA.	jmorser@stanford.edu; lawrence.leung@stanford.edu			National Institutes of Health [HL057530]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057530, T32HL098049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL057530.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anand M, 2012, THROMB RES, V129, pS46, DOI 10.1016/S0049-3848(12)70015-4; Annabi B, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-8; Atai NA, 2011, IMMUNOLOGY, V132, P39, DOI 10.1111/j.1365-2567.2010.03335.x; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; Barry ST, 2000, BIOCHEM BIOPH RES CO, V267, P764, DOI 10.1006/bbrc.1999.2032; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Colin C, 2006, ONCOGENE, V25, P2818, DOI 10.1038/sj.onc.1209305; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; El-Tanani MK, 2006, CYTOKINE GROWTH F R, V17, P463, DOI 10.1016/j.cytogfr.2006.09.010; Formolo CA, 2011, J PROTEOME RES, V10, P3149, DOI 10.1021/pr200210w; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Green PM, 2001, FEBS LETT, V503, P75, DOI 10.1016/S0014-5793(01)02690-4; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Hua Y, 2005, ACTA NEUROCHIR SUPPL, V95, P403; Hua Y, 2005, J THROMB HAEMOST, V3, P1917, DOI 10.1111/j.1538-7836.2005.01446.x; Jan HJ, 2010, NEURO-ONCOLOGY, V12, P58, DOI 10.1093/neuonc/nop013; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Lahav J, 2000, FEBS LETT, V475, P89, DOI 10.1016/S0014-5793(00)01630-6; Lamour V, 2010, INT J CANCER, V126, P1797, DOI 10.1002/ijc.24751; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Lu X., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P29; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Myles T, 2008, J BIOL CHEM, V283, P17789, DOI 10.1074/jbc.M708629200; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Ornstein DL, 2002, SEMIN THROMB HEMOST, V28, P19, DOI 10.1055/s-2002-20561; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Qi B, 2009, CURR PHARM DESIGN, V15, P2336, DOI 10.2174/138161209788682352; Reynes G, 2011, J NEURO-ONCOL, V102, P35, DOI 10.1007/s11060-010-0290-x; Rice J, 2006, J VASC RES, V43, P422, DOI 10.1159/000094884; Rudland PS, 2002, CANCER RES, V62, P3417; Scheinkestel Carlos D, 2004, Emerg Med Australas, V16, P151, DOI 10.1111/j.1742-6723.2004.00567.x; Schuhmann MU, 2010, EJSO-EUR J SURG ONC, V36, P201, DOI 10.1016/j.ejso.2009.07.010; Selistre-de-Araujo HS, 2010, TOXINS, V2, P2606, DOI 10.3390/toxins2112606; Sharif SA, 2009, ARTHRITIS RHEUM-US, V60, P2902, DOI 10.1002/art.24814; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith LL, 1998, EXP CELL RES, V242, P351, DOI 10.1006/excr.1998.4108; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Stanton H, 2011, BBA-MOL BASIS DIS, V1812, P1616, DOI 10.1016/j.bbadis.2011.08.009; Takano S, 2000, BRIT J CANCER, V82, P1967; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Tehrani M, 2008, BRAIN PATHOL, V18, P164, DOI 10.1111/j.1750-3639.2007.00108.x; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Yamaguchi Y, 2011, J BIOL CHEM, V286, P39510, DOI 10.1074/jbc.M111.258921; Yan W, 2010, NEURO-ONCOLOGY, V12, P765, DOI 10.1093/neuonc/noq006; Yao XH, 2008, J PATHOL, V215, P369, DOI 10.1002/path.2356; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328	59	41	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3097	3111		10.1074/jbc.M112.362954	http://dx.doi.org/10.1074/jbc.M112.362954			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23204518	Green Published, hybrid			2022-12-28	WOS:000314397900019
J	Okumura, F; Okumura, AJ; Uematsu, K; Hatakeyama, S; Zhang, DE; Kamura, T				Okumura, Fumihiko; Okumura, Akiko J.; Uematsu, Keiji; Hatakeyama, Shigetsugu; Zhang, Dong-Er; Kamura, Takumi			Activation of Double-stranded RNA-activated Protein Kinase (PKR) by Interferon-stimulated Gene 15 (ISG15) Modification Down-regulates Protein Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; ANTIVIRAL MOLECULE; CONJUGATION SYSTEM; VIRUS-INFECTION; MESSENGER-RNA; NS1 PROTEIN; P68 KINASE; IDENTIFICATION; ISGYLATION; LIGASE	The ubiquitin-like molecule ISG15 (UCRP) and protein modification by ISG15 (ISGylation) are strongly induced by interferon, genotoxic stress, and pathogen infection, suggesting that ISG15 plays an important role in innate immune responses. However, how ISGylation contributes to innate immune responses is not clear. The dsRNA-dependent protein kinase (PKR) inhibits translation by phosphorylating eIF2 alpha to exert its anti-viral effect. ISG15 and PKR are induced by interferon, suggesting that a relationship exists between ISGylation and translational regulation. Here, we report that PKR is ISGylated at lysines 69 and 159. ISG15-modified PKR is active in the absence of virus infection and phosphorylates eIF2 alpha to down-regulate protein translation. The present study describes a novel pathway for the activation of PKR and the regulation of protein translation.	[Okumura, Fumihiko; Okumura, Akiko J.; Uematsu, Keiji; Kamura, Takumi] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Hatakeyama, Shigetsugu] Hokkaido Univ, Grad Sch Med, Dept Biochem, Sapporo, Hokkaido 0608638, Japan; [Zhang, Dong-Er] Univ Calif San Diego, Dept Pathol, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Zhang, Dong-Er] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Nagoya University; Hokkaido University; University of California System; University of California San Diego; University of California System; University of California San Diego	Okumura, F (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan.	okumura.fumihiko@a.mbox.nagoya-u.ac.jp; z47617a@nucc.cc.nagoya-u.ac.jp	Hatakeyama, Shigetsugu/C-8333-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979	Ministry of Education, Science, Sports, and Culture of Japan; Grants-in-Aid for Scientific Research [24112006, 23659144] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid from Scientific Research on Innovative Areas and grants from the Ministry of Education, Science, Sports, and Culture of Japan.	Chen LM, 2011, INT J BIOCHEM CELL B, V43, P1427, DOI 10.1016/j.biocel.2011.06.006; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Dao CT, 2005, FRONT BIOSCI-LANDMRK, V10, P2701, DOI 10.2741/1730; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; FENG GS, 1992, P NATL ACAD SCI USA, V89, P5447, DOI 10.1073/pnas.89.12.5447; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Ishibashi O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001614; JARVIS AP, 1978, CELL, V14, P879, DOI 10.1016/0092-8674(78)90343-4; Jeon YJ, 2012, J CLIN INVEST, V122, P2622, DOI 10.1172/JCI61762; Jeon YJ, 2009, EMBO REP, V10, P374, DOI 10.1038/embor.2009.23; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Ketscher L, 2012, BIOCHEM BIOPH RES CO, V417, P135, DOI 10.1016/j.bbrc.2011.11.071; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; KORANT BD, 1984, J BIOL CHEM, V259, P4835; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova O, 2002, J BIOL CHEM, V277, P14703, DOI 10.1074/jbc.M111527200; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; MEURS EF, 1992, J VIROL, V66, P5805, DOI 10.1128/JVI.66.10.5805-5814.1992; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Okumura F, 2004, J BIOL CHEM, V279, P53533, DOI 10.1074/jbc.M402916200; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Okumura F, 2011, BBA-MOL CELL RES, V1813, P1784, DOI 10.1016/j.bbamcr.2011.05.013; Okumura F, 2008, J BIOL CHEM, V283, P24484, DOI 10.1074/jbc.M803795200; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Oudshoorn D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029870; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Takeuchi T, 2006, BIOCHEM BIOPH RES CO, V348, P473, DOI 10.1016/j.bbrc.2006.07.076; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zhao C, 2010, P NATL ACAD SCI USA, V107, P2253, DOI 10.1073/pnas.0909144107; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	49	61	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2839	2847		10.1074/jbc.M112.401851	http://dx.doi.org/10.1074/jbc.M112.401851			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229543	hybrid, Green Published			2022-12-28	WOS:000314211500066
J	Oubrahim, H; Wong, A; Wilson, BA; Chock, PB				Oubrahim, Hammou; Wong, Allison; Wilson, Brenda A.; Chock, P. Boon			Mammalian Target of Rapamycin Complex 1 (mTORC1) Plays a Role in Pasteurella multocida Toxin (PMT)-induced Protein Synthesis and Proliferation in Swiss 3T3 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; POTENT MITOGEN; KINASE-C; CELL-GROWTH; PHOSPHORYLATION; S6; G-ALPHA(Q); ACTIVATION; P70(S6K); PATHWAY	Pasteurella multocida toxin (PMT) is a potent mitogen known to activate several signaling pathways via deamidation of a conserved glutamine residue in the alpha subunit of heterotrimeric G-proteins. However, the detailed mechanism behind mitogenic properties of PMT is unknown. Herein, we show that PMT induces protein synthesis, cell migration, and proliferation in serum-starved Swiss 3T3 cells. Concomitantly PMT induces phosphorylation of ribosomal S6 kinase (S6K1) and its substrate, ribosomal S6 protein (rpS6), in quiescent 3T3 cells. The extent of the phosphorylation is time and PMT concentration dependent, and is inhibited by rapamycin and Torin1, the two specific inhibitors of the mammalian target of rapamycin complex 1 (mTORC1). Interestingly, PMT-mediated mTOR signaling activation was observed in MEF WT but not in G alpha(q/11) knock-out cells. These observations are consistent with the data indicating that PMT-induced mTORC1 activation proceeds via the deamidation of G alpha(q/11), which leads to the activation of PLC beta to generate diacylglycerol and inositol trisphosphate, two known activators of the PKC pathway. Exogenously added diacylglycerol or phorbol 12-myristate 13-acetate, known activators of PKC, leads to rpS6 phosphorylation in a rapamycin-dependent manner. Furthermore, PMT-induced rpS6 phosphorylation is inhibited by PKC inhibitor, Go6976. Although PMT induces epidermal growth factor receptor activation, it exerts no effect on PMT-induced rpS6 phosphorylation. Together, our findings reveal for the first time that PMT activates mTORC1 through the G alpha(q/11)/PLC beta/PKC pathway. The fact that PMT-induced protein synthesis and cell migration is partially inhibited by rapamycin indicates that these processes are in part mediated by the mTORC1 pathway.	[Oubrahim, Hammou; Wong, Allison; Chock, P. Boon] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA; [Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Illinois System; University of Illinois Urbana-Champaign	Oubrahim, H (corresponding author), Bldg 50,Rm 2134,50 S Dr,MSC 8012, Bethesda, MD 20892 USA.	oubrahih@nhlbi.nih.gov; bchock@nih.gov			National Heart, Lung, and Blood Institute; National Institutes of Health; NIAID [AI038396]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006069, ZICHL006019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038396, R01AI038396] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported, in whole or in part, by the intramural Research Program of the National Heart, Lung, and Blood Institute and by National Institutes of Health and Grant AI038396 (to B. A. W.) from the NIAID.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Aminova LR, 2007, CELL MICROBIOL, V9, P2485, DOI 10.1111/j.1462-5822.2007.00975.x; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; BANDI HR, 1993, J BIOL CHEM, V268, P4530; Brothers MC, 2011, FEBS J, V278, P4633, DOI 10.1111/j.1742-4658.2011.08365.x; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; BUYS WECM, 1990, NUCLEIC ACIDS RES, V18, P2815, DOI 10.1093/nar/18.9.2815; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Chung YW, 2011, J BIOL CHEM, V286, P29681, DOI 10.1074/jbc.M111.264945; DUNCAN R, 1982, EUR J BIOCHEM, V123, P535; GRESSNER AM, 1974, J BIOL CHEM, V249, P6917; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Herbert TP, 2000, J BIOL CHEM, V275, P11249, DOI 10.1074/jbc.275.15.11249; HIGGINS TE, 1992, P NATL ACAD SCI USA, V89, P4240, DOI 10.1073/pnas.89.10.4240; Hoskins IC, 1997, VET REC, V140, P22, DOI 10.1136/vr.140.1.22; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacinto E, 2008, IUBMB LIFE, V60, P483, DOI 10.1002/iub.56; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kamitani S, 2011, FEBS J, V278, P2702, DOI 10.1111/j.1742-4658.2011.08197.x; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Kitadokoro K, 2007, P NATL ACAD SCI USA, V104, P5139, DOI 10.1073/pnas.0608197104; LARSEN A, 1980, J BACTERIOL, V141, P20, DOI 10.1128/JB.141.1.20-25.1980; Lax AJ, 2005, NAT REV MICROBIOL, V3, P343, DOI 10.1038/nrmicro1130; Lax AJ, 2001, INT J MED MICROBIOL, V291, P261, DOI 10.1078/1438-4221-00129; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MURPHY AC, 1992, J BIOL CHEM, V267, P25296; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Orth JHC, 2005, J BIOL CHEM, V280, P36701, DOI 10.1074/jbc.M507203200; Orth JHC, 2004, J BIOL CHEM, V279, P34150, DOI 10.1074/jbc.M405353200; Orth JHC, 2009, P NATL ACAD SCI USA, V106, P7179, DOI 10.1073/pnas.0900160106; Ozgen N, 2008, J BIOL CHEM, V283, P17009, DOI 10.1074/jbc.M709851200; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Pullinger GD, 2004, MOL MICROBIOL, V51, P255, DOI 10.1046/j.1365-2958.2003.03829.x; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; ROZENGURT E, 1990, P NATL ACAD SCI USA, V87, P123, DOI 10.1073/pnas.87.1.123; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sabri A, 2002, CIRC RES, V90, P850, DOI 10.1161/01.RES.0000016165.23795.1F; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schwab MS, 1999, MOL CELL BIOL, V19, P2485; Seo B, 2000, J BIOL CHEM, V275, P2239, DOI 10.1074/jbc.275.3.2239; STADDON JM, 1991, J BIOL CHEM, V266, P4840; STADDON JM, 1990, J BIOL CHEM, V265, P11841; Thomas W, 2001, INFECT IMMUN, V69, P5931, DOI 10.1128/IAI.69.9.5931-5935.2001; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wilson BA, 2000, INFECT IMMUN, V68, P4531, DOI 10.1128/IAI.68.8.4531-4538.2000; Wilson BA, 2011, FEBS J, V278, P4616, DOI 10.1111/j.1742-4658.2011.08158.x; Zahm JM, 1997, CELL MOTIL CYTOSKEL, V37, P33, DOI 10.1002/(SICI)1097-0169(1997)37:1<33::AID-CM4>3.0.CO;2-I; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zywietz A, 2001, J BIOL CHEM, V276, P3840, DOI 10.1074/jbc.M007819200	55	13	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2805	2815		10.1074/jbc.M112.427351	http://dx.doi.org/10.1074/jbc.M112.427351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223576	Green Published, hybrid			2022-12-28	WOS:000314211500063
J	Zou, CB; Chen, Y; Smith, RM; Snavely, C; Li, J; Coon, TA; Chen, BB; Zhao, YT; Mallampalli, RK				Zou, Chunbin; Chen, Yan; Smith, Rebecca M.; Snavely, Courtney; Li, Jin; Coon, Tiffany A.; Chen, Bill B.; Zhao, Yutong; Mallampalli, Rama K.			SCFFbxw15 Mediates Histone Acetyltransferase Binding to Origin Recognition Complex (HBO1) Ubiquitin-Proteasomal Degradation to Regulate Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; F-BOX; BETA-TRCP; ACTIVATION; LIPOPOLYSACCHARIDE; PHOSPHORYLATION; RECRUITMENT; ACETYLASE; LIGASES; TRANSCRIPTION	Histone acetyltransferase binding to origin recognition complex (HBO1) plays a crucial role in DNA replication licensing and cell proliferation, yet its molecular regulation in cells is relatively unknown. Here an uncharacterized protein, Fbxw15, directly interacts with HBO1, a labile protein (t(1/2) = similar to 3 h), to mediate its ubiquitination (Lys(338)) and degradation in the cytoplasm. Fbxw15-mediated HBO1 depletion required mitogen-activated protein kinase 1 (Mek1), which was sufficient to trigger HBO1 phosphorylation and degradation in cells. Mek1 ability to produce HBO1 degradation was blocked by Fbxw15 silencing. Lipopolysaccharide induced HBO1 degradation, an effect abrogated by Fbxw15 or Mek1 cellular depletion. Modulation of Fbxw15 levels was able to differentially regulate histone H3K14 acetylation and cellular proliferation by altering HBO1 levels. These studies authenticate Fbxw15 as a ubiquitin E3 ligase subunit that mediates endotoxin-induced HBO1 depletion in cells, thereby controlling cell replicative capacity.	[Zou, Chunbin; Chen, Yan; Smith, Rebecca M.; Snavely, Courtney; Li, Jin; Coon, Tiffany A.; Chen, Bill B.; Zhao, Yutong; Mallampalli, Rama K.] Univ Pittsburgh, Acute Lung Injury Ctr Excellence, Dept Med, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; [Chen, Yan] Cent South Univ, Xiangya Hosp 2, Dept Internal Med, Div Resp Dis, Changsha 410011, Hunan, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University	Mallampalli, RK (corresponding author), Dept Med, Div Pulm Allergy & Crit Care Med, 628 NW Montefiore,3459 5th Ave, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu	Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726	National Institutes of Health [HL096376, HL097376, HL098174, HL116472, HL01916]; United States Department of Veterans Affairs; Veterans Health Administration; Office of Research and Development; Biomedical Laboratory Research and Development; American Heart Association [12SDG12040330]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097376, R01HL112791, R01HL098174, R01HL116472, R01HL096376] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Biomedical Laboratory Research and Development(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HL096376, HL097376, and HL098174 (to R. K. M.), HL116472 (to B. B. C.), and HL01916 (to Y. Z.). This work was also supported in part by the United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, a Merit Review Award from the United States Department of Veterans Affairs, and American Heart Association Award 12SDG12040330 (to C. Z.).	Avvakumov N, 2012, MOL CELL BIOL, V32, P689, DOI 10.1128/MCB.06455-11; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Carter AB, 1998, AM J RESP CELL MOL, V18, P384, DOI 10.1165/ajrcmb.18.3.2972; Chadha GS, 2010, MOL CELL, V37, P5, DOI 10.1016/j.molcel.2009.12.028; Chen BB, 2011, MOL CELL BIOL, V31, P1905, DOI 10.1128/MCB.00723-10; Coles AH, 2010, P NATL ACAD SCI USA, V107, P11423, DOI 10.1073/pnas.0912116107; De La Chesnaye E, 2008, BIOL REPROD, V78, P714, DOI 10.1095/biolreprod.107.063826; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Haller D, 2003, J BIOL CHEM, V278, P23851, DOI 10.1074/jbc.M300075200; HAMILTON JA, 1992, J IMMUNOL, V148, P4028; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Inuzuka H, 2012, CELL, V150, P179, DOI 10.1016/j.cell.2012.05.038; Jain S, 2012, BREAST CANCER RES TR, V135, P103, DOI 10.1007/s10549-012-2069-6; Jo C, 2011, J BIOL CHEM, V286, P18903, DOI 10.1074/jbc.M111.225128; Karabinova P, 2011, CELL TISSUE RES, V346, P1, DOI 10.1007/s00441-011-1235-1; Kim CO, 2012, ARCH GERONTOL GERIAT, V54, pE35, DOI 10.1016/j.archger.2011.07.016; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Lau AW, 2012, FRONT BIOSCI-LANDMRK, V17, P2197, DOI 10.2741/4045; Li YM, 2011, J BIOL CHEM, V286, P41344, DOI 10.1074/jbc.M111.290767; Maki K, 2008, J IMMUNOL, V181, P494, DOI 10.4049/jimmunol.181.1.494; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Miotto B, 2011, MOL CELL, V44, P62, DOI 10.1016/j.molcel.2011.06.021; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Potoka DA, 2003, AM J PHYSIOL-GASTR L, V285, pG861, DOI 10.1152/ajpgi.00412.2002; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Ruemmele FM, 2002, GUT, V51, P842, DOI 10.1136/gut.51.6.842; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Shima Y, 2008, MOL CELL BIOL, V28, P7126, DOI 10.1128/MCB.00897-08; Silverman JS, 2012, TRENDS BIOCHEM SCI, V37, P66, DOI 10.1016/j.tibs.2011.10.004; Starostina NG, 2012, TRENDS CELL BIOL, V22, P33, DOI 10.1016/j.tcb.2011.10.004; Takada Y, 2005, BLOOD, V106, P641, DOI 10.1182/blood-2004-12-4589; Tan MKM, 2011, MOL CELL BIOL, V31, P3687, DOI 10.1128/MCB.05746-11; Wong PG, 2010, CELL CYCLE, V9, P4351, DOI 10.4161/cc.9.21.13596; Wu ZQ, 2008, P NATL ACAD SCI USA, V105, P1919, DOI 10.1073/pnas.0712063105; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yang LN, 2011, CELL IMMUNOL, V271, P173, DOI 10.1016/j.cellimm.2011.06.017; Zhao J, 2012, J BIOL CHEM, V287, P19105, DOI 10.1074/jbc.M112.339507; Zou CB, 2011, J BIOL CHEM, V286, P28019, DOI 10.1074/jbc.M111.253385; Zou CB, 2011, J BIOL CHEM, V286, P2719, DOI 10.1074/jbc.M110.192377	46	30	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6306	6316		10.1074/jbc.M112.426882	http://dx.doi.org/10.1074/jbc.M112.426882			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319590	hybrid, Green Published			2022-12-28	WOS:000315820700025
J	So, LM; Yea, SS; Oak, JS; Lu, MR; Manmadhan, A; Ke, QH; Janes, MR; Kessler, LV; Kucharski, JM; Li, LS; Martin, MB; Ren, PD; Jessen, KA; Liu, Y; Rommel, C; Fruman, DA				So, Lomon; Yea, Sung Su; Oak, Jean S.; Lu, Mengrou; Manmadhan, Arun; Ke, Qiao Han; Janes, Matthew R.; Kessler, Linda V.; Kucharski, Jeff M.; Li, Lian-Sheng; Martin, Michael B.; Ren, Pingda; Jessen, Katti A.; Liu, Yi; Rommel, Christian; Fruman, David A.			Selective Inhibition of Phosphoinositide 3-Kinase p110 alpha Preserves Lymphocyte Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL; T-CELLS; P110-DELTA ISOFORM; PI3K INHIBITOR; KINASE; ANTIGEN; GROWTH; IMMUNOTHERAPY; MECHANISMS; MUTATIONS	Class IA phosphoinositide 3-kinase (PI3K) is essential for clonal expansion, differentiation, and effector function of B and T lymphocytes. The p110 delta catalytic isoform of PI3K is highly expressed in lymphocytes and plays a prominent role in B and T cell responses. Another class IA PI3K catalytic isoform, p110 alpha, is a promising drug target in cancer but little is known about its function in lymphocytes. Here we used highly selective inhibitors to probe the function of p110 alpha in lymphocyte responses in vitro and in vivo. p110 alpha inhibition partially reduced B cell receptor (BCR)-dependent AKT activation and proliferation, and diminished survival supported by the cytokines BAFF and IL-4. Selective p110 delta inhibition suppressed B cell responses much more strongly, yet maximal suppression was achieved by targeting multiple PI3K isoforms. In mouse and human T cells, inhibition of single class IA isoforms had little effect on proliferation, whereas pan-class I inhibition did suppress T cell expansion. In mice, selective p110 alpha inhibition using the investigational agent MLN1117 (previously known as INK1117) did not disrupt the marginal zone B cell compartment and did not block T cell-dependent germinal center formation. In contrast, the selective p110 delta inhibitor IC87114 strongly suppressed germinal center formation and reduced marginal zone B cell numbers, similar to a pan-class I inhibitor. These findings show that although acute p110 alpha inhibition partially diminishes AKT activation, selective p110 alpha inhibitors are likely to be less immunosuppressive in vivo compared with p110 delta or pan-class I inhibitors.	[So, Lomon; Yea, Sung Su; Oak, Jean S.; Lu, Mengrou; Manmadhan, Arun; Ke, Qiao Han; Fruman, David A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [So, Lomon; Yea, Sung Su; Oak, Jean S.; Lu, Mengrou; Manmadhan, Arun; Ke, Qiao Han; Fruman, David A.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA; [Yea, Sung Su] Inje Univ, Dept Biochem, Coll Med, Pusan 614735, South Korea; [Janes, Matthew R.; Kessler, Linda V.; Kucharski, Jeff M.; Li, Lian-Sheng; Martin, Michael B.; Ren, Pingda; Jessen, Katti A.; Liu, Yi; Rommel, Christian] Intellikine Inc, La Jolla, CA 92037 USA; [Janes, Matthew R.; Kessler, Linda V.; Kucharski, Jeff M.; Li, Lian-Sheng; Martin, Michael B.; Jessen, Katti A.] Takeda Calif Inc, San Diego, CA 92121 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Inje University; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc	Fruman, DA (corresponding author), 3242 McGaugh Hall, Irvine, CA 92697 USA.	dfruman@uci.edu		Manmadhan, Arun/0000-0001-9500-8184	Intellikine, Inc.; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER	Intellikine, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a sponsored research agreement from Intellikine, Inc. (to D. A. F.).	Agarwal R, 2010, CURR OPIN INVEST DR, V11, P615; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Donahue AC, 2007, EUR J IMMUNOL, V37, P2923, DOI 10.1002/eji.200737281; Durand CA, 2009, J IMMUNOL, V183, P5673, DOI 10.4049/jimmunol.0900432; Edgar KA, 2010, CANCER RES, V70, P1164, DOI 10.1158/0008-5472.CAN-09-2525; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Fruman DA, 2011, CANCER DISCOV, V1, P562, DOI 10.1158/2159-8290.CD-11-0249; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jessen K, 2011, MOL CANC THER, V10; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kong D, 2007, CANCER SCI, V98, P1638, DOI 10.1111/j.1349-7006.2007.00580.x; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Marshall NA, 2012, CANCER RES, V72, P581, DOI 10.1158/0008-5472.CAN-11-0307; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Okkenhaug K, 2006, J IMMUNOL, V177, P5122, DOI 10.4049/jimmunol.177.8.5122; Okkenhaug K, 2010, CURR TOP MICROBIOL, V346, P57, DOI 10.1007/82_2010_45; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Ramadani F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001104; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Rewcastle GW, 2011, J MED CHEM, V54, P7105, DOI 10.1021/jm200688y; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; So L, 2012, BIOCHEM J, V442, P465, DOI 10.1042/BJ20112092; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Sun MH, 2010, P NATL ACAD SCI USA, V107, P15547, DOI 10.1073/pnas.1009652107; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Zhang TT, 2008, J ALLERGY CLIN IMMUN, V122, P811, DOI 10.1016/j.jaci.2008.08.008	42	53	54	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5718	5731		10.1074/jbc.M112.379446	http://dx.doi.org/10.1074/jbc.M112.379446			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23275335	Green Published, hybrid			2022-12-28	WOS:000315342500044
J	Ben-Yona, A; Kanner, BI				Ben-Yona, Assaf; Kanner, Baruch I.			Functional Defects in the External and Internal Thin Gates of the gamma-Aminobutyric Acid (GABA) Transporter GAT-1 Can Compensate Each Other	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; ALTERNATING ACCESS; SUBTYPE-A; RAT-BRAIN; IDENTIFICATION; SITE; BINDING; PERMEATION; EXPRESSION	The GABA transporter GAT-1 belongs to the neurotransmitter: sodium: symporters which are crucial for synaptic transmission. GAT-1 mediates electrogenic transport of GABA together with sodium and chloride. Structure-function studies indicate that the bacterial homologue LeuT, which possess extra-and intracellular thin gates, is an excellent model for this class of neurotransmitter transporters. We recently showed that a conserved aspartate residue of GAT-1, Asp-451, whose LeuT equivalent participates in its thin extracellular gate, is functionally irreplaceable in GAT-1. Only the D451E mutant exhibited residual transport activity but with an elevated apparent sodium affinity as a consequence of an increased proportion of outward-facing transporters. Because during transport the opening and closing of external and internal gates should be tightly coupled, we have addressed the question of whether mutations of the intracellular thin gate residues Arg-44 and Asp-410 can compensate for the effects of their extracellular counterparts. Mutation of Asp-410 to glutamate resulted in impaired transport activity and a reduced apparent affinity for sodium. However, the transport activity of the double mutant D410E/D451E was increased by approximately 10-fold of that of each of the single mutants. Similar compensatory effects were also seen when other combinations of intra-and extracellular thin gate mutants were analyzed. Moreover, the introduction of D410E into the D451E background resulted in lower apparent sodium affinity than that of D451E alone. Our results indicate that a functional interaction of the external and internal gates of GAT-1 is essential for transport.	[Ben-Yona, Assaf; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, POB 12272, IL-91120 Jerusalem, Israel.	baruch.kanner@mail.huji.ac.il			Israel Science Foundation; European Union Consortium European Drug Initiative on Channels and Transporters	Israel Science Foundation(Israel Science Foundation); European Union Consortium European Drug Initiative on Channels and Transporters(European Commission)	This work was supported by grants from the Israel Science Foundation and the European Union Consortium European Drug Initiative on Channels and Transporters.	Ben-Yona A, 2012, J BIOL CHEM, V287, P7159, DOI 10.1074/jbc.M111.323634; Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Ben-Yona A, 2009, J BIOL CHEM, V284, P9727, DOI 10.1074/jbc.M809423200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Bennett ER, 1997, J BIOL CHEM, V272, P1203, DOI 10.1074/jbc.272.2.1203; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Mari SA, 2006, CELL MOL LIFE SCI, V63, P100, DOI 10.1007/s00018-005-5512-6; Nelson N, 1998, J NEUROCHEM, V71, P1785; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200	31	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4549	4556		10.1074/jbc.M112.430215	http://dx.doi.org/10.1074/jbc.M112.430215			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288838	Green Published, hybrid			2022-12-28	WOS:000315340400005
J	Mast, N; Zheng, WC; Stout, CD; Pikuleva, IA				Mast, Natalia; Zheng, Wenchao; Stout, C. David; Pikuleva, Irina A.			Binding of a Cyano- and Fluoro-containing Drug Bicalutamide to Cytochrome P450 46A1 UNUSUAL FEATURES AND SPECTRAL RESPONSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC-MICROSOMAL CYTOCHROME-P-450; CHOLESTEROL HOMEOSTASIS; CRYSTAL-STRUCTURE; DIFFERENCE SPECTRA; STRUCTURAL BASIS; HUMAN BRAIN; SPIN-STATE; TURNOVER; COMPLEXES; ENZYME	Cytochrome P450 46A1 (CYP46A1) is the cholesterol 24-hydroxylase initiating the major pathways of cholesterol removal from the brain, and bicalutamide (BIC) is a drug of choice for the treatment of progressive androgen-dependent prostate cancer. We evaluated the interactions of BIC with CYP46A1 by x-ray crystallography and by conducting solution and mutagenesis studies. Because BIC is administered to patients as a racemic mixture of the S and R isomers, we studied all three, racemic BIC as well as the S and R isomers. Co-crystallization of CYP46A1 with racemic BIC led to structure determinations at 2.1A resolution with the drug complexes exhibiting novel properties. Both BIC isomers bind to the CYP46A1 active site in very similar single orientation and adopt an energetically unfavorable folded conformation. This folded BIC conformation is correlated with drug-induced localized shifts of amino acid side chains in CYP46A1 and unusual interactions in the CYP46A1-BIC complex. One of these interactions involves a water molecule that is coordinated to the P450 heme iron and also hydrogen-bonded to the BIC nitrile. Due to polarization of the water in this environment, the heme elicits previously unreported types of P450 spectral responses. We also observed that access to the P450 active site was affected by differential recognition of S versus R isomers at the CYP46A1 surface arising from BIC conformational polymorphism.	Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Visual Sci, Cleveland, OH 44106 USA; [Stout, C. David] Scripps Res Inst, La Jolla, CA 92037 USA	Case Western Reserve University; Case Western Reserve University; Scripps Research Institute	Stout, CD (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	dave@scripps.edu; iap8@case.edu		Pikuleva, Irina/0000-0001-9742-6232	United States Public Health Service [GM62882]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882, P41GM103393] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by United States Public Health Service Grant GM62882 (to I. A. P.). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS, Center for Research Resources, or the National Institutes of Health.; We thank Dr. A. T. Hagler (Department of Chemistry, University of Massachusetts) for providing the coordinates of the computed BIC structure mentioned in Ref. (42) and Dr. M. Shimoji for generating the T306A CYP46A1 mutant. Portions of this research were carried out at Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the NIGMS, National Institutes of Health (including Grant P41GM103393) and the National Center for Research Resources (Grant P41RR001209). We thank the staff at the Stanford Synchrotron Radiation Lightsource for assistance in data collection.	ANDERSSON LA, 1984, XENOBIOTICA, V14, P49, DOI 10.3109/00498258409151398; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bis JA, 2007, MOL PHARMACEUT, V4, P401, DOI 10.1021/mp070012s; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; DAWSON JH, 1982, J BIOL CHEM, V257, P3606; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleming FF, 2010, J MED CHEM, V53, P7902, DOI 10.1021/jm100762r; GIGON PL, 1968, BIOCHEM BIOPH RES CO, V31, P558, DOI 10.1016/0006-291X(68)90514-7; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Hu XR, 2005, ACTA CRYSTALLOGR E, V61, pO3897, DOI 10.1107/S1600536805034501; Isoherranen N, 2004, DRUG METAB DISPOS, V32, P1121, DOI 10.1124/dmd.104.000315; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; KUMAKI K, 1978, J BIOL CHEM, V253, P1048; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; MAILMAN RB, 1974, DRUG METAB DISPOS, V2, P301; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Mast N, 2012, MOL PHARMACOL, V82, P824, DOI 10.1124/mol.112.080424; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; Mast N, 2011, J BIOL CHEM, V286, P5607, DOI 10.1074/jbc.M110.188433; Mast N, 2010, J BIOL CHEM, V285, P31783, DOI 10.1074/jbc.M110.143313; Mast N, 2009, ARCH BIOCHEM BIOPHYS, V483, P81, DOI 10.1016/j.abb.2009.01.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukherjee A, 1996, XENOBIOTICA, V26, P117, DOI 10.3109/00498259609046693; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OMURA T, 1964, J BIOL CHEM, V239, P2370; Osguthorpe DJ, 2011, BIOCHEMISTRY-US, V50, P4105, DOI 10.1021/bi102059z; Pearson J, 2011, ARCH BIOCHEM BIOPHYS, V511, P69, DOI 10.1016/j.abb.2011.04.008; POULOS TL, 1987, BIOCHEMISTRY-US, V26, P8165, DOI 10.1021/bi00399a022; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; REMMER H, 1966, MOL PHARMACOL, V2, P187; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Seward HE, 2006, J BIOL CHEM, V281, P39437, DOI 10.1074/jbc.M607665200; Shafaati M, 2010, J LIPID RES, V51, P318, DOI 10.1194/jlr.M900174-JLR200; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; SONO M, 1982, J BIOL CHEM, V257, P5496; Vega DR, 2007, INT J PHARM, V328, P112, DOI 10.1016/j.ijpharm.2006.08.001; White MA, 2008, ACTA CRYSTALLOGR D, V64, P487, DOI 10.1107/S0907444908004046	44	35	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4613	4624		10.1074/jbc.M112.438754	http://dx.doi.org/10.1074/jbc.M112.438754			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288837	Green Published, hybrid			2022-12-28	WOS:000315340400011
J	Gururaj, AE; Gibson, L; Panchabhai, S; Bai, MH; Manyam, G; Lu, Y; Latha, K; Rojas, ML; Hwang, Y; Liang, SD; Bogler, O				Gururaj, Anupama E.; Gibson, Laura; Panchabhai, Sonali; Bai, MingHui; Manyam, Ganiraju; Lu, Yue; Latha, Khatri; Rojas, Marta L.; Hwang, Yeohyeon; Liang, Shoudan; Bogler, Oliver			Access to the Nucleus and Functional Association with c-Myc Is Required for the Full Oncogenic Potential of Delta EGFR/EGFRvIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROGNOSTIC VALUE; BREAST-CANCER; EGF RECEPTOR; EXPRESSION; ACTIVATION; GLIOMA; LOCALIZATION; INTERACTS; SEQUENCE	Delta EGFR is a potent glioblastoma oncogene which has been studied primarily as a plasma membrane kinase. Using intracranial xenograft studies in mice, we show that blocking Delta EGFR access to the nucleus attenuates its tumorigenicity and, conversely, that promoting nuclear accumulation enhances this, providing the first in vivo evidence that the nuclear actions of Delta EGFR contribute strongly to its oncogenic function. Nuclear actions of Delta EGFR include regulation of gene expression by participation in chromatin-bound complexes, and genome-wide mapping of these sequences by chromatin immunoprecipitation and massively parallel sequencing identified 2294 peaks. Bioinformatic analysis showed enrichment of the E-box motif in the dataset, and c-Myc and Delta EGFR were corecruited to the promoters of and transcriptionally activated a subset of nuclear Delta EGFR chromatin targets. Knockdown of c-Myc decreased the expression of these targets and diminished Delta EGFR-stimulated anchorage-independent colony formation. We conclude that transcriptional regulation of target genes by association with gene regulatory chromatin in cooperation with c-Myc by nuclear Delta EGFR makes a unique contribution to its oncogenicity and propose that this venue provides new targets for therapeutic intervention.	[Gururaj, Anupama E.; Gibson, Laura; Bai, MingHui; Latha, Khatri; Rojas, Marta L.; Hwang, Yeohyeon; Bogler, Oliver] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Panchabhai, Sonali] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Manyam, Ganiraju; Liang, Shoudan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Lu, Yue] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Rojas, Marta L.; Bogler, Oliver] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gururaj, AE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, 6767 Bertner Ave, Houston, TX 77030 USA.	aegururaj@mdanderson.org	Manyam, Ganiraju/E-9150-2012; Manyam, Ganiraju C/B-5890-2014	Manyam, Ganiraju/0000-0001-6006-8961; Lu, Yue/0000-0002-5479-9095; Bogler, Oliver/0000-0002-3700-0480	National Cancer Institute National Institutes of Health [RO1CA108500, P50CA127001]; M.D. Anderson Cancer Center Core Grant [NCI CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA108500, P50CA127001] Funding Source: NIH RePORTER	National Cancer Institute National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); M.D. Anderson Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by grants from the National Cancer Institute National Institutes of Health Grants RO1CA108500 (to O. B.) and P50CA127001 (to O. B. and A. E. G.). This work was also supported by M.D. Anderson Cancer Center Core Grant NCI CA016672, including the DNA Analysis facility.	Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Chen B, 2000, J BIOL CHEM, V275, P19275, DOI 10.1074/jbc.M908994199; de la Iglesia N, 2008, GENE DEV, V22, P449, DOI 10.1101/gad.1606508; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Hwang Y, 2011, MOL CANCER RES, V9, P1199, DOI 10.1158/1541-7786.MCR-11-0229; Jaganathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019605; Jensen NA, 2003, J BIOL CHEM, V278, P8300, DOI 10.1074/jbc.M211195200; Kajiwara Y, 2008, TECHNOL CANCER RES T, V7, P329, DOI 10.1177/153303460800700407; Kim J, 2007, CANCER RES, V67, P9229, DOI 10.1158/0008-5472.CAN-07-1333; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Latha K, 2013, INT J CANCER, V132, P509, DOI 10.1002/ijc.27690; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lo HW, 2005, CANCER RES, V65, P338; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Psyrri A, 2008, CANCER EPIDEM BIOMAR, V17, P1486, DOI 10.1158/1055-9965.EPI-07-2684; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Shingu T, 2010, NEURO-ONCOLOGY, V12, P1269, DOI 10.1093/neuonc/noq095; Tang QZ, 2011, CANCER RES, V71, P6940, DOI 10.1158/0008-5472.CAN-11-2091; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Xia WY, 2009, MOL CARCINOGEN, V48, P610, DOI 10.1002/mc.20504; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	37	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3428	3438		10.1074/jbc.M112.399352	http://dx.doi.org/10.1074/jbc.M112.399352			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250739	Green Published, hybrid			2022-12-28	WOS:000314397900047
J	Pal, K; Mathur, M; Kumar, P; DeFea, K				Pal, Kasturi; Mathur, Maneesh; Kumar, Puneet; DeFea, Kathryn			Divergent beta-Arrestin-dependent Signaling Events Are Dependent upon Sequences within G-protein-coupled Receptor C Termini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-2; SUBSTANCE-P; DESENSITIZATION; ENDOCYTOSIS; DOWNSTREAM; BETA-ARRESTIN-1; TRAFFICKING; MECHANISMS; MIGRATION; SCAFFOLD	beta-Arrestins are multifunctional adaptor proteins that, upon recruitment to an activated G-protein-coupled receptor, can promote desensitization of G-protein signaling and receptor internalization while simultaneously eliciting an independent signal. The result of beta-arrestin signaling depends upon the activating receptor. For example, activation of two G alpha(q)-coupled receptors, protease-activated receptor-2 (PAR(2)) and neurokinin-1 receptor (NK1R), results in drastically different signaling events. PAR(2) promotes beta-arrestin-dependent membrane-sequestered extracellular signal-regulated kinase (ERK1/2) activation, cofilin activation, and cell migration, whereas NK1R promotes nuclear ERK1/2 activation and proliferation. Using bioluminescence resonance energy transfer to monitor receptor/beta-arrestin interactions in real time, we observe that PAR(2) has a higher apparent affinity for both beta-arrestins than does NK1R, recruits them at a faster rate, and exhibits more rapid desensitization of the G-protein signal. Furthermore, recruitment of beta-arrestins to PAR(2) does not require prior G alpha(q) signaling events, whereas inhibition of G alpha(q) signaling intermediates inhibits recruitment of beta-arrestins to NK1R. Using chimeric receptors in which the C terminus of PAR(2) is fused to the N terminus of NK1R and vice versa and a critical Ser/Thr mutant of PAR(2), we demonstrate that interactions between beta-arrestins and specific phosphoresidues in the C termini of each receptor are crucial for determining the rate and magnitude of beta-arrestin recruitment as well as the ultimate signaling outcome.	[Pal, Kasturi; Mathur, Maneesh; DeFea, Kathryn] Univ Calif Riverside, Cell Mol Dev Biol Program, Riverside, CA 92521 USA; [Kumar, Puneet; DeFea, Kathryn] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	DeFea, K (corresponding author), Univ Calif Riverside, Div Biomed Sci, 900 Univ Ave, Riverside, CA 92521 USA.	kathryn.defea@ucr.edu	Pal, Kasturi/H-7059-2019	Pal, Kasturi/0000-0002-7328-5153; DeFea, Kathryn/0000-0001-6056-907X	National Institutes of Health Grant [R01GM066151]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066151] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM066151 (to K. A. D.).	Al-Ani B, 2004, MOL PHARMACOL, V65, P149, DOI 10.1124/mol.65.1.149; Bohm SK, 1997, BIOCHEM J, V322, P1; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dery O, 2001, AM J PHYSIOL-CELL PH, V280, pC1097, DOI 10.1152/ajpcell.2001.280.5.C1097; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; EXTON JH, 1994, ANNU REV PHYSIOL, V56, P349; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Kumar P, 2007, AM J PHYSIOL-CELL PH, V293, pC346, DOI 10.1152/ajpcell.00010.2007; Lovgren AK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001564; Luttrell LM, 2002, J CELL SCI, V115, P455; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; McConalogue K, 1998, MOL BIOL CELL, V9, P2305, DOI 10.1091/mbc.9.8.2305; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Seatter MJ, 2004, CELL SIGNAL, V16, P21, DOI 10.1016/S0898-6568(03)00095-0; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Yu YJ, 2009, J NEUROSCI, V29, P222, DOI 10.1523/JNEUROSCI.4315-08.2009; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200; Zoudilova M, 2010, J BIOL CHEM, V285, P14318, DOI 10.1074/jbc.M109.055806	31	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3265	3274		10.1074/jbc.M112.400234	http://dx.doi.org/10.1074/jbc.M112.400234			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235155	hybrid, Green Published			2022-12-28	WOS:000314397900033
J	Savva, CG; da Costa, SPF; Bokori-Brown, M; Naylor, CE; Cole, AR; Moss, DS; Titball, RW; Basak, AK				Savva, Christos G.; da Costa, Sergio P. Fernandes; Bokori-Brown, Monika; Naylor, Claire E.; Cole, Ambrose R.; Moss, David S.; Titball, Richard W.; Basak, Ajit K.			Molecular Architecture and Functional Analysis of NetB, a Pore-forming Toxin from Clostridium perfringens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCAL GAMMA-HEMOLYSIN; NECROTIC ENTERITIS; ALPHA-HEMOLYSIN; CRYSTAL-STRUCTURE; MEMBRANE-FLUIDITY; BROILER-CHICKENS; PROTEIN; OLIGOMERIZATION; TRANSPORT; BINDING	NetB is a pore-forming toxin produced by Clostridium perfringens and has been reported to play a major role in the pathogenesis of avian necrotic enteritis, a disease that has emerged due to the removal of antibiotics in animal feedstuffs. Here we present the crystal structure of the pore form of NetB solved to 3.9 angstrom. The heptameric assembly shares structural homology to the staphylococcal alpha-hemolysin. However, the rim domain, a region that is thought to interact with the target cell membrane, shows sequence and structural divergence leading to the alteration of a phosphocholine binding pocket found in the staphylococcal toxins. Consistent with the structure we show that NetB does not bind phosphocholine efficiently but instead interacts directly with cholesterol leading to enhanced oligomerization and pore formation. Finally we have identified conserved and non-conserved amino acid positions within the rim loops that significantly affect binding and toxicity of NetB. These findings present new insights into the mode of action of these pore-forming toxins, enabling the design of more effective control measures against necrotic enteritis and providing potential new tools to the field of bionanotechnology.	[Savva, Christos G.; Naylor, Claire E.; Cole, Ambrose R.; Moss, David S.; Basak, Ajit K.] Univ London Birkbeck Coll, Dept Biol Sci, Sch Crystallog, Inst Struct & Mol Biol, London WC1E 7HX, England; [da Costa, Sergio P. Fernandes; Bokori-Brown, Monika; Titball, Richard W.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QD, Devon, England	University of London; Birkbeck University London; University of Exeter	Titball, RW (corresponding author), Univ Exeter, Coll Life & Environm Sci, Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England.	r.w.titball@exeter.ac.uk; a.basak@mail.cryst.bbk.ac.uk	Bokori-Brown, Monika/Y-2302-2019		Wellcome Trust Award [WT089618MA]; European Union Marie Curie Network Grant [237942]	Wellcome Trust Award(Wellcome Trust); European Union Marie Curie Network Grant	This work was supported in part by Wellcome Trust Award WT089618MA (to D. M., Prof. H. Saibil, A. B., and R. T.). In addition, this work was supported by European Union Marie Curie Network Grant 237942 (to R. T.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alonso A, 2000, BIOCHEMISTRY-US, V39, P14019, DOI 10.1021/bi001739o; [Anonymous], 2001, WHO GLOBAL STRATEGY; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BHAKDI S, 1981, P NATL ACAD SCI-BIOL, V78, P5475, DOI 10.1073/pnas.78.9.5475; Brennan J, 2001, POULTRY SCI, V80, P1451, DOI 10.1093/ps/80.10.1451; Brennan J, 2001, AVIAN DIS, V45, P210, DOI 10.2307/1593030; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Comai M, 2002, MOL MICROBIOL, V44, P1251, DOI 10.1046/j.1365-2958.2002.02943.x; Dahiya JP, 2006, ANIM FEED SCI TECH, V129, P60, DOI 10.1016/j.anifeedsci.2005.12.003; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; EDWARDS DA, 1995, J CONTROL RELEASE, V34, P211, DOI 10.1016/0168-3659(94)00132-E; ELWINGER K, 1992, ACTA VET SCAND, V33, P369; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FORTI S, 1989, EUR J BIOCHEM, V181, P767, DOI 10.1111/j.1432-1033.1989.tb14790.x; Galdiero S, 2004, PROTEIN SCI, V13, P1503, DOI 10.1110/ps.03561104; Gholamiandekhordi AR, 2006, VET MICROBIOL, V113, P143, DOI 10.1016/j.vetmic.2005.10.023; Gu LQ, 2000, P NATL ACAD SCI USA, V97, P3959, DOI 10.1073/pnas.97.8.3959; KALDHUSDAL M, 1992, POULTRY SCI, V71, P1145, DOI 10.3382/ps.0711145; Kaldhusdal M, 2001, AVIAN DIS, V45, P149, DOI 10.2307/1593022; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMullen TPW, 2004, CURR OPIN COLLOID IN, V8, P459, DOI 10.1016/j.cocis.2004.01.007; Misakian M, 2003, J MEMBRANE BIOL, V195, P137, DOI 10.1007/s00232-003-0615-1; Monma N, 2004, J BIOCHEM, V136, P427, DOI 10.1093/jb/mvh140; Nagahama M, 2006, BIOCHEMISTRY-US, V45, P296, DOI 10.1021/bi051805s; Noskov SY, 2004, BIOPHYS J, V87, P2299, DOI 10.1529/biophysj.104.044008; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Potrich C, 2009, J MEMBRANE BIOL, V227, P13, DOI 10.1007/s00232-008-9140-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz S, 2001, INT J ANTIMICROB AG, V17, P431, DOI 10.1016/S0924-8579(01)00297-7; Sluis W. van der, 2000, World Poultry, V16, P42; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Steinthorsdottir V, 1998, FEMS MICROBIOL LETT, V158, P17, DOI 10.1016/S0378-1097(97)00470-9; Tanaka Y, 2011, PROTEIN SCI, V20, P448, DOI 10.1002/pro.579; TOMITA T, 1992, J BIOL CHEM, V267, P13391; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; Van der Sluis W., 2000, WORLD POULTRY SCI J, V16, P56; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108	45	67	72	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3512	3522		10.1074/jbc.M112.430223	http://dx.doi.org/10.1074/jbc.M112.430223			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23239883	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000314397900056
J	Skora, L; Fonseca-Ornelas, L; Hofele, RV; Riedel, D; Giller, K; Watzlawik, J; Schulz-Schaeffer, WJ; Urlaub, H; Becker, S; Zweckstetter, M				Skora, Lukasz; Fonseca-Ornelas, Luis; Hofele, Romina V.; Riedel, Dietmar; Giller, Karin; Watzlawik, Jens; Schulz-Schaeffer, Walter J.; Urlaub, Henning; Becker, Stefan; Zweckstetter, Markus			Burial of the Polymorphic Residue 129 in Amyloid Fibrils of Prion Stop Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; HYDROGEN/DEUTERIUM EXCHANGE; MASS-SPECTROMETRY; MAMMALIAN PRIONS; Y145STOP VARIANT; BETA-SHEET; PROTEIN; CONFORMATION; SPECTROSCOPY; CONVERSION	Misfolding of the natively alpha-helical prion protein into a beta-sheet rich isoform is related to various human diseases such as Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker syndrome. In humans, the disease phenotype is modified by a methionine/valine polymorphism at codon 129 of the prion protein gene. Using a combination of hydrogen/deuterium exchange coupled to NMR spectroscopy, hydroxyl radical probing detected by mass spectrometry, and site-directed mutagenesis, we demonstrate that stop mutants of the human prion protein have a conserved amyloid core. The 129 residue is deeply buried in the amyloid core structure, and its mutation strongly impacts aggregation. Taken together the data support a critical role of the polymorphic residue 129 of the human prion protein in aggregation and disease.	[Skora, Lukasz; Fonseca-Ornelas, Luis; Hofele, Romina V.; Riedel, Dietmar; Giller, Karin; Urlaub, Henning; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Watzlawik, Jens; Schulz-Schaeffer, Walter J.] Univ Med Ctr Gottingen, Prion & Dementia Res Unit, Dept Neuropathol, D-37075 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, D-37075 Gottingen, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Zweckstetter, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, Fassberg 11, D-37077 Gottingen, Germany.	markus.zweckstetter@dzne.de	Fonseca-Ornelas, Luis/GPX-3085-2022	Fonseca-Ornelas, Luis/0000-0001-7810-5564; Zweckstetter, Markus/0000-0002-2536-6581; Watzlawik, Jens/0000-0003-0610-0267	VolkswagenStiftung [ZN1294]; Deutsche Forschungsgemeinschaft [ZW 71/2-2, ZW 71/3-2, SFB 860, INST 186/859-1]; European Community [238316]	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission)	This work was supported by the VolkswagenStiftung (Grant ZN1294 to W. J. S.-S.), the Deutsche Forschungsgemeinschaft (Heisenberg scholarship to M. Z., ZW 71/2-2 and 3-2; Grant SFB 860 to M. Z., R. V. H., and H. U., INST 186/859-1), and the European Community's Seventh Framework Programme FP7/2009 under Grant Agreement 238316.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Breydo L, 2005, BIOCHEMISTRY-US, V44, P15534, DOI 10.1021/bi051369+; Charvatova O, 2008, J AM SOC MASS SPECTR, V19, P1692, DOI 10.1016/j.jasms.2008.07.013; Cho MK, 2011, PROTEIN SCI, V20, P387, DOI 10.1002/pro.570; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Damo SM, 2010, J BIOL CHEM, V285, P32303, DOI 10.1074/jbc.M110.114504; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helmus JJ, 2011, J AM CHEM SOC, V133, P13934, DOI 10.1021/ja206469q; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Holscher C, 1998, J VIROL, V72, P1153; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Jansen C, 2010, ACTA NEUROPATHOL, V119, P189, DOI 10.1007/s00401-009-0609-x; Jayadev S, 2011, ANN NEUROL, V69, P712, DOI 10.1002/ana.22264; Jones EM, 2006, J BIOL CHEM, V281, P8190, DOI 10.1074/jbc.M513417200; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Kunes KC, 2008, PRION, V2, P81, DOI 10.4161/pri.2.2.7059; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Nazabal A, 2009, J MASS SPECTROM, V44, P965, DOI 10.1002/jms.1572; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Perrin F, 1934, J PHYS-PARIS, V5, P497, DOI 10.1051/jphysrad:01934005010049700; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; SchulzSchaeffer WJ, 1996, CLIN NEUROPATHOL, V15, P353; Sharp JS, 2003, ANAL BIOCHEM, V313, P216, DOI 10.1016/S0003-2697(02)00612-7; Skora L, 2012, PROTEIN SCI, V21, P1948, DOI 10.1002/pro.2170; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Tahiri-Alaoui A, 2004, J BIOL CHEM, V279, P31390, DOI 10.1074/jbc.M401754200; Tateishi J, 1996, CLIN NEUROPATHOL, V15, P358; Telling GC, 2011, TOP CURR CHEM, V305, P79, DOI 10.1007/128_2011_166; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Watzlawik J, 2006, J BIOL CHEM, V281, P30242, DOI 10.1074/jbc.M605141200; Wemheuer WM, 2009, AM J PATHOL, V175, P2566, DOI 10.2353/ajpath.2009.090623; Wille H, 2007, ARCH BIOCHEM BIOPHYS, V467, P239, DOI 10.1016/j.abb.2007.08.010; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047	51	15	15	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2994	3002		10.1074/jbc.M112.423715	http://dx.doi.org/10.1074/jbc.M112.423715			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23209282	Green Published, hybrid			2022-12-28	WOS:000314397900010
J	Walavalkar, NM; Gordon, N; Williams, DC				Walavalkar, Ninad M.; Gordon, Nathaniel; Williams, David C., Jr.			Unique Features of the Anti-parallel, Heterodimeric Coiled-coil Interaction between Methyl-cytosine Binding Domain 2 (MBD2) Homologues and GATA Zinc Finger Domain Containing 2A (GATAD2A/p66 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSOR; DNA METHYLATION; HELIX FORMATION; FOLDING PROBLEM; PROTEINS MBD2; NURD COMPLEX; ULTRACENTRIFUGATION; ELECTROSTATICS; HETEROGENEITY; DIMERIZATION	The methyl-cytosine binding domain 2 (MBD2)-nucleosome remodeling and deacetylase (NuRD) complex recognizes methylated DNA and silences expression of associated genes through histone deacetylase and nucleosome remodeling functions. Our previous structural work demonstrated that a coiled-coil interaction between MBD2 and GATA zinc finger domain containing 2A (GATAD2A/p66 alpha) proteins recruits the chromodomain helicase DNA-binding protein (CHD4/Mi2 beta) to the NuRD complex and is necessary for MBD2-mediated DNA methylation-dependent gene silencing in vivo (Gnanapragasam, M. N., Scarsdale, J. N., Amaya, M. L., Webb, H. D., Desai, M. A., Walavalkar, N. M., Wang, S. Z., Zu Zhu, S., Ginder, G. D., and Williams, D. C., Jr. (2011) p66 alpha-MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2-NuRD complex. Proc. Natl. Acad. Sci. U.S.A. 108, 7487-7492). The p66 alpha-MBD2 interaction differs from most coiled-coils studied to date by forming an anti-parallel heterodimeric complex between two peptides that are largely monomeric in isolation. To further characterize unique features of this complex that drive heterodimeric specificity and high affinity binding, we carried out biophysical analyses of MBD2 and the related homologues MBD3, MBD3-like protein 1 (MBD3L1), and MBD3-like protein 2 (MBD3L2) as well as specific mutations that modify charge-charge interactions and helical propensity of the coiled-coil domains. Analytical ultracentrifugation analyses show that the individual peptides remain monomeric in isolation even at 300 mu M in concentration for MBD2. Circular dichroism analyses demonstrate a direct correlation between helical content of the coiled-coil domains in isolation and binding affinity for p66 alpha. Furthermore, complementary electrostatic surface potentials and inherent helical content of each peptide are necessary to maintain high-affinity association. These factors lead to a binding affinity hierarchy of p66 alpha for the different MBD2 homologues (MBD2 approximate to MBD3 > MBD3L1 approximate to MBD3L2) and suggest a hierarchical regulatory model in tissue and life cycle stage-specific silencing by NuRD complexes.	[Walavalkar, Ninad M.] Virginia Commonwealth Univ, Integrat Life Sci Program, Richmond, VA 23298 USA; [Walavalkar, Ninad M.; Williams, David C., Jr.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23298 USA; [Walavalkar, Ninad M.; Williams, David C., Jr.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Gordon, Nathaniel] Eastern Virginia Med Sch, Norfolk, VA 23501 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Eastern Virginia Medical School	Williams, DC (corresponding author), Virginia Commonwealth Univ, Dept Pathol, POB 980035, Richmond, VA 23298 USA.	dwilliams8@mcvh-vcu.edu			National Institutes of Health Grant [R01-GM098264]; American Cancer Society ACS [IRG-73-001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098264] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society ACS(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM098264 (to D.C.W.). This work was also supported by American Cancer Society ACS IRG-73-001 (to D.C.W.).	Aruxandei DC, 2011, BIOCHEMISTRY-US, V50, P10990, DOI [10.1021/bi20111oh, 10.1021/bi201110h]; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Doyle M. L., 2001, CURR PROTOCOLS PROTE, P2041; Dragan AI, 2002, J MOL BIOL, V321, P891, DOI 10.1016/S0022-2836(02)00699-X; Fatemi M, 2006, J CELL SCI, V119, P3033, DOI 10.1242/jcs.03099; Gnanapragasam MN, 2011, P NATL ACAD SCI USA, V108, P7487, DOI 10.1073/pnas.1015341108; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Jiang CL, 2004, J BIOL CHEM, V279, P52456, DOI 10.1074/jbc.M409149200; Jiang CL, 2002, GENOMICS, V80, P621, DOI 10.1006/geno.2002.7001; Jin SG, 2005, J BIOL CHEM, V280, P12700, DOI 10.1074/jbc.M413492200; Koepf EK, 1999, PROTEIN SCI, V8, P841, DOI 10.1110/ps.8.4.841; Kumita JR, 2000, P NATL ACAD SCI USA, V97, P3803, DOI 10.1073/pnas.97.8.3803; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Moran LB, 1999, P NATL ACAD SCI USA, V96, P10699, DOI 10.1073/pnas.96.19.10699; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Myers JK, 1999, J MOL BIOL, V289, P205, DOI 10.1006/jmbi.1999.2747; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sosnick TR, 1996, PROTEINS, V24, P427; Steinkruger JD, 2012, J AM CHEM SOC, V134, P2626, DOI 10.1021/ja208855x; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; Testa OD, 2009, NUCLEIC ACIDS RES, V37, pD315, DOI 10.1093/nar/gkn675; Wade PA, 2001, BIOESSAYS, V23, P1131, DOI 10.1002/bies.10008; Yadav MK, 2006, BIOCHEMISTRY-US, V45, P4463, DOI 10.1021/bi060092q; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zitzewitz JA, 2000, J MOL BIOL, V296, P1105, DOI 10.1006/jmbi.2000.3507	37	27	28	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3419	3427		10.1074/jbc.M112.431346	http://dx.doi.org/10.1074/jbc.M112.431346			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23239876	hybrid, Green Published			2022-12-28	WOS:000314397900046
J	Umeki, N; Nakajima, J; Noguchi, TQP; Tokuraku, K; Nagasaki, A; Ito, K; Hirose, K; Uyeda, TQP				Umeki, Nobuhisa; Nakajima, Jun; Noguchi, Taro Q. P.; Tokuraku, Kiyotaka; Nagasaki, Akira; Ito, Kohji; Hirose, Keiko; Uyeda, Taro Q. P.			Rapid Nucleotide Exchange Renders Asp-11 Mutant Actins Resistant to Depolymerizing Activity of Cofilin, Leading to Dominant Toxicity in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; NEMALINE MYOPATHY; BOUND NUCLEOTIDE; ATP HYDROLYSIS; GENE; MUTATIONS; POLYMERIZATION; ADF/COFILIN; FILAMENTS; DYNAMICS	Conserved Asp-11 of actin is a part of the nucleotide binding pocket, and its mutation to Gln is dominant lethal in yeast, whereas the mutation to Asn in human alpha-actin dominantly causes congenital myopathy. To elucidate the molecular mechanism of those dominant negative effects, we prepared Dictyostelium versions of D11N and D11Q mutant actins and characterized them in vitro. D11N and D11Q actins underwent salt-dependent reversible polymerization, although the resultant polymerization products contained small anomalous structures in addition to filaments of normal appearance. Both monomeric and polymeric D11Q actin released bound nucleotides more rapidly than the wild type, and intriguingly, both monomeric and polymeric D11Q actins hardly bound cofilin. The deficiency in cofilin binding can be explained by rapid exchange of bound nucleotide with ATP in solution, because cofilin does not bind ATP-bound actin. Copolymers of D11Q and wild type actins bound cofilin, but cofilin-induced depolymerization of the copolymers was slower than that of wild type filaments, which may presumably be the primary reason why this mutant actin is dominantly toxic in vivo. Purified D11N actin was unstable, which made its quantitative biochemical characterization difficult. However, monomeric D11N actin released nucleotides even faster than D11Q, and we speculate that D11N actin also exerts its toxic effects in vivo through a defective interaction with cofilin. We have recently found that two other dominant negative actin mutants are also defective in cofilin binding, and we propose that the defective cofilin binder is a major class of dominant negative actin mutants.	[Umeki, Nobuhisa; Nakajima, Jun; Noguchi, Taro Q. P.; Nagasaki, Akira; Hirose, Keiko; Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058562, Japan; [Nakajima, Jun; Noguchi, Taro Q. P.; Hirose, Keiko; Uyeda, Taro Q. P.] Univ Tsukuba, Dept Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Tokuraku, Kiyotaka] Muroran Inst Technol, Dept Appl Sci, Muroran, Hokkaido 0508585, Japan; [Ito, Kohji] Chiba Univ, Dept Biol, Chiba 2638522, Japan; [Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Muroran Institute of Technology; Chiba University; National Institute of Advanced Industrial Science & Technology (AIST)	Uyeda, TQP (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.	t-uyeda@aist.go.jp	Nagasaki, Akira/M-4892-2018; Ito, Kohji/K-8441-2017; Tokuraku, Kiyotaka/D-4542-2014; Hirose, Keiko/M-5429-2018	Nagasaki, Akira/0000-0002-1468-4592; Ito, Kohji/0000-0001-9573-432X; Tokuraku, Kiyotaka/0000-0002-7747-4808; Nakajima, Jun/0000-0003-1174-0816; Hirose, Keiko/0000-0003-4587-8346	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (to T.U.).	Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Agrawal PB, 2012, HUM MOL GENET, V21, P2341, DOI 10.1093/hmg/dds053; AIZAWA H, 1995, J BIOL CHEM, V270, P10923, DOI 10.1074/jbc.270.18.10923; An HS, 1996, J MOL BIOL, V260, P492, DOI 10.1006/jmbi.1996.0417; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Bryan KE, 2009, J BIOL CHEM, V284, P18260, DOI 10.1074/jbc.M109.015818; Carlier MF, 1998, CURR OPIN CELL BIOL, V10, P45, DOI 10.1016/S0955-0674(98)80085-9; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; DRUMMOND DR, 1991, MOL GEN GENET, V226, P70, DOI 10.1007/BF00273589; EGELHOFF TT, 1991, METHOD ENZYMOL, V196, P319; Fujiwara I, 2002, NAT CELL BIOL, V4, P666, DOI 10.1038/ncb841; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; IIDA K, 1993, GENE, V124, P115; JOHANNES FJ, 1991, EMBO J, V10, P3951, DOI 10.1002/j.1460-2075.1991.tb04965.x; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KITAGAWA S, 1968, ARCH BIOCHEM BIOPHYS, V125, P706, DOI 10.1016/0003-9861(68)90627-9; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kudryashov DS, 2010, J BIOL CHEM, V285, P25591, DOI 10.1074/jbc.M110.123869; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P4742, DOI 10.1073/pnas.71.12.4742; MABUCHI I, 1981, J BIOCHEM-TOKYO, V89, P1341; MACIVER SK, 1994, FEBS LETT, V347, P251, DOI 10.1016/0014-5793(94)00552-4; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; MARTONOSI A, 1960, J BIOL CHEM, V235, P1700; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Miller BM, 2008, J BIOL CHEM, V283, P19379, DOI 10.1074/jbc.M801963200; Miyauchi-Nomura S, 2012, CYTOSKELETON, V69, P290, DOI 10.1002/cm.21025; Monserrat L, 2007, EUR HEART J, V28, P1953, DOI 10.1093/eurheartj/ehm239; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; MUHLRAD A, 1994, J BIOL CHEM, V269, P11852; Muhlrad A, 2004, J MOL BIOL, V342, P1559, DOI 10.1016/j.jmb.2004.08.010; Muhlrad A, 2006, BIOPHYS J, V91, P4490, DOI 10.1529/biophysj.106.087767; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Nakashima K, 2005, J BIOCHEM, V138, P519, DOI 10.1093/jb/mvi152; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Noguchi TQP, 2007, J BIOL CHEM, V282, P27721, DOI 10.1074/jbc.M703165200; Noguchi TQP, 2010, BIOCHEM BIOPH RES CO, V396, P1006, DOI 10.1016/j.bbrc.2010.05.047; Noguchi TQP, 2010, J BIOL CHEM, V285, P4337, DOI 10.1074/jbc.M109.059881; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Ono S, 2010, CYTOSKELETON, V67, P677, DOI 10.1002/cm.20476; Pavlov D, 2006, CELL MOTIL CYTOSKEL, V63, P533, DOI 10.1002/cm.20142; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; SOLOMON TL, 1988, J BIOL CHEM, V263, P19662; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; STROHMAN RC, 1959, BIOCHIM BIOPHYS ACTA, V32, P436, DOI 10.1016/0006-3002(59)90617-1; Takaine M, 2007, J BIOL CHEM, V282, P21683, DOI 10.1074/jbc.M611371200; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; WERTMAN KF, 1992, GENETICS, V132, P337; WILLIAMS SP, 1993, BIOCHEMISTRY-US, V32, P4895, DOI 10.1021/bi00069a026; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410; ZAK R, 1977, J BIOL CHEM, V252, P3430; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	63	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1739	1749		10.1074/jbc.M112.404657	http://dx.doi.org/10.1074/jbc.M112.404657			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23212920	Green Published, hybrid			2022-12-28	WOS:000313751400030
J	Zheng, H; Li, Q; Chen, R; Zhang, J; Ran, Y; He, X; Li, S; Shu, HB				Zheng, Hao; Li, Qi; Chen, Rui; Zhang, Jing; Ran, Yong; He, Xiao; Li, Shu; Shu, Hong-Bing			The Dual-specificity Phosphatase DUSP14 Negatively Regulates Tumor Necrosis Factor- and Interleukin-1-induced Nuclear Factor-kappa B Activation by Dephosphorylating the Protein Kinase TAK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; TNF-ALPHA; MAPKKK; TAB1; PHOSPHORYLATION; MOTIF	The transcription factor NF-kappa B is critically involved in the inflammatory response triggered by the proinflammatory cytokines TNF and IL-1. Various studies have demonstrated that activation of TAK1 (TGF-beta-activated kinase 1) is an essential step in TNF- and IL-1-induced NF-kappa B activation pathways. In this study, we identified a member of the dual-specificity phosphatase family, DUSP14, as a negative regulator of TNF- and IL-1-triggered NF-kappa B activation by expression screens. We found that DUSP14 interacted with TAK1 and that this interaction was enhanced by TNF or IL-1 stimulation. Overexpression of DUSP14 dephosphorylated TAK1 at Thr-187, a residue in the activation loop critically involved in TAK1 activation. Knockdown of DUSP14 increased basal as well as TNF- and IL-1-induced TAK1 phosphorylation at Thr-187. Overexpression of DUSP14, but not its phosphatase-deficient mutant, inhibited TNF- and IL-1-induced as well as TAK1-mediated NF-kappa B activation, whereas knockdown of DUSP14 had opposite effects. These findings suggest that DUSP14 negatively regulates TNF- or IL-1-induced NF-kappa B activation by dephosphorylating TAK1 at Thr-187. Our study reveals a new post-translational regulatory mechanism of NF-kappa B activation triggered by the proinflammatory cytokines.	[Zheng, Hao; Li, Qi; Chen, Rui; Zhang, Jing; Ran, Yong; He, Xiao; Li, Shu; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn			Chinese Ministry of Science and Technology [2012CB910201, 2010DFA31100]; National Science Foundation of China [91029302, 30921001]; Chinese 111 Project [B06018]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project(Ministry of Education, China - 111 Project)	This work was supported by Chinese Ministry of Science and Technology Grants 2012CB910201 and 2010DFA31100, National Science Foundation of China Grants 91029302 and 30921001, and Chinese 111 Project Grant B06018.	Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Lountos GT, 2009, ACTA CRYSTALLOGR D, V65, P1013, DOI 10.1107/S0907444909023762; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	23	42	44	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					819	825		10.1074/jbc.M112.412643	http://dx.doi.org/10.1074/jbc.M112.412643			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23229544	Green Published, hybrid			2022-12-28	WOS:000313570300007
J	Lim, JH; Gerhart-Hines, Z; Dominy, JE; Lee, Y; Kim, S; Tabata, M; Xiang, YK; Puigserver, P				Lim, Ji-Hong; Gerhart-Hines, Zachary; Dominy, John E.; Lee, Yoonjin; Kim, Sungjin; Tabata, Mitsuhisa; Xiang, Yang K.; Puigserver, Pere			Oleic Acid Stimulates Complete Oxidation of Fatty Acids through Protein Kinase A-dependent Activation of SIRT1-PGC1 alpha Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; TRANSCRIPTIONAL COACTIVATOR; MITOCHONDRIAL BIOGENESIS; PGC-1-ALPHA EXPRESSION; METABOLIC-CONTROL; SIRT1; REGULATOR; AMPK; PATHWAY	Fatty acids are essential components of the dynamic lipid metabolism in cells. Fatty acids can also signal to intracellular pathways to trigger a broad range of cellular responses. Oleic acid is an abundant monounsaturated omega-9 fatty acid that impinges on different biological processes, but the mechanisms of action are not completely understood. Here, we report that oleic acid stimulates the cAMP/protein kinase A pathway and activates the SIRT1-PGC1 alpha transcriptional complex to modulate rates of fatty acid oxidation. In skeletal muscle cells, oleic acid treatment increased intracellular levels of cyclic adenosine monophosphate (cAMP) that turned on protein kinase A activity. This resulted in SIRT1 phosphorylation at Ser-434 and elevation of its catalytic deacetylase activity. A direct SIRT1 substrate is the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1 alpha), which became deacetylated and hyperactive after oleic acid treatment. Importantly, oleic acid, but not other long chain fatty acids such as palmitate, increased the expression of genes linked to fatty acid oxidation pathway in a SIRT1-PGC1 alpha-dependent mechanism. As a result, oleic acid potently accelerated rates of complete fatty acid oxidation in skeletal muscle cells. These results illustrate how a single long chain fatty acid specifically controls lipid oxidation through a signaling/transcriptional pathway. Pharmacological manipulation of this lipid signaling pathway might provide therapeutic possibilities to treat metabolic diseases associated with lipid dysregulation.	[Lim, Ji-Hong; Gerhart-Hines, Zachary; Dominy, John E.; Lee, Yoonjin; Tabata, Mitsuhisa; Puigserver, Pere] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Lim, Ji-Hong; Gerhart-Hines, Zachary; Dominy, John E.; Lee, Yoonjin; Tabata, Mitsuhisa; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Kim, Sungjin; Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Davis	Puigserver, P (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,CLSB-11144, Boston, MA 02215 USA.	pere_puigserver@dfci.harvard.edu			Dana-Farber Cancer Institute; American Diabetes Association; Department of Defense; National Institutes of Health/NIDDK [RO1 069966]; National Institutes of Health [RO1-HL82846]; American Heart Association [12EIA841007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069966] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute; American Diabetes Association(American Diabetes Association); Department of Defense(United States Department of Defense); National Institutes of Health/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Dana-Farber Cancer Institute, the American Diabetes Association, the Department of Defense, National Institutes of Health/NIDDK Grant RO1 069966 (to P. P.) as well as National Institutes of Health Grant RO1-HL82846 and American Heart Association Grant 12EIA841007 (to Y. K. X.).; Supported by an American Diabetes Association mentor supported post-doctoral fellowship.; Supported in part by a fellowship from the American Heart Association.; Supported in part by an National Research Service Award Kirschstein fellowship from the National Institutes of Health.	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; De Arcangelis V, 2010, MOL PHARMACOL, V78, P340, DOI 10.1124/mol.110.064444; Dominy JE, 2011, COLD SH Q B, V76, P203, DOI 10.1101/sqb.2012.76.010843; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; de Albuquerque CFG, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/601032; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kien CL, 2009, CURR DIABETES REP, V9, P43, DOI 10.1007/s11892-009-0009-6; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Postic C, 2008, DIABETES METAB, V34, P643, DOI 10.1016/S1262-3636(08)74599-3; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Raatz SK, 2001, J NUTR, V131, P231; Rasmussen BB, 1999, ANNU REV NUTR, V19, P463, DOI 10.1146/annurev.nutr.19.1.463; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schreurs M, 2010, OBES REV, V11, P380, DOI 10.1111/j.1467-789X.2009.00642.x; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Tardif N, 2011, CLIN NUTR, V30, P799, DOI 10.1016/j.clnu.2011.05.009; Tholstrup T, 2001, AM J CLIN NUTR, V73, P198; Van Den Branden C, 2003, ADV EXP MED BIOL, V544, P307; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046	40	119	128	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7117	7126		10.1074/jbc.M112.415729	http://dx.doi.org/10.1074/jbc.M112.415729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329830	Green Published, hybrid			2022-12-28	WOS:000316002400033
J	Ko, JY; Yoo, KH; Song, SA; Kim, DY; Kong, HK; Ahn, C; Lee, HW; Kang, DH; Oh, GT; Park, JH				Ko, Je Yeong; Yoo, Kyung Hyun; Song, Seon Ah; Kim, Do Yeon; Kong, Hyun Kyung; Ahn, Curie; Lee, Han Woong; Kang, Duk-Hee; Oh, Goo Taeg; Park, Jong Hoon			Inactivation of Max-interacting Protein 1 Induces Renal Cilia Disassembly through Reduction in Levels of Intraflagellar Transport 20 in Polycystic Kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL HEART-DISEASE; AUTOSOMAL-DOMINANT; MITOTIC SPINDLE; CELL-LINES; MXI1; COMPLEX; GROWTH; MISORIENTATION; DYSKINESIA; MOUSE	Cilia in ciliated cells consist of protruding structures that sense mechanical and chemical signals from the extracellular environment. Cilia are assembled with variety molecules via a process known as intraflagellar transport (IFT). What controls the length of cilia in ciliated cells is critical to understand ciliary disease such as autosomal dominant polycystic kidney disease, which involves abnormally short cilia. But this control mechanism is not well understood. Previously, multiple tubular cysts have been observed in the kidneys of max-interacting protein 1 (Mxi1)-deficient mice aged 6 months or more. Here, we clarified the relationship between Mxi1 inactivation and cilia disassembly. Cilia phenotypes were observed in kidneys of Mxi1-deficient mice using scanning electron microscopy to elucidate the effect of Mxi1 on renal cilia phenotype, and cilia disassembly was observed in Mxi1-deficient kidney. In addition, genes related to cilia were validated in vitro and in vivo using quantitative PCR, and Ift20 was selected as a candidate gene in this study. The length of cilium decreased, and p-ERK level induced by a cilia defect increased in kidneys of Mxi1-deficient mice. Ciliogenesis of Mxi1-deficient mouse embryonic fibroblasts (MEFs) decreased, and this abnormality was restored by Mxi1 transfection in Mxi1-deficient MEFs. We confirmed that ciliogenesis and Ift20 expression were regulated by Mxi1 in vitro. We also determined that Mxi1 regulates Ift20 promoter activity via Ets-1 binding to the Ift20 promoter. These results indicate that inactivating Mxi1 induces ciliary defects in polycystic kidney.	[Ko, Je Yeong; Yoo, Kyung Hyun; Song, Seon Ah; Kim, Do Yeon; Kong, Hyun Kyung; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea; [Ahn, Curie] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul 110744, South Korea; [Lee, Han Woong] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Kang, Duk-Hee] Ewha Womans Univ, Dept Internal Med, Sch Med, Seoul 120750, South Korea; [Oh, Goo Taeg] Ewha Womans Univ, Dept Biol Sci, Seoul 120750, South Korea	Sookmyung Women's University; Seoul National University (SNU); Yonsei University; Ewha Womans University; Ewha Womans University	Park, JH (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea.	parkjh@sookmyung.ac.kr	Oh, Goo Taeg/AAQ-9995-2021		Bio and Medical Technology Development Program of the National Research Foundation of Korea [2011-0031220, 2011-0019452]	Bio and Medical Technology Development Program of the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Grants 2011-0031220 and 2011-0019452 from the Bio and Medical Technology Development Program of the National Research Foundation of Korea.	Al-Bhalal L, 2005, ADV ANAT PATHOL, V12, P126, DOI 10.1097/01.pap.0000163959.29032.1f; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Blacque OE, 2008, FRONT BIOSCI-LANDMRK, V13, P2633, DOI 10.2741/2871; Brueckner M, 2007, CIRCULATION, V115, P2793, DOI 10.1161/CIRCULATIONAHA.107.699256; Cowley BD, 2008, KIDNEY INT, V73, P251, DOI 10.1038/sj.ki.5002695; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Jonassen JA, 2012, J AM SOC NEPHROL, V23, P641, DOI 10.1681/ASN.2011080829; Kawamata N, 2005, INT J ONCOL, V26, P1369; Keady BT, 2012, DEV CELL, V22, P940, DOI 10.1016/j.devcel.2012.04.009; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Ko JY, 2011, BIOCHEM BIOPH RES CO, V415, P36, DOI 10.1016/j.bbrc.2011.10.005; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Ong ACM, 2005, KIDNEY INT, V67, P1234, DOI 10.1111/j.1523-1755.2005.00201.x; Park EY, 2011, BMB REP, V44, P359, DOI 10.5483/BMBRep.2011.44.6.359; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; Pedersen LB, 2008, DEV DYNAM, V237, P1993, DOI 10.1002/dvdy.21521; Puri S, 2006, BIOCHEM BIOPH RES CO, V342, P1005, DOI 10.1016/j.bbrc.2006.02.045; REEDERS ST, 1992, NAT GENET, V1, P235, DOI 10.1038/ng0792-235; Salem H, 2010, ONCOGENE, V29, P4046, DOI 10.1038/onc.2010.162; Satir P, 2008, HISTOCHEM CELL BIOL, V129, P687, DOI 10.1007/s00418-008-0416-9; Schreiber-Agus N, 1998, BIOESSAYS, V20, P808, DOI 10.1002/(SICI)1521-1878(199810)20:10<808::AID-BIES6>3.0.CO;2-U; Schreiber-Agus N, 1998, NATURE, V393, P483, DOI 10.1038/31008; Serra R, 2008, ANAT REC, V291, P1049, DOI 10.1002/ar.20634; Takiar V, 2011, BBA-MOL BASIS DIS, V1812, P1337, DOI 10.1016/j.bbadis.2010.11.014; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; Wagner CA, 2008, J NEPHROL, V21, P14; Wang DY, 2000, PATHOL INT, V50, P373, DOI 10.1046/j.1440-1827.2000.01057.x; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; Yoo KH, 2007, BIOCHEM BIOPH RES CO, V356, P85, DOI 10.1016/j.bbrc.2007.02.103; Yoo KH, 2009, PROTEOMICS, V9, P3824, DOI 10.1002/pmic.200800753; Zaucke F, 2010, HUM MOL GENET, V19, P1985, DOI 10.1093/hmg/ddq077; Zuo XF, 2011, J BIOL CHEM, V286, P22469, DOI 10.1074/jbc.M111.238469	35	3	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6488	6497		10.1074/jbc.M112.413302	http://dx.doi.org/10.1074/jbc.M112.413302			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23316056	hybrid, Green Published			2022-12-28	WOS:000315820700042
J	Brown, A; Turner, L; Christoffersen, S; Andrews, KA; Szestak, T; Zhao, YG; Larsen, S; Craig, AG; Higgins, MK				Brown, Alan; Turner, Louise; Christoffersen, Stig; Andrews, Katrina A.; Szestak, Tadge; Zhao, Yuguang; Larsen, Sine; Craig, Alister G.; Higgins, Matthew K.			Molecular Architecture of a Complex between an Adhesion Protein from the Malaria Parasite and Intracellular Adhesion Molecule 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; CHONDROITIN-SULFATE; STRUCTURAL BASIS; BINDING DOMAIN; PLASMODIUM; ICAM-1; RECEPTOR; VARIANT; DIMERIZATION; PFEMP1	The adhesion of Plasmodium falciparum-infected erythrocytes to human tissues or endothelium is central to the pathology caused by the parasite during malaria. It contributes to the avoidance of parasite clearance by the spleen and to the specific pathologies of cerebral and placental malaria. The PfEMP1 family of adhesive proteins is responsible for this sequestration by mediating interactions with diverse human ligands. In addition, as the primary targets of acquired, protective immunity, the PfEMP1s are potential vaccine candidates. PfEMP1s contain large extracellular ectodomains made from CIDR (cysteine-rich interdomain regions) and DBL (Duffy-binding-like) domains and show extensive variation in sequence, size, and domain organization. Here we use biophysical methods to characterize the entire similar to 300-kDa ectodomain from IT4VAR13, a protein that interacts with the host receptor, intercellular adhesion molecule-1 (ICAM-1). We show through small angle x-ray scattering that IT4VAR13 is rigid, elongated, and monomeric. We also show that it interacts with ICAM-1 through the DBL beta domain alone, forming a 1: 1 complex. These studies provide a first low resolution structural view of a PfEMP1 ectodomain in complex with its ligand. They show that it combines a modular domain arrangement consisting of individual ligand binding domains, with a defined higher order architecture that exposes the ICAM-1 binding surface to allow adhesion.	[Brown, Alan; Andrews, Katrina A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Turner, Louise; Christoffersen, Stig] Univ Copenhagen, Ctr Mol Parasitol, DK-221014 Copenhagen, Denmark; [Christoffersen, Stig; Larsen, Sine] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Szestak, Tadge; Craig, Alister G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Zhao, Yuguang] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; [Higgins, Matthew K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Cambridge; University of Copenhagen; University of Copenhagen; Liverpool School of Tropical Medicine; University of Liverpool; University of Oxford; University of Oxford	Higgins, MK (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	matthew.higgins@bioch.ox.ac.uk	Brown, Alan/I-1473-2019; Larsen, Sine/A-4487-2017	Brown, Alan/0000-0002-0021-0476; Larsen, Sine/0000-0003-3848-1789; Turner, Louise/0000-0003-4494-2289; Craig, Alister/0000-0003-0914-6164; Higgins, Matthew/0000-0002-2870-1955	Wellcome Trust [087692/Z/08/Z]; University of Copenhagen Program of Excellence	Wellcome Trust(Wellcome TrustEuropean Commission); University of Copenhagen Program of Excellence	This work was supported by Wellcome Trust Grant 087692/Z/08/Z and the University of Copenhagen Program of Excellence.	Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BERENDT AR, 1992, CELL, V68, P71, DOI 10.1016/0092-8674(92)90207-S; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Bertonati C, 2007, PROTEINS, V69, P215, DOI 10.1002/prot.21691; Birmanns S, 2011, J STRUCT BIOL, V173, P428, DOI 10.1016/j.jsb.2010.11.002; CASASNOVAS JM, 1995, J BIOL CHEM, V270, P13216, DOI 10.1074/jbc.270.22.13216; Chattopadhyay R, 2004, MOL BIOCHEM PARASIT, V133, P255, DOI 10.1016/j.molbiopara.2003.08.014; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Duffy Patrick E., 2001, Trends in Parasitology, V17, P354, DOI 10.1016/S1471-4922(01)02022-0; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gamain B, 2002, P NATL ACAD SCI USA, V99, P10020, DOI 10.1073/pnas.152321599; Gardner JP, 1996, P NATL ACAD SCI USA, V93, P3503, DOI 10.1073/pnas.93.8.3503; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; GRUENBERG J, 1983, J CELL BIOL, V97, P795, DOI 10.1083/jcb.97.3.795; Guinier A., 1955, SMALL ANGLE SCATTERI; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Hughes KR, 2010, MOL BIOCHEM PARASIT, V169, P71, DOI 10.1016/j.molbiopara.2009.09.007; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; MILLER J, 1995, J EXP MED, V182, P1231, DOI 10.1084/jem.182.5.1231; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; OCKENHOUSE CF, 1992, CELL, V68, P63, DOI 10.1016/0092-8674(92)90206-R; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Owens RM, 2010, J BIOL CHEM, V285, P15906, DOI 10.1074/jbc.M110.104349; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; Porod G., 1982, GEN THEORY SMALL ANG; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; Springer AL, 2004, MOL BIOCHEM PARASIT, V137, P55, DOI 10.1016/j.molbiopara.2004.03.019; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Tse MT, 2004, MOL MICROBIOL, V51, P1039, DOI 10.1046/j.1365-2958.2003.03895.x; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Xiao CA, 2005, STRUCTURE, V13, P1019, DOI 10.1016/j.str.2005.04.011; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	60	33	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5992	6003		10.1074/jbc.M112.416347	http://dx.doi.org/10.1074/jbc.M112.416347			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297413	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000315342500067
J	Cao, CK; Zakharian, E; Borbiro, I; Rohacs, T				Cao, Chike; Zakharian, Eleonora; Borbiro, Istvan; Rohacs, Tibor			Interplay between Calmodulin and Phosphatidylinositol 4,5-Bisphosphate in Ca2(+)-induced Inactivation of Transient Receptor Potential Vanilloid 6 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CA2+ CHANNELS; K+ CHANNEL; TRPV6; PIP2; ACTIVATION; PROTEINS; BINDING	The epithelial Ca2(+) channel transient receptor potential vanilloid 6 (TRPV6) undergoes Ca2(+)-induced inactivation that protects the cell from toxic Ca2(+) overload and may also limit intestinal Ca2(+) transport. To dissect the roles of individual signaling pathways in this phenomenon, we studied the effects of Ca2(+), calmodulin (CaM), and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) in excised inside-out patches. The activity of TRPV6 strictly depended on the presence of PI(4,5) P2, and Ca2(+)-CaM inhibited the channel at physiologically relevant concentrations. Ca2(+) alone also inhibited TRPV6 at high concentrations (IC50 = similar to 20 mu M). A double mutation in the distal C-terminal CaM-binding site of TRPV6 (W695A/R699E) essentially eliminated inhibition by CaM in excised patches. In whole cell patch clamp experiments, this mutation reduced but did not eliminate Ca2(+)-induced inactivation. Providing excess PI(4,5)P-2 reduced the inhibition by CaM in excised patches and in planar lipid bilayers, but PI(4,5)P-2 did not inhibit binding of CaM to the C terminus of the channel. Overall, our data show a complex interplay between CaM and PI(4,5)P-2 and show that Ca2(+), CaM, and the depletion of PI(4,5)P-2 all contribute to inactivation of TRPV6.	[Cao, Chike; Zakharian, Eleonora; Borbiro, Istvan; Rohacs, Tibor] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Rohacs, T (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07103 USA.	tibor.rohacs@umdnj.edu			National Institutes of Health [NS055159, GM093290, GM098052]; University of Medicine and Dentistry of New Jersey Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093290, R01GM098052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Medicine and Dentistry of New Jersey Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS055159 and GM093290 (to T. R.) and GM098052 (to E. Z.). This work was also supported by a grant from the University of Medicine and Dentistry of New Jersey Foundation (to T. R.).	Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Cui J, 2002, J BIOL CHEM, V277, P47175, DOI 10.1074/jbc.M205870200; de Groot T, 2011, MOL CELL BIOL, V31, P2845, DOI 10.1128/MCB.01319-10; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Holakovska B, 2011, AMINO ACIDS, V40, P741, DOI 10.1007/s00726-010-0712-2; Kovalevskaya Nadezda V., 2012, Journal of Structural and Functional Genomics, V13, P91, DOI 10.1007/s10969-012-9128-4; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Lee J, 2005, J GEN PHYSIOL, V126, P439, DOI 10.1085/jgp.200509314; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P1, DOI 10.1007/s00424-007-0311-6; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Nilius B, 2002, J BIOL CHEM, V277, P30852, DOI 10.1074/jbc.M202418200; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Park EJ, 2009, BIOL PHARM BULL, V32, P1790, DOI 10.1248/bpb.32.1790; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V455, P157, DOI 10.1007/s00424-007-0275-6; Rohacs T, 2009, CELL CALCIUM, V45, P554, DOI 10.1016/j.ceca.2009.03.011; Rosenhouse-Dantsker A, 2007, PFLUG ARCH EUR J PHY, V455, P45, DOI 10.1007/s00424-007-0291-6; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Thyagarajan B, 2008, J BIOL CHEM, V283, P14980, DOI 10.1074/jbc.M704224200; Thyagarajan B, 2009, MOL PHARMACOL, V75, P608, DOI 10.1124/mol.108.052449; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Zakharian E, 2011, FASEB J, V25, P3915, DOI 10.1096/fj.11-184630; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	39	40	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5278	5290		10.1074/jbc.M112.409482	http://dx.doi.org/10.1074/jbc.M112.409482			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23300090	hybrid, Green Published			2022-12-28	WOS:000315342500003
J	Hosokawa, H; Dip, PV; Merkulova, M; Bakulina, A; Zhuang, ZJ; Khatri, A; Jian, XY; Keating, SM; Bueler, SA; Rubinstein, JL; Randazzo, PA; Ausiello, DA; Gruber, G; Marshansky, V				Hosokawa, Hiroyuki; Dip, Phat Vinh; Merkulova, Maria; Bakulina, Anastasia; Zhuang, Zhenjie; Khatri, Ashok; Jian, Xiaoying; Keating, Shawn M.; Bueler, Stephanie A.; Rubinstein, John L.; Randazzo, Paul A.; Ausiello, Dennis A.; Grueber, Gerhard; Marshansky, Vladimir			The N Termini of a-Subunit Isoforms Are Involved in Signaling between Vacuolar H+-ATPase (V-ATPase) and Cytohesin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; EXCHANGE FACTOR ARNO; NUCLEOTIDE EXCHANGE; VESICULAR TRAFFICKING; ARF ACTIVATION; PH; A2-SUBUNIT; RECEPTOR; DOMAINS	Previously, we reported an acidification-dependent interaction of the endosomal vacuolar H+-ATPase (V-ATPase) with cytohesin-2, a GDP/GTP exchange factor (GEF), suggesting that it functions as a pH-sensing receptor. Here, we have studied the molecular mechanism of signaling between the V-ATPase, cytohesin-2, and Arf GTP-binding proteins. We found that part of the N-terminal cytosolic tail of the V-ATPase a2-subunit (a2N), corresponding to its first 17 amino acids (a2N(1-17)), potently modulates the enzymatic GDP/GTP exchange activity of cytohesin-2. Moreover, this peptide strongly inhibits GEF activity via direct interaction with the Sec7 domain of cytohesin-2. The structure of a2N(1-17) and its amino acids Phe(5), Met(10), and Gln(14) involved in interaction with Sec7 domain were determined by NMR spectroscopy analysis. In silico docking experiments revealed that part of the V-ATPase formed by its a2N(1-17) epitope competes with the switch 2 region of Arf1 and Arf6 for binding to the Sec7 domain of cytohesin-2. The amino acid sequence alignment and GEF activity studies also uncovered the conserved character of signaling between all four (a1-a4) a-subunit isoforms of mammalian V-ATPase and cytohesin-2. Moreover, the conserved character of this phenomenon was also confirmed in experiments showing binding of mammalian cytohesin-2 to the intact yeast V-ATPase holo-complex. Thus, here we have uncovered an evolutionarily conserved function of the V-ATPase as a novel cytohesin-signaling receptor.	[Hosokawa, Hiroyuki; Merkulova, Maria; Zhuang, Zhenjie; Ausiello, Dennis A.; Marshansky, Vladimir] Massachusetts Gen Hosp, Simches Res Ctr, Ctr Syst Biol, Program Membrane Biol, Boston, MA 02114 USA; [Hosokawa, Hiroyuki; Merkulova, Maria; Zhuang, Zhenjie; Ausiello, Dennis A.; Marshansky, Vladimir] Massachusetts Gen Hosp, Simches Res Ctr, Div Nephrol, Boston, MA 02114 USA; [Ausiello, Dennis A.; Marshansky, Vladimir] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Dip, Phat Vinh; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 637551, Singapore; [Bakulina, Anastasia] State Res Ctr Virol & Biotechnol VECTOR, Koltsov 630559, Novosibirsk Reg, Russia; [Khatri, Ashok] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Khatri, Ashok] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Jian, Xiaoying; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Keating, Shawn M.; Bueler, Stephanie A.; Rubinstein, John L.] Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 1X8, Canada; [Keating, Shawn M.; Rubinstein, John L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X8, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; State Research Center of Virology & Biotechnology VECTOR; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Marshansky, V (corresponding author), Massachusetts Gen Hosp, Simches Res Ctr, Ctr Syst Biol, Program Membrane Biol, Boston, MA 02114 USA.	Marshansky.Vladimir@mgh.harvard.edu	Marshansky, Vladimir/AAZ-7890-2020; Bakulina, Anastasia/A-6215-2014; Dip, Phat Vinh/AAA-2730-2022; Dip, Phat Vinh/D-1288-2019	Dip, Phat Vinh/0000-0002-1535-9644; Dip, Phat Vinh/0000-0002-1535-9644; Zhuang, Zhenjie/0000-0002-3688-1669; Rubinstein, John/0000-0003-0566-2209	National Institutes of Health Grant [DK038452, DK57521]; Boston Area Diabetes Endocrinology Research Center Grant [DK057521-08]; National Institutes of Health Intramural Program of NCI; Canadian Institutes of Health Research Grant [MOP 81294]; A*STAR Biomedical Research Council Grant [09/1/22/19/609]; Center for the Study of Inflammatory Bowel Disease [DK43351]; Singapore International Graduate Award (SINGA) [20092010S10303]; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038452, P30DK043351, P30DK057521] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area Diabetes Endocrinology Research Center Grant; National Institutes of Health Intramural Program of NCI; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); A*STAR Biomedical Research Council Grant(Agency for Science Technology & Research (A*STAR)); Center for the Study of Inflammatory Bowel Disease; Singapore International Graduate Award (SINGA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK038452. This work was also supported by Boston Area Diabetes Endocrinology Research Center Grant DK057521-08 (to V. M.).; Recipient of a Singapore International Graduate Award (SINGA, 20092010S10303).; Supported by the National Institutes of Health Intramural Program of NCI.; Supported by Canadian Institutes of Health Research Grant MOP 81294.; Supported by A*STAR Biomedical Research Council Grant 09/1/22/19/609.; We thank Dr. Dennis Brown for critical reading and constructive suggestions during the preparation of this manuscript. We are grateful to Dr. Masamitsu Futai and Dr. James Casanova for providing cDNA encoding V-ATPase a2-isoform and cytohesin-2, respectively. We are also grateful to Dr. Sylvain Bourgoin for the generous gift of SecinH3 inhibitor. The Microscopy Core Facility of the Program in Membrane Biology received additional support from National Institutes of Health Grant DK57521 to BADERC and Grant DK43351 to Center for the Study of Inflammatory Bowel Disease.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Beaman K, 1996, AM J REPROD IMMUNOL, V35, P338; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Bill A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041179; Bill A, 2010, CELL, V143, P201, DOI 10.1016/j.cell.2010.09.011; Boger CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002989; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Dip PV, 2012, J BIOENERG BIOMEMBR, V44, P341, DOI 10.1007/s10863-012-9442-3; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; FIELDS C G, 1991, Peptide Research, V4, P95; Fischer B, 2012, HUM GENET, V131, P1761, DOI 10.1007/s00439-012-1197-8; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Goddard T. D., 1997, SPARKY VERSION 3 110; Gruber G, 2008, BIOESSAYS, V30, P1096, DOI 10.1002/bies.20827; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Hafner M, 2008, NAT PROTOC, V3, P579, DOI 10.1038/nprot.2008.15; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Jackson C, 2006, NATURE, V444, P833, DOI 10.1038/444833a; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; LEE CK, 1990, MOL IMMUNOL, V27, P1137; Liu Z, 2011, ENDOCRINOLOGY, V152, P1222, DOI 10.1210/en.2010-1034; Macia E, 2000, BIOCHEMISTRY-US, V39, P5893, DOI 10.1021/bi992795w; Macia E, 2001, J BIOL CHEM, V276, P24925, DOI 10.1074/jbc.M103284200; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Maranda B, 2001, J BIOL CHEM, V276, P18540, DOI 10.1074/jbc.M011577200; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Merkulova M, 2011, AM J PHYSIOL-CELL PH, V300, pC1442, DOI 10.1152/ajpcell.00076.2010; Merkulova M, 2010, PROTEIN SCI, V19, P1850, DOI 10.1002/pro.470; Merkulova M, 2010, BBA-BIOENERGETICS, V1797, P1398, DOI 10.1016/j.bbabio.2010.02.009; Montagnac G, 2011, CURR BIOL, V21, P574, DOI 10.1016/j.cub.2011.02.034; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; NICHOLS TC, 1994, CELL IMMUNOL, V155, P219, DOI 10.1006/cimm.1994.1114; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ntrivalas E, 2010, J REPROD IMMUNOL, V85, P106, DOI 10.1016/j.jri.2009.10.010; Panchapakesan U, 2011, CLIN EXP PHARMACOL P, V38, P84, DOI 10.1111/j.1440-1681.2010.05472.x; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Randazzo P A, 2000, Sci STKE, V2000, pre1, DOI 10.1126/stke.2000.59.re1; Recchi C, 2006, NAT CELL BIOL, V8, P107, DOI 10.1038/ncb0206-107; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rishikesan S, 2008, MOL MEMBR BIOL, V25, P400, DOI 10.1080/09687680802183434; Sandholm N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002921; Santy LC, 1999, CURR BIOL, V9, P1173, DOI 10.1016/S0960-9822(00)80019-6; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Smith AB, 2000, ORG LETT, V2, P1; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Thaker YR, 2009, FEBS LETT, V583, P1090, DOI 10.1016/j.febslet.2009.03.013; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Vaccari T, 2010, DEVELOPMENT, V137, P1825, DOI 10.1242/dev.045484; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P146; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	68	33	34	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5896	5913		10.1074/jbc.M112.409169	http://dx.doi.org/10.1074/jbc.M112.409169			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288846	hybrid, Green Published			2022-12-28	WOS:000315342500059
J	Nguyen, TTN; Kim, YM; Kim, TD; Le, OTT; Kim, JJ; Kang, HC; Hasegawa, H; Kanaho, Y; Jou, I; Lee, SY				Tu Thi Ngoc Nguyen; Kim, Yong Min; Kim, T. Doohun; Oanh Thi Tu Le; Kim, Jae Jin; Kang, Ho Chul; Hasegawa, Hiroshi; Kanaho, Yasunori; Jou, Ilo; Lee, Sang Yoon			Phosphatidylinositol 4-Phosphate 5-Kinase alpha Facilitates Toll-like Receptor 4-mediated Microglial Inflammation through Regulation of the Toll/Interleukin-1 Receptor Domain-containing Adaptor Protein (TIRAP) Location	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE; IMMUNE-RESPONSES; MURINE MICROGLIA; INNATE IMMUNITY; NADPH OXIDASE; TOLL-LIKE-RECEPTOR-4; BRAIN; LIPOPOLYSACCHARIDE	Phosphatidylinositol (PI) 4,5-bisphosphate (PIP2), generated by PI 4-phosphate 5-kinase (PIP5K), regulates many critical cellular events. PIP2 is also known to mediate plasma membrane localization of the Toll/IL-1 receptor domain-containing adaptor protein (TIRAP), required for the MyD88-dependent Toll-like receptor (TLR) 4 signaling pathway. Microglia are the primary immune competent cells in brain tissue, and TLR4 is important for microglial activation. However, a functional role for PIP5K and PIP2 in TLR4-dependent microglial activation remains unclear. Here, we knocked down PIP5K alpha, a PIP5K isoform, in a BV2 microglial cell line using stable expression of lentiviral shRNA constructs or siRNA transfection. PIP5K alpha knockdown significantly suppressed induction of inflammatory mediators, including IL-6, IL-1 beta, and nitric oxide, by lipopolysaccharide. PIP5K alpha knockdown also attenuated signaling events downstream of TLR4 activation, including p38 MAPK and JNK phosphorylation, NF-kappa B p65 nuclear translocation, and I kappa B-alpha degradation. Complementation of the PIP5K alpha knockdown cells with wild type but not kinase-dead PIP5K alpha effectively restored the LPS-mediated inflammatory response. Wefound that PIP5K alpha and TIRAP colocalized at the cell surface and interacted with each other, whereas kinase-dead PIP5K alpha rendered TIRAP soluble. Furthermore, in LPS-stimulated con- trol cells, plasma membrane PIP2 increased and subsequently declined, and TIRAP underwent bi-directional translocation between the membrane and cytosol, which temporally correlated with the changes in PIP2. In contrast, PIP5K alpha knockdown that reduced PIP2 levels disrupted TIRAP membrane targeting by LPS. Together, our results suggest that PIP5K alpha promotes TLR4-associated microglial inflammation by mediating PIP2-dependent recruitment of TIRAP to the plasma membrane.	[Tu Thi Ngoc Nguyen; Kim, Yong Min; Oanh Thi Tu Le; Jou, Ilo; Lee, Sang Yoon] Ajou Univ, Neurosci Grad Program, Chron Inflammatory Dis Res Ctr, Suwon 443721, Gyeonggi, South Korea; [Jou, Ilo] Ajou Univ, Dept Pharmacol, Suwon 443721, Gyeonggi, South Korea; [Kim, Jae Jin; Kang, Ho Chul] Ajou Univ, Dept Physiol, Sch Med, Suwon 443721, Gyeonggi, South Korea; [Kim, T. Doohun] Ajou Univ, Dept Mol Sci & Technol, Grad Sch Interdisciplinary Programs, Suwon 443721, Gyeonggi, South Korea; [Hasegawa, Hiroshi; Kanaho, Yasunori] Univ Tsukuba, Dept Physiol Chem, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058571, Japan; [Hasegawa, Hiroshi; Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058571, Japan	Ajou University; Ajou University; Ajou University; Ajou University; University of Tsukuba; University of Tsukuba	Lee, SY (corresponding author), Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, San 5, Suwon 443721, Gyeonggi, South Korea.	sangyoon@ajou.ac.kr	kim, doohun/AAC-4528-2019		Basic Science Research Program through the National Research Foundation of Korea [2011-0013962]; Ministry of Education, Science, and Technology from Korea Science and Engineering Foundation through the Chronic Inflammatory Disease Research Center at Ajou University [2012048183]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology from Korea Science and Engineering Foundation through the Chronic Inflammatory Disease Research Center at Ajou University	This work was supported by Research Grant 2011-0013962 from Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (to S. Y. L.) and Grant 2012048183 from Korea Science and Engineering Foundation through the Chronic Inflammatory Disease Research Center at Ajou University.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Barbieri MA, 2001, J BIOL CHEM, V276, P47212, DOI 10.1074/jbc.C100490200; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Jou I, 2006, AM J PATHOL, V168, P1619, DOI 10.2353/ajpath.2006.050924; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kanaho Y, 2007, BIOL PHARM BULL, V30, P1605, DOI 10.1248/bpb.30.1605; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lee SY, 2010, NEUROCHEM INT, V57, P600, DOI 10.1016/j.neuint.2010.07.008; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu B, 2002, ANN NY ACAD SCI, V962, P318, DOI 10.1111/j.1749-6632.2002.tb04077.x; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Marek LR, 2012, IMMUNITY, V36, P612, DOI 10.1016/j.immuni.2012.01.019; Min KJ, 2004, GLIA, V48, P197, DOI 10.1002/glia.20069; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; O'Neill LAJ, 2003, J ENDOTOXIN RES, V9, P55, DOI 10.1179/096805103125001351; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Park SJ, 2001, J BIOL CHEM, V276, P4781, DOI 10.1074/jbc.M010177200; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Payrastre B, 2001, CELL SIGNAL, V13, P377, DOI 10.1016/S0898-6568(01)00158-9; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Quinn KV, 2008, J PHYSIOL-LONDON, V586, P2855, DOI 10.1113/jphysiol.2008.153791; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yang MS, 2007, J NEUROSCI RES, V85, P2298, DOI 10.1002/jnr.21254; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	60	36	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5645	5659		10.1074/jbc.M112.410126	http://dx.doi.org/10.1074/jbc.M112.410126			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297396	hybrid, Green Published			2022-12-28	WOS:000315342500038
J	Vinyard, DJ; Gimpel, J; Ananyev, GM; Cornejo, MA; Golden, SS; Mayfield, SP; Dismukes, GC				Vinyard, David J.; Gimpel, Javier; Ananyev, Gennady M.; Cornejo, Mario A.; Golden, Susan S.; Mayfield, Stephen P.; Dismukes, G. Charles			Natural Variants of Photosystem II Subunit D1 Tune Photochemical Fitness to Solar Intensity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC O2 EVOLUTION; HIGH LIGHT-INTENSITY; PSBA GENES; THERMOSYNECHOCOCCUS-ELONGATUS; DISTINCT FORMS; DIFFERENTIAL EXPRESSION; ELECTRON-TRANSFER; OXYGEN EVOLUTION; WATER OXIDATION; UV-B	Photosystem II (PSII) is composed of six core polypeptides that make up the minimal unit capable of performing the primary photochemistry of light-driven charge separation and water oxidation in all oxygenic phototrophs. The D1 subunit of this complex contains most of the ligating amino acid residues for the Mn4CaO5 core of the water-oxidizing complex (WOC). Most cyanobacteria have 3-5 copies of the psbA gene coding for at least two isoforms of D1, whereas algae and plants have only one isoform. Synechococcus elongatus PCC 7942 contains two D1 isoforms; D1:1 is expressed under low light conditions, and D1:2 is up-regulated in high light or stress conditions. Using a heterologous psbA expression system in the green alga Chlamydomonas reinhardtii, we have measured growth rate, WOC cycle efficiency, and O-2 yield as a function of D1:1, D1:2, or the native algal D1 isoform. D1:1-PSII cells outcompete D1:2-PSII cells and accumulate more biomass in light-limiting conditions. However, D1:2-PSII cells easily outcompete D1:1-PSII cells at high light intensities. The native C. reinhardtii-PSII WOC cycles less efficiently at all light intensities and produces less O-2 than either cyanobacterial D1 isoform. D1:2-PSII makes more O-2 per saturating flash than D1:1-PSII, but it exhibits lower WOC cycling efficiency at low light intensities due to a 40% faster charge recombination rate in the S-3 state. These functional advantages of D1:1-PSII and D1:2-PSII at low and high light regimes, respectively, can be explained by differences in predicted redox potentials of PSII electron acceptors that control kinetic performance.	[Vinyard, David J.; Ananyev, Gennady M.; Dismukes, G. Charles] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Vinyard, David J.; Ananyev, Gennady M.; Cornejo, Mario A.; Dismukes, G. Charles] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Vinyard, David J.] Princeton Univ, Dept Chem, Princeton, NJ 08540 USA; [Gimpel, Javier; Golden, Susan S.; Mayfield, Stephen P.] Univ Calif San Diego, San Diego Ctr Algae Biotechnol, Div Biol Sci, La Jolla, CA 92093 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Princeton University; University of California System; University of California San Diego	Dismukes, GC (corresponding author), Rutgers State Univ, Waksman Inst Microbiol, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	dismukes@rci.rutgers.edu		Gimpel, Javier/0000-0002-8671-9627; Vinyard, David/0000-0002-8058-5998	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-10ER16195]; Air Force Office of Scientific Research Grant [FA9550-10-1-0052]; Department of Energy [DE-EE0003373]; Consortium for Algal Biofuels Commercialization (CAB-COMM); Department of Defense, Army Research Office, National Defense Science and Engineering Graduate Fellowship [32CFR168a]; National Science Foundation Graduate Research Fellowship [DGE-0937373]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Air Force Office of Scientific Research Grant(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Department of Energy(United States Department of Energy (DOE)); Consortium for Algal Biofuels Commercialization (CAB-COMM); Department of Defense, Army Research Office, National Defense Science and Engineering Graduate Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported in part by Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FG02-10ER16195 (to G.C.D.), Air Force Office of Scientific Research Grant FA9550-10-1-0052, and Department of Energy Grant DE-EE0003373, Consortium for Algal Biofuels Commercialization (CAB-COMM) (to S.P.M. and S.S.G.).; Supported by the Department of Defense, Army Research Office, National Defense Science and Engineering Graduate Fellowship 32CFR168a and National Science Foundation Graduate Research Fellowship DGE-0937373.	Ananyev G, 2005, PHOTOSYNTH RES, V84, P355, DOI 10.1007/s11120-004-7081-1; Ananyev GM, 1996, BIOCHEMISTRY-US, V35, P4102, DOI 10.1021/bi952667h; BABCOCK GT, 1983, BIOCHIM BIOPHYS ACTA, V723, P276, DOI 10.1016/0005-2728(83)90127-5; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Boussac A, 2011, BBA-BIOENERGETICS, V1807, P119, DOI 10.1016/j.bbabio.2010.10.004; BOUYOUB A, 1993, PLANT MOL BIOL, V21, P249, DOI 10.1007/BF00019941; BUSER CA, 1992, BIOCHEMISTRY-US, V31, P11449, DOI 10.1021/bi00161a025; BUSTOS SA, 1990, J BACTERIOL, V172, P1998, DOI 10.1128/jb.172.4.1998-2004.1990; Campbell D, 1998, P NATL ACAD SCI USA, V95, P364, DOI 10.1073/pnas.95.1.364; CAMPBELL D, 1995, EMBO J, V14, P5457, DOI 10.1002/j.1460-2075.1995.tb00232.x; Chen GY, 2012, BIOCHEMISTRY-US, V51, P138, DOI 10.1021/bi200627j; Chen R., 2010, J BOT, V2010; CLARKE AK, 1993, P NATL ACAD SCI USA, V90, P9973, DOI 10.1073/pnas.90.21.9973; CLARKE AK, 1993, P NATL ACAD SCI USA, V90, P11985, DOI 10.1073/pnas.90.24.11985; DELRIEU MJ, 1987, BIOCHIM BIOPHYS ACTA, V892, P163, DOI 10.1016/0005-2728(87)90171-X; Dyer B. D., 2003, FIELD GUIDE BACTERIA, P232; FORBUSH B, 1971, PHOTOCHEM PHOTOBIOL, V14, P307, DOI 10.1111/j.1751-1097.1971.tb06175.x; Gokhale Z., 2009, CHLAMYDOMONAS SOURCE, P573; GOLDEN SS, 1986, EMBO J, V5, P2789, DOI 10.1002/j.1460-2075.1986.tb04569.x; Hughes JL, 2010, BBA-BIOENERGETICS, V1797, P11, DOI 10.1016/j.bbabio.2009.07.007; Johnson S.G., 2011, NLOPT NONLINEAR OPTI; Joliot P., 1975, BIOENERG PHOTOSYNTH, P387; Kato Y, 2012, BBA-BIOENERGETICS, V1817, P1998, DOI 10.1016/j.bbabio.2012.06.006; Kato Y, 2009, P NATL ACAD SCI USA, V106, P17365, DOI 10.1073/pnas.0905388106; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kolling DRJ, 2009, BIOCHEMISTRY-US, V48, P1381, DOI 10.1021/bi801774f; KULKARNI RD, 1994, J BACTERIOL, V176, P959, DOI 10.1128/JB.176.4.959-965.1994; Kulkarni RD, 1995, PHOTOSYNTH RES, V46, P435, DOI 10.1007/BF00032298; LAVOREL J, 1976, J THEOR BIOL, V57, P171, DOI 10.1016/S0022-5193(76)80011-2; Loll B, 2008, BIOL CHEM, V389, P609, DOI 10.1515/BC.2008.058; Manuell AL, 2007, PLANT BIOTECHNOL J, V5, P402, DOI 10.1111/j.1467-7652.2007.00249.x; Mason CB, 2006, NAT PROTOC, V1, P2227, DOI 10.1038/nprot.2006.348; MAYFIELD SP, 1994, J CELL BIOL, V127, P1537, DOI 10.1083/jcb.127.6.1537; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; Merry SAP, 1998, BIOCHEMISTRY-US, V37, P17439, DOI 10.1021/bi980502d; MESSINGER J, 1993, BIOCHEMISTRY-US, V32, P7658, DOI 10.1021/bi00081a009; MOHAMED A, 1993, MOL GEN GENET, V238, P161, DOI 10.1007/BF00279543; Morton BR, 1996, J MOL EVOL, V43, P28, DOI 10.1007/BF02352296; Muh F, 2011, FRONT BIOSCI-LANDMRK, V16, P3072, DOI 10.2741/3900; Mulo P, 2009, CELL MOL LIFE SCI, V66, P3697, DOI 10.1007/s00018-009-0103-6; Ogami S, 2012, BBA-BIOENERGETICS, V1817, P1322, DOI 10.1016/j.bbabio.2012.01.015; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Powell M.J.D., 2009, BOBYQA ALGORITHM BOU; Prasil O, 1996, PHOTOSYNTH RES, V48, P395, DOI 10.1007/BF00029472; Rasala BA, 2011, PLANT BIOTECHNOL J, V9, P674, DOI 10.1111/j.1467-7652.2011.00620.x; Raven, 2007, AQUATIC PHOTOSYNTHES, P81; Rutherford AW, 2012, FEBS LETT, V586, P603, DOI 10.1016/j.febslet.2011.12.039; Sander J, 2010, J BIOL CHEM, V285, P29851, DOI 10.1074/jbc.M110.127142; Sane PV, 2002, J BIOL CHEM, V277, P32739, DOI 10.1074/jbc.M200444200; SCHAEFER MR, 1989, J BIOL CHEM, V264, P7412; SCHAEFER MR, 1989, J BACTERIOL, V171, P3973, DOI 10.1128/jb.171.7.3973-3981.1989; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; SCHUSTER G, 1988, EUR J BIOCHEM, V177, P403, DOI 10.1111/j.1432-1033.1988.tb14389.x; Shibamoto T, 2009, BIOCHEMISTRY-US, V48, P10682, DOI 10.1021/bi901691j; SHIM HS, 1990, PHOTOSYNTH RES, V26, P223, DOI 10.1007/BF00033135; Shinkarev VP, 2005, BIOPHYS J, V88, P412, DOI 10.1529/biophysj.104.050898; Shinopoulos KE, 2012, BBA-BIOENERGETICS, V1817, P66, DOI 10.1016/j.bbabio.2011.08.002; Sicora CI, 2009, BBA-BIOENERGETICS, V1787, P105, DOI 10.1016/j.bbabio.2008.12.002; Sippola K, 1999, PLANT MOL BIOL, V41, P425, DOI 10.1023/A:1006347808475; Stambler N, 2007, ALGAE CYANOBACTERIA, P81; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219, DOI 10.1093/oxfordjournals.pcp.a029510; Sugiura M, 2010, J BIOL CHEM, V285, P30008, DOI 10.1074/jbc.M110.136945; Sugiura M, 2010, BBA-BIOENERGETICS, V1797, P1491, DOI 10.1016/j.bbabio.2010.03.022; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; Tichy M, 2003, BBA-BIOENERGETICS, V1605, P55, DOI 10.1016/S0005-2728(03)00064-1; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VASS I, 1991, BIOCHEMISTRY-US, V30, P830, DOI 10.1021/bi00217a037; Vass I, 2009, TRENDS PLANT SCI, V14, P200, DOI 10.1016/j.tplants.2009.01.009; WHITMARSH J, 1978, BIOCHIM BIOPHYS ACTA, V501, P83, DOI 10.1016/0005-2728(78)90097-X; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	71	27	28	1	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5451	5462		10.1074/jbc.M112.394668	http://dx.doi.org/10.1074/jbc.M112.394668			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23271739	Green Published, hybrid			2022-12-28	WOS:000315342500020
J	Vitrac, H; Bogdanov, M; Dowhan, W				Vitrac, Heidi; Bogdanov, Mikhail; Dowhan, William			Proper Fatty Acid Composition Rather than an Ionizable Lipid Amine Is Required for Full Transport Function of Lactose Permease from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYTOPIC MEMBRANE-PROTEIN; MONOCLONAL-ANTIBODY 4B1; GALACTOSE-SPECIFIC PROTEINS; TOPOLOGICAL ORGANIZATION; PHOSPHOLIPID-COMPOSITION; MULTIDRUG TRANSPORTER; STRUCTURAL FEATURES; PHOSPHATIDYLETHANOLAMINE; TOPOGENESIS; BINDING	Energy-dependent uphill transport but not energy-independent downhill transport by lactose permease (LacY) is impaired when expressed in Escherichia coli cells or reconstituted in liposomes lacking phosphatidylethanolamine (PE) and containing only anionic phospholipids. The absence of PE results in inversion of the N-terminal half and misfolding of periplasmic domain P7, which are required for uphill transport of substrates. Replacement of PE in vitro by lipids with no net charge (phosphatidylcholine (PC), monoglucosyl diacylglycerol (GlcDAG), or diglucosyl diacylglycerol (GlcGlcDAG)) supported wild type transmembrane topology of the N-terminal half of LacY. The restoration of uphill transport in vitro was dependent on LacY native topology and proper folding of P7. Support of uphill transport by net neutral lipids in vitro (PE > PC >> GlcDAG not equal GlcGlcDAG provided that PE or PC contained one saturated fatty acid) paralleled the results observed previously in vivo (PE = PC > GlcDAG not equal GlcGlcDAG). Therefore, a free amino group is not required for uphill transport as previously concluded based on the lack of in vitro uphill transport when fully unsaturated PC replaced E. coli-derived PE. A close correlation was observed in vivo and in vitro between the ability of LacY to carry out uphill transport, the native conformation of P7, and the lipid headgroup and fatty acid composition. Therefore, the headgroup and the fatty acid composition of lipids are important for defining LacY topological organization and catalytically important structural features, further illustrating the direct role of lipids, independent of other cellular factors, in defining membrane protein structure/function.	[Vitrac, Heidi; Bogdanov, Mikhail; Dowhan, William] Univ Texas Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Dowhan, William] Univ Texas Med Sch, Ctr Membrane Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Bogdanov, M (corresponding author), Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, 6431 Fannin St,Suite 6-200, Houston, TX 77030 USA.	Mikhail.V.Bogdanov@uth.tmc.edu; William.Dowhan@uth.tmc.edu	Bogdanov, Mikhail/J-3695-2017; Vitrac, Heidi/R-7117-2018	Vitrac, Heidi/0000-0002-8858-4914	National Institutes of Health Grant [GM R37 20478]; John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM R37 20478 (to W. D.). This work was also supported by a grant from the John Dunn Research Foundation (to W. D.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Andersson M, 2012, STRUCTURE, V20, P1893, DOI 10.1016/j.str.2012.08.021; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Bogdanov M, 1999, J BIOL CHEM, V274, P12339, DOI 10.1074/jbc.274.18.12339; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bogdanov M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404103; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Bogdanov M, 2010, METHODS MOL BIOL, V619, P79, DOI 10.1007/978-1-60327-412-8_5; Bogdanov M, 2009, J BIOL CHEM, V284, P9637, DOI 10.1074/jbc.R800081200; CHEN CC, 1984, J BIOL CHEM, V259, P150; CHEN CC, 1986, J BIOL CHEM, V261, P2599; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dowhan W, 2012, BBA-BIOMEMBRANES, V1818, P1097, DOI 10.1016/j.bbamem.2011.09.013; Dowhan W, 2011, BIOCHEM SOC T, V39, P767, DOI 10.1042/BST0390767; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; DRIESSEN AJM, 1988, BIOCHEMISTRY-US, V27, P865, DOI 10.1021/bi00403a005; Fendler K, 1996, BIOCHEMISTRY-US, V35, P8009, DOI 10.1021/bi960175e; Fernandez MD, 2005, J AM CHEM SOC, V127, P7379, DOI 10.1021/ja051020+; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P6408, DOI 10.1021/bi970233b; Frillingos S, 1996, BIOCHEMISTRY-US, V35, P10166, DOI 10.1021/bi960995r; Gbaguidi B, 2007, CELL MOL LIFE SCI, V64, P1571, DOI 10.1007/s00018-007-7031-0; Gustot A, 2010, J BIOL CHEM, V285, P14144, DOI 10.1074/jbc.M109.079673; Hakizimana P, 2008, J BIOL CHEM, V283, P9369, DOI 10.1074/jbc.M708427200; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; PAGE MGP, 1988, J BIOL CHEM, V263, P15897; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Sanders CR, 2011, BIOCHEMISTRY-US, V50, P7858, DOI 10.1021/bi2011527; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Suarez-Germa C, 2012, J PHYS CHEM B, V116, P2438, DOI 10.1021/jp2105665; Sujatha MS, 2004, PROTEINS, V55, P44, DOI 10.1002/prot.10612; Sujatha MS, 2004, PROTEIN SCI, V13, P2502, DOI 10.1110/ps.04812804; Sun JZ, 1996, BIOCHEMISTRY-US, V35, P990, DOI 10.1021/bi952166w; Toyomizu M, 2002, BBA-BIOMEMBRANES, V1558, P54, DOI 10.1016/S0005-2736(01)00422-9; URATANI Y, 1986, J BIOL CHEM, V261, P5450; Vitrac H, 2011, J BIOL CHEM, V286, P15182, DOI 10.1074/jbc.M110.214387; Voss J, 1997, BIOCHEMISTRY-US, V36, P15055, DOI 10.1021/bi971726j; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; Wikstrom M, 2004, J BIOL CHEM, V279, P10484, DOI 10.1074/jbc.M310183200; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; Xie J, 2006, J BIOL CHEM, V281, P19172, DOI 10.1074/jbc.M602565200; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200	49	24	24	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5873	5885		10.1074/jbc.M112.442988	http://dx.doi.org/10.1074/jbc.M112.442988			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23322771	Green Published, hybrid			2022-12-28	WOS:000315342500057
J	Zhou, RF; Tomkovicz, VR; Butler, PL; Ochoa, LA; Peterson, ZJ; Snyder, PM				Zhou, Ruifeng; Tomkovicz, Vivian R.; Butler, Phillip L.; Ochoa, Luis A.; Peterson, Zerubbabel J.; Snyder, Peter M.			Ubiquitin-specific Peptidase 8 (USP8) Regulates Endosomal Trafficking of the Epithelial Na+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; LIDDLES-SYNDROME; MEDIATED DEUBIQUITINATION; FUNCTIONAL REGULATION; PROTEOLYTIC CLEAVAGE; SURFACE EXPRESSION; MEMBRANE-PROTEINS; LIGASE NEDD4-2; ENAC; DEUBIQUITYLATION	Ubiquitination plays a key role in trafficking of the epithelial Na+ channel (ENaC). Previous work indicated that ubiquitination enhances ENaC endocytosis and sorting to lysosomes for degradation. Moreover, a defect in ubiquitination causes Liddle syndrome, an inherited form of hypertension. In this work, we identified a role for USP8 in the control of ENaC ubiquitination and trafficking. USP8 increased ENaC current in Xenopus oocytes and collecting duct epithelia and enhanced ENaC abundance at the cell surface in HEK 293 cells. This resulted from altered endocytic sorting; USP8 abolished ENaC degradation in the endocytic pathway, but it had no effect on ENaC endocytosis. USP8 interacted with ENaC, as detected by co-immunoprecipitation, and it deubiquitinated ENaC. Consistent with a functional role for deubiquitination, mutation of the cytoplasmic lysines of ENaC reduced the effect of USP8 on ENaC cell surface abundance. In contrast to USP8, USP2-45 increased ENaC surface abundance by reducing endocytosis but not degradation. Thus, USP8 and USP2-45 selectively modulate ENaC trafficking at different steps in the endocytic pathway. Together with previous work, the data indicate that the ubiquitination state of ENaC is critical for the regulation of epithelial Na+ absorption.	[Zhou, Ruifeng; Tomkovicz, Vivian R.; Butler, Phillip L.; Peterson, Zerubbabel J.; Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Zhou, Ruifeng; Tomkovicz, Vivian R.; Butler, Phillip L.; Peterson, Zerubbabel J.; Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Ochoa, Luis A.] Univ Iowa, Carver Coll Med, Dept Pediat, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu		Ochoa Nunez, Luis/0000-0002-6156-610X	National Institutes of Health [HL058812, HL072256]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL058812, R01HL072256, R01HL058812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL058812 and HL072256 (to P. M. S.).	Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Berlin I, 2010, J BIOL CHEM, V285, P37895, DOI 10.1074/jbc.M110.129411; Berlin I, 2010, J BIOL CHEM, V285, P34909, DOI 10.1074/jbc.M109.016287; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Edinger RS, 2009, J BIOL CHEM, V284, P150, DOI 10.1074/jbc.M807358200; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Ruffieux-Daidie D, 2011, J BIOL CHEM, V286, P2416, DOI 10.1074/jbc.M110.176156; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Whelton PK, 2011, JAMA-J AM MED ASSOC, V306, P2262, DOI 10.1001/jama.2011.1746; Wright MH, 2011, CELL BIOCHEM BIOPHYS, V60, P39, DOI 10.1007/s12013-011-9181-9; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	41	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5389	5397		10.1074/jbc.M112.425272	http://dx.doi.org/10.1074/jbc.M112.425272			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297398	Green Published, hybrid			2022-12-28	WOS:000315342500014
J	Kleinschmit, A; Takemura, M; Dejima, K; Choi, PY; Nakato, H				Kleinschmit, Adam; Takemura, Masahiko; Dejima, Katsufumi; Choi, Pui Yee; Nakato, Hiroshi			Drosophila Heparan Sulfate 6-O-Endosulfatase Sulf1 Facilitates Wingless (Wg) Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGEN GRADIENT FORMATION; ENDOCYTIC PATHWAY; BINDING-SITES; PROTEOGLYCAN; GLYPICAN; QSULF1; IDENTIFICATION; ENDOSULFATASE; SYSTEM; GROWTH	Heparan sulfate proteoglycans regulate various physiological and developmental processes through interactions with a number of protein ligands. Heparan sulfate (HS)-ligand binding depends on the amount and patterns of sulfate groups on HS, which are controlled by various HS sulfotransferases in the Golgi apparatus as well as extracellular 6-O-endosulfatases called "Sulfs." Sulfs are a family of secreted molecules that specifically remove 6-O-sulfate groups within the highly sulfated regions on HS. Vertebrate Sulfs promote Wnt signaling, whereas the only Drosophila homologue of Sulfs, Sulf1, negatively regulates Wingless (Wg) signaling. To understand the molecular mechanism for the negative regulation of Wg signaling by Sulf1, we studied the effects of Sulf1 on HS-Wg interaction and Wg stability. Sulf1 overexpression strongly inhibited the binding of Wg to Dally, a potential target heparan sulfate proteoglycan of Sulf1. This effect of Drosophila Sulf1 on the HS-Wg interaction is similar to that of vertebrate Sulfs. Using in vitro, in vivo, and ex vivo systems, we show that Sulf1 reduces extracellular Wg protein levels, at least partly by facilitating Wg degradation. In addition, expression of human Sulf1 in the Drosophila wing disc lowers the levels of extracellular Wg protein, as observed for Drosophila Sulf1. Our study demonstrates that vertebrate and Drosophila Sulfs have an intrinsically similar activity and that the function of Sulfs in the fate of Wnt/Wg ligands is context-dependent.	[Kleinschmit, Adam; Takemura, Masahiko; Dejima, Katsufumi; Choi, Pui Yee; Nakato, Hiroshi] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Nakato, H (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 321 Church St SE, Minneapolis, MN 55455 USA.	nakat003@umn.edu		Takemura, Masahiko/0000-0003-3984-4481	National Institutes of Health [R01 HD042769]; American Heart Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD042769 (to H.N.). This work was also supported by a grant from the American Heart Association (to A. K. and H.N.).	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Bengali Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017248; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Dejima K, 2011, J BIOL CHEM, V286, P17103, DOI 10.1074/jbc.M110.208082; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Fujise M, 2001, DEV BIOL, V235, P433, DOI 10.1006/dbio.2001.0290; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Gorsi B, 2007, TRENDS CELL BIOL, V17, P173, DOI 10.1016/j.tcb.2007.02.006; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Hirst M, 2001, P NATL ACAD SCI USA, V98, P8726, DOI 10.1073/pnas.141413598; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Kleinschmit A, 2010, DEV BIOL, V345, P204, DOI 10.1016/j.ydbio.2010.07.006; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Melcher K, 2001, EMBO J, V20, P841, DOI 10.1093/emboj/20.4.841; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Piddini E, 2005, DEVELOPMENT, V132, P5479, DOI 10.1242/dev.02145; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Takeo S, 2005, DEV BIOL, V284, P204, DOI 10.1016/j.ydbio.2005.05.014; Tang RH, 2009, J BIOL CHEM, V284, P21505, DOI 10.1074/jbc.M109.028472; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Wojcinski A, 2011, DEV BIOL, V358, P168, DOI 10.1016/j.ydbio.2011.07.027; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; You J, 2011, DEV DYNAM, V240, P640, DOI 10.1002/dvdy.22562	49	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5081	5089		10.1074/jbc.M112.447029	http://dx.doi.org/10.1074/jbc.M112.447029			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23300081	Green Published, hybrid			2022-12-28	WOS:000315340400056
J	Oya, M; Kitaguchi, T; Pais, R; Reimann, F; Gribble, F; Tsuboi, T				Oya, Manami; Kitaguchi, Tetsuya; Pais, Ramona; Reimann, Frank; Gribble, Fiona; Tsuboi, Takashi			The G Protein-coupled Receptor Family C Group 6 Subtype A (GPRC6A) Receptor Is Involved in Amino Acid-induced Glucagon-like Peptide-1 Secretion from GLUTag Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TASTE RECEPTORS; ABSORPTION; EXOCYTOSIS; EXPRESSION; GUSTDUCIN; SEQUENCE; CALCIUM; CLONING; FUSION	Although amino acids are dietary nutrients that evoke the secretion of glucagon-like peptide 1 (GLP-1) from intestinal L cells, the precise molecular mechanism(s) by which amino acids regulate GLP-1 secretion from intestinal L cells remains unknown. Here, we show that the G protein-coupled receptor (GPCR), family C group 6 subtype A (GPRC6A), is involved in amino acid-induced GLP-1 secretion from the intestinal L cell line GLUTag. Application of L-ornithine caused an increase in intracellular Ca2+ concentration ([Ca2+](i)) in GLUTag cells. Application of a GPRC6A receptor antagonist, a phospholipase C inhibitor, or an IP3 receptor antagonist significantly suppressed the L-ornithine-induced [Ca2+](i) increase. We found that the increase in [Ca2+](i) stimulated by L-ornithine correlated with GLP-1 secretion and that L-ornithine stimulation increased exocytosis in a dose-dependent manner. Furthermore, depletion of endogenous GPRC6A by a specific small interfering RNA (siRNA) inhibited the L-ornithine-induced [Ca2+](i) increase and GLP-1 secretion. Taken together, these findings suggest that the GPRC6A receptor functions as an amino acid sensor in GLUTag cells that promotes GLP-1 secretion.	[Oya, Manami; Tsuboi, Takashi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Kitaguchi, Tetsuya] Waseda Univ, Waseda Biosci Res Inst Singapore WABOIS, Cell Signaling Grp, Singapore 138667, Singapore; [Pais, Ramona; Reimann, Frank; Gribble, Fiona] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Tokyo; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Tsuboi, T (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	takatsuboi@bio.c.u-tokyo.ac.jp	TSUBOI, Takashi/AAD-7976-2019; KITAGUCHI, TETSUYA/AAR-1895-2021; Kitaguchi, Tetsuya/F-5260-2017	TSUBOI, Takashi/0000-0001-8290-2021; KITAGUCHI, TETSUYA/0000-0001-6701-1933; Kitaguchi, Tetsuya/0000-0001-6701-1933; Reimann, Frank/0000-0001-9399-6377; Gribble, Fiona/0000-0002-4232-2898	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24-8221, 22790197, 24790207]; Nestle Nutrition Council, Japan; JGC-S Scholarship Foundation; Mishima Kaiun Memorial Foundation; Suntory Foundation for Life Sciences; Takeda Science Foundation; Grants-in-Aid for Scientific Research [24790207] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nestle Nutrition Council, Japan; JGC-S Scholarship Foundation; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Suntory Foundation for Life Sciences; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 24-8221 (to M.O.), 22790197 (to T.K.), and 24790207 (to T.T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by the Nestle Nutrition Council, Japan (to T.T.), the JGC-S Scholarship Foundation (to T.K.), the Mishima Kaiun Memorial Foundation (to T.T.), the Suntory Foundation for Life Sciences (to T.T.), and the Takeda Science Foundation (to T.T.).	Aoki R, 2010, BIOCHEM J, V429, P497, DOI 10.1042/BJ20091839; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Bjarndottir TK, 2005, GENE, V362, P70, DOI 10.1016/j.gene.2005.07.029; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Christiansen B, 2007, BRIT J PHARMACOL, V150, P798, DOI 10.1038/sj.bjp.0707121; Conigrave AD, 2010, PHARMACOL THERAPEUT, V127, P252, DOI 10.1016/j.pharmthera.2010.04.007; Diakogiannaki E, 2012, PHYSIOL BEHAV, V106, P387, DOI 10.1016/j.physbeh.2011.12.001; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; ELLIOTT RM, 1993, J ENDOCRINOL, V138, P159, DOI 10.1677/joe.0.1380159; Faure H, 2009, CELL CALCIUM, V46, P323, DOI 10.1016/j.ceca.2009.09.004; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Gribble FM, 2003, DIABETES, V52, P1147, DOI 10.2337/diabetes.52.5.1147; Hall WL, 2003, BRIT J NUTR, V89, P239, DOI 10.1079/BJN2002760; HERRMANN C, 1995, DIGESTION, V56, P117, DOI 10.1159/000201231; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Kawashima R, 2010, BIOCHEM BIOPH RES CO, V400, P225, DOI 10.1016/j.bbrc.2010.08.044; Lochner JE, 2006, J NEUROBIOL, V66, P564, DOI 10.1002/neu.20250; Mace OJ, 2012, J PHYSIOL-LONDON, V590, P2917, DOI 10.1113/jphysiol.2011.223800; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Neu J, 1996, FASEB J, V10, P829, DOI 10.1096/fasebj.10.8.8666159; Ohara-Imaizumi M, 2009, BIOCHEM BIOPH RES CO, V390, P16, DOI 10.1016/j.bbrc.2009.09.043; Oya M, 2011, GENES CELLS, V16, P608, DOI 10.1111/j.1365-2443.2011.01509.x; Parker HE, 2012, BRIT J PHARMACOL, V165, P414, DOI 10.1111/j.1476-5381.2011.01561.x; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Reimann F, 2004, DIABETOLOGIA, V47, P1592, DOI 10.1007/s00125-004-1498-0; Reimann F, 2002, DIABETES, V51, P2757, DOI 10.2337/diabetes.51.9.2757; Reimann F, 2012, CELL METAB, V15, P421, DOI 10.1016/j.cmet.2011.12.019; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Sato M, 2012, BIOCHEM BIOPH RES CO, V420, P417, DOI 10.1016/j.bbrc.2012.03.010; Sato M, 2010, J NEUROCHEM, V114, P171, DOI 10.1111/j.1471-4159.2010.06739.x; Smajilovic S, 2013, AMINO ACIDS, V44, P383, DOI 10.1007/s00726-012-1341-8; Tolhurst G, 2011, ENDOCRINOLOGY, V152, P405, DOI 10.1210/en.2010-0956; Tsuboi T, 2006, DIABETES, V55, P1057, DOI 10.2337/diabetes.55.04.06.db05-1577; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x	40	106	111	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4513	4521		10.1074/jbc.M112.402677	http://dx.doi.org/10.1074/jbc.M112.402677			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23269670	Green Published, hybrid			2022-12-28	WOS:000315340400002
J	Tammineni, P; Anugula, C; Mohammed, F; Anjaneyulu, M; Larner, AC; Sepuri, NBV				Tammineni, Prasad; Anugula, Chandrashekhar; Mohammed, Fareed; Anjaneyulu, Murari; Larner, Andrew C.; Sepuri, Naresh Babu Venkata			The Import of the Transcription Factor STAT3 into Mitochondria Depends on GRIM-19, a Component of the Electron Transport Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; REGULATORY GENE-PRODUCT; SIGNAL TRANSDUCER; PHOSPHORYLATION; EXPRESSION; MEMBRANE; SUBUNIT; BETA; TRANSLOCATION; LOCALIZATION	The signal transducer and activator of transcription 3 (STAT3), a nuclear transcription factor, is also present in mitochondria and regulates cellular respiration in a transcriptional-independent manner. The mechanism of STAT3 import into mitochondria remains obscure. In this report we show that mitochondrial-localized STAT3 resides in the inner mitochondrial membrane. In vitro import studies show that the gene associated with retinoid interferon induced cell mortality 19 (GRIM-19), a complex I subunit that acts as a chaperone to recruit STAT3 into mitochondria. In addition, GRIM-19 enhances the integration of STAT3 into complex I. A S727A mutation in STAT3 reduces its import and assembly even in the presence of GRIM-19. Together, our studies unveil a novel chaperone function for GRIM-19 in the recruitment of STAT3 into mitochondria.	[Tammineni, Prasad; Anugula, Chandrashekhar; Mohammed, Fareed; Anjaneyulu, Murari; Sepuri, Naresh Babu Venkata] Univ Hyderabad, Dept Biochem, Hyderabad 500046, Andhra Pradesh, India; [Larner, Andrew C.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA	University of Hyderabad; Virginia Commonwealth University	Sepuri, NBV (corresponding author), Univ Hyderabad, Dept Biochem, Hyderabad 500046, Andhra Pradesh, India.	nareshuohyd@gmail.com	Murari, Anjaneyulu/AAQ-1613-2021; Sepuri, Naresh/AAF-2704-2020	Murari, Anjaneyulu/0000-0002-7532-964X; Tammineni, Prasad/0000-0002-5030-7786	Indian Council of Medical Research; Council of Scientific and Industrial Research; Department of Biotechnology - Centre for Research and Education in Biology and Biotechnology (DBT-CREBB); University Grants Commission - Special Assistance Programme (UGC-SAP); Department of Science and Technology - Funds for Improvement of S & T Infrastructure in Higher Educational Institutions	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology - Centre for Research and Education in Biology and Biotechnology (DBT-CREBB); University Grants Commission - Special Assistance Programme (UGC-SAP)(University Grants Commission, India); Department of Science and Technology - Funds for Improvement of S & T Infrastructure in Higher Educational Institutions(Department of Science & Technology (DOST), PhilippinesDepartment of Science & Technology (India))	Supported by a Indian Council of Medical Research for Junior Research Fellowship.; Supported by the Council of Scientific and Industrial Research.; We thank Department of Biotechnology - Centre for Research and Education in Biology and Biotechnology (DBT-CREBB) and University Grants Commission - Special Assistance Programme (UGC-SAP) for funding the School of Life Sciences and Department of Science and Technology - Funds for Improvement of S & T Infrastructure in Higher Educational Institutions for funding the Department of Biochemistry, University of Hyderabad, Hyderabad. We thank Dr. Bramanandam, Department of Biochemistry, University of Hyderabad, Hyderabad for kindly providing the pcDNA-ER-alpha clone. We also thank members of the Sepuri laboratory for suggestions.	Anandatheerthavarada HK, 2009, J BIOL CHEM, V284, P17352, DOI 10.1074/jbc.M109.007492; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Bernier M, 2011, J BIOL CHEM, V286, P19270, DOI 10.1074/jbc.M110.200311; Biswas TK, 2002, J BIOL CHEM, V277, P45704, DOI 10.1074/jbc.M202565200; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Budas GR, 2010, CARDIOVASC RES, V88, P83, DOI 10.1093/cvr/cvq154; Cammarota M, 1999, J NEUROCHEM, V72, P2272, DOI 10.1046/j.1471-4159.1999.0722272.x; Chen JQ, 2004, ANN NY ACAD SCI, V1028, P258, DOI 10.1196/annals.1322.030; Chen JQ, 2004, J CELL BIOCHEM, V93, P358, DOI 10.1002/jcb.20178; Cogswell PC, 2003, J BIOL CHEM, V278, P2963, DOI 10.1074/jbc.M209995200; Delage L, 2003, MOL CELL BIOL, V23, P4000, DOI 10.1128/MCB.23.11.4000-4012.2003; Demonacos CV, 1996, STEROIDS, V61, P226, DOI 10.1016/0039-128X(96)00019-0; Diekert K, 1999, P NATL ACAD SCI USA, V96, P11752, DOI 10.1073/pnas.96.21.11752; EILERS M, 1987, EMBO J, V6, P1073, DOI 10.1002/j.1460-2075.1987.tb04860.x; Fang JK, 2007, FEBS LETT, V581, P1302, DOI 10.1016/j.febslet.2007.02.042; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Gabaldon T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; IOANNOU IM, 1988, ANTICANCER RES, V8, P1405; Kalakonda S, 2007, AM J PATHOL, V171, P1352, DOI 10.2353/ajpath.2007.070241; Kerscher O, 2000, MOL BIOL CELL, V11, P103, DOI 10.1091/mbc.11.1.103; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Lee J, 2008, J NEUROSCI RES, V86, P961, DOI 10.1002/jnr.21564; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Okamoto T, 2010, MOL CANCER THER, V9, P2333, DOI 10.1158/1535-7163.MCT-09-1147; PFANNER N, 1986, FEBS LETT, V209, P152, DOI 10.1016/0014-5793(86)81101-2; Pfanner N, 1997, ANNU REV CELL DEV BI, V13, P25, DOI 10.1146/annurev.cellbio.13.1.25; Qiu HY, 2011, CIRCULATION, V124, P406, DOI 10.1161/CIRCULATIONAHA.110.013847; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHLEYER M, 1982, EUR J BIOCHEM, V125, P109, DOI 10.1111/j.1432-1033.1982.tb06657.x; Sepuri NBV, 2007, FEBS J, V274, P4615, DOI 10.1111/j.1742-4658.2007.05990.x; Sepuri NBV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035321; Sepuri NBV, 1998, J BIOL CHEM, V273, P1420, DOI 10.1074/jbc.273.3.1420; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100	48	145	149	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4723	4732		10.1074/jbc.M112.378984	http://dx.doi.org/10.1074/jbc.M112.378984			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23271731	hybrid, Green Published			2022-12-28	WOS:000315340400021
J	Longet, S; Miled, S; Lotscher, M; Miescher, SM; Zuercher, AW; Corthesy, B				Longet, Stephanie; Miled, Sarah; Loetscher, Marius; Miescher, Sylvia M.; Zuercher, Adrian W.; Corthesy, Blaise			Human Plasma-derived Polymeric IgA and IgM Antibodies Associate with Secretory Component to Yield Biologically Active Secretory-like Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-A IGA; ANTIGEN-BINDING; MUCOSAL IMMUNITY; DIMERIC IGA; RECEPTOR; PROTECTION; INNATE; NEUTRALIZATION; PURIFICATION; EXPRESSION	Immunotherapy with monoclonal and polyclonal immunoglobulin is successfully applied to improve many clinical conditions, including infection, autoimmune diseases, or immunodeficiency. Most immunoglobulin products, recombinant or plasma-derived, are based on IgG antibodies, whereas to date, the use of IgA for therapeutic application has remained anecdotal. In particular, purification or production of large quantities of secretory IgA (SIgA) for potential mucosal application has not been achieved. In this work, we sought to investigate whether polymeric IgA (pIgA) recovered from human plasma is able to associate with secretory component (SC) to generate SIgA-like molecules. We found that similar to 15% of plasma pIgA carried J chain and displayed selective SC binding capacity either in a mixture with monomeric IgA (mIgA) or after purification. The recombinant SC associated covalently in a 1:1 stoichiometry with pIgA and with similar efficacy as colostrum-derived SC. In comparison with pIgA, the association with SC delayed degradation of SIgA by intestinal proteases. Similar results were obtained with plasma-derived IgM. In vitro, plasma-derived IgA and SIgA neutralized Shigella flexneri used as a model pathogen, resulting in a delay of bacteria-induced damage targeted to polarized Caco-2 cell monolayers. The sum of these novel data demonstrates that association of plasma-derived IgA or IgM with recombinant/colostrum-derived SC is feasible and yields SIgA- and SIgM-like molecules with similar biochemical and functional characteristics as mucosa-derived immunoglobulins.	[Longet, Stephanie; Miled, Sarah; Corthesy, Blaise] CHU Vaudois, Div Immunol & Allergy, R&D Lab, CH-1011 Lausanne, Switzerland; [Loetscher, Marius; Miescher, Sylvia M.; Zuercher, Adrian W.; Corthesy, Blaise] CSL Behring AG, CH-3000 Bern 22, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); CSL	Corthesy, B (corresponding author), CHU Vaudois, Div Immunol & Allergy, R&D Lab, Rue Bugnon, CH-1011 Lausanne, Switzerland.	blaise.corthesy@chuv.ch		Longet, Stephanie/0000-0001-5026-431X	Swiss Science Research Foundation [3100-138422]; CSL Behring PhD scholarship	Swiss Science Research Foundation(Swiss National Science Foundation (SNSF)); CSL Behring PhD scholarship	This work was supported by Grant 3100-138422 from the Swiss Science Research Foundation.; Recipient of a CSL Behring PhD scholarship.	Almogren A, 2007, IMMUNOLOGY, V120, P273, DOI 10.1111/j.1365-2567.2006.02498.x; ARRANZ E, 1992, GUT, V33, P882, DOI 10.1136/gut.33.7.882; Berdoz J, 1999, P NATL ACAD SCI USA, V96, P3029, DOI 10.1073/pnas.96.6.3029; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Brewer JW, 1997, MOL IMMUNOL, V34, P323, DOI 10.1016/S0161-5890(97)00029-1; Carbonare CB, 2005, PEDIAT ALLERG IMM-UK, V16, P574, DOI 10.1111/j.1399-3038.2005.00332.x; Corthesy B, 2005, J INFECT DIS, V192, P1441, DOI 10.1086/444425; Corthesy B, 2002, TRENDS BIOTECHNOL, V20, P65, DOI 10.1016/S0167-7799(01)01874-1; Corthesy B, 2006, J VIROL, V80, P10692, DOI 10.1128/JVI.00927-06; Corthesy Blaise, 2003, Current Pharmaceutical Biotechnology, V4, P51, DOI 10.2174/1389201033378020; Corthesy B, 2010, FUTURE MICROBIOL, V5, P817, DOI 10.2217/FMB.10.39; Cottet S, 2002, J BIOL CHEM, V277, P33978, DOI 10.1074/jbc.M201726200; Cramer M, 2009, VOX SANG, V96, P219, DOI 10.1111/j.1423-0410.2008.01143.x; Crottet P, 1999, BIOCHEM J, V341, P299, DOI 10.1042/0264-6021:3410299; Crottet P, 1998, J IMMUNOL, V161, P5445; Eckmann L, 2011, CURR TOP MICROBIOL, V349, P145, DOI 10.1007/82_2010_103; Favre LI, 2003, J CHROMATOGR B, V786, P143, DOI 10.1016/S1570-0232(02)00723-7; Fernandez MI, 2003, IMMUNITY, V18, P739, DOI 10.1016/S1074-7613(03)00122-5; Fournier B, 2009, INFECT IMMUN, V77, P4121, DOI 10.1128/IAI.00656-09; Gregersen S, 2009, RESP MED, V103, P873, DOI 10.1016/j.rmed.2008.12.015; Hachani A, 2008, MICROBES INFECT, V10, P260, DOI 10.1016/j.micinf.2007.11.011; HENDRICKSON BA, 1995, J EXP MED, V182, P1905, DOI 10.1084/jem.182.6.1905; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Johansen FE, 2000, SCAND J IMMUNOL, V52, P240; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kaetzel CS, 2001, CURR BIOL, V11, pR35, DOI 10.1016/S0960-9822(00)00041-5; Lullau E, 1996, J BIOL CHEM, V271, P16300, DOI 10.1074/jbc.271.27.16300; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Mathias A, 2011, J BIOL CHEM, V286, P17239, DOI 10.1074/jbc.M110.209015; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; Norderhaug IN, 1999, EUR J IMMUNOL, V29, P3401, DOI 10.1002/(SICI)1521-4141(199910)29:10<3401::AID-IMMU3401>3.0.CO;2-G; Oksenhendler E, 2008, CLIN INFECT DIS, V46, P1547, DOI 10.1086/587669; PARR EL, 1995, J IMMUNOL METHODS, V180, P147, DOI 10.1016/0022-1759(94)00310-S; Perrier C, 2006, J BIOL CHEM, V281, P14280, DOI 10.1074/jbc.M512958200; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Quinti I, 2011, J CLIN IMMUNOL, V31, P315, DOI 10.1007/s10875-011-9511-0; Rathman M, 2000, MOL MICROBIOL, V35, P974, DOI 10.1046/j.1365-2958.2000.01770.x; RENEGAR KB, 1991, J IMMUNOL, V146, P1972; RINDISBACHER L, 1995, J BIOL CHEM, V270, P14220, DOI 10.1074/jbc.270.23.14220; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; Stubbe H, 2000, J IMMUNOL, V164, P1952, DOI 10.4049/jimmunol.164.4.1952; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Woof JM, 2011, MUCOSAL IMMUNOL, V4, P590, DOI 10.1038/mi.2011.39; Woof JM, 2005, IMMUNOL REV, V206, P64, DOI 10.1111/j.0105-2896.2005.00290.x	47	35	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4085	4094		10.1074/jbc.M112.410811	http://dx.doi.org/10.1074/jbc.M112.410811			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23250751	Green Published, hybrid			2022-12-28	WOS:000314845000037
J	Tian, XX; Liu, YJ; Liu, Y; Wang, RW; Wagenknecht, T; Liu, Z; Chen, SRW				Tian, Xixi; Liu, Yingjie; Liu, Ying; Wang, Ruiwu; Wagenknecht, Terence; Liu, Zheng; Chen, S. R. Wayne			Ligand-dependent Conformational Changes in the Clamp Region of the Cardiac Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; INDUCED CA2+ RELEASE; 3-DIMENSIONAL STRUCTURE; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; CRYOELECTRON MICROSCOPY; SUDDEN-DEATH; FUNCTIONAL-CHARACTERIZATION; VENTRICULAR-TACHYCARDIA; ELECTRON CRYOMICROSCOPY	Global conformational changes in the three-dimensional structure of the Ca2+ release channel/ryanodine receptor (RyR) occur upon ligand activation. A number of ligands are able to activate the RyR channel, but whether these structurally diverse ligands induce the same or different conformational changes in the channel is largely unknown. Here we constructed a fluorescence resonance energy transfer (FRET)-based probe by inserting a CFP after residue Ser-2367 and a YFP after residue Tyr-2801 in the cardiac RyR (RyR2) to yield a CFP- and YFP-dual labeled RyR2 (RyR2(Ser-2367-CFP/Tyr-2801-YFP)). Both of these insertion sites have previously been mapped to the "clamp" region in the four corners of the square-shaped cytoplasmic assembly of the three-dimensional structure of RyR2. Using this novel FRET probe, we monitored the extent of conformational changes in the clamp region of RyR2(Ser-2367-CFP/Tyr-2801-YFP) induced by various ligands. We also monitored the extent of Ca2+ release induced by the same ligands in HEK293 cells expressing RyR2(Ser-2367-CFP/Tyr-2801-YFP). We detected conformational changes in the clamp region for the ligands caffeine, aminophylline, theophylline, ATP, and ryanodine but not for Ca2+ or 4-chloro-m-cresol, although they all induced Ca2+ release. Interestingly, caffeine is able to induce further conformational changes in the clamp region of the ryanodine-modified channel, suggesting that ryanodine does not lock RyR in a fixed conformation. Our data demonstrate that conformational changes in the clamp region of RyR are ligand-dependent and suggest the existence of multiple ligand dependent RyR activation mechanisms associated with distinct conformational changes.	[Tian, Xixi; Liu, Yingjie; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Tian, Xixi; Liu, Yingjie; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Liu, Ying; Wagenknecht, Terence; Liu, Zheng] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Wagenknecht, Terence] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Liu, Z (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.	liuz@wadsworth.org; swchen@ucalgary.ca		Liu, Zheng/0000-0001-6952-3406	National Institutes of Health [R01HL095541, R01AR040615]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Alberta NWT and Nunavut; Alberta Innovates-Health Solutions Studentship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta NWT and Nunavut; Alberta Innovates-Health Solutions Studentship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL095541 (to Z. L.) and R01AR040615 (to T. W.). This work was also supported by research grants from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Alberta NWT and Nunavut (to S. R. W. C.).; Recipient of an Alberta Innovates-Health Solutions Studentship Award.	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Capes EM, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-18; Chen SRW, 1997, J BIOL CHEM, V272, P24234, DOI 10.1074/jbc.272.39.24234; Du GG, 2001, P NATL ACAD SCI USA, V98, P13625, DOI 10.1073/pnas.241516898; Eisner DA, 2009, CIRC J, V73, P1561, DOI 10.1253/circj.CJ-09-0478; Eisner DA, 2004, CELL CALCIUM, V35, P583, DOI 10.1016/j.ceca.2004.01.012; ELHAYEK R, 1995, J BIOL CHEM, V270, P15634, DOI 10.1074/jbc.270.26.15634; Fessenden JD, 2003, J BIOL CHEM, V278, P28727, DOI 10.1074/jbc.M303821200; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Ikemoto N, 2002, FRONT BIOSCI-LANDMRK, V7, pD671, DOI 10.2741/ikemoto; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Jones PP, 2008, BIOCHEM J, V410, P261, DOI 10.1042/BJ20071257; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu Z, 2005, J BIOL CHEM, V280, P37941, DOI 10.1074/jbc.M505714200; Liu Z, 2004, J MOL BIOL, V338, P533, DOI 10.1016/j.jmb.2004.03.011; Liu Z, 2002, J BIOL CHEM, V277, P46712, DOI 10.1074/jbc.M208124200; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; MacLennan DH, 2011, BBA-MOL CELL RES, V1813, P948, DOI 10.1016/j.bbamcr.2010.11.009; Masumiya H, 2001, J BIOL CHEM, V276, P39727, DOI 10.1074/jbc.M106557200; Masumiya H, 2003, J BIOL CHEM, V278, P3786, DOI 10.1074/jbc.M210962200; Meissner G, 2004, CELL CALCIUM, V35, P621, DOI 10.1016/j.ceca.2004.01.015; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; Meng X, 2009, J MOL BIOL, V387, P320, DOI 10.1016/j.jmb.2009.01.059; OHKUSA T, 1991, J BIOCHEM-TOKYO, V109, P609, DOI 10.1093/oxfordjournals.jbchem.a123428; Orlova EV, 1996, NAT STRUCT BIOL, V3, P547, DOI 10.1038/nsb0696-547; Paolini C, 2004, P NATL ACAD SCI USA, V101, P12748, DOI 10.1073/pnas.0404836101; Paolini C, 2004, J MOL BIOL, V342, P145, DOI 10.1016/j.jmb.2004.07.035; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Serysheva II, 1999, BIOPHYS J, V77, P1936, DOI 10.1016/S0006-3495(99)77035-9; Serysheva II, 2002, P NATL ACAD SCI USA, V99, P10370, DOI 10.1073/pnas.162363499; SERYSHEVA II, 1995, NAT STRUCT BIOL, V2, P18, DOI 10.1038/nsb0195-18; Sharma MR, 2000, J BIOL CHEM, V275, P9485, DOI 10.1074/jbc.275.13.9485; Sharma MR, 2006, BIOPHYS J, V90, P164, DOI 10.1529/biophysj.105.063503; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; Xu L, 1998, ANN NY ACAD SCI, V853, P130; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; Zhang J, 2003, J BIOL CHEM, V278, P14211, DOI 10.1074/jbc.M213164200; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhou Q, 2008, BIOPHYS J, V95, P4289, DOI 10.1529/biophysj.108.137224; ZORZATO F, 1993, MOL PHARMACOL, V44, P1192; Zucchi R, 1997, PHARMACOL REV, V49, P1	53	12	12	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4066	4075		10.1074/jbc.M112.427864	http://dx.doi.org/10.1074/jbc.M112.427864			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258540	Green Published, hybrid			2022-12-28	WOS:000314845000035
J	Suk, HY; Zhou, C; Yang, TTC; Zhu, H; Yu, RYL; Olabisi, O; Yang, XY; Brancho, D; Kim, JY; Scherer, PE; Frank, PG; Lisanti, MP; Calvert, JW; Lefer, DJ; Molkentin, JD; Ghigo, A; Hirsch, E; Jin, JP; Chow, CW				Suk, Hee Yun; Zhou, Chen; Yang, Teddy T. C.; Zhu, Hong; Yu, Raymond Y. L.; Olabisi, Opeyemi; Yang, XiaoYong; Brancho, Deborah; Kim, Ja-Young; Scherer, Philipp E.; Frank, Philippe G.; Lisanti, Michael P.; Calvert, John W.; Lefer, David J.; Molkentin, Jeffery D.; Ghigo, Alessandra; Hirsch, Emilio; Jin, Jianping; Chow, Chi-Wing			Ablation of Calcineurin A beta Reveals Hyperlipidemia and Signaling Cross-talks with Phosphodiesterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE; MULTISITE PHOSPHORYLATION; DEPENDENT PHOSPHORYLATION; ADRENERGIC-RECEPTORS; INSULIN-RESISTANCE; CELL DEVELOPMENT; DEFICIENT MICE; CYCLOSPORINE-A; TRANSCRIPTION; LOCALIZATION	Insulin resistance, hyperlipidemia, and cardiovascular complications are common dysregulations of metabolic syndrome. Transplant patients treated with immunosuppressant drugs such as cyclosporine A (CsA), an inhibitor of calcineurin phosphatase, frequently develop similar metabolic complications. Although calcineurin is known to mediate insulin sensitivity by regulating beta-cell growth and adipokine gene transcription, its role in lipid homeostasis is poorly understood. Here, we examined lipid homeostasis in mice lacking calcineurin A beta (CnA beta(-/-)). We show that mice lacking calcineurin A beta are hyperlipidemic and develop age-dependent insulin resistance. Hyperlipidemia found in CnA beta(-/-) mice is, in part, due to increased lipolysis in adipose tissues, a process mediated by beta-adrenergic G-protein-coupled receptor signaling pathways. CnA beta(-/-) mice also exhibit additional pathophysiological phenotypes caused by the potentiated GPCR signaling pathways. A cell autonomous mechanism with sustained cAMP/PKA activation is found in CnA beta(-/-) mice or upon CsA treatment to inhibit calcineurin. Increased PKA activation and cAMP accumulation in CnA beta(-/-) mice, however, are sensitive to phosphodiesterase inhibitor. Indeed, we show that calcineurin regulates degradation of phosphodiesterase 3B, in addition to phosphodiesterase 4D. These results establish a role for calcineurin in lipid homeostasis. These data also indicate that potentiated cAMP signaling pathway may provide an alternative molecular pathogenesis for the metabolic complications elicited by CsA in transplant patients.	[Suk, Hee Yun; Zhou, Chen; Yang, Teddy T. C.; Zhu, Hong; Yu, Raymond Y. L.; Olabisi, Opeyemi; Yang, XiaoYong; Brancho, Deborah; Chow, Chi-Wing] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Kim, Ja-Young; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Internal Med & Cell Biol, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Frank, Philippe G.; Lisanti, Michael P.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Frank, Philippe G.; Lisanti, Michael P.] Thomas Jefferson Univ, Dept Mol Oncol, Philadelphia, PA 19107 USA; [Calvert, John W.; Lefer, David J.] Emory Univ, Sch Med, Carlyle Fraser Heart Ctr, Dept Surg,Div Cardiothorac Surg, Atlanta, GA 30308 USA; [Molkentin, Jeffery D.] Howard Hughes Med Inst, Childrens Hosp Med Ctr, Mol Cardiovasc Biol Program, Cincinnati, OH 45229 USA; [Ghigo, Alessandra; Hirsch, Emilio] Univ Turin, Ctr Mol Biotechnol, Dept Genet Biol & Biochem, I-10126 Turin, Italy; [Jin, Jianping] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Jefferson University; Jefferson University; Emory University; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University of Turin; University of Texas System; University of Texas Health Science Center Houston	Chow, CW (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	chi-wing.chow@einstein.yu.edu	Frank, Philippe G/A-3463-2011; Jin, Jianping/K-5002-2018; Scherer, Philipp E/K-7819-2012; Lisanti, Michael/B-6131-2018; Olabisi, Opeyemi/AAA-1852-2022; Calvert, John W/F-4497-2014; Hirsch, Emilio/F-4848-2013; Lisanti, Michael P/C-6866-2013	Frank, Philippe G/0000-0003-4857-5279; Jin, Jianping/0000-0003-4175-9104; Scherer, Philipp E/0000-0003-0680-3392; Lisanti, Michael/0000-0003-2034-1382; Olabisi, Opeyemi/0000-0003-0886-7605; Calvert, John W/0000-0001-6858-6042; Hirsch, Emilio/0000-0002-9073-6024; Lefer, David/0000-0003-2293-7278; Molkentin, Jeffery/0000-0002-3558-6529; Ghigo, Alessandra/0000-0002-1193-5296	National Institutes of Health [5T32 GM07491]; Howard Hughes Medical Institute grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491, T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute grant(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grants (to C.-W.C., J.J., D.J.L., M.P.L., J.D.M., and P.E.S.). This work was also supported by a Howard Hughes Medical Institute grant (to J. D. M.).; Trainee sponsored by National Institutes of Health Grant 5T32 GM07491.	Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; BALLANTYNE CM, 1989, JAMA-J AM MED ASSOC, V262, P53, DOI 10.1001/jama.262.1.53; Bernal-Mizrachi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011969; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Degerman E, 2011, CURR OPIN PHARMACOL, V11, P676, DOI 10.1016/j.coph.2011.09.015; Demozay D, 2011, DIABETES, V60, P2892, DOI 10.2337/db11-0341; Dufer M, 2001, MOL PHARMACOL, V60, P873; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Duranski MR, 2006, AM J PHYSIOL-HEART C, V291, pH2980, DOI 10.1152/ajpheart.01173.2005; ELIA M, 1987, METABOLISM, V36, P251, DOI 10.1016/0026-0495(87)90184-3; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; Garg A, 2002, J CLIN ENDOCR METAB, V87, P3019, DOI 10.1210/jc.87.7.3019; Gooch JL, 2004, AM J PATHOL, V165, P1755, DOI 10.1016/S0002-9440(10)63430-X; Goodyer WR, 2012, DEV CELL, V23, P21, DOI 10.1016/j.devcel.2012.05.014; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Guerini D, 1997, BIOCHEM BIOPH RES CO, V235, P271, DOI 10.1006/bbrc.1997.6802; Harndahl L, 2004, J BIOL CHEM, V279, P15214, DOI 10.1074/jbc.M308952200; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Lindh R, 2007, BBA-MOL CELL RES, V1773, P584, DOI 10.1016/j.bbamcr.2007.01.010; Marchetti P, 2000, J ENDOCRINOL INVEST, V23, P482, DOI 10.1007/BF03343761; MARCHMONT RJ, 1980, FEBS LETT, V118, P18, DOI 10.1016/0014-5793(80)81209-9; Miki T, 1996, GENOMICS, V36, P476, DOI 10.1006/geno.1996.0493; Mohapatra DP, 2007, BIOCHEM SOC T, V35, P1064, DOI 10.1042/BST0351064; Montori VM, 2002, DIABETES CARE, V25, P583, DOI 10.2337/diacare.25.3.583; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Nakazawa A, 2001, J HISTOCHEM CYTOCHEM, V49, P187, DOI 10.1177/002215540104900206; Oknianska A, 2007, BIOCHEM BIOPH RES CO, V353, P1080, DOI 10.1016/j.bbrc.2006.12.141; Perino A, 2011, MOL CELL, V42, P84, DOI 10.1016/j.molcel.2011.01.030; Poitout V, 2008, BIOCHEM SOC T, V36, P901, DOI 10.1042/BST0360901; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Pyne NJ, 2003, DIABETOLOGIA, V46, P1179, DOI 10.1007/s00125-003-1176-7; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Robidoux J, 2004, ANNU REV PHARMACOL, V44, P297, DOI 10.1146/annurev.pharmtox.44.101802.121659; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276; Shakur Y, 2001, PROG NUCLEIC ACID RE, V66, P241; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Soleimanpour SA, 2010, J BIOL CHEM, V285, P40050, DOI 10.1074/jbc.M110.154955; Strosberg AD, 1995, OBES RES, V3, pS501, DOI 10.1002/j.1550-8528.1995.tb00219.x; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Tentolouris N, 2006, ANN NY ACAD SCI, V1083, P129, DOI 10.1196/annals.1367.010; Unger RH, 2003, ANNU REV PHYSIOL, V65, P333, DOI 10.1146/annurev.physiol.65.092101.142622; Usuda N, 1996, J HISTOCHEM CYTOCHEM, V44, P13, DOI 10.1177/44.1.8543776; Vaziri ND, 2000, J PHARMACOL EXP THER, V294, P778; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Yang TTC, 2008, MOL CELL BIOL, V28, P3489, DOI 10.1128/MCB.01847-07; Yang TTC, 2006, MOL CELL BIOL, V26, P7372, DOI 10.1128/MCB.00580-06; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zhu H, 2010, MOL CELL BIOL, V30, P4379, DOI 10.1128/MCB.01193-09; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	65	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3477	3488		10.1074/jbc.M112.419150	http://dx.doi.org/10.1074/jbc.M112.419150			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23258544	Green Published, hybrid			2022-12-28	WOS:000314397900053
J	Sayed, D; He, MZ; Yang, Z; Lin, L; Abdellatif, M				Sayed, Danish; He, Minzhen; Yang, Zhi; Lin, Lin; Abdellatif, Maha			Transcriptional Regulation Patterns Revealed by High Resolution Chromatin Immunoprecipitation during Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; GENE-EXPRESSION; MESSENGER-RNAS; HEART-DISEASE; MICRORNAS; PROMOTERS; GENOME; ACTIVATION; INITIATION; MYOCYTES	Cardiac hypertrophy is characterized by a generalized increase in gene expression that is commensurate with the increase in myocyte size and mass, on which is superimposed more robust changes in the expression of specialized genes. Both transcriptional and posttranscriptional mechanisms play fundamental roles in these processes; however, genome-wide characterization of the transcriptional changes has not been investigated. Our goal was to identify the extent and modes, RNA polymerase II (pol II) pausing versus recruitment, of transcriptional regulation underlying cardiac hypertrophy. We used anti-pol II and anti-histone H3K9-acetyl (H3K9ac) chromatin immunoprecipitation-deep sequencing to determine the extent of pol II recruitment and pausing, and the underlying epigenetic modifications, respectively, during cardiac growth. The data uniquely reveal two mutually exclusive modes of transcriptional regulation. One involves an incremental increase (30-50%) in the elongational activity of preassembled, promoter-paused, pol II, and encompasses similar to 25% of expressed genes that are essential/housekeeping genes (e. g. RNA synthesis and splicing). Another involves a more robust activation via de novo pol II recruitment, encompassing similar to 5% of specialized genes (e. g. contractile and extracellular matrix). Moreover, the latter subset has relatively shorter 3'-UTRs with fewer predicted targeting miRNA, whereas most miRNA targets fall in the former category, underscoring the significance of posttranscriptional regulation by miRNA. The results, for the first time, demonstrate that promoter-paused pol II plays a role in incrementally increasing housekeeping genes, proportionate to the increase in heart size. Additionally, the data distinguish between the roles of posttranscriptional versus transcriptional regulation of specific genes.	[Sayed, Danish; He, Minzhen; Yang, Zhi; Abdellatif, Maha] Univ Med & Dent New Jersey, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA; [Lin, Lin] Childrens Hosp, Boston, MA 02115 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard University; Boston Children's Hospital	Abdellatif, M (corresponding author), Univ Med & Dent New Jersey, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA.	abdellma@umdnj.edu			National Institutes of Health [HL057970, HL104115]; American Heart Association [12SDG8820011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119726, R29HL057970, R01HL057970, R01HL104115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL057970 and HL104115 (to M. A.). This work was also supported by American Heart Association Scientist Development Grant 12SDG8820011 (to D. S.).	Abdellatif M, 1998, MOL CELL BIOL, V18, P6729, DOI 10.1128/MCB.18.11.6729; Abdellatif M, 2012, CIRC RES, V110, P638, DOI 10.1161/CIRCRESAHA.111.247437; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; CAREY RA, 1980, J MOL CELL CARDIOL, V12, P929, DOI 10.1016/0022-2828(80)90060-7; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; CUTILLETTA AF, 1978, J MOL CELL CARDIOL, V10, P677, DOI 10.1016/0022-2828(78)90403-0; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; FELDMAN AM, 1993, CIRC RES, V73, P184, DOI 10.1161/01.RES.73.1.184; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; KAMALA J, 1986, BIOCHEM INT, V13, P271; Kania G, 2009, TRENDS CARDIOVAS MED, V19, P247, DOI 10.1016/j.tcm.2010.02.005; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kong SW, 2005, PHYSIOL GENOMICS, V21, P34, DOI 10.1152/physiolgenomics.00226.2004; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lis JT, 2000, GENE DEV, V14, P792; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Paradis P, 1996, J BIOL CHEM, V271, P10827, DOI 10.1074/jbc.271.18.10827; Rajan S, 2006, PHYSIOL GENOMICS, V27, P309, DOI 10.1152/physiolgenomics.00072.2006; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Sano M, 2004, CIRC RES, V95, P867, DOI 10.1161/01.RES.0000146675.88354.04; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; SCHNEIDER MD, 1992, BASIC RES CARDIOL, V87, P33; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; SCHWARTZ K, 1986, CIRC RES, V59, P551, DOI 10.1161/01.RES.59.5.551; SIMPSON PC, 1989, J MOL CELL CARDIOL, V21, P79, DOI 10.1016/0022-2828(89)90774-8; Strom CC, 2005, FEBS J, V272, P2684, DOI 10.1111/j.1742-4658.2005.04684.x; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	39	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2546	2558		10.1074/jbc.M112.429449	http://dx.doi.org/10.1074/jbc.M112.429449			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229551	Green Published, hybrid			2022-12-28	WOS:000314211500040
J	Ravilious, GE; Westfall, CS; Jez, JM				Ravilious, Geoffrey E.; Westfall, Corey S.; Jez, Joseph M.			Redox-linked Gating of Nucleotide Binding by the N-terminal Domain of Adenosine 5 '-Phosphosulfate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-INHIBITION; ADENOSINE-5'-PHOSPHOSULFATE KINASE; PENICILLIUM-CHRYSOGENUM; ESCHERICHIA-COLI; APS-KINASE; ARABIDOPSIS-THALIANA; SULFUR ASSIMILATION; ATP SULFURYLASE; SULFATE ASSIMILATION; CRYSTAL-STRUCTURE	Adenosine 5'-phosphosulfate kinase (APSK) catalyzes the phosphorylation of adenosine 5'-phosphosulfate (APS) to 3'-phosphoadenosine-5'-phosphosulfate (PAPS). Crystallographic studies of APSK from Arabidopsis thaliana revealed the presence of a regulatory intersubunit disulfide bond (Cys(86)Cys(119)). The reduced enzyme displayed improved catalytic efficiency and decreased effectiveness of substrate inhibition by APS compared with the oxidized form. Here we examine the effect of disulfide formation and the role of the N-terminal domain on nucleotide binding using isothermal titration calorimetry (ITC) and steady-state kinetics. Formation of the disulfide bond in A. thaliana APSK (AtAPSK) inverts the binding affinities at the ATP/ADP and APS/PAPS sites from those observed in the reduced enzyme, consistent with initial binding of APS as inhibitory, and suggests a role for the N-terminal domain in guiding nucleotide binding order. To test this, an N-terminal truncation variant (AtAPSK Delta 96) was generated. The resulting protein was completely insensitive to substrate inhibition by APS. ITC analysis of AtAPSK Delta 96 showed decreased affinity for APS binding, although the N-terminal domain does not directly interact with this ligand. Moreover, AtAPSK Delta 96 displayed reduced affinity for ADP, which corresponds to a loss of substrate inhibition by formation of an E.ADP.APS dead end complex. Examination of the AtAPSK crystal structure suggested Arg(93) as important for positioning of the N-terminal domain. ITC and kinetic analysis of the R93A mutant also showed a complete loss of substrate inhibition and altered nucleotide binding affinities, which mimics the effect of the N-terminal deletion. These results show how thiol-linked changes in AtAPSK alter the energetics of binding equilibria to control its activity.	[Ravilious, Geoffrey E.; Westfall, Corey S.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu			National Science Foundation [MCB-0904215]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0904215.	Amano Y, 2007, P NATL ACAD SCI USA, V104, P18333, DOI 10.1073/pnas.0706403104; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Gay SC, 2009, ACTA CRYSTALLOGR D, V65, P1021, DOI 10.1107/S0907444909026547; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Klein M, 2004, J EXP BOT, V55, P1809, DOI 10.1093/jxb/erh183; Lansdon EB, 2002, BIOCHEMISTRY-US, V41, P13672, DOI 10.1021/bi026556b; LIANG P, 1991, PROTEINS, V9, P28, DOI 10.1002/prot.340090105; Lillig CH, 2001, ARCH BIOCHEM BIOPHYS, V392, P303, DOI 10.1006/abbi.2001.2453; MacRae IJ, 2000, BIOCHEMISTRY-US, V39, P1613, DOI 10.1021/bi9924157; MacRae IJ, 1999, ARCH BIOCHEM BIOPHYS, V361, P277, DOI 10.1006/abbi.1998.0993; Marzluf GA, 1997, ANNU REV MICROBIOL, V51, P73, DOI 10.1146/annurev.micro.51.1.73; Mugford SG, 2010, FEBS LETT, V584, P119, DOI 10.1016/j.febslet.2009.11.014; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538; Patron NJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-39; Phartiyal P, 2006, ARCH BIOCHEM BIOPHYS, V450, P20, DOI 10.1016/j.abb.2006.03.033; Ravilious GE, 2012, NAT PROD REP, V29, P1138, DOI 10.1039/c2np20009k; Ravilious GE, 2012, J BIOL CHEM, V287, P30385, DOI 10.1074/jbc.M112.387001; Ravilious GE, 2012, P NATL ACAD SCI USA, V109, P309, DOI 10.1073/pnas.1115772108; RENOSTO F, 1991, ARCH BIOCHEM BIOPHYS, V284, P30, DOI 10.1016/0003-9861(91)90258-K; RENOSTO F, 1985, J BIOL CHEM, V260, P1903; Satishchandran C, 2000, ARCH BIOCHEM BIOPHYS, V378, P210, DOI 10.1006/abbi.2000.1841; Sekowska A, 2000, J MOL MICROB BIOTECH, V2, P145; Sekulic N, 2007, J BIOL CHEM, V282, P22112, DOI 10.1074/jbc.M701713200; Sekulic N, 2007, J MOL BIOL, V367, P488, DOI 10.1016/j.jmb.2007.01.025; Sinev MA, 1996, FEBS LETT, V397, P273, DOI 10.1016/S0014-5793(96)01195-7; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Yatusevich R, 2010, PLANT J, V62, P1, DOI 10.1111/j.1365-313X.2009.04118.x; Yi H, 2010, AMINO ACIDS, V39, P963, DOI 10.1007/s00726-010-0572-9; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112; Yu ZH, 2007, J MOL BIOL, V365, P732, DOI 10.1016/j.jmb.2006.10.035; Zhang M, 2012, J AM CHEM SOC, V134, P16979, DOI 10.1021/ja3078522	33	14	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6107	6115		10.1074/jbc.M112.439414	http://dx.doi.org/10.1074/jbc.M112.439414			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322773	Green Published, hybrid			2022-12-28	WOS:000315820700008
J	Webster, SJ; Waite, SL; Cookson, VJ; Warren, A; Khan, R; Gandhi, SV; Europe-Finner, GN; Chapman, NR				Webster, Steve J.; Waite, Sarah L.; Cookson, Victoria J.; Warren, Averil; Khan, Raheela; Gandhi, Saurabh V.; Europe-Finner, G. Nicholas; Chapman, Neil R.			Regulation of GTP-binding Protein (G alpha(s)) Expression in Human Myometrial Cells A ROLE FOR TUMOR NECROSIS FACTOR IN MODULATING G alpha(s) PROMOTER ACETYLATION BY TRANSCRIPTIONAL COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; CYCLOOXYGENASE TYPE-2 EXPRESSION; HUMAN FETAL MEMBRANES; G-ALPHA-S; HUMAN AMNION; DOWN-REGULATION; OXYTOCIN RECEPTOR; UP-REGULATION; RELA SUBUNIT; ACTIVATION	The onset of parturition is associated with a number of proinflammatory mediators that are themselves regulated by the nuclear factor kappa B (NF-kappa B) family of transcription factors. In this context, we previously reported that the RelA NF-kappa B subunit represses transcription and mRNA expression of the proquiescent G alpha(s) gene in human myometrial cells following stimulation with the proinflammatory cytokine TNF. In the present study, we initially defined the functional consequence of this on myometrial contractility. Here we show that, contrary to our initial expectations, TNF did not induce myometrial contractility but did inhibit the relaxation produced by the histone deacetylase inhibitor trichostatin A, an effect that in turn was abolished by the NF-kappa B inhibitor N-4-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine. This result suggested a role for TNF in regulating G alpha(s) expression via activating NF-kappa B and modifying histone acetylation associated with the promoter region of the gene. In this context, we show that the -837 to -618 region of the endogenous G alpha(s) promoter is occupied by cAMP-response element-binding protein (CREB), Egr-1, and Sp1 transcription factors and that CREB-binding protein (CBP) transcriptional complexes form within this region where they induce histone acetylation, resulting in increased G alpha(s) expression. TNF, acting via NF-kappa B, did not change the levels of CREB, Sp1, or Egr-1 binding to the G alpha(s) promoter, but it induced a significant reduction in the level of CBP. This was associated with increased levels of histone deacetylase-1 and surprisingly an increase in H4K8 acetylation. The latter is discussed herein.	[Webster, Steve J.; Waite, Sarah L.; Cookson, Victoria J.; Chapman, Neil R.] Univ Sheffield, Acad Unit Reprod & Dev Med, Dept Human Metab, Sheffield S10 2SF, S Yorkshire, England; [Warren, Averil; Khan, Raheela] Univ Nottingham, Sch Grad Entry Med & Hlth, Royal Derby Hosp, Derby DE22 3DT, England; [Gandhi, Saurabh V.] Sheffield Teaching Hosp NHS Fdn Trust, Dept Obstet & Gynaecol, Sheffield S10 2SF, S Yorkshire, England; [Europe-Finner, G. Nicholas] Newcastle Univ, Inst Cellular Med, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Sheffield; University of Nottingham; University of Sheffield; Newcastle University - UK	Chapman, NR (corresponding author), Univ Sheffield, Acad Unit Reprod & Dev Med, Dept Human Metab, Level 4,Jessop Wing, Sheffield S10 2SF, S Yorkshire, England.	n.r.chapman@sheffield.ac.uk	europe-finner, Nicholas/F-2569-2010	Chapman, Neil/0000-0002-4853-2909; Khan, Raheela N/0000-0002-6034-269X; Webster, Steve/0000-0002-0864-1182	United Kingdom Medical Research Council [G0701322]; Jessop Wing Small Grants Scheme [OGN/06/03]; MRC [G0701322] Funding Source: UKRI; Medical Research Council [G0701322] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Jessop Wing Small Grants Scheme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by United Kingdom Medical Research Council Grant G0701322 (to N. R. C.) and Jessop Wing Small Grants Scheme Grant OGN/06/03 (to N. R. C.).	Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Bailey J, 2000, MOL HUM REPROD, V6, P648, DOI 10.1093/molehr/6.7.648; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Belt AR, 1999, AM J OBSTET GYNECOL, V181, P359, DOI 10.1016/S0002-9378(99)70562-4; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chapman NR, 2005, ENDOCRINOLOGY, V146, P4994, DOI 10.1210/en.2005-0533; Chapman NR, 2004, J CLIN ENDOCR METAB, V89, P5683, DOI 10.1210/jc.2004-0873; Chapman NR, 2000, J BIOL CHEM, V275, P4719, DOI 10.1074/jbc.275.7.4719; Chapman NR, 2002, BIOCHEM J, V366, P459, DOI 10.1042/BJ20020444; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cookson VJ, 2010, HISTOL HISTOPATHOL, V25, P945, DOI 10.14670/HH-25.945; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Elliott CL, 2001, MOL HUM REPROD, V7, P787, DOI 10.1093/molehr/7.8.787; EUROPEFINNER GN, 1993, ENDOCRINOLOGY, V132, P2484, DOI 10.1210/en.132.6.2484; EUROPEFINNER GN, 1994, J CLIN ENDOCR METAB, V79, P1835, DOI 10.1210/jc.79.6.1835; Golightly E, 2011, MOL CELL ENDOCRINOL, V335, P52, DOI 10.1016/j.mce.2010.08.005; Goodman RH, 2000, GENE DEV, V14, P1553; Government Statistical Service for the Department of Health, 2005, GOV STAT SERV DEP HL; Hiroi M, 2003, J BIOL CHEM, V278, P651, DOI 10.1074/jbc.M204544200; Horion J, 2007, J BIOL CHEM, V282, P15383, DOI 10.1074/jbc.M609166200; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Karolczak-Bayatti M, 2011, J BIOL CHEM, V286, P34346, DOI 10.1074/jbc.M111.278549; Karolczak-Bayatti M, 2011, J CELL MOL MED, V15, P94, DOI 10.1111/j.1582-4934.2009.00927.x; KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lappas M, 2004, J CLIN ENDOCR METAB, V89, P2365, DOI 10.1210/jc.2003-031385; Lappas M, 2004, PROSTAG LEUKOTR ESS, V70, P87, DOI 10.1016/j.plefa.2003.04.001; Lappas M, 2003, J CLIN ENDOCR METAB, V88, P1723, DOI 10.1210/jc.2002-021677; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lee Y, 2003, MOL HUM REPROD, V9, P213, DOI 10.1093/molehr/gag026; Lindstrom TM, 2008, MOL PHARMACOL, V74, P109, DOI 10.1124/mol.107.042838; Lindstrom TM, 2005, J CLIN ENDOCR METAB, V90, P3534, DOI 10.1210/jc.2005-0055; Long AA, 2005, J SOC GYNECOL INVEST, V12, P92, DOI 10.1016/j.jsgi.2004.10.012; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lumley J, 2003, BJOG-INT J OBSTET GY, V110, P3, DOI 10.1016/S1470-0328(03)00011-9; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mohan AR, 2007, ENDOCRINOLOGY, V148, P1850, DOI 10.1210/en.2006-1289; Moynihan A. T., 2008, AM J OBSTET GYNECOL, V199; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Pearson T, 2009, AM J PHYSIOL-ENDOC M, V297, pE647, DOI 10.1152/ajpendo.00227.2009; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; PHANEUF S, 1993, J ENDOCRINOL, V136, P497, DOI 10.1677/joe.0.1360497; Phillips RJ, 2005, J CLIN ENDOCR METAB, V90, P3479, DOI 10.1210/jc.2004-1962; Phillips RJ, 2002, J CLIN ENDOCR METAB, V87, P5675, DOI 10.1210/jc.2002-020640; Plaisance V, 2005, J BIOL CHEM, V280, P401, DOI 10.1074/jbc.M411825200; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Rodriguez MS, 1996, ONCOGENE, V12, P2425; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Silverman ES, 1998, BIOCHEM J, V336, P183, DOI 10.1042/bj3360183; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Soloff MS, 2006, MOL HUM REPROD, V12, P619, DOI 10.1093/molehr/gal067; Soloff MS, 2004, ENDOCRINOLOGY, V145, P1248, DOI 10.1210/en.2003-1310; Stjernholm-Vladic Ylva, 2004, Reprod Biol Endocrinol, V2, P74, DOI 10.1186/1477-7827-2-74; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Terzidou V, 2006, J CLIN ENDOCR METAB, V91, P2317, DOI 10.1210/jc.2005-2649; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; van Loo KMJ, 2012, J BIOL CHEM, V287, P15489, DOI 10.1074/jbc.M111.310763; Wadgaonkar R, 1999, J BIOL CHEM, V274, P1879, DOI 10.1074/jbc.274.4.1879; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Yan X, 2002, PLACENTA, V23, P288, DOI 10.1053/plac.2002.0789; Yan XJ, 2002, BIOL REPROD, V66, P1667, DOI 10.1095/biolreprod66.6.1667	70	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6704	6716		10.1074/jbc.M112.440602	http://dx.doi.org/10.1074/jbc.M112.440602			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23297421	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000315820700068
J	Ethayathulla, AS; Nguyen, HT; Viadiu, H				Ethayathulla, Abdul S.; Nguyen, H. Thien; Viadiu, Hector			Crystal Structures of the DNA-binding Domain Tetramer of the p53 Tumor Suppressor Family Member p73 Bound to Different Full-site Response Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; P63; ACETYLATION; APOPTOSIS; PROLIFERATION; VISUALIZATION; RECOGNITION; SYSTEM; MUTANT; MICE	How cells choose between developmental pathways remains a fundamental biological question. In the case of the p53 protein family, its three transcription factors (p73, p63, and p53) each trigger a gene expression pattern that leads to specific cellular pathways. At the same time, these transcription factors recognize the same response element (RE) consensus sequences, and their transactivation of target genes overlaps. We aimed to understand target gene selectivity at the molecular level by determining the crystal structures of the p73 DNA-binding domain (DBD) in complex with full-site REs that vary in sequence. We report two structures of the p73 DBD bound as a tetramer to 20-bp full-site REs based on two distinct quartersites: GAACA and GAACC. Our study confirms that the DNA-binding residues are conserved within the p53 family, whereas the dimerization and tetramerization interfaces diverge. Moreover, a conserved lysine residue in loop L1 of the DBD senses the presence of guanines in positions 2 and 3 of the quarter-site RE, whereas a conserved arginine in loop 3 adapts to changes in position 5. Sequence variations in the RE elicit a p73 conformational response that might explain target gene specificity.	[Ethayathulla, Abdul S.; Nguyen, H. Thien; Viadiu, Hector] Univ Calif San Diego, Dept Chem & Biochem, Lab Struct Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Viadiu, H (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Lab Struct Biochem, 9500 Gilman Dr,MC 0378, La Jolla, CA 92093 USA.	viadiu@ucsd.edu	Viadiu, Hector/E-7785-2013		United States Department of Energy; National Institutes of Health [P41RR001209]; Basic Energy Sciences, Office of Science, United States Department of Energy [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Energy Sciences, Office of Science, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Preliminary crystals were diffracted at beamline BL7-1 of the Stanford Synchrotron Radiation Lightsource (supported by the United States Department of Energy and National Institutes of Health Grant P41RR001209), and diffraction data were collected at beamline 8.2.2 of the Advanced Light Source at the Lawrence Berkeley National Laboratory (supported by Grant DE-AC02-05CH11231 from the Director, Basic Energy Sciences, Office of Science, United States Department of Energy).	Arbely E, 2011, P NATL ACAD SCI USA, V108, P8251, DOI 10.1073/pnas.1105028108; Arrowsmith CH, 1999, CELL DEATH DIFFER, V6, P1169, DOI 10.1038/sj.cdd.4400619; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen C, 2012, J BIOL CHEM, V287, P7477, DOI 10.1074/jbc.M111.315820; Chen C, 2011, P NATL ACAD SCI USA, V108, P6456, DOI 10.1073/pnas.1013657108; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Emamzadah S, 2011, MOL CANCER RES, V9, P1493, DOI 10.1158/1541-7786.MCR-11-0351; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ethayathulla AS, 2012, P NATL ACAD SCI USA, V109, P6066, DOI 10.1073/pnas.1115463109; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Kommagani R, 2010, CELL DEATH DIFFER, V17, P398, DOI 10.1038/cdd.2009.135; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levrero M, 2000, J CELL SCI, V113, P1661; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Malecka KA, 2009, ONCOGENE, V28, P325, DOI 10.1038/onc.2008.400; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Petty TJ, 2011, EMBO J, V30, P2167, DOI 10.1038/emboj.2011.127; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0; Zupnick A, 2006, J BIOL CHEM, V281, P20464, DOI 10.1074/jbc.M603387200	44	14	15	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4744	4754		10.1074/jbc.M112.408039	http://dx.doi.org/10.1074/jbc.M112.408039			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23243311	Green Published, hybrid			2022-12-28	WOS:000315340400023
J	Bajpai, P; Sangar, MC; Singh, S; Tang, WG; Bansal, S; Chowdhury, G; Cheng, Q; Fang, JK; Martin, MV; Guengerich, FP; Avadhani, NG				Bajpai, Prachi; Sangar, Michelle C.; Singh, Shilpee; Tang, Weigang; Bansal, Seema; Chowdhury, Goutam; Cheng, Qian; Fang, Ji-Kang; Martin, Martha V.; Guengerich, F. Peter; Avadhani, Narayan G.			Metabolism of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine by Mitochondrion-targeted Cytochrome P450 2D6 IMPLICATIONS IN PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-NAPHTHOFLAVONE; GENE POLYMORPHISM; ELECTRON-TRANSFER; LIVER MICROSOMES; N-DEMETHYLATION; MESSENGER-RNA; MPTP TOXICITY; L-DEPRENYL; BRAIN; CYP2D6	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxic side product formed in the chemical synthesis of desmethylprodine opioid analgesic, which induces Parkinson disease. Monoamine oxidase B, present in the mitochondrial outer membrane of glial cells, catalyzes the oxidation of MPTP to the toxic 1-methyl-4-phenylpyridinium ion (MPP+), which then targets the dopaminergic neurons causing neuronal death. Here, we demonstrate that mitochondrion-targeted human cytochrome P450 2D6 (CYP2D6), supported by mitochondrial adrenodoxin and adrenodoxin reductase, can efficiently catalyze the metabolism of MPTP to MPP+, as shown with purified enzymes and also in cells expressing mitochondrial CYP2D6. Neuro-2A cells stably expressing predominantly mitochondrion-targeted CYP2D6 were more sensitive to MPTP-mediated mitochondrial respiratory dysfunction and complex I inhibition than cells expressing predominantly endoplasmic reticulum-targeted CYP2D6. Mitochondrial CYP2D6 expressing Neuro-2A cells produced higher levels of reactive oxygen species and showed abnormal mitochondrial structures. MPTP treatment also induced mitochondrial translocation of an autophagic marker, Parkin, and a mitochondrial fission marker, Drp1, in differentiated neurons expressing mitochondrial CYP2D6. MPTP-mediated toxicity in primary dopaminergic neurons was attenuated by CYP2D6 inhibitor, quinidine, and also partly by monoamine oxidase B inhibitors deprenyl and pargyline. These studies show for the first time that dopaminergic neurons expressing mitochondrial CYP2D6 are fully capable of activating the pro-neurotoxin MPTP and inducing neuronal damage, which is effectively prevented by the CYP2D6 inhibitor quinidine.	[Fang, Ji-Kang; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Fang, Ji-Kang; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Marie Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Chowdhury, Goutam; Cheng, Qian; Martin, Martha V.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Chowdhury, Goutam; Cheng, Qian; Martin, Martha V.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	University of Pennsylvania; University of Pennsylvania; Vanderbilt University; Vanderbilt University	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	Narayan@vet.upenn.edu		Singh, Shilpee/0000-0003-4404-6089	National Institutes of Health [R01 GM034883, R37 CA090426, T32 GM007170]; American Recovery Act supplement; Harriet Ellison Woodward endowment; NATIONAL CANCER INSTITUTE [P30CA016520, R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883, T32GM007170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery Act supplement; Harriet Ellison Woodward endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM034883, Grant R37 CA090426 (to F. P. G.), and Training Grant T32 GM007170 (to M. C. S.). This work was also supported by an American Recovery Act supplement and by a Harriet Ellison Woodward endowment (to N. G. A.).	Anandatheerthavarada HK, 1999, J BIOL CHEM, V274, P6617, DOI 10.1074/jbc.274.10.6617; Anandatheerthavarada HK, 1998, BIOCHEMISTRY-US, V37, P1150, DOI 10.1021/bi972046j; Anandatheerthavarada HK, 2001, EMBO J, V20, P2394, DOI 10.1093/emboj/20.10.2394; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Bach MV, 2000, XENOBIOTICA, V30, P297, DOI 10.1080/004982500237686; Bansal S, 2010, J BIOL CHEM, V285, P24609, DOI 10.1074/jbc.M110.121822; Bezard E, 1999, EXP NEUROL, V155, P268, DOI 10.1006/exnr.1998.6995; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; BLOEM BR, 1990, J NEUROL SCI, V97, P273, DOI 10.1016/0022-510X(90)90225-C; Boopathi E, 2000, J BIOL CHEM, V275, P34415, DOI 10.1074/jbc.M004431200; CHIBA K, 1984, BIOCHEM BIOPH RES CO, V120, P574, DOI 10.1016/0006-291X(84)91293-2; CHIBA K, 1985, DRUG METAB DISPOS, V13, P342; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Coleman T, 1996, J PHARMACOL EXP THER, V277, P685; DIMONTE D, 1986, BIOCHEM BIOPH RES CO, V137, P310, DOI 10.1016/0006-291X(86)91211-8; Dong HB, 2009, MOL PHARMACOL, V75, P555, DOI 10.1124/mol.108.051888; Dragoni S, 2003, XENOBIOTICA, V33, P181, DOI 10.1080/0049825021000048827; Dutheil F, 2009, DRUG METAB DISPOS, V37, P1528, DOI 10.1124/dmd.109.027011; Dyck LE, 2001, DRUG METAB DISPOS, V29, P1156; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gilham DE, 1997, XENOBIOTICA, V27, P111, DOI 10.1080/004982597240802; Golab-Janowska M, 2007, NEUROL NEUROCHIR POL, V41, P113; GRACE JM, 1994, CHEM RES TOXICOL, V7, P286, DOI 10.1021/tx00039a003; Guengerich FP, 1982, PRINCIPLES METHODS T, P609; Halling J, 2008, PHARMACOGENET GENOM, V18, P209, DOI 10.1097/FPC.0b013e3282f5106e; Hanna IH, 2001, ARCH BIOCHEM BIOPHYS, V393, P255, DOI 10.1006/abbi.2001.2510; HASEGAWA E, 1990, BIOCHEM BIOPH RES CO, V170, P1049, DOI 10.1016/0006-291X(90)90498-C; Herraiz T, 2006, TOXICOL APPL PHARM, V216, P387, DOI 10.1016/j.taap.2006.06.003; KALLIO J, 1991, ACTA NEUROL SCAND, V83, P194, DOI 10.1111/j.1600-0404.1991.tb04676.x; Kohutnicka M, 1998, IMMUNOPHARMACOLOGY, V39, P167, DOI 10.1016/S0162-3109(98)00022-8; KOPIN IJ, 1988, ANNU REV NEUROSCI, V11, P81, DOI 10.1146/annurev.neuro.11.1.81; KRAJL M, 1965, BIOCHEM PHARMACOL, V14, P1684, DOI 10.1016/0006-2952(65)90025-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mann A, 2012, NEUROBIOL AGING, V33, P2160, DOI 10.1016/j.neurobiolaging.2011.08.014; Meredith GE, 2008, ACTA NEUROPATHOL, V115, P385, DOI 10.1007/s00401-008-0350-x; MIZUNO Y, 1988, NEUROSCI LETT, V91, P349, DOI 10.1016/0304-3940(88)90705-7; Modi S, 1997, BIOCHEMISTRY-US, V36, P4461, DOI 10.1021/bi962633p; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morgenstern J P, 1991, Methods Mol Biol, V7, P181, DOI 10.1385/0-89603-178-0:181; Murphy AN, 2009, EMBO MOL MED, V1, P81, DOI 10.1002/emmm.200900020; Narimatsu S, 1996, CHEM RES TOXICOL, V9, P93, DOI 10.1021/tx9500540; OMURA T, 1964, J BIOL CHEM, V239, P2370; PAI KS, 1991, BRAIN RES, V555, P239, DOI 10.1016/0006-8993(91)90347-X; Persad AS, 2003, NEUROEPIDEMIOLOGY, V22, P357, DOI 10.1159/000072926; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; RAMSAY RR, 1986, LIFE SCI, V39, P581, DOI 10.1016/0024-3205(86)90037-8; RAMSAY RR, 1987, ARCH BIOCHEM BIOPHYS, V259, P645, DOI 10.1016/0003-9861(87)90531-5; Rittenbach K A, 2007, Drug Metab Lett, V1, P97, DOI 10.2174/187231207780363589; Robertson DC, 2004, J NEUROCHEM, V89, P1126, DOI 10.1111/j.1471-4159.2004.02378.x; Robin MA, 2001, J BIOL CHEM, V276, P24680, DOI 10.1074/jbc.M100363200; ROSSETTI ZL, 1988, BIOCHEM PHARMACOL, V37, P4573, DOI 10.1016/0006-2952(88)90674-0; Sangar MC, 2010, EXPERT OPIN DRUG MET, V6, P1231, DOI 10.1517/17425255.2010.503955; Sangar MC, 2010, MOL GENET METAB, V99, P90, DOI 10.1016/j.ymgme.2009.08.009; Sangar MC, 2009, FEBS J, V276, P3440, DOI 10.1111/j.1742-4658.2009.07067.x; Sharma U, 1996, DRUG METAB DISPOS, V24, P669; Siegle I, 2001, PHARMACOGENETICS, V11, P237, DOI 10.1097/00008571-200104000-00007; SMITH CAD, 1992, LANCET, V339, P1375, DOI 10.1016/0140-6736(92)91196-F; Smith RAJ, 2011, ANTIOXID REDOX SIGN, V15, P3021, DOI 10.1089/ars.2011.3969; SONSALLA PK, 1986, EUR J PHARMACOL, V129, P339, DOI 10.1016/0014-2999(86)90444-9; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Valoti M, 2000, EUR J PHARMACOL, V391, P199, DOI 10.1016/S0014-2999(00)00078-9; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578	68	52	54	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4436	4451		10.1074/jbc.M112.402123	http://dx.doi.org/10.1074/jbc.M112.402123			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258538	hybrid, Green Published			2022-12-28	WOS:000314845000070
J	Deng, H; Maitra, U; Morris, M; Li, LW				Deng, Hui; Maitra, Urmila; Morris, Matt; Li, Liwu			Molecular Mechanism Responsible for the Priming of Macrophage Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED KINASE; KAPPA-B ACTIVATION; HIGH-FAT DIET; ENDOTOXIN TOLERANCE; MAPK PHOSPHATASE-1; IRAK-M; LIPOPOLYSACCHARIDE; INFLAMMATION; INTERLEUKIN-1; INHIBITION	Host macrophages can be preprogrammed into opposing primed or tolerant states depending upon the nature and quantities of external stimulants. The paradigm of priming and tolerance has significant implications in the pathogenesis and resolution of both acute and chronic inflammatory diseases. However, the responsible mechanisms are not well understood. Here, we report that super low dose bacterial endotoxin lipopolysaccharide (LPS), as low as 5 pg/ml, primes the expression of proinflammatory mediators in macrophages upon a second high dose LPS challenge (100 ng/ml), although 5 pg/ml LPS itself does not trigger noticeable macrophage activation. Mice primed with super low dose LPS (0.5 mu g/kg body weight) in vivo experience significantly elevated mortality following a second hit of high dose LPS as compared with saline-primed control mice. Mechanistically, we demonstrate that LPS primes macrophages by removing transcriptional suppressive RelB through interleukin receptor-associated kinase 1 and Tollip (Toll-interacting protein)-dependent mechanisms. This is in sharp contrast to the well documented RelB stabilization and induction by high dose LPS, potentially through the phosphoinositide 3-kinase (PI3K) pathway. Super low dose and high dose LPS cause opposing modulation of interleukin receptor-associated kinase 1 and PI3K pathways and lead to opposing regulation of RelB. The pathway switching induced by super low versus high dose LPS underscores the importance of competing intracellular circuitry during the establishment of macrophage priming and tolerance.	[Deng, Hui; Maitra, Urmila; Morris, Matt; Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol Sci, Lab Inflammat Biol, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Li, LW (corresponding author), Virginia Tech, Dept Biol, Life Sci 1 Bldg,Washington St, Blacksburg, VA 24061 USA.	lwli@vt.edu		Morris, Matthew/0000-0002-1236-1255; Li, Liwu/0000-0001-8870-5299	National Institutes of Health [RO1 HL115835]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL115835 (to L. L.).	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bosisio D, 2002, BLOOD, V99, P3427, DOI 10.1182/blood.V99.9.3427; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chaurasia B, 2010, MOL CELL BIOL, V30, P4354, DOI 10.1128/MCB.00069-10; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; De Gaudio AR, 2009, CURR DRUG TARGETS, V10, P60, DOI 10.2174/138945009787122879; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; DOFFERHOFF ASM, 1991, SCAND J INFECT DIS, V23, P745, DOI 10.3109/00365549109024303; Ernst M, 2002, J EXP MED, V196, P589, DOI 10.1084/jem.20020873; Gan L, 2010, MOL IMMUNOL, V47, P1278, DOI 10.1016/j.molimm.2009.12.004; GOTO T, 1994, CLIN DIAGN LAB IMMUN, V1, P684, DOI 10.1128/CDLI.1.6.684-688.1994; Gustin JA, 2006, J BIOL CHEM, V281, P16473, DOI 10.1074/jbc.M507373200; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Harada K, 2006, LIVER INT, V26, P935, DOI 10.1111/j.1478-3231.2006.01325.x; HENRICSON BE, 1993, INFECT IMMUN, V61, P2325, DOI 10.1128/IAI.61.6.2325-2333.1993; Hirohashi N, 1996, INFECT IMMUN, V64, P1011, DOI 10.1128/IAI.64.3.1011-1015.1996; Hong T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002122; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lee JY, 2011, P NATL ACAD SCI USA, V108, P14157, DOI 10.1073/pnas.1107747108; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Maitra U, 2011, J IMMUNOL, V186, P4467, DOI 10.4049/jimmunol.1003300; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Medina EA, 2010, J IMMUNOL, V185, P7562, DOI 10.4049/jimmunol.0903790; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Morris M, 2012, ARCH IMMUNOL THER EX, V60, P13, DOI 10.1007/s00005-011-0155-9; Neumann M, 2011, ONCOGENE, V30, P2485, DOI 10.1038/onc.2010.580; Ni MJ, 2012, P NATL ACAD SCI USA, V109, P267, DOI 10.1073/pnas.1111957108; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sanaa N, 2004, J BIOL CHEM, V279, P25189, DOI 10.1074/jbc.M312431200; SCHEIFELE DW, 1985, AM J CLIN PATHOL, V83, P227, DOI 10.1093/ajcp/83.2.227; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Suzuki K, 2004, CIRCULATION, V110, pII219, DOI 10.1161/01.CIR.0000138388.55416.06; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Szeto CC, 2008, CLIN J AM SOC NEPHRO, V3, P431, DOI 10.2215/CJN.03600807; Terragni J, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-6; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; VOGEL SN, 1983, J INTERFERON RES, V3, P153, DOI 10.1089/jir.1983.3.153; Weih F, 1997, J IMMUNOL, V158, P5211; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Xi CX, 2010, J LEUKOCYTE BIOL, V87, P415, DOI 10.1189/jlb.0309125; Xia YY, 1997, AM J PATHOL, V151, P375; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zacharioudaki V, 2009, J IMMUNOL, V182, P6444, DOI 10.4049/jimmunol.0803694; Zahr F, 2011, ANN THORAC SURG, V92, P1420, DOI 10.1016/j.athoracsur.2011.05.085; ZHANG XK, 1993, J EXP MED, V177, P511, DOI 10.1084/jem.177.2.511; ZHANG XK, 1993, J LEUKOCYTE BIOL, V54, P444, DOI 10.1002/jlb.54.5.444; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798	66	84	86	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3897	3906		10.1074/jbc.M112.424390	http://dx.doi.org/10.1074/jbc.M112.424390			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264622	hybrid, Green Published			2022-12-28	WOS:000314845000020
J	Kaur, G; Lieu, KG; Jans, DA				Kaur, Gurpreet; Lieu, Kim G.; Jans, David A.			70-kDa Heat Shock Cognate Protein hsc70 Mediates Calmodulin-dependent Nuclear Import of the Sex-determining Factor SRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC CHAPERONES; BINDING DOMAIN; HMG-BOX; TRANSPORT; TRANSLOCATION; LOCALIZATION; REVERSAL; REQUIRES; PATHWAY; SIGNAL	We recently showed that the developmentally important family of SOX(SRY (sex determining region on the Y chromosome)related high mobility group (HMG) box) proteins require the calcium-binding protein calmodulin (CaM) for optimal nuclear accumulation, with clinical mutations in SRY that specifically impair nuclear accumulation via this pathway resulting in XY sex reversal. However, the mechanism by which CaM facilitates nuclear accumulation is unknown. Here, we show, for the first time, that the 70-kDa heat shock cognate protein hsc70 plays a key role in CaM-dependent nuclear import of SRY. Using a reconstituted nuclear import assay, we show that antibodies to hsc70 significantly reduce nuclear accumulation of wild type SRY and mutant derivatives thereof that retain CaM-dependent nuclear import, with an increased rate of nuclear accumulation upon addition of both CaM and hsc70, in contrast to an SRY mutant derivative with impaired CaM binding. siRNA knockdown of hsc70 in intact cells showed similar results, indicating clear dependence upon hsc70 for CaM-dependent nuclear import. Analysis using the technique of fluorescence recovery after photobleaching indicated that hsc70 is required for the maximal rate of SRY nuclear import in living cells but has no impact upon SRY nuclear retention/nuclear dynamics. Finally, we demonstrate direct binding of hsc70 to the SRY.CaM complex, with immunoprecipitation experiments from cell extracts showing association of hsc70 with wild type SRY, but not with a mutant derivative with impaired CaM binding, dependent on Ca2+. Our novel findings strongly implicate hsc70 in CaM-dependent nuclear import of SRY.	[Kaur, Gurpreet; Lieu, Kim G.; Jans, David A.] Monash Univ, Nucl Signalling Lab, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Monash University	Jans, DA (corresponding author), Monash Univ, Nucl Signalling Lab, Dept Biochem & Mol Biol, Bldg 77, Clayton, Vic 3800, Australia.	david.jans@monash.edu		Jans, David/0000-0001-5115-4745	Australian Research Council [COE348239]; National Health and Medical Research Council (Australia) [APP1002486]	Australian Research Council(Australian Research Council); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Grant COE348239 and National Health and Medical Research Council (Australia) Grant APP1002486.	Akakura S, 2001, J BIOL CHEM, V276, P14649, DOI 10.1074/jbc.M100200200; Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Fan ACY, 2011, PROTEIN PEPTIDE LETT, V18, P122; Florin L, 2004, J VIROL, V78, P5546, DOI 10.1128/JVI.78.11.5546-5553.2004; Forwood JK, 2002, BIOCHEMISTRY-US, V41, P9333, DOI 10.1021/bi025548s; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; Galigniana MD, 2010, NUCLEUS-PHILA, V1, P299, DOI 10.4161/nucl.1.4.11743; Hanover JA, 2007, J BIOL CHEM, V282, P33743, DOI 10.1074/jbc.M705875200; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; Harley VR, 1996, FEBS LETT, V391, P24, DOI 10.1016/0014-5793(96)00694-1; Kaur G, 2011, FASEB J, V25, P665, DOI 10.1096/fj.10-173351; Kaur G, 2010, BIOCHEM J, V430, P39, DOI 10.1042/BJ20091758; Kose S, 2005, J CELL BIOL, V171, P19, DOI 10.1083/jcb.200506074; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Lam MHC, 2001, TRAFFIC, V2, P812, DOI 10.1034/j.1600-0854.2001.21110.x; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Lixin R, 2001, BIOCHEM BIOPH RES CO, V284, P185, DOI 10.1006/bbrc.2001.4953; Moriya M, 2004, MOL REPROD DEV, V69, P316, DOI 10.1002/mrd.20134; Roth DM, 2009, J CELL BIOCHEM, V107, P1160, DOI 10.1002/jcb.22218; Roth DM, 2011, J BIOL CHEM, V286, P14335, DOI 10.1074/jbc.M110.210302; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; STEVENSON MA, 1990, MOL CELL BIOL, V10, P1234, DOI 10.1128/MCB.10.3.1234; YANG J, 1994, MOL CELL BIOL, V14, P5088, DOI 10.1128/MCB.14.8.5088; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhou Y, 2010, J AM SOC NEPHROL, V21, P598, DOI 10.1681/ASN.2009050552	28	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4148	4157		10.1074/jbc.M112.436741	http://dx.doi.org/10.1074/jbc.M112.436741			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23235156	hybrid, Green Published			2022-12-28	WOS:000314845000043
J	Garcia, BL; Summers, BJ; Ramyar, KX; Tzekou, A; Lin, Z; Ricklin, D; Lambris, JD; Laity, JH; Geisbrecht, BV				Garcia, Brandon L.; Summers, Brady J.; Ramyar, Kasra X.; Tzekou, Apostolia; Lin, Zhuoer; Ricklin, Daniel; Lambris, John D.; Laity, John H.; Geisbrecht, Brian V.			A Structurally Dynamic N-terminal Helix Is a Key Functional Determinant in Staphylococcal Complement Inhibitor (SCIN) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE EVASION; BACKBONE DYNAMICS; CHEMICAL-SHIFTS; COMPONENT C3; ASSIGNMENT; BINDING; SYSTEM; INSIGHTS; FAMILY; C-13	Complement is a network of interacting circulatory and cell surface proteins that recognizes, marks, and facilitates clearance of microbial invaders. To evade complement attack, the pathogenic organism Staphylococcus aureus expresses a number of secreted proteins that interfere with activation and regulation of the complement cascade. Staphylococcal complement inhibitors (SCINs) are one important class of these immunomodulators and consist of three active members (SCIN-A/-B/-C).SCINs inhibit a critical enzymatic complex, the alternative pathway C3 convertase, by targeting a functional "hot spot" on the central opsonin of complement, C3b. Although N-terminal truncation mutants of SCINs retain complement inhibitory properties, they are significantly weaker binders of C3b. To provide a structural basis for this observation, we undertook a series of crystallographic and NMR dynamics studies on full-length SCINs. This work reveals that N-terminal SCIN domains are characterized by a conformationally dynamic helical motif. C3b binding and functional experiments further demonstrate that this sequence-divergent N-terminal region of SCINs is both functionally important and context-dependent. Finally, surface plasmon resonance data provide evidence for the formation of inhibitor.enzyme.substrate complexes ((SCIN center dot C3bBb)center dot C3). Similar to the (SCIN center dot C3bBb)(2) pseudodimeric complexes, ((SCIN center dot C3bBb)center dot C3) interferes with the interaction of complement receptors and C3b. This activity provides an additional mechanism by which SCIN couples convertase inhibition to direct blocking of phagocytosis. Together, these data suggest that tethering multi-host protein complexes by small modular bacterial inhibitors may be a global strategy of immune evasion used by S. aureus. The work presented here provides detailed structure-activity relationships and improves our understanding of how S. aureus circumvents human innate immunity.	[Garcia, Brandon L.; Summers, Brady J.; Ramyar, Kasra X.; Laity, John H.; Geisbrecht, Brian V.] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA; [Tzekou, Apostolia; Lin, Zhuoer; Ricklin, Daniel; Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Missouri System; University of Missouri Kansas City; University of Pennsylvania	Geisbrecht, BV (corresponding author), Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, 5100 Rockhill Rd, Kansas City, MO 64110 USA.	GeisbrechtB@umkc.edu	Ricklin, Daniel/F-5104-2011; Lambris, John/Q-5633-2018	Ricklin, Daniel/0000-0001-6140-0233; Lambris, John/0000-0002-9370-5776	United Staets Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; National Institutes of Health [AI071028, AI030040, AI068730, AI072106]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030040, R01AI071028, R01AI030040, R01AI072106, P01AI068730] Funding Source: NIH RePORTER	United Staets Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge generous technical assistance of Drs. Rod Salazar and Andy Howard during x-ray diffraction data collection and Dr. Samuel Bouyain for use of the EnSpire plate reader. Use of the Advanced Photon Source was supported by the United Staets Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) beamlines at the Advanced Photon Source, Argonne National Laboratory.; This work was supported, in whole or in part, by National Institutes of Health Grants AI071028, AI030040, AI068730, and AI072106 (to B. V. G. and J. D. L.). This work was also supported by an American Heart Association predoctoral fellowship (to B. L. G.).	Bowman P, 2006, BBA-PROTEINS PROTEOM, V1764, P182, DOI 10.1016/j.bbapap.2005.12.016; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; FRIEDRICHS MS, 1994, J BIOMOL NMR, V4, P703, DOI 10.1007/BF00404279; Garcia BL, 2012, J BIOL CHEM, V287, P628, DOI 10.1074/jbc.M111.298984; Garcia BL, 2012, ADV EXP MED BIOL, V946, P113, DOI 10.1007/978-1-4614-0106-3_7; Garcia BL, 2010, J MOL BIOL, V402, P17, DOI 10.1016/j.jmb.2010.07.029; Garcia BL, 2009, ACTA CRYSTALLOGR F, V65, P482, DOI 10.1107/S174430910901207X; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Jongerius I, 2010, J BIOL CHEM, V285, P14973, DOI 10.1074/jbc.M109.091975; Jongerius I, 2010, J IMMUNOL, V184, P420, DOI 10.4049/jimmunol.0902865; KAM CM, 1987, J BIOL CHEM, V262, P3444; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Ko YP, 2011, J BIOL CHEM, V286, P9865, DOI 10.1074/jbc.M110.199687; Laarman A, 2010, J MOL MED, V88, P115, DOI 10.1007/s00109-009-0572-y; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; Laursen NS, 2010, P NATL ACAD SCI USA, V107, P3681, DOI 10.1073/pnas.0910565107; Leopold M. F., 1994, Molecular Biotechnology, V2, P61, DOI 10.1007/BF02789290; LOHR F, 1995, J BIOMOL NMR, V5, P25, DOI 10.1007/BF00227467; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER AG, 1992, J BIOMOL NMR, V2, P103, DOI 10.1007/BF02192804; Potter BM, 2005, J BIOL CHEM, V280, P28529, DOI 10.1074/jbc.M505217200; Ramsland PA, 2007, P NATL ACAD SCI USA, V104, P15051, DOI 10.1073/pnas.0706028104; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Ringe D, 1986, Methods Enzymol, V131, P389; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2007, J IMMUNOL, V179, P2989, DOI 10.4049/jimmunol.179.5.2989; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Sandhu KS, 2007, PROTEINS, V68, P109, DOI 10.1002/prot.21328; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; Wang ZH, 2007, J MOL BIOL, V366, P375, DOI 10.1016/j.jmb.2006.11.039; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Yuan Z, 2003, PROTEIN ENG, V16, P109, DOI 10.1093/proeng/gzg014; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	58	15	15	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2870	2881		10.1074/jbc.M112.426858	http://dx.doi.org/10.1074/jbc.M112.426858			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233676	hybrid, Green Published			2022-12-28	WOS:000314211500069
J	Sun, S; Zhang, W; Mannervik, B; Andersson, DI				Sun, Song; Zhang, Wei; Mannervik, Bengt; Andersson, Dan I.			Evolution of Broad Spectrum beta-Lactam Resistance in an Engineered Metallo-beta-lactamase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STABILITY-FUNCTION TRADEOFFS; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; STRUCTURAL BASES; ENZYME; COMPLEX; GENES	The extensive use and misuse of antibiotics during the last seven decades has led to the evolution and global spread of a variety of resistance mechanisms in bacteria. Of high medical importance are beta-lactamases, a group of enzymes inactivating beta-lactam antibiotics. Metallo-beta-lactamases (MBLs) are particularly problematic because of their ability to act on virtually all classes of beta-lactam antibiotics. An engineered MBL (evMBL9) characterized by low level activity with several beta-lactam antibiotics was constructed and employed as a parental MBL in an experiment to examine how an enzyme can evolve toward increased activity with a variety of beta-lactam antibiotics. We designed and synthesized a mutant library in which the substrate activity profile was varied by randomizing six active site amino acid residues. The library was expressed in Salmonella typhimurium, clones with increased resistance against seven different beta-lactam antibiotics (penicillin G, ampicillin, cephalothin, cefaclor, cefuroxime, cefoperazone, and cefotaxime) were isolated, and the MBL variants were characterized. For the majority of the mutants, bacterial resistance was significantly increased despite marked reductions in both mRNA and protein levels relative to those of parental evMBL9, indicating that the catalytic activities of these mutant MBLs were highly increased. Multivariate analysis showed that the majority of the mutant enzymes were generalists, conferring increased resistance against most of the examined beta-lactams.	[Sun, Song; Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Zhang, Wei; Mannervik, Bengt] Uppsala Univ, Dept Chem BMC, SE-75123 Uppsala, Sweden; [Mannervik, Bengt] Stockholm Univ, Dept Neurochem, SE-10961 Stockholm, Sweden	Uppsala University; Uppsala University; Stockholm University	Andersson, DI (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.	Dan.Anderssson@imbim.uu.se		Andersson, Dan/0000-0001-6640-2174	Swedish Research Council; Vinnova; Swedish Foundation for Strategic Research; European Union [PAR 241476]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Vinnova(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Union(European Commission)	This work was supported by grants from the Swedish Research Council (to B. M.) and by the Swedish Research Council, Vinnova, Swedish Foundation for Strategic Research, and European Union Project PAR 241476 (to D. I. A.).	Alcolombri U, 2011, J MOL BIOL, V411, P837, DOI 10.1016/j.jmb.2011.06.037; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Demain AL, 1999, ANTON LEEUW INT J G, V75, P5, DOI 10.1023/A:1001738823146; Elander RP, 2003, APPL MICROBIOL BIOT, V61, P385, DOI 10.1007/s00253-003-1274-y; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Helfand Marion S., 2003, Current Drug Targets - Infectious Disorders, V3, P9, DOI 10.2174/1568005033342181; Jochens H, 2010, CHEMBIOCHEM, V11, P1861, DOI 10.1002/cbic.201000284; Kurtovic S, 2009, BIOCHEMISTRY-US, V48, P9330, DOI 10.1021/bi901168q; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; MEDEIROS AA, 1984, BRIT MED BULL, V40, P18, DOI 10.1093/oxfordjournals.bmb.a071942; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Peimbert M, 2003, PROTEIN ENG, V16, P27, DOI 10.1093/proeng/gzg008; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; Rice LB, 2006, AM J MED, V119, pS11, DOI 10.1016/j.amjmed.2006.03.012; Rice LB, 2012, MAYO CLIN PROC, V87, P198, DOI 10.1016/j.mayocp.2011.12.003; Sideraki V, 2001, P NATL ACAD SCI USA, V98, P283, DOI 10.1073/pnas.011454198; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Thomas VL, 2010, J MOL BIOL, V396, P47, DOI 10.1016/j.jmb.2009.11.005; Thomson JM, 2005, CURR OPIN MICROBIOL, V8, P518, DOI 10.1016/j.mib.2005.08.014; Tomatis PE, 2005, P NATL ACAD SCI USA, V102, P13761, DOI 10.1073/pnas.0503495102; Ullah JH, 1998, J MOL BIOL, V284, P125, DOI 10.1006/jmbi.1998.2148; Vakulenko S, 2002, ANTIMICROB AGENTS CH, V46, P646, DOI 10.1128/AAC.46.3.646-653.2002; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilke MS, 2005, CURR OPIN MICROBIOL, V8, P525, DOI 10.1016/j.mib.2005.08.016; Wright AJ, 1999, MAYO CLIN PROC, V74, P290, DOI 10.4065/74.3.290; Zhang W, 2012, BIOCHEM J, V445, P39, DOI 10.1042/BJ20120136	40	11	11	0	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2314	2324		10.1074/jbc.M112.430199	http://dx.doi.org/10.1074/jbc.M112.430199			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23209299	Green Published, hybrid			2022-12-28	WOS:000314211500021
J	Kilch, T; Alansary, D; Peglow, M; Dorr, K; Rychkov, G; Rieger, H; Peinelt, C; Niemeyer, BA				Kilch, Tatiana; Alansary, Dalia; Peglow, Martin; Doerr, Kathrin; Rychkov, Grigori; Rieger, Heiko; Peinelt, Christine; Niemeyer, Barbara A.			Mutations of the Ca2+-sensing Stromal Interaction Molecule STIM1 Regulate Ca2+ Influx by Altered Oligomerization of STIM1 and by Destabilization of the Ca2+ Channel Orai1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CALCIUM-ENTRY; T-CELL-ACTIVATION; PLASMA-MEMBRANE; CRAC CHANNELS; IMMUNOLOGICAL SYNAPSE; LINKED GLYCOSYLATION; STORE DEPLETION; MICE LACKING; SAM DOMAIN; PROTEINS	A drop of endoplasmic reticulum Ca2+ concentration triggers its Ca2+ ssensor protein stromal interaction molecule 1 (STIM1) to oligomerize and accumulate within endoplasmic reticulum-plasma membrane junctions where it activates Orai1 channels, providing store-operated Ca2+ entry. To elucidate the functional significance of N-glycosylation sites of STIM1, we created different mutations of asparagine-131 and asparagine-171. STIM1 NN/DQ resulted in a strong gain of function. Patch clamp, Total Internal Reflection Fluorescent (TIRF) microscopy, and fluorescence recovery after photobleaching (FRAP) analyses revealed that expression of STIM1 DQ mutants increases the number of active Orai1 channels and the rate of STIM1 translocation to endoplasmic reticulum-plasma membrane junctions with a decrease in current latency. Surprisingly, co-expression of STIM1 DQ decreased Orai1 protein, altering the STIM1: Orai1 stoichiometry. We describe a novel mathematical tool to delineate the effects of altered STIM1 or Orai1 diffusion parameters from stoichiometrical changes. The mutant uncovers a novel mechanism whereby "superactive" STIM1 DQ leads to altered oligomerization rate constants and to degradation of Orai1 with a change in stoichiometry of activator (STIM1) to effector (Orai1) ratio leading to altered Ca2+ homeostasis.	[Niemeyer, Barbara A.] Univ Saarland, Dept Biophys, Sch Med, D-66421 Homburg, Germany; [Peglow, Martin; Rieger, Heiko] Univ Saarland, Dept Theoret Phys, D-66041 Saarbrucken, Germany; [Rychkov, Grigori] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Saarland University; Saarland University; University of Adelaide	Niemeyer, BA (corresponding author), Univ Saarland, Dept Biophys, Sch Med, Geb 58, D-66421 Homburg, Germany.	barbara.niemeyer@uks.eu	Niemeyer, Barbara A./AAL-8972-2021; Peinelt, Christine/ABH-5292-2020; Rieger, Heiko/C-3298-2012	Alansary, Dalia/0000-0002-7541-6057; Rychkov, Grigori/0000-0002-2788-2977; Niemeyer, Barbara A./0000-0002-6963-0575; Peinelt, Christine/0000-0002-3474-6893; Rieger, Heiko/0000-0003-0205-3678	Deutsche Forschungsgemeinschaft [SFB894, NI671/3-1, 1478/5-1]; HOMFORexcellent; Boehringer Ingelheim Fond	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); HOMFORexcellent; Boehringer Ingelheim Fond(Boehringer Ingelheim)	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB894, Project A2 (to B. A. N. and C. P.), NI671/3-1 to B. A. N., Emmy Noether Program 1478/5-1 (to C. P.), and funds from HOMFORexcellent (to D. A.).; Supported by the Boehringer Ingelheim Fond.	Csutora P, 2008, J BIOL CHEM, V283, P14524, DOI 10.1074/jbc.M709575200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2011, ANN NY ACAD SCI, V1238, P74, DOI 10.1111/j.1749-6632.2011.06240.x; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Imperiali B, 1995, BIOORGAN MED CHEM, V3, P1565, DOI 10.1016/0968-0896(95)00142-5; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Li ZZ, 2011, CELL RES, V21, P305, DOI 10.1038/cr.2010.131; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Maul-Pavicic A, 2011, P NATL ACAD SCI USA, V108, P3324, DOI 10.1073/pnas.1013285108; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Qui B, 2011, CELL CALCIUM, V50, P261, DOI 10.1016/j.ceca.2011.05.015; Quintana A, 2011, EMBO J, V30, P3895, DOI 10.1038/emboj.2011.289; Scrimgeour N, 2009, J PHYSIOL-LONDON, V587, P2903, DOI 10.1113/jphysiol.2009.170662; Scrimgeour NR, 2012, BIOCHEM J, V441, P743, DOI 10.1042/BJ20110558; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; Stanisz H, 2012, J INVEST DERMATOL, V132, P1443, DOI 10.1038/jid.2011.478; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zheng L, 2011, P NATL ACAD SCI USA, V108, P1337, DOI 10.1073/pnas.1015125108	38	51	54	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1653	1664		10.1074/jbc.M112.417246	http://dx.doi.org/10.1074/jbc.M112.417246			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23212906	Green Published, hybrid			2022-12-28	WOS:000313751400021
J	Suzuki, Y; Goetze, TA; Stroebel, D; Balasuriya, D; Yoshimura, SH; Henderson, RM; Paoletti, P; Takeyasu, K; Edwardson, JM				Suzuki, Yuki; Goetze, Tom A.; Stroebel, David; Balasuriya, Dilshan; Yoshimura, Shige H.; Henderson, Robert M.; Paoletti, Pierre; Takeyasu, Kunio; Edwardson, J. Michael			Visualization of Structural Changes Accompanying Activation of N-Methyl-D-aspartate (NMDA) Receptors Using Fast-scan Atomic Force Microscopy Imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-RECEPTOR; SUBUNIT ARRANGEMENT; MOLECULAR-BASIS; BINDING; MODULATION; MECHANISMS; PROTEINS; REVEALS; DOMAIN	NMDA receptors are widely expressed in the central nervous system and play a major role in excitatory synaptic transmission and plasticity. Here, we used atomic force microscopy (AFM) imaging to visualize activation-induced structural changes in the GluN1/GluN2A NMDA receptor reconstituted into a lipid bilayer. In the absence of agonist, AFM imaging revealed two populations of particles with heights above the bilayer surface of 8.6 and 3.4 nm. The taller, but not the shorter, particles could be specifically decorated by an anti-GluN1 antibody, which recognizes the S2 segment of the agonist-binding domain, indicating that the two populations represent the extracellular and intracellular regions of the receptor, respectively. In the presence of glycine and glutamate, there was a reduction in the height of the extracellular region to 7.3 nm. In contrast, the height of the intracellular domain was unaffected. Fast-scan AFM imaging combined with UV photolysis of caged glutamate permitted the detection of a rapid reduction in the height of individual NMDA receptors. The reduction in height did not occur in the absence of the co-agonist glycine or in the presence of the selective NMDA receptor antagonist D(-)-2-amino-5-phosphonopentanoic acid, indicating that the observed structural change was caused by receptor activation. These results represent the first demonstration of an activation-induced effect on the structure of the NMDA receptor at the single-molecule level. A change in receptor size following activation could have important functional implications, in particular by affecting interactions between the NMDA receptor and its extracellular synaptic partners.	[Suzuki, Yuki; Yoshimura, Shige H.; Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane & Nucl Signaling, Kyoto 6068501, Japan; [Goetze, Tom A.; Balasuriya, Dilshan; Henderson, Robert M.; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Stroebel, David; Paoletti, Pierre] Ecole Normale Super, IBENS, CNRS UMR 8197, INSERM U1024, F-75005 Paris, France	Kyoto University; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Takeyasu, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane & Nucl Signaling, Kyoto 6068501, Japan.	takeyasu@lif.kyoto-u.ac.jp; jme1000@cam.ac.uk	Goetze, Tom/I-1891-2013; Yoshimura, Shige H./AAF-5463-2019; Paoletti, Pierre/L-7358-2013; Suzuki, Yuki/H-9950-2015	Yoshimura, Shige H./0000-0001-6033-1301; Paoletti, Pierre/0000-0002-3681-4845; Suzuki, Yuki/0000-0003-1848-0105	Human Frontier Science Program; Japan Society for the Promotion of Science (JSPS) scientific collaboration grant; Wellcome Trust; Biotechnology and Biological Sciences Research Council Japan partnering grant; Japan Ministry of Education, Culture, Sports, Science and Technology; Fondation pour la Recherche Medicale (FRM) Equipe FRM grant; Department of Pharmacology, University of Cambridge; Grants-in-Aid for Scientific Research [24115003] Funding Source: KAKEN	Human Frontier Science Program(Human Frontier Science Program); Japan Society for the Promotion of Science (JSPS) scientific collaboration grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council Japan partnering grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fondation pour la Recherche Medicale (FRM) Equipe FRM grant; Department of Pharmacology, University of Cambridge; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Human Frontier Science Program (to K. T.), a Japan Society for the Promotion of Science (JSPS) scientific collaboration grant (to K. T.), the Wellcome Trust (to J. M. E. and P. P.), a Biotechnology and Biological Sciences Research Council Japan partnering grant (to R. M. H. and J. M. E.), a Japan Ministry of Education, Culture, Sports, Science and Technology grant-in-aid for scientific research on priority areas (to S. H. Y.), and a Fondation pour la Recherche Medicale (FRM) Equipe FRM grant (to P. P.).; Recipient of a David James Bursary from the Department of Pharmacology, University of Cambridge.	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Lee CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019180; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Nakagawa T, 2010, MOL NEUROBIOL, V42, P161, DOI 10.1007/s12035-010-8149-x; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Shanks NF, 2010, J NEUROSCI, V30, P2728, DOI 10.1523/JNEUROSCI.5146-09.2010; Shinozaki Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000103; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wang CY, 2006, J NEUROSCI, V26, P2174, DOI 10.1523/JNEUROSCI.3799-05.2006; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Yokokawa M, 2006, EMBO J, V25, P4567, DOI 10.1038/sj.emboj.7601326; Yokokawa M, 2011, FEBS J, V278, P3025, DOI 10.1111/j.1742-4658.2011.08222.x; Yokokawa M, 2010, FEBS LETT, V584, P3107, DOI 10.1016/j.febslet.2010.05.050	34	17	18	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					778	784		10.1074/jbc.M112.422311	http://dx.doi.org/10.1074/jbc.M112.422311			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23223336	Green Published, hybrid			2022-12-28	WOS:000313570300003
J	Thakran, S; Sharma, P; Attia, RR; Hori, RT; Deng, X; Elam, MB; Park, EA				Thakran, Shalini; Sharma, Pragya; Attia, Ramy R.; Hori, Roderick T.; Deng, Xiong; Elam, Marshall B.; Park, Edwards A.			Role of Sirtuin 1 in the Regulation of Hepatic Gene Expression by Thyroid Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA COACTIVATOR; FATTY-ACID OXIDATION; CPT-I-ALPHA; BINDING PROTEIN BETA; KINASE 4 PDK4; MITOCHONDRIAL-FUNCTION; TRANSCRIPTION FACTORS; METABOLIC DISEASE; C/EBP-ALPHA; 1ST INTRON	Sirtuin 1 (SIRT1) is a nuclear deacetylase that modulates lipid metabolism and enhances mitochondrial activity. SIRT1 targets multiple transcription factors and coactivators. Thyroid hormone (T-3) stimulates the expression of hepatic genes involved in mitochondrial fatty acid oxidation and gluconeogenesis. We reported that T-3 induces genes for carnitine palmitoyltransferase (cpt1a), pyruvate dehydrogenase kinase 4 (pdk4), and phosphoenolpyruvate carboxykinase (pepck). SIRT1 increases the expression of these genes via the activation of several factors, including peroxisome proliferator-activated receptor alpha, estrogen-related receptor alpha, and peroxisome proliferator-activated receptor gamma coactivator (PGC-1 alpha). Previously, we reported that PGC-1 alpha participates in the T-3 induction of cpt1a and pdk4 in the liver. Given the overlapping targets of T-3 and SIRT1, we investigated whether SIRT1 participated in the T-3 regulation of these genes. Resveratrol is a small phenolic compound whose actions include the activation of SIRT1. Addition of resveratrol increased the T-3 induction of the pdk4 and cpt1a genes in hepatocytes. Furthermore, expression of SIRT1 in hepatocytes mimicked resveratrol in the regulation of gene expression by T-3. The deacetylase activity of SIRT1 was required and PGC-1 alpha was deacetylated following addition of T-3. We found that SIRT1 interacted directly with T-3 receptor (TR beta). Knockdown of SIRT1 decreased the T-3 induction of cpt1a and pdk4 and reduced the T-3 inhibition of sterol response element binding protein (srebp-1c) both in isolated hepatocytes and in rat liver. Our results indicate that SIRT1 contributes to the T-3 regulation of hepatic genes.	[Thakran, Shalini; Sharma, Pragya; Attia, Ramy R.; Deng, Xiong; Elam, Marshall B.; Park, Edwards A.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pharmacol, Memphis, TN 38163 USA; [Hori, Roderick T.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Deng, Xiong; Elam, Marshall B.] Dept Vet Affairs Med Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Park, EA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	epark@uthsc.edu			National Institutes of Health [DK0059368, DK075504]; American Heart Association [4590018]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075504, R01DK059368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health Grants DK0059368 (to E. A. P.) and DK075504 (to M. B. E.). This work was also supported by American Heart Association Grant 4590018 (to E. A. P.).	Amat R, 2007, J BIOL CHEM, V282, P34066, DOI 10.1074/jbc.M707114200; Attia RR, 2011, J BIOL CHEM, V286, P23799, DOI 10.1074/jbc.M111.246389; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Cioffi F, 2010, FASEB J, V24, P3451, DOI 10.1096/fj.10-157115; Cook GA, 2001, J MOL CELL CARDIOL, V33, P317, DOI 10.1006/jmcc.2000.1304; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; Engel N, 2008, INT J MOL MED, V21, P223; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fullerton MD, 2010, DIABETES, V59, P551, DOI 10.2337/db09-1732; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Jackson-Hayes L, 2003, J BIOL CHEM, V278, P7964, DOI 10.1074/jbc.M211062200; Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200; Jurado LA, 2002, J BIOL CHEM, V277, P27606, DOI 10.1074/jbc.M201429200; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lin HY, 2005, STEROIDS, V70, P444, DOI 10.1016/j.steroids.2005.03.001; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu Y, 2006, MOL ENDOCRINOL, V20, P483, DOI 10.1210/me.2005-0101; Ma K, 2005, J BIOL CHEM, V280, P29525, DOI 10.1074/jbc.M502236200; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; MYNATT RL, 1994, BIOCHEM BIOPH RES CO, V201, P932, DOI 10.1006/bbrc.1994.1791; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park EA, 1999, J BIOL CHEM, V274, P211, DOI 10.1074/jbc.274.1.211; Park EA, 1997, BIOCHEM J, V322, P343, DOI 10.1042/bj3220343; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rosenson RS, 2010, ATHEROSCLEROSIS, V213, P1, DOI 10.1016/j.atherosclerosis.2010.03.038; Sanchez-Pacheco A, 2009, ENDOCRINOLOGY, V150, P5143, DOI 10.1210/en.2009-0117; Song SL, 2010, MOL CELL ENDOCRINOL, V325, P54, DOI 10.1016/j.mce.2010.05.019; Song SL, 2004, BBA-GENE STRUCT EXPR, V1679, P164, DOI 10.1016/j.bbaexp.2004.06.006; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Yang JQ, 2009, J BIOL CHEM, V284, P27042, DOI 10.1074/jbc.M109.047340; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x; Zhang Y, 2004, J BIOL CHEM, V279, P53963, DOI 10.1074/jbc.M406028200; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104	55	50	51	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					807	818		10.1074/jbc.M112.437970	http://dx.doi.org/10.1074/jbc.M112.437970			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23209300	hybrid, Green Published			2022-12-28	WOS:000313570300006
J	Murakami, K; Calero, G; Brown, CR; Liu, X; Davis, RE; Boeger, H; Kornberg, RD				Murakami, Kenji; Calero, Guillermo; Brown, Christopher R.; Liu, Xin; Davis, Ralph E.; Boeger, Hinrich; Kornberg, Roger D.			Formation and Fate of a Complete 31-Protein RNA Polymerase II Transcription Preinitiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; INITIATION-FACTORS; PROMOTER DNA; FACTOR TFIIH; IN-VITRO; ELONGATION; YEAST; INTERMEDIATE; REINITIATION; RECRUITMENT	Whereas individual RNA polymerase II (pol II)-general transcription factor (GTF) complexes are unstable, an assembly of pol II with six GTFs and promoter DNA could be isolated in abundant homogeneous form. The resulting complete pol II transcription preinitiation complex (PIC) contained equimolar amounts of all 31 protein components. An intermediate in assembly, consisting of four GTFs and promoter DNA, could be isolated and supplemented with the remaining components for formation of the PIC. Nuclease digestion and psoralen cross-linking mapped the PIC between positions -70 and -9, centered on the TATA box. Addition of ATP to the PIC resulted in quantitative conversion to an open complex, which retained all 31 proteins, contrary to expectation from previous studies. Addition of the remaining NTPs resulted in run-off transcription, with an efficiency that was promoter-dependent and was as great as 17.5% with the promoters tested.	[Murakami, Kenji; Calero, Guillermo; Liu, Xin; Davis, Ralph E.; Kornberg, Roger D.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Brown, Christopher R.; Boeger, Hinrich] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	Stanford University; University of California System; University of California Santa Cruz	Kornberg, RD (corresponding author), Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu		Brown, Christopher/0000-0001-6076-4035	National Institutes of Health [GM36659, AI21144]; Japan Society for the Promotion of Science (JSPS); Kanae Foundation; Uehara Memorial Foundation; Kazato Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036659, R01GM036659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanae Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Kazato Research Foundation(Kazato Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM36659 and AI21144 (to R. D. K.).; Supported by the Japan Society for the Promotion of Science (JSPS), the Kanae Foundation, the Uehara Memorial Foundation, and the Kazato Research Foundation.	BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Cabart P, 2012, J BIOL CHEM, V287, P961, DOI 10.1074/jbc.M111.297572; CAI H, 1987, J BIOL CHEM, V262, P298; CECH T, 1977, BIOCHEMISTRY-US, V16, P5313, DOI 10.1021/bi00643a024; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Dvir A, 1996, J BIOL CHEM, V271, P7245, DOI 10.1074/jbc.271.13.7245; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Hahn S, 1998, COLD SPRING HARB SYM, V63, P181, DOI 10.1101/sqb.1998.63.181; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; LUSE DS, 1987, J BIOL CHEM, V262, P289; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Murakami K, 2012, P NATL ACAD SCI USA, V109, P4816, DOI 10.1073/pnas.1201448109; OBRIEN T, 1991, MOL CELL BIOL, V11, P5285, DOI 10.1128/MCB.11.10.5285; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SAYRE MH, 1992, J BIOL CHEM, V267, P23376; Spangler L, 2001, P NATL ACAD SCI USA, V98, P5544, DOI 10.1073/pnas.101004498; SVEJSTRUP JQ, 1994, J BIOL CHEM, V269, P28044; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	28	23	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6325	6332		10.1074/jbc.M112.433623	http://dx.doi.org/10.1074/jbc.M112.433623			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23303183	hybrid, Green Published			2022-12-28	WOS:000315820700027
J	Panjarian, S; Iacob, RE; Chen, SG; Wales, TE; Engen, JR; Smithgall, TE				Panjarian, Shoghag; Iacob, Roxana E.; Chen, Shugui; Wales, Thomas E.; Engen, John R.; Smithgall, Thomas E.			Enhanced SH3/Linker Interaction Overcomes Abl Kinase Activation by Gatekeeper and Myristic Acid Binding Pocket Mutations and Increases Sensitivity to Small Molecule Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; SRC-FAMILY KINASES; REGULATES C-ABL; BCR-ABL; TYROSINE KINASE; SH3 DOMAIN; SH3-LIGAND INTERACTIONS; HYDROGEN-EXCHANGE; STRUCTURAL BASIS; IMATINIB	Multidomain kinases such as c-Src and c-Abl are regulated by complex allosteric interactions involving their noncatalytic SH3 and SH2 domains. Here we show that enhancing natural allosteric control of kinase activity by SH3/linker engagement has long-range suppressive effects on the kinase activity of the c-Abl core. Surprisingly, enhanced SH3/linker interaction also dramatically sensitized the Bcr-Abl tyrosine kinase associated with chronic myelogenous leukemia to small molecule inhibitors that target either the active site or the myristic acid binding pocket in the kinase domain C-lobe. Dynamics analyses using hydrogen exchange mass spectrometry revealed a remarkable allosteric network linking the SH3 domain, the myristic acid binding pocket, and the active site of the c-Abl core, providing a structural basis for the biological observations. These results suggest a rational strategy for enhanced drug targeting of Bcr-Abl and other multidomain kinase systems that use multiple small molecules to exploit natural mechanisms of kinase control.	[Panjarian, Shoghag; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Iacob, Roxana E.; Chen, Shugui; Wales, Thomas E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northeastern University	Smithgall, TE (corresponding author), Bridgeside Point 2,Suite 523,450 Technol Dr, Pittsburgh, PA 15219 USA.	tsmithga@pitt.edu		Wales, Thomas E./0000-0001-6133-5689; Engen, John R./0000-0002-6918-9476	National Institutes of Health [CA169962, CA101828, GM086507, GM101135]; Waters Corporation; NATIONAL CANCER INSTITUTE [R01CA101828, R21CA169962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101135, R01GM086507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waters Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA169962 and CA101828 (to T. E. S.) and GM086507 and GM101135 (to J. R. E.), and a research collaboration with the Waters Corporation (to J. R. E.).	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Burkitt W, 2008, RAPID COMMUN MASS SP, V22, P3893, DOI 10.1002/rcm.3794; Chen S, 2008, J MOL BIOL, V383, P414, DOI 10.1016/j.jmb.2008.08.040; Chen SG, 2008, BIOCHEMISTRY-US, V47, P5795, DOI 10.1021/bi800446b; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Iacob RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015929; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nardi V, 2004, CURR OPIN HEMATOL, V11, P35, DOI 10.1097/00062752-200401000-00006; Pene-Dumitrescu T, 2008, ONCOGENE, V27, P7055, DOI 10.1038/onc.2008.330; Pene-Dumitrescu T, 2010, J BIOL CHEM, V285, P21446, DOI 10.1074/jbc.M109.090043; Pisabarro MT, 1998, J MOL BIOL, V281, P513, DOI 10.1006/jmbi.1998.1932; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1498, DOI 10.1016/j.jasms.2006.05.014; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	38	25	25	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6116	6129		10.1074/jbc.M112.431312	http://dx.doi.org/10.1074/jbc.M112.431312			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23303187	hybrid, Green Published			2022-12-28	WOS:000315820700009
J	Maiden, SL; Harrison, N; Keegan, J; Cain, B; Lynch, AM; Pettitt, J; Hardin, J				Maiden, Stephanie L.; Harrison, Neale; Keegan, Jack; Cain, Brian; Lynch, Allison M.; Pettitt, Jonathan; Hardin, Jeff			Specific Conserved C-terminal Amino Acids of Caenorhabditis elegans HMP-1/alpha-Catenin Modulate F-actin Binding Independently of Vinculin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-E-CATENIN; CELL-CELL ADHESION; E-CADHERIN; BETA-CATENIN; CYTOPLASMIC DOMAIN; MYOSIN PHOSPHATASE; JUNCTIONAL COMPLEX; APICAL JUNCTIONS; IN-VITRO; MORPHOGENESIS	Stable intercellular adhesions formed through the cadherin-catenin complex are important determinants of proper tissue architecture and help maintain tissue integrity during morphogenetic movements in developing embryos. A key regulator of this stability is alpha-catenin, which connects the cadherin-catenin complex to the actin cytoskeleton. Although the C-terminal F-actin-binding domain of alpha-catenin has been shown to be crucial for its function, a more detailed in vivo analysis of discrete regions and residues required for actin binding has not been performed. Using Caenorhabditis elegans as a model system, we have characterized mutations in hmp-1/alpha-catenin that identify HMP-1 residues 687-742 and 826-927, as well as amino acid 802, as critical to the localization of junctional proximal actin during epidermal morphogenesis. We also find that the S823F transition in a hypomorphic allele, hmp-1(fe4), decreases actin binding in vitro. Using hmp-1(fe4) animals in a mutagenesis screen, we were then able to identify 11 intragenic suppressors of hmp-1(fe4) that revert actin binding to wild-type levels. Using homology modeling, we show that these amino acids are positioned at key conserved sites within predicted alpha-helices in the C terminus. Through the use of transgenic animals, we also demonstrate that HMP-1 residues 315-494, which correspond to a putative mechanotransduction domain that binds vinculin in vertebrate alpha E-catenin, are not required during epidermal morphogenesis but may aid efficient recruitment of HMP-1 to the junction. Our studies are the first to identify key conserved amino acids in the C terminus of alpha-catenin that modulate F-actin binding in living embryos of a simple metazoan.	[Maiden, Stephanie L.; Keegan, Jack; Cain, Brian; Lynch, Allison M.; Hardin, Jeff] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Maiden, Stephanie L.; Hardin, Jeff] Univ Wisconsin, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA; [Harrison, Neale; Pettitt, Jonathan] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Aberdeen	Hardin, J (corresponding author), Univ Wisconsin, Dept Zool, 1117 W Johnson St, Madison, WI 53706 USA.	jdhardin@wisc.edu		Maiden, Stephanie/0000-0002-5144-386X; Pettitt, Jonathan/0000-0001-7988-6833	National Institutes of Health [RO1 GM58038]; American Heart Association [0815662G]; Wellcome Trust [073317/Z/03/Z]; Michael Guyer postdoctoral fellowship; National Institutes of Health Office of Research Infrastructure Program [P40 OD010440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058038] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Wellcome Trust(Wellcome TrustEuropean Commission); Michael Guyer postdoctoral fellowship; National Institutes of Health Office of Research Infrastructure Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM58038 (to J. D. H.), American Heart Association Grant 0815662G (to S. L. M.), Wellcome Trust Grant 073317/Z/03/Z (to J. P.), and a Michael Guyer postdoctoral fellowship (to A. M. L.).; We thank Shoichiro Ono, Bill Bement, Josh Sandquist, and Kevin Sonnemann for helpful discussions regarding experiments, and Jim Priess for providing hmp-1 mutant lines used in this analysis. Some strains were provided by the CGC, which is funded by the National Institutes of Health Office of Research Infrastructure Program Grant P40 OD010440.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; ABERLE H, 1994, J CELL SCI, V107, P3655; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bar RZ, 2010, J CELL BIOL, V191, P761, DOI 10.1083/jcb.201005082; BARSTEAD RJ, 1991, CELL MOTIL CYTOSKEL, V20, P69, DOI 10.1002/cm.970200108; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; BRENNER S, 1974, GENETICS, V77, P71; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Cox-Paulson EA, 2012, CURR BIOL, V22, P1500, DOI 10.1016/j.cub.2012.06.025; Dettenhofer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002497; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Ellerbrock BR, 2004, J BIOMOL SCREEN, V9, P147, DOI 10.1177/1087057103261038; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HERRENKNECHT K, 1991, P NATL ACAD SCI USA, V88, P9156, DOI 10.1073/pnas.88.20.9156; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Huber O, 1997, J CELL SCI, V110, P1759; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; King RS, 2009, DEV BIOL, V328, P234, DOI 10.1016/j.ydbio.2009.01.017; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Lei MM, 2012, J CELL BIOL, V198, P87, DOI 10.1083/jcb.201202053; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Lockwood C, 2008, CURR BIOL, V18, P1333, DOI 10.1016/j.cub.2008.07.086; Lynch AM, 2012, CURR BIOL, V22, P1891, DOI 10.1016/j.cub.2012.08.024; MacPyMOL, 2010, PYMOL MOL GRAPH SYST; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; McMahon L, 2001, J CELL SCI, V114, P2265; Mello C, 1995, METHOD CELL BIOL, V48, P451; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; Nieset JE, 1997, J CELL SCI, V110, P1013; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pappas DJ, 2006, CELL COMMUN ADHES, V13, P151, DOI 10.1080/15419060600726142; Peng X, 2012, J BIOL CHEM, V287, P7728, DOI 10.1074/jbc.M111.297481; Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136; Piekny AJ, 2000, GENETICS, V156, P1671; Piekny AJ, 2002, J CELL SCI, V115, P2271; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Rangarajan ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010679; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sarpal R, 2012, J CELL SCI, V125, P233, DOI 10.1242/jcs.096644; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Wissmann A, 1997, GENE DEV, V11, P409, DOI 10.1101/gad.11.4.409; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	66	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5694	5706		10.1074/jbc.M112.438093	http://dx.doi.org/10.1074/jbc.M112.438093			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23271732	Green Published, hybrid			2022-12-28	WOS:000315342500042
J	Hughes, CE; Sinha, U; Pandey, A; Eble, JA; O'Callaghan, CA; Watson, SP				Hughes, Craig E.; Sinha, Uma; Pandey, Anjali; Eble, Johannes A.; O'Callaghan, Christopher A.; Watson, Steve P.			Critical Role for an Acidic Amino Acid Region in Platelet Signaling by the HemITAM (Hemi-immunoreceptor Tyrosine-based Activation Motif) Containing Receptor CLEC-2 (C-type Lectin Receptor-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYK; KINASE; PHOSPHORYLATION; SPECIFICITY; BINDING; BLOOD; RECONSTITUTION; RECOGNITION; SEPARATION; EXPRESSION	CLEC-2 is a member of new family of C-type lectin receptors characterized by a cytosolic YXXL downstream of three acidic amino acids in a sequence known as a hemITAM (hemi-immunoreceptor tyrosine-based activation motif). Dimerization of two phosphorylated CLEC-2 molecules leads to recruitment of the tyrosine kinase Syk via its tandem SH2 domains and initiation of a downstream signaling cascade. Using Syk-deficient and Zap-70-deficient cell lines we show that hemITAM signaling is restricted to Syk and that the upstream triacidic amino acid sequence is required for signaling. Using surface plasmon resonance and phosphorylation studies, we demonstrate that the triacidic amino acids are required for phosphorylation of the YXXL. These results further emphasize the distinct nature of the proximal events in signaling by hemITAM relative to ITAM receptors.	[Hughes, Craig E.; Watson, Steve P.] Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Sinha, Uma; Pandey, Anjali] Portola Pharmaceut Inc, San Francisco, CA 94080 USA; [Eble, Johannes A.] Frankfurt Univ Hosp, Ctr Mol Med, D-60590 Frankfurt, Germany; [O'Callaghan, Christopher A.] Univ Oxford, Oxford OX3 7BN, England	University of Birmingham; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Oxford	Hughes, CE (corresponding author), Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England.	c.e.hughes@bham.ac.uk	Watson, Stephen P/Q-6292-2016	Watson, Stephen P/0000-0002-7846-7423; Hughes, Craig/0000-0002-9790-5820	Wellcome Trust [073107, 088410]; British Heart Foundation [PG/07/116, PG/05/134]; British Heart Foundation [PG/11/4/28645] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by the Wellcome Trust Grants 073107 and 088410 and by British Heart Foundation Grants PG/07/116 and PG/05/134. U.S. and A.P. are employees of Portola Pharmaceuticals.	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; CLARK MR, 1994, EMBO J, V13, P1911, DOI 10.1002/j.1460-2075.1994.tb06460.x; Dente L, 1997, J MOL BIOL, V269, P694, DOI 10.1006/jmbi.1997.1073; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; FARGNOLI J, 1995, J BIOL CHEM, V270, P26533, DOI 10.1074/jbc.270.44.26533; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Grucza RA, 1999, BIOCHEMISTRY-US, V38, P5024, DOI 10.1021/bi9829938; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Hernanz-Falcon P, 2001, IMMUNOGENETICS, V53, P288, DOI 10.1007/s002510100326; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Ichise H, 2009, DEVELOPMENT, V136, P191, DOI 10.1242/dev.025353; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Konigsberger S, 2012, EMBO J, V31, P3363, DOI 10.1038/emboj.2012.169; Latour S, 1997, MOL CELL BIOL, V17, P4434, DOI 10.1128/MCB.17.8.4434; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; McCarty OJT, 2004, J THROMB HAEMOST, V2, P1823, DOI 10.1111/j.1538-7836.2004.00925.x; Mori J, 2008, J BIOL CHEM, V283, P35419, DOI 10.1074/jbc.M806895200; Pollitt AY, 2010, BLOOD, V115, P2938, DOI 10.1182/blood-2009-12-257212; Qi RM, 1999, BBA-MOL CELL RES, V1451, P353, DOI 10.1016/S0167-4889(99)00105-6; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Reilly MP, 2011, BLOOD, V117, P2241, DOI 10.1182/blood-2010-03-274969; Richards JD, 1996, J BIOL CHEM, V271, P6458, DOI 10.1074/jbc.271.11.6458; Schmitz R, 1996, J MOL BIOL, V260, P664, DOI 10.1006/jmbi.1996.0429; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; Shapiro VS, 1996, J EXP MED, V184, P1663, DOI 10.1084/jem.184.5.1663; Spalton JC, 2009, J THROMB HAEMOST, V7, P1192, DOI 10.1111/j.1538-7836.2009.03451.x; Spreu J, 2010, P NATL ACAD SCI USA, V107, P5100, DOI 10.1073/pnas.0913108107; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Tomlinson MG, 2004, MOL CELL BIOL, V24, P2455, DOI 10.1128/MCB.24.6.2455-2466.2004; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Watson AA, 2007, J BIOL CHEM, V282, P3165, DOI 10.1074/jbc.M610383200; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388	42	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5127	5135		10.1074/jbc.M112.411462	http://dx.doi.org/10.1074/jbc.M112.411462			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264619	Green Published, hybrid			2022-12-28	WOS:000315340400060
J	Pidkovka, N; Rao, R; Mei, SJ; Gong, Y; Harris, RC; Wang, WH; Capdevila, JH				Pidkovka, Nataliya; Rao, Reena; Mei, Shaojun; Gong, Yan; Harris, Raymond C.; Wang, Wen-Hui; Capdevila, Jorge H.			Epoxyeicosatrienoic Acids (EETs) Regulate Epithelial Sodium Channel Activity by Extracellular Signal-regulated Kinase 1/2 (ERK1/2)-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; COLLECTING DUCT CELLS; ARACHIDONIC-ACID; NA+ CHANNEL; RAT-KIDNEY; LIDDLE-SYNDROME; ENAC; HYPERTENSION; CYTOCHROME-P450; TRANSPORT	The epithelial sodium channel (ENaC) participates in the regulation of plasma sodium and volume, and gain of function mutations in the human channel cause salt-sensitive hypertension. Roles for the arachidonic acid epoxygenase metabolites, the epoxyeicosatrienoic acids (EETs), in ENaC activity have been identified; however, their mechanisms of action remain unknown. In polarizedM1cells, 14,15-EET inhibited amiloridesensitive apical to basolateral sodium transport as effectively as epidermal growth factor (EGF). The EET effects were associated with increased threonine phosphorylation of the ENaC beta and gamma subunits and abolished by inhibitors of (a) mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal regulated kinases 1 and 2 (MEK/ERK1/2) and (b) EGF receptor signaling. CYP2C44 epoxygenase knockdown blunted the sodium transport effects of EGF, and its 14,15-EET metabolite rescued the knockdown phenotype. The relevance of these findings is indicated by (a) the hypertension that results in mice administered cetuximab, an inhibitor of EGF receptor binding, and (b) immunological data showing an association between the pressure effects of cetuximab and reductions in ENaC gamma phosphorylation. These studies (a) identify an ERK1/2dependent mechanism for ENaC inhibition by 14,15-EET, (b) point to ENaC as a proximal target for EET-activated ERK1/2 mitogenic kinases, (c) characterize a mechanistic commonality between EGF and epoxygenase metabolites as ENaC inhibitors, and (d) suggest a CYP2C epoxygenase-mediated pathway for the regulation of distal sodium transport.	[Pidkovka, Nataliya; Mei, Shaojun; Gong, Yan; Harris, Raymond C.; Capdevila, Jorge H.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Rao, Reena] Univ Kansas, Dept Med, Kansas City, KS 66160 USA; [Wang, Wen-Hui] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA	Vanderbilt University; University of Kansas; New York Medical College	Capdevila, JH (corresponding author), Vanderbilt Univ, Med Ctr N, Dept Med, Rm S-3223,1161 21st Ave S, Nashville, TN 37232 USA.	jorge.capdevila@vanderbilt.edu			National Institutes of Health from the USPHS [DK038226, DK51265, HL34300]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226, R01DK083525, R01DK051265] Funding Source: NIH RePORTER	National Institutes of Health from the USPHS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK038226 (to J. H. C. and R. C. H.), DK51265 (to R. H. C.), and HL34300 (to W. H. W.) from the USPHS.	Bubien JK, 2010, J BIOL CHEM, V285, P23527, DOI 10.1074/jbc.R109.025049; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Butterworth MB, 2008, J BIOL CHEM, V283, P35305, DOI 10.1074/jbc.R800044200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Capdevila JH, 2000, J LIPID RES, V41, P163; CAPDEVILA JH, 1991, METHOD ENZYMOL, V206, P441; Capidevila JH, 2007, CURR OPIN NEPHROL HY, V16, P465, DOI 10.1097/MNH.0b013e32827ab48c; Chen FM, 2006, BIOORG MED CHEM LETT, V16, P6281, DOI 10.1016/j.bmcl.2006.09.038; Chen JK, 1999, J BIOL CHEM, V274, P4764, DOI 10.1074/jbc.274.8.4764; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; DeLozier TC, 2004, J PHARMACOL EXP THER, V310, P845, DOI 10.1124/jpet.104.067819; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Falin R, 2005, AM J PHYSIOL-CELL PH, V288, pC1003, DOI 10.1152/ajpcell.00213.2004; Falin RA, 2007, J GEN PHYSIOL, V130, P313, DOI 10.1085/jgp.200709775; Fejes-Toth G, 2008, AM J PHYSIOL-RENAL, V294, pF1298, DOI 10.1152/ajprenal.00579.2007; Hamm LL, 2010, CURR OPIN NEPHROL HY, V19, P98, DOI 10.1097/MNH.0b013e328332bda4; Harding J, 2005, DRUG TODAY, V41, P107, DOI 10.1358/dot.2005.41.2.882662; HOLTHOFER H, 1987, CELL TISSUE RES, V249, P481; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Hu JC, 2009, J BIOL CHEM, V284, P36334, DOI 10.1074/jbc.M109.032870; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; KORBMACHER C, 1993, J GEN PHYSIOL, V102, P761, DOI 10.1085/jgp.102.4.761; Liu L, 2010, COLORECTAL DIS, V12, P399, DOI 10.1111/j.1463-1318.2009.01916.x; MAKITA K, 1994, J CLIN INVEST, V94, P2414, DOI 10.1172/JCI117608; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Nakagawa K, 2006, J CLIN INVEST, V116, P1696, DOI 10.1172/JCI27546; Nakhoul NL, 1998, AM J PHYSIOL-RENAL, V275, pF998, DOI 10.1152/ajprenal.1998.275.6.F998; Pavlov TS, 2011, AM J PHYSIOL-RENAL, V301, pF672, DOI 10.1152/ajprenal.00597.2010; Rossier BC, 2008, HYPERTENSION, V52, P595, DOI 10.1161/HYPERTENSIONAHA.107.097147; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Schild L, 1996, NEPHROLOGIE, V17, P395; Shen JP, 2003, AM J PHYSIOL-RENAL, V284, pF57, DOI 10.1152/ajprenal.00028.2002; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Shimkets RA, 1998, P NATL ACAD SCI USA, V95, P3301, DOI 10.1073/pnas.95.6.3301; Shushan A, 2007, FERTIL STERIL, V87, P127, DOI 10.1016/j.fertnstert.2006.05.056; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Thomas CP, 2004, CURR OPIN NEPHROL HY, V13, P541, DOI 10.1097/00041552-200409000-00010; VEHASKARI VM, 1989, AM J PHYSIOL, V256, pF803, DOI 10.1152/ajprenal.1989.256.5.F803; Warnock DG, 2001, AM J MED SCI, V322, P302, DOI 10.1097/00000441-200112000-00002; Wei Y, 2004, J GEN PHYSIOL, V124, P719, DOI 10.1085/jgp.200409140; Yang SL, 2009, ARCH BIOCHEM BIOPHYS, V489, P82, DOI 10.1016/j.abb.2009.05.006; Yang WQ, 2008, J PHARMACOL EXP THER, V324, P1019, DOI 10.1124/jpet.107.129577; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402; Zhang YH, 2005, AM J PHYSIOL-CELL PH, V288, pC141, DOI 10.1152/ajpcell.00343.2004	47	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5223	5231		10.1074/jbc.M112.407981	http://dx.doi.org/10.1074/jbc.M112.407981			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283969	Green Published, hybrid			2022-12-28	WOS:000315340400069
J	Wang, DH; Hoing, S; Patterson, HC; Ahmad, UM; Rathinam, VAK; Rajewsky, K; Fitzgerald, KA; Golenbock, DT				Wang, Donghai; Hoeing, Susanne; Patterson, Heide Christine; Ahmad, Umtul M.; Rathinam, Vijay A. K.; Rajewsky, Klaus; Fitzgerald, Katherine A.; Golenbock, Douglas T.			Inflammation in Mice Ectopically Expressing Human Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne (PAPA) Syndrome-associated PSTPIP1 A230T Mutant Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; AUTOINFLAMMATORY DISEASES; PYRIN; ASC; ACTIVATION; MUTATIONS; CRE; IL-1-BETA; ANAKINRA; FEVER	Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne Syndrome (PAPA syndrome) is an autoinflammatory disease caused by aberrant production of the proinflammatory cytokine interleukin-1. Mutations in the gene encoding proline serine threonine phosphatase-interacting protein-1 (PSTPIP1) have been linked to PAPA syndrome. PSTPIP1 is an adaptor protein that interacts with PYRIN, the protein encoded by the Mediterranean Fever (MEFV) gene whose mutations cause Familial Mediterranean Fever (FMF). However, the pathophysiological function of PSTPIP1 remains to be elucidated. We have generated mouse strains that either are PSTPIP1 deficient or ectopically express mutant PSTPIP1. Results from analyzing these mice suggested that PSTPIP1 is not an essential regulator of the Nlrp3, Aim2, or Nlrc4 inflammasomes. Although common features of human PAPA syndrome such as pyogenic arthritis and skin inflammation were not recapitulated in the mouse model, ectopic expression of the mutant but not the wild type PSTPIP1 in mice lead to partial embryonic lethality, growth retardation, and elevated level of circulating proinflammatory cytokines.	[Wang, Donghai; Ahmad, Umtul M.; Rathinam, Vijay A. K.; Fitzgerald, Katherine A.; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Hoeing, Susanne; Rajewsky, Klaus] Harvard Univ, Sch Med, Immune Dis Inst, Boston Childrens Hosp, Boston, MA 02115 USA; [Hoeing, Susanne; Rajewsky, Klaus] Harvard Univ, Sch Med, Program Cellular & Mol Immunol, Boston Childrens Hosp, Boston, MA 02115 USA; [Patterson, Heide Christine] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Patterson, Heide Christine] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Patterson, Heide Christine] Tech Univ Muenchen, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Technical University of Munich	Wang, DH (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, 364 Plantat St, Worcester, MA 01605 USA.	donghai.wang@umassmed.edu; douglas.golenbock@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Rathinam, Vijay/ABE-7544-2020	Rathinam, Vijay/0000-0002-8009-3977; Rajewsky, Klaus/0000-0002-6633-6370; Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health [1 R21 AI095871-01]; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases postdoctoral fellowship (National Institutes of Health) [U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R21AI095871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM102718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases postdoctoral fellowship (National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R21 AI095871-01 (to D. G. and D. W.).; Supported by the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases postdoctoral fellowship (National Institutes of Health U54 AI057159).	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 2011, NAT REV RHEUMATOL, V7, P468, DOI 10.1038/nrrheum.2011.94; Brenner M, 2009, BRIT J DERMATOL, V161, P1199, DOI 10.1111/j.1365-2133.2009.09404.x; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Demidowich AP, 2012, ARTHRITIS RHEUM-US, V64, P2022, DOI 10.1002/art.34332; Dierselhuis MP, 2005, RHEUMATOLOGY, V44, P406, DOI 10.1093/rheumatology/keh479; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Fantuzzi G, 1997, J IMMUNOL, V158, P1818; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Kozak W, 1998, ANN NY ACAD SCI, V856, P33, DOI 10.1111/j.1749-6632.1998.tb08310.x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961; Xu YY, 2008, GENE, V419, P70, DOI 10.1016/j.gene.2008.04.020; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	23	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4594	4601		10.1074/jbc.M112.443077	http://dx.doi.org/10.1074/jbc.M112.443077			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23293022	Green Published, hybrid			2022-12-28	WOS:000315340400009
J	Li, HQ; Gakh, O; Smith, DY; Ranatunga, WK; Isaya, G				Li, Hongqiao; Gakh, Oleksandr; Smith, Douglas Y.; Ranatunga, Wasantha K.; Isaya, Grazia			Missense Mutations Linked to Friedreich Ataxia Have Different but Synergistic Effects on Mitochondrial Frataxin Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST FRATAXIN; SACCHAROMYCES-CEREVISIAE; IRON HOMEOSTASIS; ASSEMBLY COMPLEX; PROTEIN; DISEASE; DETOXIFICATION; ACCUMULATION; BIOGENESIS; METABOLISM	Friedreich ataxia is an early-onset multisystemic disease linked to a variety of molecular defects in the nuclear gene FRDA. This gene normally encodes the iron-binding protein frataxin (FXN), which is critical for mitochondrial iron metabolism, global cellular iron homeostasis, and antioxidant protection. In most Friedreich ataxia patients, a large GAA-repeat expansion is present within the first intron of both FRDA alleles, that results in transcriptional silencing ultimately leading to insufficient levels of FXN protein in the mitochondrial matrix and probably other cellular compartments. The lack of FXN in turn impairs incorporation of iron into iron-sulfur cluster and heme cofactors, causing widespread enzymatic deficits and oxidative damage catalyzed by excess labile iron. In a minority of patients, a typical GAA expansion is present in only one FRDA allele, whereas a missense mutation is found in the other allele. Although it is known that the disease course for these patients can be as severe as for patients with two expanded FRDA alleles, the underlying pathophysiological mechanisms are not understood. Human cells normally contain two major mitochondrial isoforms of FXN (FXN42-210 and FXN81-210) that have different biochemical properties and functional roles. Using cell-free systems and different cellular models, we show that two of the most clinically severe FXN point mutations, I154F and W155R, have unique direct and indirect effects on the stability, biogenesis, or catalytic activity of FXN42-210 and FXN81-210 under physiological conditions. Our data indicate that frataxin point mutations have complex biochemical effects that synergistically contribute to the pathophysiology of Friedreich ataxia.	Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin, Mayo Clin Childrens Ctr, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Isaya, G (corresponding author), Mayo Clin, 200 1st St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health Grant [RO1 AG15709]; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AG15709 (to G. I.). Mayo Clinic has a financial interest associated with technology used in the authors' research that has been licensed to a commercial entity. Mayo Clinic, but not the authors, has received royalties of less than the federal threshold for significant financial interest.	Acquaviva F, 2005, J CELL SCI, V118, P3917, DOI 10.1242/jcs.02516; Andrew AJ, 2008, MOL BIOL CELL, V19, P5259, DOI 10.1091/mbc.E08-06-0622; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Bridwell-Rabb J, 2011, BIOCHEMISTRY-US, V50, P7265, DOI 10.1021/bi200895k; Calmels N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006379; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Condo I, 2010, HUM MOL GENET, V19, P1221, DOI 10.1093/hmg/ddp592; Correia AR, 2006, BIOCHEM J, V398, P605, DOI 10.1042/BJ20060345; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gakh O, 2008, J BIOL CHEM, V283, P31500, DOI 10.1074/jbc.M805415200; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gottesfeld JM, 2007, PHARMACOL THERAPEUT, V116, P236, DOI 10.1016/j.pharmthera.2007.06.014; Jeffery CJ, 2011, IUBMB LIFE, V63, P489, DOI 10.1002/iub.504; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Pastore A, 2007, J AM CHEM SOC, V129, P5374, DOI 10.1021/ja0714538; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Sacca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017627; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Soderberg CAG, 2011, J MOL BIOL, V414, P783, DOI 10.1016/j.jmb.2011.10.034; Tsai CL, 2011, BIOCHEMISTRY-US, V50, P6478, DOI 10.1021/bi200666h; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vaubel R. A., 2012, MOL CELL NE IN PRESS; Vaubel RA, 2011, J BIOL CHEM, V286, P40232, DOI 10.1074/jbc.M111.274415; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Whitnall M, 2012, P NATL ACAD SCI USA, V109, P20590, DOI 10.1073/pnas.1215349109; Xia HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047847; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798	44	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4116	4127		10.1074/jbc.M112.435263	http://dx.doi.org/10.1074/jbc.M112.435263			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23269675	Green Published, hybrid			2022-12-28	WOS:000314845000040
J	Roloff, S; Spillner, C; Kehlenbach, RH				Roloff, Stephanie; Spillner, Christiane; Kehlenbach, Ralph H.			Several Phenylalanine-Glycine Motives in the Nucleoporin Nup214 Are Essential for Binding of the Nuclear Export Receptor CRM1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEX PROTEIN; NUCLEOCYTOPLASMIC TRANSPORT; STRUCTURAL BASIS; IMPORTIN-BETA; CRYSTAL-STRUCTURE; FG-REPEAT; SET-CAN; SIGNAL; LOCALIZATION; CAN/NUP214	Nucleoporins containing phenylalanine glycine (FG) repeats play an important role in nucleocytoplasmic transport as they bind to transport receptors and mediate translocation of transport complexes across the nuclear pore complex (NPC). Nup214/CAN, a nucleoporin that is found at the cytoplasmic side of the NPC, interacts with both import and export receptors. In functional assays, dominant-negative fragments of Nup214 inhibited CRM1-dependent nuclear export, as the export receptor became rate-limiting. Several nuclear import pathways, by contrast, were not affected by the Nup214 fragments. We now characterize the CRM1-binding region of Nup214 in detail and identify several FG motives that are required for this interaction. Our results support a model where CRM1, like other transport receptors, contacts FG-Nups via multiple binding sites.	[Roloff, Stephanie; Spillner, Christiane; Kehlenbach, Ralph H.] Univ Gottingen, Dept Biochem 1, Fac Med, D-37073 Gottingen, Germany	University of Gottingen	Kehlenbach, RH (corresponding author), Univ Gottingen, Dept Biochem 1, Fac Med, Humboldtallee 23, D-37073 Gottingen, Germany.	rkehlen@gwdg.de		Kehlenbach, Ralph/0000-0003-4920-9916	Deutsche Forschungsgemeinschaft [KE 660/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant KE 660/9-1 (to R. H. K.).	Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bastos R, 1997, J CELL BIOL, V137, P989, DOI 10.1083/jcb.137.5.989; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085; Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200; Boer J, 1998, MOL CELL BIOL, V18, P1236, DOI 10.1128/MCB.18.3.1236; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Fernandez-Martinez J, 2012, CURR OPIN CELL BIOL, V24, P92, DOI 10.1016/j.ceb.2011.12.013; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; FORNEROD M, 1995, ONCOGENE, V10, P1739; Fornerod M, 1996, ONCOGENE, V13, P1801; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Hamada M, 2011, J CELL BIOL, V194, P597, DOI 10.1083/jcb.201102018; Hulsmann BB, 2012, CELL, V150, P738, DOI 10.1016/j.cell.2012.07.019; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Isgro TA, 2007, STRUCTURE, V15, P977, DOI 10.1016/j.str.2007.06.011; Kahle J, 2009, J BIOL CHEM, V284, P9382, DOI 10.1074/jbc.M805694200; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Kehlenbach RH, 2001, J BIOL CHEM, V276, P14524, DOI 10.1074/jbc.M011087200; Koyama M, 2010, EMBO J, V29, P2002, DOI 10.1038/emboj.2010.89; KRAEMER D, 1994, P NATL ACAD SCI USA, V91, P1519, DOI 10.1073/pnas.91.4.1519; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Love DC, 1998, P NATL ACAD SCI USA, V95, P10608, DOI 10.1073/pnas.95.18.10608; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; Napetschnig J, 2007, P NATL ACAD SCI USA, V104, P1783, DOI 10.1073/pnas.0610828104; Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Saijou E, 2007, J BIOL CHEM, V282, P32327, DOI 10.1074/jbc.M706793200; Saito S, 2004, INT J CANCER, V111, P501, DOI 10.1002/ijc.20296; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Tetenbaum-Novatt J, 2012, MOL CELL PROTEOMICS, V11, P31, DOI 10.1074/mcp.M111.013656; vanDeursen J, 1996, EMBO J, V15, P5574, DOI 10.1002/j.1460-2075.1996.tb00942.x; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Walde S, 2012, TRAFFIC, V13, P218, DOI 10.1111/j.1600-0854.2011.01302.x; Waldmann I, 2012, J CELL SCI, V125, P144, DOI 10.1242/jcs.090316; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Xu SL, 2009, SEMIN CELL DEV BIOL, V20, P620, DOI 10.1016/j.semcdb.2009.03.003; Yaseen NR, 1997, P NATL ACAD SCI USA, V94, P4451, DOI 10.1073/pnas.94.9.4451	63	23	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3952	3963		10.1074/jbc.M112.433243	http://dx.doi.org/10.1074/jbc.M112.433243			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264634	Green Published, hybrid			2022-12-28	WOS:000314845000025
J	Du, BW; Cawthorn, WP; Su, A; Doucette, CR; Yao, Y; Hemati, N; Kampert, S; McCoin, C; Broome, DT; Rosen, CJ; Yang, GS; MacDougald, OA				Du, Baowen; Cawthorn, William P.; Su, Alison; Doucette, Casey R.; Yao, Yao; Hemati, Nahid; Kampert, Sarah; McCoin, Colin; Broome, David T.; Rosen, Clifford J.; Yang, Gongshe; MacDougald, Ormond A.			The Transcription Factor Paired-Related Homeobox 1 (Prrx1) Inhibits Adipogenesis by Activating Transforming Growth Factor-beta (TGF beta) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PPAR-GAMMA ACTIVITY; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; ADIPOSE-TISSUE; FACTOR-ALPHA; STEM-CELLS; PROTEIN; PRX1; RECEPTOR	Differentiation of adipocytes from preadipocytes contributes to adipose tissue expansion in obesity. Impaired adipogenesis may underlie the development of metabolic diseases such as insulin resistance and type 2 diabetes. Mechanistically, a well defined transcriptional network coordinates adipocyte differentiation. The family of paired-related homeobox transcription factors, which includes Prrx1a, Prrx1b, and Prrx2, is implicated with regulation of mesenchymal cell fate, including myogenesis and skeletogenesis; however, whether these proteins impact adipogenesis remains to be addressed. In this study, we identify Prrx1a and Prrx1b as negative regulators of adipogenesis. We show that Prrx1a and Prrx1b are down-regulated during adipogenesis in vitro and in vivo. Stable knockdown of Prrx1a/b enhances adipogenesis, with increased expression of peroxisome proliferator-activated receptor-gamma, CCAAT/enhancer-binding protein-alpha and FABP4 and increased secretion of the adipokines adiponectin and chemerin. Although stable low-level expression of Prrx1a, Prrx1b, or Prrx2 does not affect 3T3-L1 adipogenesis, transient overexpression of Prrx1a or Prrx1b inhibits peroxisome proliferator-activated receptor-gamma activity. Prrx1 knockdown decreases expression of Tgfb2 and Tgfb3, and inhibition of TGF beta signaling during adipogenesis mimics the effects of Prrx1 knockdown. These data support the hypothesis that endogenous Prrx1 restrains adipogenesis by regulating expression of TGF beta ligands and thereby activating TGF beta signaling. Finally, we find that expression of Prrx1a or Prrx1b in adipose tissue increases during obesity and strongly correlates with Tgfb3 expression in BL6 mice. These observations suggest that increased Prrx1 expression may promote TGF beta activity in adipose tissue and thereby contribute to aberrant adipocyte function during obesity.	[Du, Baowen; Yang, Gongshe] NW A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Du, Baowen; Cawthorn, William P.; Su, Alison; Yao, Yao; Hemati, Nahid; McCoin, Colin; Broome, David T.; MacDougald, Ormond A.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA; [MacDougald, Ormond A.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48105 USA; [Kampert, Sarah; MacDougald, Ormond A.] Univ Michigan, Sch Med, Cell & Mol Biol Program, Ann Arbor, MI 48105 USA; [Doucette, Casey R.; Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA	Northwest A&F University - China; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Maine Medical Center	Yang, GS (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	gsyang999@hotmail.com; macdouga@umich.edu	Cawthorn, William P./Y-2115-2019	Cawthorn, William P./0000-0001-7832-5057; Yang, Gongshe/0000-0003-2003-979X; McCoin, Colin/0000-0002-8557-6441; MacDougald, Ormond/0000-0001-6907-7960	National Institutes of Health [RO1 DK62876, R24 DK092759, R25 DK088752]; Royal Commission for the Exhibition of 1851 (United Kingdom); Lilly Innovation Fellowship Award; China Scholarship Council; National Basic Research Program of China [2012CB124705]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK062876, R56DK062876, R24DK092759, R25DK088752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Commission for the Exhibition of 1851 (United Kingdom); Lilly Innovation Fellowship Award; China Scholarship Council(China Scholarship Council); National Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK62876 (to O. A. M.), R24 DK092759 (to O. A. M. and C. J. R.), and R25 DK088752 (to A. S.). This work was also supported by a Postdoctoral Research Fellowship from the Royal Commission for the Exhibition of 1851 (United Kingdom) and a Lilly Innovation Fellowship Award (to W. P. C.), and a fellowship from the China Scholarship Council and Grant 2012CB124705 from the National Basic Research Program of China (to B. D.).	Ahdjoudj S, 2005, EXP CELL RES, V303, P138, DOI 10.1016/j.yexcr.2004.09.013; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bogazzi F, 2004, EUR J ENDOCRINOL, V150, P863, DOI 10.1530/eje.0.1500863; BORTELL R, 1994, J CELL BIOCHEM, V54, P256, DOI 10.1002/jcb.240540214; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Chan GK, 2001, ENDOCRINOLOGY, V142, P4900, DOI 10.1210/en.142.11.4900; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; CSERJESI P, 1992, DEVELOPMENT, V115, P1087; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; HAWLEY RG, 1994, GENE THER, V1, P136; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Hu YS, 1998, MOL ENDOCRINOL, V12, P1721, DOI 10.1210/me.12.11.1721; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Jiang F, 2008, EXP BIOL MED, V233, P286, DOI 10.3181/0707-RM-177; Kang S, 2005, MOL CELL BIOL, V25, P1272, DOI 10.1128/MCB.25.4.1272-1282.2005; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; KERN MJ, 1992, NUCLEIC ACIDS RES, V20, P5189, DOI 10.1093/nar/20.19.5189; Koutnikova H, 2003, P NATL ACAD SCI USA, V100, P14457, DOI 10.1073/pnas.2336090100; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee YH, 2005, DIABETOLOGIA, V48, P1776, DOI 10.1007/s00125-005-1867-3; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; Lu MF, 1999, DEVELOPMENT, V126, P495; Lu XH, 2011, J BONE MINER RES, V26, P209, DOI 10.1002/jbmr.203; MACDOUGALD OA, 1995, P NATL ACAD SCI USA, V92, P9034, DOI 10.1073/pnas.92.20.9034; MacDougald OA, 2007, CELL METAB, V6, P159, DOI 10.1016/j.cmet.2007.08.010; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; MOUSTAID N, 1993, BIOCHEM J, V292, P767, DOI 10.1042/bj2920767; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; NOHNO T, 1993, DEV BIOL, V158, P254, DOI 10.1006/dbio.1993.1184; Norris RA, 2001, J BIOL CHEM, V276, P26829, DOI 10.1074/jbc.M100239200; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Peterson RE, 2005, DEV DYNAM, V233, P811, DOI 10.1002/dvdy.20412; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Stelnicki EJ, 1998, J INVEST DERMATOL, V111, P57, DOI 10.1046/j.1523-1747.1998.00238.x; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Tchoukalova Y, 2007, DIABETOLOGIA, V50, P151, DOI 10.1007/s00125-006-0496-9; ten Berge D, 1998, DEVELOPMENT, V125, P3831; ten Berge D, 2001, DEVELOPMENT, V128, P2929; TORTI FM, 1989, J CELL BIOL, V108, P1105, DOI 10.1083/jcb.108.3.1105; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; WEINER FR, 1991, J BIOL CHEM, V266, P23525; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412	63	44	49	1	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3036	3047		10.1074/jbc.M112.440370	http://dx.doi.org/10.1074/jbc.M112.440370			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250756	Green Published, hybrid			2022-12-28	WOS:000314397900014
J	Eckers, E; Petrungaro, C; Gross, D; Riemer, J; Hell, K; Deponte, M				Eckers, Elisabeth; Petrungaro, Carmelina; Gross, Dominik; Riemer, Jan; Hell, Kai; Deponte, Marcel			Divergent Molecular Evolution of the Mitochondrial Sulfhydryl: Cytochrome c Oxidoreductase Erv in Opisthokonts and Parasitic Protists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE RELAY SYSTEM; R THIOREDOXIN REDUCTASE; INTERMEMBRANE SPACE; PROTEIN IMPORT; LIVER-REGENERATION; ELECTRON-TRANSFER; BIOCHEMICAL-CHARACTERIZATION; PLASMODIUM-FALCIPARUM; SWISS-MODEL; OXIDASE	Mia40 and the sulfhydryl: cytochrome c oxidoreductase Erv1/ALR are essential for oxidative protein import into the mitochondrial intermembrane space in yeast and mammals. Although mitochondrial protein import is functionally conserved in the course of evolution, many organisms seem to lack Mia40. Moreover, except for in organello import studies and in silico analyses, nothing is known about the function and properties of protist Erv homologues. Here we compared Erv homologues from yeast, the kinetoplastid parasite Leishmania tarentolae, and the non-related malaria parasite Plasmodium falciparum. Both parasite proteins have altered cysteine motifs, formed intermolecular disulfide bonds in vitro and in vivo, and could not replace Erv1 from yeast despite successful mitochondrial protein import in vivo. To analyze its enzymatic activity, we established the expression and purification of recombinant full-length L. tarentolae Erv and compared the mechanism with related and non-related flavoproteins. Enzyme assays indeed confirmed an electron transferase activity with equine and yeast cytochrome c, suggesting a conservation of the enzymatic activity in different eukaryotic lineages. However, although Erv and non-related flavoproteins are intriguing examples of convergent molecular evolution resulting in similar enzyme properties, the mechanisms of Erv homologues from parasitic protists and opisthokonts differ significantly. In summary, the Erv-mediated reduction of cytochrome c might be highly conserved throughout evolution despite the apparent absence of Mia40 in many eukaryotes. Nevertheless, the knowledge on mitochondrial protein import in yeast and mammals cannot be generally transferred to all other eukaryotes, and the corresponding pathways, components, and mechanisms remain to be analyzed.	[Eckers, Elisabeth; Deponte, Marcel] Heidelberg Univ, Dept Parasitol, D-69120 Heidelberg, Germany; [Petrungaro, Carmelina; Riemer, Jan] Univ Kaiserslautern, Div Cellular Biochem, D-67663 Kaiserslautern, Germany; [Gross, Dominik; Hell, Kai] Univ Munich, Adolf Butenandt Inst, Lehrstuhl Physiol Chem, D-81377 Munich, Germany	Ruprecht Karls University Heidelberg; University of Kaiserslautern; University of Munich	Deponte, M (corresponding author), Heidelberg Univ, Dept Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	marcel.deponte@gmx.de	Riemer, Jan/AAC-1072-2021; Groß, Dominik/C-6050-2015	Groß, Dominik/0000-0001-9979-8531; Riemer, Jan/0000-0002-7574-8457; Deponte, Marcel/0000-0003-2141-917X	Deutsche Forschungsgemeinschaft [DE 1431/2, SFB 594,B13]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants DE 1431/2 (to M. D.) and SFB 594,B13 (to K. H.).	Aliverti A, 1999, METH MOL B, V131, P9; Allen JWA, 2008, FEBS LETT, V582, P2817, DOI 10.1016/j.febslet.2008.07.015; Ang SK, 2009, J BIOL CHEM, V284, P28754, DOI 10.1074/jbc.M109.021113; Banci L, 2012, J AM CHEM SOC, V134, P1442, DOI 10.1021/ja209881f; Banci L, 2011, P NATL ACAD SCI USA, V108, P4811, DOI 10.1073/pnas.1014542108; Bauer H, 2003, J BIOL CHEM, V278, P33020, DOI 10.1074/jbc.M303762200; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrie C, 2010, J BIOL CHEM, V285, P36138, DOI 10.1074/jbc.M110.121202; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen XX, 2003, J BIOL CHEM, V278, P49022, DOI 10.1074/jbc.M304057200; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Deponte M, 2005, J BIOL CHEM, V280, P20628, DOI 10.1074/jbc.M412519200; Deponte M, 2005, MOL BIOCHEM PARASIT, V140, P87, DOI 10.1016/j.molbiopara.2004.12.008; Deponte M, 2009, J BIOCHEM, V146, P599, DOI 10.1093/jb/mvp133; Eckers E, 2012, BIOL CHEM, V393, P513, DOI 10.1515/hsz-2011-0255; Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Farver O, 2009, J BIOL CHEM, V284, P2098, DOI 10.1074/jbc.M806316200; Fass D, 2008, BBA-MOL CELL RES, V1783, P557, DOI 10.1016/j.bbamcr.2007.11.009; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Gross DP, 2011, MOL BIOL CELL, V22, P3758, DOI 10.1091/mbc.E11-04-0296; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harner M, 2011, EMBO J, V30, P3232, DOI 10.1038/emboj.2011.235; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678; Hiller N, 2006, PROTEIN SCI, V15, P281, DOI 10.1110/ps.051891106; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Kallergi E, 2012, ACS CHEM BIOL, V7, P707, DOI 10.1021/cb200485b; Kloppel C, 2011, MOL BIOL CELL, V22, P3749, DOI 10.1091/mbc.E11-04-0293; Kojer K, 2012, EMBO J, V31, P3169, DOI 10.1038/emboj.2012.165; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; McMillan PJ, 2006, J BIOL CHEM, V281, P32967, DOI 10.1074/jbc.M601141200; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sideris DP, 2010, ANTIOXID REDOX SIGN, V13, P1189, DOI 10.1089/ars.2010.3157; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Simpson L, 1996, Methods Enzymol, V264, P99, DOI 10.1016/S0076-6879(96)64012-9; Tamarit J, 2003, J BIOL CHEM, V278, P25745, DOI 10.1074/jbc.M303477200; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; Terziyska N, 2009, J BIOL CHEM, V284, P1353, DOI 10.1074/jbc.M805035200; Thorpe C, 2007, J BIOL CHEM, V282, P13929, DOI 10.1074/jbc.R600037200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vitu E, 2006, J MOL BIOL, V362, P89, DOI 10.1016/j.jmb.2006.06.070; Wu CK, 2003, PROTEIN SCI, V12, P1109, DOI 10.1110/ps.0238103	51	27	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2676	2688		10.1074/jbc.M112.420745	http://dx.doi.org/10.1074/jbc.M112.420745			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233680	hybrid, Green Published			2022-12-28	WOS:000314211500052
J	Esser, AK; Miller, MR; Huang, Q; Meier, MM; de Bernabe, DBV; Stipp, CS; Campbell, KP; Lynch, CF; Smith, BJ; Cohen, MB; Henry, MD				Esser, Alison K.; Miller, Michael R.; Huang, Qin; Meier, Melissa M.; de Bernabe, Daniel Beltran-Valero; Stipp, Christopher S.; Campbell, Kevin P.; Lynch, Charles F.; Smith, Brian J.; Cohen, Michael B.; Henry, Michael D.			Loss of LARGE2 Disrupts Functional Glycosylation of alpha-Dystroglycan in Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIN-ASSOCIATED GLYCOPROTEINS; ALTERED GLYCOSYLATION; ABERRANT EXPRESSION; MUSCULAR-DYSTROPHY; PREDICTS SURVIVAL; PATIENT SURVIVAL; EPITHELIAL-CELLS; LAMININ-BINDING; TUMOR GRADE; GLYCOSYLTRANSFERASE	Dystroglycan (DG) is a cell surface receptor for extracellular matrix proteins and is involved in cell polarity, matrix organization, and mechanical stability of tissues. Previous studies documented loss of DG protein expression and glycosylation in a variety of cancer types, but the underlying mechanisms and the functional consequences with respect to cancer progression remain unclear. Here, we show that the level of expression of the beta DG subunit as well as the glycosylation status of the alpha DG subunit inversely correlate with the Gleason scores of prostate cancers; furthermore, we show that the functional glycosylation of alpha DG is substantially reduced in prostate cancer metastases. Additionally, we demonstrate that LARGE2 (GYLTL1B), a gene not previously implicated in cancer, regulates functional alpha DG glycosylation in prostate cancer cell lines; knock down of LARGE2 resulted in hypoglycosylation of alpha DG and loss of its ability to bind laminin-111 while overexpression restored ligand binding and diminished growth and migration of an aggressive prostate cancer cell line. Finally, our analysis of LARGE2 expression in human cancer specimens reveals that LARGE2 is significantly down-regulated in the context of prostate cancer, and that its reduction correlates with disease progression. Our results describe a novel molecular mechanism to account for the commonly observed hypoglycosylation of alpha DG in prostate cancer.	[Esser, Alison K.; Miller, Michael R.; Huang, Qin; de Bernabe, Daniel Beltran-Valero; Campbell, Kevin P.; Henry, Michael D.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Meier, Melissa M.; Cohen, Michael B.; Henry, Michael D.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Stipp, Christopher S.] Univ Iowa, Dept Biol, Coll Publ Hlth, Iowa City, IA 52242 USA; [de Bernabe, Daniel Beltran-Valero; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Coll Publ Hlth, Iowa City, IA 52242 USA; [Lynch, Charles F.] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA 52242 USA; [Smith, Brian J.] Univ Iowa, Dept Biostat, Coll Publ Hlth, Iowa City, IA 52242 USA; [Stipp, Christopher S.; Campbell, Kevin P.; Lynch, Charles F.; Smith, Brian J.; Cohen, Michael B.; Henry, Michael D.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Henry, MD (corresponding author), Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, 6-510 Bowen Sci Bldg, Iowa City, IA 52242 USA.	michael-henry@uiowa.edu	Meier, Marcia M/I-1987-2016	Miller, Michael/0000-0002-7726-0519; Campbell, Kevin/0000-0003-2066-5889; Henry, Michael/0000-0002-7871-245X	National Institutes of Health [R01CA130916, P30 CA086862, HHSN261201000032C]; NATIONAL CANCER INSTITUTE [P50CA097186, T32CA113275, R01CA136664, R01CA130916, P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA130916 and P30 CA086862 and Contract HHSN261201000032C.	Aravind L, 1999, CURR BIOL, V9, pR836, DOI 10.1016/S0960-9822(00)80039-1; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Calogero A, 2006, CANCER BIOL THER, V5, P441, DOI 10.4161/cbt.5.4.2546; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; de Bernabe DBV, 2009, J BIOL CHEM, V284, P11279, DOI 10.1074/jbc.C900007200; de Bernabe DBV, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013870; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Drake JM, 2010, J BIOL CHEM, V285, P33940, DOI 10.1074/jbc.M110.136044; Drake JM, 2009, MOL BIOL CELL, V20, P2207, DOI 10.1091/mbc.E08-10-1076; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Edge SB, 2010, AJCC CANC STAGING MA; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Esser AK, 2010, PROSTATE, V70, P777, DOI 10.1002/pros.21110; Fujimura K, 2005, BIOCHEM BIOPH RES CO, V329, P1162, DOI 10.1016/j.bbrc.2005.02.082; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; Grewal PK, 2002, BBA-GEN SUBJECTS, V1573, P216, DOI 10.1016/S0304-4165(02)00387-2; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Hayashi YK, 2001, NEUROLOGY, V57, P115, DOI 10.1212/WNL.57.1.115; Henry MD, 2001, HUM PATHOL, V32, P791, DOI 10.1053/hupa.2001.26468; Higginson JR, 2005, BIOCHEM SOC T, V33, P1254, DOI 10.1042/BST0331254; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jarad G, 2011, AM J PHYSIOL-RENAL, V300, pF811, DOI 10.1152/ajprenal.00725.2010; Jiang XH, 2011, J SURG RES, V171, P120, DOI 10.1016/j.jss.2009.11.730; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2005, FEBS LETT, V579, P4792, DOI 10.1016/j.febslet.2005.07.059; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Martin LT, 2007, HUM PATHOL, V38, P1657, DOI 10.1016/j.humpath.2007.03.025; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Mirouse V, 2009, DEV CELL, V16, P83, DOI 10.1016/j.devcel.2008.11.006; Moon YW, 2009, J SURG ONCOL, V100, P459, DOI 10.1002/jso.21347; Muschler J, 2002, CANCER RES, V62, P7102; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sgambato A, 2007, J CELL PHYSIOL, V213, P528, DOI 10.1002/jcp.21130; Sgambato A, 2004, CANCER BIOL THER, V3, P967, DOI 10.4161/cbt.3.10.1132; Sgambato A, 2003, AM J PATHOL, V162, P849, DOI 10.1016/S0002-9440(10)63881-3; Sgambato A, 2010, PATHOLOGY, V42, P248, DOI 10.3109/00313021003631361; Sgambato A, 2007, CANCER BIOL THER, V6, P1840, DOI 10.4161/cbt.6.12.4983; Sgambato A, 2006, GYNECOL ONCOL, V103, P397, DOI 10.1016/j.ygyno.2006.03.059; Shang ZJ, 2008, ORAL ONCOL, V44, P1139, DOI 10.1016/j.oraloncology.2008.02.016; Shen JG, 2012, PATHOL ONCOL RES, V18, P79, DOI 10.1007/s12253-011-9419-2; Shimojo H, 2011, PROSTATE, V71, P1151, DOI 10.1002/pros.21330; Singh J, 2004, CANCER RES, V64, P6152, DOI 10.1158/0008-5472.CAN-04-1638; Svensson RU, 2007, CANCER RES, V67, P10445, DOI 10.1158/0008-5472.CAN-07-1955; Takahashi T, 2000, GLYCOBIOLOGY, V10, P321, DOI 10.1093/glycob/10.3.321; Weir ML, 2006, J CELL SCI, V119, P4047, DOI 10.1242/jcs.03103; Yoneyama T, 2012, MOL BIOL CELL, V23, P771, DOI 10.1091/mbc.E11-06-0517; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	60	27	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2132	2142		10.1074/jbc.M112.432807	http://dx.doi.org/10.1074/jbc.M112.432807			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223448	Green Published, hybrid			2022-12-28	WOS:000314211500004
J	Ramachandran, S; Chakraborty, A; Xu, L; Mei, YW; Samso, M; Dokholyan, NV; Meissner, G				Ramachandran, Srinivas; Chakraborty, Asima; Xu, Le; Mei, Yingwu; Samso, Montserrat; Dokholyan, Nikolay V.; Meissner, Gerhard			Structural Determinants of Skeletal Muscle Ryanodine Receptor Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNEL; DISCRETE MOLECULAR-DYNAMICS; PROTEIN DATABASE SEARCHES; VOLTAGE SENSOR; CRYSTAL-STRUCTURE; S4-S5 LINKER; TOPOLOGY PREDICTION; ACTIVATION GATE; PSI-BLAST; MOVEMENT	Ryanodine receptor type 1 (RyR1) releases Ca2+ from intracellular stores upon nerve impulse to trigger skeletal muscle contraction. Effector binding at the cytoplasmic domain tightly controls gating of the pore domain of RyR1 to release Ca2+. However, the molecular mechanism that links effector binding to channel gating is unknown due to lack of structural data. Here, we used a combination of computational and electrophysiological methods and cryo-EM densities to generate structural models of the open and closed states of RyR1. Using our structural models, we identified an interface between the pore-lining helix (Tyr-4912-Glu-4948) and a linker helix (Val-4830-Val-4841) that lies parallel to the cytoplasmic membrane leaflet. To test the hypothesis that this interface controls RyR1 gating, we designed mutations in the linker helix to stabilize either the open (V4830W and T4840W) or closed (H4832W and G4834W) state and validated them using single channel experiments. To further confirm this interface, we designed mutations in the pore-lining helix to stabilize the closed state (Q4947N, Q4947T, and Q4947S), which we also validated using single channel experiments. The channel conductance and selectivity of the mutations that we designed in the linker and pore-lining helices were indistinguishable from those of WT RyR1, demonstrating our ability to modulate RyR1 gating without affecting ion permeation. Our integrated computational and experimental approach significantly advances the understanding of the structure and function of an unusually large ion channel.	[Ramachandran, Srinivas; Chakraborty, Asima; Xu, Le; Mei, Yingwu; Dokholyan, Nikolay V.; Meissner, Gerhard] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Samso, Montserrat] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Virginia Commonwealth University	Samso, M (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23298 USA.	msamso@vcu.edu; dokh@unc.edu; meissner@med.unc.edu	Dokholyan, Nikolay/D-8081-2018; Xu, Le/HDN-9623-2022	Dokholyan, Nikolay/0000-0002-8225-4025; Samso, Montserrat/0000-0002-2788-3283; Ramachandran, Srinivas/0000-0003-2929-1377	National Institutes of Health [AR018687]; American Heart Association Predoctoral Fellowship [09PRE2090068]; Virginia Commonwealth University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687, R01AR018687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); Virginia Commonwealth University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR018687 (to G. M. and N. V. D.). This work was also supported by American Heart Association Predoctoral Fellowship 09PRE2090068 (to S. R.) and Virginia Commonwealth University startup funds (to M. S.).	Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balshaw D, 1999, P NATL ACAD SCI USA, V96, P3345, DOI 10.1073/pnas.96.7.3345; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; CALLAWAY C, 1994, J BIOL CHEM, V269, P15876; Caprini M, 2005, J BIOL CHEM, V280, P18253, DOI 10.1074/jbc.M413389200; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; Du GG, 2004, J BIOL CHEM, V279, P37566, DOI 10.1074/jbc.M406637200; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Klein A, 2012, HUM MUTAT, V33, P981, DOI 10.1002/humu.22056; Kota P, 2011, BIOINFORMATICS, V27, P2209, DOI 10.1093/bioinformatics/btr374; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; LEE HB, 1994, J BIOL CHEM, V269, P13305; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Meissner G, 2004, CELL CALCIUM, V35, P621, DOI 10.1016/j.ceca.2004.01.015; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Murayama T, 2011, J BIOL CHEM, V286, P35571, DOI 10.1074/jbc.M111.255240; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Sutko JL, 1997, PHARMACOL REV, V49, P53; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wang Y, 2006, J BIOL CHEM, V281, P15572, DOI 10.1074/jbc.M600090200; WILLIAMS AJ, 1992, J MUSCLE RES CELL M, V13, P7, DOI 10.1007/BF01738423; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Yin S, 2008, J CHEM INF MODEL, V48, P1656, DOI 10.1021/ci8001167; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971	59	41	41	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6154	6165		10.1074/jbc.M112.433789	http://dx.doi.org/10.1074/jbc.M112.433789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319589	Green Published, hybrid			2022-12-28	WOS:000315820700012
J	Cui, S; Fukao, Y; Mano, S; Yamada, K; Hayashi, M; Nishimura, M				Cui, Songkui; Fukao, Yoichiro; Mano, Shoji; Yamada, Kenji; Hayashi, Makoto; Nishimura, Mikio			Proteomic Analysis Reveals That the Rab GTPase RabE1c Is Involved in the Degradation of the Peroxisomal Protein Receptor PEX7 (Peroxin 7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING SIGNAL TYPE-2; ARABIDOPSIS-THALIANA; SACCHAROMYCES-CEREVISIAE; CYTOSOLIC CHAPERONIN; MAMMALIAN-CELLS; LONGER ISOFORM; PTS1 RECEPTOR; IMPORT; BIOGENESIS; MUTANT	The biogenesis of peroxisomes is mediated by peroxins (PEXs). PEX7 is a cytosolic receptor that imports peroxisomal targeting signal type 2 (PTS2)-containing proteins. Although PEX7 is important for protein transport, the mechanisms that mediate its function are unknown. In this study, we performed proteomic analysis to identify PEX7-binding proteins using transgenic Arabidopsis expressing green fluorescent protein (GFP)-tagged PEX7. Our analysis identified RabE1c, a small GTPase, as a PEX7 binding partner. In vivo analysis revealed that GTP-bound RabE1c binds to PEX7 and that a subset of RabE1c localizes to peroxisomes and interacts with PEX7 on the peroxisome membrane. Unlike endogenous PEX7, which is predominantly localized to the cytosol, GFP-PEX7 accumulates abnormally on the peroxisomal membrane and induces degradation of endogenous PEX7, concomitant with a reduction in import of PTS2-containing proteins and decreased peroxisomal beta-oxidation activity. Thus, GFP-PEX7 on the peroxisomal membrane exerts a dominant negative effect. Mutation of RabE1c restored endogenous PEX7 protein expression and import of PTS2-containing proteins as well as peroxisomal beta-oxidation activity. Treatment with proteasome inhibitors also restored endogenous PEX7 protein levels in GFP-PEX7-expressing seedlings. Based on these findings, we conclude that RabE1c binds PEX7 and facilitates PEX7 degradation in the presence of immobile GFP-PEX7 accumulated at the membrane.	[Cui, Songkui; Mano, Shoji; Yamada, Kenji; Hayashi, Makoto; Nishimura, Mikio] Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; [Cui, Songkui; Mano, Shoji; Yamada, Kenji; Hayashi, Makoto; Nishimura, Mikio] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Fukao, Yoichiro] Nara Inst Sci & Technol, Plant Global Educ Project, Ikoma 6300192, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Nara Institute of Science & Technology	Nishimura, M (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Cell Biol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	mikosome@nibb.ac.jp	Yamada, Kenji/C-4336-2018; Cui, Songkui/ABF-4552-2021; Fukao, Yoichiro/E-7137-2013	Yamada, Kenji/0000-0003-4872-3729; Cui, Songkui/0000-0001-7777-6681; Nishimura, Mikio/0000-0001-7960-9721; Mano, Shoji/0000-0003-1323-3308	Ministry of Education, Science, Sports, and Culture of Japan [22120007]; Grants-in-Aid for Scientific Research [22112523, 25440146, 23770050] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 22120007 from the Ministry of Education, Science, Sports, and Culture of Japan (to M.N.).	Anthonio EA, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-58; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Einwachter H, 2001, EMBO REP, V2, P1035, DOI 10.1093/embo-reports/kve228; Ghys K, 2002, BIOCHEM J, V365, P41, DOI 10.1042/BJ20011432; Hayashi H, 1998, J BIOL CHEM, V273, P8301, DOI 10.1074/jbc.273.14.8301; Hayashi M, 2005, J BIOL CHEM, V280, P14829, DOI 10.1074/jbc.M411005200; Hayashi M, 1996, PLANT J, V10, P225, DOI 10.1046/j.1365-313X.1996.10020225.x; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Hayashi M, 2000, EMBO J, V19, P5701, DOI 10.1093/emboj/19.21.5701; Hino T, 2011, BIOSCI BIOTECH BIOCH, V75, P1848, DOI 10.1271/bbb.110331; Karnik SK, 2005, PLANT PHYSIOL, V138, P1967, DOI [10.1104/pp.105.061291, 10.1104/PP.105.061291]; Kato A, 1998, PLANT CELL PHYSIOL, V39, P186, DOI 10.1093/oxfordjournals.pcp.a029356; Kato A, 1996, PLANT MOL BIOL, V31, P843, DOI 10.1007/BF00019471; Kato A, 1996, PLANT CELL, V8, P1601, DOI 10.1105/tpc.8.9.1601; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Koller A, 1999, J CELL BIOL, V146, P99, DOI 10.1083/jcb.146.1.99; Kragler F, 1998, P NATL ACAD SCI USA, V95, P13336, DOI 10.1073/pnas.95.22.13336; KUBOTA H, 1995, GENE, V154, P231, DOI 10.1016/0378-1119(94)00880-2; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; Lin Y, 2004, PLANT PHYSIOL, V135, P814, DOI 10.1104/pp.103.036772; Ling QH, 2012, SCIENCE, V338, P655, DOI 10.1126/science.1225053; Mano S, 2002, PLANT CELL PHYSIOL, V43, P331, DOI 10.1093/pcp/pcf037; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; Mukai S, 2002, J BIOL CHEM, V277, P9548, DOI 10.1074/jbc.M108635200; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nito K, 2002, PLANT CELL PHYSIOL, V43, P355, DOI 10.1093/pcp/pcf057; Nito K, 2007, PLANT CELL PHYSIOL, V48, P763, DOI 10.1093/pcp/pcm053; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Purdue PE, 2001, J BIOL CHEM, V276, P47684, DOI 10.1074/jbc.M106823200; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Schollenberger L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013886; Schuhmann H, 2008, PLANT PHYSIOL, V148, P1847, DOI 10.1104/pp.108.125377; Sichting M, 2003, MOL BIOL CELL, V14, P810, DOI 10.1091/mbc.E02-08-0539; Singh T, 2009, PLANT J, V60, P488, DOI 10.1111/j.1365-313X.2009.03970.x; Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422; Woollard AAD, 2008, CURR OPIN PLANT BIOL, V11, P610, DOI 10.1016/j.pbi.2008.09.010; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; Yi CL, 2006, INT J BIOCHEM CELL B, V38, P1076, DOI 10.1016/j.biocel.2005.12.019; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65; Zheng HQ, 2005, PLANT CELL, V17, P2020, DOI 10.1105/tpc.105.031112; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691; Zolman BK, 2004, P NATL ACAD SCI USA, V101, P1786, DOI 10.1073/pnas.0304368101; Zolman BK, 2000, GENETICS, V156, P1323	50	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					6014	6023		10.1074/jbc.M112.438143	http://dx.doi.org/10.1074/jbc.M112.438143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297417	Green Published, hybrid			2022-12-28	WOS:000315342500069
J	Della Vecchia, MC; Rued, AC; Carattino, MD				Della Vecchia, Margaret C.; Rued, Anna C.; Carattino, Marcelo D.			Gating Transitions in the Palm Domain of ASIC1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; EXTRACELLULAR DOMAIN; SODIUM-CHANNEL; DESENSITIZATION; PLASTICITY	Acid-sensing ion channels (ASICs) are trimeric cation-selective proton-gated ion channels expressed in the central and peripheral nervous systems. The pore-forming transmembrane helices in these channels are linked by short loops to the palm domain in the extracellular region. Here, we explore the contribution to proton gating and desensitization of Glu-79 and Glu-416 in the palm domain of ASIC1a. Engineered Cys, Lys, and Gln substitutions at these positions shifted apparent proton affinity toward more acidic values. Double mutant cycle analysis indicated that Glu-79 and Glu-416 cooperatively facilitated pore opening in response to extracellular acidification. Channels bearing Cys at position 79 or 416 were irreversibly modified by thiol-reactive reagents in a state-dependent manner. Glu-79 and Glu-416 are located in beta-strands 1 and 12, respectively. The covalent modification by (2-(trimethylammonium)ethyl) methanethiosulfonate bromide of Cys at position 79 impacted conformational changes associated with pore closing during desensitization, whereas the modification of Cys at position 416 affected conformational changes associated with proton gating. These results suggest that beta-strands 1 and 12 contribute antagonistically to activation and desensitization of ASIC1a. Site-directed mutagenesis experiments indicated that the lower palm domain contracts in response to extracellular acidification. Taken together, our studies suggest that the lower palm domain mediates conformational movements that drive pore opening and closing events.	Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), Dept Med, Renal Electrolyte Div, S828 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mdc4@pitt.edu			National Institutes of Health Grant [R01 DK084060]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084060] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK084060.	Alijevic O, 2012, J BIOL CHEM, V287, P36059, DOI 10.1074/jbc.M112.360487; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Gautam M, 2013, FASEB J, V27, P793, DOI 10.1096/fj.12-220400; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Qadri YJ, 2012, AM J PHYSIOL-CELL PH, V302, pC943, DOI 10.1152/ajpcell.00019.2012; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Shi S, 2012, J BIOL CHEM, V287, P44027, DOI 10.1074/jbc.M112.421743; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001	29	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5487	5495		10.1074/jbc.M112.441964	http://dx.doi.org/10.1074/jbc.M112.441964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23300086	Green Published, hybrid			2022-12-28	WOS:000315342500023
J	Gonzalez, W; Zuniga, L; Cid, LP; Arevalo, B; Niemeyer, MI; Sepulveda, FV				Gonzalez, Wendy; Zuniga, Leandro; Cid, L. Pablo; Arevalo, Barbara; Niemeyer, Maria Isabel; Sepulveda, Francisco V.			An Extracellular Ion Pathway Plays a Central Role in the Cooperative Gating of a K-2P K+ Channel by Extracellular pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN POTASSIUM CHANNEL; 2-PORE DOMAIN; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; TASK-3; PORE; BLOCK; SENSITIVITY; SELECTIVITY; MECHANISM	Proton-gated TASK-3K(+) channel belongs to the K-2P family of proteins that underlie the K+ leak setting the membrane potential in all cells. TASK-3 is under cooperative gating control by extracellular [H+]. Use of recently solved K-2P structures allows us to explore the molecular mechanism of TASK-3 cooperative pH gating. Tunnel-like side portals define an extracellular ion pathway to the selectivity filter. We use a combination of molecular modeling and functional assays to show that pH-sensing histidine residues and K+ ions mutually interact electrostatically in the confines of the extracellular ion pathway. K+ ions modulate the pK(a) of sensing histidine side chains whose charge states in turn determine the open/closed transition of the channel pore. Cooperativity, and therefore steep dependence of TASK-3 K+ channel activity on extracellular pH, is dependent on an effect of the permeant ion on the channel pH(o) sensors.	[Zuniga, Leandro; Cid, L. Pablo; Niemeyer, Maria Isabel; Sepulveda, Francisco V.] Ctr Estudios Cient, Valdivia 5110466, Chile; [Gonzalez, Wendy; Arevalo, Barbara] Univ Talca, Ctr Bioinformat & Simulac Mol, Talca 3465548, Chile	Universidad de Talca	Niemeyer, MI (corresponding author), Ctr Estudios Cient, Ave Arturo Prat 514, Valdivia 5110466, Chile.	miniemeyer@cecs.cl; fsepulveda@cecs.cl		Sepulveda Valenzuela, Francisco Leandro/0000-0003-0022-6598; Cid, Pablo/0000-0003-0394-0498	Fondecyt [1090478, 11100373]; Conicyt Base Finance Program	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt Base Finance Program	This work was supported by Fondecyt Grants 1090478 (to M.I.N.) and 11100373 (to W.G.).; We are grateful to Dr. Jurgen Daut (Marburg, Germany) and Donghee Kim (Chicago, IL) for providing TASK-3 and TASK-1 cDNAs and to Dr. Jacques Teulon (Paris, France) for comments on a preliminary version of the paper. CECs is funded by the Conicyt Base Finance Program.	Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Carvacho I, 2008, J GEN PHYSIOL, V131, P147, DOI 10.1085/jgp.200709862; Chatelain FC, 2012, P NATL ACAD SCI USA, V109, P5499, DOI 10.1073/pnas.1201132109; Cid LP, 2000, AM J PHYSIOL-CELL PH, V279, pC1198, DOI 10.1152/ajpcell.2000.279.4.C1198; Clarke CE, 2008, J BIOL CHEM, V283, P16985, DOI 10.1074/jbc.M801368200; Clarke CE, 2004, J PHYSIOL-LONDON, V560, P51, DOI 10.1113/jphysiol.2004.070292; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Czirjak G, 2003, MOL PHARMACOL, V63, P646, DOI 10.1124/mol.63.3.646; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Guagliardo NA, 2012, HYPERTENSION, V59, P999, DOI 10.1161/HYPERTENSIONAHA.111.189662; Ho MC, 2009, NATURE, V459, P393, DOI 10.1038/nature07938; HODGKIN AL, 1947, J PHYSIOL-LONDON, V106, P341, DOI 10.1113/jphysiol.1947.sp004216; Niemeyer MI, 2010, J BIOL CHEM, V285, P16467, DOI 10.1074/jbc.M110.107060; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim D, 2009, J PHYSIOL-LONDON, V587, P2963, DOI 10.1113/jphysiol.2009.171181; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Musset B, 2006, J PHYSIOL-LONDON, V572, P639, DOI 10.1113/jphysiol.2006.106898; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; Niemeyer MI, 2001, J BIOL CHEM, V276, P43166, DOI 10.1074/jbc.M107192200; Pang DSJ, 2009, P NATL ACAD SCI USA, V106, P17546, DOI 10.1073/pnas.0907228106; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Stansfeld PJ, 2008, BIOCHEMISTRY-US, V47, P7414, DOI 10.1021/bi800475j; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Yuill KH, 2007, PFLUG ARCH EUR J PHY, V455, P333, DOI 10.1007/s00424-007-0282-7; Zuniga L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016141	39	30	30	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5984	5991		10.1074/jbc.M112.445528	http://dx.doi.org/10.1074/jbc.M112.445528			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23319597	Green Published, hybrid			2022-12-28	WOS:000315342500066
J	Karkare, S; Chung, TTH; Collin, F; Mitchenall, LA; McKay, AR; Greive, SJ; Meyer, JJM; Lall, N; Maxwell, A				Karkare, Shantanu; Chung, Terence T. H.; Collin, Frederic; Mitchenall, Lesley A.; McKay, Adam R.; Greive, Sandra J.; Meyer, Jacobus J. M.; Lall, Namrita; Maxwell, Anthony			The Naphthoquinone Diospyrin Is an Inhibitor of DNA Gyrase with a Novel Mechanism of Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II-ALPHA; N-TERMINAL FRAGMENT; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; NALIDIXIC-ACID; DRUG-RESISTANT; DOMAIN; IV	Tuberculosis and other bacterial diseases represent a significant threat to human health. The DNA topoisomerases are excellent targets for chemotherapy, and DNA gyrase in particular is a well-validated target for antibacterial agents. Naphthoquinones (e.g. diospyrin and 7-methyljuglone) have been shown to have therapeutic potential, particularly against Mycobacterium tuberculosis. We have found that these compounds are inhibitors of the supercoiling reaction catalyzed by M. tuberculosis gyrase and other gyrases. Our evidence strongly suggests that the compounds bind to the N-terminal domain of GyrB, which contains the ATPase active site, but are not competitive inhibitors of the ATPase reaction. We propose that naphthoquinones bind to GyrB at a novel site close to the ATPase site. This novel mode of action could be exploited to develop new antibacterial agents.	[Karkare, Shantanu; Chung, Terence T. H.; Collin, Frederic; Mitchenall, Lesley A.; Greive, Sandra J.; Maxwell, Anthony] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [McKay, Adam R.] UCL, Dept Chem, London WC1H 0AJ, England; [Meyer, Jacobus J. M.; Lall, Namrita] Univ Pretoria, Dept Plant Sci, ZA-0002 Pretoria, South Africa	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of London; University College London; University of Pretoria	Maxwell, A (corresponding author), John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	tony.maxwell@jic.ac.uk	Collin, Frederic/N-5579-2015; Lall, Namrita/S-3690-2019; Lall, Namrita/A-2635-2012	Collin, Frederic/0000-0002-6720-5444; Lall, Namrita/0000-0002-3242-3476; Lall, Namrita/0000-0002-3242-3476; Maxwell, Anthony/0000-0002-5756-6430; Mitchenall, Lesley/0000-0002-0063-1991	Early Stage Research Training Scholarship (EU); Biotechnology and Biological Sciences Research Council (UK) [BB/J004561/1]; John Innes Foundation; National Research Foundation of South Africa; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: researchfish	Early Stage Research Training Scholarship (EU); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; National Research Foundation of South Africa(National Research Foundation - South Africa); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an Early Stage Research Training Scholarship (EU, FP7), by Grant BB/J004561/1 from the Biotechnology and Biological Sciences Research Council (UK) and the John Innes Foundation, and by the National Research Foundation of South Africa.	ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Alt S, 2011, J ANTIMICROB CHEMOTH, V66, P2061, DOI 10.1093/jac/dkr247; Aubry A, 2006, BIOCHEM BIOPH RES CO, V348, P158, DOI 10.1016/j.bbrc.2006.07.017; Bates A. D., 2005, DNA TOPOLOGY; Bender RP, 2007, BIOCHEMISTRY-US, V46, P2856, DOI 10.1021/bi062017l; Bender RP, 2006, BIOCHEMISTRY-US, V45, P10140, DOI 10.1021/bi0524666; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Edwards MJ, 2011, BIOCHEMISTRY-US, V50, P3432, DOI 10.1021/bi101691k; Edwards MJ, 2009, SCIENCE, V326, P1415, DOI 10.1126/science.1179123; Flatman RH, 2005, ANTIMICROB AGENTS CH, V49, P1093, DOI 10.1128/AAC.49.3.1093-1100.2005; Fu GS, 2009, NUCLEIC ACIDS RES, V37, P5908, DOI 10.1093/nar/gkp586; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Gormley NA, 1996, BIOCHEMISTRY-US, V35, P5083, DOI 10.1021/bi952888n; Huang YY, 2006, NUCLEIC ACIDS RES, V34, P5650, DOI 10.1093/nar/gkl695; Jacob DA, 2011, BIOCHEMISTRY-US, V50, P5660, DOI 10.1021/bi200438m; Kampranis SC, 1999, J MOL BIOL, V293, P733, DOI 10.1006/jmbi.1999.3182; Kampranis SC, 1999, BIOCHEMISTRY-US, V38, P1967, DOI 10.1021/bi982320p; Kampranis SC, 1998, J BIOL CHEM, V273, P22606, DOI 10.1074/jbc.273.35.22606; Karkare S, 2012, NUCLEIC ACIDS RES, V40, P9774, DOI 10.1093/nar/gks704; KHODURSKY AB, 1995, P NATL ACAD SCI USA, V92, P11801, DOI 10.1073/pnas.92.25.11801; Lall N, 1999, J ETHNOPHARMACOL, V66, P347, DOI 10.1016/S0378-8741(98)00185-8; Lall N, 2001, J ETHNOPHARMACOL, V78, P213, DOI 10.1016/S0378-8741(01)00356-7; Lall N, 2000, J ETHNOPHARMACOL, V72, P313, DOI 10.1016/S0378-8741(00)00231-2; Lewis K, 2006, NAT BIOTECHNOL, V24, P1504, DOI 10.1038/nbt1206-1504; Lindsey RH, 2004, BIOCHEMISTRY-US, V43, P7563, DOI 10.1021/bi049756r; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0; Mahapatra A, 2007, BIOORGAN MED CHEM, V15, P7638, DOI 10.1016/j.bmc.2007.08.064; Manjunatha U. H., 2006, Journal of the Indian Institute of Science, V86, P751; Manjunatha UH, 2005, NUCLEIC ACIDS RES, V33, P3085, DOI 10.1093/nar/gki622; Maxwell A, 1999, METH MOL B, V94, P135; Mdluli Khisimuzi, 2007, Infectious Disorders - Drug Targets, V7, P159; Nollmann M, 2007, BIOCHIMIE, V89, P490, DOI 10.1016/j.biochi.2007.02.012; Pan XS, 1996, ANTIMICROB AGENTS CH, V40, P2321, DOI 10.1128/AAC.40.10.2321; Pinto AV, 2009, MOLECULES, V14, P4570, DOI 10.3390/molecules14114570; Ray S, 1998, MOL PHARMACOL, V54, P994, DOI 10.1124/mol.54.6.994; Sibanda T, 2007, AFR J BIOTECHNOL, V6, P2886; SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767; Ting CY, 2003, BIOCHEM PHARMACOL, V66, P1981, DOI 10.1016/j.bcp.2003.07.003; Tretter EM, 2012, J BIOL CHEM, V287, P18645, DOI 10.1074/jbc.M112.345736; Tretter EM, 2010, PROTEINS, V78, P492, DOI 10.1002/prot.22600; van der Kooy F, 2006, S AFR J BOT, V72, P349, DOI 10.1016/j.sajb.2005.09.009; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wang HM, 2001, BIOCHEMISTRY-US, V40, P3316, DOI 10.1021/bi002786j; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; WILLMOTT CJR, 1993, ANTIMICROB AGENTS CH, V37, P126, DOI 10.1128/AAC.37.1.126; Wright GD, 2011, CHEM COMMUN, V47, P4055, DOI 10.1039/c0cc05111j; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; ZECHIEDRICH EL, 1995, GENE DEV, V9, P2859, DOI 10.1101/gad.9.22.2859	53	53	57	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5149	5156		10.1074/jbc.M112.419069	http://dx.doi.org/10.1074/jbc.M112.419069			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23275348	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000315340400062
J	Tiwari, S; Siddiqi, S; Siddiqi, SA				Tiwari, Samata; Siddiqi, Shaila; Siddiqi, Shadab A.			CideB Protein Is Required for the Biogenesis of Very Low Density Lipoprotein (VLDL) Transport Vesicle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; PLASMA-MEMBRANE ATPASE; ENDOPLASMIC-RETICULUM; APOLIPOPROTEIN-B; APO-B; RETENTION DISEASE; SELECTIVE EXPORT; GOLGI-APPARATUS; SAR1B GENE; EFFECTOR B	Nascent very low density lipoprotein (VLDL) exits the endoplasmic reticulum (ER) in a specialized ER-derived vesicle, the VLDL transport vesicle (VTV). Similar to protein transport vesicles (PTVs), VTVs require coat complex II (COPII) proteins for their biogenesis from the ER membranes. Because the size of the VTV is large, we hypothesized that protein(s) in addition to COPII components might be required for VTV biogenesis. Our proteomic analysis, supported by Western blotting data, shows that a 26-kDa protein, CideB, is present in the VTV but not in other ER-derived vesicles such as PTV and pre-chylomicron transport vesicle. Western blotting and immunoelectron microscopy analyses suggest that CideB is concentrated in the VTV. Our co-immunoprecipitation data revealed that CideB specifically interacts with VLDL structural protein, apolipoprotein B100 (apoB100), but not with albumin, a PTV cargo protein. Confocal microscopic data indicate that CideB co-localizes with apoB100 in the ER. Additionally, CideB interacts with COPII components, Sar1 and Sec24. To investigate the role of CideB in VTV biogenesis, we performed an in vitro ER budding assay. We show that the blocking of CideB inhibits VTV budding, indicating a direct requirement of CideB in VTV formation. To confirm our findings, we knocked down CideB in primary hepatocytes and isolated ER and cytosol to examine whether they support VTV budding. Our data suggest that CideB knockdown significantly reduces VTV biogenesis. These findings suggest that CideB forms an intricate COPII coat and regulates the VTV biogenesis.	[Tiwari, Samata; Siddiqi, Shaila; Siddiqi, Shadab A.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Siddiqi, SA (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd,Rm 349, Orlando, FL 32827 USA.	shadab.siddiqi@ucf.edu			National Institutes of Health through the NIDDK [RO1 DK-81413]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081413] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK-81413 through the NIDDK (to S.A.S.).	Aridor M, 1999, J BIOL CHEM, V274, P4389, DOI 10.1074/jbc.274.7.4389; Bakillah A, 2000, BIOCHEMISTRY-US, V39, P4892, DOI 10.1021/bi9924009; BAMBERGER MJ, 1990, P NATL ACAD SCI USA, V87, P2390, DOI 10.1073/pnas.87.7.2390; BARLOWE C, 1993, J BIOL CHEM, V268, P873; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Barlowe C, 1998, BBA-MOL CELL RES, V1404, P67, DOI 10.1016/S0167-4889(98)00047-0; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; Charcosset M, 2008, MOL GENET METAB, V93, P74, DOI 10.1016/j.ymgme.2007.08.120; Chen ZJ, 2010, J BIOL CHEM, V285, P25996, DOI 10.1074/jbc.M110.141598; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Georges A, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-1; Ginsberg HN, 2002, CIRCULATION, V106, P2137, DOI 10.1161/01.CIR.0000035280.64322.31; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; Gusarova V, 2007, J BIOL CHEM, V282, P19453, DOI 10.1074/jbc.M700475200; HIGGINS JA, 1988, FEBS LETT, V232, P405, DOI 10.1016/0014-5793(88)80780-4; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Hussain MM, 1998, J BIOL CHEM, V273, P25612, DOI 10.1074/jbc.273.40.25612; Jamil H, 1996, P NATL ACAD SCI USA, V93, P11991, DOI 10.1073/pnas.93.21.11991; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Kim SD, 2012, J BIOL CHEM, V287, P10134, DOI 10.1074/jbc.M111.283382; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Levy E, 2011, ARTERIOSCL THROM VAS, V31, P2692, DOI 10.1161/ATVBAHA.111.233908; Li XH, 2012, J LIPID RES, V53, P1877, DOI 10.1194/jlr.M026591; Malhotra V, 2011, EMBO J, V30, P3475, DOI 10.1038/emboj.2011.255; Mansbach CM, 2010, ANNU REV PHYSIOL, V72, P315, DOI 10.1146/annurev-physiol-021909-135801; Neeli I, 2007, J BIOL CHEM, V282, P17974, DOI 10.1074/jbc.M610765200; Oh HY, 2006, CELL DEATH DIFFER, V13, P512, DOI 10.1038/sj.cdd.4401771; Okada T, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-78; OLOFSSON SO, 1987, ATHEROSCLEROSIS, V68, P1, DOI 10.1016/0021-9150(87)90088-8; Olofsson SO, 1999, CURR OPIN LIPIDOL, V10, P341, DOI 10.1097/00041433-199908000-00008; Rahim A, 2012, J PROTEOMICS, V75, P2225, DOI 10.1016/j.jprot.2012.01.026; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; RUSINOL A, 1993, J BIOL CHEM, V268, P3555; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Sehayek Ephraim, 1994, Current Opinion in Lipidology, V5, P350, DOI 10.1097/00041433-199410000-00006; Shelness GS, 1999, J NUTR, V129, p456S, DOI 10.1093/jn/129.2.456S; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; Shoulders CC, 2004, CURR OPIN LIPIDOL, V15, P191, DOI 10.1097/00041433-200404000-00012; Siddiqi SA, 2006, J CELL SCI, V119, P943, DOI 10.1242/jcs.02803; Siddiqi SA, 2003, J CELL SCI, V116, P415, DOI 10.1242/jcs.00215; Siddiqi SA, 2008, J CELL SCI, V121, P2327, DOI 10.1242/jcs.022780; Siddiqi SA, 2008, BIOCHEM J, V413, P333, DOI 10.1042/BJ20071469; Siddiqi SA, 2006, J BIOL CHEM, V281, P20974, DOI 10.1074/jbc.M601401200; Siddiqi S, 2010, J LIPID RES, V51, P1918, DOI 10.1194/jlr.M005611; Siddiqi S, 2010, J LIPID RES, V51, P1093, DOI 10.1194/jlr.M002758; Siddiqi S, 2010, BIOCHEM J, V429, P391, DOI 10.1042/BJ20100336; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Swift LL, 1996, J BIOL CHEM, V271, P31491; Tang BL, 2005, BBA-MOL CELL RES, V1744, P293, DOI 10.1016/j.bbamcr.2005.02.007; THORNGATE FE, 1994, P NATL ACAD SCI USA, V91, P5392, DOI 10.1073/pnas.91.12.5392; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Yamaguchi J, 2003, J BIOL CHEM, V278, P42643, DOI 10.1074/jbc.M306920200; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200	62	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5157	5165		10.1074/jbc.M112.434258	http://dx.doi.org/10.1074/jbc.M112.434258			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23297397	Green Published, hybrid			2022-12-28	WOS:000315340400063
J	Tran, H; Bustos, D; Yeh, R; Rubinfeld, B; Lam, C; Shriver, S; Zilberleyb, I; Lee, MW; Phu, L; Sarkar, AA; Zohn, IE; Wertz, IE; Kirkpatrick, DS; Polakis, P				Hoanh Tran; Bustos, Daisy; Yeh, Ronald; Rubinfeld, Bonnee; Lam, Cynthia; Shriver, Stephanie; Zilberleyb, Inna; Lee, Michelle W.; Phu, Lilian; Sarkar, Anjali A.; Zohn, Irene E.; Wertz, Ingrid E.; Kirkpatrick, Donald S.; Polakis, Paul			HectD1 E3 Ligase Modifies Adenomatous Polyposis Coli (APC) with Polyubiquitin to Promote the APC-Axin Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; BETA-CATENIN; TUMOR-SUPPRESSOR; K11-LINKED POLYUBIQUITINATION; NEGATIVE REGULATOR; UBIQUITIN LIGASE; COMPLEX; BINDING; PATHWAY; UBIQUITYLATION	The adenomatous polyposis coli (APC) protein functions as a negative regulator of the Wnt signaling pathway. In this capacity, APC forms a "destruction complex" with Axin, CK1 alpha, and GSK3 beta to foster phosphorylation of the Wnt effector beta-catenin earmarking it for Lys-48-linked polyubiquitylation and proteasomal degradation. APC is conjugated with Lys-63-linked ubiquitin chains when it is bound to Axin, but it is unclear whether this modification promotes the APC-Axin interaction or confers upon APC an alternative function in the destruction complex. Here we identify HectD1 as a candidate E3 ubiquitin ligase that modifies APC with Lys-63 polyubiquitin. Knockdown of HectD1 diminished APC ubiquitylation, disrupted the APC-Axin interaction, and augmented Wnt3a-induced beta-catenin stabilization and signaling. These results indicate that HectD1 promotes the APC-Axin interaction to negatively regulate Wnt signaling.	[Hoanh Tran; Rubinfeld, Bonnee; Polakis, Paul] Genentech Inc, Dept Canc Targets, San Francisco, CA 94080 USA; [Bustos, Daisy; Yeh, Ronald; Lee, Michelle W.; Phu, Lilian; Kirkpatrick, Donald S.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Lam, Cynthia; Wertz, Ingrid E.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Shriver, Stephanie; Zilberleyb, Inna] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Sarkar, Anjali A.; Zohn, Irene E.] Childrens Natl Med Ctr, Ctr Res Neurosci, Washington, DC 20010 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Children's National Health System	Tran, H (corresponding author), Genentech Inc, Dept Canc Targets, 1 DNA Way, San Francisco, CA 94080 USA.	tran.hoanh@gene.com; polakis.paul@gene.com		Rubinfeld, Bonnee/0000-0001-9861-6775; Zohn, Irene/0000-0001-7688-682X; Kirkpatrick, Donald/0000-0003-3091-2804	NICHD NIH HHS [R01 HD058629] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058629] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bai SW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-54; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Borgal L, 2012, J BIOL CHEM, V287, P25370, DOI 10.1074/jbc.M112.385658; Breitman M, 2008, BBA-MOL CELL RES, V1783, P1792, DOI 10.1016/j.bbamcr.2008.04.017; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Castets F, 2000, J BIOL CHEM, V275, P19970, DOI 10.1074/jbc.M909782199; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Emmerich CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002187; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guzzo RM, 2004, J CELL SCI, V117, P2271, DOI 10.1242/jcs.01079; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Tran H, 2012, J BIOL CHEM, V287, P28552, DOI 10.1074/jbc.M112.387878; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Phu LL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003756; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sarkar AA, 2012, J CELL BIOL, V196, P789, DOI 10.1083/jcb.201105101; Shi Tong, 2012, BMC Chemical Biology, V12, P4, DOI 10.1186/1472-6769-12-4; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Tauriello DVF, 2010, CELL CYCLE, V9, P3700, DOI 10.4161/cc.9.18.13204; Tran H, 2008, GENE DEV, V22, P528, DOI 10.1101/gad.463208; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; Wigley WC, 1999, J CELL BIOL, V145, P481; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zohn IE, 2007, DEV BIOL, V306, P208, DOI 10.1016/j.ydbio.2007.03.018	55	48	48	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3753	3767		10.1074/jbc.M112.415240	http://dx.doi.org/10.1074/jbc.M112.415240			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23277359	hybrid, Green Published			2022-12-28	WOS:000314845000007
J	Liu, X; Sun, XX; Wu, YC; Xie, C; Zhang, WR; Wang, D; Chen, XY; Qu, D; Gan, JH; Chen, H; Jiang, HL; Lan, LF; Yang, CG				Liu, Xing; Sun, Xiaoxu; Wu, Youcong; Xie, Cen; Zhang, Wenru; Wang, Dan; Chen, Xiaoyan; Qu, Di; Gan, Jianhua; Chen, Hao; Jiang, Hualiang; Lan, Lefu; Yang, Cai-Guang			Oxidation-sensing Regulator AbfR Regulates Oxidative Stress Responses, Bacterial Aggregation, and Biofilm Formation in Staphylococcus epidermidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALL TEICHOIC-ACIDS; GLOBAL REGULATOR; REDOX-SWITCH; TRANSCRIPTIONAL REGULATORS; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURES; SULFENIC ACID; DNA-BINDING; MARR FAMILY; MECHANISM	Staphylococcus epidermidis is a notorious human pathogen that is the major cause of infections related to implanted medical devices. Although redox regulation involving reactive oxygen species is now recognized as a critical component of bacterial signaling and regulation, the mechanism by which S. epidermidis senses and responds to oxidative stress remains largely unknown. Here, we report a new oxidation-sensing regulator, AbfR (aggregation and biofilm formation regulator) in S. epidermidis. An environment of oxidative stress mediated by H2O2 or cumene hydroperoxide markedly up-regulates the expression of abfR gene. Similar to Pseudomonas aeruginosa OspR, AbfR is negatively autoregulated and dissociates from promoter DNA in the presence of oxidants. In vivo and in vitro analyses indicate that Cys-13 and Cys-116 are the key functional residues to form an intersubunit disulfide bond upon oxidation in AbfR. We further show that deletion of abfR leads to a significant induction in H2O2 or cumene hydroperoxide resistance, enhanced bacterial aggregation, and reduced biofilm formation. These effects are mediated by derepression of SERP2195 and gpxA-2 that lie immediately downstream of the abfR gene in the same operon. Thus, oxidative stress likely acts as a signal to modulate S. epidermidis key virulence properties through AbfR.	[Liu, Xing; Sun, Xiaoxu; Xie, Cen; Zhang, Wenru; Chen, Xiaoyan; Jiang, Hualiang; Lan, Lefu; Yang, Cai-Guang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Wu, Youcong; Qu, Di] Fudan Univ, Minist Educ, Key Lab Med Mol Virol, Shanghai 200032, Peoples R China; [Wu, Youcong; Qu, Di] Fudan Univ, Minist Hlth, Inst Med Microbiol, Shanghai 200032, Peoples R China; [Wu, Youcong; Qu, Di] Fudan Univ, Inst Biomed Sci, Shanghai Med Sch, Shanghai 200032, Peoples R China; [Wang, Dan; Chen, Hao] Nanjing Univ, Inst Coordinat Chem, Sch Chem & Chem Engn, Nanjing 210093, Jiangsu, Peoples R China; [Wang, Dan; Chen, Hao] Nanjing Univ, State Key Lab Coordinat Chem, Sch Chem & Chem Engn, Nanjing 210093, Jiangsu, Peoples R China; [Gan, Jianhua] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Fudan University; Fudan University; Fudan University; Nanjing University; Nanjing University; Fudan University	Lan, LF (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China.	llan@mail.shcnc.ac.cn; yangcg@mail.shcnc.ac.cn	Qu, Di/AAO-4590-2020; Liu, Xing/AAE-9485-2020	Liu, Xing/0000-0002-3467-7103	National Natural Science Foundation of China [90913010, 21172234, 20972173, 81271791]; Hundred Talent Program of the Chinese Academy of Sciences; National Science and Technology Key New Drug Creation and Manufacturing Program Major Project [2013ZX09507-004]; Natural Science Foundation of Jiangsu Province [BK2010358]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talent Program of the Chinese Academy of Sciences; National Science and Technology Key New Drug Creation and Manufacturing Program Major Project; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China Grants 90913010, 21172234, 20972173, and 81271791; the Hundred Talent Program of the Chinese Academy of Sciences; National Science and Technology Key New Drug Creation and Manufacturing Program Major Project Grant 2013ZX09507-004; and Natural Science Foundation of Jiangsu Province Grant BK2010358.	Aiassa V, 2012, REV ARGENT MICROBIOL, V44, P16, DOI 10.1590/S0325-75412012000100004; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Aoki R, 2012, J BIOL CHEM, V287, P13500, DOI 10.1074/jbc.M112.346205; Atichartpongkul S, 2010, J BACTERIOL, V192, P2093, DOI 10.1128/JB.01510-09; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballal A, 2010, J BACTERIOL, V192, P336, DOI 10.1128/JB.01202-09; Brugarolas P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388611; Chen H, 2008, P NATL ACAD SCI USA, V105, P13586, DOI 10.1073/pnas.0803391105; Chen H, 2010, EMBO REP, V11, P685, DOI 10.1038/embor.2010.96; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CHRISTENSEN GD, 1990, J INFECT DIS, V161, P1153, DOI 10.1093/infdis/161.6.1153; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Duarte V, 2010, MOL BIOSYST, V6, P316, DOI 10.1039/b915042k; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Glynn AA, 2009, J ORTHOP RES, V27, P627, DOI 10.1002/jor.20758; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Holland LM, 2011, MICROBIOL-SGM, V157, P408, DOI 10.1099/mic.0.042234-0; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Huang RZ, 2012, ACTA PHARMACOL SIN, V33, P418, DOI 10.1038/aps.2011.166; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Ingavale S, 2005, INFECT IMMUN, V73, P1423, DOI 10.1128/IAI.73.3.1423-1431.2005; Ji QJ, 2012, J BIOL CHEM, V287, P21102, DOI 10.1074/jbc.M112.359737; Ji YD, 1999, J BACTERIOL, V181, P6585, DOI 10.1128/JB.181.21.6585-6590.1999; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Lan LF, 2010, MOL MICROBIOL, V75, P76, DOI 10.1111/j.1365-2958.2009.06955.x; Lebreton F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002834; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lou Q, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-146; Luong TT, 2003, J BACTERIOL, V185, P3703, DOI 10.1128/JB.185.13.3703-3710.2003; Moore TDE, 1996, J BACTERIOL, V178, P4301, DOI 10.1128/jb.178.14.4301-4305.1996; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palm GJ, 2012, NUCLEIC ACIDS RES, V40, P4178, DOI 10.1093/nar/gkr1316; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0; Schlag S, 2007, J BACTERIOL, V189, P7911, DOI 10.1128/JB.00598-07; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sukchawalit R, 2001, J BACTERIOL, V183, P4405, DOI 10.1128/JB.183.15.4405-4412.2001; Sun F, 2012, P NATL ACAD SCI USA, V109, P15461, DOI 10.1073/pnas.1205952109; Sun F, 2012, P NATL ACAD SCI USA, V109, P9095, DOI 10.1073/pnas.1200603109; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Uckay I, 2009, ANN MED, V41, P109, DOI 10.1080/07853890802337045; Vazquez-Torres A, 2012, ANTIOXID REDOX SIGN, V17, P1201, DOI 10.1089/ars.2012.4522; Vergara-Irigaray M, 2008, MICROBIOL-SGM, V154, P865, DOI 10.1099/mic.0.2007/013292-0; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wu RY, 2003, J BIOL CHEM, V278, P20240, DOI 10.1074/jbc.M300292200; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zianni Michael, 2006, J Biomol Tech, V17, P103; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	67	20	23	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3739	3752		10.1074/jbc.M112.426205	http://dx.doi.org/10.1074/jbc.M112.426205			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23271738	Green Published, hybrid			2022-12-28	WOS:000314845000006
J	King, GJ; Chanson, AH; McCallum, EJ; Ohme-Takagi, M; Byriel, K; Hill, JM; Martin, JL; Mylne, JS				King, Gordon J.; Chanson, Aurelie H.; McCallum, Emily J.; Ohme-Takagi, Masaru; Byriel, Karl; Hill, Justine M.; Martin, Jennifer L.; Mylne, Joshua S.			The Arabidopsis B3 Domain Protein VERNALIZATION1 (VRN1) Is Involved in Processes Essential for Development, with Structural and Mutational Studies Revealing Its DNA-binding Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; CHIMERIC REPRESSOR; MOTIF; GENE; RECOGNITION; EXPRESSION; SEQUENCE; SYSTEM	The B3 DNA-binding domain is a plant-specific domain found throughout the plant kingdom from the alga Chlamydomonas to grasses and flowering plants. Over 100 B3 domain-containing proteins are found in the model plant Arabidopsis thaliana, and one of these is critical for accelerating flowering in response to prolonged cold treatment, an epigenetic process called vernalization. Despite the specific phenotype of genetic vrn1 mutants, the VERNALIZATION1 (VRN1) protein localizes throughout the nucleus and shows sequence-nonspecific binding in vitro. In this work, we used a dominant repressor tag that overcomes genetic redundancy to show that VRN1 is involved in processes beyond vernalization that are essential for Arabidopsis development. To understand its sequence-nonspecific binding, we crystallized VRN1(208-341) and solved its crystal structure to 1.6 angstrom resolution using selenium/single-wavelength anomalous diffraction methods. The crystallized construct comprises the second VRN1 B3 domain and a preceding region conserved among VRN1 orthologs but absent in other B3 domains. We established the DNA-binding face using NMR and then mutated positively charged residues on this surface with a series of 16 Ala and Glu substitutions, ensuring that the protein fold was not disturbed using heteronuclear single quantum correlation NMR spectra. The triple mutant R249E/R289E/R296E was almost completely incapable of DNA binding in vitro. Thus, we have revealed that although VRN1 is sequence-nonspecific in DNA binding, it has a defined DNA-binding surface.	[King, Gordon J.; Chanson, Aurelie H.; McCallum, Emily J.; Byriel, Karl; Martin, Jennifer L.; Mylne, Joshua S.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Hill, Justine M.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Hill, Justine M.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia; [Ohme-Takagi, Masaru] AIST, Bioprod Res Inst, AIST 4, Tsukuba, Ibaraki 3058562, Japan	University of Queensland; University of Queensland; University of Queensland; National Institute of Advanced Industrial Science & Technology (AIST)	Martin, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	j.martin@imb.uq.edu.au; joshua.mylne@uwa.edu.au	Mylne, Josh/GMX-4544-2022; Mylne, Joshua S/A-5581-2009; Hill, Justine M/C-5781-2009; King, Gordon/J-8718-2014; Byriel, Karl/Y-4155-2019; Martin, Jennifer L./A-6039-2010	Mylne, Josh/0000-0003-4957-6388; Mylne, Joshua S/0000-0003-4957-6388; Byriel, Karl/0000-0003-1615-1551; Benfield, Aurelie/0000-0002-3068-906X; Martin, Jennifer L./0000-0002-9225-8863; Ohme-Takagi, Masaru/0000-0003-2700-4119; McCallum, Emily/0000-0001-8783-4873	University of Queensland early career research award; Australian Research Council Queen Elizabeth II Fellowship [DP0879133]; National Health and Medical Research Council R.D. Wright Fellowship [401748]; Australian Research Council Australian Laureate Fellowship [FL0992138]; Honorary National Health and Medical Research Council Research Fellowship [455829]	University of Queensland early career research award(University of Queensland); Australian Research Council Queen Elizabeth II Fellowship(Australian Research Council); National Health and Medical Research Council R.D. Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Australian Laureate Fellowship(Australian Research Council); Honorary National Health and Medical Research Council Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a University of Queensland early career research award and Australian Research Council Queen Elizabeth II Fellowship DP0879133 (to J.S.M.), a National Health and Medical Research Council R.D. Wright Fellowship 401748 (to J.M.H.), and by Australian Research Council Australian Laureate Fellowship FL0992138 and Honorary National Health and Medical Research Council Research Fellowship 455829 (to J.L.M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2005, CCP4 NEWSL, V42; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Golovenko D, 2009, NUCLEIC ACIDS RES, V37, P6613, DOI 10.1093/nar/gkp699; Grazulis S, 2005, P NATL ACAD SCI USA, V102, P15797, DOI 10.1073/pnas.0507949102; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Hiratsu K, 2002, FEBS LETT, V514, P351, DOI 10.1016/S0014-5793(02)02435-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; King G, 2009, ACTA CRYSTALLOGR F, V65, P291, DOI [10.1107/S174430910900421, 10.1107/S1744309109004217]; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mitsuda N, 2006, PLANT BIOTECHNOL J, V4, P325, DOI 10.1111/j.1467-7652.2006.00184.x; Mylne JS, 2012, BIOMOL NMR ASSIGN, V6, P5, DOI 10.1007/s12104-011-9313-6; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Oshima Y, 2011, PLANT BIOTECHNOL-NAR, V28, P201, DOI 10.5511/plantbiotechnology.11.0124a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shouldice SR, 2010, ANTIOXID REDOX SIGN, V12, P921, DOI 10.1089/ars.2009.2736; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Waltner JK, 2005, PROTEIN SCI, V14, P2478, DOI 10.1110/ps.051606305; Yamasaki K, 2004, PLANT CELL, V16, P3448, DOI 10.1105/tpc.104.026112; Yamasaki K., 2012, TRENDS PLAN IN PRESS; Zhou XYE, 2004, J MOL BIOL, V335, P307, DOI 10.1016/j.jmb.2003.10.030	33	24	31	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3198	3207		10.1074/jbc.M112.438572	http://dx.doi.org/10.1074/jbc.M112.438572			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255593	hybrid, Green Published			2022-12-28	WOS:000314397900027
J	Mant, A; Williams, S; Roncoroni, L; Lowry, E; Johnson, D; O'Kelly, I				Mant, Alexandra; Williams, Sarah; Roncoroni, Laura; Lowry, Eleanor; Johnson, Daniel; O'Kelly, Ita			N-Glycosylation-dependent Control of Functional Expression of Background Potassium Channels K(2P)3.1 and K(2P)9.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; TRAFFICKING; MODULATION; RETENTION; TRANSPORT; PROTEINS; TASK-1	Two-pore domain potassium (K-2P) channels play fundamental roles in cellular processes by enabling a constitutive leak of potassium from cells in which they are expressed, thus influencing cellular membrane potential and activity. Hence, regulation of these channels is of critical importance to cellular function. A key regulatory mechanism of K-2P channels is the control of their cell surface expression. Membrane protein delivery to and retrieval from the cell surface is controlled by their passage through the secretory and endocytic pathways, and post-translational modifications regulate their progression through these pathways. All but one of the K-2P channels possess consensus N-linked glycosylation sites, and here we demonstrate that the conserved putative N-glycosylation site in K(2P)3.1 and K(2P)9.1 is a glycan acceptor site. Patch clamp analysis revealed that disruption of channel glycosylation reduced K(2P)3.1 current, and flow cytometry was instrumental in attributing this to a decreased number of channels on the cell surface. Similar findings were observed when cells were cultured in reduced glucose concentrations. Disruption of N-linked glycosylation has less of an effect on K(2P)9.1, with a small reduction in number of channels on the surface observed, but no functional implications detected. Because nonglycosylated channels appear to pass through the secretory pathway in a manner comparable with glycosylated channels, the evidence presented here suggests that the decreased number of nonglycosylated K(2P)3.1 channels on the cell surface may be due to their decreased stability.	[Mant, Alexandra; Williams, Sarah; Roncoroni, Laura; O'Kelly, Ita] Univ Southampton, Ctr Human Dev Stem Cells & Regenerat, Fac Med, Southampton SO16 6YD, Hants, England; [Lowry, Eleanor; Johnson, Daniel] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Southampton; University of Manchester	O'Kelly, I (corresponding author), Univ Southampton, Duthie Bldg,Mail Point 808, Southampton SO16 6YD, Hants, England.	I.M.O'Kelly@southampton.ac.uk		Mant, Alexandra/0000-0001-7169-209X	Biotechnology and Biological Sciences Research Council Grant [BB/J00168/1]; Gerald Kerkut Charitable Trust; Biotechnology and Biological Sciences Research Council [BB/J008168/1, BB/E014453/2] Funding Source: researchfish; BBSRC [BB/E014453/2, BB/J008168/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gerald Kerkut Charitable Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/J00168/1 (to I. O).; Supported by the Gerald Kerkut Charitable Trust.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Buckler KJ, 2000, J PHYSIOL-LONDON, V525, P135, DOI 10.1111/j.1469-7793.2000.00135.x; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Duprat F, 2007, TRENDS NEUROSCI, V30, P573, DOI 10.1016/j.tins.2007.08.003; Egenberger B, 2010, BIOCHEM BIOPH RES CO, V391, P1262, DOI 10.1016/j.bbrc.2009.12.056; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Hall MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019317; HAYTER PM, 1992, BIOTECHNOL BIOENG, V39, P327, DOI 10.1002/bit.260390311; Hegle AP, 2010, AM J PHYSIOL-CELL PH, V298, pC1066, DOI 10.1152/ajpcell.00389.2009; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Jing L, 2012, J NEUROSCI, V32, P4080, DOI 10.1523/JNEUROSCI.5021-11.2012; Kamiya Y, 2012, BBA-GEN SUBJECTS, V1820, P1327, DOI 10.1016/j.bbagen.2011.12.017; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Mant A, 2011, J BIOL CHEM, V286, P14110, DOI 10.1074/jbc.M110.190702; Mathie A, 2010, CURR NEUROPHARMACOL, V8, P276, DOI 10.2174/157015910792246146; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Moeller HB, 2011, AM J PHYSIOL-RENAL, V300, pF1062, DOI 10.1152/ajprenal.00721.2010; O'Kelly I, 1999, AM J PHYSIOL-LUNG C, V276, pL96, DOI 10.1152/ajplung.1999.276.1.L96; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Oberg F, 2011, J BIOL CHEM, V286, P31915, DOI 10.1074/jbc.M111.242677; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Richardson DS, 2010, J FLUORESC, V20, P401, DOI 10.1007/s10895-009-0548-x; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Sola RJ, 2007, CELL MOL LIFE SCI, V64, P2133, DOI 10.1007/s00018-007-6551-y; Vagin O, 2004, J BIOL CHEM, V279, P39026, DOI 10.1074/jbc.M405453200; Zhu I, 2009, BRAIN RES, V1251, P16, DOI 10.1016/j.brainres.2008.11.033	40	16	16	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3251	3264		10.1074/jbc.M112.405167	http://dx.doi.org/10.1074/jbc.M112.405167			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250752	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000314397900032
J	Tan, B; Young, DA; Lu, ZH; Wang, T; Meier, TI; Shepard, RL; Roth, K; Zhai, Y; Huss, K; Kuo, MS; Gillig, J; Parthasarathy, S; Burkholder, TP; Smith, MC; Geeganage, S; Zhao, GS				Tan, Bo; Young, Debra A.; Lu, Zhao-Hai; Wang, Tao; Meier, Timothy I.; Shepard, Robert L.; Roth, Kenneth; Zhai, Yan; Huss, Karen; Kuo, Ming-Shang; Gillig, James; Parthasarathy, Saravanan; Burkholder, Timothy P.; Smith, Michele C.; Geeganage, Sandaruwan; Zhao, Genshi			Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD(+) Biosynthesis, in Human Cancer Cells METABOLIC BASIS AND POTENTIAL CLINICAL IMPLICATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-CANCER; FK866; DEPLETION; PATHWAY; TARGET; DEATH; FLUX; OVEREXPRESSION; CONTRIBUTES; SURVIVAL	Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the first rate-limiting step in converting nicotinamide to NAD(+), essential for cellular metabolism, energy production, and DNA repair. NAMPT has been extensively studied because of its critical role in these cellular processes and the prospect of developing therapeutics against the target, yet how it regulates cellular metabolism is not fully understood. In this study we utilized liquid chromatography-mass spectrometry to examine the effects of FK866, a small molecule inhibitor of NAMPT currently in clinical trials, on glycolysis, the pentose phosphate pathway, the tricarboxylic acid (TCA) cycle, and serine biosynthesis in cancer cells and tumor xenografts. We show for the first time that NAMPT inhibition leads to the attenuation of glycolysis at the glyceraldehyde 3-phosphate dehydrogenase step due to the reduced availability of NAD(+) for the enzyme. The attenuation of glycolysis results in the accumulation of glycolytic intermediates before and at the glyceraldehyde 3-phosphate dehydrogenase step, promoting carbon overflow into the pentose phosphate pathway as evidenced by the increased intermediate levels. The attenuation of glycolysis also causes decreased glycolytic intermediates after the glyceraldehyde 3-phosphate dehydrogenase step, thereby reducing carbon flow into serine biosynthesis and the TCA cycle. Labeling studies establish that the carbon overflow into the pentose phosphate pathway is mainly through its non-oxidative branch. Together, these studies establish the blockade of glycolysis at the glyceraldehyde 3-phosphate dehydrogenase step as the central metabolic basis of NAMPT inhibition responsible for ATP depletion, metabolic perturbation, and subsequent tumor growth inhibition. These studies also suggest that altered metabolite levels in tumors can be used as robust pharmacodynamic markers for evaluating NAMPT inhibitors in the clinic.	[Young, Debra A.; Lu, Zhao-Hai; Wang, Tao; Meier, Timothy I.; Shepard, Robert L.; Smith, Michele C.; Geeganage, Sandaruwan; Zhao, Genshi] Eli Lilly & Co, Lilly Res Labs, Canc Res, Indianapolis, IN 46285 USA; [Gillig, James; Parthasarathy, Saravanan; Burkholder, Timothy P.] Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res, Indianapolis, IN 46285 USA; [Tan, Bo; Roth, Kenneth; Zhai, Yan; Huss, Karen; Kuo, Ming-Shang] Eli Lilly & Co, Lilly Res Labs, Translat Sci & Technol, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly	Geeganage, S (corresponding author), Eli Lilly & Co, Lilly Res Labs, Canc Res, DC0434, Indianapolis, IN 46285 USA.	Geeganage_Sandaruwan@Lilly.com; Zhao_Genshi@Lilly.com			Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This work was supported by Eli Lilly and Company.	Bi TQ, 2011, ONCOL REP, V26, P1251, DOI 10.3892/or.2011.1378; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Drevs J, 2003, ANTICANCER RES, V23, P4853; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Galli U, 2008, CHEMMEDCHEM, V3, P771, DOI 10.1002/cmdc.200700311; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Hasmann M, 2003, CANCER RES, V63, P7436; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Hufton SE, 1999, FEBS LETT, V463, P77, DOI 10.1016/S0014-5793(99)01578-1; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Kelly AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025357; Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kirkland JB, 2009, CURR PHARM DESIGN, V15, P3, DOI 10.2174/138161209787185823; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Muruganandham M, 2005, CLIN CANCER RES, V11, P3503, DOI 10.1158/1078-0432.CCR-04-1399; Nahimana A, 2009, BLOOD, V113, P3276, DOI 10.1182/blood-2008-08-173369; Nakajima TE, 2009, J GASTROENTEROL, V44, P685, DOI 10.1007/s00535-009-0063-5; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Olesen UH, 2010, MOL CANCER THER, V9, P1609, DOI 10.1158/1535-7163.MCT-09-1130; OLSON JA, 1952, J BIOL CHEM, V197, P67; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Putt KS, 2004, ANAL BIOCHEM, V326, P78, DOI 10.1016/j.ab.2003.11.015; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Rosso L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000150; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Spanaki C, 2012, NEUROTOX RES, V21, P117, DOI 10.1007/s12640-011-9285-4; Spanaki C, 2010, J BIOL CHEM, V285, P16748, DOI 10.1074/jbc.M109.092999; Tong L., 2008, U.S. Patent, Patent No. 0020413; van Beijnum JR, 2002, INT J CANCER, V101, P118, DOI 10.1002/ijc.10584; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Wang B, 2011, ONCOGENE, V30, P907, DOI 10.1038/onc.2010.468; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	50	126	134	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3500	3511		10.1074/jbc.M112.394510	http://dx.doi.org/10.1074/jbc.M112.394510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23239881	Green Published, hybrid			2022-12-28	WOS:000314397900055
J	Basset, A; Zhang, F; Benes, C; Sayeed, S; Herd, M; Thompson, C; Golenbock, DT; Camilli, A; Malley, R				Basset, Alan; Zhang, Fan; Benes, Cyril; Sayeed, Sabina; Herd, Muriel; Thompson, Claudette; Golenbock, Douglas T.; Camilli, Andrew; Malley, Richard			Toll-like Receptor (TLR) 2 Mediates Inflammatory Responses to Oligomerized RrgA Pneumococcal Pilus Type 1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PNEUMONIAE; ELICIT PROTECTION; FUSION PROTEIN; CUTTING EDGE; MICE; PNEUMOLYSIN; RECOGNITION; VACCINE; COMPONENTS; VIRULENCE	The pneumococcal type 1 pilus is an inflammatory and adherence-promoting structure associated with increased virulence in mouse models. We show that RrgA, an ancillary pilus subunit devoid of a lipidation motif, particularly when presented as part of an oligomer, is a TLR2 agonist. The surface-exposed domain III, and in particular a 49-amino acid sequence (P3), of the protein is responsible for the TLR2 activity of RrgA. A pneumococcal mutant carrying RrgA with a deletion of the P3 region was significantly reduced in its ability to activate TLR2 and induce TNF-alpha responses after mouse intraperitoneal infection, whereas no such difference could be noted when TLR2(-/-) mice were challenged, further implicating this region in recognition by TLR2. Thus, we conclude that the type 1 pneumococcal pilus can activate cells via TLR2, and the ancillary pilus subunit RrgA is a key component of this activation.	[Basset, Alan; Zhang, Fan; Sayeed, Sabina; Herd, Muriel; Malley, Richard] Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Benes, Cyril] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Thompson, Claudette] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 01225 USA; [Golenbock, Douglas T.] Univ Massachusetts, Med Ctr, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA; [Camilli, Andrew] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; [Camilli, Andrew] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Tufts University; Tufts University	Malley, R (corresponding author), Childrens Hosp, Dept Med, Div Infect Dis, Enders 861-4,300 Longwood Ave, Boston, MA 02115 USA.	richard.malley@childrens.harvard.edu		Sayeed, Sabina/0000-0002-3753-0393	National Institutes of Health [R01 AI066013]; Children's Hospital, Boston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital, Boston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI066013 (to R. M.).; Supported by the Translational Research Program at Children's Hospital, Boston. To whom correspondence should be addressed: Division of Infectious Diseases, Boston Children's Hospital, Enders 861.4, 300 Longwood Ave., Boston, MA 02115. Tel.: 617-919-2902; Fax: 617-730-0255; E-mail: richard.malley@childrens.harvard.edu.	Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Balachandran P, 2002, INFECT IMMUN, V70, P2526, DOI 10.1128/IAI.70.5.2526-2534.2002; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Basset A, 2012, J BACTERIOL, V194, P1088, DOI 10.1128/JB.06078-11; Basset A, 2011, INFECT IMMUN, V79, P2974, DOI 10.1128/IAI.05117-11; BERRY AM, 1995, INFECT IMMUN, V63, P1969, DOI 10.1128/IAI.63.5.1969-1974.1995; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Black SB, 2001, PEDIATR INFECT DIS J, V20, P1105, DOI 10.1097/00006454-200112000-00002; Briles DE, 2000, VACCINE, V18, P1707, DOI 10.1016/S0264-410X(99)00511-3; De Angelis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021269; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Ehl S, 2004, EUR J IMMUNOL, V34, P1146, DOI 10.1002/eji.200324449; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; Gilbert RJC, 1998, J MOL BIOL, V284, P1223, DOI 10.1006/jmbi.1998.2258; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; Hanage WP, 2008, FUTURE MICROBIOL, V3, P23, DOI 10.2217/17460913.3.1.23; Harfouche C, 2012, INFECT IMMUN, V80, P451, DOI 10.1128/IAI.05780-11; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kirschning CJ, 2002, CURR TOP MICROBIOL, V270, P121; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Lipsitch M, 2001, AM J EPIDEMIOL, V154, P85, DOI 10.1093/aje/154.1.85; Lu YJ, 2010, VACCINE, V28, P7468, DOI 10.1016/j.vaccine.2010.09.031; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; Moffitt KL, 2011, CURR OPIN IMMUNOL, V23, P407, DOI 10.1016/j.coi.2011.04.002; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Moschioni M, 2012, VACCINE, V30, P1349, DOI 10.1016/j.vaccine.2011.12.080; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Regev-Yochay G, 2010, VACCINE, V28, P4842, DOI 10.1016/j.vaccine.2010.04.042; Regev-Yochay G, 2009, CLIN INFECT DIS, V48, P760, DOI 10.1086/597040; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Yoshimura A, 1999, J IMMUNOL, V163, P1	51	35	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2665	2675		10.1074/jbc.M112.398875	http://dx.doi.org/10.1074/jbc.M112.398875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233677	Green Published, hybrid			2022-12-28	WOS:000314211500051
J	Rakovic, A; Shurkewitsch, K; Seibler, P; Grunewald, A; Zanon, A; Hagenah, J; Krainc, D; Klein, C				Rakovic, Aleksandar; Shurkewitsch, Katharina; Seibler, Philip; Gruenewald, Anne; Zanon, Alessandra; Hagenah, Johann; Krainc, Dimitri; Klein, Christine			Phosphatase and Tensin Homolog (PTEN)-induced Putative Kinase 1 (PINK1)-dependent Ubiquitination of Endogenous Parkin Attenuates Mitophagy STUDY IN HUMAN PRIMARY FIBROBLASTS AND INDUCED PLURIPOTENT STEM CELL-DERIVED NEURONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL DYSFUNCTION; DAMAGED MITOCHONDRIA; PINK1; DEGRADATION; NEURONS; TRANSLOCATION; PROTEASOME; MUTANT; DEUBIQUITINATION; DROSOPHILA-PINK1	Mutations in the E3 ubiquitin ligase Parkin and the mitochondrial PTEN-induced putative kinase 1 (PINK1) have been identified to cause autosomal recessive forms of familial Parkinson disease, with PINK1 functioning upstream of Parkin in a pathway important for the maintenance of mitochondrial function and morphology. Upon the loss of the mitochondrial membrane potential, Parkin translocates to mitochondria in a PINK1-dependent manner to ubiquitinate mitochondrial proteins. Parkin-mediated polyubiquitination of outer mitochondrial membrane (OMM) proteins recruits the ubiquitin-and LC3-binding adaptor protein p62 to mitochondria and induces mitophagy. Although previous studies examined mitophagy in established cell lines through overexpression approaches, there is an imperative to study the role of endogenous Parkin and PINK1 in human-derived and biologically relevant cell models. Here, we demonstrate in human primary fibroblasts and induced pluripotent stem-derived neurons from controls and PINK1 mutation carriers that endogenous levels of Parkin are not sufficient to initiate mitophagy upon loss of the mitochondrial membrane potential, caused by its (self-) ubiquitination, followed by degradation via the ubiquitin proteasome system. Next, we showed differential PINK1-dependent, Parkin-mediated ubiquitination of OMM proteins, which is Parkin dose-dependent and affects primarily OMM proteins of higher molecular mass. In contrast to the situation fibroblasts, we did not detect mitophagy in induced pluripotent stem-derived neurons even upon overexpression of Parkin. Taken together, our data demonstrate that mitophagy differs between human non-neuronal and neuronal cells and between "endogenous" and "Parkin-overexpressing" cellular models.	[Rakovic, Aleksandar; Shurkewitsch, Katharina; Seibler, Philip; Gruenewald, Anne; Zanon, Alessandra; Hagenah, Johann; Klein, Christine] Med Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, D-23562 Lubeck, Germany; [Hagenah, Johann] Med Univ Lubeck, Dept Neurol, D-23562 Lubeck, Germany; [Zanon, Alessandra] Europian Acad Bozen, Ctr Biomed, I-39100 Bolzano, Italy; [Krainc, Dimitri] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA	University of Lubeck; University of Lubeck; European Academy of Bozen-Bolzano; Harvard University; Massachusetts General Hospital	Klein, C (corresponding author), Med Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Maria Goeppert Str 1, D-23562 Lubeck, Germany.	christine.klein@neuro.uni-luebeck.de	Seibler, Philip/K-4142-2019; Seibler, Philip/AAB-5097-2022; Grünewald, Anne/ABD-1255-2021; Klein, Christine/AGK-8003-2022	Grünewald, Anne/0000-0002-4179-2994; Zanon, Alessandra/0000-0003-2204-6176; Seibler, Philip/0000-0002-3496-7194; Klein, Christine/0000-0003-2102-3431	Fritz Thyssen Foundation; National Genome Research Network-plus (Federal Ministry of Education and Research); EU Grant European Project on Mendelian Forms of Parkinson's Disease (FP7); Hermann and Lilly Schilling Foundation	Fritz Thyssen Foundation; National Genome Research Network-plus (Federal Ministry of Education and Research); EU Grant European Project on Mendelian Forms of Parkinson's Disease (FP7); Hermann and Lilly Schilling Foundation	This work was supported by the Fritz Thyssen Foundation (to A. G.), National Genome Research Network-plus (Federal Ministry of Education and Research, to C. K.), and EU Grant European Project on Mendelian Forms of Parkinson's Disease (FP7).; Recipient of a career development award from the Hermann and Lilly Schilling Foundation. To whom correspondence should be addressed: Section of Clinical and Molecular Neurogenetics at the Dept. of Neurology, Maria-Goeppert-Str. 1, 23562 Lubeck, Germany. Tel.: 494512903351; Fax: 494512903355; E-mail: christine.klein@neuro.uni-luebeck.de.	Almeida A, 1997, BRAIN RES, V764, P167, DOI 10.1016/S0006-8993(97)00453-8; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Burte F, 2011, J PROTEOME RES, V10, P1974, DOI 10.1021/pr101211k; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; MIZZEN LA, 1989, J BIOL CHEM, V264, P20664; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2005, METHOD ENZYMOL, V398, P391, DOI 10.1016/S0076-6879(05)98032-4; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Ziviani E, 2010, AUTOPHAGY, V6, P660, DOI 10.4161/auto.6.5.12242; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	35	170	173	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2223	2237		10.1074/jbc.M112.391680	http://dx.doi.org/10.1074/jbc.M112.391680			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23212910	Green Published, hybrid			2022-12-28	WOS:000314211500013
J	Yang, L; Li, Y; Ding, Y; Choi, KS; Kazim, AL; Zhang, YS				Yang, Lu; Li, Yun; Ding, Yi; Choi, Kyoung-Soo; Kazim, A. Latif; Zhang, Yuesheng			Prolidase Directly Binds and Activates Epidermal Growth Factor Receptor and Stimulates Downstream Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENCY; CYCLOOXYGENASE-2; CANCER; EXPRESSION; MICE; INHIBITION; APOPTOSIS; PLASMA; GENE	Prolidase, also known as Xaa-Pro dipeptidase or peptidase D (PEPD), is a ubiquitously expressed cytosolic enzyme that hydrolyzes dipeptides with proline or hydroxyproline at the carboxyl terminus. In this article, however, we demonstrate that PEPD directly binds to and activates epidermal growth factor receptor (EGFR), leading to stimulation of signaling proteins downstream of EGFR, and that such activity is neither cell-specific nor dependent on the enzymatic activity of PEPD. In line with the pro-survival and pro-proliferation activities of EGFR, PEPD stimulates DNA synthesis. We further show that PEPD activates EGFR only when it is present in the extracellular space, but that PEPD is released from injured cells and tissues and that such release appears to result in EGFR activation. PEPD differs from all known EGFR ligands in that it does not possess an epidermal growth factor (EGF) motif and is not synthesized as a transmembrane precursor, but PEPD binding to EGFR can be blocked by EGF. In conclusion, PEPD is a ligand of EGFR and presents a novel mechanism of EGFR activation.	[Yang, Lu; Li, Yun; Ding, Yi; Zhang, Yuesheng] Roswell Pk Canc Inst, Dept Chemoprevent, Buffalo, NY 14263 USA; [Li, Yun] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Choi, Kyoung-Soo; Kazim, A. Latif] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Zhang, YS (corresponding author), Elm & Carlton St, Buffalo, NY 14263 USA.	yuesheng.zhang@roswellpark.org		Zhang, Yuesheng/0000-0002-0976-2875; Yang, Lu/0000-0003-2532-8638	National Institutes of Health from the NCI [R01CA120533, R01CA124627, P30CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA120533, R01CA124627] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA120533, R01CA124627, and P30CA016056 from the NCI.	ARATA J, 1979, ARCH DERMATOL, V115, P62, DOI 10.1001/archderm.115.1.62; Arioz DT, 2009, INT J GYNECOL CANCER, V19, P1244, DOI 10.1111/IGC.0b013e3181af711e; Aytug AF, 2006, INT J DERMATOL, V45, P867, DOI 10.1111/j.1365-4632.2006.02690.x; Baselga J, 2002, ONCOLOGIST, V7, P2; Besio R, 2010, EUR BIOPHYS J BIOPHY, V39, P935, DOI 10.1007/s00249-009-0459-4; Brzezinski J, 1998, EUR J ENDOCRINOL, V138, P388, DOI 10.1530/eje.0.1380388; Cechowska-Pasko M, 2006, INT J EXP PATHOL, V87, P289, DOI 10.1111/j.1365-2613.2006.00486.x; CHARPENTIER C, 1981, J INHERIT METAB DIS, V4, P77, DOI 10.1007/BF02263599; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Dunbar AJ, 2000, INT J BIOCHEM CELL B, V32, P805, DOI 10.1016/S1357-2725(00)00028-5; ENDO F, 1989, J BIOL CHEM, V264, P4476; Falik-Zaccai TC, 2010, AM J MED GENET B, V153B, P46, DOI 10.1002/ajmg.b.30945; Fan YX, 2004, J BIOL CHEM, V279, P38143, DOI 10.1074/jbc.M405760200; HANKINSON O, 1979, P NATL ACAD SCI USA, V76, P373, DOI 10.1073/pnas.76.1.373; Haywood M. T., 2011, FOOT ANKLE ONLINE J, V4, P4; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; ISEMURA M, 1979, CLIN CHIM ACTA, V93, P401, DOI 10.1016/0009-8981(79)90291-2; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Kajanne R, 2007, PEDIATR RES, V62, P570, DOI 10.1203/PDR.0b013e318155ac3b; Karna E, 2000, INT J EXP PATHOL, V81, P341, DOI 10.1046/j.1365-2613.2000.00168.x; Klein RD, 2005, CANCER RES, V65, P1808, DOI 10.1158/0008-5472.CAN-04-3567; Koki AT, 2002, PROSTAG LEUKOTR ESS, V66, P13, DOI 10.1054/plef.2001.0335; Leahy DJ, 2004, ADV PROTEIN CHEM, V68, P1; Ledoux P, 1996, AM J HUM GENET, V59, P1035; LEONI A, 1987, ARCH DERMATOL, V123, P493, DOI 10.1001/archderm.123.4.493; Liu G, 2005, CLIN BIOCHEM, V38, P625, DOI 10.1016/j.clinbiochem.2005.03.007; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lupi A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.043315; Lupi A, 2006, FEBS J, V273, P5466, DOI 10.1111/j.1742-4658.2006.05538.x; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Maher MJ, 2004, BIOCHEMISTRY-US, V43, P2771, DOI 10.1021/bi0356451; Murthy A, 2010, J CLIN INVEST, V120, P2731, DOI 10.1172/JCI42686; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Osterlund KL, 2010, AM J PHYSIOL-ENDOC M, V298, pE838, DOI 10.1152/ajpendo.00693.2009; Perez-Torres M, 2006, J BIOL CHEM, V281, P40183, DOI 10.1074/jbc.M607958200; PERHEENTUPA J, 1985, AM J PHYSIOL, V248, pE391, DOI 10.1152/ajpendo.1985.248.4.E391; Roomi MW, 2008, HUM EXP TOXICOL, V27, P559, DOI 10.1177/0960327108096851; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Surazynski A, 2008, INT J CANCER, V122, P1435, DOI 10.1002/ijc.23263; Surazynski A, 2010, EUR J PHARMACOL, V649, P115, DOI 10.1016/j.ejphar.2010.09.034; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; Wong RWC, 2003, CELL MOL LIFE SCI, V60, P113, DOI 10.1007/s000180300007; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoon JH, 2004, J HEPATOL, V41, P808, DOI 10.1016/j.jhep.2004.07.016; Yu ZW, 2011, BIOCHEM BIOPH RES CO, V411, P751, DOI 10.1016/j.bbrc.2011.07.019; Zbucka Monika, 2007, Folia Histochem Cytobiol, V45 Suppl 1, pS181; Zeng QH, 2002, J BIOL CHEM, V277, P50137, DOI 10.1074/jbc.M208952200	51	25	25	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2365	2375		10.1074/jbc.M112.429159	http://dx.doi.org/10.1074/jbc.M112.429159			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23212918	Green Published, hybrid			2022-12-28	WOS:000314211500025
J	Bansal, A; Singh, S; More, KR; Hans, D; Nangalia, K; Yogavel, M; Sharma, A; Chitnis, CE				Bansal, Abhisheka; Singh, Shailja; More, Kunal R.; Hans, Dhiraj; Nangalia, Kuldeep; Yogavel, Manickam; Sharma, Amit; Chitnis, Chetan E.			Characterization of Plasmodium falciparum Calcium-dependent Protein Kinase 1 (PfCDPK1) and Its Role in Microneme Secretion during Erythrocyte Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITOPHOROUS VACUOLE; ACTIVATION; MECHANISMS; REVEALS; RELEASE; EGRESS	Calcium-dependent protein kinases (CDPKs) play important roles in the life cycle of Plasmodium falciparum and other api-complexan parasites. CDPKs commonly have an N-terminal kinase domain (KD) and a C-terminal calmodulin-like domain (CamLD) with calcium-binding EF hands. The KD and CamLD are separated by a junction domain (JD). Previous studies on Plasmodium and Toxoplasma CDPKs suggest a role for the JD and CamLD in the regulation of kinase activity. Here, we provide direct evidence for the binding of the CamLD with the P3 region (Leu(356) to Thr(370)) of the JD in the presence of calcium (Ca2+). Moreover, site-directed mutagenesis of conserved hydrophobic residues in the JD (F363A/I364A, L356A, and F350A) abrogates functional activity of PfCDPK1, demonstrating the importance of these residues in PfCDPK1 function. Modeling studies suggest that these residues play a role in interaction of the CamLD with the JD. The P3 peptide, which specifically inhibits the functional activity of PfCDPK1, blocks microneme discharge and erythrocyte invasion by P. falciparum merozoites. Purfalcamine, a previously identified specific inhibitor of PfCDPK1, also inhibits microneme discharge and erythrocyte invasion, confirming a role for PfCDPK1 in this process. These studies validate PfCDPK1 as a target for drug development and demonstrate that interfering with its mechanistic regulation may provide a novel approach to design-specific PfCDPK1 inhibitors that limit blood stage parasite growth and clear malaria parasite infections.	[Bansal, Abhisheka; Singh, Shailja; More, Kunal R.; Hans, Dhiraj; Nangalia, Kuldeep; Yogavel, Manickam; Sharma, Amit; Chitnis, Chetan E.] ICGEB, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Chitnis, CE (corresponding author), ICGEB, Aruna Asaf Ali Marg, New Delhi 110067, India.	cchitnis@icgeb.res.in	More, Kunal Ravindra/AFT-2566-2022; Manickam, Yogavel/O-4570-2015; Bansal, Abhisheka/ABC-7871-2020	More, Kunal Ravindra/0000-0001-5152-5104; Manickam, Yogavel/0000-0002-2119-062X; Bansal, Abhisheka/0000-0002-2959-8494; Chitnis, Chetan/0000-0002-8773-9865	European Commission (MALSIG) [HEALTH-F3-2009-223044]; European Commission "Network of Excellence: European Virtual Institute for Malaria Research" (EviMalaR) [Health-2009-2.3.2-1-242095]; Department of Biotechnology, Government of India	European Commission (MALSIG)(European CommissionEuropean Commission Joint Research Centre); European Commission "Network of Excellence: European Virtual Institute for Malaria Research" (EviMalaR); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by European Commission Framework Program 7 (FP7) projects titled "Signaling in Malaria" (MALSIG, HEALTH-F3-2009-223044) and "Network of Excellence: European Virtual Institute for Malaria Research" (EviMalaR, Health-2009-2.3.2-1-242095) and a Program Support grant from Department of Biotechnology, Government of India.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DELPLACE P, 1988, BIOL CELL, V64, P215, DOI 10.1016/0248-4900(88)90080-9; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Gaur D, 2011, CURR OPIN MICROBIOL, V14, P422, DOI 10.1016/j.mib.2011.07.018; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Huang JF, 1996, BIOCHEMISTRY-US, V35, P13222, DOI 10.1021/bi960498a; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ranjan R, 2009, J BIOL CHEM, V284, P15267, DOI 10.1074/jbc.M900656200; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Sugi T, 2010, EUKARYOT CELL, V9, P667, DOI 10.1128/EC.00351-09; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vitart V, 2000, BIOCHEMISTRY-US, V39, P4004, DOI 10.1021/bi992373m; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; ZHAO Y, 1994, MOL BIOCHEM PARASIT, V66, P329, DOI 10.1016/0166-6851(94)90159-7	30	69	70	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1590	1602		10.1074/jbc.M112.411934	http://dx.doi.org/10.1074/jbc.M112.411934			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23204525	Green Published, hybrid			2022-12-28	WOS:000313751400015
J	Winter, AD; McCormack, G; Myllyharju, J; Page, AP				Winter, Alan D.; McCormack, Gillian; Myllyharju, Johanna; Page, Antony P.			Prolyl 4-Hydroxlase Activity Is Essential for Development and Cuticle Formation in the Human Infective Parasitic Nematode Brugia malayi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; CAENORHABDITIS-ELEGANS; ALPHA-SUBUNIT; DRAFT GENOME; 4-HYDROXYLASE; SEQUENCE; COLLAGEN; ENZYMES; ACID; INTERFERENCE	Collagen prolyl 4-hydroxylases (C-P4H) are required for formation of extracellular matrices in higher eukaryotes. These enzymes convert proline residues within the repeat regions of collagen polypeptides to 4-hydroxyproline, a modification essential for the stability of the final triple helix. C-P4H are most often oligomeric complexes, with enzymatic activity contributed by the alpha subunits, and the beta subunits formed by protein disulfide isomerase (PDI). Here, we characterize this enzyme class in the important human parasitic nematode Brugia malayi. All potential C-P4H subunits were identified by detailed bioinformatic analysis of sequence databases, function was investigated both by RNAi in the parasite and heterologous expression in Caenorhabditis elegans, whereas biochemical activity and complex formation were examined via co-expression in insect cells. Simultaneous RNAi of two B. malayi C-P4H alpha subunit-like genes resulted in a striking, highly penetrant body morphology phenotype in parasite larvae. This was replicated by single RNAi of a B. malayi C-P4H beta subunit-like PDI. Surprisingly, however, the B. malayi proteins were not capable of rescuing a C. elegans alpha subunit mutant, whereas the human enzymes could. In contrast, the B. malayi PDI did functionally complement the lethal phenotype of a C. elegans beta subunit mutant. Comparison of recombinant and parasite derived material indicates that enzymatic activity may be dependent on a non-reducible covalent link, present only in the parasite. We therefore demonstrate that C-P4H activity is essential for development of B. malayi and uncover a novel parasite-specific feature of these collagen biosynthetic enzymes that may be exploited in future parasite control.	[Winter, Alan D.; McCormack, Gillian; Page, Antony P.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G61 1QH, Lanark, Scotland; [Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Myllyharju, Johanna] Univ Oulu, Oulu Ctr Cell Matrix Res, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland	University of Glasgow; University of Oulu; University of Oulu	Winter, AD (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Garscube Estate,Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland.	Alan.Winter@glasgow.ac.uk; Tony.Page@glasgow.ac.uk			Medical Research Council; Biotechnology and Biological Sciences Research Council of Great Britain; National Institutes of Health National Center for Research Resources; Biotechnology and Biological Sciences Research Council [BB/I011218/1] Funding Source: researchfish; Medical Research Council [G117/476] Funding Source: researchfish; BBSRC [BB/I011218/1] Funding Source: UKRI; MRC [G117/476] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council of Great Britain(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council and the Biotechnology and Biological Sciences Research Council of Great Britain.; Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. We thank the following people for reagents and materials: Rick Maizels and Yvonne Harcus (University of Edinburgh) for B. malayi nematodes and staged cDNA, Steven Williams (NIAID/National Institutes of Health FR3, Smith College) for EST clones, Mark Blaxter (University of Edinburgh) for BAC library lysates and clones, and Elodie Ghedin (University of Pittsburgh) for access to the resequenced B. malayi genome data.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; JOHN DCA, 1994, BIOCHEMISTRY-US, V33, P14018, DOI 10.1021/bi00251a009; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kelly WG, 1997, GENETICS, V146, P227; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Koivunen P, 1999, EMBO J, V18, P65, DOI 10.1093/emboj/18.1.65; LAMBERG A, 1995, J BIOL CHEM, V270, P9926, DOI 10.1074/jbc.270.17.9926; Landmann F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-16; Lappi AK, 2004, J MOL BIOL, V335, P283, DOI 10.1016/j.jmb.2003.10.051; Lok JB, 2012, PARASITOLOGY, V139, P574, DOI 10.1017/S0031182011001387; Maule AG, 2011, TRENDS PARASITOL, V27, P505, DOI 10.1016/j.pt.2011.07.004; Merriweather A, 2001, MOL BIOCHEM PARASIT, V116, P185, DOI 10.1016/S0166-6851(01)00317-6; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Myllyharju J, 2002, J BIOL CHEM, V277, P29187, DOI 10.1074/jbc.M203824200; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491; Page AP, 2003, ADV PARASIT, V53, P85, DOI 10.1016/S0065-308X(03)53003-2; PETRALANDA I, 1991, EXP PARASITOL, V72, P164, DOI 10.1016/0014-4894(91)90134-I; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Rajan TV, 2003, J PARASITOL, V89, P868, DOI 10.1645/GE-3137RN; Riihimaa P, 2002, J BIOL CHEM, V277, P18238, DOI 10.1074/jbc.M200895200; Stiernagle Theresa, 2006, WormBook, P1; TAKACS AM, 1988, P NATL ACAD SCI USA, V85, P7932, DOI 10.1073/pnas.85.21.7932; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Winter AD, 2000, MOL CELL BIOL, V20, P4084, DOI 10.1128/MCB.20.11.4084-4093.2000; Winter AD, 2003, J BIOL CHEM, V278, P2554, DOI 10.1074/jbc.M210381200; Winter AD, 2007, DEV BIOL, V308, P449, DOI 10.1016/j.ydbio.2007.05.041; Winter AD, 2007, MATRIX BIOL, V26, P382, DOI 10.1016/j.matbio.2007.01.008	37	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1750	1761		10.1074/jbc.M112.397604	http://dx.doi.org/10.1074/jbc.M112.397604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23223450	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000313751400031
J	Lee, JJ; Park, JK; Jeong, J; Jeon, H; Yoon, JB; Kim, EE; Lee, KJ				Lee, Jae-Jin; Park, Joon Kyu; Jeong, Jaeho; Jeon, Hyesung; Yoon, Jong-Bok; Kim, Eunice EunKyeong; Lee, Kong-Joo			Complex of Fas-associated Factor 1 (FAF1) with Valosin-containing Protein (VCP)-Npl4-Ufd1 and Polyubiquitinated Proteins Promotes Endoplasmic Reticulum-associated Degradation (ERAD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA ATPASE P97/VCP; POSTTRANSLATIONAL MODIFICATIONS; UBIQUITIN LIGASES; UBX DOMAIN; BINDING; IDENTIFICATION; CDC48/P97; COFACTORS; INTERACTS; STRATEGY	Fas-associated factor 1 (FAF1) is a ubiquitin receptor containing multiple ubiquitin-related domains including ubiquitin-associated (UBA), ubiquitin-like (UBL) 1, UBL2, and ubiquitin regulatory X (UBX). We previously showed that N-terminal UBA domain recognizes Lys(48)-ubiquitin linkage to recruit polyubiquitinated proteins and that a C-terminal UBX domain interacts with valosin-containing protein (VCP). This study shows that FAF1 interacts only with VCP complexed with Npl4-Ufd1 heterodimer, a requirement for the recruitment of polyubiquitinated proteins to UBA domain. Intriguingly, VCP association to C-terminal UBX domain regulates ubiquitin binding to N-terminal UBA domain without direct interaction between UBA and UBX domains. These interactions are well characterized by structural and biochemical analysis. VCP-Npl4-Ufd1 complex is known as the machinery required for endoplasmic reticulum-associated degradation. We demonstrate here that FAF1 binds to VCP-Npl4-Ufd1 complex via UBX domain and polyubiquitinated proteins via UBA domain to promote endoplasmic reticulum-associated degradation.	[Lee, Jae-Jin; Jeong, Jaeho; Lee, Kong-Joo] Ewha Womans Univ, Dept Bioinspired Sci, Div Life & Pharmaceut Sci, Ctr Cell Signaling & Drug Discovery Res,Coll Phar, Seoul 120750, South Korea; [Park, Joon Kyu; Jeon, Hyesung; Kim, Eunice EunKyeong] Korea Inst Sci & Technol, Biomed Res Inst, Seoul 136791, South Korea; [Yoon, Jong-Bok] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Yoon, Jong-Bok] Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea	Ewha Womans University; Korea Institute of Science & Technology (KIST); Yonsei University; Yonsei University	Kim, EE (corresponding author), Korea Inst Sci & Technol, Biomed Res Inst, Seoul 136791, South Korea.	eunice@kist.re.kr; kjl@ewha.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020; Yoon, Jong-Bok/0000-0002-3563-0702	Center for Cell Signaling Research and Drug Discovery Research Grant at Ewha Womans University from the National Core Research Center program, [R15-2006-020]; Global Research Laboratory Program [2012045441]; Bio and Medical Technology Development Program of the National Research Foundation of Korea [2012035580]; Functional Proteomics Center; Korea Ministry of Science and Technology, and an institutional grant from the Korea Institute of Science and Technology; Korea Institute of Science and Technology	Center for Cell Signaling Research and Drug Discovery Research Grant at Ewha Womans University from the National Core Research Center program,; Global Research Laboratory Program; Bio and Medical Technology Development Program of the National Research Foundation of Korea(National Research Foundation of Korea); Functional Proteomics Center; Korea Ministry of Science and Technology, and an institutional grant from the Korea Institute of Science and Technology; Korea Institute of Science and Technology(Korea Institute of Science & Technology (KIST))	This work was supported in part by Center for Cell Signaling Research and Drug Discovery Research Grant R15-2006-020 at Ewha Womans University from the National Core Research Center program, Global Research Laboratory Program Grant 2012045441, Bio and Medical Technology Development Program Grant 2012035580 of the National Research Foundation of Korea, the Functional Proteomics Center, the 21C Frontier Research and Development Program and Global Research Laboratory Program of the Korea Ministry of Science and Technology, and an institutional grant from the Korea Institute of Science and Technology.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujiwara K, 2004, J BIOL CHEM, V279, P4760, DOI 10.1074/jbc.M309448200; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Kang Y, 2007, J MOL BIOL, V365, P1093, DOI 10.1016/j.jmb.2006.10.056; Kim HJ, 2005, J BIOL CHEM, V280, P8125, DOI 10.1074/jbc.M406297200; Kim Kwang Young, 2011, Algae, V26, P1, DOI 10.4490/algae.2011.26.1.001; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040361; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Na S, 2008, MOL CELL PROTEOMICS, V7, P2452, DOI 10.1074/mcp.M800101-MCP200; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nowis D, 2006, EXP CELL RES, V312, P2921, DOI 10.1016/j.yexcr.2006.05.013; Park MY, 2007, J BIOL CHEM, V282, P27572, DOI 10.1074/jbc.C700106200; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Song J, 2009, PROTEIN SCI, V18, P2265, DOI 10.1002/pro.237; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	42	36	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6998	7011		10.1074/jbc.M112.417576	http://dx.doi.org/10.1074/jbc.M112.417576			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23293021	Green Published, hybrid			2022-12-28	WOS:000316002400022
J	Menzies, KJ; Singh, K; Saleem, A; Hood, DA				Menzies, Keir J.; Singh, Kaustabh; Saleem, Ayesha; Hood, David A.			Sirtuin 1-mediated Effects of Exercise and Resveratrol on Mitochondrial Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CHRONIC CONTRACTILE ACTIVITY; NAD(+) SALVAGE PATHWAY; SKELETAL-MUSCLE; GLUCOSE-HOMEOSTASIS; METABOLIC ADAPTATION; CALORIC RESTRICTION; AUTOREGULATORY LOOP; ENERGY-METABOLISM; OXIDATIVE STRESS	The purpose of this study was to evaluate the role of sirtuin 1 (SirT1) in exercise-and resveratrol (RSV)-induced skeletal muscle mitochondrial biogenesis. Using muscle-specific SirT1-deficient (KO) mice and a cell culture model of differentiated myotubes, we compared the treatment of resveratrol, an activator of SirT1, with that of exercise in inducing mitochondrial biogenesis. These experiments demonstrated that SirT1 plays a modest role in maintaining basal mitochondrial content and a larger role in preserving mitochondrial function. Furthermore, voluntary exercise and RSV treatment induced mitochondrial biogenesis in a SirT1-independent manner. However, when RSV and exercise were combined, a SirT1-dependent synergistic effect was evident, leading to enhanced translocation ofPGC-1 alpha and SirT1 to the nucleus and stimulation of mitochondrial biogenesis. Thus, the magnitude of the effect of RSV on muscle mitochondrial biogenesis is reliant on SirT1, as well as the cellular environment, such as that produced by repeated bouts of exercise.	[Singh, Kaustabh; Saleem, Ayesha; Hood, David A.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 1P3, Canada; [Menzies, Keir J.; Hood, David A.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Menzies, Keir J.; Singh, Kaustabh; Saleem, Ayesha; Hood, David A.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 1P3, Canada	York University - Canada; York University - Canada; York University - Canada	Hood, DA (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Farquharson Life Sci Bldg, Toronto, ON M3J 1P3, Canada.	dhood@yorku.ca	Saleem, Ayesha/J-6685-2019	Saleem, Ayesha/0000-0003-2146-5379; Menzies, Keir J/0000-0002-1873-8500	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Canadian Institutes of Health Research (to D. A. H.).	Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE748, DOI 10.1152/ajpendo.00311.2006; Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Chabi B, 2009, J APPL PHYSIOL, V107, P1730, DOI 10.1152/japplphysiol.91451.2008; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Dal-Pan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016581; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Harper CE, 2007, CARCINOGENESIS, V28, P1946, DOI 10.1093/carcin/bgm144; Horn TL, 2007, FOOD CHEM TOXICOL, V45, P55, DOI 10.1016/j.fct.2006.07.015; Irrcher I, 2003, SPORTS MED, V33, P783, DOI 10.2165/00007256-200333110-00001; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Irrcher I, 2009, AM J PHYSIOL-CELL PH, V296, pC116, DOI 10.1152/ajpcell.00267.2007; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Joseph AM, 2012, EXP DIABETES RES, DOI 10.1155/2012/642038; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Ljubicic V, 2008, AM J PHYSIOL-ENDOC M, V295, pE195, DOI 10.1152/ajpendo.90276.2008; Menzies KJ, 2012, MITOCHONDRION, V12, P5, DOI 10.1016/j.mito.2011.03.001; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; O'Leary MFN, 2008, J APPL PHYSIOL, V105, P114, DOI 10.1152/japplphysiol.00724.2007; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Pogozelski AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007934; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rowe GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041817; Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008; Silveira LR, 2006, BBA-MOL CELL RES, V1763, P969, DOI 10.1016/j.bbamcr.2006.06.010; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Summermatter S, 2013, DIABETES, V62, P85, DOI 10.2337/db12-0291; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Uguccioni G, 2011, AM J PHYSIOL-ENDOC M, V300, pE361, DOI 10.1152/ajpendo.00292.2010; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	57	123	130	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6968	6979		10.1074/jbc.M112.431155	http://dx.doi.org/10.1074/jbc.M112.431155			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329826	hybrid, Green Published			2022-12-28	WOS:000316002400019
J	Murugan, AK; Alzahrani, A; Xing, MZ				Murugan, Avaniyapuram Kannan; Alzahrani, Ali; Xing, Mingzhao			Mutations in Critical Domains Confer the Human mTOR Gene Strong Tumorigenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; SIGNALING PATHWAY; MAMMALIAN TARGET; PIK3CA MUTATION; THYROID CANCERS; POOR-PROGNOSIS; BREAST-CANCER; S6 KINASE; GROWTH	Mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase that regulates cell growth, proliferation, and survival. mTOR is frequently activated in human cancers and is a commonly sought anticancer therapeutic target. However, whether the human mTOR gene itself is a proto-oncogene possessing tumorigenicity has not been firmly established. To answer this question, we mutated evolutionarily conserved amino acids, generated eight mutants in the HEAT repeats (M938T) and the FAT (W1456R and G1479N) and kinase (P2273S, V2284M, V2291I, T2294I, and E2288K) domains of mTOR, and studied their oncogenicity. On transient expression in HEK293T cells, these mTOR mutants displayed elevated protein kinase activities accompanied by activated mTOR/p70S6K signaling at varying levels, demonstrating the gain of function of the mTOR gene with these mutations. We selected P2273S and E2288K, the two most catalytically active mutants, to further examine their oncogenicity and tumorigenicity. Stable expression of the two mTOR mutants in NIH3T3 cells strongly activated mTOR/p70S6K signaling, induced cell transformation and invasion, and remarkably, caused rapid tumor formation and growth in athymic nude mice after subcutaneous inoculation of the transfected cells. This study confirms the oncogenic potential of mTOR suggested previously and demonstrates for the first time its tumorigenicity. Thus, beyond the pivotal position of mTOR to relay the oncogenic signals from the upstream phosphatidylinositol 3-kinase/Akt pathway in human cancer, mTOR is capable potentially of playing a direct role in human tumorigenesis if mutated. These results also further support the conclusion that mTOR is a major therapeutic target in human cancers.	[Murugan, Avaniyapuram Kannan; Alzahrani, Ali; Xing, Mingzhao] Johns Hopkins Univ, Div Endocrinol & Metab, Sch Med, Lab Cellular & Mol Thyroid Res, Baltimore, MD 21287 USA	Johns Hopkins University	Xing, MZ (corresponding author), Johns Hopkins Univ, Div Endocrinol & Metab, Sch Med, Lab Cellular & Mol Thyroid Res, Suite 333,1830 East Monument St, Baltimore, MD 21287 USA.	mxing1@jhmi.edu	Murugan, Avaniyapuram Kannan/AAI-8222-2020; Alzahrani, Ali S/L-3664-2017	Murugan, Avaniyapuram Kannan/0000-0002-3096-6100; Alzahrani, Ali S/0000-0003-4294-3624	National Institutes of Health [R01CA134225]; NATIONAL CANCER INSTITUTE [R01CA134225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA134225 (to M. X.).	Aleskandarany MA, 2010, BREAST CANCER RES TR, V122, P45, DOI 10.1007/s10549-009-0508-9; Berven LA, 2000, IMMUNOL CELL BIOL, V78, P447, DOI 10.1046/j.1440-1711.2000.00928.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738; Fukui Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014180; Galoian KA, 2011, TUMOR BIOL, V32, P745, DOI 10.1007/s13277-011-0176-3; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hardt M, 2011, GENES CELLS, V16, P141, DOI 10.1111/j.1365-2443.2010.01482.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hou P, 2008, CANCER, V113, P2440, DOI 10.1002/cncr.23869; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Liu DX, 2009, CANCER RES, V69, P7311, DOI 10.1158/0008-5472.CAN-09-1077; Liu RX, 2011, J CLIN ENDOCR METAB, V96, pE577, DOI 10.1210/jc.2010-2644; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mavrakis M, 2006, HUM MOL GENET, V15, P2962, DOI 10.1093/hmg/ddl239; Murugan AK, 2011, CANCER RES, V71, P4403, DOI 10.1158/0008-5472.CAN-10-4041; Murugan AK, 2009, CELL CYCLE, V8, P2122, DOI 10.4161/cc.8.13.8710; Nawroth R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027509; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Sekulic A, 2000, CANCER RES, V60, P3504; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Sturgill TW, 2009, ACS CHEM BIOL, V4, P999, DOI 10.1021/cb900193e; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Volante M, 2009, J CLIN ENDOCR METAB, V94, P4735, DOI 10.1210/jc.2009-1233; Weigelt B, 2011, ONCOGENE, V30, P3222, DOI 10.1038/onc.2011.42; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xing MZ, 2010, THYROID, V20, P697, DOI 10.1089/thy.2010.1646; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	45	36	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6511	6521		10.1074/jbc.M112.399485	http://dx.doi.org/10.1074/jbc.M112.399485			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322780	Green Published, hybrid			2022-12-28	WOS:000315820700044
J	Anderson, BR; Bogomolovas, J; Labeit, S; Granzier, H				Anderson, Brian R.; Bogomolovas, Julius; Labeit, Siegfried; Granzier, Henk			Single Molecule Force Spectroscopy on Titin Implicates Immunoglobulin Domain Stability as a Cardiac Disease Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; WOOLLY HAIR; PROTEIN; MUTATIONS; STIFFNESS; IDENTIFICATION; MODULATION; EXPRESSION; MYOSIN	Titin plays crucial roles in sarcomere organization and cardiac elasticity by acting as an intrasarcomeric molecular spring. A mutation in the tenth Ig-like domain of titin's spring region is associated with arrhythmogenic cardiomyopathy, a disease characterized by ventricular arrhythmias leading to cardiac arrest and sudden death. Titin is the first sarcomeric protein linked to arrhythmogenic cardiomyopathy. To characterize the disease mechanism, we have used atomic force microscopy to directly measure the effects that the disease-linked point mutation (T16I) has on the mechanical and kinetic stability of Ig10 at the single molecule level. The mutation decreases the force needed to unfold Ig10 and increases its rate of unfolding 4-fold. We also found that T16I Ig10 is more prone to degradation, presumably due to compromised local protein structure. Overall, the disease-linked mutation weakens the structural integrity of titin's Ig10 domain and suggests an Ig domain disease mechanism.	[Anderson, Brian R.] Univ Arizona, Dept Phys, Tucson, AZ 85724 USA; [Anderson, Brian R.; Granzier, Henk] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA; [Anderson, Brian R.; Granzier, Henk] Univ Arizona, Sarver Mol Cardiovasc Res Program, Tucson, AZ 85724 USA; [Bogomolovas, Julius; Labeit, Siegfried] Univ Med Mannheim, Inst Integrat Pathophysiol, D-68167 Mannheim, Germany	University of Arizona; University of Arizona; University of Arizona; Ruprecht Karls University Heidelberg	Granzier, H (corresponding author), Univ Arizona, Dept Physiol, MRB 340,1656 E Mabel St, Tucson, AZ 85724 USA.	granzier@email.arizona.edu	Bogomolovas, Julius/HGD-2595-2022; Bogomolovas, Julius/AAS-3642-2020	Bogomolovas, Julius/0000-0001-8344-1909	National Institutes of Health [GM084905, HL062881]; American Heart Association [11PRE7370083]; European Union; DZHK (German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM084905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); European Union(European Commission); DZHK (German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Training Grant GM084905 and Grant HL062881 (to H. G.). This work was also supported by American Heart Association Grant 11PRE7370083 (to B. A.) and grants from European Union FP7 SarcoSi, the DZHK (German Center for Cardiovascular Research), and the BMBF (German Ministry of Education and Research) (to J. B. and S. L.).	Basso C, 1999, Cardiol Rev, V7, P127, DOI 10.1097/00045415-199905000-00009; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chung CS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/310791; Chung CS, 2011, J MOL CELL CARDIOL, V50, P731, DOI 10.1016/j.yjmcc.2011.01.005; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DUBOIS LH, 1992, ANNU REV PHYS CHEM, V43, P437, DOI 10.1146/annurev.pc.43.100192.002253; Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Govindan S, 2012, J MUSCLE RES CELL M, V33, P17, DOI 10.1007/s10974-012-9292-y; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Grutzner A, 2009, BIOPHYS J, V97, P825, DOI 10.1016/j.bpj.2009.05.037; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Herren T, 2009, CLIN RES CARDIOL, V98, P141, DOI 10.1007/s00392-009-0751-4; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Hidalgo C, 2009, CIRC RES, V105, P631, DOI 10.1161/CIRCRESAHA.109.198465; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Irving T, 2011, BIOPHYS J, V100, P1499, DOI 10.1016/j.bpj.2011.01.059; Kruger M, 2009, J MOL CELL CARDIOL, V46, P490, DOI 10.1016/j.yjmcc.2009.01.004; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; LeWinter MM, 2010, CIRCULATION, V121, P2137, DOI 10.1161/CIRCULATIONAHA.109.860171; Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; MARGOSSIAN SS, 1992, CIRCULATION, V85, P1720, DOI 10.1161/01.CIR.85.5.1720; Marino M, 2005, J MUSCLE RES CELL M, V26, P355, DOI 10.1007/s10974-005-9017-6; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nedrud J, 2011, BIOPHYS J, V101, P1385, DOI 10.1016/j.bpj.2011.06.054; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Park Chiwook, 2006, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2011s46; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Schroeder MA, 2010, CARDIOVASC RES, V86, P82, DOI 10.1093/cvr/cvp396; Sen-Chowdhry S, 2010, ANNU REV MED, V61, P233, DOI 10.1146/annurev.med.052208.130419; Stacklies W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000306; Taylor M, 2011, CIRCULATION, V124, P876, DOI 10.1161/CIRCULATIONAHA.110.005405; Trombitas K, 1998, J CELL BIOL, V140, P853, DOI 10.1083/jcb.140.4.853; Von Castelmur E, 2008, P NATL ACAD SCI USA, V105, P1186, DOI 10.1073/pnas.0707163105; Watanabe K, 2002, J STRUCT BIOL, V137, P248, DOI 10.1006/jsbi.2002.4458; Zhmurov A, 2010, BIOPHYS J, V99, P1959, DOI 10.1016/j.bpj.2010.07.012; Zhu Y, 2009, J BIOL CHEM, V284, P13914, DOI 10.1074/jbc.M809743200	47	26	26	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5303	5315		10.1074/jbc.M112.401372	http://dx.doi.org/10.1074/jbc.M112.401372			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297410	Green Published, hybrid			2022-12-28	WOS:000315342500005
J	Furuya, Y; Inagaki, A; Khan, M; Mori, K; Penninger, JM; Nakamura, M; Udagawa, N; Aoki, K; Ohya, K; Uchida, K; Yasuda, H				Furuya, Yuriko; Inagaki, Atsushi; Khan, Masud; Mori, Kaoru; Penninger, Josef M.; Nakamura, Midori; Udagawa, Nobuyuki; Aoki, Kazuhiro; Ohya, Keiichi; Uchida, Kohji; Yasuda, Hisataka			Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-kappa B Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTMENOPAUSAL WOMEN; PARATHYROID-HORMONE; RANK LIGAND; OSTEOBLAST DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; IN-VITRO; RESORPTION; OSTEOPOROSIS; MECHANISM; CELLS	To date, parathyroid hormone is the only clinically available bone anabolic drug. The major difficulty in the development of such drugs is the lack of clarification of the mechanisms regulating osteoblast differentiation and bone formation. Here, we report a peptide (W9) known to abrogate osteoclast differentiation in vivo via blocking receptor activator of nuclear factor-kappa B ligand (RANKL)-RANK signaling that we surprisingly found exhibits a bone anabolic effect in vivo. Subcutaneous administration of W9 three times/day for 5 days significantly augmented bone mineral density in mouse cortical bone. Histomorphometric analysis showed a decrease in osteoclastogenesis in the distal femoral metaphysis and a significant increase in bone formation in the femoral diaphysis. Our findings suggest that W9 exerts bone anabolic activity. To clarify the mechanisms involved in this activity, we investigated the effects of W9 on osteoblast differentiation/mineralization in MC3T3-E1 (E1) cells. W9 markedly increased alkaline phosphatase (a marker enzyme of osteoblasts) activity and mineralization as shown by alizarin red staining. Gene expression of several osteogenesis-related factors was increased in W9-treated E1 cells. Addition of W9 activated p38 MAPK and Smad1/5/8 in E1 cells, and W9 showed osteogenesis stimulatory activity synergistically with BMP-2 in vitro and ectopic bone formation. Knockdown of RANKL-expression in E1 cells reduced the effect of W9. Furthermore, W9 showed a weak effect on RANKL-deficient osteoblasts in alkaline phosphatase assay. Taken together, our findings suggest that this peptide may be useful for the treatment of bone diseases, and W9 achieves its bone anabolic activity through RANKL on osteoblasts accompanied by production of several autocrine factors.	[Furuya, Yuriko; Uchida, Kohji; Yasuda, Hisataka] Oriental Yeast Co Ltd, Nagahama Inst Biochem Sci, Nagahama, Shiga 5260804, Japan; [Inagaki, Atsushi; Mori, Kaoru] Oriental Yeast Co Ltd, Biochem Prod & Dev Ctr, Nagahama, Shiga 5260804, Japan; Oriental Yeast Co Ltd, Bioind Div, Itabashi Ku, Tokyo 1748505, Japan; [Khan, Masud; Aoki, Kazuhiro; Ohya, Keiichi] Tokyo Med & Dent Univ, Grad Sch, Dept Biomatrix, Bunkyo Ku, Tokyo 1138549, Japan; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Nakamura, Midori; Udagawa, Nobuyuki] Matsumoto Dent Univ, Dept Biochem, Nagano 3990781, Japan	Oriental Yeast Co., Ltd.; Oriental Yeast Co., Ltd.; Oriental Yeast Co., Ltd.; Tokyo Medical & Dental University (TMDU); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Matsumoto Dental University	Furuya, Y (corresponding author), 50 Kano Cho, Nagahama, Shiga 5260804, Japan.	furuya-y@oyc.co.jp; hyasuda@oyc.co.jp	AOKI, Kazuhiro/GRO-6475-2022; Penninger, Josef M/I-6860-2013	AOKI, Kazuhiro/0000-0001-6643-6315; Penninger, Josef M/0000-0002-8194-3777; Yasuda, Hisataka/0000-0003-3511-609X	Grants-in-Aid for Scientific Research [23593054, 25293377] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aoki K, 2006, J CLIN INVEST, V116, P1525, DOI 10.1172/JCI22513; Bekker PJ, 2004, J BONE MINER RES, V19, P1059, DOI 10.1359/JBMR.040305; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; CANALIS E, 1989, J CLIN INVEST, V83, P60, DOI 10.1172/JCI113885; Chen NJ, 2001, J IMMUNOL, V166, P270, DOI 10.4049/jimmunol.166.1.270; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Eissner G, 2004, CYTOKINE GROWTH F R, V15, P353, DOI 10.1016/j.cytogfr.2004.03.011; Furuya Y, 2011, J BIOL CHEM, V286, P37023, DOI 10.1074/jbc.M111.246280; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hu YY, 2003, ENDOCRINOLOGY, V144, P2068, DOI 10.1210/en.2002-220863; ISGAARD J, 1986, AM J PHYSIOL, V250, pE367, DOI 10.1152/ajpendo.1986.250.4.E367; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Nakamura M, 2003, ENDOCRINOLOGY, V144, P5441, DOI 10.1210/en.2003-0717; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takasaki W, 1997, NAT BIOTECHNOL, V15, P1266, DOI 10.1038/nbt1197-1266; TAM CS, 1982, ENDOCRINOLOGY, V110, P506, DOI 10.1210/endo-110-2-506; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Tomimori Y, 2009, J BONE MINER RES, V24, P1194, DOI [10.1359/JBMR.090217, 10.1359/jbmr.090217]; Watts AD, 1999, EMBO J, V18, P2119, DOI 10.1093/emboj/18.8.2119; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	37	56	62	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5562	5571		10.1074/jbc.M112.426080	http://dx.doi.org/10.1074/jbc.M112.426080			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23319583	Green Published, hybrid			2022-12-28	WOS:000315342500030
J	Nury, C; Bregant, S; Czarny, B; Berthon, F; Cassar-Lajeunesse, E; Dive, V				Nury, Catherine; Bregant, Sarah; Czarny, Bertrand; Berthon, Fannely; Cassar-Lajeunesse, Evelyne; Dive, Vincent			Detection of Endogenous Matrix Metalloprotease-12 Active Form with a Novel Broad Spectrum Activity-based Probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOAFFINITY PROBE; PROTEIN; INHIBITORS; AFFINITY; CLONING; MMP-12; MMP12	Matrix metalloproteases (MMPs) have attracted considerable attention as critical mediators of pathological tissue remodeling processes. However it remains an unresolved challenge to detect their active forms in biological samples. To prove the efficacy of a recently developed MMP activity-based probe, we examined the content in MMP active forms of bronchoalveolar lavage fluids (BALf) from male C57BL/6 mice exposed to ultrafine carbon black nanoparticles, a model of chronic obstructive pulmonary disease. This probe was shown to label proteins, mostly expressed in BALf of mice exposed to nanoparticles. Using competition assays with a selective MMP-12 inhibitor as well as MMP-12knock-out mice, one of these proteins was identified as the active form of the catalytic domain of MMP-12. This new probe can detect the active form of MMP-12 down to a threshold of 1 fmol. Radioactive counting showed the concentration of the active form of MMP-12 to be around 1 fmol/mu l in BALf from nanoparticle-treated mice. A less sensitive probe would therefore not have detected MMP-12. As the probe can detect other MMPs in the femtomolar range, it is a potentially powerful tool for monitoring the levels of MMP active forms in various diseases.	[Nury, Catherine; Bregant, Sarah; Czarny, Bertrand; Berthon, Fannely; Cassar-Lajeunesse, Evelyne; Dive, Vincent] CE Saclay, CEA, IBiTec S, Serv Ingn Mol Prot SIMOPRO, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Dive, V (corresponding author), CE Saclay, CEA, IBiTec S, Serv Ingn Mol Prot SIMOPRO, Bat 152, F-91191 Gif Sur Yvette, France.	vincent.dive@cea.fr	Czarny, Bertrand/F-2001-2018; CZARNY, bertrand/AAP-6603-2020	Czarny, Bertrand/0000-0002-9586-0913; CZARNY, bertrand/0000-0002-9586-0913	Commissariat a l'Energie Atomique (CEA)	Commissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission)	This work was supported by funds from the Commissariat a l'Energie Atomique (CEA).	BANDA MJ, 1981, BIOCHEM J, V193, P589, DOI 10.1042/bj1930589; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bode W, 1996, ADV EXP MED BIOL, V389, P1; Bregant S, 2009, J PROTEOME RES, V8, P2484, DOI 10.1021/pr801069c; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Chan EWS, 2004, J AM CHEM SOC, V126, P14435, DOI 10.1021/ja047044i; Chang CC, 2011, INHAL TOXICOL, V23, P616, DOI 10.3109/08958378.2011.598965; Cobos-Correa A, 2009, NAT CHEM BIOL, V5, P628, DOI 10.1038/nchembio.196; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Dabert-Gay AS, 2008, J BIOL CHEM, V283, P31058, DOI 10.1074/jbc.M805795200; Dabert-Gay AS, 2009, BIOCONJUGATE CHEM, V20, P367, DOI 10.1021/bc800478b; David A, 2007, ANGEW CHEM INT EDIT, V46, P3275, DOI 10.1002/anie.200604408; Demedts IK, 2006, THORAX, V61, P196, DOI 10.1136/thx.2005.042432; Deu E, 2012, NAT STRUCT MOL BIOL, V19, P9, DOI 10.1038/nsmb.2203; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Florea BI, 2010, CHEM BIOL, V17, P795, DOI 10.1016/j.chembiol.2010.05.027; Freije JR, 2003, J CHROMATOGR A, V1009, P155, DOI 10.1016/S0021-9673(03)00920-8; Freije R, 2008, J CHROMATOGR A, V1189, P417, DOI 10.1016/j.chroma.2007.10.059; Geurink PP, 2012, TOP CURR CHEM, V324, P85, DOI 10.1007/128_2011_286; Gronski TJ, 1997, J BIOL CHEM, V272, P12189, DOI 10.1074/jbc.272.18.12189; Hesek D, 2006, CHEM BIOL, V13, P379, DOI 10.1016/j.chembiol.2006.01.012; HOROVITZ A, 1987, P NATL ACAD SCI USA, V84, P6654, DOI 10.1073/pnas.84.19.6654; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, P528, DOI 10.1161/ATVBAHA.110.219147; Jullien N, 2010, J MED CHEM, V53, P208, DOI 10.1021/jm9010803; Kessenbrock K, 2011, CURR PROTOC IMMUNOL, V14; Kleiner DE, 1993, CURR OPIN CELL BIOL, V5, P891, DOI 10.1016/0955-0674(93)90040-W; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; LaPan P, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-40; Leeuwenburgh MA, 2006, ORG LETT, V8, P1705, DOI 10.1021/ol060409e; Moellering RE, 2012, CHEM BIOL, V19, P11, DOI 10.1016/j.chembiol.2012.01.001; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nury C, 2013, CHEMBIOCHEM, V14, P107, DOI 10.1002/cbic.201200583; Ocana MF, 2010, ANAL BIOCHEM, V399, P202, DOI 10.1016/j.ab.2010.01.002; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Prely LM, 2012, J CHROMATOGR A, V1246, P103, DOI 10.1016/j.chroma.2012.02.076; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Yiotakis A, 2008, MOL ASPECTS MED, V29, P329, DOI 10.1016/j.mam.2008.06.001	51	7	8	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5636	5644		10.1074/jbc.M112.419499	http://dx.doi.org/10.1074/jbc.M112.419499			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23271741	Green Published, hybrid			2022-12-28	WOS:000315342500037
J	Song, S; Jang, S; Park, J; Bang, S; Choi, S; Kwon, KY; Zhuang, XX; Kim, E; Chung, J				Song, Saera; Jang, Seoyeon; Park, Jeehye; Bang, Sunhoe; Choi, Sekyu; Kwon, Kyum-Yil; Zhuang, Xiaoxi; Kim, Eunjoon; Chung, Jongkyeong			Characterization of PINK1 (PTEN-induced Putative Kinase 1) Mutations Associated with Parkinson Disease in Mammalian Cells and Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY-ONSET PARKINSONISM; MITOCHONDRIAL DYSFUNCTION; DOPAMINERGIC-NEURONS; PROTEASOME; PATHWAY; PHOSPHORYLATION; DEGRADATION; RECRUITMENT; PATHOLOGY; MEMBRANE	Mutations in PINK1 (PTEN-induced putative kinase 1) are tightly linked to autosomal recessive Parkinson disease (PD). Although more than 50 mutations in PINK1 have been discovered, the role of these mutations in PD pathogenesis remains poorly understood. Here, we characterized 17 representative PINK1 pathogenic mutations in both mammalian cells and Drosophila. These mutations did not affect the typical cleavage patterns and subcellular localization of PINK1 under both normal and damaged mitochondria conditions in mammalian cells. However, PINK1 mutations in the kinase domain failed to translocate Parkin to mitochondria and to induce mitochondrial aggregation. Consistent with the mammalian data, Drosophila PINK1 mutants with mutations in the kinase domain (G426D and L464P) did not genetically interact with Parkin. Furthermore, PINK1-null flies expressing the transgenic G426D mutant displayed defective phenotypes with increasing age, whereas L464P mutant-expressing flies exhibited the phenotypes at an earlier age. Collectively, these results strongly support the hypothesis that the kinase activity of PINK1 is essential for its function and for regulating downstream Parkin functions in mitochondria. We believe that this study provides the basis for understanding the molecular and physiological functions of various PINK1 mutations and provides insights into the pathogenic mechanisms of PINK1-linked PD.	[Song, Saera; Choi, Sekyu; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Song, Saera; Jang, Seoyeon; Bang, Sunhoe; Choi, Sekyu; Chung, Jongkyeong] Korea Adv Inst Sci & Technol, Inst Mol Biol & Genet, Taejon 305701, South Korea; [Jang, Seoyeon; Bang, Sunhoe; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Song, Saera; Jang, Seoyeon; Park, Jeehye; Bang, Sunhoe; Choi, Sekyu; Kwon, Kyum-Yil; Chung, Jongkyeong] Seoul Natl Univ, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul 151742, South Korea; [Zhuang, Xiaoxi] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU); University of Chicago	Chung, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 151742, South Korea.	jkc@snu.ac.kr	Kim, Eunjoon/C-1566-2011	Choi, Sekyu/0000-0003-2928-0942	National Creative Research Initiatives Program Grant from the Korean Ministry of Education, Science and Technology [2010-0018291]	National Creative Research Initiatives Program Grant from the Korean Ministry of Education, Science and Technology	This work was supported by National Creative Research Initiatives Program Grant 2010-0018291 from the Korean Ministry of Education, Science and Technology.	Abou-Sleiman PM, 2006, ANN NEUROL, V60, P414, DOI 10.1002/ana.20960; Becker D, 2012, J BIOL CHEM, V287, P22969, DOI 10.1074/jbc.M112.365700; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82; Brooks J, 2009, J MED GENET, V46, P375, DOI 10.1136/jmg.2008.063917; Cardona F, 2011, HUM MUTAT, V32, P369, DOI 10.1002/humu.21444; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chishti MA, 2006, ARCH NEUROL-CHICAGO, V63, P1483, DOI 10.1001/archneur.63.10.1483; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Deas E, 2009, EMBO MOL MED, V1, P152, DOI 10.1002/emmm.200900024; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hatano Y, 2004, NEUROLOGY, V63, P1482, DOI 10.1212/01.WNL.0000142258.29304.FE; Hatano Y, 2004, ANN NEUROL, V56, P424, DOI 10.1002/ana.20251; Ibanez P, 2006, BRAIN, V129, P686, DOI 10.1093/brain/awl005; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Klein C, 2007, NEUROLOGY, V69, P2093, DOI 10.1212/01.wnl.0000271880.27321.a7; Koh H, 2012, MOL CELLS, V34, P7, DOI 10.1007/s10059-012-0100-8; Koh H, 2012, J BIOL CHEM, V287, P12750, DOI 10.1074/jbc.M111.337907; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Kumazawa R, 2008, ARCH NEUROL-CHICAGO, V65, P802, DOI 10.1001/archneur.65.6.802; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; Li Y, 2005, NEUROLOGY, V64, P1955, DOI 10.1212/01.WNL.0000164009.36740.4E; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Matenia D, 2012, J BIOL CHEM, V287, P8174, DOI 10.1074/jbc.M111.262287; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Moriwaki Y, 2008, NEUROSCI RES, V61, P43, DOI 10.1016/j.neures.2008.01.006; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Prestel J, 2008, J NEUROL, V255, P643, DOI 10.1007/s00415-008-0763-4; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanaka Keiji, 2010, Rinsho Shinkeigaku, V50, P867; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Woodroof HI, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110012; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	72	52	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5660	5672		10.1074/jbc.M112.430801	http://dx.doi.org/10.1074/jbc.M112.430801			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23303188	Green Published, hybrid			2022-12-28	WOS:000315342500039
J	Ho, D; Lugo, MR; Merrill, AR				Ho, Derek; Lugo, Miguel R.; Merrill, A. Rod			Harmonic Analysis of the Fluorescence Response of Bimane Adducts of Colicin E1 at Helices 6, 7, and 10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE TOPOLOGY; MOLECULAR-BASIS; FORMING DOMAIN; INSERTION; PROTEINS; MECHANISM; PATHWAY; SURFACE; IMPORT; ENERGY	The pre-channel state of helices 6, 7, and 10 (Val(447)-Gly(475) and Ile(508)-Ile(522)) of colicin E1 was investigated by a site-directed fluorescence labeling technique. A total of 44 cysteine variants were purified and covalently labeled with monobromobimane fluorescent probe. A variety of fluorescence properties of the bimane fluorophore were measured for both the soluble and membrane-bound states of the channel peptide, including the fluorescence emission maximum, fluorescence anisotropy, and membrane bilayer penetration depth. Using site-directed fluorescence labeling combined with our novel helical periodicity analysis method, the data revealed that helices 6, 7, and 10 are separate amphipathic +/- -helices with a calculated periodicity of T = 3.34 +/- 0.08 for helix 6, T = 3.56 +/- 0.03 for helix 7, and T = 2.99 +/- 0.12 for helix 10 in the soluble state. In the membrane-bound state, the helical periodicity was determined to be T = 3.00 +/- 0.15 for helix 6, T = 3.68 +/- 0.03 for helix 7, and T = 3.47 +/- 0.04 for helix 10. Dual fluorescence quencher analysis showed that both helices 6 and 7 adopt a tilted topology that correlates well with the analysis based on the fluorescence anisotropy profile. These data provide further support for the umbrella model of the colicin E1 channel domain.	[Ho, Derek; Lugo, Miguel R.; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Merrill, Rod/M-8313-2014		Natural Sciences and Engineering Council of Canada	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Natural Sciences and Engineering Council of Canada (to A. R. M.).	Berne S, 2005, BIOCHEMISTRY-US, V44, P11137, DOI 10.1021/bi051013y; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3265, DOI 10.1021/bi026696l; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; COOPER PC, 1984, J GEN MICROBIOL, V130, P209; CORNETTE JL, 1987, J MOL BIOL, V195, P659, DOI 10.1016/0022-2836(87)90189-6; Elkins P, 1997, STRUCTURE, V5, P443, DOI 10.1016/S0969-2126(97)00200-1; ELKINS PA, 1994, PROTEINS, V19, P150, DOI 10.1002/prot.340190208; Eraso JM, 1996, J BACTERIOL, V178, P1928, DOI 10.1128/jb.178.7.1928-1935.1996; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Gouaux E, 1997, STRUCTURE, V5, P313, DOI 10.1016/S0969-2126(97)00188-3; GOULD JM, 1977, J BIOL CHEM, V252, P5491; HARKNESS RE, 1989, J BIOL CHEM, V264, P6177; Ho D, 2011, BIOCHEMISTRY-US, V50, P4830, DOI 10.1021/bi101934e; Ho D, 2009, BIOCHEMISTRY-US, V48, P1369, DOI 10.1021/bi801906v; Jakes KS, 2012, ANNU REV GENET, V46, P209, DOI 10.1146/annurev-genet-110711-155427; Kleanthous C, 2001, TRENDS BIOCHEM SCI, V26, P624, DOI 10.1016/S0968-0004(01)01941-7; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Ladokhin AS, 2002, BIOCHEMISTRY-US, V41, P13617, DOI 10.1021/bi0264418; Lazdunski CJ, 1998, J BACTERIOL, V180, P4993, DOI 10.1128/JB.180.19.4993-5002.1998; Lindeberg M, 2000, J MOL BIOL, V295, P679, DOI 10.1006/jmbi.1999.3396; Lins L, 2007, MOL MEMBR BIOL, V24, P419, DOI 10.1080/09687860701228254; Masaki H, 2002, BIOCHIMIE, V84, P433, DOI 10.1016/S0300-9084(02)01425-6; Musse AA, 2003, J BIOL CHEM, V278, P24491, DOI 10.1074/jbc.M302371200; Musse AA, 2006, J BIOL CHEM, V281, P885, DOI 10.1074/jbc.M511140200; PARKER MW, 1992, J MOL BIOL, V224, P639, DOI 10.1016/0022-2836(92)90550-4; Ridley H, 2010, ADV EXP MED BIOL, V677, P81; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Schendel SL, 2000, METHOD ENZYMOL, V322, P274; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; STEER BA, 1994, BIOCHEMISTRY-US, V33, P1108, DOI 10.1021/bi00171a009; Stroud RM, 1998, CURR OPIN STRUC BIOL, V8, P525, DOI 10.1016/S0959-440X(98)80132-2; Tian C, 2006, BBA-BIOMEMBRANES, V1758, P693, DOI 10.1016/j.bbamem.2006.03.025; Tory MC, 2002, BBA-BIOMEMBRANES, V1564, P435, DOI 10.1016/S0005-2736(02)00493-5; Wei ZK, 2007, BIOCHEMISTRY-US, V46, P6074, DOI 10.1021/bi700317k; White D, 2006, J BIOL CHEM, V281, P32375, DOI 10.1074/jbc.M605880200; Zakharov SD, 2004, FRONT BIOSCI-LANDMRK, V9, P1311, DOI 10.2741/1334; Zakharov SD, 2002, BBA-BIOMEMBRANES, V1565, P333, DOI 10.1016/S0005-2736(02)00579-5; Zhao G, 2005, BIOCHEMISTRY-US, V44, P4488, DOI 10.1021/bi047705o	41	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5136	5148		10.1074/jbc.M112.436303	http://dx.doi.org/10.1074/jbc.M112.436303			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264635	Green Published, hybrid			2022-12-28	WOS:000315340400061
J	Suzuki-Anekoji, M; Suzuki, A; Wu, SW; Angata, K; Murai, KK; Sugihara, K; Akama, TO; Khoo, KH; Nakayama, J; Fukuda, MN; Fukuda, M				Suzuki-Anekoji, Misa; Suzuki, Atsushi; Wu, Sz-Wei; Angata, Kiyohiko; Murai, Keith K.; Sugihara, Kazuhiro; Akama, Tomoya O.; Khoo, Kay-Hooi; Nakayama, Jun; Fukuda, Michiko N.; Fukuda, Minoru			In Vivo Regulation of Steroid Hormones by the Chst10 Sulfotransferase in Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; MYELIN-ASSOCIATED GLYCOPROTEIN; L-SELECTIN; HNK-1 SULFOTRANSFERASE; EXPRESSION CLONING; HEPARAN-SULFATE; O-GLYCANS; CARBOHYDRATE; ANTIBODY; BIOSYNTHESIS	Chst10 adds sulfate to glucuronic acid to form a carbohydrate antigen, HNK-1, in glycoproteins and glycolipids. To determine the role of Chst10 in vivo, we generated systemic Chst10-deficient mutant mice. Although Chst10(-/-) mice were born and grew to adulthood with no gross defects, they were subfertile. Uteri from Chst10(-/-) females at the pro-estrus stage were larger than those from wild-type females and exhibited a thick uterine endometrium. Serum estrogen levels in Chst10(-/-) females were higher than those from wild-type females, suggesting impaired down-regulation of estrogen. Because steroid hormones are often conjugated to glucuronic acid, we hypothesized that Chst10 sulfates glucuronidated steroid hormone to regulate steroid hormone in vivo. Enzymatic activity assays and structural analysis of Chst10 products by HPLC and mass spectrometry revealed that Chst10 indeed sulfates glucuronidated estrogen, testosterone, and other steroid hormones. We also identified an HPLC peak corresponding to sulfated and glucuronidated estradiol in serum from wild-type but not from Chst10 null female mice. Estrogen-response element reporter assays revealed that Chst10-modified estrogen likely did not bind to its receptor. These results suggest that subfertility exhibited by female mice following Chst10 loss results from dysregulation of estrogen. Given that Chst10 transfers sulfates to several steroid hormones, Chst10 likely functions in widespread regulation of steroid hormones in vivo.	[Suzuki-Anekoji, Misa; Suzuki, Atsushi; Angata, Kiyohiko; Murai, Keith K.; Fukuda, Michiko N.; Fukuda, Minoru] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Ctr Canc, Glycobiol Unit, La Jolla, CA 92037 USA; [Wu, Sz-Wei; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Sugihara, Kazuhiro] Hamamatsu Univ Sch Med, Dept Gynecol & Obstet, Hamamatsu, Shizuoka 4313192, Japan; [Akama, Tomoya O.] Kansai Med Univ, Dept Pharmacol, Osaka 5708506, Japan; [Nakayama, Jun] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 3908621, Japan	Sanford Burnham Prebys Medical Discovery Institute; Academia Sinica - Taiwan; Hamamatsu University School of Medicine; Kansai Medical University; Shinshu University	Fukuda, MN (corresponding author), Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Ctr Canc, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	michiko@sanfordburnham.org; minoru@sanfordburnham.org	Angata, Kiyohiko/M-2749-2018; Khoo, Kay-Hooi/E-1989-2019	Angata, Kiyohiko/0000-0001-5561-1368; Khoo, Kay-Hooi/0000-0003-2906-406X	National Institutes of Health [P01CA071932, EY014620, CA33895]; Japanese Ministry of Education [24592530]; NATIONAL CANCER INSTITUTE [P01CA071932, U01CA168925, R01CA033895] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01CA071932 (to M. N. F. and M. F.), EY014620 (to T. O. A.), and CA33895 (to M. F.). This work was also supported by Japanese Ministry of Education Grant 24592530 (to A. S.).	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; ABO T, 1982, J EXP MED, V155, P321, DOI 10.1084/jem.155.1.321; ABO T, 1981, J IMMUNOL, V127, P1024; Akama TO, 2000, NAT GENET, V26, P237, DOI 10.1038/79987; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; ARIGA T, 1987, J BIOL CHEM, V262, P848; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Caligioni C. S, 2009, CURR PROTOC NEUROSCI, V48, pA411; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; Fisher MB, 2000, DRUG METAB DISPOS, V28, P560; Frenette PS, 2000, BLOOD, V96, P2460, DOI 10.1182/blood.V96.7.2460.h8002460_2460_2468; Fukuda MN, 2008, J OBSTET GYNAECOL RE, V34, P129, DOI 10.1111/j.1447-0756.2008.00776.x; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; Gershon E, 2007, FASEB J, V21, P1893, DOI 10.1096/fj.06-7688com; Ghosh R, 2001, CONTRACEPTION, V64, P261, DOI 10.1016/S0010-7824(01)00257-8; HIRAIWA N, 1990, CANCER RES, V50, P2917; Hirakawa J, 2010, J BIOL CHEM, V285, P40864, DOI 10.1074/jbc.M110.167296; ILYAS AA, 1984, BIOCHEM BIOPH RES CO, V122, P1206, DOI 10.1016/0006-291X(84)91220-8; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; JENSEN EV, 1973, SCIENCE, V182, P126, DOI 10.1126/science.182.4108.126; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; KRUSE J, 1985, NATURE, V316, P146, DOI 10.1038/316146a0; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; Loveless RW, 1998, GLYCOBIOLOGY, V8, P1237, DOI 10.1093/glycob/8.12.1237; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; MCGARRY RC, 1983, NATURE, V306, P376, DOI 10.1038/306376a0; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Mi YL, 2008, J CLIN INVEST, V118, P1815, DOI 10.1172/JCI32467; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Ong E, 1999, J BIOL CHEM, V274, P25608, DOI 10.1074/jbc.274.36.25608; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; Ong E, 2002, J BIOL CHEM, V277, P18182, DOI 10.1074/jbc.M201312200; Pasqualini JR, 2009, ANN NY ACAD SCI, V1155, P88, DOI 10.1111/j.1749-6632.2009.04113.x; Raftogianis R, 2000, J Natl Cancer Inst Monogr, P113; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Rosen SD, 2006, J IMMUNOL, V177, P3, DOI 10.4049/jimmunol.177.1.3; SCHACHNER M, 1995, TRENDS NEUROSCI, V18, P183, DOI 10.1016/0166-2236(95)93899-9; Senn C, 2002, MOL CELL NEUROSCI, V20, P712, DOI 10.1006/mcne.2002.1142; Shibata TK, 2012, J BIOL CHEM, V287, P6592, DOI 10.1074/jbc.M111.305334; Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/endo.142.11.8547; Sorensen PW, 2005, NAT CHEM BIOL, V1, P324, DOI 10.1038/nchembio739; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Suzuki-Anekoji M, 2011, J BIOL CHEM, V286, P32824, DOI 10.1074/jbc.M111.245886; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Tong MH, 2005, NAT MED, V11, P153, DOI 10.1038/nm1184; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; TSUJI Y, 1992, J REPROD IMMUNOL, V22, P225, DOI 10.1016/0165-0378(92)90045-6; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Yamakawa N, 2007, BIOCHIMIE, V89, P1396, DOI 10.1016/j.biochi.2007.04.010; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Yuen CT, 1997, J BIOL CHEM, V272, P8924	60	6	6	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5007	5016		10.1074/jbc.M112.433474	http://dx.doi.org/10.1074/jbc.M112.433474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23269668	Green Published, hybrid			2022-12-28	WOS:000315340400047
J	Ma, QL; Zuo, XH; Yang, FS; Ubeda, OJ; Gant, DJ; Alaverdyan, M; Teng, E; Hu, SX; Chen, PP; Maiti, P; Teter, B; Cole, GM; Frautschy, SA				Ma, Qiu-Lan; Zuo, Xiaohong; Yang, Fusheng; Ubeda, Oliver J.; Gant, Dana J.; Alaverdyan, Mher; Teng, Edmond; Hu, Shuxin; Chen, Ping-Ping; Maiti, Panchanan; Teter, Bruce; Cole, Greg M.; Frautschy, Sally A.			Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE MOUSE MODELS; DETERMINES AGGREGATION; ALZHEIMERS-DISEASE; PROTEIN; OLIGOMERS; PHOSPHORYLATION; RECEPTORS; PATHOLOGY; PLAQUES; DOMAIN	The mechanisms underlying Tau-related synaptic and cognitive deficits and the interrelationships between Tau species, their clearance pathways, and synaptic impairments remain poorly understood. To gain insight into these mechanisms, we examined these interrelationships in aged non-mutant genomic human Tau mice, with established Tau pathology and neuron loss. We also examined how these interrelationships changed with an intervention by feeding mice either a control diet or one containing the brain permeable beta-amyloid and Tau aggregate binding molecule curcumin. Transgene-dependent elevations in soluble and insoluble phospho-Tau monomer and soluble Tau dimers accompanied deficits in behavior, hippocampal excitatory synaptic markers, and molecular chaperones (heat shock proteins (HSPs)) involved in Tau degradation and microtubule stability. In human Tau mice but not control mice, HSP70, HSP70/HSP72, and HSP90 were reduced in membrane-enriched fractions but not in cytosolic fractions. The synaptic proteins PSD95 and NR2B were reduced in dendritic fields and redistributed into perikarya, corresponding to changes observed by immunoblot. Curcumin selectively suppressed levels of soluble Tau dimers, but not of insoluble and monomeric phospho-Tau, while correcting behavioral, synaptic, and HSP deficits. Treatment increased PSD95 co-immunoprecipitating with NR2B and, independent of transgene, increased HSPs implicated in Tau clearance. It elevated HSP90 and HSC70 without increasing HSP mRNAs; that is, without induction of the heat shock response. Instead curcumin differentially impacted HSP90 client kinases, reducing Fyn without reducing Akt. In summary, curcumin reduced soluble Tau and elevated HSPs involved in Tau clearance, showing that even after tangles have formed, Tau-dependent behavioral and synaptic deficits can be corrected.	[Ma, Qiu-Lan; Zuo, Xiaohong; Yang, Fusheng; Ubeda, Oliver J.; Gant, Dana J.; Alaverdyan, Mher; Teng, Edmond; Hu, Shuxin; Chen, Ping-Ping; Maiti, Panchanan; Teter, Bruce; Cole, Greg M.; Frautschy, Sally A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90073 USA; [Ma, Qiu-Lan; Zuo, Xiaohong; Yang, Fusheng; Ubeda, Oliver J.; Gant, Dana J.; Alaverdyan, Mher; Teng, Edmond; Hu, Shuxin; Chen, Ping-Ping; Maiti, Panchanan; Teter, Bruce; Cole, Greg M.; Frautschy, Sally A.] Vet Greater Los Angeles Healthcare Syst, Geriatr Res Educ & Clin Ctr, Los Angeles, CA 90073 USA; [Zuo, Xiaohong] Capital Med Univ, Xuanwu Hosp, Dept Neurobiol, Key Lab Neurodegenerat Disorders,Minist Educ,Beij, Beijing 10053, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Geriatric Research Education & Clinical Center; Capital Medical University	Cole, GM (corresponding author), Vet Greater Los Angeles Healthcare Syst, Geriatr Res Educ & Clin Ctr, 11301 Wilshire Blvd,Bldg 113,Rm 312, Los Angeles, CA 90073 USA.	gmcole@ucla.edu; frautsch@ucla.edu	Zuo, Xiaohong/H-6254-2016	Frautschy, Sally A./0000-0003-0194-0363	National Institutes of Health [R01 AG021975, U0128583, RC1 AG035878, AT006816, P01 AG16570, P30-AG028748, K08 AG34628]; Alzheimer's Association Grant [NIRG-07-59659]; UCLA Mary S. Easton Translation Center; Veterans Affairs Merit grants; National Center for Complementary & Integrative Health [R01AT006816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016570, R01AG021975, RC1AG035878, P30AG028748, K08AG034628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association Grant(Alzheimer's Association); UCLA Mary S. Easton Translation Center; Veterans Affairs Merit grants; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG021975 (to S. A. F.), U0128583 (to S. A. F.), RC1 AG035878 (to S. A. F. and G. M. C.), AT006816 (to G. M. C.), P01 AG16570 (UCLA Alzheimer Disease Research Center; to G. M. C.), P30-AG028748 (UCLA Older Americans Independence Center; NIA), and K08 AG34628 (to E. T.). This work was also supported by Alzheimer's Association Grant NIRG-07-59659 (to Q-L. M.), the UCLA Mary S. Easton Translation Center (S. A. F., G. M. C.), and Veterans Affairs Merit grants (to G. M. C. and S. A. F.). S.A.F. and G.M.C. are coinventors on a UC Regents and Veteran's pending patent on a bioavailable curcumin formulation, which has been licensed by UC Regents to Verdure Sciences, Indianapolis, IN. These authors contributed equal funding to this project.	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; Chen J, 2005, PHARMAZIE, V60, P57; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Dadhaniya P, 2011, FOOD CHEM TOXICOL, V49, P1834, DOI 10.1016/j.fct.2011.05.001; Delint-Ramirez I, 2008, J NEUROCHEM, V106, P1658, DOI 10.1111/j.1471-4159.2008.05523.x; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Eckermann K, 2007, J BIOL CHEM, V282, P31755, DOI 10.1074/jbc.M705282200; Filali M, 2009, GENES BRAIN BEHAV, V8, P143, DOI 10.1111/j.1601-183X.2008.00453.x; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P14203, DOI 10.1021/bi001876l; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Giommarelli C, 2010, CELL MOL LIFE SCI, V67, P995, DOI 10.1007/s00018-009-0233-x; Gota VS, 2010, J AGR FOOD CHEM, V58, P2095, DOI 10.1021/jf9024807; Gylys KH, 2003, J NEUROCHEM, V84, P1442, DOI 10.1046/j.1471-4159.2003.01643.x; Haroutunian V, 2007, NEUROBIOL AGING, V28, P1, DOI 10.1016/j.neurobiolaging.2005.11.001; He HJ, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-81; Ho GJ, 2005, NEUROBIOL AGING, V26, P625, DOI 10.1016/j.neurobiolaging.2004.06.016; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Horiguchi T, 2003, AM J PATHOL, V163, P1021, DOI 10.1016/S0002-9440(10)63462-1; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jinwal UK, 2010, J BIOL CHEM, V285, P16798, DOI 10.1074/jbc.M110.113753; Kimura T, 2007, EMBO J, V26, P5143, DOI 10.1038/sj.emboj.7601917; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Machado P, 2011, J NEUROSCI, V31, P3, DOI 10.1523/JNEUROSCI.2533-10.2011; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Marshall GA, 2006, DEMENT GERIATR COGN, V21, P144, DOI 10.1159/000090674; Mizuno M, 2003, LEARN MEMORY, V10, P108, DOI 10.1101/lm.56003; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; Mohorko N, 2010, J NEUROPATH EXP NEUR, V69, P405, DOI 10.1097/NEN.0b013e3181d709eb; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Reynolds MR, 2005, BIOCHEMISTRY-US, V44, P1690, DOI 10.1021/bi047982v; Rocher AB, 2010, EXP NEUROL, V223, P385, DOI 10.1016/j.expneurol.2009.07.029; Sahara N, 2007, J NEUROSCI RES, V85, P3098, DOI 10.1002/jnr.21417; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Vana L, 2011, BIOCHEMISTRY-US, V50, P1203, DOI 10.1021/bi101735m; Vega IE, 2005, MOL BRAIN RES, V138, P135, DOI 10.1016/j.molbrainres.2005.04.015; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	65	132	137	3	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4056	4065		10.1074/jbc.M112.393751	http://dx.doi.org/10.1074/jbc.M112.393751			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264626	hybrid, Green Published			2022-12-28	WOS:000314845000034
J	Manso, AM; Li, RX; Monkley, SJ; Cruz, NM; Ong, S; Lao, DH; Koshman, YE; Gu, YS; Peterson, KL; Chen, J; Abel, ED; Samarel, AM; Critchley, DR; Ross, RS				Manso, Ana Maria; Li, Ruixia; Monkley, Susan J.; Cruz, Nathalia M.; Ong, Shannon; Lao, Dieu H.; Koshman, Yevgeniya E.; Gu, Yusu; Peterson, Kirk L.; Chen, Ju; Abel, E. Dale; Samarel, Allen M.; Critchley, David R.; Ross, Robert S.			Talin1 Has Unique Expression versus Talin 2 in the Heart and Modifies the Hypertrophic Response to Pressure Overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCYTE-SPECIFIC EXCISION; DILATED CARDIOMYOPATHY; CARDIAC MYOCYTES; GENE; PROTEIN; KINASE; CONTRACTILITY; LOCALIZATION; CONNECTION; ACTIVATION	Integrins are adhesive, signaling, and mechanotransduction proteins. Talin (Tln) activates integrins and links it to the actin cytoskeleton. Vertebrates contain two talin genes, tln1 and tln2. How Tln1 and Tln2 function in cardiac myocytes (CMs) is unknown. Tln1 and Tln2 expression were evaluated in the normal embryonic and adult mouse heart as well as in control and failing human adult myocardium. Tln1 function was then tested in the basal and mechanically stressed myocardium after cardiomyocyte-specific excision of the Tln1 gene. During embryogenesis, both Tln forms are highly expressed in CMs, but in the mature heart Tln2 becomes the main Tln isoform, localizing to the costameres. Tln1 expression is minimal in the adult CM. With pharmacological and mechanical stress causing hypertrophy, Tln1 is up-regulated in CMs and is specifically detected at costameres, suggesting its importance in the compensatory response to CM stress. In human failing heart, CM Tln1 also increases compared with control samples from normal functioning myocardium. To directly test Tln1 function in CMs, we generated CM-specific Tln1 knock-out mice (Tln1cKO). Tln1cKO mice showed normal basal cardiac structure and function but when subjected to pressure overload showed blunted hypertrophy, less fibrosis, and improved cardiac function versus controls. Acute responses of ERK1/2, p38, Akt, and glycogen synthase kinase 3 after mechanical stress were strongly blunted in Tln1cKO mice. Given these results, we conclude that Tln1 and Tln2 have distinct functions in the myocardium. Our data show that reduction of CM Tln1 expression can lead to improved cardiac remodeling following pressure overload.	[Manso, Ana Maria; Li, Ruixia; Cruz, Nathalia M.; Ong, Shannon; Ross, Robert S.] Vet Adm Healthcare, San Diego, CA 92161 USA; [Manso, Ana Maria; Li, Ruixia; Cruz, Nathalia M.; Ong, Shannon; Lao, Dieu H.; Gu, Yusu; Peterson, Kirk L.; Chen, Ju; Ross, Robert S.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Diabet & Metab, Salt Lake City, UT 84108 USA; [Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT 84108 USA; [Monkley, Susan J.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Koshman, Yevgeniya E.; Samarel, Allen M.] Loyola Univ, Med Ctr, Dept Physiol, Maywood, IL 60153 USA	University of California System; University of California San Diego; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Leicester; Loyola University Chicago	Ross, RS (corresponding author), VA San Diego Healthcare Syst, Cardiol Sect, 3350 La Jolla Village Dr,111A, San Diego, CA 92161 USA.	rross@ucsd.edu	gu, yu/GSD-4507-2022; Chen, Ju/E-5579-2011; Ross, Robert/ABE-1109-2020; Samarel, Allen/Q-9810-2019	Ross, Robert/0000-0003-2195-8982; Monkley, Susan/0000-0001-9174-6278; Abel, E. Dale/0000-0001-5290-0738; Samarel, Allen/0000-0001-8765-9884	National Institutes of Health [HL046345, HL103566]; Veterans Administration Merit Award; Wellcome Trust; Cancer Research UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103566, P01HL046345, R01HL066100, R01HL106968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Merit Award; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL046345 and HL103566 (to R. S. R.). This work was also supported by a Veterans Administration Merit Award (to R. S. R.) and by Wellcome Trust and Cancer Research UK (to D. R. C.).	Abel ED, 1999, J CLIN INVEST, V104, P1703, DOI 10.1172/JCI7605; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Banno A, 2012, J BIOL CHEM, V287, P13799, DOI 10.1074/jbc.M112.341214; Belkin AM, 1997, J CELL BIOL, V139, P1583, DOI 10.1083/jcb.139.6.1583; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Boudoukha S, 2010, MOL CELL BIOL, V30, P5710, DOI 10.1128/MCB.00665-10; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Chen H, 2005, LAB INVEST, V85, P1342, DOI 10.1038/labinvest.3700345; Conti FJ, 2008, DEVELOPMENT, V135, P2043, DOI 10.1242/dev.015818; Conti FJ, 2009, DEVELOPMENT, V136, P3597, DOI 10.1242/dev.035857; Cram EJ, 2003, J CELL SCI, V116, P3871, DOI 10.1242/jcs.00705; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Deng XF, 2000, CIRC RES, V87, P781, DOI 10.1161/01.RES.87.9.781; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Harston Rebecca K, 2011, J Signal Transduct, V2011, P521742, DOI 10.1155/2011/521742; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johnston RK, 2009, FASEB J, V23, P2759, DOI 10.1096/fj.08-127480; Kim DJ, 2003, CELL BIOCHEM FUNCT, V21, P41, DOI 10.1002/cbf.988; Lal H, 2007, J MOL CELL CARDIOL, V43, P137, DOI 10.1016/j.yjmcc.2007.05.012; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li RX, 2012, AM J PATHOL, V180, P952, DOI 10.1016/j.ajpath.2011.12.007; Liang XQ, 2009, CIRCULATION, V120, P568, DOI 10.1161/CIRCULATIONAHA.109.864686; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Pham CG, 2000, AM J PHYSIOL-HEART C, V279, pH2916, DOI 10.1152/ajpheart.2000.279.6.H2916; Praekelt U, 2012, EUR J CELL BIOL, V91, P180, DOI 10.1016/j.ejcb.2011.12.003; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Ross RS, 1998, CIRC RES, V82, P1160, DOI 10.1161/01.RES.82.11.1160; Senetar MA, 2005, GENE, V362, P141, DOI 10.1016/j.gene.2005.08.012; Senetar MA, 2004, BIOCHEMISTRY-US, V43, P15418, DOI 10.1021/bi0487239; Senetar MA, 2007, CELL MOTIL CYTOSKEL, V64, P157, DOI 10.1002/cm.20173; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Sheikh F, 2009, TRENDS CARDIOVAS MED, V19, P182, DOI 10.1016/j.tcm.2009.12.001; Sopko N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020184; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Yin ZR, 2008, CIRCULATION, V117, P1414, DOI 10.1161/CIRCULATIONAHA.107.759233; Yund EE, 2009, J MOL CELL CARDIOL, V47, P520, DOI 10.1016/j.yjmcc.2009.06.006; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhang YJ, 2002, J BIOL CHEM, V277, P38328, DOI 10.1074/jbc.M205576200	48	53	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4252	4264		10.1074/jbc.M112.427484	http://dx.doi.org/10.1074/jbc.M112.427484			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23266827	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000314845000054
J	Ward, PS; Lu, C; Cross, JR; Abdel-Wahab, O; Levine, RL; Schwartz, GK; Thompson, CB				Ward, Patrick S.; Lu, Chao; Cross, Justin R.; Abdel-Wahab, Omar; Levine, Ross L.; Schwartz, Gary K.; Thompson, Craig B.			The Potential for Isocitrate Dehydrogenase Mutations to Produce 2-Hydroxyglutarate Depends on Allele Specificity and Subcellular Compartmentalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDH2 MUTATIONS; ONCOMETABOLITE 2-HYDROXYGLUTARATE; ALPHA-KETOGLUTARATE; GROWTH; CELLS; TET2; LIPOGENESIS; LEUKEMIA; NADPH; CARBOXYLATION	Monoallelic point mutations in cytosolic isocitrate dehydrogenase 1 (IDH1) and its mitochondrial homolog IDH2 can lead to elevated levels of 2-hydroxyglutarate (2HG) in multiple cancers. Here we report that cellular 2HG production from cytosolic IDH1 mutation is dependent on the activity of a retained wild-type IDH1 allele. In contrast, expression of mitochondrial IDH2 mutations led to robust 2HG production in a manner independent of wild-type mitochondrial IDH function. Among the recurrent IDH2 mutations at Arg-172 and Arg-140, IDH2 Arg-172 mutations consistently led to greater 2HG accumulation than IDH2 Arg-140 mutations, and the degree of 2HG accumulation correlated with the ability of these mutations to block cellular differentiation. Cytosolic IDH1 Arg-132 mutations, although structurally analogous to mutations at mitochondrial IDH2 Arg-172, were only able to elevate intracellular 2HG to comparable levels when an equivalent level of wild-type IDH1 was co-expressed. Consistent with 2HG production from cytosolic IDH1 being limited by substrate production from wildtype IDH1, we observed 2HG levels to increase in cancer cells harboring an endogenous monoallelic IDH1 mutation when mitochondrial IDH flux was diverted to the cytosol. Finally, expression of an IDH1 construct engineered to localize to the mitochondria rather than the cytosol resulted in greater 2HG accumulation. These data demonstrate that allelic and subcellular compartment differences can regulate the potential for IDH mutations to produce 2HG in cells. The consequences of 2HG elevation are dose-dependent, and the non-equivalent 2HG accumulation resulting from IDH1 and IDH2 mutations may underlie their differential prognosis and prevalence in various cancers.	[Ward, Patrick S.; Lu, Chao; Cross, Justin R.; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Leukemia Serv, New York, NY 10065 USA; [Schwartz, Gary K.] Mem Sloan Kettering Canc Ctr, Dept Med, Melanoma & Sarcoma Serv, New York, NY 10065 USA; [Ward, Patrick S.; Lu, Chao] Univ Penn, Perelman Sch Med, Mol Biol Grad Grp, Philadelphia, PA 19104 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine	Thompson, CB (corresponding author), 1275 York Ave, New York, NY 10065 USA.	craig@mskcc.org	levine, ross/AAE-7658-2019; Ward, Patrick/H-2361-2014	Ward, Patrick/0000-0001-6437-8174; Lu, Chao/0000-0003-0982-8122; Abdel-Wahab, Omar/0000-0002-3907-6171; Cross, Justin/0000-0002-6356-057X	National Institutes of Health; National Cancer Institute; University of Pennsylvania Medical Scientist Training Program; NATIONAL CANCER INSTITUTE [R01CA168802, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Pennsylvania Medical Scientist Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health and National Cancer Institute. C. B. Thompson is a co-founder of Agios Pharmaceuticals and a member of the board directors of Merck.; Supported by the University of Pennsylvania Medical Scientist Training Program.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Atai NA, 2011, J HISTOCHEM CYTOCHEM, V59, P489, DOI 10.1369/0022155411400606; Boissel N, 2011, BLOOD, V117, P3696, DOI 10.1182/blood-2010-11-320937; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Contreras-Shannon V, 2004, ARCH BIOCHEM BIOPHYS, V423, P235, DOI 10.1016/j.abb.2003.12.038; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Ghiam AF, 2012, ONCOGENE, V31, P3826, DOI 10.1038/onc.2011.546; Grassian AR, 2012, J BIOL CHEM, V287, P42180, DOI 10.1074/jbc.M112.417832; Green CL, 2011, BLOOD, V118, P409, DOI 10.1182/blood-2010-12-322479; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Leonardi R, 2012, J BIOL CHEM, V287, P14615, DOI 10.1074/jbc.C112.353946; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pichler MM, 2011, BRIT J HAEMATOL, V152, P669, DOI 10.1111/j.1365-2141.2010.08404.x; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rydstrom J, 2006, BBA-BIOENERGETICS, V1757, P721, DOI 10.1016/j.bbabio.2006.03.010; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Scully SP, 2000, CLIN ORTHOP RELAT R, P291; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Shechter I, 2003, J LIPID RES, V44, P2169, DOI 10.1194/jlr.M300285-JLR200; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Susa M, 2009, ANTICANCER RES, V29, P1879; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Ward PS, 2012, ONCOGENE, V31, P2491, DOI 10.1038/onc.2011.416; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	47	111	118	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3804	3815		10.1074/jbc.M112.435495	http://dx.doi.org/10.1074/jbc.M112.435495			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264629	hybrid, Green Published			2022-12-28	WOS:000314845000012
J	Chi, PI; Huang, WR; Lai, IH; Cheng, CY; Liu, HJ				Chi, Pei I.; Huang, Wei R.; Lai, I. H.; Cheng, Ching Y.; Liu, Hung J.			The p17 Nonstructural Protein of Avian Reovirus Triggers Autophagy Enhancing Virus Replication via Activation of Phosphatase and Tensin Deleted on Chromosome 10 (PTEN) and AMP-activated Protein Kinase (AMPK), as well as dsRNA-dependent Protein Kinase (PKR)/eIF2 alpha Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS GENOME SEGMENTS; DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; CONJUGATION SYSTEM; CELL-DEATH; SIGMA-C; MAMMALIAN AUTOPHAGY; APOPTOSIS INDUCTION; CULTURED-CELLS; VERO CELLS	Autophagy has been shown to facilitate replication or production of avian reovirus (ARV); nevertheless, how ARV induces autophagy remains largely unknown. Here, we demonstrate that the nonstructural protein p17 of ARV functions as an activator of autophagy. ARV-infected or p17-transfected cells present a fast and strong induction of autophagy, resulting in an increased level of autophagic proteins Beclin 1 and LC3-II. Although autophagy was suppressed by 3-methyladenine or shRNAs targeting autophagic proteins (Beclin 1, ATG7, and LC3) as well as by overexpression of Bcl-2, viral transcription, sigma C protein synthesis, and virus yield were all significantly reduced, suggesting a key role of autophagosomes in supporting ARV replication. Furthermore, we revealed for the first time that p17 positively regulates phosphatase and tensin deleted on chromosome 10 (PTEN), AMP-activated protein kinase (AMPK), and dsRNA dependent protein kinase RNA (PKR)/eIF2 alpha signaling pathways, accompanied by down-regulation of Akt and mammalian target of rapamycin complex 1, thereby triggering autophagy. By using p53, PTEN, PKR, AMPK, and p17 short hairpin RNA (shRNA), activation of signaling pathways and LC3-II levels was significantly suppressed, suggesting that p17 triggers autophagy through activation of p53/PTEN, AMPK, and PKR signaling pathways. Furthermore, colocalization of LC3 with viral proteins (p17 and sigma C), p62 with LAMP2 and LC3 with Rab7 was observed under a fluorescence microscope. The expression level of p62 was increased at 18 h postinfection and then slightly decreased 24 h postinfection compared with mock infection and thapsigargin treatment. Furthermore, disruption of autophagosome-lysosome fusion by shRNAs targeting LAMP2 or Rab7a resulted in inhibition of viral protein synthesis and virus yield, suggesting that formation of autolysosome benefits virus replication. Taken together, our results suggest that ARV induces formation of autolysosome but does not induce complete autophagic flux.	[Chi, Pei I.; Huang, Wei R.; Lai, I. H.; Cheng, Ching Y.; Liu, Hung J.] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan; [Liu, Hung J.] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan	National Chung Hsing University; National Chung Hsing University	Liu, HJ (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan.	hjliu5257@nchu.edu.tw		Liu, Hung-Jen/0000-0002-1460-1494; Huang, Wei-Ru/0000-0002-2508-8374	National Science Council, Taiwan [NSC 99-2321-B-005-015-MY3]; Ministry of Education, Taiwan under the Aiming for Top University plan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan under the Aiming for Top University plan	This work was supported by National Science Council, Taiwan, Grant NSC 99-2321-B-005-015-MY3 (to H.- J. L.) and by the Ministry of Education, Taiwan under the Aiming for Top University plan.	Berkova Z, 2006, J VIROL, V80, P6061, DOI 10.1128/JVI.02167-05; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chen YI, 2008, J VIROL METHODS, V151, P95, DOI 10.1016/j.jviromet.2008.03.016; Chulu JLC, 2007, BIOCHEM BIOPH RES CO, V356, P529, DOI 10.1016/j.bbrc.2007.02.164; Chulu JLC, 2010, J VIROL, V84, P7683, DOI 10.1128/JVI.02604-09; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Costas C, 2005, J VIROL, V79, P2141, DOI 10.1128/JVI.79.4.2141-2150.2005; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Geiser V, 2008, MICROB PATHOGENESIS, V44, P459, DOI 10.1016/j.micpath.2007.10.014; Gonzalez-Lopez C, 2003, J GEN VIROL, V84, P1629, DOI 10.1099/vir.0.19004-0; Grande A, 2000, VIROLOGY, V274, P367, DOI 10.1006/viro.2000.0473; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hsu CJ, 2006, AVIAN PATHOL, V35, P320, DOI 10.1080/03079450600823386; Hsu HW, 2005, AVIAN DIS, V49, P36, DOI 10.1637/7264-081904R1; Huang PH, 2005, VIROLOGY, V332, P584, DOI 10.1016/j.virol.2004.12.005; Huang WR, 2011, J BIOL CHEM, V286, P30780, DOI 10.1074/jbc.M111.257154; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Ji WT, 2008, VET MICROBIOL, V129, P252, DOI 10.1016/j.vetmic.2007.11.025; Ji WT, 2009, J GEN VIROL, V90, P3002, DOI 10.1099/vir.0.013953-0; Ji WT, 2009, BIOCHEM BIOPH RES CO, V384, P301, DOI 10.1016/j.bbrc.2009.04.116; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kleijn M, 1996, VIROLOGY, V217, P486, DOI 10.1006/viro.1996.0143; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09; Lee DY, 2008, BLOOD, V111, P2280, DOI 10.1182/blood-2007-07-100032; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Lin PY, 2010, VIROLOGY, V400, P104, DOI 10.1016/j.virol.2010.01.024; Liu HJ, 2005, BIOCHEM BIOPH RES CO, V336, P709, DOI 10.1016/j.bbrc.2005.08.149; Liu HJ, 2003, VIROLOGY, V314, P336, DOI 10.1016/S0042-6822(03)00415-X; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Meng SS, 2012, ARCH VIROL, V157, P661, DOI 10.1007/s00705-012-1226-x; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Mizushima N, 2003, INT J BIOCHEM CELL B, V35, P553, DOI 10.1016/S1357-2725(02)00343-6; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Perales C, 2003, FEBS LETT, V533, P89, DOI 10.1016/S0014-5793(02)03764-X; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Saftig P, 2008, AUTOPHAGY, V4, P510, DOI 10.4161/auto.5724; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Shih WL, 2004, VIROLOGY, V321, P65, DOI 10.1016/j.virol.2003.12.004; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Su WC, 2011, J VIROL, V85, P10561, DOI 10.1128/JVI.00173-11; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Taylor MP, 2007, J VIROL, V81, P12543, DOI 10.1128/JVI.00755-07; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Zhou XB, 2009, VIROLOGY, V385, P192, DOI 10.1016/j.virol.2008.12.003	71	66	72	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3571	3584		10.1074/jbc.M112.390245	http://dx.doi.org/10.1074/jbc.M112.390245			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23233667	Green Published, hybrid			2022-12-28	WOS:000314397900062
J	Ng, S; Giraud, E; Duncan, O; Law, SR; Wang, Y; Xu, L; Narsai, R; Carrie, C; Walker, H; Day, DA; Blanco, NE; Strand, A; Whelan, J; Ivanova, A				Ng, Sophia; Giraud, Estelle; Duncan, Owen; Law, Simon R.; Wang, Yan; Xu, Lin; Narsai, Reena; Carrie, Chris; Walker, Hayden; Day, David A.; Blanco, Nicolas E.; Strand, Asa; Whelan, James; Ivanova, Aneta			Cyclin-dependent Kinase E1 (CDKE1) Provides a Cellular Switch in Plants between Growth and Stress Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR GENE-EXPRESSION; ALTERNATIVE OXIDASE; ARABIDOPSIS-THALIANA; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL PROTEINS; TOBACCO CELLS; ATP SYNTHASE; FLORAL DIP; SIGNALS; TRANSFORMATION	Plants must deal effectively with unfavorable growth conditions that necessitate a coordinated response to integrate cellular signals with mitochondrial retrograde signals. A genetic screen was carried out to identify regulators of alternative oxidase (rao mutants), using AOX1a expression as a model system to study retrograde signaling in plants. Two independent rao1 mutant alleles identified CDKE1 as a central nuclear component integrating mitochondrial retrograde signals with energy signals under stress. CDKE1 is also necessary for responses to general cellular stresses, such as H2O2 and cold that act, at least in part, via anterograde pathways, and integrates signals from central energy/stress sensing kinase signal transduction pathways within the nucleus. Together, these results place CDKE1 as a central kinase integrating diverse cellular signals and shed light on a mechanism by which plants can effectively switch between growth and stress responses.	[Ng, Sophia; Giraud, Estelle; Duncan, Owen; Law, Simon R.; Wang, Yan; Xu, Lin; Narsai, Reena; Carrie, Chris; Walker, Hayden; Whelan, James; Ivanova, Aneta] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Day, David A.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Blanco, Nicolas E.; Strand, Asa] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden	University of Western Australia; Flinders University South Australia; Umea University	Ivanova, A (corresponding author), Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, 35 Stirling Highway, Crawley, WA 6009, Australia.	aneta.ivanova@uwa.edu.au	Day, David/F-6325-2011; Whelan, James/F-6402-2011; Carrie, Chris/A-2638-2010; Ng, Sophia/J-8014-2014	Day, David/0000-0001-7967-2173; Whelan, James/0000-0001-5754-025X; Carrie, Chris/0000-0002-4240-4674; Duncan, Owen/0000-0001-6999-1509; Xu, Lin/0000-0001-7476-2655; WANG, YAN/0000-0003-1600-2863; Law, Simon/0000-0003-0389-6650; Blanco, Nicolas/0000-0002-5010-1307; Ng, Sophia/0000-0002-1677-863X				Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; Bitrian M, 2011, PLANT J, V65, P829, DOI 10.1111/j.1365-313X.2010.04462.x; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Boruc J, 2010, PLANT CELL, V22, P1264, DOI 10.1105/tpc.109.073635; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BRADBEER JW, 1979, NATURE, V279, P816, DOI 10.1038/279816a0; Busso C, 2010, FEBS J, V277, P4530, DOI 10.1111/j.1742-4658.2010.07862.x; CAMOUGRAND N, 1995, J MOL BIOL, V247, P588, DOI 10.1006/jmbi.1995.0165; Carrie C, 2009, PLANT J, V57, P1128, DOI 10.1111/j.1365-313X.2008.03745.x; Citovsky V, 2008, METHODS, V45, P196, DOI 10.1016/j.ymeth.2008.06.007; Clifton R, 2005, PLANT MOL BIOL, V58, P193, DOI 10.1007/s11103-005-5514-7; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Gerin S, 2010, BBA-BIOENERGETICS, V1797, P994, DOI 10.1016/j.bbabio.2010.02.034; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; Giraud E, 2008, PLANT PHYSIOL, V147, P595, DOI 10.1104/pp.107.115121; Giraud E, 2010, PLANT CELL, V22, P3921, DOI 10.1105/tpc.110.074518; Giraud E, 2009, PLANT PHYSIOL, V150, P1286, DOI 10.1104/pp.109.139782; Harrison SJ, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-19; Ho LHM, 2008, PLANT PHYSIOL, V147, P1858, DOI 10.1104/pp.108.121384; Jazwinski SM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00139; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kindgren P, 2012, MOL PLANT, V5, P901, DOI 10.1093/mp/ssr112; Kleine T, 2009, TRENDS GENET, V25, P185, DOI 10.1016/j.tig.2009.02.004; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kuchin S, 2000, P NATL ACAD SCI USA, V97, P7916, DOI 10.1073/pnas.140109897; Le Hir H, 2008, CELL, V133, P213, DOI 10.1016/j.cell.2008.04.002; LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38; Lin MZ, 2011, NUCLEIC ACIDS RES, V39, pD1134, DOI 10.1093/nar/gkq938; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Mathur S, 2011, PLANT PHYSIOL, V157, P1609, DOI 10.1104/pp.111.188300; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Moellering ER, 2010, PLANT PHYSIOL, V152, P1951, DOI 10.1104/pp.110.153262; Parsons HL, 1999, PLANT PHYSIOL, V121, P1309, DOI 10.1104/pp.121.4.1309; PELISSIER P, 1995, CURR GENET, V27, P409, DOI 10.1007/BF00311209; Pfannschmidt T, 2010, TRENDS PLANT SCI, V15, P427, DOI 10.1016/j.tplants.2010.05.009; Ramel F, 2012, P NATL ACAD SCI USA, V109, P5535, DOI 10.1073/pnas.1115982109; RHOADS DM, 1992, PLANT CELL, V4, P1131, DOI 10.1105/tpc.4.9.1131; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Sieger SM, 2005, J EXP BOT, V56, P1499, DOI 10.1093/jxb/eri146; Sun XW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1486; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Van Aken O, 2009, MOL PLANT, V2, P1310, DOI 10.1093/mp/ssp053; Wang WM, 2004, DEVELOPMENT, V131, P3147, DOI 10.1242/dev.01187; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Zarkovic J, 2005, PLANT MOL BIOL, V57, P871, DOI 10.1007/s11103-005-3249-0; Zhang R, 2009, PHOTOSYNTH RES, V100, P29, DOI 10.1007/s11120-009-9420-8; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	58	96	97	3	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3449	3459		10.1074/jbc.M112.416727	http://dx.doi.org/10.1074/jbc.M112.416727			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23229550	Green Published, hybrid			2022-12-28	WOS:000314397900049
J	Yan, WS; Chen, XF; Zhang, YH; Zhang, J; Jung, YS; Chen, XB				Yan, Wensheng; Chen, Xiufang; Zhang, Yanhong; Zhang, Jin; Jung, Yong-Sam; Chen, Xinbin			Arsenic Suppresses Cell Survival via Pirh2-mediated Proteasomal Degradation of Delta Np63 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; E3 UBIQUITIN LIGASE; P53 FAMILY; DEPENDENT DEGRADATION; INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; P63 EXPRESSION; DIRECT TARGET; DNA-DAMAGE; IN-VIVO	Transcription factor p63, a member of the p53 family, shares a high degree of sequence similarity with p53. Because of transcription from two distinct promoters, the p63 gene encodes two isoforms, TAp63 and Delta Np63. Although TAp63 acts as a tumor suppressor, Delta Np63 functions as an oncogene and is often overexpressed in squamous cell carcinomas. Thus, therapeutic agents targeting Delta Np63 might be used to manage tumors that overexpress Delta Np63. Here we found that arsenic trioxide, a frontline agent for acute promyelocytic leukemia, inhibits Delta Np63 but not TAp63 expression in time-and dose-dependent manners. In addition, we found that arsenic trioxide decreases the stability of Delta Np63 protein via a proteasome-dependent pathway but has little effect on the level of Delta Np63 transcript. Furthermore, we found that arsenic trioxide activates the Pirh2 promoter and consequently induces Pirh2 expression. Consistent with this, we found that knockdown of Pirh2 inhibits, whereas ectopic expression of Pirh2 enhances, arsenic-induced degradation of Delta Np63 protein. Importantly, we found that knockdown of Delta Np63 sensitizes, whereas ectopic expression of Delta Np63 inhibits, growth suppression induced by arsenic. Together, these data suggest that arsenic degrades Delta Np63 protein at least in part via Pirh2-dependent proteolysis and that inhibition of Delta Np63 expression facilitates tumor cells to arsenic-induced death.	[Yan, Wensheng; Zhang, Yanhong; Zhang, Jin; Jung, Yong-Sam; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA; [Chen, Xiufang] Hosp Nantong Univ, Dept Hematol, Nantong 226001, Jiangsu, Peoples R China	University of California System; University of California Davis; Nantong University	Yan, WS (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	wyan@ucdavis.edu; xbchen@ucdavis.edu			National Institutes of Health [R01 CA102188]; NATIONAL CANCER INSTITUTE [R01CA123227, R01CA102188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA102188.	Barbieri CE, 2005, CANCER RES, V65, P2314, DOI 10.1158/0008-5472.CAN-04-3449; Boldrup L, 2007, J PATHOL, V213, P384, DOI 10.1002/path.2237; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Choi JY, 2007, BIOCHEM BIOPH RES CO, V352, P366, DOI 10.1016/j.bbrc.2006.11.036; Crook T, 2000, ONCOGENE, V19, P3439, DOI 10.1038/sj.onc.1203656; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Emadi A, 2010, BLOOD REV, V24, P191, DOI 10.1016/j.blre.2010.04.001; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Galli F, 2010, J CELL SCI, V123, P2423, DOI 10.1242/jcs.061010; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Hakem A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002360; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Jung Y. S., 2012, J INVEST DE IN PRESS; Jung YS, 2011, J BIOL CHEM, V286, P35388, DOI 10.1074/jbc.M111.261537; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; King KE, 2007, MOL CARCINOGEN, V46, P716, DOI 10.1002/mc.20337; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li XR, 2012, BIOCHEM BIOPH RES CO, V423, P338, DOI 10.1016/j.bbrc.2012.05.126; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Logan IR, 2006, MOL CELL BIOL, V26, P6502, DOI 10.1128/MCB.00147-06; Mann KK, 2008, MOL CANCER THER, V7, P1680, DOI 10.1158/1535-7163.MCT-07-2164; Massion PP, 2003, CANCER RES, V63, P7113; Mitani Y, 2011, AM J PATHOL, V179, P391, DOI 10.1016/j.ajpath.2011.03.037; Mundt HM, 2010, BIOCHEM BIOPH RES CO, V396, P335, DOI 10.1016/j.bbrc.2010.04.093; Murata K, 2007, EXP MOL PATHOL, V83, P367, DOI 10.1016/j.yexmp.2007.03.006; Nonaka D, 2012, AM J SURG PATHOL, V36, P895, DOI 10.1097/PAS.0b013e3182498f2b; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rossi M, 2006, CELL CYCLE, V5, P1816, DOI 10.4161/cc.5.16.2861; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Shackelford D, 2006, CANCER RES, V66, P11360, DOI 10.1158/0008-5472.CAN-06-1774; Shen Y, 2001, LEUKEMIA, V15, P735, DOI 10.1038/sj.leu.2402106; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; Vanbokhoven H, 2011, J INVEST DERMATOL, V131, P1196, DOI 10.1038/jid.2011.84; Wang XM, 2009, CANCER-AM CANCER SOC, V115, P4554, DOI 10.1002/cncr.24494; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Yan WS, 2007, CANCER RES, V67, P9117, DOI 10.1158/0008-5472.CAN-07-0996; Yan WS, 2011, J BIOL CHEM, V286, P17478, DOI 10.1074/jbc.M111.231639; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zangen R, 2005, CELL CYCLE, V4, P1313, DOI 10.4161/cc.4.10.2066; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107; Zhang QY, 2009, P NATL ACAD SCI USA, V106, P3378, DOI 10.1073/pnas.0813142106; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	52	15	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2907	2913		10.1074/jbc.M112.428607	http://dx.doi.org/10.1074/jbc.M112.428607			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23271742	Green Published, hybrid			2022-12-28	WOS:000314397900001
J	Tjondrokoesoemo, A; Li, N; Lin, PH; Pan, Z; Ferrante, CJ; Shirokova, N; Brotto, M; Weisleder, N; Ma, JJ				Tjondrokoesoemo, Andoria; Li, Na; Lin, Pei-Hui; Pan, Zui; Ferrante, Christopher J.; Shirokova, Natalia; Brotto, Marco; Weisleder, Noah; Ma, Jianjie			Type 1 Inositol (1,4,5)-Trisphosphate Receptor Activates Ryanodine Receptor 1 to Mediate Calcium Spark Signaling in Adult Mammalian Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; CA2+ RELEASE; 1,4,5-TRISPHOSPHATE RECEPTORS; SMOOTH-MUSCLE; EXPRESSION; EVENTS; CELLS; TRISPHOSPHATE; ARRHYTHMIAS; TRANSIENTS	Functional coupling between inositol (1,4,5)-trisphosphate receptor (IP3R) and ryanodine receptor (RyR) represents a critical component of intracellular Ca2+ signaling in many excitable cells; however, the role of this mechanism in skeletal muscle remains elusive. In skeletal muscle, RyR-mediated Ca2+ sparks are suppressed in resting conditions, whereas application of transient osmotic stress can trigger activation of Ca2+ sparks that are restricted to the periphery of the fiber. Here we show that onset of these spatially confined Ca2+ sparks involves interaction between activation of IP3R and RyR near the sarcolemmal membrane. Pharmacological prevention of IP3 production or inhibition of IP3R channel activity abolishes stress-induced Ca2+ sparks in skeletal muscle. Although genetic ablation of the type 2 IP3R does not appear to affect Ca2+ sparks in skeletal muscle, specific silencing of the type 1 IP3R leads to ablation of stress-induced Ca2+ sparks. Our data indicate that membrane-delimited signaling involving cross-talk between IP(3)R1 and RyR1 contributes to Ca2+ spark activation in skeletal muscle.	[Tjondrokoesoemo, Andoria; Li, Na; Lin, Pei-Hui; Pan, Zui; Ferrante, Christopher J.; Weisleder, Noah; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Li, Na] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Ferrante, Christopher J.; Shirokova, Natalia] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med Pharmacol & Physiol, Newark, NJ 07103 USA; [Brotto, Marco] Univ Missouri, Sch Nursing, Muscle Biol Res Grp, Kansas City, MO 64108 USA; [Brotto, Marco] Univ Missouri, Sch Med, Muscle Biol Res Grp, Kansas City, MO 64108 USA; [Weisleder, Noah] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Div Surg & Biomed Sci, Columbus, OH 43210 USA; [Lin, Pei-Hui; Pan, Zui; Ma, Jianjie] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Surg, Div Surg & Biomed Sci, Columbus, OH 43210 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Nankai University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Weisleder, N (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA.	noah.weisleder@osumc.edu; jianjie.ma@osumc.edu	Weisleder, Noah L/A-7098-2013	Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088; Shirokova, Natalia/0000-0003-4648-4592; Pan, Zui/0000-0003-4105-901X	National Institutes of Health [AG28614, AG28856, HL69000, AR054793]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000, R01HL093342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR054793, R00AR054793, R01AR061385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028856, R01AG028614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG28614, AG28856, and HL69000 (to J. M.) and AR054793 (to N. W.).	Apostol S, 2009, J MUSCLE RES CELL M, V30, P97, DOI 10.1007/s10974-009-9179-8; Balghi H, 2006, J GEN PHYSIOL, V128, P219, DOI 10.1085/jgp.200609559; Blaauw B, 2012, J GEN PHYSIOL, V140, P235, DOI 10.1085/jgp.201110747; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Cardenas C, 2010, FASEB J, V24, P3210, DOI 10.1096/fj.09-152017; Casas M, 2010, J GEN PHYSIOL, V136, P455, DOI 10.1085/jgp.200910397; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Collet C, 2003, BIOPHYS J, V84, P251, DOI 10.1016/S0006-3495(03)74846-2; Domeier TL, 2008, AM J PHYSIOL-HEART C, V294, pH596, DOI 10.1152/ajpheart.01155.2007; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fujii M, 1999, BIOCHEM BIOPH RES CO, V254, P284, DOI 10.1006/bbrc.1998.9936; Glitsch MD, 2008, CELL CALCIUM, V43, P9, DOI 10.1016/j.ceca.2007.02.008; Gordienko DV, 2002, J PHYSIOL-LONDON, V542, P743, DOI 10.1113/jphysiol.2001.015966; Harzheim D, 2009, P NATL ACAD SCI USA, V106, P11406, DOI 10.1073/pnas.0905485106; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; Klein MG, 1996, NATURE, V379, P455, DOI 10.1038/379455a0; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Mackenzie L, 2004, J CELL SCI, V117, P6327, DOI 10.1242/jcs.01559; Mackenzie L, 2002, J PHYSIOL-LONDON, V541, P395, DOI 10.1113/jphysiol.2001.013411; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Mondin L, 2009, AM J PHYSIOL-CELL PH, V297, pC1133, DOI 10.1152/ajpcell.00048.2009; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Perez GJ, 1999, J GEN PHYSIOL, V113, P229, DOI 10.1085/jgp.113.2.229; Proven A, 2006, J CELL SCI, V119, P3363, DOI 10.1242/jcs.03073; Tjondrokoesoemo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025740; VALDIVIA C, 1992, BIOPHYS J, V61, P1184, DOI 10.1016/S0006-3495(92)81927-6; VERGARA J, 1985, P NATL ACAD SCI USA, V82, P6352, DOI 10.1073/pnas.82.18.6352; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; VOLPE P, 1985, NATURE, V316, P347, DOI 10.1038/316347a0; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Weisleder N, 2007, CELL CALCIUM, V42, P548, DOI 10.1016/j.ceca.2007.01.009; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Yamamoto M, 2006, J BIOL CHEM, V281, P32630, DOI 10.1074/jbc.M605928200; Zhang WM, 2003, AM J PHYSIOL-LUNG C, V285, pL680, DOI 10.1152/ajplung.00067.2003; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529	38	27	27	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2103	2109		10.1074/jbc.M112.425975	http://dx.doi.org/10.1074/jbc.M112.425975			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223241	Green Published, hybrid			2022-12-28	WOS:000314211500001
J	Kosoff, R; Chow, HY; Radu, M; Chernoff, J				Kosoff, Rachelle; Chow, Hoi Yee; Radu, Maria; Chernoff, Jonathan			Pak2 Kinase Restrains Mast Cell Fc epsilon RI Receptor Signaling through Modulation of Rho Protein Guanine Nucleotide Exchange Factor (GEF) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE; PHOSPHORYLATION; LOCALIZATION; SECRETION; DEGRANULATION; MOBILIZATION; ACTIVATION; INHIBITOR; ADHESION; BINDING	p21-activated kinase-1 (Pak1) is a serine/threonine kinase that plays a key role in mediating antigen-stimulated extracellular calcium influx and degranulation in mast cells. Another isoform in this kinase family, Pak2, is expressed at very high levels in mast cells, but its function is unknown. Here we show that Pak2 loss in murine bone marrow-derived mast cells, unlike loss of Pak1, induces increased antigen-mediated adhesion, degranulation, and cytokine secretion without changes to extracellular calcium influx. This phenotype is associated with an increase in RhoA-GTPase signaling activity to downstream effectors, including myosin light chain and p38(MAPK), and is reversed upon treatment with a Rho-specific inhibitor. Pak2, but not Pak1, negatively regulates RhoA via phosphorylation of the guanine nucleotide exchange factor GEF-H1 at an inhibitory site, leading to increased GEF-H1 microtubule binding and loss of RhoA stimulation. These data suggest that Pak2 plays a unique inhibitory role in mast cell degranulation by down-regulating RhoA via GEF-H1.	[Kosoff, Rachelle] Univ Penn, Canc Biol Program, Philadelphia, PA 19104 USA; [Kosoff, Rachelle; Chow, Hoi Yee; Radu, Maria; Chernoff, Jonathan] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	University of Pennsylvania; Fox Chase Cancer Center	Chernoff, J (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Jonathan.Chernoff@fccc.edu	Chernoff, Jonathan/I-7631-2014	Chernoff, Jonathan/0000-0002-4803-7836	National Institutes of Health [P30 CA006927, R01 CA58836, R01 CA098830]; American Asthma Foundation [08-0049]; state of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA058836, R01CA098830, P30CA006927, T32CA009035, R01CA142928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; state of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Celine DerMardirossian for anti-phospho-GEF-H1 antibodies and plasmid constructs and the Flow Cytometry Facility at Fox Chase for assistance with analysis of calcium signaling. The Fox Chase Cancer Center was supported by National Institutes of Health Grant P30 CA006927.; This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA58836 and R01 CA098830 (to J. C.). This work was also supported by American Asthma Foundation Grant 08-0049 and an appropriation from the state of Pennsylvania.	Allen JD, 2009, BLOOD, V113, P2695, DOI 10.1182/blood-2008-06-160861; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bright MD, 2009, CELL SIGNAL, V21, P1738, DOI 10.1016/j.cellsig.2009.07.005; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; DASTYCH J, 1994, J IMMUNOL, V152, P213; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gavet O, 1998, J CELL SCI, V111, P3333; Gibbs BF, 2002, J LEUKOCYTE BIOL, V72, P391; Guo CX, 2012, J MED CHEM, V55, P4728, DOI 10.1021/jm300204j; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Huang ZD, 2003, J BIOL CHEM, V278, P13101, DOI 10.1074/jbc.M212557200; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Kuntziger T, 2001, MOL BIOL CELL, V12, P437, DOI 10.1091/mbc.12.2.437; McDaniel AS, 2008, BLOOD, V112, P4646, DOI 10.1182/blood-2008-04-155085; Meiri D, 2012, MOL CELL, V45, P642, DOI 10.1016/j.molcel.2012.01.027; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Nishizumi H, 1997, J IMMUNOL, V158, P2350; Norman JC, 1996, MOL BIOL CELL, V7, P1429, DOI 10.1091/mbc.7.9.1429; PRICE LS, 1995, CURR BIOL, V5, P68, DOI 10.1016/S0960-9822(95)00018-2; Roig J, 1999, J BIOL CHEM, V274, P31119, DOI 10.1074/jbc.274.44.31119; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Staser K, 2013, EXP HEMATOL, V41, P56, DOI 10.1016/j.exphem.2012.10.001; Sullivan R, 1999, J BIOL CHEM, V274, P38140, DOI 10.1074/jbc.274.53.38140; Tao J, 2011, MOL ENDOCRINOL, V25, P1565, DOI 10.1210/me.2011-0062; THOMPSON HL, 1993, CLIN EXP ALLERGY, V23, P270, DOI 10.1111/j.1365-2222.1993.tb00321.x; THOMPSON HL, 1990, J IMMUNOL, V145, P3425; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Yamahashi Y, 2011, J BIOL CHEM, V286, P44576, DOI 10.1074/jbc.M111.267021; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200	42	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					974	983		10.1074/jbc.M112.422295	http://dx.doi.org/10.1074/jbc.M112.422295			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23204526	Green Published, hybrid			2022-12-28	WOS:000313570300022
J	Dettmer, U; Newman, AJ; Luth, ES; Bartels, T; Selkoe, D				Dettmer, Ulf; Newman, Andrew J.; Luth, Eric S.; Bartels, Tim; Selkoe, Dennis			In Vivo Cross-linking Reveals Principally Oligomeric Forms of alpha-Synuclein and beta-Synuclein in Neurons and Non-neural Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET PARKINSONS-DISEASE; CRYSTAL-STRUCTURE; MOUSE-BRAIN; PROTEIN; DJ-1; AGGREGATION; ASSOCIATION; INHIBITION; PROMOTES; MUTATION	Aggregation of alpha-synuclein (alpha Syn) in neurons produces the hallmark cytopathology of Parkinson disease and related synucleinopathies. Since its discovery, alpha Syn has been thought to exist normally in cells as an unfolded monomer. We recently reported that alpha Syn can instead exist in cells as a helically folded tetramer that resists aggregation and binds lipid vesicles more avidly than unfolded recombinant monomers (Bartels, T., Choi, J. G., and Selkoe, D. J. (2011) Nature 477, 107-110). However, a subsequent study again concluded that cellular alpha Syn is an unfolded monomer (Fauvet, B., Mbefo, M. K., Fares, M. B., Desobry, C., Michael, S., Ardah, M. T., Tsika, E., Coune, P., Prudent, M., Lion, N., Eliezer, D., Moore, D. J., Schneider, B., Aebischer, P., El-Agnaf, O. M., Masliah, E., and Lashuel, H. A. (2012) J. Biol. Chem. 287, 15345-15364). Here we describe a simple in vivo cross-linking method that reveals a major similar to 60-kDa form of endogenous alpha Syn (monomer, 14.5 kDa) in intact cells and smaller amounts of similar to 80- and similar to 100-kDa forms with the same isoelectric point as the 60-kDa species. Controls indicate that the apparent 60-kDa tetramer exists normally and does not arise from pathological aggregation. The pattern of a major 60-kDa and minor 80- and 100-kDa species plus variable amounts of free monomers occurs endogenously in primary neurons and erythroid cells as well as neuroblastoma cells overexpressing alpha Syn. A similar pattern occurs for the homologue, beta-synuclein, which does not undergo pathogenic aggregation. Cell lysis destabilizes the apparent 60-kDa tetramer, leaving mostly free monomers and some 80-kDa oligomer. However, lysis at high protein concentrations allows partial recovery of the 60-kDa tetramer. Together with our prior findings, these data suggest that endogenous alpha Syn exists principally as a 60-kDa tetramer in living cells but is lysis-sensitive, making the study of natural alpha Syn challenging outside of intact cells.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Selkoe, D (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Harvard Inst Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu	Bartels, Tim/AAD-6128-2021	Bartels, Tim/0000-0002-4071-5612; Dettmer, Ulf/0000-0001-6676-0107	Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a research grant from the Fidelity Biosciences Research Initiative.	Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Baulac S, 2004, MOL CELL NEUROSCI, V27, P236, DOI 10.1016/j.mcn.2004.06.014; BENAROUDJ N, 1995, BIOCHEMISTRY-US, V34, P15282, DOI 10.1021/bi00046a037; BUEHNER M, 1973, P NATL ACAD SCI USA, V70, P3052, DOI 10.1073/pnas.70.11.3052; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Dolder M, 1999, J STRUCT BIOL, V127, P64, DOI 10.1006/jsbi.1999.4141; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Klucken J, 2006, FASEB J, V20, P2050, DOI 10.1096/fj.05-5422com; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; LINDEN M, 1983, BIOCHIM BIOPHYS ACTA, V736, P125, DOI 10.1016/0005-2736(83)90177-3; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Payton JE, 2001, MOL BRAIN RES, V95, P138, DOI 10.1016/S0169-328X(01)00257-1; Perrin RJ, 2003, NEUROSCI LETT, V349, P133, DOI 10.1016/S0304-3940(03)00781-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Zhou Y, 2004, J BIOL CHEM, V279, P39155, DOI 10.1074/jbc.M405456200	36	167	168	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6371	6385		10.1074/jbc.M112.403311	http://dx.doi.org/10.1074/jbc.M112.403311			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319586	Green Published, hybrid			2022-12-28	WOS:000315820700032
J	Liang, Z; Zhang, YL; Agrahari, G; Chandrahas, V; Glinton, K; Donahue, DL; Balsara, RD; Ploplis, VA; Castellino, FJ				Liang, Zhong; Zhang, Yueling; Agrahari, Garima; Chandrahas, Vishwanatha; Glinton, Kristofor; Donahue, Deborah L.; Balsara, Rashna D.; Ploplis, Victoria A.; Castellino, Francis J.			A Natural Inactivating Mutation in the CovS Component of the CovRS Regulatory Operon in a Pattern D Streptococcal pyogenes Strain Influences Virulence-associated Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; HYALURONIC-ACID CAPSULE; AFFINITY PLASMINOGEN-BINDING; M-LIKE PROTEIN; SURFACE PROTEIN; STREPTOKINASE EXPRESSION; 2-COMPONENT SYSTEM; RESPONSE REGULATOR; POSITIVE REGULATOR; VIR REGULON	A skin-tropic invasive group A Streptococcus pyogenes (GAS) strain, AP53, contains a natural inactivating mutation in the covS gene (covS(M)) of the two-component responder (CovR)/sensor (CovS) gene regulatory system. The effects of this mutation on specific GAS virulence determinants have been assessed, with emphasis on expression of the extracellular protease, streptococcal pyrogenic exotoxin B (SpeB), capsular hyaluronic acid, and proteins that allow host plasmin assembly on the bacterial surface, viz. a high affinity plasminogen (Pg)/plasmin receptor, Pg-binding group A streptococcal M protein (PAM), and the human Pg activator streptokinase. To further illuminate mechanisms of the functioning of CovRS in the virulence of AP53, two AP53 isogenic strains were generated, one in which the natural covS(M) gene was mutated to WT-covS (AP53/covS(WT)) and a strain that contained an inactivated covR gene (AP53/Delta covR). Two additional strains that do not contain PAM, viz. WT-NS931 and NS931/covS(M), were also employed. SpeB was not measurably expressed in strains containing covR(WT)/covS(M), whereas in strains with natural or engineered covR(WT)/covS(WT), SpeB expression was highly up-regulated. Alternatively, capsule synthesis via the hasABC operon was enhanced in strain AP53/covS(M), whereas streptokinase expression was only slightly affected by the covS inactivation. PAM expression was not substantially influenced by the covS mutation, suggesting that covRS had minimal effects on the mga regulon that controls PAM expression. These results demonstrate that a covS inactivation results in virulence gene alterations and also suggest that the CovR phosphorylation needed for gene up-or down-regulation can occur by alternative pathways to CovS kinase.	[Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu	Chandrahas, Vishwanatha K./I-8256-2019	Chandrahas, Vishwanatha K./0000-0001-8227-5021; Glinton, Kristofor/0000-0001-9301-7132; Zhang, Yueling/0000-0002-5619-8410	National Institutes of Health [HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423, R37HL013423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL013423 (to F. J. C.).	Alves R, 2003, MOL MICROBIOL, V48, P25, DOI 10.1046/j.1365-2958.2003.03344.x; BENNASR A, 1994, EUR J BIOCHEM, V222, P267, DOI 10.1111/j.1432-1033.1994.tb18865.x; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bernish B, 1999, J BIOL CHEM, V274, P4786, DOI 10.1074/jbc.274.8.4786; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Churchward G, 2009, MICROBIOL-SGM, V155, P566, DOI 10.1099/mic.0.024620-0; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; Cnudde SE, 2006, BIOCHEMISTRY-US, V45, P11052, DOI 10.1021/bi060914j; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Federle MJ, 2002, MOL MICROBIOL, V43, P1161, DOI 10.1046/j.1365-2958.2002.02810.x; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fu QH, 2008, J BIOL CHEM, V283, P1580, DOI 10.1074/jbc.M705063200; GARDINER D, 1995, PCR METH APPL, V4, P288; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; HAANES EJ, 1992, J BACTERIOL, V174, P4967, DOI 10.1128/JB.174.15.4967-4976.1992; HAUSER AR, 1991, J CLIN MICROBIOL, V29, P1562, DOI 10.1128/JCM.29.8.1562-1567.1991; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Hondorp ER, 2007, MOL MICROBIOL, V66, P1056, DOI 10.1111/j.1365-2958.2007.06006.x; Hytonen J, 2001, MOL MICROBIOL, V39, P512, DOI 10.1046/j.1365-2958.2001.02269.x; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Liang Z, 2008, TRANSGENIC RES, V17, P979, DOI 10.1007/s11248-008-9190-7; MCIVER KS, 1995, J BACTERIOL, V177, P6619, DOI 10.1128/jb.177.22.6619-6624.1995; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; Nilsen SL, 1999, PROTEIN EXPRES PURIF, V16, P136, DOI 10.1006/prep.1999.1045; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991; PODBIELSKI A, 1993, MOL GEN GENET, V237, P287, DOI 10.1007/BF00282810; PODBIELSKI A, 1995, INFECT IMMUN, V63, P9, DOI 10.1128/IAI.63.1.9-20.1995; Rezcallah MS, 2004, MICROBIOL-SGM, V150, P365, DOI 10.1099/mic.0.26826-0; Ribardo DA, 2006, MOL MICROBIOL, V62, P491, DOI 10.1111/j.1365-2958.2006.05381.x; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Roberts SA, 2007, MOL MICROBIOL, V66, P1506, DOI 10.1111/j.1365-2958.2007.06015.x; Roberts SA, 2007, J BACTERIOL, V189, P1459, DOI 10.1128/JB.01026-06; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; Schenone MM, 2000, J PEPT RES, V56, P438, DOI 10.1034/j.1399-3011.2000.00810.x; SCHMIDT KH, 1990, ZBL BAKT-INT J MED M, V273, P216; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; SIMPSON WJ, 1990, J BACTERIOL, V172, P696, DOI 10.1128/jb.172.2.696-700.1990; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; STENBERG L, 1992, MOL MICROBIOL, V6, P1185, DOI 10.1111/j.1365-2958.1992.tb01557.x; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Svensson MD, 1999, INFECT IMMUN, V67, P3915, DOI 10.1128/IAI.67.8.3915-3920.1999; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Winram SB, 1996, MICROBIOL-SGM, V142, P2311, DOI 10.1099/13500872-142-8-2311; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808; Zimmerlein B, 2005, INFECT IMMUN, V73, P859, DOI 10.1128/IAI.73.2.859-864.2005	63	25	26	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6561	6573		10.1074/jbc.M112.442657	http://dx.doi.org/10.1074/jbc.M112.442657			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23316057	Green Published, hybrid			2022-12-28	WOS:000315820700049
J	Ahn, EEY; Higashi, T; Yan, M; Matsuura, S; Hickey, CJ; Lo, MC; Shia, WJ; DeKelver, RC; Zhang, DE				Ahn, Erin Eun-Young; Higashi, Tsunehito; Yan, Ming; Matsuura, Shinobu; Hickey, Christopher J.; Lo, Miao-Chia; Shia, Wei-Jong; DeKelver, Russell C.; Zhang, Dong-Er			SON Protein Regulates GATA-2 through Transcriptional Control of the MicroRNA 23a similar to 27a similar to 24-2 Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; IN-VIVO; MESSENGER-RNAS; EXPRESSION; DIFFERENTIATION; BINDING; DISRUPTION; REPRESSION; GENES; NF-E2	SON is a DNA-and RNA-binding protein localized in nuclear speckles. Although its function in RNA splicing for effective cell cycle progression and genome stability was recently unveiled, other mechanisms of SON functions remain unexplored. Here, we report that SON regulates GATA-2, a key transcription factor involved in hematopoietic stem cell maintenance and differentiation. SON is highly expressed in undifferentiated hematopoietic stem/progenitor cells and leukemic blasts. SON knockdown leads to significant depletion of GATA-2 protein with marginal down-regulation of GATA-2 mRNA. We show that miR-27a is up-regulated upon SON knockdown and targets the 3'-UTR of GATA-2 mRNA in hematopoietic cells. Up-regulation of miR-27a was due to activation of the promoter of the miR-23a similar to 27a similar to 24-2 cluster, suggesting that SON suppresses this promoter to lower the microRNAs from this cluster. Our data revealed a previously unidentified role of SON in microRNA production via regulating the transcription process, thereby modulating GATA-2 at the protein level during hematopoietic differentiation.	[Ahn, Erin Eun-Young; Higashi, Tsunehito; Yan, Ming; Matsuura, Shinobu; Lo, Miao-Chia; Shia, Wei-Jong; DeKelver, Russell C.; Zhang, Dong-Er] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Ahn, Erin Eun-Young; Hickey, Christopher J.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Zhang, Dong-Er] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [DeKelver, Russell C.; Zhang, Dong-Er] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of South Alabama; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhang, DE (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, Mail Drop 0815,Rm 5328,3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	d7zhang@ucsd.edu		Ahn, Eun-Young Erin/0000-0001-8795-7734; Matsuura, Shinobu/0000-0002-3914-5376	National Institutes of Health [CA096735]; University of South Alabama Mitchell Cancer Institute Startup Fund; NATIONAL CANCER INSTITUTE [R01CA096735] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL091641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Alabama Mitchell Cancer Institute Startup Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant CA096735 (to D.-E. Z.) and by the University of South Alabama Mitchell Cancer Institute Startup Fund (to E. E.-Y. A.).	Ahn EY, 2008, P NATL ACAD SCI USA, V105, P17103, DOI 10.1073/pnas.0802696105; Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; Ben-Ami O, 2009, P NATL ACAD SCI USA, V106, P238, DOI 10.1073/pnas.0811466106; BERDICHEVSKII FB, 1988, MOL BIOL+, V22, P639; Bresnick EH, 2012, NUCLEIC ACIDS RES, V40, P5819, DOI 10.1093/nar/gks281; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; CHUMAKOV IM, 1991, MOL BIOL+, V25, P592; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Feng J, 2009, BRIT J HAEMATOL, V145, P412, DOI 10.1111/j.1365-2141.2009.07632.x; Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Fleenor DE, 1996, GENE, V179, P219, DOI 10.1016/S0378-1119(96)00355-1; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Greenhalf W, 1999, YEAST, V15, P1307, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1307::AID-YEA455>3.3.CO;2-V; Jippo T, 1996, BLOOD, V87, P993, DOI 10.1182/blood.V87.3.993.bloodjournal873993; Kasashima K, 2004, BIOCHEM BIOPH RES CO, V322, P403, DOI 10.1016/j.bbrc.2004.07.130; Komori T, 2010, J BIOL CHEM, V285, P37884, DOI 10.1074/jbc.M110.148973; LABBAYE C, 1995, J CLIN INVEST, V95, P2346, DOI 10.1172/JCI117927; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; LEONARD MW, 1993, DEVELOPMENT, V119, P519; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Minegishi N, 1999, BLOOD, V93, P4196, DOI 10.1182/blood.V93.12.4196.412k23_4196_4207; Oren T, 2005, NUCLEIC ACIDS RES, V33, P4357, DOI 10.1093/nar/gki746; ORLIC D, 1995, P NATL ACAD SCI USA, V92, P4601, DOI 10.1073/pnas.92.10.4601; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Sharma A, 2011, J CELL SCI, V124, P4286, DOI 10.1242/jcs.092239; Snow JW, 2011, BLOOD, V117, P4769, DOI 10.1182/blood-2010-10-313031; SPOSI NM, 1992, P NATL ACAD SCI USA, V89, P6353, DOI 10.1073/pnas.89.14.6353; Sun CT, 2001, J BIOL CHEM, V276, P24059, DOI 10.1074/jbc.M101330200; Takahashi S, 1998, BLOOD, V92, P434, DOI 10.1182/blood.V92.2.434.414k24_434_442; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Vicente C, 2012, CRIT REV ONCOL HEMAT, V82, P1, DOI 10.1016/j.critrevonc.2011.04.007	35	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5381	5388		10.1074/jbc.M112.447227	http://dx.doi.org/10.1074/jbc.M112.447227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23322776	Green Published, hybrid			2022-12-28	WOS:000315342500013
J	Meade, KA; White, KJ; Pickford, CE; Holley, RJ; Marson, A; Tillotson, D; van Kuppevelt, TH; Whittle, JD; Day, AJ; Merry, CLR				Meade, Kate A.; White, Kathryn J.; Pickford, Claire E.; Holley, Rebecca J.; Marson, Andrew; Tillotson, Donna; van Kuppevelt, Toin H.; Whittle, Jason D.; Day, Anthony J.; Merry, Catherine L. R.			Immobilization of Heparan Sulfate on Electrospun Meshes to Support Embryonic Stem Cell Culture and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; PROTEIN INTERACTIONS; BINDING SURFACES; SELF-RENEWAL; BONE-MARROW; IN-VIVO; SCAFFOLDS; SPECIFICATION; HYALURONAN; ANTIBODIES	As our understanding of what guides the behavior of multi- and pluripotent stem cells deepens, so too does our ability to utilize certain cues to manipulate their behavior and maximize their therapeutic potential. Engineered, biologically functionalized materials have the capacity to influence stem cell behavior through a powerful combination of biological, mechanical, and topographical cues. Here, we present the development of a novel electrospun scaffold, functionalized with glycosaminoglycans (GAGs) ionically immobilized onto the fiber surface. Bound GAGs retained the ability to interact with GAG-binding molecules and, crucially, presented GAG sulfation motifs fundamental to mediating stem cell behavior. Bound GAG proved to be biologically active, rescuing the neural differentiation capacity of heparan sulfate-deficient mouse embryonic stem cells and functioning in concert with FGF4 to facilitate the formation of extensive neural processes across the scaffold surface. The combination of GAGs with electrospun scaffolds creates a biomaterial with potent applicability for the propagation and effective differentiation of pluripotent stem cells.	[Meade, Kate A.; White, Kathryn J.; Pickford, Claire E.; Marson, Andrew; Tillotson, Donna; Merry, Catherine L. R.] Univ Manchester, Sch Mat, Stem Cell Glycobiol Grp, Manchester M1 7HS, Lancs, England; [White, Kathryn J.] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Holley, Rebecca J.; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [Whittle, Jason D.] Univ S Australia, Mawson Inst, Adelaide, SA 5001, Australia	University of Manchester; University of Leeds; University of Manchester; Radboud University Nijmegen; University of South Australia	Day, AJ (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Anthony.day@manchester.ac.uk; catherine.merry@manchester.ac.uk	Day, Anthony/O-1658-2015; van Kuppevelt, A.H.M.S.M./L-4463-2015; Whittle, Jason D/E-5842-2011; Pickford, Claire/C-9815-2013	Day, Anthony/0000-0002-1415-3134; Whittle, Jason D/0000-0002-8250-1639; merry, catherine/0000-0002-3490-2809	Engineering and Physical Sciences Research Council; Medical Research Council; The Human Frontier Science Program; EPSRC [EP/H046070/1] Funding Source: UKRI; MRC [G0701165] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H046070/1] Funding Source: researchfish; Medical Research Council [G0701165] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Human Frontier Science Program(Human Frontier Science Program); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Engineering and Physical Sciences Research Council (to K. M., A. J. D., A. M., and C. L. R. M.), the Medical Research Council (to C. L. R. M.), and The Human Frontier Science Program (to R. J. H., C. P., and C. L. R. M.).	Aviss KJ, 2010, EUR CELLS MATER, V19, P193, DOI 10.22203/eCM.v019a19; Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311; Barry JJA, 2005, ADV FUNCT MATER, V15, P1134, DOI 10.1002/adfm.200400562; Bateman KL, 2000, ADV EXP MED BIOL, V480, P65; Baxter MA, 2009, STEM CELL RES, V3, P28, DOI 10.1016/j.scr.2009.03.002; Briggs D., 1992, HIGH RESOLUTION XPS; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Harmer NJ, 2006, BIOCHEM SOC T, V34, P442, DOI 10.1042/BST0340442; Helledie T, 2012, STEM CELLS DEV, V21, P1897, DOI 10.1089/scd.2011.0367; Holley RJ, 2011, J BIOL CHEM, V286, P37515, DOI 10.1074/jbc.M111.287474; Holley RJ, 2011, J BIOL CHEM, V286, P6241, DOI 10.1074/jbc.M110.178483; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221; Kurpinski KT, 2010, BIOMATERIALS, V31, P3536, DOI 10.1016/j.biomaterials.2010.01.062; Lam HJ, 2010, TISSUE ENG PT A, V16, P2641, DOI 10.1089/ten.TEA.2009.0414; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; Marson A, 2009, GLYCOBIOLOGY, V19, P1537, DOI 10.1093/glycob/cwp132; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Nur-E-Kamal A, 2008, MOL CELL BIOCHEM, V309, P157, DOI 10.1007/s11010-007-9654-8; Nur-E-Kamal A, 2006, STEM CELLS, V24, P426, DOI 10.1634/stemcells.2005-0170; Park K, 2009, MACROMOL BIOSCI, V9, P221, DOI 10.1002/mabi.200800187; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Pickford CE, 2011, STEM CELLS, V29, P629, DOI 10.1002/stem.610; Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018; Robinson DE, 2008, ADV MATER, V20, P1166, DOI 10.1002/adma.200702586; Robinson DE, 2012, BIOMATERIALS, V33, P1007, DOI 10.1016/j.biomaterials.2011.10.042; Shard AG, 2004, J PHYS CHEM B, V108, P12472, DOI 10.1021/jp048250f; Smith RAA, 2011, BIOCHEM SOC T, V39, P383, DOI 10.1042/BST0390383; Smits NC, 2006, METHOD ENZYMOL, V416, P61, DOI 10.1016/S0076-6879(06)16005-X; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Spadaccio C, 2010, REGEN MED, V5, P645, DOI 10.2217/RME.10.25; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Wijnhoven TJ, 2008, GLYCOCONJUGATE J, V25, P177, DOI 10.1007/s10719-007-9070-z; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Yang ZL, 2012, BIOMATERIALS, V33, P6615, DOI 10.1016/j.biomaterials.2012.06.055; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	50	35	36	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5530	5538		10.1074/jbc.M112.423012	http://dx.doi.org/10.1074/jbc.M112.423012			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23235146	hybrid, Green Published			2022-12-28	WOS:000315342500027
J	Cabrera, M; Arlt, H; Epp, N; Lachmann, J; Griffith, J; Perz, A; Reggiori, F; Ungermann, C				Cabrera, Margarita; Arlt, Henning; Epp, Nadine; Lachmann, Jens; Griffith, Janice; Perz, Angela; Reggiori, Fulvio; Ungermann, Christian			Functional Separation of Endosomal Fusion Factors and the Class C Core Vacuole/Endosome Tethering (CORVET) Complex in Endosome Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEINS; BINDING-PROTEIN; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE EXCHANGE; SYNTAXIN HOMOLOG; RAB INTERACTIONS; VACUOLE FUSION; SNARE COMPLEX; SEC1 HOMOLOG; SMALL GTPASE	Transport along the endolysosomal system requires multiple fusion events at early and late endosomes. Deletion of several endosomal fusion factors, including the Vac1 tether and the Class C core vacuole/endosome tethering (CORVET) complex-specific subunits Vps3 and Vps8, results in a class D vps phenotype. As these mutants have an apparently similar defect in endosomal transport, we asked whether CORVET and Vac1 could still act in distinct tethering reactions. Our data reveal that CORVET mutants can be rescued by Vac1 overexpression in the endocytic pathway but not in CPY or Cps1 sorting to the vacuole. Moreover, when we compared the ultrastructure, CORVET mutants were most similar to deletions of the Rab Vps21 and its guanine nucleotide exchange factor Vps9 and different from vac1 deletion, indicating separate functions. Likewise, CORVET still localized to endosomes even in the absence of Vac1, whereas Vac1 localization became diffuse in CORVET mutants. Importantly, CORVET localization requires the Rab5 homologs Vps21 and Ypt52, whereas Vac1 localization is strictly Vps21-dependent. In this context, we also uncover that Muk1 can compensate for loss of Vps9 in CORVET localization, indicating that two Rab5 guanine nucleotide exchange factors operate in the endocytic pathway. Overall, our study reveals a unique role of CORVET in the sorting of biosynthetic cargo to the vacuole/lysosome.	[Cabrera, Margarita; Arlt, Henning; Epp, Nadine; Lachmann, Jens; Perz, Angela; Ungermann, Christian] Univ Osnabruck, Dept Biol Chem, Biochem Sect, D-49076 Osnabruck, Germany; [Griffith, Janice; Reggiori, Fulvio] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Griffith, Janice; Reggiori, Fulvio] Univ Med Ctr Utrecht, Inst Biomembranes, NL-3584 CX Utrecht, Netherlands	University Osnabruck; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Cabrera, M (corresponding author), Biochem Sect, Dept Biol Chem, Barbarastr 13, D-49076 Osnabruck, Germany.	Margarita.Cabrera@biologie.uni-osnabrueck.de; cu@uos.de	Cabrera, Margarita/Y-1225-2019; Reggiori, Fulvio/U-8327-2019; Cabrera, Margarita/F-3306-2016	Cabrera, Margarita/0000-0002-2978-8255; Reggiori, Fulvio/0000-0003-2652-2686; Cabrera, Margarita/0000-0002-2978-8255; Arlt, Henning/0000-0001-6395-9620	project P11 [Sonderforschungsbereich (SFB) 944]; Hans Muhlenhoff Foundation; European Community Humanitarian Office (ECHO) [700.59.003]; Earth and Life Science ALW Open Program [821.02.017]; Deutsche Forschungsgemeinschaft-Netherlands Organisation for Scientific Research (DFG-NWO) [DN 82-303, UN111/7-1]	project P11; Hans Muhlenhoff Foundation; European Community Humanitarian Office (ECHO); Earth and Life Science ALW Open Program; Deutsche Forschungsgemeinschaft-Netherlands Organisation for Scientific Research (DFG-NWO)	This work was supported by Sonderforschungsbereich (SFB) 944 (project P11); by the Hans Muhlenhoff Foundation (to C. U.); and by European Community Humanitarian Office (ECHO) Grant 700.59.003, Earth and Life Science ALW Open Program Grant 821.02.017, and Deutsche Forschungsgemeinschaft-Netherlands Organisation for Scientific Research (DFG-NWO) Cooperation Grant DN 82-303 (to F. R.) and UN111/7-1 (to C. U.).	Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Burd CG, 1996, MOL CELL BIOL, V16, P2369; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; COWLES CR, 1994, J CELL SCI, V107, P3449; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Epp N, 2011, EUR J CELL BIOL, V90, P779, DOI 10.1016/j.ejcb.2011.04.007; Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Horazdovsky BF, 1996, J BIOL CHEM, V271, P33607, DOI 10.1074/jbc.271.52.33607; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kauppi M, 2002, J CELL SCI, V115, P899; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Markgraf DF, 2009, MOL BIOL CELL, V20, P5276, DOI 10.1091/mbc.E09-06-0521; Nickerson DP, 2012, TRAFFIC, V13, P1411, DOI 10.1111/j.1600-0854.2012.01390.x; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Pawelec A, 2010, EUKARYOT CELL, V9, P602, DOI 10.1128/EC.00286-09; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Peterson MR, 1999, CURR BIOL, V9, P159, DOI 10.1016/S0960-9822(99)80071-2; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; RAYMOND CK, 1990, J CELL BIOL, V111, P877, DOI 10.1083/jcb.111.3.877; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Russell MRG, 2012, J CELL SCI, V125, P5208, DOI 10.1242/jcs.111310; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Shi YF, 2011, MOL BIOL CELL, V22, P4093, DOI 10.1091/mbc.E11-05-0440; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Spang A, 2009, BIOL CHEM, V390, P753, DOI 10.1515/BC.2009.056; Subramanian S, 2004, MOL BIOL CELL, V15, P2593, DOI 10.1091/mbc.E03-10-0767; Tall GG, 1999, MOL BIOL CELL, V10, P1873, DOI 10.1091/mbc.10.6.1873; Teis D, 2009, CELL, V137, DOI 10.1016/j.cell.2009.03.027; Webb GC, 1997, GENETICS, V147, P467; WEISMAN LS, 1990, P NATL ACAD SCI USA, V87, P1076, DOI 10.1073/pnas.87.3.1076; Woolford CA, 1998, GENETICS, V148, P71; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327	56	46	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5166	5175		10.1074/jbc.M112.431536	http://dx.doi.org/10.1074/jbc.M112.431536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264632	Green Published, hybrid			2022-12-28	WOS:000315340400064
J	Gupta, SK; Carmi, S; Ben-Asher, HW; Tkacz, ID; Naboishchikov, I; Michaeli, S				Gupta, Sachin Kumar; Carmi, Shai; Ben-Asher, Hiba Waldman; Tkacz, Itai Dov; Naboishchikov, Ilana; Michaeli, Shulamit			Basal Splicing Factors Regulate the Stability of Mature mRNAs in Trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS TBUBP1; ANALYSIS REVEALS; DOMAIN PROTEINS; WIDE ANALYSIS; SM PROTEINS; BRUCEI; IDENTIFICATION; EXPRESSION; NUCLEAR; INTERFERENCE	Gene expression in trypanosomes is mainly regulated post-transcriptionally. Genes are transcribed as polycistronic mRNAs that are dissected by the concerted action of trans-splicing and polyadenylation. In trans-splicing, a common exon, the spliced leader, is added to all mRNAs from a small RNA. In this study, we examined by microarray analysis the transcriptome following RNAi silencing of the basal splicing factors U2AF65, SF1, and U2AF35. The transcriptome data revealed correlations between the affected genes and their splicing and polyadenylation signaling properties, suggesting that differential binding of these factors to pre-mRNA regulates trans-splicing and hence expression of specific genes. Surprisingly, all these factors were shown to affect not only splicing but also mRNA stability. Affinity purification of SF1 and U2AF35 complexes supported their role in mRNA stability. U2AF35 but not SF1 was shown to bind to ribosomes. To examine the role of splicing factors in mRNA stability, mutations were introduced into the polypyrimidine tract located in the 3' UTR of a mini-gene, and the results demonstrate that U2AF65 binds to such a site and controls the mRNA stability. We propose that transcripts carrying splicing signals in their 3' UTR bind the splicing factors and control their stability.	[Michaeli, Shulamit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; Bar Ilan Univ, Adv Mat & Nanotechnol Inst, IL-52900 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Michaeli, S (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	shulamit.michaeli@biu.ac.il	Carmi, Shai/F-4817-2010; Michaeli, Shulamit/AAC-8255-2022	Carmi, Shai/0000-0002-0188-2610; 	Deutsche Forcshungsgemeinschaft via Deutsche-Israelische Projektkooperation; Israel Science Foundation	Deutsche Forcshungsgemeinschaft via Deutsche-Israelische Projektkooperation; Israel Science Foundation(Israel Science Foundation)	This work was supported in part by the Deutsche Forcshungsgemeinschaft via Deutsche-Israelische Projektkooperation and the Israel Science Foundation.	AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; Alves LR, 2010, GENE, V452, P72, DOI 10.1016/j.gene.2009.12.009; Ambrosio DL, 2009, EUKARYOT CELL, V8, P990, DOI 10.1128/EC.00075-09; Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Aphasizhev R, 2003, EMBO J, V22, P913, DOI 10.1093/emboj/cdg083; Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Barth S, 2005, J BIOL CHEM, V280, P34558, DOI 10.1074/jbc.M503465200; Barth S, 2008, EUKARYOT CELL, V7, P86, DOI 10.1128/EC.00215-07; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Colasante C, 2007, MOL BIOCHEM PARASIT, V151, P193, DOI 10.1016/j.molbiopara.2006.11.003; Corioni M, 2011, NUCLEIC ACIDS RES, V39, P1868, DOI 10.1093/nar/gkq1042; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Droll D, 2010, FEBS LETT, V584, P1156, DOI 10.1016/j.febslet.2010.02.018; ELLIS JA, 1993, VET PARASITOL, V50, P143, DOI 10.1016/0304-4017(93)90015-F; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; Gunzl A, 2010, EUKARYOT CELL, V9, P1159, DOI 10.1128/EC.00113-10; Gupta SK, 2010, NUCLEIC ACIDS RES, V38, P7236, DOI 10.1093/nar/gkq599; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hartmann C, 2008, MOL BIOCHEM PARASIT, V157, P112, DOI 10.1016/j.molbiopara.2007.09.009; Hartmann C, 2007, EUKARYOT CELL, V6, P1964, DOI 10.1128/EC.00279-07; HUG M, 1994, MOL CELL BIOL, V14, P7428, DOI 10.1128/MCB.14.11.7428; Hury A, 2009, EUKARYOT CELL, V8, P56, DOI 10.1128/EC.00322-08; Ismaili N, 1999, MOL BIOCHEM PARASIT, V102, P103, DOI 10.1016/S0166-6851(99)00091-2; Ismaili N, 2000, MOL BIOCHEM PARASIT, V106, P109, DOI 10.1016/S0166-6851(99)00205-4; Jae N, 2010, EUKARYOT CELL, V9, P379, DOI 10.1128/EC.00353-09; Jensen BC, 2003, J BIOL CHEM, V278, P32204, DOI 10.1074/jbc.M304198200; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; Kol G, 2005, HUM MOL GENET, V14, P1559, DOI 10.1093/hmg/ddi164; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Liang XH, 2006, MOL BIOCHEM PARASIT, V145, P29, DOI 10.1016/j.molbiopara.2005.09.004; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Liang XH, 2001, J BIOL CHEM, V276, P40313, DOI 10.1074/jbc.M104488200; Mandelboim M, 2003, J BIOL CHEM, V278, P51469, DOI 10.1074/jbc.M308997200; Manful T, 2011, RNA, V17, P2039, DOI 10.1261/rna.2837311; Manger ID, 1998, MOL BIOCHEM PARASIT, V97, P1, DOI 10.1016/S0166-6851(98)00118-2; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; MICHAELI S, 1990, J BIOL CHEM, V265, P10582; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/FMB.11.20, 10.2217/fmb.11.20]; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Pacheco TR, 2006, MOL CELL BIOL, V26, P8183, DOI 10.1128/MCB.00350-06; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; Palfi Z, 2005, NUCLEIC ACIDS RES, V33, P2493, DOI 10.1093/nar/gki548; Palfi Z, 2009, GENE DEV, V23, P1650, DOI 10.1101/gad.526109; Prohaska K, 2009, EUKARYOT CELL, V8, P77, DOI 10.1128/EC.00234-08; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Rino J, 2008, MOL CELL BIOL, V28, P3045, DOI 10.1128/MCB.02015-07; Ruan JP, 2007, MOL BIOCHEM PARASIT, V156, P246, DOI 10.1016/j.molbiopara.2007.09.001; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Sanford JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003369; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Schwartz SH, 2008, GENOME RES, V18, P88, DOI 10.1101/gr.6818908; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Siegel TN, 2005, MOL CELL BIOL, V25, P9586, DOI 10.1128/MCB.25.21.9586-9594.2005; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; Tkacz ID, 2008, MOL BIOCHEM PARASIT, V160, P22, DOI 10.1016/j.molbiopara.2008.03.003; Tkacz ID, 2007, RNA, V13, P30, DOI 10.1261/rna.174307; Tkacz ID, 2010, J BIOL CHEM, V285, P27982, DOI 10.1074/jbc.M109.095349; VASSELLA E, 1994, NUCLEIC ACIDS RES, V22, P1359, DOI 10.1093/nar/22.8.1359; Vazquez M, 2003, MOL BIOCHEM PARASIT, V128, P77, DOI 10.1016/S0166-6851(03)00007-0; Vazquez MP, 2009, MOL BIOCHEM PARASIT, V164, P137, DOI 10.1016/j.molbiopara.2008.12.009; Wurst M, 2009, MOL BIOCHEM PARASIT, V163, P61, DOI 10.1016/j.molbiopara.2008.09.001; Xu YX, 2001, J BIOL CHEM, V276, P14289, DOI 10.1074/jbc.M007007200; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	74	27	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4991	5006		10.1074/jbc.M112.416578	http://dx.doi.org/10.1074/jbc.M112.416578			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283975	Green Published, hybrid			2022-12-28	WOS:000315340400046
J	Northey, JJ; Dong, ZF; Ngan, E; Kaplan, A; Hardy, WR; Pawson, T; Siegel, PM				Northey, Jason J.; Dong, Zhifeng; Ngan, Elaine; Kaplan, Andrew; Hardy, W. Rod; Pawson, Tony; Siegel, Peter M.			Distinct Phosphotyrosine-dependent Functions of the ShcA Adaptor Protein Are Required for Transforming Growth Factor beta (TGF beta)-induced Breast Cancer Cell Migration, Invasion, and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL-LIKE TRANSITION; TYROSINE PHOSPHORYLATION; TRANSGENIC MICE; PTB DOMAIN; KINASE; RECEPTOR; GRB2; INDUCTION; INTEGRIN; SITES	The ErbB2 and TGF beta signaling pathways cooperate to promote the migratory, invasive, and metastatic behavior of breast cancer cells. Wepreviously demonstrated that ShcA is necessary for these synergistic interactions. Through a structure/function approach, we now show that the phosphotyrosine-binding, but not the Src homology 2, domain of ShcA is required for TGF beta-induced migration and invasion of ErbB2-expressing breast cancer cells. We further demonstrate that the tyrosine phosphorylation sites within ShcA (Tyr(239)/Tyr(240) and Tyr(313)) transduce distinct and non-redundant signals that promote these TGF beta-mediated effects. We demonstrate that Grb2 is required specifically downstream of Tyr(313), whereas the Tyr(239)/Tyr(240) phosphorylation sites require the Crk adaptor proteins to augment TGF beta-induced migration and invasion. Furthermore, ShcA Tyr(313) phosphorylation enhances tumor cell survival, and ShcA Tyr(239)/Tyr(240) signaling promotes endothelial cell recruitment into ErbB2-expressing breast tumors in vivo, whereas all three ShcA tyrosine residues are required for efficient breast cancer metastasis to the lungs. Our data uncover a novel ShcA-dependent signaling axis downstream of TGF beta and ErbB2 that requires both the Grb2 and Crk adaptor proteins to increase the migratory and invasive properties of breast cancer cells. In addition, signaling downstream of specific ShcA tyrosine residues facilitates the survival, vascularization, and metastatic spread of breast tumors.	[Northey, Jason J.; Dong, Zhifeng; Ngan, Elaine; Kaplan, Andrew; Siegel, Peter M.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Northey, Jason J.; Siegel, Peter M.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Dong, Zhifeng; Ngan, Elaine; Siegel, Peter M.] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Kaplan, Andrew; Siegel, Peter M.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A3, Canada; [Hardy, W. Rod] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Pawson, Tony] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G IX5, Canada	McGill University; McGill University; McGill University; McGill University; University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Siegel, PM (corresponding author), McGill Univ, Goodman Canc Res Ctr, 1160 Pine Ave W,Rm 513, Montreal, PQ H3A 1A3, Canada.	peter.siegel@mcgill.ca	Northey, Jason/AAX-6365-2021; Pawson, Tony J/E-4578-2013	Northey, Jason/0000-0003-3115-2560	Association for International Cancer Research [11-0204]; Canadian Cancer Society Research Institute [2011-700790]; Research Institute of the McGill University Health Centre; Department of Medicine, McGill University; Fonds de recherche en sante du Quebec; United States Army Department of Defense Breast Cancer Research Program [W81XWH-11-1-0008]; Worldwide Cancer Research [11-0204] Funding Source: researchfish	Association for International Cancer Research; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Research Institute of the McGill University Health Centre; Department of Medicine, McGill University; Fonds de recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); United States Army Department of Defense Breast Cancer Research Program; Worldwide Cancer Research	This work was supported in part by Association for International Cancer Research Grant 11-0204 and Canadian Cancer Society Research Institute Grant 2011-700790) ( to P. M. S.).; Supported by studentships from the Research Institute of the McGill University Health Centre and Department of Medicine, McGill University.; Supported by a studentship from the Fonds de recherche en sante du Quebec and currently holds a studentship from the United States Army Department of Defense Breast Cancer Research Program (Grant W81XWH-11-1-0008).	Akakura S, 2005, J CELL PHYSIOL, V204, P344, DOI 10.1002/jcp.20288; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Cabodi S, 2010, FASEB J, V24, P3796, DOI 10.1096/fj.10-157347; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; Chow A, 2011, J MAMMARY GLAND BIOL, V16, P81, DOI 10.1007/s10911-011-9206-4; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Davol PA, 2003, CANCER RES, V63, P6772; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Deshmukh L, 2010, J BIOL CHEM, V285, P34875, DOI 10.1074/jbc.M110.159087; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Fathers KE, 2010, AM J PATHOL, V176, P446, DOI 10.2353/ajpath.2010.090383; Frackelton AR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1631; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Giubellino A, 2007, CANCER RES, V67, P6012, DOI 10.1158/0008-5472.CAN-07-0022; Gotoh N, 1996, EMBO J, V15, P6197, DOI 10.1002/j.1460-2075.1996.tb01008.x; Gotoh N, 1997, MOL CELL BIOL, V17, P1824, DOI 10.1128/MCB.17.4.1824; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Hardy WR, 2007, SCIENCE, V317, P251, DOI 10.1126/science.1140114; Khoury H, 2001, ONCOGENE, V20, P788, DOI 10.1038/sj.onc.1204166; Lamorte L, 2002, MOL BIOL CELL, V13, P1449, DOI 10.1091/mbc.01-10-0477; Lamorte L, 2002, J BIOL CHEM, V277, P37904, DOI 10.1074/jbc.M201743200; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nakamura T, 2002, ONCOGENE, V21, P22, DOI 10.1038/sj.onc.1205019; Northey JJ, 2008, MOL CELL BIOL, V28, P3162, DOI 10.1128/MCB.01734-07; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Rauh MJ, 1999, MOL CELL BIOL, V19, P8169; Rodrigues SP, 2005, MOL CANCER RES, V3, P183; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SALCINI AE, 1994, ONCOGENE, V9, P2827; Saucier C, 2004, P NATL ACAD SCI USA, V101, P2345, DOI 10.1073/pnas.0308065101; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Tornillo G, 2011, EUR J CELL BIOL, V90, P237, DOI 10.1016/j.ejcb.2010.09.002; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Ursini-Siegel J, 2010, CANCER RES, V70, P7776, DOI 10.1158/0008-5472.CAN-10-2229; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Wendt MK, 2009, J BIOL CHEM, V284, P34145, DOI 10.1074/jbc.M109.023614; Zang XP, 2004, CLIN EXP METASTAS, V21, P437, DOI 10.1007/s10585-004-2051-8	50	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5210	5222		10.1074/jbc.M112.424804	http://dx.doi.org/10.1074/jbc.M112.424804			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23277357	Green Published, hybrid			2022-12-28	WOS:000315340400068
J	Thomas, WA; Boscher, C; Chu, YS; Cuvelier, D; Martinez-Rico, C; Seddiki, R; Heysch, J; Ladoux, B; Thiery, JP; Mege, RM; Dufour, S				Thomas, William A.; Boscher, Cecile; Chu, Yeh-Shiu; Cuvelier, Damien; Martinez-Rico, Clara; Seddiki, Rima; Heysch, Julie; Ladoux, Benoit; Thiery, Jean Paul; Mege, Rene-Marc; Dufour, Sylvie			alpha-Catenin and Vinculin Cooperate to Promote High E-cadherin-based Adhesion Strength	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHERENS JUNCTIONS; N-CADHERIN; INTERCELLULAR-ADHESION; FORCE MEASUREMENTS; COMPLEX-FORMATION; CELL-JUNCTIONS; ACTIN; MODULATION; ACTIVATION; PROTEIN	Maintaining cell cohesiveness within tissues requires that intercellular adhesions develop sufficient strength to support traction forces applied by myosin motors and by neighboring cells. Cadherins are transmembrane receptors that mediate intercellular adhesion. The cadherin cytoplasmic domain recruits several partners, including catenins and vinculin, at sites of cell-cell adhesion. Our study used force measurements to address the role of alpha E-catenin and vinculin in the regulation of the strength of E-cadherin-based adhesion. alpha E-catenin-deficient cells display only weak aggregation and fail to strengthen intercellular adhesion over time, a process rescued by the expression of alpha E-catenin or chimeric E-cadherin center dot alpha E-catenins, including a chimera lacking the alpha E-catenin dimerization domain. Interestingly, an alpha E-catenin mutant lacking the modulation and actin-binding domains restores cadherin-dependent cell-cell contacts but cannot strengthen intercellular adhesion. The expression of alpha E-catenin mutated in its vinculin-binding site is defective in its ability to rescue cadherin-based adhesion strength in cells lacking alpha E-catenin. Vinculin depletion or the overexpression of the alpha E-catenin modulation domain strongly decreases E-cadherin-mediated adhesion strength. This supports the notion that both molecules are required for intercellular contact maturation. Furthermore, stretching of cell doublets increases vinculin recruitment and alpha 18 anti-alpha E-catenin conformational epitope immunostaining at cell-cell contacts. Taken together, our results indicate that alpha E-catenin and vinculin cooperatively support intercellular adhesion strengthening, probably via a mechanoresponsive link between the E-cadherin beta-catenin complexes and the underlying actin cytoskeleton.	[Thomas, William A.] Colby Sawyer Coll, Dept Nat Sci, New London, NH 03257 USA; [Thomas, William A.; Martinez-Rico, Clara; Heysch, Julie; Dufour, Sylvie] Inst Curie, CNRS, UMR144, F-75005 Paris, France; [Boscher, Cecile; Seddiki, Rima; Mege, Rene-Marc] Univ Paris 06, F-75005 Paris, France; [Boscher, Cecile; Mege, Rene-Marc] Inst Fer Moulin, INSERM, U839, F-75005 Paris, France; [Chu, Yeh-Shiu; Thiery, Jean Paul] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Cuvelier, Damien] Inst Curie, CNRS, UMR168, F-75005 Paris, France; [Seddiki, Rima; Ladoux, Benoit] Univ Paris 07, Lab MSC, F-75013 Paris, France; [Ladoux, Benoit; Thiery, Jean Paul] Mechanobiol Inst, Singapore 117411, Singapore; [Thiery, Jean Paul] Cancer Sci Inst, Singapore 117599, Singapore; [Thiery, Jean Paul] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; National University of Singapore	Dufour, S (corresponding author), Inst Curie, UMR144, Sect Rech, 26 Rue Ulm, F-75248 Paris 05, France.	sylvie.dufour@curie.fr	Thiery, Jean Paul/M-9387-2019; DUFOUR, Sylvie/G-2253-2019; cuvelier, damien/A-3530-2013; Mege, Rene Marc/M-9569-2013; Thiery, Jean Paul/H-1550-2011	Dufour, Sylvie/0000-0002-6663-0676; Ladoux, Benoit/0000-0003-2086-1556; Mege, Rene-Marc/0000-0001-8128-5543; Thiery, Jean Paul/0000-0003-0478-5020	National Institutes of Health, NCI/Institut National du Cancer Joint Research Project Fellowship Program; Agence National de la Recherche (ANR) [PCV07-186757, 1515 02]; Programme Incitatif et Cooperatif (PIC) of Institut Curie; Fondation Pierre Gilles de Gennes; Association pour la Recherche sur le Cancer (ARC); Association Francaise contre les Myopathies; Institute of Molecular and Cell Biology A*STAR; ARC; NICHD, National Institutes of Health	National Institutes of Health, NCI/Institut National du Cancer Joint Research Project Fellowship Program; Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Programme Incitatif et Cooperatif (PIC) of Institut Curie; Fondation Pierre Gilles de Gennes; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Institute of Molecular and Cell Biology A*STAR; ARC(Australian Research Council); NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health, NCI/Institut National du Cancer Joint Research Project Fellowship Program. This work was also supported by grants from the Agence National de la Recherche (ANR) (Physique et Chimie du Vivant I (PCVI) program, Grant PCV07-186757; BLANC program, Grant 1515 02), Programme Incitatif et Cooperatif (PIC) of Institut Curie, and Fondation Pierre Gilles de Gennes, as well as by grants from the Association pour la Recherche sur le Cancer (ARC), Association Francaise contre les Myopathies, and Institute of Molecular and Cell Biology A*STAR core funding.; Supported by an ARC Ph.D. fellowship. Present address: Dept. of Cellular and Physiolical Sciences, University of British Columbia, Vancouver, British Columbia VTZ 1Z4, Canada.; We acknowledge A. Nagafuchi for the generous gift of the mAb alpha 18, M. Lambert for advice and help in the construction of the alpha E-catenin expression vectors, and C. Carlier for technical help. We acknowledge Rebecca Jackson for critical reading of the manuscript. We acknowledge Z. Maciorowski and S. Grondin from the Flow cytometry facility, L. Sengmanivong from the Nikon Imaging Centre-Institut Curie, and V. Fraisier and F. Waharte from the PICT-IBiSA facility for help with cell sorting, imaging, and computerized video microscopy, respectively. Part of the wide field microscopy was also performed at the Institut du Fer a Moulin Cell Imaging Facility. Hybridomas obtained from the Developmental Studies Hybridoma Bank were developed under the auspices of the NICHD, National Institutes of Health, and maintained by the University of Iowa (Iowa City, IA).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Azioune A, 2011, LANGMUIR, V27, P7349, DOI 10.1021/la200970t; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Chervin-Petinot A, 2012, J BIOL CHEM, V287, P7556, DOI 10.1074/jbc.M111.328682; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Chu YS, 2006, J BIOL CHEM, V281, P2901, DOI 10.1074/jbc.M506185200; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Chu YS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028102; Dufour S, 1999, J CELL BIOL, V146, P501, DOI 10.1083/jcb.146.2.501; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Gavard J, 2004, J BIOL CHEM, V279, P36795, DOI 10.1074/jbc.M401705200; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kumper S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011801; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; Lambert M, 2002, J CELL BIOL, V157, P469, DOI 10.1083/jcb.200107104; Lambert M, 2007, EXP CELL RES, V313, P4025, DOI 10.1016/j.yexcr.2007.07.035; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Martinez-Rico C, 2005, J BIOL CHEM, V280, P4753, DOI 10.1074/jbc.M412544200; Martinez-Rico C, 2010, J CELL SCI, V123, P712, DOI 10.1242/jcs.047878; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; MEGE RM, 1988, P NATL ACAD SCI USA, V85, P7274, DOI 10.1073/pnas.85.19.7274; NAGAFUCHI A, 1994, DEV GROWTH DIFFER, V36, P59; Ozawa M, 1998, J BIOL CHEM, V273, P29524, DOI 10.1074/jbc.273.45.29524; Ozawa M, 2003, J BIOL CHEM, V278, P46014, DOI 10.1074/jbc.M307778200; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Papusheva E, 2010, EMBO J, V29, P2753, DOI 10.1038/emboj.2010.182; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Stockinger P, 2011, DEVELOPMENT, V138, P4673, DOI 10.1242/dev.071233; Sumida GM, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-48; SUNG KLP, 1986, SCIENCE, V234, P1405, DOI 10.1126/science.3491426; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; THIERY JP, 1984, DEV BIOL, V102, P61, DOI 10.1016/0012-1606(84)90175-1; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; VERMEULEN SJ, 1995, CANCER RES, V55, P4722; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yonemura S, 2011, CURR OPIN CELL BIOL, V23, P515, DOI 10.1016/j.ceb.2011.07.001; Yonemura S, 2011, BIOESSAYS, V33, P732, DOI 10.1002/bies.201100064; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	54	104	106	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4957	4969		10.1074/jbc.M112.403774	http://dx.doi.org/10.1074/jbc.M112.403774			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23266828	Green Published, hybrid			2022-12-28	WOS:000315340400043
J	de Miranda, MP; Lopes, FB; McVey, CE; Bustelo, XR; Simas, JP				de Miranda, Marta Pires; Lopes, Filipa B.; McVey, Colin E.; Bustelo, Xose R.; Pedro Simas, J.			Role of Src Homology Domain Binding in Signaling Complexes Assembled by the Murid gamma-Herpesvirus M2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-PRODUCT; TYROSINE PHOSPHORYLATION; PHOSPHOLIPASE C-GAMMA-2; SH2 DOMAINS; ACTIVATION; MECHANISM; LATENCY; VAV; GAMMAHERPESVIRUS-68; IDENTIFICATION	gamma-Herpesviruses express proteins that modulate B lymphocyte signaling to achieve persistent latent infections. One such protein is the M2 latency-associated protein encoded by the murid herpesvirus-4. M2 has two closely spaced tyrosine residues, Tyr(120) and Tyr(129), which are phosphorylated by Src family tyrosine kinases. Here we used mass spectrometry to identify the binding partners of tyrosine-phosphorylated M2. Each M2 phosphomotif is shown to bind directly and selectively to SH2-containing signaling molecules. Specifically, Src family kinases, NCK1 and Vav1, bound to the Tyr(P)(120) site, PLC gamma 2 and the SHP2 phosphatase bound to the Tyr(P)(129) motif, and the p85 alpha subunit of PI3K associated with either motif. Consistent with these data, we show that M2 coordinates the formation of multiprotein complexes with these proteins. The effect of those interactions is functionally bivalent, because it can result in either the phosphorylation of a subset of binding proteins (Vav1 and PLC gamma 2) or in the inactivation of downstream targets (AKT). Finally, we show that translocation to the plasma membrane and subsequent M2 tyrosine phosphorylation relies on the integrity of a C-terminal proline-rich SH3 binding region of M2 and its interaction with Src family kinases. Unlike other gamma-herpesviruses, that encode transmembrane proteins that mimic the activation of ITAMs, murid herpesvirus-4 perturbs B cell signaling using a cytoplasmic/membrane shuttling factor that nucleates the assembly of signaling complexes using a bilayered mechanism of phosphotyrosine and proline-rich anchoring motifs.	[de Miranda, Marta Pires; Lopes, Filipa B.; Pedro Simas, J.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [de Miranda, Marta Pires; Lopes, Filipa B.; Pedro Simas, J.] Univ Lisbon, Fac Med, Inst Microbiol, P-1649028 Lisbon, Portugal; [McVey, Colin E.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Bustelo, Xose R.] Univ Salamanca, Ctr Invest Canc, E-37007 Salamanca, Spain; [Bustelo, Xose R.] Univ Salamanca, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain	Universidade de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Simas, JP (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal.	psimas@fm.ul.pt	McVey, Colin E/C-2110-2008; Simas, J Pedro/M-5157-2013; Bustelo, Xose R./AAD-2081-2022; Bustelo, Xose R./A-9526-2010	McVey, Colin E/0000-0001-7457-2130; Simas, J Pedro/0000-0001-6982-9253; Bustelo, Xose R./0000-0001-9398-6072; Bustelo, Xose R./0000-0001-9398-6072	Portuguese Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/SAU-MII/099314/2008]; Spanish Association Against Cancer [SAF2009-07172]; Spanish Ministry of Economy and Competitiveness [RD06/0020/0001]; European FEDER program; FCT [PNRC/692/BIO/2264/2005]	Portuguese Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Spanish Association Against Cancer; Spanish Ministry of Economy and Competitiveness(Spanish Government); European FEDER program(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Portuguese Fundacao para a Ciencia e Tecnologia (FCT) Grant PTDC/SAU-MII/099314/2008 (to J. P. S.) and Spanish Association Against Cancer and Spanish Ministry of Economy and Competitiveness Grants SAF2009-07172 and RD06/0020/0001, respectively (to X. R. B.). Spanish funding is co-sponsored by the European FEDER program. The SPR equipment at the Instituto de Tecnologia Quimica e Biologica was acquired with FCT Grant PNRC/692/BIO/2264/2005. The Proteomics Laboratory at the Centro de Investigacion del Cancer is a member of ProteoRed-ISCIII.	Albrecht JC, 1999, J VIROL, V73, P4631, DOI 10.1128/JVI.73.6.4631-4639.1999; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; BUSTELO XR, 1993, CELL GROWTH DIFFER, V4, P297; Caloca MJ, 2008, J BIOL CHEM, V283, P36454, DOI 10.1074/jbc.M803814200; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Damania B, 2004, NAT REV MICROBIOL, V2, P656, DOI 10.1038/nrmicro958; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; de Miranda MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001654; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Herskowitz JH, 2008, J VIROL, V82, P3295, DOI 10.1128/JVI.02234-07; Humphries LA, 2004, J BIOL CHEM, V279, P37651, DOI 10.1074/jbc.M311985200; Jacoby MA, 2002, J VIROL, V76, P1790, DOI 10.1128/JVI.76.4.1790-1801.2002; Kim YJ, 2004, MOL CELL BIOL, V24, P9986, DOI 10.1128/MCB.24.22.9986-9999.2004; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Lagunoff M, 1999, P NATL ACAD SCI USA, V96, P5704, DOI 10.1073/pnas.96.10.5704; Lee BS, 2005, J VIROL, V79, P12173, DOI 10.1128/JVI.79.19.12173-12184.2005; Lee H, 1998, MOL CELL BIOL, V18, P5219, DOI 10.1128/MCB.18.9.5219; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Liang XZ, 2004, J VIROL, V78, P12416, DOI 10.1128/JVI.78.22.12416-12427.2004; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Macrae AI, 2003, J VIROL, V77, P9700, DOI 10.1128/JVI.77.17.9700-9709.2003; Ozdener F, 2002, MOL PHARMACOL, V62, P672, DOI 10.1124/mol.62.3.672; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pietrek M, 2010, J VIROL, V84, P8231, DOI 10.1128/JVI.01696-09; PLEIMAN CM, 1994, P NATL ACAD SCI USA, V91, P4268, DOI 10.1073/pnas.91.10.4268; Rodrigues L, 2006, J VIROL, V80, P6123, DOI 10.1128/JVI.02700-05; Rodrigues L, 2009, EMBO J, V28, P1283, DOI 10.1038/emboj.2009.74; Rodriguez R, 2001, J BIOL CHEM, V276, P47982, DOI 10.1074/jbc.M107577200; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Schweimer K, 2002, BIOCHEMISTRY-US, V41, P5120, DOI 10.1021/bi015986j; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siegel AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000039; Simas JP, 2004, J GEN VIROL, V85, P2789, DOI 10.1099/vir.0.80138-0; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Swart R, 2000, J VIROL, V74, P10838, DOI 10.1128/JVI.74.22.10838-10845.2000; Tomlinson CC, 2004, J VIROL, V78, P1918, DOI 10.1128/JVI.78.4.1918-1927.2004; Usherwood EJ, 1996, J VIROL, V70, P6516, DOI 10.1128/JVI.70.9.6516-6518.1996; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Watanabe D, 2001, J BIOL CHEM, V276, P38595, DOI 10.1074/jbc.M103675200	44	8	8	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3858	3870		10.1074/jbc.M112.439810	http://dx.doi.org/10.1074/jbc.M112.439810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258536	Green Published, hybrid			2022-12-28	WOS:000314845000017
J	Li, CH; Liu, CY; Nissim, I; Chen, J; Chen, P; Doliba, N; Zhang, TT; Nissim, I; Daikhin, Y; Stokes, D; Yudkoff, M; Bennett, MJ; Stanley, CA; Matschinsky, FM; Naji, A				Li, Changhong; Liu, Chengyang; Nissim, Itzhak; Chen, Jie; Chen, Pan; Doliba, Nicolai; Zhang, Tingting; Nissim, Ilana; Daikhin, Yevgeny; Stokes, David; Yudkoff, Marc; Bennett, Michael J.; Stanley, Charles A.; Matschinsky, Franz M.; Naji, Ali			Regulation of Glucagon Secretion in Normal and Diabetic Human Islets by gamma-Hydroxybutyrate and Glycine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; SEMIALDEHYDE DEHYDROGENASE-DEFICIENCY; ACID-INDUCED GLUCAGON; ALPHA-CELLS; INSULIN-SECRETION; GLUTAMATE-DEHYDROGENASE; GLUCOKINASE ACTIVATION; GLUCOSE-METABOLISM; GABA-METABOLISM; TRANSGENIC MICE	Paracrine signaling between pancreatic islet beta-cells and alpha-cells has been proposed to play a role in regulating glucagon responses to elevated glucose and hypoglycemia. To examine this possibility in human islets, we used a metabolomic approach to trace the responses of amino acids and other potential neurotransmitters to stimulation with [U-C-13] glucose in both normal individuals and type 2 diabetics. Islets from type 2 diabetics uniformly showed decreased glucose stimulation of insulin secretion and respiratory rate but demonstrated two different patterns of glucagon responses to glucose: one group responded normally to suppression of glucagon by glucose, but the second group was non-responsive. The non-responsive group showed evidence of suppressed islet GABA levels and of GABA shunt activity. In further studies with normal human islets, we found that gamma-hydroxybutyrate (GHB), a potent inhibitory neurotransmitter, is generated in beta-cells by an extension of the GABA shunt during glucose stimulation and interacts with alpha-cell GHB receptors, thus mediating the suppressive effect of glucose on glucagon release. We also identified glycine, acting via alpha-cell glycine receptors, as the predominant amino acid stimulator of glucagon release. The results suggest that glycine and GHB provide a counterbalancing receptor-based mechanism for controlling alpha-cell secretory responses to metabolic fuels.	[Li, Changhong; Chen, Pan; Zhang, Tingting; Stokes, David; Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol, Dept Pediat, Philadelphia, PA 19104 USA; [Nissim, Itzhak; Nissim, Ilana; Daikhin, Yevgeny; Yudkoff, Marc] Childrens Hosp Philadelphia, Div Metab Dis, Dept Pediat, Philadelphia, PA 19104 USA; [Chen, Jie; Bennett, Michael J.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Liu, Chengyang; Naji, Ali] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nissim, Itzhak; Doliba, Nicolai; Matschinsky, Franz M.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Li, Changhong; Doliba, Nicolai; Stanley, Charles A.; Matschinsky, Franz M.; Naji, Ali] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Li, CH (corresponding author), Childrens Hosp Philadelphia, Div Endocrinol, 34th St & Civic Ctr Blvd, Philadelphia, PA 19104 USA.	li@email.chop.edu		STANLEY, CHARLES/0000-0003-4881-9392	National Institutes of Health [U01DK089529, DK53012, DK22122, DK53761, HD26979, U42-RR-016600, U01 DK070430]; NIDDK/Beckman Research Center (City of Hope) Integrated Islet Distribution Program [10028044]; American Diabetes Association [7-11-BS-34];  [DK19525]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK053761, P30DK019525, R37DK056268, U01DK070430, R37DK022122, R01DK053012, R01DK022122, U01DK089529, R01DK053761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK/Beckman Research Center (City of Hope) Integrated Islet Distribution Program; American Diabetes Association(American Diabetes Association); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants U01DK089529 (to C. L., co-principal investigator), DK53012 (to C. A. S.), DK22122 (to F. M. M.), DK53761 (to I. N.), HD26979 (to M. Y.), U42-RR-016600 and U01 DK070430 (to A. N.), 10028044 from the NIDDK/Beckman Research Center (City of Hope) Integrated Islet Distribution Program, and DK19525 (to the Radioimmunoassay and Islet Cores of the Diabetes Research Center of the University of Pennsylvania, Perelman School of Medicine). This work was also supported by American Diabetes Association Grant 7-11-BS-34 (to N. D.). This work was presented in part at the 2009 and the 2011 annual meetings of the American Diabetes Association.	Andriamampandry C, 2003, FASEB J, V17, P1691, DOI 10.1096/fj.02-0846fje; Andriamampandry C, 2007, FASEB J, V21, P885, DOI 10.1096/fj.06-6509com; BERTRAND G, 1993, EUR J PHARMACOL, V237, P45, DOI 10.1016/0014-2999(93)90091-U; BESSMAN SP, 1963, NATURE, V200, P1207, DOI 10.1038/2001207a0; BLOOMENTHAL AB, 1994, MOL PHARMACOL, V46, P1156; BRAATEN JT, 1974, J CLIN INVEST, V53, P1017, DOI 10.1172/JCI107638; Crunelli V, 2006, CURR OPIN PHARMACOL, V6, P44, DOI 10.1016/j.coph.2005.10.001; De Leon DD, 2008, J BIOL CHEM, V283, P25786, DOI 10.1074/jbc.M804372200; Deng S, 2003, DIABETOLOGIA, V46, P386, DOI 10.1007/s00125-003-1038-3; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Doliba NM, 2012, DIABETES OBES METAB, V14, P109, DOI 10.1111/j.1463-1326.2012.01652.x; Doliba NM, 2012, AM J PHYSIOL-ENDOC M, V302, pE87, DOI 10.1152/ajpendo.00218.2011; Feldmann N, 2011, MOL CELL ENDOCRINOL, V338, P46, DOI 10.1016/j.mce.2011.02.019; FELIG P, 1976, DIABETES, V25, P1091, DOI 10.2337/diabetes.25.12.1091; FISHER M, 1976, P NATL ACAD SCI USA, V73, P1735, DOI 10.1073/pnas.73.5.1735; Gannon MC, 2002, AM J CLIN NUTR, V76, P1302, DOI 10.1093/ajcn/76.6.1302; Gibson KM, 1998, NEUROPEDIATRICS, V29, P14, DOI 10.1055/s-2007-973527; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; JUNG MJ, 1977, J NEUROCHEM, V29, P797, DOI 10.1111/j.1471-4159.1977.tb10721.x; KAUFMAN EE, 1983, J NEUROCHEM, V40, P1639, DOI 10.1111/j.1471-4159.1983.tb08137.x; KAUFMAN EE, 1979, J NEUROCHEM, V32, P699, DOI 10.1111/j.1471-4159.1979.tb04552.x; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; Li CH, 2004, J BIOL CHEM, V279, P13393, DOI 10.1074/jbc.M311502200; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Li CH, 2008, J BIOL CHEM, V283, P17238, DOI 10.1074/jbc.M709235200; Li CH, 2006, J BIOL CHEM, V281, P15064, DOI 10.1074/jbc.M600994200; Li CH, 2010, J BIOL CHEM, V285, P31806, DOI 10.1074/jbc.M110.123638; MacDonald MJ, 2011, J BIOL CHEM, V286, P18383, DOI 10.1074/jbc.M111.241182; Macias AT, 2004, BIOORGAN MED CHEM, V12, P1643, DOI 10.1016/j.bmc.2004.01.025; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Mathivet P, 1997, EUR J PHARMACOL, V321, P67, DOI 10.1016/S0014-2999(96)00916-8; MATSCHINSKY FM, 1980, J CLIN INVEST, V65, P207, DOI 10.1172/JCI109652; MATSCHINSKY FM, 1976, J BIOL CHEM, V251, P6053; Matschinsky FM, 1994, ENDOCRINOLOGY, P1290; Mehrvar M, 2004, ANAL SCI, V20, P1113, DOI 10.2116/analsci.20.1113; Mercer JW, 2007, J FORENSIC SCI, V52, P383, DOI 10.1111/j.1556-4029.2007.00392.x; MULLER WA, 1975, J CLIN ENDOCR METAB, V40, P418, DOI 10.1210/jcem-40-3-418; Nevin ST, 2003, J BIOL CHEM, V278, P28985, DOI 10.1074/jbc.M300097200; Nicholson KL, 2001, DRUG ALCOHOL DEPEN, V63, P1, DOI 10.1016/S0376-8716(00)00191-5; PAGLIARA AS, 1975, J CLIN INVEST, V55, P244, DOI 10.1172/JCI107928; PAGLIARA AS, 1974, J CLIN INVEST, V54, P819, DOI 10.1172/JCI107822; Pearl PL, 2003, ANN NEUROL, V54, pS73, DOI 10.1002/ana.10629; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Richard D, 2005, ANAL CHEM, V77, P1354, DOI 10.1021/ac048471h; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; SCHMIDT C, 1991, EUR J PHARMACOL, V203, P393, DOI 10.1016/0014-2999(91)90896-X; SHERWIN R, 1976, METABOLISM, V25, P1381, DOI 10.1016/S0026-0495(76)80146-1; Slucca M, 2010, DIABETES, V59, P128, DOI 10.2337/db09-1098; SORENSON RL, 1991, DIABETES, V40, P1365, DOI 10.2337/diabetes.40.11.1365; Uehara S, 2004, DIABETES, V53, P998, DOI 10.2337/diabetes.53.4.998; UNGER RH, 1970, J CLIN INVEST, V49, P837, DOI 10.1172/JCI106297; UNGER RH, 1962, J CLIN INVEST, V41, P682, DOI 10.1172/JCI104525; Walker JN, 2011, DIABETES OBES METAB, V13, P95, DOI 10.1111/j.1463-1326.2011.01450.x; Wang C, 2006, AM J PHYSIOL-ENDOC M, V290, pE494, DOI 10.1152/ajpendo.00304.2005; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; Winnock F, 2002, AM J PHYSIOL-ENDOC M, V282, pE937, DOI 10.1152/ajpendo.00071.2001; YOUNG AB, 1973, P NATL ACAD SCI USA, V70, P2832, DOI 10.1073/pnas.70.10.2832; Zhou HR, 2007, DIABETES, V56, P1107, DOI 10.2337/db06-1454	63	72	73	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3938	3951		10.1074/jbc.M112.385682	http://dx.doi.org/10.1074/jbc.M112.385682			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23266825	Green Published, hybrid			2022-12-28	WOS:000314845000024
J	Li, SY; Du, MJ; Wan, YJ; Lan, B; Liu, YH; Yang, Y; Zhang, CZ; Cao, YJ				Li, Shi-Yang; Du, Ming-Juan; Wan, Ya-Juan; Lan, Bei; Liu, Yao-Hui; Yang, Yin; Zhang, Cui-Zhu; Cao, YouJia			The N-terminal 20-Amino Acid Region of Guanine Nucleotide Exchange Factor Vav1 Plays a Distinguished Role in T Cell Receptor-mediated Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECEPTOR; FAMILY PROTEINS; DEPENDENT TRANSCRIPTION; RHO-GTPASES; ACTIVATION; VISUALIZATION; LYMPHOCYTE; INHIBITION; CALMODULIN; REGULATORS	Vav1 is a guanine nucleotide exchange factor (GEF) specifically expressed in hematopoietic cells. It consists of multiple structural domains and plays important roles in T cell activation. The other highly conserved isoforms of Vav family, Vav2 and Vav3, are ubiquitously expressed in human tissues including lymphocytes. All three Vav proteins activate Rho family small GTPases, which are involved in a variety of biological processes during T cell activation. Intensive studies have demonstrated that Vav1 is indispensable for T cell receptor (TCR)-mediated signal transduction, whereas Vav2 and Vav3 function as GEFs that overlap with Vav1 on TCR-induced cytoskeleton reorganization. T cells lacking Vav1 exhibited severe defect in TCR-mediated calcium elevation, indicating that the co-existing Vav2 and Vav3 did not compensate Vav1 in calcium signaling. What is the functional particularity of Vav1 in lymphocytes? In this study, we identified the N-terminal 20 amino acids of Vav1 in the calponin homology (CH) domain to be essential for its interaction with calmodulin (CaM) that leads to TCR-induced calcium mobilization. Substitution of the 1-20 amino acids of Vav1 with those of Vav2 or Vav3 abolished the association with CaM, and the N-terminal mutations of Vav1 failed to potentiate normal TCR-induced calcium mobilization, that in turn, suspended nuclear factor of activated T cells (NFAT) activation and IL-2 production. This study highlights the importance of the N-terminal 20 aa of Vav1 for CaM binding, and provides new insights into the distinguished and irreplaceable role of Vav1 in T cell activation and signal transduction.	[Li, Shi-Yang; Du, Ming-Juan; Wan, Ya-Juan; Liu, Yao-Hui; Zhang, Cui-Zhu; Cao, YouJia] Nankai Univ, Minist Educ, Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China; [Lan, Bei; Yang, Yin; Zhang, Cui-Zhu; Cao, YouJia] Nankai Univ, State Key Lab, Med Chem Biol Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Cao, YJ (corresponding author), Mol Biol Inst Bldg,Rm 224,94 Weijin Rd, Tianjin 300071, Peoples R China.	caoyj@nankai.edu.cn			National Natural Science Foundation of China [81171556, 31270925]; Ministry of Science and Technology of China [2012CB917204]; Program of Introducing Talents of Discipline to Universities [B08011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by National Natural Science Foundation of China Grants 81171556 and 31270925 (to Y.C.), Ministry of Science and Technology of China Grant 2012CB917204 (to Y.C), and the Program of Introducing Talents of Discipline to Universities (B08011).	Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Billadeau DD, 2000, J EXP MED, V192, P381, DOI 10.1084/jem.192.3.381; Billadeau DD, 2000, J IMMUNOL, V164, P3971, DOI 10.4049/jimmunol.164.8.3971; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Charvet C, 2002, J BIOL CHEM, V277, P15376, DOI 10.1074/jbc.M111627200; Doody GM, 2000, EMBO J, V19, P6173, DOI 10.1093/emboj/19.22.6173; Dumont C, 2009, BLOOD, V113, P3990, DOI 10.1182/blood-2008-09-181180; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010; Groysman M, 2002, J BIOL CHEM, V277, P50121, DOI 10.1074/jbc.M204299200; Groysman M, 2000, FEBS LETT, V467, P75, DOI 10.1016/S0014-5793(00)01121-2; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kaminuma O, 2001, MOL CELL BIOL, V21, P3126, DOI 10.1128/MCB.21.9.3126-3136.2001; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Knyazhitsky M, 2012, J BIOL CHEM, V287, P19725, DOI 10.1074/jbc.M111.309799; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Miletic AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006599; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Saveliev A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000420; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Sylvain NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001178; Thalappilly S, 2010, ONCOGENE, V29, P2528, DOI 10.1038/onc.2010.1; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zakaria S, 2004, J EXP MED, V199, P429, DOI 10.1084/jem.20031228; Zhou Z, 2007, J BIOL CHEM, V282, P23737, DOI 10.1074/jbc.M702975200; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	39	12	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3777	3785		10.1074/jbc.M112.426221	http://dx.doi.org/10.1074/jbc.M112.426221			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23271736	Green Published, hybrid			2022-12-28	WOS:000314845000009
J	Miller, VJ; Sharma, P; Kudlyk, TA; Frost, L; Rofe, AP; Watson, IJ; Duden, R; Lowe, M; Lupashin, VV; Ungar, D				Miller, Victoria J.; Sharma, Prateek; Kudlyk, Tetyana A.; Frost, Laura; Rofe, Adam P.; Watson, Irene J.; Duden, Rainer; Lowe, Martin; Lupashin, Vladimir V.; Ungar, Daniel			Molecular Insights into Vesicle Tethering at the Golgi by the Conserved Oligomeric Golgi (COG) Complex and the Golgin TATA Element Modulatory Factor (TMF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROGRADE TRANSPORT; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; BINDING-SITES; SNARE COMPLEX; RAB GTPASES; PROTEIN; P115; GLYCOSYLATION; TRAFFICKING	Protein sorting between eukaryotic compartments requires vesicular transport, wherein tethering provides the first contact between vesicle and target membranes. Here we map and start to functionally analyze the interaction network of the conserved oligomeric Golgi (COG) complex that mediates retrograde tethering at the Golgi. The interactions of COG subunits with members of transport factor families assign the individual subunits as specific interaction hubs. Functional analysis of selected interactions suggests a mechanistic tethering model. We find that the COG complex interacts with two different Rabs in addition to each end of the golgin "TATA element modulatory factor" (TMF). This allows COG to potentially bridge the distance between the distal end of the golgin and the target membrane thereby promoting tighter docking. Concurrently we show that the central portion of TMF can bind to Golgi membranes that are liberated of their COPI cover. This latter interaction could serve to bring vesicle and target membranes into close apposition prior to fusion. A target selection mechanism, in which a hetero-oligomeric tethering factor organizes Rabs and coiled transport factors to enable protein sorting specificity, could be applicable to vesicle targeting throughout eukaryotic cells.	[Miller, Victoria J.; Sharma, Prateek; Rofe, Adam P.; Watson, Irene J.; Ungar, Daniel] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Kudlyk, Tetyana A.; Lupashin, Vladimir V.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Frost, Laura; Lowe, Martin] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Duden, Rainer] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biol, D-23562 Lubeck, Germany	University of York - UK; University of Arkansas System; University of Arkansas Medical Sciences; University of Manchester; University of Lubeck	Ungar, D (corresponding author), Univ York, Dept Biol, Wentworth Way, York YO10 5DD, N Yorkshire, England.	dani.ungar@york.ac.uk	Lupashin, Vladimir/AAB-4312-2020; Ungar, Daniel/A-5302-2012; Duden, Rainer/C-8917-2011; Duden, Rainer/GXH-3206-2022; Lupashin, Vladimir/E-3013-2013	Lupashin, Vladimir/0000-0002-2350-1962; Ungar, Daniel/0000-0002-9852-6160; Lupashin, Vladimir/0000-0002-2350-1962	National Institutes of Health [1R01GM083144]; BBSRC [BB/F006993/1/, 201098]; MRC Senior Fellowship [G117/494]; DFG grant (Excellence Cluster "Inflammation at Interfaces"); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083144] Funding Source: NIH RePORTER; BBSRC [BB/F006993/1] Funding Source: UKRI; MRC [G117/494] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1098652, BB/F006993/1] Funding Source: researchfish; Medical Research Council [G117/494] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC Senior Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DFG grant (Excellence Cluster "Inflammation at Interfaces")(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by a National Institutes of Health Grant 1R01GM083144, (to V.L.), BBSRC Grant BB/F006993/1/ and a Marie Curie Grant 201098 (to D.U.), a MRC Senior Fellowship to ML (G117/494), and a DFG grant (Excellence Cluster "Inflammation at Interfaces") (to R.D.).	Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Belloni G, 2012, J CELL SCI, V125, P5441, DOI 10.1242/jcs.108878; Chen TY, 2003, BIOCHEM BIOPH RES CO, V303, P1114, DOI 10.1016/S0006-291X(03)00482-0; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Emr S, 2009, J CELL BIOL, V187, P449, DOI 10.1083/jcb.200909011; Farkas RM, 2003, MOL BIOL CELL, V14, P190, DOI 10.1091/mbc.E02-06-0343; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Gillingham AK, 2002, MOL BIOL CELL, V13, P3761, DOI 10.1091/mbc.E02-06-0349; Glick BS, 1997, FEBS LETT, V414, P177, DOI 10.1016/S0014-5793(97)00984-8; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Hughson FM, 2010, CURR OPIN CELL BIOL, V22, P454, DOI 10.1016/j.ceb.2010.03.011; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; James P, 1996, GENETICS, V144, P1425; Kelly EE, 2012, BIOL CELL, V104, P84, DOI 10.1111/boc.201100080; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Laufman O, 2011, J CELL BIOL, V194, P459, DOI 10.1083/jcb.201102045; Laufman O, 2009, EMBO J, V28, P2006, DOI 10.1038/emboj.2009.168; Lees JA, 2010, NAT STRUCT MOL BIOL, V17, P1292, DOI 10.1038/nsmb.1917; Lerer-Goldshtein T, 2010, DEV BIOL, V348, P12, DOI 10.1016/j.ydbio.2010.07.033; LI GP, 1993, J BIOL CHEM, V268, P24475; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Miller VJ, 2012, TRAFFIC, V13, P891, DOI 10.1111/j.1600-0854.2012.01338.x; Munro S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005256; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Oka T, 2005, J BIOL CHEM, V280, P32736, DOI 10.1074/jbc.M505558200; Oka T, 2004, MOL BIOL CELL, V15, P2423, DOI 10.1091/mbc.E03-09-0699; Opdam FJM, 2000, J CELL SCI, V113, P2725; Peanne R, 2011, GLYCOBIOLOGY, V21, P864, DOI 10.1093/glycob/cwq176; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Pokrovskaya ID, 2011, GLYCOBIOLOGY, V21, P1554, DOI 10.1093/glycob/cwr028; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; Richardson BC, 2009, P NATL ACAD SCI USA, V106, P13329, DOI 10.1073/pnas.0901966106; Rosing M, 2007, EXP CELL RES, V313, P2318, DOI 10.1016/j.yexcr.2007.03.031; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; SARASTE J, 1995, J CELL SCI, V108, P1541; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Shestakova A, 2006, TRAFFIC, V7, P191, DOI 10.1111/j.1600-0854.2005.00376.x; Shestakova A, 2007, J CELL BIOL, V179, P1179, DOI 10.1083/jcb.200705145; SHIBUYA N, 1988, J BIOL CHEM, V263, P728; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; Sohda M, 2010, TRAFFIC, V11, P1552, DOI 10.1111/j.1600-0854.2010.01123.x; Suvorova ES, 2002, J CELL BIOL, V157, P631, DOI 10.1083/jcb.200111081; Ungar D, 2006, TRENDS CELL BIOL, V16, P113, DOI 10.1016/j.tcb.2005.12.004; Ungar D, 2005, J BIOL CHEM, V280, P32729, DOI 10.1074/jbc.M504590200; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; VANDERSLUIJS P, 1991, P NATL ACAD SCI USA, V88, P6313, DOI 10.1073/pnas.88.14.6313; Vasile E, 2006, EXP CELL RES, V312, P3132, DOI 10.1016/j.yexcr.2006.06.005; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Whyte JRC, 2002, J CELL SCI, V115, P2627; Whyte JRC, 2001, DEV CELL, V1, P527, DOI 10.1016/S1534-5807(01)00063-6; Willett R., 2012, NAT COMMUN IN PRESS; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041; Yamane J, 2007, EXP CELL RES, V313, P3472, DOI 10.1016/j.yexcr.2007.07.010; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327	67	53	55	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4229	4240		10.1074/jbc.M112.426767	http://dx.doi.org/10.1074/jbc.M112.426767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23239882	Green Published, hybrid			2022-12-28	WOS:000314845000052
J	Kim, YC; Li, XH; Thompson, D; DeMartino, GN				Kim, Young-Chan; Li, Xiaohua; Thompson, David; DeMartino, George N.			ATP Binding by Proteasomal ATPases Regulates Cellular Assembly and Substrate-induced Functions of the 26 S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; CORE PARTICLE; NUCLEOTIDE-BINDING; PROTEIN FAMILY; AAA SUBUNITS; C-TERMINI; DEGRADATION; ROLES; PA700; ACTIVATION	We examined the role of ATP binding by six different ATPase subunits (Rpt1-6) in the cellular assembly and molecular functions of mammalian 26 S proteasome. Four Rpt subunits (Rpt1-4) with ATP binding mutations were incompetent for cellular assembly into 26 S proteasome. In contrast, analogous mutants of Rpt5 and Rpt6 were incorporated normally into 26 S proteasomes in both intact cells and an in vitro assembly assay. Surprisingly, purified 26 S proteasomes containing either mutant Rpt5 or Rpt6 had normal basal ATPase activity and substrate gate opening for hydrolysis of short peptides. However, these mutant 26 S proteasomes were severely defective for ATP-dependent in vitro degradation of ubiquitylated and non-ubiquitylated proteins and did not display substrate-stimulated ATPase and peptidase activities characteristic of normal proteasomes. These results reveal differential roles of ATP binding by various Rpt subunits in proteasome assembly and function. They also indicate that substrate-stimulated ATPase activity and gating depend on the concerted action of a full complement of Rpt subunits competent for ATP binding and that this regulation is essential for normal proteolysis. Thus, protein substrates appear to promote their own degradation by stimulating proteasome functions involved in proteolysis.	[Kim, Young-Chan; Li, Xiaohua; Thompson, David; DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	george.demartino@utsouthwestern.edu			National Institutes of Health Grant from the NIDDK [R01 46181]; Welch Foundation Grant [I-500]	National Institutes of Health Grant from the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Welch Foundation Grant(The Welch Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 46181 from the NIDDK (to G. N. D.). This work was also supported by Welch Foundation Grant I-500 (to G. N. D.).	Bar-Nun S, 2012, BBA-MOL CELL RES, V1823, P67, DOI 10.1016/j.bbamcr.2011.07.009; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Besche HC, 2009, CELL, V138, P25, DOI 10.1016/j.cell.2009.06.035; Beyer A, 1997, PROTEIN SCI, V6, P2043; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Erales J, 2012, J BIOL CHEM, V287, P18535, DOI 10.1074/jbc.M112.357327; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; Hendil KB, 2009, J MOL BIOL, V394, P320, DOI 10.1016/j.jmb.2009.09.038; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kumar B, 2010, J BIOL CHEM, V285, P39523, DOI 10.1074/jbc.M110.153627; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Lee SH, 2012, J BIOL CHEM, V287, P9269, DOI 10.1074/jbc.M111.316208; Lee SYC, 2011, J BIOL CHEM, V286, P36641, DOI 10.1074/jbc.M111.280875; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li XH, 2009, BIOCHEM J, V421, P397, DOI 10.1042/BJ20090528; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; MA CP, 1994, J BIOL CHEM, V269, P3539; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Matveeva EA, 1997, J BIOL CHEM, V272, P26413, DOI 10.1074/jbc.272.42.26413; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; Park S, 2010, BIOCHEM SOC T, V38, P6, DOI 10.1042/BST0380006; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Sweeney TR, 2010, J BIOL CHEM, V285, P24347, DOI 10.1074/jbc.M110.129940; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	58	28	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3334	3345		10.1074/jbc.M112.424788	http://dx.doi.org/10.1074/jbc.M112.424788			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23212908	hybrid, Green Published			2022-12-28	WOS:000314397900039
J	Oner, SS; Maher, EM; Gabay, M; Tall, GG; Blumer, JB; Lanier, SM				Oner, Sukru Sadik; Maher, Ellen M.; Gabay, Meital; Tall, Gregory G.; Blumer, Joe B.; Lanier, Stephen M.			Regulation of the G-protein Regulatory-G alpha(i) Signaling Complex by Nonreceptor Guanine Nucleotide Exchange Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; G-ALPHA-I; RECEPTOR-INDEPENDENT ACTIVATORS; RESONANCE ENERGY-TRANSFER; ASYMMETRIC CELL-DIVISION; HEROIN-SEEKING BEHAVIOR; RAS-RELATED PROTEIN; G-BETA-GAMMA; MITOTIC SPINDLE; C-ELEGANS	Group II activators of G-protein signaling (AGS) serve as binding partners for G alpha(i/o/t) via one or more G-protein regulatory (GPR) motifs. GPR-G alpha signaling modules may be differentially regulated by cell surface receptors or by different nonreceptor guanine nucleotide exchange factors. We determined the effect of the nonreceptor guanine nucleotide exchange factors AGS1, GIV/Girdin, and Ric-8A on the interaction of two distinct GPR proteins, AGS3 and AGS4, with G alpha(il) in the intact cell by bioluminescence resonance energy transfer (BRET) in human embryonic kidney 293 cells. AGS3-Rluc-G alpha(i1)-YFP and AGS4-Rluc-G alpha(i1)-YFP BRET were regulated by Ric-8A but not by G alpha-interacting vesicle-associated protein (GIV) or AGS1. The Ric-8A regulation was biphasic and dependent upon the amount of Ric-8A and G alpha(i1)-YFP. The inhibitory regulation of GPR-G alpha(i1) BRET by Ric-8A was blocked by pertussis toxin. The enhancement of GPR-G alpha(i1) BRET observed with Ric-8A was further augmented by pertussis toxin treatment. The regulation of GPR-G alpha(i) interaction by Ric-8A was not altered by RGS4. AGS3-Rluc-G alpha(i1)-YFP and AGS4-Rluc-G-G alpha(i1)-YFP BRET were observed in both pellet and supernatant subcellular fractions and were regulated by Ric-8A in both fractions. The regulation of the GPR-G alpha(i1) complex by Ric-8A, as well as the ability of Ric-8A to restore G alpha expression in Ric8A(-/-) mouse embryonic stem cells, involved two helical domains at the carboxyl terminus of Ric-8A. These data indicate a dynamic interaction between GPR proteins, G alpha(i1) and Ric-8A, in the cell that influences subcellular localization of the three proteins and regulates complex formation.	[Oner, Sukru Sadik; Maher, Ellen M.; Blumer, Joe B.; Lanier, Stephen M.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Gabay, Meital; Tall, Gregory G.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Medical University of South Carolina; University of Rochester	Blumer, JB (corresponding author), Med Univ S Carolina, 173 Ashley Ave, Charleston, SC 29425 USA.	blumerjb@musc.edu; lanier@musc.edu	Oner, Sukru/K-8032-2012	Oner, Sukru/0000-0002-8864-7356; Blumer, Joe/0000-0002-0020-3815; Lanier, Stephen/0000-0002-2740-7607	National Institutes of Health [DA025896, GM086510, GM088242]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086510, R01GM088242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA025896 (to S. M. L.), GM086510 (to J. B. B.), and GM088242 (to G. G. T.).	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; An NF, 2008, J BIOL CHEM, V283, P24718, DOI 10.1074/jbc.M803497200; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Blumer JB, 2012, ACTA PHYSIOL, V204, P202, DOI 10.1111/j.1748-1716.2011.02327.x; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; CASEY PJ, 1989, BIOCHEMISTRY-US, V28, P611, DOI 10.1021/bi00428a029; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Chauhan S, 2012, BIOCHEM J, V446, P445, DOI 10.1042/BJ20111882; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Couwenbergs C, 2004, CURR BIOL, V14, P1871, DOI 10.1016/j.cub.2004.09.059; Dalgin GS, 2007, CANCER INFORM, V3, P65; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Doherty D, 2012, AM J HUM GENET, V90, P1088, DOI 10.1016/j.ajhg.2012.04.008; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Figueroa M, 2009, PROTEIN SCI, V18, P1139, DOI 10.1002/pro.124; Gabay M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002223; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Graham TE, 2002, J BIOL CHEM, V277, P10876, DOI 10.1074/jbc.M110397200; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Groves B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008877; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Hiskens R, 2005, BIOCHEM BIOPH RES CO, V337, P1038, DOI 10.1016/j.bbrc.2005.09.149; Hofler C, 2011, J NEUROSCI, V31, P11553, DOI 10.1523/JNEUROSCI.2072-11.2011; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Kopein D, 2009, MOL BIOL CELL, V20, P3865, DOI 10.1091/mbc.E09-01-0021; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Nadella R, 2010, J AM SOC NEPHROL, V21, P1275, DOI 10.1681/ASN.2009121224; Nguyen CH, 2005, BIOCHEM BIOPH RES CO, V332, P913, DOI 10.1016/j.bbrc.2005.05.041; Nojima M, 2009, CLIN CANCER RES, V15, P4356, DOI 10.1158/1078-0432.CCR-08-3336; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Regner KR, 2011, FASEB J, V25, P1844, DOI 10.1096/fj.10-169797; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Shaw EJ, 2011, CELL ONCOL, V34, P355, DOI 10.1007/s13402-011-0036-6; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Thomas CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023197; Vaidyanathan G, 2004, ONCOGENE, V23, P5858, DOI 10.1038/sj.onc.1207774; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Vellano CP, 2011, BIOCHEMISTRY-US, V50, P752, DOI 10.1021/bi101910n; Vural A, 2010, MOL CELL BIOL, V30, P1528, DOI 10.1128/MCB.01018-09; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Yao LN, 2006, P NATL ACAD SCI USA, V103, P7877, DOI 10.1073/pnas.0602661103; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	80	23	24	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3003	3015		10.1074/jbc.M112.418467	http://dx.doi.org/10.1074/jbc.M112.418467			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23212907	Green Published, hybrid			2022-12-28	WOS:000314397900011
J	Khair, M; Bourhim, M; Barre, L; Li, D; Netter, P; Magdalou, J; Fournel-Gigleux, S; Ouzzine, M				Khair, Mostafa; Bourhim, Mustapha; Barre, Lydia; Li, Dong; Netter, Patrick; Magdalou, Jacques; Fournel-Gigleux, Sylvie; Ouzzine, Mohamed			Regulation of Xylosyltransferase I Gene Expression by Interleukin 1 beta in Human Primary Chondrocyte Cells MECHANISM AND IMPACT ON PROTEOGLYCAN SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; TRANSCRIPTION FACTORS; OSTEOARTHRITIC CARTILAGE; ARTICULAR CHONDROCYTES; CHONDROITIN SULFATE; GROWTH-FACTOR; P38 MAPK; C-FOS; AP-1; SP1	Xylosyltransferase I (XT-I) is an essential enzyme of proteoglycan (PG) biosynthesis pathway catalyzing the initial and rate-limiting step in glycosaminoglycan chain assembly. It plays a critical role in the regulation of PG synthesis in cartilage; however, little is known about underlying mechanism. Here, we provide evidence that, in human primary chondrocytes, IL-1 beta regulates XT-I gene expression into an early phase of induction and a late phase of down-regulation. Based on promoter deletions, the region up to -850 bp was defined as a major element of XT-I gene displaying both constitutive and IL-1 beta-regulated promoter activity. Point mutation and signaling analyses revealed that IL-1 beta-induced promoter activity is achieved through AP-1 response elements and mediated by SAP/JNK and p38 signaling pathways. Transactivation and chromatin immunoprecipitation assays indicated that AP-1 is a potent transactivator of XT-I promoter and that IL-1 beta-induced activity is mediated through increased recruitment of AP-1 to the promoter. Finally, we show that Sp3 is a repressor of XT-I promoter and bring evidence that the repressive effect of IL-1 beta during the late phase is mediated through Sp3 recruitment to the promoter. This suggests that modulation of Sp3 in cartilage could prevent IL-1 beta inhibition of PG synthesis and limit tissue degradation.	[Khair, Mostafa; Bourhim, Mustapha; Barre, Lydia; Li, Dong; Netter, Patrick; Magdalou, Jacques; Fournel-Gigleux, Sylvie; Ouzzine, Mohamed] Univ Lorraine, Fac Med, CNRS, UMR 7561, F-54505 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Ouzzine, M (corresponding author), Univ Lorraine, Fac Med, CNRS, UMR 7561, 9 Ave Foret de Haye, F-54505 Vandoeuvre Les Nancy, France.	ouzzine@medecine.uhp-nancy.fr	Ouzzine, Mohamed/G-4368-2013	OUZZINE, Mohamed/0000-0003-0058-4950	Agence Nationale de la Recherche [ANR-BLAN-0163-01]; Fondation pour la Recherche Medicale [DVO20081013491]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Agence Nationale de la Recherche (ANR-BLAN-0163-01, GlycoCart) and by the Fondation pour la Recherche Medicale (DVO20081013491, Vieillissement Osteoarticulaire).	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Ariga T, 2010, J NEUROSCI RES, V88, P2303, DOI 10.1002/jnr.22393; Baasanjav S, 2011, AM J HUM GENET, V89, P15, DOI 10.1016/j.ajhg.2011.05.021; Bontemps Y, 2003, J BIOL CHEM, V278, P21566, DOI 10.1074/jbc.M209366200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bui C, 2010, FASEB J, V24, P436, DOI 10.1096/fj.09-136291; Chadjichristos C, 2003, J BIOL CHEM, V278, P39762, DOI 10.1074/jbc.M303541200; Chowdhury TT, 2008, INFLAMM RES, V57, P306, DOI 10.1007/s00011-007-7126-y; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; DEVRIES BJ, 1986, RHEUMATOL INT, V6, P273, DOI 10.1007/BF00541319; Duncan G, 2001, J CLIN INVEST, V108, P511, DOI 10.1172/JCI200113737; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Gao SY, 2009, J BIOL CHEM, V284, P7995, DOI 10.1074/jbc.M809734200; Gotting C, 2007, CELL MOL LIFE SCI, V64, P1498, DOI 10.1007/s00018-007-7069-z; Gouze JN, 2001, ARTHRITIS RHEUM, V44, P351, DOI 10.1002/1529-0131(200102)44:2<351::AID-ANR53>3.3.CO;2-D; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hwang HY, 2003, J BIOL CHEM, V278, P11735, DOI 10.1074/jbc.C200518200; Ijiri K, 2008, ARTHRITIS RHEUM-US, V58, P2075, DOI 10.1002/art.23504; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; LAFEBER FPG, 1992, J RHEUMATOL, V19, P123; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Muller B, 2009, J BIOL CHEM, V284, P30775, DOI 10.1074/jbc.M109.016592; Noti JD, 1996, MOL CELL BIOL, V16, P2940; Princivalle M, 2002, INT J DEV BIOL, V46, P267; Rostand KS, 1997, INFECT IMMUN, V65, P1; Schmucker AC, 2012, J BIOL CHEM, V287, P1189, DOI 10.1074/jbc.M111.264077; Schwartz NB, 2002, GLYCOBIOLOGY, V12, p57R, DOI 10.1093/glycob/12.4.57R; SCHWARTZ NB, 1977, UPSALA J MED SCI, V82, P76, DOI 10.3109/03009737709179068; Seo NS, 2005, J BIOL CHEM, V280, P42774, DOI 10.1074/jbc.M511531200; Shriver Z, 2002, TRENDS CARDIOVAS MED, V12, P71, DOI 10.1016/S1050-1738(01)00150-5; Singh DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037012; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; THOMPSON RC, 1979, J BONE JOINT SURG AM, V61, P407, DOI 10.2106/00004623-197961030-00017; Valhmu WB, 1998, J BIOL CHEM, V273, P6196, DOI 10.1074/jbc.273.11.6196; Venkatesan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034020; Venkatesan N, 2009, FASEB J, V23, P813, DOI 10.1096/fj.08-118166; Wuyts W, 1998, AM J HUM GENET, V62, P346, DOI 10.1086/301726	41	20	21	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1774	1784		10.1074/jbc.M112.419887	http://dx.doi.org/10.1074/jbc.M112.419887			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23223231	hybrid, Green Published			2022-12-28	WOS:000313751400033
J	Raduwan, H; Isola, AL; Belden, WJ				Raduwan, Hamidah; Isola, Allison L.; Belden, William J.			Methylation of Histone H3 on Lysine 4 by the Lysine Methyltransferase SET1 Protein Is Needed for Normal Clock Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROSPORA CIRCADIAN CLOCK; DROSOPHILA-PERIOD; INDUCED TRANSCRIPTION; FEEDBACK LOOP; NEGATIVE LIMB; FREQUENCY; BINDING; PHOSPHORYLATION; DEGRADATION; RECRUITMENT	The circadian oscillator controls time-of-day gene expression by a network of interconnected feedback loops and is reset by light. The requisite for chromatin regulation in eukaryotic transcription necessitates temporal regulation of histone-modifying and chromatin-remodeling enzymes for proper clock function. CHD1is known to bindH3K4me3in mammalian cells, and Neurospora CHD1 is required for proper regulation of the frequency (frq) gene. Based on this, we examined a strain lacking SET1 to determine the role of H3K4 methylation in clock-and lightmediated frq regulation. Expression of frq was altered in strains lacking set1 under both circadian- and light-regulated gene expression. There is a delay in the phasing of H3K4me3 relative to the peak in frq expression. White Collar 2 (WC-2) association with the frq promoter persists longer in Delta set1, suggesting a more permissible chromatin state. Surprisingly, SET1 is required for DNA methylation in the frq promoter, indicating a dependence on H3K4me for DNA methylation. The data support a model where SET1 is needed for proper regulation by modulating chromatin at frq.	[Raduwan, Hamidah; Isola, Allison L.; Belden, William J.] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Belden, WJ (corresponding author), Rutgers State Univ, Dept Biochem & Microbiol, 76 Lipman Dr, New Brunswick, NJ 08901 USA.	belden@aesop.rutgers.edu		Isola, Allison/0000-0003-3633-9084; Raduwan, Hamidah/0000-0002-4939-7809	National Institutes of Health [P01GM068087, R01GM101378]; School of Environmental and Biological Science at Rutgers University; Charles and Joanna Busch Memorial Fund; James D. Macmillan Graduate Student Fellowship; NIEHS Center for Environmental Exposure and Disease (CEED) [P30ES005022]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087, R01GM101378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); School of Environmental and Biological Science at Rutgers University; Charles and Joanna Busch Memorial Fund; James D. Macmillan Graduate Student Fellowship; NIEHS Center for Environmental Exposure and Disease (CEED); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM101378 (to W.J.B.). This work was also supported by the School of Environmental and Biological Science at Rutgers University and the Charles and Joanna Busch Memorial Fund.; Supported by a James D. Macmillan Graduate Student Fellowship.; W.J.B. is a member of NIEHS Center for Environmental Exposure and Disease (CEED) (Grant P30ES005022).; We thank Dr. Peter Kahn and Dr. Tom Kusch for helpful comments on this manuscript and Dr. Luis Larrondo for luciferase stains and assistance with the data analysis. We are grateful to Dr. Kevin McCluskey at the Fungal Genetics Stock Center who provided deletion strains generated by the Neurospora Knock-out Consortium (supported by National Institutes of Health Grant P01GM068087).	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Belden WJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002166; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dubruille R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000787; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Flanagan JF, 2007, J MOL BIOL, V369, P334, DOI 10.1016/j.jmb.2007.03.024; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; Guillaumond F, 2011, FASEB J, V25, P2740, DOI 10.1096/fj.10-178616; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Jones MA, 2010, P NATL ACAD SCI USA, V107, P21623, DOI 10.1073/pnas.1014204108; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; LOROS JJ, 1986, GENETICS, V114, P1095; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Stratmann M, 2012, MOL CELL, V48, P277, DOI 10.1016/j.molcel.2012.08.012; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	83	32	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8380	8390		10.1074/jbc.M112.359935	http://dx.doi.org/10.1074/jbc.M112.359935			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23319591	Green Published, hybrid			2022-12-28	WOS:000316564500037
J	Su, PH; Chen, CC; Chang, YF; Wong, ZR; Chang, KW; Huang, BM; Yang, HY				Su, Peng-Han; Chen, Chih-Cheng; Chang, Ya-Fan; Wong, Zong-Ruei; Chang, Kai-Wei; Huang, Bu-Miin; Yang, Hsi-Yuan			Identification and Cytoprotective Function of a Novel Nestin Isoform, Nes-S, in Dorsal Root Ganglia Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT-ASSOCIATED PROTEIN; EPIDERMAL-GROWTH-FACTOR; INTERMEDIATE-FILAMENTS; REACTIVE ASTROCYTES; SYNEMIN ISOFORMS; SPLICE VARIANTS; SENSORY NEURONS; RADIAL GLIA; STEM-CELLS; EXPRESSION	In this study, the first nestin isoform, Nes-S, was identified in neurons of dorsal root ganglia (DRG) of adult rats. Nes-S cannot form filaments by itself in cytoplasmic intermediate filamentfree SW13 cells. Instead, it co-assembles into filaments with vimentin when transfected into vimentin(+) SW13 cells, and with peripherin and neurofilament proteins when transfected into N2a cells. In primary DRG neurons, endogenous Nes-S co-assembles with peripherin and neurofilament proteins. The expression of Nes-S first appears in DRG at postnatal day 5 and persists to adulthood. Among the adult tissues we examined, the expression of Nes-S is restricted to the sensory and motor neurons. Finally, exogenous Nes-S enhances viability when transfected into N2a cells, and knockdown of endogenous Nes-S impairs the survival of DRG neurons in primary cultures. Taken together, Nes-S is a new neuronal intermediate filament protein that exerts a cytoprotective function in mature sensory and motor neurons.	[Su, Peng-Han; Chang, Ya-Fan; Wong, Zong-Ruei; Chang, Kai-Wei; Yang, Hsi-Yuan] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10617, Taiwan; [Chen, Chih-Cheng] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Huang, Bu-Miin] Natl Cheng Kung Univ, Dept Cell Biol & Anat, Tainan 701, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Cheng Kung University	Yang, HY (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	hyhy@ntu.edu.tw	Chen, Chih-Cheng/AAT-1062-2021; Chen, Chih-Cheng/S-7015-2018	Chen, Chih-Cheng/0000-0003-4768-5660; Chen, Chih-Cheng/0000-0003-4768-5660	National Science Council, Executive Yuan, Taiwan [NSC98-2320-B-002-034-MY2]	National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by the National Science Council, Executive Yuan, Taiwan, through Grants NSC98-2320-B-002-034-MY2 (to H.-Y.Y.).	Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; DAHLSTRAND J, 1992, J CELL SCI, V103, P589; De Girolamo LA, 2000, J NEUROCHEM, V75, P133, DOI 10.1046/j.1471-4159.2000.0750133.x; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Ernsberger U, 2009, CELL TISSUE RES, V336, P349, DOI 10.1007/s00441-009-0784-z; FERRI GL, 1990, BRAIN RES, V515, P331, DOI 10.1016/0006-8993(90)90618-L; FRIEDMAN B, 1990, J COMP NEUROL, V295, P43, DOI 10.1002/cne.902950105; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Goldman R. D., 1990, CELLULAR MOL BIOL IN, P3; Goldman RD, 2012, J STRUCT BIOL, V177, P14, DOI 10.1016/j.jsb.2011.11.017; GRANGER BL, 1980, CELL, V22, P727, DOI 10.1016/0092-8674(80)90549-8; Guerette D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-164; HEDBERG KK, 1986, EXP CELL RES, V163, P509, DOI 10.1016/0014-4827(86)90081-9; Hendrickson ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018535; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; HERRMANN H, 1987, J BIOL CHEM, V262, P1320; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Huang YL, 2009, J BIOCHEM, V146, P307, DOI 10.1093/jb/mvp070; Huang YL, 2009, CELL SIGNAL, V21, P954, DOI 10.1016/j.cellsig.2009.02.005; Huang YL, 2008, BIOCHEM BIOPH RES CO, V377, P361, DOI 10.1016/j.bbrc.2008.09.143; Hyder CL, 2011, J CELL SCI, V124, P1363, DOI 10.1242/jcs.041244; Izmiryan A, 2006, GLIA, V54, P204, DOI 10.1002/glia.20378; Izmiryan A, 2009, EXP CELL RES, V315, P769, DOI 10.1016/j.yexcr.2008.12.009; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; JOHNSON EM, 1986, TRENDS NEUROSCI, V9, P33, DOI 10.1016/0166-2236(86)90012-3; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Langbein L, 2010, J BIOL CHEM, V285, P36909, DOI 10.1074/jbc.M110.161745; Lee CY, 2003, NEUROL RES, V25, P767, DOI 10.1179/016164103101202156; Lee JH, 2007, J CELL SCI, V120, P2259, DOI 10.1242/jcs.03468; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; Leung CL, 2001, J CELL SCI, V114, P3409; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Liu W, 2012, J CELL BIOCHEM, V113, P3186, DOI 10.1002/jcb.24195; Lopes JP, 2009, CELL CYCLE, V8, P97, DOI 10.4161/cc.8.1.7506; Marvin NJ, 1998, J CELL SCI, V111, P1951; McLean J, 2008, J NEUROCHEM, V104, P1663, DOI 10.1111/j.1471-4159.2007.05198.x; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Mohseni P, 2011, J NEUROSCI, V31, P11547, DOI 10.1523/JNEUROSCI.4396-10.2011; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Oikawa H, 2010, EXP CELL RES, V316, P940, DOI 10.1016/j.yexcr.2009.10.025; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pallari HM, 2011, MOL BIOL CELL, V22, P1539, DOI 10.1091/mbc.E10-07-0568; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Park KY, 2000, J MED GENET, V37, P851, DOI 10.1136/jmg.37.11.851; Parry DAD, 2005, ADV PROTEIN CHEM, V70, P113, DOI 10.1016/S0065-3233(04)70005-4; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; PEARSON J, 1983, DEV BIOL, V96, P32, DOI 10.1016/0012-1606(83)90308-1; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Saito T, 2007, J NEUROCHEM, V102, P133, DOI 10.1111/j.1471-4159.2007.04540.x; SARRIA AJ, 1990, J CELL BIOL, V111, P553, DOI 10.1083/jcb.111.2.553; Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881; Su PH, 2011, J ANAT, V218, P311, DOI 10.1111/j.1469-7580.2010.01331.x; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Tong JX, 1996, EXP NEUROL, V138, P45, DOI 10.1006/exnr.1996.0045; Vogelbaum MA, 1998, J NEUROSCI, V18, P8928; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Xiao S, 2008, J NEUROSCI, V28, P1833, DOI 10.1523/JNEUROSCI.3222-07.2008; Xue ZG, 2004, EXP CELL RES, V298, P431, DOI 10.1016/j.yexcr.2004.04.023; YANG HY, 1992, CELL MOTIL CYTOSKEL, V22, P185, DOI 10.1002/cm.970220306; YANG HY, 1985, J CELL BIOL, V100, P620, DOI 10.1083/jcb.100.2.620; Yang HY, 1997, EXP NEUROL, V146, P199, DOI 10.1006/exnr.1997.6518; YANG HY, 1993, J NEUROCYTOL, V22, P558, DOI 10.1007/BF01189043; Yang JF, 2011, NAT NEUROSCI, V14, P324, DOI 10.1038/nn.2747; Yuan Y, 1997, MOL CELL NEUROSCI, V10, P71, DOI 10.1006/mcne.1997.0627; Zhou ZL, 2010, MOL BIOL REP, V37, P2407, DOI 10.1007/s11033-009-9751-8; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	76	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8391	8404		10.1074/jbc.M112.408179	http://dx.doi.org/10.1074/jbc.M112.408179			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23319587	hybrid, Green Published			2022-12-28	WOS:000316564500038
J	Gargi, A; Tamilselvam, B; Powers, B; Prouty, MG; Lincecum, T; Eshraghi, A; Maldonado-Arocho, FJ; Wilson, BA; Bradley, KA; Blanke, SR				Gargi, Amandeep; Tamilselvam, Batcha; Powers, Brendan; Prouty, Michael G.; Lincecum, Tommie; Eshraghi, Aria; Maldonado-Arocho, Francisco J.; Wilson, Brenda A.; Bradley, Kenneth A.; Blanke, Steven R.			Cellular Interactions of the Cytolethal Distending Toxins from Escherichia coli and Haemophilus ducreyi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMPYLOBACTER-JEJUNI; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACTERIAL TOXIN; CHOLERA-TOXIN; CYCLE ARREST; CELLS; CDTB; ENDOSOMES; CLDT; COMPONENT	The cytolethal distending toxins (CDTs) compose a subclass of intracellularly acting genotoxins produced by many Gram-negative pathogenic bacteria that disrupt the normal progression of the eukaryotic cell cycle. Here, the intoxication mechanisms of CDTs from Escherichia coli (Ec-CDT) and Haemophilus ducreyi (Hd-CDT), which share limited amino acid sequence homology, were directly compared. Ec-CDT and Hd-CDT shared comparable in vitro DNase activities of the CdtB subunits, saturable cell surface binding with comparable affinities, and the requirement for an intact Golgi complex to induce cell cycle arrest. In contrast, disruption of endosome acidification blocked Hd-CDT-mediated cell cycle arrest and toxin transport to the endoplasmic reticulum and nucleus, while having no effects on Ec-CDT. Phosphorylation of the histone protein H2AX, as well as nuclear localization, was inhibited for Hd-CdtB, but not Ec-CdtB, in cells expressing dominant negative Rab7 (T22N), suggesting that Hd-CDT, but not Ec-CDT, is trafficked through late endosomal vesicles. In support of this idea, significantly more Hd-CdtB than Ec-CdtB co-localized with Rab9, which is enriched in late endosomal compartments. Competitive binding studies suggested that Ec-CDT and Hd-CDT bind to discrete cell surface determinants. These results suggest that Ec-CDT and Hd-CDT are transported within cells by distinct pathways, possibly mediated by their interaction with different receptors at the cell surface.	[Gargi, Amandeep; Tamilselvam, Batcha; Powers, Brendan; Prouty, Michael G.; Wilson, Brenda A.; Blanke, Steven R.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Wilson, Brenda A.; Blanke, Steven R.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Lincecum, Tommie] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Eshraghi, Aria; Maldonado-Arocho, Francisco J.; Bradley, Kenneth A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Houston System; University of Houston; University of California System; University of California Los Angeles	Blanke, SR (corresponding author), B103 CLSL,601 South Goodwin Ave, Urbana, IL 61801 USA.	sblanke@illinois.edu	Tamilselvam, Batcha/A-8212-2010	Tamilselvam, Batcha/0000-0001-9241-3846	National Institutes of Health [R01GM098756, AI0059095, AI038396, T32DE007296, F31DE022485]; James R. Beck graduate research fellowship; Francis and Harlie Clark graduate student research award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038396, R29AI038396, R21AI059095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE022485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James R. Beck graduate research fellowship; Francis and Harlie Clark graduate student research award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM098756 (to K. A. B.), AI0059095 (to S. R. B.), AI038396 (to B. A. W.), and T32DE007296 and F31DE022485 (to A. E.). This work was also supported by a James R. Beck graduate research fellowship and a Francis and Harlie Clark graduate student research award (to A. G.).	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Aragon V, 1997, INFECT IMMUN, V65, P3774, DOI 10.1128/IAI.65.9.3774-3780.1997; BAG PK, 1993, FEMS MICROBIOL LETT, V114, P285, DOI 10.1111/j.1574-6968.1993.tb06587.x; BLANKE SR, 2006, MICROBE, V1, P26; BOUZARI S, 1990, FEMS MICROBIOL LETT, V71, P193; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Cao L, 2005, MOL MICROBIOL, V58, P1303, DOI 10.1111/j.1365-2958.2005.04905.x; Cao L, 2008, INFECT IMMUN, V76, P2812, DOI 10.1128/IAI.00126-08; Cao LS, 2006, INFECT IMMUN, V74, P4990, DOI 10.1128/IAI.00697-06; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Cope LD, 1997, P NATL ACAD SCI USA, V94, P4056, DOI 10.1073/pnas.94.8.4056; Cortes-Bratti X, 1999, J CLIN INVEST, V103, P107, DOI 10.1172/JCI3831; Cortes-Bratti X, 2000, INFECT IMMUN, V68, P6903, DOI 10.1128/IAI.68.12.6903-6911.2000; Damek-Poprawa M, 2012, INFECT IMMUN, V80, P2761, DOI 10.1128/IAI.00385-12; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; DIXON WJ, 1950, ANN MATH STAT, V21, P488, DOI 10.1214/aoms/1177729747; Elwell C, 2001, INFECT IMMUN, V69, P3418, DOI 10.1128/IAI.69.5.3418-3422.2001; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Eshraghi A, 2010, J BIOL CHEM, V285, P18199, DOI 10.1074/jbc.M110.112912; Frisan T, 2003, CELL MICROBIOL, V5, P695, DOI 10.1046/j.1462-5822.2003.00311.x; Frisk A, 2001, MICROB PATHOGENESIS, V30, P313, DOI 10.1006/mpat.2000.0436; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Gargi A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00124; Ge ZM, 2008, CELL MICROBIOL, V10, P1599, DOI 10.1111/j.1462-5822.2008.01173.x; Gelfanova V, 1999, INFECT IMMUN, V67, P6394; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Guerra L, 2009, BBA-MOL CELL RES, V1793, P489, DOI 10.1016/j.bbamcr.2008.11.017; Hassane DC, 2003, INFECT IMMUN, V71, P541, DOI 10.1128/IAI.71.1.541-545.2003; Hu X, 2006, PROTEINS, V62, P421, DOI 10.1002/prot.20767; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P115, DOI 10.1016/0882-4010(88)90053-8; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P103, DOI 10.1016/0882-4010(88)90052-6; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lee RB, 2003, INFECT IMMUN, V71, P4883, DOI 10.1128/IAI.71.9.4883-4890.2003; LENCER WI, 1995, AM J PHYSIOL-GASTR L, V269, pG548, DOI 10.1152/ajpgi.1995.269.4.G548; Li LQ, 2002, CELL MICROBIOL, V4, P87, DOI 10.1046/j.1462-5822.2002.00174.x; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Mayer MPA, 1999, INFECT IMMUN, V67, P1227, DOI 10.1128/IAI.67.3.1227-1237.1999; McSweeney LA, 2005, INFECT IMMUN, V73, P2051, DOI 10.1128/IAI.73.4.2051-2060.2005; McSweeney LA, 2004, CELL MICROBIOL, V6, P447, DOI 10.1111/j.1462-5822.2004.00373.x; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Mise K, 2005, INFECT IMMUN, V73, P4846, DOI 10.1128/IAI.73.8.4846-4852.2005; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; MONTECUCCO C, 1994, FEBS LETT, V346, P92, DOI 10.1016/0014-5793(94)00449-8; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nesic D, 2005, PLOS PATHOG, V1, P214, DOI 10.1371/journal.ppat.0010028; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishikubo S, 2003, J BIOL CHEM, V278, P50671, DOI 10.1074/jbc.M305062200; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Ohara M, 2004, J BIOCHEM, V136, P409, DOI 10.1093/jb/mvh154; OKUDA J, 1995, MICROB PATHOGENESIS, V18, P167, DOI 10.1016/S0882-4010(95)90022-5; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; SIMPSON JC, 1995, J BIOL CHEM, V270, P20078, DOI 10.1074/jbc.270.34.20078; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Sun-Wada GH, 2003, CELL STRUCT FUNCT, V28, P455, DOI 10.1247/csf.28.455; Thelestam M, 2005, REV PHYSIOL BIOCH P, V152, P111, DOI 10.1007/s10254-004-0030-8; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wising C, 2010, APMIS, V118, P143, DOI 10.1111/j.1600-0463.2009.02573.x	67	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7492	7505		10.1074/jbc.M112.448118	http://dx.doi.org/10.1074/jbc.M112.448118			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23306199	Green Published, hybrid			2022-12-28	WOS:000316455300006
J	Ogata, M; Umemoto, N; Ohnuma, T; Numata, T; Suzuki, A; Usui, T; Fukamizo, T				Ogata, Makoto; Umemoto, Naoyuki; Ohnuma, Takayuki; Numata, Tomoyuki; Suzuki, Akari; Usui, Taichi; Fukamizo, Tamo			A Novel Transition-state Analogue for Lysozyme, 4-O-beta-Tri-N-acetylchitotriosyl Moranoline, Provided Evidence Supporting the Covalent Glycosyl-enzyme Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG-WHITE LYSOZYME; FREE-ENERGY CHANGE; SUBSTRATE-BINDING; CATALYSIS; 1-DEOXYNOJIRIMYCIN; HYDROLYSIS; REFINEMENT; INHIBITORS; OLIGOSACCHARIDES; TRANSGLYCOSYLASE	4-O-beta-Di-N-acetylchitobiosyl moranoline (2) and 4-O-beta-tri-N-acetylchitotriosyl moranoline (3) were produced by lysozyme-mediated transglycosylation from the substrates tetra-N-acetylchitotetraose, (GlcNAc)(4), and moranoline, and the binding modes of 2 and 3 to hen egg white lysozyme (HEWL) was examined by inhibition kinetics, isothermal titration calorimetry (ITC), and x-ray crystallography. Compounds 2 and 3 specifically bound to HEWL, acting as competitive inhibitors with K-i values of 2.01 x 10(-5) and 1.84 x 10(-6) M, respectively. From IT Canalysis, the binding of 3 was found to be driven by favorable enthalpy change (Delta H-r degrees), which is similar to those obtained for 2 and (GlcNAc)(4). However, the entropy loss (-T Delta S-r degrees) for the binding of 3 was smaller than those of 2 and (GlcNAc)(4). Thus the binding of 3 was found to be more favorable than those of the others. Judging from the K-d value of 3 (760 nM), the compound appears to have the highest affinity among the lysozyme inhibitors identified to date. X-ray crystal structure of HEWL in a complex with 3 showed that compound 3 binds to subsites -4 to -1 and the moranoline moiety adopts an undistorted C-4(1) chair conformation almost overlapping with the -1 sugar covalently bound to Asp-52 of HEWL (Vocadlo, Davies, G.J., Laine, R., and Withers, S. G. (2001) Nature 412, 835-838). From these results, we concluded that compound 3 serves as a transition-state analogue for lysozyme providing additional evidence supporting the covalent glycosyl-enzyme intermediate in the catalytic reaction.	[Ogata, Makoto; Suzuki, Akari; Usui, Taichi] Shizuoka Univ, Grad Sch Sci & Technol, Dept Biosci, Shizuoka 4228529, Japan; [Umemoto, Naoyuki; Ohnuma, Takayuki; Fukamizo, Tamo] Kinki Univ, Grad Sch Agr, Dept Adv Biosci, Nara 6318505, Japan; [Numata, Tomoyuki] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan	Shizuoka University; Kindai University (Kinki University); National Institute of Advanced Industrial Science & Technology (AIST)	Usui, T (corresponding author), 836 Ohya,Suruga Ku, Shizuoka 4228529, Japan.	usui@ipc.shizuoka.ac.jp; fukamizo@nara.kindai.ac.jp	OHNUMA, Takayuki/T-8839-2019; Fukamizo, Tamo/AAY-7251-2020; Numata, Tomoyuki/L-6952-2018	Numata, Tomoyuki/0000-0002-4244-8829; Ogata, Makoto/0000-0002-8319-1265	MEXT (Ministry of Education, Culture, Sports, Science and Technology) [S1101035]	MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by "Strategic Project to Support the Formation of Research Bases at Private Universities, Matching Fund Subsidy from MEXT (Ministry of Education, Culture, Sports, Science and Technology), 2011-2015, Grant S1101035.	Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; CHEETHAM JC, 1992, J MOL BIOL, V224, P613, DOI 10.1016/0022-2836(92)90548-X; CHIPMAN DM, 1968, J BIOL CHEM, V243, P487; Dixon M, 1979, ENZYMES, P138; Dong J, 1999, ACTA CRYSTALLOGR D, V55, P745, DOI 10.1107/S0907444998016047; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukamizo T, 2000, CURR PROTEIN PEPT SC, V1, P105, DOI 10.2174/1389203003381450; Garcia-Hernandez E, 2003, PROTEIN SCI, V12, P135, DOI 10.1110/ps.0222503; Goto T, 2007, J BIOL CHEM, V282, P27459, DOI 10.1074/jbc.M704555200; Imoto T., 1972, ENZYMES, V7, P665; Jensen HH, 2001, ANGEW CHEM INT EDIT, V40, P3447, DOI 10.1002/1521-3773(20010917)40:18<3447::AID-ANIE3447>3.0.CO;2-8; Johnson L N, 1968, Brookhaven Symp Biol, V21, P120; Kawaguchi T, 1996, BIOSCI BIOTECH BIOCH, V60, P344, DOI 10.1271/bbb.60.344; KUHARA S, 1982, J BIOCHEM-TOKYO, V92, P121, DOI 10.1093/oxfordjournals.jbchem.a133908; Kuroki R, 1997, J BIOL CHEM, V272, P19976, DOI 10.1074/jbc.272.32.19976; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; MALCOLM BA, 1989, P NATL ACAD SCI USA, V86, P133, DOI 10.1073/pnas.86.1.133; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAE Y, 1975, J BIOCHEM-TOKYO, V77, P993, DOI 10.1093/oxfordjournals.jbchem.a130825; Ogata M, 2012, BIOSCI BIOTECH BIOCH, V76, P1362, DOI 10.1271/bbb.120119; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78; Piens K, 2008, J BIOL CHEM, V283, P21864, DOI 10.1074/jbc.M803057200; Poon DKY, 2007, BIOCHEMISTRY-US, V46, P1759, DOI 10.1021/bi061694c; RUPLEY JA, 1967, P NATL ACAD SCI USA, V57, P496, DOI 10.1073/pnas.57.3.496; SAINTBLANCARD J, 1970, BIOCHIM BIOPHYS ACTA, V220, P300, DOI 10.1016/0005-2744(70)90014-8; SCHINDLER M, 1976, J BIOL CHEM, V251, P4330; SECEMSKI II, 1972, J BIOL CHEM, V247, P4740; SECEMSKI II, 1971, J AM CHEM SOC, V93, P3549; Tanaka A, 1996, BIOSCI BIOTECH BIOCH, V60, P2055, DOI 10.1271/bbb.60.2055; USUI T, 1988, BIOCHIM BIOPHYS ACTA, V953, P179, DOI 10.1016/0167-4838(88)90022-2; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Weiss MS, 2000, ACTA CRYSTALLOGR D, V56, P952, DOI 10.1107/S0907444900006685; Zechel DL, 2003, J AM CHEM SOC, V125, P14313, DOI 10.1021/ja036833h	37	17	18	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6072	6082		10.1074/jbc.M112.439281	http://dx.doi.org/10.1074/jbc.M112.439281			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23303182	hybrid, Green Published			2022-12-28	WOS:000315820700005
J	Stockdale, SR; Mahony, J; Courtin, P; Chapot-Chartier, MP; van Pijkeren, JP; Britton, RA; Neve, H; Heller, KJ; Aideh, B; Vogensen, FK; van Sinderen, D				Stockdale, Stephen R.; Mahony, Jennifer; Courtin, Pascal; Chapot-Chartier, Marie-Pierre; van Pijkeren, Jan-Peter; Britton, Robert A.; Neve, Horst; Heller, Knut J.; Aideh, Bashir; Vogensen, Finn K.; van Sinderen, Douwe			The Lactococcal Phages Tuc2009 and TP901-1 Incorporate Two Alternate Forms of Their Tail Fiber into Their Virions for Infection Specialization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTIC-ACID BACTERIA; CONTROLLED GENE-EXPRESSION; BACILLUS-SUBTILIS; ELECTRON-MICROSCOPY; MEMBRANE-RECEPTOR; PEPTIDOGLYCAN STRUCTURE; ESCHERICHIA-COLI; LAMBDA-RECEPTOR; TAPE MEASURE; PROTEIN-GPJ	Lactococcal phages Tuc2009 and TP901-1 possess a conserved tail fiber called a tail-associated lysin (referred to as Tal(2009) for Tuc2009, and Tal(901-1) for TP901-1), suspended from their tail tips that projects a peptidoglycan hydrolase domain toward a potential host bacterium. Tal(2009) and Tal(901-1) can undergo proteolytic processing mid-protein at the glycine-rich sequence GG(S/N)SGGG, removing their C-terminal structural lysin. In this study, we show that the peptidoglycan hydrolase of these Tal proteins is an M23 peptidase that exhibits D-Ala-D-Asp endopeptidase activity and that this activity is required for efficient infection of stationary phase cells. Interestingly, the observed proteolytic processing of Tal(2009) and Tal(901-1) facilitates increased host adsorption efficiencies of the resulting phages. This represents, to the best of our knowledge, the first example of tail fiber proteolytic processing that results in a heterogeneous population of two phage types. Phages that possess a full-length tail fiber, or a truncated derivative, are better adapted to efficiently infect cells with an extensively cross-linked cell wall or infect with increased host-adsorption efficiencies, respectively.	[Stockdale, Stephen R.; Mahony, Jennifer; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Courtin, Pascal; Chapot-Chartier, Marie-Pierre] INRA, UMR1319 Micalis, Jouy En Josas, France; [Courtin, Pascal; Chapot-Chartier, Marie-Pierre] AgroParisTech, UMR Micalis, Jouy En Josas, France; [van Pijkeren, Jan-Peter; Britton, Robert A.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Neve, Horst; Heller, Knut J.] Max Rubner Inst, Dept Microbiol & Biotechnol, Kiel, Germany; [Aideh, Bashir; Vogensen, Finn K.] Univ Copenhagen, Dept Food Sci, Copenhagen, Denmark	University College Cork; University College Cork; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Michigan State University; University of Copenhagen	van Sinderen, D (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland.	d.vansinderen@ucc.ie	mahony, jennifer/AAG-8357-2020; Van Sinderen, Douwe/A-6778-2015; van Pijkeren, Jan-Peter/H-5333-2019; Vogensen, Finn/E-1245-2015	mahony, jennifer/0000-0001-5846-6303; Van Sinderen, Douwe/0000-0003-1823-7957; Vogensen, Finn/0000-0003-2151-7802; Stockdale, Stephen/0000-0002-0044-3878; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	Institut National de la Recherche Agronomique (INRA); Region Ile de France; Agence Nationale Recherche (ANR) French National Research Agency (ANR Lacto-Phages); Science Foundation Ireland Principal Investigatorship award [08/IN.1/B1909]	Institut National de la Recherche Agronomique (INRA); Region Ile de France(Region Ile-de-France); Agence Nationale Recherche (ANR) French National Research Agency (ANR Lacto-Phages)(French National Research Agency (ANR)); Science Foundation Ireland Principal Investigatorship award(Science Foundation Ireland)	This work was supported by Institut National de la Recherche Agronomique (INRA), Region Ile de France, and Agence Nationale Recherche (ANR) French National Research Agency (ANR Lacto-Phages).; A recipient of a Science Foundation Ireland Principal Investigatorship award (Ref. No. 08/IN.1/B1909). To whom correspondence should be addressed: Dept. of Microbiology and Alimentary Pharmabiotic Centre, University College Cork, Ireland. Tel.: 353-21-4901365; E-mail: d.vansinderen@ucc.ie.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; ARENDT EK, 1994, APPL ENVIRON MICROB, V60, P1875, DOI 10.1128/AEM.60.6.1875-1883.1994; Baptista C, 2008, J BACTERIOL, V190, P4989, DOI 10.1128/JB.00349-08; Bebeacua C, 2013, J VIROL, V87, P1061, DOI 10.1128/JVI.02836-12; Bebeacua C, 2010, J BIOL CHEM, V285, P39079, DOI 10.1074/jbc.M110.175646; Berkane E, 2006, BIOCHEMISTRY-US, V45, P2708, DOI 10.1021/bi051800v; Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9; Boulanger P, 2008, J BIOL CHEM, V283, P13556, DOI 10.1074/jbc.M800052200; BRAUN V, 1989, J GEN MICROBIOL, V135, P2551; Campanacci V, 2010, J STRUCT BIOL, V172, P75, DOI 10.1016/j.jsb.2010.02.007; CHRISTIANSEN B, 1994, J BACTERIOL, V176, P1069, DOI 10.1128/JB.176.4.1069-1076.1994; Costello V., 1988, THESIS NATL U IRELAN; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Deveau H, 2006, APPL ENVIRON MICROB, V72, P4338, DOI 10.1128/AEM.02517-05; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P2988, DOI 10.1128/AEM.72.4.2988-2996.2006; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Garneau JE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S20; Goulet A, 2011, J BIOL CHEM, V286, P25397, DOI 10.1074/jbc.M111.243360; Gurnev PA, 2006, J MOL BIOL, V359, P1447, DOI 10.1016/j.jmb.2006.04.034; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Jakutyte L, 2012, VIROLOGY, V422, P425, DOI 10.1016/j.virol.2011.11.010; JOHNSEN MG, 1995, VIROLOGY, V212, P595, DOI 10.1006/viro.1995.1517; KATSURA I, 1975, J MOL BIOL, V91, P257, DOI 10.1016/0022-2836(75)90379-4; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Kleerebezem M, 1997, APPL ENVIRON MICROB, V63, P4581, DOI 10.1128/AEM.63.11.4581-4584.1997; Koch B, 1997, APPL ENVIRON MICROB, V63, P2439, DOI 10.1128/AEM.63.6.2439-2441.1997; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Lillehaug D, 1997, J APPL MICROBIOL, V83, P85, DOI 10.1046/j.1365-2672.1997.00193.x; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Mahony J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00335; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; Moak M, 2000, MOL MICROBIOL, V37, P345, DOI 10.1046/j.1365-2958.2000.01995.x; MOINEAU S, 1993, APPL ENVIRON MICROB, V59, P208, DOI 10.1128/AEM.59.1.208-212.1993; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Pedersen M, 2000, VIROLOGY, V276, P315, DOI 10.1006/viro.2000.0497; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Rodriguez-Rubio L, 2012, CRIT REV MICROBIOL; ROESSNER CA, 1986, J BIOL CHEM, V261, P386; ROESSNER CA, 1984, J BACTERIOL, V157, P165, DOI 10.1128/JB.157.1.165-170.1984; ROESSNER CA, 1983, J BACTERIOL, V153, P1528, DOI 10.1128/JB.153.3.1528-1534.1983; SANDERS ME, 1980, APPL ENVIRON MICROB, V40, P500, DOI 10.1128/AEM.40.3.500-506.1980; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sao-Jose C, 2004, J BACTERIOL, V186, P8337, DOI 10.1128/JB.186.24.8337-8346.2004; Sass P, 2007, APPL ENVIRON MICROB, V73, P347, DOI 10.1128/AEM.01616-06; Scholl D, 2001, J VIROL, V75, P2509, DOI 10.1128/JVI.75.6.2509-2515.2001; Seegers JFML, 2004, VIROLOGY, V329, P40, DOI 10.1016/j.virol.2004.07.003; Spencer J, 2010, J MOL BIOL, V396, P908, DOI 10.1016/j.jmb.2009.12.021; Sudiarta IP, 2010, J BIOL CHEM, V285, P41232, DOI 10.1074/jbc.M110.156273; Van Pijkeren JP, 2012, BIOENGINEERED, V3, P209, DOI 10.4161/bioe.21049; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Veesler D, 2010, J BIOL CHEM, V285, P36666, DOI 10.1074/jbc.M110.157529; Vegge CS, 2006, APPL ENVIRON MICROB, V72, P6815, DOI 10.1128/AEM.01033-06; Vegge CS, 2006, J BACTERIOL, V188, P55, DOI 10.1128/JB.188.1.55-63.2006; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	62	67	68	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5581	5590		10.1074/jbc.M112.444901	http://dx.doi.org/10.1074/jbc.M112.444901			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23300085	Green Published, hybrid			2022-12-28	WOS:000315342500032
J	Jones, DK; Peters, CH; Allard, CR; Claydon, TW; Ruben, PC				Jones, David K.; Peters, Colin H.; Allard, Charlene R.; Claydon, Tom W.; Ruben, Peter C.			Proton Sensors in the Pore Domain of the Cardiac Voltage-gated Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE INACTIVATION; SLOW INACTIVATION; PERIODIC PARALYSIS; CRYSTAL-STRUCTURE; STRUCTURAL REARRANGEMENT; MOLECULAR DETERMINANTS; NA CHANNELS; OUTER RING; ACTIVATION; ACIDOSIS	Protons impart isoform-specific modulation of inactivation in neuronal, skeletal muscle, and cardiac voltage-gated sodium (Na-V) channels. Although the structural basis of proton block in Na(V)A channels has been well described, the amino acid residues responsible for the changes in Na-V kinetics during extracellular acidosis are as yet unknown. We expressed wild-type (WT) and two pore mutant constructs (H880Q and C373F) of the human cardiac Na-V channel, Na(V)1.5, in Xenopus oocytes. C373F and H880Q both attenuated proton block, abolished proton modulation of use-dependent inactivation, and altered pH modulation of the steady-state and kinetic parameters of slow inactivation. Additionally, C373F significantly reduced the maximum probability of use-dependent inactivation and slow inactivation, relative to WT. H880Q also significantly reduced the maximum probability of slow inactivation and shifted the voltage dependence of activation and fast inactivation to more positive potentials, relative to WT. These data suggest that Cys-373 and His880 in Na(V)1.5 are proton sensors for use-dependent and slow inactivation and have implications in isoform-specific modulation of Na-V channels.	[Jones, David K.; Peters, Colin H.; Allard, Charlene R.; Claydon, Tom W.; Ruben, Peter C.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Ruben, PC (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	pruben@sfu.ca	Jones, David K./AAX-1562-2020	Claydon, Tom/0000-0002-5143-7451; Jones, David/0000-0002-6762-5254	Natural Sciences and Engineering Research Council [611509, 611527]; Canadian Foundation for Innovation Leaders Opportunity Fund [17976]; Canadian Institutes for Health Research; Heart and Stroke Foundation of Canada New Investigator Award; Michael Smith Foundation for Health Research Career Scholar Award	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada New Investigator Award; Michael Smith Foundation for Health Research Career Scholar Award	This work was supported in part by Natural Sciences and Engineering Research Council Discovery Grants 611509 (to P. C. R.) and 611527 (to T. W. C.) and Canadian Foundation for Innovation Leaders Opportunity Fund Project 17976 (to T. W. C. and P. C. R.).; Supported by a Vanier Graduate Scholarship from the Canadian Institutes for Health Research.; Supported by a Heart and Stroke Foundation of Canada New Investigator Award and a Michael Smith Foundation for Health Research Career Scholar Award.	Antzelevitch C, 2004, CIRCULATION, V110, P904, DOI 10.1161/01.CIR.0000139333.83620.5D; Balser JR, 1996, J PHYSIOL-LONDON, V494, P431, DOI 10.1113/jphysiol.1996.sp021503; Bazett HC, 1920, J PHYSIOL-LONDON, V53, P320, DOI 10.1113/jphysiol.1920.sp001881; Bendahhou S, 2002, NEUROLOGY, V58, P1266, DOI 10.1212/WNL.58.8.1266; Bendahhou S, 1999, J NEUROSCI, V19, P4762; Capes DL, 2012, P NATL ACAD SCI USA, V109, P2648, DOI 10.1073/pnas.1115575109; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Claydon TW, 2002, AM J PHYSIOL-CELL PH, V283, pC1114, DOI 10.1152/ajpcell.00542.2001; Claydon TW, 2000, J PHYSIOL-LONDON, V526, P253, DOI 10.1111/j.1469-7793.2000.00253.x; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Cummins TR, 1996, BIOPHYS J, V71, P227, DOI 10.1016/S0006-3495(96)79219-6; Drummond GB, 2009, J PHYSIOL-LONDON, V587, P713, DOI 10.1113/jphysiol.2008.167387; Featherstone DE, 1996, BIOPHYS J, V71, P3098, DOI 10.1016/S0006-3495(96)79504-8; FLEIG A, 1994, PFLUG ARCH EUR J PHY, V427, P406, DOI 10.1007/BF00374254; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Hayward LJ, 1997, BIOPHYS J, V72, P1204, DOI 10.1016/S0006-3495(97)78768-X; Jensen MO, 2002, BIOPHYS J, V83, P98, DOI 10.1016/S0006-3495(02)75152-7; Jones DK, 2011, BIOPHYS J, V101, P2147, DOI 10.1016/j.bpj.2011.08.056; Kehl SJ, 2002, J PHYSIOL-LONDON, V541, P9, DOI 10.1113/jphysiol.2001.014456; Khan A, 2006, J PHYSIOL-LONDON, V576, P493, DOI 10.1113/jphysiol.2006.115659; Khan A, 2002, J PHYSIOL-LONDON, V543, P71, DOI 10.1113/jphysiol.2002.021014; Kuzmenkin A, 2002, BRAIN, V125, P835, DOI 10.1093/brain/awf071; Makita N, 1996, J NEUROSCI, V16, P7117; McCollum IJ, 2003, FEBS LETT, V552, P163, DOI 10.1016/S0014-5793(03)00912-8; Mitrovic N, 2000, J GEN PHYSIOL, V115, P707, DOI 10.1085/jgp.115.6.707; NGUYENTHI A, 1981, CAN J PHYSIOL PHARM, V59, P876, DOI 10.1139/y81-131; NODA M, 1993, ANN NY ACAD SCI, V707, P20, DOI 10.1111/j.1749-6632.1993.tb38039.x; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Ruben P.C., 2010, BIOPHYS J A, V111a; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; Townsend C, 1997, J GEN PHYSIOL, V110, P23, DOI 10.1085/jgp.110.1.23; Vilin YY, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00109; Vilin YY, 2001, BIOPHYS J, V80, P2221, DOI 10.1016/S0006-3495(01)76195-4; Vilin YY, 2001, CELL BIOCHEM BIOPHYS, V35, P171, DOI 10.1385/CBB:35:2:171; Vilin YY, 1999, BIOPHYS J, V77, P1384, DOI 10.1016/S0006-3495(99)76987-0; Wang SY, 1997, BIOPHYS J, V72, P1633, DOI 10.1016/S0006-3495(97)78809-X; Xiong W, 2003, J GEN PHYSIOL, V122, P323, DOI 10.1085/jgp.200308881; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	43	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4782	4791		10.1074/jbc.M112.434266	http://dx.doi.org/10.1074/jbc.M112.434266			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283979	hybrid, Green Published			2022-12-28	WOS:000315340400027
J	Roff, AN; Panganiban, RP; Bond, JS; Ishmael, FT				Roff, Alanna N.; Panganiban, Ronaldo P.; Bond, Judith S.; Ishmael, Faoud T.			Post-transcriptional Regulation of Meprin alpha by the RNA-binding Proteins Hu Antigen R (HuR) and Tristetraprolin (TTP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; AU-RICH ELEMENTS; METALLOPROTEASE MEPRIN; GENE; EXPRESSION; SUBUNIT; IDENTIFICATION; TRANSMEMBRANE; TRANSCRIPTOME; SECRETION	Meprins are multimeric proteases that are implicated in inflammatory bowel disease by both genetic association studies and functional studies in knock-out mice. Patients with inflammatory bowel disease show decreased colonic expression of meprin alpha, although regulation of expression, particularly under inflammatory stimuli, has not been studied. The studies herein demonstrate that the human meprin alpha transcript is bound and stabilized by Hu antigen R at baseline, and that treatment with the inflammatory stimulus phorbol 12-myristate 13-acetate downregulates meprin alpha expression by inducing tristetraprolin. The enhanced binding of tristetraprolin to the MEP1A 3'-UTR results in destabilization of the transcript and occurs at a discrete site from Hu antigen R. This is the first report to describe a mechanism for post-transcriptional regulation of meprin alpha and will help clarify the role of meprins in the inflammatory response and disease.	[Roff, Alanna N.; Bond, Judith S.; Ishmael, Faoud T.] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA; [Panganiban, Ronaldo P.; Ishmael, Faoud T.] Penn State Univ, Sect Allergy & Immunol, Coll Med, Dept Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ishmael, FT (corresponding author), Penn State Univ, Dept Med, Coll Med, 500 Univ Dr,Mail Code H171, Hershey, PA 17033 USA.	fishmael@hmc.psu.edu		Panganiban, Ronaldo/0000-0002-5626-3147	NIH [1K08HL114100-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL114100] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by institutional funds and NIH Grant 1K08HL114100-01 (to F. T. I.).	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Banerjee S, 2011, AM J PHYSIOL-GASTR L, V300, pG273, DOI 10.1152/ajpgi.00504.2009; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Boyd M, 2010, J BIOL CHEM, V285, P25115, DOI 10.1074/jbc.M109.089516; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brown JF, 1999, AM J PHYSIOL-GASTR L, V276, pG583, DOI 10.1152/ajpgi.1999.276.3.G583; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Fan JS, 2011, J IMMUNOL, V186, P2482, DOI 10.4049/jimmunol.0903634; FRETLAND DJ, 1990, INFLAMMATION, V14, P143, DOI 10.1007/BF00917453; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Hahn D, 2000, BIOCHEM J, V346, P83, DOI 10.1042/0264-6021:3460083; Hahn D, 1997, EUR J BIOCHEM, V247, P933, DOI 10.1111/j.1432-1033.1997.00933.x; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 1999, AM J HUM GENET, V65, P1647, DOI 10.1086/302677; Hengst JA, 2004, J BIOL CHEM, V279, P34856, DOI 10.1074/jbc.M405774200; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; Huguenin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002153; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; Ishmael FT, 2011, J IMMUNOL, V186, P1189, DOI 10.4049/jimmunol.1001794; Ishmael SS, 2006, J BIOL CHEM, V281, P37404, DOI 10.1074/jbc.M602769200; Jang SI, 2006, LIFE SCI, V78, P2937, DOI 10.1016/j.lfs.2005.11.020; Jiang WP, 2000, ARCH BIOCHEM BIOPHYS, V379, P183, DOI 10.1006/abbi.2000.1873; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; MARCHAND P, 1995, J BIOL CHEM, V270, P5449, DOI 10.1074/jbc.270.10.5449; Meisner NC, 2009, J MOL BIOL, V386, P435, DOI 10.1016/j.jmb.2008.12.020; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Rath T, 2006, INFLAMM BOWEL DIS, V12, P1025, DOI 10.1097/01.mib.0000234133.97594.04; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tsukuba T, 2002, ARCH BIOCHEM BIOPHYS, V397, P191, DOI 10.1006/abbi.2001.2672; van Heel DA, 2004, HUM MOL GENET, V13, P763, DOI 10.1093/hmg/ddh090; Villa JP, 2003, BIOCHEM SOC SYMP, V70, P53, DOI 10.1042/bss0700053; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010; Yura RE, 2009, AM J PHYSIOL-RENAL, V296, pF135, DOI 10.1152/ajprenal.90524.2008	58	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4733	4743		10.1074/jbc.M112.444208	http://dx.doi.org/10.1074/jbc.M112.444208			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23269677	Green Published, hybrid			2022-12-28	WOS:000315340400022
J	Singh, Y; Kaul, V; Mehra, A; Chatterjee, S; Tousif, S; Dwivedi, VP; Suar, M; Van Kaer, L; Bishai, WR; Das, G				Singh, Yogesh; Kaul, Vandana; Mehra, Alka; Chatterjee, Samit; Tousif, Sultan; Dwivedi, Ved Prakash; Suar, Mrutyunjay; Van Kaer, Luc; Bishai, William R.; Das, Gobardhan			Mycobacterium tuberculosis Controls MicroRNA-99b (miR-99b) Expression in Infected Murine Dendritic Cells to Modulate Host Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISMS; CYTOKINES; INDUCTION; DEFENSE	Mycobacterium tuberculosis resides and replicates within host phagocytes by modulating host microbicidal responses. In addition, it suppresses the production of host protective cytokines to prevent activation of and antigen presentation by M. tuberculosis-infected cells, causing dysregulation of host protective adaptive immune responses. Many cytokines are regulated by microRNAs (miRNAs), a newly discovered class of small noncoding RNAs, which have been implicated in modulating host immune responses in many bacterial and viral diseases. Here, we show that miRNA-99b (miR-99b), an orphan miRNA, plays a key role in the pathogenesis of M. tuberculosis infection. We found that miR-99b expression was highly up-regulated in M. tuberculosis strain H37Rv-infected dendritic cells (DCs) and macrophages. Blockade of miR-99b expression by antagomirs resulted in significantly reduced bacterial growth in DCs. Interestingly, knockdown of miR-99b in DCs significantly up-regulated proinflammatory cytokines such as IL-6, IL-12, and IL-1 beta. Furthermore, mRNA and membrane-bound protein data indicated that inhibition of miR-99b augments TNF-alpha and TNFRSF-4 production. Thus, miR-99b targets TNF-alpha and TNFRSF-4 receptor genes. Treatment of anti-miR-99b-transfected DCs with anti-TNF-alpha antibody resulted in increased bacterial burden. Thus, our findings unveil a novel host evasion mechanism adopted by M. tuberculosis via miR-99b, which may open up new avenues for designing miRNA-based vaccines and therapies.	[Singh, Yogesh; Kaul, Vandana; Mehra, Alka; Chatterjee, Samit; Tousif, Sultan; Dwivedi, Ved Prakash] Int Ctr Genet Engn & Biotechnol ICGEB, Immunol Grp, New Delhi 110067, India; [Mehra, Alka] NYU, Sch Med, Div Infect Dis, New York, NY 10016 USA; [Chatterjee, Samit] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21218 USA; [Suar, Mrutyunjay] Ind Technol Univ, Sch Biotechnol, Infect Biol Lab, Kalinga Inst, Bhubaneswar 751024, Orissa, India; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Bishai, William R.] Kwazulu Natal Res Inst TB & HIV, ZA-4001 Durban, South Africa	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; New York University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Indian Institute of Technology System (IIT System); Indian Institute of Technology Bhubaneswar; Vanderbilt University	Singh, Y (corresponding author), Univ London, MicroRNA & Lymphocyte Dev Lab, Infect & Immun Res Grp, Dept Comparat Biomed Sci,Royal Vet Coll, Camden Campus, London NW1 0TU, England.	ysingh@rvc.ac.uk; dasgo@icgeb.res.in	Chatterjee, Samit/ABZ-2522-2022; kaul, vandana/C-9788-2018; Van Kaer, Luc/H-1033-2015; Mehra, Alka/GLU-8765-2022; Singh, Yogesh/T-8230-2017	Chatterjee, Samit/0000-0001-8176-3410; kaul, vandana/0000-0002-1841-5584; Van Kaer, Luc/0000-0001-5275-2309; Singh, Yogesh/0000-0001-6919-6273; Dwivedi, Ved Prakash/0000-0003-4321-2567; Tousif, Sultan/0000-0001-6174-6541; Suar, Mrutyunjay/0000-0003-4815-5477; Mehra, Alka/0000-0003-4206-7863	Wellcome Trust/Department of Biotechnology (DBT) alliance	Wellcome Trust/Department of Biotechnology (DBT) alliance(Department of Biotechnology (DBT) India)	This research was supported by a grant from the Wellcome Trust/Department of Biotechnology (DBT) alliance.	Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Behar SM, 2011, MICROBES INFECT, V13, P749, DOI 10.1016/j.micinf.2011.03.002; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Kaufmann SHE, 2005, TRENDS IMMUNOL, V26, P660, DOI 10.1016/j.it.2005.09.012; Krutzik SR, 2004, SEMIN IMMUNOL, V16, P35, DOI 10.1016/j.smim.2003.10.005; Larner-Svensson HM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-68; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Meena LS, 2010, FEBS J, V277, P2416, DOI 10.1111/j.1742-4658.2010.07666.x; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P841, DOI 10.1111/j.1348-0421.2003.tb03450.x; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Wilson M, 1998, INFECT IMMUN, V66, P2401, DOI 10.1128/IAI.66.6.2401-2409.1998	25	120	132	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5056	5061		10.1074/jbc.C112.439778	http://dx.doi.org/10.1074/jbc.C112.439778			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23233675	Green Published, hybrid			2022-12-28	WOS:000315340400053
J	Jaiswal, M; Dvorsky, R; Ahmadian, MR				Jaiswal, Mamta; Dvorsky, Radovan; Ahmadian, Mohammad Reza			Deciphering the Molecular and Functional Basis of Dbl Family Proteins A NOVEL SYSTEMATIC APPROACH TOWARD CLASSIFICATION OF SELECTIVE ACTIVATION OF THE Rho FAMILY PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; RHO-GTPASES; CRYSTAL-STRUCTURE; STRUCTURAL DETERMINANTS; RAS; DOMAIN; COMPLEX; RAC1; GEFS; MECHANISM	The diffuse B-cell lymphoma (Dbl) family of the guanine nucleotide exchange factors is a direct activator of the Rho family proteins. The Rho family proteins are involved in almost every cellular process that ranges from fundamental (e.g. the establishment of cell polarity) to highly specialized processes (e. g. the contraction of vascular smooth muscle cells). Abnormal activation of the Rho proteins is known to play a crucial role in cancer, infectious and cognitive disorders, and cardiovascular diseases. However, the existence of 74 Dbl proteins and 25 Rho-related proteins in humans, which are largely uncharacterized, has led to increasing complexity in identifying specific upstream pathways. Thus, we comprehensively investigated sequence-structure-function-property relationships of 21 representatives of the Dbl protein family regarding their specificities and activities toward 12 Rho family proteins. The meta-analysis approach provides an unprecedented opportunity to broadly profile functional properties of Dbl family proteins, including catalytic efficiency, substrate selectivity, and signaling specificity. Our analysis has provided novel insights into the following: (i) understanding of the relative differences of various Rho protein members in nucleotide exchange; (ii) comparing and defining individual and overall guanine nucleotide exchange factor activities of a large representative set of the Dbl proteins toward 12 Rho proteins; (iii) grouping the Dbl family into functionally distinct categories based on both their catalytic efficiencies and their sequence-structural relationships; (iv) identifying conserved amino acids as fingerprints of the Dbl and Rho protein interaction; and (v) defining amino acid sequences conserved within, but not between, Dbl subfamilies. Therefore, the characteristics of such specificity-determining residues identified the regions or clusters conserved within the Dbl subfamilies.	[Jaiswal, Mamta; Dvorsky, Radovan; Ahmadian, Mohammad Reza] Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Ahmadian, MR (corresponding author), Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40255 Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	jaiswal, mamta/E-5148-2016; Dvorsky, Radovan/ABE-3042-2020	jaiswal, mamta/0000-0002-5862-7506; 	Deutsche Forschungsgemeinschaft [AH 92/5-1, SFB 974]; Bundesministerium fuer Bildung und Forschung (BMBF NGFNplus Program) [01GS08100]; Research Committee of the Strategic Research Fund (SFF) of the Heinrich-Heine University Dusseldorf [F-2012/79-6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fuer Bildung und Forschung (BMBF NGFNplus Program); Research Committee of the Strategic Research Fund (SFF) of the Heinrich-Heine University Dusseldorf	This work was supported in part by Deutsche Forschungsgemeinschaft Grants AH 92/5-1 and SFB 974, Bundesministerium fuer Bildung und Forschung (BMBF NGFNplus Program) Grant 01GS08100, and the Research Committee of the Strategic Research Fund (SFF) Grant F-2012/79-6 of the Heinrich-Heine University Dusseldorf.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Bulgin R, 2010, INFECT IMMUN, V78, P1417, DOI 10.1128/IAI.01250-09; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Cheng L, 2002, MOL CELL BIOL, V22, P6895, DOI 10.1128/MCB.22.19.6895-6905.2002; Corbetta S, 2009, FASEB J, V23, P1347, DOI 10.1096/fj.08-121574; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Eberth Alexander, 2009, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1409s43; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engers R, 2000, INT J CANCER, V88, P369, DOI 10.1002/1097-0215(20001101)88:3<369::AID-IJC8>3.0.CO;2-K; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Esters H, 2001, J MOL BIOL, V310, P141, DOI 10.1006/jmbi.2001.4735; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Fiegen D, 2002, FEBS LETT, V525, P100, DOI 10.1016/S0014-5793(02)03094-6; Gad AKB, 2010, CELL SIGNAL, V22, P183, DOI 10.1016/j.cellsig.2009.10.001; Garavini H, 2002, BIOCHEMISTRY-US, V41, P6303, DOI 10.1021/bi025651h; Garcia P, 2006, YEAST, V23, P1031, DOI 10.1002/yea.1409; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Goh LL, 2012, J BIOL CHEM, V287, P31311, DOI 10.1074/jbc.M111.327056; Gu Y, 2005, CELL CYCLE, V4, P201; Haeusler LC, 2006, METHOD ENZYMOL, V406, P1, DOI 10.1016/S0076-6879(06)06001-0; Haeusler LC, 2003, FEBS LETT, V555, P556, DOI 10.1016/S0014-5793(03)01351-6; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; Hwang HS, 2011, J CELL BIOL, V195, P377, DOI 10.1083/jcb.201106138; Itzen A, 2007, J MOL BIOL, V365, P1359, DOI 10.1016/j.jmb.2006.10.096; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Jaiswal M, 2013, BIOL CHEM, V394, P89, DOI 10.1515/hsz-2012-0207; Jaiswal M, 2012, METHODS MOL BIOL, V827, P37, DOI 10.1007/978-1-61779-442-1_3; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kostenko EV, 2006, MOL CELL BIOL, V26, P8964, DOI 10.1128/MCB.00670-06; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002; Loirand G, 2008, CURR OPIN PHARMACOL, V8, P174, DOI 10.1016/j.coph.2007.12.006; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Marinissen MJ, 2005, TRENDS BIOCHEM SCI, V30, P423, DOI 10.1016/j.tibs.2005.06.006; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Mulinari Shai, 2010, Small GTPases, V1, P28; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Nimnual Anjaruwee, 2002, Sci STKE, V2002, ppe36, DOI 10.1126/stke.2002.145.pe36; Oleksy A, 2006, J BIOL CHEM, V281, P32891, DOI 10.1074/jbc.M606220200; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; Pegtel DM, 2007, CURR BIOL, V17, P1623, DOI 10.1016/j.cub.2007.08.035; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rittinger K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.291pe63; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, TRENDS BIOCHEM SCI, V30, P163, DOI 10.1016/j.tibs.2005.02.002; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shutes A, 2006, METHOD ENZYMOL, V406, P11, DOI 10.1016/S0076-6879(06)06002-2; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Viaud Julien, 2012, Advances in Biological Regulation, V52, P303, DOI 10.1016/j.jbior.2012.04.001; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yoshizawa M, 2003, GENE EXPR PATTERNS, V3, P375, DOI 10.1016/S1567-133X(03)00002-4; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	91	64	65	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4486	4500		10.1074/jbc.M112.429746	http://dx.doi.org/10.1074/jbc.M112.429746			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23255595	Green Published, hybrid			2022-12-28	WOS:000314845000074
J	Manhart, CM; McHenry, CS				Manhart, Carol M.; McHenry, Charles S.			The PriA Replication Restart Protein Blocks Replicase Access Prior to Helicase Assembly and Directs Template Specificity through Its ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-III; COORDINATED LEADING-STRAND; INITIATION; PRIMOSOME; HOLOENZYME; REPLISOME; FORK; PURIFICATION; MUTANTS; COMPLEX	The PriA protein serves as an initiator for the restart of DNA replication on stalled replication forks and as a checkpoint protein that prevents the replicase from advancing in a strand displacement reaction on forks that do not contain a functional replicative helicase. We have developed a primosomal protein-dependent fluorescence resonance energy transfer (FRET) assay using a minimal fork substrate composed of synthetic oligonucleotides. We demonstrate that a self-loading reaction, which proceeds at high helicase concentrations, occurs by threading of a preassembled helicase over free 5'-ends, an event that can be blocked by attaching a steric block to the 5'-end or coating DNA with single-stranded DNA binding protein. The specificity of PriA for replication forks is regulated by its intrinsic ATPase. ATPase-defective PriA K230R shows a strong preference for substrates that contain no gap between the leading strand and the duplex portion of the fork, as demonstrated previously. Wild-type PriA prefers substrates with larger gaps, showing maximal activity on substrates on which PriA K230R is inactive. We demonstrate that PriA blocks replicase function on forks by blocking its binding.	[Manhart, Carol M.; McHenry, Charles S.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA	University of Colorado System; University of Colorado Boulder	McHenry, CS (corresponding author), Univ Colorado, Dept Chem & Biochem, 3415 Colorado Ave,UCB596, Boulder, CO 80303 USA.	charles.mchenry@colorado.edu	Manhart, Carol/AAQ-4938-2020		National Science Foundation [MCB-0919961]	National Science Foundation(National Science Foundation (NSF))	This work was supported by Grant MCB-0919961 from the National Science Foundation.	BJORNSON KP, 1994, BIOCHEMISTRY-US, V33, P14306, DOI 10.1021/bi00251a044; Bruand C, 2005, MOL MICROBIOL, V55, P1138, DOI 10.1111/j.1365-2958.2004.04451.x; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Condon C, 2003, MICROBIOL MOL BIOL R, V67, P157, DOI 10.1128/MMBR.67.2.157-174.2003; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Dallmann HG, 2010, BIOCHEMISTRY-US, V49, P2551, DOI 10.1021/bi9020764; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; Dervyn E, 2001, SCIENCE, V294, P1716, DOI 10.1126/science.1066351; Fijalkowska IJ, 1996, P NATL ACAD SCI USA, V93, P2856, DOI 10.1073/pnas.93.7.2856; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; HOUSTON P, 1994, P NATL ACAD SCI USA, V91, P5471, DOI 10.1073/pnas.91.12.5471; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Jones JM, 1999, J MOL BIOL, V289, P503, DOI 10.1006/jmbi.1999.2783; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kaplan DL, 1999, J BIOL CHEM, V274, P6889, DOI 10.1074/jbc.274.11.6889; Kim DR, 1996, J BIOL CHEM, V271, P20681, DOI 10.1074/jbc.271.34.20681; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; LEE MS, 1987, P NATL ACAD SCI USA, V84, P8345, DOI 10.1073/pnas.84.23.8345; Lisal J, 2005, NAT STRUCT MOL BIOL, V12, P460, DOI 10.1038/nsmb927; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; Marsin S, 2001, J BIOL CHEM, V276, P45818, DOI 10.1074/jbc.M101996200; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; McHenry CS, 2011, EMBO REP, V12, P408, DOI 10.1038/embor.2011.51; MOK M, 1987, J BIOL CHEM, V262, P16644; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; Nurse P, 1999, J BIOL CHEM, V274, P25026, DOI 10.1074/jbc.274.35.25026; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; Polard P, 2002, NUCLEIC ACIDS RES, V30, P1593, DOI 10.1093/nar/30.7.1593; Sanders GM, 2010, MOL CELL, V37, P273, DOI 10.1016/j.molcel.2009.12.025; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Smits WK, 2010, MOL MICROBIOL, V75, P452, DOI 10.1111/j.1365-2958.2009.06999.x; Song MS, 2001, J BIOL CHEM, V276, P35165, DOI 10.1074/jbc.M100389200; Wieczorek A, 2006, J BIOL CHEM, V281, P12561, DOI 10.1074/jbc.M513844200; WU CA, 1992, J BIOL CHEM, V267, P4030; Xi J, 2005, BIOCHEMISTRY-US, V44, P2305, DOI 10.1021/bi0479508; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; Yuan Q, 2009, J BIOL CHEM, V284, P31672, DOI 10.1074/jbc.M109.050740; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933; ZECHNER EL, 1992, J BIOL CHEM, V267, P4045	45	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3989	3999		10.1074/jbc.M112.435966	http://dx.doi.org/10.1074/jbc.M112.435966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264623	hybrid, Green Published			2022-12-28	WOS:000314845000028
J	Murphy, EJ; Booth, JC; Davrazou, F; Port, AM; Jones, DNM				Murphy, Emma J.; Booth, Jamie C.; Davrazou, Foteini; Port, Alex M.; Jones, David N. M.			Interactions of Anopheles gambiae Odorant-binding Proteins with a Human-derived Repellent IMPLICATIONS FOR THE MODE OF ACTION OF N,N-DIETHYL-3-METHYLBENZAMIDE (DEET)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHEROMONE-BINDING; INSECT REPELLENTS; CRYSTAL-STRUCTURE; LIGAND-BINDING; GYPSY-MOTH; NMR STRUCTURE; RELEASE; MECHANISM; MOSQUITOS; SENSITIVITY	The Anopheles gambiae mosquito, which is the vector for Plasmodium falciparum malaria, uses a series of olfactory cues emanating from human sweat to select humans as their source for a blood meal. Perception of these odors within the mosquito olfactory system involves the interplay of odorant-binding proteins (OBPs) and odorant receptors and disrupting the normal responses to those odorants that guide mosquito-human interactions represents an attractive approach to prevent the transmission of malaria. Previously, it has been shown that DEET targets multiple components of the olfactory system, including OBPs and odorant receptors. Here, we present the crystal structure of A. gambiae OBP1 (OBP1) in the complex it forms with a natural repellent 6-methyl-5-heptene-2-one (6-MH). We find that 6-MH binds to OBP1 at exactly the same site as DEET. However, key interactions with a highly conserved water molecule that are proposed to be important for DEET binding are not involved in binding of 6-MH. We show that 6-MH and DEET can compete for the binding of attractive odorants and in doing so disrupt the interaction that OBP1 makes with OBP4. We further show that 6-MH and DEET can bind simultaneously to OBPs with other ligands. These results suggest that the successful discovery of novel reagents targeting OBP function requires knowledge about the specific mechanism of binding to the OBP rather than their binding affinity.	[Murphy, Emma J.; Davrazou, Foteini; Port, Alex M.; Jones, David N. M.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Booth, Jamie C.; Jones, David N. M.] Univ Colorado, Sch Med, Program Struct Biol & Biophys, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Jones, DNM (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, 12801 E 17th Ave, Aurora, CO 80045 USA.	david.jones@ucdenver.edu	Jones, David N/C-5764-2013	Murphy, Emma/0000-0003-4551-8068	National Institutes of Health [DC008834]; Program in Structural Biology and Biophysics; University of Colorado Cancer Center (National Institutes of Health) [P30-CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program in Structural Biology and Biophysics; University of Colorado Cancer Center (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC008834 (to D. N. M. J.).; We thank Dr. Jay Nix for assistance in x-ray data collection; and Patrick Jones, Jason Pitts, and Dr. Larry Zwiebel for A. gambiae cDNA libraries. Operation of the x-ray crystallography and NMR spectroscopy facilities at University of Colorado School of Medicine is supported by the Program in Structural Biology and Biophysics, and the University of Colorado Cancer Center (National Institutes of Health Grant P30-CA046934).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban LP, 2002, BIOCHEM BIOPH RES CO, V293, P50, DOI 10.1016/S0006-291X(02)00185-7; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Briassoulis G, 2001, HUM EXP TOXICOL, V20, P8, DOI 10.1191/096032701676731093; Bucci BK, 2006, BIOCHEMISTRY-US, V45, P1693, DOI 10.1021/bi0516576; Crawford JE, 2010, MOL BIOL EVOL, V27, P1739, DOI 10.1093/molbev/msq070; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; DAVIS EE, 1985, J MED ENTOMOL, V22, P237, DOI 10.1093/jmedent/22.3.237; Davrazou F, 2011, J BIOL CHEM, V286, P34175, DOI 10.1074/jbc.M111.274712; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fogh Rasmus, 2002, Nature Structural Biology, V9, P416, DOI 10.1038/nsb0602-416; Gong YM, 2011, CHEM SENSES, V36, P291, DOI 10.1093/chemse/bjq130; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Honson N, 2003, CHEM SENSES, V28, P479, DOI 10.1093/chemse/28.6.479; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lautenschlager C, 2007, STRUCTURE, V15, P1148, DOI 10.1016/j.str.2007.07.013; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239; Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Mukabana Wolfgang R., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-17; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Qiao HL, 2011, CELL MOL LIFE SCI, V68, P1799, DOI 10.1007/s00018-010-0539-8; Qiu YT, 2004, MED VET ENTOMOL, V18, P429, DOI 10.1111/j.0269-283X.2004.00534.x; Ronderos DS, 2010, J NEUROSCI, V30, P2595, DOI 10.1523/JNEUROSCI.4819-09.2010; Rossi P, 2010, J BIOMOL NMR, V46, P11, DOI 10.1007/s10858-009-9386-z; RUTLEDGE LC, 1978, J MED ENTOMOL, V14, P536, DOI 10.1093/jmedent/14.5.536; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; SKINNER WA, 1965, NATURE, V207, P661, DOI 10.1038/207661a0; Spinelli S, 2012, INSECT BIOCHEM MOLEC, V42, P41, DOI 10.1016/j.ibmb.2011.10.005; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Thode AB, 2008, J MOL BIOL, V376, P1360, DOI 10.1016/j.jmb.2007.12.063; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z; VOGT RG, 1989, J NEUROSCI, V9, P3332; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Ziemba BP, 2013, PROTEIN SCI, V22, P11, DOI 10.1002/pro.2179; Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015	54	30	34	0	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4475	4485		10.1074/jbc.M112.436386	http://dx.doi.org/10.1074/jbc.M112.436386			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23261834	Green Published, hybrid			2022-12-28	WOS:000314845000073
J	Tasseva, G; Bai, HD; Davidescu, M; Haromy, A; Michelakis, E; Vance, JE				Tasseva, Guergana; Bai, Helin Daniel; Davidescu, Magdalena; Haromy, Alois; Michelakis, Evangelos; Vance, Jean E.			Phosphatidylethanolamine Deficiency in Mammalian Mitochondria Impairs Oxidative Phosphorylation and Alters Mitochondrial Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN SUPERCOMPLEXES; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLSERINE DECARBOXYLASE; CYTOCHROME-C; ENDOPLASMIC-RETICULUM; YEAST MITOCHONDRIA; BARTH-SYNDROME; CARDIOLIPIN BIOSYNTHESIS; EMBRYONIC-DEVELOPMENT; PROTEOLYTIC CLEAVAGE	Mitochondrial dysfunction is implicated in neurodegenerative, cardiovascular, and metabolic disorders, but the role of phospholipids, particularly the nonbilayer-forming lipid phosphatidylethanolamine (PE), in mitochondrial function is poorly understood. Elimination of mitochondrial PE (mtPE) synthesis via phosphatidylserine decarboxylase in mice profoundly alters mitochondrial morphology and is embryonic lethal (Steen-bergen, R., Nanowski, T. S., Beigneux, A., Kulinski, A., Young, S. G., and Vance, J. E. (2005) J. Biol. Chem. 280, 40032-40040). We now report that moderate <30% depletion of mtPE alters mitochondrial morphology and function and impairs cell growth. Acute reduction of mtPE by RNAi silencing of phosphatidylserine decarboxylase and chronic reduction of mtPE in PSB-2 cells that have only 5% of normal phosphatidylserine synthesis decreased respiratory capacity, ATP production, and activities of electron transport chain complexes (C) I and CIV but not CV. Blue native-PAGE analysis revealed defects in the organization of CI and CIV into supercomplexes in PE-deficient mitochondria, correlated with reduced amounts of CI and CIV proteins. Thus, mtPE deficiency impairs formation and/or membrane integration of respiratory supercomplexes. Despite normal or increased levels of mitochondrial fusion proteins in mtPE-deficient cells, and no reduction in mitochondrial membrane potential, mitochondria were extensively fragmented, and mitochondrial ultrastructure was grossly aberrant. In general, chronic reduction of mtPE caused more pronounced mitochondrial defects than did acute mtPE depletion. The functional and morphological changes in PSB-2 cells were largely reversed by normalization of mtPE content by supplementation with lyso-PE, a mtPE precursor. These studies demonstrate that even a modest reduction of mtPE in mammalian cells profoundly alters mitochondrial functions.	[Tasseva, Guergana; Bai, Helin Daniel; Davidescu, Magdalena; Vance, Jean E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Tasseva, Guergana; Bai, Helin Daniel; Davidescu, Magdalena; Haromy, Alois; Michelakis, Evangelos; Vance, Jean E.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Vance, JE (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, 328 HMRC, Edmonton, AB T6G 2S2, Canada.	jean.vance@ualberta.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (to J.E.V.).	Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogdanov M, 1999, J BIOL CHEM, V274, P12339, DOI 10.1074/jbc.274.18.12339; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; BORKENHAGEN L, 1961, J BIOL CHEM, V236, pPC28; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Chan EYL, 2012, J BIOL CHEM, V287, P40131, DOI 10.1074/jbc.M112.399428; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; CULLIS PR, 1978, BIOCHIM BIOPHYS ACTA, V513, P31, DOI 10.1016/0005-2736(78)90109-8; da Cunha ES, 2011, ANAL BIOCHEM, V418, P158, DOI 10.1016/j.ab.2011.06.044; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gottesman M M, 1987, Methods Enzymol, V151, P3, DOI 10.1016/S0076-6879(87)51004-7; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; HAYERHARTL M, 1992, EUR J BIOCHEM, V209, P423, DOI 10.1111/j.1432-1033.1992.tb17305.x; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Johi A., 2012, J PHARMACOL EXP THER, V342, P619; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kainu V., 2012, BIOCHIM BIOPHYS ACTA, V1831, P429; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; KUGE O, 1991, J BIOL CHEM, V266, P6370; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; MENON AK, 1992, J BIOL CHEM, V267, P15277; Mileykovskaya E, 2012, J BIOL CHEM, V287, P23095, DOI 10.1074/jbc.M112.367888; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nebauer R, 2007, J BIOL CHEM, V282, P16736, DOI 10.1074/jbc.M611345200; OHTSUKA T, 1993, J BIOL CHEM, V268, P22908; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rostovtseva TK, 2012, J BIOL CHEM, V287, P29589, DOI 10.1074/jbc.M112.378778; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Saito K, 1998, J BIOL CHEM, V273, P17199, DOI 10.1074/jbc.273.27.17199; Saito S, 1997, J BIOL CHEM, V272, P9503; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Seelert H, 2011, BBA-BIOENERGETICS, V1807, P1185, DOI 10.1016/j.bbabio.2011.05.023; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Signorell A, 2008, J BIOL CHEM, V283, P20320, DOI 10.1074/jbc.M802430200; Signorell A, 2009, MOL MICROBIOL, V72, P1068, DOI 10.1111/j.1365-2958.2009.06713.x; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Steenbergen R, 2006, BBA-MOL CELL BIOL L, V1761, P313, DOI 10.1016/j.bbalip.2006.03.005; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; SUNDLER R, 1974, FEBS LETT, V43, P303, DOI 10.1016/0014-5793(74)80667-8; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Tomasetig L, 2002, BBA-BIOENERGETICS, V1556, P133, DOI 10.1016/S0005-2728(02)00344-4; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vance J. E., 2013, BIOCH BIOPH IN PRESS; VANCE JE, 1991, J BIOL CHEM, V266, P89; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; ZBOROWSKI J, 1983, FEBS LETT, V157, P179, DOI 10.1016/0014-5793(83)81141-7; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200	95	191	191	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4158	4173		10.1074/jbc.M112.434183	http://dx.doi.org/10.1074/jbc.M112.434183			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23250747	Green Published, hybrid			2022-12-28	WOS:000314845000044
J	Duncan, MR; Fullerton, M; Chaudhuri, M				Duncan, Melanie R.; Fullerton, Marjorie; Chaudhuri, Minu			Tim50 in Trypanosoma brucei Possesses a Dual Specificity Phosphatase Activity and Is Critical for Mitochondrial Protein Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; PREPROTEIN TRANSLOCASE; PRESEQUENCE TRANSLOCASE; INDUCIBLE EXPRESSION; DOWN-REGULATION; TIM23 COMPLEX; CELL-GROWTH; COMPONENT; TIM17; MECHANISMS	In eukaryotes, proteins are imported into mitochondria via multiprotein translocases of the mitochondrial outer and inner membranes, TOM and TIM, respectively. Trypanosoma brucei, a hemoflagellated parasitic protozoan and the causative agent of African trypanosomiasis, imports about a thousand proteins into the mitochondrion; however, the mitochondrial protein import machinery in this organism is largely unidentified. Here, we characterized a homolog of Tim50 that is localized in the mitochondrial membrane in T. brucei. Similar to Tim50 proteins from fungi and mammals, Tim50 in T. brucei (TbTim50) possesses a mitochondrial targeting signal at its N terminus and a C-terminal domain phosphatase motif at its C terminus. Knockdown of TbTim50 reduced cell growth and inhibited import of proteins that contain N-terminal targeting signals. Co-immunoprecipitation analysis revealed that TbTim50 interacts with TbTim17. Unlike its fungal counterpart but similar to the human homolog of Tim50, recombinant TbTim50 possesses a dual specificity phosphatase activity with a greater affinity for protein tyrosine phosphate than for protein serine/threonine phosphate. Mutation of the aspartic acid residues to alanine in the C-terminal domain phosphatase motif (DXDX)-D-242(V/T)(246) abolished activity for both type of substrates. TbTim50 knockdown increased and its overexpression decreased the level of voltage-dependent anion channel (VDAC). However, the VDAC level was unaltered when the phosphatase-inactive mutant of TbTim50 was overexpressed, suggesting that the phosphatase activity of TbTim50 plays a role in regulation of VDAC expression. In contrast, phosphatase activity of the TbTim50 is required neither for mitochondrial protein import nor for its interaction with TbTim17. Overall, our results show that TbTim50 plays additional roles in mitochondrial activities besides preprotein translocation.	[Duncan, Melanie R.; Fullerton, Marjorie; Chaudhuri, Minu] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA	Meharry Medical College	Chaudhuri, M (corresponding author), Meharry Med Coll, Dept Microbiol & Immunol, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA.	mchaudhuri@mmc.edu			National Institutes of Health [2SC1GM081146, 5T32HL007737, 5T32AI007281, 2R25GM059994, G12RR003032, U01NS041071, U54RR026140, S10RR0254970]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140, G12RR003032] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994, SC1GM081146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2SC1GM081146 and Training Grants 5T32HL007737, 5T32AI007281, and 2R25GM059994. The Flow Cytometry Core Facility is supported by National Institutes of Health Grant G12RR003032. The Morphology Core Facility is supported in part by National Institutes of Health Grants U01NS041071, U54RR026140, and S10RR0254970.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bagos PG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-189; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Bomer U, 1996, J MOL BIOL, V262, P389, DOI 10.1006/jmbi.1996.0522; Botelho SC, 2011, EMBO J, V30, P1003, DOI 10.1038/emboj.2011.29; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chaudhuri M, 1998, MOL BIOCHEM PARASIT, V95, P53, DOI 10.1016/S0166-6851(98)00091-7; Chaudhuri M, 2001, GENE, V266, P1, DOI 10.1016/S0378-1119(01)00367-5; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; EFFRON PN, 1993, MOL BIOCHEM PARASIT, V59, P191, DOI 10.1016/0166-6851(93)90217-L; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Guo Y, 2004, J BIOL CHEM, V279, P24813, DOI 10.1074/jbc.M402049200; Hamasaki H, 2012, MOL PLANT, V5, P461, DOI 10.1093/mp/ssr088; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; Kerner J, 2012, BBA-BIOMEMBRANES, V1818, P1520, DOI 10.1016/j.bbamem.2011.11.013; Kumar S, 2012, PLANT SCI, V183, P212, DOI 10.1016/j.plantsci.2011.08.014; Liao SH, 2010, EXP CELL RES, V316, P704, DOI 10.1016/j.yexcr.2009.12.017; Lister R, 2005, MOL MEMBR BIOL, V22, P87, DOI 10.1080/09687860500041247; Marom M, 2011, J BIOL CHEM, V286, P43809, DOI 10.1074/jbc.M111.261040; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Mokranjac D, 2009, MOL BIOL CELL, V20, P1400, DOI 10.1091/mbc.E08-09-0934; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Paris Z, 2011, MOL BIOCHEM PARASIT, V176, P116, DOI 10.1016/j.molbiopara.2010.12.010; Pawlak KJ, 2011, J BIOL CHEM, V286, P39130, DOI 10.1074/jbc.M111.290031; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060; Qian XG, 2011, J MOL BIOL, V411, P513, DOI 10.1016/j.jmb.2011.06.020; Rampazzo C, 2002, GENE, V294, P109, DOI 10.1016/S0378-1119(02)00651-0; Rassow J, 1999, J MOL BIOL, V286, P105, DOI 10.1006/jmbi.1998.2455; Sankala H, 2011, ARCH BIOCHEM BIOPHYS, V512, P52, DOI 10.1016/j.abb.2011.05.005; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Schneider A, 2008, TRENDS CELL BIOL, V18, P12, DOI 10.1016/j.tcb.2007.09.009; Schulz C, 2011, J CELL BIOL, V195, P643, DOI 10.1083/jcb.201105098; Sharma S, 2010, MOL BIOCHEM PARASIT, V174, P89, DOI 10.1016/j.molbiopara.2010.07.003; Singha UK, 2008, MOL BIOCHEM PARASIT, V159, P30, DOI 10.1016/j.molbiopara.2008.01.003; Singha UK, 2012, J BIOL CHEM, V287, P14480, DOI 10.1074/jbc.M111.322925; Singha UK, 2009, EUKARYOT CELL, V8, P1418, DOI 10.1128/EC.00132-09; Sternberg JM, 2010, PARASITOLOGY, V137, P2007, DOI 10.1017/S0031182010000946; Sugiyama S, 2007, GENETICS, V176, P927, DOI 10.1534/genetics.107.072074; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Williams S, 2008, EXP PARASITOL, V118, P420, DOI 10.1016/j.exppara.2007.10.008; WOODS A, 1989, J CELL SCI, V93, P491; Zarsky V, 2012, CURR BIOL, V22, pR479, DOI 10.1016/j.cub.2012.03.057; Zhang XB, 2010, NUCLEIC ACIDS RES, V38, P7378, DOI 10.1093/nar/gkq618; Zikova A, 2006, MOL BIOCHEM PARASIT, V149, P65, DOI 10.1016/j.molbiopara.2006.04.007	58	21	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3184	3197		10.1074/jbc.M112.436378	http://dx.doi.org/10.1074/jbc.M112.436378			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23212919	Green Published, hybrid			2022-12-28	WOS:000314397900026
J	Zhu, B; Tabor, S; Raytcheva, DA; Hernandez, A; King, JA; Richardson, CC				Zhu, Bin; Tabor, Stanley; Raytcheva, Desislava A.; Hernandez, Alfredo; King, Jonathan A.; Richardson, Charles C.			The RNA Polymerase of Marine Cyanophage Syn5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOBACTERIUM PHORMIDIUM-FOVEOLARUM; RIBONUCLEIC-ACID POLYMERASE; PHOTOSYNTHESIS GENES; GENOME SEQUENCE; SYNECHOCOCCUS; DNA; PROCHLOROCOCCUS; VIRUSES; BACTERIOPHAGE; WIDESPREAD	A single subunit DNA-dependent RNA polymerase was identified and purified to apparent homogeneity from cyanophage Syn5 that infects the marine cyanobacteria Synechococcus. Syn5 is homologous to bacteriophage T7 that infects Escherichia coli. Using the purified enzyme its promoter has been identified by examining transcription of segments of Syn5 DNA and sequencing the 5'-termini of the transcripts. Only two Syn5 RNAP promoters, having the sequence 5'-ATTGGGCACCCGTAA-3', are found within the Syn5 genome. One promoter is located within the Syn5 RNA polymerase gene and the other is located close to the right genetic end of the genome. The purified enzyme and its promoter have enabled a determination of the requirements for transcription. Unlike the salt-sensitive bacteriophage T7 RNA polymerase, this marine RNA polymerase requires 160 mM potassium for maximal activity. The optimal temperature for Syn5 RNA polymerase is 24 degrees C, much lower than that for T7 RNA polymerase. Magnesium is required as a cofactor although some activity is observed with ferrous ions. Syn5 RNA polymerase is more efficient in utilizing low concentrations of ribonucleotides than T7 RNA polymerase.	[Richardson, Charles C.] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Raytcheva, Desislava A.; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Zhu, B (corresponding author), Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, 240 Longwood Ave,C2-219, Boston, MA 02115 USA.	Bin_Zhu@hms.harvard.edu; ccr@hms.harvard.edu	Hernandez, Alfredo J/ABC-8311-2020; Hernandez, Alfredo/AAV-5584-2021	Hernandez, Alfredo J/0000-0002-0903-8932; 	National Institutes of Health [GM54397, GM17980]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI075208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM017980, R01GM017980, R01GM054397, F32GM017980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54397 (to C. C. R.) and GM17980 (to J. K.).	CHAMBERL.M, 1973, J BIOL CHEM, V248, P2235; CHAMBERL.M, 1973, J BIOL CHEM, V248, P2245; Cheetham GMT, 2000, CURR OPIN STRUC BIOL, V10, P117, DOI 10.1016/S0959-440X(99)00058-5; Chen F, 2002, APPL ENVIRON MICROB, V68, P2589, DOI 10.1128/AEM.68.5.2589-2594.2002; Chen ZH, 2005, NUCLEIC ACIDS RES, V33, P6172, DOI 10.1093/nar/gki915; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Gao EB, 2012, J VIROL, V86, P236, DOI 10.1128/JVI.06282-11; Imashimizu M, 2011, GENET RES INT, V2011, DOI 10.4061/2011/572689; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Liu XY, 2008, MICROB ECOL, V56, P671, DOI 10.1007/s00248-008-9386-7; Liu XY, 2007, VIROLOGY, V366, P28, DOI 10.1016/j.virol.2007.04.019; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Millard AD, 2009, ENVIRON MICROBIOL, V11, P2370, DOI 10.1111/j.1462-2920.2009.01966.x; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Pope WH, 2007, J MOL BIOL, V368, P966, DOI 10.1016/j.jmb.2007.02.046; Raytcheva DA, 2011, J VIROL, V85, P2406, DOI 10.1128/JVI.01601-10; Sabehi G, 2012, P NATL ACAD SCI USA, V109, P2037, DOI 10.1073/pnas.1115467109; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; Shcolnick S, 2006, PLANT PHYSIOL, V141, P805, DOI 10.1104/pp.106.079251; Sullivan MB, 2009, ENVIRON MICROBIOL, V11, P2935, DOI 10.1111/j.1462-2920.2009.02081.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Weigele PR, 2007, ENVIRON MICROBIOL, V9, P1675, DOI 10.1111/j.1462-2920.2007.01285.x; White MF, 2012, CURR OPIN STRUC BIOL, V22, P94, DOI 10.1016/j.sbi.2011.11.004; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	32	13	15	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3545	3552		10.1074/jbc.M112.442350	http://dx.doi.org/10.1074/jbc.M112.442350			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23258537	Green Published, hybrid			2022-12-28	WOS:000314397900059
J	Basham, KJ; Kieffer, C; Shelton, DN; Leonard, CJ; Bhonde, VR; Vankayalapati, H; Milash, B; Bearss, DJ; Looper, RE; Welm, BE				Basham, Kaitlin J.; Kieffer, Collin; Shelton, Dawne N.; Leonard, Christopher J.; Bhonde, Vasudev R.; Vankayalapati, Hariprasad; Milash, Brett; Bearss, David J.; Looper, Ryan E.; Welm, Bryan E.			Chemical Genetic Screen Reveals a Role for Desmosomal Adhesion in Mammary Branching Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; CELL CONTACTS; GLAND; ACTIVATION; DISTINCT; DIFFERENTIATION; MECHANISMS; INDUCTION; MIGRATION; EXPOSURE	During the process of branching morphogenesis, the mammary gland undergoes distinct phases of remodeling to form an elaborate ductal network that ultimately produces and delivers milk to newborn animals. These developmental events rely on tight regulation of critical cellular pathways, many of which are probably disrupted during initiation and progression of breast cancer. Transgenic mouse and in vitro organoid models previously identified growth factor signaling as a key regulator of mammary branching, but the functional downstream targets of these pathways remain unclear. Here, we used purified primary mammary epithelial cells stimulated with fibroblast growth factor-2 (FGF2) to model mammary branching morphogenesis in vitro. We employed a forward chemical genetic approach to identify modulators of this process and describe a potent compound, 1023, that blocks FGF2-induced branching. In primary mammary epithelial cells, we used lentivirus-mediated knockdown of the aryl hydrocarbon receptor (AHR) to demonstrate that 1023 acts through AHR to block branching. Using 1023 as a tool, we identified desmosomal adhesion as a novel target of AHR signaling and show that desmosomes are critical for AHR agonists to block branching. Our findings support a functional role for desmosomes during mammary morphogenesis and also in blocking FGF-induced invasion.	[Welm, Bryan E.] Univ Utah, Dept Surg, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Bhonde, Vasudev R.; Looper, Ryan E.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Vankayalapati, Hariprasad; Bearss, David J.] Univ Utah, Ctr Invest Therapeut, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Milash, Brett] Univ Utah, Microarray & Genom Anal Core Facil, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Welm, BE (corresponding author), Univ Utah, Dept Surg, Dept Oncol Sci, Huntsman Canc Inst, 2000 Circle Hope Dr, Salt Lake City, UT 84112 USA.	Bryan.Welm@hci.utah.edu	Bearss, David/Q-9141-2019; Vankayalapati, Hariprasad/ABB-5375-2020	Vankayalapati, Hariprasad/0000-0002-5477-2124; Basham, Kaitlin/0000-0001-6607-8167; Bearss, David/0000-0002-4280-5670; Looper, Ryan/0000-0003-1626-1363; Bearss, David/0000-0002-4458-826X	National Institutes of Health [R01-CA143815, R01-CA140296]; Department of Defense [W81XWH-09-1-04310]; NIH [5T32 HD07491]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007491] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA140296, R01CA143815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA143815 and R01-CA140296. This work was also supported by Department of Defense Breast Cancer Research Program Grant W81XWH-09-1-04310. K. J. B. is supported by an NIH Developmental Biology Training Grant (5T32 HD07491).	Barhoover MA, 2010, MOL PHARMACOL, V77, P195, DOI 10.1124/mol.109.059675; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; DEMLEHNER MP, 1995, J CELL BIOL, V131, P745, DOI 10.1083/jcb.131.3.745; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Ewald AJ, 2012, J CELL SCI, V125, P2638, DOI 10.1242/jcs.096875; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Fenton SE, 2002, TOXICOL SCI, V67, P63, DOI 10.1093/toxsci/67.1.63; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Furness SGB, 2009, PHARMACOL THERAPEUT, V124, P336, DOI 10.1016/j.pharmthera.2009.09.004; Garrod D, 2008, BIOCHEM SOC T, V36, P195, DOI 10.1042/BST0360195; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Garrod D, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/212439; Heid SE, 2000, MOL PHARMACOL, V57, P82; Klages N, 2000, MOL THER, V2, P170, DOI 10.1006/mthe.2000.0103; Klus GT, 2001, INT J ONCOL, V19, P169; Lawrence BP, 2012, NAT IMMUNOL, V13, P117, DOI 10.1038/ni.2213; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lew BJ, 2011, BIOL REPROD, V84, P1094, DOI 10.1095/biolreprod.110.087544; Lewis BC, 2001, TOXICOL SCI, V62, P46, DOI 10.1093/toxsci/62.1.46; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Lu PF, 2006, J MAMMARY GLAND BIOL, V11, P213, DOI 10.1007/s10911-006-9027-z; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Motto I, 2011, J CHEM INF MODEL, V51, P2868, DOI 10.1021/ci2001617; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; NEVILLE MC, 1995, AM J CLIN NUTR, V61, p687S, DOI 10.1093/ajcn/61.3.687S; Oshiro MM, 2005, BREAST CANCER RES, V7, pR669, DOI 10.1186/bcr1273; PENN EJ, 1987, J CELL BIOL, V105, P2327, DOI 10.1083/jcb.105.5.2327; PITELKA DR, 1973, J CELL BIOL, V56, P797, DOI 10.1083/jcb.56.3.797; POLLENZ RS, 1994, MOL PHARMACOL, V45, P428; Runswick SK, 2001, NAT CELL BIOL, V3, P823, DOI 10.1038/ncb0901-823; Simian M, 2001, DEVELOPMENT, V128, P3117; Smith BA, 2012, SEMIN CELL DEV BIOL, V23, P583, DOI 10.1016/j.semcdb.2012.03.005; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Swedenborg E, 2010, TOXICOLOGY, V268, P132, DOI 10.1016/j.tox.2009.09.007; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Tselepis C, 1998, P NATL ACAD SCI USA, V95, P8064, DOI 10.1073/pnas.95.14.8064; Vafaizadeh V, 2010, STEM CELLS, V28, P928, DOI 10.1002/stem.407; Vorderstrasse BA, 2004, TOXICOL SCI, V78, P248, DOI 10.1093/toxsci/kfh062; Welm BE, 2002, J CELL BIOL, V157, P703, DOI 10.1083/jcb.200107119; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Wiesen JF, 1999, DEVELOPMENT, V126, P335; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090	50	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2261	2270		10.1074/jbc.M112.411033	http://dx.doi.org/10.1074/jbc.M112.411033			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23212921	Green Published, hybrid			2022-12-28	WOS:000314211500016
J	Kawai, M; Kinoshita, S; Kimoto, A; Hasegawa, Y; Miyagawa, K; Yamazaki, M; Ohata, Y; Ozono, K; Michigami, T				Kawai, Masanobu; Kinoshita, Saori; Kimoto, Akihito; Hasegawa, Yasuhiro; Miyagawa, Kazuaki; Yamazaki, Miwa; Ohata, Yasuhisa; Ozono, Keiichi; Michigami, Toshimi			FGF23 Suppresses Chondrocyte Proliferation in the Presence of Soluble alpha-Klotho both in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; CIRCULATING LEVELS; FACTOR RECEPTOR-3; BONE-DEVELOPMENT; INDIAN HEDGEHOG; PHOSPHATE; MICE; DIFFERENTIATION; FGF-23; FGFR3	Fibroblast growth factor-23 (FGF23) is well established to play crucial roles in the regulation of phosphate homeostasis. X-linked hypophosphatemic rickets (XLH) is characterized by impaired mineralization and growth retardation associated with elevated circulating FGF23 levels. Administration of phosphate and calcitriol is effective in improving growth retardation, but is not sufficient to fully reverse impaired growth, suggesting the existence of a disease-specific mechanism in the development of growth retardation in addition to dysregulated phosphate metabolism. However, the precise mechanisms of growth retardation in XLH remain elusive. Here, we postulated that FGF23 suppressed chondrocyte proliferation in the presence of soluble alpha-Klotho (sKL). In vitro and ex vivo studies revealed that FGF23 formed a protein complex with sKL through KL1 internal repeat and suppressed the linear growth of metatarsals in the presence of sKL, which was antagonized by co-incubation with neutralizing antibodies against FGF23 or by knocking-down FGFR3 expression. Additionally, FGF23 binding to FGFR3 was enhanced in the presence of sKL. Histologically, the length of the proliferating zone was diminished and was associated with decreased chondrocyte proliferation. FGF23/sKL suppressed Indian hedgehog (Ihh) expression and administration of Ihh protein partially rescued the suppressive effect of FGF23/sKL on metatarsal growth. Intraperitoneal administration of sKL in Hyp mice, a murine model for XLH, caused a decrease in the length of the proliferating zone associated with decreased chondrocyte proliferation without altering circulating phosphate levels. These findings suggest that suppression of chondrocyte proliferation by FGF23 could have a causative role in the development of growth retardation in XLH.	[Kawai, Masanobu; Kinoshita, Saori; Miyagawa, Kazuaki; Yamazaki, Miwa; Ohata, Yasuhisa; Michigami, Toshimi] Osaka Med Ctr, Dept Bone & Mineral Res, Izumi, Osaka 5941101, Japan; [Kimoto, Akihito] Osaka Med Ctr, Dept Pathol, Izumi, Osaka 5941101, Japan; [Kawai, Masanobu] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan; [Hasegawa, Yasuhiro; Ohata, Yasuhisa; Ozono, Keiichi] Osaka Univ, Dept Pediat, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University	Kawai, M (corresponding author), Osaka Med Ctr, Dept Bone & Mineral Res, 840 Murodo Cho Izumi, Izumi, Osaka 5941101, Japan.	kawaim@mch.pref.osaka.jp	Michigami, Toshimi/AAU-2326-2021; Ohata, Yasuhisa/AAJ-4615-2020	Ohata, Yasuhisa/0000-0001-6084-6620; Kawai, Masanobu/0000-0003-4466-1559	Japan Foundation for Pediatric Research; Grants-in-Aid for Scientific Research [23791216, 23591227] Funding Source: KAKEN	Japan Foundation for Pediatric Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from the Japan Foundation for Pediatric Research (to M. K.).	Aono Y, 2009, J BONE MINER RES, V24, P1879, DOI [10.1359/JBMR.090509, 10.1359/jbmr.090509]; Bai XY, 2004, ENDOCRINOLOGY, V145, P5269, DOI 10.1210/en.2004-0233; Carpenter TO, 2010, J CLIN ENDOCR METAB, V95, pE352, DOI 10.1210/jc.2010-0589; Chen L, 1999, J CLIN INVEST, V104, P1517, DOI 10.1172/JCI6690; Chen L, 2001, HUM MOL GENET, V10, P457, DOI 10.1093/hmg/10.5.457; CHESNEY RW, 1983, PEDIATRICS, V71, P559; De Beur SMJ, 2002, J BONE MINER RES, V17, P1102, DOI 10.1359/jbmr.2002.17.6.1102; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; FRIEDMAN NE, 1993, J CLIN ENDOCR METAB, V76, P839, DOI 10.1210/jc.76.4.839; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; jbc.org, SCI; Kawai M, 2011, J BIOL CHEM, V286, P14670, DOI 10.1074/jbc.M110.193334; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Koshimizu T, 2012, J BIOL CHEM, V287, P15760, DOI 10.1074/jbc.M111.308072; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Li CL, 1999, HUM MOL GENET, V8, P35, DOI 10.1093/hmg/8.1.35; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Naski MC, 1998, DEVELOPMENT, V125, P4977; Ohata Y, 2011, J CLIN ENDOCR METAB, V96, pE943, DOI 10.1210/jc.2010-2357; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Segev O, 2000, HUM MOL GENET, V9, P249, DOI 10.1093/hmg/9.2.249; Shalhoub V, 2011, CALCIFIED TISSUE INT, V89, P140, DOI 10.1007/s00223-011-9501-5; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang H, 2008, J BONE MINER RES, V23, P939, DOI 10.1359/JBMR.080220; Wang YC, 1999, P NATL ACAD SCI USA, V96, P4455, DOI 10.1073/pnas.96.8.4455; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110	38	38	39	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2414	2427		10.1074/jbc.M112.410043	http://dx.doi.org/10.1074/jbc.M112.410043			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23235154	hybrid, Green Published			2022-12-28	WOS:000314211500029
J	Zhou, YN; Lubkowska, L; Hui, M; Court, C; Chen, S; Court, DL; Strathern, J; Jin, DJ; Kashlev, M				Zhou, Yan Ning; Lubkowska, Lucyna; Hui, Monica; Court, Carolyn; Chen, Shuo; Court, Donald L.; Strathern, Jeffrey; Jin, Ding Jun; Kashlev, Mikhail			Isolation and Characterization of RNA Polymerase rpoB Mutations That Alter Transcription Slippage during Elongation in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION APPARATUS; GENE-EXPRESSION; FRAMESHIFT PROTEINS; STRUCTURAL BASIS; FIDELITY; MUTANTS; SEQUENCE; DISCRIMINATION; PURIFICATION; RESISTANCE	Transcription fidelity is critical for maintaining the accurate flow of genetic information. The study of transcription fidelity has been limited because the intrinsic error rate of transcription is obscured by the higher error rate of translation, making identification of phenotypes associated with transcription infidelity challenging. Slippage of elongating RNA polymerase (RNAP) on homopolymeric A/T tracts in DNA represents a special type of transcription error leading to disruption of open reading frames in Escherichia coli mRNA. However, the regions in RNAP involved in elongation slippage and its molecular mechanism are unknown. We constructed an A/T tract that is out of frame relative to a downstream lacZ gene on the chromosome to examine transcriptional slippage during elongation. Further, we developed a genetic system that enabled us for the first time to isolate and characterize E. coli RNAP mutants with altered transcriptional slippage in vivo. We identified several amino acid residues in the beta subunit of RNAP that affect slippage in vivo and in vitro. Interestingly, these highly clustered residues are located near the RNA strand of the RNA-DNA hybrid in the elongation complex. Our E. coli study complements an accompanying study of slippage by yeast RNAP II and provides the basis for future studies on the mechanism of transcription fidelity.	[Jin, Ding Jun] NCI, Gene Regulat & Chromosome Biol Lab, Ctr Canc Res, Frederick Natl Lab Canc Res,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jin, DJ (corresponding author), NCI, Gene Regulat & Chromosome Biol Lab, Ctr Canc Res, Frederick Natl Lab Canc Res,NIH, POB B, Frederick, MD 21702 USA.	jind@mail.nih.gov; kashlevm@mail.nih.gov			National Institutes of Health; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010992, ZIABC010795, ZIABC010632, ZIABC010336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program. This work was also supported by the National Cancer Institute and the Center for Cancer Research.	ALTON NK, 1979, NATURE, V282, P864, DOI 10.1038/282864a0; Anikin M, 2010, NUCLEIC ACIDS MOL BI, V24, P409, DOI 10.1007/978-0-387-89382-2_19; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; Ba Y, 2000, MUTAT RES-FUND MOL M, V447, P209, DOI 10.1016/S0027-5107(99)00209-2; Baranov PV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r25; CHAKRABARTI SL, 1977, P NATL ACAD SCI USA, V74, P1157, DOI 10.1073/pnas.74.3.1157; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; de Vries N, 2002, J BACTERIOL, V184, P6615, DOI 10.1128/JB.184.23.6615-6624.2002; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Gordon AJE, 2009, PLOS BIOL, V7, P364, DOI 10.1371/journal.pbio.1000044; Holmes SF, 2006, J BIOL CHEM, V281, P18677, DOI 10.1074/jbc.M600543200; JIN DJ, 1989, J BACTERIOL, V171, P5229, DOI 10.1128/jb.171.9.5229-5231.1989; JIN DJ, 1991, J BIOL CHEM, V266, P14478; JIN DJ, 1994, J BIOL CHEM, V269, P17221; Jin DJ, 1996, J BIOL CHEM, V271, P11659; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; JIN DJ, 1994, J MOL BIOL, V236, P72, DOI 10.1006/jmbi.1994.1119; Kireeva M, 2009, METHODS, V48, P333, DOI 10.1016/j.ymeth.2009.04.008; Kireeva ML, 2008, MOL CELL, V30, P557, DOI 10.1016/j.molcel.2008.04.017; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Koyama H, 2010, GENES CELLS, V15, P151, DOI 10.1111/j.1365-2443.2009.01372.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Larsen B, 2000, P NATL ACAD SCI USA, V97, P1683, DOI 10.1073/pnas.97.4.1683; LIBBY RT, 1989, EMBO J, V8, P3153, DOI 10.1002/j.1460-2075.1989.tb08469.x; LIBBY RT, 1991, MOL MICROBIOL, V5, P999, DOI 10.1111/j.1365-2958.1991.tb01872.x; Linton MF, 1997, J BIOL CHEM, V272, P14127, DOI 10.1074/jbc.272.22.14127; LISITSYN NA, 1984, MOL GEN GENET, V196, P173, DOI 10.1007/BF00334112; LIU CG, 1994, GENE DEV, V8, P2904, DOI 10.1101/gad.8.23.2904; Penno C, 2005, MOL MICROBIOL, V56, P204, DOI 10.1111/j.1365-2958.2004.04530.x; Penno C, 2006, MOL MICROBIOL, V62, P1460, DOI 10.1111/j.1365-2958.2006.05456.x; Raabe M, 1998, AM J MED GENET, V76, P101, DOI 10.1002/(SICI)1096-8628(19980226)76:1<101::AID-AJMG19>3.0.CO;2-P; Ratinier M, 2008, J GEN VIROL, V89, P1569, DOI 10.1099/vir.0.83614-0; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Samkurashvili I, 1996, J BIOL CHEM, V271, P23495, DOI 10.1074/jbc.271.38.23495; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Shaw RJ, 2002, J BIOL CHEM, V277, P24420, DOI 10.1074/jbc.M202059200; SPRINGGATE CF, 1975, J MOL BIOL, V97, P577, DOI 10.1016/S0022-2836(75)80060-X; Strathern J, 2013, J BIOL CHEM, V288, P2689, DOI 10.1074/jbc.M112.429506; Strathern JN, 2012, BBA-GENE REGUL MECH, V1819, P694, DOI 10.1016/j.bbagrm.2012.02.005; Svenningsen SL, 2005, P NATL ACAD SCI USA, V102, P4465, DOI 10.1073/pnas.0409839102; Svetlov V, 2004, J BIOL CHEM, V279, P38087, DOI 10.1074/jbc.C400316200; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Trinh V, 2006, MICROBIOL MOL BIOL R, V70, P12, DOI 10.1128/MMBR.70.1.12-36.2006; Turnbough CL, 2008, MOL MICROBIOL, V69, P10, DOI 10.1111/j.1365-2958.2008.06272.x; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; van Leeuwen FW, 2006, BIOCHEM SOC T, V34, P738, DOI 10.1042/BST0340738; van Leeuwen FW, 2000, NEUROBIOL AGING, V21, P879, DOI 10.1016/S0197-4580(00)00151-2; van Leeuwen FW, 2006, NEUROLOGY, V66, pS86, DOI 10.1212/01.wnl.0000193882.46003.6d; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; Van Leeuwen FW, 2000, ANN NY ACAD SCI, V908, P267; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; WAGNER LA, 1990, NUCLEIC ACIDS RES, V18, P3529, DOI 10.1093/nar/18.12.3529; ZALENSKAYA K, 1990, GENE, V89, P7, DOI 10.1016/0378-1119(90)90199-2	61	47	47	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2700	2710		10.1074/jbc.M112.429464	http://dx.doi.org/10.1074/jbc.M112.429464			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223236	Green Published, hybrid			2022-12-28	WOS:000314211500054
J	Qu, C; Li, WQ; Shao, QQ; Dwyer, T; Huang, H; Yang, T; Liu, GF				Qu, Chao; Li, Weiquan; Shao, Qiangqiang; Dwyer, Trisha; Huang, Huai; Yang, Tao; Liu, Guofa			c-Jun N-terminal Kinase 1 (JNK1) Is Required for Coordination of Netrin Signaling in Axon Guidance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; COLORECTAL-CANCER; COMMISSURAL AXONS; GENETIC-ANALYSIS; DISTINCT ROLES; GUIDES CELL; RECEPTOR; DCC; PROTEIN; OUTGROWTH	The JNK family of MAPKs is involved in a large variety of physiological and pathological processes in brain development, such as neural survival, migration, and polarity as well as axon regeneration. However, whether JNK activation is involved in axon guidance remains unknown. Here, we provide evidence indicating the JNK pathway is required for Netrin signaling in the developing nervous system. Netrin-1 increased JNK1, not JNK2 or JNK3, activity in the presence of deleted in colorectal cancer (DCC) or Down syndrome cell adhesion molecule (DSCAM), and expression of both of them further enhanced Netrin-1-induced JNK1 activity in vitro. Inhibition of JNK signaling either by a JNK inhibitor, SP600125, or expression of a dominant negative form of MKK4, a JNK upstream activator, blocked Netrin-1-induced JNK1 activation in HEK293 cells. Netrin-1 increased endogenous JNK activity in primary neurons. Netrin-1-induced JNK activation was inhibited either by the JNK inhibitor or an anti-DCC function-blocking antibody. Combination of the anti-DCC function-blocking antibody with expression of DSCAM shRNA in primary neurons totally abolished Netrin-1-induced JNK activation, whereas knock-down of DSCAM partially inhibited the Netrin-1 effect. In the developing spinal cord, phospho-JNK was strongly expressed in commissural axons before and as they crossed the floor plate, and Netrin-1 stimulation dramatically increased the level of endogenous phospho-JNK in commissural axon growth cones. Inhibition of JNK signaling either by JNK1 RNA interference (RNAi) or the JNK inhibitor suppressed Netrin-1-induced neurite outgrowth and axon attraction. Knockdown of JNK1 in ovo caused defects in spinal cord commissural axon projection and pathfinding. Our study reveals that JNK1 is important in the coordination of DCC and DSCAM in Netrin-mediated attractive signaling.	[Qu, Chao; Shao, Qiangqiang; Dwyer, Trisha; Huang, Huai; Yang, Tao; Liu, Guofa] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [Li, Weiquan] Univ Michigan, Dept Pathol, Geriatr Ctr, Ann Arbor, MI 48109 USA	University System of Ohio; University of Toledo; University of Michigan System; University of Michigan	Li, WQ (corresponding author), Univ Michigan, Dept Pathol, Geriatr Ctr, 3138 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	wqli@med.umich.edu; Guofa.Liu@utoledo.edu	Li, Weiquan/B-4897-2011; Shao, Qiangqiang/GXZ-6789-2022	Shao, Qiangqiang/0000-0002-0674-1868	National Institutes of Health; Whitehall Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation	This work was supported, in whole or in part, by the National Institutes of Health (to G. L.). This work was also supported by and the Whitehall Foundation (to G. L.).	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Alcantara S, 2000, DEVELOPMENT, V127, P1359; Andrews GL, 2008, DEVELOPMENT, V135, P3839, DOI 10.1242/dev.023739; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Bai G, 2011, CELL, V144, P106, DOI 10.1016/j.cell.2010.11.053; Barnat M, 2010, J NEUROSCI, V30, P7804, DOI 10.1523/JNEUROSCI.0372-10.2010; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Causeret F, 2004, DEVELOPMENT, V131, P2841, DOI 10.1242/dev.01162; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Finger JH, 2002, J NEUROSCI, V22, P10346; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Haeusgen W, 2009, NEUROSCIENCE, V161, P951, DOI 10.1016/j.neuroscience.2009.04.014; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hirai S, 2011, J NEUROSCI, V31, P6468, DOI 10.1523/JNEUROSCI.5038-10.2011; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Keeling SL, 1997, ONCOGENE, V15, P691, DOI 10.1038/sj.onc.1201225; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolodkin Alex L, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001727; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li WQ, 2004, J BIOL CHEM, V279, P32824, DOI 10.1074/jbc.M401878200; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu GF, 2007, J NEUROSCI, V27, P957, DOI 10.1523/JNEUROSCI.4616-06.2007; Liu GF, 2009, P NATL ACAD SCI USA, V106, P2951, DOI 10.1073/pnas.0811083106; Lucanic M, 2006, DEVELOPMENT, V133, P4549, DOI 10.1242/dev.02648; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2&lt;281::AID-NEU16&gt;3.0.CO;2-4; Moore SW, 2008, DEVELOPMENT, V135, P2855, DOI 10.1242/dev.024133; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Palmesino E, 2012, J NEUROSCI, V32, P411, DOI 10.1523/JNEUROSCI.3563-11.2012; Purohit AA, 2012, J BIOL CHEM, V287, P27126, DOI 10.1074/jbc.M112.340174; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Tong JF, 2001, J BIOL CHEM, V276, P40917, DOI 10.1074/jbc.M103872200; Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002; Watari-Goshima N, 2007, NAT NEUROSCI, V10, P169, DOI 10.1038/nn1834; Yamasaki T, 2011, J NEUROSCI, V31, P16872, DOI 10.1523/JNEUROSCI.1111-11.2011; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006	76	48	51	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1883	1895		10.1074/jbc.M112.417881	http://dx.doi.org/10.1074/jbc.M112.417881			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23223444	Green Published, hybrid			2022-12-28	WOS:000313751400042
J	Isaac, R; Boura-Halfon, S; Gurevitch, D; Shainskaya, A; Levkovitz, Y; Zick, Y				Isaac, Roi; Boura-Halfon, Sigalit; Gurevitch, Diana; Shainskaya, Alla; Levkovitz, Yechiel; Zick, Yehiel			Selective Serotonin Reuptake Inhibitors (SSRIs) Inhibit Insulin Secretion and Action in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; RECEPTOR SUBSTRATE 1; INDUCED APOPTOSIS; OXIDATIVE STRESS; ISLET CELLS; PHOSPHORYLATION; PROTEIN; ANTIDEPRESSANTS; KINASE; GLUCOSE	Selective serotonin reuptake inhibitors (SSRIs) are antidepressants used for the treatment of mood and anxiety disorders. Here, we demonstrate that incubation (2 h) of murine islets or Min6 beta cell line with the SSRIs paroxetine, fluoxetine, or sertraline inhibited insulin-induced Tyr phosphorylation of insulin receptor substrate (IRS)-2 protein and the activation of its downstream targets Akt and the ribosomal protein S6 kinase-1 (S6K1). Inhibition was dose-dependent with half-maximal effects at similar to 15-20 mu M. It correlated with a rapid dephosphorylation and activation of the IRS kinase GSK3 beta. Introduction of GSK3 beta siRNAs eliminated the inhibitory effects of the SSRIs. Inhibition of IRS-2 action by 30 mu M SSRI was associated with a marked inhibition of glucose-stimulated insulin secretion from murine and human pancreatic islets. Secretion induced by basic secretagogues (KCl and Arg) was not affected by these drugs. Prolonged treatment (16 h) of Min6 cells with sertraline resulted in the induction of inducible nitric oxide synthase; activation of endoplasmic reticulum stress, and the initiation of the unfolded protein response, manifested by enhanced transcription of ATF4 and C/EBP homologous protein. This triggered an apoptotic process, manifested by enhanced caspase 3/7 activity, which resulted in beta cell death. These findings implicate SSRIs as inhibitors of IRS protein function and insulin action through the activation of GSK3 beta. They further suggest that SSRIs inhibit insulin secretion; induce the unfolded protein response; activate an apoptotic process, and trigger beta cell death. Given that SSRIs promote insulin resistance while inhibiting insulin secretion, these drugs might accelerate the transition from an insulin-resistant state to overt diabetes.	[Isaac, Roi; Boura-Halfon, Sigalit; Gurevitch, Diana; Zick, Yehiel] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Shainskaya, Alla] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Isaac, Roi; Levkovitz, Yechiel] Tel Aviv Univ, Sackler Fac Med, Shalvata Mental Hlth Ctr, IL-6997801 Ramat Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine	Zick, Y (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	Yehiel.Zick@weizmann.ac.il	Zick, Yehiel/K-1479-2012		European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Novo Nordisk program; Israel Science Foundation [759/09]; Mitchel Kaplan Fund	European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Novo Nordisk program; Israel Science Foundation(Israel Science Foundation); Mitchel Kaplan Fund	This work was supported by research grants from the European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Novo Nordisk program, The Israel Science Foundation (founded by the Israel Academy of Sciences and Humanities Grant 759/09), and the Mitchel Kaplan Fund.	ALTAMURA AC, 1994, CLIN PHARMACOKINET, V26, P201, DOI 10.2165/00003088-199426030-00004; Andersohn F, 2009, AM J PSYCHIAT, V166, P591, DOI 10.1176/appi.ajp.2008.08071065; Antoine MH, 2004, DIABETOLOGIA, V47, P909, DOI 10.1007/s00125-004-1384-9; Back SH, 2012, EXP DIABETES RES, DOI 10.1155/2012/618396; Beck A, 2011, DIABETOLOGIA, V54, P2845, DOI 10.1007/s00125-011-2277-3; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Boura-Halfon S, 2010, MOL ENDOCRINOL, V24, P2179, DOI 10.1210/me.2010-0072; Boura-Halfon S, 2009, VITAM HORM, V80, P313, DOI 10.1016/S0083-6729(08)00612-2; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Brown LC, 2008, DIABETES RES CLIN PR, V79, P61, DOI 10.1016/j.diabres.2007.07.009; Chou CT, 2007, TOXICOL APPL PHARM, V218, P265, DOI 10.1016/j.taap.2006.11.012; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; Fava M, 2000, J CLIN PSYCHIAT, V61, P863, DOI 10.4088/JCP.v61n1109; Fiory F, 2011, DIABETOLOGIA, V54, P2941, DOI 10.1007/s00125-011-2280-8; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; GarciaColunga J, 1997, P NATL ACAD SCI USA, V94, P2041, DOI 10.1073/pnas.94.5.2041; GRAM LF, 1994, NEW ENGL J MED, V331, P1354; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Gurevitch D, 2010, DIABETES, V59, P2188, DOI 10.2337/db09-0890; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Himmerich H, 2004, J PSYCHIAT RES, V38, P485, DOI 10.1016/j.jpsychires.2004.02.002; Hiyama A, 2011, J CELL BIOCHEM, V112, P2974, DOI 10.1002/jcb.23217; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; HOWELL SL, 1984, DIABETOLOGIA, V26, P319; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; KARSON CN, 1993, J NEUROPSYCH CLIN N, V5, P322; Kellerer M, 1998, DIABETOLOGIA, V41, P833, DOI 10.1007/s001250050995; Khan AH, 2002, DIABETOLOGIA, V45, P1475, DOI 10.1007/s00125-002-0974-7; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Le Roith D, 2001, DIABETES CARE, V24, P588, DOI 10.2337/diacare.24.3.588; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Levkovitz Y, 2005, J MOL NEUROSCI, V27, P29, DOI 10.1385/JMN:27:1:029; Levkovitz Y, 2007, MOL CELL NEUROSCI, V36, P305, DOI 10.1016/j.mcn.2007.05.009; Liu YF, 2004, MOL CELL BIOL, V24, P9668, DOI 10.1128/MCB.24.21.9668-9681.2004; LUNDMARK J, 1989, ACTA PSYCHIAT SCAND, V80, P76, DOI 10.1111/j.1600-0447.1989.tb07177.x; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pancrazio JJ, 1998, J PHARMACOL EXP THER, V284, P208; Pariante CM, 2001, BRIT J PHARMACOL, V134, P1335, DOI 10.1038/sj.bjp.0704368; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; PEERS B, 1994, MOL ENDOCRINOL, V8, P1798, DOI 10.1210/me.8.12.1798; Preskorn SH, 1997, CLIN PHARMACOKINET, V32, P1, DOI 10.2165/00003088-199700321-00003; Raeder MB, 2006, J CLIN PSYCHIAT, V67, P1974, DOI 10.4088/JCP.v67n1219; Reaven G, 2005, CIRCULATION, V112, P3030, DOI 10.1161/CIRCULATIONAHA.105.504670; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SHARGILL NS, 1986, BIOCHEM BIOPH RES CO, V137, P286, DOI 10.1016/0006-291X(86)91208-8; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; STANTON T, 1993, BIOCHEM PHARMACOL, V45, P2352, DOI 10.1016/0006-2952(93)90211-E; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595; Ungvari Z, 2000, J CARDIOVASC PHARM, V35, P849, DOI 10.1097/00005344-200006000-00004; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; YASUDA K, 1992, DIABETES, V41, P76, DOI 10.2337/diabetes.41.1.76; Yoshimura R, 2008, HUM PSYCHOPHARM CLIN, V23, P707, DOI 10.1002/hup.979	66	55	56	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5682	5693		10.1074/jbc.M112.408641	http://dx.doi.org/10.1074/jbc.M112.408641			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23275337	Green Published, hybrid			2022-12-28	WOS:000315342500041
J	Badri, DV; Chaparro, JM; Zhang, RF; Shen, QR; Vivanco, JM				Badri, Dayakar V.; Chaparro, Jacqueline M.; Zhang, Ruifu; Shen, Qirong; Vivanco, Jorge M.			Application of Natural Blends of Phytochemicals Derived from the Root Exudates of Arabidopsis to the Soil Reveal That Phenolic-related Compounds Predominantly Modulate the Soil Microbiome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL COMMUNITY STRUCTURE; RIBOSOMAL-RNA; PLANTS; PSEUDOMONAS; THALIANA; SIGNALS; IMPACT; ACTINOBACTERIA; STRIGOLACTONES; FLAVONOIDS	The roots of plants have the ability to influence its surrounding microbiology, the so-called rhizosphere microbiome, through the creation of specific chemical niches in the soil mediated by the release of phytochemicals. Here we report how these phytochemicals could modulate the microbial composition of a soil in the absence of the plant. For this purpose, root exudates of Arabidopsis were collected and fractionated to obtain natural blends of phytochemicals at various relative concentrations that were characterized by GC-MS and applied repeatedly to a soil. Soil bacterial changes were monitored by amplifying and pyro-sequencing the 16 S ribosomal small subunit region. Our analyses reveal that one phytochemical can culture different operational taxonomic units (OTUs), mixtures of phytochemicals synergistically culture groups of OTUs, and the same phytochemical can act as a stimulator or deterrent to different groups of OTUs. Furthermore, phenolic-related compounds showed positive correlation with a higher number of unique OTUs compared with other groups of compounds (i.e. sugars, sugar alcohols, and amino acids). For instance, salicylic acid showed positive correlations with species of Corynebacterineae, Pseudonocardineae and Streptomycineae, and GABA correlated with species of Sphingomonas, Methylobacterium, Frankineae, Variovorax, Micromonosporineae, and Skermanella. These results imply that phenolic compounds act as specific substrates or signaling molecules for a large group of microbial species in the soil.	[Badri, Dayakar V.; Chaparro, Jacqueline M.; Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Badri, Dayakar V.; Chaparro, Jacqueline M.; Vivanco, Jorge M.] Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA; [Zhang, Ruifu; Shen, Qirong] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China	Colorado State University; Colorado State University; Nanjing Agricultural University	Zhang, RF (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China.	rfzhang@njau.edu.cn; j.vivanco@colostate.edu	Shen, Qirong/AAB-6531-2020; Zhang, Ruifu/HDN-0340-2022; Zhang, Ruifu/HDN-0417-2022		National Science Foundation [MCB0950857]; National Natural Science Foundation of China [41271271]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; 111 Project [B12009]	National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; 111 Project(Ministry of Education, China - 111 Project)	This work was supported by National Science Foundation Grant MCB0950857 (to J.M.V.).; Supported by the National Natural Science Foundation of China (41271271) and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions.; Part of the 111 Project (B12009).	Abdel-Lateif K, 2012, PLANT SIGNAL BEHAV, V7, P636, DOI 10.4161/psb.20039; Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497; Badri DV, 2008, NEW PHYTOL, V179, P209, DOI 10.1111/j.1469-8137.2008.02458.x; Badri DV, 2008, PLANT PHYSIOL, V146, P762, DOI 10.1104/pp.107.109587; Badri DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046640; Badri Dayakar V, 2012, Front Plant Sci, V3, P149, DOI 10.3389/fpls.2012.00149; Badri DV, 2009, CURR OPIN BIOTECH, V20, P642, DOI 10.1016/j.copbio.2009.09.014; Badri DV, 2009, PLANT PHYSIOL, V151, P2006, DOI 10.1104/pp.109.147462; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; Bakker MG, 2012, PLANT SOIL, V360, P1, DOI 10.1007/s11104-012-1361-x; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; BEHERA B, 1974, SOIL SCI SOC AM J, V38, P591, DOI 10.2136/sssaj1974.03615995003800040021x; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Broughton WJ, 2003, PLANT SOIL, V252, P129, DOI 10.1023/A:1024179717780; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Cai T, 2009, MOL MICROBIOL, V73, P507, DOI 10.1111/j.1365-2958.2009.06790.x; Castillo UF, 2007, MICROB ECOL, V53, P12, DOI 10.1007/s00248-006-9129-6; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Chen G, 2003, RES MICROBIOL, V154, P393, DOI 10.1016/S0923-2508(03)00082-2; Chevrot R, 2006, P NATL ACAD SCI USA, V103, P7460, DOI 10.1073/pnas.0600313103; Conn VM, 2008, MOL PLANT MICROBE IN, V21, P208, DOI 10.1094/MPMI-21-2-0208; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Doornbos RF, 2012, AGRON SUSTAIN DEV, V32, P227, DOI 10.1007/s13593-011-0028-y; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eilers KG, 2010, SOIL BIOL BIOCHEM, V42, P896, DOI 10.1016/j.soilbio.2010.02.003; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Hosie AHF, 2002, J BACTERIOL, V184, P4071, DOI 10.1128/JB.184.15.4071-4080.2002; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Li X, 2010, MOL PLANT, V3, P91, DOI 10.1093/mp/ssp090; Lin YT, 2012, APPL SOIL ECOL, V60, P49, DOI 10.1016/j.apsoil.2012.03.001; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mercado-Blanco J, 2007, ANTON LEEUW INT J G, V92, P367, DOI 10.1007/s10482-007-9167-1; Micallef SA, 2009, PLANT SIGNAL BEHAV, V4, P777, DOI 10.1093/jxb/erp053; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; Neal AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035498; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Omrane S, 2009, PLANT SIGNAL BEHAV, V4, P1066, DOI 10.4161/psb.4.11.9735; Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367; Prithiviraj B, 2005, INFECT IMMUN, V73, P5319, DOI 10.1128/IAI.73.9.5319-5328.2005; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin S, 2009, APPL ENVIRON MICROB, V75, P6176, DOI 10.1128/AEM.01034-09; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Saleem M, 2007, J IND MICROBIOL BIOT, V34, P635, DOI 10.1007/s10295-007-0240-6; Sana TR, 2010, METABOLOMICS, V6, P451, DOI 10.1007/s11306-010-0218-7; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Singh BK, 2007, APPL SOIL ECOL, V36, P147, DOI 10.1016/j.apsoil.2007.01.004; Somers E, 2004, CRIT REV MICROBIOL, V30, P205, DOI 10.1080/10408410490468786; Sood SG, 2003, FEMS MICROBIOL ECOL, V45, P219, DOI 10.1016/S0168-6496(03)00155-7; Speed T. P., 2003, STAT ANAL GENE EXPRE, P222; Steinkellner S, 2007, MOLECULES, V12, P1290, DOI 10.3390/12071290; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Wallace RJ, 2004, P NUTR SOC, V63, P621, DOI 10.1079/PNS2004393; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yoneyama K, 2008, NEW PHYTOL, V179, P484, DOI 10.1111/j.1469-8137.2008.02462.x; Zhang J, 2009, PLANT J, V57, P171, DOI 10.1111/j.1365-313X.2008.03676.x	67	290	306	15	52	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4502	4512		10.1074/jbc.M112.433300	http://dx.doi.org/10.1074/jbc.M112.433300			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23293028	Green Published, hybrid			2022-12-28	WOS:000315340400001
J	He, C; Li, FD; Zhang, JH; Wu, JH; Shi, YY				He, Chao; Li, Fudong; Zhang, Jiahai; Wu, Jihui; Shi, Yunyu			The Methyltransferase NSD3 Has Chromatin-binding Motifs, PHD5-C5HCH, That Are Distinct from Other NSD (Nuclear Receptor SET Domain) Family Members in Their Histone H3 Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; TANDEM PHD FINGER; LYSINE 36; COMBINATORIAL READOUT; MULTIPLE-MYELOMA; LINKS; GENE; METHYLATION; MECHANISM; BROMODOMAIN	The NSD (nuclear receptor SET domain-containing) family members, consisting of NSD1, NSD2 (MMSET/WHSC1), and NSD3 (WHSC1L1), are SET domain-containing methyltransferases and aberrant expression of each member has been implicated in multiple diseases. They have specific mono-and dimethylase activities for H3K36, whereas play nonredundant roles during development. Aside from the well characterized catalytic SET domain, NSD proteins have multiple potential chromatin-binding motifs that are clinically relevant, including the fifth plant homeodomain (PHD5) and the adjacent Cys-His-rich domain (C5HCH) located at the C terminus. Herein, we report the crystal structures of the PHD5-C5HCH module of NSD3, in the free state and in complex with H3(1-7) (H3 residues 1-7), H3(1-15) (H3 residues 1-15), and H3(1-15)K9me3 (H3 residues 1-15 with trimethylation on K9) peptides. These structures reveal that the PHD5 and C5HCH domains fold into a novel integrated PHD-PHD-like structural module with H3 peptide bound only on the surface of PHD5 and provide the molecular basis for the recognition of unmodified H3K4 and trimethylated H3K9 by NSD3 PHD5. Structural studies and binding assays show that differences exist in histone binding specificity of the PHD5 domain between three members of the NSD family. For NSD2, the PHD5-C5HCH: H3 N terminus interaction is largely conserved, although with a stronger preference for unmethylated H3K9 (H3K9me0) than trimethylated H3K9 (H3K9me3), and NSD1 PHD5-C5HCH does not bind to H3 peptides. Our results shed light on how NSD proteins that mediate H3K36 methylation are localized to specific genomic sites and provide implications for the mechanism of functional diversity of NSD proteins.	[Wu, Jihui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Shi, Yunyu/B-3240-2009	Shi, Yunyu/0000-0002-1348-4759	National Basic Research Program of China 973 Program [2011CB966302, 2012CB917201, 2011CB911104]; Chinese National Natural Science Foundation [30830031, 31170693]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China 973 Program Grants 2011CB966302, 2012CB917201, and 2011CB911104 and Chinese National Natural Science Foundation Grants 30830031 and 31170693.	Angrand PO, 2001, GENOMICS, V74, P79, DOI 10.1006/geno.2001.6524; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Cerveira N, 2003, LEUKEMIA, V17, P2244, DOI 10.1038/sj.leu.2403104; Chignola Francesca, 2009, Nucleic Acids Res, V37, P2951, DOI 10.1093/nar/gkp166; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Douglas J, 2005, EUR J HUM GENET, V13, P150, DOI 10.1038/sj.ejhg.5201298; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Faravelli F, 2005, AM J MED GENET C, V137C, P24, DOI 10.1002/ajmg.c.30061; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Keats JJ, 2005, BLOOD, V105, P4060, DOI 10.1182/blood-2004-09-3704; Keats JJ, 2003, BLOOD, V101, P1520, DOI 10.1182/blood-2002-06-1675; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Lucio-Eterovic AK, 2011, TRANSCR-AUSTIN, V2, P158, DOI 10.4161/trns.2.4.16217; Lucio-Eterovic AK, 2010, P NATL ACAD SCI USA, V107, P16952, DOI 10.1073/pnas.1002653107; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musselman CA, 2012, P NATL ACAD SCI USA, V109, P787, DOI 10.1073/pnas.1113655109; Nielsen AL, 2004, MOL CELL BIOL, V24, P5184, DOI 10.1128/MCB.24.12.5184-5196.2004; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Qin S, 2011, J BIOL CHEM, V286, P36944, DOI 10.1074/jbc.M111.244400; Qiu Y, 2012, GENE DEV, V26, P1376, DOI 10.1101/gad.188359.112; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Shen WQ, 2007, BIOCHEMISTRY-US, V46, P2100, DOI 10.1021/bi0611208; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Slama P, 2011, NUCLEIC ACIDS RES, V39, P1666, DOI 10.1093/nar/gkq947; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright TJ, 1997, HUM MOL GENET, V6, P317, DOI 10.1093/hmg/6.2.317; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139	50	40	44	0	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4692	4703		10.1074/jbc.M112.426148	http://dx.doi.org/10.1074/jbc.M112.426148			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23269674	Green Published, hybrid			2022-12-28	WOS:000315340400018
J	Moroz, NA; Novak, SM; Azevedo, R; Colpan, M; Uversky, VN; Gregorio, CC; Kostyukova, AS				Moroz, Natalia A.; Novak, Stefanie M.; Azevedo, Ricardo; Colpan, Mert; Uversky, Vladimir N.; Gregorio, Carol C.; Kostyukova, Alla S.			Alteration of Tropomyosin-binding Properties of Tropomodulin-1 Affects Its Capping Ability and Localization in Skeletal Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINUS; CIRCULAR-DICHROISM; STRIATED-MUSCLE; FILAMENT ARCHITECTURE; ACTIN POLYMERIZATION; ALPHA-TROPOMYOSIN; CARDIAC MYOCYTES; PROTEIN; MYOSIN; DYNAMICS	Tropomodulin (Tmod) is an actin-capping protein that binds to the two tropomyosins (TM) at the pointed end of the actin filament to prevent further actin polymerization and depolymerization. Therefore, understanding the role of Tmod is very important when studying actin filament dependent processes such as muscle contraction and intracellular transport. The capping ability of Tmod is highly influenced by TM and is 1000-fold greater in the presence of TM. There are four Tmod isoforms (Tmod1-4), three of which, Tmod1, Tmod3, and Tmod4, are expressed in skeletal muscles. The affinity of Tmod1 to skeletal striated TM (stTM) is higher than that of Tmod3 and Tmod4 to stTM. In this study, we tested mutations in the TM-binding sites of Tmod1, using circular dichroism (CD) and prediction analysis (PONDR). The mutations R11K, D12N, and Q144K were chosen because they decreased the affinity of Tmod1 to stTM, making it similar to that of affinity of Tmod3 and Tmod4 to stTM. Significant reduction of inhibition of actin pointed-end polymerization in the presence of stTM was shown for Tmod1 (R11K/D12N/Q144K) as compared with WT Tmod1. When GFP-Tmod1 and mutants were expressed in primary chicken skeletal myocytes, decreased assembly of Tmod1 mutants was revealed. This indicates a direct correlation between TM-binding and the actin-capping abilities of Tmod. Our data confirmed the hypothesis that assembly of Tmod at the pointed-end of the actin filament depends on its TM-binding affinity.	[Moroz, Natalia A.; Colpan, Mert; Kostyukova, Alla S.] Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Novak, Stefanie M.; Gregorio, Carol C.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA; [Novak, Stefanie M.; Gregorio, Carol C.] Univ Arizona, Sarver Mol Cardiovasc Res Program, Tucson, AZ 85724 USA; [Azevedo, Ricardo; Kostyukova, Alla S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia; [Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA	Washington State University; University of Arizona; University of Arizona; Rutgers State University New Brunswick; Rutgers State University Medical Center; Russian Academy of Sciences; State University System of Florida; University of South Florida	Kostyukova, AS (corresponding author), Washington State Univ, Voiland Sch Chem Engn & Bioengn, 118 Dana Hall,Spokane St, Pullman, WA 99164 USA.	alla.kostyukova@wsu.edu	Moroz, Natalia A/E-5287-2013; Uversky, Vladimir N./F-4515-2011	Moroz, Natalia A/0000-0001-5621-3898; Uversky, Vladimir N./0000-0002-4037-5857	National Institutes of Health [GM081688, HL083146, HL108625]; American Heart Association [11900038]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081386, R01HL108625, R01HL083146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM081688 (to A. S. K.) and HL083146 and HL108625 (to C. C. G.).; Supported by American Heart Association Grant 11900038.	Cheng YG, 2006, BIOCHEMISTRY-US, V45, P10448, DOI 10.1021/bi060981d; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FASMAN GD, 1989, TRENDS BIOCHEM SCI, V14, P295, DOI 10.1016/0968-0004(89)90068-6; Fischer RS, 2006, J BIOL CHEM, V281, P36454, DOI 10.1074/jbc.M606315200; Garner, 1999, Genome Inform Ser Workshop Genome Inform, V10, P41; GERHARD MD, 1985, J BIOL CHEM, V260, P3221; Gilbert R, 1996, J CELL SCI, V109, P101; Gokhin DS, 2010, J CELL BIOL, V189, P95, DOI 10.1083/jcb.201001125; Greenfield NJ, 1998, BIOCHEMISTRY-US, V37, P7834, DOI 10.1021/bi973167m; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Greenfield NJ, 2001, J MOL BIOL, V312, P833, DOI 10.1006/jmbi.2001.4982; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Greenfield Norma J, 2004, Methods Mol Biol, V261, P55; GREGORIO CC, 1995, NATURE, V377, P83, DOI 10.1038/377083a0; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Kostyukova A, 2000, EUR J BIOCHEM, V267, P6470, DOI 10.1046/j.1432-1327.2000.01738.x; Kostyukova AS, 2008, CELL MOL LIFE SCI, V65, P563, DOI 10.1007/s00018-007-7347-9; Kostyukova AS, 2007, J MOL BIOL, V372, P608, DOI 10.1016/j.jmb.2007.05.084; Kostyukova AS, 2006, BIOCHEMISTRY-US, V45, P12068, DOI 10.1021/bi060899i; Kostyukova AS, 2004, J BIOL CHEM, V279, P5066, DOI 10.1074/jbc.M311186200; Kostyukova AS, 2001, BIOPHYS J, V81, P345, DOI 10.1016/S0006-3495(01)75704-9; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Mudry RE, 2003, J CELL BIOL, V162, P1057, DOI 10.1083/jcb.200305031; NAWROTZKI R, 1995, J MUSCLE RES CELL M, V16, P45, DOI 10.1007/BF00125309; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Pappas CT, 2008, MOL BIOL CELL, V19, P1837, DOI 10.1091/mbc.E07-07-0690; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUNG LA, 1994, BIOCHEM BIOPH RES CO, V201, P627, DOI 10.1006/bbrc.1994.1747; Sussman MA, 1998, CIRC RES, V82, P94; Tsukada T, 2011, J BIOL CHEM, V286, P2194, DOI 10.1074/jbc.M110.186924; Uversky VN, 2011, J MOL RECOGNIT, V24, P647, DOI 10.1002/jmr.1093; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031; Yamashiro S, 2010, J BIOL CHEM, V285, P33265, DOI 10.1074/jbc.M110.144873	41	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4899	4907		10.1074/jbc.M112.434522	http://dx.doi.org/10.1074/jbc.M112.434522			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23271735	hybrid, Green Published			2022-12-28	WOS:000315340400038
J	Toichi, K; Yamanaka, K; Furukawa, Y				Toichi, Keisuke; Yamanaka, Koji; Furukawa, Yoshiaki			Disulfide Scrambling Describes the Oligomer Formation of Superoxide Dismutase (SOD1) Proteins in the Familial Form of Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU,ZN-SUPEROXIDE DISMUTASE; POSTTRANSLATIONAL MODIFICATIONS; DECREASED STABILITY; AGGREGATION; APO; MUTATIONS; MUTANTS; CU	Dominant mutations in Cu,Zn-superoxide dismutase (SOD1) are a cause of a familial form of amyotrophic lateral sclerosis. Wild-type SOD1 forms a highly conserved intra-molecular disulfide bond, whereas pathological SOD1 proteins are crosslinked via intermolecular disulfide bonds and form insoluble oligomers. A thiol-disulfide status in SOD1 will thus play a regulatory role in determining its folding/misfolding pathways; however, it remains unknown how pathogenic mutations in SOD1 affect the thiol-disulfide status to facilitate the protein misfolding. Here, we show that the structural destabilization of SOD1 scrambles a disulfide bond among four Cys residues in an SOD1 molecule. The disulfide scrambling produces SOD1 monomers with distinct electrophoretic mobility and also reproduces the formation of disulfide-linked oligomers. We have also found that the familial form of amyotrophic lateral sclerosis-causing mutations facilitate the disulfide scrambling in SOD1. Based upon our results, therefore, scrambling of the conserved disulfide bond will be a key event to cause the pathological changes in disease-associated mutant SOD1 proteins.	[Toichi, Keisuke; Furukawa, Yoshiaki] Keio Univ, Dept Chem, Lab Mechanist Chem Biomol, Yokohama, Kanagawa 2238522, Japan; [Yamanaka, Koji] RIKEN Brain Sci Inst, Lab Motor Neuron Dis, Wako, Saitama 3510198, Japan	Keio University; RIKEN	Furukawa, Y (corresponding author), Keio Univ, Dept Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	furukawa@chem.keio.ac.jp	Yamanaka, Koji/ABD-1034-2020; Furukawa, Yoshiaki/F-2871-2014; Yamanaka, Koji/H-5806-2011	Yamanaka, Koji/0000-0003-4655-0035; Furukawa, Yoshiaki/0000-0002-1918-372X; Yamanaka, Koji/0000-0003-4655-0035	Ministry of Education, Culture, Sports, Science and Technology of Japan [24111542, 23111006, 24657093]; Research Committee of CNS Degenerative Diseases from the Ministry of Health, Labor, and Welfare of Japan; CREST, Japan Science and Technology Agency; Japan ALS association; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Committee of CNS Degenerative Diseases from the Ministry of Health, Labor, and Welfare of Japan; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan ALS association; Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was supported by Grants-in-aid 24111542 (to Y. F.) and 23111006 (to K. Y.) for Scientific Research on Innovative Areas and 24657093 (to Y. F.) for Challenging Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, grants-in-aid from the Research Committee of CNS Degenerative Diseases from the Ministry of Health, Labor, and Welfare of Japan and from CREST, Japan Science and Technology Agency (to K. Y.), a grant from Japan ALS association (to Y. F.), and a grant from the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to Y. F.).	Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; BORDO D, 1994, J MOL BIOL, V238, P366, DOI 10.1006/jmbi.1994.1298; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Bruns CK, 2007, EMBO J, V26, P855, DOI 10.1038/sj.emboj.7601528; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Furukawa Y, 2011, AMYOTROPHIC LATERAL SCLEROSIS, P335; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; Rumfeldt JAO, 2006, J MOL BIOL, V355, P106, DOI 10.1016/j.jmb.2005.10.042; Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200	32	53	54	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4970	4980		10.1074/jbc.M112.414235	http://dx.doi.org/10.1074/jbc.M112.414235			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264618	Green Published, hybrid			2022-12-28	WOS:000315340400044
J	Wang, Z; Anderson, NS; Benning, C				Wang, Zhen; Anderson, Nicholas Scott; Benning, Christoph			The Phosphatidic Acid Binding Site of the Arabidopsis Trigalactosyldiacylglycerol 4 (TGD4) Protein Required for Lipid Import into Chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; TRAFFICKING; METABOLISM; ELECTROPHORESIS; ACTIVATION; SEQUENCE; GROWTH; ER	Chloroplast membrane lipid synthesis relies on the import of glycerolipids from the ER. The TGD (TriGalactosylDiacylglycerol) proteins are required for this lipid transfer process. The TGD1, -2, and -3 proteins form a putative ABC (ATP-binding cassette) transporter transporting ER-derived lipids through the inner envelope membrane of the chloroplast, while TGD4 binds phosphatidic acid (PtdOH) and resides in the outer chloroplast envelope. We identified two sequences in TGD4, amino acids 1-80 and 110-145, which are necessary and sufficient for PtdOH binding. Deletion of both sequences abolished PtdOH binding activity. We also found that TGD4 from 18: 3 plants bound specifically and with increased affinity PtdOH. TGD4 did not interact with other proteins and formed a homodimer both in vitro and in vivo. Our results suggest that TGD4 is an integral dimeric beta-barrel lipid transfer protein that binds PtdOH with its N terminus and contains dimerization domains at its C terminus.	[Wang, Zhen; Anderson, Nicholas Scott; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Benning, C (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	benning@msu.edu	Benning, Christoph/Y-2528-2019; Wang, Zhen/B-5067-2014	Benning, Christoph/0000-0001-8585-3667; Wang, Zhen/0000-0003-4823-8002; Wang, Zhen/0000-0002-3244-690X	United States National Science Foundation [MCB 0741395, MCB 1157231]; Div Of Molecular and Cellular Bioscience [1157231] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in parts by Grants MCB 0741395 and MCB 1157231 from the United States National Science Foundation (to C. B.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Du ZY, 2010, PLANT PHYSIOL, V152, P1585, DOI 10.1104/pp.109.147066; Dubots E, 2010, J BIOL CHEM, V285, P6003, DOI 10.1074/jbc.M109.071928; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; FRENTZEN M, 1983, EUR J BIOCHEM, V129, P629; Haarmann R, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454124; Hayat S, 2012, BIOINFORMATICS, V28, P516, DOI 10.1093/bioinformatics/btr710; HEINZ E, 1983, PLANT PHYSIOL, V72, P273, DOI 10.1104/pp.72.2.273; Imai K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-79; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lu BB, 2007, J BIOL CHEM, V282, P35945, DOI 10.1074/jbc.M704063200; Lu BB, 2009, J BIOL CHEM, V284, P17420, DOI 10.1074/jbc.M109.016014; Mongrand S, 1998, PHYTOCHEMISTRY, V49, P1049, DOI 10.1016/S0031-9422(98)00243-X; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakamura Y, 2007, J BIOL CHEM, V282, P29013, DOI 10.1074/jbc.M704385200; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Roston R, 2011, PLANT J, V66, P759, DOI 10.1111/j.1365-313X.2011.04536.x; Roston RL, 2012, J BIOL CHEM, V287, P21406, DOI 10.1074/jbc.M112.370213; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SHAPIRO AL, 1969, ANAL BIOCHEM, V29, P505, DOI 10.1016/0003-2697(69)90335-2; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Testerink C, 2004, PLANT J, V39, P527, DOI 10.1111/j.1365-313X.2004.02152.x; Wang Z, 2012, PLANT J, V70, P614, DOI 10.1111/j.1365-313X.2012.04900.x; Wang Z, 2012, BIOCHEM SOC T, V40, P457, DOI 10.1042/BST20110752; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Xu CC, 2008, PLANT CELL, V20, P2190, DOI 10.1105/tpc.108.061176; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101	34	46	48	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4763	4771		10.1074/jbc.M112.438986	http://dx.doi.org/10.1074/jbc.M112.438986			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23297418	Green Published, hybrid			2022-12-28	WOS:000315340400025
J	Chatterjee, D; Chaudhuri, K				Chatterjee, Debashree; Chaudhuri, Keya			Vibrio cholerae O395 Outer Membrane Vesicles Modulate Intestinal Epithelial Cells in a NOD1 Protein-dependent Manner and Induce Dendritic Cell-mediated Th2/Th17 Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSE; INFLAMMATORY MEDIATORS; PSEUDOMONAS-AERUGINOSA; ACTIVATION; INTERLEUKIN-17; IL-17; PEPTIDOGLYCAN; EXPRESSION; VIRULENCE	Like other Gram-negative pathogens, Vibrio cholerae, the causative agent of the diarrheal disease cholera, secretes outer membrane vesicles (OMVs). OMVs are complex entities composed of a subset of envelope lipid and protein components and play a role in the delivery of effector molecules to host cells. We previously showed that V. cholerae O395 cells secrete OMVs that are internalized by host cells, but their role in pathogenesis has not been well elucidated. In the present study, we evaluated the interaction of OMVs with intestinal epithelial cells. These vesicles induced expression of proinflammatory cytokines such as IL-8 and GM-CSF and chemokines such as CCL2, CCL20, and thymic stromal lymphopoietin in epithelial cells through activation of MAPK and NF-kappa B pathways in NOD1-dependent manner. Epithelial cells stimulated with OMVs activated dendritic cells (DCs) in a direct co-culture system. Activated DCs expressed high levels of co-stimulatory molecules; released inflammatory cytokines IL-1 beta, IL-6, TNF-alpha, and IL-23 and chemokines CCL22 and CCL17; and subsequently primed CD4(+) T cells leading to IL-4, IL-13, and IL-17 expression. These results suggest that V. cholerae O395 OMVs modulate the epithelial proinflammatory response and activate DCs, which promote T cell polarization toward an inflammatory Th2/Th17 response.	[Chatterjee, Debashree; Chaudhuri, Keya] Indian Inst Chem Biol, CSIR, Mol & Human Genet Div, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Chaudhuri, K (corresponding author), Indian Inst Chem Biol, CSIR, Mol & Human Genet Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	keya.chaudhuri@gmail.com			Council of Scientific and Industrial Research (CSIR), Government of India; CSIR fellowship	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR fellowship(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by the Council of Scientific and Industrial Research (CSIR), Government of India.; Recipient of a CSIR fellowship.	Allison CC, 2009, J IMMUNOL, V183, P8099, DOI 10.4049/jimmunol.0900664; Bandyopadhaya A, 2008, MICROB PATHOGENESIS, V44, P524, DOI 10.1016/j.micpath.2008.01.004; Bandyopadhaya A, 2007, INT J BIOCHEM CELL B, V39, P1863, DOI 10.1016/j.biocel.2007.05.005; Bandyopadhaya A, 2009, MOL IMMUNOL, V46, P1129, DOI 10.1016/j.molimm.2008.11.003; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Bettelli E, 2005, J EXP MED, V201, P169, DOI 10.1084/jem.20042279; Bhowmick S, 2012, INT J BIOCHEM CELL B, V44, P1779, DOI 10.1016/j.biocel.2012.06.030; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chatterjee D, 2011, FEBS LETT, V585, P1357, DOI 10.1016/j.febslet.2011.04.017; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gunn MD, 2003, SEMIN IMMUNOL, V15, P271, DOI 10.1016/j.smim.2003.08.004; Ismail S, 2003, INFECT IMMUN, V71, P5670, DOI 10.1128/IAI.71.10.5670-5675.2003; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kawaguchi M, 2004, J ALLERGY CLIN IMMUN, V114, P1265, DOI 10.1016/j.jaci.2004.10.019; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; Luzza F, 2000, J IMMUNOL, V165, P5332, DOI 10.4049/jimmunol.165.9.5332; Maeda S, 2001, J BIOL CHEM, V276, P44856, DOI 10.1074/jbc.M105381200; Matson JS, 2010, J BACTERIOL, V192, P2044, DOI 10.1128/JB.00023-10; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Naumann M, 2000, BIOCHEM PHARMACOL, V60, P1109, DOI 10.1016/S0006-2952(00)00390-7; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; Opitz B, 2006, J IMMUNOL, V176, P484, DOI 10.4049/jimmunol.176.1.484; Qadri F, 2002, CLIN DIAGN LAB IMMUN, V9, P221, DOI 10.1128/CDLI.9.2.221-229.2002; Qadri F, 2004, GUT, V53, P62, DOI 10.1136/gut.53.1.62; Rimoldi M, 2005, BLOOD, V106, P2818, DOI 10.1182/blood-2004-11-4321; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Sanchez J, 2005, CURR OPIN IMMUNOL, V17, P388, DOI 10.1016/j.coi.2005.06.007; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497	41	58	61	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4299	4309		10.1074/jbc.M112.408302	http://dx.doi.org/10.1074/jbc.M112.408302			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23275338	hybrid, Green Published			2022-12-28	WOS:000314845000058
J	Efendiev, R; Bavencoffe, A; Hu, HZ; Zhu, MX; Dessauer, CW				Efendiev, Riad; Bavencoffe, Alexis; Hu, Hongzhen; Zhu, Michael X.; Dessauer, Carmen W.			Scaffolding by A-Kinase Anchoring Protein Enhances Functional Coupling between Adenylyl Cyclase and TRPV1 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED ION-CHANNEL; CAPSAICIN RECEPTOR; PROSTAGLANDIN E-2; MICE LACKING; INFLAMMATORY PAIN; COMPLEX; AKAP79; DESENSITIZATION; SENSITIZATION; MEMBRANE	Scaffolding proteins often bring kinases together with their substrates to facilitate cell signaling. This arrangement is critical for the phosphorylation and regulation of the transient receptor potential vanilloid 1 (TRPV1) channel, a key target of inflammatory mediators such as prostaglandins. The protein kinase A anchoring protein AKAP79/150 organizes a multiprotein complex to position protein kinase A (PKA) and protein kinase C (PKC) in the immediate proximity of TRPV1 channels to enhance phosphorylation efficiency. This arrangement suggests that regulators upstream of the kinases must also be present in the signalosome. Here, we show that AKAP79/150 facilitates a complex containing TPRV1 and adenylyl cyclase (AC). The anchoring of AC to this complex generates local pools of cAMP, shifting the concentration of forskolin required to attenuate capsaicin-dependent TRPV1 desensitization by similar to 100-fold. Anchoring of AC to the complex also sensitizes the channel to activation by beta-adrenergic receptor agonists. Significant AC activity is found associated with TRPV1 in dorsal root ganglia. The dissociation of AC from an AKAP150-TRPV1 complex in dorsal root ganglia neurons abolishes sensitization of TRPV1 induced by forskolin and prostaglandin E-2. Thus, the direct anchoring of both PKA and AC to TRPV1 by AKAP79/150 facilitates the response to inflammatory mediators and may be critical in the pathogenesis of thermal hyperalgesia.	[Efendiev, Riad; Bavencoffe, Alexis; Hu, Hongzhen; Zhu, Michael X.; Dessauer, Carmen W.] Univ Texas Houston, Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Dessauer, CW (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	Carmen.W.Dessauer@uth.tmc.edu	; Dessauer, Carmen/N-6933-2018	Bavencoffe, Alexis Guillaume/0000-0001-5659-5988; Dessauer, Carmen/0000-0003-1210-4280; Hu, Hongzhen/0000-0002-8967-7522	National Institutes of Health [GM60419, GM60419-10S1, DK081654, GM081658, GM092759]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419, R01GM081658, R01GM092759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60419 and GM60419-10S1 (to C. W. D.) and DK081654, GM081658, and GM092759 (to M. X. Z.).	Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bhave G, 2004, J NEUROBIOL, V61, P88, DOI 10.1002/neu.20083; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Brandao KE, 2012, J COMP NEUROL, V520, P81, DOI 10.1002/cne.22692; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Distler C, 2003, J NEUROPHYSIOL, V89, P2499, DOI 10.1152/jn.00713.2002; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Halls ML, 2010, EMBO J, V29, P2772, DOI 10.1038/emboj.2010.168; Holzer P, 2008, BRIT J PHARMACOL, V155, P1145, DOI 10.1038/bjp.2008.351; Hu HJ, 2002, J NEUROSCI, V22, P7444; Huang JH, 2006, CURR NEUROPHARMACOL, V4, P197, DOI 10.2174/157015906778019554; Jeske NA, 2008, PAIN, V138, P604, DOI 10.1016/j.pain.2008.02.022; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Kim KS, 2007, GENES BRAIN BEHAV, V6, P120, DOI 10.1111/j.1601-183X.2006.00238.x; Kim KS, 2006, P NATL ACAD SCI USA, V103, P3908, DOI 10.1073/pnas.0508812103; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Li Y, 2012, J BIOL CHEM, V287, P29815, DOI 10.1074/jbc.M112.380568; Lin CR, 2006, J PHARMACOL EXP THER, V319, P1096, DOI 10.1124/jpet.106.105569; Lopshire JC, 1998, J NEUROSCI, V18, P6081; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; Moriyama T, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-3; Nagy I, 2004, EUR J PHARMACOL, V500, P351, DOI 10.1016/j.ejphar.2004.07.037; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Palazzo E, 2012, CURR OPIN PHARMACOL, V12, P9, DOI 10.1016/j.coph.2011.10.022; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Por ED, 2010, BIOCHEM J, V432, P549, DOI 10.1042/BJ20100936; PREMONT RT, 1994, METHOD ENZYMOL, V238, P116; Rathee PK, 2002, J NEUROSCI, V22, P4740, DOI 10.1523/JNEUROSCI.22-11-04740.2002; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Sadana R, 2009, MOL PHARMACOL, V76, P1256, DOI 10.1124/mol.109.058370; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Sanderson JL, 2011, NEUROSCIENTIST, V17, P321, DOI 10.1177/1073858410384740; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Southall MD, 2001, J BIOL CHEM, V276, P16083, DOI 10.1074/jbc.M011408200; Vadakkan KI, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-7; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Yang DN, 2002, J NEUROSCI, V22, P6388; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015	51	36	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3929	3937		10.1074/jbc.M112.428144	http://dx.doi.org/10.1074/jbc.M112.428144			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264624	Green Published, hybrid			2022-12-28	WOS:000314845000023
J	Liu, ZX; Liu, H; Desai, S; Schmitt, DC; Zhou, M; Khong, HT; Klos, KS; McClellan, S; Fodstad, O; Tan, M				Liu, Zixing; Liu, Hao; Desai, Shruti; Schmitt, David C.; Zhou, Ming; Khong, Hung T.; Klos, Kristine S.; McClellan, Steven; Fodstad, Oystein; Tan, Ming			miR-125b Functions as a Key Mediator for Snail-induced Stem Cell Propagation and Chemoresistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; MICRORNA EXPRESSION; PACLITAXEL TAXOL; GENE-EXPRESSION; DOWN-REGULATION; RESISTANCE; OVARIAN; DIFFERENTIATION; DEREGULATION	Chemoresistance is a major obstacle in cancer treatment. Our previous studies have shown that miR-125b plays an important role in chemoresistance. Here we report a novel mechanism that up-regulation of miR-125b through Wnt signaling by Snail enriches cancer stem cells. Overexpression of Snail dramatically increases the expression of miR-125b through the Snail-activated Wnt/beta-catenin/TCF4 axis. Snail confers chemoresistance by repressing Bak1 through up-regulation of miR-125b. Restoring the expression of Bak1 or depleting miR-125b re-sensitizes Snail-expressing cancer cells to Taxol, indicating that miR-125b is critical in Snail-induced chemoresistance. Moreover, overexpression of miR-125b significantly increases the cancer stem cell population (CD24-CD44+), while depletion of miR-125b or rescue of the expression of Bak1 increases the non-stem cell population (CD24+CD44+) in Snail-overexpressing cells. These findings strongly support that miR-125b functions as a key mediator in Snail-induced cancer stem cell enrichment and chemoresistance. This novel mechanism for Snail-induced stem cell propagation and chemoresistance may have important implications in the development of strategies for overcoming cancer cell resistance to chemotherapy.	[Liu, Zixing; Liu, Hao; Desai, Shruti; Schmitt, David C.; McClellan, Steven; Tan, Ming] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Liu, Hao] Sichuan Univ, W China Med Ctr, Dept Biochem & Mol Biol, Chengdu 610041, Peoples R China; [Zhou, Ming] Cent S Univ, Canc Res Inst, Changsha 41008, Hunan, Peoples R China; [Khong, Hung T.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Klos, Kristine S.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Fodstad, Oystein] Univ Oslo, Norwegian Radium Hosp, Dept Tumor Biol, N-0310 Oslo, Norway; [Tan, Ming] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36608 USA	University of South Alabama; Sichuan University; Central South University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; University of Oslo; University of South Alabama	Tan, M (corresponding author), Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA.	mtan@usouthal.edu	Tan, Ming/ABD-5847-2021	Tan, Ming/0000-0003-2007-9898	National Institutes of Health/NCI [R01CA149646]; Vincent F. Kilborn, Jr. Cancer Research Foundation; Norwegian Radiumhospitalet Legater [334003]; NATIONAL CANCER INSTITUTE [R01CA149646] Funding Source: NIH RePORTER	National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vincent F. Kilborn, Jr. Cancer Research Foundation; Norwegian Radiumhospitalet Legater; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health/NCI Grant R01CA149646 (to M. T.), the Vincent F. Kilborn, Jr. Cancer Research Foundation (to M. T.), and The Norwegian Radiumhospitalet Legater (Project 334003, to M. T. and O. F.).	ARBUCK SG, 1994, HEMATOL ONCOL CLIN N, V8, P121, DOI 10.1016/S0889-8588(18)30191-6; Bishop J F, 1997, Oncology (Williston Park), V11, P19; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen Wei-Juan, 2010, Chin J Cancer, V29, P151; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Donnenberg VS, 2005, J CLIN PHARMACOL, V45, P872, DOI 10.1177/0091270005276905; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Giaccone, 1996, Oncologist, V1, P82; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gururajan M, 2010, INT IMMUNOL, V22, P583, DOI 10.1093/intimm/dxq042; HORTOBAGYI GN, 1994, ONCOLOGY, V51, P29, DOI 10.1159/000227413; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Li X, 2012, CELL DEATH DIFFER, V19, P378, DOI 10.1038/cdd.2011.127; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MEDEN H, 1994, GEBURTSH FRAUENHEILK, V54, P187, DOI 10.1055/s-2007-1023580; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Parekh H, 1997, BIOCHEM PHARMACOL, V53, P461, DOI 10.1016/S0006-2952(97)83383-7; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; SLEDGE GW, 1994, SEMIN ONCOL, V21, P15; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Yin T, 2007, J SURG RES, V141, P196, DOI 10.1016/j.jss.2006.09.027; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	46	48	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4334	4345		10.1074/jbc.M112.419168	http://dx.doi.org/10.1074/jbc.M112.419168			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23255607	Green Published, hybrid			2022-12-28	WOS:000314845000061
J	Aston-Mourney, K; Zraika, S; Udayasankar, J; Subramanian, SL; Green, PS; Kahn, SE; Hull, RL				Aston-Mourney, Kathryn; Zraika, Sakeneh; Udayasankar, Jayalakshmi; Subramanian, Shoba L.; Green, Pattie S.; Kahn, Steven E.; Hull, Rebecca L.			Matrix Metalloproteinase-9 Reduces Islet Amyloid Formation by Degrading Islet Amyloid Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL APOPTOSIS; DIABETES-MELLITUS; TRANSGENIC MOUSE; PANCREATIC-ISLETS; FIBRIL FORMATION; HUMAN AMYLIN; PEPTIDE; MICE; INSULIN; HYPERGLYCEMIA	Deposition of islet amyloid polypeptide ( IAPP) as amyloid is a pathological hallmark of the islet in type 2 diabetes, which is toxic to beta-cells. We previously showed that the enzyme neprilysin reduces islet amyloid deposition and thereby reduces beta-cell apoptosis, by inhibiting fibril formation. Two other enzymes, matrix metalloproteinase ( MMP)-2 and MMP-9, are extracellular gelatinases capable of degrading another amyloidogenic peptide, A beta, the constituent of amyloid deposits in Alzheimer disease. We therefore investigated whether MMP-2 and MMP-9 play a role in reducing islet amyloid deposition. MMP-2 and MMP-9 mRNA were present in mouse islets but only MMP-9 activity was detectable. In an islet culture model where human IAPP ( hIAPP) transgenic mouse islets develop amyloid but nontransgenic islets do not, a broad spectrum MMP inhibitor ( GM6001) and an MMP-2/9 inhibitor increased amyloid formation and the resultant beta-cell apoptosis. In contrast, a specific MMP-2 inhibitor had no effect on either amyloid deposition or beta-cell apoptosis. Mass spectrometry demonstrated that MMP-9 degraded amyloidogenic hIAPP but not nonamyloidogenic mouse IAPP. Thus, MMP-9 constitutes an endogenous islet protease that limits islet amyloid deposition and its toxic effects via degradation of hIAPP. Because islet MMP-9 mRNA levels are decreased in type 2 diabetic subjects, islet MMP-9 activity may also be decreased in human type 2 diabetes, thereby contributing to increased islet amyloid deposition and beta-cell loss. Approaches to increase islet MMP-9 activity could reduce or prevent amyloid deposition and its toxic effects in type 2 diabetes.	[Aston-Mourney, Kathryn; Zraika, Sakeneh; Udayasankar, Jayalakshmi; Subramanian, Shoba L.; Green, Pattie S.; Kahn, Steven E.; Hull, Rebecca L.] Vet Affairs Puget Sound Hlth Care Syst, Washington, WA 98108 USA; [Aston-Mourney, Kathryn; Zraika, Sakeneh; Udayasankar, Jayalakshmi; Subramanian, Shoba L.; Green, Pattie S.; Kahn, Steven E.; Hull, Rebecca L.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Aston-Mourney, Kathryn] Deakin Univ, Sch Med, Metab Res Unit, Waurn Ponds, Vic 3216, Australia	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Deakin University	Hull, RL (corresponding author), VA Puget Sound Hlth Care Syst, 1660 S Columbian Way 151, Seattle, WA 98108 USA.	rhull@u.washington.edu	Hull-Meichle, Rebecca L./CAG-5879-2022; Aston-Mourney, Kathryn/AGY-5164-2022	Aston-Mourney, Kathryn/0000-0003-1412-6715; Kahn, Steven/0000-0001-7307-9002; Hull, Rebecca/0000-0001-9690-4087	Department of Veterans Affairs, Veterans Affairs Puget Sound Health Care System (Seattle, WA); National Institutes of Health [DK-075998, DK-074404, DK-080945, DK-017047, DK-007247]; American Diabetes Association Mentor-Based fellowship; University of Washington McAbee fellowship; Deakin University Alfred Deakin Postdoctoral research fellowship; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK080945, T32DK007247, K01DK074404, R01DK075998, P30DK017047, R00DK080945] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Affairs Puget Sound Health Care System (Seattle, WA)(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Mentor-Based fellowship(American Diabetes Association); University of Washington McAbee fellowship; Deakin University Alfred Deakin Postdoctoral research fellowship; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Department of Veterans Affairs, Veterans Affairs Puget Sound Health Care System (Seattle, WA) and National Institutes of Health Grants DK-075998 (to S. E. K.), DK-074404 (to R. L. H.), DK-080945 (to S. Z.), DK-017047 (to the Cellular and Molecular Imaging Core of the University of Washington Diabetes Research Center), and DK-007247.; Supported by an American Diabetes Association Mentor-Based fellowship, the University of Washington McAbee fellowship, and a Deakin University Alfred Deakin Postdoctoral research fellowship.; Supported by a Juvenile Diabetes Research Foundation postdoctoral fellowship.	Backstrom JR, 1996, J NEUROSCI, V16, P7910; Bai JZ, 1999, BIOCHEM J, V343, P53, DOI 10.1042/0264-6021:3430053; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; DALESSIO DA, 1994, DIABETES, V43, P1457, DOI 10.2337/diabetes.43.12.1457; Guan H, 2012, DIABETOLOGIA, V55, P2989, DOI 10.1007/s00125-012-2678-y; HOPPENER JWM, 1993, DIABETOLOGIA, V36, P1258, DOI 10.1007/BF00400803; Hull RL, 2005, DIABETES, V54, P2235, DOI 10.2337/diabetes.54.7.2235; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Hull RL, 2003, DIABETES, V52, P372, DOI 10.2337/diabetes.52.2.372; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Levy M, 2006, FEBS J, V273, P5724, DOI 10.1111/j.1742-4658.2006.05562.x; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Mazzaglia A, 2010, J PHYS CHEM B, V114, P705, DOI 10.1021/jp908436s; Miettinen PJ, 2000, DEVELOPMENT, V127, P2617; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; Moriarty DF, 1999, BIOCHEMISTRY-US, V38, P1811, DOI 10.1021/bi981658g; NETZELARNETT S, 1993, BIOCHEMISTRY-US, V32, P6427, DOI 10.1021/bi00076a016; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Nilsson MR, 1999, J MOL BIOL, V294, P1375, DOI 10.1006/jmbi.1999.3286; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Subramanian SL, 2012, DIABETOLOGIA, V55, P166, DOI 10.1007/s00125-011-2338-7; Tomita T, 1997, MODERN PATHOL, V10, P47; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; WESTERMARK P, 1978, DIABETOLOGIA, V15, P417, DOI 10.1007/BF01219652; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Zhou YP, 2005, DIABETES, V54, P2612, DOI 10.2337/diabetes.54.9.2612; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x; Zraika S, 2007, BIOCHEM BIOPH RES CO, V354, P234, DOI 10.1016/j.bbrc.2006.12.187; Zraika S, 2010, J BIOL CHEM, V285, P18177, DOI 10.1074/jbc.M109.082032	36	29	33	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3553	3559		10.1074/jbc.M112.438457	http://dx.doi.org/10.1074/jbc.M112.438457			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23229548	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000314397900060
J	Cho, JH; Dimri, M; Dimri, GP				Cho, Joon-Ho; Dimri, Manjari; Dimri, Goberdhan P.			A Positive Feedback Loop Regulates the Expression of Polycomb Group Protein BMI1 via WNT Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MAMMARY EPITHELIAL-CELLS; STEM-CELLS; SELF-RENEWAL; BETA-CATENIN/TCF; COLON-CANCER; H-RAS; C-MYC; PROLIFERATION; SENESCENCE	Polycomb group protein BMI1 plays an important role in cellular homeostasis by maintaining a balance between proliferation and senescence. It is often overexpressed in cancer cells and is required for self-renewal of stem cells. At present, very little is known about the signaling pathways that regulate the expression of BMI1. Here, we report that BMI1 autoactivates its own promoter via an E-box present in its promoter. We show that BMI1 acts as an activator of the WNT pathway by repressing Dickkopf (DKK) family of WNT inhibitors. BMI1 mediated repression of DKK proteins; in particular, DKK1 led to up-regulation of WNT target c-Myc, which in turn further led to transcriptional autoactivation of BMI1. Thus, a positive feedback loop connected by the WNT signaling pathway regulates BMI1 expression. This positive feedback loop regulating BMI1 expression may be relevant to the role of BMI1 in promoting cancer and maintaining stem cell phenotype.	[Cho, Joon-Ho; Dimri, Manjari; Dimri, Goberdhan P.] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Dimri, GP (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, 2300 Eye St NW, Washington, DC 20037 USA.	gdimri@gwu.edu	Dimri, Goberdhan/AAO-4210-2021		National Institutes of Health Grant from the NCI [RO1 CA094150]; United States Army Medical Research and Materiel Command Award [W81XWH-09-1-0685]; NATIONAL CANCER INSTITUTE [R01CA094150] Funding Source: NIH RePORTER	National Institutes of Health Grant from the NCI; United States Army Medical Research and Materiel Command Award(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA094150 from the NCI (to G. P. D.). This work was also supported by United States Army Medical Research and Materiel Command Award W81XWH-09-1-0685 (to G. P. D.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Dimri GP, 2002, CANCER RES, V62, P4736; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Glinsky GV, 2005, CELL CYCLE, V4, P1171, DOI 10.4161/cc.4.9.2001; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li SKM, 2008, J BIOL CHEM, V283, P16545, DOI 10.1074/jbc.M709604200; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Moon JH, 2011, CELL RES, V21, P1305, DOI 10.1038/cr.2011.107; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Sahasrabuddhe AA, 2011, CELL CYCLE, V10, P1322, DOI 10.4161/cc.10.8.15372; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Wilkins JA, 2008, CANCER RES, V68, P4963, DOI 10.1158/0008-5472.CAN-07-5558; Yadav AK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-158; Yu TX, 2012, J BIOL CHEM, V287, P3760, DOI 10.1074/jbc.M111.316349	42	62	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3406	3418		10.1074/jbc.M112.422931	http://dx.doi.org/10.1074/jbc.M112.422931			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23239878	Green Published, hybrid			2022-12-28	WOS:000314397900045
J	Harpsoe, K; Hald, H; Timmermann, DB; Jensen, ML; Dyhring, T; Nielsen, EO; Peters, D; Balle, T; Gajhede, M; Kastrup, JS; Ahring, PK				Harpsoe, Kasper; Hald, Helle; Timmermann, Daniel B.; Jensen, Marianne L.; Dyhring, Tino; Nielsen, Elsebet O.; Peters, Dan; Balle, Thomas; Gajhede, Michael; Kastrup, Jette S.; Ahring, Philip K.			Molecular Determinants of Subtype-selective Efficacies of Cytisine and the Novel Compound NS3861 at Heteromeric Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOKING-CESSATION DRUGS; LIGAND-BINDING DOMAIN; 4 BETA 2; ALLOSTERIC MODULATOR; HYDROGEN-BOND; ALPHA-4-BETA-2; SENSITIVITY; ALPHA; RAT; AGONISTS	Deciphering which specific agonist-receptor interactions affect efficacy levels is of high importance, because this will ultimately aid in designing selective drugs. The novel compound NS3861 and cytisine are agonists of nicotinic acetylcholine receptors (nAChRs) and both bind with high affinity to heteromeric alpha 3 beta 4 and alpha 4 beta 2 nAChRs. However, initial data revealed that the activation patterns of the two compounds show very distinct maximal efficacy readouts at various heteromeric nAChRs. To investigate the molecular determinants behind these observations, we performed in-depth patch clamp electrophysiological measurements of efficacy levels at heteromeric combinations of alpha 3- and alpha 4-, with beta 2- and beta 4-subunits, and various chimeric constructs thereof. Compared with cytisine, which selectively activates receptors containing beta 4- but not beta 2-subunits, NS3861 displays the opposite beta-subunit preference and a complete lack of activation at alpha 4-containing receptors. The maximal efficacy of NS3861 appeared solely dependent on the nature of the ligand-binding domain, whereas efficacy of cytisine was additionally affected by the nature of the beta-subunit transmembrane domain. Molecular docking to nAChR subtype homology models suggests agonist specific interactions to two different residues on the complementary subunits as responsible for the beta-subunit preference of both compounds. Furthermore, a principal subunit serine to threonine substitution may explain the lack of NS3861 activation at alpha 4-containing receptors. In conclusion, our results are consistent with a hypothesis where agonist interactions with the principal subunit (alpha) primarily determine binding affinity, whereas interactions with key amino acids at the complementary subunit (beta) affect agonist efficacy.	[Harpsoe, Kasper; Hald, Helle; Gajhede, Michael; Kastrup, Jette S.] Univ Copenhagen, Fac Hlth & Med Sci, DK-1168 Copenhagen, Denmark; [Hald, Helle; Timmermann, Daniel B.; Jensen, Marianne L.; Dyhring, Tino; Nielsen, Elsebet O.; Peters, Dan; Ahring, Philip K.] Aniona ApS, DK-2750 Ballerup, Denmark; [Balle, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of Copenhagen; University of Sydney	Ahring, PK (corresponding author), Aniona ApS, 93 Pederstrupvej, DK-2750 Ballerup, Denmark.	pka@aniona.com	Harpsøe, Kasper/V-6870-2018; Hald, Helle/J-3561-2013	Harpsøe, Kasper/0000-0002-9326-9644; Dyhring, Tino/0000-0002-9607-0577; Balle, Thomas/0000-0002-0233-8350; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Kastrup, Jette Sandholm/0000-0003-2654-1510; Gajhede, Michael/0000-0001-9864-2287	Drug Research Academy, Faculty of Pharmaceutical Sciences, University of Copenhagen; Danish Ministry of Science, Innovation and Higher Education; Carlsberg Foundation; Lundbeck Foundation	Drug Research Academy, Faculty of Pharmaceutical Sciences, University of Copenhagen; Danish Ministry of Science, Innovation and Higher Education; Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by grants from the Drug Research Academy, Faculty of Pharmaceutical Sciences, University of Copenhagen (to K. H.), the Danish Ministry of Science, Innovation and Higher Education (to H. H.), the Carlsberg Foundation (to T. B. and K. H.), and the Lundbeck Foundation (to T. B.).	[Anonymous], 2011, SCHROD SUIT 2011 PRO; [Anonymous], 2011, MACROMODEL VERS 9 9; [Anonymous], 2011, PYMOL MOL GRAPH SYST; [Anonymous], 2011, MAESTR VERS 9 2; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Billen B, 2012, P NATL ACAD SCI USA, V109, P9173, DOI 10.1073/pnas.1116397109; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Blum AP, 2010, P NATL ACAD SCI USA, V107, P13206, DOI 10.1073/pnas.1007140107; Brams M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001034; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buisson B, 1996, J NEUROSCI, V16, P7880; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chavez-Noriega LE, 2000, NEUROPHARMACOLOGY, V39, P2543, DOI 10.1016/S0028-3908(00)00134-9; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Gleitsman KR, 2008, J BIOL CHEM, V283, P35638, DOI 10.1074/jbc.M807226200; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Harvey SC, 1996, J NEUROCHEM, V67, P1953; Harvey SC, 1996, J NEUROSCI, V16, P3798; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; HOUGHTLING RA, 1995, MOL PHARMACOL, V48, P280; Houlihan LM, 2001, J NEUROCHEM, V78, P1029, DOI 10.1046/j.1471-4159.2001.00481.x; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Kuryatov A, 2000, EUR J PHARMACOL, V393, P11, DOI 10.1016/S0014-2999(00)00027-3; Lewis TM, 1997, J PHYSIOL-LONDON, V505, P299, DOI 10.1111/j.1469-7793.1997.299bb.x; LUETJE CW, 1991, J NEUROSCI, V11, P837; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mirza NR, 2008, J PHARMACOL EXP THER, V327, P954, DOI 10.1124/jpet.108.138859; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Parker MJ, 1998, MOL PHARMACOL, V54, P1132, DOI 10.1124/mol.54.6.1132; Parker MJ, 2001, J PHARMACOL EXP THER, V299, P385; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Pohlsgaard J, 2011, NEUROPHARMACOLOGY, V60, P135, DOI 10.1016/j.neuropharm.2010.08.004; Quick MW, 2002, J NEUROBIOL, V53, P457, DOI 10.1002/neu.10109; Quik M, 1996, J NEUROCHEM, V67, P145; Rohde LAH, 2012, J BIOL CHEM, V287, P4248, DOI 10.1074/jbc.M111.292243; Rucktooa P, 2012, J BIOL CHEM, V287, P23283, DOI 10.1074/jbc.M112.360347; Schrodinger LLC, 2011, SCHROD SUIT 2011 IND; Shahsavar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040757; SINE SM, 1984, BIOPHYS J, V46, P277, DOI 10.1016/S0006-3495(84)84022-9; SLILATY SN, 1990, ANAL BIOCHEM, V185, P194, DOI 10.1016/0003-2697(90)90279-I; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436	46	23	24	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2559	2570		10.1074/jbc.M112.436337	http://dx.doi.org/10.1074/jbc.M112.436337			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229547	hybrid, Green Published			2022-12-28	WOS:000314211500041
J	Lipinska, N; Zietkiewicz, S; Sobczak, A; Jurczyk, A; Potocki, W; Morawiec, E; Wawrzycka, A; Gumowski, K; Slusarz, M; Rodziewicz-Motowidlo, S; Chrusciel, E; Liberek, K				Lipinska, Natalia; Zietkiewicz, Szymon; Sobczak, Alicja; Jurczyk, Agnieszka; Potocki, Wojciech; Morawiec, Ewa; Wawrzycka, Aleksandra; Gumowski, Krzysztof; Slusarz, Magdalena; Rodziewicz-Motowidlo, Sylwia; Chrusciel, Elzbieta; Liberek, Krzysztof			Disruption of Ionic Interactions between the Nucleotide Binding Domain 1 (NBD1) and Middle (M) Domain in Hsp100 Disaggregase Unleashes Toxic Hyperactivity and Partial Independence from Hsp70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISAGGREGATION; CLPB CHAPERONE; DNAK CHAPERONE; SACCHAROMYCES-CEREVISIAE; GUANIDINE-HYDROCHLORIDE; ESCHERICHIA-COLI; CENTRAL PORE; COILED-COIL; YEAST; PRION	Hsp100 chaperones cooperate with the Hsp70 chaperone system to disaggregate and reactivate heat-denatured aggregated proteins to promote cell survival after heat stress. The homology models of Hsp100 disaggregases suggest the presence of a conserved network of ionic interactions between the first nucleotide binding domain (NBD1) and the coiled-coil middle subdomain, the signature domain of disaggregating chaperones. Mutations intended to disrupt the putative ionic interactions in yeast Hsp104 and bacterial ClpB disaggregases resulted in remarkable changes of their biochemical properties. These included an increase in ATPase activity, a significant increase in the rate of in vitro substrate renaturation, and partial independence from the Hsp70 chaperone in disaggregation. Paradoxically, the increased activities resulted in serious growth impediments in yeast and bacterial cells instead of improvement of their thermotolerance. Our results suggest that this toxic activity is due to the ability of the mutated disaggregases to unfold independently from Hsp70, native folded proteins. Complementary changes that restore particular salt bridges within the suggested network suppressed the toxic effects. We propose a novel structural aspect of Hsp100 chaperones crucial for specificity and efficiency of the disaggregation reaction.	[Lipinska, Natalia; Zietkiewicz, Szymon; Sobczak, Alicja; Jurczyk, Agnieszka; Potocki, Wojciech; Morawiec, Ewa; Wawrzycka, Aleksandra; Gumowski, Krzysztof; Chrusciel, Elzbieta; Liberek, Krzysztof] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Mol & Cellular Biol, PL-80822 Gdansk, Poland; [Slusarz, Magdalena; Rodziewicz-Motowidlo, Sylwia] Univ Gdansk, Fac Chem, PL-80852 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Zietkiewicz, S (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Mol & Cellular Biol, Kladki 24, PL-80822 Gdansk, Poland.	szymon@biotech.ug.gda.pl; liberek@biotech.ug.gda.pl	Liberek, Krzysztof/F-5812-2011; Ziętkiewicz, Szymon/L-5259-2014; Potocki, Wojciech/AAG-8486-2019	Potocki, Wojciech/0000-0001-6476-4833; Slusarz, Magdalena J./0000-0002-9411-4679; Zietkiewicz, Szymon/0000-0002-3435-4603; Rodziewicz-Motowidlo, Sylwia/0000-0002-4471-5951; Liberek, Krzysztof/0000-0002-7532-9279; Chrusciel, Elzbieta/0000-0001-9621-2013; Klosowska, Agnieszka/0000-0001-5295-9473	Foundation for Polish Science [2009-3/5]; Ministry of Science and Higher Education [N N301 507338]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Foundation for Polish Science under the TEAM 2009-3/5 Programme (to N. L., S. Z., A. J., W. P., E. M., and A. W.).; Supported by Ministry of Science and Higher Education Grant N N301 507338.	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Barends TRM, 2010, CURR OPIN STRUC BIOL, V20, P46, DOI 10.1016/j.sbi.2009.12.014; Case D, 2006, AMBER 9; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; DeLano W.L, PYMOL MOL GRAPHICS S; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Doyle SM, 2007, P NATL ACAD SCI USA, V104, P11138, DOI 10.1073/pnas.0703980104; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Konieczny I, 1997, J BIOL CHEM, V272, P33312, DOI 10.1074/jbc.272.52.33312; Konieczny I, 2002, J BIOL CHEM, V277, P18483, DOI 10.1074/jbc.M107580200; Krzewska J, 2001, FEBS LETT, V489, P92, DOI 10.1016/S0014-5793(00)02423-6; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lee U, 2005, PLANT CELL, V17, P559, DOI 10.1105/tpc.104.027540; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Norden C, 2004, MOL MICROBIOL, V53, P469, DOI 10.1111/j.1365-2958.2004.04148.x; Nowicki L, 2012, CELL STRESS CHAPERON, V17, P361, DOI 10.1007/s12192-011-0312-4; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; SHIFRINE M, 1954, J BACTERIOL, V68, P28, DOI 10.1128/JB.68.1.28-35.1954; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200; Watanabe YH, 2009, BIOCHEM J, V421, P71, DOI 10.1042/BJ20082238; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; WOO KM, 1992, J BIOL CHEM, V267, P20429; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; Zietkiewicz S, 2004, J BIOL CHEM, V279, P44376, DOI 10.1074/jbc.M402405200; Zietkiewicz S, 2010, BIOPOLYMERS, V93, P47, DOI 10.1002/bip.21294; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x	51	47	47	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2857	2869		10.1074/jbc.M112.387589	http://dx.doi.org/10.1074/jbc.M112.387589			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233670	Green Published, hybrid			2022-12-28	WOS:000314211500068
J	Burstenbinder, K; Savchenko, T; Muller, J; Adamson, AW; Stamm, G; Kwong, R; Zipp, BJ; Dinesh, DC; Abel, S				Buerstenbinder, Katharina; Savchenko, Tatyana; Mueller, Jens; Adamson, Aaron W.; Stamm, Gina; Kwong, Raymond; Zipp, Brandon J.; Dinesh, Dhurvas Chandrasekaran; Abel, Steffen			Arabidopsis Calmodulin-binding Protein IQ67-Domain 1 Localizes to Microtubules and Interacts with Kinesin Light Chain-related Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; GLUCOSINOLATE METABOLISM; IQ MOTIFS; CALCIUM; SUPERFAMILY; RECOGNITION; DIVERSITY; THALIANA; VECTORS; NETWORK	Calcium (Ca2+) is a key second messenger in eukaryotes and regulates diverse cellular processes, most notably via calmodulin (CaM). In Arabidopsis thaliana, IQD1 (IQ67 domain 1) is the founding member of the IQD family of putative CaM targets. The 33 predicted IQD proteins share a conserved domain of 67 amino acids that is characterized by a unique arrangement of multiple CaM recruitment motifs, including so-called IQ motifs. Whereas IQD1 has been implicated in the regulation of defense metabolism, the biochemical functions of IQD proteins remain to be elucidated. In this study we show that IQD1 binds to multiple Arabidopsis CaM and CaM-like (CML) proteins in vitro and in yeast two-hybrid interaction assays. CaM overlay assays revealed moderate affinity of IQD1 to CaM2 (K-d similar to 0.6 mu M). Deletion mapping of IQD1 demonstrated the importance of the IQ67 domain for CaM2 binding in vitro, which is corroborated by interaction of the shortest IQD member, IQD20, with Arabidopsis CaM/CMLs in yeast. A genetic screen of a cDNA library identified Arabidopsis kinesin light chain-related protein-1 (KLCR1) as an IQD1 interactor. The subcellular localization of GFP-tagged IQD1 proteins to microtubules and the cell nucleus in transiently and stably transformed plant tissues (tobacco leaves and Arabidopsis seedlings) suggests direct interaction of IQD1 and KLCR1 in planta that is supported by GFP similar to IQD1-dependent recruitment of RFP similar to KLCR1 and RFP similar to CaM2 to microtubules. Collectively, the prospect arises that IQD1 and related proteins provide Ca2+/CaM-regulated scaffolds for facilitating cellular transport of specific cargo along microtubular tracks via kinesin motor proteins.	[Buerstenbinder, Katharina; Mueller, Jens; Stamm, Gina; Dinesh, Dhurvas Chandrasekaran; Abel, Steffen] Leibniz Inst Plant Biochem, Dept Mol Signal Proc, D-06120 Halle, Germany; [Savchenko, Tatyana; Adamson, Aaron W.; Kwong, Raymond; Zipp, Brandon J.; Abel, Steffen] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Abel, Steffen] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany	Leibniz Institut fur Pflanzenbiochemie; University of California System; University of California Davis; Martin Luther University Halle Wittenberg	Abel, S (corresponding author), Leibniz Inst Plant Biochem, Dept Mol Signal Proc, Weinberg 3, D-06120 Halle, Germany.	sabel@ipb-halle.de	Savchenko, Tatyana/E-7091-2014; Dinesh, Dhurvas Chandrasekaran/AAR-1948-2020	Savchenko, Tatyana/0000-0003-0126-4932; Dinesh, Dhurvas Chandrasekaran/0000-0001-9125-4775; Burstenbinder, Katharina/0000-0002-3493-4800	National Research Initiative of the United States Department of Agriculture Cooperative State Research Education and Extension Service Grant [2005-02507]; Deutsche Forschungsgemeinschaft [GRK1026]; state of Saxony-Anhalt; Federal Republic of Germany	National Research Initiative of the United States Department of Agriculture Cooperative State Research Education and Extension Service Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); state of Saxony-Anhalt; Federal Republic of Germany	This work was supported by the National Research Initiative of the United States Department of Agriculture Cooperative State Research Education and Extension Service Grant 2005-02507 (to S. A.), by a pre-doctoral fellowship from the Deutsche Forschungsgemeinschaft (GRK1026; to D. C. D.), and by core funding to the Leibniz-Institute of Plant Biochemistry from the state of Saxony-Anhalt and the Federal Republic of Germany.	Abel S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-72; Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Black DJ, 2009, BIOCHEMISTRY-US, V48, P11766, DOI 10.1021/bi9014874; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Choi MS, 2005, J BIOL CHEM, V280, P40820, DOI 10.1074/jbc.M504616200; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Clough SJ, 2005, METH MOL B, V286, P91; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; DeFalco TA, 2010, FEBS LETT, V584, P4717, DOI 10.1016/j.febslet.2010.10.059; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; Dixon DP, 2009, J BIOL CHEM, V284, P21249, DOI 10.1074/jbc.M109.020107; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kang CH, 2006, CELL DEATH DIFFER, V13, P84, DOI 10.1038/sj.cdd.4401712; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kohler C, 2000, FEBS LETT, V471, P133, DOI 10.1016/S0014-5793(00)01383-1; Koroleva OA, 2010, PLANT J, V64, P456, DOI 10.1111/j.1365-313X.2010.04339.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Muller J, 2010, PLANT J, V61, P234, DOI 10.1111/j.1365-313X.2009.04046.x; Munshi HG, 1996, BIOCHEMISTRY-US, V35, P15883, DOI 10.1021/bi962107y; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nutricati E, 2006, PLANT CELL REP, V25, P997, DOI 10.1007/s00299-006-0146-1; Reddy A S, 2001, BMC Genomics, V2, P2, DOI 10.1186/1471-2164-2-2; Reddy ASN, 2011, PHYTOCHEMISTRY, V72, P1007, DOI 10.1016/j.phytochem.2010.12.022; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Reddy VS, 1999, J BIOL CHEM, V274, P31727, DOI 10.1074/jbc.274.44.31727; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Reddy VS, 2004, PLANT CELL, V16, P185, DOI 10.1105/tpc.016600; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schnapp BJ, 2003, J CELL SCI, V116, P2125, DOI 10.1242/jcs.00488; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wagner U, 2002, PLANT MOL BIOL, V49, P515, DOI 10.1023/A:1015557300450; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu S, 2011, PLANT PHYSIOL, V157, P1175, DOI 10.1104/pp.111.181065; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yang TB, 2000, J BIOL CHEM, V275, P38467, DOI 10.1074/jbc.M003566200; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhu CM, 2012, PROTOPLASMA, V249, P887, DOI 10.1007/s00709-011-0343-9	62	72	77	6	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1871	1882		10.1074/jbc.M112.396200	http://dx.doi.org/10.1074/jbc.M112.396200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23204523	Green Published, hybrid			2022-12-28	WOS:000313751400041
J	Sierra, A; Zhu, ZY; Sapay, N; Sharotri, V; Kline, CF; Luczak, ED; Subbotina, E; Sivaprasadarao, A; Snyder, PM; Mohler, PJ; Anderson, ME; Vivaudou, M; Zingman, LV; Hodgson-Zingman, DM				Sierra, Ana; Zhu, Zhiyong; Sapay, Nicolas; Sharotri, Vikas; Kline, Crystal F.; Luczak, Elizabeth D.; Subbotina, Ekaterina; Sivaprasadarao, Asipu; Snyder, Peter M.; Mohler, Peter J.; Anderson, Mark E.; Vivaudou, Michel; Zingman, Leonid V.; Hodgson-Zingman, Denice M.			Regulation of Cardiac ATP-sensitive Potassium Channel Surface Expression by Calcium/Calmodulin-dependent Protein Kinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTION-POTENTIAL DURATION; K+ CHANNELS; SULFONYLUREA RECEPTOR; MOLECULAR-BASIS; MEDIATED PHOSPHORYLATION; BINDING-SITE; CAMKII; KIR6.2; ADENOSINE; SUBUNIT	Cardiac ATP-sensitive potassium (K-ATP) channels are key sensors and effectors of the metabolic status of cardiomyocytes. Alteration in their expression impacts their effectiveness in maintaining cellular energy homeostasis and resistance to injury. We sought to determine how activation of calcium/calmodulin-dependent protein kinase II (CaMKII), a central regulator of calcium signaling, translates into reduced membrane expression and current capacity of cardiac K-ATP channels. We used real-time monitoring of K-ATP channel current density, immunohistochemistry, and biotinylation studies in isolated hearts and cardiomyocytes from wild-type and transgenic mice as well as HEK cells expressing wild-type and mutant K-ATP channel subunits to track the dynamics of K-ATP channel surface expression. Results showed that activation of CaMKII triggered dynamin-dependent internalization of K-ATP channels. This process required phosphorylation of threonine at 180 and 224 and an intact (YSKF333)-Y-330 endocytosis motif of the K-ATP channel Kir6.2 pore-forming subunit. A molecular model of the mu 2 subunit of the endocytosis adaptor protein, AP2, complexed with Kir6.2 predicted that mu 2 docks by interaction with (YSKF333)-Y-330 and Thr-180 on one and Thr-224 on the adjacent Kir6.2 subunit. Phosphorylation of Thr-180 and Thr-224 would favor interactions with the corresponding arginine-and lysine-rich loops on mu 2. We concluded that calcium-dependent activation of CaMKII results in phosphorylation of Kir6.2, which promotes endocytosis of cardiac K-ATP channel subunits. This mechanism couples the surface expression of cardiac K-ATP channels with calcium signaling and reveals new targets to improve cardiac energy efficiency and stress resistance.	[Sierra, Ana; Zhu, Zhiyong; Sharotri, Vikas; Luczak, Elizabeth D.; Subbotina, Ekaterina; Snyder, Peter M.; Anderson, Mark E.; Zingman, Leonid V.; Hodgson-Zingman, Denice M.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Zhu, Zhiyong] Univ Grenoble 1, Lab Chim & Biol Met, Commissariat Energie Atom, CNRS, F-38054 Grenoble, France; [Kline, Crystal F.; Mohler, Peter J.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [Kline, Crystal F.; Mohler, Peter J.] Ohio State Univ, Dept Internal Med, Wexner Med Ctr, Columbus, OH 43210 USA; [Sivaprasadarao, Asipu] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Vivaudou, Michel] Univ Grenoble 1, CNRS, Commissariat Energie Atom, Inst Biol Struct, F-75794 Grenoble, France; [Zingman, Leonid V.] Med Ctr, Dept Vet Affairs, Iowa City, IA 52246 USA	University of Iowa; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Leeds; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Zingman, LV (corresponding author), Carver Coll Med, Dept Med, 200 Hawkins, Iowa City, IA 52242 USA.	leonid-zingman@uiowa.edu; denice-zingman@uiowa.edu	Subbotina, Ekaterina/AAB-9670-2020; Zingman, Leonid V/GXG-0136-2022; zhu, zhiyong/B-4336-2015; Vivaudou, Michel/C-5338-2008	Zingman, Leonid V/0000-0002-7566-4616; Vivaudou, Michel/0000-0002-9777-3127; Subbotina, Ekaterina/0000-0002-9659-6261; Hodgson-Zingman, Denice/0000-0002-6875-1367; Sivaprasadarao, Asipu/0000-0002-6755-3502	National Institutes of Health [HL092286, R01HL113089, HL093368, R01DK092412, R01HL079031, R01HL62494, R01HL70250, R01HL113001, HL084583, HL083422, HL058812]; VA Merit Review Program [1I0BX000718]; Medical Research Council, United Kingdom [G0802050]; Carver Trust [01-224]; Central Society for Clinical Research; Fraternal Order of Eagles; Saving Tiny Hearts Society; American Heart Association; Agence Nationale de la Recherche [ANR-09-PIRI-0010]; Agence Nationale de la Recherche (Laboratory of Excellence "Ion Channel Science and Therapeutics" network); Fondation Leducq; MRC [G0802050] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113089, R01HL070250, R01HL079031, R01HL084583, R29HL058812, K08HL092286, R01HL083422, R01HL058812, R01HL113001, R01HL062494, R01HL096652, K08HL093368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092412] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000718] Funding Source: NIH RePORTER; Medical Research Council [G0802050] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Program(US Department of Veterans Affairs); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Carver Trust; Central Society for Clinical Research; Fraternal Order of Eagles; Saving Tiny Hearts Society; American Heart Association(American Heart Association); Agence Nationale de la Recherche(French National Research Agency (ANR)); Agence Nationale de la Recherche (Laboratory of Excellence "Ion Channel Science and Therapeutics" network)(French National Research Agency (ANR)); Fondation Leducq(Leducq Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Institutes of Health Grants HL092286 and R01HL113089 (to D. H.-Z.), HL093368 and R01DK092412 (to L. Z.), R01HL079031, R01HL62494, R01HL70250, and R01HL113001 (to M. E. A.), HL084583 and HL083422 (to P. J. M.), and HL058812 (to P. M. S). This work was also supported by VA Merit Review Program Grant 1I0BX000718 (to L. Z.), The Medical Research Council, United Kingdom Grant G0802050 (to A. Sivaprasadarao), The Carver Trust Grant 01-224 (to D. H.-Z. and L. Z.), The Central Society for Clinical Research (to D. H.-Z.), The Fraternal Order of Eagles (to D. H.-Z. and L. Z.), Saving Tiny Hearts Society (to P. J. M.), an American Heart Association Established Investigator Award (to P. J. M.), Agence Nationale de la Recherche (ANR-09-PIRI-0010 and Laboratory of Excellence "Ion Channel Science and Therapeutics" network grant; to M. V.), and Fondation Leducq Award to the Alliance for Calmodulin Kinase Signaling in Heart Disease (to M. E. A. and P. J. M.).	Abraham MR, 2002, J BIOL CHEM, V277, P24427, DOI 10.1074/jbc.M201777200; Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Alekseev AE, 2010, CELL METAB, V11, P58, DOI 10.1016/j.cmet.2009.11.009; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Ashcroft FM, 2000, TRENDS PHARMACOL SCI, V21, P439; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; Aziz Q, 2012, J BIOL CHEM, V287, P6196, DOI 10.1074/jbc.M111.243923; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Brown DA, 2005, J PHYSIOL-LONDON, V569, P913, DOI 10.1113/jphysiol.2005.095729; Carrasco AJ, 2001, P NATL ACAD SCI USA, V98, P7623, DOI 10.1073/pnas.121038198; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Ferrero JM, 1996, CIRC RES, V79, P208, DOI 10.1161/01.RES.79.2.208; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Herrmann TL, 2005, J LEUKOCYTE BIOL, V78, P1397, DOI 10.1189/jlb.0205105; Hodgson DM, 2003, EMBO J, V22, P1732, DOI 10.1093/emboj/cdg192; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; Hu KL, 1996, CIRC RES, V78, P492, DOI 10.1161/01.RES.78.3.492; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Ito K, 2001, J PHYSIOL-LONDON, V532, P165, DOI 10.1111/j.1469-7793.2001.0165g.x; Kushnir A, 2010, P NATL ACAD SCI USA, V107, P10274, DOI 10.1073/pnas.1005843107; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Lefer DJ, 2009, TRENDS CARDIOVAS MED, V19, P61, DOI 10.1016/j.tcm.2009.04.008; Li JD, 2007, CHANNELS, V1, P387, DOI 10.4161/chan.5449; Li JD, 2006, CIRC RES, V99, P1092, DOI 10.1161/01.RES.0000249369.71709.5c; Light P, 1996, BBA-REV BIOMEMBRANES, V1286, P65, DOI 10.1016/0304-4157(96)00004-4; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Liu YG, 1996, CIRC RES, V78, P443, DOI 10.1161/01.RES.78.3.443; Maier LS, 2009, FRONT BIOSCI-LANDMRK, V14, P486, DOI 10.2741/3257; Mankouri J, 2006, EMBO J, V25, P4142, DOI 10.1038/sj.emboj.7601275; Moreau C, 2000, EMBO J, V19, P6644, DOI 10.1093/emboj/19.24.6644; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Neef Stefan, 2007, Curr Heart Fail Rep, V4, P11, DOI 10.1007/s11897-007-0020-7; NICHOLS CG, 1991, AM J PHYSIOL, V261, pH1675, DOI 10.1152/ajpheart.1991.261.6.H1675; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; Perry C, 2007, AM J PHYSIOL-RENAL, V293, pF68, DOI 10.1152/ajprenal.00454.2006; Sasaki N, 2001, AM J PHYSIOL-HEART C, V280, pH1882, DOI 10.1152/ajpheart.2001.280.4.H1882; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Tong XY, 2006, AM J PHYSIOL-HEART C, V291, pH543, DOI 10.1152/ajpheart.00051.2006; Trapp S, 2003, EMBO J, V22, P2903, DOI 10.1093/emboj/cdg282; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; WEISS JN, 1993, CARDIOVASC DRUG THER, V7, P499, DOI 10.1007/BF00877614; Wu YM, 2012, J MOL CELL CARDIOL, V53, P429, DOI 10.1016/j.yjmcc.2012.06.019; Wu YJ, 2006, J MOL CELL CARDIOL, V40, P213, DOI 10.1016/j.yjmcc.2005.11.005; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhu ZY, 2011, BIOCHEM BIOPH RES CO, V415, P637, DOI 10.1016/j.bbrc.2011.10.125; Zingman LV, 2007, J APPL PHYSIOL, V103, P1888, DOI 10.1152/japplphysiol.00747.2007; Zingman LV, 2011, J MOL CELL CARDIOL, V51, P72, DOI 10.1016/j.yjmcc.2011.03.010; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199; Zingman LV, 2002, J BIOL CHEM, V277, P14206, DOI 10.1074/jbc.M109452200; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	61	20	22	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1568	1581		10.1074/jbc.M112.429548	http://dx.doi.org/10.1074/jbc.M112.429548			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23223335	hybrid, Green Published			2022-12-28	WOS:000313751400013
J	Qu, YG; Zhou, F; Yu, LD; Yu, CA				Qu, Yuan-Gang; Zhou, Fei; Yu, Linda; Yu, Chang-An			Effect of Mutations of Arginine 94 on Proton Pumping, Electron Transfer, and Superoxide Anion Generation in Cytochrome b of the bc(1) Complex from Rhodobacter sphaeroides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; UBIQUINOL OXIDATION; Q-CYCLE; QUINOL OXIDATION; Q(O) SITE; MECHANISM; TRANSLOCATION; MITOCHONDRIAL; RECONSTITUTION; VESICLES	Proton transfer involving internal water molecules that provide hydrogen bonds and facilitate proton diffusion has been identified in some membrane proteins. Arg-94 in cytochrome b of the Rhodobacter sphaeroides bc(1) complex is fully conserved and is hydrogen-bonded to the heme propionate and a chain of water molecules. To further elucidate the role of Arg-94, we generated the mutations R94A, R94D, and R94N. The wild-type and mutant bc(1) complexes were purified and then characterized. The results show that substitution of Arg-94 decreased electron transfer activity and proton pumping capability and increased O-2(radical anion) production, suggesting the importance of Arg-94 in the catalytic mechanism of the bc(1) complex in R. sphaeroides. This also suggests that the transport of H+, O-2, and O-2(radical anion) in the bc(1) complex may occur by the same pathway.	[Qu, Yuan-Gang; Zhou, Fei; Yu, Linda; Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Qu, YG (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, 255 Noble Res Ctr, Stillwater, OK 74078 USA.	yuangangqu@yahoo.com			National Institutes of Health [GM30721]; National Science Foundation [MCB0077650]; Oklahoma Agricultural Experiment Station Projects from Oklahoma State University [1819, 2372]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030721, R37GM030721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Oklahoma Agricultural Experiment Station Projects from Oklahoma State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM30721 (to C.-A. Y.). This work was also supported by National Science Foundation Grant MCB0077650 (to L. Y.) and Oklahoma Agricultural Experiment Station Projects 1819 and 2372 from Oklahoma State University.	ALEXANDRE A, 1979, J BIOL CHEM, V254, P1555; Bartoschek S, 2001, J BIOL CHEM, V276, P35231, DOI 10.1074/jbc.C100365200; BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; COCCO T, 1992, EUR J BIOCHEM, V209, P475, DOI 10.1111/j.1432-1033.1992.tb17312.x; Covian R, 2001, EUR J BIOCHEM, V268, P5783, DOI 10.1046/j.0014-2956.2001.02521.x; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15807, DOI 10.1021/bi990962m; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Crofts AR, 1999, P NATL ACAD SCI USA, V96, P10021, DOI 10.1073/pnas.96.18.10021; DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N; DENICOLA A, 1995, FREE RADICAL BIO MED, V19, P11, DOI 10.1016/0891-5849(94)00239-G; DEVRIES S, 1981, J BIOL CHEM, V256, P1996; ERECINSKA M, 1972, P NATL ACAD SCI USA, V69, P50, DOI 10.1073/pnas.69.1.50; Gennis RB, 1999, SCIENCE, V286, P252, DOI 10.1126/science.286.5438.252; GUNER S, 1991, BIOCHIM BIOPHYS ACTA, V1058, P269, DOI 10.1016/S0005-2728(05)80247-6; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Junemann S, 1998, J BIOL CHEM, V273, P21603, DOI 10.1074/jbc.273.34.21603; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; LEUNG KH, 1975, J BIOL CHEM, V250, P8467; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; LORUSSO M, 1983, EUR J BIOCHEM, V137, P413, DOI 10.1111/j.1432-1033.1983.tb07844.x; MATHER MW, 1995, J BIOL CHEM, V270, P28668, DOI 10.1074/jbc.270.48.28668; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; NAKANO M, 1990, METHOD ENZYMOL, V186, P585; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; Snyder CH, 2000, J BIOL CHEM, V275, P13535, DOI 10.1074/jbc.275.18.13535; Tian H, 1997, J BIOL CHEM, V272, P23722, DOI 10.1074/jbc.272.38.23722; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; Wikstrom M, 2003, BBA-BIOENERGETICS, V1604, P61, DOI 10.1016/S0005-2728(03)00041-0; WIKSTROM MK, 1972, BIOCHIM BIOPHYS ACTA, V283, P403, DOI 10.1016/0005-2728(72)90258-7; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xiao KH, 2004, BIOCHEMISTRY-US, V43, P1488, DOI 10.1021/bi035378z; Yang SQ, 2008, J BIOL CHEM, V283, P28767, DOI 10.1074/jbc.M803013200; Yin Y, 2010, J BIOL CHEM, V285, P17038, DOI 10.1074/jbc.M110.104364; Yin Y, 2009, BBA-BIOENERGETICS, V1787, P913, DOI 10.1016/j.bbabio.2009.03.018; YU CA, 1972, J BIOL CHEM, V247, P1012; YU CA, 1982, BIOCHEMISTRY-US, V21, P4096, DOI 10.1021/bi00260a028; YU L, 1986, BIOCHIM BIOPHYS ACTA, V852, P203, DOI 10.1016/0005-2728(86)90225-2; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104	45	2	2	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1047	1054		10.1074/jbc.M112.397521	http://dx.doi.org/10.1074/jbc.M112.397521			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23209298	Green Published, hybrid			2022-12-28	WOS:000313570300028
J	Heinnickel, ML; Alric, J; Wittkopp, T; Yang, WQ; Catalanotti, C; Dent, R; Niyogi, KK; Wollman, FA; Grossman, AR				Heinnickel, Mark L.; Alric, Jean; Wittkopp, Tyler; Yang, Wenqiang; Catalanotti, Claudia; Dent, Rachel; Niyogi, Krishna K.; Wollman, Francis-Andre; Grossman, Arthur R.			Novel Thylakoid Membrane GreenCut Protein CPLD38 Impacts Accumulation of the Cytochrome b(6)f Complex and Associated Regulatory Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS-REINHARDTII; ELECTRON-TRANSFER; PHOTOSYSTEM-II; MESSENGER-RNA; ARCHITECTURE; RESOLUTION; CHLORORESPIRATION; PHOTOSYNTHESIS; CHLOROPLAST; DEPRIVATION	Based on previous comparative genomic analyses, a set of nearly 600 polypeptides was identified that is present in green algae and flowering and nonflowering plants but is not present (or is highly diverged) in nonphotosynthetic organisms. The gene encoding one of these "GreenCut" proteins, CPLD38, is in the same operon as ndhL in most cyanobacteria; the NdhL protein is part of a complex essential for cyanobacterial respiration. A cpld38 mutant of Chlamydomonas reinhardtii does not grow on minimal medium, is high light-sensitive under photoheterotrophic conditions, has lower accumulation of photosynthetic complexes, reduced photosynthetic electron flow to P700(+), and reduced photochemical efficiency of photosystem II (Phi PSII); these phenotypes are rescued by a wild-type copy of CPLD38. Single turnover flash experiments and biochemical analyses demonstrated that cytochrome b(6)f function was severely compromised, and the levels of transcripts and polypeptide subunits of the cytochrome b(6)f complex were also significantly lower in the cpld38 mutant. Furthermore, subunits of the cytochrome b(6)f complex in mutant cells turned over much more rapidly than in wild-type cells. Interestingly, PTOX2 and NDA2, two major proteins involved in chlororespiration, were more than 5-fold higher in mutants relative to wild-type cells, suggesting a shift in the cpld38 mutant from photosynthesis toward chlororespiratory metabolism, which is supported by experiments that quantify the reduction state of the plastoquinone pool. Together, these findings support the hypothesis that CPLD38 impacts the stability of the cytochrome b(6)f complex and possibly plays a role in balancing redox inputs to the quinone pool from photosynthesis and chlororespiration.	[Heinnickel, Mark L.; Alric, Jean; Wittkopp, Tyler; Yang, Wenqiang; Catalanotti, Claudia; Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Dent, Rachel; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Dent, Rachel; Niyogi, Krishna K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Alric, Jean; Wollman, Francis-Andre] CNRS, Inst Biol Physicochim, UMR 7141, F-75005 Paris, France; [Alric, Jean; Wollman, Francis-Andre] Univ Paris 06, F-75005 Paris, France	Carnegie Institution for Science; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Heinnickel, ML (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	mlh300@stanford.edu	Alric, Jean/E-3538-2013	Alric, Jean/0000-0003-3574-2234	National Science Foundation [MCB0824469, MCB0235878]; Brigitte Berthelemot; Direct For Biological Sciences [0951094] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Brigitte Berthelemot; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grants MCB0824469 and MCB0235878 (to A. R. G.) and by private funds donated by Brigitte Berthelemot.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Bennoun P, 2001, BBA-BIOENERGETICS, V1506, P133, DOI 10.1016/S0005-2728(01)00190-6; BULTE L, 1992, EUR J BIOCHEM, V204, P327, DOI 10.1111/j.1432-1033.1992.tb16641.x; Catalanotti C, 2012, PLANT CELL, V24, P692, DOI 10.1105/tpc.111.093146; Choquet Y, 1998, P NATL ACAD SCI USA, V95, P4380, DOI 10.1073/pnas.95.8.4380; CHUA NH, 1971, BIOCHIM BIOPHYS ACTA, V245, P277, DOI 10.1016/0005-2728(71)90146-0; Cruz JA, 2001, PLANT PHYSIOL, V127, P1167, DOI 10.1104/pp.127.3.1167; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Desplats C, 2009, J BIOL CHEM, V284, P4148, DOI 10.1074/jbc.M804546200; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Gonzalez-Ballester D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-24; Grossman AR, 2010, PHOTOSYNTH RES, V106, P3, DOI 10.1007/s11120-010-9555-7; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HIYAMA T, 1972, BIOCHIM BIOPHYS ACTA, V267, P160, DOI 10.1016/0005-2728(72)90147-8; Houille-Vernes L, 2011, P NATL ACAD SCI USA, V108, P20820, DOI 10.1073/pnas.1110518109; Jans F, 2008, P NATL ACAD SCI USA, V105, P20546, DOI 10.1073/pnas.0806896105; JOLIOT P, 1974, BIOCHIM BIOPHYS ACTA, V357, P267, DOI 10.1016/0005-2728(74)90066-8; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Karpowicz SJ, 2011, J BIOL CHEM, V286, P21427, DOI 10.1074/jbc.M111.233734; KURAS R, 1994, EMBO J, V13, P1019, DOI 10.1002/j.1460-2075.1994.tb06350.x; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Ledford HK, 2004, MOL GENET GENOMICS, V272, P470, DOI 10.1007/s00438-004-1078-5; Lennartz K, 2006, PLANT J, V45, P101, DOI 10.1111/j.1365-313X.2005.02605.x; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Malnoe A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1299; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Peltier JB, 2004, J BIOL CHEM, V279, P49367, DOI 10.1074/jbc.M406763200; PIERRE Y, 1995, J BIOL CHEM, V270, P29342, DOI 10.1074/jbc.270.49.29342; Pootakham W, 2010, PLANT PHYSIOL, V153, P1653, DOI 10.1104/pp.110.157875; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; WHITE CC, 1978, BIOCHIM BIOPHYS ACTA, V502, P127, DOI 10.1016/0005-2728(78)90137-8; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129; Xiao JW, 2012, PLANT PHYSIOL, V160, P1911, DOI 10.1104/pp.112.204891; YANOFSKY C, 1981, NUCLEIC ACIDS RES, V9, P6647, DOI 10.1093/nar/9.24.6647; YILDIZ FH, 1994, PLANT PHYSIOL, V104, P981, DOI 10.1104/pp.104.3.981	52	22	22	0	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7024	7036		10.1074/jbc.M112.427476	http://dx.doi.org/10.1074/jbc.M112.427476			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23303190	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000316002400024
J	Giege, R				Giege, Richard			Fifty Years Excitement with Science: Recollections with and without tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RIBONUCLEIC-ACID; MOSAIC-VIRUS RNA; ESCHERICHIA-COLI; TERTIARY STRUCTURE; CRYSTAL-STRUCTURE; SYNTHETASE; YEAST; CRYSTALLIZATION; AMINOACYLATION; SPECIFICITY		[Giege, Richard] CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; [Giege, Richard] Univ Strasbourg, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Giege, R (corresponding author), CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France.	r.giege@ibmc-cnrs.unistra.fr			CNRS; Societe Francaise de Biochimie et de Biologie Moleculaire (SFBBM); Universite de Strasbourg; City of Strasbourg, Region Alsace; Universite Franco-Allemande	CNRS(Centre National de la Recherche Scientifique (CNRS)); Societe Francaise de Biochimie et de Biologie Moleculaire (SFBBM); Universite de Strasbourg; City of Strasbourg, Region Alsace(Region Grand-Est); Universite Franco-Allemande	I express my gratitude to my mentors in science and to all of my students, postdoctoral fellow, collaborators, and staff members at IBMC Strasbourg as well as to my worldwide friends and colleagues from the tRNA, aaRS, bioorganic chemistry, and crystallogenesis communities for exchanging ideas and results over the years. With all of them, I spent fifty rewarding years in the wonderland of science. This Reflections is based on a talk I gave at the Perspectives in tRNA Biology Symposium that took place on October 28-30, 2012, in Strasbourg and was organized by Catherine Florentz, Joern Putz, Claude Sauter, and Eric Westhof to honor my scientific contributions to the field of tRNA biology. Particular thanks are addressed to the sponsors of the symposium, notably the CNRS, the Societe Francaise de Biochimie et de Biologie Moleculaire (SFBBM), the Universite de Strasbourg, the City of Strasbourg, Region Alsace, and the Universite Franco-Allemande.	Bonnefond L, 2007, STRUCTURE, V15, P1505, DOI 10.1016/j.str.2007.09.018; Bour T, 2009, J BIOL CHEM, V284, P18893, DOI 10.1074/jbc.M109.015297; CHEN MC, 1975, BIOCHEMISTRY-US, V14, P4385, DOI 10.1021/bi00691a007; DEDUVE C, 1988, NATURE, V333, P117, DOI 10.1038/333117a0; DESSEN P, 1978, J MOL BIOL, V126, P293, DOI 10.1016/0022-2836(78)90042-6; Dhouib K, 2009, LAB CHIP, V9, P1412, DOI 10.1039/b819362b; DIETRICH A, 1980, J MOL BIOL, V138, P129, DOI 10.1016/S0022-2836(80)80008-8; Ducruix A., 1992, CRYSTALLIZATION NUCL; DUMAS P, 1987, J BIOMOL STRUCT DYN, V4, P707, DOI 10.1080/07391102.1987.10507674; EBEL JP, 1973, BIOCHIMIE, V55, P547, DOI 10.1016/S0300-9084(73)80415-8; FLORENTZ C, 1982, EMBO J, V1, P269, DOI 10.1002/j.1460-2075.1982.tb01158.x; FRUGIER M, 1993, BIOCHEMISTRY-US, V32, P14053, DOI 10.1021/bi00213a039; GIEGE R, 1973, FEBS LETT, V37, P166, DOI 10.1016/0014-5793(73)80450-8; GIEGE R, 1973, FEBS LETT, V30, P291, DOI 10.1016/0014-5793(73)80672-6; GIEGE R, 1980, CR ACAD SCI D NAT, V291, P393; GIEGE R, 1977, J MOL BIOL, V115, P91, DOI 10.1016/0022-2836(77)90248-0; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Giege R, 1998, CURR OPIN STRUC BIOL, V8, P286, DOI 10.1016/S0959-440X(98)80060-2; GIEGE R, 1974, EUR J BIOCHEM, V45, P351, DOI 10.1111/j.1432-1033.1974.tb03560.x; GIEGE R, 1982, BIOCHIMIE, V64, P357, DOI 10.1016/S0300-9084(82)80440-9; GIEGE R, 1968, BIOCHIM BIOPHYS ACTA, V161, P125, DOI 10.1016/0005-2787(68)90301-8; GIEGE R, 1977, NUCLEIC ACIDS RES, V4, P2421, DOI 10.1093/nar/4.7.2421; Giege R., 1972, THESIS L PASTEUR STR; GIEGE R, 2001, RNA, P71; Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g; Holmes CE, 1996, NUCLEIC ACIDS RES, V24, P3399, DOI 10.1093/nar/24.17.3399; Leguay JJ, 2006, BIOCHIMIE, V88, P1513, DOI 10.1016/j.biochi.2006.10.002; LENGYEL P, 1966, J GEN PHYSIOL, V49, P305, DOI 10.1085/jgp.49.6.305; LI ZQ, 1983, BIOCHEMISTRY-US, V22, P4380, DOI 10.1021/bi00288a006; Lin SX, 2007, CRYST GROWTH DES, V7, P2124, DOI 10.1021/cg700745r; Lowary P., 1986, STRUCTURE DYNAMICS R, V110, P69; Madore E, 1999, NUCLEIC ACIDS RES, V27, P3583, DOI 10.1093/nar/27.17.3583; MIKOL V, 1990, J MOL BIOL, V213, P187, DOI 10.1016/S0022-2836(05)80130-5; MORAS D, 1980, NATURE, V288, P669, DOI 10.1038/288669a0; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; Ng JD, 2002, ACTA CRYSTALLOGR D, V58, P645, DOI 10.1107/S0907444902003177; NUREKI O, 1994, J MOL BIOL, V236, P710, DOI 10.1006/jmbi.1994.1184; PERRET V, 1990, NATURE, V344, P787, DOI 10.1038/344787a0; PODYMINOGIN MA, 1993, NUCLEIC ACIDS RES, V21, P5950, DOI 10.1093/nar/21.25.5950; PUGLISI JD, 1993, NUCLEIC ACIDS RES, V21, P41, DOI 10.1093/nar/21.1.41; RiesKautt M, 1997, J CRYST GROWTH, V181, P79, DOI 10.1016/S0022-0248(97)00280-7; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; ROMBY P, 1985, J MOL BIOL, V184, P455, DOI 10.1016/0022-2836(85)90294-3; Rudinger J, 1996, EMBO J, V15, P650, DOI 10.1002/j.1460-2075.1996.tb00397.x; Ryckelynck M, 2005, J MOL BIOL, V354, P614, DOI 10.1016/j.jmb.2005.09.063; Sauter C, 2000, J MOL BIOL, V299, P1313, DOI 10.1006/jmbi.2000.3791; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; SCHOEMAKER HJP, 1975, J BIOL CHEM, V250, P4440; THEOBALD A, 1988, BIOCHIMIE, V70, P205, DOI 10.1016/0300-9084(88)90062-4	49	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6679	6687		10.1074/jbc.X113.453894	http://dx.doi.org/10.1074/jbc.X113.453894			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23325807	Green Published, hybrid			2022-12-28	WOS:000315820700066
J	Kukreti, H; Amuthavalli, K; Harikumar, A; Sathiyamoorthy, S; Feng, PZ; Anantharaj, R; Tan, SLK; Lokireddy, S; Bonala, S; Sriram, S; McFarlane, C; Kambadur, R; Sharma, M				Kukreti, Himani; Amuthavalli, Kottaiswamy; Harikumar, Arigela; Sathiyamoorthy, Sushmitha; Feng, Peng Zhao; Anantharaj, Rengaraj; Tan, Suan Liang Kelvin; Lokireddy, Sudarsanareddy; Bonala, Sabeera; Sriram, Sandhya; McFarlane, Craig; Kambadur, Ravi; Sharma, Mridula			Muscle-specific MicroRNA1 (miR1) Targets Heat Shock Protein 70 (HSP70) during Dexamethasone-mediated Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; GLUCOCORTICOID-RECEPTOR; PROTEOLYTIC SYSTEM; UBIQUITIN LIGASES; GENE-EXPRESSION; MYOSTATIN GENE; HEAT-SHOCK; DIFFERENTIATION	High doses of dexamethasone (Dex) or myostatin (Mstn) induce severe atrophy of skeletal muscle. Here we show a novel microRNA1 (miR1)-mediated mechanism through which Dex promotes skeletal muscle atrophy. Using both C2C12 myotubes and mouse models of Dex-induced atrophy we show that Dex induces miR1 expression through glucocorticoid receptor (GR). We further show that Mstn treatment facilitates GR nuclear translocation and thereby induces miR1 expression. Inhibition of miR1 in C2C12 myotubes attenuated the Dex-induced increase in atrophy-related proteins confirming a role for miR1 in atrophy. Analysis of miR1 targets revealed that HSP70 is regulated by miR1 during atrophy. Our results demonstrate that increased miR1 during atrophy reduced HSP70 levels, which resulted in decreased phosphorylation of AKT, as HSP70 binds to and protects phosphorylation of AKT. We further show that loss of pAKT leads to decreased phosphorylation, and thus, enhanced activation of FOXO3, up-regulation of MuRF1 and Atrogin-1, and progression of skeletal muscle atrophy. Based on these results, we propose a model whereby Dex- and Mstn-mediated atrophic signals are integrated through miR1, which then either directly or indirectly, inhibits the proteins involved in providing protection against atrophy.	[Kukreti, Himani; Amuthavalli, Kottaiswamy; Sathiyamoorthy, Sushmitha; Feng, Peng Zhao; Anantharaj, Rengaraj; Tan, Suan Liang Kelvin; Sharma, Mridula] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Harikumar, Arigela; Lokireddy, Sudarsanareddy; Bonala, Sabeera; Sriram, Sandhya; Kambadur, Ravi] Nanyang Technol Univ, Sch Biol Sci, Dept Genom & Genet, Singapore 637551, Singapore; [McFarlane, Craig; Kambadur, Ravi] Brenner Ctr Mol Med, Growth Dev & Metab Program, Singapore Inst Clin Sci, Singapore 117609, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Sharma, M (corresponding author), Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, 8 Med Dr MD7, Singapore 117597, Singapore.	bchmridu@nus.edu.sg	McFarlane, Craig/R-2968-2019; ARIGELA, HARIKUMAR/J-9872-2019	McFarlane, Craig/0000-0002-7056-8887; ARIGELA, HARIKUMAR/0000-0003-3293-7618; Bonala, Sabeerabi/0000-0002-0783-0862	BioMedical Research Council (BMRC); National Research Foundation (NRF), Republic of Singapore	BioMedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); National Research Foundation (NRF), Republic of Singapore	This work was supported by the BioMedical Research Council (BMRC) and National Research Foundation (NRF), Republic of Singapore.	Allen DL, 2011, AM J PHYSIOL-CELL PH, V300, pC124, DOI 10.1152/ajpcell.00142.2010; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonala S, 2012, J BIOL CHEM, V287, P12935, DOI 10.1074/jbc.M111.319145; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Dittmar KD, 1997, J BIOL CHEM, V272, P13047, DOI 10.1074/jbc.272.20.13047; Dodd S, 2009, BIOGERONTOLOGY, V10, P605, DOI 10.1007/s10522-008-9203-1; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Gilson H, 2007, ENDOCRINOLOGY, V148, P452, DOI 10.1210/en.2006-0539; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kayama M, 2011, AM J PATHOL, V178, P1080, DOI 10.1016/j.ajpath.2010.11.072; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li BG, 2004, J BURN CARE REHABIL, V25, P112, DOI 10.1097/01.BCR.0000105100.44745.36; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; Luo GJ, 2001, AM J PHYSIOL-REG I, V281, pR1193, DOI 10.1152/ajpregu.2001.281.4.R1193; Ma K, 2001, AM J PHYSIOL-ENDOC M, V281, pE1128, DOI 10.1152/ajpendo.2001.281.6.E1128; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; McArdle A, 2003, FASEB J, V17, P355, DOI 10.1096/fj.03-0395fje; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McFarlane C, 2011, AM J PHYSIOL-CELL PH, V301, pC195, DOI 10.1152/ajpcell.00012.2011; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Rachagani Satyanarayana, 2010, BMC Res Notes, V3, P297, DOI 10.1186/1756-0500-3-297; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schakman O, 2009, HORM RES, V72, P36, DOI 10.1159/000229762; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; Shan ZX, 2010, FEBS LETT, V584, P3592, DOI 10.1016/j.febslet.2010.07.027; Siriett V, 2007, MOL THER, V15, P1463, DOI 10.1038/sj.mt.6300182; Sriram S, 2011, AGING CELL, V10, P931, DOI 10.1111/j.1474-9726.2011.00734.x; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Welch S, 2002, CIRC RES, V90, P641, DOI 10.1161/01.RES.0000013780.77774.75; WING SS, 1993, AM J PHYSIOL, V264, pE668, DOI 10.1152/ajpendo.1993.264.4.E668; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373; Zhao WD, 2009, BIOCHEM BIOPH RES CO, V378, P668, DOI 10.1016/j.bbrc.2008.11.123; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	45	90	93	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6663	6678		10.1074/jbc.M112.390369	http://dx.doi.org/10.1074/jbc.M112.390369			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23297411	Green Published, hybrid			2022-12-28	WOS:000315820700065
J	de Vries, S; Naarmann-de Vries, IS; Urlaub, H; Lue, HQ; Bernhagen, J; Ostareck, DH; Ostareck-Lederer, A				de Vries, Sebastian; Naarmann-de Vries, Isabel S.; Urlaub, Henning; Lue, Hongqi; Bernhagen, Juergen; Ostareck, Dirk H.; Ostareck-Lederer, Antje			Identification of DEAD-box RNA Helicase 6 (DDX6) as a Cellular Modulator of Vascular Endothelial Growth Factor Expression under Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MESSENGER-RNA; RIBOSOME ENTRY SITE; HIPPEL-LINDAU PROTEIN; TRANSLATION INITIATION; GENE-EXPRESSION; HNRNP-K; C-SRC; POSTTRANSCRIPTIONAL REGULATION; INDUCIBLE FACTOR-1; CYTOPLASMIC FOCI	Vascular endothelial growth factor A (VEGF) is a crucial proangiogenic factor, which regulates blood vessel supply under physiologic and pathologic conditions. The VEGF mRNA 5'-untranslated region (5'-UTR) bears internal ribosome entry sites (IRES), which confer sustained VEGF mRNA translation under hypoxia when 5'-cap-dependent mRNA translation is inhibited. VEGF IRES-mediated initiation of translation requires the modulated interaction of trans-acting factors. To identify trans-acting factors that control VEGF mRNA translation under hypoxic conditions we established an in vitro translation system based on human adenocarcinoma cells (MCF-7). Cytoplasmic extracts of MCF-7 cells grown under hypoxia (1% oxygen) recapitulate VEGF IRES-mediated reporter mRNA translation. Employing the VEGF mRNA 5'-UTR and 3'-UTR in an RNA affinity approach we isolated interacting proteins from translational active MCF-7 extract prepared from cells grown under normoxia or hypoxia. Interestingly, mass spectrometry analysis identified the DEAD-box RNA helicase 6 (DDX6) that interacts with the VEGF mRNA 5'-UTR. Recombinant DDX6 inhibits VEGF IRES-mediated translation in normoxic MCF-7 extract. Under hypoxia the level of DDX6 declines, and its interaction with VEGF mRNA is diminished in vivo. Depletion of DDX6 by RNAi further promotes VEGF expression in MCF-7 cells. Increased secretion of VEGF from DDX6 knockdown cells positively affects vascular tube formation of human umbilical vein endothelial cells (HUVEC) in vitro. Our results indicate that the decrease of DDX6 under hypoxia contributes to the activation of VEGF expression and promotes its proangiogenic function.	[de Vries, Sebastian; Naarmann-de Vries, Isabel S.; Ostareck, Dirk H.; Ostareck-Lederer, Antje] Rhein Westfal TH Aachen, Dept Intens Care & Intermediate Care, Univ Hosp, Expt Res Unit, D-52074 Aachen, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Dept Bioanalyt Mass Spectrometry, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, D-37075 Gottingen, Germany; [Lue, Hongqi; Bernhagen, Juergen] Rhein Westfal TH Aachen, Univ Hosp, Inst Biochem & Mol Cell Biol, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Max Planck Society; University of Gottingen; RWTH Aachen University; RWTH Aachen University Hospital	Ostareck, DH (corresponding author), Rhein Westfal TH Aachen, Dept Intens Care & Intermediate Care, Univ Hosp, Expt Res Unit, D-52074 Aachen, Germany.	dostareck@ukaachen.de; aostareck@ukaachen.de		Ostareck, Dirk/0000-0001-9406-7190; Ostareck-Lederer, Antje/0000-0003-0733-7071	Deutsche Forschungsgemeinschaft Heisenberg Fellowship [OS290/1-2]; Deutsche Forschungsgemeinschaft [OS290/4-1, OS290/3-2]; IZKF Aachen [K-TV4]; European Community (EuCAR) [IRTG 1508/1-P13]	Deutsche Forschungsgemeinschaft Heisenberg Fellowship(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Aachen; European Community (EuCAR)	The work was supported by Deutsche Forschungsgemeinschaft Heisenberg Fellowship OS290/1-2 (to A. O.-L.) and Deutsche Forschungsgemeinschaft Grants OS290/4-1 (to A. O.-L. and D. H. O.) and OS290/3-2 (to D. H. O. and A. O.-L.).; Supported by Grants of the IZKF Aachen K-TV4 and the European Community (EuCAR) IRTG 1508/1-P13.	Akiri G, 1998, ONCOGENE, V17, P227, DOI 10.1038/sj.onc.1202019; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; BARTON DJ, 1993, J VIROL, V67, P822, DOI 10.1128/JVI.67.2.822-831.1993; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; Coleman AM, 2008, J IMMUNOL, V181, P2330, DOI 10.4049/jimmunol.181.4.2330; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Dibbens JA, 1999, MOL BIOL CELL, V10, P907, DOI 10.1091/mbc.10.4.907; Ernoult-Lange M, 2012, RNA, V18, P1702, DOI 10.1261/rna.034314.112; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Fahling M, 2009, ACTA PHYSIOL, V195, P205, DOI 10.1111/j.1748-1716.2008.01894.x; Ferrara N, 2005, EXP SUPPL, V94, P209; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gallo CM, 2008, DEV BIOL, V323, P76, DOI 10.1016/j.ydbio.2008.07.008; Hamasaki K, 1998, BIOCHEMISTRY-US, V37, P656, DOI 10.1021/bi971095t; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Kaiser C, 2008, RNA, V14, P2170, DOI 10.1261/rna.1171808; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Levy AP, 1996, J BIOL CHEM, V271, P25492, DOI 10.1074/jbc.271.41.25492; Levy AP, 1996, J BIOL CHEM, V271, P2746, DOI 10.1074/jbc.271.5.2746; Levy NS, 1997, BBA-GENE STRUCT EXPR, V1352, P167, DOI 10.1016/S0167-4781(97)00052-3; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui T, 2006, GENES CELLS, V11, P439, DOI 10.1111/j.1365-2443.2006.00951.x; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Messias AC, 2006, J MOL BIOL, V361, P470, DOI 10.1016/j.jmb.2006.06.025; Miller DL, 1998, FEBS LETT, V434, P417, DOI 10.1016/S0014-5793(98)01025-4; Naarmann IS, 2008, J BIOL CHEM, V283, P18461, DOI 10.1074/jbc.M710328200; Naarmann IS, 2010, RNA, V16, P2189, DOI 10.1261/rna.2211110; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; PLOUET J, 1989, EMBO J, V8, P3801, DOI 10.1002/j.1460-2075.1989.tb08557.x; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Saito K, 2011, NUCLEIC ACIDS RES, V39, P6086, DOI 10.1093/nar/gkr194; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Weinlich S, 2009, RNA, V15, P1528, DOI 10.1261/rna.1578409; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Xin H, 2012, MOL CANCER RES, V10, P108, DOI 10.1158/1541-7786.MCR-11-0435; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200; Zygalaki E, 2005, CLIN CHEM, V51, P1518, DOI 10.1373/clinchem.2004.046987	60	41	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5815	5827		10.1074/jbc.M112.420711	http://dx.doi.org/10.1074/jbc.M112.420711			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23293030	Green Published, hybrid			2022-12-28	WOS:000315342500052
J	Song, P; Kim, JH; Ghim, J; Yoon, JH; Lee, A; Kwon, Y; Hyun, H; Moon, HY; Choi, HS; Berggren, PO; Suh, PG; Ryu, SH				Song, Parkyong; Kim, Jong Hyun; Ghim, Jaewang; Yoon, Jong Hyuk; Lee, Areum; Kwon, Yonghoon; Hyun, Hyunjung; Moon, Hyo-Youl; Choi, Hueng-Sik; Berggren, Per-Olof; Suh, Pann-Ghill; Ryu, Sung Ho			Emodin Regulates Glucose Utilization by Activating AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; DEPENDENT DIABETES-MELLITUS; RAT SKELETAL-MUSCLE; COMPLEX-I; SIGNALING PATHWAY; ADIPOSE-TISSUE; INSULIN; METFORMIN; CELLS; TRANSPORT	AMP-activated protein kinase has been described as a key signaling protein that can regulate energy homeostasis. Here, we aimed to characterize novel AMP-activated kinase (AMPK)-activating compounds that have a much lower effective concentration than metformin. As a result, emodin, a natural anthraquinone derivative, was shown to stimulate AMPK activity in skeletal muscle and liver cells. Emodin enhanced GLUT4 translocation and [C-14]glucose uptake into the myotube in an AMPK-dependent manner. Also, emodin inhibited glucose production by suppressing the expression of key gluconeogenic genes, such as phosphoenolpyruvate carboxykinase and glucose-6-phosphatase, in hepatocytes. Furthermore, we found that emodin can activate AMPK by inhibiting mitochondrial respiratory complex I activity, leading to increased reactive oxygen species and Ca2+/calmodulin-dependent protein kinase kinase activity. Finally, we confirmed that a single dose administration of emodin significantly decreased the fasting plasma glucose levels and improved glucose tolerance in C57Bl/6J mice. Increased insulin sensitivity was also confirmed after daily injection of emodin for 8 days using an insulin tolerance test and insulin-stimulated PI3K phosphorylation in wild type and high fat diet-induced diabetic mouse models. Our study suggests that emodin regulates glucose homeostasis in vivo by AMPK activation and that this may represent a novel therapeutic principle in the treatment of type 2 diabetic models.	[Song, Parkyong; Kim, Jong Hyun; Ghim, Jaewang; Lee, Areum; Kwon, Yonghoon; Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea; [Yoon, Jong Hyuk] NovaCell Technol Inc, Pohang 790784, Kyungbuk, South Korea; [Hyun, Hyunjung; Berggren, Per-Olof; Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Moon, Hyo-Youl; Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, Sch Nanobiotechnol & Chem Engn, Ulsan 689805, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea; [Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17177 Stockholm, Sweden	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Ulsan National Institute of Science & Technology (UNIST); Chonnam National University; Karolinska Institutet	Ryu, SH (corresponding author), POSTECH Biotech Ctr, San 31 Hyojadong, Pohang 790784, South Korea.	sungho@postech.ac.kr	Suh, Pann-Ghill/F-3610-2010	Berggren, Per-Olof/0000-0001-8991-413X; Kwon, yonghoon/0000-0002-6232-4305; Moon, Hyo Youl/0000-0001-8207-1301; Ryu, Sung Ho/0000-0003-0913-3048	21C Frontier Functional Proteomics Project [FPR08B1-160]; World Class University Program [R31-2008-000-10105-0]; Korean Ministry of Education, Science and Technology; Ministry of Health and Welfare, Republic of Korea [A111345]; Swedish Research Council; Family Erling-Persson Foundation; Stichting af Jochnick Foundation	21C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); World Class University Program; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Swedish Research Council(Swedish Research CouncilEuropean Commission); Family Erling-Persson Foundation; Stichting af Jochnick Foundation	This work was supported by 21C Frontier Functional Proteomics Project Grant FPR08B1-160, World Class University Program Grant R31-2008-000-10105-0 funded by the Korean Ministry of Education, Science and Technology, Korea Health Technology R&D Project Grant A111345 from the Ministry of Health and Welfare, Republic of Korea, the Swedish Research Council, The Family Erling-Persson Foundation, and The Stichting af Jochnick Foundation.	An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Cha TL, 2005, CANCER RES, V65, P2287, DOI 10.1158/0008-5472.CAN-04-3250; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Feng Y, 2010, BRIT J PHARMACOL, V161, P113, DOI 10.1111/j.1476-5381.2010.00826.x; Fujita Y, 2010, DIABETOLOGIA, V53, P1472, DOI 10.1007/s00125-010-1729-5; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hattori A, 2010, OBESITY, V18, P48, DOI 10.1038/oby.2009.145; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Imanishi Y, 2004, J HEPATOL, V41, P242, DOI 10.1016/j.jhep.2004.04.005; Jahnke GD, 2004, BIRTH DEFECTS RES B, V71, P89, DOI 10.1002/bdrb.20002; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kandror Konstantin V, 2003, Sci STKE, V2003, pPE5, DOI 10.1126/stke.2003.169.pe5; Katz A, 2007, J APPL PHYSIOL, V102, P1671, DOI 10.1152/japplphysiol.01066.2006; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; Kumar A, 1998, ONCOGENE, V17, P913, DOI 10.1038/sj.onc.1201998; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Lenaz G, 2006, BBA-BIOENERGETICS, V1757, P1406, DOI 10.1016/j.bbabio.2006.05.007; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Liu YX, 2009, TRANSPL P, V41, P1837, DOI 10.1016/j.transproceed.2009.02.090; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Merry TL, 2009, IUBMB LIFE, V61, P479, DOI 10.1002/iub.179; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Oshida K, 2011, J APPL TOXICOL, V31, P790, DOI 10.1002/jat.1637; Park IJ, 2009, ANN NY ACAD SCI, V1171, P538, DOI 10.1111/j.1749-6632.2009.04698.x; Ross RM, 2007, DIABETES, V56, P2885, DOI 10.2337/db07-0745; Sandeep TC, 2005, DIABETES, V54, P872, DOI 10.2337/diabetes.54.3.872; Sandstrom ME, 2006, J PHYSIOL-LONDON, V575, P251, DOI 10.1113/jphysiol.2006.110601; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Somwar R, 2000, DIABETES, V49, P1794, DOI 10.2337/diabetes.49.11.1794; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Su YT, 2005, BIOCHEM PHARMACOL, V70, P229, DOI 10.1016/j.bcp.2005.04.026; Tzeng TF, 2012, PLANTA MED, V78, P943, DOI 10.1055/s-0031-1298626; Tzeng TF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/781812; Wang CH, 2007, WORLD J GASTROENTERO, V13, P378, DOI 10.3748/wjg.v13.i3.378; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Yang Y, 2007, BIOCHEM BIOPH RES CO, V353, P225, DOI 10.1016/j.bbrc.2006.11.134; Yea K, 2008, J MOL MED-JMM, V86, P211, DOI 10.1007/s00109-007-0269-z; Yi J, 2004, CANCER RES, V64, P108, DOI 10.1158/0008-5472.CAN-2820-2; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	52	51	61	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5732	5742		10.1074/jbc.M112.441477	http://dx.doi.org/10.1074/jbc.M112.441477			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23303186	Green Published, hybrid			2022-12-28	WOS:000315342500045
J	Ye, QQ; Lai, FF; Banerjee, M; Duan, QM; Li, ZC; Si, SY; Xie, ZJ				Ye, Qiqi; Lai, Fangfang; Banerjee, Moumita; Duan, Qiming; Li, Zhichuan; Si, Shuyi; Xie, Zijian			Expression of Mutant alpha 1 Na/K-ATPase Defective in Conformational Transition Attenuates Src-mediated Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; ONSET DYSTONIA-PARKINSONISM; TRANSMEMBRANE SEGMENT M3; NA+-K+-ATPASE; PROTEIN-KINASE; TYROSINE KINASE; SODIUM-PUMP; NA+,K+-ATPASE; BINDING; ACTIVATION	The alpha 1 Na/K-ATPase possesses both pumping and signaling functions. Using purified enzyme we found that the alpha 1 Na/K-ATPase might interact with and regulate Src activity in a conformation-dependent manner. Here we further explored the importance of the conformational transition capability of alpha 1 Na/K-ATPase in regulation of Src-related signal transduction in cell culture. We first rescued the alpha 1-knockdown cells by wild-type rat alpha 1 or alpha 1 mutants (I279A and F286A) that are known to be defective in conformational transition. Stable cell lines with comparable expression of wild type alpha 1, I279A, and F286A were characterized. As expected, the defects in conformation transition resulted in comparable degree of inhibition of pumping activity in the mutant-rescued cell lines. However, I279A was more effective in inhibiting basal Src activity than either the wild-type or the F286A. Although much higher ouabain concentration was required to stimulate Src in I279A-rescued cells, extracellular K+ was comparably effective in regulating Src in both control and I279A cells. In contrast, ouabain and extracellular K+ failed to produce detectable changes in Src activity in F286A-rescued cells. Furthermore, expression of either mutant inhibited integrin-induced activation of Src/FAK pathways and slowed cell spreading processes. Finally, the expression of these mutants inhibited cell growth, with I279A being more potent than that of F286A. Taken together, the new findings suggest that the alpha 1 Na/K-ATPase may be a key player in dynamic regulation of cellular Src activity and that the capability of normal conformation transition is essential for both pumping and signaling functions of alpha 1 Na/K-ATPase.	[Ye, Qiqi; Lai, Fangfang; Banerjee, Moumita; Duan, Qiming; Li, Zhichuan; Xie, Zijian] Univ Toledo, Coll Med, Dept Physiol, Toledo, OH 43614 USA; [Ye, Qiqi; Lai, Fangfang; Banerjee, Moumita; Duan, Qiming; Li, Zhichuan; Xie, Zijian] Univ Toledo, Coll Med, Dept Pharmacol, Toledo, OH 43614 USA; [Ye, Qiqi; Lai, Fangfang; Banerjee, Moumita; Duan, Qiming; Li, Zhichuan; Xie, Zijian] Univ Toledo, Coll Med, Dept Med, Toledo, OH 43614 USA; [Si, Shuyi] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; [Lai, Fangfang; Si, Shuyi] Peking Union Med Coll, Beijing 100050, Peoples R China; [Lai, Fangfang] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS	Xie, ZJ (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Mail Stop 1008,3000 Arlington Ave, Toledo, OH 43614 USA.	Zi-jian.Xie@utoledo.edu	Li, Zhichuan/Q-7379-2017; Duan, Qiming/I-1822-2019; Banerjee, Moumita/Y-7651-2019	Duan, Qiming/0000-0002-6204-3028; Banerjee, Moumita/0000-0002-4463-7914	National Institutes of Health [HL-36573, HL-109015, GM-78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109015, P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573 and HL-109015 (NHLBI) and GM-78565 (NIGMS).	AKERA T, 1991, LIFE SCI, V48, P97, DOI 10.1016/0024-3205(91)90402-W; Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; Aperia A, 2007, J INTERN MED, V261, P44, DOI 10.1111/j.1365-2796.2006.01745.x; Arnaud-Batista FJ, 2012, AM J PHYSIOL-RENAL, V302, pF959, DOI 10.1152/ajprenal.00130.2011; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Chen Y, 2008, J BIOL CHEM, V283, P1128, DOI 10.1074/jbc.M708025200; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; Einholm AP, 2005, P NATL ACAD SCI USA, V102, P11254, DOI 10.1073/pnas.0501201102; Ferrandi M, 1999, AM J PHYSIOL-HEART C, V277, pH1338, DOI 10.1152/ajpheart.1999.277.4.H1338; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Haas M, 2000, J BIOL CHEM, V275, P27832; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Karpova LV, 2010, CELL BIOCHEM FUNCT, V28, P135, DOI 10.1002/cbf.1632; Khundmiri SJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1171, DOI 10.1152/ajpcell.00535.2006; Kirshenbaum GS, 2011, GENES BRAIN BEHAV, V10, P542, DOI 10.1111/j.1601-183X.2011.00691.x; Kirshenbaum GS, 2011, P NATL ACAD SCI USA, V108, P18144, DOI 10.1073/pnas.1108416108; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Liu LJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1489, DOI 10.1152/ajpcell.00158.2007; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Nguyen ANT, 2011, AM J PHYSIOL-RENAL, V301, pF897, DOI 10.1152/ajprenal.00095.2011; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PENG ZY, 1995, ONCOGENE, V11, P1955; PERIYASAMY SM, 1983, COMP BIOCHEM PHYS B, V76, P449, DOI 10.1016/0305-0491(83)90274-2; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; SABE H, 1994, P NATL ACAD SCI USA, V91, P3984, DOI 10.1073/pnas.91.9.3984; Schack VR, 2012, J BIOL CHEM, V287, P2191, DOI 10.1074/jbc.M111.323022; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; Segall L, 2005, P NATL ACAD SCI USA, V102, P11106, DOI 10.1073/pnas.0504323102; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Toustrup-Jensen M, 2005, J BIOL CHEM, V280, P10210, DOI 10.1074/jbc.M411214200; Toustrup-Jensen M, 2003, ANN NY ACAD SCI, V986, P267, DOI 10.1111/j.1749-6632.2003.tb07181.x; Toustrup-Jensen M, 2003, J BIOL CHEM, V278, P38653, DOI 10.1074/jbc.M305521200; Toustrup-Jensen M, 2003, J BIOL CHEM, V278, P11402, DOI 10.1074/jbc.M212136200; Toustrup-Jensen M, 2002, J BIOL CHEM, V277, P38607, DOI 10.1074/jbc.M203665200; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Uddin MN, 2008, J BIOL CHEM, V283, P17946, DOI 10.1074/jbc.M800958200; Vilsen B, 2003, ANN NY ACAD SCI, V986, P50, DOI 10.1111/j.1749-6632.2003.tb07138.x; WALLICK ET, 1980, ARCH BIOCHEM BIOPHYS, V202, P442, DOI 10.1016/0003-9861(80)90448-8; Wang Z, 2009, CANCER RES, V69, P6556, DOI 10.1158/0008-5472.CAN-09-0891; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Ye QQ, 2011, J BIOL CHEM, V286, P6225, DOI 10.1074/jbc.M110.202051; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Zheng J, 2011, CARDIOVASC RES, V89, P51, DOI 10.1093/cvr/cvq263	57	36	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5803	5814		10.1074/jbc.M112.442608	http://dx.doi.org/10.1074/jbc.M112.442608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288841	hybrid, Green Published			2022-12-28	WOS:000315342500051
J	Baron, JA; Laws, KM; Chen, JS; Culotta, VC				Baron, J. Allen; Laws, Kaitlin M.; Chen, Janice S.; Culotta, Valeria C.			Superoxide Triggers an Acid Burst in Saccharomyces cerevisiae to Condition the Environment of Glucose-starved Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; PLASMA-MEMBRANE; YEAST-CELLS; MITOCHONDRIAL DISEASE; MANGANESE; DISMUTASE; MUTATIONS; MUTANTS; GROWTH; SITE	Although yeast cells grown in abundant glucose tend to acidify their extracellular environment, they raise the pH of the environment when starved for glucose or when grown strictly with non-fermentable carbon sources. Following prolonged periods in this alkaline phase, Saccharomyces cerevisiae cells will switch to producing acid. The mechanisms and rationale for this "acid burst" were unknown. Herein we provide strong evidence for the role of mitochondrial superoxide in initiating the acid burst. Yeast mutants lacking the mitochondrial matrix superoxide dismutase (SOD2) enzyme, but not the cytosolic Cu,Zn-SOD1 enzyme, exhibited marked acceleration in production of acid on non-fermentable carbon sources. Acid production is also dramatically enhanced by the superoxide-producing agent, paraquat. Conversely, the acid burst is eliminated by boosting cellular levels of Mn-antioxidant mimics of SOD. We demonstrate that the acid burst is dependent on the mitochondrial aldehyde dehydrogenase Ald4p. Our data are consistent with a model in which mitochondrial superoxide damage to Fe-S enzymes in the tricarboxylic acid (TCA) cycle leads to acetate buildup by Ald4p. The resultant expulsion of acetate into the extracellular environment can provide a new carbon source to glucose-starved cells and enhance growth of yeast. By triggering production of organic acids, mitochondrial superoxide has the potential to promote cell population growth under nutrient depravation stress.	[Baron, J. Allen; Laws, Kaitlin M.; Chen, Janice S.; Culotta, Valeria C.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Culotta, VC (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	vculotta@jhsph.edu	Laws, Kaitlin Michelle/GPX-8412-2022	Chen, Janice/0000-0003-4797-3056; Baron, Allen/0000-0002-0593-3569; Laws, Kaitlin/0000-0003-4075-968X	National Institutes of Health [ES 08996, GM 50016]; Johns Hopkins University NIEHS, National Institutes of Health, center; National Institutes of Health NCI Training Grant [T32 CA009110]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008996, P30ES003819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM050016, T32GM066698, R01GM050016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University NIEHS, National Institutes of Health, center; National Institutes of Health NCI Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES 08996 and GM 50016 (to V. C. C.) and the Johns Hopkins University NIEHS, National Institutes of Health, center.; Supported by National Institutes of Health NCI Training Grant T32 CA009110.	Ackrell B A, 1978, Methods Enzymol, V53, P466; Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n; Barnese K, 2012, P NATL ACAD SCI USA, V109, P6892, DOI 10.1073/pnas.1203051109; BLASZCZYNSKI M, 1985, ACTA MICROBIOL POL, V34, P243; Boubekeur S, 1999, J BIOL CHEM, V274, P21044, DOI 10.1074/jbc.274.30.21044; Burhans WC, 2009, CELL CYCLE, V8, P2300, DOI 10.4161/cc.8.14.8852; Burtner CR, 2011, CELL CYCLE, V10, P1385, DOI 10.4161/cc.10.9.15464; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Cap Michal, 2010, Commun Integr Biol, V3, P198; Cap M, 2009, J BIOL CHEM, V284, P32572, DOI 10.1074/jbc.M109.022871; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cocheme HM, 2009, METHOD ENZYMOL, V456, P395, DOI 10.1016/S0076-6879(08)04422-4; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Demir AB, 2010, BIOCHEM BIOPH RES CO, V400, P106, DOI 10.1016/j.bbrc.2010.08.019; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gleason JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024741; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; GUSKOVA RA, 1984, BIOCHIM BIOPHYS ACTA, V778, P579, DOI 10.1016/0005-2736(84)90409-7; Hayashi M, 1998, YEAST, V14, P905; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Inoue Y, 1999, J BIOL CHEM, V274, P27002, DOI 10.1074/jbc.274.38.27002; Jules M, 2004, APPL ENVIRON MICROB, V70, P2771, DOI 10.1128/AEM.70.5.2771-2778.2004; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Luk E, 2003, P NATL ACAD SCI USA, V100, P10353, DOI 10.1073/pnas.1632471100; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Mbengue A, 2012, BRIT J HAEMATOL, V157, P171, DOI 10.1111/j.1365-2141.2012.09044.x; McCammon MT, 1996, GENETICS, V144, P57; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Merkel O, 1999, J BIOL CHEM, V274, P28121, DOI 10.1074/jbc.274.40.28121; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; MONK BC, 1991, J BACTERIOL, V173, P6826, DOI 10.1128/jb.173.21.6826-6836.1991; Navarro-Avino JP, 1999, YEAST, V15, P829, DOI 10.1002/(SICI)1097-0061(199907)15:10A<829::AID-YEA423>3.0.CO;2-9; Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Palkova Z, 2000, J CELL SCI, V113, P1923; Palkova Z, 2002, MOL BIOL CELL, V13, P3901, DOI 10.1091/mbc.E01-12-0149; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; Palkova Z, 2003, INT REV CYTOL, V225, P229, DOI 10.1016/S0074-7696(05)25006-4; Palkova Z, 2009, MOL MEMBR BIOL, V26, P228, DOI 10.1080/09687680902893130; Pedrajas JR, 1999, J BIOL CHEM, V274, P6366, DOI 10.1074/jbc.274.10.6366; PERLIN DS, 1989, J BIOL CHEM, V264, P21857; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Reddi AR, 2011, GENETICS, V189, P1261, DOI 10.1534/genetics.111.134007; Reddi AR, 2009, FREE RADICAL BIO MED, V46, P154, DOI 10.1016/j.freeradbiomed.2008.09.032; Sanchez RJ, 2005, J BIOL INORG CHEM, V10, P913, DOI 10.1007/s00775-005-0044-y; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; SIGLER K, 1981, BIOCHIM BIOPHYS ACTA, V643, P583, DOI 10.1016/0005-2736(81)90354-0; SIKORSKI RS, 1989, GENETICS, V122, P19; Strain J, 1998, J BIOL CHEM, V273, P31138, DOI 10.1074/jbc.273.47.31138; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; SUMEGI B, 1992, BIOCHEMISTRY-US, V31, P8720, DOI 10.1021/bi00152a006; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Szeto SSW, 2010, J PROTEOME RES, V9, P6729, DOI 10.1021/pr100880y; VANDERREST ME, 1995, MICROBIOL REV, V59, P304, DOI 10.1128/MMBR.59.2.304-322.1995; VOGEL K, 1990, MOL MICROBIOL, V4, P2013, DOI 10.1111/j.1365-2958.1990.tb00560.x; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793	70	13	13	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4557	4566		10.1074/jbc.M112.409508	http://dx.doi.org/10.1074/jbc.M112.409508			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23281478	Green Published, hybrid			2022-12-28	WOS:000315340400006
J	Chang, SH; Lu, YC; Li, X; Hsieh, WY; Xiong, YQ; Ghosh, M; Evans, T; Elemento, O; Hla, T				Chang, Sung-Hee; Lu, Yi-Chien; Li, Xi; Hsieh, Wan-Ying; Xiong, Yuquan; Ghosh, Mallika; Evans, Todd; Elemento, Olivier; Hla, Timothy			Antagonistic Function of the RNA-binding Protein HuR and miR-200b in Post-transcriptional Regulation of Vascular Endothelial Growth Factor-A Expression and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIRNA-MEDIATED REPRESSION; 3' UNTRANSLATED REGION; FACTOR MESSENGER-RNA; TUMOR ANGIOGENESIS; TARGET; VEGF; MICRORNAS; ELEMENT; IDENTIFICATION; STABILIZATION	HuR, also known as Elavl1, is an RNA-binding protein that regulates embryonic development, progenitor cell survival, and cell stress responses. The role of HuR in angiogenesis is not known. Using a myeloid-specific HuR knock-out mouse model (Elavl1Mo KO), we show that HuR expression in bone marrow-derived macrophages (BMDMs) is needed to maintain the expression of genes enriched in AU-rich elements and U-rich elements in the 3'-UTR. In addition, BMDMs from Elavl1Mo KO mice also showed alterations in expression of several miRNAs. Interestingly, computational analysis suggested that miR-200b, which is up-regulated in Elavl1Mo KO BMDMs, interacts with myeloid mRNAs very close to the HuR binding sites, suggesting competitive regulation of gene expression. One such mRNA encodes vascular endothelial growth factor (VEGF)-A, a major regulator of angiogenesis. Immunoprecipitation of RNA-protein complexes and luciferase reporter assays indicate that HuR antagonizes the suppressive activity of miR-200b, down-regulates miR-200b expression, and promotes VEGF-A expression. Indeed, Vegf-a and other angiogenic regulatory transcripts were down-regulated in Elavl1Mo KO BMDMs. Interestingly, tumor growth, angiogenesis, vascular sprouting, branching, and permeability were significantly attenuated in Elavl1Mo KO mice, suggesting that HuR-regulated myeloid-derived factors modulate tumor angiogenesis in trans. Zebrafish embryos injected with an elavl1 morpholino oligomer or miR-200b mimic showed angiogenesis defects in the subintestinal vein plexus, and elavl1 mRNA rescued the repressive effect of miR-200b. In addition, miR-200b and HuR morpholino oligomer suppressed the activity of a zVEGF 3'-UTR luciferase reporter construct. Together, these studies reveal an evolutionarily conserved post-transcriptional mechanism involving competitive interactions between HuR and miR-200b that controls angiogenesis.	[Chang, Sung-Hee; Lu, Yi-Chien; Li, Xi; Hsieh, Wan-Ying; Xiong, Yuquan; Hla, Timothy] Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10065 USA; [Evans, Todd] Cornell Univ, Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Elemento, Olivier] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, Inst Computat Biomed, New York, NY 10065 USA; [Ghosh, Mallika] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA	Cornell University; Cornell University; Cornell University; University of Connecticut	Hla, T (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, 1300 York Ave, New York, NY 10065 USA.	tih2002@med.cornell.edu	Ghosh, Mallika/Q-2976-2016; Hla, Timothy/G-5873-2012	Ghosh, Mallika/0000-0002-5090-1275; Hla, Timothy/0000-0001-8355-4065	National Institutes of Health [HL49094, HL56182]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111400, R01HL056182, R01HL049094, R37HL056182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported, in whole or in part, by National Institutes of Health Grants HL49094 (to T. H.) and HL56182 (to T. E.).	Avraham-Davidi I, 2012, NAT MED, V18, P967, DOI 10.1038/nm.2759; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; Chang SH, 2011, TRENDS MOL MED, V17, P650, DOI 10.1016/j.molmed.2011.06.008; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Fellows A, 2012, MOL BIOL CELL, V23, P1414, DOI 10.1091/mbc.E11-06-0545; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Ghosh M, 2009, J CLIN INVEST, V119, P3530, DOI 10.1172/JCI38263; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; Jafarifar F, 2011, EMBO J, V30, P1324, DOI 10.1038/emboj.2011.38; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Katsanou V, 2009, MOL CELL BIOL, V29, P2762, DOI 10.1128/MCB.01393-08; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Kundu P, 2012, NUCLEIC ACIDS RES, V40, P5088, DOI 10.1093/nar/gks148; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Maragkakis M, 2011, NUCLEIC ACIDS RES, V39, pW145, DOI 10.1093/nar/gkr294; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Papadaki O, 2009, J IMMUNOL, V182, P6779, DOI 10.4049/jimmunol.0900377; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Takeda Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007513; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Uren PJ, 2011, J BIOL CHEM, V286, P37063, DOI 10.1074/jbc.C111.266882; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Yiakouvaki A, 2012, J CLIN INVEST, V122, P48, DOI 10.1172/JCI45021; Zhang JG, 2012, AM J PATHOL, V180, P1751, DOI 10.1016/j.ajpath.2011.12.025; Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033	54	53	54	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4908	4921		10.1074/jbc.M112.423871	http://dx.doi.org/10.1074/jbc.M112.423871			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23223443	Green Published, hybrid			2022-12-28	WOS:000315340400039
J	Moore, SF; van den Bosch, MTJ; Hunter, RW; Sakamoto, K; Poole, AW; Hers, I				Moore, Samantha F.; van den Bosch, Marion T. J.; Hunter, Roger W.; Sakamoto, Kei; Poole, Alastair W.; Hers, Ingeborg			Dual Regulation of Glycogen Synthase Kinase 3 (GSK3)alpha/beta by Protein Kinase C (PKC)alpha and Akt Promotes Thrombin-mediated Integrin alpha(IIb)beta(3) Activation and Granule Secretion in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; PHOSPHOINOSITIDE 3-KINASE; PHOSPHORYLATION; INHIBITORS; AGGREGATION; COLLAGEN	Glycogen synthase kinase-3 is a Ser/Thr kinase, tonically active in resting cells but inhibited by phosphorylation of an N-terminal Ser residue (Ser(21) in GSK3 alpha and Ser(9) in GSK3 beta) in response to varied external stimuli. Recent work suggests that GSK3 functions as a negative regulator of platelet function, but how GSK3 is regulated in platelets has not been examined in detail. Here, we show that early thrombin-mediated GSK3 phosphorylation (0-30 s) was blocked by PKC inhibitors and largely absent in platelets from PKC alpha knock-out mice. In contrast, late (2-5 min) GSK3 phosphorylation was dependent on the PI3K/Akt pathway. Similarly, early thrombin-mediated inhibition of GSK3 activity was blocked in PKC alpha knock-out platelets, whereas the Akt inhibitor MK2206 reduced late thrombin-mediated GSK3 inhibition and largely prevented GSK3 inhibition in PKC alpha knock-out platelets. More importantly, GSK3 phosphorylation contributes to platelet function as knock-in mice where GSK3 alpha Ser(21) and GSK3 beta Ser(9) were mutated to Ala showed a significant reduction in PAR4-mediated platelet aggregation, fibrinogen binding, and P-selectin expression, whereas the GSK3 inhibitor CHIR99021 enhanced these responses. Together, these results demonstrate that PKC alpha and Akt modulate platelet function by phosphorylating and inhibiting GSK3 alpha/beta, thereby relieving the negative effect of GSK3 alpha/beta on thrombin-mediated platelet activation.	[Moore, Samantha F.; van den Bosch, Marion T. J.; Poole, Alastair W.; Hers, Ingeborg] Univ Bristol, Sch Med Sci, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Hunter, Roger W.; Sakamoto, Kei] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Hunter, Roger W.; Sakamoto, Kei] Nestle Inst Hlth Sci SA, CH-1015 Lausanne, Switzerland	University of Bristol; University of Dundee; Nestle SA	Hers, I (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Med Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England.	i.hers@bris.ac.uk	sakamoto, kei/C-8806-2019; Hers, Ingeborg/ABG-3357-2020	sakamoto, kei/0000-0001-8839-5980; Hers, Ingeborg/0000-0002-6467-5715; Hunter, Roger/0000-0003-0177-1512; van den Bosch, Marion/0000-0002-4635-4416; Poole, Alastair/0000-0002-0868-297X; Moore, Samantha/0000-0003-0944-7055	British Heart Foundation [PG/08/056, PG/09/059, PG/10/100, RG/10/006, FS/11/62]; British Medical Research Council; British Heart Foundation [FS/11/62/28934, PG/10/100/28658, FS/12/22/29510, PG/08/056/25325, RG/10/006/28299] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grants PG/08/056, PG/09/059, PG/10/100, RG/10/006, and FS/11/62.; Supported by the British Medical Research Council.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barry FA, 2003, FEBS LETT, V553, P173, DOI 10.1016/S0014-5793(03)01015-9; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Canobbio I, 2009, BLOOD, V114, P2193, DOI 10.1182/blood-2009-03-208074; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; Cosemans JMEM, 2010, J THROMB HAEMOST, V8, P1797, DOI 10.1111/j.1538-7836.2010.03935.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Mesquita DD, 2001, FEBS LETT, V502, P84, DOI 10.1016/S0014-5793(01)02669-2; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Gambaryan S, 2008, J THROMB HAEMOST, V6, P1376, DOI 10.1111/j.1538-7836.2008.03014.x; Garcia A, 2010, BIOCHEM J, V429, P369, DOI 10.1042/BJ20100166; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; GOODE N, 1992, J BIOL CHEM, V267, P16878; Harper MT, 2010, CELL CALCIUM, V48, P333, DOI 10.1016/j.ceca.2010.10.006; Hers I, 1999, FEBS LETT, V460, P433, DOI 10.1016/S0014-5793(99)01389-7; Hers I, 2007, BLOOD, V110, P4243, DOI 10.1182/blood-2006-10-050633; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hunter RW, 2008, J THROMB HAEMOST, V6, P1923, DOI 10.1111/j.1538-7836.2008.03140.x; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Martin V, 2010, BLOOD, V115, P2008, DOI 10.1182/blood-2009-04-217224; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Moore SF, 2011, J BIOL CHEM, V286, P24553, DOI 10.1074/jbc.M110.202341; O'Brien KA, 2011, BLOOD, V118, P4215, DOI 10.1182/blood-2010-12-323204; Pasquet JM, 2000, BLOOD, V95, P3429, DOI 10.1182/blood.V95.11.3429.011k22_3429_3434; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; SAITO Y, 1994, BIOCHEM J, V303, P27, DOI 10.1042/bj3030027; Stojanovic A, 2006, J BIOL CHEM, V281, P16333, DOI 10.1074/jbc.M512378200; Sutherland C., 2011, INT J ALZHEIMERS DIS, V2011; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Xia Z, 1996, BRIT J HAEMATOL, V93, P204, DOI 10.1046/j.1365-2141.1996.445980.x; Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522	39	103	111	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3918	3928		10.1074/jbc.M112.429936	http://dx.doi.org/10.1074/jbc.M112.429936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23239877	Green Published, hybrid			2022-12-28	WOS:000314845000022
J	Paintlia, MK; Paintlia, AS; Singh, AK; Singh, I				Paintlia, Manjeet K.; Paintlia, Ajaib S.; Singh, Avtar K.; Singh, Inderjit			S-Nitrosoglutathione Induces Ciliary Neurotrophic Factor Expression in Astrocytes, Which Has Implications to Protect the Central Nervous System under Pathological Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLARY ACIDIC PROTEIN; ACTIVATED-RECEPTOR-GAMMA; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE ACTIVATION; IN-VITRO; SIGNALING PATHWAY; GLIAL-CELLS; CYCLOOXYGENASE-2 EXPRESSION; OLIGODENDROCYTE PROGENITORS; DEMYELINATING DISEASES	Accumulating evidence suggests that reactive astrogliosis has beneficial and detrimental outcomes in various CNS disorders, but the mechanism behind this dichotomy is unclear. Recent advances in this direction suggested that NO signaling is critical to regulate the outcomes of reactive astrogliosis in vivo. Using biochemical and genetic approaches, we here investigated the effect of S-nitrosoglutathione (GSNO; a physiological NO donor) in astrocytes in vitro settings. GSNO enhanced the expressions of glial fibrillary acidic protein and neurotrophic factors including ciliary neurotrophic factor (CNTF) in astrocytes in a dose-dependent manner. The enhanced CNTF expression in GSNO-treated astrocytes was ascribed to NO-mediated sGC/cGMP/PKG signaling. It was associated with p38 MAPK-dependent increased peroxisome proliferator-activated receptor-gamma transactivation. In addition, the chromatin accessibility of peroxisome proliferator-activated receptor-gamma accompanied with ATF2 and CREB (cAMP-response element-binding protein) was enhanced across the CNTF gene promoter in GSNO treated astrocytes. Interestingly, secreted CNTF was responsible for increased expression of glial fibrillary acidic protein in GSNO-treated astrocytes in an autocrine manner via a JAK2- and STAT3-dependent mechanism. In addition, CNTF secreted by GSNO-treated astrocytes enhanced the differentiation of immature oligodendrocytes in vitro. These effects of GSNO were consistent with an endogenously produced NO in astrocytes stimulated with proinflammatory cytokines in vitro. We conclude that NO signaling induces CNTF expression in astrocytes that favors the beneficial outcomes of reactive astrogliosis in vivo. Our data suggest that the endogenously produced NO or its exogenous source has potential to modulate the outcomes of reactive astrogliosis to protect CNS under pathological conditions.	[Paintlia, Manjeet K.; Paintlia, Ajaib S.; Singh, Inderjit] Med Univ S Carolina, Dept Pediat, Darby Childrens Res Inst, Charleston, SC 29425 USA; [Singh, Avtar K.] Ralph H Johnson Vet Affairs Med Ctr, Dept Pathol & Lab Med, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Singh, I (corresponding author), Med Univ S Carolina, Dept Pediat, 173 Ashley Ave, Charleston, SC 29425 USA.	singhi@musc.edu	Singh, Ashok/HGF-2506-2022		National Institutes of Health [NS-22576, NS-37766, VA-1BX001072, VA-BX001999, C06 RR018823, C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS022576, R01NS037766, R01NS022576, R01NS072511] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants NS-22576, NS-37766, VA-1BX001072, VA-BX001999, C06 RR018823, and C06 RR015455.	Abramov AY, 2005, PHILOS T R SOC B, V360, P2309, DOI 10.1098/rstb.2005.1766; Albrecht PJ, 2003, NEUROBIOL DIS, V13, P89, DOI 10.1016/S0969-9961(03)00019-6; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Bishop A, 2005, TOXICOLOGY, V208, P193, DOI 10.1016/j.tox.2004.11.034; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Browning DD, 1999, J BIOL CHEM, V274, P537, DOI 10.1074/jbc.274.1.537; Browning DD, 2000, J BIOL CHEM, V275, P2811, DOI 10.1074/jbc.275.4.2811; BRUHWYLER J, 1993, NEUROSCI BIOBEHAV R, V17, P373, DOI 10.1016/S0149-7634(05)80114-9; Chien WL, 2008, EUR J PHARMACOL, V590, P233, DOI 10.1016/j.ejphar.2008.06.040; Chou PCT, 2011, J MAGN RESON IMAGING, V33, P1301, DOI 10.1002/jmri.22574; Ciani E, 2002, J NEUROCHEM, V82, P1282, DOI 10.1046/j.1471-4159.2002.01080.x; Crowe DL, 2000, ANTICANCER RES, V20, P2945; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Doronzo G, 2011, ATHEROSCLEROSIS, V216, P44, DOI 10.1016/j.atherosclerosis.2011.01.019; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Escartin C, 2007, J NEUROSCI, V27, P7094, DOI 10.1523/JNEUROSCI.0174-07.2007; GHIRNIKAR RS, 1994, J NEUROSCI RES, V38, P376, DOI 10.1002/jnr.490380403; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hebert MA, 2000, ANN NY ACAD SCI, V914, P238, DOI 10.1111/j.1749-6632.2000.tb05200.x; Herx LM, 2001, J NEUROPATH EXP NEUR, V60, P961, DOI 10.1093/jnen/60.10.961; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; Janabi N, 2002, J IMMUNOL, V168, P4747, DOI 10.4049/jimmunol.168.9.4747; Kacem K, 1998, GLIA, V23, P1; Kahn MA, 1997, J NEUROCHEM, V68, P1413; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Li ZM, 2004, J NEUROSCI RES, V78, P824, DOI 10.1002/jnr.20346; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Liu B, 2001, ARCH OPHTHALMOL-CHIC, V119, P240; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; MAGRINAT G, 1992, BLOOD, V80, P1880; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; Mander PK, 2006, J IMMUNOL, V176, P1046, DOI 10.4049/jimmunol.176.2.1046; MAYER M, 1994, DEVELOPMENT, V120, P143; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Na YJ, 2007, J NEUROCHEM, V103, P637, DOI 10.1111/j.1471-4159.2007.04769.x; Nath N, 2010, J NEUROIMMUNE PHARM, V5, P240, DOI 10.1007/s11481-009-9187-x; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Niedbala W, 2011, P NATL ACAD SCI USA, V108, P9220, DOI 10.1073/pnas.1100667108; Paintlia AS, 2006, J IMMUNOL, V176, P4385, DOI 10.4049/jimmunol.176.7.4385; Paintlia AS, 2010, GLIA, V58, P1669, DOI 10.1002/glia.21039; Paintlia AS, 2008, MOL PHARMACOL, V73, P1381, DOI 10.1124/mol.107.044230; Paintlia AS, 2005, FASEB J, V19, P1407, DOI 10.1096/fj.05-3861com; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Rostworowski M, 1997, J NEUROSCI, V17, P3664; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P81; Singh I, 1998, J BIOL CHEM, V273, P20354, DOI 10.1074/jbc.273.32.20354; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Vega-Avelaira D, 2007, BRAIN BEHAV IMMUN, V21, P617, DOI 10.1016/j.bbi.2006.10.007; Wilkins A, 2005, J NEUROCHEM, V92, P1487, DOI 10.1111/j.1471-4159.2004.02981.x; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306	69	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3831	3843		10.1074/jbc.M112.405654	http://dx.doi.org/10.1074/jbc.M112.405654			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264628	Green Published, hybrid			2022-12-28	WOS:000314845000015
J	Rajput, C; Kini, V; Smith, M; Yazbeck, P; Chavez, A; Schmidt, T; Zhang, W; Knezevic, N; Komarova, Y; Mehta, D				Rajput, Charu; Kini, Vidisha; Smith, Monica; Yazbeck, Pascal; Chavez, Alejandra; Schmidt, Tracy; Zhang, Wei; Knezevic, Nebojsa; Komarova, Yulia; Mehta, Dolly			Neural Wiskott-Aldrich Syndrome Protein (N-WASP)-mediated p120-Catenin Interaction with Arp2-Actin Complex Stabilizes Endothelial Adherens Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VE-CADHERIN; P120 CATENIN; CA2+ ENTRY; N-WASP; RHOA ACTIVATION; ARP2/3 COMPLEX; ALPHA-CATENIN; CELL-ADHESION; MECHANISMS; RECEPTOR	Stable adherens junctions (AJs) are required for formation of restrictive endothelial barrier. Vascular endothelial cadherin from contiguous endothelial cells forms AJs, which are stabilized intracellularly by binding of p120-catenin and cortical actin. Mechanisms inducing cortical actin formation and enabling its linkage with p120-catenin remain enigmatic. We altered the function of neural Wiskott-Aldrich syndrome protein (N-WASP), which induces actin polymerization through actin-related protein 2/3 complex (Arp2/3), to address the role of N-WASP in regulating AJ stability and thereby endothelial permeability. We show that depletion of N-WASP in endothelial cells impaired AJ adhesion and favored the organization of actin from cortical actin to stress fibers, resulting thereby in formation of leaky endothelial barrier. Exposure of the N-WASP-depleted endothelial cell monolayer to the permeability-increasing mediator, thrombin, exaggerated AJ disruption and stress fiber formation, leading to an irreversible increase in endothelial permeability. We show that N-WASP binds p120-catenin through its verprolin cofilin acid (VCA) domain, induces cortical actin formation through Arp2, and links p120-catenin with cortical actin. The interaction of N-WASP with p120-catenin, actin, and Arp2 requires phosphorylation of N-WASP at the Tyr-256 residue by focal adhesion kinase. Expression of the VCA domain of N-WASP or phosphomimicking (Y256D)-N-WASP mutant in endothelial cells stabilizes AJs and facilitates barrier recovery after thrombin stimulation. Our study demonstrates that N-WASP, by mediating p120-catenin interaction with actin-polymerizing machinery, maintains AJs and mitigates disruption of endothelial barrier function by edemagenic agents, therefore representing a novel target for preventing leaky endothelial barrier syndrome.	[Mehta, Dolly] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mehta, D (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave, Chicago, IL 60612 USA.	dmehta@uic.edu	Knezevic, Nebojsa Nick/H-9921-2019	Knezevic, Nebojsa Nick/0000-0001-8028-1495	National Institutes of Health [HL71794, PO1 HL060678, HL84153]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678, T32HL007829, R01HL071794, R01HL084153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL71794, PO1 HL060678, and HL84153 (to D. M.).	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Chiasson CM, 2009, MOL BIOL CELL, V20, P1970, DOI 10.1091/mbc.E08-07-0735; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Iyer S, 2004, AM J PHYSIOL-LUNG C, V286, pL1143, DOI 10.1152/ajplung.00305.2003; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Knezevic N, 2007, MOL CELL BIOL, V27, P6323, DOI 10.1128/MCB.00523-07; Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Kowalski JR, 2005, J CELL SCI, V118, P79, DOI 10.1242/jcs.01586; Liu KD, 2008, CLIN J AM SOC NEPHRO, V3, P578, DOI 10.2215/CJN.01630407; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Peifer M, 2003, J CELL BIOL, V163, P437, DOI 10.1083/jcb.200310090; PHILLIPS PG, 1994, SEMIN THROMB HEMOST, V20, P417, DOI 10.1055/s-2007-1001930; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Ramchandran R, 2008, AM J PHYSIOL-LUNG C, V295, pL363, DOI 10.1152/ajplung.90241.2008; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; STELZNER TJ, 1989, J CELL PHYSIOL, V139, P157, DOI 10.1002/jcp.1041390122; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Taveau JC, 2008, BIOCHEM SOC T, V36, P189, DOI 10.1042/BST0360189; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Vincent PA, 2004, AM J PHYSIOL-CELL PH, V286, pC987, DOI 10.1152/ajpcell.00522.2003; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200	41	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4241	4250		10.1074/jbc.M112.440396	http://dx.doi.org/10.1074/jbc.M112.440396			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23212915	Green Published, hybrid			2022-12-28	WOS:000314845000053
J	Bao, H; Duong, F				Bao, Huan; Duong, Franck			ATP Alone Triggers the Outward Facing Conformation of the Maltose ATP-binding Cassette Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRENE EXCIMER FLUORESCENCE; CHEMICAL CROSS-LINKING; ABC-TRANSPORTER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ACTIVE-TRANSPORT; PROTEIN; MECHANISM; HYDROLYSIS; NANODISCS	The maltose transporter MalFGK(2) is a study prototype for ABC importers. During catalysis, the MalFG membrane domain alternates between inward and outward facing conformations when the MalK dimer closes and hydrolyzes ATP. Because a rapid ATP hydrolysis depends on MalE and maltose, it has been proposed that closed liganded MalE facilitates the transition to the outward facing conformation. Here we find that, in contrast to the expected, ATP is sufficient for the closure of MalK and for the conversion of MalFG to the outward facing state. The outward facing transporter binds MalE with nanomolar affinity, yet neither MalE nor maltose is necessary or facilitates the transition. Thus, the rapid hydrolysis of ATP observed in the presence of MalE and maltose is not because closed liganded MalE accelerates the formation of the outward facing conformation. These findings have fundamental implications for the description of the transport reaction.	[Bao, Huan; Duong, Franck] Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Duong, F (corresponding author), Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fduong@mail.ubc.ca		Duong Van Hoa, Franck/0000-0001-7328-6124; Bao, Huan/0000-0002-4301-4627	Canadian Foundation for Innovation; University of British Columbia; Chaires de Recherche du Canada	Canadian Foundation for Innovation(Canada Foundation for Innovation); University of British Columbia; Chaires de Recherche du Canada	This work was supported by an infrastructure grant from the Canadian Foundation for Innovation.; Supported by a Four Year Fellowship (FYF) from the University of British Columbia.; Supported by Chaires de Recherche du Canada. To whom correspondence should be addressed: Dept. of Biochemistry & Molecular Biology, Life Sciences Institute, Faculty of Medicine, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada. Tel.: 604-822-5975; Fax: 604-822-522; E-mail: fduong@mail.ubc.ca.	Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; Bao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034836; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; Dalal K, 2010, METHODS MOL BIOL, V619, P145, DOI 10.1007/978-1-60327-412-8_9; Daus ML, 2007, MOL MICROBIOL, V66, P1107, DOI 10.1111/j.1365-2958.2007.05982.x; Daus ML, 2007, J BIOL CHEM, V282, P22387, DOI 10.1074/jbc.M701979200; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Grote M, 2008, BIOPHYS J, V95, P2924, DOI 10.1529/biophysj.108.132456; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hunke S, 2000, J BIOL CHEM, V275, P15526, DOI 10.1074/jbc.275.20.15526; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Lehrer S S, 1995, Subcell Biochem, V24, P115; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reich-Slotky R, 2000, J BACTERIOL, V182, P993, DOI 10.1128/JB.182.4.993-1000.2000; Sahoo D, 2000, BIOCHEMISTRY-US, V39, P6594, DOI 10.1021/bi992609m; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Shilton BH, 2008, BBA-BIOMEMBRANES, V1778, P1772, DOI 10.1016/j.bbamem.2007.09.005; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956	34	23	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3439	3448		10.1074/jbc.M112.431932	http://dx.doi.org/10.1074/jbc.M112.431932			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23243313	Green Published, hybrid			2022-12-28	WOS:000314397900048
J	Duan, HC; Wang, JN				Duan, Haichuan; Wang, Joanne			Impaired Monoamine and Organic Cation Uptake in Choroid Plexus in Mice with Targeted Disruption of the Plasma Membrane Monoamine Transporter (Slc29a4) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-CSF BARRIER; CEREBROSPINAL-FLUID; FUNCTIONAL-CHARACTERIZATION; EPITHELIAL-CELLS; PRIMARY CULTURE; HUMAN BRAIN; RAT-BRAIN; EXPRESSION; PEPT2; LOCALIZATION	The choroid plexus (CP) forms the blood-cerebrospinal fluid (CSF) barrier and protects the brain from circulating metabolites, drugs, and toxins. The plasma membrane monoamine transporter (PMAT, SLC29A4) is a new polyspecific organic cation transporter that transports a wide variety of organic cations including biogenic amines, cationic drugs, and neurotoxins. PMAT is known to be expressed in the CP, but its specific role in CP transport of organic cations has not been clearly defined. Here we showed that PMAT transcript is highly expressed in human and mouse CPs, whereas transcripts of other functionally related transporters are minimally expressed in the CPs. Immunofluorescence staining further revealed that PMAT protein is localized to the apical (CSF-facing) membrane of the CP epithelium, consistent with a role of transporting organic cations from the CSF into CP epithelial cells. To further evaluate the role of PMAT in the CP, mice with targeted deletion of the Slc29a4 gene were generated and validated. Although Pmat(-/-) mice showed no overt abnormalities, the uptake of monoamines and the neurotoxin 1-methyl-4-phenylpyridinium was significantly reduced in CP tissues isolated from the knock-out mice. Together, our data demonstrated that PMAT is a major transporter for CP uptake of bioactive amines and xenobiotic cations. By removing its substrates from the CSF, PMAT may play an important role in protecting the brain from cationic neurotoxins and other potentially toxic organic cations.	[Duan, Haichuan; Wang, Joanne] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wang, JN (corresponding author), Univ Washington, Dept Pharmaceut, H272J Hlth Sci Bldg, Seattle, WA 98195 USA.	jowang@uw.edu			National Institutes of Health [GM066233, GM066233-07S1]; National Disease Research Interchange with from National Institutes of Health [5 U42 RR006042]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Disease Research Interchange with from National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM066233 and GM066233-07S1 (to J. W.). This work was also supported by National Disease Research Interchange with support from National Institutes of Health Grant 5 U42 RR006042.	Choudhuri S, 2003, DRUG METAB DISPOS, V31, P1337, DOI 10.1124/dmd.31.11.1337; Collins MA, 2000, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, P115; Dahlin A, 2007, NEUROSCIENCE, V146, P1193, DOI 10.1016/j.neuroscience.2007.01.072; Dahlin A, 2009, J PHARMACOL EXP THER, V329, P558, DOI 10.1124/jpet.108.149831; Duan HC, 2010, J PHARMACOL EXP THER, V335, P743, DOI 10.1124/jpet.110.170142; Engel K, 2005, MOL PHARMACOL, V68, P1397, DOI 10.1124/mol.105.016832; Engel K, 2004, J BIOL CHEM, V279, P50042, DOI 10.1074/jbc.M407913200; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Graff CL, 2004, CURR DRUG METAB, V5, P95, DOI 10.2174/1389200043489126; Ho Horace T B, 2012, Front Pharmacol, V3, P154, DOI 10.3389/fphar.2012.00154; Ho HTB, 2011, J PHARMACOL EXP THER, V339, P376, DOI 10.1124/jpet.111.184036; Hu YJ, 2007, J NEUROCHEM, V103, P2058, DOI 10.1111/j.1471-4159.2007.04905.x; Itagaki S, 2012, DRUG METAB DISPOS, V40, P1138, DOI 10.1124/dmd.111.042432; KAPLAN GP, 1981, BRAIN RES, V204, P353, DOI 10.1016/0006-8993(81)90594-1; Kimura T, 2007, MOL BIOL CELL, V18, P4508, DOI 10.1091/mbc.E06-08-0711; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Kusuhara H, 2004, ADV DRUG DELIVER REV, V56, P1741, DOI 10.1016/j.addr.2004.07.007; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; LINDVALL M, 1980, ACTA PHYSIOL SCAND, V108, P215, DOI 10.1111/j.1748-1716.1980.tb06525.x; Mignini F, 2000, J AUTON PHARMACOL, V20, P325, DOI 10.1046/j.1365-2680.2000.00198.x; Miller DS, 1999, AM J PHYSIOL-CELL PH, V276, pC955, DOI 10.1152/ajpcell.1999.276.4.C955; Nagatsu T, 1997, NEUROSCI RES, V29, P99, DOI 10.1016/S0168-0102(97)00083-7; Okura T, 2011, J PHARM SCI-US, V100, P3924, DOI 10.1002/jps.22594; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Pasqualetti M, 1999, NEUROSCIENCE, V92, P601, DOI 10.1016/S0306-4522(99)00011-1; Pavone LM, 2007, ANAT REC, V290, P1492, DOI 10.1002/ar.20610; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, pC59, DOI 10.1152/ajpcell.00433.2005; Redzic Z, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-3; Roberts JC, 2002, BRAIN RES, V934, P49, DOI 10.1016/S0006-8993(02)02360-0; Shen H, 2003, J BIOL CHEM, V278, P4786, DOI 10.1074/jbc.M207397200; Shu C, 2002, J PHARMACOL EXP THER, V301, P820, DOI 10.1124/jpet.301.3.820; Smith DE, 2011, J CEREBR BLOOD F MET, V31, P250, DOI 10.1038/jcbfm.2010.84; Smith DE, 2004, ADV DRUG DELIVER REV, V56, P1765, DOI 10.1016/j.addr.2004.07.008; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Spector R, 2010, J NEUROCHEM, V112, P13, DOI 10.1111/j.1471-4159.2009.06451.x; SUZUKI H, 1986, J PHARMACOL EXP THER, V239, P927; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Sweet DH, 2001, J BIOL CHEM, V276, P41611, DOI 10.1074/jbc.M108472200; Teuscher NS, 2000, J PHARMACOL EXP THER, V294, P494; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Vialou V, 2007, NEUROSCIENCE, V144, P616, DOI 10.1016/j.neuroscience.2006.09.058; Villalobos AR, 1997, J PHARMACOL EXP THER, V282, P1109; Vitalis T, 2002, J COMP NEUROL, V442, P331, DOI 10.1002/cne.10093; Xia L, 2007, AM J PHYSIOL-RENAL, V292, pF682, DOI 10.1152/ajprenal.00302.2006; Xia L, 2009, AM J PHYSIOL-RENAL, V296, pF1307, DOI 10.1152/ajprenal.00046.2009; Zhou MY, 2010, DRUG METAB DISPOS, V38, P1798, DOI 10.1124/dmd.110.032987	46	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3535	3544		10.1074/jbc.M112.436972	http://dx.doi.org/10.1074/jbc.M112.436972			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255610	hybrid, Green Published			2022-12-28	WOS:000314397900058
J	Korschen, HG; Yildiz, Y; Raju, DN; Schonauer, S; Bonigk, W; Jansen, V; Kremmer, E; Kaupp, UB; Wachten, D				Koerschen, Heinz G.; Yildiz, Yildiz; Raju, Diana Nancy; Schonauer, Sophie; Boenigk, Wolfgang; Jansen, Vera; Kremmer, Elisabeth; Kaupp, U. Benjamin; Wachten, Dagmar			The Non-lysosomal beta-Glucosidase GBA2 Is a Non-integral Membrane-associated Protein at the Endoplasmic Reticulum (ER) and Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLOTHO-RELATED PROTEIN; GAUCHERS-DISEASE; GLYCOSPHINGOLIPID SYNTHESIS; GLUCOCEREBROSIDASE GENE; MOLECULAR-CLONING; HUMAN LIVER; RAT-LIVER; GLUCOSYLCERAMIDE; RECONSTITUTION; MUTATION	GBA1 and GBA2 are both beta-glucosidases, which cleave glucosylceramide (GlcCer) to glucose and ceramide. GlcCer is a main precursor for higher order glycosphingolipids but might also serve as intracellular messenger. Mutations in the lysosomal GBA1 underlie Gaucher disease, the most common lysosomal storage disease in humans. Knocking out the non-lysosomal GBA2 in mice results in accumulation of GlcCer outside the lysosomes in various tissues (e. g. testis and liver) and impairs sperm development and liver regeneration. However, the underlying mechanisms are not well understood. To reveal the physiological function of GBA2 and, thereby, of the non-lysosomal GlcCer pool, it is important to characterize the localization of GBA2 and its activity in different tissues. Thus, we generated GBA2-specific antibodies and developed an assay that discriminates between GBA1 and GBA2 without the use of detergent. We show that GBA2 is not, as previously thought, an integral membrane protein but rather a cytosolic protein that tightly associates with cellular membranes. The interaction with the membrane, in particular with phospholipids, is important for its activity. GBA2 is localized at the ER and Golgi, which puts GBA2 in a key position for a lysosome-independent route of GlcCer-dependent signaling. Furthermore, our results suggest that GBA2 might affect the phenotype of Gaucher disease, because GBA2 activity is reduced in Gba1 knock-out fibroblasts and fibroblasts from a Gaucher patient. Our results provide the basis to understand the mechanism for GBA2 function in vivo and might help to unravel the role of GBA2 during pathogenesis of Gaucher disease.	[Koerschen, Heinz G.; Raju, Diana Nancy; Schonauer, Sophie; Boenigk, Wolfgang; Jansen, Vera; Kaupp, U. Benjamin; Wachten, Dagmar] Ctr Adv European Studies & Res, Dept Mol Sensory Syst, D-53175 Bonn, Germany; [Yildiz, Yildiz; Raju, Diana Nancy] Univ Klinikum Bonn, Med Klin 1, D-53105 Bonn, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	Center of Advanced European Studies & Research (CAESAR); University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Wachten, D (corresponding author), Ctr Adv European Studies & Res, Dept Mol Sensory Syst, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	dagmar.wachten@caesar.de			Deutsche Forschungsgemeinschaft Grant [SFB 645]	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 645.	Aureli M, 2012, J INHERIT METAB DIS, V35, P1081, DOI 10.1007/s10545-012-9478-x; BENYOSEPH Y, 1978, J CLIN PATHOL, V31, P1091, DOI 10.1136/jcp.31.11.1091; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; Chalat M, 2012, J BIOL CHEM, V287, P15523, DOI 10.1074/jbc.M112.343038; COOK NJ, 1986, J BIOL CHEM, V261, P7033; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; De Graaf M, 2001, BIOCHEM J, V356, P907, DOI 10.1042/0264-6021:3560907; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Germain DP, 1998, AM J HUM GENET, V63, P415, DOI 10.1086/301969; Gonzalez-Carmona MA, 2012, LIVER INT, V32, P1354, DOI 10.1111/j.1478-3231.2012.02841.x; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Hirabayashi Y, 2012, P JPN ACAD B-PHYS, V88, P129, DOI 10.2183/pjab.88.129; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Korschen HG, 1999, NATURE, V400, P761, DOI 10.1038/23468; Lachmann RH, 2004, QJM-INT J MED, V97, P199, DOI 10.1093/qjmed/hch036; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; LANNERT H, 1994, FEBS LETT, V342, P91, DOI 10.1016/0014-5793(94)80591-1; Legler G, 1977, Methods Enzymol, V46, P368; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Matern H, 2001, J BIOL CHEM, V276, P37929; Matern H, 1997, J BIOL CHEM, V272, P11261; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Paul P, 1996, J BIOL CHEM, V271, P2287, DOI 10.1074/jbc.271.4.2287; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; ROBINSON D, 1956, BIOCHEM J, V63, P39, DOI 10.1042/bj0630039; Stanley P, 2009, ESSENTIALS GLYCOBIOL; TURNER BM, 1977, BIOCHIM BIOPHYS ACTA, V480, P442, DOI 10.1016/0005-2744(77)90036-5; TURNER BM, 1978, AM J HUM GENET, V30, P346; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; VACCARO AM, 1994, FEBS LETT, V349, P181, DOI 10.1016/0014-5793(94)00659-8; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; Yahata K, 2000, J MOL MED, V78, P389, DOI 10.1007/s001090000131; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	41	63	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3381	3393		10.1074/jbc.M112.414714	http://dx.doi.org/10.1074/jbc.M112.414714			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250757	Green Published, hybrid			2022-12-28	WOS:000314397900043
J	Zhang, L; Li, WH; He, ZG				Zhang, Lei; Li, Weihui; He, Zheng-Guo			DarR, a TetR-like Transcriptional Factor, Is a Cyclic Di-AMP-responsive Repressor in Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT PROTEIN; GENE-REGULATION; INDUCIBLE GENE; REVEALS; GMP; RESISTANCE; RECEPTOR; DAMAGE	Cyclic dinucleotides, including cyclic di-AMP (c-di-AMP), are known to be ubiquitous second messengers involved in bacterial signal transduction. However, no transcriptional regulator has been characterized as a c-di-AMP receptor/effector to date. In the present study, using a c-di-AMP/transcription factor binding screen, we identified Ms5346, a TetR family regulator in Mycobacterium smegmatis, as a c-di-AMP receptor in bacteria. Ms5346 could specifically bind c-di-AMP with K-d of 2.3 +/- 0.5 mu M. Using EMSA and DNase I footprinting assays, c-di-AMP was found to stimulate the DNA binding activity of Ms5346 and to enhance its ability to protect its target DNA sequence. A conserved 14-bp palindromic motif was identified as the DNA-binding site for Ms5346. Further, Ms5346 was found to negatively regulate expression of three target genes including Ms5347 (encoding a major facilitator family transporter), Ms5348 (encoding a medium chain fatty acyl-CoA ligase), and Ms5696 (encoding a cold shock protein, CspA). Ms5346 is the first cyclic di-AMP receptor regulator to be identified in bacteria, and we have designated it as DarR. Our findings enhance our understanding of the function and regulatory mechanism of the second messenger c-di-AMP in bacteria.	[Zhang, Lei; Li, Weihui; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Ctr Prote Res, Wuhan 430070, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China.	he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014; Zhang, Lei/M-6146-2013	Zhang, Lei/0000-0002-8566-6068	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Creative Research Groups of Hubei; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Creative Research Groups of Hubei; Hubei Chutian Scholar Program	This work was supported by National Natural Science Foundation of China Grants 31025002 and 30930003, Fundamental Research Funds for the Central Universities Grant 2011PY140, Creative Research Groups of Hubei, and Hubei Chutian Scholar Program (to H. Z.-G.).	Bai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035206; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Cha DM, 2009, J CHROMATOGR A, V1216, P1450, DOI 10.1016/j.chroma.2008.12.039; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Jiang WN, 1997, J BIOL CHEM, V272, P196; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Mohanty D, 2011, TUBERCULOSIS, V91, P448, DOI 10.1016/j.tube.2011.04.006; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; O'Sullivan DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032836; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Phadtare S, 2010, RNA BIOL, V7, P788, DOI 10.4161/rna.7.6.13482; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tojo S, 2011, J BACTERIOL, V193, P2388, DOI 10.1128/JB.00016-11; Uppal S, 2011, J BACTERIOL, V193, P6142, DOI 10.1128/JB.05728-11; Wang Y, 2011, J BIOL CHEM, V286, P31159, DOI 10.1074/jbc.M111.241802; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yamamoto T, 2012, INFECT IMMUN, V80, P2323, DOI 10.1128/IAI.06162-11; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zhang L, 2009, P NATL ACAD SCI USA, V106, P7792, DOI 10.1073/pnas.0813056106	33	86	97	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3085	3096		10.1074/jbc.M112.428110	http://dx.doi.org/10.1074/jbc.M112.428110			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250743	hybrid, Green Published			2022-12-28	WOS:000314397900018
J	Ehrensberger, KM; Mason, C; Corkins, ME; Anderson, C; Dutrow, N; Cairns, BR; Dalley, B; Milash, B; Bird, AJ				Ehrensberger, Kate M.; Mason, Carter; Corkins, Mark E.; Anderson, Cole; Dutrow, Natalie; Cairns, Bradley R.; Dalley, Brian; Milash, Brett; Bird, Amanda J.			Zinc-dependent Regulation of the adh1 Antisense Transcript in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; BIDIRECTIONAL PROMOTERS; GENE-EXPRESSION; NONCODING RNAS; LACZ FUSIONS; DEFICIENCY; DISEASE; METABOLISM; MECHANISMS	In yeast, Adh1 (alcohol dehydrogenase 1) is an abundant zinc-binding protein that is required for the conversion of acetaldehyde to ethanol. Through transcriptome profiling of the Schizosaccharomyces pombe genome, we identified a natural antisense transcript at the adh1 locus that is induced in response to zinc limitation. This antisense transcript (adh1AS) shows a reciprocal expression pattern to that of the adh1 mRNA partner. In this study, we show that increased expression of the adh1AS transcript in zinc-limited cells is necessary for the repression of adh1 gene expression and that the increased level of the adh1AS transcript in zinc-limited cells is a result of two mechanisms. At the transcriptional level, the adh1AS transcript is expressed at a high level in zinc-limited cells. In addition to this transcriptional control, adh1AS transcripts preferentially accumulate in zinc-limited cells when the adh1AS transcript is expressed from a constitutive promoter. This secondary mechanism requires the simultaneous expression of adh1. Our studies reveal how multiple mechanisms can synergistically control the ratio of sense to antisense transcripts and highlight a novel mechanism by which adh1 gene expression can be controlled by cellular zinc availability.	[Ehrensberger, Kate M.; Mason, Carter; Corkins, Mark E.; Anderson, Cole; Bird, Amanda J.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Mason, Carter; Bird, Amanda J.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA; [Ehrensberger, Kate M.; Bird, Amanda J.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Dutrow, Natalie] Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84132 USA; [Cairns, Bradley R.] Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA; [Cairns, Bradley R.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84132 USA; [Dalley, Brian] Univ Utah, Sch Med, Microarray Core Facil, Salt Lake City, UT 84112 USA; [Milash, Brett] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Ohio State University; Ohio State University; Ohio State University; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Bird, AJ (corresponding author), Ohio State Univ, Dept Human Nutr, 1787 Neil Ave, Columbus, OH 43210 USA.	bird.96@osu.edu	Bird, Amanda Jane/ABD-2295-2021	Bird, Amanda Jane/0000-0002-1846-7050; Anderson, Cole/0000-0002-4366-6166	National Institutes of Health [R01 GM056285]; National Institutes of Health/NCI [CA140158]; Center for RNA Biology at The Ohio State University; National Science Foundation Biological Sciences REU [DBI 0750631]; NATIONAL CANCER INSTITUTE [P50CA140158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1062144] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for RNA Biology at The Ohio State University; National Science Foundation Biological Sciences REU(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM056285 (to Dave Eide) and seed grant money from National Institutes of Health/NCI Leukemia Spore Grant CA140158. This work was also supported by a graduate student fellowship from the Center for RNA Biology at The Ohio State University (to K. M. E.) and National Science Foundation Biological Sciences REU Grant DBI 0750631 (to C. A.).	Auld DS, 2008, CELL MOL LIFE SCI, V65, P3961, DOI 10.1007/s00018-008-8593-1; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Dainty SJ, 2008, EUKARYOT CELL, V7, P454, DOI 10.1128/EC.00408-07; de Smidt O, 2008, FEMS YEAST RES, V8, P967, DOI 10.1111/j.1567-1364.2008.00387.x; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Faghihi MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013177; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; KEENEY JB, 1994, GENETICS, V136, P849; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Li JT, 2008, NUCLEIC ACIDS RES, V36, P4833, DOI 10.1093/nar/gkn470; Maruyama R, 2012, P NATL ACAD SCI USA, V109, P2820, DOI 10.1073/pnas.1010559107; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015271; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Peters NT, 2003, RNA, V9, P698, DOI 10.1261/rna.2120703; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Werner A, 2010, BIOCHEM SOC T, V38, P1144, DOI 10.1042/BST0381144; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhang XM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r20; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044	48	18	19	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					759	769		10.1074/jbc.M112.406165	http://dx.doi.org/10.1074/jbc.M112.406165			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23223230	Green Published, hybrid			2022-12-28	WOS:000313570300001
J	Jacobson, LS; Lima, H; Goldberg, MF; Gocheva, V; Tsiperson, V; Sutterwala, FS; Joyce, JA; Gapp, BV; Blomen, VA; Chandran, K; Brummelkamp, TR; Diaz-Griffero, F; Brojatsch, J				Jacobson, Lee S.; Lima, Heriberto, Jr.; Goldberg, Michael F.; Gocheva, Vasilena; Tsiperson, Vladislav; Sutterwala, Fayyaz S.; Joyce, Johanna A.; Gapp, Bianca V.; Blomen, Vincent A.; Chandran, Kartik; Brummelkamp, Thijn R.; Diaz-Griffero, Felipe; Brojatsch, Juergen			Cathepsin-mediated Necrosis Controls the Adaptive Immune Response by Th2 (T helper type 2)-associated Adjuvants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; ALUMINUM-HYDROXIDE; NALP3 INFLAMMASOME; VACCINE ADJUVANTS; SILICA CRYSTALS; TUMOR-CELLS; APOPTOSIS; NLRP3; ACTIVATION; SYSTEM	Immunologic adjuvants are critical components of vaccines, but it remains unclear how prototypical adjuvants enhance the adaptive immune response. Recent studies have shown that necrotic cells could trigger an immune response. Although most adjuvants have been shown to be cytotoxic, this activity has traditionally been considered a side effect. We set out to test the role of adjuvant-mediated cell death in immunity and found that alum, the most commonly used adjuvant worldwide, triggers a novel form of cell death in myeloid leukocytes characterized by cathepsin-dependent lysosome-disruption. We demonstrated that direct lysosome-permeabilization with a soluble peptide, Leu-Leu-OMe, mimics the alum-like form of necrotic cell death in terms of cathepsin dependence and cell-type specificity. Using a combination of a haploid genetic screen and cathepsin-deficient cells, we identified specific cathepsins that control lysosome-mediated necrosis. We identified cathepsin C as critical for Leu-Leu-OMe-induced cell death, whereas cathepsins B and S were required for alum-mediated necrosis. Consistent with a role of necrotic cell death in adjuvant effects, Leu-Leu-OMe replicated an alum-like immune response in vivo, characterized by dendritic cell activation, granulocyte recruitment, and production of Th2-associated antibodies. Strikingly, cathepsin C deficiency not only blocked Leu-Leu-OMe-mediated necrosis but also impaired Leu-Leu-OMe-enhanced immunity. Together our findings suggest that necrotic cell death is a powerful mediator of a Th2-associated immune response.	[Jacobson, Lee S.; Lima, Heriberto, Jr.; Goldberg, Michael F.; Tsiperson, Vladislav; Diaz-Griffero, Felipe; Brojatsch, Juergen] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Gocheva, Vasilena; Joyce, Johanna A.] Mem Sloan Kettering, Dept Canc Biol & Genet, New York, NY 10065 USA; [Sutterwala, Fayyaz S.] Univ Iowa, Dept Internal Med, Iowa City, IA 52241 USA; [Gapp, Bianca V.; Blomen, Vincent A.; Brummelkamp, Thijn R.] Netherlands Canc Inst, Dept Biochem, NL-1066 CX Amsterdam, Netherlands	Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; University of Iowa; Netherlands Cancer Institute	Brojatsch, J (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	jurgen.brojatsch@einstein.yu	blomen, vincent/AAE-1477-2020; Sutterwala, Fayyaz/AAH-5859-2021; Cassel, Suzanne/AAI-3947-2021	Cassel, Suzanne/0000-0003-2492-1923; brojatsch, jurgen/0000-0002-7424-365X	National Institutes of Health [1R56AI092497-01A1, 5R01CA125162-05, 5R01AI087630-02, 5R01AI088027-02]; Martin Turkish Foundation, Inc.; M-O'Connor-Foundation; NATIONAL CANCER INSTITUTE [R01CA125162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI092497, R01AI087390, R01AI088027, R01AI087630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Martin Turkish Foundation, Inc.; M-O'Connor-Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R56AI092497-01A1 (to J. B.), 5R01CA125162-05 (to J. A. J.), 5R01AI087630-02 (to F. S. S.), and 5R01AI088027-02 (to K. C.). This work was also supported by the Martin Turkish Foundation, Inc. and the M-O'Connor-Foundation.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Alileche A, 2005, PLOS PATHOG, V1, P150, DOI 10.1371/journal.ppat.0010019; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; DRISCOLL KE, 1990, AM J RESP CELL MOL, V2, P381, DOI 10.1165/ajrcmb/2.4.381; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Fujisawa A, 2007, BLOOD, V109, P2903, DOI 10.1182/blood-2006-07-033597; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Gupta R C, 1993, IARC Sci Publ, P11; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hara H, 2007, INFECT IMMUN, V75, P3791, DOI 10.1128/IAI.01779-06; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; KELSO JM, 1993, J ALLERGY CLIN IMMUN, V91, P867, DOI 10.1016/0091-6749(93)90344-F; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Moore A, 1999, VACCINE, V17, P2517, DOI 10.1016/S0264-410X(99)00062-6; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Noe SM, 2010, VACCINE, V28, P3588, DOI 10.1016/j.vaccine.2010.02.085; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Petrovsky N, 2008, EXPERT REV VACCINES, V7, P7, DOI 10.1586/14760584.7.1.7; Przetak M, 2003, VACCINE, V21, P961, DOI 10.1016/S0264-410X(02)00737-5; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058; Spreafico R, 2010, EUR J IMMUNOL, V40, P638, DOI 10.1002/eji.200940039; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; THIELE DL, 1990, J EXP MED, V172, P183, DOI 10.1084/jem.172.1.183; THIELE DL, 1992, J IMMUNOL, V148, P3950; Ulanova M, 2001, INFECT IMMUN, V69, P1151, DOI 10.1128/IAI.69.2.1151-1159.2001; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Zhang HL, 2009, J IMMUNOL, V182, P6993, DOI 10.4049/jimmunol.0802502	54	58	61	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7481	7491		10.1074/jbc.M112.400655	http://dx.doi.org/10.1074/jbc.M112.400655			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23297415	hybrid, Green Published			2022-12-28	WOS:000316455300005
J	Lee, W; VanderVen, BC; Fahey, RJ; Russell, DG				Lee, Wonsik; VanderVen, Brian C.; Fahey, Ruth J.; Russell, David G.			Intracellular Mycobacterium tuberculosis Exploits Host-derived Fatty Acids to Limit Metabolic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL LIPIDS; CHOLESTEROL CATABOLISM; PROPIONATE METABOLISM; METHYLCITRATE CYCLE; BOVIS BCG; VIRULENCE; MACROPHAGES; REQUIRES; GROWTH; PERSISTENCE	Recent data indicate that the nutrients available to Mycobacterium tuberculosis (Mtb) inside its host cell are restricted in their diversity. Fatty acids and cholesterol appear more favored; however, their degradation can result in certain metabolic stresses. Their breakdown can generate propionyl-CoA, which gives rise to potentially toxic intermediates. Detoxification of propionyl-CoA relies on the activity of the methylcitrate cycle, the methylmalonyl pathway, or incorporation of the propionyl-CoA into methyl-branched lipids in the cell wall. The current work explores carbon flux through these pathways, focusing primarily on those pathways responsible for the incorporation of propionyl-CoA into virulence-associated cell wall lipids. Exploiting both genetic and biochemical rescue, we demonstrate that these metabolic pressures are experienced by Mtb inside its host macrophage and that the bacterium accesses host fatty acid stores. The metabolism of these host lipids expands the acetyl-CoA pool and alleviates the pressure from propionyl-CoA. These data have major implications for our appreciation of central metabolism of Mtb during the course of infection.	[Lee, Wonsik; VanderVen, Brian C.; Fahey, Ruth J.; Russell, David G.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14850 USA	Cornell University	Russell, DG (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14850 USA.	dgr8@cornell.edu	Russell, David G/D-4533-2009; Russell, David G/N-5280-2019	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X; VanderVen, Brian/0000-0003-3655-4390	National Institutes of Health [AI 067027, AI080651, HL055936]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080651, R01AI067027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 067027, AI080651, and HL055936 (to D. G. R.).	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Brock M, 2004, EUR J BIOCHEM, V271, P3227, DOI 10.1111/j.1432-1033.2004.04255.x; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; DUBOS RJ, 1950, J EXP MED, V92, P319, DOI 10.1084/jem.92.4.319; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Krithika R, 2006, P NATL ACAD SCI USA, V103, P2069, DOI 10.1073/pnas.0507924103; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; Maloney E, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00019; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Miner MD, 2009, INDIAN J EXP BIOL, V47, P407; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Murry Jeffrey P., 2008, V416, P45, DOI 10.1007/978-1-59745-321-9_4; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Podinovskaia M., 2013, CELL MICROB IN PRESS; RAINWATER DL, 1982, J BACTERIOL, V151, P905, DOI 10.1128/JB.151.2.905-911.1982; Rhoades E, 2003, MOL MICROBIOL, V48, P875, DOI 10.1046/j.1365-2958.2003.03473.x; Rhoades ER, 2005, TUBERCULOSIS, V85, P159, DOI 10.1016/j.tube.2004.10.001; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Rombouts Y, 2011, J BIOL CHEM, V286, P33678, DOI 10.1074/jbc.M111.273920; Rousseau C, 2003, MICROBIOL-SGM, V149, P1837, DOI 10.1099/mic.0.26278-0; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Trivedi OA, 2005, MOL CELL, V17, P631, DOI 10.1016/j.molcel.2005.02.009; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Yang XX, 2009, BIOCHEMISTRY-US, V48, P3819, DOI 10.1021/bi9005418	48	243	253	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6788	6800		10.1074/jbc.M112.445056	http://dx.doi.org/10.1074/jbc.M112.445056			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23306194	Green Published, hybrid			2022-12-28	WOS:000316002400002
J	Tran, DT; Ten Hagen, KG				Tran, Duy T.; Ten Hagen, Kelly G.			Mucin-type O-Glycosylation during Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; FAMILIAL TUMORAL CALCINOSIS; UDP-GALNAC; MICE LACKING; MOLECULAR CHAPERONE; CELL-ADHESION; DROSOPHILA; EXPRESSION; MUTATION; CLONING	Mucin-type O-glycosylation is an evolutionarily conserved protein modification present on membrane-bound and secreted proteins. Aberrations in O-glycosylation are responsible for certain human diseases and are associated with disease risk factors. Recent studies have demonstrated essential roles for mucin-type O-glycosylation in protein secretion, stability, processing, and function. Here, we summarize our current understanding of the diverse roles of mucin-type O-glycosylation during eukaryotic development. Appreciating how this conserved modification operates in developmental processes will provide insight into its roles in human disease and disease susceptibilities.	[Tran, Duy T.; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ten Hagen, KG (corresponding author), NIDCR, Dev Glycobiol Sect, NIH, Bethesda, MD 20892 USA.	kelly.tenhagen@nih.gov			Intramural Research Program of the NIDCR, National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000713] Funding Source: NIH RePORTER	Intramural Research Program of the NIDCR, National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program of the NIDCR, National Institutes of Health. This is the third article in the Thematic Minireview Series on Glycobiology and Extracellular Matrices: Glycan Functions Pervade Biology at All Levels.	Alexander WS, 2006, P NATL ACAD SCI USA, V103, P16442, DOI 10.1073/pnas.0607872103; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Araya K, 2005, J CLIN ENDOCR METAB, V90, P5523, DOI 10.1210/jc.2005-0301; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Broide DH, 2002, AM J PHYSIOL-LUNG C, V282, pL259, DOI 10.1152/ajplung.00214.2001; Chefetz I, 2009, BBA-MOL BASIS DIS, V1792, P847, DOI 10.1016/j.bbadis.2008.10.008; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Herr P, 2008, DEVELOPMENT, V135, P1813, DOI 10.1242/dev.019323; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Ichikawa S, 2005, J CLIN ENDOCR METAB, V90, P2420, DOI 10.1210/jc.2004-2302; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Ju TZ, 2006, GLYCOBIOLOGY, V16, P947, DOI 10.1093/glycob/cwl008; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kakani S, 2012, AM J PATHOL, V180, P1431, DOI 10.1016/j.ajpath.2011.12.023; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; Kim YS, 1996, GLYCOCONJUGATE J, V13, P693, DOI 10.1007/BF00702333; Kingsley PD, 2000, GLYCOBIOLOGY, V10, P1317, DOI 10.1093/glycob/10.12.1317; Lin YR, 2008, DEV DYNAM, V237, P3703, DOI 10.1002/dvdy.21775; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Miyazaki T., 2012, HISTOCHEM C IN PRESS; Muller R, 2005, FEBS J, V272, P4295, DOI 10.1111/j.1742-4658.2005.04838.x; Narimatsu Y, 2008, BIOCHEM BIOPH RES CO, V366, P199, DOI 10.1016/j.bbrc.2007.11.121; Nehrke K, 1998, GLYCOBIOLOGY, V8, P367, DOI 10.1093/glycob/8.4.367; North SJ, 2006, GLYCOCONJUGATE J, V23, P345, DOI 10.1007/s10719-006-6693-4; O'Halloran AM, 2009, J THROMB THROMBOLYS, V27, P175, DOI 10.1007/s11239-008-0196-z; Ono M, 2003, GLYCOCONJUGATE J, V20, P71, DOI 10.1023/B:GLYC.0000018019.22070.7d; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Raman J, 2012, GLYCOBIOLOGY, V22, P768, DOI 10.1093/glycob/cwr183; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; SHOGREN R, 1989, BIOCHEMISTRY-US, V28, P5525, DOI 10.1021/bi00439a029; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; TABAK LA, 1995, ANNU REV PHYSIOL, V57, P547, DOI 10.1146/annurev.ph.57.030195.002555; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Takeuchi H, 2002, EUR J BIOCHEM, V269, P6173, DOI 10.1046/j.1432-1033.2002.03334.x; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Tian E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1874; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Tran DT, 2012, J BIOL CHEM, V287, P5243, DOI 10.1074/jbc.M111.306159; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang YC, 2012, P NATL ACAD SCI USA, V109, P16143, DOI 10.1073/pnas.1208253109; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Xu YX, 2010, J BIOL CHEM, V285, P24600, DOI 10.1074/jbc.M110.134544; Yoshida H, 2008, GLYCOBIOLOGY, V18, P1094, DOI 10.1093/glycob/cwn094; Zara J, 1996, BIOCHEM BIOPH RES CO, V228, P38, DOI 10.1006/bbrc.1996.1613; Zhang LP, 2010, J BIOL CHEM, V285, P34477, DOI 10.1074/jbc.M110.133561; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200	76	172	181	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6921	6929		10.1074/jbc.R112.418558	http://dx.doi.org/10.1074/jbc.R112.418558			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329828	hybrid, Green Published			2022-12-28	WOS:000316002400014
J	Sosunova, E; Sosunov, V; Epshtein, V; Nikiforov, V; Mustaev, A				Sosunova, Ekaterina; Sosunov, Vasily; Epshtein, Vitaly; Nikiforov, Vadim; Mustaev, Arkady			Control of Transcriptional Fidelity by Active Center Tuning as Derived from RNA Polymerase Endonuclease Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3.3 ANGSTROM RESOLUTION; II ELONGATION COMPLEX; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRIGGER LOOP; CATALYTIC RESIDUES; TERNARY COMPLEXES; CLEAVAGE FACTORS; MECHANISM	Precise transcription by cellular RNA polymerase requires the efficient removal of noncognate nucleotide residues that are occasionally incorporated. Mis-incorporation causes the transcription elongation complex to backtrack, releasing a single strand 3'-RNA segment bearing a noncognate residue, which is hydrolyzed by the active center that carries two Mg2+ ions. However, in most x-ray structures only one Mg2+ is present. This Mg2+ is tightly bound to the active center aspartates, creating an inactive stable state. The first residue of the single strand RNA segment in the backtracked transcription elongation complex strongly promotes transcript hydrolytic cleavage by establishing a network of interactions that force a shift of stably bound Mg2+ to release some of its aspartate coordination valences for binding to the second Mg2+ thus enabling catalysis. Such a rearrangement that we call active center tuning (ACT) occurs when all recognition contacts of the active center-bound RNA segment are established and verified by tolerance to stress. Transcription factor Gre builds on the ACT mechanism in the same reaction by increasing the retention of the second Mg2+ and by activating the attacking water, causing 3000-4000-fold reaction acceleration and strongly reinforcing proofreading. The unified mechanism for RNA synthesis and degradation by RNA polymerase predicts that ACT also executes NTP selection thereby contributing to high transcription fidelity.	[Sosunova, Ekaterina; Sosunov, Vasily; Epshtein, Vitaly; Nikiforov, Vadim; Mustaev, Arkady] Univ Med & Dent New Jersey, PHRI Ctr, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Nikiforov, Vadim] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Rutgers State University New Brunswick; Rutgers State University Medical Center; Russian Academy of Sciences	Mustaev, A (corresponding author), Univ Med & Dent New Jersey, PHRI Ctr, New Jersey Med Sch, Dept Microbiol & Mol Genet, 225 Warren St, Newark, NJ 07103 USA.	mustaear@umdnj.edu			National Institutes of Health [RO1 GM-30717-21]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM-30717-21.	Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Chlenov M, 2005, J MOL BIOL, V353, P138, DOI 10.1016/j.jmb.2005.07.073; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; HIGUCHI H, 1990, BIOCHEMISTRY-US, V29, P8747, DOI 10.1021/bi00489a035; HOARD DE, 1965, J AM CHEM SOC, V87, P1785, DOI 10.1021/ja01086a031; Hogan BP, 2002, J BIOL CHEM, V277, P967, DOI 10.1074/jbc.M108737200; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; REINES D, 1992, J BIOL CHEM, V267, P15516; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; Sosunov V, 2005, NUCLEIC ACIDS RES, V33, P4202, DOI 10.1093/nar/gki688; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; SURRATT CK, 1991, P NATL ACAD SCI USA, V88, P7983, DOI 10.1073/pnas.88.18.7983; Svetlov V, 2004, J BIOL CHEM, V279, P38087, DOI 10.1074/jbc.C400316200; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Yuzenkova Y, 2010, P NATL ACAD SCI USA, V107, P10878, DOI 10.1073/pnas.0914424107; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732; Zhu R, 2008, THEOR CHEM ACC, V120, P479, DOI 10.1007/s00214-008-0440-9	43	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6688	6703		10.1074/jbc.M112.424002	http://dx.doi.org/10.1074/jbc.M112.424002			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23283976	hybrid, Green Published			2022-12-28	WOS:000315820700067
J	Korkina, O; Dong, ZW; Marullo, A; Warshaw, G; Symons, M; Ruggieri, R				Korkina, Olga; Dong, Zhiwan; Marullo, Allison; Warshaw, Gregg; Symons, Marc; Ruggieri, Rosamaria			The MLK-related Kinase (MRK) Is a Novel RhoC Effector That Mediates Lysophosphatidic Acid (LPA)-stimulated Tumor Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; MAP KINASE; IN-VITRO; C-JUN; SIGNALING PATHWAY; BREAST-CANCER; SMALL GTPASES; MIGRATION; ACTIVATION; METASTASIS	The small GTPase RhoC is overexpressed in many invasive tumors and is essential for metastasis. Despite its high structural homology to RhoA, RhoC appears to perform functions that are different from those controlled by RhoA. The identity of the signaling components that are differentially regulated by these two GTPases is only beginning to emerge. Here, we show that the MAP3K protein MRK directly binds to the GTP-bound forms of both RhoA and RhoC in vitro. However, siRNA-mediated depletion of MRK in cells phenocopies depletion of RhoC, rather than that of RhoA. MRK depletion, like that of RhoC, inhibits LPA-stimulated cell invasion, while depletion of RhoA increases invasion. We also show that active MRK enhances LPA-stimulated invasion, further supporting a role for MRK in the regulation of invasion. Depletion of either RhoC or MRK causes sustained myosin light chain phosphorylation after LPA stimulation. In addition, activation of MRK causes a reduction in myosin light chain phosphorylation. In contrast, as expected, depletion of RhoA inhibits myosin light chain phosphorylation. We also present evidence that both RhoC and MRK are required for LPA-induced stimulation of the p38 and ERK MAP kinases. In conclusion, we have identified MRK as a novel RhoC effector that controls LPA-stimulated cell invasion at least in part by regulating myosin dynamics, ERK and p38.	[Korkina, Olga; Dong, Zhiwan; Marullo, Allison; Warshaw, Gregg; Symons, Marc; Ruggieri, Rosamaria] Feinstein Inst Med Res, Oncol & Cell Biol Ctr, Manhasset, NY 11030 USA	Northwell Health	Symons, M (corresponding author), Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY 11030 USA.	msymons@nshs.edu; mruggier@nshs.edu			National Institutes of Health [CA100747]; Swim Across America Foundation; Institutional Grant from the Feinstein Institute for Medical Research; NATIONAL CANCER INSTITUTE [R01CA100747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swim Across America Foundation; Institutional Grant from the Feinstein Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA100747 (to R. R.), a grant from the Swim Across America Foundation (to M. S.), and an Institutional Grant from the Feinstein Institute for Medical Research (to R. R.).	Barrantes ID, 2012, BIOCHEM SOC T, V40, P79, DOI 10.1042/BST20110676; Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Bian D, 2006, ONCOGENE, V25, P2234, DOI 10.1038/sj.onc.1209261; Boone B, 2009, J CUTAN PATHOL, V36, P629, DOI 10.1111/j.1600-0560.2008.01117.x; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chuang YY, 2004, CANCER RES, V64, P8271, DOI 10.1158/0008-5472.CAN-04-2097; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; Dietrich KA, 2009, BIOL CHEM, V390, P1063, DOI 10.1515/BC.2009.110; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; Faried A, 2006, EUR J CANCER, V42, P1455, DOI 10.1016/j.ejca.2006.02.012; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gotoh I, 2001, J BIOL CHEM, V276, P4276, DOI 10.1074/jbc.M008595200; Gross EA, 2002, J BIOL CHEM, V277, P13873, DOI 10.1074/jbc.M111994200; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Ho TTG, 2008, J BIOL CHEM, V283, P21588, DOI 10.1074/jbc.M710033200; Horiuchi A, 2003, LAB INVEST, V83, P861, DOI 10.1097/01.LAB.0000073128.16098.31; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hutchison N, 2009, CELL SIGNAL, V21, P1522, DOI 10.1016/j.cellsig.2009.05.012; Islam M, 2009, MOL CANCER RES, V7, P1771, DOI 10.1158/1541-7786.MCR-08-0512; Jia ZJ, 2006, BIOL CELL, V98, P337, DOI 10.1042/BC20050088; Kamai T, 2001, BJU INT, V87, P227, DOI 10.1046/j.1464-410x.2001.02030.x; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Katoh K, 2011, J R SOC INTERFACE, V8, P305, DOI 10.1098/rsif.2010.0419; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; Kondo T, 2004, PATHOBIOLOGY, V71, P19, DOI 10.1159/000072958; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; Liu TC, 2000, BIOCHEM BIOPH RES CO, V274, P811, DOI 10.1006/bbrc.2000.3236; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Pan CQ, 2012, CELL SIGNAL, V24, P2143, DOI 10.1016/j.cellsig.2012.06.002; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Pua TL, 2009, FUTURE ONCOL, V5, P1659, DOI 10.2217/FON.09.120; Radhika V, 2004, J BIOL CHEM, V279, P49406, DOI 10.1074/jbc.M408836200; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Sengupta S, 2004, SEMIN CELL DEV BIOL, V15, P503, DOI 10.1016/j.semcdb.2004.05.003; Shikada Y, 2003, CLIN CANCER RES, V9, P5282; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Street CA, 2011, ANTICANCER RES, V31, P3645; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; SYMONS M, 1995, CURR OPIN BIOTECH, V6, P668, DOI 10.1016/0958-1669(95)80110-3; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; Tosti E, 2004, J BIOL CHEM, V279, P47652, DOI 10.1074/jbc.M409961200; Vacratsis PO, 2000, J BIOL CHEM, V275, P27893; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang W, 2008, CLIN CANCER RES, V14, P6804, DOI 10.1158/1078-0432.CCR-07-4820; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Xia DL, 2005, EXP CELL RES, V304, P506, DOI 10.1016/j.yexcr.2004.11.025	73	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5364	5373		10.1074/jbc.M112.414060	http://dx.doi.org/10.1074/jbc.M112.414060			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23319595	Green Published, hybrid			2022-12-28	WOS:000315342500011
J	Zeng, DN; Zhao, JS; Chung, HS; Guan, ZQ; Raetz, CRH; Zhou, P				Zeng, Daina; Zhao, Jinshi; Chung, Hak Suk; Guan, Ziqiang; Raetz, Christian R. H.; Zhou, Pei			Mutants Resistant to LpxC Inhibitors by Rebalancing Cellular Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-DEPENDENT DEACETYLASE; GRAM-NEGATIVE INFECTIONS; FATTY-ACID BIOSYNTHESIS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; TRANSFER-RNA; ANTIBIOTIC-ACTIVITY; MEMBRANE-PROTEINS; ACTIVE-SITE; IN-VIVO	LpxC, the deacetylase that catalyzes the second and committed step of lipid A biosynthesis in Escherichia coli, is an essential enzyme in virtually all Gram-negative bacteria and is one of the most promising antibiotic targets for treatment of multidrug-resistant Gram-negative infections. Despite the rapid development of LpxC-targeting antibiotics, the potential mechanisms of bacterial resistance to LpxC inhibitors remain poorly understood. Here, we report the isolation and biochemical characterization of spontaneously arising E. coli mutants that are over 200-fold more resistant to LpxC inhibitors than the wild-type strain. These mutants have two chromosomal point mutations that account for resistance additively and independently; one is in fabZ, a dehydratase in fatty acid biosynthesis; the other is in thrS, the Thr-tRNA ligase. For both enzymes, the isolated mutations result in reduced enzymatic activities in vitro. Unexpectedly, we observed a decreased level of LpxC in bacterial cells harboring fabZ mutations in the absence of LpxC inhibitors, suggesting that the biosyntheses of fatty acids and lipid A are tightly regulated to maintain a balance between phospholipids and lipid A. Additionally, we show that the mutation in thrS slows protein production and cellular growth, indicating that reduced protein biosynthesis can confer a suppressive effect on inhibition of membrane biosynthesis. Altogether, our studies reveal a previously unrecognized mechanism of antibiotic resistance by rebalancing cellular homeostasis.	[Zeng, Daina; Zhao, Jinshi; Chung, Hak Suk; Guan, Ziqiang; Raetz, Christian R. H.; Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Chung, Hak Suk] Korea Inst Sci & Technol, Ctr Integrated Risk Res, Seoul 136791, South Korea	Duke University; Korea Institute of Science & Technology (KIST)	Zhou, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	Guan, Ziqiang/AAE-5110-2019; Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416; Chung, Hak Suk/0000-0003-1166-9909	National Institutes of Health Grant [GM-51310, AI-055588]; National Institutes of Health Lipid Maps Large Scale Collaborative Grant [GM-069338]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051310, U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Lipid Maps Large Scale Collaborative Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-51310 (to C. R. H. R.) and Grant AI-055588 (to P. Z.).; Supported by National Institutes of Health Lipid Maps Large Scale Collaborative Grant GM-069338.; We thank all members of the Raetz laboratory for stimulating discussions. We are especially grateful to Drs. Xiaofei Liang and Eric Toone for the generous gifts of LpxC inhibitors used in this study, Ali Masoudi for help in the preparation of acyl-ACP, Dr. William T. Doerrler for providing the polyclonal LpxC antibody, and Drs. Michael D. Been and John Hsieh for help in ThrS assay design. The Mass Spectrometry Facility, Department of Biochemistry, Duke University Medical Center, was supported by National Institutes of Health Lipid Maps Large Scale Collaborative Grant GM-069338.	ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9; Barb AW, 2007, P NATL ACAD SCI USA, V104, P18433, DOI 10.1073/pnas.0709412104; Barb AW, 2007, BIOCHEMISTRY-US, V46, P3793, DOI 10.1021/bi6025165; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodewits K, 2010, ANTIMICROB AGENTS CH, V54, P3531, DOI 10.1128/AAC.01600-09; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Bovee ML, 2003, BIOCHEMISTRY-US, V42, P15102, DOI 10.1021/bi0355701; Brown MF, 2012, J MED CHEM, V55, P914, DOI 10.1021/jm2014748; Caughlan RE, 2012, ANTIMICROB AGENTS CH, V56, P17, DOI 10.1128/AAC.05417-11; Chung HS, 2010, BIOCHEMISTRY-US, V49, P4126, DOI 10.1021/bi100343e; Clements JM, 2002, ANTIMICROB AGENTS CH, V46, P1793, DOI 10.1128/AAC.46.6.1793-1799.2002; Clementz T, 1997, J BIOL CHEM, V272, P10353; Cole KE, 2011, BIOCHEMISTRY-US, V50, P258, DOI 10.1021/bi101622a; Cosgrove SE, 2002, ARCH INTERN MED, V162, P185, DOI 10.1001/archinte.162.2.185; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Evans HL, 2007, CRIT CARE MED, V35, P89, DOI 10.1097/01.CCM.0000251496.61520.75; Fallon EO, 2009, J GERONTOL A-BIOL, V64, P138, DOI 10.1093/gerona/gln020; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P800, DOI 10.1016/j.bbalip.2011.04.009; Harris A, 1999, CLIN INFECT DIS, V28, P1128, DOI 10.1086/514760; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; JOHNSON EJ, 1977, J BACTERIOL, V129, P66, DOI 10.1128/JB.129.1.66-70.1977; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; Langklotz S, 2011, J BACTERIOL, V193, P1090, DOI 10.1128/JB.01043-10; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Lee CJ, 2011, CHEM BIOL, V18, P38, DOI 10.1016/j.chembiol.2010.11.011; Liang XF, 2011, BIOORGAN MED CHEM, V19, P852, DOI 10.1016/j.bmc.2010.12.017; Lu YH, 2011, J BIOL CHEM, V286, P5506, DOI 10.1074/jbc.M110.199265; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Montgomery JI, 2012, J MED CHEM, V55, P1662, DOI 10.1021/jm2014875; NIKAIDO H, 1996, ESCHERICHIA COLI SAL, P29; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Pop-Vicas AE, 2005, CLIN INFECT DIS, V40, P1792, DOI 10.1086/430314; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Shimohata N, 2002, GENES CELLS, V7, P653, DOI 10.1046/j.1365-2443.2002.00554.x; Slama TG, 2008, CRIT CARE, V12, DOI 10.1186/cc6820; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; Sorensen PG, 1996, J BIOL CHEM, V271, P25898, DOI 10.1074/jbc.271.42.25898; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wang J, 2011, COLD SH Q B, V76, P183, DOI 10.1101/sqb.2011.76.010835; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Warmus JS, 2012, BIOORG MED CHEM LETT, V22, P2536, DOI 10.1016/j.bmcl.2012.01.140; Wayne P.A, 1997, PERF VOL ANT SUSC FL, Vsixth	53	42	42	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5475	5486		10.1074/jbc.M112.447607	http://dx.doi.org/10.1074/jbc.M112.447607			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23316051	Green Published, hybrid			2022-12-28	WOS:000315342500022
J	Wu, J; Cheng, Z; Reddie, K; Carroll, K; Hammad, LA; Karty, JA; Bauer, CE				Wu, Jiang; Cheng, Zhuo; Reddie, Khalilah; Carroll, Kate; Hammad, Loubna A.; Karty, Jonathan A.; Bauer, Carl E.			RegB Kinase Activity Is Repressed by Oxidative Formation of Cysteine Sulfenic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTER GENE-EXPRESSION; REDOX SWITCHES; SENSOR; AUTOPHOSPHORYLATION; IDENTIFICATION; TRANSDUCTION; REGB/REGA; SYSTEM	RegB/RegA comprise a global redox-sensing signal transduction system utilized by a wide range of proteobacteria to sense environmental changes in oxygen tension. The conserved cysteine 265 in the sensor kinase RegB was previously reported to form an intermolecular disulfide bond under oxidizing conditions that converts RegB from an active dimer into an inactive tetramer. In this study, we demonstrate that a stable sulfenic acid (-SOH) derivative also forms at Cys-265 in vitro and in vivo when RegB is exposed to oxygen. This sulfenic acid modification is reversible and stable in the air. Autophosphorylation assay shows that reduction of the SOH at Cys-265 to a free thiol (SH) can increase RegB kinase activity in vitro. Our results suggest that a sulfenic acid modification at Cys-265 performs a regulatory role in vivo and that it may be the major oxidation state of Cys-265 under aerobic conditions. Cys-265 thus functions as a complex redox switch that can form multiple thiol modifications in response to different redox signals to control the kinase activity of RegB.	[Wu, Jiang; Cheng, Zhuo; Bauer, Carl E.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Hammad, Loubna A.; Karty, Jonathan A.] Indiana Univ, METACyt Biochem Anal Ctr, Dept Chem, Bloomington, IN 47405 USA; [Reddie, Khalilah] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Carroll, Kate] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Michigan System; University of Michigan; Scripps Research Institute	Bauer, CE (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Simon Hall MSB,212 S Hawthorne Dr, Bloomington, IN 47405 USA.	bauer@indiana.edu	Wu, Jiang/N-3838-2014	Wu, Jiang/0000-0002-9336-457X; Carroll, Kate/0000-0002-7624-9617; Karty, Jonathan/0000-0003-1022-9100	National Institutes of Health [R37 GM040941, R01 GM102187]; Camile Henry Dreyfus Teacher Scholar Award; NATIONAL CANCER INSTITUTE [R01CA174864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102187, R37GM040941] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Camile Henry Dreyfus Teacher Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM040941 (to C. E. B.) and Grant R01 GM102187 (to K. S. C.) as well as funding from the Camile Henry Dreyfus Teacher Scholar Award.	Alvarez B, 2010, METHOD ENZYMOL, V473, P117, DOI 10.1016/S0076-6879(10)73005-6; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Bird TH, 1999, J BIOL CHEM, V274, P16343, DOI 10.1074/jbc.274.23.16343; BOYER PD, 1954, J AM CHEM SOC, V76, P4331, DOI 10.1021/ja01646a025; BOYER PD, 1979, CC/LIFE SCI, P14; Charles RL, 2007, MOL CELL PROTEOMICS, V6, P1473, DOI 10.1074/mcp.M700065-MCP200; Cheng Z, 2012, MOL MICROBIOL, V85, P734, DOI 10.1111/j.1365-2958.2012.08135.x; CLAIBORNE A, 1993, FASEB J, V7, P1483, DOI 10.1096/fasebj.7.15.8262333; Elsen S, 2004, MICROBIOL MOL BIOL R, V68, P263, DOI 10.1128/MMBR.68.2.263-279.2004; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; INOUE K, 1995, BIOCHEMISTRY-US, V34, P391, DOI 10.1021/bi00002a002; Kim YJ, 2007, J BACTERIOL, V189, P5617, DOI 10.1128/JB.00443-07; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Leonard SE, 2011, ANGEW CHEM INT EDIT, V50, P4423, DOI 10.1002/anie.201007871; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; MOSLEY CS, 1994, J BACTERIOL, V176, P7566, DOI 10.1128/JB.176.24.7566-7573.1994; Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003; POOLE LB, 1989, J BIOL CHEM, V264, P12330; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Reddie KG, 2008, MOL BIOSYST, V4, P521, DOI 10.1039/b719986d; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; SGANGA MW, 1992, CELL, V68, P945, DOI 10.1016/0092-8674(92)90037-D; Swem LR, 2006, J BIOL CHEM, V281, P6768, DOI 10.1074/jbc.M509687200; Swem LR, 2003, EMBO J, V22, P4699, DOI 10.1093/emboj/cdg461; Torchinsky Y. M., 1981, PROPERTIES SH GROUPS; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Wu J., 2007, BACTERIAL SIGNAL TRA, P131; Wu J, 2008, ADV EXP MED BIOL, V631, P131, DOI 10.1007/978-0-387-78885-2_9; Wu JA, 2010, MBIO, V1, DOI 10.1128/mBio.00272-10	33	36	36	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4755	4762		10.1074/jbc.M112.413492	http://dx.doi.org/10.1074/jbc.M112.413492			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23306201	hybrid, Green Published			2022-12-28	WOS:000315340400024
J	Dagil, R; O'Shea, C; Nykjaer, A; Bonvin, AMJJ; Kragelund, BB				Dagil, Robert; O'Shea, Charlotte; Nykjaer, Anders; Bonvin, Alexandre M. J. J.; Kragelund, Birthe B.			Gentamicin Binds to the Megalin Receptor as a Competitive Inhibitor Using the Common Ligand Binding Motif of Complement Type Repeats INSIGHT FROM THE NMR STRUCTURE OF THE 10TH COMPLEMENT TYPE REPEAT DOMAIN ALONE AND IN COMPLEX WITH GENTAMICIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; CYSTEINE-RICH; ULTRASTRUCTURAL-LOCALIZATION; AMINOGLYCOSIDE ANTIBIOTICS; INDUCED NEPHROTOXICITY; EXTRACELLULAR DOMAIN; RENAL ACCUMULATION; HEYMANN NEPHRITIS; STRUCTURAL BASIS; RAP COMPLEX	Gentamicin is an aminoglycoside widely used in treatments of, in particular, enterococcal, mycobacterial, and severe Gram-negative bacterial infections. Large doses of gentamicin cause nephrotoxicity and ototoxicity, entering the cell via the receptor megalin. Until now, no structural information has been available to describe the interaction with gentamicin in atomic detail, and neither have any three-dimensional structures of domains from the human megalin receptor been solved. To address this gap in our knowledge, we have solved the NMR structure of the 10th complement type repeat of human megalin and investigated its interaction with gentamicin. Using NMR titration data in HADDOCK, we have generated a three-dimensional model describing the complex between megalin and gentamicin. Gentamicin binds to megalin with low affinity and exploits the common ligand binding motif previously described (Jensen, G. A., Andersen, O. M., Bonvin, A. M., Bjerrum-Bohr, I., Etzerodt, M., Thogersen, H. C., O'Shea, C., Poulsen, F. M., and Kragelund, B. B. (2006) J. Mol. Biol. 362, 700-716) utilizing the indole side chain of Trp-1126 and the negatively charged residues Asp-1129, Asp-1131, and Asp-1133. Binding to megalin is highly similar to gentamicin binding to calreticulin. We discuss the impact of this novel insight for the future structure-based design of gentamicin antagonists.	[Dagil, Robert; O'Shea, Charlotte; Kragelund, Birthe B.] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, DK-2200 Copenhagen, Denmark; [Nykjaer, Anders] Univ Aarhus, Dept Biomed, Lundbeck Fdn Res Ctr MIND, DK-8000 Aarhus C, Denmark; [Bonvin, Alexandre M. J. J.] Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	University of Copenhagen; Aarhus University; Lundbeckfonden; Utrecht University	Kragelund, BB (corresponding author), Univ Copenhagen, Dept Biol, SBiNLab, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	bbk@bio.ku.dk	Bonvin, Alexandre M.J.J./A-5420-2009; Kragelund, Birthe/M-3927-2014	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Kragelund, Birthe/0000-0002-7454-1761; Dagil, Robert/0000-0002-5594-0716; Nykjaer, Anders/0000-0001-6422-6736	Oticon Foundation; European FP7 e-Infrastructure grant [261572]; national grid Initiative of Belgium via the Dutch BiG Grid project; national grid Initiative of Italy via the Dutch BiG Grid project; national grid Initiative of Germany via the Dutch BiG Grid project; national grid Initiative of the Netherlands via the Dutch BiG Grid project; Gisela project	Oticon Foundation; European FP7 e-Infrastructure grant; national grid Initiative of Belgium via the Dutch BiG Grid project; national grid Initiative of Italy via the Dutch BiG Grid project; national grid Initiative of Germany via the Dutch BiG Grid project; national grid Initiative of the Netherlands via the Dutch BiG Grid project; Gisela project	This work was supported by a grant from the Oticon Foundation.; We thank Line Hyltoft Kristensen, Simon Erlendsson, Kaare Teilum, and Johan G. Olsen for fruitful discussions and Kresten Lindorff-Larsen for help with the water refinements. Signe Sjorup and Michael Nielsen are thanked for their excellent technical assistance. The Worldwide e-infrastructure for NMR and structural biology (WeNMR) project (European FP7 e-Infrastructure grant, Contract 261572), supported by the national grid Initiatives of Belgium, Italy, Germany, the Netherlands (via the Dutch BiG Grid project), Portugal, the United Kingdom, South Africa, Taiwan, and the Latin America grid infrastructure via the Gisela project, is acknowledged for the use of web portals, computing, and storage facilities. We also thank the Danish Instrument Center at the Carlsberg Research Center for spectrometer time.	Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berjanskii M, 2012, J BIOMOL NMR, V53, P167, DOI 10.1007/s10858-012-9637-2; Blanchard SC, 1998, BIOCHEMISTRY-US, V37, P7716, DOI 10.1021/bi973125y; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; CHATELET F, 1986, AM J PATHOL, V122, P500; Chen LF, 2009, INFECT DIS CLIN N AM, V23, P1053, DOI 10.1016/j.idc.2009.06.004; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; CHRISTENSEN EI, 1992, J HISTOCHEM CYTOCHEM, V40, P1481, DOI 10.1177/40.10.1382088; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fernandez-Recio J, 2004, J MOL BIOL, V335, P843, DOI 10.1016/j.jmb.2003.10.069; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Gallagher H, 2004, BIOCHIMIE, V86, P179, DOI 10.1016/j.biochi.2004.03.001; Gettins PGW, 2012, BIOCHEM J, V443, P65, DOI 10.1042/BJ20111867; Guttman M, 2011, BIOCHEMISTRY-US, V50, P11001, DOI 10.1021/bi2014486; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; Hariprasad G, 2012, J MOL MODEL, V18, P2645, DOI 10.1007/s00894-011-1289-8; Horibe T, 2004, BIOCHEM BIOPH RES CO, V323, P281, DOI 10.1016/j.bbrc.2004.08.099; Hsin K, 2008, J APPL CRYSTALLOGR, V41, P963, DOI 10.1107/S002188980802476X; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KERJASCHKI D, 1982, P NATL ACAD SCI-BIOL, V79, P5557, DOI 10.1073/pnas.79.18.5557; Konig O, 2008, FASEB J, V22, P410, DOI 10.1096/fj.07-9171com; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Krzeminski M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-51; Lesniak W, 2003, CARBOHYD RES, V338, P2853, DOI 10.1016/j.carres.2003.08.005; Lopez-Novoa JM, 2011, KIDNEY INT, V79, P33, DOI 10.1038/ki.2010.337; Mizuta K, 1999, HEARING RES, V129, P83, DOI 10.1016/S0378-5955(98)00221-4; MOESTRUP SK, 1993, J BIOL CHEM, V268, P16564; Nabavi SF, 2012, FOOD FUNCT, V3, P28, DOI 10.1039/c1fo10173k; Nagai J, 2006, J CONTROL RELEASE, V112, P43, DOI 10.1016/j.jconrel.2006.01.003; Nagai J, 2002, J PHARM PHARMACOL, V54, P1491, DOI 10.1211/00223570272; Nagai J, 2001, AM J PHYSIOL-RENAL, V281, pF337, DOI 10.1152/ajprenal.2001.281.2.F337; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; Ojano-Dirain CP, 2012, LARYNGOSCOPE, V122, P2543, DOI 10.1002/lary.23593; Orlando RA, 1997, P NATL ACAD SCI USA, V94, P2368, DOI 10.1073/pnas.94.6.2368; Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267; RAYCHOWDHURY R, 1989, SCIENCE, V244, P1163, DOI 10.1126/science.2786251; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Rybak MJ, 1999, ANTIMICROB AGENTS CH, V43, P1549, DOI 10.1128/AAC.43.7.1549; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Sandoval RM, 2004, AM J PHYSIOL-RENAL, V286, pF617, DOI 10.1152/ajprenal.00130.2003; Schmitz C, 2002, J BIOL CHEM, V277, P618, DOI 10.1074/jbc.M109959200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Takamoto K, 2005, BBA-GEN SUBJECTS, V1722, P247, DOI 10.1016/j.bbagen.2004.12.006; Takamoto K, 2003, BIOCHEM BIOPH RES CO, V308, P866, DOI 10.1016/S0006-291X(03)01502-X; Tauris J, 2009, AUDIOL NEURO-OTOL, V14, P267, DOI 10.1159/000199446; Turnidge J, 2003, INFECT DIS CLIN N AM, V17, P503, DOI 10.1016/S0891-5520(03)00057-6; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; VERPOOTEN GA, 1989, CLIN PHARMACOL THER, V45, P22, DOI 10.1038/clpt.1989.4; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Watanabe A, 2004, J CONTROL RELEASE, V95, P423, DOI 10.1016/j.jconrel.2003.12.005; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Wolf CA, 2007, J BIOMOL NMR, V37, P321, DOI 10.1007/s10858-006-9129-3; Wong CH, 1998, CHEM BIOL, V5, P397, DOI 10.1016/S1074-5521(98)90073-4; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02	70	38	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4424	4435		10.1074/jbc.M112.434159	http://dx.doi.org/10.1074/jbc.M112.434159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23275343	Green Published, hybrid			2022-12-28	WOS:000314845000069
J	Flacke, JP; Flacke, H; Appukuttan, A; Palisaar, RJ; Noldus, J; Robinson, BD; Reusch, HP; Zippin, JH; Ladilov, Y				Flacke, Jan-Paul; Flacke, Hanna; Appukuttan, Avinash; Palisaar, Rein-Jueri; Noldus, Joachim; Robinson, Brian D.; Reusch, H. Peter; Zippin, Jonathan H.; Ladilov, Yury			Type 10 Soluble Adenylyl Cyclase Is Overexpressed in Prostate Carcinoma and Controls Proliferation of Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; G(2)/M TRANSITION; CAMP; APOPTOSIS; EPAC; MELANOMA; SIGNAL; DIFFERENTIATION; ACTIVATION; SURVIVAL	cAMP signaling plays an essential role in modulating the proliferation of different cell types, including cancer cells. Until now, the regulation of this pathway was restricted to the transmembrane class of adenylyl cyclases. In this study, significant overexpression of soluble adenylyl cyclase (sAC), an alternative source of cAMP, was found in human prostate carcinoma, and therefore, the contribution of this cyclase was investigated in the prostate carcinoma cell lines LNCaP and PC3. Suppression of sAC activity by treatment with the sAC-specific inhibitor KH7 or by sAC-specific knockdown mediated by siRNA or shRNA transfection prevented the proliferation of prostate carcinoma cells, led to lactate dehydrogenase release, and induced apoptosis. Cell cycle analysis revealed a significant rise in the G(2) phase population 12 h after sAC inhibition, which was accompanied by the down-regulation of cyclin B-1 and CDK1. sAC-dependent regulation of proliferation involves the EPAC/Rap1/B-Raf signaling pathway. In contrast, protein kinase A does not play a role. In conclusion, this study suggests a novel sAC-dependent signaling pathway that controls the proliferation of prostate carcinoma cells.	[Flacke, Jan-Paul; Flacke, Hanna; Appukuttan, Avinash; Reusch, H. Peter; Ladilov, Yury] Ruhr Univ Bochum, Dept Clin Pharmacol, D-44801 Bochum, Germany; [Palisaar, Rein-Jueri; Noldus, Joachim] Ruhr Univ Bochum, Urol Clin, D-44801 Bochum, Germany; [Robinson, Brian D.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Robinson, Brian D.] Weill Cornell Med Coll, Dept Urol, New York, NY 10065 USA; [Zippin, Jonathan H.] Weill Cornell Med Coll, Dept Dermatol, New York, NY 10065 USA	Ruhr University Bochum; Ruhr University Bochum; Cornell University; Cornell University; Cornell University	Ladilov, Y (corresponding author), Ruhr Univ Bochum, Dept Clin Pharmacol, Univ Str 150, D-44801 Bochum, Germany.	yury.ladilov@rub.de	Ladilov, Yury/AAN-2603-2020; Ladilov, Yury/AAD-3547-2021		Deutsche Forschungsgemeinschaft [LA 1159/7-1]; Ruhr University Bochum [F690-2010, F719-2011]; Clinique Clinical Scholars fellowship; National Institutes of Health from NCI [K08 CA160657]; NATIONAL CANCER INSTITUTE [K08CA160657] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruhr University Bochum; Clinique Clinical Scholars fellowship; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grant LA 1159/7-1 from the Deutsche Forschungsgemeinschaft and by Forum Grants F690-2010 and F719-2011 from Ruhr University Bochum.; Supported by a Clinique Clinical Scholars fellowship and National Institutes of Health Grant K08 CA160657 from NCI.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Appukuttan A, 2012, CARDIOVASC RES, V93, P340, DOI 10.1093/cvr/cvr306; Baljinnyam E, 2010, CANCER RES, V70, P5607, DOI 10.1158/0008-5472.CAN-10-0056; Barnes DM, 1996, BRIT J CANCER, V74, P1445, DOI 10.1038/bjc.1996.563; Borland G, 2009, BRIT J PHARMACOL, V158, P70, DOI 10.1111/j.1476-5381.2008.00087.x; Borysova MK, 2008, CELL CYCLE, V7, P2894, DOI 10.4161/cc.7.18.6678; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cao JN, 2010, CANCER RES, V70, P6004, DOI 10.1158/0008-5472.CAN-09-4490; Chen TC, 1998, LAB INVEST, V78, P165; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Farrell J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003251; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Hayne C, 2000, J BIOL CHEM, V275, P31876, DOI 10.1074/jbc.M002766200; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Hewer RC, 2011, J MOL CELL CARDIOL, V50, P87, DOI 10.1016/j.yjmcc.2010.10.010; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Kumar S, 2009, J BIOL CHEM, V284, P14760, DOI 10.1074/jbc.M900925200; Leone V, 2007, AM J PHYSIOL-GASTR L, V293, pG673, DOI 10.1152/ajpgi.00584.2006; Lucchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020785; Magro CM, 2012, ARCH DERMATOL, V148, P335, DOI 10.1001/archdermatol.2011.338; Massard C, 2011, CLIN CANCER RES, V17, P3876, DOI 10.1158/1078-0432.CCR-10-2815; Merkle D, 2011, CELL SIGNAL, V23, P507, DOI 10.1016/j.cellsig.2010.08.017; Misra UK, 2009, J CELL BIOCHEM, V108, P998, DOI 10.1002/jcb.22333; Poetsch M, 2003, MELANOMA RES, V13, P29, DOI 10.1097/00008390-200302000-00006; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rinne A, 2006, J MUSCLE RES CELL M, V27, P413, DOI 10.1007/s10974-006-9087-0; Rudolph JA, 2004, J BIOL CHEM, V279, P14828, DOI 10.1074/jbc.M310289200; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Xu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021119; Zhang LZ, 2006, CANCER RES, V66, P898, DOI 10.1158/0008-5472.CAN-05-3025; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200; Zheng H, 2009, CANCER RES, V69, P449, DOI 10.1158/0008-5472.CAN-08-2399; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje; Zippin JH, 2010, J INVEST DERMATOL, V130, P1279, DOI 10.1038/jid.2009.440	41	38	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3126	3135		10.1074/jbc.M112.403279	http://dx.doi.org/10.1074/jbc.M112.403279			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255611	hybrid, Green Published			2022-12-28	WOS:000314397900021
J	Garcia-Prieto, C; Ahmed, KBR; Chen, Z; Zhou, Y; Hammoudi, N; Kang, Y; Lou, CG; Mei, Y; Jin, ZD; Huang, P				Garcia-Prieto, Celia; Ahmed, Kausar Begam Riaz; Chen, Zhao; Zhou, Yan; Hammoudi, Naima; Kang, Ying; Lou, Changgang; Mei, Yan; Jin, Zhendong; Huang, Peng			Effective Killing of Leukemia Cells by the Natural Product OSW-1 through Disruption of Cellular Calcium Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENT ANTITUMOR SAPONIN; ENDOPLASMIC-RETICULUM; GLYCOSIDES BEARING; MALIGNANT GLIOMAS; STEROIDAL SAPONIN; PROSTATE-CANCER; CA2+ TRANSPORT; UP-REGULATION; PROTEIN; ANALOGS	3 beta,16 beta,17 alpha-Trihydroxycholest-5-en-22-one 16-O-(2-O-4-methoxybenzoyl-beta-D-xylopyranosyl)-(1 -> 3)-2-O-acetyl-alpha-L-arabinopyranoside (OSW-1) is a natural product with potent antitumor activity against various types of cancer cells, but the exact mechanisms of action remain to be defined. In this study, we showed that OSW-1 effectively killed leukemia cells at subnanomolar concentrations through a unique mechanism by causing a time-dependent elevation of cytosolic Ca2+ prior to induction of apoptosis. A mechanistic study revealed that this compound inhibited the sodium-calcium exchanger 1 on the plasma membrane, leading to an increase in cytosolic Ca2+ and a decrease in cytosolic Na+. The elevated cytosolic Ca2+ caused mitochondrial calcium overload and resulted in a loss of mitochondrial membrane potential, release of cytochrome c, and activation of caspase-3. Furthermore, OSW-1 also caused a Ca2+-dependent cleavage of the survival factor GRP78. Inhibition of Ca2+ entry into the mitochondria by the uniporter inhibitor RU360 or by cyclosporin A significantly prevented the OSW-1-induced cell death, indicating the important role of mitochondria in mediating the cytotoxic activity. The extremely potent activity of OSW-1 against leukemia cells and its unique mechanism of action suggest that this compound may be potentially useful in the treatment of leukemia.	[Garcia-Prieto, Celia; Ahmed, Kausar Begam Riaz; Chen, Zhao; Hammoudi, Naima; Huang, Peng] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Garcia-Prieto, Celia] Univ Texas MD Anderson Canc Ctr, Canc Prevent Div, Dept Hlth Dispar Res, Houston, TX 77030 USA; [Ahmed, Kausar Begam Riaz; Hammoudi, Naima] Univ Texas Grad Sch Biomed Sci, Houston, TX 77030 USA; [Chen, Zhao] Univ Penn, Sch Med, Dept Genet, Genet Diagnost Lab, Philadelphia, PA 19104 USA; [Kang, Ying] E Tennessee State Univ, Dept Internal Med, James H Quillen Coll Med, Johnson City, TN 37614 USA; [Kang, Ying; Lou, Changgang; Mei, Yan; Jin, Zhendong] Univ Iowa, Coll Pharm, Dept Pharmaceut Sci & Expt Therapeut, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; East Tennessee State University; University of Iowa	Huang, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Unit 0951,1515 Holcombe Blvd, Houston, TX 77030 USA.	phuang@mdanderson.org			National Institutes of Health [CA085563, CA100428, CA109041, CA16672, P60MD000503]; NATIONAL CANCER INSTITUTE [R01CA109041, P30CA016672, R01CA100428, R01CA085563] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants CA085563, CA100428, CA109041, CA16672, and P60MD000503.	Ashby MC, 2001, SEMIN CELL DEV BIOL, V12, P11, DOI 10.1006/scdb.2000.0212; Aung CS, 2007, BIOCHEM BIOPH RES CO, V355, P932, DOI 10.1016/j.bbrc.2007.02.050; Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; BERAN M, 1993, CANCER RES, V53, P3603; Berridge M, 1999, CURR BIOL, V9, pR157, DOI 10.1016/S0960-9822(99)80101-8; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Deng SJ, 1999, J ORG CHEM, V64, P202, DOI 10.1021/jo981685c; Dong DZ, 2005, CANCER RES, V65, P5785, DOI 10.1158/0008-5472.CAN-05-0754; Guan YY, 2011, BIOORG MED CHEM LETT, V21, P2921, DOI 10.1016/j.bmcl.2011.03.065; Guo CX, 1998, TETRAHEDRON LETT, V39, P1099, DOI 10.1016/S0040-4039(97)10814-0; Harley W, 2010, BRAIN RES, V1363, P159, DOI 10.1016/j.brainres.2010.09.059; Iwamoto T, 2006, J PHARMACOL SCI, V102, P32, DOI 10.1254/jphs.FMJ06002X6; Khorchid A, 2002, NAT STRUCT BIOL, V9, P239, DOI 10.1038/nsb0402-239; KUBO S, 1992, PHYTOCHEMISTRY, V31, P3969, DOI 10.1016/S0031-9422(00)97565-4; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lipskaia L, 2009, PFLUG ARCH EUR J PHY, V457, P673, DOI 10.1007/s00424-007-0428-7; Liu MY, 1997, J BIOL CHEM, V272, P18801, DOI 10.1074/jbc.272.30.18801; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Ma XQ, 2001, BIOORG MED CHEM LETT, V11, P2153, DOI 10.1016/S0960-894X(01)00389-4; Ma XQ, 2000, CARBOHYD RES, V329, P495, DOI 10.1016/S0008-6215(00)00225-1; Ma XQ, 2001, CARBOHYD RES, V334, P159, DOI 10.1016/S0008-6215(01)00171-9; Maj J, 2011, J MED CHEM, V54, P3298, DOI 10.1021/jm101648h; McConkey DJ, 1996, J LEUKOCYTE BIOL, V59, P775, DOI 10.1002/jlb.59.6.775; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Morzycki JW, 2004, BIOORG MED CHEM LETT, V14, P3323, DOI 10.1016/j.bmcl.2004.03.102; Morzycki JW, 2002, CARBOHYD RES, V337, P1269, DOI 10.1016/S0008-6215(02)00126-X; Newman RA, 2007, INTEGR CANCER THER, V6, P354, DOI 10.1177/1534735407309623; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pathak S, 2000, ANTI-CANCER DRUG, V11, P455, DOI 10.1097/00001813-200007000-00006; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Ribiczey P, 2007, CELL CALCIUM, V42, P590, DOI 10.1016/j.ceca.2007.02.003; Rizzuto R, 2003, J CELL BIOL, V163, P441, DOI 10.1083/jcb.200309111; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Shi BF, 2005, J ORG CHEM, V70, P10354, DOI 10.1021/jo051536b; Tamura K, 1997, BRIT J PHARMACOL, V121, P1796, DOI 10.1038/sj.bjp.0701309; Tang PP, 2007, BIOORG MED CHEM LETT, V17, P1003, DOI 10.1016/j.bmcl.2006.11.032; Tschamber T, 2007, BIOORG MED CHEM LETT, V17, P5101, DOI 10.1016/j.bmcl.2007.07.017; Vanoverberghe K, 2004, CELL DEATH DIFFER, V11, P321, DOI 10.1038/sj.cdd.4401375; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; WETZLER M, 1993, J CLIN INVEST, V92, P1925, DOI 10.1172/JCI116786; Wojtkielewicz A, 2007, J MED CHEM, V50, P3667, DOI 10.1021/jm0613572; Wu GS, 2009, P NATL ACAD SCI USA, V106, P10829, DOI 10.1073/pnas.0903408106; Wu Y, 2005, CANCER RES, V65, P9073, DOI 10.1158/0008-5472.CAN-05-2016; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545; Yokoyama S., 2005, MATER TECHNOL, V23, P54; Yu WS, 2002, J AM CHEM SOC, V124, P6576, DOI 10.1021/ja012119t; Yu WS, 2001, J AM CHEM SOC, V123, P3369, DOI 10.1021/ja004098t; Zhang H, 2008, LEUKEMIA, V22, P1191, DOI 10.1038/leu.2008.74; Zheng D, 2011, BIOORG MED CHEM LETT, V21, P3257, DOI 10.1016/j.bmcl.2011.04.030; Zheng D, 2010, BIOORG MED CHEM LETT, V20, P5439, DOI 10.1016/j.bmcl.2010.07.085; Zhou Y, 2005, JNCI-J NATL CANCER I, V97, P1781, DOI 10.1093/jnci/dji404; Zhu JB, 2005, MOL PHARMACOL, V68, P1831, DOI 10.1124/mol.105.015826	59	43	44	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3240	3250		10.1074/jbc.M112.384776	http://dx.doi.org/10.1074/jbc.M112.384776			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250754	Green Published, hybrid			2022-12-28	WOS:000314397900031
J	Adachi, E; Nakajima, H; Mizuguchi, C; Dhanasekaran, P; Kawashima, H; Nagao, K; Akaji, K; Lund-Katz, S; Phillips, MC; Saito, H				Adachi, Emi; Nakajima, Hiroyuki; Mizuguchi, Chiharu; Dhanasekaran, Padmaja; Kawashima, Hiroyuki; Nagao, Kohjiro; Akaji, Kenichi; Lund-Katz, Sissel; Phillips, Michael C.; Saito, Hiroyuki			Dual Role of an N-terminal Amyloidogenic Mutation in Apolipoprotein A-I DESTABILIZATION OF HELIX BUNDLE AND ENHANCEMENT OF FIBRIL FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID INTERACTION; CRYSTAL-STRUCTURE; DOMAIN; MECHANISM; OLIGOMERS; HDL; ORGANIZATION; KINETICS; REVEALS; BINDING	A number of naturally occurring mutations of apolipoprotein (apo) A-I, the major protein of HDL, are known to be associated with hereditary amyloidosis and atherosclerosis. Here, we examined the effects of the G26R point mutation in apoA-I (apoA-I-Iowa) on the structure, stability, and aggregation propensity to form amyloid fibril of full-length apoA-I and the N-terminal fragment of apoA-I. Circular dichroism and fluorescence measurements demonstrated that the G26R mutation destabilizes the N-terminal helix bundle domain of full-length protein, leading to increased hydrophobic surface exposure, whereas it has no effect on the initial structure of the N-terminal 1-83 fragment, which is predominantly a random coil structure. Upon incubation for extended periods at neutral pH, the N-terminal 1-83 variants undergo a conformational change to beta-sheet-rich structure with a great increase in thioflavin T fluorescence, whereas no structural change is observed in full-length proteins. Comparison of fibril-forming propensity among substituted mutants at Gly-26 position of 1-83 fragments demonstrated that the G26R mutation enhances the nucleation step of fibril formation, whereas G26K and G26E mutations have small or inhibiting effects on the formation of fibrils. These fibrils of the 1-83 variants have long and straight morphology as revealed by atomic force microscopy and exhibited significant toxicity with HEK293 cells. Our results indicate dual critical roles of the arginine residue at position 26 in apoA-I-Iowa: destabilization of the N-terminal helix bundle structure in full-length protein and enhancement of amyloid fibril formation by the N-terminal 1-83 fragment.	[Nagao, Kohjiro; Saito, Hiroyuki] Univ Tokushima, Inst Hlth Biosci, Tokushima 7708505, Japan; [Nagao, Kohjiro; Saito, Hiroyuki] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Kawashima, Hiroyuki; Akaji, Kenichi] Kyoto Pharmaceut Univ, Dept Med Chem, Yamashina Ku, Kyoto 6078412, Japan; [Dhanasekaran, Padmaja; Lund-Katz, Sissel; Phillips, Michael C.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Lipid Res Grp,Gastroenterol Hepatol & Nutr Div, Philadelphia, PA 19104 USA	Tokushima University; Tokushima University; Kyoto Pharmaceutical University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Saito, H (corresponding author), Univ Tokushima, Inst Hlth Biosci, 1-78-1 Shomachi, Tokushima 7708505, Japan.	hsaito@tokushima-u.ac.jp		Phillips, Michael/0000-0002-7147-8007	National Institutes of Health [HL22633]; Japan Society for the Promotion of Science [22590046]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL22633 (to M. C. P.). This work was also supported by Grant-in-Aid for Scientific Research 22590046 (to H. S.) from the Japan Society for the Promotion of Science.	Andreola A, 2003, J BIOL CHEM, V278, P2444, DOI 10.1074/jbc.M204801200; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Chetty PS, 2012, BIOCHEMISTRY-US, V51, P8993, DOI 10.1021/bi300926j; Crespo R, 2012, J BIOL CHEM, V287, P30585, DOI 10.1074/jbc.M112.375345; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Di Gaetano S, 2006, BIOCHEM BIOPH RES CO, V351, P223, DOI 10.1016/j.bbrc.2006.10.026; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fang YL, 2003, BIOCHEMISTRY-US, V42, P13260, DOI 10.1021/bi0354031; Frare E, 2004, J MOL BIOL, V340, P1153, DOI 10.1016/j.jmb.2004.05.056; Genschel J, 1998, FEBS LETT, V430, P145, DOI 10.1016/S0014-5793(98)00668-1; Gursky O, 2012, BIOCHEMISTRY-US, V51, P10, DOI 10.1021/bi2017014; Hatters DM, 2002, EUR BIOPHYS J BIOPHY, V31, P2, DOI 10.1007/s002490100172; Hill SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018171; Hristova K, 2011, J MEMBRANE BIOL, V239, P49, DOI 10.1007/s00232-010-9323-9; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kono M, 2010, J LIPID RES, V51, P809, DOI 10.1194/jlr.M002113; Lagerstedt JO, 2007, BIOCHEMISTRY-US, V46, P9693, DOI 10.1021/bi7005493; Lindgren M, 2005, BIOPHYS J, V88, P4200, DOI 10.1529/biophysj.104.049700; Lindgren M, 2010, FEBS J, V277, P1380, DOI 10.1111/j.1742-4658.2010.07571.x; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; NICHOLS WC, 1988, BIOCHEM BIOPH RES CO, V156, P762, DOI 10.1016/S0006-291X(88)80909-4; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Petrlova J, 2012, J LIPID RES, V53, P390, DOI 10.1194/jlr.M020883; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; RADER DJ, 1992, J LIPID RES, V33, P755; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Ramella NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043755; Ramella NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022532; Rocken C, 2006, ARTERIOSCL THROM VAS, V26, P676, DOI 10.1161/01.ATV.0000201930.10103.be; Rowczenio D, 2011, AM J PATHOL, V179, P1978, DOI 10.1016/j.ajpath.2011.06.024; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; SEGREST JP, 1992, J LIPID RES, V33, P141; Shukla D, 2010, J PHYS CHEM B, V114, P13426, DOI 10.1021/jp108399g; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; SORCITHOMAS M, 1993, J BIOL CHEM, V268, P21403; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tanaka M, 2008, BIOCHEMISTRY-US, V47, P2172, DOI 10.1021/bi702332b; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Teoh CL, 2011, PROTEIN CELL, V2, P116, DOI 10.1007/s13238-011-1013-6; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Vacca RA, 1997, J BIOL CHEM, V272, P21932, DOI 10.1074/jbc.272.35.21932; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Wong YQ, 2012, FEBS LETT, V586, P1754, DOI 10.1016/j.febslet.2012.05.007; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Yanagi K, 2011, J BIOL CHEM, V286, P23959, DOI 10.1074/jbc.M111.226688; Zaiou M, 2000, J LIPID RES, V41, P1087; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832	54	33	33	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2848	2856		10.1074/jbc.M112.428052	http://dx.doi.org/10.1074/jbc.M112.428052			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233678	hybrid, Green Published			2022-12-28	WOS:000314211500067
J	Giorda, KM; Raghava, S; Zhang, MW; Hebert, DN				Giorda, Kristina M.; Raghava, Smita; Zhang, Macy W.; Hebert, Daniel N.			The Viroporin Activity of the Minor Structural Proteins VP2 and VP3 Is Required for SV40 Propagation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; CAPSID PROTEIN; MOLECULAR CODE; POLYOMA-VIRUS; SIMIAN-VIRUS-40; MEMBRANE; ENTRY; RECOGNITION; INSERTION; ACCURACY	For nonenveloped viruses such as Simian Virus 40, the mechanism used to translocate viral components across membranes is poorly understood. Previous results indicated that the minor structural proteins, VP2 and VP3, might act as membrane proteins during infection. Here, purified VP2 and VP3 were found to form pores in host cell membranes. To identify possible membrane domains, individual hydrophobic domains from VP2 and VP3 were expressed in a model protein and tested for their ability to integrate into membranes. Several domains from the late proteins supported endoplasmic reticulum membrane insertion as transmembrane domains. Mutations in VP2 and VP3 were engineered that inhibited membrane insertion and pore formation. When these mutations were introduced into the viral genome, viral propagation was inhibited. This comprehensive approach revealed that the viroporin activity of VP2 and VP3 was inhibited by targeted disruptions of individual hydrophobic domains and the loss of membrane disruption activity impaired viral infection.	[Giorda, Kristina M.; Raghava, Smita; Zhang, Macy W.; Hebert, Daniel N.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Giorda, Kristina M.; Hebert, Daniel N.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hebert, DN (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St, Amherst, MA 01003 USA.	dhebert@biochem.umass.edu	Raghava, Smita/ABB-1479-2020		United States Public Health Grant [AI078142]; National Science Foundation, Integrative Graduate Education and Research Traineeship (IGERT), Institute for Cellular Engineering [DGE-0654128]; National Institutes of Health Chemistry-Biology Interface Training Grant [T32GM00815]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515] Funding Source: NIH RePORTER	United States Public Health Grant; National Science Foundation, Integrative Graduate Education and Research Traineeship (IGERT), Institute for Cellular Engineering; National Institutes of Health Chemistry-Biology Interface Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Grant AI078142 (to D. N. H.) and supported in part by National Science Foundation, Integrative Graduate Education and Research Traineeship (IGERT), Institute for Cellular Engineering (DGE-0654128), and by National Institutes of Health Chemistry-Biology Interface Training Grant T32GM00815 (to K. M. G.).	Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Campanero-Rhodes MA, 2007, J VIROL, V81, P12846, DOI 10.1128/JVI.01311-07; Chen XJS, 1998, EMBO J, V17, P3233, DOI 10.1093/emboj/17.12.3233; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Daniels R, 2006, MOL CELL, V24, P955, DOI 10.1016/j.molcel.2006.11.001; Daniels R, 2006, J VIROL, V80, P6575, DOI 10.1128/JVI.00347-06; Drayman N, 2010, J VIROL METHODS, V164, P145, DOI 10.1016/j.jviromet.2009.12.003; Engel S, 2011, J VIROL, V85, P4198, DOI 10.1128/JVI.02179-10; FIERS W, 1978, NATURE, V273, P113, DOI 10.1038/273113a0; Geiger R, 2011, NAT CELL BIOL, V13, P1305, DOI 10.1038/ncb2339; Giorda KM, 2012, J VIROL, V86, P3180, DOI 10.1128/JVI.07047-11; GOOD PJ, 1988, J VIROL, V62, P944, DOI 10.1128/JVI.62.3.944-953.1988; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Kawano M, 2006, J BIOL CHEM, V281, P10164, DOI 10.1074/jbc.M511261200; LAI CJ, 1978, CELL, V14, P971, DOI 10.1016/0092-8674(78)90351-3; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; MOORE KE, 1987, J BIOL CHEM, V262, P8806; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Raghava S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002116; REDDY VB, 1978, SCIENCE, V200, P494, DOI 10.1126/science.205947; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; SCHERRER R, 1971, J BACTERIOL, V108, P868, DOI 10.1128/JB.108.2.868-873.1971; SEDMAN SA, 1989, J VIROL, V63, P3884, DOI 10.1128/JVI.63.9.3884-3893.1989; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; STREULI CH, 1987, NATURE, V326, P619, DOI 10.1038/326619a0; Suzuki T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000801; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Yu YJ, 2006, J VIROL, V80, P6553, DOI 10.1128/JVI.00517-06	40	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2510	2520		10.1074/jbc.M112.428425	http://dx.doi.org/10.1074/jbc.M112.428425			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223228	Green Published, hybrid			2022-12-28	WOS:000314211500037
J	Pfeffer, JM; Weadge, JT; Clarke, AJ				Pfeffer, John M.; Weadge, Joel T.; Clarke, Anthony J.			Mechanism of Action of Neisseria gonorrhoeae O-Acetylpeptidoglycan Esterase, an SGNH Serine Esterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; STRUCTURE PREDICTION SERVER; CIRCULAR-DICHROISM SPECTRA; CRYSTAL-STRUCTURE; PEPTIDOGLYCAN; IDENTIFICATION; SEQUENCE; FAMILY; ACETYLATION; DEACETYLASE	O-Acetylpeptidoglycan esterase from Neisseria gonorrhoeae functions to release O-acetyl groups from the C-6 position of muramoyl residues in O-acetylated peptidoglycan, thereby permitting the continued metabolism of this essential cell wall heteropolymer. It has been demonstrated to be a serine esterase with sequence similarity to the family CE-3 carbohydrate esterases of the CAZy classification system. In the absence of a three-dimensional structure for any Ape, further knowledge of its structure and function relationship is dependent on modeling and kinetic studies. In this study, we predicted Neisseria gonorrhoeae Ape1a to be an SGNH hydrolase with an adopted alpha/beta-hydrolase fold containing a central twisted four-stranded parallel beta-sheet flanked by six alpha-helices with the putative catalytic triad, Asp-366, His-369, and Ser-80 appropriately aligned within a pocket. The role of eight invariant and highly conserved residues localized to the active site was investigated by site-directed replacements coupled with kinetic characterization and binding studies of the resultant engineered enzymes. Based on these data and theoretical considerations, Gly-236 and Asn-268 were identified as participating at the oxyanion hole to stabilize the tetrahedral species in the reaction mechanism, whereas Gly-78, Asp-79, His-81, Asn-235, Thr-267, and Val-368 are proposed to position appropriately the catalytic residues and participate in substrate binding.	[Pfeffer, John M.; Weadge, Joel T.; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Clarke, AJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 1W1, Canada.	a.clarke@exec.uoguelph.ca			Canadian Institutes of Health Research [MOP 81223]; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Operating Grant MOP 81223 (to A. J. C.) from the Canadian Institutes of Health Research and postgraduate scholarships (PGSD; to J. M. P. and J. T. W.) from the Natural Sciences and Engineering Research Council of Canada.	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; BLAKE CCF, 1981, J MOL BIOL, V147, P73, DOI 10.1016/0022-2836(81)90080-2; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chang RC, 1996, BIOCHEM BIOPH RES CO, V221, P477, DOI 10.1006/bbrc.1996.0620; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; CLARKE AJ, 1993, J BACTERIOL, V175, P4550, DOI 10.1128/JB.175.14.4550-4553.1993; Correia MAS, 2008, J MOL BIOL, V379, P64, DOI 10.1016/j.jmb.2008.03.037; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; DUPONT C, 1991, EUR J BIOCHEM, V195, P763, DOI 10.1111/j.1432-1033.1991.tb15764.x; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Hekmat O, 2003, BIOCHEM J, V374, P369, DOI 10.1042/BJ20030204; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lo YC, 2003, J MOL BIOL, V330, P539, DOI 10.1016/S0022-2836(03)00637-5; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Moynihan PJ, 2011, INT J BIOCHEM CELL B, V43, P1655, DOI 10.1016/j.biocel.2011.08.007; Pagotto FJ, 2000, GENE, V244, P13, DOI 10.1016/S0378-1119(99)00557-0; Pfeffer JM, 2012, CHEMBIOCHEM, V13, P722, DOI 10.1002/cbic.201100744; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Scheurwater EM, 2008, J BIOL CHEM, V283, P8363, DOI 10.1074/jbc.M710135200; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Weadge JT, 2007, BIOCHEMISTRY-US, V46, P4932, DOI 10.1021/bi700254m; Weadge JT, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-49; Weadge JT, 2006, BIOCHEMISTRY-US, V45, P839, DOI 10.1021/bi051679s	32	28	28	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2605	2613		10.1074/jbc.M112.436352	http://dx.doi.org/10.1074/jbc.M112.436352			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23209280	Green Published, hybrid			2022-12-28	WOS:000314211500045
J	Agrawal, B; Czymmek, KJ; Sparks, DL; Bais, HP				Agrawal, Bhavana; Czymmek, Kirk J.; Sparks, Donald L.; Bais, Harsh P.			Transient Influx of Nickel in Root Mitochondria Modulates Organic Acid and Reactive Oxygen Species Production in Nickel Hyperaccumulator Alyssum murale	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; OXIDATIVE STRESS; CYTOCHROME-C; SUBCELLULAR-LOCALIZATION; MALATE-DEHYDROGENASE; SEBERTIA-ACUMINATA; FREE HISTIDINE; NADPH OXIDASE; TOLERANCE; TRANSITION	Mitochondria are important targets of metal toxicity and are also vital for maintaining metal homeostasis. Here, we examined the potential role of mitochondria in homeostasis of nickel in the roots of nickel hyperaccumulator plant Alyssum murale. We evaluated the biochemical basis of nickel tolerance by comparing the role of mitochondria in closely related nickel hyperaccumulator A. murale and non-accumulator Alyssum montanum. Evidence is presented for the rapid and transient influx of nickel in root mitochondria of nickel hyperaccumulator A. murale. In an early response to nickel treatment, substantial nickel influx was observed in mitochondria prior to sequestration in vacuoles in the roots of hyperaccumulator A. murale compared with non-accumulator A. montanum. In addition, the mitochondrial Krebs cycle was modulated to increase synthesis of malic acid and citric acid involvement in nickel hyperaccumulation. Furthermore, malic acid, which is reported to form a complex with nickel in hyperaccumulators, was also found to reduce the reactive oxygen species generation induced by nickel. We propose that the interaction of nickel with mitochondria is imperative in the early steps of nickel uptake in nickel hyperaccumulator plants. Initial uptake of nickel in roots results in biochemical responses in the root mitochondria indicating its vital role in homeostasis of nickel ions in hyperaccumulation.	[Agrawal, Bhavana; Sparks, Donald L.; Bais, Harsh P.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA; [Czymmek, Kirk J.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Agrawal, Bhavana; Czymmek, Kirk J.; Sparks, Donald L.; Bais, Harsh P.] Delaware Biotechnol Inst, Newark, DE 19711 USA; [Sparks, Donald L.; Bais, Harsh P.] Ctr Crit Zone Res, Newark, DE 19711 USA	University of Delaware; University of Delaware	Bais, HP (corresponding author), Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA.	hbais@udel.edu	Rechsteiner, Cynthia/C-5894-2011	Czymmek, Kirk/0000-0002-5471-7395	National Science Foundation Grant EPSCoR	National Science Foundation Grant EPSCoR	This work was supported by National Science Foundation Grant EPSCoR (to H. P. B., K. J. C., and D. L. S.).	Agius SC, 1998, PHYSIOL PLANTARUM, V104, P329, DOI 10.1034/j.1399-3054.1998.1040306.x; Asemaneh T, 2006, PLANTA, V225, P193, DOI 10.1007/s00425-006-0340-y; BAKER A J M, 1989, Biorecovery, V1, P81; Baker AJM, 2000, PHYTOREMEDIATION OF CONTAMINATED SOIL AND WATER, P85; Balk J, 1999, FEBS LETT, V463, P151, DOI 10.1016/S0014-5793(99)01611-7; Balk J, 2001, PLANT CELL, V13, P1803, DOI 10.1105/tpc.13.8.1803; Berazain R, 2007, PLANT SOIL, V293, P99, DOI 10.1007/s11104-007-9227-3; Bhatia NP, 2004, FUNCT PLANT BIOL, V31, P1061, DOI 10.1071/FP03192; Bidwell SD, 2004, PLANT CELL ENVIRON, V27, P705, DOI 10.1111/j.0016-8025.2003.01170.x; Boominathan R, 2003, J BIOTECHNOL, V101, P131, DOI 10.1016/S0168-1656(02)00320-6; Boyd RS, 1998, AM J BOT, V85, P259, DOI 10.2307/2446314; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS RR, 1979, PROC R SOC SER B-BIO, V203, P387, DOI 10.1098/rspb.1979.0005; BROOKS RR, 1981, PHYSIOL PLANTARUM, V51, P167, DOI 10.1111/j.1399-3054.1981.tb02693.x; Callahan DL, 2008, PHYTOCHEMISTRY, V69, P240, DOI 10.1016/j.phytochem.2007.07.001; Chaney RL, 2007, J ENVIRON QUAL, V36, P1429, DOI 10.2134/jeq2006.0514; Chen CY, 2009, CLEAN-SOIL AIR WATER, V37, P304, DOI 10.1002/clen.200800199; de la Fuente V, 2007, PLANT BIOSYST, V141, P170, DOI 10.1080/11263500701401422; Delhaize E, 2004, P NATL ACAD SCI USA, V101, P15249, DOI 10.1073/pnas.0406258101; Douchkov D, 2005, PLANT CELL ENVIRON, V28, P365, DOI 10.1111/j.1365-3040.2005.01273.x; Ermler U, 1998, CURR OPIN STRUC BIOL, V8, P749, DOI 10.1016/S0959-440X(98)80095-X; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Freeman JL, 2004, PLANT CELL, V16, P2176, DOI 10.1105/tpc.104.023036; Gomes RA, 2006, PLANT PHYSIOL BIOCH, V44, P420, DOI 10.1016/j.plaphy.2006.06.002; Hao FS, 2006, PLANT SCI, V170, P151, DOI 10.1016/j.plantsci.2005.08.014; HOMER FA, 1991, PHYTOCHEMISTRY, V30, P2141, DOI 10.1016/0031-9422(91)83602-H; Ingle RA, 2005, BIOMETALS, V18, P627, DOI 10.1007/s10534-005-2999-0; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Kaiser J, 2003, SCIENCE, V302, P376, DOI 10.1126/science.302.5644.376; Kerkeb L, 2003, PLANT PHYSIOL, V131, P716, DOI 10.1104/pp102.010686; KERSTEN WJ, 1980, PHYTOCHEMISTRY, V19, P1963, DOI 10.1016/0031-9422(80)83013-5; Kobayashi Y, 2007, PLANT PHYSIOL, V145, P843, DOI 10.1104/pp.107.102335; Kolisek M, 2003, EMBO J, V22, P1235, DOI 10.1093/emboj/cdg122; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Kramer U, 2000, PLANT PHYSIOL, V122, P1343, DOI 10.1104/pp.122.4.1343; Kramer U, 1996, NATURE, V379, P635, DOI 10.1038/379635a0; Kumar P, 2007, J PLANT NUTR SOIL SC, V170, P796, DOI 10.1002/jpln.200625126; Kupper H, 2001, J EXP BOT, V52, P2291, DOI 10.1093/jexbot/52.365.2291; Kupper H., 2007, METAL IONS LIFE SCI, P31, DOI DOI 10.1002/9780470028131.CH2; LEE J, 1978, PHYTOCHEMISTRY, V17, P1033, DOI 10.1016/S0031-9422(00)94274-2; LEE J, 1977, PHYTOCHEMISTRY, V16, P1503, DOI 10.1016/0031-9422(77)84010-7; McNear DH, 2010, PHYTOCHEMISTRY, V71, P188, DOI 10.1016/j.phytochem.2009.10.023; Mesjasz-Przybylowicz J, 2007, PLANT SOIL, V293, P61, DOI 10.1007/s11104-007-9237-1; MOLLER IM, 1982, PHYSIOL PLANTARUM, V54, P267, DOI 10.1111/j.1399-3054.1982.tb00258.x; Montarges-Pelletier E, 2008, PHYTOCHEMISTRY, V69, P1695, DOI 10.1016/j.phytochem.2008.02.009; Morgunov I, 1998, J BIOL CHEM, V273, P29540, DOI 10.1074/jbc.273.45.29540; Murphey WH, 1969, METHOD ENZYMOL, V8, P145, DOI [10.1016/0076-6879(69)13029-3, DOI 10.1016/0076-6879(69)13029-3]; Noctor G, 2007, TRENDS PLANT SCI, V12, P125, DOI 10.1016/j.tplants.2007.01.005; Ochoa S, 1955, METHODS ENZYMOLOGY, V1; PELOSI P, 1976, AGR BIOL CHEM TOKYO, V40, P1641, DOI 10.1080/00021369.1976.10862273; Perrier N, 2004, CR GEOSCI, V336, P567, DOI 10.1016/j.crte.2003.12.014; Pierrel F, 2007, BIOMETALS, V20, P675, DOI 10.1007/s10534-006-9052-9; Pompeu GB, 2008, SCI AGR, V65, P548, DOI 10.1590/S0103-90162008000500015; Rafelski SM, 2008, NAT REV MOL CELL BIO, V9, P593, DOI 10.1038/nrm2460; Randhawa VK, 2001, CAN J MICROBIOL, V47, P987, DOI 10.1139/cjm-47-11-987; Riesen O, 2005, J PLANT NUTR, V28, P421, DOI 10.1081/PLN-200049153; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Sagner S, 1998, PHYTOCHEMISTRY, V47, P339, DOI 10.1016/S0031-9422(97)00593-1; Saito A, 2010, PLANT CELL ENVIRON, V33, P174, DOI 10.1111/j.1365-3040.2009.02068.x; Scorrano L, 1999, J BIOL CHEM, V274, P24657, DOI 10.1074/jbc.274.35.24657; Smart KE, 2007, INT J MASS SPECTROM, V260, P107, DOI 10.1016/j.ijms.2006.08.011; Tappero R, 2007, NEW PHYTOL, V175, P641, DOI 10.1111/j.1469-8137.2007.02134.x; Tesfaye M, 2001, PLANT PHYSIOL, V127, P1836, DOI 10.1104/pp.010376; Veeger C., 1969, METHODS ENZYMOLOGY, VXIII, P81, DOI [https://doi.org/10.1016/0076-6879(69)13020-7, DOI 10.1016/0076-6879(69)13020-7]; Weir IE, 2003, CYTOM PART A, V54A, P109, DOI 10.1002/cyto.a.10054; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000; Zhao JF, 2009, ANAL BIOCHEM, V384, P34, DOI 10.1016/j.ab.2008.09.019	67	22	22	2	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7351	7362		10.1074/jbc.M112.406645	http://dx.doi.org/10.1074/jbc.M112.406645			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23322782	Green Published, hybrid			2022-12-28	WOS:000316002400054
J	Yu, YM; Zhu, JH; Huang, PS; Wang, JH; Pullen, N; Springer, TA				Yu, Yamei; Zhu, Jianghai; Huang, Po-Ssu; Wang, Jia-huai; Pullen, Nick; Springer, Timothy A.			Domain 1 of Mucosal Addressin Cell Adhesion Molecule Has an I1-set Fold and a Flexible Integrin-binding Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL EXPRESSION; STRUCTURAL SPECIALIZATIONS; CRYSTAL-STRUCTURE; I-DOMAIN; MADCAM-1; RECOGNITION; IMMUNOGLOBULIN; VCAM-1; ALPHA(4)BETA(7); FRAGMENT	Mucosal addressin cell adhesion molecule (MAdCAM) binds integrin alpha(4)beta(7). Their interaction directs lymphocyte homing to mucosa-associated lymphoid tissues. The interaction between the two immunoglobulin superfamily (IgSF) domains of MAdCAM and integrin alpha(4)beta(7) is unusual in its ability to mediate either rolling adhesion or firm adhesion of lymphocytes on vascular surfaces. We determined four crystal structures of the IgSF domains of MAdCAM to test for unusual structural features that might correlate with this functional diversity. Higher resolution 1.7- and 1.4-angstrom structures of the IgSF domains of MAdCAM in a previously described crystal lattice revealed two alternative conformations of the integrin-binding loop, which were deformed by large lattice contacts. New crystal forms in the presence of two different Fabs to MAdCAM demonstrate a shift in IgSF domain topology from the I2- to I1-set, with a switch of integrin-binding loop from CC' to CD. The I1-set fold and CD loop appear biologically relevant. The different conformations seen in crystal structures suggest that the integrin-binding loop of MAdCAM is inherently flexible. This contrasts with rigidity of the corresponding loops in vascular cell adhesion molecule, intercellular adhesion molecule (ICAM)-1, ICAM-2, ICAM-3, and ICAM-5 and may reflect a specialization of MAdCAM to mediate both rolling and firm adhesion by binding to different alpha(4)beta(7) integrin conformations.	[Yu, Yamei; Zhu, Jianghai; Springer, Timothy A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02215 USA; [Yu, Yamei; Zhu, Jianghai; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; [Huang, Po-Ssu] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Wang, Jia-huai] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Wang, Jia-huai] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02215 USA; [Pullen, Nick] Pfizer Global Res & Dev, Cambridge, MA 02140 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Pfizer	Springer, TA (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, 3 Blackfan Circle, Boston, MA 02115 USA.	springer@idi.harvard.edu	Zhu, Jianghai/B-7339-2014	Huang, Possu/0000-0002-7948-2895	National Institutes of Health [HL103526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL103526.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Baerga-Ortiz A, 2000, J MOL BIOL, V296, P651, DOI 10.1006/jmbi.1999.3447; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Briskin M, 1997, AM J PATHOL, V151, P97; Briskin MJ, 1996, J IMMUNOL, V156, P719; BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0; Casasnovas JM, 1997, NATURE, V387, P312, DOI 10.1038/387312a0; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen XH, 2007, P NATL ACAD SCI USA, V104, P15358, DOI 10.1073/pnas.0707406104; CHIU HH, 1995, J IMMUNOL, V155, P5257; Dando J, 2002, ACTA CRYSTALLOGR D, V58, P233, DOI 10.1107/S0907444901020522; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Green N, 1999, CELL ADHES COMMUN, V7, P167, DOI 10.3109/15419069909010800; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; JONES EY, 1995, NATURE, V373, P539, DOI 10.1038/373539a0; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newham P, 1997, J BIOL CHEM, V272, P19429, DOI 10.1074/jbc.272.31.19429; Parikh A, 2012, INFLAMM BOWEL DIS, V18, P1470, DOI 10.1002/ibd.21896; Pullen N, 2009, BRIT J PHARMACOL, V157, P281, DOI 10.1111/j.1476-5381.2009.00137.x; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; Sun H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208900; Tan K, 1998, STRUCTURE, V6, P793, DOI 10.1016/S0969-2126(98)00080-X; Taylor P, 2001, ACTA CRYSTALLOGR D, V57, P1579, DOI 10.1107/S0907444901011209; van den Bedem H, 2005, ACTA CRYSTALLOGR D, V61, P2, DOI 10.1107/S0907444904025697; Vermeire S, 2011, GUT, V60, P1068, DOI 10.1136/gut.2010.226548; Viney JL, 1996, J IMMUNOL, V157, P2488; WANG JH, 1995, P NATL ACAD SCI USA, V92, P5714, DOI 10.1073/pnas.92.12.5714; Wang JH, 1998, IMMUNOL REV, V163, P197, DOI 10.1111/j.1600-065X.1998.tb01198.x; Yu YM, 2012, J CELL BIOL, V196, P131, DOI 10.1083/jcb.201110023; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022	46	5	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6284	6294		10.1074/jbc.M112.413153	http://dx.doi.org/10.1074/jbc.M112.413153			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23297416	Green Published, hybrid			2022-12-28	WOS:000315820700023
J	Tavecchio, M; Lisanti, S; Lam, A; Ghosh, JC; Martin, NM; O'Connell, M; Weeraratna, AT; Kossenkov, AV; Showe, LC; Altieri, DC				Tavecchio, Michele; Lisanti, Sofia; Lam, Aaron; Ghosh, Jagadish C.; Martin, Nina M.; O'Connell, Michael; Weeraratna, Ashani T.; Kossenkov, Andrew V.; Showe, Louise C.; Altieri, Dario C.			Cyclophilin D Extramitochondrial Signaling Controls Cell Cycle Progression and Chemokine-directed Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; UNFOLDED PROTEIN RESPONSE; KAPPA-B; STAT3 ACTIVATION; HEXOKINASE-II; CANCER; PATHWAY; CARDIOPROTECTION; TRANSPLANTATION; INACTIVATION	Mitochondria control bioenergetics and cell fate decisions, but how they influence nuclear gene expression is understood poorly. Here, we show that deletion or reduction in the levels of cyclophilin D (CypD, also called Ppif), a mitochondrial matrix peptidyl prolyl isomerase and apoptosis regulator, results in increased cell proliferation and enhanced cell migration and invasion. These responses are associated with extensive transcriptional changes, modulation of a chemokine/chemokine receptor gene signature, and activation of the pleiotropic inflammatory mediator, STAT3. In the absence of CypD, active STAT3 enhances cell proliferation via accelerated entry into S-phase and stimulates autocrine/paracrine cell motility through Cxcl12-Cxcr4-directed chemotaxis. Therefore, CypD directs mitochondria-to-nuclei inflammatory gene expression in normal and tumor cells. This pathway may contribute to malignant traits under conditions of CypD modulation.	[Tavecchio, Michele; Lisanti, Sofia; Lam, Aaron; Ghosh, Jagadish C.; Martin, Nina M.; Altieri, Dario C.] Wistar Inst Anat & Biol, Prostate Canc Discovery & Dev Program, Philadelphia, PA 19104 USA; [O'Connell, Michael; Weeraratna, Ashani T.] Wistar Inst Anat & Biol, Melanoma Res Ctr, Philadelphia, PA 19104 USA; [Weeraratna, Ashani T.] Wistar Inst Anat & Biol, Tumor Microenvironm & Metastasis Program, Philadelphia, PA 19104 USA; [Kossenkov, Andrew V.; Showe, Louise C.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Showe, Louise C.; Altieri, Dario C.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA	The Wistar Institute; The Wistar Institute; The Wistar Institute; The Wistar Institute; The Wistar Institute	Altieri, DC (corresponding author), Wistar Inst Anat & Biol, Ctr Canc, 3601 Spruce St, Philadelphia, PA 19104 USA.	daltieri@wistar.org	O'Connell, Michael/F-9236-2017	Martin, Nina/0000-0002-3361-7037	National Institutes of Health [CA140043, CA78810, CA118005]; Cancer Center Support Grant (CCSG) [CA010815]; NATIONAL CANCER INSTITUTE [R01CA118005, P01CA140043, R01CA078810, P30CA010815] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA140043, CA78810, and CA118005. This work was also supported by Cancer Center Support Grant (CCSG) CA010815 (to The Wistar Institute).	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernier M, 2011, J BIOL CHEM, V286, P19270, DOI 10.1074/jbc.M110.200311; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Carreira RS, 2010, AUTOPHAGY, V6, P462, DOI 10.4161/auto.6.4.11553; Chae YC, 2012, CANCER CELL, V22, P331, DOI 10.1016/j.ccr.2012.07.015; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Fujimoto K, 2010, P NATL ACAD SCI USA, V107, P10214, DOI 10.1073/pnas.0914209107; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Ghosh JC, 2010, CANCER RES, V70, P8988, DOI 10.1158/0008-5472.CAN-10-2225; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hausenloy DJ, 2012, BRIT J PHARMACOL, V165, P1235, DOI 10.1111/j.1476-5381.2011.01700.x; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Heusch G, 2011, CIRC RES, V109, P1302, DOI 10.1161/CIRCRESAHA.111.255604; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kahan BD, 2011, TRANSPL P, V43, P2853, DOI 10.1016/j.transproceed.2011.08.058; Kinnally KW, 2011, BBA-MOL CELL RES, V1813, P616, DOI 10.1016/j.bbamcr.2010.09.013; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Malouitre S, 2010, BIOCHEM J, V425, P137, DOI 10.1042/BJ20090332; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nefedova Y, 2007, CURR CANCER DRUG TAR, V7, P71, DOI 10.2174/156800907780006887; Nguyen TT, 2011, J BIOL CHEM, V286, P40184, DOI 10.1074/jbc.M111.243469; Phillips D, 2010, J BIOL CHEM, V285, P23532, DOI 10.1074/jbc.C110.152652; Rama I, 2010, NAT REV NEPHROL, V6, P511, DOI 10.1038/nrneph.2010.102; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Soriano SF, 2002, J EXP MED, V196, P311, DOI 10.1084/jem.20012041; Srinivasan V, 2010, AGING CELL, V9, P933, DOI 10.1111/j.1474-9726.2010.00622.x; Storey John D, 2003, Methods Mol Biol, V224, P149; Szczepanek K, 2012, TRENDS CELL BIOL, V22, P429, DOI 10.1016/j.tcb.2012.05.001; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; To LB, 2011, BLOOD, V118, P4530, DOI 10.1182/blood-2011-06-318220; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhou LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021680	49	37	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5553	5561		10.1074/jbc.M112.433045	http://dx.doi.org/10.1074/jbc.M112.433045			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23303179	Green Published, hybrid			2022-12-28	WOS:000315342500029
J	Wu, FY; Peacock, SO; Rao, SY; Lemmon, SK; Burnstein, KL				Wu, Fayi; Peacock, Stephanie O.; Rao, Shuyun; Lemmon, Sandra K.; Burnstein, Kerry L.			Novel Interaction between the Co-chaperone Cdc37 and Rho GTPase Exchange Factor Vav3 Promotes Androgen Receptor Activity and Prostate Cancer Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-BINDING; PHASE-II TRIAL; TRANSCRIPTIONAL ACTIVITY; MOLECULAR CHAPERONE; AR COREGULATORS; CELL-LINE; HSP90; ACTIVATION; DOMAIN; IDENTIFICATION	Elevated androgen receptor (AR) activity in castration-resistant prostate cancer may occur through increased levels of AR co-activator proteins. Vav3, a guanine nucleotide exchange factor, is up-regulated following progression to castration resistance in preclinical models and is overexpressed in a significant number of human prostate cancers. Vav3 is a novel co-activator of the AR. We sought to identify Vav3 binding partners in an effort to understand the molecular mechanisms underlying Vav3 enhancement of AR activity and to identify new therapeutic targets. The cell division cycle 37 homolog (Cdc37), a protein kinase-specific co-chaperone for Hsp90, was identified as a Vav3 interacting protein by yeast two-hybrid screening. Vav3-Cdc37 interaction was confirmed by GST pulldown and, for native proteins, by co-immunoprecipitation experiments in prostate cancer cells. Cdc37 potentiated Vav3 co-activation of AR transcriptional activity and Vav3 enhancement of AR N-terminal-C-terminal interaction, which is essential for optimal receptor transcriptional activity. Cdc37 increased prostate cancer cell proliferation selectively in Vav3-expressing cells. Cdc37 did not affect Vav3 nucleotide exchange activity, Vav3 protein levels, or subcellular localization. Disruption of Vav3-Cdc37 interaction inhibited Vav3 enhancement of AR transcriptional activity and AR N-C interaction. Diminished Vav3-Cdc37 interaction also caused decreased prostate cancer cell proliferation selectively in Vav3-expressing cells. Taken together, we identified a novel Vav3 interacting protein that enhances Vav3 co-activation of AR and prostate cancer cell proliferation. Vav3-Cdc37 interaction may provide a new therapeutic target in prostate cancer.	[Wu, Fayi; Peacock, Stephanie O.; Rao, Shuyun; Lemmon, Sandra K.; Burnstein, Kerry L.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Burnstein, KL (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	kburnstein@med.miami.edu	Rao, Shuyun/AAE-9724-2019	Lemmon, Sandra/0000-0002-8022-130X	National Institutes of Health Grant [RO1CA132200]; Department of Defense Post-doctoral Grant [W81XWH-07-1-0151]; NATIONAL CANCER INSTITUTE [R01CA132200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG038275] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Post-doctoral Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA132200 (to K. L. B.).; Supported in part by Department of Defense Post-doctoral Grant W81XWH-07-1-0151.	Abbas-Terki T, 2000, FEBS LETT, V467, P111, DOI 10.1016/S0014-5793(00)01134-0; Askew EB, 2012, MOL CELL ENDOCRINOL, V348, P403, DOI 10.1016/j.mce.2011.03.026; Banach-Petrosky W, 2007, CANCER RES, V67, P9089, DOI 10.1158/0008-5472.CAN-07-2887; Bandhakavi S, 2003, J BIOL CHEM, V278, P2829, DOI 10.1074/jbc.M206662200; Berrevoets CA, 1998, MOL ENDOCRINOL, V12, P1172, DOI 10.1210/me.12.8.1172; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Colomba A, 2008, ONCOGENE, V27, P2728, DOI 10.1038/sj.onc.1210921; Dong ZY, 2006, MOL ENDOCRINOL, V20, P2315, DOI 10.1210/me.2006-0048; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gray PJ, 2007, CANCER RES, V67, P11942, DOI 10.1158/0008-5472.CAN-07-3162; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Heath EI, 2008, CLIN CANCER RES, V14, P7940, DOI 10.1158/1078-0432.CCR-08-0221; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Lee P, 2002, J CELL BIOL, V159, P1051, DOI 10.1083/jcb.200210121; Lin KT, 2012, CANCER RES, V72, P3000, DOI 10.1158/0008-5472.CAN-11-2502; Lin KY, 2012, MOL CANCER RES, V10, P750, DOI 10.1158/1541-7786.MCR-11-0598-T; Liu Y, 2008, CANCER RES, V68, P6396, DOI 10.1158/0008-5472.CAN-08-0645; Lyons LS, 2008, MOL ENDOCRINOL, V22, P597, DOI 10.1210/me.2007-0158; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; Lyu J, 2009, J BIOL CHEM, V284, P12940, DOI 10.1074/jbc.M900207200; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Malanchuk OM, 2005, EXP ONCOL, V27, P186; Markus SM, 2002, MOL BIOL CELL, V13, P670, DOI 10.1091/mbc.01-10-0513; Marques RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013500; Miyata Y, 2005, MOL CELL BIOCHEM, V274, P171, DOI 10.1007/s11010-005-2949-8; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Oh WK, 2011, UROLOGY, V78, P626, DOI 10.1016/j.urology.2011.04.041; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Rao J, 2001, J BIOL CHEM, V276, P5814, DOI 10.1074/jbc.M007385200; Rao S, 2012, ONCOGENE, V31, P716, DOI 10.1038/onc.2011.273; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Rosenblatt AE, 2011, ENDOCR-RELAT CANCER, V18, P207, DOI 10.1677/ERC-10-0049; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Schmidt LJ, 2009, PROSTATE, V69, P1730, DOI 10.1002/pros.21022; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schutz AR, 1997, J CELL BIOL, V136, P969, DOI 10.1083/jcb.136.5.969; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stepanova L, 2000, ONCOGENE, V19, P2186, DOI 10.1038/sj.onc.1203561; Tatebe H, 2003, MOL CELL BIOL, V23, P5132, DOI 10.1128/MCB.23.15.5132-5142.2003; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang XT, 2002, J BIOL CHEM, V277, P24361, DOI 10.1074/jbc.M202198200; Yabana N, 2002, ONCOGENE, V21, P7720, DOI 10.1038/sj.onc.1205927; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zeng LY, 2000, MOL CELL BIOL, V20, P9212, DOI 10.1128/MCB.20.24.9212-9224.2000; Zhuang SH, 1998, ENDOCRINOLOGY, V139, P1197, DOI 10.1210/en.139.3.1197; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	59	15	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5463	5474		10.1074/jbc.M112.390963	http://dx.doi.org/10.1074/jbc.M112.390963			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23281476	hybrid, Green Published			2022-12-28	WOS:000315342500021
J	Frasch, SC; Fernandez-Boyanapalli, RF; Berry, KAZ; Murphy, RC; Leslie, CC; Nick, JA; Henson, PM; Bratton, DL				Frasch, S. Courtney; Fernandez-Boyanapalli, Ruby F.; Berry, Karin A. Zemski; Murphy, Robert C.; Leslie, Christina C.; Nick, Jerry A.; Henson, Peter M.; Bratton, Donna L.			Neutrophils Regulate Tissue Neutrophilia in Inflammation via the Oxidant-modified Lipid Lysophosphatidylserine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; APOPTOTIC CELL CLEARANCE; NADPH OXIDASE; RESOLUTION; MACROPHAGES; RECEPTOR; PHAGOCYTOSIS; ACTIVATION; RESPONSES; GAMMA	Resolution of neutrophilia characteristic of acute inflammation requires cessation of neutrophil recruitment and removal of tissue neutrophils. Based on in vitro studies, a role in these events was hypothesized for oxidant-generated lysophosphatidylserine (lyso-PS) on recruited neutrophils signaling via the G2A receptor on macrophages. Peritoneal exudate neutrophils harvested from wild type (WT) mice had 5-fold more lyso-PS (lyso-PShigh) than those of gp91(phox-/-) (lyso-PSlow) mice. Ex vivo engulfment of lyso-PShigh neutrophils (95% viable) by WT peritoneal macrophages was quantitatively similar to UV-irradiated apoptotic blood neutrophils, although the signaling pathway for the former was uniquely dependent on macrophage G2A. In contrast, lyso-PSlow neutrophils were poorly engulfed unless presented with exogenous lyso-PS. Enhanced clearance of lyso-PShigh neutrophils was also seen in vivo following their adoptive transfer into inflamed peritonea of WT but not G2A(-/-) mice, further supporting a requirement for signaling via G2A. To investigate downstream effects of lyso-PS/G2A signaling, antibody blockade of G2A in WT mice reduced macrophage CD206 expression and efferocytosis during peritonitis. Conversely, adoptive transfer of lyso-PShigh neutrophils early in inflammation in gp91(phox-/-) mice led to accelerated development of efferocytic(high) and CD206(high) macrophages. This macrophage reprogramming was associated with suppressed production of pro-inflammatory mediators and reduced neutrophilia. These effects were not seen if G2A was blocked or lyso-PSlow neutrophils were transferred. Taken together, the results demonstrate that oxidant-generated lyso-PS made by viable tissue neutrophils is an endogenous anti-inflammatory mediator working in vivo to orchestrate the "early" and rapid clearance of recruited neutrophils as well as the reprogramming of "resolving" macrophages.	[Frasch, S. Courtney; Fernandez-Boyanapalli, Ruby F.; Leslie, Christina C.; Henson, Peter M.; Bratton, Donna L.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Nick, Jerry A.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Leslie, Christina C.; Henson, Peter M.; Bratton, Donna L.] Natl Jewish Hlth, Cell Biol Program, Denver, CO 80206 USA; [Berry, Karin A. Zemski; Murphy, Robert C.] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA	National Jewish Health; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Frasch, SC (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	fraschc@njhealth.org	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	National Institutes of Health [AI058228, HL34303, HL81151]; Chronic Granulomatous Disorder Society; Catherine Kramer Foundation in Pediatric Medicine; Eugene F. and Easton M. Crawford Charitable Lead Unitrust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081151, P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058228, R56AI058228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chronic Granulomatous Disorder Society; Catherine Kramer Foundation in Pediatric Medicine; Eugene F. and Easton M. Crawford Charitable Lead Unitrust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058228 (to D. L. B.), HL34303 (to D. L. B., C. C. L., P. M. H., and R. C. M.), and HL81151 (to P. M. H.). This work was also supported by the Chronic Granulomatous Disorder Society (to D. L. B.), the Catherine Kramer Foundation in Pediatric Medicine (to D. L. B.), and the Eugene F. and Easton M. Crawford Charitable Lead Unitrust (to R. F. F.-B.).	Bolick DT, 2007, CIRC RES, V100, P572, DOI 10.1161/01.RES.0000258877.57836.d2; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; Brown JR, 2003, J LEUKOCYTE BIOL, V73, P591, DOI 10.1189/jlb.1202599; Bylund J, 2007, EUR J IMMUNOL, V37, P1087, DOI 10.1002/eji.200636651; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Fernandez-Boyanapalli R, 2010, BLOOD, V116, P4512, DOI 10.1182/blood-2010-02-272005; Fernandez-Boyanapalli RF, 2009, BLOOD, V113, P2047, DOI 10.1182/blood-2008-05-160564; Frasch SC, 2007, J IMMUNOL, V178, P6540, DOI 10.4049/jimmunol.178.10.6540; Frasch SC, 2012, PROG LIPID RES, V51, P199, DOI 10.1016/j.plipres.2012.03.001; Frasch SC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181800; Frasch SC, 2008, J BIOL CHEM, V283, P33736, DOI 10.1074/jbc.M807047200; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; GALLIN JI, 1983, INFLAMMATION, V7, P227, DOI 10.1007/BF00917259; HASLETT C, 1985, AM J PATHOL, V119, P101; Henson PM, 2009, PHAGOCYTE-PATHOGEN INTERACTIONS: MACROPHAGES AND THE HOST RESPONSE TO INFECTION, P341; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; Kabarowski JH, 2009, PROSTAG OTH LIPID M, V89, P73, DOI 10.1016/j.prostaglandins.2009.04.007; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; Lopes F, 2011, ARTHRITIS RHEUM-US, V63, P2651, DOI 10.1002/art.30448; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McIlroy D, 2000, GENE DEV, V14, P549; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Mukaro VRS, 2011, CURR DRUG TARGETS, V12, P460; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; NIBBERING PH, 1990, J IMMUNOL METHODS, V129, P143, DOI 10.1016/0022-1759(90)90432-U; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Parks BW, 2005, J LIPID RES, V46, P1405, DOI 10.1194/jlr.M500085-JLR200; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rajakariar R, 2009, J IMMUNOL, V182, P3262, DOI 10.4049/jimmunol.0801739; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Sanford AN, 2006, RHEUMATOLOGY, V45, P178, DOI 10.1093/rheumatology/kei135; Sanmun D, 2009, AM J PHYSIOL-CELL PH, V297, pC621, DOI 10.1152/ajpcell.00651.2008; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Silva MT, 2011, J LEUKOCYTE BIOL, V89, P675, DOI 10.1189/jlb.0910536; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Vandivier RW, 2009, AM J PHYSIOL-LUNG C, V297, pL677, DOI 10.1152/ajplung.00030.2009; Voltan S, 2008, GASTROENTEROLOGY, V135, P1216, DOI 10.1053/j.gastro.2008.07.007; Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Zhang B, 2003, J BIOL CHEM, V278, P28443, DOI 10.1074/jbc.M210727200; Zhang Y, 2010, J INTERF CYTOK RES, V30, P113, DOI 10.1089/jir.2010.0004	54	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4583	4593		10.1074/jbc.M112.438507	http://dx.doi.org/10.1074/jbc.M112.438507			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23293064	hybrid, Green Published			2022-12-28	WOS:000315340400008
J	Tanimura, N; Saito, M; Ebisuya, M; Nishida, E; Ishikawa, F				Tanimura, Nobuyuki; Saito, Motoki; Ebisuya, Miki; Nishida, Eisuke; Ishikawa, Fuyuki			Stemness-related Factor Sall4 Interacts with Transcription Factors Oct-3/4 and Sox2 and Occupies Oct-Sox Elements in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; INTERACTION NETWORK; DROSOPHILA EMBRYO; GENE-EXPRESSION; FINGER PROTEIN; HOMEOTIC GENE; POU-DOMAIN; PLURIPOTENCY; COMPLEX; DIFFERENTIATION	A small number of transcription factors, including Oct-3/4 and Sox2, constitute the transcriptional network that maintains pluripotency in embryonic stem (ES) cells. Previous reports suggested that some of these factors form a complex that binds the Oct-Sox element, a composite sequence consisting of closely juxtaposed Oct-3/4 binding and Sox2 binding sites. However, little is known regarding the components of the complex. In this study we show that Sall4, a member of the Spalt-like family of proteins, directly interacts with Sox2 and Oct-3/4. Sall4 in combination with Sox2 or Oct-3/4 simultaneously occupies the Oct-Sox elements in mouse ES cells. Overexpression of Sall4 in ES cells increased reporter activities in a luciferase assay when the Pou5f1- or Nanog-derived Oct-Sox element was included in the reporter. Microarray analyses revealed that Sall4 and Sox2 bound to the same genes in ES cells significantly more frequently than expected from random coincidence. These factors appeared to bind the promoter regions of a subset of the Sall4 and Sox2 double-positive genes in precisely similar distribution patterns along the promoter regions, suggesting that Sall4 and Sox2 associate with such Sall4/Sox2-overlapping genes as a complex. Importantly, gene ontology analyses indicated that the Sall4/Sox2-overlapping gene set is enriched for genes involved in maintaining pluripotency. Sall4/Sox2/Oct-3/4 triple-positive genes identified by referring to a previous study identifying Oct3/4-bound genes in ES cells were further enriched for pluripotency genes than Sall4/Sox2 double-positive genes. These results demonstrate that Sall4 contributes to the transcriptional network operating in pluripotent cells together with Oct-3/4 and Sox2.	[Tanimura, Nobuyuki; Saito, Motoki; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Kyoto 6068501, Japan; [Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068501, Japan; [Ebisuya, Miki] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Kyoto University	Ishikawa, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fishikaw@lif.kyoto-u.ac.jp	Ishikawa, Fuyuki/AAU-4056-2021; Ebisuya, Miki/N-5388-2015	Ishikawa, Fuyuki/0000-0002-5580-2305; Ebisuya, Miki/0000-0003-1854-7496	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Cancer Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to F. I.).	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V51, P9, DOI 10.1007/s12013-008-9007-6; Chakravarthy H, 2008, J CELL PHYSIOL, V216, P651, DOI 10.1002/jcp.21440; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Iwafuchi-Doi M, 2011, DEV BIOL, V352, P354, DOI 10.1016/j.ydbio.2010.12.027; JURGENS G, 1988, EMBO J, V7, P189, DOI 10.1002/j.1460-2075.1988.tb02799.x; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Scaffidi P, 2001, J BIOL CHEM, V276, P47296, DOI 10.1074/jbc.M107619200; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Warren M, 2007, GENESIS, V45, P51, DOI 10.1002/dvg.20264; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	39	29	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5027	5038		10.1074/jbc.M112.411173	http://dx.doi.org/10.1074/jbc.M112.411173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23269686	hybrid, Green Published			2022-12-28	WOS:000315340400049
J	Teh, PG; Chen, MJ; Engel, JL; Worby, CA; Manning, G; Dixon, JE; Zhang, J				Teh, Phildrich G.; Chen, Mark J.; Engel, James L.; Worby, Carolyn A.; Manning, Gerard; Dixon, Jack E.; Zhang, Ji			Identification of a Mammalian-type Phosphatidylglycerophosphate Phosphatase in the Eubacterium Rhodopirellula baltica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE PROTEIN-SEQUENCE; MITOCHONDRIAL PHOSPHATASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; LIPID 2ND-MESSENGER; WEB SERVER; PEL1 GENE; CARDIOLIPIN; DEPHOSPHORYLATES; BACTERIAL	Cardiolipin is a glycerophospholipid found predominantly in the mitochondrial membranes of eukaryotes and in bacterial membranes. Cardiolipin interacts with protein complexes and plays pivotal roles in cellular energy metabolism, membrane dynamics, and stress responses. We recently identified the mitochondrial phosphatase, PTPMT1, as the enzyme that converts phosphatidylglycerolphosphate (PGP) to phosphatidylglycerol, a critical step in the de novo biosynthesis of cardiolipin. Upon examination of PTPMT1 evolutionary distribution, we found a PTPMT1-like phosphatase in the bacterium Rhodopirellula baltica. The purified recombinant enzyme dephosphorylated PGP in vitro. Moreover, its expression restored cardiolipin deficiency and reversed growth impairment in a Saccharomyces cerevisiae mutant lacking the yeast PGP phosphatase, suggesting that it is a bona fide PTPMT1 ortholog. When ectopically expressed, this bacterial PGP phosphatase was localized in the mitochondria of yeast and mammalian cells. Together, our results demonstrate the conservation of function between bacterial and mammalian PTPMT1 orthologs.	[Teh, Phildrich G.; Dixon, Jack E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Engel, James L.; Worby, Carolyn A.; Dixon, Jack E.; Zhang, Ji] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Chen, Mark J.; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA; [Chen, Mark J.; Manning, Gerard] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Dixon, Jack E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; Roche Holding; Genentech; Howard Hughes Medical Institute	Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	jedixon@ucsd.edu; jz3@ucsd.edu	Manning, Gerard/C-8308-2009; Chen, Mark/O-3937-2014	Chen, Mark/0000-0003-1169-563X; Manning, Gerard/0000-0002-5087-9151	National Institutes of Health [DK18024, DK18849, HG004164]; Barth Syndrome Foundation; American Heart Association [12SDG12070058]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; American Heart Association(American Heart Association)	This work was supported by Grants DK18024 and DK18849 (to J. E. D.), HG004164 (to G. M.) from the National Institutes of Health, the Barth Syndrome Foundation research grant and the American Heart Association Scientist Development Grant # 12SDG12070058 (to J. Z.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brachmann CB, 1998, YEAST, V14, P115; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; CHANG YY, 1967, J LIPID RES, V8, P456; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Corcelli A, 2009, BBA-BIOMEMBRANES, V1788, P2101, DOI 10.1016/j.bbamem.2009.05.010; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Devos DP, 2010, SCIENCE, V330, P1187, DOI 10.1126/science.1196720; DOWHAN W, 1992, METHOD ENZYMOL, V209, P313; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; FUNK CR, 1992, J BACTERIOL, V174, P205, DOI 10.1128/jb.174.1.205-213.1992; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Habib SJ, 2007, METHOD CELL BIOL, V80, P761, DOI 10.1016/S0091-679X(06)80035-X; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; ICHO T, 1983, J BACTERIOL, V153, P722, DOI 10.1128/JB.153.2.722-730.1983; JANITOR M, 1993, CURR GENET, V24, P307, DOI 10.1007/BF00336781; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; KELLY BL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P144, DOI 10.1016/0005-2760(90)90181-V; Lindsay MR, 2001, ARCH MICROBIOL, V175, P413, DOI 10.1007/s002030100280; Lu YH, 2011, J BIOL CHEM, V286, P5506, DOI 10.1074/jbc.M110.199265; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Pagliarini DJ, 2004, J BIOL CHEM, V279, P38590, DOI 10.1074/jbc.M404959200; Papatheodorou P, 2006, CELL MICROBIOL, V8, P677, DOI 10.1111/j.1462-5822.2005.00660.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Winkelmann N, 2009, J MICROBIOL METH, V77, P276, DOI 10.1016/j.mimet.2009.03.002; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; Xiao JY, 2011, P NATL ACAD SCI USA, V108, P11860, DOI 10.1073/pnas.1109290108; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007	51	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5176	5185		10.1074/jbc.M112.413617	http://dx.doi.org/10.1074/jbc.M112.413617			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23293031	Green Published, hybrid			2022-12-28	WOS:000315340400065
J	Wan, M; Liang, JC; Xiong, YY; Shi, FT; Zhang, Y; Lu, WS; He, QY; Yang, D; Chen, R; Liu, D; Barton, M; Zhou, SY				Wan, Ma; Liang, Jiancong; Xiong, Yuanyan; Shi, Fengtao; Zhang, Yi; Lu, Weisi; He, Quanyuan; Yang, Dong; Chen, Rui; Liu, Dan; Barton, Michelle; Zhou Songyang			The Trithorax Group Protein Ash2l Is Essential for Pluripotency and Maintaining Open Chromatin in Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; H3K4 METHYLATION; TRANSCRIPTIONAL REPRESSION; HISTONE-H3 LYSINE-4; CRYSTAL-STRUCTURE; RECRUITMENT; REVEALS; GENES; DNA; DIFFERENTIATION	Embryonic stem (ES) cells exhibit general characteristics of open chromatin, a state that may be necessary for ES cells to efficiently self-renew while remaining poised for differentiation. Histone H3K4 and H3K9 trimethylation associate as a general rule, with open and silenced chromatin, respectively, for ES cell pluripotency maintenance. However, how histone modifications are regulated to maintain open chromatin in ES cells remains largely unknown. Here, we demonstrate that trithorax protein Ash2l, homologue of the Drosophila Ash2 (absent, small, homeotic-2) protein, is a key regulator of open chromatin in ES cells. Consistent with Ash2l being a core subunit of mixed lineage leukemia methyltransferase complex, RNAiknockdownofAsh2lwassufficienttoreduceH3K4 methylation levels and drive ES cells to a silenced chromatin state with high H3K9 trimethylation. Genome-wide ChIP-seq analysis indicated that Ash2l is recruited to target loci through two distinct modes and enriched at a family of genes implicated in open chromatin regulation, including chromatin remodeler Cdh7, transcription factor c-Myc, and H3K9 demethylase Kdm4c. Our results underscore the importance of Ash2l in open chromatin regulation and provide insight into how the open chromatin landscape is maintained in ES cells.	[Xiong, Yuanyan; Lu, Weisi; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Xiong, Yuanyan; Lu, Weisi; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Wan, Ma; Liang, Jiancong; Shi, Fengtao; Zhang, Yi; He, Quanyuan; Yang, Dong; Liu, Dan; Zhou Songyang] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Barton, Michelle; Zhou Songyang] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Barton, Michelle] Univ Texas MD Anderson Canc Ctr, Univ Texas Houston, Grad Sch Biomed Sci,Dept Biochem & Mol Biol, Ctr Stem Cell & Dev Biol,Grad Program Genes & Dev, Houston, TX 77030 USA	Sun Yat Sen University; Sun Yat Sen University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Zhou, SY (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	songyang@bcm.edu	Liang, Jiancong/AAC-1321-2022; Lu, Weisi/Q-2357-2015	Liang, Jiancong/0000-0002-7215-4346; Lu, Weisi/0000-0001-6039-6009; Barton, Michelle/0000-0002-4042-1374	National Basic Research Program (973 Program) [2010CB945400, 2012CB911201]; National Natural Science Foundation of China [NSFC 91019020]; NIGMS, National Institutes of Health [GM081627]; NCI, National Institutes of Health [CA133249, GM095599]; Welch Foundation [Q-1673]; Leukemia and Lymphoma Society; Dan L. Duncan Cancer Center [P30CA125123]; Administrative and Genome-wide RNAi Screens Cores [IDDRC P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA133249, P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095599, P01GM081627] Funding Source: NIH RePORTER	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Welch Foundation(The Welch Foundation); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Dan L. Duncan Cancer Center; Administrative and Genome-wide RNAi Screens Cores; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Basic Research Program (973 Program 2010CB945400 and 2012CB911201); National Natural Science Foundation of China (NSFC 91019020); NIGMS, National Institutes of Health (GM081627), NCI, National Institutes of Health (CA133249 and GM095599); the Welch Foundation (Q-1673), and the Leukemia and Lymphoma Society. This work was also supported by the Dan L. Duncan Cancer Center (P30CA125123) and the Administrative and Genome-wide RNAi Screens Cores (IDDRC P30HD024064).	Ahmed K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010531; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Avdic V, 2011, STRUCTURE, V19, P101, DOI 10.1016/j.str.2010.09.022; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen Y, 2012, CELL RES, V22, P598, DOI 10.1038/cr.2012.9; Chen Y, 2011, EMBO REP, V12, P797, DOI 10.1038/embor.2011.101; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Koh FM, 2010, CURR OPIN GENET DEV, V20, P492, DOI 10.1016/j.gde.2010.06.002; Krejci J, 2009, J CELL PHYSIOL, V219, P677, DOI 10.1002/jcp.21714; Kubicek S, 2006, E SCHERING RES FDN W, V57, P1; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Loh YH, 2011, ANNU REV GENOM HUM G, V12, P165, DOI 10.1146/annurev-genom-082410-101506; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Malik S, 2010, FEBS J, V277, P1805, DOI 10.1111/j.1742-4658.2010.07607.x; Mattout A, 2010, CURR OPIN CELL BIOL, V22, P334, DOI 10.1016/j.ceb.2010.02.001; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park SH, 2004, ULTRASTRUCT PATHOL, V28, P229, DOI 10.1080/01913120490515595; Ram EVSR, 2009, GENE DEV, V23, P2793, DOI 10.1101/gad.1881609; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Sarvan S, 2011, NAT STRUCT MOL BIOL, V18, P857, DOI 10.1038/nsmb.2093; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan CC, 2008, P NATL ACAD SCI USA, V105, P7472, DOI 10.1073/pnas.0711896105; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wu H, 2006, PEDIATR RES, V59, p21R, DOI 10.1203/01.pdr.0000203565.76028.2a; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yang D, 2011, CELL RES, V21, P1013, DOI 10.1038/cr.2011.39; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	65	45	47	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5039	5048		10.1074/jbc.M112.424515	http://dx.doi.org/10.1074/jbc.M112.424515			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23239880	Green Published, hybrid			2022-12-28	WOS:000315340400050
J	Chambers, JW; Pachori, A; Howard, S; Iqbal, S; LoGrasso, PV				Chambers, Jeremy W.; Pachori, Alok; Howard, Shannon; Iqbal, Sarah; LoGrasso, Philip V.			Inhibition of JNK Mitochondrial Localization and Signaling Is Protective against Ischemia/Reperfusion Injury in Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; PYRUVATE-DEHYDROGENASE ACTIVITY; ACTIVATION; APOPTOSIS; PATHWAY; PROTEIN; DEATH; IDENTIFICATION; BIOENERGETICS; REPERFUSION	To build upon recent findings that mitochondrial JNK signaling is inhibited by selectively blocking the interaction between JNK and Sab, we utilized a cell-permeable peptide to demonstrate that ischemia/reperfusion (I/R) injury could be protected in vivo and that JNK mitochondrial signaling was the mechanism by which reactive oxygen species (ROS) generation, mitochondrial dysfunction, and cardiomyocyte cell death occur. We also demonstrated that 5 mg/kg SR-3306 (a selective JNK inhibitor) was able to protect against I/R injury, reducing infarct volume by 34% (p < 0.05) while also decreasing I/R-induced increases in the activity of creatine phosphokinase and creatine kinase-MB. TUNEL staining showed that the percent TUNEL positive nuclei in rat hearts increased 10-fold after I/R injury and that this was reduced 4-fold (p < 0.01) by SR-3306. These data suggest that blocking JNK mitochondrial translocation or JNK inhibition prevents ROS increases and mitochondrial dysfunction and may be an effective treatment for I/R-induced cardiomyocyte death.	Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	LoGrasso, PV (corresponding author), 130 Scripps Way,A2A, Jupiter, FL 33458 USA.	lograsso@scripps.edu		Chambers, Jeremy/0000-0002-6143-3091	National Institutes of Health [NS057153]; Saul and Theresa Esman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saul and Theresa Esman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS057153 (to P. V. L.). This work was also supported by the Saul and Theresa Esman Foundation. Philip LoGrasso serves as a consultant for OPKO Health.	Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Chambers JW, 2011, ACS CHEM BIOL, V6, P808, DOI 10.1021/cb200062a; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chambers JW, 2011, ACS CHEM NEUROSCI, V2, P198, DOI 10.1021/cn100109k; Chen T, 2009, BIOCHEM J, V420, P283, DOI 10.1042/BJ20081899; De SK, 2010, BIOORGAN MED CHEM, V18, P590, DOI 10.1016/j.bmc.2009.12.013; De SK, 2009, J MED CHEM, V52, P1943, DOI 10.1021/jm801503n; De SK, 2009, BIOORGAN MED CHEM, V17, P2712, DOI 10.1016/j.bmc.2009.02.046; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Dougherty CJ, 2002, BIOCHEM J, V362, P561, DOI 10.1042/0264-6021:3620561; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kamenecka T, 2010, J MED CHEM, V53, P419, DOI 10.1021/jm901351f; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; MOHIT AA, 1995, NEURON, V14, P67, DOI 10.1016/0896-6273(95)90241-4; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4; SCHNAITMAN C, 1967, J CELL BIOL, V32, P719, DOI 10.1083/jcb.32.3.719; Stebbins JL, 2008, P NATL ACAD SCI USA, V105, P16809, DOI 10.1073/pnas.0805677105; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Wiltshire C, 2002, BIOCHEM J, V367, P577, DOI 10.1042/BJ20020553; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Zhao Y, 2009, MOL CELL NEUROSCI, V41, P186, DOI 10.1016/j.mcn.2009.02.012; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x; Zhou QQ, 2009, FEBS LETT, V583, P1132, DOI 10.1016/j.febslet.2009.02.043	31	60	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4000	4011		10.1074/jbc.M112.406777	http://dx.doi.org/10.1074/jbc.M112.406777			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258542	Green Published, hybrid			2022-12-28	WOS:000314845000029
J	Del Re, DP; Yang, YF; Nakano, N; Cho, J; Zhai, PY; Yamamoto, T; Zhang, NL; Yabuta, N; Nojima, H; Pan, DJ; Sadoshima, J				Del Re, Dominic P.; Yang, Yanfei; Nakano, Noritsugu; Cho, Jaeyeaon; Zhai, Peiyong; Yamamoto, Takanobu; Zhang, Nailing; Yabuta, Norikazu; Nojima, Hiroshi; Pan, Duojia; Sadoshima, Junichi			Yes-associated Protein Isoform 1 (Yap1) Promotes Cardiomyocyte Survival and Growth to Protect against Myocardial Ischemic Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; HIPPO PATHWAY; MYOCYTE APOPTOSIS; HEART-FAILURE; PROLIFERATION; MST1; REGULATOR; HYPERTROPHY; LATS2	Yap1 is an important regulator of cardiomyocyte proliferation and embryonic heart development, yet the function of endogenous Yap1 in the adult heart remains unknown. We studied the role of Yap1 in maintaining basal cardiac function and in modulating injury after chronic myocardial infarction (MI). Cardiomyocyte-specific homozygous inactivation of Yap1 in the postnatal heart (Yap(F/F)Cre) elicited increased myocyte apoptosis and fibrosis, dilated cardiomyopathy, and premature death. Heterozygous deletion (Yap(+/F)Cre) did not cause an overt cardiac phenotype compared with Yap(F/F) control mice at base line. In response to stress (MI), nuclear Yap1 was found selectively in the border zone and not in the remote area of the heart. After chronic MI (28 days), Yap(+/F)Cre mice had significantly increased myocyte apoptosis and fibrosis, with attenuated compensatory cardiomyocyte hypertrophy, and further impaired function versus Yap(+/F) control mice. Studies in isolated cardiomyocytes demonstrated that Yap1 expression is sufficient to promote increased cell size and hypertrophic gene expression and protected cardiomyocytes against H2O2-induced cell death, whereas Yap1 depletion attenuated phenylephrine-induced hypertrophy and augmented apoptosis. Finally, we observed a significant decrease in cardiomyocyte proliferation in Yap(+/F)Cre hearts compared with Yap(+/F) controls after MI and demonstrated that Yap1 is sufficient to promote cardiomyocyte proliferation in isolated cardiomyocytes. Our findings suggest that Yap1 is critical for basal heart homeostasis and that Yap1 deficiency exacerbates injury in response to chronic MI.	[Del Re, Dominic P.; Yang, Yanfei; Nakano, Noritsugu; Cho, Jaeyeaon; Zhai, Peiyong; Yamamoto, Takanobu; Sadoshima, Junichi] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Newark, NJ 07103 USA; [Del Re, Dominic P.; Yang, Yanfei; Nakano, Noritsugu; Cho, Jaeyeaon; Zhai, Peiyong; Yamamoto, Takanobu; Sadoshima, Junichi] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Zhang, Nailing; Pan, Duojia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21218 USA; [Zhang, Nailing; Pan, Duojia] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21218 USA; [Yabuta, Norikazu; Nojima, Hiroshi] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Yabuta, Norikazu; Nojima, Hiroshi] Osaka Univ, Dept Mol Genet, Suita, Osaka 5650871, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Osaka University; Osaka University	Sadoshima, J (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, 185 S Orange Ave,MSB G-609, Newark, NJ 07103 USA.	sadoshju@umdnj.edu	yang, yanfei/GZK-2283-2022	Del Re, Dominic/0000-0002-5504-9114; Sadoshima, Junichi/0000-0003-3724-4132	National Institutes of Health [HL59139, HL67724, HL69020, HL91469, AG27211]; Fondation Leducq Transatlantic Network of Excellence; American Heart Association [11SDG7240067, 0930179N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059139, P01HL069020, R01HL067724, R01HL112330, R01HL102738, R01HL091469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027211, R21AG042678] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23370086] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	work was supported, in whole or in part, by National Institutes of Health Grants HL59139, HL67724, HL69020, HL91469, and AG27211 (United States Public Health Service). This work was also supported by the Fondation Leducq Transatlantic Network of Excellence (to J. S.).; Supported by American Heart Association Scientist Development Grants 11SDG7240067 and 0930179N.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; CONRAD CH, 1995, CIRCULATION, V91, P161, DOI 10.1161/01.CIR.91.1.161; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mani K, 2003, J AM COLL CARDIOL, V41, P761, DOI 10.1016/S0735-1097(02)02958-3; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Sciarretta S, 2012, CIRCULATION, V125, P1134, DOI 10.1161/CIRCULATIONAHA.111.078212; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Velagaleti RS, 2008, CIRCULATION, V118, P2057, DOI 10.1161/CIRCULATIONAHA.108.784215; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	30	167	171	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3977	3988		10.1074/jbc.M112.436311	http://dx.doi.org/10.1074/jbc.M112.436311			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23275380	hybrid, Green Published			2022-12-28	WOS:000314845000027
J	Mollan, TL; Banerjee, S; Wu, G; Siburt, CJP; Tsai, AL; Olson, JS; Weiss, MJ; Crumbliss, AL; Alayash, AI				Mollan, Todd L.; Banerjee, Sambuddha; Wu, Gang; Siburt, Claire J. Parker; Tsai, Ah-Lim; Olson, John S.; Weiss, Mitchell J.; Crumbliss, Alvin L.; Alayash, Abdu I.			alpha-Hemoglobin Stabilizing Protein (AHSP) Markedly Decreases the Redox Potential and Reactivity of alpha-Subunits of Human HbA with Hydrogen Peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-THALASSEMIA; IN-VIVO; MOLECULAR-MECHANISM; HUMAN OXYHEMOGLOBIN; GLOBIN BINDING; GUINEA-PIGS; CHAINS; OXIDATION; HEME; MYOGLOBIN	alpha-Hemoglobin stabilizing protein (AHSP) is a molecular chaperone that binds monomeric alpha-subunits of human hemoglobin A (HbA) and modulates heme iron oxidation and subunit folding states. Although AHSP center dot alpha Hb complexes autoxidize more rapidly than HbA, the redox mechanisms appear to be similar. Both metHbA and isolated met-beta-subunits undergo further oxidation in the presence of hydrogen peroxide (H2O2) to form ferryl heme species. Surprisingly, much lower levels of H2O2-induced ferryl heme are produced by free met-alpha-subunits as compared with met-beta-subunits, and no ferryl heme is detected in H2O2-treated AHSP center dot met-alpha-complex at pH values from 5.0 to 9.0 at 23 degrees C. Ferryl heme species were similarly not detected in AHSP center dot met-alpha Pro-30 mutants known to exhibit different rates of autoxidation and hemin loss. EPR data suggest that protein-based radicals associated with the ferryl oxidation state exist within HbA alpha- and beta-subunits. In contrast, treatment of free alpha-subunits with H2O2 yields much smaller radical signals, and no radicals are detected when H2O2 is added to AHSP center dot alpha-complexes. AHSP binding also dramatically reduces the redox potential of alpha-subunits, from +40 to -78 mV in 1 M glycine buffer, pH 6.0, at 8 degrees C, demonstrating independently that AHSP has a much higher affinity for Fe(III) versus Fe(II) alpha-subunits. Hexacoordination in the AHSP center dot met-alpha complex markedly decreases the rate of the initial H2O2 reaction with iron and thus provides alpha-subunits protection against damaging oxidative reactions.	[Mollan, Todd L.; Alayash, Abdu I.] US FDA, Lab Biochem & Vasc Biol, Div Hematol, Ctr Biol Evaluat & Res, Bethesda, MD 20852 USA; [Banerjee, Sambuddha; Siburt, Claire J. Parker; Crumbliss, Alvin L.] Duke Univ, Dept Chem, Durham, NC 27708 USA; [Wu, Gang; Tsai, Ah-Lim] Univ Texas Houston, Sch Med, Dept Internal Med, Div Hematol, Houston, TX 77030 USA; [Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Weiss, Mitchell J.] Univ Penn, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA	US Food & Drug Administration (FDA); Duke University; University of Texas System; University of Texas Health Science Center Houston; Rice University; University of Pennsylvania	Alayash, AI (corresponding author), US FDA, CBER, NIH, 8800 Rockville Pike,Bldg 29,Rm 112, Bethesda, MD 20852 USA.	abdu.alayash@fda.hhs.gov	Weiss, Mitchell J/W-9814-2018	Weiss, Mitchell J/0000-0003-2460-3036; Olson, John/0000-0002-0760-5403; , Sambuddha/0000-0002-4810-9561	National Institutes of Health [HL110900, HL095821, HL47020, GM35649, DK61692, HL087427, GM008362]; Welch Grant [C-0612]; National Science Foundation [CHE 0809466]; United States Food and Drug Administration [MODSCI 2011]; Duke University; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087427, P01HL110900, R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061692, R01DK061692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, T32GM008362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Grant; National Science Foundation(National Science Foundation (NSF)); United States Food and Drug Administration; Duke University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL110900 (to A. I. A.), HL095821 (to A.-L. T.), HL47020 (to J. S. O.), HL110900 (to J. S. O.), GM35649 (to J. S. O.), DK61692 (to M. J. W.), HL087427 (to M. J. W.), and GM008362 (to T. L. M.), Welch Grant C-0612 (to J. S. O.), National Science Foundation Grant CHE 0809466 (to A. L. C.), and the United States Food and Drug Administration (MODSCI 2011) (to A. I. A.).; Supported by a grant from Duke University.	ABRAHAM EC, 1975, J BIOL CHEM, V250, P3929; Baek JH, 2012, J CLIN INVEST, V122, P1444, DOI 10.1172/JCI59770; BANERJEE R, 1969, BIOCHEMISTRY-US, V8, P2862, DOI 10.1021/bi00835a025; BANERJEE R, 1969, J MOL BIOL, V42, P337, DOI 10.1016/0022-2836(69)90047-3; Banerjee S, 2012, FREE RADICAL BIO MED, V53, P1317, DOI 10.1016/j.freeradbiomed.2012.07.023; BERZOFSKY JA, 1971, J BIOL CHEM, V246, P3367; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Boretti FS, 2009, J CLIN INVEST, V119, P2271, DOI 10.1172/JCI39115; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Brittain T, 1997, BIOCHEM J, V326, P109, DOI 10.1042/bj3260109; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Bunn HF, 1986, HEMOGLOBIN MOL GENET; Cooper C.E., 2012, ANTIOXID RE IN PRESS; FAULKNER KM, 1995, J BIOL CHEM, V270, P13604, DOI 10.1074/jbc.270.23.13604; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; FLYNN TP, 1983, J CLIN INVEST, V71, P1215, DOI 10.1172/JCI110870; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Gell DA, 2009, J BIOL CHEM, V284, P29462, DOI 10.1074/jbc.M109.027045; GERACI G, 1969, J BIOL CHEM, V244, P4664; GIULIVI C, 1994, METHOD ENZYMOL, V231, P490; Gray HB, 2010, BBA-BIOENERGETICS, V1797, P1563, DOI 10.1016/j.bbabio.2010.05.001; Hamdane D, 2007, J BIOL CHEM, V282, P6398, DOI 10.1074/jbc.M610543200; JAROLIM P, 1990, BLOOD, V76, P2125; Kaim W, 2008, SPECTROELECTROCHEMISTRY, P1, DOI 10.1039/9781847558404; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Khandros E, 2012, J BIOL CHEM, V287, P11325, DOI 10.1074/jbc.M111.313205; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; MAIORINO M, 1994, FREE RADICAL BIO MED, V16, P661, DOI 10.1016/0891-5849(94)90067-1; MISRA HP, 1972, J BIOL CHEM, V247, P6960; Mollan TL, 2012, J BIOL CHEM, V287, P11338, DOI 10.1074/jbc.M111.313247; Mollan TL, 2010, ANTIOXID REDOX SIGN, V12, P219, DOI 10.1089/ars.2009.2780; Nasimuzzaman M, 2010, AM J HEMATOL, V85, P820, DOI 10.1002/ajh.21829; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Reeder BJ, 2001, FREE RADICAL BIO MED, V30, P1311, DOI 10.1016/S0891-5849(01)00534-2; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Reeder BJ, 2002, BIOCHEM SOC T, V30, P745, DOI 10.1042/bst0300745; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Reeder BJ, 2008, J BIOL CHEM, V283, P30780, DOI 10.1074/jbc.M804709200; Rifkind JM, 2004, ANTIOXID REDOX SIGN, V6, P657, DOI 10.1089/152308604773934422; SCHRIER SL, 1989, BLOOD, V74, P2194; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; Silaghi-Dumitrescu R, 2007, BIOCHEM J, V403, P391, DOI 10.1042/BJ20061421; Svistunenko DA, 1997, J BIOL CHEM, V272, P7114, DOI 10.1074/jbc.272.11.7114; Taboy CH, 1999, BIOELECTROCH BIOENER, V48, P79, DOI 10.1016/S0302-4598(98)00236-0; TOMODA A, 1978, BIOCHEM J, V171, P329, DOI 10.1042/bj1710329; Tsai AL, 1996, J BIOL CHEM, V271, P32563, DOI 10.1074/jbc.271.51.32563; Tsantes AE, 2006, ANTIOXID REDOX SIGN, V8, P1205, DOI 10.1089/ars.2006.8.1205; Tsuruga M, 1998, J BIOL CHEM, V273, P8607, DOI 10.1074/jbc.273.15.8607; VALDES R, 1978, P NATL ACAD SCI USA, V75, P311, DOI 10.1073/pnas.75.1.311; Vasseur-Godbillon C, 2006, PROTEIN ENG DES SEL, V19, P91, DOI 10.1093/protein/gzj006; Vollaard NBJ, 2005, FREE RADICAL BIO MED, V39, P1216, DOI 10.1016/j.freeradbiomed.2005.06.012; WATKINS JA, 1985, BIOCHEM BIOPH RES CO, V132, P742, DOI 10.1016/0006-291X(85)91195-7; Weiss MJ, 2009, BLOOD, V113, P2136, DOI 10.1182/blood-2008-09-115238; Weiss MJ, 2005, ANN NY ACAD SCI, V1054, P103, DOI 10.1196/annals.1345.013; WIEDERMANN BL, 1975, J BIOL CHEM, V250, P5273; Zhou SP, 2006, J BIOL CHEM, V281, P32611, DOI 10.1074/jbc.M607311200	58	27	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4288	4298		10.1074/jbc.M112.412064	http://dx.doi.org/10.1074/jbc.M112.412064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264625	Green Published, hybrid			2022-12-28	WOS:000314845000057
J	Pearson, RJ; Morf, L; Singh, U				Pearson, Richard J.; Morf, Laura; Singh, Upinder			Regulation of H2O2 Stress-responsive Genes through a Novel Transcription Factor in the Protozoan Pathogen Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; BINDING-PROTEIN; EXPRESSION; IDENTIFICATION; VIRULENCE; ACTIVATION; PARASITE; REGULON; OXYR	Outcome of infection depends upon complex interactions between the invading pathogen and the host. As part of the host's innate immune response, the release of reactive oxygen and nitrogen species by phagocytes represents a major obstacle to the establishment of infection. The ability of the human parasite Entamoeba histolytica to survive reactive oxygen and nitrogen species is central to its pathogenic potential and contributes to disease outcome. In order to define the transcriptional network associated with oxidative stress, we utilized the MEME and MAST programs to analyze the promoter regions of 57 amoebic genes that had increased expression specifically in response to H2O2 exposure. We functionally characterized an H2O2-regulatory motif (HRM) ((1)AAACCTCAATGAAGA(15)), which was enriched in these promoters and specifically bound amoebic nuclear protein(s). Assays with promoter-luciferase fusions established the importance of key residues and that the HRM motif directly impacted the ability of H2O2-responsive promoters to drive gene expression. DNA affinity chromatography and mass spectrometry identified EHI_108720 as an HRM DNA-binding protein. Overexpression and down-regulation of EHI_108720 demonstrated the specificity of EHI_108720 protein binding to the HRM, and overexpression increased basal expression from an H2O2-responsive wild-type promoter but not from its mutant counterpart. Thus, EHI_108720, or HRM binding protein, represents a new stress-responsive transcription factor in E. histolytica that controls a transcriptional regulatory network associated with oxidative stress. Overexpression of EHI_108720 increased parasite virulence. Insight into how E. histolytica responds to oxidative stress increases our understanding of how this important human pathogen establishes invasive disease.	[Pearson, Richard J.; Morf, Laura; Singh, Upinder] Stanford Univ, Sch Med, Dept Internal Med, Div Infect Dis, Stanford, CA 94305 USA; [Singh, Upinder] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Singh, U (corresponding author), Stanford Univ, Sch Med, Dept Internal Med, Div Infect Dis, S-143 Grant Bldg,300 Pasteur Dr, Stanford, CA 94305 USA.	usingh@stanford.edu		Singh, Upinder/0000-0003-0630-0306	National Institutes of Health [AI053724, T32 AI07328]; Stanford University; Swiss National Foundation [PBZHP3]; National Center for Research Resources [S10RR027425]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, R01AI053724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University(Stanford University); Swiss National Foundation(Swiss National Science Foundation (SNSF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI053724 (to U. S.) and Training Grant in Microbiology T32 AI07328 (to R. P.). This work was also supported by a Stanford University Dean's Fellowship (to R. P.) and a Swiss National Foundation PBZHP3 grant (to L. M.). Mass spectrometry was supported by National Center for Research Resources Award S10RR027425.	Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bruchhaus I, 1997, BIOCHEM J, V326, P785, DOI 10.1042/bj3260785; Bsat N, 1998, MOL MICROBIOL, V29, P189, DOI 10.1046/j.1365-2958.1998.00921.x; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis PH, 2007, MOL BIOCHEM PARASIT, V151, P118, DOI 10.1016/j.molbiopara.2006.10.014; Davis PH, 2006, MOL MICROBIOL, V61, P1523, DOI 10.1111/j.1365-2958.2006.05344.x; de Dios-Bravo G, 2005, FEBS J, V272, P1354, DOI 10.1111/j.1742-4658.2005.04566.x; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Dinamarco TM, 2012, EUKARYOT CELL, V11, P518, DOI 10.1128/EC.00016-12; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Ehrenkaufer GM, 2009, CELL MICROBIOL, V11, P898, DOI 10.1111/j.1462-5822.2009.01300.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Georgiou G, 2002, CELL, V111, P607, DOI 10.1016/S0092-8674(02)01165-0; Gilchrist CA, 2003, J BIOL CHEM, V278, P4646, DOI 10.1074/jbc.M211271200; Gilchrist CA, 2001, J BIOL CHEM, V276, P11838, DOI 10.1074/jbc.M007375200; Gilchrist CA, 1998, INFECT IMMUN, V66, P2383, DOI 10.1128/IAI.66.5.2383-2386.1998; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Hackney JA, 2007, NUCLEIC ACIDS RES, V35, P2141, DOI 10.1093/nar/gkm028; Halliwell B.G.J.M.C., 2007, FREE RADICALS BIOL M; Herbig AF, 2001, MOL MICROBIOL, V41, P849, DOI 10.1046/j.1365-2958.2001.02543.x; JacquierSarlin MR, 1996, BIOCHEM J, V318, P187, DOI 10.1042/bj3180187; Justino MC, 2005, J BIOL CHEM, V280, P2636, DOI 10.1074/jbc.M411070200; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Li H, 2004, J BACTERIOL, V186, P3331, DOI 10.1128/JB.186.11.3331-3345.2004; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lorenzi HA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000716; MacFarlane RC, 2006, INFECT IMMUN, V74, P340, DOI 10.1128/IAI.74.1.340-351.2006; Masloboeva N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043421; MATTERN CFT, 1978, AM J TROP MED HYG, V27, P882, DOI 10.4269/ajtmh.1978.27.882; Meneses E, 2010, GENE, V455, P32, DOI 10.1016/j.gene.2010.02.004; Meng ZJ, 2006, J PROTEOME RES, V5, P1931, DOI 10.1021/pr060009l; Moreno H, 2010, EUKARYOT CELL, V9, P695, DOI 10.1128/EC.00346-09; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Ning JL, 2010, CHINESE MED J-PEKING, V123, P1063, DOI 10.3760/cma.j.issn.0366-6999.2010.08.016; Pearson RJ, 2010, CELL MICROBIOL, V12, P1681, DOI 10.1111/j.1462-5822.2010.01524.x; Purdy JE, 1996, MOL BIOCHEM PARASIT, V78, P91, DOI 10.1016/S0166-6851(96)02614-X; PURDY JE, 1994, P NATL ACAD SCI USA, V91, P7099, DOI 10.1073/pnas.91.15.7099; Rastew E, 2012, INT J PARASITOL, V42, P1007, DOI 10.1016/j.ijpara.2012.08.006; SCHMIDT KN, 1995, CHEM BIOL, V2, P13, DOI 10.1016/1074-5521(95)90076-4; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith AJ, 2011, MOL CELL BIOL, V31, P1444, DOI 10.1128/MCB.00745-10; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; STEPHEN DWS, 1995, MOL MICROBIOL, V16, P415, DOI 10.1111/j.1365-2958.1995.tb02407.x; Vandenbroucke K, 2008, MOL BIOL EVOL, V25, P507, DOI 10.1093/molbev/msm276; Vicente JB, 2012, EUKARYOT CELL, V11, P1112, DOI 10.1128/EC.00149-12; Vicente JB, 2009, CELL MICROBIOL, V11, P51, DOI 10.1111/j.1462-5822.2008.01236.x; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	54	29	30	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4462	4474		10.1074/jbc.M112.423467	http://dx.doi.org/10.1074/jbc.M112.423467			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23250742	Green Published, hybrid			2022-12-28	WOS:000314845000072
J	Sathanoori, R; Olde, B; Erlinge, D; Goransson, O; Wierup, N				Sathanoori, Ramasri; Olde, Bjorn; Erlinge, David; Goransson, Olga; Wierup, Nils			Cocaine- and Amphetamine-regulated Transcript (CART) Protects Beta Cells against Glucotoxicity and Increases Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; RECEPTOR SUBSTRATE 2; MESSENGER-RNA; IRS PROTEINS; KINASE-A; GLUCOSE; EXPRESSION; ACTIVATION; SURVIVAL; APOPTOSIS	Cocaine- and amphetamine-regulated transcript (CART) is an islet peptide that promotes glucose-stimulated insulin secretion in beta cells via cAMP/PKA-dependent pathways. In addition, CART is a regulator of neuronal survival. In this study, we examined the effect of exogenous CART 55-102 on beta cell viability and dissected its signaling mechanisms. Evaluation of DNA fragmentation and chromatin condensation revealed that CART 55-102 reduced glucotoxicity-induced apoptosis in both INS-1 (832/13) cells and isolated rat islets. Glucotoxicity in INS-1 (832/13) cells also caused a 50% reduction of endogenous CART protein. We show that CART increased proliferation in INS-1 (832/13) cells, an effect that was blocked by PKA, PKB, and MEK1 inhibitors. In addition, CART induced phosphorylation of CREB, IRS, PKB, FoxO1, p44/42 MAPK, and p90RSK in INS-1 (832/13) cells and isolated rat islets, all key mediators of cell survival and proliferation. Thus, we demonstrate that CART 55-102 protects beta cells against glucotoxicity and promotes proliferation. Taken together our data point to the potential use of CART in therapeutic interventions targeted at enhancing functional beta cell mass and long-term insulin secretion in T2D.	[Sathanoori, Ramasri; Olde, Bjorn; Erlinge, David] Lund Univ, Dept Cardiol, SE-22184 Lund, Sweden; [Goransson, Olga] Lund Univ, Prot Phosphorylat Res Grp, SE-22184 Lund, Sweden; [Wierup, Nils] Lund Univ, Ctr Diabet, SE-20502 Malmo, Sweden	Lund University; Lund University; Lund University	Wierup, N (corresponding author), Lund Univ, Ctr Diabet, Dept Clin Sci, Scania Univ Hosp,Clin Res Ctr, Jan Waldenstroms Gata 35, SE-20502 Malmo, Sweden.	nils.wierup@med.lu.se		Goransson, Olga/0000-0002-7209-8022	Swedish Medical Research Council [2008-4216]; Novo Nordisk Foundation; European Foundation for the Study of Diabetes; Merck Sharpe and Dohme; Medical Faculty at Lund University; The Crafoord Foundation; The Gyllenstiernska Krapperup Foundation; The Tore Nilsson Foundation; The Ake Wibergs Foundation; The Fredrik and Ingrid Thuring Foundation; The Magnus Bergwall Foundation; The Albert Pahlsson Foundation; Novo Nordisk Fonden [NNF13OC0005033] Funding Source: researchfish	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Foundation for the Study of Diabetes; Merck Sharpe and Dohme(Merck & Company); Medical Faculty at Lund University; The Crafoord Foundation; The Gyllenstiernska Krapperup Foundation; The Tore Nilsson Foundation; The Ake Wibergs Foundation; The Fredrik and Ingrid Thuring Foundation; The Magnus Bergwall Foundation; The Albert Pahlsson Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Swedish Medical Research Council (Project Number 2008-4216), the Novo Nordisk Foundation, the European Foundation for the Study of Diabetes and Merck Sharpe and Dohme, the Medical Faculty at Lund University, The Crafoord Foundation, The Gyllenstiernska Krapperup Foundation, The Tore Nilsson Foundation, The Ake Wibergs Foundation, The Fredrik and Ingrid Thuring Foundation, The Magnus Bergwall Foundation, and The Albert Pahlsson Foundation.	Arumugam R, 2007, ENDOCRINOLOGY, V148, P258, DOI 10.1210/en.2006-0888; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Burks DJ, 2001, DIABETES, V50, pS140, DOI 10.2337/diabetes.50.2007.S140; Buteau J, 2007, DIABETES OBES METAB, V9, P140, DOI 10.1111/j.1463-1326.2007.00782.x; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Buzzi F, 2010, MOL CELL BIOL, V30, P601, DOI 10.1128/MCB.00719-09; Costes S, 2004, ANN NY ACAD SCI, V1030, P230, DOI 10.1196/annals.1329.029; Dalle Stephane, 2011, Curr Mol Pharmacol, V4, P187; Dey A, 2003, J BIOL CHEM, V278, P15007, DOI 10.1074/jbc.M212128200; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; Goehring I, 2011, DIABETOLOGIA, V54, P2584, DOI 10.1007/s00125-011-2249-7; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jia J, 2008, NEUROPEPTIDES, V42, P653, DOI 10.1016/j.npep.2008.05.006; Jones DC, 2009, NEUROSCIENCE, V160, P339, DOI 10.1016/j.neuroscience.2009.02.051; Jones DC, 2006, J PHARMACOL EXP THER, V317, P454, DOI 10.1124/jpet.105.096123; Jones DC, 2008, SYNAPSE, V62, P122, DOI 10.1002/syn.20476; Karaca M, 2009, DIABETES METAB, V35, P77, DOI 10.1016/j.diabet.2008.09.007; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kuhar MJ, 1999, SYNAPSE, V33, P163, DOI 10.1002/(SICI)1098-2396(19990901)33:3<163::AID-SYN1>3.0.CO;2-T; Lakatos A, 2005, NEUROSCI LETT, V384, P198, DOI 10.1016/j.neulet.2005.04.072; Landerholm K, 2012, CLIN CANCER RES, V18, P3668, DOI 10.1158/1078-0432.CCR-11-2513; Landerholm K, 2011, NEUROENDOCRINOLOGY, V94, P228, DOI 10.1159/000329044; Lee YH, 2004, ARCH PHARM RES, V27, P361, DOI 10.1007/BF02980074; Lin YM, 2011, NEUROPEPTIDES, V45, P351, DOI 10.1016/j.npep.2011.07.006; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Lingohr MK, 2003, MOL CELL ENDOCRINOL, V204, P85, DOI 10.1016/S0303-7207(03)00124-2; Lingohr MK, 2002, DIABETES, V51, P966, DOI 10.2337/diabetes.51.4.966; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045711; Maedler K, 2008, FASEB J, V22, P1905, DOI 10.1096/fj.07-101824; Maedler K, 2008, DIABETES OBES METAB, V10, P408, DOI 10.1111/j.1463-1326.2007.00718.x; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Persaud SJ, 2011, DIABETOLOGIA, V54, P1109, DOI 10.1007/s00125-011-2050-7; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Ritzel RA, 2009, FRONT BIOSCI-LANDMRK, V14, P1835, DOI 10.2741/3345; Rogge GA, 2009, BRAIN RES, V1251, P42, DOI 10.1016/j.brainres.2008.11.011; Schuppin GT, 1998, DIABETES, V47, P1074, DOI 10.2337/diabetes.47.7.1074; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Thim L, 1998, FEBS LETT, V428, P263, DOI 10.1016/S0014-5793(98)00543-2; Trumper A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740233; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Wang HW, 2011, METABOLISM, V60, P1081, DOI 10.1016/j.metabol.2010.11.004; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Wierup N, 2004, J HISTOCHEM CYTOCHEM, V52, P169, DOI 10.1177/002215540405200204; Wierup N, 2006, DIABETES, V55, P305, DOI 10.2337/diabetes.55.02.06.db04-1383; Wierup N, 2005, REGUL PEPTIDES, V129, P203, DOI 10.1016/j.regpep.2005.02.016; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Xie T, 2010, J ENDOCRINOL, V206, P261, DOI 10.1677/JOE-10-0030; Xu Y, 2006, P NATL ACAD SCI USA, V103, P14489, DOI 10.1073/pnas.0602932103	62	24	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3208	3218		10.1074/jbc.M112.437145	http://dx.doi.org/10.1074/jbc.M112.437145			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250745	hybrid, Green Published			2022-12-28	WOS:000314397900028
J	Wang, P; Wu, YF; Li, XM; Ma, XF; Zhong, LW				Wang, Pei; Wu, Yunfei; Li, Xiaoming; Ma, Xiaofeng; Zhong, Liangwei			Thioredoxin and Thioredoxin Reductase Control Tissue Factor Activity by Thiol Redox-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; PROCOAGULANT ACTIVITY; BLOOD-COAGULATION; MESOTHELIAL CELLS; FACTOR ACTIVATION; OXIDATIVE STRESS; FACTOR-VII; BOND; EXPRESSION; DISEASE	Abnormally enhanced tissue factor (TF) activity is related to increased thrombosis risk in which oxidative stress plays a critical role. Human cytosolic thioredoxin (hTrx1) and thioredoxin reductase (TrxR), also secreted into circulation, have the power to protect against oxidative stress. However, the relationship between hTrx1/TrxR and TF remains unknown. Here we show reversible association of hTrx1 with TF in human serum and plasma samples. The association is dependent on hTrx1-Cys-73 that bridges TF-Cys-209 via a disulfide bond. hTrx1-Cys-73 is absolutely required for hTrx1 to interfere with FVIIa binding to purified and cell-surface TF, consequently suppressing TF-dependent procoagulant activity and proteinase-activated receptor-2 activation. Moreover, hTrx1/TrxR plays an important role in sensing the alterations of NADPH/NADP(+) states and transducing this redox-sensitive signal into changes in TF activity. With NADPH, hTrx1/TrxR readily facilitates the reduction of TF, causing a decrease in TF activity, whereas with NADP(+), hTrx1/TrxR promotes the oxidation of TF, leading to an increase in TF activity. By comparison, TF is more likely to favor the reduction by hTrx1-TrxR-NADPH. This reversible reduction-oxidation reaction occurs in the TF extracellular domain that contains partially opened Cys-49/-57 and Cys-186/-209 disulfide bonds. The cell-surface TF procoagulant activity is significantly increased after hTrx1-knockdown. The response of cell-surface TF procoagulant activity to H2O2 is efficiently suppressed through elevating cellular TrxR activity via selenium supplementation. Our data provide a novel mechanism for redox regulation of TF activity. By modifying Cys residues or regulating Cys redox states in TF extracellular domain, hTrx1/TrxR function as a safeguard against inappropriate TF activity.	[Wang, Pei; Wu, Yunfei; Ma, Xiaofeng; Zhong, Liangwei] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Li, Xiaoming] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS	Zhong, LW (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, YuQuan Rd 19 A, Beijing 100049, Peoples R China.	liazho@ucas.ac.cn			National Natural Science Foundation of China [30970629, 31170764]; Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences Grant [KSCX2-EW-J-29]; Special Science and Technology Projects for Outstanding Young Persons in Life Sciences Grant [KSCX2-EW-Q-19]; Ministry of Science and Technology of the People's Republic of China [2009ZX09103-432, 2012ZX09103-101-063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences Grant; Special Science and Technology Projects for Outstanding Young Persons in Life Sciences Grant; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China Grants 30970629 and 31170764, Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences Grant KSCX2-EW-J-29, Special Science and Technology Projects for Outstanding Young Persons in Life Sciences Grant KSCX2-EW-Q-19, and Ministry of Science and Technology of the People's Republic of China Grants 2009ZX09103-432 and 2012ZX09103-101-063.	Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; BACH R, 1988, BIOCHEMISTRY-US, V27, P4227, DOI 10.1021/bi00412a004; BACH R, 1990, P NATL ACAD SCI USA, V87, P6995, DOI 10.1073/pnas.87.18.6995; Bach RR, 2006, ARTERIOSCL THROM VAS, V26, P456, DOI 10.1161/01.ATV.0000202656.53964.04; Bayele HK, 2002, FEBS LETT, V510, P67, DOI 10.1016/S0014-5793(01)03209-4; Belting M, 2005, ARTERIOSCL THROM VAS, V25, P1545, DOI 10.1161/01.ATV.0000171155.05809.bf; Berk BC, 1999, THROMB HAEMOSTASIS, V82, P810; Biro E, 2003, J THROMB HAEMOST, V1, P2561, DOI 10.1046/j.1538-7836.2003.00456.x; BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761; Cao XR, 2010, DISCRETE EVENT DYN S, V20, P1, DOI 10.1007/s10626-010-0088-1; Chen VM, 2006, BIOCHEMISTRY-US, V45, P12020, DOI 10.1021/bi061271a; Cimmino G, 2011, INTERN EMERG MED, V6, P29, DOI 10.1007/s11739-010-0423-4; Gonzalez-Pacheco FR, 2002, NEPHROL DIAL TRANSPL, V17, P392, DOI 10.1093/ndt/17.3.392; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Hampton MB, 2002, J LEUKOCYTE BIOL, V71, P775; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; HESSEL B, 1984, THROMB RES, V35, P637, DOI 10.1016/0049-3848(84)90267-6; Higashi S, 1997, J BIOL CHEM, V272, P25724, DOI 10.1074/jbc.272.41.25724; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Jekell A, 2004, EUR J HEART FAIL, V6, P883, DOI 10.1016/j.ejheart.2004.03.003; Kothari H, 2010, BLOOD, V115, P4273, DOI 10.1182/blood-2009-09-241356; KUMAR A, 1994, THROMB HAEMOSTASIS, V71, P587; Liang HPH, 2011, BIOCHEM J, V437, P455, DOI 10.1042/BJ20110718; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; Mallat Z, 1999, CIRCULATION, V99, P348, DOI 10.1161/01.CIR.99.3.348; Mitsumoto A, 2001, FREE RADICAL BIO MED, V30, P625, DOI 10.1016/S0891-5849(00)00503-7; Nakamura H, 1998, FREE RADICAL BIO MED, V24, P1176, DOI 10.1016/S0891-5849(97)00429-2; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P15143, DOI 10.1073/pnas.191498798; Passam FH, 2010, J THROMB HAEMOST, V8, P1754, DOI 10.1111/j.1538-7836.2010.03944.x; Patenaude A, 2010, CAN J PHYSIOL PHARM, V88, P1102, DOI [10.1139/Y10-084, 10.1139/y10-084]; Pendurthi UR, 2007, BLOOD, V110, P3900, DOI 10.1182/blood-2007-07-101469; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; RAO LVM, 1988, P NATL ACAD SCI USA, V85, P6687, DOI 10.1073/pnas.85.18.6687; REHEMTULLA A, 1991, J BIOL CHEM, V266, P10294; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Riewald M, 2003, CRIT CARE, V7, P123, DOI 10.1186/cc1825; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; RUBARTELLI A, 1995, CANCER RES, V55, P675; Solov'eva M E, 2007, Tsitologiia, V49, P70; Song KS, 2004, YONSEI MED J, V45, P38, DOI 10.3349/ymj.2004.45.1.38; STONE MJ, 1995, BIOCHEM J, V310, P605, DOI 10.1042/bj3100605; Tartier L, 2000, CELL DEATH DIFFER, V7, P1002, DOI 10.1038/sj.cdd.4400726; Tracy RP, 2003, CHEST, V124, p49S, DOI 10.1378/chest.124.3_suppl.49S; van der Merwe JQ, 2009, AM J PHYSIOL-GASTR L, V296, pG1258, DOI 10.1152/ajpgi.90425.2008; VERHAGEN HJM, 1995, THROMB HAEMOSTASIS, V74, P1096; Wedgwood S, 2003, ANTIOXID REDOX SIGN, V5, P759, DOI 10.1089/152308603770380061; World C, 2011, ARTERIOSCL THROM VAS, V31, P1890, DOI 10.1161/ATVBAHA.111.226340; Wu YF, 2010, ATHEROSCLEROSIS, V212, P351, DOI 10.1016/j.atherosclerosis.2010.06.002; Xing J, 2010, AM J PHYSIOL-CELL PH, V298, pC274, DOI 10.1152/ajpcell.00394.2009; Zhai Guang-Lei, 2010, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V26, P243; Zhang HH, 2010, EUR J PHARMACOL, V626, P276, DOI 10.1016/j.ejphar.2009.09.034; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897; Zhong LW, 2002, METHOD ENZYMOL, V347, P236; Zhou JN, 1998, MOL CARCINOGEN, V21, P234, DOI 10.1002/(SICI)1098-2744(199804)21:4<234::AID-MC2>3.0.CO;2-K	59	40	42	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3346	3358		10.1074/jbc.M112.418046	http://dx.doi.org/10.1074/jbc.M112.418046			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23223577	Green Published, hybrid			2022-12-28	WOS:000314397900040
J	Abdian, PL; Caramelo, JJ; Ausmees, N; Zorreguieta, A				Abdian, Patricia L.; Caramelo, Julio J.; Ausmees, Nora; Zorreguieta, Angeles			RapA2 Is a Calcium-binding Lectin Composed of Two Highly Conserved Cadherin-like Domains That Specifically Recognize Rhizobium leguminosarum Acidic Exopolysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-SYMBIONT INTERACTIONS; BIOFILM FORMATION; PROTEIN SECRETION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CELL-SURFACE; I SECRETION; POLYSACCHARIDES; IDENTIFICATION; NODULATION	In silico analyses have revealed a conserved protein domain (CHDL) widely present in bacteria that has significant structural similarity to eukaryotic cadherins. A CHDL domain was shown to be present in RapA, a protein that is involved in autoaggregation of Rhizobium cells, biofilm formation, and adhesion to plant roots as shown by us and others. Structural similarity to cadherins suggested calcium-dependent oligomerization of CHDL domains as a mechanistic basis for RapA action. Here we show by circular dichroism spectroscopy, light scattering, isothermal titration calorimetry, and other methods that RapA2 from Rhizobium leguminosarum indeed exhibits a cadherin-like beta-sheet conformation and that its proper folding and stability are dependent on the binding of one calcium ion per protein molecule. By further in silico analysis we also reveal that RapA2 consists of two CHDL domains and expand the range of CHDL-containing proteins in bacteria and archaea. However, light scattering assays at various concentrations of added calcium revealed that RapA2 formed neither homo-oligomers nor hetero-oligomers with RapB (a distinct CHDL protein), indicating that RapA2 does not mediate cellular interactions through a cadherin-like mechanism. Instead, we demonstrate that RapA2 interacts specifically with the acidic exopolysaccharides (EPSs) produced by R. leguminosarum in a calcium-dependent manner, sustaining a role of these proteins in the development of the biofilm matrix made of EPS. Because EPS binding by RapA2 can only be attributed to its two CHDL domains, we propose that RapA2 is a calcium-dependent lectin and that CHDL domains in various bacterial and archaeal proteins confer carbohydrate binding activity to these proteins.	[Abdian, Patricia L.; Caramelo, Julio J.; Zorreguieta, Angeles] IIBBA Consejo Nacl Invest Cient & Tecnol, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Caramelo, Julio J.; Zorreguieta, Angeles] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Ausmees, Nora] Lund Univ, Dept Biol, S-22362 Lund, Sweden	Leloir Institute; University of Buenos Aires; Lund University	Zorreguieta, A (corresponding author), IIBBA Consejo Nacl Invest Cient & Tecnol, Fdn Inst Leloir, Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	azorreguieta@leloir.org.ar	Abdian, Patricia/AAW-2420-2020	Abdian, Patricia/0000-0002-8366-8115	Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT) [PICT 20334]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [PIP 545]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-0376]; Swedish Research Council	Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT)(ANPCyTFONCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT, PICT 20334; to A. Z.) a grant (PIP 545) from Consejo Nacional de Investigaciones Cientificas y Tecnologicas (to A. Z.), a grant from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2010-0376) to J. J. C., and a grant from the Swedish Research Council to N. A.	Abbott DW, 2007, J MOL BIOL, V368, P1215, DOI 10.1016/j.jmb.2007.02.083; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; Aravind P, 2009, J MOL BIOL, V385, P163, DOI 10.1016/j.jmb.2008.10.035; Ausmees N, 2001, MICROBIOL-UK, V147, P549, DOI 10.1099/00221287-147-3-549; Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Butcher BG, 2007, J BACTERIOL, V189, P8616, DOI 10.1128/JB.01181-07; Cao LH, 2005, FEMS MICROBIOL LETT, V251, P203, DOI 10.1016/j.femsle.2005.08.004; Chen CP, 1998, GLYCOBIOLOGY, V8, P7, DOI 10.1093/glycob/8.1.7; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; DAZZO FB, 1982, APPL ENVIRON MICROB, V44, P478, DOI 10.1128/AEM.44.2.478-490.1982; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Dickens NJ, 2002, CURR BIOL, V12, pR197, DOI 10.1016/S0960-9822(02)00748-0; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; DOWNIE JA, 1983, EMBO J, V2, P947, DOI 10.1002/j.1460-2075.1983.tb01526.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FILISETTICOZZI TMCC, 1991, ANAL BIOCHEM, V197, P157, DOI 10.1016/0003-2697(91)90372-Z; Finnie C, 1997, MOL MICROBIOL, V25, P135, DOI 10.1046/j.1365-2958.1997.4471803.x; Finnie C, 1998, J BACTERIOL, V180, P1691, DOI 10.1128/JB.180.7.1691-1699.1998; Fraiberg M, 2011, J BACTERIOL, V193, P283, DOI 10.1128/JB.00842-10; Fraiberg M, 2010, J BACTERIOL, V192, P1066, DOI 10.1128/JB.01236-09; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Goodstadt L, 2001, BIOINFORMATICS, V17, P845, DOI 10.1093/bioinformatics/17.9.845; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Jefferson K. K., 2006, METHODS MOL BIOL CEL, P119; JOHNSTON AWB, 1975, J GEN MICROBIOL, V87, P343, DOI 10.1099/00221287-87-2-343; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; Krehenbrink M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-55; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laus MC, 2004, J BACTERIOL, V186, P6617, DOI 10.1128/JB.186.19.6617-6625.2004; LEIGH JA, 1985, P NATL ACAD SCI USA, V82, P6231, DOI 10.1073/pnas.82.18.6231; LOEWUS MW, 1952, J BIOL CHEM, V199, P857; MCNEIL M, 1986, CARBOHYD RES, V146, P307, DOI 10.1016/0008-6215(86)85048-0; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; MILLER KJ, 1990, J BACTERIOL, V172, P136, DOI 10.1128/JB.172.1.136-142.1990; Mongiardini EJ, 2008, FEMS MICROBIOL ECOL, V65, P279, DOI 10.1111/j.1574-6941.2008.00467.x; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Orans J, 2010, P NATL ACAD SCI USA, V107, P1065, DOI 10.1073/pnas.0911616107; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Rinaudi LV, 2010, FEMS MICROBIOL LETT, V304, P1, DOI 10.1111/j.1574-6968.2009.01840.x; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Russo DM, 2006, J BACTERIOL, V188, P4474, DOI 10.1128/JB.00246-06; Sandford P. A., 1977, ACS SYM SER, V45, P192; SHERWOOD MT, 1970, J APPL BACTERIOL, V33, P708, DOI 10.1111/j.1365-2672.1970.tb02253.x; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; WATKINS NJ, 1995, BIOCHEM J, V306, P865, DOI 10.1042/bj3060865; Williams A, 2008, J BACTERIOL, V190, P4706, DOI 10.1128/JB.01694-07; Wolff N, 2003, J BIOL CHEM, V278, P38247, DOI 10.1074/jbc.M302322200; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Zeng XQ, 2012, ANAL BIOANAL CHEM, V402, P3161, DOI 10.1007/s00216-011-5594-y; ZEVENHUIZEN LPTM, 1983, CARBOHYD RES, V118, P127, DOI 10.1016/0008-6215(83)88041-0; Zorreguieta A, 2000, J BACTERIOL, V182, P1304, DOI 10.1128/JB.182.5.1304-1312.2000	56	22	23	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2893	2904		10.1074/jbc.M112.411769	http://dx.doi.org/10.1074/jbc.M112.411769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23235153	Green Published, hybrid			2022-12-28	WOS:000314211500071
J	Choi, CH; Thomason, PA; Zaki, M; Insall, RH; Barber, DL				Choi, Chang-Hoon; Thomason, Peter A.; Zaki, Mehreen; Insall, Robert H.; Barber, Diane L.			Phosphorylation of Actin-related Protein 2 (Arp2) Is Required for Normal Development and cAMP Chemotaxis in Dictyostelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX; WASP; DYNAMICS; LAMELLIPODIA; ACTIVATION; EXPRESSION; NUCLEATION; SUBUNIT; LACKING; DOMAIN	Phosphorylation of the actin-related protein 2 (Arp2) subunit of the Arp2/3 complex on evolutionarily conserved threonine and tyrosine residues was recently identified and shown to be necessary for nucleating activity of the Arp2/3 complex and membrane protrusion of Drosophila cells. Here we use the Dictyostelium diploid system to replace the essential Arp2 protein with mutants that cannot be phosphorylated at Thr-235/6 and Tyr-200. We found that aggregation of the resulting mutant cells after starvation was substantially slowed with delayed early developmental gene expression and that chemotaxis toward a cAMP gradient was defective with loss of polarity and attenuated F-actin assembly. Chemotaxis toward cAMP was also diminished with reduced cell speed and directionality and shorter pseudopod lifetime when Arp2 phosphorylation mutant cells were allowed to develop longer to a responsive state similar to that of wild-type cells. However, clathrin-mediated endocytosis and chemotaxis under agar to folate in vegetative cells were only subtly affected in Arp2 phosphorylation mutants. Thus, phosphorylation of threonine and tyrosine is important for a subset of the functions of the Arp2/3 complex, in particular an unexpected major role in regulating development.	[Choi, Chang-Hoon; Barber, Diane L.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Thomason, Peter A.; Zaki, Mehreen; Insall, Robert H.] Canc Res UK Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University of California System; University of California San Francisco; Beatson Institute	Barber, DL (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, HSW618, San Francisco, CA 94143 USA.	diane.barber@ucsf.edu	Insall, Robert/G-5611-2011	Insall, Robert/0000-0003-4898-040X; Choi, Changhoon/0000-0002-2847-1168; Thomason, Peter/0000-0003-3104-8392	National Institutes of Health [GM58642]; Medical Research Council [G117/537]; Cancer Research UK; National Center for Research Resources, National Institute of Health [C06 RR16490]; MRC [G117/537] Funding Source: UKRI; Cancer Research UK [15672] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [RC1DC010633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Center for Research Resources, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58642 (to D. L. B.). This work was also supported by Medical Research Council Grant G117/537 and a Cancer Research UK core grant (to R. H. I.).; We thank Lawrence LeClaire and Andre Schonichen for helpful discussions and Gabriela Kalna for help with statistical analysis. Work by C. C. and D. L. B. was conducted in a facility constructed with support from Research Facilities Improvement Program Grant C06 RR16490 from the National Center for Research Resources, National Institute of Health.	Aguado-Velasco C, 1999, MOL BIOL CELL, V10, P4419, DOI 10.1091/mbc.10.12.4419; Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; Blagg SL, 2003, CURR BIOL, V13, P1480, DOI 10.1016/S0960-9822(03)00580-3; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carnell M, 2011, J CELL BIOL, V193, P831, DOI 10.1083/jcb.201009119; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Choi CH, 2010, MOL BIOL CELL, V21, P3162, DOI 10.1091/mbc.E09-12-1058; Das S, 2011, J BIOL CHEM, V286, P38649, DOI 10.1074/jbc.M111.284182; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Insall R, 2001, CELL MOTIL CYTOSKEL, V50, P115, DOI 10.1002/cm.10005; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Kitayama C, 2003, J CELL SCI, V116, P711, DOI 10.1242/jcs.00265; Langridge PD, 2007, EXP CELL RES, V313, P2563, DOI 10.1016/j.yexcr.2007.04.029; LeClaire LL, 2008, J CELL BIOL, V182, P647, DOI 10.1083/jcb.200802145; Muinonen-Martin AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015309; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Narayanan A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002226; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rajan A, 2009, NAT CELL BIOL, V11, P815, DOI 10.1038/ncb1888; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Shu S, 2012, MOL BIOL CELL, V23, P390, DOI 10.1091/mbc.E11-09-0764; Shu S, 2010, J BIOL CHEM, V285, P27713, DOI 10.1074/jbc.M110.116277; Singh S, 2003, J BIOL CHEM, V278, P36410, DOI 10.1074/jbc.M306428200; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Takeda K, 2007, J BIOL CHEM, V282, P11874, DOI 10.1074/jbc.M610984200; Traynor D, 2007, J CELL SCI, V120, P2318, DOI 10.1242/jcs.007732; Ura S, 2012, CURR BIOL, V22, P553, DOI 10.1016/j.cub.2012.02.020; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Veltman DM, 2011, BIOCHEM J, V436, P45, DOI 10.1042/BJ20101684; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Zaki M, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-28; Zech T, 2011, J CELL SCI, V124, P3753, DOI 10.1242/jcs.080986	41	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2464	2474		10.1074/jbc.M112.435313	http://dx.doi.org/10.1074/jbc.M112.435313			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223240	hybrid, Green Published			2022-12-28	WOS:000314211500033
J	Gupta, A; Cooper, ZA; Tulapurkar, ME; Potla, R; Maity, T; Hasday, JD; Singh, IS				Gupta, Aditi; Cooper, Zachary A.; Tulapurkar, Mohan E.; Potla, Ratnakar; Maity, Tapan; Hasday, Jeffrey D.; Singh, Ishwar S.			Toll-like Receptor Agonists and Febrile Range Hyperthermia Synergize to Induce Heat Shock Protein 70 Expression and Extracellular Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; TUMOR-NECROSIS-FACTOR; SIGNAL-TRANSDUCTION PATHWAY; GENE-EXPRESSION; FACTOR-I; HSP70 FAMILY; HISTONE H3; ACTIVATION; STRESS; PHOSPHORYLATION	Heat shock protein (Hsp) 70 expression can be stimulated by febrile range temperature (FRT). Hsp70 has been shown to be elevated in serum of patients with sepsis, and when released from cells, extracellular Hsp70 exerts endotoxin-like effects through Toll-like receptor 4 (TLR4) receptors. Circulating TLR agonists and fever both persist for the first several days of sepsis, and each can activate Hsp70 expression; however, the effect of combined exposure to FRT and TLR agonists on Hsp70 expression is unknown. We found that concurrent exposure to FRT (39.5 degrees C) and agonists for TLR4 (LPS), TLR2 (Pam3Cys), or TLR3 (poly(IC)) synergized to increase Hsp70 expression and extracellular release in RAW264.7 macrophages. The increase in Hsp70 expression was associated with activation of p38 and ERK MAP kinases, phosphorylation of histone H3, and increased recruitment of HSF1 to the Hsp70 promoter. Pretreatment with the p38 MAPK inhibitor SB283580 but not the ERK pathway inhibitor UO126 significantly reduced Hsp70 gene modification and Hsp70 expression in RAW cells co-exposed to LPS and FRT. In mice challenged with intratracheal LPS and then exposed to febrile range hyperthermia (core temperature, similar to 39.5 degrees C), Hsp70 levels in lung tissue and in cell-free lung lavage were increased compared with mice exposed to either hyperthermia or LPS alone. We propose a model of how enhanced Hsp70 expression and extracellular release in patients concurrently exposed to fever and TLR agonists may contribute to the pathogenesis of sepsis.	[Gupta, Aditi; Cooper, Zachary A.; Tulapurkar, Mohan E.; Potla, Ratnakar; Maity, Tapan; Hasday, Jeffrey D.; Singh, Ishwar S.] Univ Maryland, Sch Med, Div Pulm & Crit Care, Dept Med, Baltimore, MD 21201 USA; [Hasday, Jeffrey D.; Singh, Ishwar S.] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Hasday, Jeffrey D.] Univ Maryland, Sch Med, Cytokine Core Lab, Baltimore, MD 21201 USA; [Hasday, Jeffrey D.; Singh, Ishwar S.] Baltimore Veteran Affairs Med Ctr, Res Serv, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Singh, IS (corresponding author), Univ Maryland, Sch Med, Div Pulm & Crit Care, Dept Med, Rm 311,Hlth Sci Facil 2,20 Penn St, Baltimore, MD 21201 USA.	isingh@umaryland.edu	tulapurkar, mohan/F-1926-2015; Gupta, Aditi/HGD-9632-2022; Potla, Ratnakar/AAF-8217-2019	tulapurkar, mohan/0000-0002-2476-5417; Cooper, Zachary/0000-0003-1059-0940; Potla, Ratnakar/0000-0001-5712-271X	National Institutes of Health [GM069431, GM066855, HL69057, HL085256]; Veterans Affairs Merit Review grants; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085256, R01HL069057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069431, R01GM066855] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review grants(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants GM069431 (to I. S. S.) and GM066855, HL69057, and HL085256 (to J. D. H.). This work was also supported by Veterans Affairs Merit Review grants (to I. S. S. and J. D. H.).	Abboud PA, 2008, SHOCK, V30, P285, DOI 10.1097/SHK.0b013e318164e2c3; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Aneja R, 2006, J IMMUNOL, V177, P7184, DOI 10.4049/jimmunol.177.10.7184; Applequist SE, 2002, INT IMMUNOL, V14, P1065, DOI 10.1093/intimm/dxf069; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea Alexzander, 2008, V183, P111; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Calderwood S K, 2010, Sign Transduct Insights, V2, P13; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Cooper ZA, 2010, AM J PHYSIOL-CELL PH, V298, pC171, DOI 10.1152/ajpcell.00346.2009; Cunha BA, 1999, INTENS CARE MED, V25, P648, DOI 10.1007/s001340050925; Davie James R, 2003, Sci STKE, V2003, pPE33; De Nardo D, 2005, J BIOL CHEM, V280, P9813, DOI 10.1074/jbc.M409745200; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dyson MH, 2005, CELL CYCLE, V4, P13, DOI 10.4161/cc.4.1.1362; ENSOR JE, 1995, AM J PHYSIOL-CELL PH, V269, pC1140, DOI 10.1152/ajpcell.1995.269.5.C1140; FINCATO G, 1991, BLOOD, V77, P579; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Gastpar R, 2004, J IMMUNOL, V172, P972, DOI 10.4049/jimmunol.172.2.972; Gelain DP, 2011, SHOCK, V35, P466, DOI 10.1097/SHK.0b013e31820fe704; Gogate SS, 2012, J BONE MINER RES, V27, P1106, DOI 10.1002/jbmr.1571; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; GUIDET B, 1994, CHEST, V106, P1194, DOI 10.1378/chest.106.4.1194; Hashiguchi N, 2001, J TRAUMA, V51, P1104, DOI 10.1097/00005373-200112000-00015; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Magalhaes FC, 2010, J PHYSIOL ANTHROPOL, V29, P1, DOI 10.2114/jpa2.29.1; Maity TK, 2011, CYTOKINE, V54, P61, DOI 10.1016/j.cyto.2010.12.017; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Oehler R, 2001, CELL STRESS CHAPERON, V6, P306, DOI 10.1379/1466-1268(2001)006<0306:CTSVIT>2.0.CO;2; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Park GY, 2004, AM J PHYSIOL-LUNG C, V286, pL956, DOI 10.1152/ajplung.00338.2003; Park HS, 2002, MOL CELL BIOL, V22, P7721, DOI 10.1128/MCB.22.22.7721-7730.2002; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Rice P, 2005, J IMMUNOL, V174, P3676, DOI 10.4049/jimmunol.174.6.3676; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Sareh H, 2011, CELL STRESS CHAPERON, V16, P297, DOI 10.1007/s12192-010-0240-8; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; Singh I. S., 2009, PROKARYOTIC EUKARYOT, P1; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Singh IS, 2004, J ENDOTOXIN RES, V10, P175, DOI 10.1179/096805104225004851; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; Singh IS, 2008, AM J RESP CELL MOL, V39, P235, DOI 10.1165/rcmb.2007-0294OC; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; Stathopoulou K, 2006, J EXP BIOL, V209, P1344, DOI 10.1242/jeb.02134; Stephanou A, 1998, BIOCHEM J, V330, P189, DOI 10.1042/bj3300189; Stephanou A, 1999, J BIOL CHEM, V274, P1723, DOI 10.1074/jbc.274.3.1723; Sugisawa N, 2004, TOXICOL APPL PHARM, V196, P206, DOI 10.1016/j.taap.2003.12.021; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tetievsky A, 2010, J APPL PHYSIOL, V109, P1552, DOI 10.1152/japplphysiol.00469.2010; Thomson S, 2004, MOL CELL, V15, P585, DOI 10.1016/j.molcel.2004.08.002; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Tulapurkar ME, 2011, INT J HYPERTHER, V27, P717, DOI 10.3109/02656736.2011.601528; Tulapurkar ME, 2009, CELL STRESS CHAPERON, V14, P499, DOI 10.1007/s12192-009-0103-3; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; van Eden W, 2012, CELL STRESS CHAPERON, V17, P281, DOI 10.1007/s12192-011-0311-5; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Wang RB, 2006, BLOOD, V107, P1636, DOI 10.1182/blood-2005-06-2559; Wheeler Derek S, 2005, Pediatr Crit Care Med, V6, P308, DOI 10.1097/01.PCC.0000161075.97355.2E; Wilhide ME, 2011, J MOL CELL CARDIOL, V51, P82, DOI 10.1016/j.yjmcc.2011.03.011; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; ZHANG YH, 1994, INFECT IMMUN, V62, P4140, DOI 10.1128/IAI.62.10.4140-4144.1994; Zheng HY, 2010, J BIOL CHEM, V285, P349, DOI 10.1074/jbc.M109.024612	74	53	58	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2756	2766		10.1074/jbc.M112.427336	http://dx.doi.org/10.1074/jbc.M112.427336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23212905	Green Published, hybrid			2022-12-28	WOS:000314211500059
J	Homma, K; Duan, CW; Zheng, J; Cheatham, MA; Dallos, P				Homma, Kazuaki; Duan, Chongwen; Zheng, Jing; Cheatham, Mary Ann; Dallos, Peter			The V499G/Y501H Mutation Impairs Fast Motor Kinetics of Prestin and Has Significance for Defining Functional Independence of Individual Prestin Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR CELL; PROTEIN PRESTIN; COCHLEAR FUNCTION; MOTILITY; CAPACITANCE; ZEBRAFISH; EVOLUTION	Outer hair cells (OHCs) are a mammalian innovation for mechanically amplifying sound energy to overcome the viscous damping of the cochlear partition. Although the voltage-dependent OHC membrane motor, prestin, has been demonstrated to be essential for mammalian cochlear amplification, the molecular mechanism by which prestin converts electrical energy into mechanical displacement/force remains elusive. Identifying mutations that alter the motor function of prestin provides vital information for unraveling the energy transduction mechanism of prestin. We show that the V499G/Y501H mutation does not deprive prestin of its voltage-induced motor activity, but it does significantly impair the fast motor kinetics and voltage operating range. Furthermore, mutagenesis studies suggest that Val-499 is the primary site responsible for these changes. We also show that V499G/Y501H prestin forms heteromers with wildtype prestin and that the fast motor kinetics of wild-type prestin is not affected by heteromer formation with V499G/Y501H prestin. These results suggest that prestin subunits are individually functional within a given multimer.	[Homma, Kazuaki; Duan, Chongwen; Zheng, Jing] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA; [Zheng, Jing; Cheatham, Mary Ann; Dallos, Peter] Northwestern Univ, Hugh Knowles Ctr Clin & Basic Sci Hearing & Its D, Evanston, IL 60208 USA; [Cheatham, Mary Ann; Dallos, Peter] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL 60208 USA; [Dallos, Peter] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Northwestern University	Homma, K (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, 303 E Chicago Ave, Chicago, IL 60611 USA.	k-homma@northwestern.edu	Dallos, Peter/Q-9360-2019; Zheng, Jing/F-5273-2017	Dallos, Peter/0000-0002-9731-6591; Zheng, Jing/0000-0003-2790-1143	National Institutes of Health [DC00089, DC010633]; Hugh Knowles Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [RC1DC010633, R01DC011813, R01DC000089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hugh Knowles Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC00089 (to P. D.) and DC010633 (to J. Z.). This work was also supported by The Hugh Knowles Center.	Albert JT, 2007, J PHYSIOL-LONDON, V580, P451, DOI 10.1113/jphysiol.2007.127993; Ashmore J F, 1990, Neurosci Res Suppl, V12, pS39, DOI 10.1016/0921-8696(90)90007-P; Elgoyhen AB, 2011, HEARING RES, V273, P100, DOI 10.1016/j.heares.2009.12.028; Burnham K.P., 2002, MODEL SELECTION MULT, P60; Cheatham MA, 2007, AUDIOL NEURO-OTOL, V12, P378, DOI 10.1159/000106481; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; Cheatham MA, 2005, J PHYSIOL-LONDON, V569, P229, DOI 10.1113/jphysiol.2005.093518; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Gao JG, 2007, P NATL ACAD SCI USA, V104, P12542, DOI 10.1073/pnas.0700356104; Hallworth R, 2012, J NEUROPHYSIOL, V107, P5, DOI 10.1152/jn.00728.2011; Homma K, 2011, J BIOL CHEM, V286, P2297, DOI 10.1074/jbc.M110.185694; Homma K, 2010, BBA-BIOMEMBRANES, V1798, P1029, DOI 10.1016/j.bbamem.2010.02.001; Izumi C, 2011, BIOPHYS J, V100, P2614, DOI 10.1016/j.bpj.2011.04.032; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Mio K, 2008, J BIOL CHEM, V283, P1137, DOI 10.1074/jbc.M702681200; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Pasqualetto E, 2010, J MOL BIOL, V400, P448, DOI 10.1016/j.jmb.2010.05.013; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Rybalchenko V, 2008, BIOPHYS J, V95, P4439, DOI 10.1529/biophysj.108.134197; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2002, PFLUG ARCH EUR J PHY, V444, P99, DOI 10.1007/s00424-002-0804-2; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Schaechinger TJ, 2011, EMBO J, V30, P2793, DOI 10.1038/emboj.2011.202; Shelden MC, 2010, MOL MEMBR BIOL, V27, P11, DOI 10.3109/09687680903400120; Song L, 2010, BIOPHYS J, V98, P371, DOI 10.1016/j.bpj.2009.10.027; Tadenuma T., 2008, J BIOMECH SCI ENG, V3, P287; Tan XD, 2012, J CELL SCI, V125, P1039, DOI 10.1242/jcs.097337; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; Tang J, 2011, J BIOL CHEM, V286, P31014, DOI 10.1074/jbc.M111.259564; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2005, J CELL SCI, V118, P2987, DOI 10.1242/jcs.02431; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	36	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2452	2463		10.1074/jbc.M112.411579	http://dx.doi.org/10.1074/jbc.M112.411579			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23212912	Green Published, hybrid			2022-12-28	WOS:000314211500032
J	Stroud, DA; Formosa, LE; Wijeyeratne, XW; Nguyen, TN; Ryan, MT				Stroud, David A.; Formosa, Luke E.; Wijeyeratne, Xiaonan W.; Nguyen, Thanh N.; Ryan, Michael T.			Gene Knockout Using Transcription Activator-like Effector Nucleases (TALENs) Reveals That Human NDUFA9 Protein Is Essential for Stabilizing the Junction between Membrane and Matrix Arms of Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; SUBUNITS; DISEASE; IDENTIFICATION; MITOCHONDRIA; DEFECTS; MODULES; DESIGN; IMPORT; TOOLS	Transcription activator-like effector nucleases (TALENs) represent a promising approach for targeted knock-out of genes in cultured human cells. We used TALEN-technology to knock out the nuclear gene encoding NDUFA9, a subunit of mitochondrial respiratory chain complex I in HEK293T cells. Screening for the knock-out revealed a mixture of NDUFA9 cell clones that harbored partial deletions of the mitochondrial N-terminal targeting signal but were still capable of import. A cell line lacking functional copies of both NDUFA9 alleles resulted in a loss of NDUFA9 protein expression, impaired assembly of complex I, and cells incapable of growth in galactose medium. Cells lacking NDUFA9 contained a complex I subcomplex consisting of membrane arm subunits but not marker subunits of the matrix arm. Re-expression of NDUFA9 restored the defects in complex I assembly. We conclude that NDUFA9 is involved in stabilizing the junction between membrane and matrix arms of complex I, a late assembly step critical for complex I biogenesis and activity.	[Ryan, Michael T.] La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; La Trobe Univ, ARC Ctr Excellence Coherent Xray Sci, Melbourne, Vic 3086, Australia	La Trobe University; La Trobe University	Ryan, MT (corresponding author), La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia.	M.Ryan@latrobe.edu.au	Stroud, David Arthur/HGB-4331-2022; Ryan, Michael T/C-6673-2011; Stroud, David A/B-4929-2016; Ryan, Michael/X-2152-2019	Stroud, David Arthur/0000-0002-2048-3383; Ryan, Michael T/0000-0003-2586-8829; Stroud, David A/0000-0002-2048-3383; Ryan, Michael/0000-0003-2586-8829; Wang, Xiaonan/0000-0002-5112-1895; Formosa, Luke/0000-0002-7740-6151; Nguyen, Thanh Ngoc/0000-0001-9698-0020	National Health and Medical Research Council (NHMRC); Australian Research Council Centre of Excellence for Coherent X-ray Science	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence for Coherent X-ray Science(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council (NHMRC) and Australian Research Council Centre of Excellence for Coherent X-ray Science.	Angerer H, 2011, BIOCHEM J, V437, P279, DOI 10.1042/BJ20110359; Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Dieteren CEJ, 2012, J BIOL CHEM, V287, P41851, DOI 10.1074/jbc.M112.391151; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; FEARNLEY IM, 1991, BIOCHEM J, V278, P821, DOI 10.1042/bj2780821; Hirst Judy, 2011, Biochem J, V437, pe1, DOI 10.1042/BJ20110918; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Marx V, 2012, NAT METHODS, V9, P1055, DOI 10.1038/nmeth.2220; McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Rendon OZ, 2012, HUM MOL GENET, V21, P3815, DOI 10.1093/hmg/dds209; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; van den Bosch BJC, 2012, J MED GENET, V49, P10, DOI 10.1136/jmedgenet-2011-100466; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	32	61	67	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1685	1690		10.1074/jbc.C112.436766	http://dx.doi.org/10.1074/jbc.C112.436766			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23223238	Green Published, hybrid			2022-12-28	WOS:000313751400024
J	Yu, YT; Mo, YK; Ebenezer, D; Bhattacharyya, S; Liu, H; Sundaravel, S; Giricz, O; Wontakal, S; Cartier, J; Caces, B; Artz, A; Nischal, S; Bhagat, T; Bathon, K; Maqbool, S; Gligich, O; Suzuki, M; Steidl, U; Godley, L; Skoultchi, A; Greally, J; Wickrema, A; Verma, A				Yu, Yiting; Mo, Yongkai; Ebenezer, David; Bhattacharyya, Sanchari; Liu, Hui; Sundaravel, Sriram; Giricz, Orsolya; Wontakal, Sandeep; Cartier, Jessy; Caces, Bennett; Artz, Andrew; Nischal, Sangeeta; Bhagat, Tushar; Bathon, Kathleen; Maqbool, Shahina; Gligich, Oleg; Suzuki, Masako; Steidl, Ulrich; Godley, Lucy; Skoultchi, Art; Greally, John; Wickrema, Amittha; Verma, Amit			High Resolution Methylome Analysis Reveals Widespread Functional Hypomethylation during Adult Human Erythropoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSINE METHYLATION; GENE-EXPRESSION; DNA METHYLATION; DIFFERENTIATION; GATA-1; CANCER; CELLS; PU.1; EPIGENETICS	Differentiation of hematopoietic stem cells to red cells requires coordinated expression of numerous erythroid genes and is characterized by nuclear condensation and extrusion during terminal development. To understand the regulatory mechanisms governing these widespread phenotypic changes, we conducted a high resolution methylomic and transcriptomic analysis of six major stages of human erythroid differentiation. We observed widespread epigenetic differences between early and late stages of erythropoiesis with progressive loss of methylation being the dominant change during differentiation. Gene bodies, intergenic regions, and CpG shores were preferentially demethylated during erythropoiesis. Epigenetic changes at transcription factor binding sites correlated significantly with changes in gene expression and were enriched for binding motifs for SCL, MYB, GATA, and other factors not previously implicated in erythropoiesis. Demethylation at gene promoters was associated with increased expression of genes, whereas epigenetic changes at gene bodies correlated inversely with gene expression. Important gene networks encoding erythrocyte membrane proteins, surface receptors, and heme synthesis proteins were found to be regulated by DNA methylation. Furthermore, integrative analysis enabled us to identify novel, potential regulatory areas of the genome as evident by epigenetic changes in a predicted PU.1 binding site in intron 1 of the GATA1 gene. This intronic site was found to be conserved across species and was validated to be a novel PU.1 binding site by quantitative ChIP in erythroid cells. Altogether, our study provides a comprehensive analysis of methylomic and transcriptomic changes during erythroid differentiation and demonstrates that human terminal erythropoiesis is surprisingly associated with hypomethylation of the genome.	[Yu, Yiting; Mo, Yongkai; Bhattacharyya, Sanchari; Giricz, Orsolya; Wontakal, Sandeep; Cartier, Jessy; Nischal, Sangeeta; Bhagat, Tushar; Bathon, Kathleen; Maqbool, Shahina; Gligich, Oleg; Suzuki, Masako; Steidl, Ulrich; Skoultchi, Art; Greally, John; Verma, Amit] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Ebenezer, David; Liu, Hui; Sundaravel, Sriram; Caces, Bennett; Artz, Andrew; Godley, Lucy; Wickrema, Amittha] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Yeshiva University; Albert Einstein College of Medicine; University of Chicago	Wickrema, A (corresponding author), Univ Chicago, Dept Med, MC2115,5841 South Maryland Ave, Chicago, IL 60637 USA.	awickrem@medicine.bsd.uchicago.edu; amit.verma@einstein.yu.edu	Greally, John/AAF-9540-2019; Suzuki, Masako/ABF-6497-2020	Greally, John/0000-0001-6069-7960; Suzuki, Masako/0000-0003-0605-9225; Sundaravel, Sriram/0000-0003-1638-710X; CARTIER, Jessy/0000-0002-0366-8546	National Institutes of Health [R01HL116336]; Partnership for Cures and Immunooncology Training Program Grant T32 (National Institutes of Health) [CA009173]; Leukemia and Lymphoma society; Department of Defense; Giving Tree Foundation; Searle Family Fund (Chicago Biomedical Consortium); William Deputy Memorial Fund; NATIONAL CANCER INSTITUTE [T32CA009173] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Partnership for Cures and Immunooncology Training Program Grant T32 (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma society(Leukemia and Lymphoma Society); Department of Defense(United States Department of Defense); Giving Tree Foundation; Searle Family Fund (Chicago Biomedical Consortium); William Deputy Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL116336 (to A. V. and A. W.) and Partnership for Cures and Immunooncology Training Program Grant T32 (National Institutes of Health) CA009173 (to A. V.). This work was also supported by the Leukemia and Lymphoma society (to A. V. and A. W.), the Department of Defense (to A. V.), the Giving Tree Foundation (to A. W.), the Searle Family Fund (Chicago Biomedical Consortium) (to A. W.), and the William Deputy Memorial Fund (to A. W. and A. A.).	Alvarez H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001356; Arai E, 2011, INT J CLIN EXP PATHO, V4, P58; Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Esteller M, 2003, ADV EXP MED BIOL, V532, P39; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Figueroa ME, 2009, BLOOD, V113, P2795, DOI 10.1182/blood-2008-08-172387; Figueroa ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001882; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kang JA, 2008, J BIOL CHEM, V283, P6997, DOI 10.1074/jbc.M706712200; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Oda M, 2009, NUCLEIC ACIDS RES, V37, P3829, DOI 10.1093/nar/gkp260; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Seshasayee D, 2000, J BIOL CHEM, V275, P22969, DOI 10.1074/jbc.M002931200; Shearstone JR, 2011, SCIENCE, V334, P799, DOI 10.1126/science.1207306; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Thompson RF, 2008, BIOINFORMATICS, V24, P1161, DOI 10.1093/bioinformatics/btn096; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; Wickrema A, 2007, ONCOGENE, V26, P6803, DOI 10.1038/sj.onc.1210763; Wontakal SN, 2012, P NATL ACAD SCI USA, V109, P3832, DOI 10.1073/pnas.1121019109; Wontakal SN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001392; Yamamoto ML, 2009, BLOOD, V113, P3363, DOI 10.1182/blood-2008-05-160325	26	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8805	8814		10.1074/jbc.M112.423756	http://dx.doi.org/10.1074/jbc.M112.423756			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23306203	Green Published, hybrid			2022-12-28	WOS:000316862200003
J	Ha, JH; Shin, JS; Yoon, MK; Lee, MS; He, F; Bae, KH; Yoon, HS; Lee, CK; Park, SG; Muto, Y; Chi, SW				Ha, Ji-Hyang; Shin, Jae-Sun; Yoon, Mi-Kyung; Lee, Min-Sung; He, Fahu; Bae, Kwang-Hee; Yoon, Ho Sup; Lee, Chong-Kil; Park, Sung Goo; Muto, Yutaka; Chi, Seung-Wook			Dual-site Interactions of p53 Protein Transactivation Domain with Anti-apoptotic Bcl-2 Family Proteins Reveal a Highly Convergent Mechanism of Divergent p53 Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL INTERACTIONS; ACTIVATION DOMAIN; BINDING DOMAIN; TAZ2 DOMAIN; NUCLEAR; COMPLEX; MODULATION; SUBDOMAINS; MUTANT; P300	Molecular interactions between the tumor suppressor p53 and the anti-apoptotic Bcl-2 family proteins play an important role in the transcription-independent apoptosis of p53. The p53 transactivation domain (p53TAD) contains two conserved Phi XX Phi Phi motifs (Phi indicates a bulky hydrophobic residue and X is any other residue) referred to as p53TAD1 (residues 15-29) and p53TAD2 (residues 39-57). We previously showed that p53TAD1 can act as a binding motif for anti-apoptotic Bcl-2 family proteins. In this study, we have identified p53TAD2 as a binding motif for anti-apoptotic Bcl-2 family proteins by using NMR spectroscopy, and we calculated the structures of Bcl-X-L/Bcl-2 in complex with the p53TAD2 peptide. NMR chemical shift perturbation data showed that p53TAD2 peptide binds to diverse members of the anti-apoptotic Bcl-2 family independently of p53TAD1, and the binding between p53TAD2 and p53TAD1 to Bcl-X-L is competitive. Refined structural models of the Bcl-X-L.p53TAD2 and Bcl-2.p53TAD2 complexes showed that the binding sites occupied by p53TAD2 in Bcl-X-L and Bcl-2 overlap well with those occupied by pro-apoptotic BH3 peptides. Taken together with the mutagenesis, isothermal titration calorimetry, and paramagnetic relaxation enhancement data, our structural comparisons provided the structural basis of p53TAD2-mediated interaction with the anti-apoptotic proteins, revealing that Bcl-X-L/Bcl-2, MDM2, and cAMP-response element-binding protein-binding protein/p300 share highly similar modes of binding to the dual p53TAD motifs, p53TAD1 and p53TAD2. In conclusion, our results suggest that the dual-site interaction of p53TAD is a highly conserved mechanism underlying target protein binding in the transcription-dependent and transcription-independent apoptotic pathways of p53.	[Ha, Ji-Hyang; Shin, Jae-Sun; Yoon, Mi-Kyung; Lee, Min-Sung; Bae, Kwang-Hee; Park, Sung Goo; Chi, Seung-Wook] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon 305806, South Korea; [Ha, Ji-Hyang; Lee, Chong-Kil] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea; [He, Fahu; Muto, Yutaka] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 637511, Singapore	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; RIKEN; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Muto, Y (corresponding author), RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	ymuto@gsc.riken.jp; swchi@kribb.re.kr	He, Fahu/N-1442-2014; Yoon, Ho Sup/A-2193-2011	Yoon, Ho Sup/0000-0002-8243-3904; Bae, Kwang-Hee/0000-0002-5868-2556	Korean Ministry of Education, Science and Technology [T32221]; National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0016011]	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	We thank Eun-Hee Kim for help with the NMR data collection and Dr. Eunha Hwang for use of the Auto-iTC<INF>200</INF> Microcalorimeter at Korea Basic Science Institute. This study made use of the NMR facility at Korea Basic Science Institute, which is supported by Advanced MR Technology Program of the Korean Ministry of Education, Science and Technology (T32221).; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0016011).	Acevedo ML, 2004, MOL CELL, V13, P725, DOI 10.1016/S1097-2765(04)00121-2; Arai M, 2012, J AM CHEM SOC, V134, P3792, DOI 10.1021/ja209936u; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bharatham N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026014; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; CHANG J, 1995, J BIOL CHEM, V270, P25014, DOI 10.1074/jbc.270.42.25014; Chi SW, 2005, J BIOL CHEM, V280, P38795, DOI 10.1074/jbc.M508578200; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Denisov AY, 2003, J BIOL CHEM, V278, P21124, DOI 10.1074/jbc.M301798200; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Feng HQ, 2009, STRUCTURE, V17, P202, DOI 10.1016/j.str.2008.12.009; Fernandez-Recio J, 2004, J MOL BIOL, V335, P843, DOI 10.1016/j.jmb.2003.10.069; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; Ha JH, 2011, J AM CHEM SOC, V133, P1244, DOI 10.1021/ja109521f; Hagn F, 2010, J BIOL CHEM, V285, P3439, DOI 10.1074/jbc.M109.065391; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jenkins LMM, 2009, BIOCHEMISTRY-US, V48, P1244, DOI 10.1021/bi801716h; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Lee CW, 2009, BIOCHEMISTRY-US, V48, P2115, DOI 10.1021/bi802055v; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rajagopalan S, 2010, P NATL ACAD SCI USA, V107, P8587, DOI 10.1073/pnas.1003689107; Rajagopalan S, 2009, J BIOL CHEM, V284, P21728, DOI 10.1074/jbc.M109.006429; Sayan BS, 2006, J BIOL CHEM, V281, P13566, DOI 10.1074/jbc.M512467200; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Shan B, 2012, J BIOL CHEM, V287, P30376, DOI 10.1074/jbc.M112.369793; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Sot B, 2007, J BIOL CHEM, V282, P29193, DOI 10.1074/jbc.M705544200; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Venot C, 1999, ONCOGENE, V18, P2405, DOI 10.1038/sj.onc.1202539; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P6765, DOI 10.1093/nar/gkp750; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Xu HB, 2006, BIOCHEM BIOPH RES CO, V341, P938, DOI 10.1016/j.bbrc.2005.12.227; Xu HB, 2009, BIOCHEMISTRY-US, V48, P12159, DOI 10.1021/bi901188s; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	49	37	37	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7387	7398		10.1074/jbc.M112.400754	http://dx.doi.org/10.1074/jbc.M112.400754			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23316052	hybrid, Green Published			2022-12-28	WOS:000316002400057
J	Hoogendijk, AJ; Pinhancos, SS; van der Poll, T; Wieland, CW				Hoogendijk, Arie J.; Pinhancos, Sandra S.; van der Poll, Tom; Wieland, Catharina W.			AMP-activated Protein Kinase Activation by 5-Aminoimidazole-4-carbox-amide-1-beta-D-ribofuranoside (AICAR) Reduces Lipoteichoic Acid-induced Lung Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INJURY; RECEPTOR; INHIBITION; PNEUMONIA; INFECTION; ADENOSINE; INNATE	Adenosine monophosphate-activated protein (AMP)-activated kinase (AMPK) is a highly conserved kinase that plays a key role in energy homeostasis. Activation of AMPK was shown to reduce inflammation in response to lipolysaccharide in vitro and in vivo. 5-Aminoimidazole-4-carbox-amide-1-beta-D-ribofuranoside (AICAR) is intracellularly converted to the AMP analog ZMP, which activates AMPK. Lipoteichoic acid (LTA) is a major component of the cell wall of Gram-positive bacteria that can trigger inflammatory responses. In contrast to lipopolysaccharide, little is known on the effects of AMPK activation in LTA-triggered innate immune responses. Here, we studied the potency of AMPK activation to reduce LTA-induced inflammation in vitro and in lungs in vivo. Activation of AMPK in vitro reduced cytokine production in the alveolar macrophage cell line MH-S. In vivo, AMPK activation reduced LTA-induced neutrophil influx, as well as protein leak and cytokine/chemokine levels in the bronchoalveolar space. In conclusion, AMPK activation inhibits LTA-induced lung inflammation in mice.	[Hoogendijk, Arie J.; Pinhancos, Sandra S.; van der Poll, Tom; Wieland, Catharina W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Hoogendijk, Arie J.; Pinhancos, Sandra S.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Wieland, Catharina W.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Hoogendijk, AJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9,G2-105, NL-1105 AZ Amsterdam, Netherlands.	a.j.hoogendijk@amc.uva.nl		Mimoso Pinhancos, Sandra Sofia/0000-0002-6748-5554				Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Davis KA, 2000, J TRAUMA, V49, P892, DOI 10.1097/00005373-200011000-00017; Fan JS, 2011, J IMMUNOL, V186, P2482, DOI 10.4049/jimmunol.0903634; Gaskin FS, 2007, AM J PHYSIOL-HEART C, V292, pH326, DOI 10.1152/ajpheart.00744.2006; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim TB, 2007, CLIN EXP ALLERGY, V37, P1709, DOI 10.1111/j.1365-2222.2007.02812.x; Knapp S, 2008, J IMMUNOL, V180, P3478, DOI 10.4049/jimmunol.180.5.3478; Leemans JC, 2002, AM J RESP CRIT CARE, V165, P1445, DOI 10.1164/rccm.2106045; Renckens R, 2007, BLOOD, V109, P1593, DOI 10.1182/blood-2006-05-025197; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Torres A, 2010, AM J RESP CRIT CARE, V181, P782, DOI 10.1164/rccm.201001-0030UP; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; van der Windt GJW, 2011, AM J RESP CELL MOL, V44, P377, DOI 10.1165/rcmb.2010-0158OC; van Zoelen MAD, 2009, AM J PATHOL, V174, P2182, DOI 10.2353/ajpath.2009.080914; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Zajkowicz A, 2011, MECH AGEING DEV, V132, P543, DOI 10.1016/j.mad.2011.09.002; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	23	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7047	7052		10.1074/jbc.M112.413138	http://dx.doi.org/10.1074/jbc.M112.413138			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23322781	Green Published, hybrid			2022-12-28	WOS:000316002400026
J	Nothaft, H; Szymanski, CM				Nothaft, Harald; Szymanski, Christine M.			Bacterial Protein N-Glycosylation: New Perspectives and Applications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INFLUENZAE HMW1 ADHESIN; GRAM-NEGATIVE BACTERIUM; CAMPYLOBACTER-JEJUNI; LINKED GLYCOSYLATION; ACTINOBACILLUS-PLEUROPNEUMONIAE; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; NEISSERIA-GONORRHOEAE; GLYCOPROTEIN; GLYCANS	Protein glycosylation is widespread throughout all three domains of life. Bacterial protein N-glycosylation and its application to engineering recombinant glycoproteins continue to be actively studied. Here, we focus on advances made in the last 2 years, including the characterization of novel bacterial N-glycosylation pathways, examination of pathway enzymes and evolution, biological roles of protein modification in the native host, and exploitation of the N-glycosylation pathways to create novel vaccines and diagnostics.	[Nothaft, Harald] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2E9, Canada; Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Alberta; University of Alberta	Nothaft, H (corresponding author), Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2E9, Canada.	nothaft@ualberta.ca; cszymans@ualberta.ca						Aas FE, 2006, J BIOL CHEM, V281, P27712, DOI 10.1074/jbc.M604324200; Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Anonsen JH, 2012, INFECT IMMUN, V80, P22, DOI 10.1128/IAI.05920-11; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Celik E, 2010, PROTEIN SCI, V19, P2006, DOI 10.1002/pro.472; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Chen MM, 2007, BIOCHEMISTRY-US, V46, P14342, DOI 10.1021/bi701956x; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Choi KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015888; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Cullen TW, 2010, P NATL ACAD SCI USA, V107, P5160, DOI 10.1073/pnas.0913451107; Davis LM, 2009, J BACTERIOL, V191, P1631, DOI 10.1128/JB.01394-08; Durr C, 2010, GLYCOBIOLOGY, V20, P1366, DOI 10.1093/glycob/cwq102; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Feldman MF, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P903; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Frasch CE, 2009, VACCINE, V27, P6468, DOI 10.1016/j.vaccine.2009.06.013; Glover KJ, 2006, BIOCHEMISTRY-US, V45, P5343, DOI 10.1021/bi0602056; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Grass S, 2003, MOL MICROBIOL, V48, P737, DOI 10.1046/j.1365-2958.2003.03450.x; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Hug I, 2011, J BIOL CHEM, V286, P37887, DOI 10.1074/jbc.M111.287755; Ielmini MV, 2011, GLYCOBIOLOGY, V21, P734, DOI 10.1093/glycob/cwq192; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Ihssen J, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-61; Iwashkiw JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-13; Jaffee MB, 2011, BIOCHEMISTRY-US, V50, P7557, DOI 10.1021/bi201018d; Jervis AJ, 2012, J BACTERIOL, V194, P2355, DOI 10.1128/JB.00042-12; Jervis AJ, 2010, J BACTERIOL, V192, P5228, DOI 10.1128/JB.00211-10; Kakuda T, 2006, INFECT IMMUN, V74, P4715, DOI 10.1128/IAI.00033-06; Kakuda T, 2012, VET MICROBIOL, V160, P53, DOI 10.1016/j.vetmic.2012.04.044; Kawai F, 2011, J BIOL CHEM, V286, P38546, DOI 10.1074/jbc.M111.237602; Kelly J, 2006, J BACTERIOL, V188, P2427, DOI 10.1128/JB.188.7.2427-2434.2006; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Ku SC, 2009, BIOCHEM BIOPH RES CO, V378, P84, DOI 10.1016/j.bbrc.2008.11.025; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; Larsen JC, 2004, J BACTERIOL, V186, P6508, DOI 10.1128/JB.186.19.6508-6514.2004; Lin J, 2003, INFECT IMMUN, V71, P4250, DOI 10.1128/IAI.71.8.4250-4259.2003; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lizak C, 2011, BIOCONJUGATE CHEM, V22, P488, DOI 10.1021/bc100511k; Lockhart Stephen, 2003, Expert Rev Vaccines, V2, P633, DOI 10.1586/14760584.2.5.633; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Nothaft H, 2012, MOL CELL PROTEOMICS, V11, P1203, DOI 10.1074/mcp.M112.021519; Nothaft Harald, 2010, Virulence, V1, P546, DOI 10.4161/viru.1.6.13801; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Nothaft H, 2009, P NATL ACAD SCI USA, V106, P15019, DOI 10.1073/pnas.0903078106; Olivier NB, 2006, BIOCHEMISTRY-US, V45, P13659, DOI 10.1021/bi061456h; Pandhal J, 2012, BIOCHEM BIOPH RES CO, V419, P472, DOI 10.1016/j.bbrc.2012.02.020; Pandhal J, 2011, BIOTECHNOL BIOENG, V108, P902, DOI 10.1002/bit.23011; Pandhal J, 2010, BIOTECHNOL LETT, V32, P1189, DOI 10.1007/s10529-010-0289-6; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Santos-Silva T, 2007, J MOL BIOL, V370, P659, DOI 10.1016/j.jmb.2007.04.055; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Schwarz F, 2011, J BIOL CHEM, V286, P35267, DOI 10.1074/jbc.M111.277160; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Scott NE, 2012, J BIOL CHEM, V287, P29384, DOI 10.1074/jbc.M112.380212; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Scott NE, 2009, J PROTEOME RES, V8, P4654, DOI 10.1021/pr900544x; Sharon N, 2007, GLYCOBIOLOGY, V17, P1150, DOI 10.1093/glycob/cwm089; St Geme JW, 1998, INFECT IMMUN, V66, P364; STGEME JW, 1993, P NATL ACAD SCI USA, V90, P2875, DOI 10.1073/pnas.90.7.2875; Stork R, 2008, J BIOL CHEM, V283, P7804, DOI 10.1074/jbc.M709179200; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Szymanski CM, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P259; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI 10.1093/glycob/cwg075; Trotter CL, 2008, VACCINE, V26, P4434, DOI 10.1016/j.vaccine.2008.05.073; Valderrama-Rincon JD, 2012, NAT CHEM BIOL, V8, P434, DOI [10.1038/NCHEMBIO.921, 10.1038/nchembio.921]; van Sorge NM, 2009, CELL MICROBIOL, V11, P1768, DOI 10.1111/j.1462-5822.2009.01370.x; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Weintraub A, 2003, CARBOHYD RES, V338, P2539, DOI 10.1016/j.carres.2003.07.008; Young EJ, 2000, CLIN INFECT DIS, V31, P904, DOI 10.1086/318129; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	92	108	113	5	72	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6912	6920		10.1074/jbc.R112.417857	http://dx.doi.org/10.1074/jbc.R112.417857			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329827	Green Published, hybrid			2022-12-28	WOS:000316002400013
J	Meinecke, M; Boucrot, E; Camdere, G; Hon, WC; Mittal, R; McMahon, HT				Meinecke, Michael; Boucrot, Emmanuel; Camdere, Gamze; Hon, Wai-Ching; Mittal, Rohit; McMahon, Harvey T.			Cooperative Recruitment of Dynamin and BIN/Amphiphysin/Rvs (BAR) Domain-containing Proteins Leads to GTP-dependent Membrane Scission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; SYNAPTIC VESICLE ENDOCYTOSIS; SH3 DOMAIN; CRYSTAL-STRUCTURE; NERVE-TERMINALS; COATED VESICLES; BINDING-SITE; AMPHIPHYSIN; ENDOPHILIN; CURVATURE	Dynamin mediates various membrane fission events, including the scission of clathrin-coated vesicles. Here, we provide direct evidence for cooperative membrane recruitment of dynamin with the BIN/ amphiphysin/Rvs (BAR) proteins, endophilin and amphiphysin. Surprisingly, endophilin and amphiphysin recruitment to membranes was also dependent on binding to dynamin due to auto-inhibition of BAR-membrane interactions. Consistent with reciprocal recruitment in vitro, dynamin recruitment to the plasma membrane in cells was strongly reduced by concomitant depletion of endophilin and amphiphysin, and conversely, depletion of dynamin dramatically reduced the recruitment of endophilin. In addition, amphiphysin depletion was observed to severely inhibit clathrin-mediated endocytosis. Furthermore, GTP-dependent membrane scission by dynamin was dramatically elevated by BAR domain proteins. Thus, BAR domain proteins and dynamin act in synergy in membrane recruitment and GTP-dependent vesicle scission.	[Meinecke, Michael; Boucrot, Emmanuel; Camdere, Gamze; Hon, Wai-Ching; Mittal, Rohit; McMahon, Harvey T.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Meinecke, Michael] Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany; [Boucrot, Emmanuel] UCL, Inst Struct & Mol Biol, Div Biosci, London WC1E 6BT, England	MRC Laboratory Molecular Biology; University of Gottingen; University of London; Birkbeck University London; University College London	Meinecke, M (corresponding author), Univ Gottingen, Abt Biochem 2, D-37073 Gottingen, Germany.	michael.meinecke@med.uni-goettingen.de; hmm@mrc-lmb.cam.ac.uk	Meinecke, Michael/C-4833-2013	Meinecke, Michael/0000-0003-1414-6951; Boucrot, Emmanuel/0000-0001-7312-6462	Medical Research Council [U105178805]; Human Frontiers Science Program Fellowship; Deutsche Forschungsgemeinschaft [SFB 803]; Medical Research Council [MC_U105178795] Funding Source: researchfish; MRC [MC_U105178795] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontiers Science Program Fellowship(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council File Reference U105178805, a Human Frontiers Science Program Fellowship (to M. M.), and Deutsche Forschungsgemeinschaft Grant SFB 803 (to M. M.).	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Lombardi R, 2001, J BIOL CHEM, V276, P6016, DOI 10.1074/jbc.M008735200; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shpetner HS, 1996, J BIOL CHEM, V271, P13, DOI 10.1074/jbc.271.1.13; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355	47	99	101	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6651	6661		10.1074/jbc.M112.444869	http://dx.doi.org/10.1074/jbc.M112.444869			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23297414	hybrid, Green Published			2022-12-28	WOS:000315820700064
J	Allman, E; Waters, K; Ackroyd, S; Nehrke, K				Allman, Erik; Waters, Korrie; Ackroyd, Sarah; Nehrke, Keith			Analysis of Ca2+ Signaling Motifs That Regulate Proton Signaling through the Na+/H+ Exchanger NHX-7 during a Rhythmic Behavior in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCINEURIN HOMOLOGOUS PROTEIN; MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; ESSENTIAL COFACTOR; EXTRACELLULAR PH; NERVE-TERMINALS; MOTOR PROGRAM; NA; IDENTIFICATION; CHANNELS	Membrane proton transporters contribute to pH homeostasis but have also been shown to transmit information between cells in close proximity through regulated proton secretion. For example, the nematode intestinal Na+/H+ exchanger NHX-7 causes adjacent muscle cells to contract by transiently acidifying the extracellular space between the intestine and muscle. NHX-7 operates during a Ca2+- dependent rhythmic behavior and contains several conserved motifs for regulation by Ca2+ input, including motifs for calmodulin and phosphatidylinositol 4,5-bisphosphate binding, protein kinase C- and calmodulin-dependent protein kinase type II phosphorylation, and a binding site for calcineurin homologous protein. Here, we tested the idea that Ca2+ input differentiates proton signaling from pH housekeeping activity. Each of these motifs was mutated, and their contribution to NHX-7 function was assessed. These functions included pH recovery from acidification in cells in culture expressing recombinant NHX-7, extracellular acidification measured during behavior in live moving worms, and muscle contraction strength as a result of this acidification. Our data suggest that multiple levels of Ca2+ input regulate NHX-7, whose transport capacity normally exceeds the minimum necessary to cause muscle contraction. Furthermore, extracellular acidification limits NHX-7 proton transport through feedback inhibition, likely to prevent metabolic acidosis from occurring. Our findings are consistent with an integrated network whereby both Ca2+ and pH contribute to proton signaling. Finally, our results obtained by expressing rat NHE1 in Caenorhabditis elegans suggest that a conserved mechanism of regulation may contribute to cell-cell communication or proton signaling by Na+/H+ exchangers in mammals.	[Allman, Erik; Nehrke, Keith] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Ackroyd, Sarah; Nehrke, Keith] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Waters, Korrie] Ohio Univ, Dept Family Med, Athens, OH 45701 USA	University of Rochester; University of Rochester; Ohio University	Nehrke, K (corresponding author), Univ Rochester, Med Ctr, Dept Med, 601 Elmwood Ave, Rochester, NY 14642 USA.	keith_nehrke@urmc.rochester.edu		Allman, Erik/0000-0002-6560-0889; Nehrke, Keith/0000-0001-9697-726X; Ackroyd, Sarah/0000-0001-9070-616X	Ruth L. Kirschstein National Research Service Institutional Award from the National Institutes of Health [GM068411]; National Science Foundation Grant [IOS0919848]; National Institutes of Health Office of Research Infrastructure Program [P40 OD010440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Institutional Award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Grant(National Science Foundation (NSF)); National Institutes of Health Office of Research Infrastructure Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Ruth L. Kirschstein National Research Service Institutional Award GM068411 from the National Institutes of Health (to E. A.). This work was also supported by National Science Foundation Grant IOS0919848 (to K. N.).; We thank Teresa Sherman for technical assistance, Dr. L. Pablo Cid for the extracellular pH sensor, and Dr. Maureen Peters for critical comments. Some strains used in this work were provided by the C. elegans Gene Knockout Consortium and the Caenorhabditis Genetics Center, which is supported by National Institutes of Health Office of Research Infrastructure Program P40 OD010440.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Allman E, 2009, AM J PHYSIOL-CELL PH, V297, pC1071, DOI 10.1152/ajpcell.00284.2009; Alper SL, 2002, ANNU REV PHYSIOL, V64, P899, DOI 10.1146/annurev.physiol.64.092801.141759; ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Baird NR, 1999, J BIOL CHEM, V274, P4377, DOI 10.1074/jbc.274.7.4377; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; BRENNER S, 1974, GENETICS, V77, P71; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; COBBE SM, 1980, J MOL CELL CARDIOL, V12, P745, DOI 10.1016/0022-2828(80)90077-2; CROLL NA, 1978, J ZOOL, V184, P507; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Diering GH, 2011, MOL BIOL CELL, V22, P2246, DOI 10.1091/mbc.E11-01-0066; Dietrich CJ, 2010, J NEUROSCI, V30, P16044, DOI 10.1523/JNEUROSCI.6364-09.2010; DRAY A, 1995, BRIT J ANAESTH, V75, P125, DOI 10.1093/bja/75.2.125; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; FLIEGEL L, 1992, BIOCHEM J, V282, P139, DOI 10.1042/bj2820139; Garbern JY, 2010, BRAIN, V133, P1391, DOI 10.1093/brain/awq071; Goyal S, 2003, AM J PHYSIOL-RENAL, V284, pF467, DOI 10.1152/ajprenal.00352.2002; He PJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/238080; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Imahashi K, 2007, AM J PHYSIOL-HEART C, V292, pH2237, DOI 10.1152/ajpheart.00855.2006; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; IWASAKI K, 1995, P NATL ACAD SCI USA, V92, P10317, DOI 10.1073/pnas.92.22.10317; Jang IS, 2006, J NEUROCHEM, V99, P1224, DOI 10.1111/j.1471-4159.2006.04168.x; Johnson D, 2012, AM J PHYSIOL-CELL PH, V302, pC1045, DOI 10.1152/ajpcell.00411.2011; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; Li SY, 2004, J CLIN INVEST, V114, P1782, DOI 10.1172/JCI200418046; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; LIU DWC, 1994, J NEUROSCI, V14, P1953; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nehrke K, 2008, AM J PHYSIOL-CELL PH, V294, pC333, DOI 10.1152/ajpcell.00303.2007; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; Nehrke K, 2002, J BIOL CHEM, V277, P29036, DOI 10.1074/jbc.M203200200; NOEL J, 1995, AM J PHYSIOL-CELL PH, V268, pC283, DOI 10.1152/ajpcell.1995.268.2.C283; Numata M, 1998, J BIOL CHEM, V273, P6951, DOI 10.1074/jbc.273.12.6951; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Pfeiffer J, 2008, CURR BIOL, V18, P297, DOI 10.1016/j.cub.2008.01.054; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rocha MA, 2008, J NEUROCHEM, V106, P231, DOI 10.1111/j.1471-4159.2008.05355.x; ROTIN D, 1989, CANCER RES, V49, P205; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Teramoto T, 2006, CELL CALCIUM, V40, P319, DOI 10.1016/j.ceca.2006.04.009; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; THOMAS JH, 1990, GENETICS, V124, P855; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; Trudeau LE, 1999, J NEUROPHYSIOL, V81, P2627, DOI 10.1152/jn.1999.81.6.2627; Urra J, 2008, PFLUG ARCH EUR J PHY, V457, P233, DOI 10.1007/s00424-008-0497-2; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; Vila-Petroff M, 2010, J MOL CELL CARDIOL, V49, P106, DOI 10.1016/j.yjmcc.2009.12.007; Wagner J, 2011, AM J PHYSIOL-CELL PH, V301, pC1389, DOI 10.1152/ajpcell.00139.2011; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WANG Z, 1993, J BIOL CHEM, V268, P11925; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xing J, 2010, AM J PHYSIOL-CELL PH, V298, pC274, DOI 10.1152/ajpcell.00394.2009	70	5	8	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5886	5895		10.1074/jbc.M112.434852	http://dx.doi.org/10.1074/jbc.M112.434852			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23319594	Green Published, hybrid			2022-12-28	WOS:000315342500058
J	Martinez-Macias, MI; Cordoba-Canero, D; Ariza, RR; Roldan-Arjona, T				Isabel Martinez-Macias, Maria; Cordoba-Canero, Dolores; Ariza, Rafael R.; Roldan-Arjona, Teresa			The DNA Repair Protein XRCC1 Functions in the Plant DNA Demethylation Pathway by Stimulating Cytosine Methylation (5-meC) Excision, Gap Tailoring, and DNA Ligation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; ARABIDOPSIS-THALIANA; LIGASE-III; GLYCOSYLASE/LYASE ROS1; MOLECULAR-CLONING; SINGLE; DEMETER; DOMAIN; GENE; GENOME	DNA methylation patterns are the dynamic outcome of antagonist methylation and demethylation mechanisms, but the latter are still poorly understood. Active DNA demethylation in plants is mediated by a family of DNA glycosylases typified by Arabidopsis ROS1 (repressor of silencing 1). ROS1 and its homologs remove 5-methylcytosine and incise the sugar backbone at the abasic site, thus initiating a base excision repair pathway that finally inserts an unmethylated cytosine. The DNA 3'-phosphatase ZDP processes some of the incision products generated by ROS1, allowing subsequent DNA polymerization and ligation steps. In this work, we examined the possible role of plant XRCC1 (x-ray cross-complementing group protein 1) in DNA demethylation. We found that XRCC1 interacts in vitro with ROS1 and ZDP and stimulates the enzymatic activity of both proteins. Furthermore, extracts from xrcc1 mutant plants exhibit a reduced capacity to complete DNA demethylation initiated by ROS1. An anti-XRCC1 antibody inhibits removal of the blocking 3'-phosphate in the single-nucleotide gap generated during demethylation and reduces the capacity of Arabidopsis cell extracts to ligate a nicked DNA intermediate. Our results suggest that XRCC1 is a component of plant base excision repair and functions at several stages during active DNA demethylation in Arabidopsis.	[Isabel Martinez-Macias, Maria; Cordoba-Canero, Dolores; Ariza, Rafael R.; Roldan-Arjona, Teresa] Univ Cordoba, Dept Genet, Maimonides Inst Biomed Res IMIBIC, E-14071 Cordoba, Spain	Universidad de Cordoba	Roldan-Arjona, T (corresponding author), Univ Cordoba, Dept Genet, Edif Gregor Mendel,Campus Rabanales S-N, E-14071 Cordoba, Spain.	ge2roarm@uco.es	Martinez Macias, Maria Isabel/ACH-3606-2022; Roldan-Arjona, Teresa/H-5976-2015; Macias, Maria Isabel Martinez/B-4571-2019; Cordoba Canero, Dolores/H-8450-2018	Martinez Macias, Maria Isabel/0000-0001-8611-476X; Roldan-Arjona, Teresa/0000-0003-2842-3956; Macias, Maria Isabel Martinez/0000-0001-8611-476X; Rodriguez Ariza, Rafael/0000-0002-0338-7306; Cordoba Canero, Dolores/0000-0002-9659-4928	Spanish Ministry of Economy and Competitiveness; European Regional Development Fund [BFU2010-18838]; Junta de Andalucia [P07-CVI-02770]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund(European Commission); Junta de Andalucia(Junta de Andalucia)	This work was supported by the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (Grant BFU2010-18838) and by the Junta de Andalucia (Grant P07-CVI-02770).; Recipient of a Ph. D. fellowship from the Spanish Ministry of Economy and Competitiveness.	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Akbari M, 2010, DNA REPAIR, V9, P785, DOI 10.1016/j.dnarep.2010.04.002; Ali AAE, 2009, NUCLEIC ACIDS RES, V37, P1701, DOI 10.1093/nar/gkn1086; Andreuzza S, 2010, DEVELOPMENT, V137, P73, DOI 10.1242/dev.041020; Babiychuk E, 1998, PLANT J, V15, P635, DOI 10.1046/j.1365-313x.1998.00240.x; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Campalans A, 2005, DNA REPAIR, V4, P826, DOI 10.1016/j.dnarep.2005.04.014; Charbonnel C, 2010, PLANT J, V64, P280, DOI 10.1111/j.1365-313X.2010.04331.x; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cordoba-Canero Dolores, 2012, Methods Mol Biol, V920, P263, DOI 10.1007/978-1-61779-998-3_18; Cordoba-Canero D, 2011, PLANT J, V68, P693, DOI 10.1111/j.1365-313X.2011.04720.x; Cordoba-Canero D, 2009, PLANT J, V60, P716, DOI 10.1111/j.1365-313X.2009.03994.x; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Gong ZZ, 2011, CELL RES, V21, P1649, DOI 10.1038/cr.2011.140; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hays JB, 2002, DNA REPAIR, V1, P579, DOI 10.1016/S1568-7864(02)00093-9; Martinez-Macias MI, 2012, MOL CELL, V45, P357, DOI 10.1016/j.molcel.2011.11.034; Ponferrada-Marin MI, 2012, NUCLEIC ACIDS RES, V40, P11554, DOI 10.1093/nar/gks894; Ponferrada-Marin MI, 2010, J BIOL CHEM, V285, P23030, DOI 10.1074/jbc.M110.124578; Ponferrada-Marin MI, 2009, NUCLEIC ACIDS RES, V37, P4264, DOI 10.1093/nar/gkp390; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Mackey ZB, 1997, MOL CELL BIOL, V17, P989, DOI 10.1128/MCB.17.2.989; Mani RS, 2004, BIOCHEMISTRY-US, V43, P16505, DOI 10.1021/bi048615m; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Nazarkina ZK, 2007, DNA REPAIR, V6, P254, DOI 10.1016/j.dnarep.2006.10.002; Ortega-Galisteo AP, 2008, PLANT MOL BIOL, V67, P671, DOI 10.1007/s11103-008-9346-0; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Roldan-Arjona T., 2009, DNA RNA MODIFICATION, P149; Taylor RM, 1998, PLANT J, V14, P75, DOI 10.1046/j.1365-313X.1998.00094.x; Taylor RM, 2002, MOL CELL BIOL, V22, P2556, DOI 10.1128/MCB.22.8.2556-2563.2002; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; Uchiyama Y, 2008, PLANTA, V227, P1233, DOI 10.1007/s00425-008-0695-3; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Waterworth WM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-79; WEI YF, 1995, MOL CELL BIOL, V15, P3206; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Wu YQ, 2001, PLANT MOL BIOL, V46, P161, DOI 10.1023/A:1010679901911; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	51	24	30	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5496	5505		10.1074/jbc.M112.427617	http://dx.doi.org/10.1074/jbc.M112.427617			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23316050	Green Published, hybrid			2022-12-28	WOS:000315342500024
J	Panwar, P; Du, X; Sharma, V; Lamour, G; Castro, M; Li, HB; Bromme, D				Panwar, Preety; Du, Xin; Sharma, Vidhu; Lamour, Guillaume; Castro, Mickael; Li, Hongbin; Broemme, Dieter			Effects of Cysteine Proteases on the Structural and Mechanical Properties of Collagen Fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT TAIL TENDON; ATOMIC-FORCE MICROSCOPY; I COLLAGEN; CATHEPSIN-K; DECORIN; GLYCOSAMINOGLYCANS; FIBRILS; COMPLEX; PROTEOGLYCAN; ORGANIZATION	Excessive cathepsin K (catK)-mediated turnover of fibrillar type I and II collagens in bone and cartilage leads to osteoporosis and osteoarthritis. However, little is known about how catK degrades compact collagen macromolecules. The present study is aimed to explore the structural and mechanical consequences of collagen fiber degradation by catK. Mouse tail type I collagen fibers were incubated with either catK or non-collagenase cathepsins. Methods used include scanning electron microscopy, protein electrophoresis, atomic force microscopy, and tensile strength testing. Our study revealed evidence of proteoglycan network degradation, followed by the progressive disassembly of macroscopic collagen fibers into primary structural elements by catK. Proteolytically released GAGs are involved in the generation of collagenolytically active catK-GAG complexes as shown by AFM. In addition to their structural disintegration, a decrease in the tensile properties of fibers was observed due to the action of catK. The Young's moduli of untreated collagen fibers versus catK-treated fibers in dehydrated conditions were 3.2 +/- 0.68 GPa and 1.9 +/- 0.65 GPa, respectively. In contrast, cathepsin L, V, B, and S revealed no collagenase activity, except the disruption of proteoglycan-GAG interfibrillar bridges, which slightly decreased the tensile strength of fibers.	[Panwar, Preety; Du, Xin; Sharma, Vidhu; Broemme, Dieter] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Broemme, Dieter] Univ British Columbia, Fac Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Lamour, Guillaume; Li, Hongbin] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Castro, Mickael] Univ Bretagne Sud, Lab Ingn Mat Bretagne, European Univ Brittany, F-56100 Lorient, France	University of British Columbia; University of British Columbia; University of British Columbia	Bromme, D (corresponding author), Univ British Columbia, Fac Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	dbromme@dentistry.ubc.ca	Li, Hongbin/G-2949-2012; Lamour, Guillaume/D-6758-2015	Li, Hongbin/0000-0001-7813-1332; Lamour, Guillaume/0000-0002-9331-5532; CASTRO, Mickael/0000-0002-9694-9274; Sharma, Vidhu/0000-0003-3451-2736	Canadian Institutes of Health Research [MOP89974]; Canada Research Chair award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by Canadian Institutes of Health Research Grant MOP89974 and the Canada Research Chair award.	BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BASELT DR, 1993, BIOPHYS J, V65, P2644, DOI 10.1016/S0006-3495(93)81329-8; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Billinghurst RC, 2000, ARTHRITIS RHEUM, V43, P664, DOI 10.1002/1529-0131(200003)43:3<664::AID-ANR24>3.0.CO;2-D; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; BURLEIGH MC, 1974, BIOCHEM J, V137, P387, DOI 10.1042/bj1370387; Eppell SJ, 2006, J R SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Fratzl P., 2008, COLLAGEN STRUCTURE M, DOI 10.1007/978-0-387-73906-9; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0; Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0; KIRSCHKE H, 1982, BIOCHEM J, V201, P367, DOI 10.1042/bj2010367; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; Liu XH, 2005, BIOCHEM BIOPH RES CO, V338, P1342, DOI 10.1016/j.bbrc.2005.10.096; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; OKUYAMA K, 1977, POLYM J, V9, P341, DOI 10.1295/polymj.9.341; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Orgel JPRO, 2001, STRUCTURE, V9, P1061, DOI 10.1016/S0969-2126(01)00669-4; Ottani V, 2002, MICRON, V33, P587, DOI 10.1016/S0968-4328(02)00033-1; Paige MF, 2001, MICRON, V32, P341, DOI 10.1016/S0968-4328(00)00037-8; Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005; Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033; Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430; RASPANTI M, 1989, INT J BIOL MACROMOL, V11, P367, DOI 10.1016/0141-8130(89)90009-3; Raspanti M, 2008, J STRUCT BIOL, V164, P134, DOI 10.1016/j.jsb.2008.07.001; Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7; Rees SG, 2000, BIOCHEM J, V350, P181, DOI 10.1042/0264-6021:3500181; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; SCOTT JE, 1981, BIOCHEM J, V195, P573, DOI 10.1042/bj1950573; SCOTT JE, 1992, FASEB J, V6, P2639, DOI 10.1096/fasebj.6.9.1612287; Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0; Starborg T, 2008, METHODS, V45, P53, DOI 10.1016/j.ymeth.2008.01.004; Tan EPS, 2005, BIOMATERIALS, V26, P1453, DOI 10.1016/j.biomaterials.2004.05.021; van der Rijt JAJ, 2006, MACROMOL BIOSCI, V6, P697, DOI 10.1002/mabi.200600063; Vesentini S, 2005, J BIOMECH, V38, P433, DOI 10.1016/j.jbiomech.2004.04.032; Yamashita DS, 2000, CURR PHARM DESIGN, V6, P1, DOI 10.2174/1381612003401569; Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058; Yasuda Y, 2005, ADV DRUG DELIVER REV, V57, P973, DOI 10.1016/j.addr.2004.12.013; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	49	71	73	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5940	5950		10.1074/jbc.M112.419689	http://dx.doi.org/10.1074/jbc.M112.419689			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297404	Green Published, hybrid			2022-12-28	WOS:000315342500062
J	Yang, RT; Lim, GL; Dong, ZH; Lee, AM; Yee, CT; Fuller, RS; Ritchie, HH				Yang, Robert T.; Lim, Glendale L.; Dong, Zhihong; Lee, Arthur M.; Yee, Colin T.; Fuller, Robert S.; Ritchie, Helena H.			The Efficiency of Dentin Sialoprotein-Phosphophoryn Processing Is Affected by Mutations Both Flanking and Distant from the Cleavage Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; SIALOPHOSPHOPROTEIN DSPP; PROTEASES; GENE; PROTEINS; SPECIFICITY; NUCLEOTIDE; INHIBITOR; UROKINASE; SUBSTRATE	Normal dentin mineralization re quires two highly acidic proteins, dentin sialoprotein (DSP) and phosphophoryn (PP). DSP and PP are synthesized as part of a single secreted precursor, DSP-PP, which is conserved in marsupial and placental mammals. Using a baculovirus expression system, we previously found that DSP-PP is accurately cleaved into DSP and PP after secretion into medium by an endogenous, secreted, zinc-dependent Sf9 cell activity. Here we report that mutation of conserved residues near and distant from the G(447)down arrow D-448 cleavage site in DSP-PP240 had dramatic effects on cleavage efficiency by the endogenous Sf9 cell processing enzyme. We found that: 1) mutation of residues flanking the cleavage site from P4 to P4' blocked, impaired, or enhanced DSP-PP240 cleavage; 2) certain conserved amino acids distant from the cleavage site were important for precursor cleavage; 3) modification of the C terminus by appending a C-terminal tag altered the pattern of processing; and 4) mutations in DSP-PP240 had similar effects on cleavage by recombinant human BMP1, a candidate physiological processing enzyme, as was seen with the endogenous Sf9 cell activity. An analysis of a partial TLR1 cDNA from Sf9 cells indicates that residues that line the substrate-binding cleft of Sf9 TLR1 and human BMP1 are nearly perfectly conserved, offering an explanation of why Sf9 cells so accurately process mammalian DSP-PP. The fact that several mutations in DSP-PP240 significantly modified the amount of PP240 product generated from DSP-PP240 precursor protein cleavage suggests that such mutation may affect the mineralization process.	[Yang, Robert T.; Lim, Glendale L.; Dong, Zhihong; Lee, Arthur M.; Yee, Colin T.; Ritchie, Helena H.] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA; [Fuller, Robert S.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fuller, RS (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 3220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	bfuller@umich.edu; helenar@umich.edu			National Institutes of Health from the NIDCR [DE18901]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018901] Funding Source: NIH RePORTER	National Institutes of Health from the NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE18901 from the NIDCR (to H.H.R.).	Butler W T, 1995, Connect Tissue Res, V33, P59, DOI 10.3109/03008209509016983; Crossen R., 1996, BACULOVIRUS EXPRESSI; DEBIE I, 1995, J BIOL CHEM, V270, P1020, DOI 10.1074/jbc.270.3.1020; Godovikova V, 2006, DEV BIOL, V289, P507, DOI 10.1016/j.ydbio.2005.10.002; Godovikova V, 2007, J BIOL CHEM, V282, P31341, DOI 10.1074/jbc.M702605200; Gu K, 2000, EUR J ORAL SCI, V108, P35, DOI 10.1034/j.1600-0722.2000.00765.x; Gu KN, 1998, EUR J ORAL SCI, V106, P1043, DOI 10.1046/j.0909-8836..t01-9-.x; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Ke SH, 1997, J BIOL CHEM, V272, P16603, DOI 10.1074/jbc.272.26.16603; Ke SH, 1997, J BIOL CHEM, V272, P20456, DOI 10.1074/jbc.272.33.20456; LINDE A, 1989, CALCIFIED TISSUE INT, V44, P286, DOI 10.1007/BF02553763; LINDE A, 1989, ANAT REC, V224, P154, DOI 10.1002/ar.1092240206; Qin CL, 2001, J BIOL CHEM, V276, P904, DOI 10.1074/jbc.M006271200; Rajpar MH, 2002, HUM MOL GENET, V11, P2559, DOI 10.1093/hmg/11.21.2559; Ritchie HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041110; Ritchie HH, 2000, BBA-GENE STRUCT EXPR, V1493, P27, DOI 10.1016/S0167-4781(00)00150-0; Ritchie HH, 2001, BBA-GENE STRUCT EXPR, V1520, P212, DOI 10.1016/S0167-4781(01)00274-3; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Rockwell NC, 2002, J BIOL CHEM, V277, P17531, DOI 10.1074/jbc.M111909200; ROEBROEK AJM, 1993, EMBO J, V12, P1853, DOI 10.1002/j.1460-2075.1993.tb05834.x; ROEBROEK AJM, 1995, DNA CELL BIOL, V14, P223, DOI 10.1089/dna.1995.14.223; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Sun Y, 2010, J DENT RES, V89, P498, DOI 10.1177/0022034510363109; Tsuchiya S, 2011, J BONE MINER RES, V26, P220, DOI 10.1002/jbmr.202; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Wermter C, 2007, BIOL CHEM, V388, P513, DOI 10.1515/BC.2007.054; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	31	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					6024	6033		10.1074/jbc.M112.382952	http://dx.doi.org/10.1074/jbc.M112.382952			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297400	Green Published, hybrid			2022-12-28	WOS:000315342500070
J	Botelho, SC; Tatsuta, T; von Heijne, G; Kim, H				Botelho, Salome Calado; Tatsuta, Takashi; von Heijne, Gunnar; Kim, Hyun			Dislocation by the m-AAA Protease Increases the Threshold Hydrophobicity for Retention of Transmembrane Helices in the Inner Membrane of Yeast Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; RHOMBOID PROTEASE; SEQUENCE; MGM1; RECOGNITION; TRANSLOCON; MORPHOLOGY; INSERTION; PROTEINS	Sorting of mitochondrial inner membrane proteins is a complex process in which translocons and proteases function in a concerted way. Many inner membrane proteins insert into the membrane via the TIM23 translocon, and some are then further acted upon by the mitochondrial m-AAA protease, a molecular motor capable of dislocating proteins from the inner membrane. This raises the possibility that the threshold hydrophobicity for the retention of transmembrane segments in the inner membrane is different depending on whether they belong to membrane proteins that are m-AAA protease substrates or not. Here, using model transmembrane segments engineered into m-AAA protease-dependent proteins, we show that the threshold hydrophobicity for membrane retention measured in yeast cells in the absence of a functional m-AAA protease is markedly lower than that measured in its presence. Whether a given hydrophobic segment in a mitochondrial inner membrane protein will ultimately form a transmembrane helix may therefore depend on whether or not it will be exposed to the pulling force exerted by the m-AAA protease during biogenesis.	[Botelho, Salome Calado; von Heijne, Gunnar; Kim, Hyun] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Kim, Hyun] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, SE-17121 Stockholm, Sweden; [Tatsuta, Takashi] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Tatsuta, Takashi] Univ Cologne, Ctr Mol Med CMMC, D-50674 Cologne, Germany	Stockholm University; Seoul National University (SNU); Stockholm University; University of Cologne; University of Cologne	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se; joy@snu.ac.kr	von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011	von Heijne, Gunnar/0000-0002-4490-8569	Swedish Research Council; Swedish Cancer Foundation; Swedish Foundation for Strategic Research; European Research Council [ERC-2008-AdG 232648]; National Research Foundation of Korea [NRF0409-20100093, GRN-C00048]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/36107/2007]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Research Council(European Research Council (ERC)European Commission); National Research Foundation of Korea(National Research Foundation of Korea); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported in part by grants from the Swedish Research Council, the Swedish Cancer Foundation, and the Swedish Foundation for Strategic Research and European Research Council Grant ERC-2008-AdG 232648 (to G. v. H.) and by National Research Foundation of Korea Grants NRF0409-20100093 and GRN-C00048 (to H. K.).; Recipient of Graduate Student Fellowship SFRH/BD/36107/2007 from the Fundacao para a Ciencia e a Tecnologia, Portugal.	Arlt H, 1998, EMBO J, V17, P4837, DOI 10.1093/emboj/17.16.4837; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Bonn F, 2011, EMBO J, V30, P2545, DOI 10.1038/emboj.2011.169; Botelho SC, 2011, EMBO J, V30, P1003, DOI 10.1038/emboj.2011.29; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; FUKUHARA H, 1978, MOL GEN GENET, V162, P191, DOI 10.1007/BF00267876; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hessa T, 2009, J MOL BIOL, V386, P1222, DOI 10.1016/j.jmb.2009.01.027; Jiang H, 2006, J INORG BIOCHEM, V100, P1996, DOI 10.1016/j.jinorgbio.2006.07.017; Korbel D, 2004, EMBO REP, V5, P698, DOI 10.1038/sj.embor.7400186; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Osterberg M, 2011, FEBS LETT, V585, P1238, DOI 10.1016/j.febslet.2011.03.056; Schafer A, 2010, J MOL BIOL, V401, P182, DOI 10.1016/j.jmb.2010.06.014; SPEE JH, 1993, NUCLEIC ACIDS RES, V21, P777, DOI 10.1093/nar/21.3.777; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Tatsuta T, 2009, RES MICROBIOL, V160, P711, DOI 10.1016/j.resmic.2009.09.005; TAUER R, 1994, FEBS LETT, V353, P197, DOI 10.1016/0014-5793(94)01045-5; VANLOON APGM, 1986, CELL, V44, P801, DOI 10.1016/0092-8674(86)90846-9; VONHEIJNE G, 1986, FEBS LETT, V198, P1, DOI 10.1016/0014-5793(86)81172-3	25	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4792	4798		10.1074/jbc.M112.430892	http://dx.doi.org/10.1074/jbc.M112.430892			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283966	Green Published, hybrid			2022-12-28	WOS:000315340400028
J	Chikka, MR; McCabe, DD; Tyra, HM; Rutkowski, DT				Chikka, Madhusudana R.; McCabe, Diane DeZwaan; Tyra, Heather M.; Rutkowski, D. Thomas			C/EBP Homologous Protein (CHOP) Contributes to Suppression of Metabolic Genes during Endoplasmic Reticulum Stress in the Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR CHOP; ER STRESS; MESSENGER-RNA; CELL-SURVIVAL; EXPRESSION; BINDING; BETA; INHIBITION; INDUCTION; GADD153	The unfolded protein response (UPR) senses stress in the endoplasmic reticulum (ER) and initiates signal transduction cascades that culminate in changes to gene regulation. Long recognized as a means for improving ER protein folding through up-regulation of ER chaperones, the UPR is increasingly recognized to play a role in the regulation of metabolic pathways. ER stress is clearly connected to altered metabolism in tissues such as the liver, but the mechanisms underlying this connection are only beginning to be elucidated. Here, working exclusively in vivo, we tested the hypothesis that the UPR-regulated CCAAT/enhancer-binding protein (C/EBP) homologous protein (CHOP) participates in the transcriptional regulation of metabolism during hepatic ER stress. We found that metabolic dysregulation was associated with induction of eIF2 alpha signaling and CHOP up-regulation during challenge with tunicamycin or Velcade. CHOP was necessary for suppression of genes encoding the transcriptional master regulators of lipid metabolism: Cebpa, Ppara, and Srebf1. This action of CHOP required a contemporaneous CHOP-independent stress signal. CHOP bound directly to C/EBP-binding regions in the promoters of target genes, whereas binding of C/EBP alpha and C/EBP beta to the same regions was diminished during ER stress. Our results thus highlight a role for CHOP in the transcriptional regulation of metabolism.	[Chikka, Madhusudana R.; McCabe, Diane DeZwaan; Tyra, Heather M.; Rutkowski, D. Thomas] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Rutkowski, D. Thomas] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52246 USA	University of Iowa; University of Iowa	Rutkowski, DT (corresponding author), Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, 51 Newton Rd, Iowa City, IA 52246 USA.	thomas-rutkowski@uiowa.edu		Rutkowski, Thomas/0000-0001-6586-4449	National Institutes of Health from NIDDK [R01 DK084058]; Carver Medical Research Trust Initiative; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084058] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Carver Medical Research Trust Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK084058 from NIDDK (to D. T. R.). This work was also supported by the Carver Medical Research Trust Initiative.	Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Bek MF, 2006, AM J PATHOL, V168, P20, DOI 10.2353/ajpath.2006.040774; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Fawcett TW, 1996, J BIOL CHEM, V271, P14285, DOI 10.1074/jbc.271.24.14285; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Gao JH, 2011, CIRCULATION, V124, P830, DOI 10.1161/CIRCULATIONAHA.110.014050; Gow A, 2009, CURR OPIN NEUROBIOL, V19, P505, DOI 10.1016/j.conb.2009.08.007; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Ishikawa F, 2009, J BIOCHEM, V146, P123, DOI 10.1093/jb/mvp052; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Maris M, 2012, DIABETOLOGIA, V55, P1167, DOI 10.1007/s00125-011-2427-7; Oliveira SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006618; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Ryu D, 2011, DIABETES, V60, P1072, DOI 10.2337/db10-1046; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; So JS, 2012, CELL METAB, V16, P487, DOI 10.1016/j.cmet.2012.09.004; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Su QZ, 2009, HEPATOLOGY, V50, P77, DOI 10.1002/hep.22960; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tyra HM, 2012, MOL BIOL CELL, V23, P811, DOI 10.1091/mbc.E11-12-1011; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52	58	71	76	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4405	4415		10.1074/jbc.M112.432344	http://dx.doi.org/10.1074/jbc.M112.432344			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23281479	Green Published, hybrid			2022-12-28	WOS:000314845000067
J	Strittmatter, E; Liers, C; Ullrich, R; Wachter, S; Hofrichter, M; Plattner, DA; Piontek, K				Strittmatter, Eric; Liers, Christiane; Ullrich, Rene; Wachter, Sabrina; Hofrichter, Martin; Plattner, Dietmar A.; Piontek, Klaus			First Crystal Structure of a Fungal High-redox Potential Dye-decolorizing Peroxidase SUBSTRATE INTERACTION SITES AND LONG-RANGE ELECTRON TRANSFER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THANATEPHORUS-CUCUMERIS DEC-1; LIGNIN PEROXIDASE; MOLECULAR-GRAPHICS; BETA; REFINEMENT; MECHANISM; OXIDATION; RESIDUE	Dye-decolorizing peroxidases (DyPs) belong to the large group of heme peroxidases. They utilize hydrogen peroxide to catalyze oxidations of various organic compounds. AauDyPI from Auricularia auricula-judae (fungi) was crystallized, and its crystal structure was determined at 2.1 angstrom resolution. The mostly helical structure also shows a beta-sheet motif typical for DyPs and Cld (chlorite dismutase)-related structures and includes the complete polypeptide chain. At the distal side of the heme molecule, a flexible aspartate residue (Asp-168) plays a key role in catalysis. It guides incoming hydrogen peroxide toward the heme iron and mediates proton rearrangement in the process of Compound I formation. Afterward, its side chain changes its conformation, now pointing toward the protein backbone. We propose an extended functionality of Asp-168, which acts like a gatekeeper by altering the width of the heme cavity access channel. Chemical modifications of potentially redox-active amino acids show that a tyrosine is involved in substrate interaction. Using spin-trapping experiments, a transient radical on the surface-exposed Tyr-337 was identified as the oxidation site for bulky substrates. A possible long-range electron transfer pathway from the surface of the enzyme to the redox cofactor (heme) is discussed.	[Piontek, Klaus] Univ Freiburg, Inst Organ Chem, D-79104 Freiburg, Germany; [Liers, Christiane; Ullrich, Rene; Hofrichter, Martin] Int Grad Sch Zittau, Dept Bio & Environm Sci, D-02763 Zittau, Germany	University of Freiburg; Technische Universitat Dresden	Piontek, K (corresponding author), Univ Freiburg, Inst Organ Chem, Albertstr 21, D-79104 Freiburg, Germany.	Klaus.Piontek@ocbc.uni-freiburg.de		Hofrichter, Martin/0000-0001-5174-7604; Liers, Christiane/0000-0002-2000-0820	Commission of the European Communities within the Sixth European Framework Programme (BIORENEW) [NMP2-CT-2006-026456]; International Research Training Group Grant "Catalysts and Catalytic Reactions for Organic Synthesis" (CCROS) of the Deutsche Forschungsgemeinschaft (DFG) [IRTG 1038]	Commission of the European Communities within the Sixth European Framework Programme (BIORENEW); International Research Training Group Grant "Catalysts and Catalytic Reactions for Organic Synthesis" (CCROS) of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was partially financed by a grant from the Commission of the European Communities within the Sixth European Framework Programme (BIORENEW contract NMP2-CT-2006-026456) (to K. P. and M. H.) and by funding from the International Research Training Group Grant IRTG 1038 "Catalysts and Catalytic Reactions for Organic Synthesis" (CCROS) of the Deutsche Forschungsgemeinschaft (DFG) (to D. A. P.).	Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; Balland V, 2006, BIOCHEMISTRY-US, V45, P2072, DOI 10.1021/bi051696h; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Blodig W, 1999, ARCH BIOCHEM BIOPHYS, V370, P86, DOI 10.1006/abbi.1999.1365; Blodig W, 1998, BIOCHEMISTRY-US, V37, P8832, DOI 10.1021/bi9727186; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goblirsch B, 2011, J MOL BIOL, V408, P379, DOI 10.1016/j.jmb.2011.02.047; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; INOKUCHI N, 1982, J BIOCHEM-TOKYO, V91, P1661, DOI 10.1093/oxfordjournals.jbchem.a133857; Jones P, 2005, J INORG BIOCHEM, V99, P2292, DOI 10.1016/j.jinorgbio.2005.08.009; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIM SJ, 1995, J FERMENT BIOENG, V79, P601, DOI 10.1016/0922-338X(95)94755-G; Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029; KLAPPER MH, 1979, Q REV BIOPHYS, V12, P465, DOI 10.1017/S0033583500002791; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Liers C, 2013, APPL MICROBIOL BIOT, V97, P5839, DOI 10.1007/s00253-012-4521-2; Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; MAURO JM, 1988, BIOCHEMISTRY-US, V27, P6243, DOI 10.1021/bi00417a008; McCarthy AA, 2009, J SYNCHROTRON RADIAT, V16, P803, DOI 10.1107/S0909049509035377; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miki Y, 2011, J BIOL CHEM, V286, P15525, DOI 10.1074/jbc.M111.220996; Piontek K, 2001, BIOCHEM SOC T, V29, P111, DOI 10.1042/BST0290111; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; POULOS TL, 1980, J BIOL CHEM, V255, P8199; Prytkova TR, 2005, J PHYS CHEM B, V109, P1618, DOI 10.1021/jp0457491; Sato T, 2004, ACTA CRYSTALLOGR D, V60, P149, DOI 10.1107/S0907444903025472; Scheibner M, 2008, APPL MICROBIOL BIOT, V77, P1241, DOI 10.1007/s00253-007-1261-9; Singh R, 2012, J BIOL CHEM, V287, P10623, DOI 10.1074/jbc.M111.332171; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Smith AT, 2009, P NATL ACAD SCI USA, V106, P16084, DOI 10.1073/pnas.0904535106; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8; Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200; Sugano Y, 2006, APPL MICROBIOL BIOT, V73, P862, DOI 10.1007/s00253-006-0545-9; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Bloois E, 2010, APPL MICROBIOL BIOT, V86, P1419, DOI 10.1007/s00253-009-2369-x; Welinder KG., 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [10.1016/0959-440x(92)90230-5, DOI 10.1016/0959-440X(92)90230-5]; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Yoshida T, 2011, FEBS J, V278, P2387, DOI 10.1111/j.1742-4658.2011.08161.x; Zamocky M, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P7, DOI 10.1007/978-3-642-12627-7_2; Zhao XB, 2004, J BIOL CHEM, V279, P7606, DOI 10.1074/jbc.M311884200; Zubieta C, 2007, PROTEINS, V69, P223, DOI 10.1002/prot.21550	49	75	76	0	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4095	4102		10.1074/jbc.M112.400176	http://dx.doi.org/10.1074/jbc.M112.400176			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23235158	hybrid, Green Published			2022-12-28	WOS:000314845000038
J	Abrams, CK; Islam, M; Mahmoud, R; Kwon, T; Bargiello, TA; Freidin, MM				Abrams, Charles K.; Islam, Mahee; Mahmoud, Rola; Kwon, Taekyung; Bargiello, Thaddeus A.; Freidin, Mona M.			Functional Requirement for a Highly Conserved Charged Residue at Position 75 in the Gap Junction Protein Connexin 32	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; MOLECULAR-DYNAMICS SIMULATIONS; GREEN FLUORESCENT PROTEIN; ALTERED TRAFFICKING; DOMINANT DEAFNESS; PERIPHERAL-NERVE; SCHWANN-CELLS; MUTATIONS; CHANNELS; EXPRESSION	Charcot Marie Tooth disease (CMT) is a group of inherited disorders characterized clinically by exclusively or predominantly peripheral nerve dysfunction. CMT1X, the most common form of X-linked CMT is caused by mutations in connexin 32 (Cx32). In this work, we used dual whole cell patch clamp recording to examine the functional effects of mutations at the Arg(75) position. This residue is highly conserved among members of the connexin family, and disease-causing mutations have been identified at this (or the corresponding) position in Cx26, Cx43, and Cx46. Thus, a better understanding of the effects of mutations of this position in Cx32 may have relevance to pathogenesis of a number of different human diseases. All three mutants associated with CMT1X (R75P, R75Q, and R75W) showed very low levels of coupling similar to those of the cells transfected with vector alone. Heterotypic pairing with Cx32 WT showed that the absence of coupling for these mutants in the homotypic configuration could be explained by shifts in their hemichannel G(j)-V-j relations. Examination of the expression levels and gating characteristics of seven additional mutants (R75A, R75D, R75E, R75H, R75K, R75L, and R75V) at this position suggest that the positive charge at position 75 in Cx32 is required for normal channel function but not for gap junction assembly. Our studies also suggest that disease treatment strategies for CMT1X, which correct trafficking abnormalities in Cx32, may be ineffective for the group of mutations also conferring changes in gating properties of Cx32 channels.	[Abrams, Charles K.; Islam, Mahee; Mahmoud, Rola; Freidin, Mona M.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Abrams, Charles K.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Kwon, Taekyung; Bargiello, Thaddeus A.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Yeshiva University; Albert Einstein College of Medicine	Abrams, CK (corresponding author), Suny Downstate Med Ctr, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	charles.abrams@downstate.edu	Mahmoud, Rola/GNP-0681-2022	Freidin, Mona/0000-0002-3162-4858	National Institutes of Health [1R01NS050705]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant 1R01NS050705 and Muscular Dystrophy Association research grants (to C. K. A.).	Abrams CK, 2003, J NEUROSCI, V23, P10548; Abrams CK, 2001, BRAIN RES, V900, P9, DOI 10.1016/S0006-8993(00)03327-8; Altevogt BM, 2002, J NEUROSCI, V22, P6458; Balice-Gordon RJ, 1998, J CELL BIOL, V142, P1095, DOI 10.1083/jcb.142.4.1095; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; BUKAUSKAS FF, 1992, EXP PHYSIOL, V77, P903, DOI 10.1113/expphysiol.1992.sp003657; Burdon KP, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.018333; Chandross KJ, 1996, MOL CELL NEUROSCI, V7, P501, DOI 10.1006/mcne.1996.0036; Chen YY, 2005, FASEB J, V19, P1516, DOI 10.1096/fj.04-3491fje; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Deng YQ, 2006, HEARING RES, V220, P87, DOI 10.1016/j.heares.2006.07.004; Deschenes SM, 1997, J NEUROSCI, V17, P9077; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; JANSSENTIMMEN U, 1983, EMBO J, V2, P295, DOI 10.1002/j.1460-2075.1983.tb01422.x; Kleopa KA, 2002, J NEUROSCI RES, V68, P522, DOI 10.1002/jnr.10255; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Kwon T, 2012, BIOPHYS J, V102, P1341, DOI 10.1016/j.bpj.2012.02.009; Kwon T, 2011, J GEN PHYSIOL, V138, P475, DOI 10.1085/jgp.201110679; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Mambetisaeva ET, 1999, J NEUROSCI RES, V57, P166, DOI 10.1002/(SICI)1097-4547(19990715)57:2<166::AID-JNR2>3.3.CO;2-P; Martin PEM, 2000, J NEUROCHEM, V74, P711, DOI 10.1046/j.1471-4159.2000.740711.x; Matsuyama W, 2001, J HUM GENET, V46, P307, DOI 10.1007/s100380170064; Meier C, 2004, J NEUROSCI, V24, P3186, DOI 10.1523/JNEUROSCI.5146-03.2004; Oh S, 2000, J GEN PHYSIOL, V116, P13, DOI 10.1085/jgp.116.1.13; Oh S, 1999, J GEN PHYSIOL, V114, P339, DOI 10.1085/jgp.114.3.339; Oh S, 1997, NEURON, V19, P927, DOI 10.1016/S0896-6273(00)80973-3; Orthmann-Murphy JL, 2007, J NEUROSCI, V27, P13949, DOI 10.1523/JNEUROSCI.3395-07.2007; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Richard G, 1998, HUM GENET, V103, P393, DOI 10.1007/s004390050839; Scherer SS, 1995, J NEUROSCI, V15, P8281; Siskind CE, 2011, SEMIN NEUROL, V31, P494, DOI 10.1055/s-0031-1299788; Sutor B, 2000, CEREB CORTEX, V10, P684, DOI 10.1093/cercor/10.7.684; Tang QX, 2009, J GEN PHYSIOL, V133, P555, DOI 10.1085/jgp.200910207; VERSELIS VK, 1991, BIOPHYS J, V59, P114, DOI 10.1016/S0006-3495(91)82204-4; Verselis VK, 2009, J BIOL CHEM, V284, P4484, DOI 10.1074/jbc.M807430200; Wang HL, 2004, NEUROBIOL DIS, V15, P361, DOI 10.1016/j.nbd.2003.11.005; WILGENBUS KK, 1992, INT J CANCER, V51, P522, DOI 10.1002/ijc.2910510404; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yum SW, 2002, NEUROBIOL DIS, V11, P43, DOI 10.1006/nbdi.2002.0545	43	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3609	3619		10.1074/jbc.M112.392670	http://dx.doi.org/10.1074/jbc.M112.392670			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23209285	Green Published, hybrid			2022-12-28	WOS:000314397900065
J	Nurse, P; Marians, KJ				Nurse, Pearl; Marians, Kenneth J.			Purification and Characterization of Escherichia coli MreB Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROKARYOTIC CELL-CYCLE; BACTERIAL ACTIN MREB; CHROMOSOME SEGREGATION; BACILLUS-SUBTILIS; DNA SEGREGATION; RNA-POLYMERASE; WALL SYNTHESIS; HOMOLOG MREB; PLASMID DNA; REGION	The actin homolog MreB is required in rod-shaped bacteria for maintenance of cell shape and is intimately connected to the holoenzyme that synthesizes the peptidoglycan layer. The protein has been reported variously to exist in helical loops under the cell surface, to rotate, and to move in patches in both directions around the cell surface. Studies of the Escherichia coli protein in vitro have been hampered by its tendency to aggregate. Here we report the purification and characterization of native E. coli MreB. The protein requires ATP hydrolysis for polymerization, forms bundles with a left-hand twist that can be as long as 4 mu m, forms sheets in the presence of calcium, and has a critical concentration for polymerization of 1.5 mu M.	[Nurse, Pearl; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu			National Institutes of Health Grant [GM34558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34558 (to K. J. M.).	Bean GJ, 2008, BIOCHEMISTRY-US, V47, P826, DOI 10.1021/bi701538e; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaballah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025129; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Karczmarek A, 2007, MOL MICROBIOL, V65, P51, DOI 10.1111/j.1365-2958.2007.05777.x; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Kruse T, 2006, GENE DEV, V20, P113, DOI 10.1101/gad.366606; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Madabhushi R, 2009, MOL CELL, V33, P171, DOI 10.1016/j.molcel.2009.01.001; Mayer JA, 2009, CELL MOTIL CYTOSKEL, V66, P109, DOI 10.1002/cm.20332; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Popp D, 2010, J BIOL CHEM, V285, P15858, DOI 10.1074/jbc.M109.095901; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346; Srinivasan R, 2007, CURR BIOL, V17, P266, DOI 10.1016/j.cub.2006.11.069; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Swulius MT, 2011, BIOCHEM BIOPH RES CO, V407, P650, DOI 10.1016/j.bbrc.2011.03.062; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Vats P, 2007, P NATL ACAD SCI USA, V104, P17795, DOI 10.1073/pnas.0708739104; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; Wang XD, 2010, J BACTERIOL, V192, P6143, DOI 10.1128/JB.00861-10; White CL, 2012, TRENDS MICROBIOL, V20, P74, DOI 10.1016/j.tim.2011.11.004	31	26	26	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3469	3475		10.1074/jbc.M112.413708	http://dx.doi.org/10.1074/jbc.M112.413708			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235161	hybrid, Green Published			2022-12-28	WOS:000314397900051
J	Wang, JD; Leung, JWC; Gong, ZH; Feng, L; Shi, XB; Chen, JJ				Wang, Jiadong; Leung, Justin Wai-chung; Gong, Zihua; Feng, Lin; Shi, Xiaobing; Chen, Junjie			PHF6 Regulates Cell Cycle Progression by Suppressing Ribosomal RNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORSSMAN-LEHMANN-SYNDROME; ACUTE LYMPHOBLASTIC-LEUKEMIA; DEMETHYLASE PHF8; MAMMALIAN-CELLS; MUTATIONS; PROTEIN; TRANSCRIPTION; REPAIR; BINDING; BREAKS	Mutation of PHF6, which results in the X-linked mental retardation disorder Borjeson-Forssman-Lehmann syndrome, is also present in about 38% of adult T-cell acute lymphoblastic leukemias and 3% of adult acute myeloid leukemias. However, it remains to be determined exactly how PHF6 acts in vivo and what functions of PHF6 may be associated with its putative tumor suppressor function. Here, we demonstrate that PHF6 is a nucleolus, ribosomal RNA promoter-associated protein. PHF6 directly interacts with upstream binding factor (UBF) through its PHD1 domain and suppresses ribosomal RNA (rRNA) transcription by affecting the protein level of UBF. Knockdown of PHF6 impairs cell proliferation and arrests cells at G(2)/M phase, which is accompanied by an increased level of phosphorylated H2AX, indicating that PHF6 deficiency leads to the accumulation of DNA damage in the cell. We found that increased DNA damage occurs at the ribosomal DNA (rDNA) locus in PHF6-deficient cells. This effect could be reversed by knocking down UBF or overexpressing RNASE1, which removes RNA-DNA hybrids, suggesting that there is a functional link between rRNA synthesis and genomic stability at the rDNA locus. Together, these results reveal that the key function of PHF6 is involved in regulating rRNA synthesis, which may contribute to its roles in cell cycle control, genomic maintenance, and tumor suppression.	[Wang, Jiadong; Leung, Justin Wai-chung; Gong, Zihua; Feng, Lin; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 66, 1515 Holcombe Blvd,Rm Y3-6006, Houston, TX 77030 USA.	jchen8@mdanderson.org		Shi, Xiaobing/0000-0001-5242-8189; Leung, Justin Wai Chung/0000-0003-4601-390X	National Institutes of Health [CA089239, CA092312, CA100109, CA016672]; Department of Defense [W81XWH-05-1-0470]; NATIONAL CANCER INSTITUTE [R01CA100109, R01CA092312, R01CA089239, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.).; Recipient of an Era of Hope Scholar award from the Department of Defense (Grant W81XWH-05-1-0470) and a member of M. D. Anderson Cancer Center (National Institutes of Health Grant CA016672).	ARIS JP, 1991, P NATL ACAD SCI USA, V88, P931, DOI 10.1073/pnas.88.3.931; Chao MM, 2010, PEDIATR BLOOD CANCER, V55, P722, DOI 10.1002/pbc.22574; Donati G, 2011, ONCOGENE, V30, P3274, DOI 10.1038/onc.2011.48; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kruhlak M, 2007, NATURE, V447, P730, DOI 10.1038/nature05842; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Lower KM, 2002, NAT GENET, V32, P661, DOI 10.1038/ng1040; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Schultz A, 2006, MOL CELL BIOL, V26, P5146, DOI 10.1128/MCB.02374-05; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Turner G, 2004, CLIN GENET, V65, P226, DOI 10.1111/j.0009-9163.2004.00215.x; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Visootsak J, 2004, J PEDIATR-US, V145, P819, DOI 10.1016/j.jpeds.2004.07.041; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017	20	64	66	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3174	3183		10.1074/jbc.M112.414839	http://dx.doi.org/10.1074/jbc.M112.414839			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23229552	Green Published, hybrid			2022-12-28	WOS:000314397900025
J	Wang, JQ; Chen, Q; Wang, XH; Wang, QC; Wang, Y; Cheng, HP; Guo, CX; Sun, QM; Chen, Q; Tang, TS				Wang, Jiu-Qiang; Chen, Qian; Wang, Xianhua; Wang, Qiao-Chu; Wang, Yun; Cheng, He-Ping; Guo, Caixia; Sun, Qinmiao; Chen, Quan; Tang, Tie-Shan			Dysregulation of Mitochondrial Calcium Signaling and Superoxide Flashes Cause Mitochondrial Genomic DNA Damage in Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED EXCITOTOXICITY; TRANSGENIC MOUSE MODEL; D-ASPARTATE RECEPTORS; MUTANT HUNTINGTIN; OXIDATIVE-STRESS; 2-AMINOETHOXYDIPHENYL BORATE; NEURODEGENERATIVE DISEASES; PERMEABILITY TRANSITION; SINGLE MITOCHONDRIA; PARKINSONS-DISEASE	Huntington disease (HD) is an inherited, fatal neurodegenerative disorder characterized by the progressive loss of striatal medium spiny neurons. Indications of oxidative stress are apparent in brain tissues from both HD patients and HD mouse models; however, the origin of this oxidant stress remains a mystery. Here, we used a yeast artificial chromosome transgenic mouse model of HD (YAC128) to investigate the potential connections between dysregulation of cytosolic Ca2+ signaling and mitochondrial oxidative damage in HD cells. We found that YAC128 mouse embryonic fibroblasts exhibit a strikingly higher level of mitochondrial matrix Ca2+ loading and elevated superoxide generation compared with WT cells, indicating that both mitochondrial Ca2+ signaling and superoxide generation are dysregulated in HD cells. The excessive mitochondrial oxidant stress is critically dependent on mitochondrial Ca2+ loading in HD cells, because blocking mitochondrial Ca2+ uptake abolished elevated superoxide generation. Similar results were obtained using neurons from HD model mice and fibroblast cells from HD patients. More importantly, mitochondrial Ca2+ loading in HD cells caused a 2-fold higher level of mitochondrial genomic DNA (mtDNA) damage due to the excessive oxidant generation. This study provides strong evidence to support a new causal link between dysregulated mitochondrial Ca2+ signaling, elevated mitochondrial oxidant stress, and mtDNA damage in HD. Our results also indicate that reducing mitochondrial Ca2+ uptake could be a therapeutic strategy for HD.	[Wang, Jiu-Qiang; Chen, Qian; Wang, Qiao-Chu; Wang, Yun; Sun, Qinmiao; Chen, Quan; Tang, Tie-Shan] Chinese Acad Sci, State Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing 100101, Peoples R China; [Wang, Xianhua; Cheng, He-Ping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Beijing 100871, Peoples R China; [Guo, Caixia] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individual Med, Beijing 100029, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Peking University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Tang, TS (corresponding author), State Key Lab Biomembrane & Membrane Biotechnol, 1 Beichen W Rd, Beijing 100101, Peoples R China.	tangtsh@ioz.ac.cn	Heping, Cheng/AAE-2680-2019; cheng, heping/A-7299-2011	Heping, Cheng/0000-0002-9604-6702; 	National Basic Research Program of China [2011CB965003, 2012CB944702, 2011CB809102, NSFC30970931, NSFC31130067]; Chinese Academy of Sciences [KSCX2-YW-R-148]; One-Hundred-Talent Program	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); One-Hundred-Talent Program(Chinese Academy of Sciences)	This work was supported National Basic Research Program of China Grants 2011CB965003, 2012CB944702, 2011CB809102, NSFC30970931, and NSFC31130067 and Knowledge Innovation Program of Chinese Academy of Sciences Grant KSCX2-YW-R-148, and by the One-Hundred-Talent Program (to C. G. and Q. S.).	Acevedo-Torres K, 2009, DNA REPAIR, V8, P126, DOI 10.1016/j.dnarep.2008.09.004; ALNASSER I, 1986, BIOCHEM J, V239, P19, DOI 10.1042/bj2390019; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018; Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; CHOE CU, 2006, SCI STKE, pRE15; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Fan MMY, 2007, J NEUROSCI, V27, P3768, DOI 10.1523/JNEUROSCI.4356-06.2007; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Fernandes HB, 2007, J NEUROSCI, V27, P13614, DOI 10.1523/JNEUROSCI.3455-07.2007; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Fukui H, 2007, HUM MOL GENET, V16, P783, DOI 10.1093/hmg/ddm023; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Guidetti P, 2001, EXP NEUROL, V169, P340, DOI 10.1006/exnr.2000.7626; Guo C, 2008, J BIOL CHEM, V283, P4658, DOI 10.1074/jbc.M709275200; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Heng MY, 2009, J NEUROSCI, V29, P3200, DOI 10.1523/JNEUROSCI.5599-08.2009; HORTON TM, 1995, NEUROLOGY, V45, P1879, DOI 10.1212/WNL.45.10.1879; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Isakson BE, 2008, J CELL SCI, V121, P3664, DOI 10.1242/jcs.037481; Jones L, 2011, BBA-BIOMEMBRANES, V1808, P745, DOI 10.1016/j.bbamem.2010.12.013; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lim D, 2008, J BIOL CHEM, V283, P5780, DOI 10.1074/jbc.M704704200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794; MacDonald Marcy E, 2003, Sci STKE, V2003, ppe48; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; McCombs JE, 2008, METHODS, V46, P152, DOI 10.1016/j.ymeth.2008.09.015; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Mitra S, 2007, DNA REPAIR, V6, P461, DOI 10.1016/j.dnarep.2006.10.010; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Perez-Severiano F, 2000, BRAIN RES, V862, P234, DOI 10.1016/S0006-8993(00)02082-5; Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Shehadeh J, 2006, NEUROBIOL DIS, V21, P392, DOI 10.1016/j.nbd.2005.08.001; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Solans A, 2006, HUM MOL GENET, V15, P3063, DOI 10.1093/hmg/ddl248; Song C, 2003, J BIOL CHEM, V278, P33364, DOI 10.1074/jbc.M304240200; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Sun Y, 2001, J BIOL CHEM, V276, P24713, DOI 10.1074/jbc.M103501200; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Tang TS, 2007, J NEUROSCI, V27, P7899, DOI 10.1523/JNEUROSCI.1396-07.2007; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; Viola HM, 2007, CIRC RES, V100, P1036, DOI 10.1161/01.RES.0000263010.19273.48; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wu J, 2011, CHEM BIOL, V18, P777, DOI 10.1016/j.chembiol.2011.04.012; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zhang H, 2008, NEUROBIOL DIS, V31, P80, DOI 10.1016/j.nbd.2008.03.010	81	64	66	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3070	3084		10.1074/jbc.M112.407726	http://dx.doi.org/10.1074/jbc.M112.407726			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250749	hybrid, Green Published			2022-12-28	WOS:000314397900017
J	Qiu, RD; Zhang, J; Xiang, X				Qiu, Rongde; Zhang, Jun; Xiang, Xin			Identification of a Novel Site in the Tail of Dynein Heavy Chain Important for Dynein Function in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUG-OF-WAR; MICROTUBULE PLUS ENDS; CYTOPLASMIC DYNEIN; ASPERGILLUS-NIDULANS; INTERMEDIATE-CHAIN; NUCLEAR MIGRATION; DYNACTIN INTERACTION; CRYSTAL-STRUCTURE; BINDING; DOMAIN	The minus end-directed microtubule motor cytoplasmic dynein is responsible for the intracellular movements of many organelles, including nuclei and endosomes. The dynein heavy chain contains a C-terminal motor domain and an N-terminal tail domain. The tail binds other dynein subunits and the cargo-interacting dynactin complex but is dispensable for movement of single dynein molecules in vitro. Here, we identified a mutation in the Aspergillus nidulans heavy chain tail domain, nudA(F208V), which causes obvious defects in dynein-mediated nuclear positioning and early endosome movement. Astonishingly, the nudA(F208I) mutation in the same position does not cause the same defects, suggesting that a subtle difference in the size of the amino acid side chain at this position has a significant consequence. Importantly, our biochemical analyses indicate that the nudA(F208V) mutation does not affect dynein subunit interactions and the mutant dynein is also able to bind dynactin and another dynein regulator, NUDF/LIS1. The mutant dynein is able to physically interact with the early endosome cargo, but dynein-mediated early endosome movement away from the hyphal tip occurs at a significantly reduced frequency. Within the small group of early endosomes that move away from the hyphal tip in the mutant, the average speed of movement is lower than that in the wild type. Given the dispensability of the dynein tail in dynein motility in vitro, our results support the notion that the structural integrity of the dynein tail is critical in vivo for the coordination of dynein force production and movement when the motor is heavily loaded.	[Qiu, Rongde; Zhang, Jun; Xiang, Xin] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Xiang, X (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA.	xin.xiang@usuhs.edu		Qiu, Rongde/0000-0003-2078-9718	National Institutes of Health [1RO1GM097580-01]; Center for Neuroscience and Regenerative Medicine, Department of Defense; Uniformed Services University of the Health Sciences intramural grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Neuroscience and Regenerative Medicine, Department of Defense; Uniformed Services University of the Health Sciences intramural grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (1RO1GM097580-01), the Center for Neuroscience and Regenerative Medicine, Department of Defense, and a Uniformed Services University of the Health Sciences intramural grant.	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; Billington N, 2011, NAT STRUCT MOL BIOL, V18, P635, DOI 10.1038/nsmb.2082; Bloom KS, 2008, CHROMOSOMA, V117, P103, DOI 10.1007/s00412-007-0138-0; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Deng WH, 2010, J BIOL CHEM, V285, P39922, DOI 10.1074/jbc.M110.178087; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Egan MJ, 2012, CURR OPIN MICROBIOL, V15, P637, DOI 10.1016/j.mib.2012.10.003; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Habura A, 1999, J BIOL CHEM, V274, P15447, DOI 10.1074/jbc.274.22.15447; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; Hendricks AG, 2012, P NATL ACAD SCI USA, V109, P18447, DOI 10.1073/pnas.1215462109; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hook P, 2012, NAT STRUCT MOL BIOL, V19, P467, DOI 10.1038/nsmb.2290; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; King SM, 2000, J CELL SCI, V113, P2521; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Leidel C, 2012, BIOPHYS J, V103, P492, DOI 10.1016/j.bpj.2012.06.038; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Markus SM, 2011, DEV CELL, V20, P639, DOI 10.1016/j.devcel.2011.04.011; Markus SM, 2009, CURR BIOL, V19, P196, DOI 10.1016/j.cub.2008.12.047; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; McNaughton L, 2010, J BIOL CHEM, V285, P15994, DOI 10.1074/jbc.M109.083535; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Nayak T, 2010, J CELL BIOL, V190, P317, DOI 10.1083/jcb.201002105; Numata N, 2008, BIOCHEM SOC T, V36, P131, DOI 10.1042/BST0360131; Nyarko A, 2012, J BIOL CHEM, V287, P24884, DOI 10.1074/jbc.M112.376038; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Penalva Miguel A, 2012, Cell Logist, V2, P2; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Roberts AJ, 2012, STRUCTURE, V20, P1670, DOI 10.1016/j.str.2012.07.003; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Shima T, 2006, P NATL ACAD SCI USA, V103, P17736, DOI 10.1073/pnas.0606794103; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Sivagurunathan S, 2012, CYTOSKELETON, V69, P613, DOI 10.1002/cm.21049; Sivagurunathan S, 2012, GENETICS, V191, P1157, DOI 10.1534/genetics.112.141580; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Steinberg G, 2011, CURR OPIN MICROBIOL, V14, P660, DOI 10.1016/j.mib.2011.09.013; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Wang SS, 2011, J BIOL CHEM, V286, P587, DOI 10.1074/jbc.M110.181578; WILLINS DA, 1995, GENETICS, V141, P1287; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Xiang X, 1999, CURR GENET, V35, P626, DOI 10.1007/s002940050461; XIANG X, 1995, P NATL ACAD SCI USA, V92, P9890, DOI 10.1073/pnas.92.21.9890; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; Xiang X, 2012, DYNEINS: STRUCTURE, BIOLOGY AND DISEASE, P455, DOI 10.1016/B978-0-12-382004-4.10017-2; Yao XL, 2012, TRAFFIC, V13, P375, DOI 10.1111/j.1600-0854.2011.01312.x; Yeh TY, 2012, MOL BIOL CELL, V23, P3827, DOI 10.1091/mbc.E12-07-0496; Zekert N, 2009, MOL BIOL CELL, V20, P673, DOI 10.1091/mbc.E08-07-0685; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516; Zhang J, 2002, MOL MICROBIOL, V44, P381, DOI 10.1046/j.1365-2958.2002.02900.x; Zhang J, 2008, TRAFFIC, V9, P1073, DOI 10.1111/j.1600-0854.2008.00748.x; Zhang J, 2011, J CELL BIOL, V193, P1245, DOI 10.1083/jcb.201011022; Zhang J, 2010, J CELL SCI, V123, P3596, DOI 10.1242/jcs.075259; Zhang J, 2009, J BIOL CHEM, V284, P34760, DOI 10.1074/jbc.M109.026872; Zhuang L, 2007, GENETICS, V175, P1185, DOI 10.1534/genetics.106.069013; Zylkiewicz E, 2011, J CELL BIOL, V192, P433, DOI 10.1083/jcb.201011142	80	16	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2271	2280		10.1074/jbc.M112.412403	http://dx.doi.org/10.1074/jbc.M112.412403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23212922	Green Published, hybrid			2022-12-28	WOS:000314211500017
J	Hussain, A; Mohammad, DK; Gustafsson, MO; Uslu, M; Hamasy, A; Nore, BF; Mohamed, AJ; Smith, CIE				Hussain, Alamdar; Mohammad, Dara K.; Gustafsson, Manuela O.; Uslu, Merve; Hamasy, Abdulrahman; Nore, Beston F.; Mohamed, Abdalla J.; Smith, C. I. Edvard			Signaling of the ITK (Interleukin 2-inducible T Cell Kinase)-SYK (Spleen Tyrosine Kinase) Fusion Kinase Is Dependent on Adapter SLP-76 and on the Adapter Function of the Kinases SYK and ZAP70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; ZAP-70; PHOSPHORYLATION; RECEPTOR; DOMAIN; ACTIVATION; TRANSDUCTION; LYMPHOMA; MUTATION; COMPLEX	The inducible T cell kinase-spleen tyrosine kinase (ITK-SYK) oncogene consists of the Tec homology-pleckstrin homology domain of ITK and the kinase domain of SYK, and it is believed to be the cause of peripheral T cell lymphoma. We and others have recently demonstrated that this fusion protein is constitutively tyrosine-phosphorylated and is transforming both in vitro and in vivo. To gain a deeper insight into the molecular mechanism( s) underlying its activation and signaling, we mutated a total of eight tyrosines located in the SYK portion of the chimera into either phenylalanine or to the negatively charged glutamic acid. Although mutations in the interdomain-B region affected ITK-SYK kinase activity, they only modestly altered downstream signaling events. In contrast, mutations that were introduced in the kinase domain triggered severe impairment of downstream signaling. Moreover, we show here that SLP-76 is critical for ITK-SYK activation and is particularly required for the ITK-SYK-dependent phosphorylation of SYK activation loop tyrosines. In Jurkat cell lines, we demonstrate that expression of ITK-SYK fusion requires an intact SLP-76 function and significantly induces IL-2 secretion and CD69 expression. Furthermore, the SLP-76-mediated induction of IL-2 and CD69 could be further enhanced by SYK or ZAP-70, but it was independent of their kinase activity. Notably, ITK-SYK expression in SYF cells phosphorylates SLP-76 in the absence of SRC family kinases. Altogether, our data suggest that ITK-SYK exists in the active conformation state and is therefore capable of signaling without SRC family kinases or stimulation of the T cell receptor.	[Hussain, Alamdar; Mohammad, Dara K.; Gustafsson, Manuela O.; Uslu, Merve; Hamasy, Abdulrahman; Nore, Beston F.; Mohamed, Abdalla J.; Smith, C. I. Edvard] Karolinska Inst, Karolinska Hosp, Dept Lab Med, SE-14186 Stockholm, Sweden; [Hussain, Alamdar] COMSATS Inst Informat Technol, Dept Biosci, Islamabad 44000, Pakistan; [Nore, Beston F.] Univ Sulaimani, Fac Med Sci, Sch Med, Dept Biochem, Sulaimani 46001, Kurdistan Regio, Iraq; [Mohamed, Abdalla J.] Univ Brunei Darussalam, Fac Sci, Dept Biol, Bandar Seri Begawan, Brunei	Karolinska Institutet; Karolinska University Hospital; COMSATS University Islamabad (CUI); University of Sulimanyah; University Brunei Darussalam	Hussain, A (corresponding author), Karolinska Inst, Dept Lab Med, Unit Mol Cell Biol & Gene Therapy Sci, Kliniskt Forskningscentrum, SE-14186 Stockholm, Sweden.	alamdar.hussain@ki.se; edvard.smith@ki.se	Nore, Beston F./N-9288-2016	Nore, Beston F./0000-0003-3865-2920; SMITH, C. I. Edvard/0000-0003-1907-3392; Mohammad, Dara K./0000-0001-9201-0991; gustafsson, manuela/0000-0002-0268-9476	Swedish Cancer Society; Swedish Research Council; European Council FP7 Grant EURO-PAD net; Stockholm County Council; Karolinska Institutet; Ministry of Higher Education and Scientific Research in Kurdistan Regional-Government/Iraq; Sodertorn University-College, Stockholm, Sweden	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Council FP7 Grant EURO-PAD net; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Ministry of Higher Education and Scientific Research in Kurdistan Regional-Government/Iraq; Sodertorn University-College, Stockholm, Sweden	This work was supported in part by the Swedish Cancer Society, the Swedish Research Council, European Council FP7 Grant EURO-PAD net, and the regional agreement on medical training and clinical research (Avtalet mellan Landstinget och staten om samarbete om Lakarutbildning och Forskning) between Stockholm County Council and Karolinska Institutet.; Recipient of a Ph.D. fellowship from Ministry of Higher Education and Scientific Research in Kurdistan Regional-Government/Iraq.; Recipient of a Ph.D. scholarship from Sodertorn University-College, Stockholm, Sweden.	Abudula A, 2007, J BIOL CHEM, V282, P29059, DOI 10.1074/jbc.M704043200; Ashe JM, 1999, J EXP MED, V189, P1163, DOI 10.1084/jem.189.7.1163; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Au-Yeung BB, 2010, NAT IMMUNOL, V11, P1085, DOI 10.1038/ni.1955; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Carsetti L, 2009, CELL SIGNAL, V21, P1187, DOI 10.1016/j.cellsig.2009.03.007; Chen LG, 2008, BLOOD, V111, P2685, DOI 10.1182/blood-2006-12-062265; de Castro RO, 2010, J BIOL CHEM, V285, P26674, DOI 10.1074/jbc.M110.134262; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dierks C, 2010, CANCER RES, V70, P6193, DOI 10.1158/0008-5472.CAN-08-3719; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Geahlen RL, 2009, BBA-MOL CELL RES, V1793, P1115, DOI 10.1016/j.bbamcr.2009.03.004; Groesch TD, 2006, J MOL BIOL, V356, P1222, DOI 10.1016/j.jmb.2005.11.095; Hong JJ, 2002, J BIOL CHEM, V277, P31703, DOI 10.1074/jbc.M201362200; Huang YL, 2009, AM J SURG PATHOL, V33, P682, DOI 10.1097/PAS.0b013e3181971591; Hussain A, 2011, FEBS J, V278, P2001, DOI 10.1111/j.1742-4658.2011.08134.x; Hussain A, 2009, BIOCHEM BIOPH RES CO, V390, P892, DOI 10.1016/j.bbrc.2009.10.070; Jin L, 2004, J BIOL CHEM, V279, P42818, DOI 10.1074/jbc.M407096200; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Ota Y, 1996, J EXP MED, V184, P1713, DOI 10.1084/jem.184.5.1713; Pechloff K, 2010, J EXP MED, V207, P1031, DOI 10.1084/jem.20092042; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Rigby S, 2009, J BIOL CHEM, V284, P26871, DOI 10.1074/jbc.M109.034272; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Streubel B, 2006, LEUKEMIA, V20, P313, DOI 10.1038/sj.leu.2404045; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Yu L, 2011, FEBS J, V278, P1969, DOI 10.1111/j.1742-4658.2011.08135.x; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; Zhang YJ, 2008, P NATL ACAD SCI USA, V105, P11760, DOI 10.1073/pnas.0708583105; Zhao QH, 1996, MOL CELL BIOL, V16, P6765	38	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7338	7350		10.1074/jbc.M112.374967	http://dx.doi.org/10.1074/jbc.M112.374967			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23293025	hybrid, Green Published			2022-12-28	WOS:000316002400053
J	Kopfmann, S; Hess, WR				Kopfmann, Stefan; Hess, Wolfgang R.			Toxin-Antitoxin Systems on the Large Defense Plasmid pSYSA of Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; INHIBITS TRANSLATION; F-PLASMID; CYANOBACTERIUM; SEQUENCE; PROTEIN; BACTERIA; LOCI; CLEAVAGE; DECAY	Bacterial toxin-antitoxin (TA) systems are genetic elements, which are encoded by plasmid as well as chromosomal loci and mediate plasmid and genomic island maintenance through post-segregational killing mechanisms. TA systems exist in surprisingly high numbers in all prokaryotes, but cyanobacterial TA systems have been only very poorly experimentally characterized so far. Cyanobacteria are the only prokaryotes that perform oxygenic photosynthesis. As such, cyanobacteria are of high ecological importance and are considered promising for the production of biofuels. Here, we present the molecular characterization of the sll7003/ssl7004 TA system encoded on plasmid pSYSA of the model cyanobacterium Synechocystis sp. PCC 6803 as involving a Mg2+-dependent RNA endonuclease activity targeting single-stranded RNA regions and demonstrate the functionality of four more TA systems encoded on this 100,749-bp plasmid. Furthermore, one additional type I, one additional type II, and three freestanding TA system components are predicted on pSYSA, all of which appear active judged by their expression. By harboring at least seven simultaneously active TA systems, pSYSA appears as the plasmid most strongly selected for among all plasmids studied in this respect thus far. These results point to a high biological relevance of pSYSA, whose coding capacity is 75% devoted to three distinct clustered regularly interspaced short palindromic repeats (CRISPR) systems mediating antiviral defense.	[Kopfmann, Stefan; Hess, Wolfgang R.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	University of Freiburg	Hess, WR (corresponding author), Univ Freiburg, Fac Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	wolfgang.hess@biologie.uni-freiburg.de		Hess, Wolfgang/0000-0002-5340-3423	Deutsche Forschungsgemeinschaft, Bonn [HE 2544/6-1]	Deutsche Forschungsgemeinschaft, Bonn(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, Bonn, Grant HE 2544/6-1 (to W. R. H.).	Ahidjo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021738; Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Blower TR, 2012, NUCLEIC ACIDS RES, V40, P6158, DOI 10.1093/nar/gks231; Blower TR, 2011, NAT STRUCT MOL BIOL, V18, P185, DOI 10.1038/nsmb.1981; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Christensen-Dalsgaard M, 2008, METHOD ENZYMOL, V447, P521, DOI 10.1016/S0076-6879(08)02225-8; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Danika T, 2012, DNA RES, V19, P435, DOI 10.1093/dnares/dss024; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; GERDES K, 1988, J MOL BIOL, V203, P119, DOI 10.1016/0022-2836(88)90096-4; Hess WR, 2011, CURR OPIN MICROBIOL, V14, P608, DOI 10.1016/j.mib.2011.07.024; JAFFE A, 1985, J BACTERIOL, V163, P841; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Kaneko T, 2003, DNA RES, V10, P221, DOI 10.1093/dnares/10.5.221; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; McKenzie JL, 2012, RNA, V18, P1267, DOI 10.1261/rna.031229.111; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Ning DG, 2011, CURR MICROBIOL, V63, P496, DOI 10.1007/s00284-011-0011-5; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Rothenbacher FP, 2012, J BACTERIOL, V194, P3464, DOI 10.1128/JB.00217-12; Schuster CF, 2013, J BACTERIOL, V195, P115, DOI 10.1128/JB.00400-12; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Stazic D, 2011, NUCLEIC ACIDS RES, V39, P4890, DOI 10.1093/nar/gkr037; Steglich C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000173; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Van Melderen L, 2002, INT J MED MICROBIOL, V291, P537; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Winther KS, 2009, MOL MICROBIOL, V72, P918, DOI 10.1111/j.1365-2958.2009.06694.x; Xu WD, 1997, PLASMID, V37, P95, DOI 10.1006/plas.1997.1281; Yamaguchi Y, 2009, PROG MOL BIOL TRANSL, V85, P467, DOI 10.1016/S0079-6603(08)00812-X; YANG XY, 1993, J BACTERIOL, V175, P3981, DOI 10.1128/JB.175.13.3981-3991.1993; YANG XY, 1994, PLASMID, V31, P131, DOI 10.1006/plas.1994.1014; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	44	21	22	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7399	7409		10.1074/jbc.M112.434100	http://dx.doi.org/10.1074/jbc.M112.434100			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23322786	Green Published, hybrid			2022-12-28	WOS:000316002400058
J	Dulce, RA; Yiginer, O; Gonzalez, DR; Goss, G; Feng, N; Zheng, MZ; Hare, JM				Dulce, Raul A.; Yiginer, Omer; Gonzalez, Daniel R.; Goss, Garrett; Feng, Ning; Zheng, Meizi; Hare, Joshua M.			Hydralazine and Organic Nitrates Restore Impaired Excitation-Contraction Coupling by Reducing Calcium Leak Associated with Nitroso-Redox Imbalance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; MYOCARDIAL OXYGEN-CONSUMPTION; XANTHINE-OXIDASE; SARCOPLASMIC-RETICULUM; OXIDATIVE STRESS; HEART-FAILURE; PHOSPHOLAMBAN PHOSPHORYLATION; ISOSORBIDE DINITRATE; S-NITROSYLATION; RABBIT AORTA	Although the combined use of hydralazine and isosorbide dinitrate confers important clinical benefits in patients with heart failure, the underlying mechanism of action is still controversial. We used two models of nitroso-redox imbalance, neuronal NO synthase-deficient (NOS1(-/-)) mice and spontaneously hypertensive heart failure rats, to test the hypothesis that hydralazine (HYD) alone or in combination with nitroglycerin (NTG) or isosorbide dinitrate restores Ca2+ cycling and contractile performance and controls superoxide production in isolated cardiomyocytes. The response to increased pacing frequency was depressed in NOS1(-/-) compared with wild type myocytes. Both sarcomere length shortening and intracellular Ca2+ transient (Delta[Ca2+](i)) responses in NOS1(-/-) cardiomyocytes were augmented by HYD in a dose-dependent manner. NTG alone did not affect myocyte shortening but reduced Delta[Ca2+](i) across the range of pacing frequencies and increased myofilament Ca2+ sensitivity thereby enhancing contractile efficiency. Similar results were seen in failing myocytes from the heart failure rat model. HYD alone or in combination with NTG reduced sarcoplasmic reticulum (SR) leak, improved SR Ca2+ reuptake, and restored SR Ca2+ content. HYD and NTG at low concentrations (1 mu M), scavenged superoxide in isolated cardiomyocytes, whereas in cardiac homogenates, NTG inhibited xanthine oxidoreductase activity and scavenged NADPH oxidase-dependent superoxide more efficiently than HYD. Together, these results revealed that by reducing SR Ca2+ leak, HYD improves Ca2+ cycling and contractility impaired by nitroso-redox imbalance, and NTG enhanced contractile efficiency, restoring cardiac excitation-contraction coupling.	[Dulce, Raul A.; Goss, Garrett; Hare, Joshua M.] Univ Miami, Miller Sch Med, ISCI, Miami, FL 33136 USA; [Yiginer, Omer] Gulhane Mil Med Acad, Haydarpasa Hosp, Dept Cardiol, TR-34668 Istanbul, Turkey; [Yiginer, Omer; Feng, Ning] Johns Hopkins Sch Med, Div Cardiol, Baltimore, MD 21287 USA; [Gonzalez, Daniel R.] Univ Talca, Fac Ciencias Salud, Dept Ciencias Basicas Biomed, Talca 3460000, Chile; [Zheng, Meizi] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21207 USA	University of Miami; Gulhane Military Medical Academy; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Johns Hopkins University; Johns Hopkins Medicine; Universidad de Talca; University System of Maryland; University of Maryland Baltimore	Hare, JM (corresponding author), Biomed Res Bldg BRB,1501 NW 10th Ave,Room 916, Miami, FL 33136 USA.	JHare@med.miami.edu	Yiğiner, Ömer/AAO-2477-2020	GONZALEZ, DANIEL/0000-0002-3437-8998; Goss, Garrett/0000-0002-0155-4334	National Institutes of Health [HL-65455, 5R01AG025017, R01 HL094849]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065455, R01HL094849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-65455, 5R01AG025017, and R01 HL094849 (to J. M. H.).	Amado LC, 2005, J MOL CELL CARDIOL, V39, P531, DOI 10.1016/j.yjmcc.2005.04.008; Antoons G, 2006, J MOL CELL CARDIOL, V40, P350, DOI 10.1016/j.yjmcc.2005.12.002; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Barouch LA, 2003, J MOL CELL CARDIOL, V35, P637, DOI 10.1016/S0022-2828(03)00079-8; BASSANI RA, 1992, J PHYSIOL-LONDON, V453, P591, DOI 10.1113/jphysiol.1992.sp019246; BAUER JA, 1991, CIRCULATION, V84, P35, DOI 10.1161/01.CIR.84.1.35; Beigi F, 2012, P NATL ACAD SCI USA, V109, P4314, DOI 10.1073/pnas.1113319109; Bergamini C, 2009, EUR J HEART FAIL, V11, P444, DOI 10.1093/eurjhf/hfp042; Burger DE, 2009, CIRCULATION, V120, P1345, DOI 10.1161/CIRCULATIONAHA.108.846402; Cappola TP, 2001, CIRCULATION, V104, P2407, DOI 10.1161/hc4501.098928; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Cole RT, 2011, CIRCULATION, V123, P2414, DOI 10.1161/CIRCULATIONAHA.110.012781; Cote CG, 1996, AM J PHYSIOL-LUNG C, V271, pL869, DOI 10.1152/ajplung.1996.271.5.L869; Daiber A, 2005, AM J CARDIOL, V96, p25I, DOI 10.1016/j.amjcard.2005.07.030; Ekelund UEG, 1999, CIRC RES, V85, P437, DOI 10.1161/01.RES.85.5.437; Ellershaw DC, 2001, BRIT J PHARMACOL, V134, P621, DOI 10.1038/sj.bjp.0704302; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; GOGIA H, 1995, J AM COLL CARDIOL, V26, P1575, DOI 10.1016/0735-1097(95)00368-1; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Gonzalez DR, 2010, J BIOL CHEM, V285, P28938, DOI 10.1074/jbc.M110.154948; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GURNEY AM, 1995, BRIT J PHARMACOL, V114, P238, DOI 10.1111/j.1476-5381.1995.tb14931.x; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Hare JM, 2004, NEW ENGL J MED, V351, P2112, DOI 10.1056/NEJMe048269; Hare JM, 2008, J AM COLL CARDIOL, V51, P2301, DOI 10.1016/j.jacc.2008.01.068; Harrison CB, 2010, CLIN EXP PHARMACOL P, V37, P429, DOI 10.1111/j.1440-1681.2009.05317.x; Janero DR, 2004, P NATL ACAD SCI USA, V101, P16958, DOI 10.1073/pnas.0406075101; Katori T, 2006, FREE RADICAL BIO MED, V41, P1606, DOI 10.1016/j.freeradbiomed.2006.08.023; Khan SA, 2004, P NATL ACAD SCI USA, V101, P15944, DOI 10.1073/pnas.0404136101; Khan SA, 2003, CIRC RES, V92, P1322, DOI 10.1161/01.RES.0000078171.52542.9E; Kinugawa S, 2005, CIRC RES, V96, P355, DOI 10.1161/01.RES.0000155331.09458.A7; Kohr MJ, 2008, CARDIOVASC RES, V77, P353, DOI 10.1093/cvr/cvm018; Lamberts RR, 2007, J PHYSIOL-LONDON, V582, P695, DOI 10.1113/jphysiol.2007.134486; Layland J, 2002, J PHYSIOL-LONDON, V540, P457, DOI 10.1113/jphysiol.2001.014126; Leiro JM, 2004, INT IMMUNOPHARMACOL, V4, P163, DOI 10.1016/j.intimp.2003.10.004; Miao L, 1997, EUR J PHARMACOL, V321, P201, DOI 10.1016/S0014-2999(96)00946-6; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562; ROBAK J, 1988, BIOCHEM PHARMACOL, V37, P837, DOI 10.1016/0006-2952(88)90169-4; Rossman EI, 2004, J MOL CELL CARDIOL, V36, P33, DOI 10.1016/j.yjmcc.2003.09.001; Saavedra WF, 2002, CIRC RES, V90, P297, DOI 10.1161/hh0302.104531; Saraiva RM, 2005, CIRCULATION, V112, P3415, DOI 10.1161/CIRCULATIONAHA.105.557892; Saraiva RM, 2007, NITRIC OXIDE-BIOL CH, V16, P331, DOI 10.1016/j.niox.2006.12.001; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Shinyashiki M, 2004, FREE RADICAL BIO MED, V37, P713, DOI 10.1016/j.freeradbiomed.2004.05.031; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Taylor AL, 2012, J CARD FAIL, V18, P600, DOI 10.1016/j.cardfail.2012.06.526; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; THADANI U, 1988, CLIN PHARMACOKINET, V15, P32, DOI 10.2165/00003088-198815010-00003; Tziomalos K, 2009, FRONT BIOSCI-LANDMRK, V14, P237, DOI 10.2741/3243; Vila-Petroff MG, 1999, CIRC RES, V84, P1020, DOI 10.1161/01.RES.84.9.1020; Wang H, 2008, AM J PHYSIOL-CELL PH, V294, pC1566, DOI 10.1152/ajpcell.00367.2007; Wang HL, 2010, J PHYSIOL-LONDON, V588, P2905, DOI 10.1113/jphysiol.2010.192617; Yano M, 2005, J CLIN INVEST, V115, P556, DOI 10.1172/JCI200524159; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949	58	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6522	6533		10.1074/jbc.M112.412130	http://dx.doi.org/10.1074/jbc.M112.412130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23319593	hybrid, Green Published			2022-12-28	WOS:000315820700045
J	Feng, YQ; Love, RP; Chelico, L				Feng, Yuqing; Love, Robin P.; Chelico, Linda			HIV-1 Viral Infectivity Factor (Vif) Alters Processive Single-stranded DNA Scanning of the Retroviral Restriction Factor APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SMALL-MOLECULE INHIBITION; TYPE-1 VIF; CYTIDINE DEAMINASE; AMINO-ACID; VIRION INCORPORATION; MESSENGER-RNA; REVERSE-TRANSCRIPTASE; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G	APOBEC3G is a retroviral restriction factor that can inhibit the replication of human immunodeficiency virus, type 1 (HIV-1) in the absence of the viral infectivity factor (Vif) protein. Virion-encapsidated APOBEC3G can deaminate cytosine to uracil in viral (-)DNA, which leads to hypermutation and inactivation of the provirus. APOBEC3G catalyzes these deaminations processively on single-stranded DNA using sliding and jumping movements. Vif is thought to primarily overcome APOBEC3G through an interaction that mediates APOBEC3G ubiquitination and results in its proteasomal degradation. However, Vif may also inhibit APOBEC3G mRNA translation, virion encapsidation, and deamination activity. Here we investigated the molecular mechanism of Vif(IIIB)- and Vif(HXB2)-mediated inhibition of APOBEC3G deamination activity. Biochemical assays using a model HIV-1 replication assay and synthetic single-stranded or partially double-stranded DNA substrates demonstrated that APOBEC3G has an altered processive mechanism in the presence of Vif. Specifically, Vif(HXB2) inhibited the jumping and Vif(IIIB) inhibited the sliding movements of APOBEC3G. The absence of such an effect by Vif on degradation-resistant APOBEC3G D128K indicates that a Vif-APOBEC3G interaction mediates this effect. That the partially processive APOBEC3G was less effective at inducing mutagenesis in a model HIV-1 replication assay suggests that Vif co-encapsidation with APOBEC3G can promote sublethal mutagenesis of HIV-1 proviral DNA.	[Feng, Yuqing; Love, Robin P.; Chelico, Linda] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Chelico, L (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada.	linda.chelico@usask.ca		Feng, Yuqing/0000-0002-7156-1628; Chelico, Linda/0000-0003-4673-8978; Love, Robin/0000-0002-2509-706X	Canadian Institutes of Health Operating Grant [HOP-111407]; Saskatchewan Health Research Foundation; Canadian Foundation for Innovation; Tri-Link Biotechnologies Research Rewards Program	Canadian Institutes of Health Operating Grant(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); Tri-Link Biotechnologies Research Rewards Program	This work was supported by Canadian Institutes of Health Operating Grant HOP-111407, a new investigator establishment grant from the Saskatchewan Health Research Foundation, the Canadian Foundation for Innovation, and the Tri-Link Biotechnologies Research Rewards Program.	Albin JS, 2010, J BIOL CHEM, V285, P40785, DOI 10.1074/jbc.M110.173161; Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; Bernacchi S, 2007, J BIOL CHEM, V282, P26361, DOI 10.1074/jbc.M703122200; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Britan-Rosich E, 2011, J MOL BIOL, V410, P1065, DOI 10.1016/j.jmb.2011.03.058; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Cadima-Couto I, 2011, J NEUROIMMUNE PHARM, V6, P296, DOI 10.1007/s11481-011-9258-7; Camaur D, 1996, J VIROL, V70, P6106, DOI 10.1128/JVI.70.9.6106-6111.1996; Chaipan C, 2013, J VIROL, V87, P444, DOI 10.1128/JVI.00676-12; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chelico L, 2009, PHILOS T R SOC B, V364, P583, DOI 10.1098/rstb.2008.0195; COFFIN JM, 1997, RETROVIRUSES, P121; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Feng YQ, 2011, J BIOL CHEM, V286, P11415, DOI 10.1074/jbc.M110.199604; Fouchier RAM, 1996, J VIROL, V70, P8263, DOI 10.1128/JVI.70.12.8263-8269.1996; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Goila-Gaur R, 2009, J VIROL, V83, P1156, DOI 10.1128/JVI.01734-08; Golla-Gaur R, 2008, VIROLOGY, V372, P136, DOI 10.1016/j.virol.2007.10.017; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Henriet S, 2005, J MOL BIOL, V354, P55, DOI 10.1016/j.jmb.2005.09.025; Henriet S, 2009, MICROBIOL MOL BIOL R, V73, P211, DOI 10.1128/MMBR.00040-08; Hu CL, 2010, J VIROL, V84, P11981, DOI 10.1128/JVI.00723-10; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2009, P NATL ACAD SCI USA, V106, P19539, DOI 10.1073/pnas.0906652106; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Kao S, 2003, J VIROL, V77, P1131, DOI 10.1128/JVI.77.2.1131-1140.2003; Kao Sandra, 2004, Retrovirology, V1, P27, DOI 10.1186/1742-4690-1-27; Karczewski MK, 1996, J VIROL, V70, P494, DOI 10.1128/JVI.70.1.494-507.1996; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Lavens D, 2010, NUCLEIC ACIDS RES, V38, P1902, DOI 10.1093/nar/gkp1154; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Marin M, 2008, J VIROL, V82, P987, DOI 10.1128/JVI.01078-07; McDougall WM, 2011, J BIOL CHEM, V286, P30655, DOI 10.1074/jbc.M111.269506; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mercenne G, 2010, NUCLEIC ACIDS RES, V38, P633, DOI 10.1093/nar/gkp1009; Miller JH, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-81; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Pillai SK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-26; Rausch JW, 2004, INT J BIOCHEM CELL B, V36, P1752, DOI 10.1016/j.biocel.2004.02.016; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Santa-Marta M, 2005, J BIOL CHEM, V280, P8765, DOI 10.1074/jbc.M409309200; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shlyakhtenko LS, 2012, BIOCHEMISTRY-US, V51, P6432, DOI 10.1021/bi300733d; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Smith JL, 2010, J VIROL, V84, P12599, DOI 10.1128/JVI.01437-10; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Uyttendaele I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044143; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou V, 2006, VIROLOGY, V349, P31, DOI 10.1016/j.virol.2005.12.035; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zuo T, 2012, J VIROL, V86, P5497, DOI 10.1128/JVI.06957-11	83	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6083	6094		10.1074/jbc.M112.421875	http://dx.doi.org/10.1074/jbc.M112.421875			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23316055	Green Published, hybrid			2022-12-28	WOS:000315820700006
J	Xu, AJ; Springer, TA				Xu, Amy J.; Springer, Timothy A.			Mechanisms by which von Willebrand Disease Mutations Destabilize the A2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VONWILLEBRAND DISEASE; MULTIMERS; CLEAVAGE; ADHESION; UPDATE; IIA	von Willebrand Factor (VWF) is an ultralong, concatameric, and adhesive glycoprotein. On short time scales, adhesiveness for platelets is activated by elongation of VWF by altered hydrodynamics at sites of hemostasis. Over longer time scales, the length of VWF is regulated by ADAMTS13 (a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13), cleavage by which in the VWF A2 domain is dependent on elongational force. Patients with von Willebrand disease type 2A present with increased bleeding due to mutations within the VWF A2 domain that enhance cleavage. We tested using temperature and force the hypothesis that von Willebrand disease mutations disrupt A2 force sensing by destabilizing the folded state. Mutations R1597W, M1528V, and E1638K reduced A2 thermal stability by 10-18 degrees C. M1528V and E1638K showed a marked further decrease in stability upon calcium removal. In contrast, R1597W, which resides within the A2 calcium-binding loop, exhibited similar stability in the presence and absence of calcium. Using single molecule optical tweezers and R1597W, we measured the force dependence of unfolding and refolding kinetics. In the presence of calcium, the R1597W mutation slowed the rate of refolding but had no effect on unfolding. The three mutations highlight the calcium-binding loop (R1597W), the hydrophobic core around the vicinal disulfide (M1528V), and hydrogen bonds to the alpha 4-less loop (E1638K), as structural features critically important to the function of A2 as a force sensor in regulating thrombogenic activity in the vasculature.	[Springer, Timothy A.] Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Springer, TA (corresponding author), Childrens Hosp Boston, Program Cellular & Mol Med, 3 Blackfan Circle, Boston, MA 02115 USA.	springer@idi.harvard.edu		Xu, Amy/0000-0001-9650-9458	National Institutes of Health [HL-48675]; Molecular Biophysics and General Medical Sciences Training Grants from NIGMS [T32 GM008313, GM007753]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675, R01HL108248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM008313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biophysics and General Medical Sciences Training Grants from NIGMS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant HL-48675 (to T. A. S.) and Molecular Biophysics and General Medical Sciences Training Grants T32 GM008313 and GM007753 (from NIGMS; to A. J. X.).	Auton M, 2007, J MOL BIOL, V366, P986, DOI 10.1016/j.jmb.2006.10.067; CHRISTOPHE O, 1994, BLOOD, V83, P3553; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hampshire DJ, 2011, SEMIN THROMB HEMOST, V37, P470, DOI 10.1055/s-0031-1281031; Hassenpflug WA, 2006, BLOOD, V107, P2339, DOI 10.1182/blood-2005-04-1758; HOYER LW, 1980, BLOOD, V55, P1056; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; LAVERGNE JM, 1991, BLOOD COAGUL FIBRIN, V2, P293, DOI 10.1097/00001721-199104000-00012; Luken BM, 2010, BLOOD, V115, P4910, DOI 10.1182/blood-2009-12-257949; LYONS SE, 1992, J BIOL CHEM, V267, P4424; RIBBA AS, 1992, J BIOL CHEM, V267, P23209; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Springer TA, 2011, J THROMB HAEMOST, V9, P130, DOI 10.1111/j.1538-7836.2011.04320.x; TOUMADJE A, 1992, ANAL BIOCHEM, V200, P321, DOI 10.1016/0003-2697(92)90473-K; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Xu AJ, 2012, P NATL ACAD SCI USA, V109, P3742, DOI 10.1073/pnas.1121261109; Ying JY, 2010, BIOPHYS J, V98, P1685, DOI 10.1016/j.bpj.2009.12.4324; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zhou MY, 2011, BLOOD, V117, P4623, DOI 10.1182/blood-2010-11-321596; Zhou YF, 2011, EMBO J, V30, P4098, DOI 10.1038/emboj.2011.297	25	17	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6317	6324		10.1074/jbc.M112.422618	http://dx.doi.org/10.1074/jbc.M112.422618			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322777	Green Published, hybrid			2022-12-28	WOS:000315820700026
J	Li, L; Nelson, CJ; Carrie, C; Gawryluk, RMR; Solheim, C; Gray, MW; Whelan, J; Millar, AH				Li, Lei; Nelson, Clark J.; Carrie, Chris; Gawryluk, Ryan M. R.; Solheim, Cory; Gray, Michael W.; Whelan, James; Millar, A. Harvey			Subcomplexes of Ancestral Respiratory Complex I Subunits Rapidly Turn Over in Vivo as Productive Assembly Intermediates in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; MITOCHONDRIAL PROTEOME; MEMBRANE ARM; COMPONENTS; CHAIN; CHAPERONES; PROTEINS; INSIGHTS; OXIDASE; MODULES	Subcomplexes of mitochondrial respiratory complex I (CI; EC 1.6.5.3) are shown to turn over in vivo, and we propose a role in an ancestral assembly pathway. By progressively labeling Arabidopsis cell cultures with N-15 and isolating mitochondria, we have identified CI subcomplexes through differences in N-15 incorporation into their protein subunits. The 200-kDa subcomplex, containing the ancestral gamma-carbonic anhydrase (gamma-CA), gamma-carbonic anhydrase-like, and 20.9-kDa subunits, had a significantly higher turnover rate than intact CI or CI + CIII2. In vitro import of precursors for these CI subunits demonstrated rapid generation of subcomplexes and revealed that their specific abundance varied when different ancestral subunits were imported. Time course studies of precursor import showed the further assembly of these subcomplexes into CI and CI + CIII2, indicating that the subcomplexes are productive intermediates of assembly. The strong transient incorporation of new subunits into the 200-kDa subcomplex in a gamma-CA mutant is consistent with this subcomplex being a key initiator of CI assembly in plants. This evidence alongside the pattern of coincident occurrence of genes encoding these particular proteins broadly in eukaryotes, except for opisthokonts, provides a framework for the evolutionary conservation of these accessory subunits and evidence of their function in ancestral CI assembly.	[Li, Lei; Nelson, Clark J.; Carrie, Chris; Solheim, Cory; Millar, A. Harvey] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Li, Lei; Nelson, Clark J.; Solheim, Cory; Whelan, James; Millar, A. Harvey] Univ Western Australia, Ctr Comparat Anal Biomol Networks, Crawley, WA 6009, Australia; [Gawryluk, Ryan M. R.; Gray, Michael W.] Dalhousie Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS B3H 4R2, Canada	University of Western Australia; University of Western Australia; Dalhousie University	Millar, AH (corresponding author), Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, M316,35 Stirling Highway, Crawley, WA 6009, Australia.	harvey.millar@uwa.edu.au	Carrie, Chris/A-2638-2010; Li, Lei/A-1631-2012; Whelan, James/F-6402-2011; Millar, A. Harvey/A-5452-2008	Carrie, Chris/0000-0002-4240-4674; Li, Lei/0000-0003-1508-5484; Whelan, James/0000-0001-5754-025X; Millar, A. Harvey/0000-0001-9679-1473; Gawryluk, Ryan/0000-0003-1251-882X; Gray, Michael/0000-0001-7125-2625; Nelson, Clark/0000-0002-8796-8326	Australian Research Council (ARC) Centre of Excellence in Plant Energy Biology Grant [CE0561495]; Scholarship International Research Fees, a University International Stipend (UIS); Top Up Scholarship; ARC [FT110100242]	Australian Research Council (ARC) Centre of Excellence in Plant Energy Biology Grant(Australian Research Council); Scholarship International Research Fees, a University International Stipend (UIS); Top Up Scholarship; ARC(Australian Research Council)	This work was supported by Australian Research Council (ARC) Centre of Excellence in Plant Energy Biology Grant CE0561495 (to A. H. M. and J. W.).; Supported by Scholarship International Research Fees, a University International Stipend (UIS), and a Top Up Scholarship for UIS.; An ARC Australian Future Fellow (Grant FT110100242). To whom correspondence should be addressed. Tel.: 61-8-6488-7245; Fax: 61-8-64884401; E-mail: harvey.millar@uwa.edu.au.	Acestor N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006908; Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Bender T, 2010, PROTEOMICS, V10, P1426, DOI 10.1002/pmic.200800619; Brown MW, 2012, CURR BIOL, V22, P1123, DOI 10.1016/j.cub.2012.04.021; Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446; Cardol P, 2004, BBA-BIOENERGETICS, V1658, P212, DOI 10.1016/j.bbabio.2004.06.001; Cardol P, 2011, BBA-BIOENERGETICS, V1807, P1390, DOI 10.1016/j.bbabio.2011.06.015; Carrie C, 2010, J BIOL CHEM, V285, P36138, DOI 10.1074/jbc.M110.121202; Cavalier-Smith T, 2010, PROTIST, V161, P549, DOI 10.1016/j.protis.2010.04.002; Czarna M, 2010, PROTEOMICS, V10, P6, DOI 10.1002/pmic.200900352; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; Gawryluk RMR, 2012, BBA-BIOENERGETICS, V1817, P2027, DOI 10.1016/j.bbabio.2012.06.005; Gawryluk RMR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-176; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Heazlewood JL, 2003, BBA-BIOENERGETICS, V1604, P159, DOI 10.1016/S0005-2728(03)00045-8; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Klodmann J, 2011, PLANT PHYSIOL, V157, P587, DOI 10.1104/pp.111.182352; Klodmann J, 2011, PROTEOMICS, V11, P1834, DOI 10.1002/pmic.201000638; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Kuffner R, 1998, J MOL BIOL, V283, P409, DOI 10.1006/jmbi.1998.2114; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lee CP, 2008, MOL CELL PROTEOMICS, V7, P1297, DOI 10.1074/mcp.M700535-MCP200; Li L, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010025, 10.1074/mcp.M111.014209]; Meyer EH, 2008, J PROTEOME RES, V7, P786, DOI 10.1021/pr700595p; Meyer EH, 2011, J BIOL CHEM, V286, P26081, DOI 10.1074/jbc.M110.209601; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Perales M, 2005, J MOL BIOL, V350, P263, DOI 10.1016/j.jmb.2005.04.062; Perales M, 2004, PLANT MOL BIOL, V56, P947, DOI 10.1007/s11103-004-6324-z; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHULTE U, 1994, BBA-BIOENERGETICS, V1187, P121, DOI 10.1016/0005-2728(94)90096-5; Schulte U, 2001, J BIOENERG BIOMEMBR, V33, P205, DOI 10.1023/A:1010730919074; Smith DGS, 2007, J MOL BIOL, V374, P837, DOI 10.1016/j.jmb.2007.09.051; Sperling E, 2008, ANAL CHEM, V80, P4906, DOI 10.1021/ac800080v; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Sunderhaus S, 2006, J BIOL CHEM, V281, P6482, DOI 10.1074/jbc.M511542200; Taylor NL, 2005, MOL CELL PROTEOMICS, V4, P1122, DOI 10.1074/mcp.M400210-MCP200; TUSCHEN G, 1990, J MOL BIOL, V213, P845, DOI 10.1016/S0022-2836(05)80268-2; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Videira A, 2002, BBA-BIOENERGETICS, V1555, P187, DOI 10.1016/S0005-2728(02)00276-1; Videira A, 2001, J BIOENERG BIOMEMBR, V33, P197, DOI 10.1023/A:1010778802236; Villarreal F, 2009, PLANT MOL BIOL, V70, P471, DOI 10.1007/s11103-009-9484-z; Vogel RO, 2007, MOL GENET METAB, V91, P176, DOI 10.1016/j.ymgme.2007.02.007; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; Wang Q, 2012, PLANT PHYSIOL, V160, P1373, DOI 10.1104/pp.112.204339; Yip CY, 2011, J BIOL CHEM, V286, P5023, DOI 10.1074/jbc.M110.194993; Zabaleta E, 2012, PLANT SCI, V187, P97, DOI 10.1016/j.plantsci.2012.02.001	51	39	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5707	5717		10.1074/jbc.M112.432070	http://dx.doi.org/10.1074/jbc.M112.432070			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23271729	Green Published, hybrid			2022-12-28	WOS:000315342500043
J	Sucic, S; Koban, F; El-Kasaby, A; Kudlacek, O; Stockner, T; Sitte, HH; Freissmuth, M				Sucic, Sonja; Koban, Florian; El-Kasaby, Ali; Kudlacek, Oliver; Stockner, Thomas; Sitte, Harald H.; Freissmuth, Michael			Switching the Clientele A LYSINE RESIDING IN THE C TERMINUS OF THE SEROTONIN TRANSPORTER SPECIFIES ITS PREFERENCE FOR THE COAT PROTEIN COMPLEX II COMPONENT SEC24C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC-ACID TRANSPORTER-1; DEPENDENT NEUROTRANSMITTER TRANSPORTERS; EARLY SECRETORY PATHWAY; ENDOPLASMIC-RETICULUM; GABA TRANSPORTER-1; OLIGOMER FORMATION; BACTERIAL HOMOLOG; GOLGI TRAFFICKING; PROTEIN-KINASE; EXPORT	The serotonin transporter (SERT) maintains serotonergic neurotransmission via rapid reuptake of serotonin from the synaptic cleft. SERT relies exclusively on the coat protein complex II component SEC24C for endoplasmic reticulum (ER) export. The closely related transporters for noradrenaline and dopamine depend on SEC24D. Here, we show that discrimination between SEC24C and SEC24D is specified by the residue at position +2 downstream from the ER export motif ((RI608)-R-607 in SERT). Substituting Lys(610) with tyrosine, the corresponding residue found in the noradrenaline and dopamine transporters, switched the SEC24 isoform preference: SERT-K610Y relied solely on SEC24D to reach the cell surface. This analysis was extended to other SLC6 (solute carrier 6) transporter family members: siRNA-dependent depletion of SEC24C, but not of SEC24D, reduced surface levels of the glycine transporter-1a, the betaine/GABA transporter and the GABA transporter-4. Experiments with dominant negative versions of SEC24C and SEC24D recapitulated these findings. We also verified that the presence of two ER export motifs (in concatemers of SERT and GABA transporter-1) supported recruitment of both SEC24C and SEC24D. To the best of our knowledge, this is the first report to document a change in SEC24 specificity by mutation of a single residue in the client protein. Our observations allowed for deducing a rule for SLC6 family members: a hydrophobic residue (Tyr or Val) in the + 2 position specifies interaction with SEC24D, and a hydrophilic residue (Lys, Asn, or Gln) recruits SEC24C. Variations in SEC24C are linked to neuropsychiatric disorders. The present findings provide a mechanistic explanation. Variations in SEC24C may translate into distinct surface levels of neurotransmitter transporters.	[Sucic, Sonja; Koban, Florian; El-Kasaby, Ali; Kudlacek, Oliver; Stockner, Thomas; Sitte, Harald H.; Freissmuth, Michael] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [El-Kasaby, Ali] Mansoura Univ, Dept Pharmacol, Fac Vet Med, Mansoura 35516, Egypt	Medical University of Vienna; Egyptian Knowledge Bank (EKB); Mansoura University	Freissmuth, M (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at	Stockner, Thomas/A-9509-2014; Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013	Stockner, Thomas/0000-0002-7071-8283; Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Koban, Florian/0000-0003-0912-3114; Kudlacek, Oliver/0000-0002-3086-8551; Freissmuth, Michael/0000-0001-9398-1765; Sucic, Sonja/0000-0001-5136-8022	Austrian Science Fund/FWF [SFB35]	Austrian Science Fund/FWF(Austrian Science Fund (FWF))	This work was supported by Project Program Grant SFB35 from the Austrian Science Fund/FWF (to M.F.).	Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2008, J CELL SCI, V121, P753, DOI 10.1242/jcs.017681; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Farhan H, 2011, J CELL SCI, V124, P171, DOI 10.1242/jcs.076455; Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; Fernandez-Sanchez E, 2008, BIOCHEM J, V409, P669, DOI 10.1042/BJ20070533; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Korkhov VM, 2004, J BIOL CHEM, V279, P55728, DOI 10.1074/jbc.M409449200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; Lee SA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S20; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Morgan AR, 2007, AM J MED GENET B, V144B, P762, DOI 10.1002/ajmg.b.30509; Ohisa S, 2010, DEV BIOL, V342, P85, DOI 10.1016/j.ydbio.2010.03.016; Prasad HC, 2005, P NATL ACAD SCI USA, V102, P11545, DOI 10.1073/pnas.0501432102; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Sharpe LJ, 2011, TRAFFIC, V12, P19, DOI 10.1111/j.1600-0854.2010.01133.x; Steinkellner T, 2012, J BIOL CHEM, V287, P29627, DOI 10.1074/jbc.M112.367219; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Wansleeben C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019357; Wansleeben C, 2010, DEVELOPMENT, V137, P1067, DOI 10.1242/dev.041434; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu W, 2010, BIOINFORMATICS, V26, P145, DOI 10.1093/bioinformatics/btp618; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390	38	41	41	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5330	5341		10.1074/jbc.M112.408237	http://dx.doi.org/10.1074/jbc.M112.408237			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288844	hybrid, Green Published			2022-12-28	WOS:000315342500007
J	Cortez, LM; Kumar, J; Renault, L; Young, HS; Sim, VL				Cortez, Leonardo M.; Kumar, Jitendra; Renault, Ludovic; Young, Howard S.; Sim, Valerie L.			Mouse Prion Protein Polymorphism Phe-108/Val-189 Affects the Kinetics of Fibril Formation and the Response to Seeding EVIDENCE FOR A TWO-STEP NUCLEATION POLYMERIZATION MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; INCUBATION PERIOD; AMYLOID FIBRILS; SCRAPIE; DISEASE; SHEEP; POLYMERIZATION; NUCLEATION; CONVERSION; MECHANISM	Prion diseases are fatal neurodegenerative disorders associated with the polymerization of the cellular form of prion protein (PrPC) into an amyloidogenic beta-sheet infectious form (PrPSc). The sequence of host PrP is the major determinant of host prion disease susceptibility. In mice, the presence of allele a (Prnp(a), encoding the polymorphism Leu-108/Thr-189) or b (Prnp(b), Phe-108/Val-189) is associated with short or long incubation times, respectively, following infection with PrPSc. The molecular bases linking PrP sequence, infection susceptibility, and convertibility of PrPC into PrPSc remain unclear. Here we show that recombinant PrPa and PrPb aggregate and respond to seeding differently in vitro. Our kinetic studies reveal differences during the nucleation phase of the aggregation process, where PrPb exhibits a longer lag phase that cannot be completely eliminated by seeding the reaction with preformed fibrils. Additionally, PrPb is more prone to propagate features of the seeds, as demonstrated by conformational stability and electron microscopy studies of the formed fibrils. We propose a model of polymerization to explain how the polymorphisms at positions 108 and 189 produce the phenotypes seen in vivo. This model also provides insight into phenomena such as species barrier and prion strain generation, two phenomena also influenced by the primary structure of PrP.	[Sim, Valerie L.] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada; [Renault, Ludovic; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada; [Sim, Valerie L.] Univ Alberta, Dept Med Neurol, Edmonton, AB T6G 2G3, Canada; [Sim, Valerie L.] Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2E1, Canada	University of Alberta; University of Alberta; National Research Council Canada; University of Alberta; University of Alberta; University of Alberta	Sim, VL (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, 204 BARB, Edmonton, AB T6G 2M8, Canada.	valerie.sim@ualberta.ca	Sim, Valerie/C-4137-2013	Sim, Valerie/0000-0002-0088-8666; Cortez, Leonardo/0000-0003-4080-8728; Young, Howard/0000-0002-5990-8422; Renault, Ludovic/0000-0001-6464-8808	Alberta Innovates Health Solutions	Alberta Innovates Health Solutions	This work was supported by Alberta Innovates Health Solutions (formerly Alberta Heritage Foundation for Medical Research).	Akhtar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028741; Alvarez-Martinez MT, 2011, BBA-PROTEINS PROTEOM, V1814, P1305, DOI 10.1016/j.bbapap.2011.05.016; Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; BARLOW RM, 1976, RES VET SCI, V21, P110, DOI 10.1016/S0034-5288(18)33406-4; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; Chen SG, 2002, NEURON, V34, P854, DOI 10.1016/S0896-6273(02)00736-5; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Dima RI, 2004, P NATL ACAD SCI USA, V101, P15335, DOI 10.1073/pnas.0404235101; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; FERRONE FA, 1985, J MOL BIOL, V183, P611, DOI 10.1016/0022-2836(85)90175-5; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Green KM, 2008, J GEN VIROL, V89, P598, DOI 10.1099/vir.0.83168-0; Hammarstrom P, 2010, BIOCHEMISTRY-US, V49, P6838, DOI 10.1021/bi100922r; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hill Andrew F., 2004, V11, P33; Houston F, 2003, NATURE, V423, P498, DOI 10.1038/423498a; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Julien O, 2011, BIOCHEMISTRY-US, V50, P7536, DOI 10.1021/bi200731e; Kirby L, 2010, BIOCHEMISTRY-US, V49, P1448, DOI 10.1021/bi901855z; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Lloyd SE, 2004, J GEN VIROL, V85, P2471, DOI 10.1099/vir.0.79889-0; Lloyd SE, 2004, MAMM GENOME, V15, P383, DOI 10.1007/s00335-004-3041-5; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Makarava N, 2007, J BIOL CHEM, V282, P36704, DOI 10.1074/jbc.M704926200; Moore RA, 2005, ARCH VIROL, P187; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Polano M, 2009, J MOL BIOL, V393, P1033, DOI 10.1016/j.jmb.2009.08.056; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Qi X, 2012, BIOCHEMISTRY-US, V51, P4600, DOI 10.1021/bi300201e; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Tizzano B, 2005, PROTEINS, V59, P72, DOI 10.1002/prot.20395; van Keulen LJM, 2008, ARCH VIROL, V153, P445, DOI 10.1007/s00705-007-0007-4; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WESTAWAY D, 1994, GENE DEV, V8, P959, DOI 10.1101/gad.8.8.959; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	46	12	13	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4772	4781		10.1074/jbc.M112.414581	http://dx.doi.org/10.1074/jbc.M112.414581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283973	hybrid, Green Published			2022-12-28	WOS:000315340400026
J	Kearney, CJ; Sheridan, C; Cullen, SP; Tynan, GA; Logue, SE; Afonina, IS; Vucic, D; Lavelle, EC; Martin, SJ				Kearney, Conor J.; Sheridan, Clare; Cullen, Sean P.; Tynan, Graham A.; Logue, Susan E.; Afonina, Inna S.; Vucic, Domagoj; Lavelle, Ed C.; Martin, Seamus J.			Inhibitor of Apoptosis Proteins (IAPs) and Their Antagonists Regulate Spontaneous and Tumor Necrosis Factor (TNF)-induced Proinflammatory Cytokine and Chemokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; INDUCED CELL-DEATH; RHEUMATOID-ARTHRITIS; THERAPEUTIC TARGETS; TNF; ACTIVATION; CANCER; INFLAMMATION; CIAP1	Inhibitor of apoptosis proteins (IAPs) play a major role in determining whether cells undergo apoptosis in response to TNF as well as other stimuli. However, TNF is also highly proinflammatory through its ability to trigger the secretion of multiple inflammatory cytokines and chemokines, which is arguably the most important role of TNF in vivo. Indeed, deregulated production of TNF-induced cytokines is a major driver of inflammation in several autoimmune conditions such as rheumatoid arthritis. Here, we show that IAPs are required for the production of multiple TNF-induced proinflammatory mediators. Ablation or antagonism of IAPs potently suppressed TNF- or RIPK1-induced proinflammatory cytokine and chemokine production. Surprisingly, IAP antagonism also led to spontaneous production of chemokines, particularly RANTES, in vitro and in vivo. Thus, IAPs play a major role in influencing the production of multiple inflammatory mediators, arguing that these proteins are important regulators of inflammation in addition to apoptosis. Furthermore, small molecule IAP antagonists can modulate spontaneous as well as TNF-induced inflammatory responses, which may have implications for use of these agents in therapeutic settings.	[Kearney, Conor J.; Sheridan, Clare; Cullen, Sean P.; Logue, Susan E.; Afonina, Inna S.; Martin, Seamus J.] Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland; [Cullen, Sean P.; Tynan, Graham A.; Lavelle, Ed C.; Martin, Seamus J.] Trinity Coll Dublin, Immunobiol Res Ctr, Dublin 2, Ireland; [Tynan, Graham A.; Lavelle, Ed C.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Adjuvant Res Grp, Dublin 2, Ireland; [Vucic, Domagoj] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Roche Holding; Genentech	Martin, SJ (corresponding author), Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland.	martinsj@tcd.ie	Kearney, Conor/AAP-7860-2020; Lavelle, Ed/A-1716-2008; Logue, Susan/K-7748-2019; Afonina, Inna/AAM-8978-2020	Lavelle, Ed/0000-0002-3167-1080; Logue, Susan/0000-0001-7938-3558; Afonina, Inna/0000-0001-8894-5305; Martin, Seamus/0000-0002-8539-3143	Science Foundation Ireland [07/SRC/B1144, 08/IN.1/B2031]; Irish Research Council for Science, Engineering and Technology Postgraduate Studentship [RS/2010/2542]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering and Technology Postgraduate Studentship(Irish Research Council for Science, Engineering and Technology)	This work was supported by Strategic Research Cluster 07/SRC/B1144 and Principal Investigator 08/IN.1/B2031 Grants from Science Foundation Ireland.; Supported by an Irish Research Council for Science, Engineering and Technology Postgraduate Studentship (RS/2010/2542).	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Feldmann M, 2008, J CLIN INVEST, V118, P3533, DOI 10.1172/JCI37346; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Moulin M, 2012, EMBO J, V31, P1679, DOI 10.1038/emboj.2012.18; O'Riordan MXD, 2008, DEV CELL, V15, P497, DOI 10.1016/j.devcel.2008.09.012; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Scheinecker C, 2008, IMMUNITY, V28, P440, DOI 10.1016/j.immuni.2008.03.005; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	34	30	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4878	4890		10.1074/jbc.M112.422410	http://dx.doi.org/10.1074/jbc.M112.422410			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23275336	Green Published, hybrid			2022-12-28	WOS:000315340400036
J	Yamashita-Sugahara, Y; Tokuzawa, Y; Nakachi, Y; Kanesaki-Yatsuka, Y; Matsumoto, M; Mizuno, Y; Okazaki, Y				Yamashita-Sugahara, Yzumi; Tokuzawa, Yoshimi; Nakachi, Yutaka; Kanesaki-Yatsuka, Yukiko; Matsumoto, Masahito; Mizuno, Yosuke; Okazaki, Yasushi			Fam57b ( Family with Sequence Similarity 57, Member B), a Novel Peroxisome Proliferator-activated Receptor gamma Target Gene That Regulates Adipogenesis through Ceramide Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; PPAR-GAMMA; 3T3-L1 ADIPOCYTES; ABDOMINAL OBESITY; EXPRESSION; INSULIN; DIFFERENTIATION; ACCUMULATION; SYSTEM; ALPHA	This report identifies a novel gene encoding Fam57b (family with sequence similarity 57, member B) as a novel peroxisome proliferator-activated receptor gamma (PPAR gamma)-responsive transmembrane gene that is related to obesity. The gene was identified based on an integrated bioinformatics analysis of the following three expression profiling data sets: adipocyte differentiation of mouse stromal cells (ST2 cells), adipose tissues from obesity mice, and siRNA-mediated knockdown of Ppar gamma using ST2 cells. Fam57b consists of three variants expressed from different promoters and contains a Tram-Lag1-CLN8 domain that is related to ceramide synthase. Reporter and ChIP assays showed that Fam57b variant 2 is a bona fide PPAR gamma target gene in ST2 cells. Fam57b was up-regulated during adipocyte differentiation, suggesting that FAM57B is involved in this process. Surprisingly, FAM57B overexpression inhibited adipogenesis, and siRNA-mediated knockdown promoted adipocyte differentiation. Analysis of the ceramide content by lipid assay found that ceramides were in fact augmented in FAM57B-overexpressing ST2 cells. We also confirmed that ceramide inhibits adipogenesis. Therefore, the aforementioned results of FAM57B overexpression and siRNA experiments are reconciled by ceramide synthesis. In summary, we present in vitro evidence showing that PPAR gamma regulates Fam57b transcription during the adipogenesis of ST2 cells. In addition, our results suggest that PPAR gamma activation contributes to the regulation of ceramide metabolism during adipogenesis via FAM57B.	[Yamashita-Sugahara, Yzumi; Tokuzawa, Yoshimi; Nakachi, Yutaka; Kanesaki-Yatsuka, Yukiko; Matsumoto, Masahito; Mizuno, Yosuke; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Funct Genom & Syst Med, Hidaka City, Saitama 3501241, Japan	Saitama Medical University	Okazaki, Y (corresponding author), Saitama Med Univ, Res Ctr Genom Med, Div Funct Genom & Syst Med, 1397-1 Yamane, Hidaka City, Saitama 3501241, Japan.	okazaki@saitama-med.ac.jp	Nakachi, Yutaka/M-2446-2013; Matsumoto, Masahito/AGS-0755-2022	Nakachi, Yutaka/0000-0003-1964-2495; Okazaki, Yasushi/0000-0003-3241-5502	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for the "Genome Network Project" (to Y.O.) and "Support Project of Strategic Research Center in Private Universities" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to Saitama Medical University Research Center for Genomic Medicine).	Bonora E, 2008, G ITAL CARDIOL, V9, p40S, DOI 10.1714/669.7812; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Choi KM, 2011, BIOL PHARM BULL, V34, P912, DOI 10.1248/bpb.34.912; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; Demiralp DO, 2008, CLIN APPL THROMB-HEM, V14, P438, DOI 10.1177/1076029607305081; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fiorito M, 2007, OBESITY, V15, P2889, DOI 10.1038/oby.2007.343; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Gray SL, 2005, BIOCHEM SOC T, V33, P1053, DOI 10.1042/BST0331053; Gulbins E, 2003, PHARMACOL RES, V47, P393, DOI 10.1016/S1043-6618(03)00052-5; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Horie M, 1998, GENOMICS, V53, P365, DOI 10.1006/geno.1998.5462; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hutley L, 2005, AM J MED SCI, V330, P280, DOI 10.1097/00000441-200512000-00005; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nair S, 2005, DIABETOLOGIA, V48, P1784, DOI 10.1007/s00125-005-1868-2; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Neve EPA, 2012, J BIOL CHEM, V287, P6307, DOI 10.1074/jbc.M111.328237; Pan H, 2001, GENOMICS, V77, P58, DOI 10.1006/geno.2001.6614; Perry DK, 1998, BBA-MOL CELL BIOL L, V1436, P233, DOI 10.1016/S0005-2760(98)00145-3; Poll M, 2010, HAEMATOL-HEMATOL J, V95, P1832, DOI 10.3324/haematol.2010.027003; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Samad F, 2011, ADV EXP MED BIOL, V721, P67, DOI 10.1007/978-1-4614-0650-1_5; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Sprott KM, 2002, BIOCHEM J, V365, P181, DOI 10.1042/BJ20020215; Tokuzawa Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001019; Tomaru T, 2009, J BIOL CHEM, V284, P6116, DOI 10.1074/jbc.M808407200; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang BH, 2007, DNA SEQUENCE, V18, P92, DOI 10.1080/10425170601060947; Wang Jiao-Li, 2011, Zhonghua Jie He He Hu Xi Za Zhi, V34, P433; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Xu F, 2010, APPL BIOCHEM BIOTECH, V160, P197, DOI 10.1007/s12010-008-8505-8; Xu LB, 2012, NEUROBIOL DIS, V45, P923, DOI 10.1016/j.nbd.2011.12.011; Yagi K, 2004, BIOCHEM BIOPH RES CO, V321, P967, DOI 10.1016/j.bbrc.2004.07.055; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008	55	21	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4522	4537		10.1074/jbc.M112.440792	http://dx.doi.org/10.1074/jbc.M112.440792			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23275342	Green Published, hybrid			2022-12-28	WOS:000315340400003
J	Amritraj, A; Wang, YL; Revett, TJ; Vergote, D; Westaway, D; Kar, S				Amritraj, Asha; Wang, Yanlin; Revett, Timothy J.; Vergote, David; Westaway, David; Kar, Satyabrata			Role of Cathepsin D in U18666A-induced Neuronal Cell Death POTENTIAL IMPLICATION IN NIEMANN-PICK TYPE C DISEASE PATHOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; CHOLESTEROL TRANSPORT; PRECURSOR PROTEIN; OXIDATIVE STRESS; LYSOSOMAL CHOLESTEROL; ALZHEIMERS-DISEASE; CHRONIC EXPOSURE; AUTOPHAGY; NEURODEGENERATION; CASPASE	Cathepsin D is an aspartyl protease that plays a crucial role in normal cellular functions and in a variety of neurodegenerative disorders, including Niemann-Pick type C (NPC) disease, which is characterized by intracellular accumulation of cholesterol and glycosphingolipids in many tissues, including the brain. There is evidence that the level and activity of cathepsin D increased markedly in vulnerable neurons in NPC pathology, but its involvement in neurodegeneration remains unclear. In the present study, using mouse hippocampal cultured neurons, we evaluated the significance of cathepsin D in toxicity induced by U18666A, a class II amphiphile, which triggers cell death by impairing the trafficking of cholesterol, as observed in NPC pathology. Our results showed that U18666A-mediated toxicity is accompanied by an increase in cathepsin D mRNA and enzyme activity but a decrease in the total peptide content. The cytosolic level of cathepsin D, on the other hand, was increased along with cytochrome c and activated caspase-3 in U18666A-treated neurons. The cathepsin D inhibitor, pepstatin A, partially protected neurons against toxicity by attenuating these signaling mechanisms. Additionally, down-regulation of cathepsin D level prevented, whereas overexpression of the protease increased, vulnerability of cultured N2a cells to U18666A-induced toxicity. We also showed that extracellular cathepsin D from U18666A-treated neurons or application of exogenous enzyme can induce neurotoxicity by activating the autophagic pathway. These results suggest that increased release/activation of cathepsin D can trigger neurodegeneration and possibly development of NPC pathology. Thus, targeting cathepsin D level/activity may provide a new therapeutic opportunity for the treatment of NPC pathology.	[Amritraj, Asha; Wang, Yanlin; Kar, Satyabrata] Univ Alberta, Ctr Prions & Prot Folding Dis, Dept Psychiat, Edmonton, AB T6G 2M8, Canada; [Revett, Timothy J.; Vergote, David; Westaway, David; Kar, Satyabrata] Univ Alberta, Ctr Prions & Prot Folding Dis, Dept Med Neurol, Edmonton, AB T6G 2M8, Canada	University of Alberta; University of Alberta	Kar, S (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Dept Psychiat, Edmonton, AB T6G 2M8, Canada.	skar@ualberta.ca		Vergote, David/0000-0002-1298-3783	Canadian Institutes of Health Research [MOP-94375, MOP-97837]; Alberta Innovated Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovated Health Solutions	This work was supported by grants from the Canadian Institutes of Health Research (MOP-94375 and MOP-97837).; Recipient of a Tier-I Canada Research Chair and Scientist award from Alberta Innovated Health Solutions.	Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Appelqvist H, 2011, AM J PATHOL, V178, P629, DOI 10.1016/j.ajpath.2010.10.030; Arikketh D, 2008, J BIOL CHEM, V283, P12888, DOI 10.1074/jbc.M800714200; AUER IA, 1995, ACTA NEUROPATHOL, V90, P547; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Bendiske J, 2003, J NEUROPATH EXP NEUR, V62, P451, DOI 10.1093/jnen/62.5.451; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Bi XN, 2005, AM J PATHOL, V167, P1081, DOI 10.1016/S0002-9440(10)61197-2; BORNIG H, 1974, ACTA HISTOCHEM, V50, P110; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Cande C, 2004, J CELL SCI, V117, P4461, DOI 10.1242/jcs.01356; Castino R, 2007, FREE RADICAL BIO MED, V42, P1305, DOI 10.1016/j.freeradbiomed.2006.12.030; Ceccariglia S, 2011, NEUROSCIENCE, V174, P160, DOI 10.1016/j.neuroscience.2010.11.024; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Cheung NS, 2004, BIOCHEM BIOPH RES CO, V315, P408, DOI 10.1016/j.bbrc.2004.01.066; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Dash C, 2003, CRIT REV BIOCHEM MOL, V38, P89, DOI 10.1080/713609213; Davis W, 2008, CURR ALZHEIMER RES, V5, P448, DOI 10.2174/156720508785908900; Denton D, 2009, CURR BIOL, V19, P1741, DOI 10.1016/j.cub.2009.08.042; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Figueiredo C, 2008, J NEUROCHEM, V107, P73, DOI 10.1111/j.1471-4159.2008.05577.x; Flavin MP, 1997, NEUROSCIENCE, V80, P437, DOI 10.1016/S0306-4522(97)00078-X; Fusek Martin, 2005, Biomedical Papers (Olomouc), V149, P43; Gan L, 2004, J BIOL CHEM, V279, P5565, DOI 10.1074/jbc.M306183200; German DC, 2002, NEUROSCIENCE, V109, P437, DOI 10.1016/S0306-4522(01)00517-6; German DC, 2001, J COMP NEUROL, V433, P415, DOI 10.1002/cne.1149; Gowran A, 2008, J NEUROCHEM, V105, P1513, DOI 10.1111/j.1471-4159.2008.05278.x; HARMALA AS, 1994, BBA-LIPID LIPID MET, V1211, P317, DOI 10.1016/0005-2760(94)90156-2; Hawkes C, 2006, AM J PATHOL, V169, P1140, DOI 10.2353/ajpath.2006.051208; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Huang ZL, 2006, J NEUROCHEM, V97, P280, DOI 10.1111/j.1471-4159.2006.03733.x; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Hurwitz SJ, 1997, BLOOD, V89, P3745, DOI 10.1182/blood.V89.10.3745.3745_3745_3754; Iliev AI, 2003, FASEB J, V17, P412, DOI 10.1096/fj.03-0670fje; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Johansson AC, 2003, CELL DEATH DIFFER, V10, P1253, DOI 10.1038/sj.cdd.4401290; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kodam A, 2008, NEUROBIOL AGING, V29, P724, DOI 10.1016/j.neurobiolaging.2006.12.005; Koh CHV, 2006, J NEUROCHEM, V98, P1278, DOI 10.1111/j.1471-4159.2006.03958.x; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; Krantic S, 2007, PROG NEUROBIOL, V81, P179, DOI 10.1016/j.pneurobio.2006.12.002; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Lange Y, 2002, J LIPID RES, V43, P198; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Liao GH, 2009, BRAIN RES, V1270, P140, DOI 10.1016/j.brainres.2009.03.027; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; Lopez OL, 2003, REV NEUROLOGIA, V37, P155, DOI 10.33588/rn.3702.2002441; Marino G, 2004, CELL MOL LIFE SCI, V61, P1439, DOI 10.1007/s00018-004-4012-4; MATUS A, 1987, BIOCHEMISTRY-US, V26, P8083, DOI 10.1021/bi00399a010; Menzel K, 2006, CLIN EXP IMMUNOL, V146, P169, DOI 10.1111/j.1365-2249.2006.03188.x; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; Nixon RA, 2004, AM J PATHOL, V164, P757, DOI 10.1016/S0002-9440(10)63163-X; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pacheco Chris D., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800080X; Peake KB, 2011, BBA-MOL BASIS DIS, V1812, P1121, DOI 10.1016/j.bbadis.2011.06.003; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Roberg K, 1998, AM J PATHOL, V152, P1151; Roberg K, 2002, AM J PATHOL, V161, P89, DOI 10.1016/S0002-9440(10)64160-0; Rowe PSN, 2006, BONE, V39, P773, DOI 10.1016/j.bone.2006.04.012; Saito Y, 2002, ANN NEUROL, V52, P351, DOI 10.1002/ana.10266; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; Shin JH, 2012, BIOL PHARM BULL, V35, P1069, DOI 10.1248/bpb.b12-00009; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Song MS, 2008, EUR J NEUROSCI, V28, P1989, DOI 10.1111/j.1460-9568.2008.06498.x; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Tang Y, 2010, CLIN EXP PHARMACOL P, V37, P132, DOI 10.1111/j.1440-1681.2009.05235.x; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tofighi R, 2011, NEUROTOX RES, V19, P183, DOI 10.1007/s12640-010-9159-1; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Turk B, 2002, BIOL CHEM, V383, P1035, DOI 10.1515/BC.2002.112; Umeda A, 2003, J LIPID RES, V44, P1821, DOI 10.1194/jlr.M300153-JLR200; Underwood KW, 1998, J BIOL CHEM, V273, P4266, DOI 10.1074/jbc.273.7.4266; Vance JE, 2006, FEBS LETT, V580, P5518, DOI 10.1016/j.febslet.2006.06.008; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Vene R, 2007, MOL CANCER THER, V6, P286, DOI 10.1158/1535-7163.MCT-06-0346; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Vitner EB, 2010, HUM MOL GENET, V19, P3583, DOI 10.1093/hmg/ddq273; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wei Z, 2008, NEUROPHARMACOLOGY, V54, P721, DOI 10.1016/j.neuropharm.2007.12.006; WILLIAMS KR, 1986, J NEUROSCI RES, V15, P137, DOI 10.1002/jnr.490150203; Wu GS, 1998, ONCOGENE, V16, P2177, DOI 10.1038/sj.onc.1201755; Xie XF, 2011, P NATL ACAD SCI USA, V108, P15330, DOI 10.1073/pnas.1112751108; Xilouri M, 2010, CNS NEUROL DISORD-DR, V9, P701, DOI 10.2174/187152710793237421; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; Zaidi AU, 2001, J NEUROPATH EXP NEUR, V60, P937, DOI 10.1093/jnen/60.10.937; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099; Zampieri S, 2009, J CELL MOL MED, V13, P3786, DOI 10.1111/j.1582-4934.2008.00493.x; Zhao M, 2003, EUR J BIOCHEM, V270, P3778, DOI 10.1046/j.1432-1033.2003.03765.x; Zheng WH, 2002, NEUROSCIENCE, V115, P201, DOI 10.1016/S0306-4522(02)00404-9; Zheng X, 2008, BBA-MOL CELL RES, V1783, P2294, DOI 10.1016/j.bbamcr.2008.07.027	101	46	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3136	3152		10.1074/jbc.M112.412460	http://dx.doi.org/10.1074/jbc.M112.412460			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250759	Green Published, hybrid			2022-12-28	WOS:000314397900022
J	Basu, RS; Murakami, KS				Basu, Ritwika S.; Murakami, Katsuhiko S.			Watching the Bacteriophage N4 RNA Polymerase Transcription by Time-dependent Soak-trigger-freeze X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE; STRUCTURAL BASIS; CRYSTAL-STRUCTURES; MECHANISM; INITIATION; PROTEIN; FIDELITY; FRAGMENT	The challenge for structural biology is to understand atomic-level macromolecular motions during enzymatic reaction. X-ray crystallography can reveal high resolution structures; however, one perceived limitation is that it reveals only static views. Here we use time-dependent soak-trigger-freeze X- ray crystallography, namely, soaking nucleotide and divalent metal into the bacteriophage RNA polymerase (RNAP)-promoter DNA complex crystals to trigger the nucleotidyl transfer reaction and freezing crystals at different time points, to capture real-time intermediates in the pathway of transcription. In each crystal structure, different intensities and shapes of electron density maps corresponding to the nucleotide and metal were revealed at the RNAP active site which allow watching the nucleotide and metal bindings and the phosphodiester bond formation in a time perspective. Our study provides the temporal order of substrate assembly and metal co-factor binding at the active site of enzyme which completes our understanding of the two-metal-ion mechanism and fidelity mechanism in single-subunit RNAPs. The nucleotide-binding metal (Me-B) is coordinated at the active site prior to the catalytic metal (Me-A). Me-A coordination is only temporal, established just before and dissociated immediately after phosphodiester bond formation. We captured these elusive intermediates exploiting the slow enzymatic reaction in crystallo. These results demonstrate that the simple time-dependent soak-trigger-freeze X- ray crystallography offers a direct means for monitoring enzymatic reactions.	[Basu, Ritwika S.; Murakami, Katsuhiko S.] Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Murakami, KS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA.	kum14@psu.edu		Murakami, Katsuhiko/0000-0003-2244-0501	National Institutes of Health Grant [AI12575]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI012575] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI12575.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Batabyal D, 2010, J BIOL CHEM, V285, P34191, DOI 10.1074/jbc.M110.156182; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Bourgeois D, 2005, CURR OPIN STRUC BIOL, V15, P538, DOI 10.1016/j.sbi.2005.08.002; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Chen YY, 2011, J AM CHEM SOC, V133, P12544, DOI 10.1021/ja201557w; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Gleghorn ML, 2011, P NATL ACAD SCI USA, V108, P3566, DOI 10.1073/pnas.1016691108; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kennedy WP, 2007, J MOL BIOL, V370, P256, DOI 10.1016/j.jmb.2007.03.041; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RECHINSKY VO, 1995, MOL GEN GENET, V247, P110, DOI 10.1007/BF00425827; Schmidt M., 2008, P201, DOI 10.1007/978-3-540-73566-3_9; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5	37	30	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3305	3311		10.1074/jbc.M112.387712	http://dx.doi.org/10.1074/jbc.M112.387712			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235152	hybrid, Green Published			2022-12-28	WOS:000314397900036
J	Moen, RJ; Thomas, DD; Klein, JC				Moen, Rebecca J.; Thomas, David D.; Klein, Jennifer C.			Conformationally Trapping the Actin-binding Cleft of Myosin with a Bifunctional Spin Label	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; MICROSECOND ROTATIONAL MOTIONS; ATP-INDUCED DISSOCIATION; TIME-RESOLVED EPR; STRUCTURAL DYNAMICS; FORCE-GENERATION; MUSCLE; HEADS; ACTOMYOSIN; SITE	We have trapped the catalytic domain of Dictyostelium (Dicty) myosin II in a weak actin-binding conformation by chemically crosslinking two engineered cysteines across the actin-binding cleft, using a bifunctional spin label (BSL). By connecting the lower and upper 50 kDa domains of myosin, the crosslink restricts the conformation of the actin-binding cleft. Crosslinking has no effect on the basal ATPase activity of isolated myosin, but it impairs rigor actin binding and actin-activation of myosin ATPase. EPR spectra of BSL provide insight into actomyosin structural dynamics. BSL is highly immobilized within the actin-binding cleft and is thus exquisitely sensitive to the global orientation and rotational motions of the myosin head. Conventional EPR shows that myosin heads bound to oriented actin filaments are highly disordered with respect to the actin filament axis, in contrast to the nearly crystalline order of myosin heads in rigor. This disorder is similar to that of weakly bound heads induced by ATP, but saturation transfer EPR shows that the disorder of crosslinked myosin is at least 100 times slower. Thus this cleft-crosslinked myosin is remarkably similar, in both actin affinity and rotational dynamics, to SH1-SH2 crosslinked BSL-myosin S1. We conclude that, whether myosin is trapped at the actin-myosin interface or in the force-generating region between the active site and lever arm, the structural state of myosin is intermediate between the weak-binding state preceding phosphate release and the strong-binding state that succeeds it. We propose that it represents the threshold of force generation.	[Moen, Rebecca J.; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Klein, Jennifer C.] Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System	Thomas, DD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	ddt@umn.edu; jklein@uwlax.edu		Thomas, David D./0000-0002-8822-2040	National Institutes of Health [AR32961, AG26160, AR057220, AG037303]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR032961, T32AR007612, R01AR032961, P30AR057220, R01AR063007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG029796, R01AG026160, F31AG037303, R37AG026160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in whole or in part, by National Institutes of Health Grants AR32961, AG26160, and AR057220 (to D. D. T.).; Supported by National Institutes of Health Fellowship Grant AG037303.	Agafonov RV, 2008, P NATL ACAD SCI USA, V105, P13397, DOI 10.1073/pnas.0801342105; Agafonov RV, 2009, P NATL ACAD SCI USA, V106, P21625, DOI 10.1073/pnas.0909757106; Bagshaw CR., 1993, MUSCLE CONTRACTION, DOI 10.1007/978-94-015-6839-5; Baker JE, 1998, P NATL ACAD SCI USA, V95, P2944, DOI 10.1073/pnas.95.6.2944; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BERGER CL, 1989, P NATL ACAD SCI USA, V86, P8753, DOI 10.1073/pnas.86.22.8753; BERGER CL, 1993, BIOCHEMISTRY-US, V32, P3812, DOI 10.1021/bi00065a038; BERGER CL, 1991, BIOCHEMISTRY-US, V30, P11036, DOI 10.1021/bi00110a005; BERGER CL, 1994, BIOPHYS J, V67, P250, DOI 10.1016/S0006-3495(94)80476-X; Bobkov AA, 2000, BIOPHYS J, V79, P460, DOI 10.1016/S0006-3495(00)76307-7; CHALOVICH JM, 1983, P NATL ACAD SCI-BIOL, V80, P4909, DOI 10.1073/pnas.80.16.4909; Conibear PB, 2003, NAT STRUCT BIOL, V10, P831, DOI 10.1038/nsb986; COOKE R, 1982, NATURE, V300, P776, DOI 10.1038/300776a0; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; FAJER PG, 1990, P NATL ACAD SCI USA, V87, P5538, DOI 10.1073/pnas.87.14.5538; FAJER PG, 1991, BIOPHYS J, V60, P642, DOI 10.1016/S0006-3495(91)82093-8; FAJER PG, 1990, J MAGN RESON, V88, P111, DOI 10.1016/0022-2364(90)90112-M; Fajer PG, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/285208; Fleissner MR, 2011, P NATL ACAD SCI USA, V108, P16241, DOI 10.1073/pnas.1111420108; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; GEEVES MA, 1986, BIOCHEMISTRY-US, V25, P8454, DOI 10.1021/bi00374a020; GOLDMAN SA, 1972, J PHYS CHEM-US, V76, P1858, DOI 10.1021/j100657a013; Gyimesi M, 2008, J BIOL CHEM, V283, P8153, DOI 10.1074/jbc.M708863200; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Joel PB, 2001, J BIOL CHEM, V276, P2998, DOI 10.1074/jbc.M006930200; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; Kirby TL, 2004, BIOCHEMISTRY-US, V43, P5842, DOI 10.1021/bi035749b; Klein JC, 2008, P NATL ACAD SCI USA, V105, P12867, DOI 10.1073/pnas.0802286105; Klein JC, 2011, BIOCHEMISTRY-US, V50, P10318, DOI 10.1021/bi201279u; Kuhner S, 2011, P NATL ACAD SCI USA, V108, P7793, DOI 10.1073/pnas.1018420108; LaConte LEW, 2003, BIOCHEMISTRY-US, V42, P9797, DOI 10.1021/bi034288r; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Mello RN, 2012, BIOPHYS J, V102, P1088, DOI 10.1016/j.bpj.2011.11.4027; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Onishi H, 2006, P NATL ACAD SCI USA, V103, P6136, DOI 10.1073/pnas.0601595103; Prochniewicz E, 2004, BIOCHEMISTRY-US, V43, P10642, DOI 10.1021/bi049914e; Prochniewicz E, 2001, BIOCHEMISTRY-US, V40, P13933, DOI 10.1021/bi010893n; Prochniewicz E, 2008, AM J PHYSIOL-CELL PH, V294, pC613, DOI 10.1152/ajpcell.00232.2007; Rasband W.S., 1997, IMAGE J; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; ROOPNARINE O, 1995, BIOPHYS J, V68, P1461, DOI 10.1016/S0006-3495(95)80319-X; ROOPNARINE O, 1994, BIOPHYS J, V67, P1634, DOI 10.1016/S0006-3495(94)80636-8; Sasaki N, 2002, J MUSCLE RES CELL M, V23, P697, DOI 10.1023/A:1024415409406; Sasaki N, 1999, J BIOL CHEM, V274, P37840, DOI 10.1074/jbc.274.53.37840; Sasaki N, 2000, J BIOL CHEM, V275, P38705, DOI 10.1074/jbc.M001966200; SQUIER TC, 1986, BIOPHYS J, V49, P921, DOI 10.1016/S0006-3495(86)83720-1; STEIN RA, 1990, BIOCHEMISTRY-US, V29, P10023, DOI 10.1021/bi00495a003; Sun MX, 2008, P NATL ACAD SCI USA, V105, P8631, DOI 10.1073/pnas.0710793105; SVENSSON EC, 1986, BIOPHYS J, V50, P999, DOI 10.1016/S0006-3495(86)83541-X; Taylor KA, 1999, CELL, V99, P421, DOI 10.1016/S0092-8674(00)81528-7; Thomas DD, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P226, DOI 10.1016/B978-0-12-374920-8.00415-X; Thomas DD, 2009, ANNU REV BIOPHYS, V38, P347, DOI 10.1146/annurev.biophys.35.040405.102118; THOMAS DD, 1976, J CHEM PHYS, V65, P3006, DOI 10.1063/1.433512; THOMAS DD, 1980, BIOPHYS J, V32, P891, DOI 10.1016/S0006-3495(80)85024-7; THOMAS DD, 1975, P NATL ACAD SCI USA, V72, P1729, DOI 10.1073/pnas.72.5.1729; THOMAS DD, 1995, BIOPHYS J, V68, pS135; THOMAS DD, 1980, BIOPHYS J, V32, P873, DOI 10.1016/S0006-3495(80)85023-5; Thompson A. R., 2009, THESIS U MINNESOTA M; Thompson AR, 2008, BIOPHYS J, V95, P5238, DOI 10.1529/biophysj.108.138982; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Volkmann N, 2000, NAT STRUCT BIOL, V7, P1147; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010; Yengo CM, 2002, J BIOL CHEM, V277, P24114, DOI 10.1074/jbc.M111253200	68	12	12	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3016	3024		10.1074/jbc.M112.428565	http://dx.doi.org/10.1074/jbc.M112.428565			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250750	Green Published, hybrid			2022-12-28	WOS:000314397900012
J	Eisele, PS; Salatino, S; Sobek, J; Hottiger, MO; Handschin, C				Eisele, Petra S.; Salatino, Silvia; Sobek, Jens; Hottiger, Michael O.; Handschin, Christoph			The Peroxisome Proliferator-activated Receptor gamma Coactivator 1 alpha/beta (PGC-1) Coactivators Repress the Transcriptional Activity of NF-kappa B in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AORTIC SMOOTH-MUSCLE; OXIDATIVE-METABOLISM; INSULIN-RESISTANCE; P65 SUBUNIT; IKK-BETA; PGC-1-ALPHA; INFLAMMATION; EXERCISE; GENE; EXPRESSION	A persistent, low-grade inflammation accompanies many chronic diseases that are promoted by physical inactivity and improved by exercise. The beneficial effects of exercise are mediated in large part by peroxisome proliferator-activated receptor gamma coactivator (PGC) 1 alpha, whereas its loss correlates with propagation of local and systemic inflammatory markers. We examined the influence of PGC-1 alpha and the related PGC-1 beta on inflammatory cytokines upon stimulation of muscle cells with TNF alpha, Toll-like receptor agonists, and free fatty acids. PGC-1s differentially repressed expression of proinflammatory cytokines by targeting NF-kappa B signaling. Interestingly, PGC-1 alpha and PGC-1 beta both reduced phoshorylation of the NF-kappa B family member p65 and thereby its transcriptional activation potential. Taken together, the data presented here show that the PGC-1 coactivators are able to constrain inflammatory events in muscle cells and provide a molecular link between metabolic and immune pathways. The PGC-1s therefore represent attractive targets to not only improve metabolic health in diseases like type 2 diabetes but also to limit the detrimental, low-grade inflammation in these patients.	[Eisele, Petra S.; Salatino, Silvia; Handschin, Christoph] Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland; [Eisele, Petra S.; Hottiger, Michael O.; Handschin, Christoph] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Sobek, Jens] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Hottiger, Michael O.] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland	University of Basel; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Handschin, C (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	christoph.handschin@unibas.ch	Hottiger, Michael O./J-7747-2013; Handschin, Christoph/E-6886-2015	Hottiger, Michael O./0000-0002-7323-2270; Handschin, Christoph/0000-0003-0603-1097; Salatino, Silvia/0000-0003-1286-3076	Swiss National Science Foundation; Muscular Dystrophy Association USA (MDA); SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung"; Swiss Society for Research on Muscle Diseases (SSEM); Swiss Diabetes Association; Roche Research Foundation; United Mitochondrial Disease Foundation (UMDF); Association Francaise contre les Myopathies (AFM); Gebert-Ruf Foundation "Rare Diseases" Program; University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Muscular Dystrophy Association USA (MDA)(Muscular Dystrophy Association); SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung"; Swiss Society for Research on Muscle Diseases (SSEM); Swiss Diabetes Association; Roche Research Foundation; United Mitochondrial Disease Foundation (UMDF); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Gebert-Ruf Foundation "Rare Diseases" Program; University of Basel	This work was supported by grants from the Swiss National Science Foundation, Muscular Dystrophy Association USA (MDA), SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung," Swiss Society for Research on Muscle Diseases (SSEM), Swiss Diabetes Association, Roche Research Foundation, United Mitochondrial Disease Foundation (UMDF), Association Francaise contre les Myopathies (AFM), Gebert-Ruf Foundation "Rare Diseases" Program, and the University of Basel.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Arnold P, 2012, BIOINFORMATICS, V28, P487, DOI 10.1093/bioinformatics/btr695; Bakkar N, 2012, J CELL BIOL, V196, P497, DOI 10.1083/jcb.201108118; Bhatnagar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013262; Blanquart C, 2004, MOL ENDOCRINOL, V18, P1906, DOI 10.1210/me.2003-0327; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Creus KK, 2009, ANN NY ACAD SCI, V1173, P370, DOI 10.1111/j.1749-6632.2009.04874.x; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Jayne S, 2009, J MOL BIOL, V394, P485, DOI 10.1016/j.jmb.2009.09.032; Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Olesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032222; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Spencer MJ, 1997, J CLIN INVEST, V99, P2745, DOI 10.1172/JCI119464; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Suliman HB, 2010, J CELL SCI, V123, P2565, DOI 10.1242/jcs.064089; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4; TRACEY KJ, 1988, J EXP MED, V167, P1211, DOI 10.1084/jem.167.3.1211; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	59	132	138	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2246	2260		10.1074/jbc.M112.375253	http://dx.doi.org/10.1074/jbc.M112.375253			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223635	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000314211500015
J	Zhang, ZC; Gutierrez, D; Li, X; Bidlack, F; Cao, HJ; Wang, JB; Andrade, K; Margolis, HC; Amendt, BA				Zhang, Zichao; Gutierrez, Diana; Li, Xiao; Bidlack, Felicitas; Cao, Huojun; Wang, Jianbo; Andrade, Kelsey; Margolis, Henry C.; Amendt, Brad A.			The LIM Homeodomain Transcription Factor LHX6 A TRANSCRIPTIONAL REPRESSOR THAT INTERACTS WITH PITUITARY HOMEOBOX 2 (PITX2) TO REGULATE ODONTOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTAL EPITHELIUM; FUNCTIONAL INTERACTIONS; CELL-PROLIFERATION; BETA-CATENIN; STEM-CELLS; EXPRESSION; DOMAIN; GENE; TOOTH; PROTEIN	LHX6 is a LIM-homeobox transcription factor expressed during embryogenesis; however, the molecular mechanisms regulating LHX6 transcriptional activities are unknown. LHX6 and the PITX2 homeodomain transcription factor have overlapping expression patterns during tooth and craniofacial development, and in this report, we demonstrate new transcriptional mechanisms for these factors. PITX2 and LHX6 are co-expressed in the oral and dental epithelium and epithelial cell lines. Lhx6 expression is increased in Pitx2c transgenic mice and decreased in Pitx2 null mice. PITX2 activates endogenous Lhx6 expression and the Lhx6 promoter, whereas LHX6 represses its promoter activity. Chromatin immunoprecipitation experiments reveal endogenous PITX2 binding to the Lhx6 promoter. LHX6 directly interacts with PITX2 to inhibit PITX2 transcriptional activities and activation of multiple promoters. Bimolecular fluorescence complementation assays reveal an LHX6.PITX2 nuclear interaction in living cells. LHX6 has a dominant repressive effect on the PITX2 synergistic activation with LEF-1 and beta-catenin co-factors. Thus, LHX6 acts as a transcriptional repressor and represses the expression of several genes involved in odontogenesis. We have identified specific defects in incisor, molar, mandible, bone, and root development and late stage enamel formation in Lhx6 null mice. Amelogenin and ameloblastin expression is reduced and/or delayed in the Lhx6 null mice, potentially resulting from defects in dentin deposition and ameloblast differentiation. Our results demonstrate that LHX6 regulates cell proliferation in the cervical loop and promotes cell differentiation in the anterior region of the incisor. We demonstrate new molecular mechanisms for LHX6 and an interaction with PITX2 for normal craniofacial and tooth development.	[Zhang, Zichao; Gutierrez, Diana; Li, Xiao; Cao, Huojun; Wang, Jianbo; Andrade, Kelsey; Amendt, Brad A.] Texas A&M Univ, Hlth Sci Ctr, Ctr Environm & Genet Med, Inst Biosci & Technol, Houston, TX 77030 USA; [Bidlack, Felicitas; Margolis, Henry C.] Forsyth Inst, Dept Biomineralizat, Boston, MA 02142 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Forsyth Institute	Amendt, BA (corresponding author), Univ Iowa, Craniofacial Anomalies Res Ctr, 1-675 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	brad-amendt@uiowa.edu	cao, huojun/M-5431-2017; Li, Xiao/X-3429-2019	Li, Xiao/0000-0001-8527-4438; Bidlack, Felicitas/0000-0001-8105-223X; Amendt, Brad A./0000-0001-6524-1006; Cao, Huojun/0000-0003-4428-8686	National Institutes of Health [DE13941, DE18885, DE016376]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941, R01DE018885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016376, R56DE016376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE13941 and DE18885 (to B. A. A.) and DE016376 (to H. C. M.).	Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; Breen JJ, 1998, J BIOL CHEM, V273, P4712, DOI 10.1074/jbc.273.8.4712; Cao HJ, 2010, DEV BIOL, V347, P289, DOI 10.1016/j.ydbio.2010.08.031; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Denaxa M, 2009, DEV BIOL, V333, P324, DOI 10.1016/j.ydbio.2009.07.001; Diamond E, 2006, NUCLEIC ACIDS RES, V34, P5951, DOI 10.1093/nar/gkl689; Espinoza HM, 2005, BIOCHEMISTRY-US, V44, P3942, DOI 10.1021/bi048362x; Flandin P, 2011, NEURON, V70, P939, DOI 10.1016/j.neuron.2011.04.020; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Granger A, 2006, MOL ENDOCRINOL, V20, P2093, DOI 10.1210/me.2005-0184; Green PD, 2001, GENE EXPRESSION, V9, P265, DOI 10.3727/000000001783992515; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Gritli-Linde A, 2002, DEVELOPMENT, V129, P5323, DOI 10.1242/dev.00100; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Liu W, 2003, DEVELOPMENT, V130, P6375, DOI 10.1242/dev.00849; Matthews JM, 2003, EMBO REP, V4, P1132, DOI 10.1038/sj.embor.7400030; Mucchielli ML, 1996, MOL CELL NEUROSCI, V8, P258, DOI 10.1006/mcne.1996.0062; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Paine ML, 2003, J BIOL CHEM, V278, P19447, DOI 10.1074/jbc.M300445200; Segawa H, 2001, NEURON, V30, P423, DOI 10.1016/S0896-6273(01)00283-5; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shibaguchi T, 2003, ARCH HISTOL CYTOL, V66, P95, DOI 10.1679/aohc.66.95; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Tummers M, 2003, DEVELOPMENT, V130, P1049, DOI 10.1242/dev.00332; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; Waite MR, 2011, DEV DYNAM, V240, P333, DOI 10.1002/dvdy.22532; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Wang XP, 2004, DEV CELL, V7, P719, DOI 10.1016/j.devcel.2004.09.012; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Zhang Y, 2002, Orthod Craniofac Res, V5, P65, DOI 10.1034/j.1600-0544.2002.02198.x; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772; Zhao YG, 1999, P NATL ACAD SCI USA, V96, P15002, DOI 10.1073/pnas.96.26.15002	54	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2485	2500		10.1074/jbc.M112.402933	http://dx.doi.org/10.1074/jbc.M112.402933			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229549	Green Published, hybrid			2022-12-28	WOS:000314211500035
J	DeGrande, ST; Little, SC; Nixon, DJ; Wright, P; Snyder, J; Dun, W; Murphy, N; Kilic, A; Higgins, R; Binkley, PF; Boyden, PA; Carnes, CA; Anderson, ME; Hund, TJ; Mohler, PJ				DeGrande, Sean T.; Little, Sean C.; Nixon, Derek J.; Wright, Patrick; Snyder, Jedidiah; Dun, Wen; Murphy, Nathaniel; Kilic, Ahmet; Higgins, Robert; Binkley, Philip F.; Boyden, Penelope A.; Carnes, Cynthia A.; Anderson, Mark E.; Hund, Thomas J.; Mohler, Peter J.			Molecular Mechanisms Underlying Cardiac Protein Phosphatase 2A Regulation in Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL RYANODINE RECEPTOR; ANKYRIN-B; FAILURE PROGRESSION; CATALYTIC SUBUNIT; ION-CHANNEL; C-TERMINUS; KINASE-II; CAMKII; PP2A; DYSFUNCTION	Kinase/phosphatase balance governs cardiac excitability in health and disease. Although detailed mechanisms for cardiac kinase regulation are established, far less is known regarding cardiac protein phosphatase 2A (PP2A) regulation. This is largely due to the complexity of the PP2A holoenzyme structure (combinatorial assembly of three subunit enzyme from >17 subunit genes) and the inability to segregate "global" PP2A function from the activities of multiple "local" holoenzyme populations. Here we report that PP2A catalytic, regulatory, and scaffolding subunits are tightly regulated at transcriptional, translational, and post-translational levels to tune myocyte function at base line and in disease. We show that past global read-outs of cellular PP2A activity more appropriately represent the collective activity of numerous individual PP2A holoenzymes, each displaying a specific subcellular localization (dictated by select PP2A regulatory subunits) as well as local specific post-translational catalytic subunit methylation and phosphorylation events that regulate local and rapid holoenzyme assembly/disassembly (via leucine carboxymethyltransferase 1/phosphatase methylesterase 1 (LCMT-1/PME-1). We report that PP2A subunits are selectively regulated between human and animal models, across cardiac chambers, and even within specific cardiac cell types. Moreover, this regulation can be rapidly tuned in response to cellular activation. Finally, we report that global PP2A is altered in human and experimental models of heart disease, yet each pathology displays its own distinct molecular signature though specific PP2A subunit modulatory events. These new data provide an initial view into the signaling pathways that govern PP2A function in heart but also establish the first step in defining specific PP2A regulatory targets in health and disease.	[DeGrande, Sean T.; Little, Sean C.; Nixon, Derek J.; Wright, Patrick; Snyder, Jedidiah; Murphy, Nathaniel; Kilic, Ahmet; Higgins, Robert; Binkley, Philip F.; Carnes, Cynthia A.; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [DeGrande, Sean T.; Snyder, Jedidiah; Binkley, Philip F.; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Dept Internal Med, Div Cardiovasc Med, Wexner Med Ctr, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Dept Physiol & Cell Biol, Wexner Med Ctr, Columbus, OH 43210 USA; [Kilic, Ahmet; Higgins, Robert] Ohio State Univ, Div Cardiac Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Snyder, Jedidiah; Hund, Thomas J.] Ohio State Univ, Dept Biomed Engn, Coll Engn, Columbus, OH 43210 USA; [Carnes, Cynthia A.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Anderson, Mark E.] Univ Iowa, Carver Coll Med, Dept Internal Med, Div Cardiovasc Med, Iowa City, IA 52242 USA; [DeGrande, Sean T.; Anderson, Mark E.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Dun, Wen; Boyden, Penelope A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Iowa; University of Iowa; Columbia University	Mohler, PJ (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Wexner Med Ctr, 473 W 12th Ave, Columbus, OH 43210 USA.	peter.mohler@osumc.edu	Hund, Thomas/C-9222-2012		National Institutes of Health [HL084583, HL083422, HL079031, HL62494, HL70250, HL089836, HL066140, HL096805, HL114893]; Saving Tiny Hearts Society; American Heart Association Established Investigator Award; Gilead Sciences Research Scholars Program; Fondation Leducq Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089836, R01HL062494, R01HL113001, R01HL114893, R01HL096652, R01HL079031, R00HL096805, R01HL084583, R01HL070250, K99HL096805, R01HL066140, R01HL083422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saving Tiny Hearts Society; American Heart Association Established Investigator Award(American Heart Association); Gilead Sciences Research Scholars Program; Fondation Leducq Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084583 and HL083422 (to P. J. M.), HL079031, HL62494, and HL70250 (to M. E. A.), HL089836 (to C. A. C.), HL066140 (to P. A. B.), and HL096805 and HL114893 (to T. J. H.). This work was also supported in part by a grant from the Saving Tiny Hearts Society (to P. J. M.), an American Heart Association Established Investigator Award (to P. J. M.), the Gilead Sciences Research Scholars Program (to T. J. H.), and the Fondation Leducq Award to the Alliance for Calmodulin Kinase Signaling in Heart Disease (to P. J. M., M. E. A., and T. J. H.).	Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Ai X, 2011, CARDIOVASC RES, V92, P106, DOI 10.1093/cvr/cvr163; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Baba S, 2005, CIRCULATION, V112, P2386, DOI 10.1161/CIRCULATIONAHA.105.534784; Belevych AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028324; Bers DM, 2011, HEART RHYTHM, V8, P1101, DOI 10.1016/j.hrthm.2011.01.030; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Chelu MG, 2009, J CLIN INVEST, V119, P1940, DOI 10.1172/JCI37059; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cunha SR, 2008, J BIOL CHEM, V283, P31968, DOI 10.1074/jbc.M806050200; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Cunha SR, 2011, CIRCULATION, V124, P1212, DOI 10.1161/CIRCULATIONAHA.111.023986; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; DeGrande S, 2012, HEART RHYTHM, V9, P2034, DOI 10.1016/j.hrthm.2012.08.026; Deshmukh PA, 2007, AM J PHYSIOL-HEART C, V292, pH792, DOI 10.1152/ajpheart.00225.2006; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Gergs U, 2004, J BIOL CHEM, V279, P40827, DOI 10.1074/jbc.M405770200; Gudmundsson H, 2012, J MOL CELL CARDIOL, V52, P1183, DOI 10.1016/j.yjmcc.2012.02.008; Gudmundsson H, 2010, CIRC RES, V107, P84, DOI 10.1161/CIRCRESAHA.110.216713; Gupta RC, 2003, AM J PHYSIOL-HEART C, V285, pH2373, DOI 10.1152/ajpheart.00442.2003; He BJ, 2011, NAT MED, V17, P1610, DOI 10.1038/nm.2506; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; Hund TJ, 2009, CARDIOVASC RES, V81, P742, DOI 10.1093/cvr/cvn348; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kashef F, 2012, J BIOL CHEM, V287, P30268, DOI 10.1074/jbc.M112.368415; Kohr MJ, 2009, NITRIC OXIDE-BIOL CH, V20, P217, DOI 10.1016/j.niox.2009.01.003; Lambrecht C., 2012, FEBS J IN PRESS; Le Scouarnec S, 2008, P NATL ACAD SCI USA, V105, P15617, DOI 10.1073/pnas.0805500105; Lehnart SE, 2007, CIRCULATION, V116, P2325, DOI 10.1161/CIRCULATIONAHA.107.711689; Linck B, 1996, BRIT J PHARMACOL, V119, P545, DOI 10.1111/j.1476-5381.1996.tb15706.x; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Luss H, 2000, J MOL CELL CARDIOL, V32, P2349, DOI 10.1006/jmcc.2000.1265; Marshall M, 2009, CARDIOVASC RES, V82, P67, DOI 10.1093/cvr/cvp037; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mishra S, 2002, J HEART LUNG TRANSPL, V21, P366, DOI 10.1016/S1053-2498(01)00390-4; Miura T, 2009, CIRC J, V73, P1184, DOI 10.1253/circj.CJ-09-0284; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; NEUMANN J, 1994, J PHARMACOL EXP THER, V271, P535; NEUMANN J, 1993, AM J PHYSIOL, V265, pH257, DOI 10.1152/ajpheart.1993.265.1.H257; NEUMANN J, 1995, J PHARMACOL EXP THER, V274, P530; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Nicolaou P, 2009, FRONT BIOSCI-LANDMRK, V14, P3571, DOI 10.2741/3472; Nishijima Y, 2005, J CARD FAIL, V11, P638, DOI 10.1016/j.cardfail.2005.05.006; PACKER M, 1985, CIRCULATION, V72, P681, DOI 10.1161/01.CIR.72.4.681; Pathak A, 2005, CIRC RES, V96, P756, DOI 10.1161/01.RES.0000161256.85833.fa; Reiken S, 2001, CIRCULATION, V104, P2843, DOI 10.1161/hc4701.099578; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Rudrabhatla P, 2011, CURR ALZHEIMER RES, V8, P623, DOI 10.2174/156720511796717168; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Shan J, 2010, J CLIN INVEST, V120, P4388, DOI 10.1172/JCI32726; Shelton RJ, 2009, HEART, V95, P924, DOI 10.1136/hrt.2008.158931; Swaminathan PD, 2011, J CLIN INVEST, V121, P3277, DOI 10.1172/JCI57833; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wijnker PJM, 2011, J MUSCLE RES CELL M, V32, P221, DOI 10.1007/s10974-011-9261-x; Xu H, 2010, BIOCHEMISTRY-US, V49, P10298, DOI 10.1021/bi101018c; Yamada M, 2006, FASEB J, V20, P1197, DOI 10.1096/fj.05-5299fje; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	65	69	70	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1032	1046		10.1074/jbc.M112.426957	http://dx.doi.org/10.1074/jbc.M112.426957			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23204520	hybrid, Green Published			2022-12-28	WOS:000313570300027
J	Davis, AJ; Lee, KJ; Chen, DJ				Davis, Anthony J.; Lee, Kyung-Jong; Chen, David J.			The N-terminal Region of the DNA-dependent Protein Kinase Catalytic Subunit Is Required for Its DNA Double-stranded Break-mediated Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; PHOSPHORYLATION SITES; IDENTIFICATION; PKCS; KU; AUTOPHOSPHORYLATION; REPAIR; REVEALS; COMPLEX; HETERODIMER	DNA-dependent protein kinase (DNA-PK) plays an essential role in the repair of DNA double-stranded breaks (DSBs) mediated by the nonhomologous end-joining pathway. DNA-PK is a holoenzyme consisting of a DNA-binding (Ku70/Ku80) and catalytic (DNA-PKcs) subunit. DNA-PKcs is a serine/threonine protein kinase that is recruited to DSBs via Ku70/80 and is activated once the kinase is bound to the DSB ends. In this study, two large, distinct fragments of DNA-PKcs, consisting of the N terminus (amino acids 1-2713), termed N-PKcs, and the C terminus (amino acids 2714-4128), termed C-PKcs, were produced to determine the role of each terminal region in regulating the activity of DNA-PKcs. N-PKcs but not C-PKcs interacts with the Ku-DNA complex and is required for the ability of DNA-PKcs to localize to DSBs. C-PKcs has increased basal kinase activity compared with DNA-PKcs, suggesting that the N-terminal region of DNA-PKcs keeps basal activity low. The kinase activity of C-PKcs is not stimulated by Ku70/80 and DNA, further supporting that the N-terminal region is required for binding to the Ku-DNA complex and full activation of kinase activity. Collectively, the results show the N-terminal region mediates the interaction between DNA-PKcs and the Ku-DNA complex and is required for its DSB-induced enzymatic activity.	[Davis, Anthony J.; Lee, Kyung-Jong; Chen, David J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, DJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, 2201 Inwood Rd, Dallas, TX 75390 USA.	david.chen@utsouthwestern.edu	Classen, Scott/AAY-8176-2020	Davis, Anthony/0000-0003-0184-3651	National Institutes of Health [CA50519, CA13499]; Cancer Prevention Research Institute of Texas [RP110465]; NATIONAL CANCER INSTITUTE [R01CA050519, P01CA092584, R01CA162804, R37CA050519, R01CA134991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA50519 and CA13499. This work was also supported by Cancer Prevention Research Institute of Texas Grant RP110465.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Beamish HJ, 2000, NUCLEIC ACIDS RES, V28, P1506, DOI 10.1093/nar/28.7.1506; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Gupta S, 2005, NUCLEIC ACIDS RES, V33, P6972, DOI 10.1093/nar/gki990; Gurley KE, 2009, EMBO REP, V10, P87, DOI 10.1038/embor.2008.214; Hammarsten O, 2000, J BIOL CHEM, V275, P1541, DOI 10.1074/jbc.275.3.1541; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hill R, 2008, DNA REPAIR, V7, P1484, DOI 10.1016/j.dnarep.2008.05.007; Hollick JJ, 2003, BIOORG MED CHEM LETT, V13, P3083, DOI 10.1016/S0960-894X(03)00652-8; Izzard RA, 1999, CANCER RES, V59, P2581; Jin SF, 1997, J BIOL CHEM, V272, P24763, DOI 10.1074/jbc.272.40.24763; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kurimasa A, 1999, MOL CELL BIOL, V19, P3877; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lee KJ, 2004, DNA REPAIR, V3, P267, DOI 10.1016/j.dnarep.2003.11.005; Lee KJ, 2002, J IMMUNOL, V169, P3413, DOI 10.4049/jimmunol.169.6.3413; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Meek K, 2012, NUCLEIC ACIDS RES, V40, P2964, DOI 10.1093/nar/gkr1211; Merkle D, 2002, BIOCHEMISTRY-US, V41, P12706, DOI 10.1021/bi0263558; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Rivera-Calzada A, 2005, STRUCTURE, V13, P243, DOI 10.1016/j.str.2004.12.006; Rivera-Calzada A, 2007, EMBO REP, V8, P56, DOI 10.1038/sj.embor.7400847; Shao ZP, 2012, DNA REPAIR, V11, P310, DOI 10.1016/j.dnarep.2011.12.007; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Yajima H, 2006, MOL CELL BIOL, V26, P7520, DOI 10.1128/MCB.00048-06; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200	54	35	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7037	7046		10.1074/jbc.M112.434498	http://dx.doi.org/10.1074/jbc.M112.434498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23322783	Green Published, hybrid			2022-12-28	WOS:000316002400025
J	O'Meara, JA; Lemke, CT; Godbout, C; Kukolj, G; Lagace, L; Moreau, B; Thibeault, D; White, PW; Llinas-Brunet, M				O'Meara, Jeff A.; Lemke, Christopher T.; Godbout, Cedrickx; Kukolj, George; Lagace, Lisette; Moreau, Benoit; Thibeault, Diane; White, Peter W.; Llinas-Brunet, Montse			Molecular Mechanism by Which a Potent Hepatitis C Virus NS3-NS4A Protease Inhibitor Overcomes Emergence of Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NS3 PROTEASE; PRECLINICAL PROFILE; BILN-2061; BINDING; TMC435; DOMAIN	Although optimizing the resistance profile of an inhibitor can be challenging, it is potentially important for improving the long term effectiveness of antiviral therapy. This work describes our rational approach toward the identification of a macrocyclic acylsulfonamide that is a potent inhibitor of the NS3-NS4A proteases of all hepatitis C virus genotypes and of a panel of genotype 1-resistant variants. The enhanced potency of this compound versus variants D168V and R155K facilitated x-ray determination of the inhibitor-variant complexes. In turn, these structural studies revealed a complex molecular basis of resistance and rationalized how such compounds are able to circumvent these mechanisms.	[O'Meara, Jeff A.; Lemke, Christopher T.; Godbout, Cedrickx; Kukolj, George; Lagace, Lisette; Moreau, Benoit; Thibeault, Diane; White, Peter W.; Llinas-Brunet, Montse] Boehringer Ingelheim Canada Ltd, Res & Dev, Laval, PQ H7S 2G5, Canada	Boehringer Ingelheim	O'Meara, JA (corresponding author), Boehringer Ingelheim Canada Ltd, Res & Dev, Laval, PQ H7S 2G5, Canada.	RESGeneral.lav@boehringer-ingelheim.com	Moreau, Benoit/J-4335-2015	Moreau, Benoit/0000-0003-1591-2312				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berger K., 2012, REV ANTIVIRAL THERAP, V6, P29; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cummings MD, 2010, ANGEW CHEM INT EDIT, V49, P1652, DOI 10.1002/anie.200906696; Di Marco S, 2000, J BIOL CHEM, V275, P7152, DOI 10.1074/jbc.275.10.7152; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hinrichsen H, 2004, GASTROENTEROLOGY, V127, P1347, DOI 10.1053/j.gastro.2004.08.002; IRVINE GB, 1990, ANAL BIOCHEM, V185, P304, DOI 10.1016/0003-2697(90)90298-N; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Lagace L, 2012, ANTIMICROB AGENTS CH, V56, P569, DOI 10.1128/AAC.05166-11; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lemke CT, 2011, J BIOL CHEM, V286, P11434, DOI 10.1074/jbc.M110.211417; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lin TI, 2009, ANTIMICROB AGENTS CH, V53, P1377, DOI 10.1128/AAC.01058-08; Llinas-Brunet M., 2011, U.S. Patent WO, Patent No. [2011/063502 A1, 2011063502]; Malcolm BA, 2006, ANTIMICROB AGENTS CH, V50, P1013, DOI 10.1128/AAC.50.3.1013-1020.2006; Manns MP, 2011, J HEPATOL, V54, P1114, DOI 10.1016/j.jhep.2010.08.040; Massariol MJ, 2010, BIOCHEM BIOPH RES CO, V391, P692, DOI 10.1016/j.bbrc.2009.11.122; Mehellou Y, 2010, J MED CHEM, V53, P521, DOI 10.1021/jm900492g; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Muzammil S, 2007, J VIROL, V81, P5144, DOI 10.1128/JVI.02706-06; Nalam MNL, 2010, J VIROL, V84, P5368, DOI 10.1128/JVI.02531-09; Ohtaka H, 2005, PROG BIOPHYS MOL BIO, V88, P193, DOI 10.1016/j.pbiomolbio.2004.07.005; Ozer N, 2010, BIOPHYS J, V99, P1650, DOI 10.1016/j.bpj.2010.06.064; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Romano KP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002832; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Tanwar S, 2012, EXPERT OPIN INV DRUG, V21, P1193, DOI 10.1517/13543784.2012.690392; Thibeault D, 2004, J VIROL, V78, P7352, DOI 10.1128/JVI.78.14.7352-7359.2004; Thibeault D, 2009, BIOCHEMISTRY-US, V48, P744, DOI 10.1021/bi801931e; Tsantrizos YS, 2003, ANGEW CHEM INT EDIT, V42, P1355, DOI 10.1002/anie.200390347; White PW, 2010, ANTIMICROB AGENTS CH, V54, P4611, DOI 10.1128/AAC.00787-10; Yee NK, 2006, J ORG CHEM, V71, P7133, DOI 10.1021/jo060285j	39	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5673	5681		10.1074/jbc.M112.439455	http://dx.doi.org/10.1074/jbc.M112.439455			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23271737	Green Published, hybrid			2022-12-28	WOS:000315342500040
J	Fratangeli, A; Parmigiani, E; Fumagalli, M; Lecca, D; Benfante, R; Passafaro, M; Buffo, A; Abbracchio, MP; Rosa, P				Fratangeli, Alessandra; Parmigiani, Elena; Fumagalli, Marta; Lecca, Davide; Benfante, Roberta; Passafaro, Maria; Buffo, Annalisa; Abbracchio, Maria P.; Rosa, Patrizia			The Regulated Expression, Intracellular Trafficking, and Membrane Recycling of the P2Y-like Receptor GPR17 in Oli-neu Oligodendroglial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTOSIS; PROTEINS; BINDING; TARGET; DIFFERENTIATION; EXOCYTOSIS; ENDOSOMES; SENSOR; DAMAGE; RAB5	GPR17 is a G-protein-coupled receptor that is activated by two classes of molecules: uracil-nucleotides and cysteinyl-leukotrienes. GPR17 is required for initiating the differentiation of oligodendrocyte precursors but has to be down-regulated to allow cells to undergo terminal maturation. Although a great deal has been learned about GPR17 expression and signaling, no information is currently available about the trafficking of native receptors after the exposure of differentiating oligodendrocytes to endogenous agonists. Here, we demonstrate that neuron-conditioned medium induces the transcriptionally mediated, time-regulated expression of GPR17 in Oli-neu, an oligodendrocyte precursor cell line, making these cells suitable for studying the endocytic traffic of the native receptor. Agonist-induced internalization, intracellular trafficking, and membrane recycling of GPR17 were analyzed by biochemical and immunofluorescence assays using an ad hoc-developed antibody against the extracellular N-terminal of GPR17. Both UDP-glucose and LTD4 increased GPR17 internalization, although with different efficiency. At early time points, internalized GPR17 co-localized with transferrin receptor, whereas at later times it partially colocalized with the lysosomal marker Lamp1, suggesting that a portion of GPR17 is targeted to lysosomes upon ligand binding. Ananalysis of receptor recycling and degradation demonstrated that a significant aliquot of GPR17 is recycled to the cell surface. Furthermore, internalized GPR17 displayed a co-localization with the marker of the "short loop" recycling endosomes, Rab4, while showing very minor co-localization with the "long loop" recycling marker, Rab11. Our results provide the first data on the agonist-induced trafficking of native GPR17 in oligodendroglial cells and may have implications for both physiological and pathological myelination.	[Fratangeli, Alessandra; Parmigiani, Elena; Benfante, Roberta; Passafaro, Maria; Rosa, Patrizia] Univ Milan, Dept Med Biotechnol & Translat Med BIOMETRA, Consiglio Nazl Ric, Inst Neurosci, I-20129 Milan, Italy; [Fumagalli, Marta; Lecca, Davide; Abbracchio, Maria P.] Univ Milan, Dept Pharmacol & Biomol Sci, Lab Mol & Cellular Pharmacol Purinerg Transmiss, I-20133 Milan, Italy; [Parmigiani, Elena; Buffo, Annalisa] Univ Turin, Physiol Sect, Neurosci Inst Turin, Neurosci Inst Cavalieri Ottolenghi,Dept Neurosci, I-10043 Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; University of Turin	Rosa, P (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, CNR, Inst Neurosci, Via Vanvitelli 32, I-20129 Milan, Italy.	p.rosa@in.cnr.it	Lecca, Davide/A-8850-2010; Abbracchio, Maria Pia/B-9342-2014; Fumagalli, Marta/AEP-4117-2022; Buffo, Annalisa/O-7207-2019; Benfante, Roberta/C-1513-2015; Parmigiani, Elena/AAD-7524-2021; Parmigiani, Elena/ABE-6167-2021	Lecca, Davide/0000-0002-3258-363X; Abbracchio, Maria Pia/0000-0002-7833-3388; Buffo, Annalisa/0000-0001-7637-0006; Benfante, Roberta/0000-0001-5396-5429; Parmigiani, Elena/0000-0002-3433-1823; Fumagalli, Marta/0000-0002-0158-842X; Rosa, Patrizia/0000-0002-2590-6955	Progetti di Ricerca di Interesse Nazionale, Ministero dell'Istruzione dell' Universita e Della Ricerca; Cariplo Fuondation [2012-0546]; FISM [2010/R2]; CNR-Progetto Invecchiamento [CUP B51J11000820005]	Progetti di Ricerca di Interesse Nazionale, Ministero dell'Istruzione dell' Universita e Della Ricerca; Cariplo Fuondation(Fondazione Cariplo); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); CNR-Progetto Invecchiamento	This work was supported by Progetti di Ricerca di Interesse Nazionale COFIN-PRIN 2008, Ministero dell'Istruzione dell' Universita e Della Ricerca "Purinoceptors and neuroprotection: focus on the new purinergic receptor GPR17," Regione Lombardia Project NUTEC ID 30263049 and Cariplo Fuondation rif.no. 2012-0546 (to P. R.). This work was supported in part by FISM Fondazione Italiana Sclerosi Multipla Grant 2010/R2 (to M. P. A.) and CNR-Progetto Invecchiamento, CUP B51J11000820005.	Benned-Jensen T, 2010, BRIT J PHARMACOL, V159, P1092, DOI 10.1111/j.1476-5381.2009.00633.x; Boda E, 2011, GLIA, V59, P1958, DOI 10.1002/glia.21237; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Ceruti S, 2011, GLIA, V59, P363, DOI 10.1002/glia.21107; Ceruti S, 2009, BRAIN, V132, P2206, DOI 10.1093/brain/awp147; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Conti F, 2009, AM J PHYSIOL-ENDOC M, V296, pE532, DOI 10.1152/ajpendo.90590.2008; Daniele S, 2011, J PHARMACOL EXP THER, V338, P559, DOI 10.1124/jpet.110.178715; Daniele S, 2010, CELL SIGNAL, V22, P697, DOI 10.1016/j.cellsig.2009.12.006; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dunham JH, 2009, TRENDS BIOTECHNOL, V27, P541, DOI 10.1016/j.tibtech.2009.06.005; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fumagalli M, 2011, J BIOL CHEM, V286, P10593, DOI 10.1074/jbc.M110.162867; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Jablonska B, 2012, J NEUROSCI, V32, P14775, DOI 10.1523/JNEUROSCI.2060-12.2012; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kippert A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-40; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Linetti A, 2010, J CELL SCI, V123, P595, DOI 10.1242/jcs.060681; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maekawa A, 2009, P NATL ACAD SCI USA, V106, P11685, DOI 10.1073/pnas.0905364106; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Parravicini C, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-8; Parravicini C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-263; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Pugliese AM, 2009, AM J PHYSIOL-CELL PH, V297, pC1028, DOI 10.1152/ajpcell.00658.2008; Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Taverna E, 2007, J NEUROCHEM, V100, P664, DOI 10.1111/j.1471-4159.2006.04225.x; von Zastrow M., 2000, REGULATION G PROTEIN, P4; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; Winterstein C, 2008, J CELL SCI, V121, P834, DOI 10.1242/jcs.022731; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	40	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5241	5256		10.1074/jbc.M112.404996	http://dx.doi.org/10.1074/jbc.M112.404996			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288840	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000315340400071
J	Zigdon, H; Kogot-Levin, A; Park, JW; Goldschmidt, R; Kelly, S; Merrill, AH; Scherz, A; Pewzner-Jung, Y; Saada, A; Futerman, AH				Zigdon, Hila; Kogot-Levin, Aviram; Park, Joo-Won; Goldschmidt, Ruth; Kelly, Samuel; Merrill, Alfred H., Jr.; Scherz, Avigdor; Pewzner-Jung, Yael; Saada, Ann; Futerman, Anthony H.			Ablation of Ceramide Synthase 2 Causes Chronic Oxidative Stress Due to Disruption of the Mitochondrial Respiratory Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; QUANTITATIVE-ANALYSIS; LIVER; SPHINGOLIPIDS; METABOLISM; COMPLEX; GENERATION; INHIBITION; APOPTOSIS; SPECIFICITY	Ceramide is a key intermediate in the pathway of sphingolipid biosynthesis and is an important intracellular messenger. We recently generated a ceramide synthase 2 (CerS2) null mouse that cannot synthesize very long acyl chain (C22-C24) ceramides. This mouse displays severe and progressive hepatopathy. Significant changes were observed in the sphingolipid profile of CerS2 null mouse liver, including elevated C16-ceramide and sphinganine levels in liver and in isolated mitochondrial fractions. Because ceramide may be involved in reactive oxygen species (ROS) formation, we examined whether ROS generation was affected in CerS2 null mice. Levels of a number of antioxidant enzymes were elevated, as were lipid peroxidation, protein nitrosylation, and ROS. ROS were generated from mitochondria due to impaired complex IV activity. C16-ceramide, sphingosine, and sphinganine directly inhibited complex IV activity in isolated mitochondria and in mitoplasts, whereas other ceramide species, sphingomyelin, and diacylglycerol were without effect. A fluorescent analog of sphinganine accumulated in mitochondria. Heart mitochondria did not display a substantial alteration in the sphingolipid profile or in complex IV activity. We suggest that C16-ceramide and/or sphinganine induce ROS formation through the modulation of mitochondrial complex IV activity, resulting in chronic oxidative stress. These results are of relevance for understanding modulation of ROS signaling by sphingolipids.	[Zigdon, Hila; Park, Joo-Won; Pewzner-Jung, Yael; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Goldschmidt, Ruth; Scherz, Avigdor] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Kogot-Levin, Aviram; Saada, Ann] Hadassah Hebrew Univ, Med Ctr, Dept Genet & Metab Dis, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel; [Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Weizmann Institute of Science; Weizmann Institute of Science; Hebrew University of Jerusalem; Hadassah University Medical Center; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il	Saada, Ann/J-6864-2017; Pewzner, Faivish/I-6225-2017	Saada, Ann/0000-0003-2951-0656; Pewzner, Faivish/0000-0002-7490-8121; Merrill, Alfred/0000-0002-6673-968X; Futerman, Anthony/0000-0003-0013-0115	National Institutes of Health [GM076217]; Israel Science Foundation [0888/11]; Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076217. This work was also supported by the Israel Science Foundation (0888/11) and the Minerva Foundation.	Ardail D, 2001, FEBS LETT, V488, P160, DOI 10.1016/S0014-5793(00)02332-2; Ben-David O, 2011, J BIOL CHEM, V286, P30022, DOI 10.1074/jbc.M111.261206; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Esposti MD, 2002, METHODS, V26, P335, DOI 10.1016/S1046-2023(02)00039-7; Flock G, 2007, DIABETES, V56, P3006, DOI 10.2337/db07-0697; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hardman MJ, 2008, ENDOCRINOLOGY, V149, P551, DOI 10.1210/en.2007-1042; HASINOFF BB, 1989, BIOCHEM J, V258, P101, DOI 10.1042/bj2580101; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; HOFF HF, 1993, J LIPID RES, V34, P1209; Idkowiak-Baldys J, 2010, BIOCHEM J, V427, P265, DOI 10.1042/BJ20091589; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Kim HJ, 2012, J LIPID RES, V53, P1701, DOI 10.1194/jlr.D025627; Kroesen BJ, 2003, J BIOL CHEM, V278, P14723, DOI 10.1074/jbc.M210756200; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Laskin JD, 2010, ANN NY ACAD SCI, V1203, P92, DOI 10.1111/j.1749-6632.2010.05605.x; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Li X, 2010, CELL PHYSIOL BIOCHEM, V26, P41, DOI 10.1159/000315104; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mansat-De Mas V, 1999, MOL PHARMACOL, V56, P867, DOI 10.1124/mol.56.5.867; Mattson MP, 2009, EXP GERONTOL, V44, P625, DOI 10.1016/j.exger.2009.07.003; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Novgorodov SA, 2011, J BIOL CHEM, V286, P25352, DOI 10.1074/jbc.M110.214866; PAGANO RE, 1989, J CELL BIOL, V109, P2067, DOI 10.1083/jcb.109.5.2067; Park J. W., 2012, HEPATOLOGY IN PRESS; Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Preethy CP, 2012, J PHARMACOL PHARMACO, V3, P26, DOI 10.4103/0976-500X.92500; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Saada A, 2004, ANAL BIOCHEM, V335, P66, DOI 10.1016/j.ab.2004.08.015; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shimeno H, 1998, LIPIDS, V33, P601, DOI 10.1007/s11745-998-0246-2; Silva LC, 2012, J LIPID RES, V53, P430, DOI 10.1194/jlr.M022715; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Sullards M C, 2001, Sci STKE, V2001, ppl1; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Voss KA, 2006, TOXICOL SCI, V89, P108, DOI 10.1093/toxsci/kfj019; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; Won JS, 2006, FREE RADICAL BIO MED, V40, P1875, DOI 10.1016/j.freeradbiomed.2006.01.035; Yurlova L, 2011, BIOPHYS J, V101, P2713, DOI 10.1016/j.bpj.2011.10.026; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063	59	135	142	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4947	4956		10.1074/jbc.M112.402719	http://dx.doi.org/10.1074/jbc.M112.402719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283968	Green Published, hybrid			2022-12-28	WOS:000315340400042
J	Gupta, A; Wodziak, D; Tun, M; Bouley, DM; Lowe, AW				Gupta, Aparna; Wodziak, Dariusz; Tun, May; Bouley, Donna M.; Lowe, Anson W.			Loss of Anterior Gradient 2 (Agr2) Expression Results in Hyperplasia and Defective Lineage Maturation in the Murine Stomach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE STOMACH; GLYCOCONJUGATE HISTOCHEMISTRY; TRANSGENIC OVEREXPRESSION; SPASMOLYTIC POLYPEPTIDE; INTESTINAL METAPLASIA; CELL-PROLIFERATION; EPITHELIAL-CELLS; PROGENITOR-CELL; PARIETAL-CELL; HUMAN HOMOLOG	Recent studies of epithelial tissues have revealed the presence of tissue-specific stem cells that are able to establish multiple cell lineages within an organ. The stem cells give rise to progenitors that replicate before differentiating into specific cell lineages. The mechanism by which homeostasis is established between proliferating stem or progenitor cells and terminally differentiated cells is unclear. This study demonstrates that Agr2 expression by mucous neck cells in the stomach promotes the differentiation of multiple cell lineages while also inhibiting the proliferation of stem or progenitor cells. When Agr2 expression is absent, gastric mucous neck cells increased in number as does the number of proliferating cells. Agr2 expression loss also resulted in the decline of terminally differentiated cells, which was supplanted by cells that exhibited nuclear SOX9 labeling. Sox9 expression has been associated with progenitor and stem cells. Similar effects of the Agr2 null on cell proliferation in the intestine were also observed. Agr2 consequently serves to maintain the balance between proliferating and differentiated epithelial cells.	[Gupta, Aparna; Wodziak, Dariusz; Tun, May; Lowe, Anson W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Bouley, Donna M.] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Lowe, AW (corresponding author), Alway Bldg,Rm M211,300 Pasteur Dr, Stanford, CA 94305 USA.	lowe@stanford.edu			National Institutes of Health [DK063624]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK063624 (to A. W. L.).	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Bai ZG, 2011, INT J ONCOL, V38, P375, DOI 10.3892/ijo.2010.873; Bjerknes M, 2002, AM J PHYSIOL-GASTR L, V283, pG767, DOI 10.1152/ajpgi.00415.2001; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034408; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Ebisu S, 1978, Methods Enzymol, V50, P350; Edgell TA, 2010, CLIN SCI, V118, P717, DOI 10.1042/CS20090537; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P703, DOI 10.14670/HH-22.703; Fukuhara H, 2010, LAB INVEST, V90, P556, DOI 10.1038/labinvest.2010.42; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; GERDES J, 1984, J IMMUNOL, V133, P1710; Goldenring JR, 2010, GASTROENTEROLOGY, V138, P2207, DOI 10.1053/j.gastro.2010.04.023; Gupta A, 2012, J BIOL CHEM, V287, P4773, DOI 10.1074/jbc.M111.301531; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Huh WJ, 2012, GASTROENTEROLOGY, V142, P21, DOI 10.1053/j.gastro.2011.09.050; IHIDA K, 1988, AM J ANAT, V182, P250, DOI 10.1002/aja.1001820306; JEFFREY GP, 1994, GASTROENTEROLOGY, V106, P336, DOI 10.1016/0016-5085(94)90590-8; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; Karam SM, 1997, AM J PHYSIOL-GASTR L, V272, pG1209, DOI 10.1152/ajpgi.1997.272.5.G1209; KATAOKA K, 1990, CELL TISSUE RES, V261, P211, DOI 10.1007/BF00318662; Keeley TM, 2010, AM J PHYSIOL-GASTR L, V299, pG1241, DOI 10.1152/ajpgi.00239.2010; Kimura MS, 2011, J GASTROENTEROL, V46, P1292, DOI 10.1007/s00535-011-0443-5; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; LEE ER, 1985, AM J ANAT, V172, P187, DOI 10.1002/aja.1001720303; LEE ER, 1982, AM J ANAT, V164, P187, DOI 10.1002/aja.1001640302; Lee S, 2006, ONCOL REP, V16, P747; LEFEBVRE O, 1993, J CELL BIOL, V122, P191, DOI 10.1083/jcb.122.1.191; Li QT, 1996, J BIOL CHEM, V271, P3671, DOI 10.1074/jbc.271.7.3671; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Miyaoka Y, 2004, ONCOGENE, V23, P3572, DOI 10.1038/sj.onc.1207333; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Nam KT, 2010, GASTROENTEROLOGY, V139, P2028, DOI 10.1053/j.gastro.2010.09.005; Nomura S, 2005, AM J PHYSIOL-GASTR L, V288, pG362, DOI 10.1152/ajpgi.00160.2004; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Nozaki K, 2008, GASTROENTEROLOGY, V134, P511, DOI 10.1053/j.gastro.2007.11.058; OINUMA T, 1991, ANAT REC, V230, P502, DOI 10.1002/ar.1092300409; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Quante M, 2010, GASTROENTEROLOGY, V139, P2018, DOI 10.1053/j.gastro.2010.08.003; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schmidt PH, 1999, LAB INVEST, V79, P639; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; Steele IA, 2007, AM J PHYSIOL-GASTR L, V293, pG347, DOI 10.1152/ajpgi.00076.2007; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; WORKMAN C, 2002, GENOME BIOL, V0003; Yamaoka T, 2000, BIOCHEM BIOPH RES CO, V278, P368, DOI 10.1006/bbrc.2000.3813; Zalzali H, 2008, ONCOGENE, V27, P7131, DOI 10.1038/onc.2008.331; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020	58	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4321	4333		10.1074/jbc.M112.433086	http://dx.doi.org/10.1074/jbc.M112.433086			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23209296	hybrid, Green Published			2022-12-28	WOS:000314845000060
J	Voronova, A; Coyne, E; Al Madhoun, A; Fair, JV; Bosiljcic, N; St-Louis, C; Li, G; Thurig, S; Wallace, VA; Wiper-Bergeron, N; Skerjanc, IS				Voronova, Anastassia; Coyne, Erin; Al Madhoun, Ashraf; Fair, Joel V.; Bosiljcic, Neven; St-Louis, Catherine; Li, Grace; Thurig, Sherry; Wallace, Valerie A.; Wiper-Bergeron, Nadine; Skerjanc, Ilona S.			Hedgehog Signaling Regulates MyoD Expression and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE STEM-CELLS; SKELETAL-MUSCLE; SONIC HEDGEHOG; TRANSCRIPTION-FACTOR; SATELLITE CELLS; GENE-EXPRESSION; REDUNDANT FUNCTIONS; OTHERS EXPRESSION; PRECURSOR CELLS; FAMILY-MEMBERS	The inhibition of MyoD expression is important for obtaining muscle progenitors that can replenish the satellite cell niche during muscle repair. Progenitors could be derived from either embryonic stem cells or satellite cells. Hedgehog (Hh) signaling is important for MyoD expression during embryogenesis and adult muscle regeneration. To date, the mechanistic understanding of MyoD regulation by Hh signaling is unclear. Here, we demonstrate that the Hh effector, Gli2, regulates MyoD expression and associates with MyoD gene elements. Gain- and loss-of-function experiments in pluripotent P19 cells show that Gli2 activity is sufficient and required for efficient MyoD expression during skeletal myogenesis. Inhibition of Hh signaling reduces MyoD expression during satellite cell activation in vitro. In addition to regulating MyoD expression, Hh signaling regulates MyoD transcriptional activity, and MyoD activates Hh signaling in myogenic conversion assays. Finally, Gli2, MyoD, and MEF2C form a protein complex, which enhances MyoD activity on skeletal muscle-related promoters. We therefore link Hh signaling to the function and expression of MyoD protein during myogenesis in stem cells.	[Voronova, Anastassia; Coyne, Erin; Al Madhoun, Ashraf; Fair, Joel V.; Bosiljcic, Neven; Thurig, Sherry; Wallace, Valerie A.; Skerjanc, Ilona S.] Dasman Diabet Inst, Dept Biochem Microbiol & Immunol, Dasman 15462, Kuwait; [Al Madhoun, Ashraf] Dasman Diabet Inst, Pancreat Islet Biol & Transplantat Unit, Dasman 15462, Kuwait; [St-Louis, Catherine; Li, Grace; Wiper-Bergeron, Nadine] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Thurig, Sherry; Wallace, Valerie A.] Ottawa Hosp Res Inst, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Skerjanc, IS (corresponding author), Dasman Diabet Inst, Dept Biochem Microbiol & Immunol, Dasman 15462, Kuwait.	iskerjan@uottawa.ca	Wiper-Bergeron, Nadine/AAO-4370-2021; Voronova, Anastassia/GLR-8891-2022; Skerjanc, Ilona/AAN-3318-2020	Wiper-Bergeron, Nadine/0000-0001-8448-3246; Voronova, Anastassia/0000-0001-7504-1905; Al Madhoun, Ashraf/0000-0001-8593-3878	Canadian Institutes of Health Research [MOP-84458]; Heart and Stroke Foundation of Canada; Ontario Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported in part by Grant MOP-84458 (to I. S. S.) from the Canadian Institutes of Health Research.; Supported by a doctoral research award from the Heart and Stroke Foundation of Canada.; Supported by an Ontario Graduate Scholarship.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Al Madhoun AS, 2011, EMBO J, V30, P2477, DOI 10.1038/emboj.2011.153; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Anderson C, 2012, GENE DEV, V26, P2103, DOI 10.1101/gad.187807.112; Archer TK, 1997, METHODS, V11, P235, DOI 10.1006/meth.1996.0410; Asakura A, 2007, P NATL ACAD SCI USA, V104, P16552, DOI 10.1073/pnas.0708145104; Astigiano S, 2005, DIFFERENTIATION, V73, P484, DOI 10.1111/j.1432-0436.2005.00043.x; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Borycki AG, 2000, DEVELOPMENT, V127, P2075; Borycki AG, 1999, DEVELOPMENT, V126, P4053; Borycki AG, 1998, DEVELOPMENT, V125, P777; Bren-Mattison Y, 2002, DEV BIOL, V242, P130, DOI 10.1006/dbio.2001.0528; Buscher D, 1998, DEV DYNAM, V211, P88; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chen JCJ, 2004, DEV BIOL, V265, P502, DOI 10.1016/j.ydbio.2003.09.018; Chen JCJ, 2002, DEV BIOL, V245, P213, DOI 10.1006/dbio.2002.0638; Chen JCJ, 2001, DEV DYNAM, V221, P274, DOI 10.1002/dvdy.1138; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Darabi R, 2011, STEM CELLS, V29, P777, DOI 10.1002/stem.625; Dufort D, 1998, DEVELOPMENT, V125, P3015; Duprez D, 1998, DEVELOPMENT, V125, P495; Duquet A, 2006, EMBO REP, V7, P1140, DOI 10.1038/sj.embor.7400820; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Elia D, 2007, BBA-MOL CELL RES, V1773, P1438, DOI 10.1016/j.bbamcr.2007.06.006; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Feng XS, 2006, DEV BIOL, V300, P736, DOI 10.1016/j.ydbio.2006.08.056; Fong AP, 2012, DEV CELL, V22, P721, DOI 10.1016/j.devcel.2012.01.015; Froeschle A, 1998, ONCOGENE, V16, P3369, DOI 10.1038/sj.onc.1201894; Gayraud-Morel B, 2012, J CELL SCI, V125, P1738, DOI 10.1242/jcs.097006; Gianakopoulos PJ, 2011, J BIOL CHEM, V286, P2517, DOI 10.1074/jbc.M110.163709; Gianakopoulos PJ, 2005, J BIOL CHEM, V280, P21022, DOI 10.1074/jbc.M502977200; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Heo JS, 2007, STEM CELLS, V25, P3069, DOI 10.1634/stemcells.2007-0550; Hu JKH, 2012, GENE DEV, V26, P2088, DOI 10.1101/gad.187385.112; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Jamali M, 2001, J BIOL CHEM, V276, P42252, DOI 10.1074/jbc.M107814200; Karamboulas Christina, 2006, J Cell Sci, V119, P4315, DOI 10.1242/jcs.03186; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; Kim CH, 2008, MOL CELL BIOL, V28, P2941, DOI 10.1128/MCB.01682-07; Kruger M, 2001, DEVELOPMENT, V128, P743; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lee J, 1997, DEVELOPMENT, V124, P2537; Li Xiaopeng, 2004, BMC Dev Biol, V4, P9, DOI 10.1186/1471-213X-4-9; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Madhala-Levy D, 2012, J CELL PHYSIOL, V227, P1455, DOI 10.1002/jcp.22861; Matise MP, 1998, DEVELOPMENT, V125, P2759; Mau E, 2007, DEV BIOL, V305, P28, DOI 10.1016/j.ydbio.2007.01.031; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Mo R, 1997, DEVELOPMENT, V124, P113; Mokalled MH, 2012, GENE DEV, V26, P190, DOI 10.1101/gad.179663.111; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Montross WT, 2000, J CELL SCI, V113, P1759; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; Osborn DPS, 2011, DEV BIOL, V350, P464, DOI 10.1016/j.ydbio.2010.12.010; OTT MO, 1991, DEVELOPMENT, V111, P1097; Ovcharenko I, 2005, NUCLEIC ACIDS RES, V33, pW403, DOI 10.1093/nar/gki466; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Park HL, 2000, DEVELOPMENT, V127, P1593; Petropoulos H, 2004, J BIOL CHEM, V279, P23874, DOI 10.1074/jbc.M312612200; Petropoulos H, 2002, J BIOL CHEM, V277, P15393, DOI 10.1074/jbc.M112141200; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Ridgeway AG, 2000, J BIOL CHEM, V275, P41, DOI 10.1074/jbc.275.1.41; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryan T, 2012, STEM CELL REV REP, V8, P482, DOI 10.1007/s12015-011-9284-0; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Savage J, 2010, DIFFERENTIATION, V79, P31, DOI 10.1016/j.diff.2009.08.008; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Straface G, 2009, J CELL MOL MED, V13, P2424, DOI 10.1111/j.1582-4934.2008.00440.x; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Thomas NA, 2008, DEVELOPMENT, V135, P3789, DOI 10.1242/dev.024083; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Voronova A, 2012, NUCLEIC ACIDS RES, V40, P3329, DOI 10.1093/nar/gkr1232; Voronova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019174; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	111	32	34	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4389	4404		10.1074/jbc.M112.400184	http://dx.doi.org/10.1074/jbc.M112.400184			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23266826	Green Published, hybrid			2022-12-28	WOS:000314845000066
J	Wu, XL; Hernandez-Enriquez, B; Banas, M; Xu, R; Sesti, F				Wu, Xilong; Hernandez-Enriquez, Berenice; Banas, Michelle; Xu, Robin; Sesti, Federico			Molecular Mechanisms Underlying the Apoptotic Effect of KCNB1 K+ Channel Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; TYROSINE KINASE; KV2.1 CHANNEL; LIPID RAFTS; SRC; PHOSPHORYLATION; ENDOCYTOSIS; ACTIVATION; RECEPTOR; DYNAMIN	Potassium (K+) channels are targets of reactive oxygen species in the aging nervous system. KCNB1 (formerly Kv2.1), a voltage-gated K+ channel abundantly expressed in the cortex and hippocampus, is oxidized in the brains of aging mice and of the triple transgenic 3xTg-AD mouse model of Alzheimer's disease. KCNB1 oxidation acts to enhance apoptosis in mammalian cell lines, whereas a KCNB1 variant resistant to oxidative modification, C73A-KCNB1, is cytoprotective. Here we investigated the molecular mechanisms through which oxidized KCNB1 channels promote apoptosis. Biochemical evidence showed that oxidized KCNB1 channels, which form oligomers held together by disulfide bridges involving Cys-73, accumulated in the plasma membrane as a result of defective endocytosis. In contrast, C73A-mutant channels, which do not oligomerize, were normally internalized. KCNB1 channels localize in lipid rafts, and their internalization was dynamin 2-dependent. Accordingly, cholesterol supplementation reduced apoptosis promoted by oxidation of KCNB1. In contrast, cholesterol depletion exacerbated apoptotic death in a KCNB1-independent fashion. Inhibition of raft-associating c-Src tyrosine kinase and downstream JNK kinase by pharmacological and molecular means suppressed the pro-apoptotic effect of KCNB1 oxidation. Together, these data suggest that the accumulation of KCNB1 oligomers in the membrane disrupts planar lipid raft integrity and causes apoptosis via activating the c-Src/JNK signaling pathway.	[Wu, Xilong; Hernandez-Enriquez, Berenice; Banas, Michelle; Xu, Robin; Sesti, Federico] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sesti, F (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 683 Hoes Ln W, Piscataway, NJ 08854 USA.	sestife@umdnj.edu			National Science Foundation [0842708, 1026958]; American Heart Association [09GRNT2250529]; RISE Research in Science and Engineering Rutgers-University of Medicine and Dentistry of New Jersey joint program	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); RISE Research in Science and Engineering Rutgers-University of Medicine and Dentistry of New Jersey joint program	This work was supported by National Science Foundation Grants 0842708 and 1026958 and an American Heart Association Grant 09GRNT2250529 (to F. S.). This work was also supported by the RISE Research in Science and Engineering Rutgers-University of Medicine and Dentistry of New Jersey joint program (to M. B.).	ANDERSON SK, 1985, MOL CELL BIOL, V5, P1122, DOI 10.1128/MCB.5.5.1122; Cai SQ, 2009, NAT NEUROSCI, V12, P611, DOI 10.1038/nn.2291; Catarzi S, 2005, BBA-MOL CELL RES, V1745, P166, DOI 10.1016/j.bbamcr.2005.03.004; Cotella D, 2012, J NEUROSCI, V32, P4133, DOI 10.1523/JNEUROSCI.6153-11.2012; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Morgan MJ, 2007, ANTIOXID REDOX SIGN, V9, P1471, DOI 10.1089/ars.2007.1658; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Pal S, 2003, J NEUROSCI, V23, P4798; Pal SK, 2006, CELL DEATH DIFFER, V13, P661, DOI 10.1038/sj.cdd.4401792; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; Sesti F, 2010, TRENDS CELL BIOL, V20, P45, DOI 10.1016/j.tcb.2009.09.008; Sobko A, 1998, EMBO J, V17, P4723, DOI 10.1093/emboj/17.16.4723; Song MY, 2012, J PROTEOME RES, V11, P1018, DOI 10.1021/pr200770v; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Suprynowicz FA, 2002, ONCOGENE, V21, P1695, DOI 10.1038/sj.onc.1205223; Tiran Z, 2003, J BIOL CHEM, V278, P17509, DOI 10.1074/jbc.M212766200; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Xu XH, 2009, CARDIOVASC RES, V82, P430, DOI 10.1093/cvr/cvp047	24	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4128	4134		10.1074/jbc.M112.440933	http://dx.doi.org/10.1074/jbc.M112.440933			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23275378	Green Published, hybrid			2022-12-28	WOS:000314845000041
J	Fujita, M; Takada, YK; Takada, Y				Fujita, Masaaki; Takada, Yoko K.; Takada, Yoshikazu			Insulin-like Growth Factor (IGF) Signaling Requires alpha v beta 3-IGF1-IGF Type 1 Receptor (IGF1R) Ternary Complex Formation in Anchorage Independence, and the Complex Formation Does Not Require IGF1R and Src Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MELANOMA CELLS; SMOOTH-MUSCLE-CELLS; FACTOR-I RECEPTOR; V BETA 3; INTEGRIN ALPHA-V-BETA-3; DIRECT BINDING; TYROSINE PHOSPHORYLATION; HUMAN SKIN; ALPHA(V)BETA(3); ANGIOGENESIS	Integrin alpha v beta 3 plays a role in insulin-like growth factor 1 (IGF1) signaling (integrin-IGF1 receptor (IGF1R) cross-talk) in non-transformed cells in anchorage-dependent conditions. We reported previously that IGF1 directly binds to alpha v beta 3 and induces alpha v beta 3-IGF1-IGF1R ternary complex formation in these conditions. The integrin-binding defective IGF1 mutant (R36E/R37E) is defective in inducing ternary complex formation and IGF signaling, whereas it still binds to IGF1R. We studied if IGF1 can induce signaling in anchorage-independent conditions in transformed Chinese hamster ovary cells that express alpha v beta 3 (beta 3-CHO) cells. Here we describe that IGF1 signals were more clearly detectable in anchorage-independent conditions (poly-HEMA-coated plates) than in anchorage-dependent conditions. This suggests that IGF signaling is masked by signals from cell-matrix interaction in anchorage-dependent conditions. IGF signaling required alpha v beta 3 expression, and R36E/R37E was defective in inducing signals in polyHEMA-coated plates. These results suggest that alpha v beta 3-IGF1 interaction, not alpha v beta 3-extracellular matrix interaction, is essential for IGF signaling. Inhibitors of IGF1R, Src, AKT, and ERK1/2 did not suppress alpha v beta 3-IGF-IGF1R ternary complex formation, suggesting that activation of these kinases are not required for ternary complex formation. Also, mutations of the beta 3 cytoplasmic tail (Y747F and Y759F) that block beta 3 tyrosine phosphorylation did not affect IGF1R phosphorylation or AKT activation. We propose a model in which IGF1 binding to IGF1R induces recruitment of integrin alpha v beta 3 to the IGF-IGF1R complex and then beta 3 and IGF1R are phosphorylated. It is likely that alpha v beta 3 should be together with the IGF1-IGF1R complex for triggering IGF signaling.	[Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Takada, Y (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Suite 3300,4645 2nd Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu		takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [CA13015, DOD W81XWH-10-1-0312]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK088752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA13015 and DOD W81XWH-10-1-0312 (to Y. T.).	Akakura N, 2006, CANCER RES, V66, P9691, DOI 10.1158/0008-5472.CAN-06-1686; Blystone SD, 2002, J BIOL CHEM, V277, P46886, DOI 10.1074/jbc.M209506200; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Clemmons DR, 2007, GROWTH HORM IGF RES, V17, P265, DOI 10.1016/j.ghir.2007.01.004; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Clemmons DR, 2003, ENDOCRINOLOGY, V144, P1664, DOI 10.1210/en.2002-221102; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Felding-Habermann B, 2002, CLIN EXP METASTAS, V19, P427, DOI 10.1023/A:1016377114119; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; FUKAZAWA H, 1995, ANAL BIOCHEM, V228, P83, DOI 10.1006/abio.1995.1318; GEHLSEN KR, 1992, CLIN EXP METASTAS, V10, P111, DOI 10.1007/BF00114587; Huveneers S, 2010, THESCIENTIFICWORLDJO, V10, P1100, DOI 10.1100/tsw.2010.114; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Jones John I., 1995, Progress in Growth Factor Research, V6, P319, DOI 10.1016/0955-2235(95)00015-1; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Ling Y, 2005, J BIOL CHEM, V280, P3151, DOI 10.1074/jbc.M411035200; Ling Y, 2003, MOL ENDOCRINOL, V17, P1824, DOI 10.1210/me.2003-0143; Maile LA, 2001, J CELL SCI, V114, P1417; MITJANS F, 1995, J CELL SCI, V108, P2825; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; NIP J, 1992, J CLIN INVEST, V90, P1406, DOI 10.1172/JCI116007; Petitclerc E, 1999, CANCER RES, V59, P2724; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Soung YH, 2010, BMB REP, V43, P311, DOI 10.5483/BMBRep.2010.43.5.311; STEPHENSON JR, 1971, P NATL ACAD SCI USA, V68, P1542, DOI 10.1073/pnas.68.7.1542; Stromblad S, 1996, J CLIN INVEST, V98, P426, DOI 10.1172/JCI118808; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Xi G, 2008, J CELL PHYSIOL, V214, P306, DOI 10.1002/jcp.21196; Yamaji S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010273; Zheng B, 1998, J BIOL CHEM, V273, P8994, DOI 10.1074/jbc.273.15.8994	39	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3059	3069		10.1074/jbc.M112.412536	http://dx.doi.org/10.1074/jbc.M112.412536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23243309	Green Published, hybrid			2022-12-28	WOS:000314397900016
J	Avet, C; Garrel, G; Denoyelle, C; Laverriere, JN; Counis, R; Cohen-Tannoudji, J; Simon, V				Avet, Charlotte; Garrel, Ghislaine; Denoyelle, Chantal; Laverriere, Jean-Noel; Counis, Raymond; Cohen-Tannoudji, Joelle; Simon, Violaine			SET Protein Interacts with Intracellular Domains of the Gonadotropin-releasing Hormone Receptor and Differentially Regulates Receptor Signaling to cAMP and Calcium in Gonadotrope Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR; GNRH RECEPTOR; KINASE-A; LUTEINIZING-HORMONE; PHOSPHATASE 2A; CYCLIC-AMP; FACTOR-I; PITUITARY; GENE; PHOSPHORYLATION	In mammals, the receptor of the neuropeptide gonadotropin-releasing hormone (GnRHR) is unique among the G protein-coupled receptor (GPCR) family because it lacks the carboxyl-terminal tail involved in GPCR desensitization. Therefore, mechanisms involved in the regulation of GnRHR signaling are currently poorly known. Here, using immunoprecipitation and GST pull-down experiments, we demonstrated that SET interacts with GnRHR and targets the first and third intracellular loops. We delineated, by site-directed mutagenesis, SET binding sites to the basic amino acids (KRKK69)-K-66 and (RK247)-R-246, located next to sequences required for receptor signaling. The impact of SET on GnRHR signaling was assessed by decreasing endogenous expression of SET with siRNA in gonadotrope cells. Using cAMP and calcium biosensors in gonadotrope living cells, we showed that SET knockdown specifically decreases GnRHR-mediated mobilization of intracellular cAMP, whereas it increases its intracellular calcium signaling. This suggests that SET influences signal transfer between GnRHR and G proteins to enhance GnRHR signaling to cAMP. Accordingly, complexing endogenous SET by introduction of the first intracellular loop of GnRHR in alpha T3-1 cells significantly reduced GnRHR activation of the cAMP pathway. Furthermore, decreasing SET expression prevented cAMP-mediated GnRH stimulation of Gnrhr promoter activity, highlighting a role of SET in gonadotropin-releasing hormone regulation of gene expression. In conclusion, we identified SET as the first direct interacting partner of mammalian GnRHR and showed that SET contributes to a switch of GnRHR signaling toward the cAMP pathway.	[Avet, Charlotte; Garrel, Ghislaine; Denoyelle, Chantal; Laverriere, Jean-Noel; Counis, Raymond; Cohen-Tannoudji, Joelle; Simon, Violaine] Univ Paris Diderot, Equipe Physiol Axe Gonadotrope, CNRS EAC 4413, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Simon, V (corresponding author), Univ Paris Diderot, Equipe Physiol Axe Gonadotrope, CNRS EAC 4413, Case Courrier 7007,4 Rue MA Lagroua Weill Halle, F-75013 Paris, France.	violaine.simon@univ-paris-diderot.fr	GARREL, Ghislaine/L-2654-2017; Laverriere, Jean-Noel/L-3286-2017	GARREL, Ghislaine/0000-0001-8547-1191; Laverriere, Jean-Noel/0000-0003-0442-1358; simon, violaine/0000-0002-4417-127X	Paris 7 University; CNRS; University Paris 11	Paris 7 University; CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paris 11	This work was supported by grants from Paris 7 University and CNRS.; Supported by a fellowship from the University Paris 11.	Arora KK, 1998, J BIOL CHEM, V273, P25581, DOI 10.1074/jbc.273.40.25581; BAUERDANTOIN AC, 1993, ENDOCRINOLOGY, V133, P1911, DOI 10.1210/en.133.4.1911; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Borroto-Escuela DO, 2011, J NEUROSCI METH, V195, P161, DOI 10.1016/j.jneumeth.2010.11.025; Chauvin S, 2000, MOL PHARMACOL, V57, P625, DOI 10.1124/mol.57.3.625; Cohen-Tannoudji Joelle, 2012, Front Endocrinol (Lausanne), V3, P107, DOI 10.3389/fendo.2012.00107; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Counis R, 2005, REPROD NUTR DEV, V45, P243, DOI 10.1051/rnd:2005017; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Garrel G, 2010, BIOL REPROD, V82, P1170, DOI 10.1095/biolreprod.109.082925; Granger A, 2006, MOL ENDOCRINOL, V20, P2093, DOI 10.1210/me.2005-0184; Hamid T, 2008, INT J ONCOL, V33, P1055, DOI 10.3892/ijo_00000094; HORN F, 1991, MOL ENDOCRINOL, V5, P347, DOI 10.1210/mend-5-3-347; Horton CD, 2004, J MOL ENDOCRINOL, V32, P291, DOI 10.1677/jme.0.0320291; KAISER UB, 1993, ENDOCRINOLOGY, V133, P931, DOI 10.1210/en.133.2.931; Kendall RT, 2011, J BIOL CHEM, V286, P19880, DOI 10.1074/jbc.M111.233080; KIMURA F, 1980, ENDOCRINOLOGY, V106, P631, DOI 10.1210/endo-106-2-631; Krsmanovic LZ, 2003, P NATL ACAD SCI USA, V100, P2969, DOI 10.1073/pnas.0535708100; Lariviere S, 2007, ENDOCRINOLOGY, V148, P1099, DOI 10.1210/en.2006-1473; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; LERRANT Y, 1995, ENDOCRINOLOGY, V136, P2803, DOI 10.1210/en.136.7.2803; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu FJ, 2003, ENDOCRINOLOGY, V144, P4354, DOI 10.1210/en.2003-0204; Luttrell LM, 2002, J CELL SCI, V115, P455; MA QP, 1995, J PHYSIOL-LONDON, V486, P769, DOI 10.1113/jphysiol.1995.sp020852; Matsumoto K, 1999, MOL CELL BIOL, V19, P6940; Maurice P, 2011, ADV PHARMACOL, V62, P349, DOI 10.1016/B978-0-12-385952-5.00001-4; McArdle CA, 1996, J BIOL CHEM, V271, P23711, DOI 10.1074/jbc.271.39.23711; McArdle CA, 2002, J ENDOCRINOL, V173, P1, DOI 10.1677/joe.0.1730001; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Myburgh DB, 1998, BIOCHEM J, V331, P893, DOI 10.1042/bj3310893; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; OLSEN SR, 1991, MOL ENDOCRINOL, V5, P1246, DOI 10.1210/mend-5-9-1246; Pantel J, 2011, EUR J PHARMACOL, V660, P139, DOI 10.1016/j.ejphar.2011.01.031; Pincas H, 2001, J BIOL CHEM, V276, P23562, DOI 10.1074/jbc.M100563200; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Sadie H, 2003, ENDOCRINOLOGY, V144, P1958, DOI 10.1210/en.2002-220874; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; SAVOYMOORE RT, 1980, SCIENCE, V209, P942, DOI 10.1126/science.6250218; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shacham S, 2005, J BIOL CHEM, V280, P28981, DOI 10.1074/jbc.M500312200; Shi J, 2007, J PHARMACOL EXP THER, V323, P248, DOI 10.1124/jpet.107.122317; Simon V, 2012, MOL PHARMACOL, V82, P17, DOI 10.1124/mol.111.075523; Simon V, 2006, J BIOL CHEM, V281, P40310, DOI 10.1074/jbc.M603858200; STARZEC A, 1989, MOL ENDOCRINOL, V3, P618, DOI 10.1210/mend-3-4-618; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Thomas P, 1996, ENDOCRINOLOGY, V137, P2979, DOI 10.1210/en.137.7.2979; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; Vera J, 2007, PROTEOMICS, V7, P578, DOI 10.1002/pmic.200600458; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Willars GB, 1999, J BIOL CHEM, V274, P30146, DOI 10.1074/jbc.274.42.30146; Willars GB, 2001, J BIOL CHEM, V276, P3123, DOI 10.1074/jbc.M008916200	57	10	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2641	2654		10.1074/jbc.M112.388876	http://dx.doi.org/10.1074/jbc.M112.388876			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233674	Green Published, hybrid			2022-12-28	WOS:000314211500049
J	Beazley, KE; Eghtesad, S; Nurminskaya, MV				Beazley, Kelly E.; Eghtesad, Saman; Nurminskaya, Maria V.			Quercetin Attenuates Warfarin-induced Vascular Calcification in Vitro Independently from Matrix Gla Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ISOLATED SYSTOLIC HYPERTENSION; BONE MORPHOGENETIC PROTEIN-2; CATENIN SIGNALING PATHWAY; ARTERIAL CALCIFICATION; OSTEOBLAST DIFFERENTIATION; OXIDATIVE STRESS; VITAMIN-K; PHOSPHATE; OSTEOPONTIN	Warfarin can stimulate vascular calcification in vitro via activation of beta-catenin signaling and/or inhibition of matrix Gla protein (MGP) carboxylation. Calcification was induced in vascular smooth muscle cells (VSMCs) with therapeutic levels of warfarin in normal calcium and clinically acceptable phosphate levels. Although TGF/BMP and PKA pathways are activated in calcifying VSMCs, pharmacologic analysis reveals that their activation is not contributory. However, beta-catenin activity is important because inhibition of beta-catenin with shRNA or bioflavonoid quercetin prevents calcification in primary human VSMCs, rodent aortic rings, and rat A10 VSMC line. In the presence of quercetin, reactivation of beta-catenin using the glycogen synthase kinase-3 beta (GSK-3 beta) inhibitor LiCl restores calcium accumulation, confirming that quercetin mechanism of action hinges on inhibition of the beta-catenin pathway. Calcification in VSMCs induced by 10 mu M warfarin does not associate with reduced levels of carboxylated MGP, and inhibitory effects of quercetin do not involve induction of MGP carboxylation. Further, down-regulation of MGP by shRNA does not alter the effect of quercetin. These results suggest a new beta-catenin-targeting strategy to prevent vascular calcification induced by warfarin and identify quercetin as a potential therapeutic in this pathology.	[Beazley, Kelly E.; Eghtesad, Saman; Nurminskaya, Maria V.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Nurminskaya, MV (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	mnurminskaya@som.umaryland.edu	Nurminskaya, Maria/GQH-4607-2022		National Institutes of Health [R01HL093305, T32AR007592]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL093305 (to M. V. N.) and Fellowship T32AR007592 (to K. E. B.).	Al-Aly Z, 2007, ARTERIOSCL THROM VAS, V27, P2589, DOI 10.1161/ATVBAHA.107.153668; Alcocer F, 2002, SURGERY, V131, P198, DOI 10.1067/msy.2002.119190; Beazley KE, 2012, ARTERIOSCL THROM VAS, V32, P123, DOI 10.1161/ATVBAHA.111.237834; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Bostrom KI, 2011, CIRC RES, V109, P564, DOI 10.1161/CIRCRESAHA.110.234278; Bostrom K, 2001, J BIOL CHEM, V276, P14044, DOI 10.1074/jbc.M008103200; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Carlson ME, 2008, EXP CELL RES, V314, P1951, DOI 10.1016/j.yexcr.2008.03.017; Chatrou MLL, 2011, HAMOSTASEOLOGIE, V31, P251, DOI 10.5482/ha-1157; Dao HH, 2002, J HYPERTENS, V20, P1597, DOI 10.1097/00004872-200208000-00023; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Edwards RL, 2007, J NUTR, V137, P2405, DOI 10.1093/jn/137.11.2405; Essalihi R, 2003, AM J HYPERTENS, V16, P103, DOI 10.1016/S0895-7061(02)03204-1; Faverman L, 2008, FEBS LETT, V582, P1552, DOI 10.1016/j.febslet.2008.03.053; Giachelli CM, 2005, CIRC RES, V96, P717, DOI 10.1161/01.RES.0000161997.24797.c0; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Han WH, 2009, FEBS J, V276, P6603, DOI 10.1111/j.1742-4658.2009.07370.x; Handrigan GR, 2010, DEV BIOL, V348, P130, DOI 10.1016/j.ydbio.2010.09.003; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; Hsu JJ, 2009, FEBS LETT, V583, P1344, DOI 10.1016/j.febslet.2009.03.039; Huang MS, 2008, BIOCHEM BIOPH RES CO, V374, P553, DOI 10.1016/j.bbrc.2008.07.062; Huxley RR, 2003, EUR J CLIN NUTR, V57, P904, DOI 10.1038/sj.ejcn.1601624; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Lerner RG, 2009, J THROMB HAEMOST, V7, P2023, DOI 10.1111/j.1538-7836.2009.03630.x; Lomashvili KA, 2004, J AM SOC NEPHROL, V15, P1392, DOI 10.1097/01.ASN.0000128955.83129.9C; Lomashvili KA, 2011, J BIOL CHEM, V286, P28715, DOI 10.1074/jbc.M111.251462; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; Mikhaylova L, 2007, CALCIFIED TISSUE INT, V81, P372, DOI 10.1007/s00223-007-9073-6; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Osinbowale O, 2009, CLEV CLIN J MED, V76, P724, DOI 10.3949/ccjm.76a.09062; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Perez-Vizcaino F, 2006, BIOCHEM BIOPH RES CO, V346, P919, DOI 10.1016/j.bbrc.2006.05.198; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Rajamannan NM, 2011, J CELL BIOCHEM, V112, P2222, DOI 10.1002/jcb.23182; Rennenberg RJMW, 2010, BLOOD, V115, P5121, DOI 10.1182/blood-2010-01-264598; Rulcova A, 2010, J THROMB HAEMOST, V8, P2708, DOI 10.1111/j.1538-7836.2010.04036.x; Rutsch F, 2011, CIRC RES, V109, P578, DOI 10.1161/CIRCRESAHA.111.247965; Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x; Schurgers LJ, 2007, BLOOD, V109, P2823, DOI 10.1182/blood-2006-07-035345; Shan BE, 2009, CANCER INVEST, V27, P604, DOI 10.1080/07357900802337191; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shao JS, 2007, ANN NY ACAD SCI, V1117, P40, DOI 10.1196/annals.1402.075; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Shimizu T, 2011, J BIOL CHEM, V286, P19138, DOI 10.1074/jbc.M110.175786; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Terao J, 2009, FORUM NUTR, V61, P87, DOI 10.1159/000212741; Tintut Y, 1998, J BIOL CHEM, V273, P7547, DOI 10.1074/jbc.273.13.7547; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zhao L, 2009, J BONE MINER RES, V24, P826, DOI [10.1359/JBMR.081236, 10.1359/jbmr.081236]	57	29	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2632	2640		10.1074/jbc.M112.368639	http://dx.doi.org/10.1074/jbc.M112.368639			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223575	hybrid, Green Published			2022-12-28	WOS:000314211500048
J	De Arras, L; Seng, A; Lackford, B; Keikhaee, MR; Bowerman, B; Freedman, JH; Schwartz, DA; Alper, S				De Arras, Lesly; Seng, Amara; Lackford, Brad; Keikhaee, Mohammad R.; Bowerman, Bruce; Freedman, Jonathan H.; Schwartz, David A.; Alper, Scott			An Evolutionarily Conserved Innate Immunity Protein Interaction Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; C. ELEGANS; TRANSLATIONAL INHIBITION; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; UBIQUITIN LIGASE	The innate immune response plays a critical role in fighting infection; however, innate immunity also can affect the pathogenesis of a variety of diseases, including sepsis, asthma, cancer, and atherosclerosis. To identify novel regulators of innate immunity, we performed comparative genomics RNA interference screens in the nematode Caenorhabditis elegans and mouse macrophages. These screens have uncovered many candidate regulators of the response to lipopolysaccharide (LPS), several of which interact physically in multiple species to form an innate immunity protein interaction network. This protein interaction network contains several proteins in the canonical LPS-responsive TLR4 pathway as well as many novel interacting proteins. Using RNAi and overexpression studies, we show that almost every gene in this network can modulate the innate immune response in mouse cell lines. We validate the importance of this network in innate immunity regulation in vivo using available mutants in C. elegans and mice.	[De Arras, Lesly; Seng, Amara; Alper, Scott] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [De Arras, Lesly; Seng, Amara; Alper, Scott] Univ Colorado, Denver, CO 80206 USA; [De Arras, Lesly; Seng, Amara; Schwartz, David A.; Alper, Scott] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA; [Lackford, Brad] NIEHS, Mol Carcinogenesis Lab, NIH, Durham, NC 27709 USA; [Keikhaee, Mohammad R.; Bowerman, Bruce] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Freedman, Jonathan H.] NIEHS, Lab Toxicol & Pharmacol, NIH, Durham, NC 27709 USA; [Schwartz, David A.] Univ Colorado, Dept Med, Aurora, CO 80045 USA	National Jewish Health; University of Colorado System; University of Colorado Denver; National Jewish Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Oregon; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Colorado System; University of Colorado Anschutz Medical Campus	Alper, S (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.	alpers@njhealth.org			National Institutes of Health from NIEHS [R21ES019256, Z01ES102045, Z01ES101946]; NHLBI; NIGMS [GM049869]; American Lung Association [RG-169529-N]; NCRR, National Institutes of Health; National Bioresource Project; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019256, Z01ES102045, ZIAES102045, Z01ES101946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049869] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Lung Association; NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Bioresource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21ES019256, Z01ES102045, and Z01ES101946 from NIEHS, Intramural Research Programs of NHLBI, and Grant GM049869 from NIGMS. This work was also supported by American Lung Association Grant RG-169529-N.; C. elegans strains were provided by the Caenorhabditis Genetics Center, which is funded by NCRR, National Institutes of Health, and by Dr. Shohei Mitani at the National Bioresource Project. We thank Dr. Ronald Liem for providing the conditional Macf1 knock-out mice and Macf1 overexpression construct.	Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Alper S, 2008, P NATL ACAD SCI USA, V105, P7016, DOI 10.1073/pnas.0802405105; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; [Anonymous], 2003, NAT CELL BIOL, V5, P489, DOI 10.1038/ncb0603-490; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Bocca SN, 2001, BIOCHEM BIOPH RES CO, V286, P357, DOI 10.1006/bbrc.2001.5394; Bottero V, 2001, J BIOL CHEM, V276, P21317, DOI 10.1074/jbc.M005850200; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Burgo A, 2012, DEV CELL, V23, P166, DOI 10.1016/j.devcel.2012.04.019; Burke B., 2002, MACROPHAGE; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Chae M, 2008, BIOCHEM BIOPH RES CO, V370, P519, DOI 10.1016/j.bbrc.2008.03.136; Chaudhuri N, 2005, CLIN SCI, V109, P125, DOI 10.1042/CS20050044; Chen YC, 2010, NAT METHODS, V7, P667, DOI 10.1038/nmeth0910-667; Childs KS, 2003, NUCLEIC ACIDS RES, V31, P3016, DOI 10.1093/nar/gkg431; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Collins LJ, 2009, J HERED, V100, P597, DOI 10.1093/jhered/esp064; Connolly DJ, 2012, CURR OPIN PHARMACOL, V12, P510, DOI 10.1016/j.coph.2012.06.002; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Cuesta N, 2003, J IMMUNOL, V170, P5739, DOI 10.4049/jimmunol.170.11.5739; De Arras L, 2012, J IMMUNOL, V188, P2905, DOI 10.4049/jimmunol.1102595; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Feng ZH, 2001, NEUROSCI LETT, V305, P17, DOI 10.1016/S0304-3940(01)01793-1; Fernandez-Botran R., 2001, METHODS CELLULAR IMM, P8; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goel R, 2012, MOL BIOSYST, V8, P453, DOI 10.1039/c1mb05340j; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Goryunov D, 2010, MOL CELL NEUROSCI, V44, P1, DOI 10.1016/j.mcn.2010.01.010; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; HODGES PE, 1994, CURR BIOL, V4, P264, DOI 10.1016/S0960-9822(00)00061-0; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Irazoqui JE, 2010, CLIN EXP IMMUNOL, V160, P48, DOI 10.1111/j.1365-2249.2010.04122.x; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Jaresova I, 2007, MICROBES INFECT, V9, P1359, DOI 10.1016/j.micinf.2007.06.009; Kakinuma T, 2004, EXP CELL RES, V298, P388, DOI 10.1016/j.yexcr.2004.04.047; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; KAUFMANN SHE, 2004, INNATE IMMUNE RESPON; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Lynn DJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-117; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Manderson AP, 2007, J CELL BIOL, V178, P57, DOI 10.1083/jcb.200612131; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Mochii M, 1999, P NATL ACAD SCI USA, V96, P15020, DOI 10.1073/pnas.96.26.15020; Moerman Donald G., 2008, Briefings in Functional Genomics & Proteomics, V7, P195, DOI 10.1093/bfgp/eln016; Muhammed M, 2012, MED MYCOL, V50, P488, DOI 10.3109/13693786.2011.648217; MUKAIDA N, 1989, J IMMUNOL, V143, P1366; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Murali T, 2011, NUCLEIC ACIDS RES, V39, pD736, DOI 10.1093/nar/gkq1092; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Neufeld TP, 1998, GENETICS, V148, P277; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; Phan HH, 2006, GENE, V371, P121, DOI 10.1016/j.gene.2005.11.019; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Pukkila-Worley R, 2012, CURR OPIN IMMUNOL, V24, P3, DOI 10.1016/j.coi.2011.10.004; Pukkila-Worley R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002074; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Rino J, 2009, TRENDS CELL BIOL, V19, P375, DOI 10.1016/j.tcb.2009.05.004; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salkowski CA, 1999, J IMMUNOL, V163, P1529; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Sperling J, 2008, STRUCTURE, V16, P1605, DOI 10.1016/j.str.2008.08.011; Stanley AC, 2012, J LEUKOCYTE BIOL, V92, P1227, DOI 10.1189/jlb.0412191; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stow JL, 2009, IMMUNOBIOLOGY, V214, P601, DOI 10.1016/j.imbio.2008.11.005; Strack P, 2000, ONCOGENE, V19, P3529, DOI 10.1038/sj.onc.1203647; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Vigneshkumar B, 2012, ARCH MICROBIOL, V194, P229, DOI 10.1007/s00203-011-0750-5; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Wiles AM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-36; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Wood WB, 1988, NEMATODE CAENORHABDI; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Yang IV, 2011, MOL IMMUNOL, V48, P1886, DOI 10.1016/j.molimm.2011.05.015; Yang IV, 2011, AM J RESP CELL MOL, V45, P393, DOI 10.1165/rcmb.2010-0342OC; Yang IV, 2009, GENETICS, V183, P1535, DOI 10.1534/genetics.109.107540; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]	117	23	23	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1967	1978		10.1074/jbc.M112.407205	http://dx.doi.org/10.1074/jbc.M112.407205			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23209288	Green Published, hybrid			2022-12-28	WOS:000313751400049
J	Xia, T; Levy, L; Levillayer, F; Jia, BS; Li, GY; Neuveut, C; Buendia, MA; Lan, K; Wei, Y				Xia, Tian; Levy, Laurence; Levillayer, Florence; Jia, Baosen; Li, Gaiyun; Neuveut, Christine; Buendia, Marie-Annick; Lan, Ke; Wei, Yu			The Four and a Half LIM-only Protein 2 (FHL2) Activates Transforming Growth Factor beta (TGF-beta) Signaling by Regulating Ubiquitination of the E3 Ligase Arkadia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COACTIVATOR; DEGRADATION; INTERACTS; RECEPTOR; CATENIN; EXPRESSION; CHAINS; DOMAIN; ALPHA; SMAD7	Arkadia is a RING-based ubiquitin ligase that positively regulates TGF-beta signaling by targeting several pathway components for ubiquitination and degradation. However, little is known about the mechanisms controlling Arkadia activity. Here we show that the LIM-only protein FHL2 binds and synergistically cooperates with Arkadia to activate Smad3/Smad4-dependent transcription. Knockdown of FHL2 by RNA interference decreases Arkadia level and restricts the amplitude of Arkadia-induced TGF-beta target gene responses. We found that Arkadia is ubiquitinated via K63- and K27-linked polyubiquitination. A single mutation at the RING domain that abolishes the E3 activity diminishes Arkadia ubiquitination, indicating that this modification partly involves autocatalytic process. Mutation of seven lysines at the C-terminal region of Arkadia severely impairs ubiquitination through the K27 but not the K63 linkage and slows down the turnover of Arkadia, suggesting that K27-linked polyubiquitination might promote proteolysis-dependent regulation of Arkadia. We show that FHL2 increases the half-life of Arkadia through inhibition of ubiquitin chain assembly on the protein, which provides a molecular basis for functional cooperation between Arkadia and FHL2 in enhancing TGF-beta signaling. Our study uncovers a novel regulatory mechanism of Arkadia by ubiquitination and identifies FHL2 as important regulator of Arkadia ubiquitination and TGF-beta signal transduction.	[Xia, Tian; Jia, Baosen; Li, Gaiyun; Lan, Ke] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai Inst Biol Sci, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China; [Xia, Tian; Levillayer, Florence; Neuveut, Christine; Buendia, Marie-Annick; Wei, Yu] Inst Pasteur, Unite Oncogenese & Virol Mol, F-75015 Paris, France; [Levy, Laurence] INSERM, U673, F-75571 Paris, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lan, K (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai Inst Biol Sci, Key Lab Mol Virol & Immunol, 411 Hefei Rd, Shanghai 200025, Peoples R China.	lanke@sibs.ac.cn; yu.wei@pasteur.fr	XIA, Tian/A-5392-2015; Wei, Yu/A-7289-2016; LEVY, Laurence/AAF-5672-2021	XIA, Tian/0000-0002-9665-5858; Neuveut, Christine/0000-0001-6520-271X	French Ligue contre le Cancer; Comite d'Ile-de-France; Association pour la Recherche sur le Cancer; Total-IPS scientific partnership program; National Science and Technology Major Projects of China [2008ZX10002006, 2012ZX10002007]; French Ministry of Foreign and European Affaires (Egide)	French Ligue contre le Cancer(Ligue nationale contre le cancer); Comite d'Ile-de-France; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Total-IPS scientific partnership program; National Science and Technology Major Projects of China; French Ministry of Foreign and European Affaires (Egide)	This work was supported in part by the French Ligue contre le Cancer, Comite d'Ile-de-France, the Association pour la Recherche sur le Cancer, Total-IPS scientific partnership program, and National Science and Technology Major Projects of China (2008ZX10002006, 2012ZX10002007).; Supported in part by the French Ministry of Foreign and European Affaires (Egide).	Bai S, 2008, J BIOL CHEM, V283, P30861, DOI 10.1074/jbc.M802525200; Bai ST, 2005, J CLIN INVEST, V115, P2742, DOI 10.1172/JCI24921; Chen DH, 2003, CANCER RES, V63, P6626; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda H, 2008, MOL BIOL CELL, V19, P4588, DOI 10.1091/mbc.E08-05-0496; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Labalette C, 2008, J BIOL CHEM, V283, P15201, DOI 10.1074/jbc.M800708200; Laney J.D., 2011, CURR PROTOC PROTEIN; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Mavrakis KJ, 2007, PLOS BIOL, V5, P586, DOI 10.1371/journal.pbio.0050067; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Park J, 2008, FASEB J, V22, P2508, DOI 10.1096/fj.07-095521; Paul C, 2006, ONCOGENE, V25, P5475, DOI 10.1038/sj.onc.1209567; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Samson T, 2004, J BIOL CHEM, V279, P28641, DOI 10.1074/jbc.M312894200; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Wixler V, 2000, J BIOL CHEM, V275, P33669, DOI 10.1074/jbc.M002519200; Yan JH, 2003, FEBS LETT, V553, P183, DOI 10.1016/S0014-5793(03)00978-5; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0	35	24	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1785	1794		10.1074/jbc.M112.439760	http://dx.doi.org/10.1074/jbc.M112.439760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23212909	Green Published, hybrid			2022-12-28	WOS:000313751400034
J	Doshi, R; Ali, A; Shi, W; Freeman, EV; Fagg, LA; van Veen, HW				Doshi, Rupak; Ali, Anam; Shi, Wilma; Freeman, Elizabeth V.; Fagg, Lisa A.; van Veen, Hendrik W.			Molecular Disruption of the Power Stroke in the ATP-binding Cassette Transport Protein MsbA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG ABC TRANSPORTER; ESCHERICHIA-COLI MSBA; ALTERNATING ACCESS; P-GLYCOPROTEIN; RESISTANCE; DOMAINS; COMPLEX; ENERGY; SWITCH; CYCLE	ATP-binding cassette transporters affect drug pharmacokinetics and are associated with inherited human diseases and impaired chemotherapeutic treatment of cancers and microbial infections. Current alternating access models for ATP-binding cassette exporter activity suggest that ATP binding at the two cytosolic nucleotide-binding domains provides a power stroke for the conformational switch of the two membrane domains from the inward-facing conformation to the outward-facing conformation. In outward-facing crystal structures of the bacterial homodimeric ATP-binding cassette transporters MsbA from Gram-negative bacteria and Sav1866 from Staphylococcus aureus, two transmembrane helices (3 and 4) in the membrane domains have their cytoplasmic extensions in close proximity, forming a tetrahelix bundle interface. In biochemical experiments on MsbA from Escherichia coli, we show for the first time that a robust network of inter-monomer interactions in the tetrahelix bundle is crucial for the transmission of nucleotide-dependent conformational changes to the extracellular side of the membrane domains. Our observations are the first to suggest that modulation of tetrahelix bundle interactions in ATP-binding cassette exporters might offer a potent strategy to alter their transport activity.	[Doshi, Rupak; Ali, Anam; Shi, Wilma; Freeman, Elizabeth V.; Fagg, Lisa A.; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	van Veen, HW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008	van Veen, Hendrik W./0000-0002-9658-8077	Biotechnology and Biological Sciences Research Council; Cambridge Commonwealth and Overseas Trust; Charter Studentship; Croucher Foundation; Biotechnology and Biological Sciences Research Council [BB/I002383/1] Funding Source: researchfish; BBSRC [BB/I002383/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Commonwealth and Overseas Trust; Charter Studentship; Croucher Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council. Recipient of Cambridge Commonwealth and Overseas Trust scholarships and the Charter Studentship. Recipient of a scholarship from the Croucher Foundation.	Aittoniemi J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000762; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Doshi R, 2011, BIOCHEM SOC T, V39, P807, DOI 10.1042/BST0390807; Doshi R, 2010, PROTEINS, V78, P2867, DOI 10.1002/prot.22813; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Marquez B, 2011, CURR DRUG TARGETS, V12, P600, DOI 10.2174/138945011795378504; McDevitt CA, 2008, FEBS J, V275, P4354, DOI 10.1111/j.1742-4658.2008.06578.x; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Schaedler TA, 2012, J BIOL CHEM, V287, P27682, DOI 10.1074/jbc.M112.372334; Seeger MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037845; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Vigano C, 2002, FEBS LETT, V530, P197, DOI 10.1016/S0014-5793(02)03485-3; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward A, 2009, J STRUCT BIOL, V165, P169, DOI 10.1016/j.jsb.2008.11.006; Weng JW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.056432; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051	39	31	32	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6801	6813		10.1074/jbc.M112.430074	http://dx.doi.org/10.1074/jbc.M112.430074			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23306205	Green Published, hybrid			2022-12-28	WOS:000316002400003
J	Kaminski, PA; Labesse, G				Kaminski, Pierre Alexandre; Labesse, Gilles			Phosphodeoxyribosyltransferases, Designed Enzymes for Deoxyribonucleotides Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-N-DEOXYRIBOSYLASE; HERPES-SIMPLEX VIRUS; LACTOBACILLUS-HELVETICUS; NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE; DROSOPHILA-MELANOGASTER; MULTIFUNCTIONAL ENZYME; SUBSTRATE-SPECIFICITY; THYMIDYLATE KINASE; ACTIVE-SITE; BASES	A large number of nucleoside analogues and 2'-deoxynucleoside triphosphates (dNTP) have been synthesized to interfere with DNA metabolism. However, in vivo the concentration and phosphorylation of these analogues are key limiting factors. In this context, we designed enzymes to switch nucleobases attached to a deoxyribose monophosphate. Active chimeras were made from two distantly related enzymes: a nucleoside deoxyribosyltransferase from lactobacilli and a 5'-monophosphate-2'-deoxyribonucleoside hydrolase from rat. Then their unprecedented activity was further extended to deoxyribose triphosphate, and in vitro biosyntheses could be successfully performed with several base analogues. These new enzymes provide new tools to synthesize dNTP analogues and to deliver them into cells.	[Kaminski, Pierre Alexandre] Inst Pasteur, Unite Chim & Biocatalyse, F-75724 Paris 15, France; [Kaminski, Pierre Alexandre] CNRS, UMR 3523, F-75724 Paris 15, France; [Labesse, Gilles] CNRS, UMR 5048, Ctr Biochim Struct, F-34090 Montpellier, France; [Labesse, Gilles] INSERM, U1054, F-34090 Montpellier, France; [Labesse, Gilles] Univ Montpellier 1 & 2, IFR3, F-34090 Montpellier, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Kaminski, PA (corresponding author), Inst Pasteur, Unite Chim & Biocatalyse, 28 Rue Dr Roux, F-75724 Paris 15, France.	pierre-alexandre.kaminski@pasteur.fr		Kaminski, Pierre Alexandre/0000-0001-9841-6837; Labesse, Gilles/0000-0002-6861-3300				Armstrong SR, 1996, STRUCTURE, V4, P97, DOI 10.1016/S0969-2126(96)00013-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao J, 2007, BIOTECHNOL BIOENG, V98, P1, DOI 10.1002/bit.21498; Benner SA, 2004, ACCOUNTS CHEM RES, V37, P784, DOI 10.1021/ar040004z; Burgess K, 2000, CHEM REV, V100, P2047, DOI 10.1021/cr990045m; CARDINAUD R, 1979, BIOCHIM BIOPHYS ACTA, V568, P339, DOI 10.1016/0005-2744(79)90301-2; Caton-Williams J, 2011, ORG LETT, V13, P4156, DOI 10.1021/ol201073e; CHEN MS, 1979, J VIROL, V30, P942, DOI 10.1128/JVI.30.3.942-945.1979; CHEN MS, 1979, J BIOL CHEM, V254, P747; Doddapaneni K, 2011, BIOCHEMISTRY-US, V50, P4712, DOI 10.1021/bi101742z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; FREEMAN GA, 1995, BIOORGAN MED CHEM, V3, P447, DOI 10.1016/0968-0896(95)00030-K; Gerlt JA, 2009, CURR OPIN CHEM BIOL, V13, P10, DOI 10.1016/j.cbpa.2009.01.014; Ghiorghi YK, 2007, J BIOL CHEM, V282, P8150, DOI 10.1074/jbc.M610648200; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Hebrard C, 2009, CANCER GENE THER, V16, P541, DOI 10.1038/cgt.2009.25; Hohne M, 2010, NAT CHEM BIOL, V6, P807, DOI [10.1038/nchembio.447, 10.1038/NCHEMBIO.447]; HOLGUIN J, 1975, EUR J BIOCHEM, V54, P515, DOI 10.1111/j.1432-1033.1975.tb04164.x; HUANG MC, 1983, ARCH BIOCHEM BIOPHYS, V222, P133, DOI 10.1016/0003-9861(83)90510-6; HUANG MC, 1981, BIOCHEM PHARMACOL, V30, P2663, DOI 10.1016/0006-2952(81)90535-9; Jochens H, 2010, CHEMBIOCHEM, V11, P1861, DOI 10.1002/cbic.201000284; Johansson M, 1999, J BIOL CHEM, V274, P23814, DOI 10.1074/jbc.274.34.23814; Johnson D. C., 2004, CURRENT PROTOCOLS NU; Kaminski PA, 2002, J BIOL CHEM, V277, P14400, DOI 10.1074/jbc.M111995200; Kaminski PA, 2008, J BIOL CHEM, V283, P20053, DOI 10.1074/jbc.M802706200; Khakshoor O, 2011, CHEM COMMUN, V47, P7018, DOI 10.1039/c1cc11021g; KIRNOS MD, 1977, NATURE, V270, P369, DOI 10.1038/270369a0; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; LADNER WE, 1985, J ORG CHEM, V50, P1076, DOI 10.1021/jo00207a032; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Marliere P, 2011, ANGEW CHEM INT EDIT, V50, P7109, DOI 10.1002/anie.201100535; Mikhailopulo IA, 2011, MENDELEEV COMMUN, V21, P57, DOI 10.1016/j.mencom.2011.03.001; Muller M, 1996, CHEM RES TOXICOL, V9, P1140, DOI 10.1021/tx9600661; Munch-Petersen B, 1998, J BIOL CHEM, V273, P3926, DOI 10.1074/jbc.273.7.3926; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Padilla A, 2013, ACTA CRYSTALLOGR D, V69, P247, DOI 10.1107/S0907444912045039; Pons JL, 2009, NUCLEIC ACIDS RES, V37, pW485, DOI 10.1093/nar/gkp368; PORTER DJT, 1995, J BIOL CHEM, V270, P15551, DOI 10.1074/jbc.270.26.15551; Schnetz-Boutaud NC, 2000, CHEM RES TOXICOL, V13, P90, DOI 10.1021/tx990141i; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; WARREN RAJ, 1980, ANNU REV MICROBIOL, V34, P137, DOI 10.1146/annurev.mi.34.100180.001033; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang YS, 2009, J MOL BIOL, V394, P435, DOI 10.1016/j.jmb.2009.10.004	47	13	13	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6534	6541		10.1074/jbc.M112.446492	http://dx.doi.org/10.1074/jbc.M112.446492			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23325804	Green Published, hybrid			2022-12-28	WOS:000315820700046
J	Wang, HY; He, LF; Ma, F; Regan, MM; Balk, SP; Richardson, AL; Yuan, X				Wang, Hongyun; He, Lingfeng; Ma, Fen; Regan, Meredith M.; Balk, Steven P.; Richardson, Andrea L.; Yuan, Xin			SOX9 Regulates Low Density Lipoprotein Receptor-related Protein 6 (LRP6) and T-cell Factor 4 (TCF4) Expression and Wnt/beta-catenin Activation in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY STEM-CELLS; AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; BETA-CATENIN; CHONDROCYTE DIFFERENTIATION; INTESTINAL EPITHELIUM; CAMPOMELIC DYSPLASIA; TRANSCRIPTION FACTOR; GLAND DEVELOPMENT; WNT PROTEINS	Gene expression profiling has identified breast cancer (BCa) subtypes, including an aggressive basal-like (BL) subtype. The molecular signals underlying the behavior observed in BL-BCa group are largely unknown, although recent results indicate a prevalent increase in Wnt/beta-catenin activity. Our immunohistochemistry study confirmed that SOX9, one of the BL-BCa signature genes, was expressed by most BL-BCa, and its expression correlated with indicators of poor prognosis. Importantly, BCa gene expression profiling strongly associated SOX9 with the expression of Wnt/beta-catenin pathway components, LRP6 and TCF4. In cancer cell lines, SOX9 silencing reduced cell proliferation and invasion, LRP6 and TCF4 transcription, and decreased Wnt/beta-catenin activation. SOX9 expression was also increased by Wnt, indicating that SOX9 is at the center of a positive feedback loop that enhances Wnt/beta-catenin signaling. Consistently, SOX9 overexpression in BCa cell lines and transgenic SOX9 expression in breast epithelium caused increased LRP6 and TCF4 expression and Wnt/beta-catenin activation. These results identify SOX9-mediated Wnt/beta-catenin activation as one of the molecular mechanisms underlying aberrant Wnt/beta-catenin activity in BCa, especially in the BL-BCa subgroup.	[Wang, Hongyun; He, Lingfeng; Ma, Fen; Balk, Steven P.; Yuan, Xin] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Boston, MA 02215 USA; [Regan, Meredith M.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Richardson, Andrea L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Richardson, AL (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,Smith 936A, Boston, MA 02215 USA.	arichardson@partners.org; xyuan@bidmc.harvard.edu			National Institutes of Health [R01 DK079962]; Dana-Farber/Harvard SPORE in Prostate Cancer Grant [P50 CA 090381]; Dana-Farber/Harvard SPORE in Breast Cancer Grant [CA089393]; Breast Cancer Research Foundation; Department of Defense [W81XWH-08-1-0160]; NATIONAL CANCER INSTITUTE [P50CA090381, P50CA089393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard SPORE in Prostate Cancer Grant; Dana-Farber/Harvard SPORE in Breast Cancer Grant; Breast Cancer Research Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK079962 (to X. Y.); the Dana-Farber/Harvard SPORE in Prostate Cancer Grant P50 CA 090381 (to S. P. B.) and Dana-Farber/Harvard SPORE in Breast Cancer Grant CA089393 (to A. L. R.), the Breast Cancer Research Foundation (to A. L. R.), and Department of Defense Postdoctoral Award W81XWH-08-1-0160 (to H. W.).	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Brisken C, 2000, GENE DEV, V14, P650; BUHLER TA, 1993, DEV BIOL, V155, P87, DOI 10.1006/dbio.1993.1009; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; Hennighausen L, 1995, J CELL BIOCHEM, V59, P463, DOI 10.1002/jcb.240590407; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Jonsson M, 2000, EUR J CANCER, V36, P242, DOI 10.1016/S0959-8049(99)00276-2; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Matros E, 2005, BREAST CANCER RES TR, V91, P179, DOI 10.1007/s10549-004-7603-8; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Muller P, 2010, BREAST CANCER RES TR, V120, P317, DOI 10.1007/s10549-009-0381-6; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polakis P, 2000, GENE DEV, V14, P1837; Rakha E, 2009, ARCH PATHOL LAB MED, V133, P860, DOI 10.1043/1543-2165-133.6.860; Roarty K, 2010, CURR OPIN PHARMACOL, V10, P643, DOI 10.1016/j.coph.2010.07.004; Rother K, 2004, ONCOGENE, V23, P3376, DOI 10.1038/sj.onc.1207464; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schlosshauer PW, 2000, CARCINOGENESIS, V21, P1453, DOI 10.1093/carcin/21.7.1453; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; WEBERHALL SJ, 1994, DIFFERENTIATION, V57, P205, DOI 10.1046/j.1432-0436.1994.5730205.x; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhou G, 1998, J BIOL CHEM, V273, P14989, DOI 10.1074/jbc.273.24.14989	60	52	56	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6478	6487		10.1074/jbc.M112.419184	http://dx.doi.org/10.1074/jbc.M112.419184			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23306204	hybrid, Green Published			2022-12-28	WOS:000315820700041
J	Aukrust, I; Bjorkhaug, L; Negahdar, M; Molnes, J; Johansson, BB; Muller, Y; Haas, W; Gygi, SP; Sovik, O; Flatmark, T; Kulkarni, RN; Njolstad, PR				Aukrust, Ingvild; Bjorkhaug, Lise; Negahdar, Maria; Molnes, Janne; Johansson, Bente B.; Muller, Yvonne; Haas, Wilhelm; Gygi, Steven P.; Sovik, Oddmund; Flatmark, Torgeir; Kulkarni, Rohit N.; Njolstad, Pal R.			SUMOylation of Pancreatic Glucokinase Regulates Its Cellular Stability and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME UBC9; PROTEIN; GLUCOSE; CELLS; SUMO; IDENTIFICATION; MUTATIONS; BINDING; YOUNG; GENE	Glucokinase is the predominant hexokinase expressed in hepatocytes and pancreatic beta-cells, with a pivotal role in regulating glucose-stimulated insulin secretion, illustrated by glucokinase gene mutations causing monogenic diabetes and congenital hyperinsulinemic hypoglycemia. A complex tissue-specific network of mechanisms regulates this enzyme, and a major unanswered question in glucokinase biology is how post-translational modifications control the function of the enzyme. Here, we show that the pancreatic isoform of human glucokinase is SUMOylated in vitro, using recombinant enzymes, and in insulin-secreting model cells. Three N-terminal lysines unique for the pancreatic isoform (Lys-12/Lys-13 and/or Lys-15) may represent one SUMOylation site, with an additional site (Lys-346) common for the pancreatic and the liver isoform. SUMO-1 and E2 overexpression stabilized preferentially the wild-type human pancreatic enzyme in MIN6 beta-cells, and SUMOylation increased the catalytic activity of recombinant human glucokinase in vitro and also of glucokinase in target cells. Small ubiquitin-like modifier conjugation represents a novel form of post-translational modification of the enzyme, and it may have an important regulatory function in pancreatic beta-cells.	[Aukrust, Ingvild; Bjorkhaug, Lise; Negahdar, Maria; Molnes, Janne; Johansson, Bente B.; Muller, Yvonne; Sovik, Oddmund; Njolstad, Pal R.] KG Jebsen Ctr Diabet Res, Dept Clin Med, N-5020 Bergen, Norway; [Aukrust, Ingvild; Bjorkhaug, Lise; Molnes, Janne; Muller, Yvonne; Flatmark, Torgeir] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway; [Aukrust, Ingvild; Bjorkhaug, Lise; Negahdar, Maria; Johansson, Bente B.; Muller, Yvonne] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Aukrust, Ingvild; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Joslin Diabet Ctr, Boston, MA 02215 USA; [Molnes, Janne; Johansson, Bente B.; Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Haas, Wilhelm; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Bergen; University of Bergen; Haukeland University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Bergen; Haukeland University Hospital; Harvard University; Harvard Medical School	Bjorkhaug, L (corresponding author), Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway.	lise.gundersen@pedi.uib.no; pal.njolstad@uib.no	Aukrust, Ingvild/AAY-9434-2020; Johansson, Bente Berg/AAE-7666-2022; Aukrust, Ingvild/ABB-4526-2021; Bjørkhaug, Lise/AAA-4356-2021; Aukrust, Ingvild/ABG-2219-2021	Bjørkhaug, Lise/0000-0002-9695-4559; Johansson, Bente Berg/0000-0001-8893-1915	National Institutes of Health [RO1 DK067536]; Helse Vest, Innovest; Novo Nordisk Foundation; Bergen Medical Research Foundation; University of Bergen; Nils Norman Foundation; Norwegian Diabetes Association; Meltzer Foundation; KG Jebsen Foundation; European Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helse Vest, Innovest; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Bergen Medical Research Foundation; University of Bergen; Nils Norman Foundation; Norwegian Diabetes Association; Meltzer Foundation; KG Jebsen Foundation; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK067536 (to R.N.K.). This work was also supported by Helse Vest, Innovest, the Novo Nordisk Foundation, the Bergen Medical Research Foundation, the University of Bergen, the Nils Norman Foundation, the Norwegian Diabetes Association, the Meltzer Foundation, the KG Jebsen Foundation, and the European Research Council (to P.R.N.).	Agius L, 1996, J BIOL CHEM, V271, P30479, DOI 10.1074/jbc.271.48.30479; Baltrusch S, 2001, J BIOL CHEM, V276, P43915, DOI 10.1074/jbc.M105470200; Bjorkhaug L, 2007, J BIOL CHEM, V282, P22757, DOI 10.1074/jbc.M700517200; Burke CV, 1999, BIOCHEM J, V342, P345, DOI 10.1042/0264-6021:3420345; Charbonnier S, 2006, PROTEIN EXPRES PURIF, V50, P89, DOI 10.1016/j.pep.2006.06.010; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Christesen HBT, 2002, DIABETES, V51, P1240, DOI 10.2337/diabetes.51.4.1240; Christesen HBT, 2008, EUR J ENDOCRINOL, V159, P27, DOI 10.1530/EJE-08-0203; Dai XQ, 2011, DIABETES, V60, P838, DOI 10.2337/db10-0440; Dai XQ, 2009, J CELL SCI, V122, P775, DOI 10.1242/jcs.036632; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; DeLano S.L., 2008, PYMOL MOL GRAPHICS S; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Fox JEM, 2012, CAN J PHYSIOL PHARM, V90, P765, DOI 10.1139/Y11-134; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Galan M, 2006, BIOCHEM J, V393, P389, DOI 10.1042/BJ20051137; Galisson F, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004796; Garzon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028557; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; JETTON TL, 1994, J BIOL CHEM, V269, P3641; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kanai K, 2010, GENES CELLS, V15, P971, DOI 10.1111/j.1365-2443.2010.01431.x; Kishi A, 2003, AM J PHYSIOL-ENDOC M, V284, pE830, DOI 10.1152/ajpendo.00390.2002; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knuesel M, 2005, MOL CELL PROTEOMICS, V4, P1626, DOI 10.1074/mcp.T500011-MCP200; KORANYI LI, 1992, DIABETES, V41, P807, DOI 10.2337/diabetes.41.7.807; Kovalenko OV, 1996, P NATL ACAD SCI USA, V93, P2958, DOI 10.1073/pnas.93.7.2958; Larion M, 2010, BIOCHEMISTRY-US, V49, P7969, DOI 10.1021/bi101098f; Liu SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007983; MAGNUSON MA, 1990, DIABETES, V39, P523, DOI 10.2337/diabetes.39.5.523; Massa L, 2004, DIABETES, V53, P1020, DOI 10.2337/diabetes.53.4.1020; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; MEGLASSON MD, 1984, AM J PHYSIOL, V246, pE1, DOI 10.1152/ajpendo.1984.246.1.E1; Molnes J, 2008, FEBS J, V275, P2467, DOI 10.1111/j.1742-4658.2008.06391.x; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Murata T, 1997, FEBS LETT, V406, P109, DOI 10.1016/S0014-5793(97)00253-6; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; Negahdar M, 2012, BBA-MOL BASIS DIS, V1822, P1705, DOI 10.1016/j.bbadis.2012.07.005; Njolstad PR, 2001, NEW ENGL J MED, V344, P1588, DOI 10.1056/NEJM200105243442104; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Park J, 2007, P NATL ACAD SCI USA, V104, P17028, DOI 10.1073/pnas.0609852104; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rallabhandi P, 2002, J BIOL CHEM, V277, P40020, DOI 10.1074/jbc.M200388200; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Saitoh H, 2002, J BIOL CHEM, V277, P4755, DOI 10.1074/jbc.M104453200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Shiota C, 1999, J BIOL CHEM, V274, P37125, DOI 10.1074/jbc.274.52.37125; Tolonen AC, 2011, MOL SYST BIOL, V7, DOI [10.1038/msb.2010.116, 10.1038/MSB.2010.116]; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; Watts FZ, 2004, SEMIN CELL DEV BIOL, V15, P211, DOI 10.1016/j.semcdb.2003.12.002; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Xu X, 2010, EMBO REP, V11, P299, DOI 10.1038/embor.2010.18	57	29	29	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5951	5962		10.1074/jbc.M112.393769	http://dx.doi.org/10.1074/jbc.M112.393769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297408	Green Published, hybrid			2022-12-28	WOS:000315342500063
J	Hayashi, K; Morita, T				Hayashi, Ken'ichiro; Morita, Tsuyoshi			Differences in the Nuclear Export Mechanism between Myocardin and Myocardin-related Transcription Factor A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; MUSCLE GENE-EXPRESSION; MEGAKARYOBLASTIC LEUKEMIA; ACTIN; SRF; COACTIVATOR; LOCALIZATION; PROTEINS; COFACTOR; IMPORT	Myocardin (Mycd), a key factor in smooth muscle cell differentiation, is constitutively located in the nucleus, whereas myocardin-related transcription factors A and B (MRTF-A/B) reside mostly in the cytoplasm and translocate to the nucleus in a Rho-dependent manner. Here, we investigated the nuclear export of Mycd family members. They possess two leucine-rich sequences: L1 in the N terminus and L2 in the Gln-rich domain. Although L2 (but not L1) served as a CRM1-binding site for Mycd, CRM1-mediated nuclear export did not affect its subcellular localization. Serum response factor (SRF) competitively inhibited Mycd/CRM1 interaction. Furthermore, such interaction was autonomously inhibited. The N terminus of Mycd bound intramolecularly to Mycd, resulting in masking L2. In contrast, the CRM1-binding affinity of MRTF-A was much higher than that of Mycd because both L1 and L2 of MRTF-A served as functional CRM1-binding sites, and the autoinhibition observed in the Mycd/CRM1 interaction was absent in the MRTF-A/CRM1 interaction. Additionally, because the SRF-binding affinity of MRTF-A was lower than that of Mycd, the inhibitory effect of SRF on the MRTF-A/CRM1 interaction was weak. Thus, MRTF-A is much more likely to be exported from the nucleus. These differences could be the reason for the distinct subcellular localization of Mycd and MRTF-A.	[Hayashi, Ken'ichiro; Morita, Tsuyoshi] Osaka Univ, Grad Sch Med, Dept Neurosci D13, Suita, Osaka 5650871, Japan	Osaka University	Hayashi, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosci D13, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	khayashi@nbiochem.med.osaka-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [23590332]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 23590332 from the Ministry of Education, Science, Sports and Culture of Japan ( to K. H.).	Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Hieda M, 1999, J CELL BIOL, V144, P645, DOI 10.1083/jcb.144.4.645; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Moroianu J, 1998, J CELL BIOCHEM, V70, P231; Mouilleron S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001750; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Nakamura S, 2010, J BIOL CHEM, V285, P37314, DOI 10.1074/jbc.M110.180786; Nakielny S, 1997, CURR OPIN CELL BIOL, V9, P420, DOI 10.1016/S0955-0674(97)80016-6; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Ransom JF, 2008, J BIOL CHEM, V283, P35845, DOI 10.1074/jbc.M805909200; Settleman J, 2003, MOL CELL, V11, P1121, DOI 10.1016/S1097-2765(03)00189-8; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yashiroda Y, 2003, CURR MED CHEM, V10, P741, DOI 10.2174/0929867033457791; Yoneda Y, 1999, CELL STRUCT FUNCT, V24, P425, DOI 10.1247/csf.24.425	30	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5743	5755		10.1074/jbc.M112.408120	http://dx.doi.org/10.1074/jbc.M112.408120			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23283978	Green Published, hybrid			2022-12-28	WOS:000315342500046
J	Poole, DP; Amadesi, S; Veldhuis, NA; Abogadie, FC; Lieu, T; Darby, W; Liedtke, W; Lew, MJ; McIntyre, P; Bunnett, NW				Poole, Daniel P.; Amadesi, Silvia; Veldhuis, Nicholas A.; Abogadie, Fe C.; Lieu, TinaMarie; Darby, William; Liedtke, Wolfgang; Lew, Michael J.; McIntyre, Peter; Bunnett, Nigel W.			Protease-activated Receptor 2 (PAR(2)) Protein and Transient Receptor Potential Vanilloid 4 (TRPV4) Protein Coupling Is Required for Sustained Inflammatory Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN RECEPTOR; PROTEASE-ACTIVATED-RECEPTOR-2 SENSITIZES; NEUROGENIC INFLAMMATION; NOCICEPTIVE NEURONS; PHOSPHOLIPASE A(2); SENSORY NEURONS; PAIN PATHWAY; ION-CHANNEL; KINASE-A; HYPERALGESIA	G protein-coupled receptors of nociceptive neurons can sensitize transient receptor potential (TRP) ion channels, which amplify neurogenic inflammation and pain. Protease-activated receptor 2 (PAR(2)), a receptor for inflammatory proteases, is a major mediator of neurogenic inflammation and pain. We investigated the signaling mechanisms by which PAR(2) regulates TRPV4 and determined the importance of tyrosine phosphorylation in this process. Human TRPV4 was expressed in HEK293 cells under control of a tetracycline-inducible promoter, allowing controlled and graded channel expression. In cells lacking TRPV4, the PAR(2) agonist stimulated a transient increase in [Ca2+](i). TRPV4 expression led to a markedly sustained increase in [Ca2+](i). Removal of extracellular Ca2+ and treatment with the TRPV4 antagonists Ruthenium Red or HC067047 prevented the sustained response. Inhibitors of phospholipase A(2) and cytochrome P450 epoxygenase attenuated the sustained response, suggesting that PAR(2) generates arachidonic acid-derived lipid mediators, such as 5',6'-EET, that activate TRPV4. Src inhibitor 1 suppressed PAR(2)-induced activation of TRPV4, indicating the importance of tyrosine phosphorylation. The TRPV4 tyrosine mutants Y110F, Y805F, and Y110F/Y805F were expressed normally at the cell surface. However, PAR(2) was unable to activate TRPV4 with the Y110F mutation. TRPV4 antagonism suppressed PAR(2) signaling to primary nociceptive neurons, and TRPV4 deletion attenuated PAR(2)-stimulated neurogenic inflammation. Thus, PAR(2) activation generates a signal that induces sustained activation of TRPV4, which requires a key tyrosine residue (TRPV4-Tyr-110). This mechanism partly mediates the proinflammatory actions of PAR(2).	[Poole, Daniel P.; Veldhuis, Nicholas A.; Lieu, TinaMarie; Bunnett, Nigel W.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Poole, Daniel P.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Darby, William; Lew, Michael J.; McIntyre, Peter] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3010, Australia; [Amadesi, Silvia] Univ Reading, Sch Pharm, Reading RG6 6UR, Berks, England; [Abogadie, Fe C.; McIntyre, Peter] RMIT Univ, Sch Med Sci, Bundoora, Vic 3083, Australia; [Abogadie, Fe C.; McIntyre, Peter] RMIT Univ, Hlth Innovat Res Inst, Bundoora, Vic 3083, Australia; [Liedtke, Wolfgang] Duke Univ, Med Ctr, Div Neurol, Dept Med, Durham, NC 27710 USA	University of Melbourne; University of Melbourne; University of Reading; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Duke University	Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	nigel.bunnett@monash.edu	Mcintyre, Peter/N-4109-2013; Poole, Daniel/AET-6645-2022; Liedtke, Wolfgang/GNH-1878-2022; Lieu, TinaMarie/AAM-7691-2020	Poole, Daniel/0000-0002-6168-8422; McIntyre, Peter/0000-0001-9506-5998; Lew, Michael/0000-0002-2523-7990; Veldhuis, Nicholas/0000-0002-8902-9365; Bunnett, Nigel W./0000-0003-3367-0644	National Institutes of Health [DK57840, DK43207]; National Health and Medical Research Council [1049682, 633033, 1024683, 1046860, 454858]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057840, R56DK043207, R01DK043207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57840 and DK43207 (to N. W. B.). This work was also supported by National Health and Medical Research Council Grants 1049682 and 633033 (to N. W. B.), 1024683 and 1046860 (to P. M. and N. W. B.), and 454858 (to D. P. P.).	Adapala RK, 2011, AM J PHYSIOL-HEART C, V301, pH757, DOI 10.1152/ajpheart.00142.2011; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Aley KO, 1999, J NEUROSCI, V19, P2181; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Birder L, 2007, J PHARMACOL EXP THER, V323, P227, DOI 10.1124/jpet.107.125435; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cattaruzza F, 2010, AM J PHYSIOL-GASTR L, V298, pG81, DOI 10.1152/ajpgi.00221.2009; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Cenac N, 2008, GASTROENTEROLOGY, V135, P937, DOI 10.1053/j.gastro.2008.05.024; Cenac N, 2007, J CLIN INVEST, V117, P636, DOI 10.1172/JCI29255; Ceppa EP, 2011, AM J PHYSIOL-GASTR L, V300, pG1033, DOI 10.1152/ajpgi.00305.2010; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; D'Andrea MR, 2003, AM J PATHOL, V162, P907, DOI 10.1016/S0002-9440(10)63886-2; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Ducret T, 2008, CELL CALCIUM, V43, P315, DOI 10.1016/j.ceca.2007.05.018; Ferreira J, 2004, BRIT J PHARMACOL, V141, P787, DOI 10.1038/sj.bjp.0705546; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Hoogerwerf WA, 2001, J NEUROSCI, V21, P9036, DOI 10.1523/JNEUROSCI.21-22-09036.2001; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Kim BM, 2004, NEUROSCI LETT, V361, P159, DOI 10.1016/j.neulet.2004.01.019; Kim YH, 2009, J NEUROSCI, V29, P10000, DOI 10.1523/JNEUROSCI.5030-08.2009; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Lohman RJ, 2012, FASEB J, V26, P2877, DOI 10.1096/fj.11-201004; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Materazzi S, 2008, P NATL ACAD SCI USA, V105, P12045, DOI 10.1073/pnas.0802354105; McGuire JJ, 2004, J PHARMACOL EXP THER, V309, P1124, DOI 10.1124/jpet.103.064584; McLean PG, 2002, CIRC RES, V90, P465, DOI 10.1161/hh0402.105372; Moriyama T, 2003, J NEUROSCI, V23, P6058, DOI 10.1523/JNEUROSCI.23-14-06058.2003; Moriyama T, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-3; Nagataki M, 2008, CELL BIOCHEM FUNCT, V26, P279, DOI 10.1002/cbf.1434; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Peng HQ, 2010, BIOCHEM BIOPH RES CO, V391, P1721, DOI 10.1016/j.bbrc.2009.12.140; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Sculptoreanu A, 2008, EUR J NEUROSCI, V27, P3171, DOI 10.1111/j.1460-9568.2008.06267.x; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Sipe WEB, 2008, AM J PHYSIOL-GASTR L, V294, pG1288, DOI 10.1152/ajpgi.00002.2008; Sisignano M, 2012, J NEUROSCI, V32, P6364, DOI 10.1523/JNEUROSCI.5793-11.2012; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Veldhuis NA, 2012, J BIOL CHEM, V287, P21765, DOI 10.1074/jbc.M112.342022; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Vellani V, 2006, J NEUROSCI, V26, P5109, DOI 10.1523/JNEUROSCI.3870-05.2006; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Wegierski T, 2009, J BIOL CHEM, V284, P2923, DOI 10.1074/jbc.M805357200; Woo DH, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-42; Xu F, 2003, BRIT J PHARMACOL, V140, P413, DOI 10.1038/sj.bjp.0705443; Xu HS, 2003, J BIOL CHEM, V278, P11520, DOI 10.1074/jbc.M211061200; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100; Zhang H, 2007, J NEUROSCI, V27, P12067, DOI 10.1523/JNEUROSCI.0496-07.2007	70	111	112	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5790	5802		10.1074/jbc.M112.438184	http://dx.doi.org/10.1074/jbc.M112.438184			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288842	Green Published, hybrid			2022-12-28	WOS:000315342500050
J	Ripple, MO; Kim, N; Springett, R				Ripple, Maureen O.; Kim, Namjoon; Springett, Roger			Mammalian Complex I Pumps 4 Protons per 2 Electrons at High and Physiological Proton Motive Force in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; RESPIRATORY-CHAIN; BC(1) COMPLEX; STOICHIOMETRY; MEMBRANE; GRADIENT; NADH; TRANSLOCATION; METABOLISM	Mitochondrial complex I couples electron transfer between matrix NADH and inner-membrane ubiquinone to the pumping of protons against a proton motive force. The accepted proton pumping stoichiometry was 4 protons per 2 electrons transferred (4H(+)/2e(-)) but it has been suggested that stoichiometry may be 3H(+)/2e(-) based on the identification of only 3 proton pumping units in the crystal structure and a revision of the previous experimental data. Measurement of proton pumping stoichiometry is challenging because, even in isolated mitochondria, it is difficult to measure the proton motive force while simultaneously measuring the redox potentials of the NADH/NAD(+) and ubiquinol/ubiquinone pools. Here we employ a new method to quantify the proton motive force in living cells from the redox poise of the bc(1) complex measured using multiwavelength cell spectroscopy and show that the correct stoichiometry for complex I is 4H(+)/2e(-) in mouse and human cells at high and physiological proton motive force.	[Ripple, Maureen O.; Kim, Namjoon; Springett, Roger] Geisel Sch Med Dartmouth, Dept Radiol, Hanover, NH 03755 USA	Dartmouth College	Springett, R (corresponding author), Geisel Sch Med Dartmouth, Dept Radiol, Remsen 319, Hanover, NH 03755 USA.	RSpringett@Dartmouth.edu	Springett, Roger/P-2274-2019		National Institutes of Health [5R21RR25803, R01NS054298]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Grants 5R21RR25803 and R01NS054298 from the National Institutes of Health.	Belevich G, 2011, MOL MICROBIOL, V82, P1086, DOI 10.1111/j.1365-2958.2011.07883.x; BROWN GC, 1985, BIOCHEM J, V225, P399, DOI 10.1042/bj2250399; BROWN GC, 1988, BIOCHEM J, V252, P473, DOI 10.1042/bj2520473; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; COSTA LE, 1984, J BIOL CHEM, V259, P4802; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DEJONGE PC, 1982, BIOCHEM J, V204, P515, DOI 10.1042/bj2040515; Dzbek J, 2008, J BIOL CHEM, V283, P33232, DOI 10.1074/jbc.M802404200; Efremov RG, 2012, BBA-BIOENERGETICS, V1817, P1785, DOI 10.1016/j.bbabio.2012.02.015; Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; FORMAN NG, 1982, J BIOL CHEM, V257, P2908; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; HALLER T, 1994, ANAL BIOCHEM, V218, P338, DOI 10.1006/abio.1994.1188; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kim N, 2012, BIOPHYS J, V102, P1194, DOI 10.1016/j.bpj.2012.02.003; Kim N, 2011, BBA-BIOENERGETICS, V1807, P779, DOI 10.1016/j.bbabio.2011.03.008; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; Moser CC, 2006, BBA-BIOENERGETICS, V1757, P1096, DOI 10.1016/j.bbabio.2006.04.015; MURAOKA S, 1969, BIOCHIM BIOPHYS ACTA, V180, P227, DOI 10.1016/0005-2728(69)90109-1; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; Papa S, 2002, J BIOENERG BIOMEMBR, V34, P1, DOI 10.1023/A:1013863018115; Ransac S, 2008, BBA-BIOENERGETICS, V1777, P1053, DOI 10.1016/j.bbabio.2008.05.003; Ransac S, 2012, BBA-BIOENERGETICS, V1817, P1958, DOI 10.1016/j.bbabio.2012.03.037; Schilling B, 2005, MOL CELL PROTEOMICS, V4, P84, DOI 10.1074/mcp.M400143-MCP200; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shinkarev VP, 2001, BIOCHEMISTRY-US, V40, P12584, DOI 10.1021/bi011334j; VILLALOBO A, 1984, ARCH BIOCHEM BIOPHYS, V233, P417, DOI 10.1016/0003-9861(84)90463-6; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003	34	42	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5374	5380		10.1074/jbc.M112.438945	http://dx.doi.org/10.1074/jbc.M112.438945			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23306206	Green Published, hybrid			2022-12-28	WOS:000315342500012
J	Thom, SR; Bhopale, VM; Milovanova, TN; Yang, M; Bogush, M; Buerk, DG				Thom, Stephen R.; Bhopale, Veena M.; Milovanova, Tatyana N.; Yang, Ming; Bogush, Marina; Buerk, Donald G.			Nitric-oxide Synthase-2 Linkage to Focal Adhesion Kinase in Neutrophils Influences Enzyme Activity and beta(2) Integrin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERBARIC-OXYGEN THERAPY; ACTIN S-NITROSYLATION; MYOCARDIAL-INFARCTION; REPERFUSION; INHIBITION; MECHANISM; BETA(2)-INTEGRIN; SEQUESTRATION; THROMBOLYSIS; INJURY	This investigation was to elucidate the basis for augmentation of nitric-oxide synthesis in neutrophils exposed to hyperbaric oxygen. Hyperoxia increases synthesis of reactive species leading to S-nitrosylation of beta-actin, which causes temporary inhibition of beta(2) integrin adherence. Impaired beta(2) integrin function and actin S-nitrosylation do not occur in neutrophils from mice lacking type-2 nitric-oxide synthase (iNOS) or when incubated with 1400W, an iNOS inhibitor. Similarly, effects of hyperoxia were abrogated in cells depleted of focal adhesion kinase (FAK) by treatment with small inhibitory RNA and those exposed to a specific FAK inhibitor concurrent with hyperoxia. Nitric oxide production doubles within 10 min exposure to hyperoxia but declines to approximately half-maximum production over an additional 10 min. Elevated nitric oxide production did not occur after FAK depletion or inhibition, or when filamentous actin formation was inhibited by cytochalasin D. Intracellular content of iNOS triples over the course of a 45-min exposure to hyperoxia and iNOS dimers increase in a commensurate fashion. Confocal microscopy and immunoprecipitation demonstrated that co-localization/linkage of FAK, iNOS, and filamentous actin increased within 15 min exposure to hyperoxia but then decreased below the control level. Using isolated enzymes in ex vivo preparations an association between iNOS and filamentous actin mediated by FAK could be demonstrated and complex formation was impeded when actin was S-nitrosylated. We conclude that iNOS activity is increased by an FAK-mediated association with actin filaments but peak nitric oxide production is transient due to actin S-nitrosylation during exposure to hyperoxia.	[Thom, Stephen R.] Univ Penn, Dept Emergency Med, Med Ctr, Philadelphia, PA 19104 USA; [Thom, Stephen R.; Bhopale, Veena M.; Milovanova, Tatyana N.; Yang, Ming; Bogush, Marina] Univ Penn, Inst Environm Med, Med Ctr, Philadelphia, PA 19104 USA; [Buerk, Donald G.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Drexel University	Thom, SR (corresponding author), Univ Penn, Inst Environm Med, Med Ctr, 1 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	sthom@mail.med.upenn.edu	Buerk, Donald G/F-6888-2014		Office of Naval Research	Office of Naval Research(Office of Naval Research)	This work was supported by a grant from the Office of Naval Research.	Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; Atochin DN, 2000, UNDERSEA HYPERBAR M, V27, P185; Brown EJ, 1996, ANN MED, V28, P201, DOI 10.3109/07853899609033121; Buerk DG, 1996, MICROVASC RES, V52, P13, DOI 10.1006/mvre.1996.0040; Daniliuc S, 2003, J IMMUNOL, V171, P3225, DOI 10.4049/jimmunol.171.6.3225; de Frutos T, 2001, J AM COLL CARDIOL, V37, P800, DOI 10.1016/S0735-1097(00)01185-2; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gatto EM, 2000, NITRIC OXIDE-BIOL CH, V4, P534, DOI 10.1006/niox.2000.0288; Greenberg SS, 1998, NITRIC OXIDE-BIOL CH, V2, P203, DOI 10.1006/niox.1998.0176; Kalns J, 2002, IMMUNOL LETT, V83, P125, DOI 10.1016/S0165-2478(02)00068-8; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Labrouche S, 1999, THROMB RES, V96, P309, DOI 10.1016/S0049-3848(99)00107-3; MADER JT, 1980, J INFECT DIS, V142, P915, DOI 10.1093/infdis/142.6.915; Martin JD, 2002, AVIAT SPACE ENVIR MD, V73, P565; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Sada K, 1997, EUR J BIOCHEM, V248, P827, DOI 10.1111/j.1432-1033.1997.00827.x; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Sethi S, 2001, NITRIC OXIDE-BIOL CH, V5, P482, DOI 10.1006/niox.2001.0375; Shandling AH, 1997, AM HEART J, V134, P544, DOI 10.1016/S0002-8703(97)70093-0; Sharifi M, 2004, AM J CARDIOL, V93, P1533, DOI 10.1016/j.amjcard.2004.03.009; Sharifi Mohsen, 2002, Cardiovasc Radiat Med, V3, P124, DOI 10.1016/S1522-1865(03)00104-5; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Stavitsky Y, 1998, CARDIOLOGY, V90, P131, DOI 10.1159/000006832; Su YC, 2005, CELL BIOCHEM BIOPHYS, V43, P439, DOI 10.1385/CBB:43:3:439; Tabassam FH, 1999, CELL IMMUNOL, V193, P179, DOI 10.1006/cimm.1999.1472; Tahepold P, 2003, J THORAC CARDIOV SUR, V125, P650, DOI 10.1067/mtc.2003.36; Tahepold P, 2001, LIFE SCI, V68, P1629, DOI 10.1016/S0024-3205(01)00964-X; THOM SR, 1993, TOXICOL APPL PHARM, V123, P248, DOI 10.1006/taap.1993.1243; Thom SR, 1997, AM J PHYSIOL-CELL PH, V272, pC770, DOI 10.1152/ajpcell.1997.272.3.C770; Thom SR, 2002, J NEUROBIOL, V51, P85, DOI 10.1002/neu.10044; THOM SR, 1986, J INFECT DIS, V154, P504, DOI 10.1093/infdis/154.3.504; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Thom SR, 2012, J BIOL CHEM, V287, P30346, DOI 10.1074/jbc.M112.355875; Thom SR, 2011, J BIOL CHEM, V286, P32854, DOI 10.1074/jbc.M111.255778; Totani L, 2006, BIOCHEM J, V396, P89, DOI 10.1042/BJ20051924; Ueno S, 1999, HEPATO-GASTROENTEROL, V46, P1798; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Wong Howard P., 1996, Surgical Forum, V47, P705; Yang ZJ, 2001, EUR J APPL PHYSIOL, V85, P96, DOI 10.1007/s004210100391; ZAMBONI WA, 1993, PLAST RECONSTR SURG, V91, P1110, DOI 10.1097/00006534-199305000-00022; Zheng DH, 2009, BIOCHEM BIOPH RES CO, V388, P301, DOI 10.1016/j.bbrc.2009.07.156	46	26	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4810	4818		10.1074/jbc.M112.426353	http://dx.doi.org/10.1074/jbc.M112.426353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23297409	hybrid, Green Published			2022-12-28	WOS:000315340400030
J	Zhang, LY; Liu, M; Li, X; Tang, H				Zhang, Ling-yun; Liu, Min; Li, Xin; Tang, Hua			miR-490-3p Modulates Cell Growth and Epithelial to Mesenchymal Transition of Hepatocellular Carcinoma Cells by Targeting Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 (ERGIC3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; DOWN-REGULATION; MESSENGER-RNAS; UP-REGULATION; LIVER-CANCER; PROMOTES; PROLIFERATION; BIOGENESIS; MIGRATION; MIR-125B	MicroRNAs (miRNAs) are considered to be regulators of various biological processes in cancers, including the epithelial to mesenchymal transition (EMT), which is a key factor in cancer metastasis. In this study, we aimed to clarify the potential roles of miR-490-3p in hepatocellular carcinoma (HCC) cells. Using real-time quantitative RT-PCR, we discovered that miR-490-3p was up-regulated in HCC tissues and cells compared with the adjacent non-tumor tissues and normal cells. We also found that overexpression of miR-490-3p led to an increase in cell proliferation, migration, and invasion abilities and that it contributed to EMT. The inhibition of miR-490-3p had the opposite effect on the cells. We identified ERGIC3 (endoplasmic reticulum-Golgi intermediate compartment protein 3) as a direct target gene for miR-490-3p. Unlike most miRNA-mRNA interactions, miR-490-3p increased ERGIC3 mRNA and protein levels as well as the intensity of expression of the EGFP reporter gene controlled by the 3'-UTR of ERGIC3 mRNA. The up-regulation by miR-490-3p also required the participation of Ago2. The inhibition of miR-490-3p reduced the expression of ERGIC3. Overexpression of ERGIC3 led to the same effect on HCC cells as miR-490-3p overexpression, including EMT. Importantly, silencing ERGIC3 reversed the cellular responses mediated by miR-490-3p overexpression. In conclusion, our study indicated for the first time that miR-490-3p functioned like an oncogenic miRNA in HCC cells and that the inhibition of miR-490-3p might provide an potential treatment approach for HCC patients.	[Liu, Min] Tianjin Med Univ, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China; Tianjin Med Univ, Basic Med Sch, Tianjin 300070, Peoples R China	Tianjin Medical University; Tianjin Medical University	Liu, M (corresponding author), Tianjin Med Univ, Tianjin Life Sci Res Ctr, 22 Qi Xiang Tai Rd, Tianjin 300070, Peoples R China.	luke1958@sina.com; htang2002@yahoo.com			National Natural Science Foundation of China [31270818, 91029714, 31071191]; Natural Science Foundation of Tianjin [12JCZDJC25100, 09JCZDJC17500]; "211" Project Innovation Foundation of Tianjin Medical University [2010GSI12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); "211" Project Innovation Foundation of Tianjin Medical University	This work was supported by National Natural Science Foundation of China Grants 31270818, 91029714, and 31071191; Natural Science Foundation of Tianjin Grants 12JCZDJC25100 and 09JCZDJC17500; and the "211" Project Innovation Foundation of Tianjin Medical University for Ph.D. Graduate Grant 2010GSI12.	Alpini G, 2011, J HEPATOL, V55, P1339, DOI 10.1016/j.jhep.2011.04.015; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Buurman R, 2012, GASTROENTEROLOGY, V143, P811, DOI 10.1053/j.gastro.2012.05.033; Callegari E, 2012, HEPATOLOGY, V56, P1025, DOI 10.1002/hep.25747; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dong PX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-99; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamfjord J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034150; Heo I, 2009, CELL, V139, P28, DOI 10.1016/j.cell.2009.09.013; Huang V, 2012, NUCLEIC ACIDS RES, V40, P1695, DOI 10.1093/nar/gkr934; Jiang FZ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-425; Kang HW, 2012, FEBS LETT, V586, P897, DOI 10.1016/j.febslet.2012.02.020; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kroepil F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046665; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin J, 2011, CARCINOGENESIS, V32, P1641, DOI 10.1093/carcin/bgr199; Liu LH, 2011, BIOCHEM BIOPH RES CO, V416, P31, DOI 10.1016/j.bbrc.2011.10.117; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Nakatani F, 2012, J PATHOL, V226, P796, DOI 10.1002/path.3007; Nishikawa M, 2007, GENE, V386, P42, DOI 10.1016/j.gene.2006.06.030; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Shi W, 2011, CANCER RES, V71, P2926, DOI 10.1158/0008-5472.CAN-10-3369; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Sreekumar Rahul, 2011, Frontiers in Genetics, V2, P58, DOI 10.3389/fgene.2011.00058; Sudo T, 2013, ANN SURG ONCOL, V20, pS324, DOI 10.1245/s10434-012-2418-z; Tang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035435; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Waly Raphael S., 2012, ISRN ONCOL, V2012; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435	47	139	149	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4035	4047		10.1074/jbc.M112.410506	http://dx.doi.org/10.1074/jbc.M112.410506			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23212913	hybrid, Green Published			2022-12-28	WOS:000314845000032
J	Li, M; Zhang, Z; Koh, HL; Lu, R; Jiang, ZR; Alioua, A; Garcia-Valdes, J; Stefani, E; Toro, L				Li, Min; Zhang, Zhu; Koh, Huilin; Lu, Rong; Jiang, Zhaorong; Alioua, Abderrahmane; Garcia-Valdes, Jesus; Stefani, Enrico; Toro, Ligia			The beta 1-Subunit of the MaxiK Channel Associates with the Thromboxane A(2) Receptor and Reduces Thromboxane A(2) Functional Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNEL; VASCULAR SMOOTH-MUSCLE; LARGE-CONDUCTANCE; BK CHANNEL; BETA-1 SUBUNIT; BETA(1) SUBUNIT; POTASSIUM CHANNELS; DOWN-REGULATION; HYPERTENSION; ACTIVATION	The large conductance voltage-and Ca2+-activated K+ channel (MaxiK, BKCa, BK) is composed of four pore-forming alpha-subunits and can be associated with regulatory beta-subunits. One of the functional roles of MaxiK is to regulate vascular tone. We recently found that the MaxiK channel from coronary smooth muscle is trans-inhibited by activation of the vasoconstricting thromboxane A(2) prostanoid receptor (TP), a mechanism supported by MaxiK alpha-subunit (MaxiK alpha)-TP physical interaction. Here, we examined the role of the MaxiK beta 1-subunit in TP-MaxiK association. We found that the beta 1-subunit can by itself interact with TP and that this association can occur independently of MaxiK alpha. Subcellular localization analysis revealed that beta 1 and TP are closely associated at the cell periphery. The molecular mechanism of beta 1-TP interaction involves predominantly the beta 1 extracellular loop. As reported previously, TP activation by the thromboxane A(2) analog U46619 caused inhibition of MaxiK alpha macroscopic conductance or fractional open probability (FPo) as a function of voltage. However, the positive shift of the FPo versus voltage curve by U46619 relative to the control was less prominent when beta 1 was coexpressed with TP and MaxiK alpha proteins (20 +/- 6 mV, n = 7) than in cells expressing TP and MaxiK alpha alone (51 +/- 7 mV, n = 7). Finally, beta 1 gene ablation reduced the EC50 of the U46619 agonist in mediating aortic contraction from 18 +/- 1 nM (n = 12) to 9 +/- 1 nM (n = 12). The results indicate that the beta 1-subunit can form a tripartite complex with TP and MaxiK alpha, has the ability to associate with each protein independently, and diminishes U46619-induced MaxiK channel trans-inhibition as well as vasoconstriction.	[Li, Min; Zhang, Zhu; Koh, Huilin; Lu, Rong; Jiang, Zhaorong; Alioua, Abderrahmane; Garcia-Valdes, Jesus; Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Toro, Ligia] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Stefani, Enrico] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Cardiovasc Res Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Stefani, E (corresponding author), Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA.	estefani@ucla.edu			National Institutes of Health [HL096740, HL107418, HL088640]; American Heart Association [0825273F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096740, R01HL107418, R01HL088640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL096740 and HL107418 (to E. S. and L. T.) and HL088640 (to E. S.). This work was also supported by American Heart Association Postdoctoral Fellowship 0825273F (to M. L.).	Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Amberg GC, 2003, CIRC RES, V93, P965, DOI 10.1161/01.RES.0000100068.43006.36; BEZANILLA F, 1994, ANNU REV BIOPH BIOM, V23, P819, DOI 10.1146/annurev.bb.23.060194.004131; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Bukiya AN, 2007, MOL PHARMACOL, V72, P359, DOI 10.1124/mol.107.034330; Bukiya AN, 2009, FEBS LETT, V583, P2779, DOI 10.1016/j.febslet.2009.07.019; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Li M, 2010, P NATL ACAD SCI USA, V107, P19096, DOI 10.1073/pnas.1002685107; Liu GX, 2008, P NATL ACAD SCI USA, V105, P10727, DOI 10.1073/pnas.0805212105; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 1996, FEBS LETT, V382, P84, DOI 10.1016/0014-5793(96)00151-2; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; Nimigean CM, 2000, J GEN PHYSIOL, V115, P719, DOI 10.1085/jgp.115.6.719; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; Wu Y, 2010, BIOPHYS J, V98, P493, DOI 10.1016/j.bpj.2009.10.037; Zhang DM, 2010, CIRC RES, V107, P1454, DOI 10.1161/CIRCRESAHA.110.228361	21	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3668	3677		10.1074/jbc.M112.426585	http://dx.doi.org/10.1074/jbc.M112.426585			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255603	Green Published, hybrid			2022-12-28	WOS:000314397900070
J	Schilling, JD; Machkovech, HM; He, L; Sidhu, R; Fujiwara, H; Weber, K; Ory, DS; Schaffer, JE				Schilling, Joel D.; Machkovech, Heather M.; He, Li; Sidhu, Rohini; Fujiwara, Hideji; Weber, Kassandra; Ory, Daniel S.; Schaffer, Jean E.			Palmitate and Lipopolysaccharide Trigger Synergistic Ceramide Production in Primary Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; MYOCARDIAL-INFARCTION; SPHINGOLIPID HOMEOSTASIS; DIABETIC MOUSE; CELL-DEATH; INFLAMMATION; OBESITY; TLR4; INFLAMMASOMES; BIOSYNTHESIS	Macrophages play a key role in host defense and in tissue repair after injury. Emerging evidence suggests that macrophage dysfunction in states of lipid excess can contribute to the development of insulin resistance and may underlie inflammatory complications of diabetes. Ceramides are sphingolipids that modulate a variety of cellular responses including cell death, autophagy, insulin signaling, and inflammation. In this study we investigated the intersection between TLR4-mediated inflammatory signaling and saturated fatty acids with regard to ceramide generation. Primary macrophages treated with lipopolysaccharide (LPS) did not produce C16 ceramide, whereas palmitate exposure led to a modest increase in this sphingolipid. Strikingly, the combination of LPS and palmitate led to a synergistic increase in C16 ceramide. This response occurred via cross-talk at the level of de novo ceramide synthesis in the ER. The synergistic response required TLR4 signaling via MyD88 and TIR-domain-containing adaptor-inducing interferon beta (TRIF), whereas palmitate-induced ceramide production occurred independent of these inflammatory molecules. This ceramide response augmented IL-1 beta and TNF alpha release, a process that may contribute to the enhanced inflammatory response in metabolic diseases characterized by dyslipidemia.	[Schilling, Joel D.; Machkovech, Heather M.; He, Li; Sidhu, Rohini; Fujiwara, Hideji; Weber, Kassandra; Ory, Daniel S.; Schaffer, Jean E.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Schilling, Joel D.; Machkovech, Heather M.; He, Li; Sidhu, Rohini; Fujiwara, Hideji; Weber, Kassandra; Ory, Daniel S.; Schaffer, Jean E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Schilling, Joel D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Schaffer, JE (corresponding author), Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA.	jschaff@wustl.edu	Sidhu, Rohini/G-3547-2012	Sidhu, Rohini/0000-0003-1703-2167	National Institutes of Health [R01 DK064989, P20 HL113444, K08HL098373, U24 DK076169, P60 DK020579]; Burroughs Wellcome Foundation [1005935]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113444, K08HL098373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, U24DK076169, R01DK064989, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK064989 and P20 HL113444 (to J. E. S.), K08HL098373 (to J. D. S.), U24 DK076169, and P60 DK020579. This work was also supported by Burroughs Wellcome Foundation Grant 1005935 (to J. E. S.).	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Assimacopoulos-Jeannet F, 2004, INT J OBESITY, V28, pS53, DOI 10.1038/sj.ijo.0802857; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cascio G, 2012, CURR DIABETES REV, V8, P2, DOI 10.2174/157339912798829241; Chang ZQ, 2011, PROSTAG OTH LIPID M, V94, P44, DOI 10.1016/j.prostaglandins.2010.12.003; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; CZYZK A, 1980, DIABETES CARE, V3, P526, DOI 10.2337/diacare.3.4.526; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Greer JJM, 2006, AM J PHYSIOL-HEART C, V290, pH146, DOI 10.1152/ajpheart.00583.2005; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Kaisho T, 2000, CRIT REV IMMUNOL, V20, P393; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Olson NC, 2012, J CLIN ENDOCR METAB, V97, P1032, DOI 10.1210/jc.2011-2155; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Rosen DA, 2008, INFECT IMMUN, V76, P4290, DOI 10.1128/IAI.00255-08; Rutti MF, 2009, J LIPID RES, V50, P1237, DOI 10.1194/jlr.D900001-JLR200; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Silke J, 2011, CURR OPIN IMMUNOL, V23, P620, DOI 10.1016/j.coi.2011.08.002; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Weatherill AR, 2005, J IMMUNOL, V174, P5390, DOI 10.4049/jimmunol.174.9.5390; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022	43	108	110	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2923	2932		10.1074/jbc.M112.419978	http://dx.doi.org/10.1074/jbc.M112.419978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250746	hybrid, Green Published			2022-12-28	WOS:000314397900003
J	Vishnivetskiy, SA; Chen, QY; Palazzo, MC; Brooks, EK; Altenbach, C; Iverson, TM; Hubbell, WL; Gurevich, VV				Vishnivetskiy, Sergey A.; Chen, Qiuyan; Palazzo, Maria C.; Brooks, Evan K.; Altenbach, Christian; Iverson, Tina M.; Hubbell, Wayne L.; Gurevich, Vsevolod V.			Engineering Visual Arrestin-1 with Special Functional Characteristics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; BETA-ARRESTIN; PHOSPHORYLATION-RECOGNITION; NONVISUAL ARRESTINS; RHODOPSIN KINASE; CONE ARRESTIN; RETINAL RODS; GENE-THERAPY; BINDING	Arrestin-1 preferentially binds active phosphorylated rhodopsin. Previously, a mutant with enhanced binding to unphosphorylated active rhodopsin (Rh*) was shown to partially compensate for lack of rhodopsin phosphorylation in vivo. Here we showed that reengineering of the receptor binding surface of arrestin-1 further improves the binding to Rh* while preserving protein stability. In mammals, arrestin-1 readily self-associates at physiological concentrations. The biological role of this phenomenon can only be elucidated by replacing wild type arrestin-1 in living animals with a non-oligomerizing mutant retaining all other functions. We demonstrate that constitutively monomeric forms of arrestin-1 are sufficiently stable for in vivo expression. We also tested the idea that individual functions of arrestin-1 can be independently manipulated to generate mutants with the desired combinations of functional characteristics. Here we showed that this approach is feasible; stable forms of arrestin-1 with high Rh* binding can be generated with or without the ability to self-associate. These novel molecular tools open the possibility of testing of the biological role of arrestin-1 self-association and pave the way to elucidation of full potential of compensational approach to gene therapy of gain-of-function receptor mutations.	[Vishnivetskiy, Sergey A.; Chen, Qiuyan; Palazzo, Maria C.; Iverson, Tina M.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Brooks, Evan K.; Altenbach, Christian; Hubbell, Wayne L.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	Vanderbilt University; University of California System; University of California Los Angeles	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Gurevich, Vsevolod/A-3236-2008; Vishnivetskiy, Sergey/AAJ-8661-2020	Gurevich, Vsevolod/0000-0002-3950-5351; Kraemer, Maria/0000-0002-1806-5641	National Institutes of Health [EY011500, GM077561, GM081756, EY05216, GM079419, GM095633]; Jules Stein Professorship Endowment; NATIONAL EYE INSTITUTE [R01EY011500, R37EY005216, R01EY005216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R01GM079419, R01GM077561, R01GM095633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jules Stein Professorship Endowment; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY011500, GM077561, and GM081756 (to V. V. G.), and EY05216 (to W. L. H.), and GM079419 and GM095633 (to T. M. I.). This work was also supported by and the Jules Stein Professorship Endowment (to W. L. H.).	APFELSTEDTSYLLA E, 1993, BRIT J OPHTHALMOL, V77, P495, DOI 10.1136/bjo.77.8.495; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Caruso G, 2011, P NATL ACAD SCI USA, V108, P7804, DOI 10.1073/pnas.1018960108; Caruso G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001031; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Celver JP, 2001, J BIOL CHEM, V276, P4894, DOI 10.1074/jbc.M007437200; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Coffa S, 2011, BIOCHEMISTRY-US, V50, P6951, DOI 10.1021/bi200745k; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Gross OP, 2010, J NEUROSCI, V30, P3450, DOI 10.1523/JNEUROSCI.5391-09.2010; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich V. V., 1995, J BIOL CHEM, V270, ps731; Gurevich VV, 2008, MOL PHARMACOL, V74, P312, DOI 10.1124/mol.108.049015; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2012, CELL SIGNAL, V24, P1899, DOI 10.1016/j.cellsig.2012.05.012; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2008, STRUCTURE, V16, P924, DOI 10.1016/j.str.2008.03.006; Hanson SM, 2008, BIOCHEMISTRY-US, V47, P1070, DOI 10.1021/bi7021359; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Imamoto Y, 2003, BIOPHYS J, V85, P1186, DOI 10.1016/S0006-3495(03)74554-8; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim M, 2011, BIOCHEMISTRY-US, V50, P2235, DOI 10.1021/bi1018607; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; RIM J, 1995, BIOCHEMISTRY-US, V34, P11938, DOI 10.1021/bi00037a035; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schubert C, 1999, J BIOL CHEM, V274, P21186, DOI 10.1074/jbc.274.30.21186; Seo J, 2011, J BIOL CHEM, V286, P27894, DOI 10.1074/jbc.M111.260448; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	70	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3394	3405		10.1074/jbc.M112.445437	http://dx.doi.org/10.1074/jbc.M112.445437			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23250748	Green Published, hybrid			2022-12-28	WOS:000314397900044
J	Bosch, DE; Siderovski, DP				Bosch, Dustin E.; Siderovski, David P.			Structural Determinants of Ubiquitin Conjugation in Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; INSIGHTS; COMPLEX; ENZYME; DOMAIN; ACTIVATION; PROTEINS; FEATURES; SYSTEM; LIGASE	Ubiquitination is important for numerous cellular processes in most eukaryotic organisms, including cellular proliferation, development, and protein turnover by the proteasome. The intestinal parasite Entamoeba histolytica harbors an extensive ubiquitin-proteasome system. Proteasome inhibitors are known to impair parasite proliferation and encystation, suggesting the ubiquitin-proteasome pathway as a viable therapeutic target. However, no functional studies of the E. histolytica ubiquitination enzymes have yet emerged. Here, we have cloned and characterized multiple E. histolytica ubiquitination components, spanning ubiquitin and its activating (E1), conjugating (E2), and ligating (E3) enzymes. Crystal structures of EhUbiquitin reveal a clustering of unique residues on the alpha 1 helix surface, including an eighth surface lysine not found in other organisms, which may allow for a unique polyubiquitin linkage in E. histolytica. EhUbiquitin is activated by and forms a thioester bond with EhUba1( E1) in vitro, in an ATP- and magnesium-dependent fashion. EhUba1 exhibits a greater maximal initial velocity of pyrophosphate: ATP exchange than its human homolog, suggesting different kinetics of ubiquitin activation in E. histolytica. EhUba1 engages the E2 enzyme EhUbc5 through its ubiquitin-fold domain to transfer the EhUbiquitin thioester. However, EhUbc5 has a >10-fold preference for EhUba1 similar to Ub compared with unconjugated EhUba1. A crystal structure of EhUbc5 allowed prediction of a noncovalent "backside" interaction with EhUbiquitin and E3 enzymes. EhUbc5 selectively engages EhRING1 (E3) to the exclusion of two HECT family E3 ligases, and mutagenesis indicates a conserved mode of E2/RING-E3 interaction in E. histolytica.	[Bosch, Dustin E.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Siderovski, David P.] W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA	University of North Carolina; University of North Carolina Chapel Hill; West Virginia University	Siderovski, DP (corresponding author), W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Robert C Byrd Hlth Sci Ctr, 3051A Hlth Sci N,POB 9229, Morgantown, WV 26506 USA.	dpsiderovski@hsc.wvu.edu	, PEP-MX Core/AGV-4051-2022; Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Bosch, Dustin/0000-0002-7430-2939	National Institutes of Health [R01 GM082892]; independent F30 NRSA National Institutes of Health, NIDDK [DK091978]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); independent F30 NRSA National Institutes of Health, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM082892 (to D. P. S.).; Supported by independent F30 NRSA National Institutes of Health, NIDDK Grant DK091978.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arya S, 2012, PARASITOL RES, V111, P37, DOI 10.1007/s00436-011-2799-0; Bosanac I, 2011, J MOL BIOL, V408, P420, DOI 10.1016/j.jmb.2011.03.011; Bosch DE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003040; Bosch DE, 2011, J BIOL CHEM, V286, P39236, DOI 10.1074/jbc.M111.253898; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Burroughs AM, 2012, METHODS MOL BIOL, V832, P15, DOI 10.1007/978-1-61779-474-2_2; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Edelmann MJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002031; Emmerich CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002187; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gilchrist CA, 2006, MOL BIOCHEM PARASIT, V147, P163, DOI 10.1016/j.molbiopara.2006.02.007; HAAS AL, 1982, J BIOL CHEM, V257, P329; Haque R, 2003, NEW ENGL J MED, V348, P1565, DOI 10.1056/NEJMra022710; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Kimple AJ, 2010, METHODS MOL BIOL, V627, P91, DOI 10.1007/978-1-60761-670-2_5; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Makioka A, 2002, PARASITOL RES, V88, P454, DOI 10.1007/s00436-002-0601-z; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Stoll KE, 2011, J BIOL CHEM, V286, P15165, DOI 10.1074/jbc.M110.203968; WOSTMANN C, 1992, FEBS LETT, V308, P54, DOI 10.1016/0014-5793(92)81049-R; Wostmann C, 1996, MOL BIOCHEM PARASIT, V82, P81, DOI 10.1016/0166-6851(96)02725-9; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605	43	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2290	2302		10.1074/jbc.M112.417337	http://dx.doi.org/10.1074/jbc.M112.417337			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23209297	Green Published, hybrid			2022-12-28	WOS:000314211500019
J	Ephstein, Y; Singleton, PA; Chen, WG; Wang, LC; Salgia, R; Kanteti, P; Dudek, SM; Garcia, JGN; Jacobson, JR				Ephstein, Yulia; Singleton, Patrick A.; Chen, Weiguo; Wang, Lichun; Salgia, Ravi; Kanteti, Prasad; Dudek, Steven M.; Garcia, Joe G. N.; Jacobson, Jeffrey R.			Critical Role of S1PR1 and Integrin beta 4 in HGF/c-Met-mediated Increases in Vascular Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL BARRIER ENHANCEMENT; GROWTH-FACTOR RECEPTOR; SPHINGOSINE 1-PHOSPHATE; MICROVASCULAR PERMEABILITY; CYTOSKELETAL REARRANGEMENT; ALPHA(6)BETA(4) INTEGRIN; ALPHA-6-BETA-4 INTEGRIN; S1P(1) RECEPTOR; CELL-ADHESION; C-MET	Vascular endothelial cell (EC) barrier integrity is critical to vessel homeostasis whereas barrier dysfunction is a key feature of inflammatory disorders and tumor angiogenesis. We previously reported that hepatocyte growth factor (HGF)-mediated increases in EC barrier integrity are signaled through a dynamic complex present in lipid rafts involving its receptor, c-Met (1). We extended these observations to confirm that S1PR1 (sphingosine 1-phosphate receptor 1) and integrin beta 4 (ITGB4) are essential participants in HGF-induced EC barrier enhancement. Immunoprecipitation experiments demonstrated HGF-mediated recruitment of c-Met, ITGB4 and S1PR1 to caveolin-enriched lipid rafts in human lung EC with direct interactions of c-Met with both S1PR1 and ITGB4 accompanied by c-Met-dependent S1PR1 and ITGB4 transactivation. Reduced S1PR1 expression (siRNA) attenuated both ITGB4 and Rac1 activation as well as c-Met/ITGB4 interaction and resulted in decreased transendothelial electrical resistance. Furthermore, reduced ITGB4 expression attenuated HGF-induced c-Met activation, c-Met/S1PR1 interaction, and effected decreases in S1P- and HGF-induced EC barrier enhancement. Finally, the c-Met inhibitor, XL880, suppressed HGF-induced c-Met activation as well as S1PR1 and ITGB4 transactivation. These results support a critical role for S1PR1 and ITGB4 transactivation as rate-limiting events in the transduction of HGF signals via a dynamic c-Met complex resulting in enhanced EC barrier integrity.	[Ephstein, Yulia; Chen, Weiguo; Wang, Lichun; Kanteti, Prasad; Dudek, Steven M.; Garcia, Joe G. N.; Jacobson, Jeffrey R.] Univ Illinois, Sect Pulm Crit Care Sleep & Allergy, Inst Personalized Resp Med, Chicago, IL 60612 USA; [Singleton, Patrick A.; Salgia, Ravi] Univ Illinois, Med Ctr, Dept Med, Chicago, IL 60603 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Jacobson, JR (corresponding author), Univ Illinois, Sect Pulm Crit Care Sleep & Allergy, Inst Personalized Resp Med, 840 S Wood St, Chicago, IL 60612 USA.	jrjacob@uic.edu	wang, lichun/D-3969-2013		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064, R01HL095723, R01HL096887] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL096887, R01 HL095723, P01 HL058064, P01 HL126609] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdel-Ghany M, 2002, J BIOL CHEM, V277, P34391, DOI 10.1074/jbc.M205307200; Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Becker PM, 2001, AM J PHYSIOL-LUNG C, V281, pL1500, DOI 10.1152/ajplung.2001.281.6.L1500; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chen WG, 2008, AM J PHYSIOL-LUNG C, V295, pL575, DOI 10.1152/ajplung.00428.2007; Chen WG, 2012, AM J PHYSIOL-LUNG C, V303, pL279, DOI 10.1152/ajplung.00361.2011; Chen WG, 2010, J CELL BIOCHEM, V110, P718, DOI 10.1002/jcb.22582; Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Duan HF, 2004, EXP CELL RES, V298, P593, DOI 10.1016/j.yexcr.2004.04.049; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; Dudek SM, 2010, MOL BIOL CELL, V21, P4042, DOI 10.1091/mbc.E09-10-0876; Echarri A, 2006, CELL CYCLE, V5, P2179, DOI 10.4161/cc.5.19.3264; Eder JP, 2010, CLIN CANCER RES, V16, P3507, DOI 10.1158/1078-0432.CCR-10-0574; Endo A, 2002, J BIOL CHEM, V277, P23747, DOI 10.1074/jbc.M111794200; Finigan JH, 2009, AM J PHYSIOL-LUNG C, V296, pL1002, DOI 10.1152/ajplung.90555.2008; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; Gagnoux-Palacios L, 2003, J CELL BIOL, V162, P1189, DOI 10.1083/jcb.200305006; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Giancotti FG, 2007, TRENDS PHARMACOL SCI, V28, P506, DOI 10.1016/j.tips.2007.08.004; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Jacobson JR, 2007, CURR DRUG TARGETS, V8, P509, DOI 10.2174/138945007780362719; Jacobson JR, 2006, AM J PHYSIOL-LUNG C, V291, pL289, DOI 10.1152/ajplung.00343.2005; Jacobson JR, 2004, AM J RESP CELL MOL, V30, P662, DOI 10.1165/rcmb.2003-0267OC; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Kolosova IA, 2008, AM J PHYSIOL-LUNG C, V294, pL319, DOI 10.1152/ajplung.00283.2007; Lebman DA, 2008, J LIPID RES, V49, P1388, DOI 10.1194/jlr.R800008-JLR200; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; MAINIERO F, 1995, EMBO J, V14, P4470, DOI 10.1002/j.1460-2075.1995.tb00126.x; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Murgia C, 1998, EMBO J, V17, P3940, DOI 10.1093/emboj/17.14.3940; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Qian F, 2009, CANCER RES, V69, P8009, DOI 10.1158/0008-5472.CAN-08-4889; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Singleton PA, 2004, EXP CELL RES, V295, P102, DOI 10.1016/j.yexcr.2003.12.025; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Singleton PA, 2010, AM J PHYSIOL-LUNG C, V299, pL639, DOI 10.1152/ajplung.00405.2009; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tanimoto T, 2002, J BIOL CHEM, V277, P42997, DOI 10.1074/jbc.M204764200; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Zhao J, 2009, CELL SIGNAL, V21, P1945, DOI 10.1016/j.cellsig.2009.09.002	52	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2191	2200		10.1074/jbc.M112.404780	http://dx.doi.org/10.1074/jbc.M112.404780			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23212923	Green Published, hybrid			2022-12-28	WOS:000314211500010
J	Tohmonda, T; Yoda, M; Mizuochi, H; Morioka, H; Matsumoto, M; Urano, F; Toyama, Y; Horiuchi, K				Tohmonda, Takahide; Yoda, Masaki; Mizuochi, Hiroshi; Morioka, Hideo; Matsumoto, Morio; Urano, Fumihiko; Toyama, Yoshiaki; Horiuchi, Keisuke			The IRE1 alpha-XBP1 Pathway Positively Regulates Parathyroid Hormone (PTH)/PTH-related Peptide Receptor Expression and Is Involved in PTH-induced Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; ER STRESS; TRANSCRIPTION; ACTIVATION; KINASE; DECISIONS; OSTERIX	To address the "endoplasmic reticulum stress" triggered by the burden of protein synthesis, the unfolded protein response is induced during osteoblast differentiation. In this study, we show that the transcription of parathyroid hormone (PTH)/PTH-related peptide receptor (PTH1R) is regulated by one of the endoplasmic reticulum-stress mediators, the IRE1 alpha-XBP1 pathway, in osteoblasts. We found that the increase in Pth1r transcription upon BMP2 treatment is significantly suppressed in mouse embryonic fibroblasts lacking IRE1 alpha. As expected, gene silencing of Ire1 alpha and Xbp1 resulted in a decrease in Pth1r transcripts in BMP2-treated embryonic fibroblasts. We identified two potential binding sites for XBP1 in the promoter region of Pth1r and found that XBP1 promotes the transcription of Pth1r by directly binding to those sites. Moreover, we confirmed that the gene silencing of Xbp1 suppresses PTH-induced Rankl expression in primary osteoblasts and thereby abolishes osteoclast formation in an in vitro model of osteoclastogenesis. Thus, the present study reveals potential involvement of the IRE1 alpha-XBP1 pathway in PTH-induced osteoclastogenesis through the regulation of PTH1R expression.	[Tohmonda, Takahide; Yoda, Masaki; Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Antiaging Orthoped Res, Tokyo 1608582, Japan; [Horiuchi, Keisuke] Keio Univ, Dept Orthoped Surg, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Urano, Fumihiko] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Med, St Louis, MO 63110 USA	Keio University; Keio University; Washington University (WUSTL)	Horiuchi, K (corresponding author), Keio Univ, Dept Orthoped Surg, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	horiuchi@z3.keio.jp	Matsumoto, Morio M/L-6227-2013; Urano, Fumihiko/AAF-4492-2020; Horiuchi, Keisuke/L-2277-2013; Toyama, Yoshiaki/K-5743-2013	Horiuchi, Keisuke/0000-0001-7063-9609; 	Keio University; MEXT KAKENHI [24390358, 24791566]	Keio University; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Keio University Kanrinmaru Project (to K. H.) and MEXT KAKENHI Grants 24390358 (to K. H.) and 24791566 (to T. T.).	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; McCauley LK, 2012, J BONE MINER RES, V27, P1231, DOI 10.1002/jbmr.1617; MCCUAIG KA, 1995, NUCLEIC ACIDS RES, V23, P1948, DOI 10.1093/nar/23.11.1948; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Oikawa D, 2010, FEBS LETT, V584, P1066, DOI 10.1016/j.febslet.2010.02.012; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Reimold AM, 2000, GENE DEV, V14, P152; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Tohmonda T, 2011, EMBO REP, V12, P451, DOI 10.1038/embor.2011.34; Urano F, 2000, J CELL SCI, V113, P3697; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	26	13	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1691	1695		10.1074/jbc.C112.424606	http://dx.doi.org/10.1074/jbc.C112.424606			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23235147	Green Published, hybrid			2022-12-28	WOS:000313751400025
J	Zhu, YY; Massen, S; Terenzio, M; Lang, V; Chen-Lindner, S; Eils, R; Novak, I; Dikic, I; Hamacher-Brady, A; Brady, NR				Zhu, Yanyan; Massen, Stefan; Terenzio, Marco; Lang, Verena; Chen-Lindner, Silu; Eils, Roland; Novak, Ivana; Dikic, Ivan; Hamacher-Brady, Anne; Brady, Nathan R.			Modulation of Serines 17 and 24 in the LC3-interacting Region of Bnip3 Determines Pro-survival Mitophagy versus Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; BCL-X-L; BH3 DOMAIN; CELL-DEATH; ENDOPLASMIC-RETICULUM; INDUCED AUTOPHAGY; PROTEIN BNIP3; OKADAIC ACID; NIX; PHOSPHORYLATION	BH3-only proteins integrate apoptosis and autophagy pathways, yet regulation and functional consequences of pathway cross-talk are not fully resolved. The BH3-only protein Bnip3 is an autophagy receptor that signals autophagic degradation of mitochondria (mitophagy) via interaction of its LC3-interacting region (LIR) with Atg8 proteins. Here we report that phosphorylation of serine residues 17 and 24 flanking the Bnip3 LIR promotes binding to specific Atg8 members LC3B and GATE-16. Using quantitative multispectral image-based flow cytometry, we demonstrate that enhancing Bnip3-Atg8 interactions via phosphorylation-mimicked LIR mutations increased mitochondrial sequestration, lysosomal delivery, and degradation. Importantly, mitochondria were targeted by mitophagy prior to cytochrome c release, resulting in reduced cellular cytochrome c release capacity. Intriguingly, pro-survival Bcl-xL positively regulated Bnip3 binding to LC3B, sequestration, and mitochondrial autophagy, further supporting an anti-apoptotic role for Bnip3-induced mitophagy. The ensemble of these results demonstrates that the phosphorylation state of the Bnip3 LIR signals either the induction of apoptosis or pro-survival mitophagy.	[Eils, Roland; Hamacher-Brady, Anne] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Zhu, Yanyan; Terenzio, Marco; Chen-Lindner, Silu; Brady, Nathan R.] Heidelberg Univ, Fac Med, Dept Surg, D-69120 Heidelberg, Germany; [Novak, Ivana] Univ Split, Sch Med, HR-21000 Split, Croatia; [Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, D-60590 Frankfurt, Germany; [Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Split; Goethe University Frankfurt; Goethe University Frankfurt	Hamacher-Brady, A (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Neuenheimer Feld 267, D-69120 Heidelberg, Germany.	a.brady@dkfz.de; n.brady@dkfz.de	Dikic, Ivan/O-4650-2015; Brady, Nathan/H-2452-2013; Eils, Roland/B-6121-2009; Hamacher-Brady, Anne/G-4268-2013; Novak, Ivana/D-4852-2017	Dikic, Ivan/0000-0001-8156-9511; Eils, Roland/0000-0002-0034-4036; Novak, Ivana/0000-0003-0682-7052; Hamacher-Brady, Anne/0000-0001-5042-1338; Terenzio, Marco/0000-0002-4480-5746; Brady, Nathan/0000-0002-1901-5996	SBCancer within the Helmholtz Alliance on Systems Biology; Initiative and Networking Fund of the Helmholtz Association; MedSys Project Multi-Scale Models [FKZ 0315416C]; FORSYS-ViroQuant [0313923]; e:Bio [0316191]; Federal Ministry of Education and Research (BMBF), Germany	SBCancer within the Helmholtz Alliance on Systems Biology; Initiative and Networking Fund of the Helmholtz Association; MedSys Project Multi-Scale Models; FORSYS-ViroQuant; e:Bio; Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	This work was supported through SBCancer within the Helmholtz Alliance on Systems Biology funded by the Initiative and Networking Fund of the Helmholtz Association and through the MedSys Project Multi-Scale Models (FKZ 0315416C), FORSYS-ViroQuant (0313923), and e:Bio (0316191) funded by the Federal Ministry of Education and Research (BMBF), Germany.	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Betin VMS, 2009, J CELL SCI, V122, P2554, DOI 10.1242/jcs.046250; Brady NR, 2007, FEBS J, V274, P3184, DOI 10.1111/j.1742-4658.2007.05849.x; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Chen Y, 2010, P NATL ACAD SCI USA, V107, P9035, DOI 10.1073/pnas.0914013107; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Graham RM, 2007, ANTIOXID REDOX SIGN, V9, P1309, DOI 10.1089/ars.2007.1726; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, AUTOPHAGY, V2, P307, DOI 10.4161/auto.2947; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; HOLEN I, 1993, EUR J BIOCHEM, V215, P113, DOI 10.1111/j.1432-1033.1993.tb18013.x; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kwon KY, 2011, BIOCHEM BIOPH RES CO, V416, P343, DOI 10.1016/j.bbrc.2011.11.038; Leo C, 2006, INT J GYNECOL CANCER, V16, P1314, DOI 10.1111/j.1525-1438.2006.00394.x; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Morishima N, 2004, J BIOL CHEM, V279, P50375, DOI 10.1074/jbc.M408493200; NAKANISHI S, 1986, J ANTIBIOT, V39, P1066; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Tan EY, 2007, CLIN CANCER RES, V13, P467, DOI 10.1158/1078-0432.CCR-06-1466; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yasuda M, 1998, J BIOL CHEM, V273, P12415, DOI 10.1074/jbc.273.20.12415; Yasuda M, 1999, CANCER RES, V59, P533; Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28; Yoon SY, 2008, J NEUROSCI RES, V86, P3230, DOI 10.1002/jnr.21760; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16	57	265	287	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1099	1113		10.1074/jbc.M112.399345	http://dx.doi.org/10.1074/jbc.M112.399345			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23209295	Green Published, hybrid			2022-12-28	WOS:000313570300033
J	Selvakumar, D; Drescher, MJ; Drescher, DG				Selvakumar, Dakshnamurthy; Drescher, Marian J.; Drescher, Dennis G.			Cyclic Nucleotide-gated Channel alpha-3 (CNGA3) Interacts with Stereocilia Tip-Link Cadherin 23 plus Exon 68 or Alternatively with Myosin VIIa, Two Proteins Required for Hair Cell Mechanotransduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							USHER-SYNDROME PROTEINS; BINDING PROTEINS; DEAFNESS DFNB12; MOLECULAR-BASIS; MUTATIONS; HARMONIN; CDH23; TRANSDUCTION; EXPRESSION; HEARING	Previously, we obtained evidence for a photoreceptor/olfactory type of CNGA3 transcript in a purified teleost vestibular hair cell preparation with immunolocalization of CNGA3 protein to stereocilia of teleost vestibular and mammalian cochlear hair cells. The carboxyl terminus of highly Ca2+-permeable CNGA3 expressed in the mammalian organ of Corti and saccular hair cells was found to interact with an intracellular domain of microfibril interface-located protein 1 (EMILIN 1), a member of the elastin superfamily, also immunolocalizd to hair cell stereocilia (Selvakumar, D., Drescher, M. J., Dowdall, J. R., Khan, K. M., Hatfield, J. S., Ramakrishnan, N. A., and Drescher, D. G. (2012) Biochem. J. 443, 463-476). Here, we provide evidence for organ of Corti proteins, of Ca2+-dependent binding of the amino terminus of CNGA3 specifically to the carboxyl terminus of stereocilia tip-link protein CDH23 +68 (cadherin 23 with expressed exon 68) by yeast two-hybrid mating and co-transformation protocols, pulldown assays, and surface plasmon resonance analysis. Myosin VIIa, required for adaptation of hair cell mechanotransduction (MET) channel(s), competed with CDH23 +68, with direct Ca2+-dependent binding to the amino terminus of CNGA3. Based upon the premise that hair cell stereocilia tip-link proteins are closely coupled with MET, these results are consistent with the possibility that CNGA3 participates in hair-cell MET. Together with the demonstration of protein-protein interaction between HCN1 and tip-link protein protocadherin 15 CD3 (Ramakrishnan, N. A., Drescher, M. J., Barretto, R. L., Beisel, K. W., Hatfield, J. S., and Drescher, D. G. (2009) J. Biol. Chem. 284, 3227-3238; Ramakrishnan, N. A., Drescher, M. J., Khan, K. M., Hatfield, J. S., and Drescher, D. G. (2012) J. Biol. Chem. 287, 37628-37646), a protein-protein interaction for CNGA3 and a second tip-link protein, CDH23 +68, further suggests possible association of two different channels with a single stereocilia tip link.	[Selvakumar, Dakshnamurthy; Drescher, Marian J.; Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Otolaryngol, Lab Biootol, Detroit, MI 48201 USA; [Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Drescher, MJ (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol, Lab Biootol, 261 Lande Med Res Bldg,540 East Canfield Ave, Detroit, MI 48201 USA.	mdresche@med.wayne.edu			National Institutes of Health [R01 DC004076, R01 DC000156]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004076, R01DC000156, P30DC005188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DC004076 (to M. J. D.) and R01 DC000156 (to D. G. D.).	Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; Bahloul A, 2010, HUM MOL GENET, V19, P3557, DOI 10.1093/hmg/ddq271; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Biel M, 2009, J BIOL CHEM, V284, P9017, DOI 10.1074/jbc.R800075200; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Bright SR, 2007, MOL PHARMACOL, V71, P176, DOI 10.1124/mol.106.026401; Corey D, 2003, J CELL SCI, V116, P1, DOI 10.1242/jcs.00101; de Brouwer APM, 2003, HUM GENET, V112, P156, DOI 10.1007/s00439-002-0833-0; Di Palma F, 2001, GENE, V281, P31, DOI 10.1016/S0378-1119(01)00761-2; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Drescher M. J., 2001, ASS RES OT ABSTR, V24, P40; Drescher MJ, 2002, MOL BRAIN RES, V98, P1, DOI 10.1016/S0169-328X(01)00289-3; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Fettiplace R, 2009, PFLUG ARCH EUR J PHY, V458, P1115, DOI 10.1007/s00424-009-0683-x; Frolenkov G., 2012, ASS RES OT ABSTR, V35, P204; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Hudspeth AJ, 1997, NEURON, V19, P947, DOI 10.1016/S0896-6273(00)80385-2; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Meyer MR, 2000, P NATL ACAD SCI USA, V97, P10595, DOI 10.1073/pnas.97.19.10595; Nishiguchi KM, 2005, HUM MUTAT, V25, P248, DOI 10.1002/humu.20142; Oh CK, 1999, MOL BRAIN RES, V70, P135, DOI 10.1016/S0169-328X(99)00110-2; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Peng CH, 2003, J BIOL CHEM, V278, P24617, DOI 10.1074/jbc.M301699200; Ramakrishnan NA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375832; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P3227, DOI 10.1074/jbc.M806177200; Reuter P, 2008, HUM MUTAT, V29, P1228, DOI 10.1002/humu.20790; Ricci AJ, 2006, J MEMBRANE BIOL, V209, P71, DOI 10.1007/s00232-005-0834-8; Schultz JM, 2011, J MED GENET, V48, P767, DOI 10.1136/jmedgenet-2011-100262; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Selvakumar D, 2012, BIOCHEM J, V443, P463, DOI 10.1042/BJ20111255; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Sengupta S, 2009, J BIOL CHEM, V284, P20121, DOI 10.1074/jbc.M109.025668; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Spessotto P, 2003, J BIOL CHEM, V278, P6160, DOI 10.1074/jbc.M208322200; Sul B, 2010, BIOPHYS J, V99, P1027, DOI 10.1016/j.bpj.2010.05.029; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; van Netten SM, 2009, PFLUG ARCH EUR J PHY, V458, P273, DOI 10.1007/s00424-008-0617-z; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Wang X, 2011, HUM MUTAT, V32, P1450, DOI 10.1002/humu.21587; Xu ZG, 2008, J NEUROSCI, V28, P11269, DOI 10.1523/JNEUROSCI.3833-08.2008; Xu ZG, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-80; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhao YD, 1996, P NATL ACAD SCI USA, V93, P15469, DOI 10.1073/pnas.93.26.15469; Zheng LL, 2010, J NEUROSCI, V30, P7187, DOI 10.1523/JNEUROSCI.0852-10.2010; Zhou Y, 2006, PROTEINS, V65, P643, DOI 10.1002/prot.21139	57	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7215	7229		10.1074/jbc.M112.443226	http://dx.doi.org/10.1074/jbc.M112.443226			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329832	Green Published, hybrid			2022-12-28	WOS:000316002400042
J	Luechapanichkul, R; Chen, XW; Taha, HA; Vyas, S; Guan, XY; Freitas, MA; Hadad, CM; Pei, DH				Luechapanichkul, Rinrada; Chen, Xianwen; Taha, Hashem A.; Vyas, Shubham; Guan, Xiaoyan; Freitas, Michael A.; Hadad, Christopher M.; Pei, Dehua			Specificity Profiling of Dual Specificity Phosphatase Vaccinia VH1-related (VHR) Reveals Two Distinct Substrate Binding Modes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; PHOSPHOTYROSINE-CONTAINING PEPTIDES; POTENTIAL FUNCTIONS; LIQUID WATER; ACTIVATION; APOPTOSIS; ERK; JNK; DEPHOSPHORYLATION; IDENTIFICATION	Vaccinia VH1-related (VHR) is a dual specificity phosphatase that consists of only a single catalytic domain. Although several protein substrates have been identified for VHR, the elements that control the in vivo substrate specificity of this enzyme remain unclear. In this work, the in vitro substrate specificity of VHR was systematically profiled by screening combinatorial peptide libraries. VHR exhibits more stringent substrate specificity than classical protein-tyrosine phosphatases and recognizes two distinct classes of Tyr(P) peptides. The class I substrates are similar to the Tyr(P) motifs derived from the VHR protein substrates, having sequences of (D/E/phi)(D/S/N/T/E)(P/I/M/S/A/V) pY(G/A/S/Q) or (D/E/phi)(T/S)(D/E) pY(G/A/S/Q) (where phi is a hydrophobic amino acid and pY is phosphotyrosine). The class II substrates have the consensus sequence of (V/A) P(I/L/M/V/F)X(1-6)pY (where X is any amino acid) with V/A preferably at the N terminus of the peptide. Site-directed mutagenesis and molecular modeling studies suggest that the class II peptides bind to VHR in an opposite orientation relative to the canonical binding mode of the class I substrates. In this alternative binding mode, the Tyr(P) side chain binds to the active site pocket, but the N terminus of the peptide interacts with the carboxylate side chain of Asp(164), which normally interacts with the Tyr(P) + 3 residue of a class I substrate. Proteins containing the class II motifs are efficient VHR substrates in vitro, suggesting that VHR may act on a novel class of yet unidentified Tyr(P) proteins in vivo.	[Luechapanichkul, Rinrada; Chen, Xianwen; Taha, Hashem A.; Vyas, Shubham; Guan, Xiaoyan; Hadad, Christopher M.; Pei, Dehua] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Freitas, Michael A.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Sch Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Pei, DH (corresponding author), Ohio State Univ, Dept Chem & Biochem, 484 W 12th Ave, Columbus, OH 43210 USA.	pei.3@osu.edu	Freitas, Michael/C-8953-2009; Guan, Xiaoyan/O-9369-2014; Pei, Dehua/P-4594-2016; Guan, Xiaoyan/I-7500-2015	Freitas, Michael/0000-0002-3103-8410; Pei, Dehua/0000-0002-2057-6934; Hadad, Christopher/0000-0003-1211-4315	National Institutes of Health [CA132855, GM062820, 2-U54-NS058183]; Defense Threat Reduction Agency [HDTRA1-11-1-0042]; Ohio Supercomputer Center; Minister of Science and Technology, Thailand; NATIONAL CANCER INSTITUTE [R01CA132855] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311, R01GM062820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS058183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Ohio Supercomputer Center; Minister of Science and Technology, Thailand; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132855, GM062820, and 2-U54-NS058183. This work was also supported by Defense Threat Reduction Agency Grant HDTRA1-11-1-0042 and the Ohio Supercomputer Center.; Supported by a predoctoral fellowship from the Minister of Science and Technology, Thailand.	Alonso, 2010, EMERGING SIGNALING P, P185; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2003, NAT IMMUNOL, V4, P44, DOI 10.1038/ni856; Alonso A, 2001, J BIOL CHEM, V276, P4766, DOI 10.1074/jbc.M006497200; Arnoldussen YJ, 2008, CANCER RES, V68, P9255, DOI 10.1158/0008-5472.CAN-08-1224; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Chen XW, 2010, J BIOL CHEM, V285, P31268, DOI 10.1074/jbc.M110.114181; DENU JM, 1995, J BIOL CHEM, V270, P3796, DOI 10.1074/jbc.270.8.3796; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fogolari F, 2003, BIOPHYS J, V85, P159, DOI 10.1016/S0006-3495(03)74462-2; Garaud M, 2007, J AM CHEM SOC, V129, P5366, DOI 10.1021/ja071275i; Gopishetty B, 2008, ORG LETT, V10, P4605, DOI 10.1021/ol801868a; Hao L, 2007, INT J CANCER, V121, P39, DOI 10.1002/ijc.22597; Hegde R, 2003, J BIOL CHEM, V278, P38699, DOI 10.1074/jbc.M303179200; Henkens R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-147; Hoyt R, 2007, J IMMUNOL, V179, P3402, DOI 10.4049/jimmunol.179.6.3402; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; Jardin C, 2012, J BIOMOL STRUCT DYN, V29, P777, DOI 10.1080/07391102.2012.10507413; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang TH, 2006, NAT CELL BIOL, V8, P863, DOI 10.1038/ncb1447; Li SW, 2007, ANGEW CHEM INT EDIT, V46, P4751, DOI 10.1002/anie.200700633; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; Schumacher MA, 2002, BIOCHEMISTRY-US, V41, P3009, DOI 10.1021/bi015799l; Sigalov G, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1857811; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Thakkar A, 2006, ANAL CHEM, V78, P5935, DOI 10.1021/ac0607414; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Todd JL, 2002, ONCOGENE, V21, P2573, DOI 10.1038/sj.onc.1205344; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Vetter SW, 2000, J BIOL CHEM, V275, P2265, DOI 10.1074/jbc.275.4.2265; Walchli S, 2004, J BIOL CHEM, V279, P311, DOI 10.1074/jbc.M307617200; Wang JY, 2011, J BIOL CHEM, V286, P10177, DOI 10.1074/jbc.M110.163295; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	47	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6498	6510		10.1074/jbc.M112.449611	http://dx.doi.org/10.1074/jbc.M112.449611			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322772	Green Published, hybrid			2022-12-28	WOS:000315820700043
J	Miles, RR; Perry, W; Haas, JV; Mosior, MK; N'Cho, M; Wang, JWJ; Yu, P; Calley, J; Yue, Y; Carter, Q; Han, B; Foxworthy, P; Kowala, MC; Ryan, TP; Solenberg, PJ; Michael, LF				Miles, Rebecca R.; Perry, William; Haas, Joseph V.; Mosior, Marian K.; N'Cho, Mathias; Wang, Jian W. J.; Yu, Peng; Calley, John; Yue, Yong; Carter, Quincy; Han, Bomie; Foxworthy, Patricia; Kowala, Mark C.; Ryan, Timothy P.; Solenberg, Patricia J.; Michael, Laura F.			Genome-wide Screen for Modulation of Hepatic Apolipoprotein A-I (ApoA-I) Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; CENP-F; RISK; ATHEROSCLEROSIS; INHIBITORS; MARKERS; LIPIDS; BLOCK	Control of plasma cholesterol levels is a major therapeutic strategy for management of coronary artery disease (CAD). Although reducing LDL cholesterol (LDL-c) levels decreases morbidity and mortality, this therapeutic intervention only translates into a 25-40% reduction in cardiovascular events. Epidemiological studies have shown that a high LDL-c level is not the only risk factor for CAD; low HDL cholesterol (HDL-c) is an independent risk factor for CAD. Apolipoprotein A-I (ApoA-I) is the major protein component of HDL-c that mediates reverse cholesterol transport from tissues to the liver for excretion. Therefore, increasing ApoA-I levels is an attractive strategy for HDL-c elevation. Using genome-wide siRNA screening, targets that regulate hepatocyte ApoA-I secretion were identified through transfection of 21,789 siRNAs into hepatocytes whereby cell supernatants were assayed for ApoA-I. Approximately 800 genes were identified and triaged using a convergence of information, including genetic associations with HDL-c levels, tissue-specific gene expression, druggability assessments, and pathway analysis. Fifty-nine genes were selected for reconfirmation; 40 genes were confirmed. Here we describe the siRNA screening strategy, assay implementation and validation, data triaging, and example genes of interest. The genes of interest include known and novel genes encoding secreted enzymes, proteases, G-protein-coupled receptors, metabolic enzymes, ion transporters, and proteins of unknown function. Repression of farnesyltransferase (FNTA) by siRNA and the enzyme inhibitor manumycin A caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing hApoA-I and cholesterol ester transfer protein transgenes. In total, this work underscores the power of functional genetic assessment to identify new therapeutic targets.	[Miles, Rebecca R.; Perry, William; Haas, Joseph V.; Mosior, Marian K.; N'Cho, Mathias; Wang, Jian W. J.; Yu, Peng; Calley, John; Yue, Yong; Carter, Quincy; Han, Bomie; Foxworthy, Patricia; Kowala, Mark C.; Ryan, Timothy P.; Solenberg, Patricia J.; Michael, Laura F.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly	Michael, LF (corresponding author), Eli Lilly & Co, Lilly Res Labs, DC0520, Indianapolis, IN 46285 USA.	laura_michael@lilly.com	Han, Bomie/GXH-5054-2022					Ashar HR, 2000, J BIOL CHEM, V275, P30451, DOI 10.1074/jbc.M003469200; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Cartwright IJ, 1996, BIOCHEM J, V314, P977, DOI 10.1042/bj3140977; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; JOHNSTON PA, 1991, NEURON, V7, P101, DOI 10.1016/0896-6273(91)90078-E; Lindstedt L, 2003, BIOCHEM BIOPH RES CO, V312, P1019, DOI 10.1016/j.bbrc.2003.11.020; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Moskaug JO, 2008, EUR J NUTR, V47, P460, DOI 10.1007/s00394-008-0749-0; Nicholls Stephen J, 2011, Curr Cardiol Rep, V13, P537, DOI 10.1007/s11886-011-0223-0; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Pooley RD, 2008, J CELL SCI, V121, P3413, DOI 10.1242/jcs.032847; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Segal M, 2012, BIOL OPEN, V1, P220, DOI 10.1242/bio.2012307; Sittampalam G. S., 2012, ASSAY GUIDANCE MANUA; Sniderman AD, 2011, CIRC-CARDIOVASC QUAL, V4, P337, DOI 10.1161/CIRCOUTCOMES.110.959247; Steiner G, 2001, AM J CARDIOL, V88, p37N; Sugita M, 2007, ARTERIOSCL THROM VAS, V27, P1390, DOI 10.1161/ATVBAHA.107.140673; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wildsmith KR, 2009, ANAL BIOCHEM, V395, P116, DOI 10.1016/j.ab.2009.07.049	21	11	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6386	6396		10.1074/jbc.M112.410092	http://dx.doi.org/10.1074/jbc.M112.410092			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322769	Green Published, hybrid			2022-12-28	WOS:000315820700033
J	Chen, PW; Jian, XY; Yoon, HY; Randazzo, PA				Chen, Pei-Wen; Jian, Xiaoying; Yoon, Hye-Young; Randazzo, Paul A.			ARAP2 Signals through Arf6 and Rac1 to Control Focal Adhesion Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; ADP-RIBOSYLATION FACTOR; DOWNSTREAM ACTIVATION; CELL-MIGRATION; ACTIN DYNAMICS; LEADING-EDGE; RHO GTPASES; COMPLEX; MICROTUBULE; INTERACTS	Focal adhesions (FAs) are dynamic structures that connect the actin cytoskeleton with the extracellular matrix. At least six ADP-ribosylation factor (Arf) GTPase-activating proteins (GAPs), including ARAP2 (an Arf6 GAP), are implicated in regulation of FAs but the mechanisms for most are not well defined. Although Rac1 has been reported to function downstream of Arf6 to control membrane ruffling and cell migration, this pathway has not been directly examined as a regulator of FAs. Here we test the hypothesis that ARAP2 promotes the growth of FAs by converting Arf6.GTP to Arf6.GDP thereby preventing the activation of the Rho family GTP-binding protein Rac1. Reduced expression of ARAP2 decreased the number and size of FAs in cells and increased cellular Arf6.GTP and Rac1.GTP levels. Overexpression of ARAP2 had the opposite effects. The effects of ARAP2 on FAs and Rac1 were dependent on a functional ArfGAP domain. Constitutively active Arf6 affected FAs in the same way as did reduced ARAP2 expression and dominant negative mutants of Arf6 and Rac1 reversed the effect of reduced ARAP2 expression. However, neither dominant negative Arf6 nor Rac1 had the same effect as ARAP2 overexpression. We conclude that changes in Arf6 and Rac1 activities are necessary but not sufficient for ARAP2 to promote the growth of FAs and we speculate that ARAP2 has additional functions that are effector in nature to promote or stabilize FAs.	[Chen, Pei-Wen; Jian, Xiaoying; Yoon, Hye-Young; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, Bldg 37 Room 2042, Bethesda, MD 20892 USA.	randazzp@mail.nih.gov	Chen, Pei-Wen/B-7142-2015		NCI, National Institutes of Health [BC 007365]; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the intramural program of the NCI, National Institutes of Health (Project BC 007365).	Benard V, 2002, METHOD ENZYMOL, V345, P349; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Campa F, 2009, J BIOL CHEM, V284, P28069, DOI 10.1074/jbc.M109.028266; Chao WT, 2010, MOL CELL BIOL, V30, P4463, DOI 10.1128/MCB.01207-09; Chen P.W., 2010, CELL ADH MIGR, V4; Chen P. W., 2012, CURR PROTOCOLS CELL; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; Daher Z, 2008, CELL SIGNAL, V20, P2256, DOI 10.1016/j.cellsig.2008.08.021; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Funakoshi Y, 2010, ADV ENZYME REGUL, V50, P72, DOI 10.1016/j.advenzreg.2009.11.001; Gambardella L, 2011, BLOOD, V118, P1087, DOI 10.1182/blood-2010-10-312959; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hasegawa J, 2012, MOL BIOL CELL, V23, P2481, DOI 10.1091/mbc.E12-01-0017; HAUN RS, 1993, J BIOL CHEM, V268, P7064; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Koo TH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-29; Koronakis V, 2011, P NATL ACAD SCI USA, V108, P14449, DOI 10.1073/pnas.1107666108; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Manabe R, 2002, J CELL SCI, V115, P1497; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mazaki Y, 2001, MOL BIOL CELL, V12, P645, DOI 10.1091/mbc.12.3.645; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Moravec R, 2012, J BIOL CHEM, V287, P31138, DOI 10.1074/jbc.M112.383117; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Norman JC, 1998, J CELL BIOL, V143, P1981, DOI 10.1083/jcb.143.7.1981; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Quast T, 2009, BLOOD, V113, P5801, DOI 10.1182/blood-2008-08-176123; Raaijmakers JH, 2007, CELL SIGNAL, V19, P1249, DOI 10.1016/j.cellsig.2006.12.015; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1999, J CELL SCI, V112, P855; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rooney C, 2010, EMBO REP, V11, P292, DOI 10.1038/embor.2010.10; Sakurai A, 2011, J BIOL CHEM, V286, P34335, DOI 10.1074/jbc.M111.259499; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tong WY, 2010, MOL CELL PROTEOMICS, V9, P2089, DOI 10.1074/mcp.M110.001966; Torii T, 2010, J BIOL CHEM, V285, P24270, DOI 10.1074/jbc.M110.125658; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Yoon HY, 2005, METHOD ENZYMOL, V404, P316, DOI 10.1016/S0076-6879(05)04028-0; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Yoon HY, 2011, BIOL CELL, V103, P171, DOI 10.1042/BC20100154; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhu YJ, 2009, J BIOL CHEM, V284, P13489, DOI 10.1074/jbc.M900469200	71	22	22	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5849	5860		10.1074/jbc.M112.415778	http://dx.doi.org/10.1074/jbc.M112.415778			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23295182	hybrid, Green Published			2022-12-28	WOS:000315342500055
J	Andrews, WJ; Panova, T; Normand, C; Gadal, O; Tikhonova, IG; Panov, KI				Andrews, William J.; Panova, Tatiana; Normand, Christophe; Gadal, Olivier; Tikhonova, Irina G.; Panov, Konstantin I.			Old Drug, New Target ELLIPTICINES SELECTIVELY INHIBIT RNA POLYMERASE I TRANSCRIPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; ANTICANCER AGENT ELLIPTICINE; UPSTREAM BINDING-FACTOR; CANCER-CELLS; RIBOSOMAL DNA; G-QUADRUPLEX; III TRANSCRIPTION; COMPLEX-FORMATION; DOWN-REGULATION; HUMAN BRAIN	Transcription by RNA polymerase I (Pol-I) is the main driving force behind ribosome biogenesis, a fundamental cellular process that requires the coordinated transcription of all three nuclear polymerases. Increased Pol-I transcription and the concurrent increase in ribosome biogenesis has been linked to the high rates of proliferation in cancers. The ellipticine family contains a number of potent anticancer therapeutic agents, some having progressed to stage I and II clinical trials; however, the mechanism by which many of the compounds work remains unclear. It has long been thought that inhibition of Top2 is the main reason behind the drugs antiproliferative effects. Here we report that a number of the ellipticines, including 9-hydroxyellipticine, are potent and specific inhibitors of Pol-I transcription, with IC50 in vitro and in cells in the nanomolar range. Essentially, the drugs did not affect Pol-II and Pol-III transcription, demonstrating a high selectivity. Wehave shown that Pol-I inhibition occurs by a p53-, ATM/ATR-, and Top2-independent mechanism. We discovered that the drug influences the assembly and stability of preinitiation complexes by targeting the interaction between promoter recognition factor SL1 and the rRNA promoter. Our findings will have an impact on the design and development of novel therapeutic agents specifically targeting ribosome biogenesis.	[Andrews, William J.; Panova, Tatiana; Panov, Konstantin I.] Queens Univ Belfast, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland; [Panov, Konstantin I.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland; [Tikhonova, Irina G.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland; [Normand, Christophe; Gadal, Olivier] CNRS, Lab Biol Mol Eucaryotes, F-31000 Toulouse, France; [Normand, Christophe; Gadal, Olivier] Univ Toulouse, F-31000 Toulouse, France	Queens University Belfast; Queens University Belfast; Queens University Belfast; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse	Panov, KI (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland.	k.panov@qub.ac.uk	Gadal, Olivier/A-4731-2008; Normand, Christophe/C-5281-2009; Normand, Christophe/C-2879-2013	Gadal, Olivier/0000-0001-9421-0831; Normand, Christophe/0000-0001-6104-1285; Panov, Konstantin/0000-0003-1375-7814	Medical Research Council New Investigator Award [89365]; DEL (The Department for Employment and Learning) postgraduate studentship; ATIP-plus (Actions Thematiques et Incitatives sur Programme) grant from CNRS (Centre National de la Recherche Scientifique); Agence Nationale de la Recherche (Nucleopol); Agence Nationale de la Recherche (Ribeuc); Agence Nationale de la Recherche (Jeune Chercheur Program); Medical Research Council [G0801834] Funding Source: researchfish; MRC [G0801834] Funding Source: UKRI	Medical Research Council New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DEL (The Department for Employment and Learning) postgraduate studentship; ATIP-plus (Actions Thematiques et Incitatives sur Programme) grant from CNRS (Centre National de la Recherche Scientifique); Agence Nationale de la Recherche (Nucleopol)(French National Research Agency (ANR)); Agence Nationale de la Recherche (Ribeuc)(French National Research Agency (ANR)); Agence Nationale de la Recherche (Jeune Chercheur Program)(French National Research Agency (ANR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council New Investigator Award Grant 89365 (to K. P.).; Recipient a DEL (The Department for Employment and Learning) postgraduate studentship.; Supported by an ATIP-plus (Actions Thematiques et Incitatives sur Programme) grant from CNRS (Centre National de la Recherche Scientifique) and by Agence Nationale de la Recherche (Nucleopol, Ribeuc, and the Jeune Chercheur Program).	Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; BERTRAND JR, 1985, CHEMIOTERAPIA, V4, P445; Brown RV, 2011, J BIOL CHEM, V286, P41018, DOI 10.1074/jbc.M111.274720; Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; BUHLER JM, 1974, J BIOL CHEM, V249, P5963; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Canals A, 2005, ACTA CRYSTALLOGR D, V61, P1009, DOI 10.1107/S0907444905015404; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; Daly NL, 2005, ONCOGENE, V24, P880, DOI 10.1038/sj.onc.1208031; Donati G, 2011, J CELL SCI, V124, P3017, DOI 10.1242/jcs.086074; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Elcock AH, 1996, BIOPOLYMERS, V39, P309, DOI 10.1002/(SICI)1097-0282(199609)39:3<309::AID-BIP4>3.3.CO;2-O; Friedrich JK, 2005, J BIOL CHEM, V280, P29551, DOI 10.1074/jbc.M501595200; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P14998, DOI 10.1074/jbc.270.25.14998; Garbett Nichola C., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P149, DOI 10.2174/1568011043482070; Godard T, 2002, MUTAT RES-GEN TOX EN, V520, P47, DOI 10.1016/S1383-5718(02)00174-2; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; KENNEY S, 1995, BIOCHEM PHARMACOL, V49, P23, DOI 10.1016/0006-2952(94)00471-W; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kim JY, 2011, TOXICOLOGY, V289, P91, DOI 10.1016/j.tox.2011.07.014; Kopp K, 2007, MOL BIOL CELL, V18, P394, DOI 10.1091/mbc.E06-03-0249; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Kruhlak M, 2007, NATURE, V447, P730, DOI 10.1038/nature05842; KULKENS T, 1991, NUCLEIC ACIDS RES, V19, P5363, DOI 10.1093/nar/19.19.5363; Kuo PL, 2005, ANTI-CANCER DRUG, V16, P789, DOI 10.1097/01.cad.0000171768.36317.93; Kuo PL, 2005, CANCER LETT, V223, P293, DOI 10.1016/j.canlet.2004.09.046; Kuo YC, 2006, LIFE SCI, V78, P2550, DOI 10.1016/j.lfs.2005.10.041; LEARNED RM, 1983, P NATL ACAD SCI-BIOL, V80, P3558, DOI 10.1073/pnas.80.12.3558; LEPECQ JB, 1973, CR ACAD SCI D NAT, V277, P2289; LESCA P, 1978, BIOCHEM PHARMACOL, V27, P1203, DOI 10.1016/0006-2952(78)90453-7; Mathe G, 1998, BIOMED PHARMACOTHER, V52, P391, DOI 10.1016/S0753-3322(99)80007-9; Milkereit P, 1997, BIOL CHEM, V378, P1433, DOI 10.1515/bchm.1997.378.12.1433; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373; OHASHI M, 1995, JPN J CANCER RES, V86, P819, DOI 10.1111/j.1349-7006.1995.tb03091.x; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Panov KI, 2001, MOL CELL BIOL, V21, P2641, DOI 10.1128/MCB.21.8.2641-2649.2001; Panov KI, 2006, EMBO J, V25, P3310, DOI 10.1038/sj.emboj.7601221; Panov KI, 2006, MOL CELL BIOL, V26, P5436, DOI 10.1128/MCB.00230-06; Panova TB, 2006, MOL CELL BIOL, V26, P5957, DOI 10.1128/MCB.00673-06; RENAULT G, 1987, TOXICOL APPL PHARM, V89, P281, DOI 10.1016/0041-008X(87)90049-4; ROSS WE, 1978, BIOCHIM BIOPHYS ACTA, V519, P23, DOI 10.1016/0005-2787(78)90059-X; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Sato N, 1998, FEBS LETT, V441, P318, DOI 10.1016/S0014-5793(98)01571-3; Schneider DA, 2012, GENE, V493, P176, DOI 10.1016/j.gene.2011.08.006; Shahabuddin MS, 2011, INVEST NEW DRUG, V29, P523, DOI 10.1007/s10637-009-9379-5; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Stiborova M, 2003, INT J CANCER, V107, P885, DOI 10.1002/ijc.11511; Stiborova M, 2001, BIOCHEM PHARMACOL, V62, P1675, DOI 10.1016/S0006-2952(01)00806-1; Stiborova Marie, 2006, Biomedical Papers (Olomouc), V150, P13; Stiborova Marie, 2011, Interdiscip Toxicol, V4, P98, DOI 10.2478/v10102-011-0017-7; Sugikawa E, 1999, ANTICANCER RES, V19, P3099; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; VISTICA DT, 1994, BIOCHEM BIOPH RES CO, V200, P1762, DOI 10.1006/bbrc.1994.1657; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023	62	53	54	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4567	4582		10.1074/jbc.M112.411611	http://dx.doi.org/10.1074/jbc.M112.411611			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23293027	Green Published, hybrid			2022-12-28	WOS:000315340400007
J	Krishnan, S; Zhou, XS; Paredes, JA; Kuiper, RV; Curbo, S; Karlsson, A				Krishnan, Shuba; Zhou, Xiaoshan; Paredes, Joao A.; Kuiper, Raoul V.; Curbo, Sophie; Karlsson, Anna			Transgene Expression of Drosophila melanogaster Nucleoside Kinase Reverses Mitochondrial Thymidine Kinase 2 Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTISUBSTRATE DEOXYRIBONUCLEOSIDE KINASE; DEOXYNUCLEOSIDE SALVAGE ENZYMES; CANCER CELL-LINES; DNA; POOLS; DEOXYURIDINE; MECHANISM; SUBSTRATE; P53R2; GENE	A strategy to reverse the symptoms of thymidine kinase 2 (TK2) deficiency in a mouse model was investigated. The nucleoside kinase from Drosophila melanogaster (Dm-dNK) was expressed in TK2-deficient mice that have been shown to present with a severe phenotype caused by mitochondrial DNA depletion. The Dm-dNK(+/-) transgenic mice were shown to be able to rescue the TK2-deficient mice. TheDm-dNK(+/-)TK2(-/-) mice were normal as judged by growth and behavior during the observation time of 6 months. The Dm-dNK-expressing mice showed a substantial increase in thymidine-phosphorylating activity in investigated tissues. The Dm-dNK expression also resulted in highly elevated dTTP pools. The dTTP pool alterations did not cause specific mitochondrial DNA mutations or deletions when 6-month-old mice were analyzed. The mitochondrial DNA was also detected at normal levels. In conclusion, the Dm-dNK(+/-)TK2(-/-) mouse model illustrates how dTMP synthesized in the cell nucleus can compensate for loss of intramitochondrial dTMP synthesis in differentiated tissue. The data presented open new possibilities to treat the severe symptoms of TK2 deficiency.	[Krishnan, Shuba; Zhou, Xiaoshan; Paredes, Joao A.; Curbo, Sophie; Karlsson, Anna] Karolinska Univ Hosp, Dept Lab Med, Div Clin Microbiol, SE-14186 Huddinge, Sweden; [Kuiper, Raoul V.] Karolinska Univ Hosp, Dept Lab Med, Div Pathol, Karolinska Inst, SE-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Karlsson, A (corresponding author), Karolinska Univ Hosp, Dept Lab Med, Div Clin Microbiol, F68, SE-14186 Huddinge, Sweden.	anna.karlsson@ki.se	curbo, sophie/AAA-8614-2020; Karlsson, Anna/E-7945-2018	curbo, sophie/0000-0002-0964-0712; Kuiper, Raoul/0000-0001-5645-2389; Karlsson, Anna/0000-0001-6843-6685; Paredes, Joao/0000-0002-7788-8939	Swedish Cancer Society [CAN 2011/1277]; Swedish Research Council [2010-2828]; Karolinska Institute	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute(Karolinska Institutet)	This work was supported by the Swedish Cancer Society (Grant CAN 2011/1277), Swedish Research Council (Grant 2010-2828), and Karolinska Institute.	Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; Babinet C, 2000, J AM SOC NEPHROL, V11, pS88; Bertoli A, 2005, FEBS J, V272, P3918, DOI 10.1111/j.1742-4658.2005.04808.x; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Bridges EG, 1999, J BIOL CHEM, V274, P4620, DOI 10.1074/jbc.274.8.4620; ERIKSSON S, 1994, ADV ENZYME REGUL, V34, P13, DOI 10.1016/0065-2571(94)90006-X; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Franzolin E, 2006, BIOCHEM BIOPH RES CO, V344, P30, DOI 10.1016/j.bbrc.2006.03.147; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; Gisch N, 2008, J MED CHEM, V51, P6752, DOI 10.1021/jm800853p; Gonzalez-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035; Johansson M, 1999, J BIOL CHEM, V274, P23814, DOI 10.1074/jbc.274.34.23814; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; Lopez LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Mehellou Y, 2009, CHEMMEDCHEM, V4, P1779, DOI 10.1002/cmdc.200900289; Meier C, 2008, Nucleic Acids Symp Ser (Oxf), P83, DOI 10.1093/nass/nrn042; Munch-Petersen B, 2000, J BIOL CHEM, V275, P6673, DOI 10.1074/jbc.275.9.6673; Munch-Petersen B, 1998, J BIOL CHEM, V273, P3926, DOI 10.1074/jbc.273.7.3926; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Solaroli N, 2007, GENE THER, V14, P86, DOI 10.1038/sj.gt.3302835; Solaroli N, 2007, MOL PHARMACOL, V72, P1593, DOI 10.1124/mol.107.037051; Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017; Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042; Wang L, 2010, NUCLEOS NUCLEOT NUCL, V29, P370, DOI 10.1080/15257771003729732; Wang L, 2010, NUCLEOS NUCLEOT NUCL, V29, P400, DOI 10.1080/15257771003741042; Wang LY, 2008, NUCLEOS NUCLEOT NUCL, V27, P858, DOI 10.1080/15257770802146510; Zegerman P, 2009, DNA REPAIR, V8, P1077, DOI 10.1016/j.dnarep.2009.04.023; Zheng XY, 2001, MOL PHARMACOL, V60, P262, DOI 10.1124/mol.60.2.262; Zheng XY, 2000, J BIOL CHEM, V275, P39125, DOI 10.1074/jbc.M006212200; Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133; Zhou XS, 2010, J INHERIT METAB DIS, V33, P231, DOI 10.1007/s10545-010-9102-x	37	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5072	5079		10.1074/jbc.M112.437152	http://dx.doi.org/10.1074/jbc.M112.437152			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288848	Green Published, hybrid			2022-12-28	WOS:000315340400055
J	Vela, L; Gonzalo, O; Naval, J; Marzo, I				Vela, Laura; Gonzalo, Oscar; Naval, Javier; Marzo, Isabel			Direct Interaction of Bax and Bak Proteins with Bcl-2 Homology Domain 3 (BH3)-only Proteins in Living Cells Revealed by Fluorescence Complementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC ACTIVITY; BH3 DOMAINS; FAMILY; ACTIVATION; PUMA; BIM; BINDING; MCL-1; VISUALIZATION; ABSENCE	The key event in the mitochondrial pathway of apoptosis is the activation of Bax and Bak by BH3-only proteins through a molecular mechanism that is still a matter of debate. Here we studied interactions among anti-and proapoptotic proteins of the Bcl-2 family in living cells by using bimolecular fluorescence complementation analysis. Our results indicate that the antiapoptotic proteins Mcl-1 and Bcl-xL bind preferably to the BH3-only proteins Bim, PUMA, and Noxa but can also bind to Bak and Bax. We also found a direct interaction between Bim, PUMA, or Noxa with either Bax or Bak during apoptosis induction. In HeLa cells, interaction of Bim with Bax occurs in cytosol, and then Bim-Bax complexes translocate to mitochondria. Complexes of either PUMA or Noxa with Bax or Bak were always detected at mitochondria. Overexpression of Bcl-xL or Mcl-1 delayed Bim/Bax translocation to mitochondria. These results reveal the ability of main BH3-only proteins to directly activate Bax and Bak in living cells and suggest that a complex network of interactions regulate the function of Bcl-2 family members during apoptosis.	[Vela, Laura; Gonzalo, Oscar; Naval, Javier; Marzo, Isabel] Univ Zaragoza, Fac Ciencias, Dept Biochem Mol & Cell Biol, Zaragoza 5009, Spain	University of Zaragoza	Marzo, I (corresponding author), Univ Zaragoza, Fac Sci, Dept Biochem Mol & Cell Biol, E-50009 Zaragoza, Spain.	imarzo@unizar.es	Marzo, Isabel/E-6918-2016	Marzo, Isabel/0000-0002-2315-9079	Ministerio de Ciencia e Innovacion [SAF2007-60748, SAF2010-14920]; Red Tematica de Investigacion Cooperativa en Cancer-Instituto de Salud Carlos III [RD06/0020]; Gobierno de Aragon/Fondo Social Europeo Grant [B16]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red Tematica de Investigacion Cooperativa en Cancer-Instituto de Salud Carlos III(Instituto de Salud Carlos III); Gobierno de Aragon/Fondo Social Europeo Grant	This study was supported by Ministerio de Ciencia e Innovacion Grants SAF2007-60748, SAF2010-14920, and Red Tematica de Investigacion Cooperativa en Cancer-Instituto de Salud Carlos III Grant RD06/0020, and Gobierno de Aragon/Fondo Social Europeo Grant B16.	Aranovich A, 2012, MOL CELL, V45, P754, DOI 10.1016/j.molcel.2012.01.030; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Ding JZ, 2010, J BIOL CHEM, V285, P28749, DOI 10.1074/jbc.M110.148361; Du H, 2011, J BIOL CHEM, V286, P491, DOI 10.1074/jbc.M110.167148; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Germain M, 2008, J BIOL CHEM, V283, P6384, DOI 10.1074/jbc.M707762200; Hoetelmans RWM, 2000, CELL DEATH DIFFER, V7, P384, DOI 10.1038/sj.cdd.4400664; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Lee Y, 2010, J CELL SCI, V123, P3547, DOI 10.1242/jcs.070300; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Lopez-Royuela N, 2010, BIOCHEM PHARMACOL, V79, P1746, DOI 10.1016/j.bcp.2010.02.010; Lopez-Royuela N, 2010, BBA-MOL CELL RES, V1803, P311, DOI 10.1016/j.bbamcr.2009.11.004; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Pang YP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00257; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Villunger A, 2011, CELL DEATH DIFFER, V18, P1545, DOI 10.1038/cdd.2011.100; Wang RR, 2012, J BIOL CHEM, V287, P10738, DOI 10.1074/jbc.M111.323493; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wong C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.28; Yee KS, 2008, APOPTOSIS, V13, P87, DOI 10.1007/s10495-007-0140-2; Yivgi-Ohana N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.47; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	49	62	64	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4935	4946		10.1074/jbc.M112.422204	http://dx.doi.org/10.1074/jbc.M112.422204			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283967	Green Published, hybrid			2022-12-28	WOS:000315340400041
J	Wilkins, HM; Kirchhof, D; Manning, E; Joseph, JW; Linseman, DA				Wilkins, Heather M.; Kirchhof, Danielle; Manning, Evan; Joseph, Jamie W.; Linseman, Daniel A.			Mitochondrial Glutathione Transport Is a Key Determinant of Neuronal Susceptibility to Oxidative and Nitrosative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICARBOXYLATE CARRIER; CELL-DEATH; PARKINSONS-DISEASE; BRAIN MITOCHONDRIA; DYSFUNCTION; BCL-2; APOPTOSIS; DEPLETION; ASTROCYTES; INDUCTION	Mitochondrial oxidative stress significantly contributes to the underlying pathology of several devastating neurodegenerative disorders. Mitochondria are highly sensitive to the damaging effects of reactive oxygen and nitrogen species; therefore, these organelles are equipped with a number of free radical scavenging systems. In particular, the mitochondrial glutathione (GSH) pool is a critical antioxidant reserve that is derived entirely from the larger cytosolic pool via facilitated transport. The mechanism of mitochondrial GSH transport has not been extensively studied in the brain. However, the dicarboxylate (DIC) and 2-oxoglutarate (OGC) carriers localized to the inner mitochondrial membrane have been established as GSH transporters in liver and kidney. Here, we investigated the role of these carriers in protecting neurons from oxidative and nitrosative stress. Immunoblot analysis of DIC and OGC in primary cultures of rat cerebellar granule neurons (CGNs) and cerebellar astrocytes showed differential expression of these carriers, with CGNs expressing only DIC and astrocytes expressing both DIC and OGC. Consistent with these findings, butylmalonate specifically reduced mitochondrial GSH in CGNs, whereas both butylmalonate and phenylsuccinate diminished mitochondrial GSH in astrocytes. Moreover, preincubation with butylmalonate but not phenylsuccinate significantly enhanced susceptibility of CGNs to oxidative and nitrosative stressors. This increased vulnerability was largely prevented by incubation with cell-permeable GSH monoethylester but not malate. Finally, knockdown of DIC with adenoviral siRNA also rendered CGNs more susceptible to oxidative stress. These findings demonstrate that maintenance of the mitochondrial GSH pool via sustained mitochondrial GSH transport is essential to protect neurons from oxidative and nitrosative stress.	[Wilkins, Heather M.; Kirchhof, Danielle; Manning, Evan; Linseman, Daniel A.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Wilkins, Heather M.; Kirchhof, Danielle; Manning, Evan; Linseman, Daniel A.] Univ Denver, Eleanor Roosevelt Inst, Denver, CO 80208 USA; [Joseph, Jamie W.] Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada; [Linseman, Daniel A.] Vet Affairs Med Ctr, Res Serv, Denver, CO 80220 USA; [Linseman, Daniel A.] Univ Colorado Denver, Div Clin Pharmacol & Toxicol, Dept Med, Aurora, CO 80045 USA; [Linseman, Daniel A.] Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA	University of Denver; University of Denver; University of Waterloo; US Department of Veterans Affairs; Veterans Health Administration (VHA); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Linseman, DA (corresponding author), Univ Denver, Dept Biol Sci, 2199 S Univ Blvd, Denver, CO 80208 USA.	daniel.linseman@du.edu	Linseman, Daniel/L-3846-2019	Wilkins, Heather/0000-0003-4563-4544	National Institutes of Health [R01 NS062766]; Department of Veterans Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062766] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS062766 (to D. A. L.). This work was also supported by a Merit Review grant from the Department of Veterans Affairs (to D. A. L.).	Andreassen OA, 2000, ANN NEUROL, V47, P447, DOI 10.1002/1531-8249(200004)47:4<447::AID-ANA7>3.3.CO;2-I; Arthur CR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-37; Babu GN, 2008, NEUROCHEM INT, V52, P1284, DOI 10.1016/j.neuint.2008.01.009; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Chen ZF, 1998, J PHARMACOL EXP THER, V285, P608; Chen ZF, 2000, ARCH BIOCHEM BIOPHYS, V373, P193, DOI 10.1006/abbi.1999.1527; Chi L, 2007, NEUROSCIENCE, V144, P991, DOI 10.1016/j.neuroscience.2006.09.064; Chinta SJ, 2007, J NEUROSCI, V27, P13997, DOI 10.1523/JNEUROSCI.3885-07.2007; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Eckert A, 2003, BIOCHEM PHARMACOL, V66, P1627, DOI 10.1016/S0006-2952(03)00534-3; Flanagan SW, 2002, J NEUROCHEM, V81, P170, DOI 10.1046/j.1471-4159.2002.00812.x; GRIFFITH OW, 1985, P NATL ACAD SCI USA, V82, P4668, DOI 10.1073/pnas.82.14.4668; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; HUANG JA, 1995, BRAIN RES, V680, P16, DOI 10.1016/0006-8993(95)00209-9; Huypens P, 2011, DIABETOLOGIA, V54, P135, DOI 10.1007/s00125-010-1923-5; Isobe C, 2010, NEUROSCI LETT, V469, P159, DOI 10.1016/j.neulet.2009.11.065; Kajimoto K, 2005, MOL GENET METAB, V85, P46, DOI 10.1016/j.ymgme.2005.01.006; Kamga CK, 2010, AM J PHYSIOL-CELL PH, V299, pC497, DOI 10.1152/ajpcell.00058.2010; Lash LH, 2006, CHEM-BIOL INTERACT, V163, P54, DOI 10.1016/j.cbi.2006.03.001; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Merad-Boudia M, 1998, BIOCHEM PHARMACOL, V56, P645, DOI 10.1016/S0006-2952(97)00647-3; Mizuarai S, 2005, J BIOL CHEM, V280, P32434, DOI 10.1074/jbc.M503152200; Mu XJ, 1996, ANN NEUROL, V40, P379, DOI 10.1002/ana.410400307; Muratai T, 2008, FREE RADICAL RES, V42, P221, DOI 10.1080/10715760701877262; Muyderman H, 2007, J NEUROCHEM, V102, P1369, DOI 10.1111/j.1471-4159.2007.04641.x; PALMIERI F, 1971, EUR J BIOCHEM, V22, P66, DOI 10.1111/j.1432-1033.1971.tb01515.x; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Pedrini S, 2010, HUM MOL GENET, V19, P2974, DOI 10.1093/hmg/ddq202; PERRY TL, 1986, NEUROSCI LETT, V67, P269, DOI 10.1016/0304-3940(86)90320-4; RAVINDRANATH V, 1989, NEUROSCI LETT, V101, P187, DOI 10.1016/0304-3940(89)90528-4; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Vargas MR, 2011, NEUROBIOL DIS, V43, P543, DOI 10.1016/j.nbd.2011.04.025; Wadey AL, 2009, J NEUROCHEM, V109, P101, DOI 10.1111/j.1471-4159.2009.05936.x; Wilkins HM, 2012, FREE RADICAL BIO MED, V52, P410, DOI 10.1016/j.freeradbiomed.2011.10.495; Wullner U, 1999, BRAIN RES, V826, P53, DOI 10.1016/S0006-8993(99)01228-7; Zimmermann AK, 2005, J NEUROCHEM, V94, P22, DOI 10.1111/j.1471-4159.2005.03156.x; Zimmermann AK, 2007, J BIOL CHEM, V282, P29296, DOI 10.1074/jbc.M702853200; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	41	38	38	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5091	5101		10.1074/jbc.M112.405738	http://dx.doi.org/10.1074/jbc.M112.405738			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283974	hybrid, Green Published			2022-12-28	WOS:000315340400057
J	Wang, SZ; Makhina, EN; Masia, R; Hyrc, KL; Formanack, ML; Nichols, CG				Wang, Shizhen; Makhina, Elena N.; Masia, Ricard; Hyrc, Krzysztof L.; Formanack, Mary Lynn; Nichols, Colin G.			Domain Organization of the ATP-sensitive Potassium Channel Complex Examined by Fluorescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; K+ CHANNEL; SULFONYLUREA RECEPTOR; CYTOSOLIC DOMAINS; STOICHIOMETRY; ACTIVATION; MECHANISM; PROTEIN; TRAFFICKING; SUBUNITS	KATP channels link cell metabolism to excitability in many cells. They are formed as tetramers of Kir6.2 subunits, each associated with a SUR1 subunit. We used mutant GFP-based FRET to assess domain organization in channel complexes. Full-length Kir6.2 subunits were linked to YFP or cyan fluorescent protein (CFP) at N or C termini, and all such constructs, including double-tagged YFP-Kir6.2-CFP (Y6.2C), formed functional K-ATP channels. In intact COSm6 cells, background emission of YFP excited by 430-nm light was similar to 6%, but the Y6.2C construct expressed alone exhibited an apparent FRET efficiency of similar to 25%, confirmed by trypsin digestion, with or without SUR1 co-expression. Similar FRET efficiency was detected in mixtures of CFP- and YFP-tagged full-length Kir6.2 subunits and transmembrane domain only constructs, when tagged at the C termini but not at the N termini. The FRET-reported Kir6.2 tetramer domain organization was qualitatively consistent with Kir channel crystal structures: C termini and M2 domains are centrally located relative to N termini and M1 domains, respectively. Additional FRET analyses were performed on cells in which tagged full-length Kir6.2 and tagged SUR1 constructs were co-expressed. These analyses further revealed that 1) NBD1 of SUR1 is closer to the C terminus of Kir6.2 than to the N terminus; 2) the Kir6.2 cytoplasmic domain is not essential for complexation with SUR1; and 3) the N-terminal half of SUR1 can complex with itself in the absence of either the C-terminal half or Kir6.2.	[Wang, Shizhen; Makhina, Elena N.; Masia, Ricard; Hyrc, Krzysztof L.; Formanack, Mary Lynn; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Wang, Shizhen; Hyrc, Krzysztof L.; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 425 S Euclid Ave, St Louis, MO 63110 USA.	cnichols@wustl.edu	Wang, Shizhen/N-6577-2017	Wang, Shizhen/0000-0003-1065-4756	National Institutes of Health [HL45742]; American Heart Association [10POST4280056]; National Institutes of Health Neuroscience Blueprint Center Core Grant [P30 NS057105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health Neuroscience Blueprint Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL45742 (to C. G. N.). This work was also supported by American Heart Association Postdoctoral Fellowship 10POST4280056 (to S. W.) and National Institutes of Health Neuroscience Blueprint Center Core Grant P30 NS057105 (to Washington University).	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Bavro VN, 2012, NAT STRUCT MOL BIOL, V19, P158, DOI 10.1038/nsmb.2208; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Chen ZH, 2002, J BIOL CHEM, V277, P24653, DOI 10.1074/jbc.M111862200; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Enkvetchakul D, 2003, J GEN PHYSIOL, V122, P471, DOI 10.1085/jgp.200308878; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; John SA, 1998, J PHYSIOL-LONDON, V510, P333, DOI 10.1111/j.1469-7793.1998.333bk.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lippiat JD, 2002, DIABETES, V51, pS377, DOI 10.2337/diabetes.51.2007.S377; Makhina EN, 1998, J BIOL CHEM, V273, P3369, DOI 10.1074/jbc.273.6.3369; Masia R, 2008, J BIOL CHEM, V283, P30322, DOI 10.1074/jbc.M804318200; Masia R, 2007, CHANNELS, V1, P315, DOI 10.4161/chan.5083; Matsuoka T, 2000, CIRC RES, V87, P873, DOI 10.1161/01.RES.87.10.873; McCusker EC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.C111.228122; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Mitra RD, 1996, GENE, V173, P13, DOI 10.1016/0378-1119(95)00768-7; NICHOLS CG, 1993, PFLUG ARCH EUR J PHY, V422, P617, DOI 10.1007/BF00374011; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; PROKS P, 1993, PFLUG ARCH EUR J PHY, V424, P63, DOI 10.1007/BF00375103; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Sala-Rabanal M, 2012, J BIOL CHEM, V287, P8746, DOI 10.1074/jbc.M111.336131; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tsuboi T, 2004, P NATL ACAD SCI USA, V101, P76, DOI 10.1073/pnas.0306347101; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Wang SZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1625; Wang S, 2009, J BIOL CHEM, V284, P2854, DOI 10.1074/jbc.M807474200; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046	40	7	7	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4378	4388		10.1074/jbc.M112.388629	http://dx.doi.org/10.1074/jbc.M112.388629			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23223337	Green Published, hybrid			2022-12-28	WOS:000314845000065
J	Pazos, M; Natale, P; Vicente, M				Pazos, Manuel; Natale, Paolo; Vicente, Miguel			A Specific Role for the ZipA Protein in Cell Division STABILIZATION OF THE FtsZ PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL TAIL; ESCHERICHIA-COLI; SEPTAL RING; SELF-INTERACTION; BINDING; CLPA; MEMBRANE; DYNAMICS; DOMAIN; ACTIN	In Escherichia coli, the cell division protein FtsZ is anchored to the cytoplasmic membrane by the action of the bitopic membrane protein ZipA and the cytoplasmic protein FtsA. Although the presence of both ZipA and FtsA is strictly indispensable for cell division, an FtsA gain-of-function mutant FtsA* (R286W) can bypass the ZipA requirement for cell division. This observation casts doubts on the role of ZipA and its need for cell division. Maxicells are nucleoid-free bacterial cells used as a whole cell in vitro system to probe protein-protein interactions without the need of protein purification. We show that ZipA protects FtsZ from the ClpXP-directed degradation observed in E. coli maxicells and that ZipA-stabilized FtsZ forms membrane-attached spiral-like structures in the bacterial cytoplasm. The overproduction of the FtsZ-binding ZipA domain is sufficient to protect FtsZ from degradation, whereas other C-terminal ZipA partial deletions lacking it are not. Individual overproduction of the proto-ring component FtsA or its gain-of-function mutant FtsA* does not result in FtsZ protection. Overproduction of FtsA or FtsA* together with ZipA does not interfere with the FtsZ protection. Moreover, neither FtsA nor FtsA* protects FtsZ when overproduced together with ZipA mutants lacking the FZB domain. We propose that ZipA protects FtsZ from degradation by ClpP by making the FtsZ site of interaction unavailable to the ClpX moiety of the ClpXP protease. This role cannot be replaced by either FtsA or FtsA*, suggesting a unique function for ZipA in proto-ring stability.	[Pazos, Manuel; Natale, Paolo; Vicente, Miguel] CSIC, CNB, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Vicente, M (corresponding author), CSIC, CNB, C Darwin 3, Madrid 28049, Spain.	mvicente@cnb.csic.es	Pazos, Manuel/AAH-7922-2019; Natale, Paolo/E-9326-2012	Pazos, Manuel/0000-0002-8774-4453; Natale, Paolo/0000-0002-4759-0816	Human Frontier Science Program [RGP0050/2010]; European Commission [HEALTH-F3-2009-223431]; Ministerio de Ciencia e Innovacion [BIO2008-04478-C03-01, BIO2011-28941-C03-01]; program Formacion de Personal Investigador Ministerio de Educacion y Ciencia; Juan de la Cierva program Ministerio de Educacion y Ciencia	Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); program Formacion de Personal Investigador Ministerio de Educacion y Ciencia; Juan de la Cierva program Ministerio de Educacion y Ciencia(German Research Foundation (DFG))	This work was supported by the Human Frontier Science Program though Grant RGP0050/2010, the European Commission through Contract HEALTH-F3-2009-223431 (DIVINOCELL), and Grants BIO2008-04478-C03-01 and BIO2011-28941-C03-01 from Ministerio de Ciencia e Innovacion (all to M. V.).; Supported by a fellowship from program Formacion de Personal Investigador Ministerio de Educacion y Ciencia.; Supported by a fellowship from Juan de la Cierva program Ministerio de Educacion y Ciencia.	Addinall SG, 1996, J BACTERIOL, V178, P3877, DOI 10.1128/jb.178.13.3877-3884.1996; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Camberg JL, 2011, J BACTERIOL, V193, P1911, DOI 10.1128/JB.01317-10; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; DEVEAUX LC, 1986, J BACTERIOL, V167, P920, DOI 10.1128/jb.167.3.920-927.1986; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Geissler B, 2005, MOL MICROBIOL, V58, P596, DOI 10.1111/j.1365-2958.2005.04858.x; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hale CA, 1999, J BACTERIOL, V181, P167, DOI 10.1128/JB.181.1.167-176.1999; Hale CA, 2002, J BACTERIOL, V184, P2552, DOI 10.1128/JB.184.9.2552-2556.2002; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11536, DOI 10.1021/bi801101p; Krol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043293; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Margolin W, 2004, MOLECULES IN TIME AND SPACE: BACTERIAL SHAPE, DIVISON AND PHYLOGENY, P79, DOI 10.1007/0-306-48579-6_5; Miller J. H., 1972, EXPT MOL GENETICS, P268; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Ohashi T, 2002, J BACTERIOL, V184, P4313, DOI 10.1128/JB.184.15.4313-4315.2002; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Pichoff S, 2012, MOL MICROBIOL, V83, P151, DOI 10.1111/j.1365-2958.2011.07923.x; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Sambrook J., 2001, MOL CLONING LAB MANU, P81; SANCAR A, 1979, J BACTERIOL, V137, P692, DOI 10.1128/JB.137.1.692-693.1979; SANCAR A, 1978, GENE, V4, P295, DOI 10.1016/0378-1119(78)90047-1; SANCHEZ M, 1994, EMBO J, V13, P4919, DOI 10.1002/j.1460-2075.1994.tb06819.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Singh JK, 2008, J BIOL CHEM, V283, P31116, DOI 10.1074/jbc.M805910200; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Weichart D, 2003, J BACTERIOL, V185, P115, DOI 10.1128/JB.185.1.115-125.2003; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000	45	41	42	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3219	3226		10.1074/jbc.M112.434944	http://dx.doi.org/10.1074/jbc.M112.434944			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23233671	hybrid, Green Published			2022-12-28	WOS:000314397900029
J	Tahvanainen, J; Kylaniemi, MK; Kanduri, K; Gupta, B; Lahteenmaki, H; Kallonen, T; Rajavuori, A; Rasool, O; Koskinen, PJ; Rao, KVS; Lahdesmaki, H; Lahesmaa, R				Tahvanainen, Johanna; Kylaniemi, Minna K.; Kanduri, Kartiek; Gupta, Bhawna; Lahteenmaki, Hanna; Kallonen, Teemu; Rajavuori, Anna; Rasool, Omid; Koskinen, Paivi J.; Rao, Kanury V. S.; Lahdesmaki, Harri; Lahesmaa, Riitta			Proviral Integration Site for Moloney Murine Leukemia Virus (PIM) Kinases Promote Human T Helper 1 Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD4(+) T-CELLS; NF-KAPPA-B; INTERFERON-GAMMA; IFN-GAMMA; TGF-BETA; GENE-EXPRESSION; PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVITY; SUBUNIT EXPRESSION; NUCLEAR-FACTOR	The differentiation of human primary T helper 1 (Th1) cells from naive precursor cells is regulated by a complex, interrelated signaling network. The identification of factors regulating the early steps of Th1 cell polarization can provide important insight in the development of therapeutics for many inflammatory and autoimmune diseases. The serine/threonine-specific proviral integration site for Moloney murine leukemia virus (PIM) kinases PIM1 and PIM2 have been implicated in the cytokine-dependent proliferation and survival of lymphocytes. We have established that the third member of this family, PIM3, is also expressed in human primary Th cells and identified a new function for the entire PIM kinase family in T lymphocytes. Although PIM kinases are expressed more in Th1 than Th2 cells, we demonstrate here that these kinases positively influence Th1 cell differentiation. Our RNA interference results from human primary Th cells also suggest that PIM kinases promote the production of IFN gamma, the hallmark cytokine produced by Th1 cells. Consistent with this, they also seem to be important for the up-regulation of the critical Th1-driving factor, T box expressed in T cells (T-BET), and the IL-12/STAT4 signaling pathway during the early Th1 differentiation process. In summary, we have identified PIM kinases as new regulators of human primary Th1 cell differentiation, thus providing new insights into the mechanisms controlling the selective development of human Th cell subsets.	[Tahvanainen, Johanna; Kylaniemi, Minna K.; Kanduri, Kartiek; Gupta, Bhawna; Rajavuori, Anna; Rasool, Omid; Koskinen, Paivi J.; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Tahvanainen, Johanna; Kylaniemi, Minna K.; Kanduri, Kartiek; Gupta, Bhawna; Rajavuori, Anna; Rasool, Omid; Koskinen, Paivi J.; Lahesmaa, Riitta] Abo Akad Univ, Turku 20520, Finland; [Kallonen, Teemu] Univ Turku, Dept Med Microbiol & Immunol, SF-20500 Turku, Finland; [Koskinen, Paivi J.] Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland; [Kylaniemi, Minna K.] Abo Akad Univ, Natl Doctoral Programme Informat & Struct Biol, Turku 20520, Finland; [Lahteenmaki, Hanna] Univ Oulu, Dept Biol, FIN-90570 Oulu, Finland; [Rao, Kanury V. S.] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India; [Lahdesmaki, Harri] Aalto Univ, Dept Informat & Comp Sci, Sch Sci, Espoo 02150, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku; Abo Akademi University; University of Oulu; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Aalto University	Lahesmaa, R (corresponding author), Turku Ctr Biotechnol, Tykistokatu 6A, FIN-20520 Turku, Finland.	riitta.lahesmaa@btk.fi	Koskinen, Päivi J/G-8939-2014; Kallonen, Teemu/B-5507-2008	Kallonen, Teemu/0000-0003-1741-6486; Kylaniemi, Minna/0000-0001-7374-9862; Kanduri, Kartiek/0000-0002-5639-0701; Koskinen, Paivi/0000-0002-6864-4457	Academy of Finland; European Union; Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research) [250114]; Sigrid Juselius Foundation; Department of Biotechnology, The Government of India; National Technology Agency of Finland (TEKES); Finnish Cultural Foundation; Turku University Hospital Research Fund (EVO); Vaino and Laina Kivi Foundation; Foundation for Finnish Society against Tuberculosis; Oskar Oflund Foundation; Research Foundation of the Pulmonary Diseases; Ida Montin Foundation	Academy of Finland(Academy of Finland); European Union(European Commission); Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research)(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Department of Biotechnology, The Government of India(Department of Biotechnology (DBT) India); National Technology Agency of Finland (TEKES)(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Turku University Hospital Research Fund (EVO); Vaino and Laina Kivi Foundation; Foundation for Finnish Society against Tuberculosis; Oskar Oflund Foundation; Research Foundation of the Pulmonary Diseases; Ida Montin Foundation	This work was supported by The Academy of Finland, European Union FP7 Grant "Systems Biology of T-cell activation in health and disease" (SYBILLA), the Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research, 2012-2017, Decision 250114), The Sigrid Juselius Foundation, The Department of Biotechnology, The Government of India, The National Technology Agency of Finland (TEKES), The Finnish Cultural Foundation, The Turku University Hospital Research Fund (EVO), The Vaino and Laina Kivi Foundation, The Foundation for Finnish Society against Tuberculosis, Oskar Oflund Foundation, The Research Foundation of the Pulmonary Diseases, and The Ida Montin Foundation.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Aho TL, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-21; Aho TLT, 2005, IMMUNOLOGY, V116, P82, DOI 10.1111/j.1365-2567.2005.02201.x; Aronica MA, 1999, J IMMUNOL, V163, P5116; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Barbulescu K, 1998, J IMMUNOL, V160, P3642; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chang JT, 1999, J EXP MED, V189, P969, DOI 10.1084/jem.189.6.969; Chen WG, 2004, J ALLERGY CLIN IMMUN, V114, P476, DOI 10.1016/j.jaci.2004.06.042; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Eichmann A, 2000, ONCOGENE, V19, P1215, DOI 10.1038/sj.onc.1203355; Feldman JD, 1998, J BIOL CHEM, V273, P16535, DOI 10.1074/jbc.273.26.16535; Filen S, 2010, J IMMUNOL, V184, P4990, DOI 10.4049/jimmunol.0903106; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Gozdecka M, 2012, BIOCHEM SOC T, V40, P230, DOI 10.1042/BST20110630; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369; Hammerman PS, 2004, CANCER RES, V64, P8341, DOI 10.1158/0008-5472.CAN-04-2284; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson LJ, 2012, CELL IMMUNOL, V272, P200, DOI 10.1016/j.cellimm.2011.10.011; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Lawless VA, 2000, J IMMUNOL, V165, P6803, DOI 10.4049/jimmunol.165.12.6803; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Letimier FA, 2007, EMBO J, V26, P1292, DOI 10.1038/sj.emboj.7601586; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lund R, 2003, J IMMUNOL, V171, P5328, DOI 10.4049/jimmunol.171.10.5328; Lund RJ, 2003, EUR J IMMUNOL, V33, P1105, DOI 10.1002/eji.200323899; McCracken SA, 2007, EUR J IMMUNOL, V37, P1386, DOI 10.1002/eji.200636322; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nishikomori R, 2002, J IMMUNOL, V169, P4388, DOI 10.4049/jimmunol.169.8.4388; Palaty CK, 1997, BIOCHEM CELL BIOL, V75, P153, DOI 10.1139/bcb-75-2-153; Peltola KJ, 2004, BLOOD, V103, P3744, DOI 10.1182/blood-2003-09-3126; Peng C, 2007, J BIOCHEM, V141, P353, DOI 10.1093/jb/mvm040; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Porter CM, 2002, J IMMUNOL, V168, P4936, DOI 10.4049/jimmunol.168.10.4936; Rainio EM, 2002, J IMMUNOL, V168, P1524, DOI 10.4049/jimmunol.168.4.1524; Rautajoki KJ, 2008, ANN MED, V40, P322, DOI 10.1080/07853890802068582; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Tahvanainen J, 2006, J IMMUNOL METHODS, V310, P30, DOI 10.1016/j.jim.2005.11.024; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang Z, 2001, J Vet Sci, V2, P167; White E, 2003, GENE DEV, V17, P1813, DOI 10.1101/gad.1123103; Yamamoto J, 2000, J LEUKOCYTE BIOL, V68, P568; Ylikoski E, 2005, EUR J IMMUNOL, V35, P3297, DOI 10.1002/eji.200526101; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	60	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3048	3058		10.1074/jbc.M112.361709	http://dx.doi.org/10.1074/jbc.M112.361709			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23209281	Green Published, hybrid			2022-12-28	WOS:000314397900015
J	Woo, SK; Kwon, MS; Ivanov, A; Gerzanich, V; Simard, JM				Woo, Seung Kyoon; Kwon, Min Seong; Ivanov, Alexander; Gerzanich, Volodymyr; Simard, J. Marc			The Sulfonylurea Receptor 1 (Sur1)-Transient Receptor Potential Melastatin 4 (Trpm4) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNEL; K-ATP CHANNELS; SENSITIVE POTASSIUM CHANNELS; SPINAL-CORD-INJURY; ADULT-RAT BRAIN; REACTIVE ASTROCYTES; CELLS; SUR1; STOICHIOMETRY; TRAFFICKING	The sulfonylurea receptor 1 (Sur1)-NCCa-ATP channel plays a central role in necrotic cell death in central nervous system (CNS) injury, including ischemic stroke, and traumatic brain and spinal cord injury. Here, we show that Sur1-NCCa-ATP channels are formed by co-assembly of Sur1 and transient receptor potential melastatin 4 (Trpm4). Co-expression of Sur1 and Trpm4 yielded Sur1-Trpm4 heteromers, as shown in experiments with Forster resonance energy transfer (FRET) and co-immunoprecipitation. Co-expression of Sur1 and Trpm4 also yielded functional Sur1-Trpm4 channels with biophysical properties of Trpm4 and pharmacological properties of Sur1. Co-assembly with Sur1 doubled the affinity of Trpm4 for calmodulin and doubled its sensitivity to intracellular calcium. Experiments with FRET and co-immunoprecipitation showed de novo appearance of Sur1-Trpm4 heteromers after spinal cord injury in rats. Our findings depart from the long-held view of an exclusive association between Sur1 and K-ATP channels and reveal an unexpected molecular partnership with far-ranging implications for CNS injury.	[Woo, Seung Kyoon; Kwon, Min Seong; Ivanov, Alexander; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Simard, JM (corresponding author), Univ Maryland, Dept Neurosurg, 22 S Greene St,Suite S12D, Baltimore, MD 21201 USA.	msimard@smail.umaryland.edu			National Institutes of Health [NS060801, NS061808, HL082517, NS061934, NS072501]; Department of Veterans Affairs (Baltimore, MD); Department of the Army [W81XWH 1010898]; Christopher and Dana Reeve Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060801, R01NS061934, R01NS061808, R01NS072501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs (Baltimore, MD)(US Department of Veterans Affairs); Department of the Army; Christopher and Dana Reeve Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS060801 and NS061808 (NINDS) and HL082517 (NHLBI) (to J. M. S.) and NS061934 and NS072501 (NINDS) (to V. G.). This work was also supported by grants from the Department of Veterans Affairs (Baltimore, MD), the Department of the Army (Grant W81XWH 1010898), and the Christopher and Dana Reeve Foundation (to J. M. S.). J. M. S. holds a United States patent (Number 7,285,574), "A novel non-selective cation channel in neural cells and methods for treating brain swelling." J. M. S. is a member of the scientific advisory board and holds shares in Remedy Pharmaceuticals. No support, direct or indirect, was provided to J. M. S., or for this project, by Remedy Pharmaceuticals.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Conti LR, 2002, J BIOL CHEM, V277, P25416, DOI 10.1074/jbc.M203109200; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; GILLIS KD, 1989, AM J PHYSIOL, V257, pC1119, DOI 10.1152/ajpcell.1989.257.6.C1119; Guinamard R, 2011, ADV EXP MED BIOL, V704, P147, DOI 10.1007/978-94-007-0265-3_8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Hyun YM, 2009, J IMMUNOL, V183, P359, DOI 10.4049/jimmunol.0803388; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Meissner M, 2011, TRP CHANNELS, P135; Mikhailov MV, 2001, FEBS LETT, V499, P154, DOI 10.1016/S0014-5793(01)02538-8; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Sala-Rabanal M, 2012, J BIOL CHEM, V287, P8746, DOI 10.1074/jbc.M111.336131; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2012, PFLUG ARCH EUR J PHY, V464, P573, DOI 10.1007/s00424-012-1166-z; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Song MY, 2010, ADV EXP MED BIOL, V661, P99, DOI 10.1007/978-1-60761-500-2_6; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vennekens R., 2007, V179, P269; Vila-Carriles WH, 2007, FASEB J, V21, P18, DOI 10.1096/fj.06-6730hyp; Winkler M, 2009, J BIOL CHEM, V284, P6752, DOI 10.1074/jbc.M805435200; Yoshida H, 2004, J MOL CELL CARDIOL, V37, P857, DOI 10.1016/j.yjmcc.2004.05.022; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	38	127	140	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3655	3667		10.1074/jbc.M112.428219	http://dx.doi.org/10.1074/jbc.M112.428219			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255597	Green Published, hybrid			2022-12-28	WOS:000314397900069
J	Hussain, I; Fabregue, J; Anderes, L; Ousson, S; Borlat, F; Eligert, V; Berger, S; Dimitrov, M; Alattia, JR; Fraering, PC; Beher, D				Hussain, Ishrut; Fabregue, Julien; Anderes, Laurence; Ousson, Solenne; Borlat, Frederic; Eligert, Valerie; Berger, Sebastien; Dimitrov, Mitko; Alattia, Jean-Rene; Fraering, Patrick C.; Beher, Dirk			The Role of gamma-Secretase Activating Protein (GSAP) and Imatinib in the Regulation of gamma-Secretase Activity and Amyloid-beta Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; INHIBITOR; PRECURSOR; PURIFICATION; MODULATION; COMPLEX	gamma-Secretase is a large enzyme complex comprising presenilin, nicastrin, presenilin enhancer 2, and anterior pharynx-defective 1 that mediates the intramembrane proteolysis of a large number of proteins including amyloid precursor protein and Notch. Recently, a novel gamma-secretase activating protein (GSAP) was identified that interacts with gamma-secretase and the C-terminal fragment of amyloid precursor protein to selectively increase amyloid-beta production. In this study we have further characterized the role of endogenous and exogenous GSAP in the regulation of gamma-secretase activity and amyloid-beta production in vitro. Knockdown of GSAP expression in N2a cells decreased amyloid-beta levels. In contrast, overexpression of GSAP in HEK cells expressing amyloid precursor protein or in N2a cells had no overt effect on amyloid-beta generation. Likewise, purified recombinant GSAP had no effect on amyloid-beta generation in two distinct in vitro gamma-secretase assays. In subsequent cellular studies with imatinib, a kinase inhibitor that reportedly prevents the interaction of GSAP with the C-terminal fragment of amyloid precursor protein, a concentration-dependent decrease in amyloid-beta levels was observed. However, no interaction between GSAP and the C-terminal fragment of amyloid precursor protein was evident in co-immunoprecipitation studies. In addition, subchronic administration of imatinib to rats had no effect on brain amyloid-beta levels. In summary, these findings suggest the roles of GSAP and imatinib in the regulation of gamma-secretase activity and amyloid-beta generation are uncertain.	[Hussain, Ishrut; Fabregue, Julien; Anderes, Laurence; Ousson, Solenne; Eligert, Valerie; Beher, Dirk] Merck Serono SA, Dept Therapeut Area Neurodegenerat Dis, CH-1202 Geneva, Switzerland; [Borlat, Frederic] Merck Serono SA, Dept Prot & Cell Sci, CH-1202 Geneva, Switzerland; [Berger, Sebastien] Merck Serono SA, Dept Quantitat Bioanalyt, D-64293 Darmstadt, Germany; [Dimitrov, Mitko; Alattia, Jean-Rene; Fraering, Patrick C.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	Merck KGaA; EMD Serono Inc.; Merck KGaA; EMD Serono Inc.; Merck KGaA; EMD Serono Inc.; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hussain, I (corresponding author), Merck Serono SA, Dept Therapeut Area Neurodegenerat Dis, Chemin Mines 9, CH-1202 Geneva, Switzerland.	ishruthssn@gmail.com		Beher, Dirk/0000-0001-8005-5359; Fraering, Patrick/0000-0002-5841-5327	Swiss National Science Foundation Grant [31003A_134938/1]; Ecole Polytechnique Federale de Lausanne (EPFL)-Merck Serono grant	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF)); Ecole Polytechnique Federale de Lausanne (EPFL)-Merck Serono grant	This work was supported by Swiss National Science Foundation Grant 31003A_134938/1 (to P. C. F.) and an Ecole Polytechnique Federale de Lausanne (EPFL)-Merck Serono grant (to J. R. A. and M. D.).	Alattia JR, 2011, FASEB J, V25, P2287, DOI 10.1096/fj.10-174078; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bauer C, 2011, J ALZHEIMERS DIS, V27, P511, DOI 10.3233/JAD-2011-110746; Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007; Beher D, 2003, BIOCHEMISTRY-US, V42, P8133, DOI 10.1021/bi034045z; Beher D, 2008, CURR TOP MED CHEM, V8, P34, DOI 10.2174/156802608783334051; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Deatherage CL, 2012, BIOCHEMISTRY-US, V51, P5153, DOI 10.1021/bi300605u; Eisele YS, 2007, MOL BIOL CELL, V18, P3591, DOI 10.1091/mbc.E07-01-0035; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Imbimbo BP, 2011, EXPERT OPIN INV DRUG, V20, P325, DOI 10.1517/13543784.2011.550572; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Pardossi-Piquard R, 2009, J BIOL CHEM, V284, P28634, DOI 10.1074/jbc.M109.059345; Schor NF, 2011, ANN NEUROL, V69, P237, DOI 10.1002/ana.22365; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Sutcliffe JG, 2011, J NEUROSCI RES, V89, P808, DOI 10.1002/jnr.22603; Takayama N, 2002, BRIT J HAEMATOL, V119, P106, DOI 10.1046/j.1365-2141.2002.03881.x; Wolfe MS, 2007, CURR ALZHEIMER RES, V4, P571, DOI 10.2174/156720507783018299; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Wu F, 2010, FASEB J, V24, P2464, DOI 10.1096/fj.09-148031; Xu XM, 2009, J ALZHEIMERS DIS, V16, P211, DOI 10.3233/JAD-2009-0957; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	29	37	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2521	2531		10.1074/jbc.M112.370924	http://dx.doi.org/10.1074/jbc.M112.370924			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23209290	Green Published, hybrid			2022-12-28	WOS:000314211500038
J	Kang, K; Lee, D; Hong, S; Park, SG; Song, MR				Kang, Kyungjoon; Lee, Donghoon; Hong, Seulgi; Park, Sung-Gyoo; Song, Mi-Ryoung			The E3 Ligase Mind Bomb-1 (Mib1) Modulates Delta-Notch Signaling to Control Neurogenesis and Gliogenesis in the Developing Spinal Cord	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; RADIAL GLIAL-CELLS; MOTOR-NEURON; UBIQUITIN LIGASE; OLIGODENDROCYTE SPECIFICATION; ACTIVATE NOTCH; CIS-INHIBITION; DROSOPHILA; INTERNEURON; ASTROCYTES	The Notch signaling pathway is essential for neuronal and glial specification during CNS development. Mind bomb-1 (Mib1) is an E3 ubiquitin ligase that ubiquitinates and promotes the endocytosis of Notch ligands. Although Mib1 is essential for transmitting the Notch signal, it is still unclear whether it is a primary regulator of Notch ligand activity in the developing spinal cord. In Mib1 conditional knock-out mice, we observed depletion of spinal progenitors, premature differentiation of neurons, and unbalanced specification of V2 interneurons, all of which mimic the conventional Notch phenotype. In agreement with this, the reduction of progenitors in the absence of Mib1 led to a loss of both astrocytes and oligodendrocytes. Late removal of Mib1 using a drug-inducible system suppressed glial differentiation, suggesting that Mib1 continues to play a role in the formation of late progenitors mainly designated for gliogenesis. Finally, misexpression of Mib1 or Mib1 deletion mutants revealed that the ring domain of Mib1 is required for the specification of V2 interneurons in the chick neural tube. Together, these findings suggest that Mib1 is a major component of the signal-sending cells required to provide Notch ligand activity for specifying neurons and glia in the spinal cord.	[Song, Mi-Ryoung] Gwangju Inst Sci & Technol, Sch Life Sci, Bioimaging Res Ctr, Kwangju 500712, South Korea; Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju 500712, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Song, MR (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Bioimaging Res Ctr, Kwangju 500712, South Korea.	msong@gist.ac.kr	Park, Sung-Gyoo/H-8652-2019	Park, Sung-Gyoo/0000-0003-3702-5765	National Research Foundation of Korea [2011-0029179, NRF-2008-313-E00343, 2012-0002097]; National Research Foundation of Korea, Cell Dynamics Research Center [2012-0000768]; BioImaging Research Center at Gwangju Institute of Science and Technology; "Basic Research Projects in High-tech Industrial Technology" Project at Gwangju Institute of Science and Technology	National Research Foundation of Korea(National Research Foundation of Korea); National Research Foundation of Korea, Cell Dynamics Research Center; BioImaging Research Center at Gwangju Institute of Science and Technology; "Basic Research Projects in High-tech Industrial Technology" Project at Gwangju Institute of Science and Technology	This work was supported by National Research Foundation of Korea Grants 2011-0029179, NRF-2008-313-E00343, and 2012-0002097, Cell Dynamics Research Center Grant 2012-0000768, and the BioImaging Research Center and "Basic Research Projects in High-tech Industrial Technology" Project at Gwangju Institute of Science and Technology (to M.-R. S.).	Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Barsi JC, 2005, MECH DEVELOP, V122, P1106, DOI 10.1016/j.mod.2005.06.005; Bernardos RL, 2005, DEV BIOL, V278, P381, DOI 10.1016/j.ydbio.2004.11.018; Berndt JD, 2011, J CELL BIOL, V194, P737, DOI 10.1083/jcb.201107021; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Caprioli A, 2002, MECH DEVELOP, V116, P161, DOI 10.1016/S0925-4773(02)00136-3; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; deCelis JF, 1997, DEVELOPMENT, V124, P3241; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Del Barrio MG, 2007, DEVELOPMENT, V134, P3427, DOI 10.1242/dev.005868; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Glittenberg M, 2006, EMBO J, V25, P4697, DOI 10.1038/sj.emboj.7601337; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Haddon C, 1998, DEVELOPMENT, V125, P359; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jin YJ, 2006, J BIOL CHEM, V281, P39033, DOI 10.1074/jbc.M605097200; Kawaguchi D, 2008, DEVELOPMENT, V135, P3849, DOI 10.1242/dev.024570; Kim H, 2008, DEV DYNAM, V237, P2081, DOI 10.1002/dvdy.21620; Klein T, 1997, DEV BIOL, V189, P123, DOI 10.1006/dbio.1997.8564; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Li SG, 2010, GENESIS, V48, P667, DOI 10.1002/dvg.20669; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Mizuguchi R, 2006, NAT NEUROSCI, V9, P770, DOI 10.1038/nn1706; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Panayi H, 2010, J NEUROSCI, V30, P12274, DOI 10.1523/JNEUROSCI.2402-10.2010; Park HC, 2003, DEVELOPMENT, V130, P3747, DOI 10.1242/dev.00576; Peng CY, 2007, NEURON, V53, P813, DOI 10.1016/j.neuron.2007.02.019; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Pringle NP, 2003, DEVELOPMENT, V130, P93, DOI 10.1242/dev.00184; Rabadan MA, 2012, CELL DEATH DIFFER, V19, P209, DOI 10.1038/cdd.2011.84; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Shimada IS, 2011, STROKE, V42, P3231, DOI 10.1161/STROKEAHA.111.623280; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Weinmaster G, 2011, DEV CELL, V21, P134, DOI 10.1016/j.devcel.2011.06.006; Yang XD, 2006, DEV NEUROSCI-BASEL, V28, P102, DOI 10.1159/000090757; Yeh E, 2000, EMBO J, V19, P4827, DOI 10.1093/emboj/19.17.4827; Yeo SY, 2007, P NATL ACAD SCI USA, V104, P5913, DOI 10.1073/pnas.0607062104; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018	58	33	35	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2580	2592		10.1074/jbc.M112.398263	http://dx.doi.org/10.1074/jbc.M112.398263			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223237	Green Published, hybrid			2022-12-28	WOS:000314211500043
J	Cao, J; Burke, JE; Dennis, EA				Cao, Jian; Burke, John E.; Dennis, Edward A.			Using Hydrogen/Deuterium Exchange Mass Spectrometry to Define the Specific Interactions of the Phospholipase A(2) Superfamily with Lipid Substrates, Inhibitors, and Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACTIVATING-FACTOR ACETYLHYDROLASE; BETA(2) ADRENERGIC-RECEPTOR; LOW-DENSITY-LIPOPROTEIN; GROUP HYDROGEN-EXCHANGE; MITOTIC KINESIN EG5; CRYSTAL-STRUCTURE; C2 DOMAIN; MOLECULAR-BASIS; BINDING SURFACE; PROTEIN	The phospholipase A(2) (PLA(2)) superfamily consists of 16 groups and many subgroups and constitutes a diverse set of enzymes that have a common catalytic activity due to convergent evolution. However, different PLA(2) types have unique three-dimensional structures and catalytic residues as well as specific tissue localization and distinct biological functions. Understanding how the different PLA(2) enzymes associate with phospholipid membranes, specific phospholipid substrate molecules, and inhibitors on a molecular basis has advanced in recent years due to the introduction of hydrogen/deuterium exchange mass spectrometry. Its theory, practical considerations, and application to understanding PLA(2)/membrane interactions are addressed.	[Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Dennis, EA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	edennis@ucsd.edu	Burke, John/H-3922-2019; Dennis, Edward A./M-5554-2019	Burke, John/0000-0001-7904-9859; Dennis, Edward A./0000-0003-3738-3140	National Institutes of Health [R01 GM20501-37]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM20501-37.	BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAI YW, 1994, PROTEINS, V20, P4, DOI 10.1002/prot.340200103; Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Bezzine S, 2002, J BIOL CHEM, V277, P48523, DOI 10.1074/jbc.M203137200; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Brier S, 2006, RAPID COMMUN MASS SP, V20, P456, DOI 10.1002/rcm.2329; Brier S, 2006, J MOL BIOL, V360, P360, DOI 10.1016/j.jmb.2006.04.062; Burke JE, 2008, J BIOL CHEM, V283, P31227, DOI 10.1074/jbc.M804492200; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; Burke JE, 2011, STRUCTURE, V19, P1127, DOI 10.1016/j.str.2011.06.003; Burke JE, 2009, J AM CHEM SOC, V131, P8083, DOI 10.1021/ja900098y; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Cao J, 2013, J LIPID RES, V54, P127, DOI 10.1194/jlr.M030221; Cao J, 2011, BIOCHEMISTRY-US, V50, P5314, DOI 10.1021/bi101916w; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Changeux JP, 2010, ANNU REV PHARMACOL, V50, P1, DOI 10.1146/annurev.pharmtox.010909.105741; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; Davis B, 2008, J BIOL CHEM, V283, P6428, DOI 10.1074/jbc.M709970200; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Fernandes F, 2004, BIOPHYS J, V87, P344, DOI 10.1529/biophysj.104.040337; FREMONT DH, 1993, P NATL ACAD SCI USA, V90, P342, DOI 10.1073/pnas.90.1.342; Hamuro Y, 2002, J MOL BIOL, V321, P703, DOI 10.1016/S0022-2836(02)00419-9; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Hsu YH, 2008, J BIOL CHEM, V283, P9820, DOI 10.1074/jbc.M708143200; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Karabina SA, 2010, BIOCHIMIE, V92, P594, DOI 10.1016/j.biochi.2010.02.002; Kimberlin CR, 2010, P NATL ACAD SCI USA, V107, P314, DOI 10.1073/pnas.0910547107; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lin Y, 1998, SCIENCE, V279, P1925, DOI 10.1126/science.279.5358.1925; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; Liu T, 2012, J AM SOC MASS SPECTR, V23, P43, DOI 10.1007/s13361-011-0267-9; Magrioti V, 2010, EXPERT OPIN THER PAT, V20, P1, DOI 10.1517/13543770903463905; Malmberg NJ, 2003, BIOCHEMISTRY-US, V42, P13227, DOI 10.1021/bi035119+; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; Min JH, 1999, BIOCHEMISTRY-US, V38, P12935, DOI 10.1021/bi991149u; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; Pan YH, 2010, BBA-PROTEINS PROTEOM, V1804, P1443, DOI 10.1016/j.bbapap.2010.03.004; Pang XY, 2012, J BIOL CHEM, V287, P35260, DOI 10.1074/jbc.M112.398859; Percy AJ, 2012, ANAL CHIM ACTA, V721, P7, DOI 10.1016/j.aca.2012.01.037; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Samanta U, 2008, J BIOL CHEM, V283, P31617, DOI 10.1074/jbc.M804750200; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; Scott KF, 2010, BIOCHIMIE, V92, P601, DOI 10.1016/j.biochi.2010.03.019; Skinner JJ, 2012, PROTEIN SCI, V21, P996, DOI 10.1002/pro.2081; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; Stafforini DM, 1999, J BIOL CHEM, V274, P7018, DOI 10.1074/jbc.274.11.7018; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; West GM, 2011, STRUCTURE, V19, P1424, DOI 10.1016/j.str.2011.08.001; WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787; Winget JM, 2006, BBA-MOL CELL BIOL L, V1761, P1260, DOI 10.1016/j.bbalip.2006.08.002	63	45	46	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1806	1813		10.1074/jbc.R112.421909	http://dx.doi.org/10.1074/jbc.R112.421909			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23209293	Green Published, hybrid			2022-12-28	WOS:000313751400036
J	Caruthers, MH				Caruthers, Marvin H.			The Chemical Synthesis of DNA/RNA: Our Gift to Science	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							POLYMER; PHOSPHORAMIDITES	It is a great privilege to contribute to the Reflections essays. In my particular case, this essay has allowed me to weave some of my major scientific contributions into a tapestry held together by what I have learned from three colleagues (Robert Letsinger, Gobind Khorana, and George Rathmann) who molded my career at every important junction. To these individuals, I remain eternally grateful, as they always led by example and showed many of us how to break new ground in both science and biotechnology. Relative to my scientific career, I have focused primarily on two related areas. The first is methodologies we developed for chemically synthesizing DNA and RNA. Synthetic DNA and RNA continue to be an essential research tool for biologists, biochemists, and molecular biologists. The second is developing new approaches for solving important biological problems using synthetic DNA, RNA, and their analogs.	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA	University of Colorado System; University of Colorado Boulder	Caruthers, MH (corresponding author), Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA.	marvin.caruthers@colorado.edu						BEAUCAGE SL, 1981, TETRAHEDRON LETT, V22, P1859, DOI 10.1016/S0040-4039(01)90461-7; Caruthers M. H., 1987, STRUCTURE EXPRESSION, P157; Dellinger DJ, 2011, J AM CHEM SOC, V133, P11540, DOI 10.1021/ja201561z; DUBENDORFF JW, 1987, J BIOL CHEM, V262, P892; GOEDDEL DV, 1978, P NATL ACAD SCI USA, V75, P3578, DOI 10.1073/pnas.75.8.3578; HUBBARD AJ, 1990, BIOCHEMISTRY-US, V29, P9241, DOI 10.1021/bi00491a019; KHORANA HG, 1972, J MOL BIOL, V72, P209, DOI 10.1016/0022-2836(72)90146-5; KHORANA HG, 1968, BIOCHEM J, V109, P709, DOI 10.1042/bj1090709c; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; LETSINGE.RL, 1965, J AM CHEM SOC, V87, P3526, DOI 10.1021/ja01093a058; LETSINGE.RL, 1967, BIOCHEMISTRY-US, V6, P1379, DOI 10.1021/bi00857a021; LETSINGER RL, 1963, J AM CHEM SOC, V85, P3045, DOI 10.1021/ja00902a054; LETSINGER RL, 1967, J AM CHEM SOC, V89, P7146, DOI 10.1021/ja01002a074; MATTEUCCI MD, 1981, J AM CHEM SOC, V103, P3185, DOI 10.1021/ja00401a041; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Scaringe SA, 1998, J AM CHEM SOC, V120, P11820, DOI 10.1021/ja980730v	16	47	71	6	69	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1420	1427		10.1074/jbc.X112.442855	http://dx.doi.org/10.1074/jbc.X112.442855			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23223445	hybrid, Green Published			2022-12-28	WOS:000313570300062
J	Tsuruoka, N; Arima, M; Yoshida, N; Okada, S; Sakamoto, A; Hatano, M; Satake, H; Arguni, E; Wang, JY; Yang, JH; Nishikura, K; Sekiya, S; Shozu, M; Tokuhisa, T				Tsuruoka, Nobuhide; Arima, Masafumi; Yoshida, Nobuya; Okada, Seiji; Sakamoto, Akemi; Hatano, Masahiko; Satake, Hisae; Arguni, Eggi; Wang, Ji-Yang; Yang, Jing-Hua; Nishikura, Kazuko; Sekiya, Souei; Shozu, Makio; Tokuhisa, Takeshi			ADAR1 Protein Induces Adenosine-targeted DNA Mutations in Senescent Bcl6 Gene-deficient Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; GERMINAL-CENTER FORMATION; CYTIDINE DEAMINASE AID; CENTER B-CELLS; ACTIVATION-INDUCED DEAMINASE; CLASS SWITCH RECOMBINATION; RNA-EDITING ENZYME; CD8(+) T-CELLS; SOMATIC HYPERMUTATION; POLYMERASE-ETA	Somatic mutations accumulate in senescent cells. Bcl6, which functions as a transcriptional repressor, has been identified as a potent inhibitor of cell senescence, but a role of Bcl6 in the accumulation of somatic mutations has remained unclear. Ig class-switch recombination simultaneously induces somatic mutations in an IgM class-switch (Ig-S mu) region of IgG B cells. Surprisingly, mutations were detected in the Ig-S mu region of Bcl6-deficient IgM B cells without class-switch recombination, and these mutations were mainly generated by conversion of adenosine to guanosine, suggesting a novel DNA mutator in the B cells. The ADAR1 (adenosine deaminase acting on RNA1) gene was overexpressed in Bcl6-deficient cells, and its promoter analysis revealed that ADAR1 is a molecular target of Bcl6. Exogenous ADAR1 induced adenosine-targeted DNA mutations in IgM B cells from ADAR1-transgenic mice and in wild-type mouse embryonic fibroblasts (MEFs). These mutations accumulated in senescent MEFs accompanied with endogenous ADAR1 expression, and the frequency in senescent Bcl6-deficient MEFs was higher than senescent wild-type MEFs. Thus, Bcl6 protects senescent cells from accumulation of adenosine-targeted DNA mutations induced by ADAR1.	[Tokuhisa, Takeshi] Chiba Univ, Grad Sch Med, Dept Dev Genet H2, Chuo Ku, Chiba 2608670, Japan; [Tsuruoka, Nobuhide; Sekiya, Souei; Shozu, Makio] Chiba Univ, Grad Sch Med, Dept Reprod Med G4, Chiba 2608670, Japan; [Hatano, Masahiko] Chiba Univ, Grad Sch Med, Dept Biomed Sci M14, Chiba 2608670, Japan; [Okada, Seiji] Kumamoto Univ, Ctr AIDS Res, Div Hematopoiesis, Kumamoto, Japan; [Wang, Ji-Yang] RIKEN Res Ctr Allergy & Immunol, Lab Immune Divers, Yokohama, Kanagawa, Japan; [Yang, Jing-Hua] Boston Univ, Sch Med, Dept Surg, Boston, MA 02130 USA; [Nishikura, Kazuko] Wistar Inst Anat & Biol, Dept Gene Express & Regulat, Philadelphia, PA 19104 USA	Chiba University; Chiba University; Chiba University; Kumamoto University; RIKEN; Boston University; The Wistar Institute	Tokuhisa, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Dev Genet H2, Chuo Ku, Inohana 1-8-1, Chiba 2608670, Japan.	tokuhisa@faculty.chiba-u.jp	Arima, Masafumi/L-1951-2018; Arguni, Eggi/AFO-5492-2022; Okada, Seiji/F-5785-2013	Arima, Masafumi/0000-0002-5169-7536; Arguni, Eggi/0000-0001-7462-7904; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan; National Institutes of Health; Ellison Medical Foundation; Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health; Grants-in-Aid for Scientific Research [25460380, 25460604] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan. The work was also supported by grants from the National Institutes of Health, the Ellison Medical Foundation, and the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health (to K. N.).	Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Eckmann CR, 2001, MOL BIOL CELL, V12, P1911, DOI 10.1091/mbc.12.7.1911; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; George CX, 1999, GENE, V229, P203, DOI 10.1016/S0378-1119(99)00017-7; Goodman Myron F, 2007, Adv Immunol, V94, P127, DOI 10.1016/S0065-2776(06)94005-X; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Karanjawala ZE, 2004, MECH AGEING DEV, V125, P405, DOI 10.1016/j.mad.2004.04.003; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Maas S, 2003, J BIOL CHEM, V278, P1391, DOI 10.1074/jbc.R200025200; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muramatsu Masamichi, 2007, Adv Immunol, V94, P1, DOI 10.1016/S0065-2776(06)94001-2; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Odegard VH, 2005, IMMUNITY, V23, P101, DOI 10.1016/j.immuni.2005.05.007; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Steele EJ, 2006, DNA REPAIR, V5, P1346, DOI 10.1016/j.dnarep.2006.06.002; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Takeda N, 2003, J IMMUNOL, V171, P426, DOI 10.4049/jimmunol.171.1.426; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; WILDIN RS, 1995, J IMMUNOL, V155, P1286; Wolf FI, 2002, EXP GERONTOL, V37, P647, DOI 10.1016/S0531-5565(02)00005-0; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9; Yang JH, 2003, J BIOL CHEM, V278, P45833, DOI 10.1074/jbc.M308612200; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yoshida K, 2006, EUR J IMMUNOL, V36, P3146, DOI 10.1002/eji.200636165; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	53	10	10	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					826	836		10.1074/jbc.M112.365718	http://dx.doi.org/10.1074/jbc.M112.365718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23209284	Green Published, hybrid			2022-12-28	WOS:000313570300008
J	Sproviero, D; Julien, S; Burford, B; Taylor-Papadimitriou, J; Burchell, JM				Sproviero, Daisy; Julien, Sylvain; Burford, Brian; Taylor-Papadimitriou, Joyce; Burchell, Joy M.			Cyclooxygenase-2 Enzyme Induces the Expression of the alpha-2,3-Sialyltransferase-3 (ST3Gal-I) in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELL MATURATION; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; UP-REGULATION; GLYCOSYLATION; GLYCOSYLTRANSFERASES; METASTASIS; EP4; ANGIOGENESIS; ACTIVATION	Aberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the core 2-based glycans observed in normal mammary epithelium cells. This has been shown, in part, to be due to changes in the expression of glycosyltransferases, including the up-regulation of some sialyltransferases. Using the breast cancer cell line T47D, we have shown that PGE2, one of the final products of the cyclooxygenase-2 (COX-2) pathway, can induce the mRNA expression of the sialyltransferase alpha-2,3-sialyltransferase-3 (ST3Gal-I), resulting in increased sialyltransferase activity, demonstrated by a reduction in PNA lectin staining. Induction of COX-2 in the MDA-MB- 231 breast cancer cell line also results in the increased expression of ST3Gal-I, leading to increased sialylation of the substrate of ST3Gal-I, core 1 Gal beta 1,3GalNAc. This effect on sialylation could be reversed by the selective COX-2 inhibitor celecoxib. The use of siRNA to knock down COX-2 and overexpression of COX-2 in MDA-MD-231 cells confirmed the involvement of COX-2 in the up-regulation of ST3Gal-I. Moreover, analysis of the expression of ST3Gal-I and COX-2 by 74 primary breast cancers showed a significant correlation between the two enzymes. COX-2 expression has been associated with a number of tumors, including breast cancer, where its expression is associated with poor prognoses. Thus, these results suggest the intriguing possibility that some of the malignant characteristics associated with COX-2 expression may be via the influence that COX-2 exerts on the glycosylation of tumor cells.	[Sproviero, Daisy; Julien, Sylvain; Burford, Brian; Taylor-Papadimitriou, Joyce; Burchell, Joy M.] Kings Coll London, Breast Canc Biol Lab, Guys Hosp, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Burchell, JM (corresponding author), Kings Coll London, Breast Canc Biol Lab, Guys Hosp, 3rd Floor, London SE1 9RT, England.	joy.burchell@kcl.ac.uk	Sproviero, Daisy/AAB-8752-2019; Sproviero, Daisy/GSN-0961-2022	Sproviero, Daisy/0000-0001-5061-683X; Burchell, Joy/0000-0003-0413-3823	Breast Cancer Campaign [2008NovPhD28]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's; St Thomas' National Health Service Foundation Trust and King's College London; Experimental Cancer Medicine Centre at King's College London	Breast Cancer Campaign; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's(National Institute for Health Research (NIHR)); St Thomas' National Health Service Foundation Trust and King's College London; Experimental Cancer Medicine Centre at King's College London	This work was supported by Grant 2008NovPhD28 from the Breast Cancer Campaign and supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service Foundation Trust and King's College London. This work was also supported by the Experimental Cancer Medicine Centre at King's College London.	Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Boland GP, 2004, BRIT J CANCER, V90, P423, DOI 10.1038/sj.bjc.6601534; BOURIN MC, 1982, CARCINOGENESIS, V3, P671, DOI 10.1093/carcin/3.6.671; BROCKHAUSEN I, 1995, EUR J BIOCHEM, V233, P607, DOI 10.1111/j.1432-1033.1995.607_2.x; Brunner C, 2000, J IMMUNOL, V165, P6278, DOI 10.4049/jimmunol.165.11.6278; Burchell J, 1999, GLYCOBIOLOGY, V9, P1307, DOI 10.1093/glycob/9.12.1307; Burchell JM, 2001, J MAMMARY GLAND BIOL, V6, P355, DOI 10.1023/A:1011331809881; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Costa C, 2002, J CLIN PATHOL, V55, P429, DOI 10.1136/jcp.55.6.429; Dalziel M, 2001, J BIOL CHEM, V276, P11007, DOI 10.1074/jbc.M006523200; Davies G, 2003, CLIN CANCER RES, V9, P2651; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Eltze E, 2005, INT J ONCOL, V26, P1525; FITZPATRICK FA, 1980, PROSTAGLANDINS, V19, P917, DOI 10.1016/0090-6980(80)90126-4; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Higai K, 2006, BIOL PHARM BULL, V29, P2372, DOI 10.1248/bpb.29.2372; Julien S, 2007, J IMMUNOL, V179, P5701, DOI 10.4049/jimmunol.179.9.5701; Julien S, 2011, CANCER RES, V71, P7683, DOI 10.1158/0008-5472.CAN-11-1139; Kudo T, 1998, LAB INVEST, V78, P797; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Legler DF, 2006, J IMMUNOL, V176, P966, DOI 10.4049/jimmunol.176.2.966; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Mungul A, 2004, INT J ONCOL, V25, P937; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Nishigaki N, 1996, MOL PHARMACOL, V50, P1031; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ono M, 2003, GLYCOCONJUGATE J, V20, P71, DOI 10.1023/B:GLYC.0000018019.22070.7d; Pan MR, 2008, J BIOL CHEM, V283, P11155, DOI 10.1074/jbc.M710038200; Picco G, 2010, GLYCOBIOLOGY, V20, P1241, DOI 10.1093/glycob/cwq085; Potapenko IO, 2010, MOL ONCOL, V4, P98, DOI 10.1016/j.molonc.2009.12.001; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Ristimaki A, 2002, CANCER RES, V62, P632; Son SW, 2011, BIOCHEM BIOPH RES CO, V414, P159, DOI 10.1016/j.bbrc.2011.09.043; Stasinopoulos I, 2007, MOL CANCER RES, V5, P435, DOI 10.1158/1541-7786.MCR-07-0010; Subbaramaiah K, 2008, J BIOL CHEM, V283, P3433, DOI 10.1074/jbc.M705409200; Takkouche B, 2008, JNCI-J NATL CANCER I, V100, P1439, DOI 10.1093/jnci/djn324; Taniguchi A, 2001, GLYCOBIOLOGY, V11, P241, DOI 10.1093/glycob/11.3.241; Tsuboi S, 2001, BIOESSAYS, V23, P46, DOI 10.1002/1521-1878(200101)23:1<46::AID-BIES1006>3.3.CO;2-V; Videira PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-357	40	20	21	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44490	44497		10.1074/jbc.M112.427827	http://dx.doi.org/10.1074/jbc.M112.427827			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23275522	Green Published, Bronze			2022-12-28	WOS:000312938600045
J	Bradburne, CE; Verhoeven, AB; Manyam, GC; Chaudhry, SA; Chang, EL; Thach, DC; Bailey, CL; van Hoek, ML				Bradburne, Christopher E.; Verhoeven, Anne B.; Manyam, Ganiraju C.; Chaudhry, Saira A.; Chang, Eddie L.; Thach, Dzung C.; Bailey, Charles L.; van Hoek, Monique L.			Temporal Transcriptional Response during Infection of Type II Alveolar Epithelial Cells with Francisella tularensis Live Vaccine Strain (LVS) Supports a General Host Suppression and Bacterial Uptake by Macropinocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSE; MURINE MACROPHAGES; MICROARRAY ANALYSIS; RESPIRATORY CHALLENGE; PULMONARY INFECTION; TULAREMIA VACCINE; YERSINIA EFFECTOR; INDUCED APOPTOSIS; HUMAN MONOCYTES; SEVERE SEPSIS	Pneumonic tularemia is caused by inhalation of Francisella tularensis, one of the most infectious microbes known. We wanted to study the kinetics of the initial and early interactions between bacterium and host cells in the lung. To do this, we examined the infection of A549 airway epithelial cells with the live vaccine strain (LVS) of F. tularensis. A549 cells were infected and analyzed for global transcriptional response at multiple time points up to 16 h following infection. At 15 min and 2 h, a strong transcriptional response was observed including cytoskeletal rearrangement, intracellular transport, and interferon signaling. However, at later time points (6 and 16 h), very little differential gene expression was observed, indicating a general suppression of the host response consistent with other reported cell lines and murine tissues. Genes for macropinocytosis and actin/cytoskeleton rearrangement were highly up-regulated and common to the 15 min and 2 h time points, suggesting the use of this method for bacterial entry into cells. We demonstrate macropinocytosis through the uptake of FITC-dextran and amiloride inhibition of Francisella LVS uptake. Our results suggest that macropinocytosis is a potential mechanism of intracellular entry by LVS and that the host cell response is suppressed during the first 2-6 h of infection. These results suggest that the attenuated Francisella LVS induces significant host cell signaling at very early time points after the bacteria's interaction with the cell.	[Bradburne, Christopher E.; Chang, Eddie L.; Thach, Dzung C.] USN, Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA; [Bradburne, Christopher E.] Johns Hopkins Univ, Appl Phys Lab, Asymmetr Operat Dept, Laurel, MD 20723 USA; [Verhoeven, Anne B.; Manyam, Ganiraju C.; Chaudhry, Saira A.; van Hoek, Monique L.] George Mason Univ, Sch Syst Biol, Manassas, VA 20110 USA; [Manyam, Ganiraju C.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Thach, Dzung C.] NIAID, NIH, Bethesda, MD 20892 USA; [Bailey, Charles L.; van Hoek, Monique L.] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; George Mason University; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); George Mason University	van Hoek, ML (corresponding author), George Mason Univ, Discovery Hall,MSN 1H8,10910 Univ Blvd, Manassas, VA 20110 USA.	mvanhoek@gmu.edu	Manyam, Ganiraju/E-9150-2012; van Hoek, Monique/E-1629-2011; Manyam, Ganiraju C/B-5890-2014	Manyam, Ganiraju/0000-0001-6006-8961; van Hoek, Monique/0000-0003-1679-4899; Bradburne, Christopher/0000-0003-4968-8208; Ahmad, Saira/0000-0002-5339-7211	Joint Science and Technology Office for Chemical and Biological Defense/Defense Threat Reduction Agency; U.S. Army Medical Research and Material Command [W81XWH-06-C-0360, HDTRA1-12-C-0039]; National Research Council	Joint Science and Technology Office for Chemical and Biological Defense/Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Research Council(Consiglio Nazionale delle Ricerche (CNR))	This work was supported through the Joint Science and Technology Office for Chemical and Biological Defense/Defense Threat Reduction Agency and contracted through the U.S. Army Medical Research and Material Command under Contract No. W81XWH-06-C-0360 (to A. B. V., C. L. B., and M. V. H.) and HDTRA1-12-C-0039 (to M. V. H.).; Supported by a fellowship from the National Research Council while at the Center for Bio/Molecular Science and Engineering/United States Naval Research Laboratory and by internal funding from the Asymmetric Operations Department while at Johns Hopkins University/Applied Physics Laboratory.	Ahmad S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-123; Akimana C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011025; Alvord WG, 2007, BRIEF BIOINFORM, V8, P415, DOI 10.1093/bib/bbm043; Andersson H, 2006, J MED MICROBIOL, V55, P1023, DOI 10.1099/jmm.0.46553-0; Asare R, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00145; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Chong A, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00138; Clemens DL, 2012, INFECT IMMUN, V80, P952, DOI 10.1128/IAI.05221-11; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Cole LE, 2006, J IMMUNOL, V176, P6888, DOI 10.4049/jimmunol.176.11.6888; Cole LE, 2011, J LEUKOCYTE BIOL, V90, P787, DOI 10.1189/jlb.0111014; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DRABICK JJ, 1994, AM J MED SCI, V308, P83, DOI 10.1097/00000441-199408000-00003; Duits LA, 2002, IMMUNOLOGY, V106, P517, DOI 10.1046/j.1365-2567.2002.01430.x; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Garcia-Perez BE, 2008, MICROB PATHOGENESIS, V45, P1, DOI 10.1016/j.micpath.2008.01.009; Garcia-Perez BE, 2003, MICROB PATHOGENESIS, V35, P49, DOI 10.1016/S0882-4010(03)00089-5; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Han S, 2008, BIOCHEM BIOPH RES CO, V371, P670, DOI 10.1016/j.bbrc.2008.04.092; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hrstka R, 2005, MICROBES INFECT, V7, P619, DOI 10.1016/j.micinf.2004.12.020; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lai XH, 2003, INFECT IMMUN, V71, P4642, DOI 10.1128/IAI.71.8.4642-4646.2003; Lai XH, 2004, MICROB PATHOGENESIS, V37, P225, DOI 10.1016/j.micpath.2004.07.002; Law HT, 2011, SCI REP-UK, V1, DOI 10.1038/srep00192; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Lindemann SR, 2007, INFECT IMMUN, V75, P3178, DOI 10.1128/IAI.01811-06; Lundequist A, 2011, MOL IMMUNOL, V48, P1753, DOI 10.1016/j.molimm.2011.04.017; MacRedmond R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-116; Malik M, 2007, J IMMUNOL, V178, P1013, DOI 10.4049/jimmunol.178.2.1013; Mares CA, 2008, INFECT IMMUN, V76, P3001, DOI 10.1128/IAI.00215-08; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Meibom KL, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00140; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Nikolsky Y, 2005, DRUG DISCOV TODAY, V10, P653, DOI 10.1016/S1359-6446(05)03420-3; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rajaram MVS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007919; Ranjard L, 2003, APPL ENVIRON MICROB, V69, P3784, DOI 10.1128/AEM.69.7.3784-3790.2003; RAZAK AA, 1990, BIOL TRACE ELEM RES, V25, P187, DOI 10.1007/BF02990413; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Roden JC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-194; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, AM J MED SCI, V241, P689, DOI 10.1097/00000441-196106000-00001; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1498, DOI 10.1099/mic.0.025445-0; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Sharma J, 2009, J LEUKOCYTE BIOL, V86, P491, DOI 10.1189/jlb.1208728; Shin S, 2008, CELL MICROBIOL, V10, P1209, DOI 10.1111/j.1462-5822.2008.01145.x; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; SMYTH GK, 2007, LIMMA LINEAR MODELS; STADTMAN T C, 1989, Biofactors, V2, P35; Stadtman TC, 2002, J BIOL CHEM, V277, P49091, DOI 10.1074/jbc.X200005200; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veiga E, 2005, TRENDS CELL BIOL, V15, P2, DOI 10.1016/j.tcb.2004.11.005; Waag DM, 1996, FEMS IMMUNOL MED MIC, V13, P205, DOI 10.1111/j.1574-695X.1996.tb00238.x; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Wilson JE, 2009, INFECT IMMUN, V77, P4953, DOI 10.1128/IAI.00844-09; Wu TH, 2009, VACCINE, V27, P4684, DOI 10.1016/j.vaccine.2009.05.060	79	14	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10780	10791		10.1074/jbc.M112.362178	http://dx.doi.org/10.1074/jbc.M112.362178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23322778	Green Published, hybrid			2022-12-28	WOS:000317565000056
J	Midde, K; Rich, R; Marandos, P; Fudala, R; Li, A; Gryczynski, I; Borejdo, J				Midde, Krishna; Rich, Ryan; Marandos, Peter; Fudala, Rafal; Li, Amy; Gryczynski, Ignacy; Borejdo, Julian			Comparison of Orientation and Rotational Motion of Skeletal Muscle Cross-bridges Containing Phosphorylated and Dephosphorylated Myosin Regulatory Light Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; TRYPTOPHAN FLUORESCENCE; STRUCTURAL-CHANGES; RHODAMINE ISOMERS; CA2+ SENSITIVITY; FORCE GENERATION; ATP TURNOVER; POLARIZATION; MECHANISM; RIGOR	Calcium binding to thin filaments is a major element controlling active force generation in striated muscles. Recent evidence suggests that processes other than Ca2+ binding, such as phosphorylation of myosin regulatory light chain (RLC) also controls contraction of vertebrate striated muscle (Cooke, R. (2011) Biophys. Rev. 3, 33-45). Electron paramagnetic resonance (EPR) studies using nucleotide analog spin label probes showed that dephosphorylated myosin heads are highly ordered in the relaxed fibers and have very low ATPase activity. This ordered structure of myosin cross-bridges disappears with the phosphorylation of RLC (Stewart, M. (2010) Proc. Natl. Acad. Sci. U. S. A. 107, 430-435). The slower ATPase activity in the dephosporylated moiety has been defined as a new super-relaxed state (SRX). It can be observed in both skeletal and cardiac muscle fibers (Hooijman, P., Stewart, M. A., and Cooke, R. (2011) Biophys. J. 100, 1969-1976). Given the importance of the finding that suggests a novel pathway of regulation of skeletal muscle, we aim to examine the effects of phosphorylation on cross-bridge orientation and rotational motion. We find that: (i) relaxed cross-bridges, but not active ones, are statistically better ordered in muscle where the RLC is dephosporylated compared with phosphorylated RLC; (ii) relaxed phosphorylated and dephosphorylated cross-bridges rotate equally slowly; and (iii) active phosphorylated cross-bridges rotate considerably faster than dephosphorylated ones during isometric contraction but the duty cycle remained the same, suggesting that both phosphorylated and dephosphorylated muscles develop the same isometric tension at full Ca2+ saturation. A simple theory was developed to account for this fact.	[Midde, Krishna; Rich, Ryan; Fudala, Rafal; Gryczynski, Ignacy; Borejdo, Julian] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX 76107 USA; [Midde, Krishna; Rich, Ryan; Fudala, Rafal; Gryczynski, Ignacy; Borejdo, Julian] Univ N Texas, Hlth Sci Ctr, Ctr Commercializat Fluorescence Technol, Ft Worth, TX 76107 USA; [Marandos, Peter] PM Consulting Serv LLC, Henderson, NV 89074 USA; [Li, Amy] Univ Sydney, Bosch Inst, Muscle Res Unit, Dept Anat, Sydney, NSW 2006, Australia	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of Sydney	Borejdo, J (corresponding author), 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	Julian.Borejdo@unthsc.edu	Midde, Krishna/AAM-2438-2020; Midde, Krishna/F-6916-2013	Li, Amy/0000-0001-5413-3771	National Institutes of Health [R01AR048622, R01HL090786]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR048622 (to J. B.) and R01HL090786 (to J. B. and Dr. D. Szczesna).	Alamo L, 2008, J MOL BIOL, V384, P780, DOI 10.1016/j.jmb.2008.10.013; ARONSON JF, 1969, BIOCHEMISTRY-US, V8, P4517, DOI 10.1021/bi00839a044; BAGSHAW CR, 1982, MUSCLE CONTRACTION; Barman T, 1998, BIOPHYS J, V74, P3120, DOI 10.1016/S0006-3495(98)78018-X; Berger CL, 1996, BIOPHYS J, V71, P3330, DOI 10.1016/S0006-3495(96)79526-7; Bershitsky SY, 1997, NATURE, V388, P186, DOI 10.1038/40651; BOREJDO J, 1982, J MOL BIOL, V158, P391, DOI 10.1016/0022-2836(82)90205-4; BOREJDO J, 1979, P NATL ACAD SCI USA, V76, P6346, DOI 10.1073/pnas.76.12.6346; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; COOKE R, 1982, NATURE, V300, P776, DOI 10.1038/300776a0; Cooke R., 2011, 55 ANN M BIOPH SOC M, P37; Cooke R, 2007, MUSCLE NERVE, V36, P756, DOI 10.1002/mus.20891; Cooke Roger, 2011, Biophys Rev, V3, P33; CRAIG R, 1987, J CELL BIOL, V105, P1319, DOI 10.1083/jcb.105.3.1319; CRAIG R, 1992, J MOL BIOL, V228, P474, DOI 10.1016/0022-2836(92)90836-9; DOSREMEDIOS CG, 1972, P NATL ACAD SCI USA, V69, P2542; DOSREMEDIOS CG, 1972, J GEN PHYSIOL, V59, P103, DOI 10.1085/jgp.59.1.103; Elson E. L., 2007, INTRO FCS; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; ELSON EL, 1975, ANNU REV BIOPHYS BIO, V4, P311, DOI 10.1146/annurev.bb.04.060175.001523; ELSON EL, 1985, ANNU REV PHYS CHEM, V36, P379, DOI 10.1146/annurev.physchem.36.1.379; FERENCZI MA, 1978, BIOCHEM J, V171, P165, DOI 10.1042/bj1710165; GOLDMAN YE, 1984, J PHYSIOL-LONDON, V354, P605, DOI 10.1113/jphysiol.1984.sp015395; Greenberg MJ, 2010, AM J PHYSIOL-REG I, V298, pR989, DOI 10.1152/ajpregu.00566.2009; Harrington W F, 1988, Adv Exp Med Biol, V226, P307; HERRMANN C, 1993, BIOCHEMISTRY-US, V32, P7255, DOI 10.1021/bi00079a023; Hooijman P, 2011, BIOPHYS J, V100, P1969, DOI 10.1016/j.bpj.2011.02.061; Hopkins SC, 1998, BIOPHYS J, V74, P3093, DOI 10.1016/S0006-3495(98)78016-6; Hopkins SC, 2002, J MOL BIOL, V318, P1275, DOI 10.1016/S0022-2836(02)00189-4; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; James J, 2011, J BIOL CHEM, V286, P9913, DOI 10.1074/jbc.R110.171801; Kapusta P, 2007, J FLUORESC, V17, P43, DOI 10.1007/s10895-006-0145-1; Koberlink, 2009, PICOQUANT APPL NOTE; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LEVINE RJC, 1995, BIOPHYS J, V68, pS224; LEVINE RJC, 1991, J CELL BIOL, V113, P563, DOI 10.1083/jcb.113.3.563; Ling N, 1996, BIOPHYS J, V70, P1836, DOI 10.1016/S0006-3495(96)79749-7; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Mettikolla P, 2011, J THEOR BIOL, V284, P71, DOI 10.1016/j.jtbi.2011.06.014; Midde K, 2011, BIOPHYS J, V100, P1024, DOI 10.1016/j.bpj.2011.01.007; Midde K, 2012, BIOPHYS REV IN PRESS; MORALES MF, 1984, P NATL ACAD SCI-BIOL, V81, P145, DOI 10.1073/pnas.81.1.145; NIHEI T, 1974, BIOPHYS J, V14, P236, DOI 10.1016/S0006-3495(74)85911-4; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Qian H, 2002, P NATL ACAD SCI USA, V99, P10376, DOI 10.1073/pnas.152007599; Reisler E, 1973, J Mechanochem Cell Motil, V2, P163; Sabido-David C, 1998, BIOPHYS J, V74, P3083, DOI 10.1016/S0006-3495(98)78015-4; Sabido-David C, 1998, J MOL BIOL, V279, P387, DOI 10.1006/jmbi.1998.1771; Stewart MA, 2010, P NATL ACAD SCI USA, V107, P430, DOI 10.1073/pnas.0909468107; STULL JT, 1990, PROG CLIN BIOL RES, V327, P107; Szczesna D, 2002, J APPL PHYSIOL, V92, P1661, DOI 10.1152/japplphysiol.00858.2001; THOMAS DD, 1980, BIOPHYS J, V32, P891, DOI 10.1016/S0006-3495(80)85024-7; TREGEAR RT, 1975, BIOPHYS J, V15, P455, DOI 10.1016/S0006-3495(75)85830-9; Tsaturyan AK, 1999, BIOPHYS J, V77, P354, DOI 10.1016/S0006-3495(99)76895-5; Ushakov DS, 2011, J BIOL CHEM, V286, P842, DOI 10.1074/jbc.M110.149526; Willems M, 2012, SKELETAL MUSCLE PHYS	56	16	16	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7012	7023		10.1074/jbc.M112.434209	http://dx.doi.org/10.1074/jbc.M112.434209			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23319584	Green Published, hybrid			2022-12-28	WOS:000316002400023
J	Akama, KT; Thompson, LI; Milner, TA; McEwen, BS				Akama, Keith T.; Thompson, Louisa I.; Milner, Teresa A.; McEwen, Bruce S.			Post-synaptic Density-95 (PSD-95) Binding Capacity of G-protein-coupled Receptor 30 (GPR30), an Estrogen Receptor That Can Be Identified in Hippocampal Dendritic Spines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM PDZ DOMAINS; PLASMA-MEMBRANE; ULTRASTRUCTURAL-LOCALIZATION; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; SEX-DIFFERENCES; BREAST-CANCER; AGING BRAIN; RAT-BRAIN; TRAFFICKING	The estrogen 17 beta-estradiol (E2) modulates dendritic spine plasticity in the cornu ammonis 1 (CA1) region of the hippocampus, and GPR30 (G-protein coupled estrogen receptor 1 (GPER1)) is an estrogen-sensitive G-protein-coupled receptor (GPCR) that is expressed in the mammalian brain and in specific subregions that are responsive to E2, including the hippocampus. The subcellular localization of hippocampal GPR30, however, remains unclear. Here, we demonstrate that GPR30 immunoreactivity is detected in dendritic spines of rat CA1 hippocampal neurons in vivo and that GPR30 protein can be found in rat brain synaptosomes. GPR30 immunoreactivity is identified at the post-synaptic density (PSD) and in the adjacent peri-synaptic zone, and GPR30 can associate with the spine scaffolding protein PSD-95 both in vitro and in vivo. This PSD-95 binding capacity of GPR30 is specific and determined by the receptor C-terminal tail that is both necessary and sufficient for PSD-95 interaction. The interaction with PSD-95 functions to increase GPR30 protein levels residing at the plasma membrane surface. GPR30 associates with the N-terminal tandem pair of PDZ domains in PSD-95, suggesting that PSD-95 may be involved in clustering GPR30 with other receptors in the hippocampus. We demonstrate that GPR30 has the potential to associate with additional post-synaptic GPCRs, including the membrane progestin receptor, the corticotropin releasing hormone receptor, and the 5HT1a serotonin receptor. These data demonstrate that GPR30 is well positioned in the dendritic spine compartment to integrate E2 sensitivity directly onto multiple inputs on synaptic activity and might begin to provide a molecular explanation as to how E2 modulates dendritic spine plasticity.	[Akama, Keith T.; Milner, Teresa A.; McEwen, Bruce S.] Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10065 USA; [Thompson, Louisa I.; Milner, Teresa A.] Weill Cornell Med Coll, Div Neurobiol, Dept Neurol & Neurosci, New York, NY 10065 USA	Rockefeller University; Cornell University	McEwen, BS (corresponding author), Rockefeller Univ, Neuroendocrinol Lab, 1230 York Ave,Box 165, New York, NY 10065 USA.	mcewen@rockefeller.edu	McEwen, Bruce/Z-1630-2019		National Institutes of Health [AG016765, NS007080, DA08259, HL098351]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS007080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG016765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants AG016765 and NS007080 (to B. S. Mc) and DA08259 and HL098351 (to T. A. M.).	Abel T, 2008, PROG BRAIN RES, V169, P97, DOI 10.1016/S0079-6123(07)00006-4; Bezprozvanny I, 2001, FEBS LETT, V509, P457, DOI 10.1016/S0014-5793(01)03214-8; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bonini JA, 1997, BIOCHEM BIOPH RES CO, V234, P190, DOI 10.1006/bbrc.1997.6591; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Cai ZL, 2005, ENDOCRINOLOGY, V146, P5522, DOI 10.1210/en.2005-0759; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Chen XB, 2011, J NEUROSCI, V31, P6329, DOI 10.1523/JNEUROSCI.5968-10.2011; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; Christenn M, 2007, FEBS LETT, V581, P5173, DOI 10.1016/j.febslet.2007.10.003; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; Dumitriu D, 2010, ANN NY ACAD SCI, V1204, P104, DOI 10.1111/j.1749-6632.2010.05529.x; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Foy MR, 2010, VITAM HORM, V82, P219, DOI 10.1016/S0083-6729(10)82012-6; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Gee SH, 2000, BIOCHEMISTRY-US, V39, P14638, DOI 10.1021/bi001633t; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Hammond R, 2011, PSYCHONEUROENDOCRINO, V36, P182, DOI 10.1016/j.psyneuen.2010.07.007; Hammond R, 2011, BRAIN RES, V1379, P53, DOI 10.1016/j.brainres.2010.11.098; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Haucke V, 2006, CELL, V127, P35, DOI 10.1016/j.cell.2006.09.012; Hazell GGJ, 2009, J ENDOCRINOL, V202, P223, DOI 10.1677/JOE-09-0066; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; Kalyoncu S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-357; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kelly MJ, 2009, MOL CELL ENDOCRINOL, V308, P17, DOI 10.1016/j.mce.2009.03.008; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim KM, 2008, BIOCHEM BIOPH RES CO, V366, P42, DOI 10.1016/j.bbrc.2007.11.055; Kramar Eniko A, 2009, Mol Cell Pharmacol, V1, P258; Kreienkamp HJ, 2002, CURR OPIN PHARMACOL, V2, P581, DOI 10.1016/S1471-4892(02)00203-5; Langer G, 2010, STEROIDS, V75, P603, DOI 10.1016/j.steroids.2009.12.006; Lasiecka ZM, 2011, MOL CELL NEUROSCI, V48, P278, DOI 10.1016/j.mcn.2011.06.013; Le Saux M, 2005, J PSYCHIATR NEUROSCI, V30, P110; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Levin ER, 2009, ENDOCRINOLOGY, V150, P1563, DOI 10.1210/en.2008-1759; Li CJ, 2004, P NATL ACAD SCI USA, V101, P2185, DOI 10.1073/pnas.0307313101; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Luttrell Louis M., 2006, V332, P3; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Matsuda KI, 2008, NEUROSCI LETT, V441, P94, DOI 10.1016/j.neulet.2008.05.108; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; McEwen BS, 2007, BRAIN RES REV, V55, P343, DOI 10.1016/j.brainresrev.2007.02.006; McEwen BS, 2010, ANN NY ACAD SCI, V1204, pE38, DOI 10.1111/j.1749-6632.2010.05568.x; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; McGough IJ, 2011, TRAFFIC, V12, P963, DOI 10.1111/j.1600-0854.2011.01201.x; Milner TA, 2005, J COMP NEUROL, V491, P81, DOI 10.1002/cne.20724; Mizukami Y, 2010, ENDOCR J, V57, P101, DOI 10.1507/endocrj.K09E-332; Morrison JH, 2006, J NEUROSCI, V26, P10332, DOI 10.1523/JNEUROSCI.3369-06.2006; Olde B, 2009, TRENDS ENDOCRIN MET, V20, P409, DOI 10.1016/j.tem.2009.04.006; Peters A., 1991, FINE STRUCTURE NERVO; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Piroli GG, 2002, J COMP NEUROL, V452, P103, DOI 10.1002/cne.10368; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Prossnitz ER, 2004, LIFE SCI, V75, P893, DOI 10.1016/j.lfs.2004.04.003; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P1, DOI 10.1016/j.mce.2009.04.005; Pula G, 2004, J NEUROCHEM, V89, P1009, DOI 10.1111/j.1471-4159.2004.02387.x; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Riad N, 2000, J COMP NEUROL, V417, P181, DOI 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A; Roepke TA, 2011, FRONT BIOSCI-LANDMRK, V16, P1560, DOI 10.2741/3805; Romeo RD, 2005, NEUROENDOCRINOLOGY, V81, P391, DOI 10.1159/000089557; Rossi DV, 2010, PSYCHONEUROENDOCRINO, V35, P1023, DOI 10.1016/j.psyneuen.2010.01.003; Rybaczyk Leszek A, 2005, BMC Womens Health, V5, P12, DOI 10.1186/1472-6874-5-12; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; Wang W, 2009, J AM CHEM SOC, V131, P787, DOI 10.1021/ja8076022; Williams TJ, 2011, EXP NEUROL, V230, P186, DOI 10.1016/j.expneurol.2011.04.012; WOOLLEY CS, 1994, J NEUROSCI, V14, P7680; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Xu H, 2009, NEUROSCIENCE, V158, P1599, DOI 10.1016/j.neuroscience.2008.11.028; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Xu ZQD, 2007, ACTA PHYSIOL, V190, P39, DOI 10.1111/j.1365-201X.2007.01695.x; YAMAMURA HI, 1973, J NEUROCHEM, V21, P1355, DOI 10.1111/j.1471-4159.1973.tb06022.x; Young SF, 2007, CELL MOL NEUROBIOL, V27, P439, DOI 10.1007/s10571-006-9135-8; Zhang J, 2011, J BIOL CHEM, V286, P41776, DOI 10.1074/jbc.M111.272583	98	102	111	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6438	6450		10.1074/jbc.M112.412478	http://dx.doi.org/10.1074/jbc.M112.412478			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300088	Green Published, hybrid			2022-12-28	WOS:000315820700038
J	Pan, Q; Tian, Y; Li, XH; Ye, J; Liu, Y; Song, LL; Yang, YT; Zhu, R; He, YH; Chen, L; Chen, WS; Mao, XH; Peng, ZH; Wang, RQ				Pan, Qiong; Tian, Yin; Li, Xiaohuan; Ye, Jun; Liu, Yun; Song, Lili; Yang, Yongtao; Zhu, Rong; He, Yonghong; Chen, Lei; Chen, Wensheng; Mao, Xuhu; Peng, Zhihong; Wang, Rongquan			Enhanced Membrane-tethered Mucin 3 (MUC3) Expression by a Tetrameric Branched Peptide with a Conserved TFLK Motif Inhibits Bacteria Adherence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTESTINAL MUCIN; SERUM AMYLOID A3; IN-VITRO; BOVINE COLOSTRUM; EPITHELIAL-CELLS; GENE-EXPRESSION; CARCINOMA CELLS; IV GENE; PROMOTER; TRANSCRIPTION	We investigated whether a synthetic tetrameric branched peptide based on the conserved TFLK motif from mammary-associated serum amyloid A3 (M-SAA3) is more efficient than the monomeric peptide at up-regulating MUC3 expression and examined the possible mechanism(s) and biological significance of this process. We used standard solid-phase methods to synthesize a tetrameric branched peptide (sequence GWLTFL-KAAG) containing a trilysine core, termed the TFLK-containing 10-mer BP. The aberrant expression of transcription factors was analyzed using a transcription factor protein/DNA array. MUC3 and relevant transcription factors were detected using real-time PCR and/or Western blots. The luciferase assay, EMSA, and ChIP assays were used to analyze the activity of the human MUC3 promoter. The bacterial adherence assay was used to evaluate the in vitro inhibition of enteropathogenic Escherichia coli or enterohemorrhage E. coli serotype O157:H7 (EHEC O157:H7) adherence to HT-29-Gal cells after treatment with the TFLK-containing 10-mer BP. In HT-29-Gal cells, the TFLK-containing 10-mer BP induced higher levels of MUC3 expression than the M-SAA3-derived N-terminal 10-mer monomeric peptide, and MUC3 expression was activated through transcriptional mechanisms, including the induction of multiple transcription factors and further binding with their cis-elements between nucleotides -242 and -62 within MUC3 promoter. Interestingly, the TFLK-containing 10-mer BP dramatically inhibited enteropathogenic E. coli and EHEC O157:H7 adherence to the HT-29-Gal cells compared with the controls. This finding suggests a potential therapeutic use for this peptide to prevent gastrointestinal infection.	[Pan, Qiong; Tian, Yin; Li, Xiaohuan; Ye, Jun; Liu, Yun; Song, Lili; Yang, Yongtao; Zhu, Rong; He, Yonghong; Chen, Lei; Chen, Wensheng; Peng, Zhihong; Wang, Rongquan] Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing 400038, Peoples R China; [Mao, Xuhu] Third Mil Med Univ, Dept Clin Microbiol & Immunol, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Peng, ZH (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing 400038, Peoples R China.	pengzhh@yahoo.com.cn; rongquanw@hotmail.com		ye, jun/0000-0002-0631-556X; Wang, Rongquan/0000-0001-5307-0086; pan, qiong/0000-0003-1033-3098	National Natural Science Foundation of China [30800519, 81170340]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 30800519 and 81170340.	Bodammer P, 2011, J NUTR, V141, P1056, DOI 10.3945/jn.110.128702; BOHM SK, 1995, BIOCHEM J, V311, P835; Caballero-Franco C, 2007, AM J PHYSIOL-GASTR L, V292, pG315, DOI 10.1152/ajpgi.00265.2006; Chai J, 2012, HEPATOLOGY, V55, P1485, DOI 10.1002/hep.24801; Domenech A, 2012, PROTEIN PEPTIDE LETT, V19, P299, DOI 10.2174/092986612799363217; Edwards PJ, 2009, CURR OPIN DRUG DISC, V12, P899; Erickson RH, 2000, GENE, V258, P77, DOI 10.1016/S0378-1119(00)00422-4; Falciani C, 2007, CHEM BIOL DRUG DES, V69, P216, DOI 10.1111/j.1747-0285.2007.00487.x; Gardiner GE, 2009, FEMS IMMUNOL MED MIC, V55, P404, DOI 10.1111/j.1574-695X.2009.00539.x; Gout S, 2004, EXP CELL RES, V299, P498, DOI 10.1016/j.yexcr.2004.06.008; GUERRANT RL, 1990, REV INFECT DIS, V12, pS41; Gum JR, 2003, J BIOL CHEM, V278, P49600, DOI 10.1074/jbc.M305769200; Gum JR, 1997, BIOCHEM J, V325, P259, DOI 10.1042/bj3250259; Ho NK, 2012, INFECT IMMUN, V80, P2307, DOI 10.1128/IAI.00255-12; Ho SB, 2010, BBA-GEN SUBJECTS, V1800, P629, DOI 10.1016/j.bbagen.2010.03.010; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; Jin ZH, 2010, BIOL PHARM BULL, V33, P370, DOI 10.1248/bpb.33.370; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Larson MA, 2003, BIOCHEM BIOPH RES CO, V300, P531, DOI 10.1016/S0006-291X(02)02901-7; Lieleg O, 2012, BIOMACROMOLECULES, V13, P1724, DOI 10.1021/bm3001292; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Luu Y, 2010, INT J BIOCHEM CELL B, V42, P996, DOI 10.1016/j.biocel.2010.03.001; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Mack DR, 2003, PEDIATR RES, V53, P137, DOI 10.1203/01.PDR.0000041517.15440.F3; MACK DR, 1994, BIOCHEM BIOPH RES CO, V199, P1012, DOI 10.1006/bbrc.1994.1330; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; Moller HK, 2011, BRIT J NUTR, V105, P44, DOI 10.1017/S0007114510003168; Pini A, 2010, FASEB J, V24, P1015, DOI 10.1096/fj.09-145474; Playford RJ, 2000, AM J CLIN NUTR, V72, P5; Ponticelli S, 2008, J BIOL CHEM, V283, P34250, DOI 10.1074/jbc.M806607200; Rawal P, 2008, INDIAN J PEDIATR, V75, P917, DOI 10.1007/s12098-008-0192-5; Ruvo M, 2011, CURR MED CHEM, V18, P2429, DOI 10.2174/092986711795843191; Sakai H, 2011, INT IMMUNOPHARMACOL, V11, P1133, DOI 10.1016/j.intimp.2011.02.014; Shekels LL, 2003, BBA-GENE STRUCT EXPR, V1627, P90, DOI 10.1016/S0167-4781(03)00081-2; Shin DS, 2005, J BIOCHEM MOL BIOL, V38, P517; Traber PG, 1996, ANNU REV PHYSIOL, V58, P275, DOI 10.1146/annurev.physiol.58.1.275; VELCICH A, 1995, CELL GROWTH DIFFER, V6, P749	37	19	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5407	5416		10.1074/jbc.M112.408245	http://dx.doi.org/10.1074/jbc.M112.408245			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23316049	Green Published, hybrid			2022-12-28	WOS:000315342500016
J	Tol, MB; Deluz, C; Hassaine, G; Graff, A; Stahlberg, H; Vogel, H				Tol, Menno B.; Deluz, Cedric; Hassaine, Gherici; Graff, Alexandra; Stahlberg, Henning; Vogel, Horst			Thermal Unfolding of a Mammalian Pentameric Ligand-gated Ion Channel Proceeds at Consecutive, Distinct Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; BLUE NATIVE ELECTROPHORESIS; SEROTONIN 5-HT3 RECEPTOR; NONIONIC SURFACTANTS; CIRCULAR-DICHROISM; PROTEIN-STABILITY; MEMBRANE; BINDING; TORPEDO; THERMOSTABILITY	Pentameric ligand-gated ion channels (LGICs) play an important role in fast synaptic signal transduction. Binding of agonists to the beta-sheet-structured extracellular domain opens an ion channel in the transmembrane alpha-helical region of the LGIC. How the structurally distinct and distant domains are functionally coupled for such central transmembrane signaling processes remains an open question. To obtain detailed information about the stability of and the coupling between these different functional domains, we analyzed the thermal unfolding of a homopentameric LGIC, the 5-hydroxytryptamine receptor (ligand binding, secondary structure, accessibility of Trp and Cys residues, and aggregation), in plasma membranes as well as during detergent extraction, purification, and reconstitution into artificial lipid bilayers. We found a large loss in thermostability correlating with the loss of the lipid bilayer during membrane solubilization and purification. Thermal unfolding of the 5-hydroxytryptamine receptor occurred in consecutive steps at distinct protein locations. A loss of ligand binding was detected first, followed by formation of different transient low oligomeric states of receptor pentamers, followed by partial unfolding of helical parts of the protein, which finally lead to the formation receptor aggregates. Structural destabilization of the receptor in detergents could be partially reversed by reconstituting the receptor into lipid bilayers. Our results are important because they quantify the stability of LGICs during detergent extraction and purification and can be used to create stabilized receptor proteins for structural and functional studies.	[Tol, Menno B.; Deluz, Cedric; Hassaine, Gherici; Vogel, Horst] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, CH-1015 Lausanne, Switzerland; [Graff, Alexandra; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, CH-4085 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Basel	Vogel, H (corresponding author), Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol Lausanne, LCPPM, Stn 6, CH-1015 Lausanne, Switzerland.	horst.vogel@epfl.ch	Stahlberg, Henning/H-1868-2011; Vogel, Horst/AAJ-5490-2021	Stahlberg, Henning/0000-0002-1185-4592; 	European Community's Seventh Framework Program [211800]; Swiss National Science Foundation [31003A-118148]; Ecole Polytechnique Federale de Lausanne	European Community's Seventh Framework Program(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne	This work was supported by the European Community's Seventh Framework Program FP7/2007-2013 under Grant 211800, the Swiss National Science Foundation (the SystemsX program and SNF Grant 31003A-118148), and internal funds of the Ecole Polytechnique Federale de Lausanne.	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; ARTIGUES A, 1987, ARCH BIOCHEM BIOPHYS, V258, P33, DOI 10.1016/0003-9861(87)90319-5; Asmar-Rovira GA, 2008, J MEMBRANE BIOL, V223, P13, DOI 10.1007/s00232-008-9107-7; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bowie JU, 2001, CURR OPIN STRUC BIOL, V11, P397, DOI 10.1016/S0959-440X(00)00223-2; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chen ML, 2007, CHEM RES CHINESE U, V23, P715, DOI 10.1016/S1005-9040(07)60156-1; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; Dellisanti CD, 2011, J BIOL CHEM, V286, P3658, DOI 10.1074/jbc.M110.156851; Derewenda ZS, 2010, ACTA CRYSTALLOGR D, V66, P604, DOI 10.1107/S090744491000644X; Frauenfelder H, 2006, P NATL ACAD SCI USA, V103, P15469, DOI 10.1073/pnas.0607168103; FRAUENFELDER H, 1987, BIOCHEMISTRY-US, V26, P254, DOI 10.1021/bi00375a035; Garriga P, 1996, P NATL ACAD SCI USA, V93, P4560, DOI 10.1073/pnas.93.10.4560; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; HALTIA T, 1995, BBA-BIOENERGETICS, V1228, P1, DOI 10.1016/0005-2728(94)00161-W; Harris NJ, 2012, BBA-BIOMEMBRANES, V1818, P1055, DOI 10.1016/j.bbamem.2011.11.006; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Heyden M, 2012, SOFT MATTER, V8, P7742, DOI 10.1039/c2sm25402f; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101; Hong H, 2009, METHOD ENZYMOL, V455, P213, DOI 10.1016/S0076-6879(08)04208-0; Hovius R, 1998, J NEUROCHEM, V70, P824; Jenney FE, 2008, EXTREMOPHILES, V12, P39, DOI 10.1007/s00792-007-0087-9; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; Machu TK, 2011, PHARMACOL THERAPEUT, V130, P338, DOI 10.1016/j.pharmthera.2011.02.003; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Maksay G, 1996, J NEUROCHEM, V67, P407; Mancusso R, 2011, METHODS, V55, P324, DOI 10.1016/j.ymeth.2011.07.008; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; O'Malley MA, 2010, BIOCHEMISTRY-US, V49, P9181, DOI 10.1021/bi101155r; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; PEREZRAMIREZ B, 1994, MOL CELL BIOCHEM, V132, P91, DOI 10.1007/BF00926917; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Purohit P, 2010, J GEN PHYSIOL, V135, P321, DOI 10.1085/jgp.200910384; Quirk PL, 2004, J NEUROSCI RES, V77, P498, DOI 10.1002/jnr.20185; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rees DC, 2001, PROTEIN SCI, V10, P1187, DOI 10.1110/ps.180101; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schlinkmann KM, 2012, J MOL BIOL, V422, P414, DOI 10.1016/j.jmb.2012.05.039; Schreiter C, 2003, J BIOL CHEM, V278, P22709, DOI 10.1074/jbc.M301801200; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Sharma KS, 2003, COLLOID SURFACE A, V219, P67, DOI 10.1016/S0927-7757(03)00012-8; Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001; Tairi AP, 1998, BIOCHEMISTRY-US, V37, P15850, DOI 10.1021/bi981812z; Tate CG, 2010, METHODS MOL BIOL, V601, P187, DOI 10.1007/978-1-60761-344-2_12; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Tsetlin V, 2011, J NEUROCHEM, V116, P734, DOI 10.1111/j.1471-4159.2010.07060.x; Ulmschneider JP, 2011, J AM CHEM SOC, V133, P15487, DOI 10.1021/ja204042f; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VOGEL H, 1988, P NATL ACAD SCI USA, V85, P5067, DOI 10.1073/pnas.85.14.5067; VOGEL H, 1987, BIOCHEMISTRY-US, V26, P4562, DOI 10.1021/bi00388a060; Walstab J, 2010, PHARMACOL THERAPEUT, V128, P146, DOI 10.1016/j.pharmthera.2010.07.001; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Yeh AP, 2006, ACTA CRYSTALLOGR D, V62, P451, DOI 10.1107/S0907444906005233; Zelent B, 1998, BIOPHYS CHEM, V73, P53, DOI 10.1016/S0301-4622(98)00137-9	69	15	15	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5756	5769		10.1074/jbc.M112.422287	http://dx.doi.org/10.1074/jbc.M112.422287			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23275379	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000315342500047
J	Fernandez-Castaneda, A; Arandjelovic, S; Stiles, TL; Schlobach, RK; Mowen, KA; Gonias, SL; Gaultier, A				Fernandez-Castaneda, Anthony; Arandjelovic, Sanja; Stiles, Travis L.; Schlobach, Ryan K.; Mowen, Kerri A.; Gonias, Steven L.; Gaultier, Alban			Identification of the Low Density Lipoprotein (LDL) Receptor-related Protein-1 Interactome in Central Nervous System Myelin Suggests a Role in the Clearance of Necrotic Cell Debris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; MULTIPLE-SCLEROSIS; BASIC-PROTEIN; PEPTIDYLARGININE DEIMINASE; SURFACE CALRETICULIN; APOPTOTIC CELLS; BINDING; BRAIN; 3-PHOSPHODIESTERASE; OVEREXPRESSION	In the central nervous system (CNS), fast neuronal signals are facilitated by the oligodendrocyte-produced myelin sheath. Oligodendrocyte turnover or injury generates myelin debris that is usually promptly cleared by phagocytic cells. Failure to remove dying oligodendrocytes leads to accumulation of degraded myelin, which, if recognized by the immune system, may contribute to the development of autoimmunity in diseases such as multiple sclerosis. We recently identified low density lipoprotein receptor-related protein-1 (LRP1) as a novel phagocytic receptor for myelin debris. Here, we report characterization of the LRP1 interactome in CNS myelin. Fusion proteins were designed corresponding to the extracellular ligand-binding domains of LRP1. LRP1 partners were isolated by affinity purification and characterized by mass spectrometry. We report that LRP1 binds intracellular proteins via its extracellular domain and functions as a receptor for necrotic cells. Peptidyl arginine deiminase-2 and cyclic nucleotide phosphodiesterase are novel LRP1 ligands identified in our screen, which interact with full-length LRP1. Furthermore, the extracellular domain of LRP1 is a target of peptidyl arginine deiminase-2-mediated deimination in vitro. We propose that LRP1 functions as a receptor for endocytosis of intracellular components released during cellular damage and necrosis.	[Fernandez-Castaneda, Anthony; Schlobach, Ryan K.; Gaultier, Alban] Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA; [Fernandez-Castaneda, Anthony; Schlobach, Ryan K.; Gaultier, Alban] Univ Virginia, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA; [Arandjelovic, Sanja; Mowen, Kerri A.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Stiles, Travis L.; Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of Virginia; University of Virginia; Scripps Research Institute; University of California System; University of California San Diego	Gaultier, A (corresponding author), Univ Virginia, Dept Neurosci, 409 Lane Rd, Charlottesville, VA 22908 USA.	ag7h@virginia.edu			National Institutes of Health [R21 NS071347, R01 HL-060551, R01 GM085117, R01 AI067460]; Arthritis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R21 NS071347 (to A.G.), R01 HL-060551 (to S.L.G.), and R01 GM085117 and R01 AI067460 (to K.A.M.). This work was also supported by the Philip S. Magaram, Esq., Research Award from the Arthritis Foundation (to S.A.).	Adie EJ, 2003, ASSAY DRUG DEV TECHN, V1, P251, DOI 10.1089/15406580360545062; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Bifulco M, 2002, P NATL ACAD SCI USA, V99, P1807, DOI 10.1073/pnas.042678799; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Buser AM, 2009, MOL CELL NEUROSCI, V40, P156, DOI 10.1016/j.mcn.2008.10.002; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; GARNER CC, 1990, J NEUROCHEM, V55, P146, DOI 10.1111/j.1471-4159.1990.tb08832.x; Gaultier A, 2008, BLOOD, V111, P5316, DOI 10.1182/blood-2007-12-127613; Gaultier A, 2010, J PROTEOME RES, V9, P6689, DOI 10.1021/pr1008288; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Gonias SL, 2004, THROMB HAEMOSTASIS, V91, P1056, DOI 10.1160/TH04-01-0023; Gonias SL, 2011, CURR PHARM DESIGN, V17, P1962; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; Gravel M, 1996, MOL CELL NEUROSCI, V7, P453, DOI 10.1006/mcne.1996.0033; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Hall PA, 2012, J PATHOL, V226, P287, DOI 10.1002/path.3024; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Kim JK, 2003, MOL CELL PROTEOMICS, V2, P453, DOI 10.1074/mcp.M200050-MCP200; Kozlov G, 2003, J BIOL CHEM, V278, P46021, DOI 10.1074/jbc.M305176200; LAMENSA JWE, 1993, J NEUROCHEM, V61, P987, DOI 10.1111/j.1471-4159.1993.tb03612.x; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee J, 2005, J CELL BIOL, V170, P661, DOI 10.1083/jcb.200411047; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mastronardi FG, 2007, J NEUROSCI RES, V85, P2006, DOI 10.1002/jnr.21329; Miyaoka Y, 2010, DEVELOPMENT, V137, P159, DOI 10.1242/dev.041574; MOSCARELLO MA, 1994, J CLIN INVEST, V94, P146, DOI 10.1172/JCI117300; Muraro PA, 2002, J NEUROIMMUNOL, V130, P233, DOI 10.1016/S0165-5728(02)00229-1; Musse AA, 2007, INT REV NEUROBIOL, V79, P149, DOI 10.1016/S0074-7742(07)79007-4; Musse AA, 2008, DIS MODEL MECH, V1, P229, DOI 10.1242/dmm.000729; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Rosener M, 1997, J NEUROIMMUNOL, V75, P28, DOI 10.1016/S0165-5728(96)00230-5; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Stern M, 1996, AM J PATHOL, V149, P911; Stiles T. L., 2012, J CELL SCI; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Studzinski DM, 2003, J NEUROSCI RES, V73, P31, DOI 10.1002/jnr.10642; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wood DD, 1996, ANN NEUROL, V40, P18, DOI 10.1002/ana.410400106; Wood DD, 2008, LAB INVEST, V88, P354, DOI 10.1038/labinvest.3700748; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	50	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4538	4548		10.1074/jbc.M112.384693	http://dx.doi.org/10.1074/jbc.M112.384693			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264627	Green Published, hybrid			2022-12-28	WOS:000315340400004
J	Kato, U; Inadome, H; Yamamoto, M; Emoto, K; Kobayashi, T; Umeda, M				Kato, Utako; Inadome, Hironori; Yamamoto, Masatoshi; Emoto, Kazuo; Kobayashi, Toshihide; Umeda, Masato			Role for Phospholipid Flippase Complex of ATP8A1 and CDC50A Proteins in Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; PUTATIVE AMINOPHOSPHOLIPID TRANSLOCASES; PLASMA-MEMBRANE; SUBCELLULAR-LOCALIZATION; LIPID ASYMMETRY; TRANSPORT; DYNAMICS; PHOSPHATIDYLSERINE; IDENTIFICATION; P4-ATPASE	Type IV P-type ATPases (P4-ATPases) and CDC50 family proteins form a putative phospholipid flippase complex that mediates the translocation of aminophospholipids such as phosphatidylserine (PS) and phosphatidylethanolamine (PE) from the outer to inner leaflets of the plasma membrane. In Chinese hamster ovary (CHO) cells, at least eight members of P4-ATPases were identified, but only a single CDC50 family protein, CDC50A, was expressed. We demonstrated that CDC50A associated with and recruited P4-ATPase ATP8A1 to the plasma membrane. Overexpression of CDC50A induced extensive cell spreading and greatly enhanced cell migration. Depletion of either CDC50A or ATP8A1 caused a severe defect in the formation of membrane ruffles, thereby inhibiting cell migration. Analyses of phospholipid translocation at the plasma membrane revealed that the depletion of CDC50A inhibited the inward translocation of both PS and PE, whereas the depletion of ATP8A1 inhibited the translocation of PE but not that of PS, suggesting that the inward translocation of cell-surface PE is involved in cell migration. This hypothesis was further examined by using a PE-binding peptide and a mutant cell line with defective PE synthesis; either cell-surface immobilization of PE by the PE-binding peptide or reduction in the cell-surface content of PE inhibited the formation of membrane ruffles, causing a severe defect in cell migration. These results indicate that the phospholipid flippase complex of ATP8A1 and CDC50A plays a major role in cell migration and suggest that the flippase-mediated translocation of PE at the plasma membrane is involved in the formation of membrane ruffles to promote cell migration.	[Kato, Utako; Yamamoto, Masatoshi; Umeda, Masato] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Inadome, Hironori] Kirin Holdings Co Ltd, Cent Labs Frontier Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Emoto, Kazuo] Osaka Biosci Inst, Dept Cell Biol, Suita, Osaka 5650874, Japan; [Kobayashi, Toshihide] RIKEN, Discovery Res Inst, Lipid Biol Lab, Wako, Saitama 3510198, Japan	Kyoto University; Kirin Holdings Co Ltd; RIKEN	Umeda, M (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan.	umeda@sbchem.kyoto-u.ac.jp	Kobayashi, Toshihide/B-6298-2015; KOBAYASHI, TOSHIHIDE/S-8313-2019; EMOTO, KAZUO/G-4992-2014	Kobayashi, Toshihide/0000-0002-4811-7270; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation for Research on Metabolic Disorders	This work was supported by a grant-in-aid for scientific research, the 21st Century COE Program "Genome Science," a grant-in-aid for the Global COE Program "International Center for Integrated Research and Advanced Education in Materials Science" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a research grant from Astellas Foundation for Research on Metabolic Disorders.	Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Cacciagli P, 2010, EUR J HUM GENET, V18, P1360, DOI 10.1038/ejhg.2010.126; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Daleke DL, 2000, BBA-MOL CELL BIOL L, V1486, P108, DOI 10.1016/S1388-1981(00)00052-4; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Das A, 2012, NAT CELL BIOL, V14, P304, DOI 10.1038/ncb2444; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Emoto K, 1999, P NATL ACAD SCI USA, V96, P12400, DOI 10.1073/pnas.96.22.12400; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gorzalczany Y, 2002, J BIOL CHEM, V277, P18605, DOI 10.1074/jbc.M202114200; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Hanson PJ, 2003, ECOL STUD-ANAL SYNTH, V166, P3; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Kooijman EE, 2009, BIOCHEMISTRY-US, V48, P9360, DOI 10.1021/bi9008616; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Kreck ML, 1996, BIOCHEMISTRY-US, V35, P15683, DOI 10.1021/bi962064l; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; NAM KS, 1990, BIOCHIM BIOPHYS ACTA, V1046, P89, DOI 10.1016/0005-2760(90)90098-I; Parachoniak CA, 2012, TRENDS CELL BIOL, V22, P231, DOI 10.1016/j.tcb.2012.02.002; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Paulusma CC, 2005, BBA-MOL BASIS DIS, V1741, P11, DOI 10.1016/j.bbadis.2005.04.006; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Ruaud AF, 2009, TRAFFIC, V10, P88, DOI 10.1111/j.1600-0854.2008.00844.x; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Saito K, 2007, DEV CELL, V13, P743, DOI 10.1016/j.devcel.2007.09.014; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Smriti, 2007, BIOCHEMISTRY-US, V46, P2249, DOI 10.1021/bi061333x; Stevens HC, 2008, J BIOL CHEM, V283, P35060, DOI 10.1074/jbc.M802379200; Takahashi Y, 2011, J BIOCHEM, V149, P423, DOI 10.1093/jb/mvq155; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	66	61	66	0	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4922	4934		10.1074/jbc.M112.402701	http://dx.doi.org/10.1074/jbc.M112.402701			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23269685	hybrid, Green Published			2022-12-28	WOS:000315340400040
J	Leung, MC; Hitchen, PG; Ward, DG; Messer, AE; Marston, SB				Leung, Man-Ching; Hitchen, Paul G.; Ward, Douglas G.; Messer, Andrew E.; Marston, Steven B.			Z-band Alternatively Spliced PDZ Motif Protein (ZASP) Is the Major O-Linked beta-N-Acetylglucosamine-substituted Protein in Human Heart Myofibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C PHOSPHORYLATION; BINDING; MUSCLE; DOMAIN; CARDIOMYOPATHY; GLCNACYLATION; TRANSFERASE; MUTATIONS; CYPHER	We studied O-linked beta-N-acetylglucosamine (O-GlcNAc) modification of contractile proteins in human heart using SDS-PAGE and three detection methods: specific enzymatic conjugation of O-GlcNAc with UDP-N-azidoacetylgalactosamine (UDP-GalNAz) that is then linked to a tetramethylrhodamine fluorescent tag and CTD110.6 and RL2 monoclonal antibodies to O-GlcNAc. All three methods showed that O-GlcNAc modification was predominantly in a group of bands similar to 90 kDa that did not correspond to any of the major myofibrillar proteins. MALDI-MS/MS identified the 90-kDa band as the protein ZASP (Z-band alternatively spliced PDZ motif protein), a minor component of the Z-disc (about 1 per 400 alpha-actinin) important for myofibrillar development and mechanotransduction. This was confirmed by the co-localization of O-GlcNAc and ZASP in Western blotting and by immunofluorescence microscopy. O-GlcNAcylation of ZASP increased in diseased heart, being 49 +/- 5% of all O-GlcNAc in donor, 68 +/- 9% in end-stage failing heart, and 76 +/- 6% in myectomy muscle samples (donor versus myectomy p < 0.05). ZASP is only 22% of all O-GlcNAcylated proteins in mouse heart myofibrils.	[Leung, Man-Ching; Messer, Andrew E.; Marston, Steven B.] Univ London Imperial Coll Sci Technol & Med, NHLI, Myocardial Funct Sect, London W12 0NN, England; [Hitchen, Paul G.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Ward, Douglas G.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England	Imperial College London; Imperial College London; University of Birmingham	Marston, SB (corresponding author), Imperial Ctr Translat & Expt Med, Du Cane Rd, London W12 0NN, England.	s.marston@imperial.ac.uk		Ward, Douglas/0000-0002-2328-1445	British Heart Foundation; European Community [241577]; British Heart Foundation [PG/08/077/25587, RG/11/20/29266] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); European Community(European Commission); British Heart Foundation(British Heart Foundation)	This work was supported by grants from the British Heart Foundation and European Community Seventh Framework Programme (2007-2013) Grant Agreement 241577 (BIG-Heart).	Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; Au YH, 2004, STRUCTURE, V12, P611, DOI 10.1016/j.str.2004.02.019; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Bayliss CR, 2013, CARDIOVASC RES, V97, P500, DOI 10.1093/cvr/cvs322; Belke DD, 2011, J APPL PHYSIOL, V111, P157, DOI 10.1152/japplphysiol.00147.2011; Brainard RE, 2011, CIRCULATION, V124; Buyandelger B, 2011, J CARDIOVASC TRANSL, V4, P238, DOI 10.1007/s12265-011-9262-6; Cieniewski-Bernard C, 2004, MOL CELL PROTEOMICS, V3, P577, DOI 10.1074/mcp.M400024-MCP200; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Fulop N, 2007, AM J PHYSIOL-CELL PH, V292, pC1370, DOI 10.1152/ajpcell.00422.2006; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hedou J, 2007, J BIOL CHEM, V282, P10360, DOI 10.1074/jbc.M606787200; Hedou J, 2009, PROTEOMICS, V9, P2139, DOI 10.1002/pmic.200800617; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Jacques AM, 2008, CARDIOVASC RES, V79, P481, DOI 10.1093/cvr/cvn094; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Khidekel N, 2003, J AM CHEM SOC, V125, P16162, DOI 10.1021/ja038545r; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Knoll R, 2003, J MOL MED, V81, P750, DOI 10.1007/s00109-003-0488-x; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; Marston S, 2009, CIRC RES, V105, P219, DOI 10.1161/CIRCRESAHA.109.202440; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Messer AE, 2009, PROTEOM CLIN APPL, V3, P1371, DOI 10.1002/prca.200900071; Ramirez G, 2011, CIRCULATION, V124; Ramirez-Correa GA, 2011, BIOPHYS J, V100, P451; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; Sheikh F, 2007, TRENDS CARDIOVAS MED, V17, P258, DOI 10.1016/j.tcm.2007.09.002; Theis JL, 2006, BIOCHEM BIOPH RES CO, V351, P896, DOI 10.1016/j.bbrc.2006.10.119; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Xing YL, 2006, MOL GENET METAB, V88, P71, DOI 10.1016/j.ymgme.2005.11.009; Zheng M, 2010, J MOL CELL BIOL, V2, P96, DOI 10.1093/jmcb/mjp038; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	39	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4891	4898		10.1074/jbc.M112.410316	http://dx.doi.org/10.1074/jbc.M112.410316			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23271734	Green Published, hybrid			2022-12-28	WOS:000315340400037
J	Luis, AS; Venditto, I; Temple, MJ; Rogowski, A; Basle, A; Xue, J; Knox, JP; Prates, JAM; Ferreira, LMA; Fontes, CMGA; Najmudin, S; Gilbert, HJ				Luis, Ana S.; Venditto, Immacolata; Temple, Max J.; Rogowski, Artur; Basle, Arnaud; Xue, Jie; Knox, J. Paul; Prates, Jose A. M.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Najmudin, Shabir; Gilbert, Harry J.			Understanding How Noncatalytic Carbohydrate Binding Modules Can Display Specificity for Xyloglucan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT-CELL WALLS; CELLULOMONAS-FIMI; LIGAND-BINDING; EUBACTERIUM-CELLULOSOLVENS; CLOSTRIDIUM-THERMOCELLUM; ENDOGLUCANASE CEL5A; RECOGNITION; FAMILY; XYLANASE; DOMAIN	Plant biomass is central to the carbon cycle and to environmentally sustainable industries exemplified by the biofuel sector. Plant cell wall degrading enzymes generally contain noncatalytic carbohydrate binding modules (CBMs) that fulfil a targeting function, which enhances catalysis. CBMs that bind beta-glucan chains often display broad specificity recognizing beta 1,4-glucans (cellulose), beta 1,3-beta 1,4-mixed linked glucans and xyloglucan, a beta 1,4-glucan decorated with beta 1,6-xylose residues, by targeting structures common to the three polysaccharides. Thus, CBMs that recognize xyloglucan target the beta 1,4-glucan backbone and only accommodate the xylose decorations. Here we show that two closely related CBMs, CBM65A and CBM65B, derived from EcCel5A, a Eubacterium cellulosolvens endoglucanase, bind to a range of beta-glucans but, uniquely, display significant preference for xyloglucan. The structures of the two CBMs reveal a beta-sandwich fold. The ligand binding site comprises the beta-sheet that forms the concave surface of the proteins. Binding to the backbone chains of beta-glucans is mediated primarily by five aromatic residues that also make hydrophobic interactions with the xylose side chains of xyloglucan, conferring the distinctive specificity of the CBMs for the decorated polysaccharide. Significantly, and in contrast to other CBMs that recognize beta-glucans, CBM65A utilizes different polar residues to bind cellulose and mixed linked glucans. Thus, Gln(106) is central to cellulose recognition, but is not required for binding to mixed linked glucans. This report reveals the mechanism by which beta-glucan-specific CBMs can distinguish between linear and mixed linked glucans, and show how these CBMs can exploit an extensive hydrophobic platform to target the side chains of decorated beta-glucans.	[Luis, Ana S.; Venditto, Immacolata; Prates, Jose A. M.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Najmudin, Shabir] Univ Tecn Lisboa, Fac Med Vet, CIISA, P-1300477 Lisbon, Portugal; [Temple, Max J.; Rogowski, Artur; Basle, Arnaud; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE 4HH, Tyne & Wear, England; [Xue, Jie; Knox, J. Paul] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England	Universidade de Lisboa; Newcastle University - UK; University of Leeds	Fontes, CMGA (corresponding author), Univ Tecn Lisboa, Fac Med Vet, CIISA, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	cafontes@fmv.utl.pt; h.j.gilbert@ncl.ac.uk	Luis, Ana/ABE-5158-2020; Prates, José A M/K-9934-2013; Knox, Paul/H-4577-2012	Luis, Ana/0000-0002-5086-7353; Prates, José A M/0000-0003-1032-5987; Knox, Paul/0000-0002-9231-6891; VENDITTO, IMMACOLATA/0000-0003-0392-2871; Ferreira, Luis/0000-0002-3543-9166; Basle, Arnaud/0000-0002-4899-3086; Najmudin, Shabir/0000-0002-0429-5454; Temple, Max/0000-0003-4678-9396; Fontes, Carlos/0000-0002-1219-9753	Biochemical and Biotechnological Research Council [BB/K001949/1]; Wellcome Research Trust [WT097907MA]; Fundacao para a Ciencia e a Tecnologia [PTDC/BIA-PRO/103980/2008, PTDC/BIA-PRO/69732/2006]; European Union Seventh Framework Programme under the WallTraC project [263916]; BBSRC [BB/E015190/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E015190/1, BB/C005074/1] Funding Source: researchfish	Biochemical and Biotechnological Research Council; Wellcome Research Trust(Wellcome Trust); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Union Seventh Framework Programme under the WallTraC project; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the Biochemical and Biotechnological Research Council (BB/K001949/1), Wellcome Research Trust (WT097907MA), Fundacao para a Ciencia e a Tecnologia (PTDC/BIA-PRO/103980/2008 and PTDC/BIA-PRO/69732/2006), and from the European Union Seventh Framework Programme (FP7 2007-2013) under the WallTraC project (Grant Agreement no. 263916). We also acknowledge the Synchrotron Radiation Facilities at SOLEIL (PROXIMA-1) and DIAMOND (beamlines IO2 and IO4).	Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; Bolam DN, 2001, BIOCHEMISTRY-US, V40, P2468, DOI 10.1021/bi002564l; Boraston AB, 2006, J BIOL CHEM, V281, P587, DOI 10.1074/jbc.M509958200; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Flint J, 2004, J MOL BIOL, V337, P417, DOI 10.1016/j.jmb.2003.12.081; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Luis AS, 2011, ACTA CRYSTALLOGR F, V67, P491, DOI 10.1107/S1744309111004246; MACKIE RI, 1990, J DAIRY SCI, V73, P2971, DOI 10.3168/jds.S0022-0302(90)78986-2; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; McCartney L, 2006, P NATL ACAD SCI USA, V103, P4765, DOI 10.1073/pnas.0508887103; McCartney L, 2004, ANAL BIOCHEM, V326, P49, DOI 10.1016/j.ab.2003.11.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Money VA, 2008, ORG BIOMOL CHEM, V6, P851, DOI 10.1039/b719288f; Montanier CY, 2011, J BIOL CHEM, V286, P22499, DOI 10.1074/jbc.M110.217372; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Najmudin S, 2005, ACTA CRYSTALLOGR F, V61, P1043, DOI 10.1107/S1744309105035670; NIEDUSZYNSKI IA, 1972, BIOPOLYMERS, V11, P1335, DOI 10.1002/bip.1972.360110703; Simpson PJ, 1999, STRUCTURE, V7, P853, DOI 10.1016/S0969-2126(99)80108-7; Simpson PJ, 2002, BIOCHEMISTRY-US, V41, P5712, DOI 10.1021/bi012093i; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Szabo L, 2001, J BIOL CHEM, V276, P49061, DOI 10.1074/jbc.M109558200; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoda K, 2005, APPL ENVIRON MICROB, V71, P5787, DOI 10.1128/AEM.71.10.5787-5793.2005	44	28	31	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4799	4809		10.1074/jbc.M112.432781	http://dx.doi.org/10.1074/jbc.M112.432781			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23229556	Green Published, hybrid			2022-12-28	WOS:000315340400029
J	Shi, J; Koteiche, HA; McDonald, ET; Fox, TL; Stewart, PL; Mchaourab, HS				Shi, Jian; Koteiche, Hanane A.; McDonald, Ezelle T.; Fox, Tara L.; Stewart, Phoebe L.; Mchaourab, Hassane S.			Cryoelectron Microscopy Analysis of Small Heat Shock Protein 16.5 (Hsp16.5) Complexes with T4 Lysozyme Reveals the Structural Basis of Multimode Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; CHAPERONE ACTIVITY; MISSENSE MUTATION; 2-MODE BINDING; MECHANISM; SUBSTRATE; DOMAIN; DETERMINANTS; DISSOCIATION; POLYDISPERSITY	Small heat shock proteins (sHSPs) are ubiquitous chaperones that bind and sequester non-native proteins preventing their aggregation. Despite extensive studies of sHSPs chaperone activity, the location of the bound substrate within the sHSP oligomer has not been determined. In this paper, we used cryoelectron microscopy (cryoEM) to visualize destabilized mutants of T4 lysozyme (T4L) bound to engineered variants of the small heat shock protein Hsp16.5. In contrast to wild type Hsp16.5, binding of T4L to these variants does not induce oligomer heterogeneity enabling cryoEM analysis of the complexes. CryoEM image reconstruction reveals the sequestration of T4L in the interior of the Hsp16.5 oligomer primarily interacting with the buried N-terminal domain but also tethered by contacts with the alpha-crystallin domain shell. Analysis of Hsp16.5-WT/T4L complexes uncovers oligomer expansion as a requirement for high affinity binding. In contrast, a low affinity mode of binding is found to involve T4L binding on the outer surface of the oligomer bridging the formation of large complexes of Hsp16.5. These mechanistic principles were validated by cryoEM analysis of an expanded variant of Hsp16.5 in complex with T4L and Hsp16.5-R107G, which is equivalent to a mutant of human alpha B-crystallin linked to cardiomyopathy. In both cases, high affinity binding is found to involve conformational changes in the N-terminal region consistent with a central role of this region in substrate recognition.	[Shi, Jian; Koteiche, Hanane A.; McDonald, Ezelle T.; Fox, Tara L.; Stewart, Phoebe L.; Mchaourab, Hassane S.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Stewart, PL (corresponding author), Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Dept Pharmacol, Cleveland, OH 44106 USA.	pls47@case.edu; hassane.mchaourab@vanderbilt.edu			National Institutes of Health from NEI [EY12018]; NATIONAL EYE INSTITUTE [R01EY012018, R29EY012018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health from NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant EY12018 from the NEI (to H. S. M.).	Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Berengian AR, 1997, BIOCHEMISTRY-US, V36, P9951, DOI 10.1021/bi9712347; Bova MP, 2002, J BIOL CHEM, V277, P38468, DOI 10.1074/jbc.M205594200; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Carver JA, 2002, J MOL BIOL, V318, P815, DOI 10.1016/S0022-2836(02)00144-4; Cheng GL, 2008, J BIOL CHEM, V283, P26634, DOI 10.1074/jbc.M802946200; Clark AR, 2011, J MOL BIOL, V408, P118, DOI 10.1016/j.jmb.2011.02.020; Claxton DP, 2008, J MOL BIOL, V375, P1026, DOI 10.1016/j.jmb.2007.11.014; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Giese KC, 2005, P NATL ACAD SCI USA, V102, P18896, DOI 10.1073/pnas.0506169103; Graw J, 2001, INVEST OPHTH VIS SCI, V42, P2909; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Haley DA, 2000, J MOL BIOL, V298, P261, DOI 10.1006/jmbi.2000.3657; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Kim DR, 2003, BIOCHEM BIOPH RES CO, V307, P991, DOI 10.1016/S0006-291X(03)01302-0; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kim R, 2003, P NATL ACAD SCI USA, V100, P8151, DOI 10.1073/pnas.1032940100; Koteiche HA, 2003, J BIOL CHEM, V278, P10361, DOI 10.1074/jbc.M211851200; Koteiche HA, 2005, STRUCTURE, V13, P1165, DOI 10.1016/j.str.2005.05.006; Koteiche HA, 1999, J MOL BIOL, V294, P561, DOI 10.1006/jmbi.1999.3242; Koteiche HA, 2002, FEBS LETT, V519, P16, DOI 10.1016/S0014-5793(02)02688-1; Koteiche HA, 2006, J BIOL CHEM, V281, P14273, DOI 10.1074/jbc.M512938200; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mansoor SE, 1999, BIOCHEMISTRY-US, V38, P16383, DOI 10.1021/bi991331v; McDonald ET, 2012, BIOCHEMISTRY-US, V51, P1257, DOI 10.1021/bi2017624; Mchaourab HS, 2012, BIOCHEMISTRY-US, V51, P5105, DOI 10.1021/bi300525x; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; MCHAOURAB HS, 1993, BIOCHEMISTRY-US, V32, P11895, DOI 10.1021/bi00095a019; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mchaourab HS, 2002, J BIOL CHEM, V277, P40557, DOI 10.1074/jbc.M206250200; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sathish HA, 2004, J BIOL CHEM, V279, P16425, DOI 10.1074/jbc.M313402200; Sathish HA, 2003, J BIOL CHEM, V278, P44214, DOI 10.1074/jbc.M307578200; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Shi J, 2006, J BIOL CHEM, V281, P40420, DOI 10.1074/jbc.M608322200; Stromer T, 2004, J BIOL CHEM, V279, P11222, DOI 10.1074/jbc.M310149200; Stromer T, 2003, J BIOL CHEM, V278, P18015, DOI 10.1074/jbc.M301640200; Treweek TM, 2000, BBA-PROTEIN STRUCT M, V1481, P175, DOI 10.1016/S0167-4838(00)00109-6; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	55	29	31	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4819	4830		10.1074/jbc.M112.388132	http://dx.doi.org/10.1074/jbc.M112.388132			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23277356	hybrid, Green Published			2022-12-28	WOS:000315340400031
J	Tomanicek, SJ; Standaert, RF; Weiss, KL; Ostermann, A; Schrader, TE; Ng, JD; Coates, L				Tomanicek, Stephen J.; Standaert, Robert F.; Weiss, Kevin L.; Ostermann, Andreas; Schrader, Tobias E.; Ng, Joseph D.; Coates, Leighton			Neutron and X-ray Crystal Structures of a Perdeuterated Enzyme Inhibitor Complex Reveal the Catalytic Proton Network of the Toho-1 beta-Lactamase for the Acylation Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ULTRAHIGH-RESOLUTION STRUCTURE; SITE-DIRECTED MUTAGENESIS; EXTENDED-SPECTRUM; ANTIBIOTIC-RESISTANCE; GENERAL BASE; MECHANISM; SPECIFICITY; GLU166; STATE; QM/MM	The mechanism by which class A beta-lactamases hydrolyze beta-lactam antibiotics has been the subject of intensive investigation using many different experimental techniques. Here, we report on the novel use of both neutron and high resolution x-ray diffraction to help elucidate the identity of the catalytic base in the acylation part of the catalytic cycle, wherein the beta-lactam ring is opened and an acyl-enzyme intermediate forms. To generate protein crystals optimized for neutron diffraction, we produced a perdeuterated form of the Toho-1 beta-lactamase R274N/R276N mutant. Protein perdeuteration, which involves replacing all of the hydrogen atoms in a protein with deuterium, gives a much stronger signal in neutron diffraction and enables the positions of individual deuterium atoms to be located. We also synthesized a perdeuterated acylation transition state analog, benzothiophene-2-boronic acid, which was also isotopically enriched with B-11, as B-10 is a known neutron absorber. Using the neutron diffraction data from the perdeuterated enzyme-inhibitor complex, we were able to determine the positions of deuterium atoms in the active site directly rather than by inference. The neutron diffraction results, along with supporting bond-length analysis from high resolution x-ray diffraction, strongly suggest that Glu-166 acts as the general base during the acylation reaction.	[Tomanicek, Stephen J.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Standaert, Robert F.; Weiss, Kevin L.; Coates, Leighton] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA; [Standaert, Robert F.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Standaert, Robert F.] Univ Tennessee, Dept Biochem & Mol & Cellular Biol, Knoxville, TN 37996 USA; [Ostermann, Andreas] Tech Univ Munich, Forsch Neutronenquelle Heinz Maier Leibnitz FRM 2, D-85747 Garching, Germany; [Schrader, Tobias E.] Forschungszentrum Julich, Outstn FRM 2, Julich Ctr Neutron Sci, D-85747 Garching, Germany; [Ng, Joseph D.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; Technical University of Munich; Helmholtz Association; Research Center Julich; University of Alabama System; University of Alabama Huntsville	Coates, L (corresponding author), Oak Ridge Natl Lab, Biol & Soft Matter Div, POB 2008, Oak Ridge, TN 37831 USA.	coatesl@ornl.gov	Standaert, Robert F/D-9467-2013; Weiss, Kevin/I-4669-2013; Coates, Leighton/AAJ-7148-2021; Standaert, Robert F./AAI-1532-2021	Standaert, Robert F/0000-0002-5684-1322; Weiss, Kevin/0000-0002-6486-8007; Coates, Leighton/0000-0003-2342-049X; Ostermann, Andreas/0000-0002-1477-5590; Schrader, Tobias Erich/0000-0001-5159-0846	Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (ORNL); United States Department of Energy [DE-AC05-00OR22725]; Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (ORNL); United States Department of Energy(United States Department of Energy (DOE)); Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported by the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (ORNL), managed by UT-Battelle LLC for the United States Department of Energy under Contract DE-AC05-00OR22725.; The Office of Biological and Environmental Research supported research at the Oak Ridge National Laboratory Center for Structural Molecular Biology (CSMB), using facilities supported by the Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy. Results shown in this study are derived from work performed at Argonne National Laboratory (ANL), Structural Biology Center at the Advanced Photon Source. ANL is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. We thank Nancy Engle and Dr. Timothy Tschaplinski for assistance with GC-MS.	Adams PD, 2009, ACTA CRYSTALLOGR D, V65, P567, DOI 10.1107/S0907444909011548; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine P. V., 2005, CCP4 NEWSLETTETTER P; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Atanasov BP, 2000, P NATL ACAD SCI USA, V97, P3160, DOI 10.1073/pnas.060027897; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blakeley MP, 2009, CRYSTALLOGR REV, V15, P157, DOI 10.1080/08893110902965003; Blakeley MP, 2008, P NATL ACAD SCI USA, V105, P1844, DOI 10.1073/pnas.0711659105; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Chen Y, 2005, J AM CHEM SOC, V127, P5423, DOI 10.1021/ja042850a; Chen Y, 2005, J MOL BIOL, V348, P349, DOI 10.1016/j.jmb.2005.02.010; Chen Y, 2007, J AM CHEM SOC, V129, P5378, DOI 10.1021/ja0712064; CLARK PD, 1993, PHOSPHORUS SULFUR, V84, P149, DOI 10.1080/10426509308034326; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delmas J, 2010, J MOL BIOL, V400, P108, DOI 10.1016/j.jmb.2010.04.062; DUBOIS SK, 1995, J ANTIMICROB CHEMOTH, V35, P7; ESCOBAR WA, 1994, BIOCHEMISTRY-US, V33, P7619, DOI 10.1021/bi00190a015; Fisher SJ, 2012, ACTA CRYSTALLOGR D, V68, P800, DOI 10.1107/S0907444912012589; Gardberg AS, 2010, ACTA CRYSTALLOGR D, V66, P558, DOI 10.1107/S0907444910005494; GIBSON RM, 1990, BIOCHEM J, V272, P613, DOI 10.1042/bj2720613; Golemi-Kotra D, 2004, J BIOL CHEM, V279, P34665, DOI 10.1074/jbc.M313143200; HAWTHORNE SB, 1989, FRESEN Z ANAL CHEM, V334, P421, DOI 10.1007/BF00469464; Hermann JC, 2005, J AM CHEM SOC, V127, P4454, DOI 10.1021/ja044210d; Hermann JC, 2003, J AM CHEM SOC, V125, P9590, DOI 10.1021/ja034434g; Ibuka A, 1999, J MOL BIOL, V285, P2079, DOI 10.1006/jmbi.1998.2432; Ibuka AS, 2003, BIOCHEMISTRY-US, V42, P10634, DOI 10.1021/bi0342822; ISHII Y, 1995, ANTIMICROB AGENTS CH, V39, P2269, DOI 10.1128/AAC.39.10.2269; KNOX JR, 1995, ANTIMICROB AGENTS CH, V39, P2593, DOI 10.1128/AAC.39.12.2593; LAMOTTEBRASSEUR J, 1991, BIOCHEM J, V279, P213, DOI 10.1042/bj2790213; Lietz EJ, 2000, BIOCHEMISTRY-US, V39, P4971, DOI 10.1021/bi992681k; Matagne A, 1999, NAT PROD REP, V16, P1, DOI 10.1039/a705983c; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Maveyraud L, 1998, BIOCHEMISTRY-US, V37, P2622, DOI 10.1021/bi972501b; Meilleur F, 2004, BIOCHEMISTRY-US, V43, P8744, DOI 10.1021/bi049418q; Meilleur F, 2009, METHODS MOL BIOL, V544, P281, DOI 10.1007/978-1-59745-483-4_18; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; Nitanai Y, 2010, BBA-PROTEINS PROTEOM, V1804, P684, DOI 10.1016/j.bbapap.2009.10.023; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shimamura T, 2002, J BIOL CHEM, V277, P46601, DOI 10.1074/jbc.M207884200; Shimamura T, 2009, ACTA CRYSTALLOGR F, V65, P379, DOI 10.1107/S1744309109008240; Shu F, 2000, P NATL ACAD SCI USA, V97, P3872, DOI 10.1073/pnas.060024697; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Thomas VL, 2005, BIOCHEMISTRY-US, V44, P9330, DOI 10.1021/bi0502700; Tomanicek SJ, 2011, FEBS LETT, V585, P364, DOI 10.1016/j.febslet.2010.12.017; Tomanicek SJ, 2010, J MOL BIOL, V396, P1070, DOI 10.1016/j.jmb.2009.12.036; Tzouvelekis LS, 2000, INT J ANTIMICROB AG, V14, P137, DOI 10.1016/S0924-8579(99)00165-X; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X	50	39	39	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4715	4722		10.1074/jbc.M112.436238	http://dx.doi.org/10.1074/jbc.M112.436238			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23255594	Green Published, hybrid			2022-12-28	WOS:000315340400020
J	Li, S; Zhou, QB; He, H; Zhao, YH; Liu, ZH				Li, Sheng; Zhou, Qibing; He, Huan; Zhao, Yahui; Liu, Zhihua			Peroxisome Proliferator-activated Receptor gamma Agonists Induce Cell Cycle Arrest through Transcriptional Regulation of Kruppel-like Factor 4 (KLF4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; PPAR-GAMMA; LIGAND TROGLITAZONE; TUMOR-SUPPRESSOR; DOWN-REGULATION; INHIBIT GROWTH; BREAST-CANCER; IN-VITRO; EXPRESSION; APOPTOSIS	Peroxisome proliferator-activated receptor gamma(PPAR gamma), a sub-group of ligand-activated nuclear receptors, plays critical roles in cell cycle regulation, differentiation, apoptosis, and invasion. PPAR gamma is involved in tumorigenesis and is a potent target for cancer therapy. PPAR gamma transactivation of KLF4 has been demonstrated in various studies; however, how PPAR gamma regulates KLF4 expression is not clear. In this study, we reveal that PPAR gamma regulates the expression of KLF4 by binding directly to the PPAR response element (PPRE) within the KLF4 promoter. The PPRE resides at - 1657 to - 1669 bp upstream of the KLF4 ATG codon, which is essential for the transactivation of troglitazone-induced KLF4 expression. Furthermore, we found that stable silencing of KLF4 obviously suppressed the G(1)/S arrest and anti-proliferation effects induced by PPAR gamma ligands. Taken together, our data indicate that up-regulation of KLF4 upon PPAR gamma activation is mediated through the PPRE in the KLF4 promoter, thus providing further insights into the PPAR gamma signal transduction pathway as well as a novel cancer therapeutic strategy.	Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, ZH (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn		Zhao, Yahui/0000-0002-9613-1384; Li, Sheng/0000-0001-8080-9712	National Basic Research Program of China [2011CB504205]; National Natural Science Foundation of China [81130043, 81021061]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2011CB504205 and National Natural Science Foundation of China Grants 81130043 and 81021061.	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Burstein HJ, 2003, BREAST CANCER RES TR, V79, P391, DOI 10.1023/A:1024038127156; Cekanova M, 2010, EUR J PHARMACOL, V637, P30, DOI 10.1016/j.ejphar.2010.03.055; Chen ZY, 2005, MOL PHARMACOL, V68, P1203, DOI 10.1124/mol.105.014944; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; Guan HF, 2010, BLOOD, V116, P1469, DOI 10.1182/blood-2009-12-256446; Hu WX, 2009, CLIN CANCER RES, V15, P5688, DOI 10.1158/1078-0432.CCR-09-0310; Itami A, 2001, INT J CANCER, V94, P370, DOI 10.1002/ijc.1488; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Koeffler HP, 2003, CLIN CANCER RES, V9, P1; Kubota T, 1998, CANCER RES, V58, P3344; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Ming M, 2006, WORLD J GASTROENTERO, V12, P7263, DOI 10.3748/wjg.v12.i45.7263; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Ohta K, 2001, J CLIN ENDOCR METAB, V86, P2170, DOI 10.1210/jc.86.5.2170; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Papi A, 2010, CANCER LETT, V297, P65, DOI 10.1016/j.canlet.2010.04.026; Rageul J, 2009, INT J CANCER, V125, P2802, DOI 10.1002/ijc.24683; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Takahashi N, 1999, FEBS LETT, V455, P135, DOI 10.1016/S0014-5793(99)00871-6; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Toyota M, 2002, LIFE SCI, V70, P1565, DOI 10.1016/S0024-3205(01)01524-7; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; Wang N, 2002, WORLD J GASTROENTERO, V8, P966, DOI 10.3748/wjg.v8.i6.966; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Zhou QB, 2009, CANCER RES, V69, P8284, DOI 10.1158/0008-5472.CAN-09-1345	33	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4076	4084		10.1074/jbc.M111.317487	http://dx.doi.org/10.1074/jbc.M111.317487			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23275339	Green Published, hybrid			2022-12-28	WOS:000314845000036
J	Lin, MH; Hsu, FF; Miner, JH				Lin, Meei-Hua; Hsu, Fong-Fu; Miner, Jeffrey H.			Requirement of Fatty Acid Transport Protein 4 for Development, Maturation, and Function of Sebaceous Glands in a Mouse Model of Ichthyosis Prematurity Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA SYNTHETASE; MEIBOMIAN GLANDS; ECTODERMAL DYSPLASIA; TARGETED DISRUPTION; WRINKLE-FREE; MICE; SKIN; LIPIDS; FATP4; GENE	Fatty acid transport protein 4 (FATP4) is one of a family of six transmembrane proteins that facilitate long-and very long-chain fatty acid uptake. FATP4 is expressed in several tissues, including skin. Mutations in human SLC27A4, which encodes FATP4, cause ichthyosis prematurity syndrome, characterized by a thick desquamating epidermis and premature birth. Mice lacking FATP4, which genetically model the human disease, are born with tight, thick skin and a defective skin barrier; they die neonatally due to dehydration and restricted movements. Both the skin phenotype and the lethality are rescued by transgene expression of FATP4 in suprabasal keratinocytes. Sebaceous glands in Fatp4 null skin grafted onto nude mice were found to be dystrophic and enwrapped by thick layers of epithelial cells. Consistent with these results, transgene-rescued Fatp4 null mice showed a subnormal level of FATP4 expression in sebocytes and exhibited abnormal development of both sebaceous glands and meibomian glands, specialized sebaceous glands of the eyelids. Sebum from these mice contained a reduced level of type II diester wax, a major mouse sebum lipid species, and showed perturbations in mass spectrometric profiles of diester wax and cholesteryl ester species. In addition, these mice showed an impaired ability to repel water and regulate body temperature after water immersion. Taken together, our results suggest that FATP4 plays crucial roles in the development and maturation of both sebaceous and meibomian glands, as well as in the formation and composition of sebum, likely by regulating the trafficking of fatty acids necessary for proper synthesis of sebum lipids.	[Lin, Meei-Hua; Miner, Jeffrey H.] Washington Univ, Sch Med, Dept Internal Med, Div Renal, St Louis, MO 63110 USA; [Hsu, Fong-Fu] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Miner, Jeffrey H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Miner, JH (corresponding author), Box 8126,660 S Euclid Ave, St Louis, MO 63110 USA.	minerj@wustl.edu		Hsu, Fong-Fu/0000-0001-5368-0183	National Institutes of Health [R01AR049269, P30DK056341, P41RR00954, P60DK020579, P30DK079333, P01HL029594, C06RR015502]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015502, P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P30DK079333, P30DK056341, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR049269 (to J. H. M.), P30DK056341, P41RR00954, P60DK020579, P30DK079333, P01HL029594, and C06RR015502.	Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Cheng YS, 2011, LIPIDS, V46, P95, DOI 10.1007/s11745-010-3494-0; Cui CY, 2005, AM J PATHOL, V167, P89, DOI 10.1016/S0002-9440(10)62956-2; ENOCH HG, 1978, BIOCHEMISTRY-US, V17, P4927, DOI 10.1021/bi00616a011; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Gu LH, 2008, AM J PATHOL, V173, P752, DOI 10.2353/ajpath.2008.071089; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Herrmann T, 2005, J INVEST DERMATOL, V125, P1228, DOI 10.1111/j.0022-202X.2005.23972.x; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; House JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009837; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; JESTER JV, 1989, INVEST OPHTH VIS SCI, V30, P936; Kenchegowda D, 2011, DEV BIOL, V356, P5, DOI 10.1016/j.ydbio.2011.05.005; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Lee L, 2007, J INVEST DERMATOL, V127, P16, DOI 10.1038/sj.jid.5700511; Lin MH, 2010, DEV BIOL, V344, P707, DOI 10.1016/j.ydbio.2010.05.503; MACALA LJ, 1983, J LIPID RES, V24, P1243; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Moulson CL, 2007, J BIOL CHEM, V282, P15912, DOI 10.1074/jbc.M701779200; Moulson CL, 2003, P NATL ACAD SCI USA, V100, P5274, DOI 10.1073/pnas.0431186100; Naito A, 2002, P NATL ACAD SCI USA, V99, P8766, DOI 10.1073/pnas.132636999; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; NICOLAIDES N, 1970, LIPIDS, V5, P299, DOI 10.1007/BF02531461; Nien CJ, 2010, MOL VIS, V16, P1132; Obata H, 2002, CORNEA, V21, pS70, DOI 10.1097/01.ico.0000263122.45898.09; Patel Sejal, 2001, Journal of Insect Science (Tucson), V1, P1; Plikus M, 2004, AM J PATHOL, V164, P1099, DOI 10.1016/S0002-9440(10)63197-5; Reneerkens J, 2005, J EXP BIOL, V208, P4199, DOI 10.1242/jeb.01872; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Schmuth M, 2005, J INVEST DERMATOL, V125, P1174, DOI 10.1111/j.0022-202X.2005.23934.x; Senba Y, 2009, BRIT J DERMATOL, V160, P454, DOI 10.1111/j.1365-2133.2008.08964.x; Sobol Maria, 2011, BMC Res Notes, V4, P90, DOI 10.1186/1756-0500-4-90; STEWART ME, 1991, ADV LIPID RES, V24, P263; THODY AJ, 1989, PHYSIOL REV, V69, P383, DOI 10.1152/physrev.1989.69.2.383; Tsau C, 2011, DEVELOPMENT, V138, P3307, DOI 10.1242/dev.066241; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; White CR, 1996, CUTANEOUS MED SURG, P3; WILKINSON DI, 1966, J INVEST DERMATOL, V47, P449, DOI 10.1038/jid.1966.168; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zheng Y, 1999, NAT GENET, V23, P268, DOI 10.1038/15446; Zouboulis CC, 2003, J INVEST DERMATOL, V120, pXIV, DOI 10.1046/j.1523-1747.2003.12263.x	43	21	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3964	3976		10.1074/jbc.M112.416990	http://dx.doi.org/10.1074/jbc.M112.416990			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23271751	Green Published, hybrid			2022-12-28	WOS:000314845000026
J	Fan, HP; Zhao, XF; Sun, SG; Luo, M; Guan, JL				Fan, Huaping; Zhao, Xiaofeng; Sun, Shaogang; Luo, Ming; Guan, Jun-Lin			Function of Focal Adhesion Kinase Scaffolding to Mediate Endophilin A2 Phosphorylation Promotes Epithelial-Mesenchymal Transition and Mammary Cancer Stem Cell Activities in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; TRANSGENIC MOUSE MODEL; BREAST-CANCER; TYROSINE PHOSPHORYLATION; TUMOR PROGRESSION; E-CADHERIN; FAK; SRC; DISRUPTION; MIGRATION	Tyrosine kinases have been shown to play critical roles in cancer development and progression, and their inhibitors hold the potential as effective targeted therapies for breast and other cancers. However, some of these kinases like focal adhesion kinase (FAK) also possess scaffolding functions in intracellular signaling, but such kinase-independent functions of FAK or other kinases have not been examined in cancer directly in vivo. Here, we report that disruption of the function of FAK scaffolding through its Pro-878/881 motif suppressed mammary tumor growth and metastasis in a well characterized murine model of human breast cancer. P878A/P881A mutation in the endogenous FAK gene decreased the expression of markers for epithelial-mesenchymal transition (EMT) and mammary cancer stem cell (MaCSC) activities in tumors derived from mutant mice. This mutation disrupted the function of FAK scaffolding to mediate endophilin A2 phosphorylation at Tyr-315 by Src, leading to the decreased surface expression of MT1-MMP, as observed previously in transformed fibroblasts in vitro. Inhibition of the downstream components of this FAK scaffolding function by Y315F endophilin A2 mutant or MT1-MMP knockdown reduced markers for EMT and MaCSC activities. Conversely, bypass of the scaffolding function using the phosphorylation mimic mutant Y315E endophilin A2 or endophilin A2 knockdown rescued the decreased markers for EMT and MaCSCs as well as surface expression of MT1-MMP in tumor cells harboring the P878A/P881A mutation. Together, these results identify a novel role of FAK scaffolding function in breast cancer, which could serve as a new target in combination with kinase inhibition for more effective treatment strategies.	[Fan, Huaping; Zhao, Xiaofeng; Sun, Shaogang; Luo, Ming; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med, Ann Arbor, MI 48109 USA; [Fan, Huaping; Zhao, Xiaofeng; Sun, Shaogang; Luo, Ming; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Genet, Ann Arbor, MI 48109 USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Fan, Huaping/B-8762-2012		National Institutes of Health [CA163493, CA150926, CA046592]; John S. and Suzanne C. Munn cancer fund of the University of Michigan Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P30CA046592, R01CA150926, R01CA163493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John S. and Suzanne C. Munn cancer fund of the University of Michigan Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA163493 and CA150926. This work was also supported in part by the John S. and Suzanne C. Munn cancer fund of the University of Michigan Comprehensive Cancer Center (to J.-L. G.).; We are grateful to Dr. Thom Saunders of the University of Michigan for advice on the generation of knock-in mice and C. Bian and A. Serna for technical assistance. We thank Dr. Stephen Weiss of the University of Michigan and members of the Guan laboratory for discussions and helpful comments. We acknowledge E. Hughes, Y. Y. Qu, K. Childs, and G. Gavrilina for the preparation of gene-targeted mice and the University of Michigan Biomedical Research Core Facility, which was supported in part by National Institutes of Health Grant CA046592.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Bailey KM, 2008, J BIOL CHEM, V283, P13714, DOI 10.1074/jbc.M709329200; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; Fan HP, 2011, J BIOL CHEM, V286, P18573, DOI 10.1074/jbc.M110.200717; Golubovskaya VM, 2007, INT REV CYTOL, V263, P103, DOI 10.1016/S0074-7696(07)63003-4; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Han DC, 2000, J BIOL CHEM, V275, P28911, DOI 10.1074/jbc.M001997200; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; Kim J, 2012, P NATL ACAD SCI USA, V109, P6124, DOI 10.1073/pnas.1203203109; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li XY, 2011, J CELL BIOL, V195, P729, DOI 10.1083/jcb.201105103; Littlepage LE, 2005, CANCER CELL, V7, P499, DOI 10.1016/j.ccr.2005.05.019; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Messina S, 2003, J NEUROCHEM, V84, P253, DOI 10.1046/j.1471-4159.2003.01519.x; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nagy T, 2007, J BIOL CHEM, V282, P31766, DOI 10.1074/jbc.M705403200; Nakamura K, 2001, ONCOGENE, V20, P2626, DOI 10.1038/sj.onc.1204359; Parsons JT, 2008, CLIN CANCER RES, V14, P627, DOI 10.1158/1078-0432.CCR-07-2220; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Rodrigo JP, 2007, ARCH OTOLARYNGOL, V133, P145, DOI 10.1001/archotol.133.2.145; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; Strizzi L, 2004, J CELL PHYSIOL, V201, P266, DOI 10.1002/jcp.20062; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhao XF, 2010, J CELL BIOL, V189, P955, DOI 10.1083/jcb.200912094	58	59	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3322	3333		10.1074/jbc.M112.420497	http://dx.doi.org/10.1074/jbc.M112.420497			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255596	Green Published, hybrid			2022-12-28	WOS:000314397900038
J	Fargue, S; Lewin, J; Rumsby, G; Danpure, CJ				Fargue, Sonia; Lewin, Jackie; Rumsby, Gill; Danpure, Christopher J.			Four of the Most Common Mutations in Primary Hyperoxaluria Type 1 Unmask the Cryptic Mitochondrial Targeting Sequence of Alanine:glyoxylate Aminotransferase Encoded by the Polymorphic Minor Allele	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-GLYOXYLATE AMINOTRANSFERASE; ENZYME TRAFFICKING DEFECT; ALANINEGLYOXYLATE AMINOTRANSFERASE; SACCHAROMYCES-CEREVISIAE; PEROXISOMAL ALANINE; IMPORT; PHENOTYPE; DIMERIZATION; GENOTYPE; DISEASE	The gene encoding the liver-specific peroxisomal enzyme alanine: glyoxylate aminotransferase (AGT, EC. 2.6.1.44) exists as two common polymorphic variants termed the "major" and "minor" alleles. The P11L amino acid replacement encoded by the minor allele creates a hidden N-terminal mitochondrial targeting sequence, the unmasking of which occurs in the hereditary calcium oxalate kidney stone disease primary hyperoxaluria type 1 (PH1). This unmasking is due to the additional presence of a common disease-specific G170R mutation, which is encoded by about one third of PH1 alleles. The P11L and G170R replacements interact synergistically to reroute AGT to the mitochondria where it cannot fulfill its metabolic role (i.e. glyoxylate detoxification) effectively. In the present study, we have reinvestigated the consequences of the interaction between P11L and G170R in stably transformed CHO cells and have studied for the first time whether a similar synergism exists between P11L and three other mutations that segregate with the minor allele (i.e. I244T, F152I, and G41R). Our investigations show that the latter three mutants are all able to unmask the cryptic P11L-generated mitochondrial targeting sequence and, as a result, all are mistargeted to the mitochondria. However, whereas the G170R, I244T, and F152I mutants are able to form dimers and are catalytically active, the G41R mutant aggregates and is inactive. These studies open up the possibility that all PH1 mutations, which segregate with the minor allele, might also lead to the peroxisome-to-mitochondrion mistargeting of AGT, a suggestion that has important implications for the development of treatment strategies for PH1.	[Danpure, Christopher J.] UCL, Dept Cell & Dev Biol, Div Biosci, London WC1E 6BT, England; [Lewin, Jackie] Royal Free & Univ Coll Med Sch, Electron Microscopy Unit, London NW3 2PF, England; [Rumsby, Gill] Univ Coll London Hosp, Dept Clin Biochem, London W1T 4EU, England	University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Danpure, CJ (corresponding author), UCL, Dept Cell & Dev Biol, Div Biosci, Gower St, London WC1E 6BT, England.	c.danpure@ucl.ac.uk	Fargue, Sonia/J-1706-2019	Fargue, Sonia/0000-0001-7451-7481	Oxalosis and Hyperoxaluria Foundation; Societe Francaise de Nephrologie	Oxalosis and Hyperoxaluria Foundation; Societe Francaise de Nephrologie	This work was supported by grants from the Oxalosis and Hyperoxaluria Foundation (to C. J. D.) and the Societe Francaise de Nephrologie (to S. F.).	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Behnam JI, 2006, BIOCHEM J, V394, P409, DOI 10.1042/BJ20051397; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Cellini B, 2007, BIOCHEM J, V408, P39, DOI 10.1042/BJ20070637; Cellini B, 2010, BIOCHIMIE, V92, P1801, DOI 10.1016/j.biochi.2010.08.005; Cellini B, 2010, P NATL ACAD SCI USA, V107, P2896, DOI 10.1073/pnas.0908565107; Cellini B, 2009, J BIOL CHEM, V284, P8349, DOI 10.1074/jbc.M808965200; Coulter-Mackie MB, 2006, MOL GENET METAB, V89, P349, DOI 10.1016/j.ymgme.2006.07.013; Coulter-Mackie MB, 2008, CLIN BIOCHEM, V41, P598, DOI 10.1016/j.clinbiochem.2008.01.018; Coulter-Mackie MB, 2005, PROTEIN EXPRES PURIF, V41, P18, DOI 10.1016/j.pep.2004.11.004; Danpure C. J., 2001, METABOLIC MOL BASES, V2, P3323; Danpure CJ, 2006, BBA-MOL CELL RES, V1763, P1776, DOI 10.1016/j.bbamcr.2006.08.021; DANPURE CJ, 1993, BIOCHIMIE, V75, P309, DOI 10.1016/0300-9084(93)90091-6; DANPURE CJ, 1993, AM J HUM GENET, V53, P417; DANPURE CJ, 1986, FEBS LETT, V201, P20, DOI 10.1016/0014-5793(86)80563-4; DANPURE CJ, 1989, J CELL BIOL, V108, P1345, DOI 10.1083/jcb.108.4.1345; Djordjevic S, 2010, ACTA CRYSTALLOGR F, V66, P233, DOI 10.1107/S1744309109054645; EILERS M, 1988, CELL, V52, P481, DOI 10.1016/0092-8674(88)90458-8; ELGERSMA Y, 1995, EMBO J, V14, P3472, DOI 10.1002/j.1460-2075.1995.tb07353.x; Fan JQ, 2007, FEBS J, V274, P4962, DOI 10.1111/j.1742-4658.2007.06041.x; Harambat J, 2010, KIDNEY INT, V77, P443, DOI 10.1038/ki.2009.435; Hopper ED, 2008, J BIOL CHEM, V283, P30493, DOI 10.1074/jbc.M803525200; Knott TG, 2000, BIOCHEM J, V352, P409, DOI 10.1042/0264-6021:3520409; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Lee JG, 2000, J BIOCHEM-TOKYO, V128, P1059, DOI 10.1093/oxfordjournals.jbchem.a022834; Leiper JM, 1996, J CELL BIOL, V135, P939, DOI 10.1083/jcb.135.4.939; Lumb MJ, 2003, BIOCHEM J, V374, P79, DOI 10.1042/BJ20030371; Lumb MJ, 1999, J BIOL CHEM, V274, P20587, DOI 10.1074/jbc.274.29.20587; Lumb MJ, 2000, J BIOL CHEM, V275, P36415, DOI 10.1074/jbc.M006693200; Monico CG, 2005, AM J NEPHROL, V25, P183, DOI 10.1159/000085411; Montioli R, 2012, INT J BIOCHEM CELL B, V44, P536, DOI 10.1016/j.biocel.2011.12.007; MOTLEY A, 1995, J CELL BIOL, V131, P95, DOI 10.1083/jcb.131.1.95; Oatey PB, 1996, EUR J BIOCHEM, V241, P374, DOI 10.1111/j.1432-1033.1996.00374.x; Obita T, 2003, J MOL BIOL, V328, P495, DOI 10.1016/S0022-2836(03)00288-2; Petrova VY, 2004, BIOCHEM J, V380, P393, DOI 10.1042/BJ20040042; PURDUE PE, 1991, P NATL ACAD SCI USA, V88, P10900, DOI 10.1073/pnas.88.23.10900; PURDUE PE, 1992, GENOMICS, V13, P215, DOI 10.1016/0888-7543(92)90225-H; PURDUE PE, 1990, J CELL BIOL, V111, P2341, DOI 10.1083/jcb.111.6.2341; Rumsby G, 1997, ANN CLIN BIOCHEM, V34, P400, DOI 10.1177/000456329703400411; Santana A, 2003, P NATL ACAD SCI USA, V100, P7277, DOI 10.1073/pnas.1131968100; Sass E, 2003, J BIOL CHEM, V278, P45109, DOI 10.1074/jbc.M302344200; Siekierska A, 2012, J BIOL CHEM, V287, P28386, DOI 10.1074/jbc.M112.351056; Strobel G, 2002, MOL BIOL CELL, V13, P1439, DOI 10.1091/mbc.01-08-0396; Tarn AC, 1997, J INHERIT METAB DIS, V20, P689, DOI 10.1023/A:1005326510239; van Woerden CS, 2004, KIDNEY INT, V66, P746, DOI 10.1111/j.1523-1755.2004.00796.x; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Williams E, 2007, CLIN CHEM, V53, P1216, DOI 10.1373/clinchem.2006.084434; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	50	64	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2475	2484		10.1074/jbc.M112.432617	http://dx.doi.org/10.1074/jbc.M112.432617			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229545	Green Published, hybrid			2022-12-28	WOS:000314211500034
J	Rindler, PM; Plafker, SM; Szweda, LI; Kinter, M				Rindler, Paul M.; Plafker, Scott M.; Szweda, Luke I.; Kinter, Michael			High Dietary Fat Selectively Increases Catalase Expression within Cardiac Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; INSULIN-RESISTANCE; HYDROGEN-PEROXIDE; INDUCED OBESITY; CARDIOVASCULAR-DISEASE; TRANSCRIPTION FACTOR; MICE LACKING; HEART; ACID; INFLAMMATION	Obesity is a predictor of diabetes and cardiovascular disease. One consequence of obesity is dyslipidemia characterized by high blood triglycerides. It has been proposed that oxidative stress, driven by utilization of lipids for energy, contributes to these diseases. The effects of oxidative stress are mitigated by an endogenous antioxidant enzyme network, but little is known about its response to high fat utilization. Our experiments used a multiplexed quantitative proteomics method to measure antioxidant enzyme expression in heart tissue in a mouse model of diet-induced obesity. This experiment showed a rapid and specific up-regulation of catalase protein, with subsequent assays showing increases in activity and mRNA. Catalase, traditionally considered a peroxisomal protein, was found to be present in cardiac mitochondria and significantly increased in content and activity during high fat feeding. These data, coupled with the fact that fatty acid oxidation enhances mitochondrial H2O2 production, suggest that a localized catalase increase is needed to consume excessive mitochondrial H2O2 produced by increased fat metabolism. To determine whether the catalase-specific response is a common feature of physiological conditions that increase blood triglycerides and fatty acid oxidation, we measured changes in antioxidant expression in fasted versus fed mice. Indeed, a similar specific catalase increase was observed in mice fasted for 24 h. Our findings suggest a fundamental metabolic process in which catalase expression is regulated to prevent damage while preserving an H2O2-mediated sensing of diet composition that appropriately adjusts insulin sensitivity in the short term as needed to prioritize lipid metabolism for complete utilization.	[Rindler, Paul M.; Plafker, Scott M.; Szweda, Luke I.; Kinter, Michael] Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, Oklahoma City, OK 73104 USA; [Szweda, Luke I.; Kinter, Michael] Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK 73104 USA; [Szweda, Luke I.; Kinter, Michael] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Plafker, Scott M.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Kinter, M (corresponding author), Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	mike-kinter@omrf.org		Kinter, Michael/0000-0001-7409-8918	National Institutes of Health from NIGMS [AG016339, GM092900]; Oklahoma Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016339] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Oklahoma Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG016339 (to L. I. S.) and GM092900 from NIGMS (to S. M. P.). This work was also supported by the Oklahoma Medical Research Foundation.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Aebi H, 1984, Methods Enzymol, V105, P121; Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Anderson EJ, 2012, BIOCHEM J, V441, P359, DOI 10.1042/BJ20110626; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bhandari U, 2011, HUM EXP TOXICOL, V30, P1313, DOI 10.1177/0960327110389499; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; DECRAEMER D, 1994, J LIPID RES, V35, P1241; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fang CX, 2008, AM J PHYSIOL-HEART C, V295, pH1206, DOI 10.1152/ajpheart.00319.2008; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Gaetani GF, 1996, BLOOD, V87, P1595, DOI 10.1182/blood.V87.4.1595.bloodjournal8741595; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Ho YS, 2004, J BIOL CHEM, V279, P32804, DOI 10.1074/jbc.M404800200; Horton TJ, 2001, J APPL PHYSIOL, V90, P155, DOI 10.1152/jappl.2001.90.1.155; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Iwakami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027401; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kinter CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050016; Liu TJ, 2007, J ENDOCRINOL, V192, P149, DOI 10.1677/joe.1.07020; Loo AEK, 2011, FREE RADICAL BIO MED, V51, P884, DOI 10.1016/j.freeradbiomed.2011.06.001; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Ludwig C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013987; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; McLain AL, 2011, FREE RADICAL RES, V45, P29, DOI 10.3109/10715762.2010.534163; Nicholls P, 2001, ADV INORG CHEM, V51, P51; Noeman SA, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-17; ORFALI KA, 1993, FEBS LETT, V336, P501, DOI 10.1016/0014-5793(93)80864-Q; Penckofer Sue, 2002, J Cardiovasc Nurs, V16, P68; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; RADI R, 1991, J BIOL CHEM, V266, P22028; RANDLE PJ, 1964, BIOCHEM J, V93, P652, DOI 10.1042/bj0930652; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Sonta T, 2004, FREE RADICAL BIO MED, V37, P115, DOI 10.1016/j.freeradbiomed.2004.04.001; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Tsutsui H, 2006, ANTIOXID REDOX SIGN, V8, P1737, DOI 10.1089/ars.2006.8.1737; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Verhoeven NM, 1998, J LIPID RES, V39, P66; Vincent HK, 2001, INT J OBESITY, V25, P378, DOI 10.1038/sj.ijo.0801536; Wang HT, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-145; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017; Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P71, DOI 10.1007/s12012-008-9016-0	56	96	97	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1979	1990		10.1074/jbc.M112.412890	http://dx.doi.org/10.1074/jbc.M112.412890			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23204527	hybrid, Green Published			2022-12-28	WOS:000313751400050
J	Tsao, KC; Tu, CF; Lee, SJ; Yang, RB				Tsao, Ku-Chi; Tu, Cheng-Fen; Lee, Shyh-Jye; Yang, Ruey-Bing			Zebrafish scube1 (Signal Peptide-CUB (Complement Protein C1r/C1s, Uegf, and Bmp1)-EGF (Epidermal Growth Factor) Domain-containing Protein 1) Is Involved in Primitive Hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE GLYCOPROTEIN; FUNCTIONAL-ANALYSIS; GENE; BMP; ERYTHROPOIESIS; EXPRESSION; SCUBE2; BLOOD; IDENTIFICATION; TRANSCRIPTION	scube1 (signal peptide-CUB (complement protein C1r/C1s, Uegf, and Bmp1)-EGF domain-containing protein 1), the founding member of a novel secreted and cell surface SCUBE protein family, is expressed predominantly in various developing tissues in mice. However, its function in primitive hematopoiesis remains unknown. In this study, we identified and characterized zebrafish scube1 and analyzed its function by injecting antisense morpholino-oligonucleotide into embryos. Whole-mount in situ hybridization revealed that zebrafish scube1 mRNA is maternally expressed and widely distributed during early embryonic development. Knockdown of scube1 by morpholino-oligonucleotide down-regulated the expression of marker genes associated with early primitive hematopoietic precursors (scl) and erythroid (gata1 and hbbe1), as well as early (pu.1) and late (mpo and l-plastin) myelomonocytic lineages. However, the expression of an early endothelial marker fli1a and vascular morphogenesis appeared normal in scube1 morphants. Overexpression of bone morphogenetic protein (bmp) rescued the expression of scl in the posterior lateral mesoderm during early primitive hematopoiesis in scube1 morphants. Biochemical and molecular analysis revealed that Scube1 could be a BMP co-receptor to augment BMP signaling. Our results suggest that scube1 is critical for and functions at the top of the regulatory hierarchy of primitive hematopoiesis by modulating BMP activity during zebrafish embryogenesis.	[Tsao, Ku-Chi; Tu, Cheng-Fen; Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Tu, Cheng-Fen; Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Taiwan Int Grad Program, Program Mol Med, Taipei 11529, Taiwan; [Tu, Cheng-Fen; Yang, Ruey-Bing] Natl Yang Ming Univ, Sch Med, Inst Biochem & Mol Biol, Taipei 11221, Taiwan; [Yang, Ruey-Bing] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 11221, Taiwan; [Lee, Shyh-Jye] Natl Taiwan Univ, Inst Zool, Taipei 10617, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan University	Yang, RB (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sec 2, Taipei 11529, Taiwan.	rbyang@ibms.sinica.edu.tw	Lee, Shyh-Jye/C-6092-2008; Yang, Ruey-Bing/O-1494-2018	Lee, Shyh-Jye/0000-0001-8452-9152; Yang, Ruey-Bing/0000-0003-3017-3714; Tu, Cheng-Fen/0000-0003-3624-7884	National Science Council [NSC 99-2311-B-001-022-MY3, NSC-98-2311-B-002-006-MY3, 101-2321-B-001-026, 101-2321-B-400-014]; National Taiwan University [NTU CESRP-10R70602A5, NTU ERP-10R80600]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was supported by National Science Council Grant NSC 99-2311-B-001-022-MY3 (to R.-B. Y.) and by National Science Council Grant NSC-98-2311-B-002-006-MY3 and National Taiwan University Grants NTU CESRP-10R70602A5 and NTU ERP-10R80600 (to S.-J. L.).; We thank the Zebrafish International Resource Center (ZIRC), Taiwan Zebrafish Core Facility at Academia Sinica (supported by grant 101-2321-B-001-026 from the National Science Council), and Taiwan Zebrafish Core Facility at NTHU/NHRI (supported by grant 101-2321-B-400-014 from the National Science Council) for providing AB, Tg(kdr:EGFP), Tg(gata1:dsRed) fish lines, and some ISH probes used in this study.	Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Blank U, 2011, LEUKEMIA, V25, P1379, DOI 10.1038/leu.2011.95; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; Cheng CJ, 2009, CANCER RES, V69, P3634, DOI 10.1158/0008-5472.CAN-08-3615; Chiang PM, 2011, DEVELOPMENT, V138, P2833, DOI 10.1242/dev.061440; Ciau-Uitz A, 2010, INT J DEV BIOL, V54, P1139, DOI 10.1387/ijdb.093055ac; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Grimmond S, 2000, GENOMICS, V70, P74, DOI 10.1006/geno.2000.6370; Grimmond S, 2001, MECH DEVELOP, V102, P209, DOI 10.1016/S0925-4773(00)00586-4; Gupta S, 2006, DEVELOPMENT, V133, P2177, DOI 10.1242/dev.02386; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hogan BM, 2006, CURR BIOL, V16, P506, DOI 10.1016/j.cub.2006.01.047; Hollway GE, 2006, DEV BIOL, V294, P104, DOI 10.1016/j.ydbio.2006.02.032; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; Jing LL, 2011, DIS MODEL MECH, V4, P433, DOI 10.1242/dmm.006791; Johnson JLFA, 2012, DEV BIOL, V368, P193, DOI 10.1016/j.ydbio.2012.05.007; Kawakami A, 2005, CURR BIOL, V15, P480, DOI 10.1016/j.cub.2005.02.018; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Lin YC, 2011, J BIOL CHEM, V286, P27039, DOI 10.1074/jbc.M111.244418; Marom K, 2005, DEV BIOL, V282, P442, DOI 10.1016/j.ydbio.2005.03.024; McReynolds LJ, 2007, BLOOD, V110, P3881, DOI 10.1182/blood-2007-04-085753; McReynolds LJ, 2008, EXP HEMATOL, V36, P1604, DOI 10.1016/j.exphem.2008.08.005; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Prince VE, 1998, DEVELOPMENT, V125, P393; Quinkertz A, 1999, DEV GENES EVOL, V209, P126, DOI 10.1007/s004270050235; Schmerer M, 2003, BLOOD, V102, P3196, DOI 10.1182/blood-2003-04-1094; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Tsai MT, 2009, BIOCHEM J, V422, P119, DOI 10.1042/BJ20090341; Tu CF, 2008, J BIOL CHEM, V283, P12478, DOI 10.1074/jbc.M705872200; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Walmsley M, 2002, DEVELOPMENT, V129, P5683, DOI 10.1242/dev.00169; Woods IG, 2005, PLOS BIOL, V3, P476, DOI 10.1371/journal.pbio.0030066; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Xavier GM, 2009, J EXP ZOOL PART B, V312B, P518, DOI 10.1002/jez.b.21260; Xavier GM, 2010, GENESIS, V48, P684, DOI 10.1002/dvg.20678; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200	50	16	17	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5017	5026		10.1074/jbc.M112.375196	http://dx.doi.org/10.1074/jbc.M112.375196			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23271740	Green Published, hybrid			2022-12-28	WOS:000315340400048
J	Cho, HJ; Oh, YJ; Han, SH; Chung, HJ; Kim, CH; Lee, NS; Kim, WJ; Choi, JM; Kim, H				Cho, Hyun Jung; Oh, Yun Jung; Han, Seung Hun; Chung, Hee Jin; Kim, Chang Hee; Lee, Nam Soo; Kim, Won-Ju; Choi, Je-Min; Kim, Hongtae			Cdk1 Protein-mediated Phosphorylation of Receptor-associated Protein 80 (RAP80) Serine 677 Modulates DNA Damage-induced G(2)/M Checkpoint and Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETS BRCA1; REPAIR; COMPLEX; SITES; CYCLE; CANCERS; CCDC98	Post-translational phosphorylation plays critical roles in the assembly of signaling and repair proteins in the DNA damage response pathway. RAP80, a component of the BRCA1-A complex, is crucial in cell cycle checkpoint activation and DNA damage repair. However, its molecular mechanism is unclear. In this study, we identified Cdk1 as a new RAP80-binding protein and demonstrated that the Cdk1-cyclin B-1 complex phosphorylates RAP80 at Ser-677 using an in vitro kinase assay and a phosphopeptide-specific antibody against phospho-Ser-677 of RAP80. RAP80 Ser-677 phosphorylation occurred in the M phase of the cell cycle when Cdk1 was in an active state. In addition, ionizing radiation (IR) induced RAP80 phosphorylation at Ser-677. Mutation of Ser-677 to alanine sensitized cells to IR and functioned in G(2)/M checkpoint control. These results suggest that post-translational phosphorylation of RAP80 by the Cdk1-cyclin B-1 complex is important for RAP80 functional sensitivity to IR and G(2)/M checkpoint control.	[Cho, Hyun Jung; Oh, Yun Jung; Han, Seung Hun; Chung, Hee Jin; Kim, Chang Hee; Lee, Nam Soo; Kim, Hongtae] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Kim, Won-Ju; Choi, Je-Min] Hanyang Univ, Dept Life Sci, Res Inst Nat Sci, Seoul 133791, South Korea	Sungkyunkwan University (SKKU); Hanyang University	Choi, JM (corresponding author), Hanyang Univ, 55 Wangsimni Ro, Seoul 133791, South Korea.	jeminchoi@hanyang.ac.kr; khtcat@skku.edu		Kim, Wonju/0000-0002-1800-0485; Choi, Je-Min/0000-0002-9482-710X	National Research Foundation of Korea (NRF) from the Korean Ministry of Education, Science and Technology (MEST) [20110030831]; National R&D Program for Cancer Control from the Ministry for Health, Welfare and Family Affairs, Republic of Korea [A111643]	National Research Foundation of Korea (NRF) from the Korean Ministry of Education, Science and Technology (MEST); National R&D Program for Cancer Control from the Ministry for Health, Welfare and Family Affairs, Republic of Korea	This work was supported by National Research Foundation of Korea (NRF) Grant 20110030831 from the Korean Ministry of Education, Science and Technology (MEST) and National R&D Program for Cancer Control Grant A111643 from the Ministry for Health, Welfare and Family Affairs, Republic of Korea.	Cho HJ, 2012, MOL CANCER RES, V10, P615, DOI 10.1158/1541-7786.MCR-11-0481; Cho HJ, 2010, MOL CELLS, V30, P355, DOI 10.1007/s10059-010-0134-8; Deans AJ, 2006, CANCER RES, V66, P8219, DOI 10.1158/0008-5472.CAN-05-3945; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Gupta M, 2007, J BIOL CHEM, V282, P4301, DOI 10.1074/jbc.M607910200; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Johnson N, 2011, NAT MED, V17, P875, DOI 10.1038/nm.2377; Kim HT, 2008, MOL CELLS, V25, P457; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wu JX, 2012, J BIOL CHEM, V287, P22919, DOI 10.1074/jbc.M112.351007; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yata K, 2009, DNA REPAIR, V8, P6, DOI 10.1016/j.dnarep.2008.09.002; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	24	23	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3768	3776		10.1074/jbc.M112.401299	http://dx.doi.org/10.1074/jbc.M112.401299			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23264621	Green Published, hybrid			2022-12-28	WOS:000314845000008
J	Watanabe, S; Kaneko, K; Yamanaka, K				Watanabe, Shoji; Kaneko, Kumi; Yamanaka, Koji			Accelerated Disease Onset with Stabilized Familial Amyotrophic Lateral Sclerosis (ALS)-linked Mutant TDP-43 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; TARDBP GENE-MUTATIONS; MOTOR DEFICITS; RNA DEPLETION; ALS; AGGREGATION; EXPRESSION; NEURONS; IDENTIFICATION; INSTABILITY	Abnormal protein accumulation is a pathological hallmark of neurodegenerative diseases, including accumulation of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis (ALS). Dominant mutations in the TDP-43 gene are causative for familial ALS; however, the relationship between mutant protein biochemical phenotypes and disease course and their significance to disease pathomechanism are not known. Here, we found that longer half-lives of mutant proteins correlated with accelerated disease onset. Based on our findings, we established a cell model in which chronic stabilization of wildtype TDP-43 protein provoked cytotoxicity and recapitulated pathogenic protein cleavage and insolubility to the detergent Sarkosyl, TDP-43 properties that have been observed in sporadic ALS lesions. Furthermore, these cells showed proteasomal impairment and dysregulation of their own mRNA levels. These results suggest that chronically increased stability of mutant or wild-type TDP-43 proteins results in a gain of toxicity through abnormal proteostasis.	[Watanabe, Shoji; Kaneko, Kumi; Yamanaka, Koji] RIKEN, Brain Sci Inst, Lab Motor Neuron Dis, Wako, Saitama 3510198, Japan; [Watanabe, Shoji] Doshisha Univ, Grad Sch Brain Sci, Kyoto 6190225, Japan; [Yamanaka, Koji] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Yamanaka, Koji] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan; [Yamanaka, Koji] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan	RIKEN; Doshisha University; Japan Science & Technology Agency (JST); Saitama University; Kyoto University	Yamanaka, K (corresponding author), RIKEN, Brain Sci Inst, Lab Motor Neuron Dis, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kyamanaka@brain.riken.jp	Yamanaka, Koji/ABD-1034-2020; Yamanaka, Koji/H-5806-2011	Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035	Ministry for Education, Culture, and Sports, Science and Technology of Japan [23111006, 23110523, 22700404]; Research Committee of CNS Degenerative Diseases; Ministry of Health, Labour, and Welfare of Japan; Takeda Science Foundation; Naito Foundation	Ministry for Education, Culture, and Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Committee of CNS Degenerative Diseases(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation)	This work was supported by Grants-in-aid for Scientific Research on Innovative Areas 23111006 and 23110523 (to K. Y.) and 22700404 (to S. W.) for Young Scientists (B) from the Ministry for Education, Culture, and Sports, Science and Technology of Japan, grants-in-aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour, and Welfare of Japan, The Takeda Science Foundation, and The Naito Foundation (to K. Y.).	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Del Bo R, 2009, EUR J NEUROL, V16, P727, DOI 10.1111/j.1468-1331.2009.02574.x; Fujita Y, 2011, NEUROLOGY, V77, P1427, DOI 10.1212/WNL.0b013e318232ab87; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kamada M, 2009, J NEUROL SCI, V284, P69, DOI 10.1016/j.jns.2009.04.017; Kirby J, 2010, NEUROGENETICS, V11, P217, DOI 10.1007/s10048-009-0218-9; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lemmens R, 2009, J NEUROL NEUROSUR PS, V80, P354, DOI 10.1136/jnnp.2008.157677; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; MATSUYAMA S, 1993, EMBO J, V12, P265, DOI 10.1002/j.1460-2075.1993.tb05652.x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nozaki I, 2010, INTERNAL MED, V49, P1209, DOI 10.2169/internalmedicine.49.3300; Origone P, 2010, AMYOTROPH LATERAL SC, V11, P223, DOI 10.3109/17482960903165039; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tamaoka A, 2010, INTERNAL MED, V49, P331, DOI 10.2169/internalmedicine.49.2915; Tashiro Y, 2012, J BIOL CHEM, V287, P42984, DOI 10.1074/jbc.M112.417600; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; Tsai CP, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.009; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Williams KL, 2009, J NEUROL NEUROSUR PS, V80, P1286, DOI 10.1136/jnnp.2008.163261; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xiong HL, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-8; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392	60	80	80	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3641	3654		10.1074/jbc.M112.433615	http://dx.doi.org/10.1074/jbc.M112.433615			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235148	Green Published, hybrid			2022-12-28	WOS:000314397900068
J	Yeo, YS; Nybo, SE; Chittiboyina, AG; Weerasooriya, AD; Wang, YH; Gongora-Castillo, E; Vaillancourt, B; Buell, CR; DellaPenna, D; Celiz, MD; Jones, AD; Wurtele, ES; Ransom, N; Dudareva, N; Shaaban, KA; Tibrewal, N; Chandra, S; Smillie, T; Khan, IA; Coates, RM; Watt, DS; Chappell, J				Yeo, Yun-Soo; Nybo, S. Eric; Chittiboyina, Amar G.; Weerasooriya, Aruna D.; Wang, Yan-Hong; Gongora-Castillo, Elsa; Vaillancourt, Brieanne; Buell, C. Robin; DellaPenna, Dean; Celiz, Mary Dawn; Jones, A. Daniel; Wurtele, Eve Syrkin; Ransom, Nick; Dudareva, Natalia; Shaaban, Khaled A.; Tibrewal, Nidhi; Chandra, Suman; Smillie, Troy; Khan, Ikhlas A.; Coates, Robert M.; Watt, David S.; Chappell, Joe			Functional Identification of Valerena-1,10-diene Synthase, a Terpene Synthase Catalyzing a Unique Chemical Cascade in the Biosynthesis of Biologically Active Sesquiterpenes in Valeriana officinalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALERENA-4,7(11)-DIENE; EXPRESSION; EXTRACTS; ALCOHOL; PATHWAY; TOPHAT; PLANTS; ACID	Valerian is an herbal preparation from the roots of Valeriana officinalis used as an anxiolytic and sedative and in the treatment of insomnia. The biological activities of valerian are attributed to valerenic acid and its putative biosynthetic precursor valerenadiene, sesquiterpenes, found in V. officinalis roots. These sesquiterpenes retain an isobutenyl side chain whose origin has been long recognized as enigmatic because a chemical rationalization for their biosynthesis has not been obvious. Using recently developed metabolomic and transcriptomic resources, we identified seven V. officinalis terpene synthase genes (VoTPSs), two that were functionally characterized as monoterpene synthases and three that preferred farnesyl diphosphate, the substrate for sesquiterpene synthases. The reaction products for two of the sesquiterpene synthases exhibiting root-specific expression were characterized by a combination of GC-MS and NMR in comparison to the terpenes accumulating in planta. VoTPS7 encodes for a synthase that biosynthesizes predominately germacrene C, whereas VoTPS1 catalyzes the conversion of farnesyl diphosphate to valerena-1,10-diene. Using a yeast expression system, specific labeled [C-13] acetate, and NMR, we investigated the catalytic mechanism for VoTPS1 and provide evidence for the involvement of a caryophyllenyl carbocation, a cyclobutyl intermediate, in the biosynthesis of valerena-1,10-diene. We suggest a similar mechanism for the biosynthesis of several other biologically related isobutenyl-containing sesquiterpenes.	[Yeo, Yun-Soo; Nybo, S. Eric; Chappell, Joe] Univ Kentucky, Plant Biol Program, Lexington, KY 40503 USA; [Chittiboyina, Amar G.; Weerasooriya, Aruna D.; Wang, Yan-Hong; Chandra, Suman; Smillie, Troy; Khan, Ikhlas A.] Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA; [Gongora-Castillo, Elsa; Vaillancourt, Brieanne; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [DellaPenna, Dean; Celiz, Mary Dawn; Jones, A. Daniel] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Jones, A. Daniel] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Wurtele, Eve Syrkin; Ransom, Nick] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Dudareva, Natalia] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Shaaban, Khaled A.; Tibrewal, Nidhi] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Watt, David S.] Univ Kentucky, Dept Cellular & Mol Biochem, Lexington, KY 40536 USA; [Coates, Robert M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Kentucky; University of Mississippi; Michigan State University; Michigan State University; Michigan State University; Iowa State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Kentucky; University of Kentucky; University of Illinois System; University of Illinois Urbana-Champaign	Chappell, J (corresponding author), Univ Kentucky, Plant Biol Program, Lexington, KY 40503 USA.	chappell@uky.edu	Khan, Ikhlas/AAA-1829-2020; Khan, Ikhlas/AAA-1490-2020; Jones, Arthur D/C-2670-2013; Góngora-Castillo, Elsa B/R-8854-2016; Dudareva, Natalia/S-8710-2017; Chittiboyina, Amar G/F-4898-2016; Shaaban, Khaled A./AAN-3108-2021	Góngora-Castillo, Elsa B/0000-0001-6327-6993; Dudareva, Natalia/0000-0003-0777-7763; Chittiboyina, Amar G/0000-0002-7047-5373; Shaaban, Khaled A./0000-0001-7638-4942; Jones, A. Daniel/0000-0002-7408-6690; Vaillancourt, Brieanne/0000-0002-6795-5173; Weerasooriya, Aruna/0000-0002-2001-6101; Wurtele, Eve/0000-0003-1552-9495; Buell, C Robin/0000-0002-6727-4677	National Institutes of Health [1RC2GM092521]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RC2GM092521 (to the Medicinal Plant Consortium).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BACK K, 1995, J BIOL CHEM, V270, P7375, DOI 10.1074/jbc.270.13.7375; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bent S, 2006, AM J MED, V119, P1005, DOI 10.1016/j.amjmed.2006.02.026; Bos R, 1996, PHYTOCHEM ANALYSIS, V7, P143, DOI 10.1002/(SICI)1099-1565(199605)7:3<143::AID-PCA284>3.0.CO;2-1; BOS R, 1986, PHYTOCHEMISTRY, V25, P1234, DOI 10.1016/S0031-9422(00)81590-3; BOWERS WS, 1977, SCIENCE, V196, P680, DOI 10.1126/science.558651; Cao R, 2010, PROTEINS, V78, P2417, DOI 10.1002/prot.22751; Chappell J, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P609; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; CONNOLLY JD, 1984, TETRAHEDRON LETT, V25, P1401, DOI 10.1016/S0040-4039(01)80169-6; Disch A, 1998, FEMS MICROBIOL LETT, V168, P201, DOI 10.1016/S0378-1097(98)00442-X; Gongora-Castillo E, 2012, METHOD ENZYMOL, V517, P139, DOI 10.1016/B978-0-12-404634-4.00007-3; Grieve M., 1974, MODERN HERBAL, P824; Gu LP, 2010, PLANT J, V61, P579, DOI 10.1111/j.1365-313X.2009.04083.x; Hirai N, 2000, BIOSCI BIOTECH BIOCH, V64, P1448, DOI 10.1271/bbb.64.1448; Houghton P., 1997, VALERIAN GENUS VALER; Houghton PJ, 1999, J PHARM PHARMACOL, V51, P505, DOI 10.1211/0022357991772772; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; IZAC RR, 1982, TETRAHEDRON LETT, V23, P3743, DOI 10.1016/S0040-4039(00)87695-9; Kitayama T, 2010, BIOSCI BIOTECH BIOCH, V74, P1963, DOI 10.1271/bbb.100297; Lefebvre T, 2004, J PHARM PHARM SCI, V7, P265; Murphy K, 2010, PHYTOMEDICINE, V17, P674, DOI 10.1016/j.phymed.2009.10.020; Paul C, 2001, PHYTOCHEMISTRY, V57, P307, DOI 10.1016/S0031-9422(01)00018-8; Pyle BW, 2012, FEBS J, V279, P3136, DOI 10.1111/j.1742-4658.2012.08692.x; Rising KA, 2000, J AM CHEM SOC, V122, P6526, DOI 10.1021/ja004652z; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; TAKAHASHI K, 1983, J ANTIBIOT, V36, P1531, DOI 10.7164/antibiotics.36.1531; Takahashi S, 2007, BIOTECHNOL BIOENG, V97, P170, DOI 10.1002/bit.21216; Takemoto H, 2009, J NAT MED-TOKYO, V63, P380, DOI 10.1007/s11418-009-0340-x; Tanaka K, 2008, J NAT MED, V62, P112, DOI 10.1007/s11418-007-0199-7; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Weeks BS, 2009, MED SCI MONITOR, V15, pRA256; WEINHEIMER A J, 1970, Tetrahedron Letters, V7, P497; Wu SQ, 2006, NAT BIOTECHNOL, V24, P1441, DOI 10.1038/nbt1251	36	30	32	2	81	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3163	3173		10.1074/jbc.M112.415836	http://dx.doi.org/10.1074/jbc.M112.415836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23243312	Green Published, hybrid			2022-12-28	WOS:000314397900024
J	Cabana, J; Holleran, B; Beaulieu, ME; Leduc, R; Escher, E; Guillemette, G; Lavigne, P				Cabana, Jerome; Holleran, Brian; Beaulieu, Marie-Eve; Leduc, Richard; Escher, Emanuel; Guillemette, Gaetan; Lavigne, Pierre			Critical Hydrogen Bond Formation for Activation of the Angiotensin II Type 1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CONSTITUTIVELY ACTIVE MUTANT; LIGAND-BINDING POCKET; AMYLOID BETA-PEPTIDE; AT(1) RECEPTOR; TRANSMEMBRANE HELICES; OPIOID RECEPTOR; CRYSTAL-STRUCTURES; LIPID-BILAYER; AGONIST	G protein-coupled receptors contain selectively important residues that play central roles in the conformational changes that occur during receptor activation. Asparagine 111 (N111(3.35)) is such a residue within the angiotensin II type 1 (AT(1)) receptor. Substitution of N111(3.35) for glycine leads to a constitutively active receptor, whereas substitution for tryptophan leads to an inactivable receptor. Here, we analyzed the AT(1) receptor and two mutants (N111G and N111W) by molecular dynamics simulations, which revealed a novel molecular switch involving the strictly conserved residue D74(2.50). Indeed, D74(2.50) forms a stable hydrogen bond (H-bond) with the residue in position 111(3.35) in the wild-type and the inactivable receptor. However, in the constitutively active mutant N111G-AT(1) receptor, residue D74 is reoriented to form a new H-bond with another strictly conserved residue, N46(1.50). When expressed in HEK293 cells, the mutant N46G-AT(1) receptor was poorly activable, although it retained a high binding affinity. Interestingly, the mutant N46G/N111G-AT(1) receptor was also inactivable. Molecular dynamics simulations also revealed the presence of a cluster of hydrophobic residues from transmembrane domains 2, 3, and 7 that appears to stabilize the inactive form of the receptor. Whereas this hydrophobic cluster and the H- bond between D74(2.50) and W111(3.35) are more stable in the inactivable N111W-AT(1) receptor, the mutant N111W/F77A-AT(1) receptor, designed to weaken the hydrophobic core, showed significant agonist-induced signaling. These results support the potential for the formation of an H-bond between residues D74(2.50) and N46(1.50) in the activation of the AT(1) receptor.	[Cabana, Jerome; Holleran, Brian; Beaulieu, Marie-Eve; Leduc, Richard; Escher, Emanuel; Guillemette, Gaetan] Univ Sherbrooke, Dept Pharmacol, Fac Med & Hlth Sci, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada; [Lavigne, Pierre] Univ Sherbrooke, Dept Biochem, Fac Med & Hlth Sci, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke; University of Sherbrooke	Lavigne, P (corresponding author), Univ Sherbrooke, Dept Biochem, Fac Med & Hlth Sci, Inst Pharmacol Sherbrooke, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Pierre.Lavigne@USherbrooke.ca		Escher, Emanuel/0000-0001-6601-987X; Beaulieu, Marie-Eve/0000-0001-5224-8436	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Anezo C, 2003, J PHYS CHEM B, V107, P9424, DOI 10.1021/jp0348981; Arsenault J, 2010, BIOCHEM PHARMACOL, V80, P990, DOI 10.1016/j.bcp.2010.06.004; Auger-Messier M, 2003, ENDOCRINOLOGY, V144, P5277, DOI 10.1210/en.2003-0677; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245, DOI 10.1074/jbc.272.7.4245; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; BERWEGER CD, 1995, CHEM PHYS LETT, V232, P429, DOI 10.1016/0009-2614(94)01391-8; Bhattacharya S, 2008, BIOPHYS J, V94, P2027, DOI 10.1529/biophysj.107.117648; Bhuiyan MA, 2010, J PHARMACOL SCI, V112, P459, DOI 10.1254/jphs.09343SC; Bhuiyan MA, 2009, J PHARMACOL SCI, V111, P227, DOI 10.1254/jphs.09202FP; BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Clement M, 2005, J BIOL CHEM, V280, P27121, DOI 10.1074/jbc.M413653200; Clement M, 2009, J BIOL CHEM, V284, P26603, DOI 10.1074/jbc.M109.012922; Colson AO, 1998, MOL PHARMACOL, V54, P968, DOI 10.1124/mol.54.6.968; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; de Gasparo M, 2000, PHARMACOL REV, V52, P415; de Vries AH, 2004, J PHYS CHEM B, V108, P2454, DOI 10.1021/jp0366926; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Domazet I, 2009, J BIOL CHEM, V284, P31953, DOI 10.1074/jbc.M109.051839; Domazet I, 2009, J BIOL CHEM, V284, P11922, DOI 10.1074/jbc.M808113200; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Feng YH, 2005, MOL PHARMACOL, V68, P347, DOI 10.1124/mol.105.011601; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Fillion D, 2010, J MED CHEM, V53, P2063, DOI 10.1021/jm9015747; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; GUILLEMETTE G, 1983, BIOCHEMISTRY-US, V22, P5591, DOI 10.1021/bi00293a021; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; JOSEPH MP, 1995, J PROTEIN CHEM, V14, P381, DOI 10.1007/BF01886795; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kulinska K, 2000, COMPUT CHEM, V24, P451, DOI 10.1016/S0097-8485(99)00085-6; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le MT, 2002, J BIOL CHEM, V277, P23107, DOI 10.1074/jbc.C200201200; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lee C, 2007, FEBS LETT, V581, P2517, DOI 10.1016/j.febslet.2007.04.069; Lemkul JA, 2008, ARCH BIOCHEM BIOPHYS, V470, P54, DOI 10.1016/j.abb.2007.11.004; Lemkul JA, 2009, FEBS J, V276, P3060, DOI 10.1111/j.1742-4658.2009.07024.x; MacCallum JL, 2006, J AM CHEM SOC, V128, P125, DOI 10.1021/ja0535099; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; Miura S, 2003, J BIOL CHEM, V278, P3720, DOI 10.1074/jbc.M211338200; Miura SI, 2008, MOL ENDOCRINOL, V22, P139, DOI 10.1210/me.2007-0312; Nikiforovich GV, 2005, J PEPT RES, V66, P236, DOI 10.1111/j.1399-3011.2005.00293.x; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Nygaard R, 2010, J BIOL CHEM, V285, P19625, DOI 10.1074/jbc.M110.106021; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Perlman JH, 1997, J BIOL CHEM, V272, P11937, DOI 10.1074/jbc.272.18.11937; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sadee W, 2005, LIFE SCI, V76, P1427, DOI 10.1016/j.lfs.2004.10.024; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Thomas WG, 2000, J BIOL CHEM, V275, P2893, DOI 10.1074/jbc.275.4.2893; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Tieleman D. Peter, 2004, BMC Biochemistry, V5, P10, DOI 10.1186/1471-2091-5-10; Tieleman DP, 2003, J AM CHEM SOC, V125, P6382, DOI 10.1021/ja029504i; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van der Spoel D, 2011, WIRES COMPUT MOL SCI, V1, P710, DOI 10.1002/wcms.50; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Werner T, 2012, ADV DRUG DELIVER REV, V64, P323, DOI 10.1016/j.addr.2011.11.011; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yan LP, 2010, J BIOL CHEM, V285, P2227, DOI 10.1074/jbc.M109.077180; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	77	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2593	2604		10.1074/jbc.M112.395939	http://dx.doi.org/10.1074/jbc.M112.395939			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223579	hybrid, Green Published			2022-12-28	WOS:000314211500044
J	Desai, SD; Reed, RE; Babu, S; Lorio, EA				Desai, Shyamal D.; Reed, Ryan E.; Babu, Shilka; Lorio, Eric A.			ISG15 Deregulates Autophagy in Genotoxin-treated Ataxia Telangiectasia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; TOPOISOMERASE-I; ATM; PROTEIN; NEURODEGENERATION; DEGRADATION; CANCER; HOMOLOG; PATHWAY; DISEASE	Ataxia-telangiectasia (A-T) is a cerebellar neurodegenerative disorder; however, the basis for the neurodegeneration in A-T is not well established. Lesions in the ubiquitin and autophagy pathways are speculated to contribute to the neurodegeneration in other neurological diseases and may have a role in A-T neurodegeneration. Our recent studies revealed that the constitutively elevated ISG15 pathway impairs targeted proteasome-mediated protein degradation in A-T cells. Here, we demonstrate that the basal autophagy pathway is activated in the ubiquitin pathway-compromised A-T cells. We also show that genotoxic stress triggers aberrant degradation of the proteasome and autophagy substrates (autophagic flux) in A-T cells. Inhibition of autophagy at an early stage using 3-methyladenine blocked UV-induced autophagic flux in A-T cells. On the other hand, bafilomycin A1, which inhibits autophagy at a late stage, failed to block UV-induced autophagic flux, suggesting that overinduction of autophagy may underlie aberrant autophagic flux in A-T cells. The ISG15-specific shRNA that restored proteasome function restores autophagic function in A-T cells. These findings suggest that autophagy compensates for the ISG15-dependent ablation of proteasome-mediated protein degradation in A-T cells. Genotoxic stress overactivates this compensatory mechanism, triggering aberrant autophagic flux in A-T cells. Supporting the model, we show that autophagy is activated in the brain tissues of human A-T patients. This highlights a plausible causal contribution of a novel "ISG15 proteinopathy" in A-T neuronal cell death.	[Desai, Shyamal D.; Reed, Ryan E.; Babu, Shilka; Lorio, Eric A.] Louisiana State Univ, Sch Med, Dept Biochem & Mol Biol, Hlth Sci Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Desai, SD (corresponding author), Louisiana State Univ, Sch Med, Dept Biochem & Mol Biol, Hlth Sci Ctr, 1901 Perdido St, New Orleans, LA 70112 USA.	sdesai@lsuhsc.edu		Lorio, Eric/0000-0002-7811-0192	National Institutes of Health, NINDS [R21NS060960]; A-T Children's Project Foundation; Louisiana State University Health Sciences Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS060960] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); A-T Children's Project Foundation; Louisiana State University Health Sciences Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R21NS060960 (to S. D.). This work was also supported by an A-T Children's Project Foundation grant and Louisiana State University Health Sciences Center start-up funds (to S. D.).	AGAMANOLIS DP, 1979, J NEUROPATH EXP NEUR, V38, P475, DOI 10.1097/00005072-197909000-00003; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; Boder E, 1985, Kroc Found Ser, V19, P1; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1167, DOI 10.1038/sj.cdd.4401691; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; Desai SD, 2008, MOL CANCER THER, V7, P1430, DOI 10.1158/1535-7163.MCT-07-2345; Desai SD, 2012, EXP BIOL MED, V237, P38, DOI 10.1258/ebm.2011.011236; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; Eilam R, 2003, NEUROSCIENCE, V121, P83, DOI 10.1016/S0306-4522(03)00322-1; Figueiredo-Pereira ME, 1999, MOL BIOL REP, V26, P65, DOI 10.1023/A:1006909918866; Frappart PO, 2006, NEUROMOL MED, V8, P495, DOI 10.1385/NMM:8:4:495; Ge PF, 2009, ACTA PHARMACOL SIN, V30, P1046, DOI 10.1038/aps.2009.71; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Katyal S, 2008, MECH AGEING DEV, V129, P483, DOI 10.1016/j.mad.2008.03.008; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lavin LF, 1999, INT J RADIAT BIOL, V75, P1201; Lavin MF, 2005, MUTAT RES-FUND MOL M, V569, P123, DOI 10.1016/j.mrfmmm.2004.04.020; Lavin MF, 2004, DNA REPAIR, V3, P1197, DOI 10.1016/j.dnarep.2004.03.011; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Lu G, 2006, CELL MOL BIOL, V52, P29, DOI 10.1170/T695; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Metcalf DJ, 2012, EXP NEUROL, V238, P22, DOI 10.1016/j.expneurol.2010.11.003; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Narasimhan J, 1996, J BIOL CHEM, V271, P324, DOI 10.1074/jbc.271.1.324; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Pandey UB, 2007, AUTOPHAGY, V3, P643, DOI 10.4161/auto.5050; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rolig RL, 2000, TRENDS NEUROSCI, V23, P417, DOI 10.1016/S0166-2236(00)01625-8; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Rubinsztein DC, 2007, NEURON, V54, P854, DOI 10.1016/j.neuron.2007.06.005; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schmitt HP, 2006, MED HYPOTHESES, V67, P311, DOI 10.1016/j.mehy.2006.02.023; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sharma A, 2010, J BIOL CHEM, V285, P8352, DOI 10.1074/jbc.M109.041129; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; Sun X, 2002, J PEDIATR-US, V140, P724, DOI 10.1067/mpd.2002.123879; Takeuchi T, 2005, BIOCHEM BIOPH RES CO, V336, P9, DOI 10.1016/j.bbrc.2005.08.034; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Thomson TM, 2010, BIOCHEM SOC T, V38, P116, DOI 10.1042/BST0380116; Valentin-Vega YA, 2012, BLOOD, V119, P1490, DOI 10.1182/blood-2011-08-373639; Wang RG, 2011, GLIA, V59, P946, DOI 10.1002/glia.21167; Wood LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016422; Wu WKK, 2008, BIOCHEM BIOPH RES CO, V374, P258, DOI 10.1016/j.bbrc.2008.07.031; Wu X, 2000, COLD SPRING HARB SYM, V65, P535, DOI 10.1101/sqb.2000.65.535; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110; Zou WG, 2007, BIOCHEM BIOPH RES CO, V354, P321, DOI 10.1016/j.bbrc.2006.12.210; Zou WG, 2005, BIOCHEM BIOPH RES CO, V336, P61, DOI 10.1016/j.bbrc.2005.08.038	67	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2388	2402		10.1074/jbc.M112.403832	http://dx.doi.org/10.1074/jbc.M112.403832			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23212917	Green Published, hybrid			2022-12-28	WOS:000314211500027
J	Stupka, N; Kintakas, C; White, JD; Fraser, FW; Hanciu, M; Aramaki-Hattori, N; Martin, S; Coles, C; Collier, F; Ward, AC; Apte, SS; McCulloch, DR				Stupka, Nicole; Kintakas, Christopher; White, Jason D.; Fraser, Fiona W.; Hanciu, Michael; Aramaki-Hattori, Noriko; Martin, Sheree; Coles, Chantal; Collier, Fiona; Ward, Alister C.; Apte, Suneel S.; McCulloch, Daniel R.			Versican Processing by a Disintegrin-like and Metalloproteinase Domain with Thrombospondin-1 Repeats Proteinases-5 and-15 Facilitates Myoblast Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; ADAMTS METALLOPROTEASES; MUSCLE GROWTH; IN-VIVO; CELL; EXPRESSION; DIFFERENTIATION; CARTILAGE; MYOGENESIS; MICE	Skeletal muscle development and regeneration requires the fusion of myoblasts into multinucleated myotubes. Because the enzymatic proteolysis of a hyaluronan and versican-rich matrix by ADAMTS versicanases is required for developmental morphogenesis, we hypothesized that the clearance of versican may facilitate the fusion of myoblasts during myogenesis. Here, we used transgenic mice and an in vitro model of myoblast fusion, C2C12 cells, to determine a potential role for ADAMTS versicanases. Versican processing was observed during in vivo myogenesis at the time when myoblasts were fusing to form multinucleated myotubes. Relevant ADAMTS genes, chief among them Adamts5 and Adamts15, were expressed both in developing embryonic muscle and differentiating C2C12 cells. Reducing the levels of Adamts5 mRNA in vitro impaired myoblast fusion, which could be rescued with catalytically active but not the inactive forms of ADAMTS5 or ADAMTS15. The addition of inactive ADAMTS5, ADAMTS15, or full-length V1 versican effectively impaired myoblast fusion. Finally, the expansion of a hyaluronan and versican-rich matrix was observed upon reducing the levels of Adamts5 mRNA in myoblasts. These data indicate that these ADAMTS proteinases contribute to the formation of multinucleated myotubes such as is necessary for both skeletal muscle development and during regeneration, by remodeling a versican-rich pericellular matrix of myoblasts. Our study identifies a possible pathway to target for the improvement of myogenesis in a plethora of diseases including cancer cachexia, sarcopenia, and muscular dystrophy.	[Stupka, Nicole; Kintakas, Christopher; Fraser, Fiona W.; Hanciu, Michael; Martin, Sheree; Ward, Alister C.; McCulloch, Daniel R.] Deakin Univ, Sch Med, Geelong, Vic 3216, Australia; [Stupka, Nicole; Kintakas, Christopher; Fraser, Fiona W.; Hanciu, Michael; Martin, Sheree; Ward, Alister C.; McCulloch, Daniel R.] Deakin Univ, Mol & Med Res SRC, Geelong, Vic 3216, Australia; [Kintakas, Christopher; White, Jason D.; Coles, Chantal] Murdoch Childrens Res Inst, Muscular Dystrophy Res Grp, Parkville, Vic 3052, Australia; [White, Jason D.; Coles, Chantal] Univ Melbourne, Sch Vet, Parkville, Vic 3010, Australia; [Aramaki-Hattori, Noriko; Apte, Suneel S.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Collier, Fiona] Geelong Hosp, Barwon Hlth, Geelong, Vic 3220, Australia	Deakin University; Deakin University; Murdoch Children's Research Institute; University of Melbourne; Cleveland Clinic Foundation; Geelong Hospital	McCulloch, DR (corresponding author), 75 Pigdons Rd, Geelong, Vic 3216, Australia.	daniel.mcculloch@deakin.edu.au	White, Jason/AAF-8712-2020; McCulloch, Daniel/N-9142-2013	White, Jason/0000-0002-0557-392X; McCulloch, Daniel/0000-0003-0269-5857; Apte, Suneel/0000-0001-8441-1226; Stupka, Nicole/0000-0002-1000-1707; Ward, Alister/0000-0001-7945-7975	National Institutes of Health [PO1-HL107147]; Financial Markets Foundation for Children Grant [162-2010]; National Health and Medical Research Council; Molecular and Medical Research SRC, Deakin University; Muscular Dystrophy Australia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Financial Markets Foundation for Children Grant; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Molecular and Medical Research SRC, Deakin University; Muscular Dystrophy Australia(Muscular Dystrophy Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1-HL107147 (to S. A.) and The Financial Markets Foundation for Children Grant 162-2010 (to D. McC., N. S. and A. W.).; Supported in part by a National Health and Medical Research Council Peter Doherty Fellowship.; Supported by Postgraduate Scholarships from the Molecular and Medical Research SRC, Deakin University, and Muscular Dystrophy Australia.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; Brown HM, 2006, DEV BIOL, V300, P699, DOI 10.1016/j.ydbio.2006.10.012; Calve S, 2012, FASEB J, V26, P2538, DOI 10.1096/fj.11-200162; Carrino DA, 1999, POULTRY SCI, V78, P769, DOI 10.1093/ps/78.5.769; Demircan K, 2005, ARTHRITIS RHEUM-US, V52, P1451, DOI 10.1002/art.21010; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Enomoto H, 2010, DEVELOPMENT, V137, P4029, DOI 10.1242/dev.050591; Ermakova II, 2011, BIOCHEMISTRY-MOSCOW+, V76, P359, DOI 10.1134/S0006297911030102; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; GOLDSPINK G, 1979, J PHYSIOL-LONDON, V296, P453, DOI 10.1113/jphysiol.1979.sp013016; Grounds MD, 2005, SCAND J MED SCI SPOR, V15, P381, DOI 10.1111/j.1600-0838.2005.00467.x; Hattori N, 2011, J BIOL CHEM, V286, P34298, DOI 10.1074/jbc.M111.254938; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Jansen KM, 2006, J CELL BIOL, V174, P403, DOI 10.1083/jcb.200601102; Jungers KA, 2005, GENE EXPR PATTERNS, V5, P609, DOI 10.1016/j.modgep.2005.03.004; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kintakas C, 2011, MATRIX BIOL, V30, P311, DOI 10.1016/j.matbio.2011.05.004; KNUDSON CB, 1987, DEV BIOL, V124, P82, DOI 10.1016/0012-1606(87)90462-3; Koo BH, 2007, J BIOL CHEM, V282, P16146, DOI 10.1074/jbc.M610161200; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; Liu HJ, 2010, J CELL SCI, V123, P2914, DOI 10.1242/jcs.057620; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Malfait AM, 2008, ARCH BIOCHEM BIOPHYS, V478, P43, DOI 10.1016/j.abb.2008.07.012; McCulloch DR, 2010, OSTEOARTHR CARTILAGE, V18, P455, DOI 10.1016/j.joca.2009.10.014; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; McCulloch DR, 2004, CLIN CANCER RES, V10, P314, DOI 10.1158/1078-0432.CCR-0846-3; Melo F, 1996, J CELL BIOCHEM, V62, P227, DOI 10.1002/(SICI)1097-4644(199608)62:2<227::AID-JCB11>3.0.CO;2-I; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; ORKIN RW, 1985, DEV BIOL, V107, P527, DOI 10.1016/0012-1606(85)90333-1; Park IH, 2005, J BIOL CHEM, V280, P32009, DOI 10.1074/jbc.M506120200; RAGANATHAN S, 1995, CELL BIOL INT, V19, P161, DOI 10.1006/cbir.1995.1057; Reed UC, 2009, ARQ NEURO-PSIQUIAT, V67, P144, DOI 10.1590/S0004-282X2009000100038; Rogerson FM, 2008, ARTHRITIS RHEUM-US, V58, P1664, DOI 10.1002/art.23458; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Snow HE, 2005, ANAT REC PART A, V282A, P95, DOI 10.1002/ar.a.20151; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stewart MC, 2006, OSTEOARTHR CARTILAGE, V14, P392, DOI 10.1016/j.joca.2005.11.009; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; Velasco J, 2011, J BIOL CHEM, V286, P26016, DOI 10.1074/jbc.M110.208694; Velleman SG, 2012, POULTRY SCI, V91, P1964, DOI 10.3382/ps.2012-02147; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318	48	48	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1907	1917		10.1074/jbc.M112.429647	http://dx.doi.org/10.1074/jbc.M112.429647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23233679	hybrid, Green Published			2022-12-28	WOS:000313751400044
J	Schamber-Reis, BLF; Petritus, PM; Caetano, BC; Martinez, ER; Okuda, K; Golenbock, D; Scott, P; Gazzinelli, RT				Schamber-Reis, Bruno Luiz Fonseca; Petritus, Patricia M.; Caetano, Braulia C.; Martinez, Espiridion R.; Okuda, Kendi; Golenbock, Douglas; Scott, Phillip; Gazzinelli, Ricardo T.			UNC93B1 and Nucleic Acid-sensing Toll-like Receptors Mediate Host Resistance to Infection with Leishmania major	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUTANEOUS LEISHMANIASIS; INTERFERON-GAMMA; CELL-DEVELOPMENT; DENDRITIC CELLS; MICE; SUSCEPTIBILITY; IL-12; RESOLUTION; RESPONSES; MYD88	The mammalian homolog B1 of Unc-93 Caenorhabditis elegans known as UNC93B1 is a chaperone protein that mediates translocation of the nucleic acid-sensing Toll-like receptors (TLRs) from the endoplasmic reticulum to the endolysosomes. The triple deficient (UNC93B1 mutant) mice have a functional single point mutation in the UNC93B1 that results in non-functional TLR3, TLR7, and TLR9. Herein, we demonstrate that UNC93B1 mutant mice, in the C57BL/6 (resistant) genetic background, are highly susceptible to Leishmania major infection. Enhanced swelling of the footpad was associated with high levels of interleukin 10, decreased levels of interferon gamma, and increased parasitism. None of the single TLR3, TLR7, and TLR9 knock-out (KO) mice resemble the UNC93B1 mutant phenotype upon infection with L. major. Whereas the double TLR7/TLR9 KO showed a partial phenotype, the triple TLR3/TLR7/TLR9 KO mice were as susceptible as the UNC93B1 mutant mice, when infected with Leishmania parasites. Finally, we demonstrate that treatment with either anti-interleukin 10 receptor monoclonal antibody or recombinant interleukin 12 restored a robust anti-parasite T(H)1 response and reverted the susceptible phenotype of UNC93B1 mutant mice. Altogether, our results indicate the redundant and essential role of nucleic acid-sensing TLR3, TLR7 and TLR9 in inducing interleukin 12, development of a T(H)1 response, and resistance to L. major infection in resistant C57BL/6 mice.	[Schamber-Reis, Bruno Luiz Fonseca; Caetano, Braulia C.; Martinez, Espiridion R.; Okuda, Kendi; Golenbock, Douglas; Gazzinelli, Ricardo T.] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Petritus, Patricia M.; Scott, Phillip] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Golenbock, Douglas; Gazzinelli, Ricardo T.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil; [Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil	University of Massachusetts System; University of Massachusetts Worcester; University of Pennsylvania; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Gazzinelli, RT (corresponding author), Univ Massachusetts, Sch Med, Dept Med, LRB Rm 302, Worcester, MA 01605 USA.	ricardo.gazzinelli@umassmed.edu	Okuda, Kendi/D-4562-2013	Gazzinelli, Ricardo/0000-0003-2427-7699	National Institutes of Health [R01 AI071319-01, R01 AI76257, T32 AI55400-8]; National Institute of Science and Technology for Vaccines; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); CAPES/Brazil; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076257, R01AI071319, T32AI055400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Science and Technology for Vaccines; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health Grants R01 AI071319-01 and R01 AI76257 and T32 AI55400-8 and the National Institute of Science and Technology for Vaccines, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG).; A recipient of a postdoctoral fellowship from CAPES/Brazil.	Abou Fakher FH, 2009, J IMMUNOL, V182, P1386, DOI 10.4049/jimmunol.182.3.1386; AFONSO LCC, 1993, INFECT IMMUN, V61, P2952, DOI 10.1128/IAI.61.7.2952-2959.1993; Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9; Berberich C, 2003, J IMMUNOL, V170, P3171, DOI 10.4049/jimmunol.170.6.3171; Caetano BC, 2011, J IMMUNOL, V187, P1903, DOI 10.4049/jimmunol.1003911; Carvalho LP, 2012, J IMMUNOL, V188, P1394, DOI 10.4049/jimmunol.1101018; Cockburn IA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001318; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; Flandin JF, 2006, EUR J IMMUNOL, V36, P411, DOI 10.1002/eji.200535079; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Hemmi Hiroaki, 2005, V86, P120, DOI 10.1159/000086657; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; Melo MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001071; Muraille E, 2003, J IMMUNOL, V170, P4237, DOI 10.4049/jimmunol.170.8.4237; Noben-Trauth N, 2003, J IMMUNOL, V170, P5152, DOI 10.4049/jimmunol.170.10.5152; Pifer R, 2011, J BIOL CHEM, V286, P3307, DOI 10.1074/jbc.M110.171025; Radwanska M, 2007, PLOS PATHOG, V3, P619, DOI 10.1371/journal.ppat.0030068; Revaz-Breton M, 2010, EUR J IMMUNOL, V40, P1697, DOI 10.1002/eji.200939821; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; SCHARTONKERSTEN T, 1995, J IMMUNOL, V154, P5320; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; Siednienko J, 2010, EUR J IMMUNOL, V40, P3150, DOI 10.1002/eji.201040547; Stobie L, 2000, P NATL ACAD SCI USA, V97, P8427, DOI 10.1073/pnas.160197797; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; von Stebut E, 2000, EUR J IMMUNOL, V30, P3498, DOI 10.1002/1521-4141(2000012)30:12&lt;3498::AID-IMMU3498&gt;3.0.CO;2-6; Zimmermann S, 1998, J IMMUNOL, V160, P3627	35	31	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7127	7136		10.1074/jbc.M112.407684	http://dx.doi.org/10.1074/jbc.M112.407684			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23325805	Green Published, hybrid			2022-12-28	WOS:000316002400034
J	Rilla, K; Oikari, S; Jokela, TA; Hyttinen, JMT; Karna, R; Tammi, RH; Tammi, MI				Rilla, Kirsi; Oikari, Sanna; Jokela, Tiina A.; Hyttinen, Juha M. T.; Karna, Riikka; Tammi, Raija H.; Tammi, Markku I.			Hyaluronan Synthase 1 (HAS1) Requires Higher Cellular UDP-GlcNAc Concentration than HAS2 and HAS3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; MESANGIAL CELLS; DOWN-REGULATION; N-ACETYLHEXOSAMINES; CHONDROITIN SULFATE; MONOCYTE ADHESION; MAMMALIAN-CELLS; O-GLCNACYLATION; GROWTH-FACTOR; IN-VIVO	Mammals have three homologous genes encoding proteins with hyaluronan synthase activity (Has1-3), all producing an identical polymer from UDP-N-acetylglucosamine and UDP-glucuronic acid. To compare the properties of these isoenzymes, COS-1 cells, with minor endogenous hyaluronan synthesis, were transfected with human Has1-3 isoenzymes. HAS1 was almost unable to secrete hyaluronan or form a hyaluronan coat, in contrast to HAS2 and HAS3. This failure of HAS1 to synthesize hyaluronan was compensated by increasing the cellular content of UDP-N-acetyl glucosamine by similar to 10-fold with 1 mM glucosamine in the growth medium. Hyaluronan synthesis driven by HAS2 was less affected by glucosamine addition, and HAS3 was not affected at all. Glucose-free medium, leading to depletion of the UDP-sugars, markedly reduced hyaluronan synthesis by all HAS isoenzymes while raising its concentration from 5 to 25 mM had a moderate stimulatory effect. The results indicate that HAS1 is almost inactive in cells with low UDPsugar supply, HAS2 activity increases with UDP-sugars, and HAS3 produces hyaluronan at high speed even with minimum substrate content. Transfected Has2 and particularly Has3 consumed enough UDP-sugars to reduce their content in COS-1 cells. Comparison of different human cell types revealed similar to 50-fold differences in the content of UDP-N-acetylhexosamines and UDP-glucuronic acid, correlating with the expression level of Has1, suggesting cellular coordination between Has1 expression and the content of UDP-sugars.	[Rilla, Kirsi] Univ Eastern Finland, Inst Biomed, FIN-70211 Kuopio, Finland; Univ Eastern Finland, Inst Dent, FIN-70211 Kuopio, Finland; Univ Eastern Finland, Bioctr Kuopio, FIN-70211 Kuopio, Finland; Univ Eastern Finland, Ctr Canc, FIN-70211 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland	Rilla, K (corresponding author), Univ Eastern Finland, Inst Biomed, POB 1627, FIN-70211 Kuopio, Finland.	kirsi.rilla@uef.fi	Jokela, Tiina/O-9206-2015; Tammi, Markku/AAQ-7878-2021	Jokela, Tiina/0000-0002-7521-3866; Rilla, Kirsi/0000-0002-7862-5727; Hyttinen, Juha/0000-0002-3414-4032	Academy of Finland; Sigrid Juselius Foundation; EVO (Erityisvaltionosuus) Funds of Kuopio University Hospital; North-Savo Cancer Foundation; Cancer Center of Eastern Finland	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); EVO (Erityisvaltionosuus) Funds of Kuopio University Hospital; North-Savo Cancer Foundation; Cancer Center of Eastern Finland	This work was supported by funds from the Academy of Finland (to M.I.T.), Sigrid Juselius Foundation (to R.H.T. and M.I.T.), EVO (Erityisvaltionosuus) Funds of Kuopio University Hospital (to M.I.T.), the North-Savo Cancer Foundation (to K.R.), and the Cancer Center of Eastern Finland.	BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brinck J, 1999, EXP CELL RES, V252, P342, DOI 10.1006/excr.1999.4645; CLARRIS BJ, 1968, EXP CELL RES, V49, P181, DOI 10.1016/0014-4827(68)90530-2; Dunlop ME, 1996, KIDNEY INT, V50, P40, DOI 10.1038/ki.1996.284; Erikstrup C, 2001, EUR J ENDOCRINOL, V145, P193, DOI 10.1530/eje.0.1450193; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; Hubbard C, 2012, J MOL BIOL, V418, P21, DOI 10.1016/j.jmb.2012.01.053; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 1999, CANCER RES, V59, P2499; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Jokela TA, 2011, J BIOL CHEM, V286, P33632, DOI 10.1074/jbc.M111.265637; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Knudson Cheryl B., 2003, Birth Defects Research, V69, P174, DOI 10.1002/bdrc.10013; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kultti A, 2010, J BIOL CHEM, V285, P22899, DOI 10.1074/jbc.M109.088435; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; LAURENT TC, 1986, CIBA F SYMP, V124, P9; MAHADEVAN P, 1995, DIABETOLOGIA, V38, P298, DOI 10.1007/s001250050285; Meyer K, 1934, J BIOL CHEM, V107, P629; Mine S, 2006, ENDOCR J, V53, P761, DOI 10.1507/endocrj.K05-119; PREHM P, 1983, BIOCHEM J, V211, P181, DOI 10.1042/bj2110181; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; REED RK, 1988, ACTA PHYSIOL SCAND, V134, P405, DOI 10.1111/j.1748-1716.1988.tb08508.x; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Sainio A, 2010, GLYCOBIOLOGY, V20, P1117, DOI 10.1093/glycob/cwq076; Schwientek T, 1996, J BIOL CHEM, V271, P3398; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; Spicer AP, 1999, BIOCHEM SOC T, V27, P109, DOI 10.1042/bst0270109; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Stuhlmeier KM, 2007, BBA-GEN SUBJECTS, V1770, P121, DOI 10.1016/j.bbagen.2006.07.001; Takeda M, 2001, METABOLISM, V50, P789, DOI 10.1053/meta.2001.24207; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Thompson CB, 2010, MOL CANCER THER, V9, P3052, DOI 10.1158/1535-7163.MCT-10-0470; Tien JYL, 2005, DEV DYNAM, V233, P130, DOI 10.1002/dvdy.20328; Tomiya N, 2001, ANAL BIOCHEM, V293, P129, DOI 10.1006/abio.2001.5091; Uchiyama T, 2005, BIOCHEM BIOPH RES CO, V327, P927, DOI 10.1016/j.bbrc.2004.12.092; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; WALDMAN BC, 1990, BIOCHEMISTRY-US, V29, P44, DOI 10.1021/bi00453a006; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Wilkinson TS, 2006, J CELL PHYSIOL, V206, P378, DOI 10.1002/jcp.20468; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497; ZHU XY, 1990, J BIOL CHEM, V265, P14250	52	77	78	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5973	5983		10.1074/jbc.M112.443879	http://dx.doi.org/10.1074/jbc.M112.443879			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23303191	hybrid, Green Published			2022-12-28	WOS:000315342500065
J	Inoue, Y; Kubota-Koketsu, R; Yamashita, A; Nishimura, M; Ideno, S; Ono, K; Okuno, Y; Ikuta, K				Inoue, Yuji; Kubota-Koketsu, Ritsuko; Yamashita, Akifumi; Nishimura, Mitsuhiro; Ideno, Shoji; Ono, Ken-ichiro; Okuno, Yoshinobu; Ikuta, Kazuyoshi			Induction of Anti-influenza Immunity by Modified Green Fluorescent Protein (GFP) Carrying Hemagglutinin-derived Epitope Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-A VIRUS; H1N1 VIRUS; VACCINE; SEQUENCE; BETA	The development of vaccination methods that can overcome the emergence of new types of influenza strains caused by escape mutations is desirable to avoid future pandemics. Here, a novel type of immunogen was designed that targeted the conformation of a highly conserved region of influenza A virus hemagglutinin (HA) composed of two separate sequences that associate to form an anti-parallel beta-sheet structure. Our previous study identified this beta-sheet region as the structural core in the epitope of a characteristic antibody (B-1) that strongly neutralizes a wide variety of strains within the H3N2 serotype, and therefore this beta-sheet region was considered a good target to induce broadly reactive immunity against the influenza A virus. To design the immunogen, residues derived from the B-1 epitope were introduced directly onto a part of enhanced green fluorescent protein (EGFP), whose surface is mostly composed of beta-sheets. Through site-directed mutagenesis, several modified EGFPs with an epitope-mimicking structure embedded in their surface were prepared. Two EGFP variants, differing from wild-type (parental) EGFP by only five and nine residues, induced mice to produce antibodies that specifically bind to H3-type HA and neutralize H3N2 virus. Moreover, three of five mice immunized with each of these EGFP variants followed by a booster with equivalent mCherry variants acquired anti-viral immunity against challenge with H3N2 virus at a lethal dosage. In contrast to conventional methods, such as split HA vaccine, preparation of this type of immunogen requires less time and is therefore expected to be quickly responsive to newly emerged influenza viral strains.	[Inoue, Yuji; Kubota-Koketsu, Ritsuko; Nishimura, Mitsuhiro; Ikuta, Kazuyoshi] Osaka Univ, Microbial Dis Res Inst, Res Ctr Infect Dis Control, Dept Virol, Suita, Osaka 5650871, Japan; [Yamashita, Akifumi] Osaka Univ, Microbial Dis Res Inst, Genome Informat Res Ctr, Dept Genome Informat, Suita, Osaka 5650871, Japan; [Kubota-Koketsu, Ritsuko; Okuno, Yoshinobu] Osaka Univ, Res Fdn Microbial Dis, Kanonji Inst, Kanonji, Kagawa 7680061, Japan; [Ideno, Shoji] Benesis Corp, Osaka Lab, Infect Pathogen Res Grp, Osaka 5328505, Japan; [Ono, Ken-ichiro] Med & Biol Labs Corp Ltd, Ina Lab, Ina, Nagano 3960002, Japan	Osaka University; Osaka University; Osaka University	Inoue, Y (corresponding author), Osaka Univ, Microbial Dis Res Inst, Res Ctr Infect Dis Control, Dept Virol, Suita, Osaka 5650871, Japan.	uzinoue@biken.osaka-u.ac.jp			Global Centers of Excellence Program (Frontier Biomedical Science Underlying Organelle Network Biology), Ministry of Education, Culture, Sports, Science, and Technology, Japan; Mitsubishi Tanabe Pharma Corp.; Benesis Corp.; Medical and Biological Laboratories Corp.; Grants-in-Aid for Scientific Research [23406017] Funding Source: KAKEN	Global Centers of Excellence Program (Frontier Biomedical Science Underlying Organelle Network Biology), Ministry of Education, Culture, Sports, Science, and Technology, Japan; Mitsubishi Tanabe Pharma Corp.; Benesis Corp.; Medical and Biological Laboratories Corp.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Global Centers of Excellence Program (Frontier Biomedical Science Underlying Organelle Network Biology), Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work was also supported by Mitsubishi Tanabe Pharma Corp., Benesis Corp., and Medical and Biological Laboratories Corp.	AIR GM, 1981, P NATL ACAD SCI-BIOL, V78, P7639, DOI 10.1073/pnas.78.12.7639; Amendola A, 2011, J Prev Med Hyg, V52, P107; Ben-Yedidia T, 2007, EXPERT REV VACCINES, V6, P939, DOI 10.1586/14760584.6.6.939; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0; CODY CW, 1993, BIOCHEMISTRY-US, V32, P1212, DOI 10.1021/bi00056a003; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Kettling U, 1998, P NATL ACAD SCI USA, V95, P1416, DOI 10.1073/pnas.95.4.1416; Kubota-Koketsu R, 2009, BIOCHEM BIOPH RES CO, V387, P180, DOI 10.1016/j.bbrc.2009.06.151; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; OKUNO Y, 1990, J CLIN MICROBIOL, V28, P1308, DOI 10.1128/JCM.28.6.1308-1313.1990; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Takahashi T, 2007, CHEMBIOCHEM, V8, P985, DOI 10.1002/cbic.200700108; Takahashi T, 2010, PROTEINS, V78, P336, DOI 10.1002/prot.22546; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003; WARD WW, 1982, PHOTOCHEM PHOTOBIOL, V35, P803, DOI 10.1111/j.1751-1097.1982.tb02651.x; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Yamashita A, 2010, BIOCHEM BIOPH RES CO, V393, P614, DOI 10.1016/j.bbrc.2010.02.031	23	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4981	4990		10.1074/jbc.M112.420547	http://dx.doi.org/10.1074/jbc.M112.420547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23264630	Green Published, hybrid			2022-12-28	WOS:000315340400045
J	Bullwinkle, TJ; Zou, SB; Rajkovic, A; Hersch, SJ; Elgamal, S; Robinson, N; Smil, D; Bolshan, Y; Navarre, WW; Ibba, M				Bullwinkle, Tammy J.; Zou, S. Betty; Rajkovic, Andrei; Hersch, Steven J.; Elgamal, Sara; Robinson, Nathaniel; Smil, David; Bolshan, Yuri; Navarre, William Wiley; Ibba, Michael			(R)-beta-Lysine-modified Elongation Factor P Functions in Translation Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-EF-P; TRANSFER-RNA; PEPTIDE-BOND; POSTTRANSLATIONAL MODIFICATION; GENE; RIBOSOME; PARALOG; POXA; SITE	Post-translational modification of bacterial elongation factor P (EF-P) with (R)-beta-lysine at a conserved lysine residue activates the protein in vivo and increases puromycin reactivity of the ribosome in vitro. The additional hydroxylation of EF-P at the same lysine residue by the YfcM protein has also recently been described. The roles of modified and unmodified EF-P during different steps in translation, and how this correlates to its physiological role in the cell, have recently been linked to the synthesis of polyproline stretches in proteins. Polysome analysis indicated that EF-P functions in translation elongation, rather than initiation as proposed previously. This was further supported by the inability of EF-P to enhance the rate of formation of fMet-Lys or fMet-Phe, indicating that the role of EF-P is not to specifically stimulate formation of the first peptide bond. Investigation of hydroxyl-(beta)-lysyl-EF-P showed 30% increased puromycin reactivity but no differences in dipeptide synthesis rates when compared with the beta-lysylated form. Unlike disruption of the other genes required for EF-P modification, deletion of yfcM had no phenotypic consequences in Salmonella. Taken together, our findings indicate that EF-P functions in translation elongation, a role critically dependent on post-translational beta-lysylation but not hydroxylation.	[Bullwinkle, Tammy J.; Elgamal, Sara; Robinson, Nathaniel; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Rajkovic, Andrei; Ibba, Michael] Ohio State Univ, Mol Cell & Dev Biol Program, Columbus, OH 43210 USA; [Zou, S. Betty; Hersch, Steven J.; Navarre, William Wiley] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Smil, David; Bolshan, Yuri] Univ Toronto, Struct Genom Consortium, Toronto, ON M5S 1A8, Canada	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Toronto; University of Toronto; Structural Genomics Consortium	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu	Elgamal, Sara/GQH-4293-2022	Robinson, Nathaniel/0000-0003-1020-5440; Elgamal, Sara/0000-0003-2274-9891; Hersch, Steven/0000-0001-6186-0133; Navarre, William/0000-0002-9293-9220; Smil, David/0000-0002-6232-6087	National Institutes of Health [GM 65183]; Vanier Canada Graduate Scholarships; Canada Institutes for Health Research [MOP-86683, MSH-87729]; Natural Sciences and Engineering Research Council of Canada [RGPIN 386286-10]; Canadian Institutes for Health Research; Genome Canada; Canadian Foundation for Innovation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Wellcome Trust; AbbVie; Eli Lilly Canada; GlaxoSmithKline; Novartis; Pfizer; Takeda; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanier Canada Graduate Scholarships; Canada Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); AbbVie(AbbVie); Eli Lilly Canada(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 65183.; Funded by Vanier Canada Graduate Scholarships.; Supported by an Operating Grant and a New Investigator Award from the Canada Institutes for Health Research (MOP-86683 and MSH-87729) and a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN 386286-10).; We thank Dr. Kurt Fredrick and the members of the Fredrick laboratory for helpful advice and discussions as well as strains for the initiation factors. The Structural Genomics Consortium is a registered charity (Number 1097737) that receives funds from the Canadian Institutes for Health Research, Genome Canada, the Canadian Foundation for Innovation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, the Wellcome Trust, AbbVie, Eli Lilly Canada, GlaxoSmithKline, Novartis, Pfizer, and Takeda.	Aoki H, 1997, BIOCHIMIE, V79, P7, DOI 10.1016/S0300-9084(97)87619-5; AOKI H, 1991, NUCLEIC ACIDS RES, V19, P6215, DOI 10.1093/nar/19.22.6215; Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Beringer M, 2007, BIOL CHEM, V388, P687, DOI 10.1515/BC.2007.077; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Bulkley D, 2010, P NATL ACAD SCI USA, V107, P17158, DOI 10.1073/pnas.1008685107; Dale T, 2009, NUCLEIC ACIDS RES, V37, P1202, DOI 10.1093/nar/gkn1040; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; GANOZA MC, 1985, EUR J BIOCHEM, V146, P287, DOI 10.1111/j.1432-1033.1985.tb08651.x; Ganoza MC, 2000, BIOL CHEM, V381, P553, DOI 10.1515/BC.2000.071; Gilreath MS, 2011, FEBS LETT, V585, P3284, DOI 10.1016/j.febslet.2011.09.008; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Levengood J, 2004, J BIOL CHEM, V279, P17707, DOI 10.1074/jbc.M313665200; Ling J, 2007, RNA, V13, P1881, DOI 10.1261/rna.684107; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; McGarry KG, 2005, MOL CELL, V20, P613, DOI 10.1016/j.molcel.2005.10.007; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Swaney S, 2006, J BIOMOL SCREEN, V11, P736, DOI 10.1177/1087057106291634; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Walker SE, 2008, METHODS, V44, P81, DOI 10.1016/j.ymeth.2007.09.003; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039	33	38	39	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4416	4423		10.1074/jbc.M112.438879	http://dx.doi.org/10.1074/jbc.M112.438879			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23277358	Green Published, hybrid			2022-12-28	WOS:000314845000068
J	Garbers, C; Spudy, B; Aparicio-Siegmund, S; Waetzig, GH; Sommer, J; Holscher, C; Rose-John, S; Grotzinger, J; Lorenzen, I; Scheller, J				Garbers, Christoph; Spudy, Bjoern; Aparicio-Siegmund, Samadhi; Waetzig, Georg H.; Sommer, Jan; Hoelscher, Christoph; Rose-John, Stefan; Groetzinger, Joachim; Lorenzen, Inken; Scheller, Juergen			An Interleukin-6 Receptor-dependent Molecular Switch Mediates Signal Transduction of the IL-27 Cytokine Subunit p28 (IL-30) via a gp130 Protein Receptor Homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; INHIBITION; ANTAGONIST; COMPLEX; BINDING; WSX-1	IL-27 consists of the cytokine subunit p28 and the non-signaling alpha-receptor EBI3. p28 was shown to additionally act via the non-signaling membrane-bound IL-6 alpha-receptor (IL-6R) as an agonistic cytokine but also as a gp130 beta-receptor antagonist, leading to inhibition of IL-6 signaling. Here, we developed a strategy for bacterial expression, purification, and refolding of murine p28. We show that p28 did not interfere with IL-6- or IL-27-induced signaling, indicating that p28 has no antagonistic properties. Moreover, we demonstrate that murine p28 acts as an agonistic cytokine via the murine and human IL-6R, indicating that p28 exhibits no species specificity. p28 was able to induce p28-trans-signaling via the soluble IL-6R (sIL-6R), a characteristic property that was initially described for trans-signaling of IL-6 via the sIL-6R. Of notice, p28/sIL-6R trans-signaling was inhibited by the IL-6 trans-signaling antagonist, soluble gp130. At higher concentrations, p28 but not IL-6 was able to induce signaling even in the absence of IL-6R or EBI3. Although IL-27 signals via a heterodimer of the beta-receptor chains gp130 and Wsx-1, p28/IL-6R specifically recruits two gp130 beta-receptor chains for signal transduction. The binding of p28 to a gp130/Wsx-1 heterodimer or a gp130 homodimer is highly selective and controlled by a novel molecular switch induced by EBI3 or IL-6R, respectively.	[Garbers, Christoph; Aparicio-Siegmund, Samadhi; Sommer, Jan; Scheller, Juergen] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Spudy, Bjoern; Rose-John, Stefan; Groetzinger, Joachim; Lorenzen, Inken] Univ Kiel, Inst Biochem, Kiel, Germany; [Waetzig, Georg H.] CONARIS Res Inst AG, Kiel, Germany; [Hoelscher, Christoph] Res Ctr Borstel, Borstel, Germany; [Waetzig, Georg H.; Hoelscher, Christoph; Rose-John, Stefan; Groetzinger, Joachim] Cluster Excellence Inflammat Interfaces, Borstel, Germany	Heinrich Heine University Dusseldorf; University of Kiel; Forschungszentrum Borstel	Scheller, J (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Univ Str 1, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Waetzig, Georg/AAV-7486-2021; Scheller, Jürgen/K-5290-2015; Rose-John, Stefan/A-7998-2010; Hölscher, Christoph/O-1732-2018; Garbers, Christoph/D-9932-2015	Rose-John, Stefan/0000-0002-7519-3279; Hölscher, Christoph/0000-0002-7520-9146; Garbers, Christoph/0000-0003-4939-6950	Deutsche Forschungsgemeinschaft (Bonn, Germany) [DFG SCHE 907/2-1, SFB877]; Research Commission of the Medical Faculty of the Heinrich-Heine-University	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Research Commission of the Medical Faculty of the Heinrich-Heine-University	This work was funded by Deutsche Forschungsgemeinschaft (Bonn, Germany) Grant DFG SCHE 907/2-1, SFB877 (A1, A6; SR-J, AC, JG), and by the Research Commission of the Medical Faculty of the Heinrich-Heine-University (to C. G. and J. S.).	Adam N, 2009, J VIROL, V83, P5117, DOI 10.1128/JVI.01601-08; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; Dams-Kozlowska H, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-8; Dibra D, 2012, HEPATOLOGY, V55, P1204, DOI 10.1002/hep.24814; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Gu ZJ, 1996, J IMMUNOL METHODS, V190, P21, DOI 10.1016/0022-1759(95)00232-4; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Koch M, 2007, BIOCHEM BIOPH RES CO, V364, P483, DOI 10.1016/j.bbrc.2007.10.053; MACKIEWICZ A, 1992, J IMMUNOL, V149, P2021; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Scheller J, 2005, BIOCHEM BIOPH RES CO, V326, P724, DOI 10.1016/j.bbrc.2004.11.098; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Schuster B, 2003, J BIOL CHEM, V278, P9528, DOI 10.1074/jbc.M210044200; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Suthaus J, 2011, EUR J CELL BIOL, V90, P495, DOI 10.1016/j.ejcb.2010.10.016; Tenhumberg S, 2008, J BIOL CHEM, V283, P27200, DOI 10.1074/jbc.M803694200; Wijdenes J, 1995, EUR J IMMUNOL, V25, P3474, DOI 10.1002/eji.1830251240; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0	28	96	98	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4346	4354		10.1074/jbc.M112.432955	http://dx.doi.org/10.1074/jbc.M112.432955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23209286	hybrid, Green Published			2022-12-28	WOS:000314845000062
J	Hawkins, AS; Han, YJ; Bennett, RK; Adams, MWW; Kelly, RM				Hawkins, Aaron S.; Han, Yejun; Bennett, Robert K.; Adams, Michael W. W.; Kelly, Robert M.			Role of 4-Hydroxybutyrate-CoA Synthetase in the CO2 Fixation Cycle in Thermoacidophilic Archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOTROPHIC CARBON FIXATION; METALLOSPHAERA-SEDULA; 3-HYDROXYPROPIONATE CYCLE; CRYSTAL-STRUCTURE; ELEMENTAL SULFUR; ACETYL-COENZYME; SULFOLOBUS; OXIDATION; REDUCTASE; GENUS	Metallosphaera sedula is an extremely thermoacidophilic archaeon that grows heterotrophically on peptides and chemolithoautotrophically on hydrogen, sulfur, or reduced metals as energy sources. During autotrophic growth, carbon dioxide is incorporated into cellular carbon via the 3-hydroxypropionate/4-hydroxybutyrate cycle (3HP/4HB). To date, all of the steps in the pathway have been connected to enzymes encoded in specific genes, except for the one responsible for ligation of coenzyme A (CoA) to 4HB. Although several candidates for this step have been identified through bioinformatic analysis of the M. sedula genome, none have been shown to catalyze this biotransformation. In this report, transcriptomic analysis of cells grown under strict H-2-CO2 autotrophy was consistent with the involvement of Msed_0406 and Msed_0394. Recombinant versions of these enzymes catalyzed the ligation of CoA to 4HB, with similar affinities for 4HB (K-m values of 1.9 and 1.5 mM for Msed_0406 and Msed_0394, respectively) but with different rates (1.69 and 0.22 mu mol x min(-1) x mg(-1) for Msed_0406 and Msed_0394, respectively). Neither Msed_0406 nor Msed_0394 have close homologs in other Sulfolobales, although low sequence similarity is not unusual for acyl-adenylate-forming enzymes. The capacity of these two enzymes to use 4HB as a substrate may have arisen from simple modifications to acyl-adenylate-forming enzymes. For example, a single amino acid substitution (W424G) in the active site of the acetate/propionate synthetase (Msed_1353), an enzyme that is highly conserved among the Sulfolobales, changed its substrate specificity to include 4HB. The identification of the 4-HB CoA synthetase now completes the set of enzymes comprising the 3HP/4HB cycle.	[Hawkins, Aaron S.; Han, Yejun; Bennett, Robert K.; Kelly, Robert M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University of North Carolina; North Carolina State University; University System of Georgia; University of Georgia	Kelly, RM (corresponding author), N Carolina State Univ, Dept Chem & Biomol Engn, 911 Partners Way,EB-1,Box 7905, Raleigh, NC 27695 USA.	rmkelly@ncsu.edu	Han, Yejun/AAC-7411-2019	Kelly, Robert/0000-0002-0639-3592; Adams, Michael/0000-0002-9796-5014	National Institutes of Health [R01GM90209]; Department of Energy Advanced Research Project Agency-Energy Grant [DE-AR0000081]; Department of Energy Advanced Research Project Defense Threat Reduction Agency Grant [HDTRA1-09-1-0030]; United States Department of Education [P200A070582-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Advanced Research Project Agency-Energy Grant; Department of Energy Advanced Research Project Defense Threat Reduction Agency Grant; United States Department of Education(US Department of Education); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM90209. This work was also supported by Department of Energy Advanced Research Projects Agency-Energy Grant DE-AR0000081 and Defense Threat Reduction Agency Grant HDTRA1-09-1-0030.; Supported by Graduate Assistance in Areas on National Need Molecular Biotechnology Fellowship P200A070582-09 from the United States Department of Education.	Alber B, 2006, J BACTERIOL, V188, P8551, DOI 10.1128/JB.00987-06; Alber BE, 2008, J BACTERIOL, V190, P1383, DOI 10.1128/JB.01593-07; Auernik KS, 2010, APPL ENVIRON MICROB, V76, P931, DOI 10.1128/AEM.01336-09; Auernik KS, 2008, APPL ENVIRON MICROB, V74, P7723, DOI 10.1128/AEM.01545-08; Bathe S, 2007, APPL ENVIRON MICROB, V73, P2491, DOI 10.1128/AEM.02589-06; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Brasen C, 2005, EXTREMOPHILES, V9, P355, DOI 10.1007/s00792-005-0449-0; Brasen C, 2005, FEBS LETT, V579, P477, DOI 10.1016/j.febslet.2004.12.016; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Estelmann S, 2011, J BACTERIOL, V193, P1191, DOI 10.1128/JB.01155-10; Gerhardt A, 2000, ARCH MICROBIOL, V174, P189, DOI 10.1007/s002030000195; GOLD T, 1992, P NATL ACAD SCI USA, V89, P6045, DOI 10.1073/pnas.89.13.6045; GROGAN DW, 1989, J BACTERIOL, V171, P6710, DOI 10.1128/jb.171.12.6710-6719.1989; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Guo L, 2011, J BACTERIOL, V193, P1672, DOI 10.1128/JB.01487-10; Han YJ, 2012, APPL ENVIRON MICROB, V78, P6194, DOI 10.1128/AEM.01312-12; Hawkins AS, 2011, ACS CATAL, V1, P1043, DOI 10.1021/cs2003017; HUBER G, 1989, SYST APPL MICROBIOL, V12, P38; Huber H, 2008, P NATL ACAD SCI USA, V105, P7851, DOI 10.1073/pnas.0801043105; Hugler M, 2003, EUR J BIOCHEM, V270, P736, DOI 10.1046/j.1432-1033.2003.03434.x; Hugler M, 2003, ARCH MICROBIOL, V179, P160, DOI 10.1007/s00203-002-0512-5; Ingram-Smith C, 2006, BIOCHEMISTRY-US, V45, P11482, DOI 10.1021/bi061023e; Ingram-Smith Cheryl, 2007, Archaea, V2, P95; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Kletzin A, 2004, J BIOENERG BIOMEMBR, V36, P77, DOI 10.1023/B:JOBB.0000019600.36757.8c; Kockelkorn D, 2009, J BACTERIOL, V191, P6352, DOI 10.1128/JB.00794-09; Laska S, 2003, MICROBIOL-SGM, V149, P2357, DOI 10.1099/mic.0.26455-0; Menendez C, 1999, J BACTERIOL, V181, P1088, DOI 10.1128/JB.181.4.1088-1098.1999; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Ramos-Vera WH, 2011, J BACTERIOL, V193, P1201, DOI 10.1128/JB.01156-10; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; SHIVVERS DW, 1973, J BACTERIOL, V114, P706, DOI 10.1128/JB.114.2.706-710.1973; Sleep NH, 2004, P NATL ACAD SCI USA, V101, P12818, DOI 10.1073/pnas.0405289101; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Teufel R, 2009, J BACTERIOL, V191, P4572, DOI 10.1128/JB.00068-09; VALENTIN HE, 1995, EUR J BIOCHEM, V227, P43, DOI 10.1111/j.1432-1033.1995.tb20358.x; WILHELM E, 1977, CHEM REV, V77, P219, DOI 10.1021/cr60306a003	43	20	23	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4012	4022		10.1074/jbc.M112.413195	http://dx.doi.org/10.1074/jbc.M112.413195			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258541	Green Published, hybrid			2022-12-28	WOS:000314845000030
J	Singh, SK; Boyle, AL; Main, ERG				Singh, Sunny K.; Boyle, Aimee L.; Main, Ewan R. G.			LcrH, a Class II Chaperone from the Type Three Secretion System, Has a Highly Flexible Native Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATOR PROTEIN IPAB; FLY-CASTING MECHANISM; KAPPA-B-ALPHA; REPEAT PROTEINS; TETRATRICOPEPTIDE REPEATS; MOLECULAR RECOGNITION; QUATERNARY STRUCTURE; DIMERIC PROTEINS; BINDING; STABILITY	The type three secretion system is a large and complex protein nano-machine that many Gram-negative pathogens employ to infect host cells. A key structure of this machine is a proteinaceous pore that inserts into the target membrane and forms a channel for bacterial toxins to flow from bacteria into the host cell. The pore is mainly formed from two large membrane proteins called "translocators." Importantly, effective secretion and thus pore formation of the translocators depend on their binding to and being transported by small specialized chaperones after synthesis in the bacterial cytosol. Recent crystal structures have shown these chaperones are formed from modular tetratricopeptide repeats. However, each crystal structure produced different homodimeric structures, suggesting flexibility in their topology that may be of importance to function. Given the crucial role of the translocator chaperones, we investigated the conformational stability of the chaperone LcrH (Yersinia pestis). Mutational analysis coupled with analytical ultracentrifugation and equilibrium denaturations showed that LcrH is a weak and thermodynamically unstable dimer (K-D approximate to 15 mu M, Delta G(H2O) = 7.4 kcal mol(-1)). The modular tetratricopeptide repeat structure of the dimer allows it to readily unfold in a noncooperative manner to a one-third unfolded dimeric intermediate (Delta G(H2O) = 1.7 kcal mol(-1)), before cooperatively unfolding to a monomeric denatured state (Delta G(H2O) = 5.7 kcal mol(-1)). Thus, under physiological conditions, the chaperone is able to populate C-terminally unraveled partially folded states, while being held together by its dimeric interface. Such ability suggests a "fly-casting" mechanism as a route to binding their far larger translocator cargo.	[Singh, Sunny K.; Main, Ewan R. G.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Singh, Sunny K.] Univ Sussex, Sch Life Sci, Falmer BN1 9QJ, Near Brighton, England; [Boyle, Aimee L.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of London; University of Sussex; University of Bristol	Main, ERG (corresponding author), Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	e.main@qmul.ac.uk	Singh, Sunny/B-1442-2017	Singh, Sunny/0000-0002-2306-4096; Boyle, Aimee/0000-0003-4176-6080; Main, Ewan/0000-0001-6087-9000	Queen Mary, University of London; Sussex Universities; Sussex University studentship; Biotechnology and Biological Sciences Research Council	Queen Mary, University of London; Sussex Universities; Sussex University studentship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Queen Mary, University of London, and Sussex Universities.; Supported by a Sussex University studentship.; Supported by a Biotechnology and Biological Sciences Research Council studentship with Prof. Dek Woolfson.	Adam PR, 2012, BIOCHEMISTRY-US, V51, P4062, DOI 10.1021/bi300243z; Barta ML, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-21; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Buttner CR, 2008, J MOL BIOL, V375, P997, DOI 10.1016/j.jmb.2007.11.009; Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017; Deu E, 2007, BIOCHEMISTRY-US, V46, P5810, DOI 10.1021/bi602621t; Doyle SM, 2000, BIOCHEMISTRY-US, V39, P11667, DOI 10.1021/bi000299y; Edqvist PJ, 2006, MOL MICROBIOL, V59, P31, DOI 10.1111/j.1365-2958.2005.04923.x; Grimsley JK, 1997, BIOCHEMISTRY-US, V36, P14366, DOI 10.1021/bi971596e; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hayes D. B., 1998, SEDNTERP; Javadi Y, 2009, P NATL ACAD SCI USA, V106, P17383, DOI 10.1073/pnas.0907455106; Job V, 2010, J BIOL CHEM, V285, P23222, DOI 10.1074/jbc.M110.111278; Lamboy JA, 2011, P NATL ACAD SCI USA, V108, P10178, DOI 10.1073/pnas.1102226108; Levy Y, 2007, J AM CHEM SOC, V129, P738, DOI 10.1021/ja065531n; Lokareddy RK, 2010, J BIOL CHEM, V285, P39965, DOI 10.1074/jbc.M110.135616; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Main ERG, 2005, CURR OPIN STRUC BIOL, V15, P464, DOI 10.1016/j.sbi.2005.07.003; Main ERG, 2005, P NATL ACAD SCI USA, V102, P5721, DOI 10.1073/pnas.0404530102; Main ERG, 2003, CURR OPIN STRUC BIOL, V13, P482, DOI 10.1016/S0959-440X(03)00105-2; Marlovits TC, 2010, CURR OPIN MICROBIOL, V13, P47, DOI 10.1016/j.mib.2009.11.001; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; Mei G, 1997, BIOCHEMISTRY-US, V36, P10917, DOI 10.1021/bi970614p; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Perham M, 2005, J AM CHEM SOC, V127, P16402, DOI 10.1021/ja055574o; Phillips JJ, 2012, PROTEIN SCI, V21, P327, DOI 10.1002/pro.2018; Riley PW, 2007, J MOL BIOL, V367, P558, DOI 10.1016/j.jmb.2006.12.066; Rumfeldt JAO, 2008, PROG BIOPHYS MOL BIO, V98, P61, DOI 10.1016/j.pbiomolbio.2008.05.004; Schreiner M, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-13; Scott D. J., 2005, ULTRASCAN COMPREHENS; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Tan YW, 2009, PROTEIN SCI, V18, P1724, DOI 10.1002/pro.187; Truhlar SME, 2006, P NATL ACAD SCI USA, V103, P18951, DOI 10.1073/pnas.0605794103; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320	35	7	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4048	4055		10.1074/jbc.M112.395889	http://dx.doi.org/10.1074/jbc.M112.395889			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23233673	Green Published, hybrid			2022-12-28	WOS:000314845000033
J	Liberton, M; Page, LE; O'Dell, WB; O'Neill, H; Mamontov, E; Urban, VS; Pakrasi, HB				Liberton, Michelle; Page, Lawrence E.; O'Dell, William B.; O'Neill, Hugh; Mamontov, Eugene; Urban, Volker S.; Pakrasi, Himadri B.			Organization and Flexibility of Cyanobacterial Thylakoid Membranes Examined by Neutron Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS; MUTANTS	Cyanobacteria are prokaryotes that can use photosynthesis to convert sunlight into cellular fuel. Knowledge of the organization of the membrane systems in cyanobacteria is critical to understanding the metabolic processes in these organisms. We examined the wild-type strain of Synechocystis sp. PCC6803 and a series of mutants with altered light-harvesting phycobilisome antenna systems for changes in thylakoid membrane architecture under different conditions. Using small-angle neutron scattering, it was possible to resolve correlation distances of subcellular structures in live cells on the nanometer scale and capture dynamic light-induced changes to these distances. Measurements made from samples with varied scattering contrasts confirmed that these distances could be attributed to the thylakoid lamellar system. We found that the changes to the thylakoid system were reversible between light-and dark-adapted states, demonstrating a robust structural flexibility in the architecture of cyanobacterial cells. Chemical disruption of photosynthetic electron transfer diminished these changes, confirming the involvement of the photosynthetic apparatus. We have correlated these findings with electron microscopy data to understand the origin of the changes in the membranes and found that light induces an expansion in the center-to-center distances between the thylakoid membrane layers. These combined data lend a dynamic dimension to the intracellular organization in cyanobacterial cells.	[Liberton, Michelle; Page, Lawrence E.; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [O'Dell, William B.; O'Neill, Hugh; Urban, Volker S.] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA; [Mamontov, Eugene] Oak Ridge Natl Lab, Chem & Engn Mat Div, Oak Ridge, TN 37831 USA	Washington University (WUSTL); United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	pakrasi@wustl.edu	O'Dell, William B/R-2753-2017; Urban, Volker S/N-5361-2015; Mamontov, Eugene/Q-1003-2015	O'Dell, William B/0000-0002-8063-5190; Urban, Volker S/0000-0002-7962-3408; Mamontov, Eugene/0000-0002-5684-2675; O'Neill, Hugh/0000-0003-2966-5527	Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC 0001035]; United States Department of Energy, Office of Science, Office of Biological and Environmental Research Project [ERKP291]; United States Department of Energy, Scientific User Facilities Division, Office of Basic Energy Sciences	Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); United States Department of Energy, Office of Science, Office of Biological and Environmental Research Project(United States Department of Energy (DOE)); United States Department of Energy, Scientific User Facilities Division, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank Ghada Ajlani for the kind gift of the phycobilisome mutant strains used in this study. We thank all members of the Pakrasi laboratory for helpful discussions and Howard Berg (Donald Danforth Plant Science Center Integrated Microscopy Facility) for TEM assistance. We thank Sai Venkatesh Pingali for implementing software used for SANS data analysis. This material is based upon work supported as part of the Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center funded by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Award DE-SC 0001035. The Bio-SANS instrument used in these studies is a resource of the Center for Structural Molecular Biology at Oak Ridge National Laboratory, which is supported by United States Department of Energy, Office of Science, Office of Biological and Environmental Research Project ERKP291. Bio-SANS is located at the Oak Ridge National Laboratory High Flux Isotope Reactor, and the BASIS instrument is located at the Spallation Neutron Source. Both neutron sources are sponsored by the United States Department of Energy, Scientific User Facilities Division, Office of Basic Energy Sciences.	Ajlani G, 1998, PLANT MOL BIOL, V37, P577, DOI 10.1023/A:1005924730298; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Arteni AA, 2009, BBA-BIOENERGETICS, V1787, P272, DOI 10.1016/j.bbabio.2009.01.009; Azuah RT, 2009, J RES NATL INST STAN, V114, P341, DOI 10.6028/jres.114.025; Collins AM, 2012, PLANT PHYSIOL, V158, P1600, DOI 10.1104/pp.111.192849; Kirchhoff H, 2011, P NATL ACAD SCI USA, V108, P20248, DOI 10.1073/pnas.1104141109; Larkum AWD, 2003, ADV PHOTO RESPIRAT, V14, P11; Liberton M., 2008, CYANOBACTERIA MOL BI, P217; Liberton M, 2011, PLANT PHYSIOL, V155, P1656, DOI 10.1104/pp.110.165332; Lynn GW, 2006, PHYSICA B, V385-86, P880, DOI 10.1016/j.physb.2006.05.133; Mamontov E, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3626214; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Mullineaux CW, 1999, AUST J PLANT PHYSIOL, V26, P671, DOI 10.1071/PP99027; MURAKAMI S, 1970, PLANT PHYSIOL, V45, P289, DOI 10.1104/pp.45.3.289; Murugova T.N., 2011, NEUTRON NEWS, V22, P11, DOI [10.1080/10448632.2011.598800, DOI 10.1080/10448632.2011.598800]; Nagy G, 2012, PHOTOSYNTH RES, V111, P71, DOI 10.1007/s11120-011-9693-6; Nagy G, 2011, BIOCHEM J, V436, P225, DOI 10.1042/BJ20110180; Nevo R, 2009, ADV PHOTOSYNTH RESP, V30, P295; Olive J, 1997, BBA-BIOENERGETICS, V1319, P275, DOI 10.1016/S0005-2728(96)00168-5; SADLER DM, 1982, J MOL BIOL, V159, P467, DOI 10.1016/0022-2836(82)90295-9; Tang KH, 2012, PHOTOSYNTH RES, V111, P205, DOI 10.1007/s11120-011-9665-x; Ughy B, 2004, MICROBIOL-SGM, V150, P4147, DOI 10.1099/mic.0.27498-0; van de Meene AMT, 2012, BBA-BIOMEMBRANES, V1818, P1427, DOI 10.1016/j.bbamem.2012.01.019; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y	24	75	76	0	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3632	3640		10.1074/jbc.M112.416933	http://dx.doi.org/10.1074/jbc.M112.416933			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23255600	hybrid, Green Published			2022-12-28	WOS:000314397900067
J	Hou, ZH; Yu, X				Hou, Zai-Hua; Yu, Xiang			Activity-regulated Somatostatin Expression Reduces Dendritic Spine Density and Lowers Excitatory Synaptic Transmission via Postsynaptic Somatostatin Receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; DISYNAPTIC INHIBITION; ELECTRICAL-ACTIVITY; KAINIC ACID; PLASTICITY; INTERNEURONS; NEUROTRANSMISSION; HIPPOCAMPUS; SEIZURES; INCREASE	Neuronal activity regulates multiple aspects of the morphological and functional development of neural circuits. One mechanism by which it achieves this is through regulation of gene expression. In a screen for activity-induced genes, we identified somatostatin (SST), a neuropeptide secreted by the SST subtype of interneurons. Using real time quantitative PCR and ELISA, we showed that persistent elevation of neuronal activity increased both the gene expression and protein secretion of SST over a relatively prolonged time course of 48 h. Using primary hippocampal neuronal cultures, we found that SST treatment for 1 day significantly reduced the density of dendritic spines, the morphological bases of excitatory synapses. Furthermore, the density of pre- and postsynaptic markers of excitatory synapses was significantly lowered following SST treatment, whereas that of inhibitory synapses was not affected. Consistently, SST treatment reduced the frequency of miniature excitatory postsynaptic currents, without affecting inhibition. Finally, lowering the endogenous level of SST receptor subtype 4 in individual hippocampal pyramidal neurons significantly blocked the effect of SST in reducing spine density and excitatory synaptic transmission in a cell autonomous fashion, suggesting that the effect of SST in regulating excitatory synaptic transmission is mainly mediated by SST receptor subtype 4. Together, our results demonstrated that activity-dependent release of SST reduced the density of dendritic spines and the number of excitatory synapses through postsynaptic activation of SST receptor subtype 4 in pyramidal neurons. To our knowledge, this is the first demonstration of the long term effect of SST on neuronal morphology.	[Hou, Zai-Hua; Yu, Xiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Hou, Zai-Hua; Yu, Xiang] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Hou, Zai-Hua] Univ Chinese Acad Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, X (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yuxiang@ion.ac.cn		Yu, Xiang/0000-0003-1225-7666	Ministry of Science and Technology [2011CBA00400]; National Natural Science Foundation of China [31125015, 31021063]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology Grant 2011CBA00400 and National Natural Science Foundation of China Grants 31125015 and 31021063.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Applied Biosystems, 2001, APP BIOS US B; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Boehm S, 1997, J NEUROSCI, V17, P4066; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; Buckmaster PS, 2002, EPILEPSY RES, V48, P43, DOI 10.1016/S0920-1211(01)00318-7; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Csaba Z, 2001, NEUROPEPTIDES, V35, P1, DOI 10.1054/npep.2001.0848; EPELBAUM J, 1986, PROG NEUROBIOL, V27, P63, DOI 10.1016/0301-0082(86)90012-2; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Gastambide F, 2010, HIPPOCAMPUS, V20, P745, DOI 10.1002/hipo.20680; HASHIMOTO T, 1991, NEUROSCI RES, V12, P514, DOI 10.1016/S0168-0102(09)80004-7; He S, 2010, J NEUROSCI, V30, P7910, DOI 10.1523/JNEUROSCI.6375-09.2010; Hofer SB, 2006, CURR OPIN NEUROBIOL, V16, P451, DOI 10.1016/j.conb.2006.06.007; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Jinno S, 2006, NEUROSCI RES, V56, P229, DOI 10.1016/j.neures.2006.07.007; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kumar U, 2010, RESULTS PROBL CELL D, V50, P137, DOI 10.1007/400_2009_29; Liu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030803; Loebrich S, 2009, PHYSIOL REV, V89, P1079, DOI 10.1152/physrev.00013.2009; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; MANFRIDI A, 1991, NEUROSCIENCE, V41, P127, DOI 10.1016/0306-4522(91)90203-Z; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MAZARATI AM, 1992, NEUROPHARMACOLOGY, V31, P793, DOI 10.1016/0028-3908(92)90043-O; MOORE SD, 1988, SCIENCE, V239, P278, DOI 10.1126/science.2892268; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Peng YR, 2010, J NEUROSCI, V30, P16220, DOI 10.1523/JNEUROSCI.3085-10.2010; Qiu C, 2008, J NEUROSCI, V28, P3567, DOI 10.1523/JNEUROSCI.4679-07.2008; Rossignol E, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/649325; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Schreff M, 2000, J NEUROSCI, V20, P3785, DOI 10.1523/JNEUROSCI.20-10-03785.2000; SCHWEITZER P, 1990, NATURE, V346, P464, DOI 10.1038/346464a0; Schweitzer P, 1998, J NEUROPHYSIOL, V79, P1230, DOI 10.1152/jn.1998.79.3.1230; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Tallent MK, 2008, MOL CELL ENDOCRINOL, V286, P96, DOI 10.1016/j.mce.2007.12.004; Tallent MK, 1999, J NEUROPHYSIOL, V81, P1626, DOI 10.1152/jn.1999.81.4.1626; Tallent MK, 1997, J NEUROPHYSIOL, V78, P3008, DOI 10.1152/jn.1997.78.6.3008; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tan ZJ, 2010, P NATL ACAD SCI USA, V107, P9873, DOI 10.1073/pnas.1003480107; Vezzani A, 1999, EUR J NEUROSCI, V11, P3767, DOI 10.1046/j.1460-9568.1999.00838.x; Viollet C, 2008, MOL CELL ENDOCRINOL, V286, P75, DOI 10.1016/j.mce.2007.09.007; WANSCHER B, 1990, NEUROSCI LETT, V118, P33, DOI 10.1016/0304-3940(90)90242-2; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	53	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2501	2509		10.1074/jbc.M112.419051	http://dx.doi.org/10.1074/jbc.M112.419051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233668	hybrid, Green Published			2022-12-28	WOS:000314211500036
J	Walsh, CM; Suchanek, AL; Cyphert, TJ; Kohan, AB; Szeszel-Fedorowicz, W; Salati, LM				Walsh, Callee M.; Suchanek, Amanda L.; Cyphert, Travis J.; Kohan, Alison B.; Szeszel-Fedorowicz, Wioletta; Salati, Lisa M.			Serine Arginine Splicing Factor 3 Is Involved in Enhanced Splicing of Glucose-6-phosphate Dehydrogenase RNA in Response to Nutrients and Hormones in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR MESSENGER-RNA; SR PROTEINS; NUTRITIONAL REGULATION; ARACHIDONIC-ACID; GLOBAL ANALYSIS; POLYMERASE-II; IN-VIVO; INSULIN; GENE; TRANSCRIPTION	Expression of G6PD is controlled by changes in the degree of splicing of the G6PD mRNA in response to nutrients in the diet. This regulation involves an exonic splicing enhancer (ESE) in exon 12 of the mRNA. Using the G6PD model, we demonstrate that nutrients and hormones control the activity of serine-arginine-rich (SR) proteins, a family of splicing co-activators, and thereby regulate the splicing of G6PD mRNA. In primary rat hepatocyte cultures, insulin increased the amount of phosphorylated SR proteins, and this effect was counteracted by arachidonic acid. The results of RNA affinity analysis with nuclear extracts from intact liver demonstrated that the SR splicing factor proteins SRSF3 and SRSF4 bound to the G6PD ESE. Consequently, siRNA-mediated depletion of SRSF3, but not SRSF4, in liver cells inhibited accumulation of both mRNA expressed from a minigene containing exon 12 and the endogenous G6PD mRNA. Consistent with the functional role of SRSF3 in regulating splicing, SRSF3 was observed to bind to the ESE in both intact cells and in animals using RNA immunoprecipitation analysis. Furthermore, refeeding significantly increased the binding of SRSF3 coincident with increased splicing and expression of G6PD. Together, these data establish that nutritional regulation of SRSF3 activity is involved in the differential splicing of the G6PD transcript in response to nutrients. Nutritional regulation of other SR proteins presents a regulatory mechanism that could cause widespread changes in mRNA splicing. Nutrients are therefore novel regulators of mRNA splicing.	[Salati, Lisa M.] W Virginia Univ, Hlth Sci Ctr, Dept Biochem, Morgantown, WV 26506 USA	West Virginia University	Salati, LM (corresponding author), W Virginia Univ, Hlth Sci Ctr, Dept Biochem, 1 Med Ctr Dr,POB 9142, Morgantown, WV 26506 USA.	Lsalati@hsc.wvu.edu	Suchanek, Amanda/HCI-3855-2022	Kohan, Alison/0000-0003-3127-7283; Walsh, Callee/0000-0002-3368-9209	National Institutes of Health [DK46897, T32 HL090610]; West Virginia Graduate Student Fellowships in Science, Technology, Engineering and Math Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL090610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046897, R29DK046897, R01DK046897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); West Virginia Graduate Student Fellowships in Science, Technology, Engineering and Math Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK46897 (to L. M. S.) and T32 HL090610 (to A. B. K.). This work was also supported by a grant from the West Virginia Graduate Student Fellowships in Science, Technology, Engineering and Math Program (to C. M. W.).	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Anko ML, 2010, NAT STRUCT MOL BIOL, V17, P962, DOI 10.1038/nsmb.1862; Amir-Ahmady B, 2001, J BIOL CHEM, V276, P10514, DOI 10.1074/jbc.M010535200; Apostolatos A, 2012, J BIOL CHEM, V287, P9299, DOI 10.1074/jbc.M111.313080; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Chalfant CE, 1998, J BIOL CHEM, V273, P910, DOI 10.1074/jbc.273.2.910; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doyle O, 2002, J STRUCT BIOL, V140, P154, DOI 10.1016/S1047-8477(02)00547-6; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Friedman JR, 2004, P NATL ACAD SCI USA, V101, P12986, DOI 10.1073/pnas.0402875101; Griffith BN, 2006, BBA-GENE STRUCT EXPR, V1759, P552, DOI 10.1016/j.bbaexp.2006.10.001; Hartmann B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r11; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; JAYADEV S, 1994, J BIOL CHEM, V269, P5757; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Longman D, 2000, EMBO J, V19, P1625, DOI 10.1093/emboj/19.7.1625; Longo L, 2002, EMBO J, V21, P4229, DOI 10.1093/emboj/cdf426; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Motta-Mena LB, 2011, J BIOL CHEM, V286, P20043, DOI 10.1074/jbc.M111.218727; NEUGEBAUER KM, 1995, J CELL BIOL, V129, P899, DOI 10.1083/jcb.129.4.899; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1875; Salati LM, 2004, J NUTR, V134, p2437S, DOI 10.1093/jn/134.9.2437S; Schaal TD, 1999, MOL CELL BIOL, V19, P1705; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Selth LA, 2009, COLD SPRING HARB PRO, V2009, DOI 10.1101/pdb.prot5234; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; Setzer DA, 1999, METH MOL B, V118, P115; Stabile LP, 1998, J LIPID RES, V39, P1951; Stabile LP, 1996, ARCH BIOCHEM BIOPHYS, V332, P269, DOI 10.1006/abbi.1996.0342; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Szeszel-Fedorowicz W, 2006, J BIOL CHEM, V281, P34146, DOI 10.1074/jbc.M603825200; Talukdar I, 2005, J BIOL CHEM, V280, P40660, DOI 10.1074/jbc.M505531200; Tao HM, 2002, J BIOL CHEM, V277, P31270, DOI 10.1074/jbc.M203196200; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Yeakley JM, 1999, J CELL BIOL, V145, P447, DOI 10.1083/jcb.145.3.447; Yin LY, 2005, MOL CELL ENDOCRINOL, V245, P43, DOI 10.1016/j.mce.2005.10.002; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	50	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2816	2828		10.1074/jbc.M112.410803	http://dx.doi.org/10.1074/jbc.M112.410803			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233666	Green Published, hybrid			2022-12-28	WOS:000314211500064
J	Wang, WB; Pan, YW; Wietecha, T; Zou, JH; Abel, GM; Kuo, CT; Xia, ZG				Wang, Wenbin; Pan, Yung-Wei; Wietecha, Tomasz; Zou, Junhui; Abel, Glen M.; Kuo, Chay T.; Xia, Zhengui			Extracellular Signal-regulated Kinase 5 (ERK5) Mediates Prolactin-stimulated Adult Neurogenesis in the Subventricular Zone and Olfactory Bulb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED DELETION; MAP KINASE; SURVIVAL; EXPRESSION; BRAIN; NEUROTROPHINS; INTERNEURONS; ACTIVATION; INHIBITORS; SECRETION	Prolactin-stimulated adult neurogenesis in the subventricular zone (SVZ) and olfactory bulb (OB) mediates several reproductive behaviors including mating/pregnancy, dominant male pheromone preference in females, and paternal recognition of offspring. However, downstream signaling mechanisms underlying prolactin-induced adult neurogenesis are completely unknown. We report here for the first time that prolactin activates extracellular signal-regulated kinase 5 (ERK5), a MAP kinase that is specifically expressed in the neurogenic regions of the adult mouse brain. Knockdown of ERK5 by retroviral infection of shRNA attenuates prolactin-stimulated neurogenesis in SVZ-derived adult neural stem/progenitor cells (aNPCs). Inducible erk5 deletion in adult neural stem cells of transgenic mice inhibits neurogenesis in the SVZ and OB following prolactin infusion or mating/pregnancy. These results identify ERK5 as a novel and critical signaling mechanism underlying prolactin-induced adult neurogenesis.	[Wang, Wenbin; Zou, Junhui; Abel, Glen M.; Xia, Zhengui] Univ Washington, Toxicol Program, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Pan, Yung-Wei; Xia, Zhengui] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Wietecha, Tomasz] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kuo, Chay T.] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Kuo, Chay T.] Duke Univ, Dept Pediat, Durham, NC 27710 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Duke University; Duke University	Xia, ZG (corresponding author), Univ Washington, Toxicol Program, Dept Environm & Occupat Hlth Sci, Box 357234, Seattle, WA 98195 USA.	zxia@u.washington.edu			National Institutes of Health [MH095840, T32HD007183, F1DC011216]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by the National Institutes of Health (MH095840, to Z. X., T32HD007183 and F1DC011216, to Y. W. P.).	BARKLEY MS, 1978, BIOL REPROD, V19, P291, DOI 10.1095/biolreprod19.2.291; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Cundiff P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005204; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Exton MS, 2001, PSYCHONEUROENDOCRINO, V26, P287, DOI 10.1016/S0306-4530(00)00053-6; Finegan KG, 2009, CELL DEATH DIFFER, V16, P674, DOI 10.1038/cdd.2008.193; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kendrick TS, 2007, FRONT BIOSCI-LANDMRK, V12, P591, DOI 10.2741/2085; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kruger THC, 2002, NEUROSCI BIOBEHAV R, V26, P31, DOI 10.1016/S0149-7634(01)00036-7; Larsen CM, 2012, BRAIN BEHAV IMMUN, V26, P201, DOI 10.1016/j.bbi.2011.07.233; Larsen CM, 2008, HORM BEHAV, V53, P509, DOI 10.1016/j.yhbeh.2007.11.020; Larsen CM, 2010, ENDOCRINOLOGY, V151, P3805, DOI 10.1210/en.2009-1385; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Mak GK, 2010, NAT NEUROSCI, V13, P753, DOI 10.1038/nn.2550; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Obara Y, 2010, MOL PHARMACOL, V77, P10, DOI 10.1124/mol.109.060236; Pan YW, 2012, J BIOL CHEM, V287, P23306, DOI 10.1074/jbc.M112.344762; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Shalizi A, 2003, J NEUROSCI, V23, P7326; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Tatake RJ, 2008, BIOCHEM BIOPH RES CO, V377, P120, DOI 10.1016/j.bbrc.2008.09.087; Torner L, 2009, J NEUROSCI, V29, P1826, DOI 10.1523/JNEUROSCI.3178-08.2009; Wang YP, 2006, J BIOL CHEM, V281, P35965, DOI 10.1074/jbc.M605503200; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; Zou JH, 2012, J NEUROSCI, V32, P4118, DOI 10.1523/JNEUROSCI.6260-11.2012	36	27	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2623	2631		10.1074/jbc.M112.401091	http://dx.doi.org/10.1074/jbc.M112.401091			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223235	Green Published, hybrid			2022-12-28	WOS:000314211500047
J	Sun, DF; Yu, F; Ma, YT; Zhao, R; Chen, X; Zhu, J; Zhang, CY; Chen, JN; Zhang, JF				Sun, Defang; Yu, Feng; Ma, Yutao; Zhao, Ran; Chen, Xi; Zhu, Jie; Zhang, Chen-Yu; Chen, Jiangning; Zhang, Junfeng			MicroRNA-31 Activates the RAS Pathway and Functions as an Oncogenic MicroRNA in Human Colorectal Cancer by Repressing RAS p21 GTPase Activating Protein 1 (RASA1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; EXPRESSION; TARGET; METASTASIS; PROGNOSIS; INVASION; BREAST; STAGE; KRAS; MUTATION	MicroRNAs (miRNAs) are known to play a vital role in colorectal cancer. We found a widespread disruption in miRNA expression during colorectal tumorigenesis using microarray and quantitative RT-PCR analysis; of the 161 miRNAs altered in colorectal cancer compared with normal adjacent tissue samples, miR-31 was the most significantly dysregulated. We identified candidate targets of miR-31 using bioinformatics approaches and validated RAS p21 GTPase activating protein 1 (RASA1) as a direct target. First, we found an inverse correlation between miR-31 and RASA1 protein levels in vivo. Second, in vitro evidence demonstrated that RASA1 expression was significantly decreased by treatment with pre-miR-31-LV, whereas anti-miR-31-LV treatment increased RASA1 protein levels. Third, a luciferase reporter assay confirmed that miR-31 directly recognizes a specific location within the 3'-untranslated region of RASA1 transcripts. Furthermore, the biological consequences of miR-31 targeting RASA1 were examined by the cell proliferation assay in vitro and by the immunodeficient mouse xenograft tumor model in vivo. Taken together, our results demonstrate for the first time that miR-31 plays a significant role in activating the RAS signaling pathway through the inhibition of RASA1 translation, thereby improving colorectal cancer cell growth and stimulating tumorigenesis.	[Sun, Defang; Yu, Feng; Ma, Yutao; Zhao, Ran; Chen, Xi; Zhu, Jie; Zhang, Chen-Yu; Chen, Jiangning; Zhang, Junfeng] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Sch Life Sci, State Key Lab Analyt Chem Life Sci, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University	Chen, JN (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Sch Life Sci, State Key Lab Analyt Chem Life Sci, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	jnchen@nju.edu.cn; jfzhang@nju.edu.cn			National Science Fund for Distinguished Young Scholars [81025019]; National Basic Research Program of China Grant [2012CB517603]; National Natural Science Foundation of China [31070722, 31271013, 31071232, 31170751, 31200695, 51173076, 91129712, 81102489]; Key Project of the Chinese Ministry of Education Grant [108059]; Ph.D. Programs Foundation of the Ministry of Education of China Grant [20100091120020]; NSFC [J1103512]; Fundamental Research Funds for the Central Universities	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Research Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Chinese Ministry of Education Grant; Ph.D. Programs Foundation of the Ministry of Education of China Grant(Ministry of Education, China); NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Science Fund for Distinguished Young Scholars Grant 81025019, the National Basic Research Program of China Grant 2012CB517603, National Natural Science Foundation of China Grants 31070722, 31271013, 31071232, 31170751, 31200695, 51173076, 91129712, and 81102489, Key Project of the Chinese Ministry of Education Grant 108059, the Ph.D. Programs Foundation of the Ministry of Education of China Grant 20100091120020, NSFC J1103512, the Fundamental Research Funds for the Central Universities.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; Donovan S, 2002, BBA-REV CANCER, V1602, P23, DOI 10.1016/S0304-419X(01)00041-5; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fakih MM, 2010, CLIN COLORECTAL CANC, V9, P22, DOI 10.3816/CCC.2010.n.003; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Nishida N, 2012, ANN SURG ONCOL, V19, P3065, DOI 10.1245/s10434-012-2246-1; Orom UA, 2006, GENE, V372, P137, DOI 10.1016/j.gene.2005.12.031; Parsons BL, 2009, BIOMARK MED, V3, P757, DOI 10.2217/BMM.09.95; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-616; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Yamashita S, 2012, ONCOLOGY-BASEL, V82, P205, DOI 10.1159/000336809; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	53	136	150	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9508	9518		10.1074/jbc.M112.367763	http://dx.doi.org/10.1074/jbc.M112.367763			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23322774	Green Published, hybrid			2022-12-28	WOS:000316862200066
J	Heul, AMV; Fowler, CA; Ramaswamy, S; Piper, RC				Heul, Aaron M. Ver; Fowler, C. Andrew; Ramaswamy, S.; Piper, Robert C.			Ubiquitin Regulates Caspase Recruitment Domain-mediated Signaling by Nucleotide-binding Oligomerization Domain-containing Proteins NOD1 and NOD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIG-I; STRUCTURAL BASIS; INNATE; RECOGNITION; ACTIVATION; AUTOPHAGY; RECEPTORS; CARD; IMMUNITY; PEPTIDOGLYCAN	NOD1 and NOD2 (nucleotide-binding oligomerization domain-containing proteins) are intracellular pattern recognition receptors that activate inflammation and autophagy. These pathways rely on the caspase recruitment domains (CARDs) within the receptors, which serve as protein interaction platforms that coordinately regulate immune signaling. We show that NOD1 CARD binds ubiquitin (Ub), in addition to directly binding its downstream targets receptor-interacting protein kinase 2 (RIP2) and autophagy-related protein 16-1 (ATG16L1). NMR spectroscopy and structure-guided mutagenesis identified a small hydrophobic surface of NOD1 CARD that binds Ub. In vitro, Ub competes with RIP2 for association with NOD1 CARD. In vivo, we found that the ligand-stimulated activity of NOD1 with a mutant CARD lacking Ub binding but retaining ATG16L1 and RIP2 binding is increased relative to wild-type NOD1. Likewise, point mutations in the tandem NOD2 CARDs at positions analogous to the surface residues defining the Ub interface on NOD1 resulted in loss of Ub binding and increased ligand-stimulated NOD2 signaling. These data suggest that Ub binding provides a negative feedback loop upon NOD-dependent activation of RIP2.	[Heul, Aaron M. Ver; Piper, Robert C.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52246 USA; [Heul, Aaron M. Ver; Ramaswamy, S.] Univ Iowa, Dept Biochem, Iowa City, IA 52246 USA; [Fowler, C. Andrew] Carver Coll Med, NMR Facil, Iowa City, IA 52246 USA; [Ramaswamy, S.] Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India	University of Iowa; University of Iowa; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Ramaswamy, S (corresponding author), Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India.	ramas@instem.res.in; Robert-Piper@uiowa.edu	Subramanian, Ramaswamy/Q-8671-2019	Subramanian, Ramaswamy/0000-0002-6709-190X; Piper, Robert/0000-0001-9995-5699; Ver Heul, Aaron/0000-0003-3386-8351; Fowler, Andrew/0000-0001-5646-5307	National Institutes of Health [5R01GM058202]; InStem, Bangalore; National Institutes of Health Biotechnology Training Grant through the University of Iowa Center for Biocatalysis and Bioprocessing [5T32GM008365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337, R01GM058202, T32GM008365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); InStem, Bangalore; National Institutes of Health Biotechnology Training Grant through the University of Iowa Center for Biocatalysis and Bioprocessing; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM058202. This work was also supported by InStem, Bangalore, intramural research grants.; Supported in part by National Institutes of Health Biotechnology Training Grant 5T32GM008365 through the University of Iowa Center for Biocatalysis and Bioprocessing.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chen YR, 2004, PROTEIN SCI, V13, P2196, DOI 10.1110/ps.03521504; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; de Marco A, 2007, NAT PROTOC, V2, P2632, DOI 10.1038/nprot.2007.400; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goddard T. D., SPARKY3; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Johnson B. A., 2010, NMRVIEWJ VERSION 8 2; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Kufer TA, 2011, NAT IMMUNOL, V12, P121, DOI 10.1038/ni.1985; Lecine P, 2007, J BIOL CHEM, V282, P15197, DOI 10.1074/jbc.M606242200; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Magalhaes JG, 2011, CURR OPIN IMMUNOL, V23, P29, DOI 10.1016/j.coi.2010.12.003; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mukherjee A, 2009, J BIOL CHEM, V284, P6486, DOI 10.1074/jbc.M807547200; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saleh M, 2011, IMMUNOL REV, V243, P235, DOI 10.1111/j.1600-065X.2011.01045.x; Shi YG, 2006, CURR OPIN CELL BIOL, V18, P677, DOI 10.1016/j.ceb.2006.09.006; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wagner RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004931; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yoo NJ, 2002, BIOCHEM BIOPH RES CO, V299, P652, DOI 10.1016/S0006-291X(02)02714-6; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	67	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6890	6902		10.1074/jbc.M112.413781	http://dx.doi.org/10.1074/jbc.M112.413781			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23300079	Green Published, hybrid			2022-12-28	WOS:000316002400010
J	Jalah, R; Rosati, M; Ganneru, B; Pilkington, GR; Valentin, A; Kulkarni, V; Bergamaschi, C; Chowdhury, B; Zhang, GM; Beach, RK; Alicea, C; Broderick, KE; Sardesai, NY; Pavlakis, GN; Felber, BK				Jalah, Rashmi; Rosati, Margherita; Ganneru, Brunda; Pilkington, Guy R.; Valentin, Antonio; Kulkarni, Viraj; Bergamaschi, Cristina; Chowdhury, Bhabadeb; Zhang, Gen-Mu; Beach, Rachel Kelly; Alicea, Candido; Broderick, Kate E.; Sardesai, Niranjan Y.; Pavlakis, George N.; Felber, Barbara K.			The p40 Subunit of Interleukin (IL)-12 Promotes Stabilization and Export of the p35 Subunit IMPLICATIONS FOR IMPROVED IL-12 CYTOKINE PRODUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL STIMULATORY FACTOR; PLASMID DNA VACCINE; HUMORAL IMMUNE-RESPONSES; GENE-THERAPY; IL-12 FAMILY; INTRATUMORAL INJECTION; RECEPTOR-ALPHA; NK CELLS; EXPRESSION; CYTOKINE	IL-12 is a 70-kDa heterodimeric cytokine composed of the p35 and p40 subunits. To maximize cytokine production from plasmid DNA, molecular steps controlling IL-12p70 biosynthesis at the posttranscriptional and posttranslational levels were investigated. We show that the combination of RNA/codon-optimized gene sequences and fine-tuning of the relative expression levels of the two subunits within a cell resulted in increased production of the IL-12p70 heterodimer. We found that the p40 subunit plays a critical role in enhancing the stability, intracellular trafficking, and export of the p35 subunit. This posttranslational regulation mediated by the p40 subunit is conserved in mammals. Based on these findings, dual gene expression vectors were generated, producing an optimal ratio of the two subunits, resulting in a similar to 1 log increase in human, rhesus, and murine IL-12p70 production compared with vectors expressing the wild type sequences. Such optimized DNA plasmids also produced significantly higher levels of systemic bioactive IL-12 upon in vivo DNA delivery in mice compared with plasmids expressing the wild type sequences. A single therapeutic injection of an optimized murine IL-12 DNA plasmid showed significantly more potent control of tumor development in the B16 melanoma cancer model in mice. Therefore, the improved IL-12p70 DNA vectors have promising potential for in vivo use as molecular vaccine adjuvants and in cancer immunotherapy.	[Zhang, Gen-Mu; Beach, Rachel Kelly; Alicea, Candido; Felber, Barbara K.] Frederick Natl Lab Canc Res, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21702 USA; [Rosati, Margherita; Ganneru, Brunda; Valentin, Antonio; Bergamaschi, Cristina; Chowdhury, Bhabadeb; Zhang, Gen-Mu; Beach, Rachel Kelly; Pavlakis, George N.] Frederick Natl Lab Canc Res, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21702 USA; [Broderick, Kate E.; Sardesai, Niranjan Y.] Inovio Pharmaceut Inc, Blue Bell, PA 19422 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Felber, BK (corresponding author), Frederick Natl Lab Canc Res, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21702 USA.	felberb@mail.nih.gov		Sardesai, Niranjan/0000-0001-6920-1167	National Institutes of Health, NCI, Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC010749, ZIABC010750, ZIABC010350, ZIABC010334] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health, NCI, Intramural Research Program.	Anderson R, 1997, HUM GENE THER, V8, P1125, DOI 10.1089/hum.1997.8.9-1125; Anwer K, 2010, GENE THER, V17, P360, DOI 10.1038/gt.2009.159; Babik JM, 1999, J IMMUNOL, V162, P4069; Bergamaschi C, 2008, J BIOL CHEM, V283, P4189, DOI 10.1074/jbc.M705725200; Bergamaschi C, 2012, BLOOD, V120, pE1, DOI 10.1182/blood-2011-10-384362; Bergamaschi C, 2009, J IMMUNOL, V183, P3064, DOI 10.4049/jimmunol.0900693; Boyer JD, 2005, J MED PRIMATOL, V34, P262, DOI 10.1111/j.1600-0684.2005.00124.x; Carra G, 2000, J IMMUNOL, V164, P4752, DOI 10.4049/jimmunol.164.9.4752; CASSATELLA MA, 1995, EUR J IMMUNOL, V25, P1, DOI 10.1002/eji.1830250102; Chong SY, 2007, VACCINE, V25, P4967, DOI 10.1016/j.vaccine.2006.11.070; Cole DJ, 2012, BLOOD, V120, P1, DOI 10.1182/blood-2012-04-425306; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Duitman EH, 2008, MOL CELL BIOL, V28, P4851, DOI 10.1128/MCB.02178-07; Duitman EH, 2011, EUR J CELL BIOL, V90, P476, DOI 10.1016/j.ejcb.2011.01.010; Egan MA, 2005, AIDS RES HUM RETROV, V21, P629, DOI 10.1089/aid.2005.21.629; Egan MA, 2006, VACCINE, V24, P4510, DOI 10.1016/j.vaccine.2005.08.024; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Goriely S, 2008, CURR OPIN ORGAN TRAN, V13, P4, DOI 10.1097/MOT.0b013e3282f406c4; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Heinzel FP, 1997, J IMMUNOL, V158, P4381; Heinzerling L, 2005, HUM GENE THER, V16, P35, DOI 10.1089/hum.2005.16.35; Heller LC, 2010, CURR GENE THER, V10, P312; Heller R, 2001, DNA CELL BIOL, V20, P21, DOI 10.1089/10445490150504666; Jalah R, 2007, DNA CELL BIOL, V26, P827, DOI 10.1089/dna.2007.0645; Jalah R, 2012, HUM VACC IMMUNOTHER, V8, P1620, DOI 10.4161/hv.21407; Jiang JJ, 2001, BIOCHEM BIOPH RES CO, V289, P1088, DOI 10.1006/bbrc.2001.6100; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kulkarni V, 2011, VACCINE, V29, P6742, DOI 10.1016/j.vaccine.2010.12.056; Lieschke GJ, 1997, NAT BIOTECHNOL, V15, P35, DOI 10.1038/nbt0197-35; LING P, 1995, J IMMUNOL, V154, P116; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu WT, 2004, BIOCHEM BIOPH RES CO, V313, P287, DOI 10.1016/j.bbrc.2003.11.125; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Mahvi DM, 2007, CANCER GENE THER, V14, P717, DOI 10.1038/sj.cgt.7701064; MATTNER F, 1993, EUR J IMMUNOL, V23, P2202, DOI 10.1002/eji.1830230923; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Murphy FJ, 2000, J IMMUNOL, V164, P839, DOI 10.4049/jimmunol.164.2.839; NASIOULAS G, 1994, J VIROL, V68, P2986, DOI 10.1128/JVI.68.5.2986-2993.1994; Ortaldo JR, 2005, J IMMUNOL, V175, P693, DOI 10.4049/jimmunol.175.2.693; Portielje JEA, 2003, CANCER IMMUNOL IMMUN, V52, P133, DOI 10.1007/s00262-002-0356-5; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Sangro B, 2005, CURR GENE THER, V5, P573, DOI 10.2174/156652305774964712; Schadeck EB, 2006, VACCINE, V24, P4677, DOI 10.1016/j.vaccine.2005.10.035; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SCHWARTZ S, 1992, J VIROL, V66, P150, DOI 10.1128/JVI.66.1.150-159.1992; SCHWARTZ S, 1992, J VIROL, V66, P7176, DOI 10.1128/JVI.66.12.7176-7182.1992; Snijders A, 1996, J IMMUNOL, V156, P1207; STAUBER R, 1995, VIROLOGY, V213, P439, DOI 10.1006/viro.1995.0016; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri Giorgio, 1992, Progress in Growth Factor Research, V4, P355, DOI 10.1016/0955-2235(92)90016-B; Vaidyanathan H, 2003, CYTOKINE, V21, P120, DOI 10.1016/S1043-4666(03)00016-4; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Villinger Francois, 2003, Expert Rev Vaccines, V2, P317, DOI 10.1586/14760584.2.2.317; Waldner MJ, 2009, CURR GENE THER, V9, P239, DOI 10.2174/156652309788921099; Weiss JM, 2007, EXPERT OPIN BIOL TH, V7, P1705, DOI 10.1517/14712598.7.11.1705; Whitworth JM, 2011, EXPERT OPIN BIOL TH, V11, P751, DOI 10.1517/14712598.2011.566854; Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11; WOLF SF, 1991, J IMMUNOL, V146, P3074; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Zhang L, 2011, MOL THER, V19, P751, DOI 10.1038/mt.2010.313	68	54	61	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6763	6776		10.1074/jbc.M112.436675	http://dx.doi.org/10.1074/jbc.M112.436675			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23297419	Green Published, hybrid			2022-12-28	WOS:000315820700073
J	Paladini, RD; Wei, G; Kundu, A; Zhao, QP; Bookbinder, LH; Keller, GA; Shepard, HM; Frost, GI				Paladini, Rudolph D.; Wei, Ge; Kundu, Anirban; Zhao, Qiping; Bookbinder, Louis H.; Keller, Gilbert A.; Shepard, H. Michael; Frost, Gregory I.			Mutations in the Catalytic Domain of Human Matrix Metalloproteinase-1 (MMP-1) That Allow for Regulated Activity through the Use of Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKIN COLLAGENASE; MAMMALIAN COLLAGENASES; LIVER FIBROSIS; RAT UTERUS; BINDING; BETA; ENVIRONMENTS; PURIFICATION; SPECIFICITY; INHIBITION	Conditionally active proteins regulated by a physiological parameter represent a potential new class of protein therapeutics. By systematically creating point mutations in the catalytic and linker domains of human MMP-1, we generated a protein library amenable to physiological parameter-based screening. Mutants screened for temperature-sensitive activity had mutations clustered at or near amino acids critical for metal binding. One mutant, GVSK (Gly(159) to Val, Ser(208) to Lys), contains mutations in regions of the catalytic domain involved in calcium and zinc binding. The in vitro activity of GVSK at 37 degrees C in high Ca2+ (10 mM) was comparable with MMP-1 (wild type), but in low Ca2+ (1 mM), there was an over 10-fold loss in activity despite having similar kinetic parameters. Activity decreased over 50% within 15 min and correlated with the degradation of the activated protein, suggesting that GVSK was unstable in low Ca2+. Varying the concentration of Zn2+ had no effect on GVSK activity in vitro. As compared with MMP-1, GVSK degraded soluble collagen I at the high but not the low Ca2+ concentration. In vivo, MMP-1 and GVSK degraded collagen I when perfused in Zucker rat ventral skin and formed higher molecular weight complexes with alpha 2-macroglobulin, an inhibitor of MMPs. In vitro and in vivo complex formation and subsequent enzyme inactivation occurred faster with GVSK, especially at the low Ca2+ concentration. These data suggest that the activity of the human MMP-1 mutant GVSK can be regulated by Ca2+ both in vitro and in vivo and may represent a novel approach to engineering matrix-remodeling enzymes for therapeutic applications.	[Paladini, Rudolph D.; Wei, Ge; Kundu, Anirban; Zhao, Qiping; Bookbinder, Louis H.; Keller, Gilbert A.; Shepard, H. Michael; Frost, Gregory I.] Halozyme Therapeut Inc, San Diego, CA 92121 USA	Halozyme	Paladini, RD (corresponding author), Halozyme Therapeut Inc, 11388 Sorrento Valley Rd, San Diego, CA 92121 USA.	rpaladini@halozyme.com						Bedair H, 2007, J APPL PHYSIOL, V102, P2338, DOI 10.1152/japplphysiol.00670.2006; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chua F, 2005, AM J RESP CELL MOL, V33, P9, DOI 10.1165/rcmb.2005-0062TR; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; EISEN AZ, 1970, J LAB CLIN MED, V75, P258; EISEN AZ, 1971, P NATL ACAD SCI USA, V68, P248, DOI 10.1073/pnas.68.1.248; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gill SE, 2011, BIOL EXTRACELL MATR, P1, DOI 10.1007/978-3-642-16861-1_1; Grinnell F, 1998, J INVEST DERMATOL, V110, P771, DOI 10.1046/j.1523-1747.1998.00192.x; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; HOUSLEY TJ, 1993, J BIOL CHEM, V268, P4481; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Iimuro Y, 2003, GASTROENTEROLOGY, V124, P445, DOI 10.1053/gast.2003.50063; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; JEFFREY JJ, 1970, BIOCHEMISTRY-US, V9, P268, DOI 10.1021/bi00804a012; Kaar JL, 2008, ACTA BIOMATER, V4, P1411, DOI 10.1016/j.actbio.2008.03.010; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; NAGAI Y, 1966, BIOCHEMISTRY-US, V5, P3123, DOI 10.1021/bi00874a007; Nagase H, 1997, BIOL CHEM, V378, P151; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; SELTZER JL, 1976, ARCH BIOCHEM BIOPHYS, V173, P355, DOI 10.1016/0003-9861(76)90270-8; TAWFIK DS, 1994, PROTEIN ENG, V7, P431, DOI 10.1093/protein/7.3.431; TOLLEFSEN T, 1980, J PERIODONTAL RES, V15, P96, DOI 10.1111/j.1600-0765.1980.tb00263.x; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; WELGUS HG, 1983, J BIOL CHEM, V258, P4162; WERB Z, 1974, BIOCHEM J, V139, P359, DOI 10.1042/bj1390359; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Zeisberg M, 2005, METH MOLEC MED, V117, P261; Zhang YN, 1997, J BIOL CHEM, V272, P1444, DOI 10.1074/jbc.272.3.1444	37	4	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6629	6639		10.1074/jbc.M112.364729	http://dx.doi.org/10.1074/jbc.M112.364729			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23322779	hybrid, Green Published			2022-12-28	WOS:000315820700062
J	Huang, WG; Barrett, M; Hajicek, N; Hicks, S; Harden, TK; Sondek, J; Zhang, QS				Huang, Weigang; Barrett, Matthew; Hajicek, Nicole; Hicks, Stephanie; Harden, T. Kendall; Sondek, John; Zhang, Qisheng			Small Molecule Inhibitors of Phospholipase C from a Novel High-throughput Screen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; POTENT INHIBITOR; CONTINUOUS ASSAY; AURINTRICARBOXYLIC ACID; PROMISCUOUS INHIBITORS; FLUOROGENIC SUBSTRATE; FLUORESCENT SUBSTRATE; HUMAN PLATELETS; IN-VITRO; U73122	Phospholipase C (PLC) isozymes are important signaling molecules, but few small molecule modulators are available to pharmacologically regulate their function. With the goal of developing a general approach for identification of novel PLC inhibitors, we developed a high-throughput assay based on the fluorogenic substrate reporter WH-15. The assay is highly sensitive and reproducible: screening a chemical library of 6280 compounds identified three novel PLC inhibitors that exhibited potent activities in two separate assay formats with purified PLC isozymes in vitro. Two of the three inhibitors also inhibited G protein-coupled receptor-stimulated PLC activity in intact cell systems. These results demonstrate the power of the high-throughput assay for screening large collections of small molecules to identify novel PLC modulators. Potent and selective modulators of PLCs will ultimately be useful for dissecting the roles of PLCs in cellular processes, as well as provide lead compounds for the development of drugs to treat diseases arising from aberrant phospholipase activity.	[Huang, Weigang; Zhang, Qisheng] Univ N Carolina, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Barrett, Matthew; Hajicek, Nicole; Hicks, Stephanie; Harden, T. Kendall; Sondek, John] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhang, QS (corresponding author), Univ N Carolina, Div Chem Biol & Med Chem, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	qszhang@unc.edu	Huang, Weigang/D-2948-2013	Sondek, John/0000-0002-1127-8310; Zhang, Qisheng/0000-0001-9808-5038	National Institutes of Health [R01 GM098894, GM57391, GM38213]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038213, R01GM098894, R01GM057391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM098894 (to Q. Z. and J. S.), GM57391 (to J. S. and T. K. H.), and GM38213 (to T. K. H.).	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; BALA GA, 1990, BIOL REPROD, V43, P704, DOI 10.1095/biolreprod43.4.704; Bembenek ME, 2003, ASSAY DRUG DEV TECHN, V1, P435, DOI 10.1089/154065803322163740; BENCHOKROUN Y, 1995, BIOCHEM PHARMACOL, V49, P305, DOI 10.1016/0006-2952(94)00465-X; Bertagnolo V, 2007, CARCINOGENESIS, V28, P1638, DOI 10.1093/carcin/bgm078; BERVEN LA, 1995, BIOCHEM PHARMACOL, V49, P1373, DOI 10.1016/0006-2952(95)00050-A; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Bourdon D. M., 2006, METHOD ENZYMOL, V406, P489; Burgdorf C, 2010, J CARDIOVASC PHARM, V55, P555, DOI 10.1097/FJC.0b013e3181d8bec5; Carter RL, 2009, MOL PHARMACOL, V76, P1341, DOI 10.1124/mol.109.058578; Feisst C, 2005, MOL PHARMACOL, V67, P1751, DOI 10.1124/mol.105.011007; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718; Follo MY, 2009, J CLIN ONCOL, V27, P782, DOI 10.1200/JCO.2008.19.3748; Gerber AN, 2009, P NATL ACAD SCI USA, V106, P4929, DOI 10.1073/pnas.0812308106; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; HARDEN TK, 1982, MOL PHARMACOL, V21, P570; Heiduschka P, 2000, NEUROPHARMACOLOGY, V39, P889, DOI 10.1016/S0028-3908(99)00245-2; Heinz DW, 1998, J MOL BIOL, V275, P635, DOI 10.1006/jmbi.1997.1490; HENDRICKSON EK, 1991, BIOORG MED CHEM LETT, V1, P619, DOI 10.1016/S0960-894X(01)81164-1; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hollywood MA, 2010, BRIT J PHARMACOL, V160, P1293, DOI 10.1111/j.1476-5381.2010.00795.x; Huang WG, 2011, ACS CHEM BIOL, V6, P223, DOI 10.1021/cb100308n; Kassis J, 1999, CLIN CANCER RES, V5, P2251; Klein RR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191783; Kurian MA, 2010, BRAIN, V133, P2964, DOI 10.1093/brain/awq238; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Liu Y, 2007, CHEMBIOCHEM, V8, P1430, DOI 10.1002/cbic.200700061; Lo Vasco VR, 2004, LEUKEMIA, V18, P1122, DOI 10.1038/sj.leu.2403368; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McOmish CE, 2008, HIPPOCAMPUS, V18, P824, DOI 10.1002/hipo.20443; Milanovic M, 2012, INT J CANCER, V130, P1060, DOI 10.1002/ijc.26066; Owens MR, 1996, THROMB RES, V81, P177, DOI 10.1016/0049-3848(95)00234-0; Pulcinelli FM, 1998, BIOCHEM PHARMACOL, V56, P1481, DOI 10.1016/S0006-2952(98)00146-4; Rebecchi M. J., 1993, J BIOL CHEM, V268, P1735; Rose TM, 2006, ORG LETT, V8, P2575, DOI 10.1021/ol060773d; Rukavishnikov AV, 1998, TETRAHEDRON LETT, V39, P6637, DOI 10.1016/S0040-4039(98)01429-4; Rukavishnikov AV, 1999, BIOORG MED CHEM LETT, V9, P1133, DOI 10.1016/S0960-894X(99)00166-3; Sala G, 2008, CANCER RES, V68, P10187, DOI 10.1158/0008-5472.CAN-08-1181; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Scholze H, 1999, ANAL BIOCHEM, V276, P72, DOI 10.1006/abio.1999.4278; SHASHIDHAR MS, 1991, ANAL BIOCHEM, V198, P10, DOI 10.1016/0003-2697(91)90498-I; Shepard CR, 2007, ONCOGENE, V26, P3020, DOI 10.1038/sj.onc.1210115; VICKERS JD, 1993, J PHARMACOL EXP THER, V266, P1156; Wang JP, 1996, N-S ARCH PHARMACOL, V353, P599, DOI 10.1007/BF00167177; Wang ZL, 2008, J CLIN INVEST, V118, P195, DOI 10.1172/JCI33139; Wilsher N, 2007, DRUG METAB DISPOS, V35, P1017, DOI 10.1124/dmd.106.014498; Woodcock EA, 2010, CURR DRUG TARGETS, V11, P1032, DOI 10.2174/138945010791591331; Zaikova TO, 2001, BIOCONJUGATE CHEM, V12, P307, DOI 10.1021/bc0001138; Zhang LH, 2011, J BIOL CHEM, V286, P23012, DOI 10.1074/jbc.M111.231993	53	21	21	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5840	5848		10.1074/jbc.M112.422501	http://dx.doi.org/10.1074/jbc.M112.422501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297405	Green Published, hybrid			2022-12-28	WOS:000315342500054
J	Momeni, MH; Payne, CM; Hansson, H; Mikkelsen, NE; Svedberg, J; Engstrom, A; Sandgren, M; Beckham, GT; Stahlberg, J				Momeni, Majid Haddad; Payne, Christina M.; Hansson, Henrik; Mikkelsen, Nils Egil; Svedberg, Jesper; Engstrom, Ake; Sandgren, Mats; Beckham, Gregg T.; Stahlberg, Jerry			Structural, Biochemical, and Computational Characterization of the Glycoside Hydrolase Family 7 Cellobiohydrolase of the Tree-killing Fungus Heterobasidion irregulare	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; TRICHODERMA-REESEI CELLOBIOHYDROLASE; PHANEROCHAETE-CHRYSOSPORIUM; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; ENDOGLUCANASE I; BIOMASS RECALCITRANCE; PROCESSIVE CELLULASE; FILAMENTOUS FUNGUS; HUMICOLA-INSOLENS	Root rot fungi of the Heterobasidion annosum complex are the most damaging pathogens in temperate forests, and the recently sequenced Heterobasidion irregulare genome revealed over 280 carbohydrate-active enzymes. Here, H. irregulare was grown on biomass, and the most abundant protein in the culture filtrate was identified as the only family 7 glycoside hydrolase in the genome, which consists of a single catalytic domain, lacking a linker and carbohydrate-binding module. The enzyme, HirCel7A, was characterized biochemically to determine the optimal conditions for activity. HirCel7A was crystallized and the structure, refined at 1.7 angstrom resolution, confirms that HirCel7A is a cellobiohydrolase rather than an endoglucanase, with a cellulose-binding tunnel that is more closed than Phanerochaete chrysosporium Cel7D and more open than Hypocrea jecorina Cel7A, suggesting intermediate enzyme properties. Molecular simulations were conducted to ascertain differences in enzyme-ligand interactions, ligand solvation, and loop flexibility between the family 7 glycoside hydrolase cellobiohydrolases from H. irregulare, H. jecorina, and P. chrysosporium. The structural comparisons and simulations suggest significant differences in enzyme-ligand interactions at the tunnel entrance in the -7 to -4 binding sites and suggest that a tyrosine residue at the tunnel entrance of HirCel7A may serve as an additional ligand-binding site. Additionally, the loops over the active site in H. jecorina Cel7A are more closed than loops in the other two enzymes, which has implications for the degree of processivity, endo- initiation, and substrate dissociation. Overall, this study highlights molecular level features important to understanding this biologically and industrially important family of glycoside hydrolases.	[Momeni, Majid Haddad; Hansson, Henrik; Mikkelsen, Nils Egil; Svedberg, Jesper; Sandgren, Mats; Stahlberg, Jerry] Swedish Univ Agr Sci, Dept Mol Biol, SE-75124 Uppsala, Sweden; [Payne, Christina M.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Payne, Christina M.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA; [Engstrom, Ake] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	Swedish University of Agricultural Sciences; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Kentucky; Uppsala University; Colorado School of Mines	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 1617 Cole Blvd,MS 3322 Golden, Golden, CO 80401 USA.	gregg.beckham@nrel.gov; jerry.stahlberg@molbio.slu.se	Payne, Christina M/C-7338-2011; Momeni, Majid Haddad/AAB-1857-2021; Hansson, Henrik/D-4467-2013; Payne, Christina/ABE-8330-2020; Stahlberg, Jerry/D-4163-2013	Payne, Christina M/0000-0001-5264-0964; Momeni, Majid Haddad/0000-0001-9653-1380; Payne, Christina/0000-0001-5264-0964; Stahlberg, Jerry/0000-0003-4059-8580; Hansson, Henrik/0000-0002-6003-2982; Sandgren, Mats/0000-0002-2358-4534	Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program "MicroDrivE"; Department of Energy Office of the Biomass Program; National Institute of Computational Science Kraken cluster under National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE) Grant [MCB090159]; National Renewable Energy Laboratory Computational Sciences Center; Department of Energy Efficiency and Renewable Energy [DE-AC36-08GO28308]	Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program "MicroDrivE"; Department of Energy Office of the Biomass Program(United States Department of Energy (DOE)); National Institute of Computational Science Kraken cluster under National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE) Grant; National Renewable Energy Laboratory Computational Sciences Center; Department of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE))	This work was supported in part by the Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program "MicroDrivE." This work was also supported by funds from the Department of Energy Office of the Biomass Program (to C. M. P. and G. T. B.). Computer time for this research was provided by the National Institute of Computational Science Kraken cluster under National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE) Grant MCB090159 and the National Renewable Energy Laboratory Computational Sciences Center supported by the Department of Energy Efficiency and Renewable Energy under Contract DE-AC36-08GO28308.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Bu LT, 2009, J PHYS CHEM B, V113, P10994, DOI 10.1021/jp904003z; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Grassick A, 2004, EUR J BIOCHEM, V271, P4495, DOI 10.1111/j.1432-1033.2004.04409.x; Grigoriev I. V., 2011, NUCLEIC ACIDS RES, P1; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Ilmen M, 1997, APPL ENVIRON MICROB, V63, P1298; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; KREMER SM, 1992, EUR J BIOCHEM, V205, P133, DOI 10.1111/j.1432-1033.1992.tb16760.x; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Lin YC, 2011, J AM CHEM SOC, V133, P16617, DOI 10.1021/ja206692g; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackenzie LF, 1998, BIOCHEM J, V335, P409, DOI 10.1042/bj3350409; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A, 1982, PREPARATION ANAL PRO; Medie FM, 2012, NAT REV MICROBIOL, V10, P227, DOI 10.1038/nrmicro2729; Munoz IG, 2001, J MOL BIOL, V314, P1097, DOI 10.1006/jmbi.2000.5180; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Parkkinen T, 2008, PROTEIN SCI, V17, P1383, DOI 10.1110/ps.034488.108; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; Sammond DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048615; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; STENLID J, 1985, CAN J BOT, V63, P2268, DOI 10.1139/b85-322; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Taylor CB, 2012, J BIOL CHEM, V287, P3147, DOI 10.1074/jbc.M111.270389; Textor LC, 2013, FEBS J, V280, P56, DOI 10.1111/febs.12049; Ubhayasekera W, 2005, FEBS J, V272, P1952, DOI 10.1111/j.1742-4658.2005.04625.x; UZCATEGUI E, 1991, J BIOTECHNOL, V19, P271, DOI 10.1016/0168-1656(91)90064-3; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Woodward S, 1998, HETEROBASIDION ANNOS, P589; Yakovlev I, 2012, APPL MICROBIOL BIOT, V95, P979, DOI 10.1007/s00253-012-4206-x	63	57	60	0	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5861	5872		10.1074/jbc.M112.440891	http://dx.doi.org/10.1074/jbc.M112.440891			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23303184	Green Published, hybrid			2022-12-28	WOS:000315342500056
J	Xu, L; Go, EP; Finney, J; Moon, H; Lantz, M; Rebecchi, K; Desaire, H; Mure, M				Xu, Li; Go, Eden P.; Finney, Joel; Moon, HeeJung; Lantz, Mason; Rebecchi, Kathryn; Desaire, Heather; Mure, Minae			Post-translational Modifications of Recombinant Human Lysyl Oxidase-like 2 (rhLOXL2) Secreted from Drosophila S2 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-ACTIVITY; GLYCOPROTEINS; COFACTOR; PROTEIN; LOXL2; PROPEPTIDE; CANCER; ACID; SITE	Human lysyl oxidase-like 2 (hLOXL2) is highly up-regulated in metastatic breast cancer cells and tissues and induces epithelial-to-mesenchymal transition, the first step of metastasis/invasion. hloxl2 encodes four N-terminal scavenger receptor cysteine-rich domains and the highly conserved C-terminal lysyl oxidase (LOX) catalytic domain. Here, we assessed the extent of the post-translational modifications of hLOXL2 using truncated recombinant proteins produced in Drosophila S2 cells. The recombinant proteins are soluble, in contrast to LOX, which is consistently reported to require 2-6 M urea for solubilization. The recombinant proteins also show activity in tropoelastin oxidation. After phenylhydrazine derivatization and trypsin digestion, we used mass spectrometry to identify peptides containing the derivatized lysine tyrosylquinone cross-link at Lys-653 and Tyr-689, as well as N-linked glycans at Asn-455 and Asn-644. Disruption of N-glycosylation by site-directed mutagenesis or tunicamycin treatment completely inhibited secretion so that only small quantities of inclusion bodies were detected. The N-glycosylation site at Asn-644 in the LOX catalytic domain is not conserved in human LOX (hLOX), although the LOX catalytic domain of hLOX shares similar to 50% identity and similar to 70% homology with hLOXL2. The catalytic domain of hLOX was not secreted from S2 cells using the same expression system. These results suggest that the N-glycan at Asn-644 of hLOXL2 enhances the solubility and stability of the LOX catalytic domain.	[Xu, Li; Go, Eden P.; Finney, Joel; Moon, HeeJung; Lantz, Mason; Rebecchi, Kathryn; Desaire, Heather; Mure, Minae] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA	University of Kansas	Desaire, H (corresponding author), Univ Kansas, Dept Chem, MRB, 2030 Becker Dr,Rm 220D, Lawrence, KS 66045 USA.	hdesaire@ku.edu; mmure@ku.edu	Finney, Joel/AAD-3773-2021	Finney, Joel/0000-0002-3755-8425	National Institutes of Health [P20 RR015563, GM079446-02, AHA0765445Z, RO1RR026061]; National Science Foundation (NSF) [CAREER MCB-0747377, CAREER CHE-0645120]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563, R01RR026061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR015563 Project 3 (to M.M., Center of Biomedical Research Excellence for Cancer Experimental Therapeutics), GM079446-02 (to M.M.), AHA0765445Z (to M.M.), and RO1RR026061 (to H.D.). This work was also supported by National Science Foundation (NSF) Grants CAREER MCB-0747377 (to M.M.) and CAREER CHE-0645120 (to H.D.).	Aumiller JJ, 2003, GLYCOBIOLOGY, V13, P497, DOI 10.1093/glycob/cwg051; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345; Bollinger JA, 2005, BIOCHEMISTRY-US, V44, P11708, DOI 10.1021/bi0504310; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; Go EP, 2007, ANAL CHEM, V79, P1708, DOI 10.1021/ac061548c; Grimsby JL, 2010, J CELL BIOCHEM, V111, P1231, DOI 10.1002/jcb.22845; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Irungu J, 2007, ANAL CHEM, V79, P3065, DOI 10.1021/ac062100e; Jourdan-Le Saux C, 1999, J BIOL CHEM, V274, P12939; Kim YK, 2005, BIOTECHNOL BIOENG, V92, P452, DOI 10.1002/bit.20605; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Mure M, 2003, J AM CHEM SOC, V125, P6113, DOI 10.1021/ja0214274; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; Rebecchi KR, 2011, ANAL CHEM, V83, P8484, DOI 10.1021/ac2017037; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; SHAH MA, 1993, J BIOL CHEM, V268, P11573; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Stanley P., 2009, ESSENTIALS GLYCOBIOL; TANG SS, 1983, J BIOL CHEM, V258, P4331; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Vora SR, 2010, BIOCHEMISTRY-US, V49, P2962, DOI 10.1021/bi902218p; Wang SX, 1997, J BIOL CHEM, V272, P28841, DOI 10.1074/jbc.272.46.28841; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078	32	28	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5357	5363		10.1074/jbc.C112.421768	http://dx.doi.org/10.1074/jbc.C112.421768			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23319596	hybrid, Green Published			2022-12-28	WOS:000315342500010
J	Yu, HY; He, K; Li, LJ; Sun, L; Tang, F; Li, RZ; Ning, W; Jin, Y				Yu, Hongyao; He, Ke; Li, Lingjie; Sun, Lei; Tang, Fan; Li, Ruizhen; Ning, Wen; Jin, Ying			Deletion of STK40 Protein in Mice Causes Respiratory Failure and Death at Birth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG MORPHOGENESIS; MOUSE LUNG; BRANCHING MORPHOGENESIS; SURFACTANT HOMEOSTASIS; BINDING-PROTEIN; C/EBP-ALPHA; FETAL LUNG; GENE; TRANSCRIPTION; DISEASE	STK40 is a putative serine/threonine kinase and was shown to induce extraembryonic endoderm differentiation from mouse embryonic stem cells. However, little is known about its physiological function in vivo. Here, we generate Stk40 knock-out mice and demonstrate that loss of the Stk40 gene causes neonatal lethality at birth. Further examination reveals that the respiratory distress and atelectasis occur in the homozygous mutants. The maturation of lung and alveolar epithelium is delayed in the mutant, as indicated by narrowed air spaces, thickened interstitial septa, and increased glycogen content in the lungs of Stk40(-/-) mice. The reduction in levels of T1-alpha, SP-B, and SP-C indicates delayed maturation of both type I and type II respiratory epithelial cells in Stk40(-/-) lungs. Moreover, Stk40 is found to be most highly expressed in lungs of both fetal and adult mice among all organs tested. Mechanistically, a genome-wide RNA microarray analysis reveals significantly altered expression of multiple genes known to participate in lung development. The expression of some genes involved in lipid metabolism, immune response, and glycogen metabolism is also disrupted in the lung of Stk40(-/-) mice. Protein affinity purification identifies RCN2, an activator ofERK/MAPKsignaling, as an STK40-associated protein. Consistently, Stk40 deficiency attenuates the ERK/MAPK activation, and inhibition of ERK/MAPK activities reduces surfactant protein gene expression in lung epithelial cells. Collectively, this study uncovers an important role of STK40 for lung maturation and neonatal survival. STK40 may associate with RCN2 to activate ERK/MAPK signaling and control the expression of multiple key regulators of lung development.	[Yu, Hongyao; Li, Lingjie; Sun, Lei; Jin, Ying] Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci,Sch Med,Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [He, Ke; Tang, Fan; Li, Ruizhen] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Lab Mol Dev Biol, Shanghai 200025, Peoples R China; [Ning, Wen] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Yu, Hongyao; Jin, Ying] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nankai University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci,Sch Med,Key Lab Stem Cell Biol, 225 South Chongqing Rd, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn	Sun, Lei/J-9943-2015; Fang, Fengqin/F-4387-2016	, jin ying/0000-0003-0070-2048; Yu, Hongyao/0000-0003-3752-8442	National Natural Science Foundation of China [91919023, 30911130361]; Ministry of Science and Technology China [2010CB945201, 2011CB965101, 2009CB941103]; Chinese Academy of Science [XDA01010102]; Shanghai Leading Academic Discipline Project [S30201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Science(Chinese Academy of Sciences); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National Natural Science Foundation of China Grants 91919023 and 30911130361; Ministry of Science and Technology China Grants 2010CB945201, 2011CB965101, and 2009CB941103; and Chinese Academy of Science Grant XDA01010102. This study was also supported by Shanghai Leading Academic Discipline Project S30201.	AVERY ME, 1959, AMA J DIS CHILD, V97, P517, DOI 10.1001/archpedi.1959.02070010519001; Bachurski CJ, 2003, MOL CELL BIOL, V23, P9014, DOI 10.1128/MCB.23.24.9014-9024.2003; Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Bellusci S, 1997, DEVELOPMENT, V124, P4867; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; BURRI PH, 1984, ANNU REV PHYSIOL, V46, P617, DOI 10.1146/annurev.ph.46.030184.003153; Cardoso WV, 2001, ANNU REV PHYSIOL, V63, P471, DOI 10.1146/annurev.physiol.63.1.471; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Cole TJ, 2004, AM J RESP CELL MOL, V30, P613, DOI 10.1165/rcmb.2003-0236OC; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imai T, 1997, BIOCHEM BIOPH RES CO, V233, P765, DOI 10.1006/bbrc.1997.6531; Kaplan F, 2000, MOL GENET METAB, V71, P321, DOI 10.1006/mgme.2000.3040; Kimura S, 1999, BIOCHIMIE, V81, P321, DOI 10.1016/S0300-9084(99)80077-7; Kling DE, 2002, AM J PHYSIOL-LUNG C, V282, pL370, DOI 10.1152/ajplung.00200.2001; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Li FF, 2012, J IMMUNOL, V189, P3159, DOI 10.4049/jimmunol.1200197; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Ridsdale R, 2004, AM J PHYSIOL-LUNG C, V287, pL743, DOI 10.1152/ajplung.00146.2004; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; TENHAVEOPBROEK AAW, 1991, EXP LUNG RES, V17, P111, DOI 10.3109/01902149109064406; Tichelaar JW, 1999, J HISTOCHEM CYTOCHEM, V47, P823, DOI 10.1177/002215549904700612; Usui H, 2004, BIOCHEM BIOPH RES CO, V322, P887, DOI 10.1016/j.bbrc.2004.07.198; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wang J, 2005, TISSUE CELL, V37, P25, DOI 10.1016/j.tice.2004.09.002; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Whitsett JA, 2002, J BIOL CHEM, V277, P22743, DOI 10.1074/jbc.M202253200; Whitsett JA, 2004, HUM MOL GENET, V13, pR207, DOI 10.1093/hmg/ddh252; Wongtrakool C, 2003, J BIOL CHEM, V278, P46911, DOI 10.1074/jbc.M307977200; Yamamoto H, 2007, DEV BIOL, V308, P44, DOI 10.1016/j.ydbio.2007.04.042; Zhang X, 2012, FASEB J, V26, P2338, DOI 10.1096/fj.11-200139	44	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5342	5352		10.1074/jbc.M112.409433	http://dx.doi.org/10.1074/jbc.M112.409433			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23293024	Green Published, hybrid			2022-12-28	WOS:000315342500008
J	Spender, LC; Carter, MJ; O'Brien, DI; Clark, LJ; Yu, J; Michalak, EM; Happo, L; Cragg, MS; Inman, GJ				Spender, Lindsay C.; Carter, Matthew J.; O'Brien, Darren I.; Clark, Louise J.; Yu, Jian; Michalak, Ewa M.; Happo, Lina; Cragg, Mark S.; Inman, Gareth J.			Transforming Growth Factor-beta Directly Induces p53-up-regulated Modulator of Apoptosis (PUMA) during the Rapid Induction of Apoptosis in Myc-driven B-cell Lymphomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BH3-ONLY PROTEIN PUMA; BCL-2 FAMILY-MEMBERS; UP-REGULATION; CANCER CELLS; GENE-EXPRESSION; BAX ACTIVATION; X-L; RESPONSES; BH3; P53	c-Myc transformed human Burkitt's lymphoma (BL) cells are highly sensitive to TGF-beta-induced apoptosis. Previously we demonstrated that TGF-beta-mediated cell death in BL cells is regulated via the mitochondrial intrinsic apoptosis pathway, which is dependent on the activation of BAX and/or BAK. TGF-beta directly induces transcription of the BH3-only protein BIK and represses expression of the pro-survival factor BCL-X-L but has no effect on the direct BAX/BAK "activators" BIM or BID (tBID). Here we show that TGF-beta induces the BH3-only activator PUMA to aid induction of the intrinsic cell death pathway. TGF-beta also induced PUMA in normal germinal center CD77-positive centroblasts isolated from human tonsil tissue. PUMA was a direct TGF-beta target gene in B-cells, and we identify a putative Smad-binding region within the human PUMA promoter that recruits Smad3 and Smad4 in cells in response to TGF-beta signaling. Constitutive activity of the isolated Smadbinding region in luciferase reporter assays was dependent on Smad consensus sequences and was partially dependent on endogenous TGF-beta signaling and Smad4. Knockdown ofPUMA in BL cells using lentiviral shRNA resulted in slower kinetics of the TGF-beta -mediated apoptotic response. Analysis of E mu-Myc cell lines demonstrated that c-myc-driven murine lymphomas are also sensitive to TGF-beta-mediated apoptosis. Moreover, Puma(-/-) E mu-Myc lines demonstrated significantly delayed kinetics of the apoptotic response when compared with wild type lymphomas. TGF-beta therefore induces a polygenic response in Myc-driven lymphomas involving transcription of PUMA, which is necessary for the rapid induction of cell death.	[Spender, Lindsay C.; Inman, Gareth J.] Univ Dundee, Ninewells Hosp & Med Sch, Jacqui Wood Canc Ctr, Div Canc Res,Med Res Inst, Dundee DD1 9SY, Scotland; [Carter, Matthew J.; Cragg, Mark S.] Univ Southampton, Southampton Gen Hosp, Canc Sci Unit, Southampton SO16 6YD, Hants, England; [O'Brien, Darren I.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Clark, Louise J.] So Gen Hosp, Dept Otolaryngol, Glasgow G51 4TF, Lanark, Scotland; [Yu, Jian] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Yu, Jian] Inst Canc Res, Pittsburgh, PA 15213 USA; [Michalak, Ewa M.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Happo, Lina] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Happo, Lina] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia	University of Dundee; University of Southampton; Beatson Institute; University of Glasgow; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Netherlands Cancer Institute; Walter & Eliza Hall Institute; University of Melbourne	Inman, GJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Jacqui Wood Canc Ctr, Div Canc Res,Med Res Inst, James Arrott Dr, Dundee DD1 9SY, Scotland.	g.j.inman@dundee.ac.uk	Cragg, Mark S/E-5965-2010; Yu, Jian/A-8301-2009	Cragg, Mark S/0000-0003-2077-089X; Yu, Jian/0000-0002-4021-1000; Inman, Gareth/0000-0002-6264-4253; Carter, Matthew/0000-0002-5198-5933; Michalak, Ewa/0000-0002-5772-2122	National Institutes of Health [CA129829, U01-DK085570]; Cancer Research UK; Association for International Cancer Research; Medical Research Council; American Cancer Society [RGS-10-124-01-CCE]; NATIONAL CANCER INSTITUTE [R01CA129829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085570] Funding Source: NIH RePORTER; Worldwide Cancer Research [11-0788] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Association for International Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Worldwide Cancer Research	This work was supported, in whole or in part, by National Institutes of Health Grants CA129829 and U01-DK085570 (to J. Y.).; 1 Supported by Cancer Research UK and the Association for International Cancer Research.; 2 Supported by a Medical Research Council studentship.; 3 Supported by American Cancer Society Grant RGS-10-124-01-CCE.	Amente S, 2011, NUCLEIC ACIDS RES, V39, P9498, DOI 10.1093/nar/gkr638; Borsutzky S, 2004, J IMMUNOL, V173, P3305, DOI 10.4049/jimmunol.173.5.3305; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Clybouw C, 2011, BLOOD, V118, P4120, DOI 10.1182/blood-2011-04-347096; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; FARRELL PJ, 1991, EMBO J, V10, P2879, DOI 10.1002/j.1460-2075.1991.tb07837.x; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Gros MJ, 2008, J IMMUNOL, V180, P8153, DOI 10.4049/jimmunol.180.12.8153; Happo L, 2010, BLOOD, V116, P5256, DOI 10.1182/blood-2010-04-280818; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Inman GJ, 2000, J IMMUNOL, V165, P2500, DOI 10.4049/jimmunol.165.5.2500; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; KEHRL JH, 1986, J IMMUNOL, V137, P3855; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Luo X, 2005, CELL DEATH DIFFER, V12, P1310, DOI 10.1038/sj.cdd.4401659; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pyati UJ, 2011, DEV CELL, V21, P492, DOI 10.1016/j.devcel.2011.07.012; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Schulz R, 2008, CELL TISSUE RES, V334, P327, DOI 10.1007/s00441-008-0714-5; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SNAPPER CM, 1993, J IMMUNOL, V151, P4625; Spender LC, 2009, CELL DEATH DIFFER, V16, P593, DOI 10.1038/cdd.2008.183; Spender LC, 2001, J VIROL, V75, P3537, DOI 10.1128/JVI.75.8.3537-3546.2001; Spender LC, 2012, MOL CANCER RES, V10, P347, DOI 10.1158/1541-7786.MCR-11-0394; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yamamura Y, 2008, FEBS LETT, V582, P2663, DOI 10.1016/j.febslet.2008.06.046; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100; Yaswen L, 1996, BLOOD, V87, P1439, DOI 10.1182/blood.V87.4.1439.bloodjournal8741439; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	46	30	32	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5198	5209		10.1074/jbc.M112.410274	http://dx.doi.org/10.1074/jbc.M112.410274			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23243310	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000315340400067
J	Noth, J; Krawietz, D; Hemschemeier, A; Happe, T				Noth, Jens; Krawietz, Danuta; Hemschemeier, Anja; Happe, Thomas			Pyruvate: Ferredoxin Oxidoreductase Is Coupled to Light-independent Hydrogen Production in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; FORMATE-LYASE; CLOSTRIDIUM-ACETOBUTYLICUM; FERMENTATIVE METABOLISM; PYRUVATEFERREDOXIN OXIDOREDUCTASE; CRYSTAL-STRUCTURES; FEFE HYDROGENASES; ENERGY-METABOLISM; EXPRESSION; GENE	In anaerobiosis, the green alga Chlamydomonas reinhardtii evolves molecular hydrogen (H-2) as one of several fermentation products. H-2 is generated mostly by the [Fe-Fe]-hydrogenase HYDA1, which uses plant type ferredoxin PETF/FDX1 (PETF) as an electron donor. Dark fermentation of the alga is mainly of the mixed acid type, because formate, ethanol, and acetate are generated by a pyruvate: formate lyase pathway similar to Escherichia coli. However, C. reinhardtii also possesses the pyruvate: ferredoxin oxidoreductase PFR1, which, like pyruvate: formate lyase and HYDA1, is localized in the chloroplast. PFR1 has long been suggested to be responsible for the low but significant H-2 accumulation in the dark because the catalytic mechanism of pyruvate: ferredoxin oxidoreductase involves the reduction of ferredoxin. With the aim of proving the biochemical feasibility of the postulated reaction, we have heterologously expressed the PFR1 gene in E. coli. Purified recombinant PFR1 is able to transfer electrons from pyruvate to HYDA1, using the ferredoxins PETF and FDX2 as electron carriers. The high reactivity of PFR1 toward oxaloacetate indicates that in vivo, fermentation might also be coupled to an anaerobically active glyoxylate cycle. Our results suggest that C. reinhardtii employs a clostridial type H-2 production pathway in the dark, especially because C. reinhardtii PFR1 was also able to allow H-2 evolution in reaction mixtures containing Clostridium acetobutylicum 2[4Fe-4S]-ferredoxin and [Fe-Fe]-hydrogenase HYDA.	[Noth, Jens; Krawietz, Danuta; Hemschemeier, Anja; Happe, Thomas] Ruhr Univ Bochum, Fak Biol & Biotechnol, AG Photobiotechnol, D-44801 Bochum, Germany	Ruhr University Bochum	Happe, T (corresponding author), Ruhr Univ Bochum, Fak Biol & Biotechnol, AG Photobiotechnol, Univ Str 150, D-44801 Bochum, Germany.	thomas.happe@rub.de		Hemschemeier, Anja/0000-0001-8879-3348; Happe, Thomas/0000-0003-1206-5234	Deutsches Zentrum fur Luft- und Raumfahrt (ModuLES); Volkswagen Foundation (LigH2t)	Deutsches Zentrum fur Luft- und Raumfahrt (ModuLES); Volkswagen Foundation (LigH2t)	This work was supported by grants from the Deutsches Zentrum fur Luft- und Raumfahrt (ModuLES) and the Volkswagen Foundation (LigH2t) ( to T. H.).	Akhtar MK, 2008, APPL MICROBIOL BIOT, V78, P853, DOI 10.1007/s00253-008-1377-6; Atteia A, 2006, J BIOL CHEM, V281, P9909, DOI 10.1074/jbc.M507862200; Atteia A, 2013, BBA-BIOENERGETICS, V1827, P210, DOI 10.1016/j.bbabio.2012.08.002; BLAMEY JM, 1993, BIOCHIM BIOPHYS ACTA, V1161, P19, DOI 10.1016/0167-4838(93)90190-3; BLASCHKOWSKI HP, 1982, EUR J BIOCHEM, V123, P563; Calusinska M, 2010, MICROBIOL-SGM, V156, P1575, DOI 10.1099/mic.0.032771-0; Carere CR, 2008, INDIAN J MICROBIOL, V48, P252, DOI 10.1007/s12088-008-0036-z; CARPENTER CE, 1987, APPL ENVIRON MICROB, V53, P549, DOI 10.1128/AEM.53.3.549-552.1987; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Catalanotti C, 2012, PLANT CELL, V24, P692, DOI 10.1105/tpc.111.093146; Cavazza C, 2006, STRUCTURE, V14, P217, DOI 10.1016/j.str.2005.10.013; Chabriere E, 1999, NAT STRUCT BIOL, V6, P182; Chen HC, 2005, PHOTOSYNTH RES, V84, P289, DOI 10.1007/s11120-004-7157-y; Chochois V, 2009, PLANT PHYSIOL, V151, P631, DOI 10.1104/pp.109.144576; CINCO RM, 1993, PHOTOSYNTH RES, V38, P27, DOI 10.1007/BF00015058; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davies JP, 1996, EMBO J, V15, P2150, DOI 10.1002/j.1460-2075.1996.tb00568.x; Demuez M, 2007, FEMS MICROBIOL LETT, V275, P113, DOI 10.1111/j.1574-6968.2007.00868.x; Desplats C, 2009, J BIOL CHEM, V284, P4148, DOI 10.1074/jbc.M804546200; Embley TM, 2003, IUBMB LIFE, V55, P387, DOI 10.1080/15216540310001592834; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Fouchard S, 2005, APPL ENVIRON MICROB, V71, P6199, DOI 10.1128/AEM.71.10.6199-6205.2005; FRANZEN LG, 1990, FEBS LETT, V260, P165, DOI 10.1016/0014-5793(90)80094-Y; Fukuda E, 2001, EUR J BIOCHEM, V268, P5639, DOI 10.1046/j.1432-1033.2001.02504.x; Furdui C, 2000, J BIOL CHEM, V275, P28494, DOI 10.1074/jbc.M003291200; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P219, DOI 10.1085/jgp.26.2.219; GFELLER RP, 1984, PLANT PHYSIOL, V75, P212, DOI 10.1104/pp.75.1.212; Ghirardi ML, 1997, APPL BIOCHEM BIOTECH, V63-5, P141, DOI 10.1007/BF02920420; GIBBS M, 1986, PLANT PHYSIOL, V82, P160, DOI 10.1104/pp.82.1.160; Girbal L, 2005, APPL ENVIRON MICROB, V71, P2777, DOI 10.1128/AEM.71.5.2777-2781.2005; Goldet G, 2009, J AM CHEM SOC, V131, P14979, DOI [10.1021/ja905388j, 10.1021/ja905388i]; Grossman AR, 2011, NEW PHYTOL, V190, P279, DOI 10.1111/j.1469-8137.2010.03534.x; Guerrini O, 2008, CURR MICROBIOL, V56, P261, DOI 10.1007/s00284-007-9072-x; Hackstein JHP, 1999, TRENDS MICROBIOL, V7, P441, DOI 10.1016/S0966-842X(99)01613-3; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; HAPPE T, 1994, EUR J BIOCHEM, V222, P769, DOI 10.1111/j.1432-1033.1994.tb18923.x; Happe T, 2002, EUR J BIOCHEM, V269, P1022, DOI 10.1046/j.0014-2956.2001.02743.x; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HAWKINS CF, 1989, FEBS LETT, V255, P77, DOI 10.1016/0014-5793(89)81064-6; Hemschemeier A, 2005, BIOCHEM SOC T, V33, P39, DOI 10.1042/BST0330039; Hemschemeier A, 2008, EUKARYOT CELL, V7, P518, DOI 10.1128/EC.00368-07; Hemschemeier A, 2008, PLANTA, V227, P397, DOI 10.1007/s00425-007-0626-8; Hemschemeier A, 2011, BBA-BIOENERGETICS, V1807, P919, DOI 10.1016/j.bbabio.2011.02.010; Hemschemeier A, 2009, PHOTOSYNTH RES, V102, P523, DOI 10.1007/s11120-009-9415-5; Horner DS, 1999, MOL BIOL EVOL, V16, P1280, DOI 10.1093/oxfordjournals.molbev.a026218; Hug LA, 2010, MOL BIOL EVOL, V27, P311, DOI 10.1093/molbev/msp237; Jacobs J, 2009, FEBS LETT, V583, P325, DOI 10.1016/j.febslet.2008.12.018; Jans F, 2008, P NATL ACAD SCI USA, V105, P20546, DOI 10.1073/pnas.0806896105; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; KIM BH, 1984, APPL ENVIRON MICROB, V48, P764, DOI 10.1128/AEM.48.4.764-770.1984; KREUZBERG K, 1984, PHYSIOL PLANTARUM, V61, P87, DOI 10.1111/j.1399-3054.1984.tb06105.x; Lambertz C, 2011, J BIOL CHEM, V286, P40614, DOI 10.1074/jbc.M111.283648; Lambertz C, 2010, EUKARYOT CELL, V9, P1747, DOI 10.1128/EC.00127-10; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin WC, 2003, ARCH MICROBIOL, V179, P444, DOI 10.1007/s00203-003-0554-3; Magneschi L, 2012, PLANT PHYSIOL, V158, P1293, DOI 10.1104/pp.111.191569; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; MEINECKE B, 1989, ARCH MICROBIOL, V152, P244, DOI 10.1007/BF00409658; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Menon S, 1997, BIOCHEMISTRY-US, V36, P8484, DOI 10.1021/bi970403k; Mignolet E, 2012, J BIOTECHNOL, V162, P81, DOI 10.1016/j.jbiotec.2012.07.002; MULLER YA, 1993, STRUCTURE, V1, P95, DOI 10.1016/0969-2126(93)90025-C; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Pape M, 2012, PLANT PHYSIOL, V159, P1700, DOI 10.1104/pp.112.200162; Park YJ, 2006, J BIOCHEM MOL BIOL, V39, P46; Philipps G, 2012, PLANTA, V235, P729, DOI 10.1007/s00425-011-1537-2; Philipps G, 2011, PLANT J, V66, P330, DOI 10.1111/j.1365-313X.2011.04494.x; Pieulle L, 1997, J BACTERIOL, V179, P5684, DOI 10.1128/jb.179.18.5684-5692.1997; PIEULLE L, 1995, BBA-PROTEIN STRUCT M, V1250, P49, DOI 10.1016/0167-4838(95)00029-T; Pineda E, 2010, FEBS J, V277, P3382, DOI 10.1111/j.1742-4658.2010.07743.x; Ragsdale SW, 2003, CHEM REV, V103, P2333, DOI 10.1021/cr020423e; Ruhle T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-107; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sambrook J, 2006, CSH PROTOC, V2006; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; STUART TS, 1972, PLANTA, V106, P101, DOI 10.1007/BF00383990; Terashima M, 2011, CURR GENET, V57, P151, DOI 10.1007/s00294-011-0339-1; Terashima M, 2010, MOL CELL PROTEOMICS, V9, P1514, DOI 10.1074/mcp.M900421-MCP200; Terauchi AM, 2009, J BIOL CHEM, V284, P25867, DOI 10.1074/jbc.M109.023622; UYEDA K, 1971, J BIOL CHEM, V246, P3111; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; von Abendroth G, 2008, INT J HYDROGEN ENERG, V33, P6076, DOI 10.1016/j.ijhydene.2008.07.122; WILLEFORD KO, 1989, PLANT PHYSIOL, V90, P788, DOI 10.1104/pp.90.3.788; Winkler M, 2002, BBA-GENE STRUCT EXPR, V1576, P330, DOI 10.1016/S0167-4781(02)00239-7; Winkler M, 2010, EUR J CELL BIOL, V89, P998, DOI 10.1016/j.ejcb.2010.06.018; Winkler M, 2009, J BIOL CHEM, V284, P36620, DOI 10.1074/jbc.M109.053496; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129; Yakunin AF, 1998, BBA-BIOENERGETICS, V1409, P39, DOI 10.1016/S0005-2728(98)00145-5; Yonekura-Sakakibara K, 2000, PLANT PHYSIOL, V122, P887, DOI 10.1104/pp.122.3.887; ZEIKUS JG, 1977, J BACTERIOL, V132, P604, DOI 10.1128/JB.132.2.604-613.1977	92	52	54	0	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4368	4377		10.1074/jbc.M112.429985	http://dx.doi.org/10.1074/jbc.M112.429985			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258532	Green Published, hybrid			2022-12-28	WOS:000314845000064
J	Owatworakit, A; Townsend, B; Louveau, T; Jenner, H; Rejzek, M; Hughes, RK; Saalbach, G; Qi, XQ; Bakht, S; Roy, AD; Mugford, ST; Goss, RJM; Field, RA; Osbourn, A				Owatworakit, Amorn; Townsend, Belinda; Louveau, Thomas; Jenner, Helen; Rejzek, Martin; Hughes, Richard K.; Saalbach, Gerhard; Qi, Xiaoquan; Bakht, Saleha; Roy, Abhijeet Deb; Mugford, Sam T.; Goss, Rebecca J. M.; Field, Robert A.; Osbourn, Anne			Glycosyltransferases from Oat (Avena) Implicated in the Acylation of Avenacins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYPEPTIDASE-LIKE PROTEIN; SERINE CARBOXYPEPTIDASE; SECONDARY METABOLISM; SALICYLIC-ACID; UGT74F2 GLUCOSYLTRANSFERASE; OXIDOSQUALENE CYCLASES; DISEASE RESISTANCE; ARABIDOPSIS; EVOLUTION; FAMILY	Plants produce a huge array of specialized metabolites that have important functions in defense against biotic and abiotic stresses. Many of these compounds are glycosylated by family 1 glycosyltransferases (GTs). Oats (Avena spp.) make root-derived antimicrobial triterpenes (avenacins) that provide protection against soil-borne diseases. The ability to synthesize avenacins has evolved since the divergence of oats from other cereals and grasses. The major avenacin, A-1, is acylated with N-methylanthranilic acid. Previously, we have cloned and characterized three genes for avenacin synthesis (for the triterpene synthase SAD1, a triterpene-modifying cytochrome P450 SAD2, and the serine carboxypeptidase-like acyl transferase SAD7), which form part of a biosynthetic gene cluster. Here, we identify a fourth member of this gene cluster encoding a GT belonging to clade L of family 1 (UGT74H5), and show that this enzyme is an N-methylanthranilic acid O-glucosyltransferase implicated in the synthesis of avenacin A-1. Two other closely related family 1 GTs (UGT74H6 and UGT74H7) are also expressed in oat roots. One of these (UGT74H6) is able to glucosylate both N-methylanthranilic acid and benzoic acid, whereas the function of the other (UGT74H7) remains unknown. Our investigations indicate that UGT74H5 is likely to be key for the generation of the activated acyl donor used by SAD7 in the synthesis of the major avenacin, A-1, whereas UGT74H6 may contribute to the synthesis of other forms of avenacin that are acylated with benzoic acid.	[Owatworakit, Amorn; Louveau, Thomas; Qi, Xiaoquan; Bakht, Saleha; Mugford, Sam T.; Osbourn, Anne] John Innes Ctr, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England; [Rejzek, Martin; Hughes, Richard K.; Saalbach, Gerhard; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Townsend, Belinda; Jenner, Helen] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Roy, Abhijeet Deb; Goss, Rebecca J. M.] Univ E Anglia, Sch Chem Sci, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Osbourn, A (corresponding author), John Innes Ctr, Dept Metab Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	anne.osbourn@jic.ac.uk	Qi, Xiaoquan/G-1545-2010; Hughes, Richard K./E-9642-2015	Qi, Xiaoquan/0000-0001-7175-115X; Hughes, Richard K./0000-0001-9910-6566; Field, Rob/0000-0001-8574-0275; Mugford, Sam/0000-0002-8537-5578; Louveau, Thomas/0000-0002-2902-2735; Jenner, Helen/0000-0003-1095-8469	Thai Royal Government Studentship award; Biotechnology and Biological Sciences Research Council [BBSRC 83/P13269, BB/C504435/1]; DuPont Agricultural Products; Biotechnology and Biological Sciences Research Council Institute Strategic Programme [BB/J004596/1]; John Innes Foundation; BBSRC [BBS/E/J/000C0618, BB/E009913/1, BB/K005952/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K005952/1, BBS/E/J/00000614, BB/E009913/1, BBS/E/J/000C0618] Funding Source: researchfish	Thai Royal Government Studentship award; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DuPont Agricultural Products; Biotechnology and Biological Sciences Research Council Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Thai Royal Government Studentship award (to A. O.), Biotechnology and Biological Sciences Research Council Grants BBSRC 83/P13269 and BB/C504435/1 (to X. Q., S. B., and B. T.) and DuPont Agricultural Products (to H. J.).; Supported by the Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant "Understanding and Exploiting Plant and Microbial Secondary Metabolism" (BB/J004596/1) and the John Innes Foundation.	Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caputi L, 2012, PLANT J, V69, P1030, DOI 10.1111/j.1365-313X.2011.04853.x; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CROMBIE WML, 1986, PHYTOCHEMISTRY, V25, P2069, DOI 10.1016/0031-9422(86)80069-3; Dean JV, 2008, PHYSIOL PLANTARUM, V132, P417, DOI 10.1111/j.1399-3054.2007.01041.X; Fraser CM, 2007, PLANT PHYSIOL, V144, P1986, DOI 10.1104/pp.107.098970; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Gachon CMM, 2005, PLANT MOL BIOL, V58, P229, DOI 10.1007/s11103-005-5346-5; Hansen KS, 2003, PHYTOCHEMISTRY, V64, P143, DOI 10.1016/S0031-9422(03)00261-9; Haralampidis K, 2001, P NATL ACAD SCI USA, V98, P13431, DOI 10.1073/pnas.231324698; Kliebenstein DJ, 2012, CURR OPIN PLANT BIOL, V15, P415, DOI 10.1016/j.pbi.2012.05.005; Landmann C, 2007, PLANTA, V226, P417, DOI 10.1007/s00425-007-0492-4; Lanot A, 2006, PLANT J, V48, P286, DOI 10.1111/j.1365-313X.2006.02872.x; Lee H, 1999, J BIOL CHEM, V274, P36637, DOI 10.1074/jbc.274.51.36637; Lehfeldt C, 2000, PLANT CELL, V12, P1295, DOI 10.1105/tpc.12.8.1295; Lim EK, 2003, GLYCOBIOLOGY, V13, P139, DOI 10.1093/glycob/cwg017; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Maniatis T., 1989, MOL CLONING LAB MANU; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Meesapyodsuk D, 2007, PLANT PHYSIOL, V143, P959, DOI 10.1104/pp.106.088484; Moraga A, 2004, PLANTA, V219, P955, DOI 10.1007/s00425-004-1299-1; Mugford ST, 2009, PLANT CELL, V21, P2473, DOI 10.1105/tpc.109.065870; Papadopoulou K, 1999, P NATL ACAD SCI USA, V96, P12923, DOI 10.1073/pnas.96.22.12923; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; Quiel JA, 2003, J BIOL CHEM, V278, P6275, DOI 10.1074/jbc.M211822200; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shirley AM, 2001, PLANT J, V28, P83, DOI 10.1046/j.1365-313X.2001.01123.x; SZERSZEN JB, 1994, SCIENCE, V265, P1699, DOI 10.1126/science.8085154; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarraga S, 2010, J EXP BOT, V61, P4325, DOI 10.1093/jxb/erq234; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; von Rad U, 2001, PLANT J, V28, P633, DOI 10.1046/j.1365-313x.2001.01161.x; Wang XQ, 2009, FEBS LETT, V583, P3303, DOI 10.1016/j.febslet.2009.09.042; Xue ZY, 2012, NEW PHYTOL, V193, P1022, DOI 10.1111/j.1469-8137.2011.03997.x; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x	43	35	38	0	45	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3696	3704		10.1074/jbc.M112.426155	http://dx.doi.org/10.1074/jbc.M112.426155			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258535	hybrid, Green Published			2022-12-28	WOS:000314845000002
J	Yu, JX; Deng, R; Zhu, HH; Zhang, SS; Zhu, CH; Montminy, M; Davis, R; Feng, GS				Yu, Jianxiu; Deng, Rong; Zhu, Helen H.; Zhang, Sharon S.; Zhu, Changhong; Montminy, Marc; Davis, Roger; Feng, Gen-Sheng			Modulation of Fatty Acid Synthase Degradation by Concerted Action of p38 MAP Kinase, E3 Ligase COP1, and SH2-Tyrosine Phosphatase Shp2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TYROSINE PHOSPHATASE; CANCER; INHIBITION; EXPRESSION; PATHWAY; ALPHA	The Src-homology 2 (SH2) domain-containing tyrosine phosphatase Shp2 has been known to regulate various signaling pathways triggered by receptor and cytoplasmic tyrosine kinases. Here we describe a novel function of Shp2 in control of lipid metabolism by mediating degradation of fatty acid synthase (FASN). p38-phosphorylated COP1 accumulates in the cytoplasm and subsequently binds FASN through Shp2 here as an adapter, leading to FASN-Shp2-COP1 complex formation and FASN degradation mediated by ubiquitination pathway. By fasting p38 is activated and stimulates FASN protein degradation in mice. Consistently, the FASN protein levels are dramatically elevated in mouse liver and pancreas in which Shp2/Ptpn11 is selectively deleted. Thus, this study identifies a new activity for Shp2 in lipid metabolism.	[Yu, Jianxiu; Deng, Rong; Zhu, Changhong] Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Sch Med SJTU SM, Shanghai 200025, Peoples R China; [Yu, Jianxiu; Deng, Rong; Zhu, Changhong] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med SJTU SM, Shanghai 200025, Peoples R China; [Yu, Jianxiu; Zhu, Helen H.; Zhang, Sharon S.; Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Montminy, Marc] Salk Inst Biol Sci, La Jolla, CA 92037 USA; [Davis, Roger] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of California System; University of California San Diego; Salk Institute; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Yu, JX (corresponding author), Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Sch Med SJTU SM, Shanghai 200025, Peoples R China.	Jianxiu.Yu@gmail.com; gfeng@ucsd.edu		Davis, Roger/0000-0002-0130-1652	National Institutes of Health [R01DK075916, R01DK073945]; National Natural Science Foundation China [31071230, 91129726]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073945, R01DK075916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK075916 and R01DK073945 (to G. S. F.) and by National Natural Science Foundation China Grants 31071230 and 91129726 (to J. Y.).	Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Brockdorff J, 1999, EUR J IMMUNOL, V29, P2539, DOI 10.1002/(SICI)1521-4141(199908)29:08<2539::AID-IMMU2539>3.0.CO;2-M; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dornan D, 2006, SCIENCE, V313, P1122, DOI 10.1126/science.1127335; Gibbons G, 2005, NAT MED, V11, P722, DOI 10.1038/nm0705-722; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Lai LA, 2004, TOP CURR GENET, V5, P275; Marine JC, 2012, NAT REV CANCER, V12, P455, DOI 10.1038/nrc3271; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Morikawa Y, 2004, J NEUROENDOCRINOL, V16, P105, DOI 10.1111/j.0953-8194.2004.01135.x; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Pizer ES, 2001, PROSTATE, V47, P102, DOI 10.1002/pros.1052; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Qiao LP, 2006, J BIOL CHEM, V281, P24390, DOI 10.1074/jbc.M603038200; Su CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-243; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yang YA, 2003, EXP CELL RES, V282, P132, DOI 10.1016/S0014-4827(02)00023-X; Yang YA, 2002, EXP CELL RES, V279, P80, DOI 10.1006/excr.2002.5600; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhang SS, 2009, P NATL ACAD SCI USA, V106, P7531, DOI 10.1073/pnas.0811715106; Zhou YL, 2012, MOL BIOL REP, V39, P9733, DOI 10.1007/s11033-012-1838-y	31	27	28	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3823	3830		10.1074/jbc.M112.397885	http://dx.doi.org/10.1074/jbc.M112.397885			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23269672	hybrid, Green Published			2022-12-28	WOS:000314845000014
J	Lopez-Castejon, G; Luheshi, NM; Compan, V; High, S; Whitehead, RC; Flitsch, S; Kirov, A; Prudovsky, I; Swanton, E; Brough, D				Lopez-Castejon, Gloria; Luheshi, Nadia M.; Compan, Vincent; High, Stephen; Whitehead, Roger C.; Flitsch, Sabine; Kirov, Aleksandr; Prudovsky, Igor; Swanton, Eileithyia; Brough, David			Deubiquitinases Regulate the Activity of Caspase-1 and Interleukin-1 beta Secretion via Assembly of the Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION; ACTIVATION; UBIQUITIN; INHIBITORS; CYTOKINE; RELEASE; RECEPTORS; MECHANISM; MOLECULE	IL-1 beta is a potent pro-inflammatory cytokine produced in response to infection or injury. It is synthesized as an inactive precursor that is activated by the protease caspase-1 within a cytosolic molecular complex called the inflammasome. Assembly of this complex is triggered by a range of structurally diverse damage or pathogen associated stimuli, and the signaling pathways through which these act are poorly understood. Ubiquitination is a post-translational modification essential for maintaining cellular homeostasis. It can be reversed by deubiquitinase enzymes (DUBs) that remove ubiquitin moieties from the protein thus modifying its fate. DUBs present specificity toward different ubiquitin chain topologies and are crucial for recycling ubiquitin molecules before protein degradation as well as regulating key cellular processes such as protein trafficking, gene transcription, and signaling. We report here that small molecule inhibitors of DUB activity inhibit inflammasome activation. Inhibition of DUBs blocked the processing and release of IL-1 beta in both mouse and human macrophages. DUB activity was necessary for inflammasome association as DUB inhibition also impaired ASC oligomerization and caspase-1 activation without directly blocking caspase-1 activity. These data reveal the requirement for DUB activity in a key reaction of the innate immune response and highlight the therapeutic potential of DUB inhibitors for chronic auto-inflammatory diseases.	[Lopez-Castejon, Gloria; Luheshi, Nadia M.; Compan, Vincent; High, Stephen; Swanton, Eileithyia; Brough, David] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Whitehead, Roger C.; Flitsch, Sabine] Univ Manchester, Sch Chem, Manchester M13 9PT, Lancs, England; [Kirov, Aleksandr; Prudovsky, Igor] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA	University of Manchester; University of Manchester; Maine Medical Center	Brough, D (corresponding author), Univ Manchester, Fac Life Sci, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	david.brough@manchester.ac.uk	Lopez-Castejon, Gloria/F-6985-2015; Compan, Vincent/M-6977-2017; Flitsch, Sabine/AAJ-6812-2020; Prudovsky, Igor/GVU-1521-2022; Whitehead, Roger/AAE-9077-2020	Lopez-Castejon, Gloria/0000-0002-8585-3381; Compan, Vincent/0000-0001-6805-1179; Brough, David/0000-0002-2250-2381; Flitsch, Sabine/0000-0003-3974-646X; Whitehead, Roger/0000-0003-2910-4033; High, Stephen/0000-0002-4532-8152; Swanton, Eileithyia/0000-0002-3299-4228	National Institutes of Health [8P30 GM103392, HL035627]; Maine Cancer Foundation; Wellcome Trust; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; BBSRC [BB/D005752/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D005752/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maine Cancer Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Prof. Stig Linder (Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden) for b-AP15. We are also grateful to Dr. Vishva Dixit of Genentech for the NLRP3 KO mice. I. P. used the services of the Maine Medical Center Research Institute Viral Core supported by National Institutes of Health Grant 8P30 GM103392 (to R. Friesel).; This work was supported, in whole or in part, by National Institutes of Health Grant HL035627 (to I. P.). This work was also supported by a grant from the Maine Cancer Foundation (to I. P.) and by the Wellcome Trust and the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Berndtsson M, 2009, INT J CANCER, V124, P1463, DOI 10.1002/ijc.24004; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cross BCS, 2009, J CELL SCI, V122, P4393, DOI 10.1242/jcs.054494; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Deretic V, 2012, J IMMUNOL, V189, P15, DOI 10.4049/jimmunol.1102108; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Ferrari D, 1997, J IMMUNOL, V159, P1451; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kumar Y, 2010, BIOCHEM J, V427, P91, DOI 10.1042/BJ20091349; Labbe K, 2011, IMMUNITY, V35, P897, DOI 10.1016/j.immuni.2011.10.016; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lindauer M, 2010, TOXINS, V2, P1500, DOI 10.3390/toxins2061500; Lopez-Castejon G, 2012, EXPERT OPIN INV DRUG, V21, P995, DOI 10.1517/13543784.2012.690032; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Luheshi NM, 2012, EUR J IMMUNOL, V42, P716, DOI 10.1002/eji.201142079; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McKibbin C, 2012, BIOCHEM J, V442, P639, DOI 10.1042/BJ20111220; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miao EA, 2010, J CLIN IMMUNOL, V30, P502, DOI 10.1007/s10875-010-9386-5; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Prudovsky I, 2003, J CELL SCI, V116, P4871, DOI 10.1242/jcs.00872; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Sanchez-Pulido L, 2012, BIOINFORMATICS, V28, P1953, DOI 10.1093/bioinformatics/bts319; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TARANTINI F, 1995, J BIOL CHEM, V270, P29039, DOI 10.1074/jbc.270.49.29039; Tarantini F, 2001, J BIOL CHEM, V276, P5147, DOI 10.1074/jbc.C000714200; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Vyleta ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036044; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Watkins LR, 1999, LIFE SCI, V65, P449, DOI 10.1016/S0024-3205(99)00095-8	66	134	140	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2721	2733		10.1074/jbc.M112.422238	http://dx.doi.org/10.1074/jbc.M112.422238			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23209292	Green Published, hybrid			2022-12-28	WOS:000314211500056
J	Srinivasan, S; Patke, S; Wang, Y; Ye, ZQ; Litt, J; Srivastava, SK; Lopez, MM; Kurouski, D; Lednev, IK; Kane, RS; Colon, W				Srinivasan, Saipraveen; Patke, Sanket; Wang, Yun; Ye, Zhuqiu; Litt, Jeffrey; Srivastava, Sunit K.; Lopez, Maria M.; Kurouski, Dmitry; Lednev, Igor K.; Kane, Ravi S.; Colon, Wilfredo			Pathogenic Serum Amyloid A 1.1 Shows a Long Oligomer-rich Fibrillation Lag Phase Contrary to the Highly Amyloidogenic Non-pathogenic SAA2.2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARGINAL STABILITY; PROTEIN-A; FIBRILS; MEMBRANE; PEPTIDE; DISEASE; COMMON; BINDS; MICE; CONFORMATIONS	Serum amyloid A (SAA) is best known for being the main component of amyloid in the inflammation-related disease amyloid A (AA) amyloidosis. Despite the high sequence identity among different SAA isoforms, not all SAA proteins are pathogenic. In most mouse strains, the AA deposits mostly consist of SAA1.1. Conversely, the CE/J type mouse expresses a single non-pathogenic SAA2.2 protein that is 94% identical to SAA1.1. Here we show that SAA1.1 and SAA2.2 differ in their quaternary structure, fibrillation kinetics, prefibrillar oligomers, and fibril morphology. At 37 C and inflammation-related SAA concentrations, SAA1.1 exhibits an oligomer-rich fibrillation lag phase of a few days, whereas SAA2.2 shows virtually no lag phase and forms small fibrils within a few hours. Deep UV resonance Raman, far UV-circular dichroism, atomic force microscopy, and fibrillation cross-seeding experiments suggest that SAA1.1 and SAA2.2 fibrils possess different morphology. Both the long-lived oligomers of pathogenic SAA1.1 and the fleeting prefibrillar oligomers of nonpathogenic SAA2.2, but not their respective amyloid fibrils, permeabilized synthetic bilayer membranes in vitro. This study represents the first comprehensive comparison between the biophysical properties of SAA isoforms with distinct pathogenicities, and the results suggest that structural and kinetic differences in the oligomerization-fibrillation of SAA1.1 and SAA2.2, more than their intrinsic amyloidogenicity, may contribute to their diverse pathogenicity.	[Srinivasan, Saipraveen; Wang, Yun; Ye, Zhuqiu; Colon, Wilfredo] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Srinivasan, Saipraveen; Patke, Sanket; Wang, Yun; Ye, Zhuqiu; Litt, Jeffrey; Srivastava, Sunit K.; Lopez, Maria M.; Kane, Ravi S.; Colon, Wilfredo] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Patke, Sanket; Litt, Jeffrey; Kane, Ravi S.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Kurouski, Dmitry; Lednev, Igor K.] SUNY Albany, Dept Chem, Albany, NY 12222 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Colon, W (corresponding author), Rensselaer Polytech Inst, Dept Chem & Chem Biol, 110 8th St, Troy, NY 12180 USA.	colonw@rpi.edu	Lednev, Igor K/J-8387-2017; Colon, Wilfredo/A-8343-2012	Lednev, Igor K/0000-0002-6504-531X; Kurouski, Dmitry/0000-0002-6040-4213	National Institutes of Health [R01 AG028158, R01 AG033719]; P.K. Lashmet Chair fund; NATIONAL INSTITUTE ON AGING [R01AG028158, R01AG033719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P.K. Lashmet Chair fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG028158 (to W. C.) and R01 AG033719 (to I. K. L.).; Supported by the P.K. Lashmet Chair fund. To whom correspondence may be addressed: Dept. of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, 110 8th St., Troy, NY 12180. Tel.: 518-276-2536; E-mail: kaner@rpi.edu.	Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; Cui D, 2008, AMYLOID, V15, P77, DOI 10.1080/13506120802005833; Cunnane G, 1999, BEST PRACT RES CL RH, V13, P615, DOI 10.1053/berh.1999.0049; Evangelisti E, 2012, J CELL SCI, V125, P2416, DOI 10.1242/jcs.098434; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Hajri T, 1998, BBA-LIPID LIPID MET, V1394, P209, DOI 10.1016/S0005-2760(98)00109-X; Hari-Dass R, 2005, J BIOL CHEM, V280, P18562, DOI 10.1074/jbc.M500490200; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Herce HD, 2009, BIOPHYS J, V97, P1917, DOI 10.1016/j.bpj.2009.05.066; Hirakura Y, 2002, AMYLOID, V9, P13, DOI 10.3109/13506120209072440; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jimenez JL, 2001, J MOL BIOL, V311, P241, DOI 10.1006/jmbi.2001.4863; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Lakota K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/528276; Lednev I. K., 2007, PROTEIN STRUCTURES B; Lednev IK, 2005, ANAL BIOANAL CHEM, V381, P431, DOI 10.1007/s00216-004-2991-5; LIANG JS, 1995, J LIPID RES, V36, P37; Lin MCA, 2002, PEPTIDES, V23, P1215, DOI 10.1016/S0196-9781(02)00057-8; Lu J., 2010, J IMMUNOL, V184; Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102; Malle E, 2009, CELL MOL LIFE SCI, V66, P9, DOI 10.1007/s00018-008-8321-x; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Nielsen SB, 2010, J COLLOID INTERF SCI, V345, P248, DOI 10.1016/j.jcis.2010.01.065; Oladepo SA, 2012, CHEM REV, V112, P2604, DOI 10.1021/cr200198a; Pellarin R, 2010, J AM CHEM SOC, V132, P14960, DOI 10.1021/ja106044u; PreciadoPatt L, 1996, J IMMUNOL, V156, P1189; Rocken C, 2002, VIRCHOWS ARCH, V440, P111, DOI 10.1007/s00428-001-0582-9; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; Senthilkumar S, 2008, BIOCHEM J, V415, P207, DOI 10.1042/BJ20071696; Shashilov VA, 2010, METHODS, V52, P23, DOI 10.1016/j.ymeth.2010.05.004; SIPE JD, 1993, AM J PATHOL, V143, P1480; Stepkowski D, 2012, ACTA BIOCHIM POL, V59, P307; STRACHAN AF, 1989, BIOCHEM J, V263, P365, DOI 10.1042/bj2630365; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tasaki M, 2010, BIOCHEM BIOPH RES CO, V400, P559, DOI 10.1016/j.bbrc.2010.08.101; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Urieli-Shoval S, 2002, BLOOD, V99, P1224, DOI 10.1182/blood.V99.4.1224; Wang LM, 2007, BIOCHEMISTRY-US, V46, P5562, DOI 10.1021/bi602629y; Wang LM, 2005, AMYLOID, V12, P139, DOI 10.1080/13506120500223084; Wang LM, 2005, PROTEIN SCI, V14, P1811, DOI 10.1110/ps.051387005; Wang LM, 2004, BIOCHEM BIOPH RES CO, V317, P157, DOI 10.1016/j.bbrc.2004.03.027; Wang LM, 2002, P NATL ACAD SCI USA, V99, P15947, DOI 10.1073/pnas.252508399; Wang Y, 2011, BIOCHEM BIOPH RES CO, V407, P725, DOI 10.1016/j.bbrc.2011.03.090; Webb NR, 1997, J LIPID RES, V38, P1583; Westermark GT, 2009, FEBS LETT, V583, P2685, DOI 10.1016/j.febslet.2009.04.026; WESTERMARK P, 1982, CLIN EXP IMMUNOL, V49, P725; Ye ZQ, 2011, BIOCHEMISTRY-US, V50, P9184, DOI 10.1021/bi200856v; Yu J, 2000, LAB INVEST, V80, P1797, DOI 10.1038/labinvest.3780191	53	38	38	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2744	2755		10.1074/jbc.M112.394155	http://dx.doi.org/10.1074/jbc.M112.394155			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223242	Green Published, hybrid			2022-12-28	WOS:000314211500058
J	Wells, L				Wells, Lance			The O-Mannosylation Pathway: Glycosyltransferases and Proteins Implicated in Congenital Muscular Dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FUKUTIN-RELATED PROTEIN; LINKED-N-ACETYLGLUCOSAMINE; PHOSPHATE-MANNOSE SYNTHASE; ALPHA-DYSTROGLYCAN; POMT2 MUTATIONS; INTRAGENIC REARRANGEMENTS; ABNORMAL GLYCOSYLATION; PHENOTYPIC SPECTRUM; GLYCAN STRUCTURES; LAMININ-BINDING	Several forms of congenital muscular dystrophy, referred to as dystroglycanopathies, result from defects in the proteinO-mannosylation biosynthetic pathway. In this minireview, I discuss 12 proteins involved in the pathway and how they play a role in the building of glycan structures (most notably on the protein alpha-dystroglycan) that allow for binding to multiple proteins of the extracellular matrix.	[Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	lwells@ccrc.uga.edu	Wells, Lance/H-3118-2013	Wells, Lance/0000-0003-4956-5363	National Institutes of Health from NIGMS [P41RR018502]; Georgia Research Alliance; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Georgia Research Alliance; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P41RR018502 from NIGMS (to L. W., senior investigator). This work was also supported by the Georgia Research Alliance (to Lars G. Ljungdahl, investigator, and L. W.). This is the fourth article in the Thematic Minireview Series on Glycobiology and Extracellular Matrices: Glycan Functions Pervade Biology at All Levels.	Akasaka-Manya K, 2004, BIOCHEM BIOPH RES CO, V325, P75, DOI 10.1016/j.bbrc.2004.10.001; Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Ashida H, 2006, J BIOL CHEM, V281, P896, DOI 10.1074/jbc.M511311200; Barone R, 2012, ANN NEUROL, V72, P550, DOI 10.1002/ana.23632; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beedle AM, 2012, J CLIN INVEST, V122, P3330, DOI 10.1172/JCI63004; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chandrasekharan K, 2010, METHOD ENZYMOL, V479, P291, DOI 10.1016/S0076-6879(10)79017-0; Cipollo JF, 2004, P NATL ACAD SCI USA, V101, P3404, DOI 10.1073/pnas.0400384101; Clement EM, 2008, ARCH NEUROL-CHICAGO, V65, P137, DOI 10.1001/archneurol.2007.2; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; Dancourt J, 2006, PEDIATR RES, V59, P835, DOI 10.1203/01.pdr.0000219430.52532.8e; de Bernabe DBV, 2009, J BIOL CHEM, V284, P11279, DOI 10.1074/jbc.C900007200; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Esapa CT, 2002, HUM MOL GENET, V11, P3319, DOI 10.1093/hmg/11.26.3319; FINNE J, 1979, J BIOL CHEM, V254, P295; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Grewal PK, 2002, BBA-GEN SUBJECTS, V1573, P216, DOI 10.1016/S0304-4165(02)00387-2; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Hehr U, 2007, NEUROGENETICS, V8, P279, DOI 10.1007/s10048-007-0096-y; Hewitt JE, 2009, BBA-MOL BASIS DIS, V1792, P853, DOI 10.1016/j.bbadis.2009.06.003; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Inamori K, 2013, GLYCOBIOLOGY, V23, P295, DOI 10.1093/glycob/cws152; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jurado LAP, 1999, GENOMICS, V58, P171, DOI 10.1006/geno.1999.5819; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kriangkripipat T, 2009, EUKARYOT CELL, V8, P1475, DOI 10.1128/EC.00040-09; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Lee JK, 2012, J BIOL CHEM, V287, P28526, DOI 10.1074/jbc.M112.367565; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Maeda Y, 2000, EMBO J, V19, P2475, DOI 10.1093/emboj/19.11.2475; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Manzini MC, 2008, HUM MUTAT, V29, pE231, DOI 10.1002/humu.20844; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Mercuri E, 2006, NEUROMUSCULAR DISORD, V16, P446, DOI 10.1016/j.nmd.2006.03.016; Mercuri E, 2003, ANN NEUROL, V53, P537, DOI 10.1002/ana.10559; Messina S, 2008, NEUROMUSCULAR DISORD, V18, P565, DOI 10.1016/j.nmd.2008.04.004; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore CJ, 2008, GENOMICS, V92, P159, DOI 10.1016/j.ygeno.2008.05.008; Muntoni F, 2008, NEUROTHERAPEUTICS, V5, P627, DOI 10.1016/j.nurt.2008.08.005; Nakamura N, 2010, SEMIN CELL DEV BIOL, V21, P622, DOI 10.1016/j.semcdb.2010.03.010; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Peat RA, 2008, NEUROLOGY, V71, P312, DOI 10.1212/01.wnl.0000284605.27654.5a; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Saredi S, 2012, J NEUROL SCI, V318, P45, DOI 10.1016/j.jns.2012.04.008; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Tran DT, 2012, J BIOL CHEM, V287, P20967, DOI 10.1074/jbc.M112.370387; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vuillaumier-Barrot S, 2011, NEUROMUSCULAR DISORD, V21, P782, DOI 10.1016/j.nmd.2011.06.001; Wells L, 2012, CELL MOL LI IN PRESS; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Yanagisawa A, 2007, NEUROLOGY, V69, P1254, DOI 10.1212/01.wnl.0000268489.60809.c4; Yanagisawa A, 2009, EUR J MED GENET, V52, P201, DOI 10.1016/j.ejmg.2008.12.004; Yis U, 2007, EUR J PAEDIATR NEURO, V11, P46, DOI 10.1016/j.ejpn.2006.10.007; Yis U, 2011, NEUROMUSCULAR DISORD, V21, P20, DOI 10.1016/j.nmd.2010.08.007; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	74	62	63	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6930	6935		10.1074/jbc.R112.438978	http://dx.doi.org/10.1074/jbc.R112.438978			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329833	Green Published, hybrid			2022-12-28	WOS:000316002400015
J	Rafikov, R; Rafikova, O; Aggarwal, S; Gross, C; Sun, XT; Desai, J; Fulton, D; Black, SM				Rafikov, Ruslan; Rafikova, Olga; Aggarwal, Saurabh; Gross, Christine; Sun, Xutong; Desai, Julin; Fulton, David; Black, Stephen M.			Asymmetric Dimethylarginine Induces Endothelial Nitric-oxide Synthase Mitochondrial Redistribution through the Nitration-mediated Activation of Akt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY-HYPERTENSION; CARDIOVASCULAR-DISEASE; PROTEIN-KINASE; ADMA LEVELS; AUTOINHIBITORY DOMAIN; SUPEROXIDE-PRODUCTION; TYROSINE NITRATION; INDUCED APOPTOSIS; OXIDATIVE STRESS; PLASMA-LEVELS	We have recently demonstrated that asymmetric dimethylarginine (ADMA) induces the translocation of endothelial nitric-oxide synthase (eNOS) to the mitochondrion via a mechanism that requires protein nitration. Thus, the goal of this study was elucidate how eNOS redistributes to mitochondria and to identify the nitrated protein responsible for this event. Our data indicate that exposure of pulmonary arterial endothelial cells to ADMA enhanced eNOS phosphorylation at the Akt1-dependent phosphorylation sites Ser(617) and Ser(1179). Mutation of these serine residues to alanine (S617A and S1179A) inhibited nitration-mediated eNOS translocation to the mitochondria, whereas the phosphormimic mutations (S617D and S1179D) exhibited increased mitochondrial redistribution in the absence of ADMA. The overexpression of a dominant-negative Akt1 also attenuated ADMA-mediated eNOS mitochondrial translocation. Furthermore, ADMA enhanced Akt1 nitration and increased its activity. Mass spectrometry identified a single nitration site in Akt1 located at the tyrosine residue (Tyr(350)) located within the client-binding domain. Replacement of Tyr(350) with phenylalanine abolished peroxynitrite-mediated eNOS translocation to mitochondria. We also found that in the absence of ADMA, eNOS translocation decreased mitochondrial oxygen consumption and superoxide production without altering cellular ATP level. This suggests that under physiologic conditions, eNOS translocation enhances mitochondria coupling. In conclusion, we have identified a new mechanism by which eNOS translocation to mitochondria is regulated by the phosphorylation of eNOS at Ser(617) and Ser(1179) by Akt1 and that this is enhanced when Akt1 becomes nitrated at Tyr(350).	[Rafikov, Ruslan; Rafikova, Olga; Aggarwal, Saurabh; Gross, Christine; Sun, Xutong; Desai, Julin; Fulton, David; Black, Stephen M.] Georgia Hlth Sci Univ, Vasc Biol Ctr, Pulm Dis Program, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Black, SM (corresponding author), 1459 Laney Walker Blvd,CB 3211-B, Augusta, GA 30912 USA.	SBLACK@gru.edu	Rafikov, Ruslan/AAG-9352-2019; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Rafikov, Ruslan/0000-0001-5950-4076	National Institutes of Health [HL60190, HL67841, HL101902]; LeDucq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067841, R01HL060190, P01HL101902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LeDucq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL60190 (to S. M. B.), HL67841 (to S. M. B.), and HL101902 (to S. M. B. and D. F.) and a Transatlantic Network Development Grant from the LeDucq Foundation (to S. M. B.).	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32318; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Boger RH, 2005, VASC MED, V10, pS19, DOI 10.1191/1358863x05vm602oa; Brooks KJ, 2000, DEV NEUROSCI-BASEL, V22, P359, DOI 10.1159/000017461; Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0; Brown GC, 1997, MOL CELL BIOCHEM, V174, P189, DOI 10.1023/A:1006800322719; Cai L, 2001, Cardiovasc Toxicol, V1, P181, DOI 10.1385/CT:1:3:181; Cameron AJ, 2007, BIOCHEM SOC T, V35, P1013, DOI 10.1042/BST0351013; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Castro LA, 1998, ARCH BIOCHEM BIOPHYS, V359, P215, DOI 10.1006/abbi.1998.0898; Cavusoglu E, 2009, CORONARY ARTERY DIS, V20, P112, DOI 10.1097/MCA.0b013e328323982f; Chandrasekar I, 2008, PEDIATR RES, V63, P67, DOI 10.1203/PDR.0b013e31815b43ee; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Conus NM, 2002, J BIOL CHEM, V277, P38021, DOI 10.1074/jbc.M203387200; Cooke JP, 2004, CIRCULATION, V109, P1813, DOI 10.1161/01.CIR.0000126823.07732.D5; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gao SJ, 2004, J BIOL CHEM, V279, P15968, DOI 10.1074/jbc.M308504200; Gorenflo M, 2001, J CARDIOVASC PHARM, V37, P489, DOI 10.1097/00005344-200104000-00016; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Hedner T, 2002, BLOOD PRESSURE, V11, P197, DOI 10.1080/08037050213763; Hortelano S, 1999, FASEB J, V13, P2311, DOI 10.1096/fasebj.13.15.2311; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Kanski J, 2005, METHOD ENZYMOL, V396, P160, DOI 10.1016/S0076-6879(05)96016-3; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kawasaki H, 2011, FREE RADICAL BIO MED, V50, P419, DOI 10.1016/j.freeradbiomed.2010.10.688; Klotz LO, 2000, BIOCHEM J, V352, P219, DOI 10.1042/0264-6021:3520219; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Lane D, 2007, INT J CANCER, V121, P1227, DOI 10.1002/ijc.22840; Lentz SR, 2003, ATHEROSCLEROSIS SUPP, V4, P61, DOI 10.1016/S1567-5688(03)00035-7; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Li HT, 2003, BIOCHEMISTRY-US, V42, P1150, DOI 10.1021/bi026385a; MacMillan-Crow LA, 2000, ARCH BIOCHEM BIOPHYS, V377, P350, DOI 10.1006/abbi.2000.1799; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; MONCADA S, 1991, PHARMACOL REV, V43, P109; Nakamura T, 2009, PHARMACOL RES, V60, P525, DOI 10.1016/j.phrs.2009.04.011; Nash DT, 2002, JAMA-J AM MED ASSOC, V287, P1451, DOI 10.1001/jama.287.11.1451; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Penckofer Sue, 2002, J Cardiovasc Nurs, V16, P68; Pitocco D, 2009, DIABETES RES CLIN PR, V86, P173, DOI 10.1016/j.diabres.2009.09.019; Puddu P, 2005, CARDIOLOGY, V103, P137, DOI 10.1159/000083440; Riobo NA, 2001, BIOCHEM J, V359, P139, DOI 10.1042/0264-6021:3590139; Ritchie SA, 2010, BIOCHEM J, V426, P85, DOI 10.1042/BJ20091580; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Schnog JB, 2005, ANN HEMATOL, V84, P282, DOI 10.1007/s00277-004-0983-3; Schulze F, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.005; Sharma S, 2008, AM J PHYSIOL-LUNG C, V294, pL46, DOI 10.1152/ajplung.00247.2007; Sharma S, 2010, VASC PHARMACOL, V52, P182, DOI 10.1016/j.vph.2009.11.010; SHAUL PW, 1995, AM J RESP CELL MOL, V13, P167, DOI 10.1165/ajrcmb.13.2.7542896; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Singer M, 2007, CRIT CARE MED, V35, pS441, DOI 10.1097/01.CCM.0000278049.48333.78; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Sun X., 2012, ANTIOXID RE IN PRESS; Sun XT, 2011, AM J RESP CELL MOL, V45, P163, DOI 10.1165/rcmb.2009-0467OC; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Tian J, 2010, FREE RADICAL BIO MED, V49, P159, DOI 10.1016/j.freeradbiomed.2010.03.023; Tran QK, 2008, BIOCHEMISTRY-US, V47, P7557, DOI 10.1021/bi8003186; Tran QK, 2009, J BIOL CHEM, V284, P11892, DOI 10.1074/jbc.M806205200; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Vickers SM, 1999, ARCH SURG-CHICAGO, V134, P245, DOI 10.1001/archsurg.134.3.245; WARBURG O, 1956, SCIENCE, V124, P269; Wedgwood S, 2003, AM J PHYSIOL-LUNG C, V284, pL650, DOI 10.1152/ajplung.00252.2002; Wendt S, 2003, J BIOL CHEM, V278, P1125, DOI 10.1074/jbc.M208572200; Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104; Zhan XQ, 2009, METHODS MOL BIOL, V566, P137, DOI 10.1007/978-1-59745-562-6_10; Zhou RH, 2003, PROTEINS, V53, P148, DOI 10.1002/prot.10483; Zinellu A, 2008, CLIN CHEM LAB MED, V46, P387, DOI 10.1515/CCLM.2008.063	78	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6212	6226		10.1074/jbc.M112.423269	http://dx.doi.org/10.1074/jbc.M112.423269			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23255608	hybrid, Green Published			2022-12-28	WOS:000315820700017
J	Totary-Jain, H; Sanoudou, D; Ben-Dov, IZ; Dautriche, CN; Guarnieri, P; Marx, SO; Tuschl, T; Marks, AR				Totary-Jain, Hana; Sanoudou, Despina; Ben-Dov, Iddo Z.; Dautriche, Cula N.; Guarnieri, Paolo; Marx, Steven O.; Tuschl, Thomas; Marks, Andrew R.			Reprogramming of the MicroRNA Transcriptome Mediates Resistance to Rapamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; RNA-BINDING PROTEIN; MTOR INHIBITORS; DEFECTIVE REGULATION; CANCER; MYC; PATHWAY; GROWTH; EXPRESSION; TARGET	The mammalian target of rapamycin (mTOR) is a central regulator of cell proliferation that is often deregulated in cancer. Inhibitors of mTOR, including rapamycin and its analogues, are being evaluated as antitumor agents. For their promise to be fulfilled, it is of paramount importance to identify the mechanisms of resistance and develop novel therapies to overcome it. Given the emerging role of microRNAs (miRNAs) in tumorigenesis, we hypothesized that miRNAs could play important roles in the response of tumors to mTOR inhibitors. Long-term rapamycin treatment showed extensive reprogramming of miRNA expression, characterized by up-regulation of miR-17-92 and related clusters and down-regulation of tumor suppressor miRNAs. Inhibition of members of the miR-17-92 clusters or delivery of tumor suppressor miRNAs restored sensitivity to rapamycin. This study identifies miRNAs as new downstream components of the mTOR-signaling pathway, which may determine the response of tumors to mTOR inhibitors. It also identifies potential markers to assess the efficacy of treatment and provides novel therapeutic targets to treat rapamycin-resistant tumors.	[Totary-Jain, Hana; Dautriche, Cula N.; Marks, Andrew R.] Columbia Univ, Dept Physiol & Cellular Biophys, Clyde & Helen Wu Ctr Mol Cardiol, New York, NY 10032 USA; [Sanoudou, Despina] Univ Athens, Sch Med, Dept Pharmacol, Athens 11527, Greece; [Ben-Dov, Iddo Z.; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Guarnieri, Paolo] Herbert Irving Comprehens Canc Ctr, Bioinformat Div, New York, NY 10032 USA; [Marx, Steven O.; Marks, Andrew R.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Athens Medical School; National & Kapodistrian University of Athens; Howard Hughes Medical Institute; Rockefeller University; Columbia University	Totary-Jain, H (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, Clyde & Helen Wu Ctr Mol Cardiol, New York, NY 10032 USA.	ht2167@columbia.edu; arm42@columbia.edu	Ben-Dov, Iddo/F-3282-2010; Sanoudou, Despina/AAD-8139-2019; Totary-Jain, Hana/ABC-3469-2021; Totary-Jain, Hana/A-6387-2014	Ben-Dov, Iddo/0000-0002-9180-3604; Sanoudou, Despina/0000-0003-3704-1941; Totary-Jain, Hana/0000-0003-2203-0377; 	National Institutes of Health from the NHLBI [F32HL088815, K99HL109133]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL109133, F32HL088815] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants F32HL088815 and K99HL109133 (to H.T.-J.) from the NHLBI.	Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Atkins MB, 2009, NAT REV DRUG DISCOV, V8, P535, DOI 10.1038/nrd2924; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Briata P, 2012, CELL DEATH DIFFER, V19, P478, DOI 10.1038/cdd.2011.117; Chan JA, 2009, CURR ONCOL REP, V11, P193, DOI 10.1007/s11912-009-0028-0; Chan S, 2004, BRIT J CANCER, V91, P1420, DOI 10.1038/sj.bjc.6602162; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dowling RJO, 2009, BIODRUGS, V23, P77, DOI 10.2165/00063030-200923020-00002; Ellard SL, 2009, J CLIN ONCOL, V27, P4536, DOI 10.1200/JCO.2008.21.3033; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Figlin Robert A, 2008, J Natl Compr Canc Netw, V6 Suppl 5, pS1; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Gridelli C, 2008, ONCOLOGIST, V13, P139, DOI 10.1634/theoncologist.2007-0171; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Havelange V, 2009, BRIT J CANCER, V101, P743, DOI 10.1038/sj.bjc.6605232; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Luo Y, 1996, MOL CELL BIOL, V16, P6744; Marx SO, 1999, MOL CELL BIOL, V19, P6041; Mavrakis KJ, 2011, CELL CYCLE, V10, P2845, DOI 10.4161/cc.10.17.16959; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Mita M, 2008, EXPERT OPIN INV DRUG, V17, P1947, DOI [10.1517/13543780802556485, 10.1517/13543780802556485 ]; Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Osaki M, 2008, BIOMARKERS, V13, P658, DOI 10.1080/13547500802646572 ; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Silver JD, 2009, BIOSTATISTICS, V10, P352, DOI 10.1093/biostatistics/kxn042; Slavik JM, 2001, J IMMUNOL, V166, P3201, DOI 10.4049/jimmunol.166.5.3201; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Totary-Jain H, 2012, CANCER RES, V72, P1836, DOI 10.1158/0008-5472.CAN-11-2195; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Treiber G, 2009, EXPERT REV ANTICANC, V9, P247, DOI 10.1586/14737140.9.2.247; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Wysocki PJ, 2009, EXPERT REV MOL DIAGN, V9, P231, DOI [10.1586/erm.09.8, 10.1586/ERM.09.8]; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	69	36	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6034	6044		10.1074/jbc.M112.416446	http://dx.doi.org/10.1074/jbc.M112.416446			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23300087	Green Published, hybrid			2022-12-28	WOS:000315820700001
J	Unoki, M; Masuda, A; Dohmae, N; Arita, K; Yoshimatsu, M; Iwai, Y; Fukui, Y; Ueda, K; Hamamoto, R; Shirakawa, M; Sasaki, H; Nakamura, Y				Unoki, Motoko; Masuda, Akiko; Dohmae, Naoshi; Arita, Kyohei; Yoshimatsu, Masanori; Iwai, Yukiko; Fukui, Yoshinori; Ueda, Koji; Hamamoto, Ryuji; Shirakawa, Masahiro; Sasaki, Hiroyuki; Nakamura, Yusuke			Lysyl 5-Hydroxylation, a Novel Histone Modification, by Jumonji Domain Containing 6 (JMJD6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE METHYLTRANSFERASE; METHYLATION; RECEPTOR; RNA; H3	JMJD6 is reported to hydroxylate lysyl residues of a splicing factor, U2AF65. In this study, we found that JMJD6 hydroxylates histone lysyl residues. In vitro experiments showed that JMJD6 has a binding affinity to histone proteins and hydroxylates multiple lysyl residues of histone H3 and H4 tails. Using JMJD6 knock-out mouse embryos, we revealed that JMJD6 hydroxylates lysyl residues of histones H2A/H2B and H3/H4 in vivo by amino acid composition analysis. 5-Hydroxylysine was detected at the highest level in histones purified from murine testis, which expressed JMJD6 at a significantly high level among various tissues examined, and JMJD6 overexpression increased the amount of 5-hydroxylysine in histones in human embryonic kidney 293 cells. These results indicate that histones are additional substrates of JMJD6 in vivo. Because 5-hydroxylation of lysyl residues inhibited N-acetylation and N-methylation by an acetyltransferase and a methyltransferase, respectively, in vitro, histone 5-hydroxylation may have important roles in epigenetic regulation of gene transcription or chromosomal rearrangement.	[Unoki, Motoko; Sasaki, Hiroyuki] Kyushu Univ, Med Inst Bioregulat, Div Epigenet, Dept Mol Genet, Fukuoka 8128582, Japan; [Unoki, Motoko; Ueda, Koji] RIKEN, Ctr Genom Med, Inst Phys & Chem Res, Lab Biomarker Dev, Tokyo 1088639, Japan; [Masuda, Akiko; Dohmae, Naoshi] RIKEN, Biomol Characterizat Team, Saitama 3510198, Japan; [Arita, Kyohei] Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan; [Yoshimatsu, Masanori; Hamamoto, Ryuji; Shirakawa, Masahiro; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1088639, Japan; [Iwai, Yukiko; Fukui, Yoshinori] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet, Fukuoka 8128582, Japan; [Hamamoto, Ryuji; Nakamura, Yusuke] Univ Chicago, Ctr Personalized Therapeut, Sect Hematol Oncol, Chicago, IL 60637 USA	Kyushu University; RIKEN; RIKEN; Kyoto University; University of Tokyo; Kyushu University; University of Chicago	Unoki, M (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Epigenet, Dept Mol Genet,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	unokim@bioreg.kyushu-u.ac.jp	Arita, Kyohei/AAJ-6402-2020; Hamamoto, Ryuji/AAF-9600-2019; Dohmae, Naoshi/C-2040-2011; Unoki, Motoko/X-3285-2019	Arita, Kyohei/0000-0002-9762-8405; Hamamoto, Ryuji/0000-0002-2632-1334; Dohmae, Naoshi/0000-0002-5242-9410; Unoki, Motoko/0000-0002-9629-3818; Fukui, Yoshinori/0000-0003-2335-8745	JSPS KAKENHI [22700867]; Kyushu University; Grants-in-Aid for Scientific Research [22680064, 24113711] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant 22700867 and Kyushu University interdisciplinary programs in education and projects in research development.	Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Han G, 2012, J CELL BIOCHEM, V113, P1663, DOI 10.1002/jcb.24035; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Mantri M, 2011, CHEMBIOCHEM, V12, P531, DOI 10.1002/cbic.201000641; Masuda A, 2010, ANAL CHEM, V82, P8939, DOI 10.1021/ac101718x; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Unoki M, 2009, BIOCHEM PHARMACOL, V78, P1279, DOI 10.1016/j.bcp.2009.05.035; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	17	101	102	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6053	6062		10.1074/jbc.M112.433284	http://dx.doi.org/10.1074/jbc.M112.433284			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23303181	hybrid, Green Published			2022-12-28	WOS:000315820700003
J	Abdul-Wahab, MF; Homma, T; Wright, M; Olerenshaw, D; Dafforn, TR; Nagata, K; Miller, AD				Abdul-Wahab, Mohd Firdaus; Homma, Takayuki; Wright, Michael; Olerenshaw, Dee; Dafforn, Timothy R.; Nagata, Kazuhiro; Miller, Andrew D.			The pH Sensitivity of Murine Heat Shock Protein 47 (HSP47) Binding to Collagen Is Affected by Mutations in the Breach Histidine Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP47; SECONDARY STRUCTURE ANALYSES; TRIPLE-HELIX; FIBRIL FORMATION; INHIBITORY CONFORMATION; 3-DIMENSIONAL STRUCTURE; HUMAN ANTITHROMBIN; MODEL PEPTIDES; I COLLAGEN; BIOSYNTHESIS	Heat shock protein 47 (HSP47) is a single-substrate molecular chaperone crucial for collagen biosynthesis. Although its function is well established, the molecular mechanisms that govern binding to procollagen peptides and triple helices in the endoplasmic reticulum (followed by controlled release in the Golgi) are unclear. HSP47 binds procollagen at a neutral pH but releases at a pH similar to the pK(a) of the imidazole side chain of histidine residues. It thus seems likely that these residues are involved in this pH-dependent mechanism. Murine HSP47 has 14 histidine residues grouped into three clusters, known as the breach, gate, and shutter. Here, we report the use of histidine mutagenesis to demonstrate the relative contribution of these three clusters to HSP47 structure and the "pH switch." Many of the tested mutants are silent; however, breach mutants H197A and H198A show binding but no apparent pH switch and are unable to control release. Another breach mutant, H191A, shows perturbed collagen release characteristics, consistent with observed perturbations in pH-driven trans-conformational changes. Thus, His-198, His-197 and His-191 are important (if not central) to HSP47 mechanism of binding/release to collagen. This is consistent with the breach cluster residues being well conserved across the HSP47 family.	[Abdul-Wahab, Mohd Firdaus; Homma, Takayuki; Wright, Michael; Olerenshaw, Dee; Miller, Andrew D.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, Imperial Coll Genet Therapies Ctr, London SW7 2AZ, England; [Abdul-Wahab, Mohd Firdaus] Univ Teknol Malaysia, Fac Biosci & Bioengn, Dept Biol Sci, Utm Skudai 81310, Johor, Malaysia; [Wright, Michael; Miller, Andrew D.] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England; [Dafforn, Timothy R.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Nagata, Kazuhiro] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068397, Japan	Imperial College London; Universiti Teknologi Malaysia; University of London; King's College London; University of Birmingham; Kyoto University	Miller, AD (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Franklin Wilkins Bldg,Waterloo Campus,150 Stamfor, London SE1 9NH, England.	andrew.d.miller@kcl.ac.uk	Miller, Andrew/G-8291-2019; Abdul-Wahab, Mohd Firdaus/J-8345-2012; Abdul-Wahab, Mohd Firdaus/P-3934-2019; Dafforn, Tim/A-9072-2015	Miller, Andrew/0000-0003-0661-249X; Abdul-Wahab, Mohd Firdaus/0000-0002-4023-0762; Abdul-Wahab, Mohd Firdaus/0000-0002-4023-0762; Dafforn, Tim/0000-0003-2257-6679	Royal Society; Wellcome Trust for the Travel Grant [P13990]; Ministry of Higher Education Malaysia; Mitsubishi Chemical Corporation; MRC [G120/738] Funding Source: UKRI; Medical Research Council [G120/738] Funding Source: researchfish	Royal Society(Royal Society of London); Wellcome Trust for the Travel Grant(Wellcome Trust); Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); Mitsubishi Chemical Corporation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Royal Society and Wellcome Trust for the Travel Grant (to A. D. M, K. N., and T. H. under the International Joint Project Grant P13990). This work was also supported by a scholarship from the Ministry of Higher Education Malaysia.; We acknowledge the Mitsubishi Chemical Corporation for financial support to the Imperial College Genetic Therapies Centre. We also thank Professors Tony Cass and Robin Leatherbarrow for discussion and assistance,	Benyon RC, 1998, J PEDIATR GASTR NUTR, V27, P75, DOI 10.1097/00005176-199807000-00013; Bulleid NJ, 1997, EMBO J, V16, P6694, DOI 10.1093/emboj/16.22.6694; Bulleid NJ, 1996, BIOCHEM J, V317, P195, DOI 10.1042/bj3170195; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Dafforn TR, 2001, J BIOL CHEM, V276, P49310, DOI 10.1074/jbc.M108896200; Davids JW, 1995, BIOORG CHEM, V23, P427, DOI 10.1006/bioo.1995.1029; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; El-Thaher S. H., 1996, PROTEIN PEPTIDE LETT, V3, P1; Elliott PR, 1996, NAT STRUCT BIOL, V3, P676, DOI 10.1038/nsb0896-676; Elliott PR, 1998, J MOL BIOL, V275, P419, DOI 10.1006/jmbi.1997.1458; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; GELMAN RA, 1979, J BIOL CHEM, V254, P1741; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; KADLER KE, 1988, J BIOL CHEM, V263, P10517; Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jbc.M509707200; Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200; Koide T, 2005, TOP CURR CHEM, V247, P85, DOI 10.1007/b103820; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Mayo KH, 1996, BIOPOLYMERS, V40, P359, DOI 10.1002/(SICI)1097-0282(1996)40:4<359::AID-BIP2>3.0.CO;2-V; Meagher JL, 1998, J BIOL CHEM, V273, P23283, DOI 10.1074/jbc.273.36.23283; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Ono T, 2012, J BIOL CHEM, V287, P6810, DOI 10.1074/jbc.M111.280248; Pearce MC, 2007, FEBS J, V274, P3622, DOI 10.1111/j.1742-4658.2007.05897.x; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; PROCKOP DJ, 1979, NEW ENGL J MED, V301, P13, DOI 10.1056/NEJM197907053010104; Rasband W. S., 1997, IMAGEJ SOFTWARE; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Satoh M, 1996, J CELL BIOL, V133, P469, DOI 10.1083/jcb.133.2.469; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; Sharp AM, 1999, STRUCTURE, V7, P111, DOI 10.1016/S0969-2126(99)80018-5; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Tasab M, 2002, J BIOL CHEM, V277, P35007, DOI 10.1074/jbc.M202782200; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; Whisstock JC, 2000, J MOL BIOL, V295, P651, DOI 10.1006/jmbi.1999.3375; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578; Yang SF, 2008, J ORAL PATHOL MED, V37, P206, DOI 10.1111/j.1600-0714.2007.00633.x	51	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4452	4461		10.1074/jbc.M112.409029	http://dx.doi.org/10.1074/jbc.M112.409029			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23212911	hybrid, Green Published			2022-12-28	WOS:000314845000071
J	Silva, GN; Fatma, S; Floyd, AM; Fischer, F; Chuawong, P; Cruz, AN; Simari, RM; Joshi, N; Kern, D; Hendrickson, TL				Silva, Gayathri N.; Fatma, Shirin; Floyd, Ashley M.; Fischer, Frederic; Chuawong, Pitak; Cruz, Amanda N.; Simari, Rachel M.; Joshi, Nilesh; Kern, Daniel; Hendrickson, Tamara L.			A tRNA-independent Mechanism for Transamidosome Assembly Promotes Aminoacyl-tRNA Transamidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR TU; HELICOBACTER-PYLORI; RIBONUCLEOPROTEIN PARTICLE; SYNTHETASE; AMIDOTRANSFERASE; BINDING; MUTATIONS	Many bacteria lack genes encoding asparaginyl- and/or glutaminyl-tRNA synthetase and consequently rely on an indirect path for the synthesis of both Asn-tRNA(Asn) and Gln-tRNA(Gln). In some bacteria such as Thermus thermophilus, efficient delivery of misacylated tRNA to the downstream amidotransferase (AdT) is ensured by formation of a stable, tRNA-dependent macromolecular complex called the Asn-transamidosome. This complex enables direct delivery of Asp-tRNA(Asn) from the nondiscriminating aspartyl-tRNA synthetase to AdT, where it is converted into Asn-tRNA(Asn). Previous characterization of the analogous Helicobacter pylori Asn-transamidosome revealed that it is dynamic and cannot be stably isolated, suggesting the possibility of an alternative mechanism to facilitate assembly of a stable complex. We have identified a novel protein partner called Hp0100 as a component of a stable, tRNA-independent H. pylori Asn-transamidosome; this complex contains a nondiscriminating aspartyl-tRNA synthetase, AdT, and Hp0100 but does not require tRNA(Asn) for assembly. Hp0100 also enhances the capacity of AdT to convert Asp-tRNA(Asn) into Asn-tRNA(Asn) by similar to 35-fold. Our results demonstrate that bacteria have adopted multiple divergent methods for transamidosome assembly and function.	[Silva, Gayathri N.; Fatma, Shirin; Floyd, Ashley M.; Cruz, Amanda N.; Simari, Rachel M.; Joshi, Nilesh; Hendrickson, Tamara L.] Wayne State Univ, Dept Chem, Detroit, MI 48230 USA; [Fischer, Frederic; Kern, Daniel] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN,UPR 9002, F-67084 Strasbourg, France; [Chuawong, Pitak] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA; [Chuawong, Pitak] Kasetsart Univ, Dept Chem, Fac Sci, Bangkok 10903, Thailand; [Chuawong, Pitak] Kasetsart Univ, Fac Sci, Ctr Excellence Innovat Chem, Bangkok 10903, Thailand	Wayne State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Johns Hopkins University; Kasetsart University; Kasetsart University	Hendrickson, TL (corresponding author), Wayne State Univ, Dept Chem, 5101 Cass Ave, Detroit, MI 48230 USA.	tamara.hendrickson@chem.wayne.edu	fatma, shirin/AIE-7476-2022	fatma, shirin/0000-0002-4504-4272; CHUAWONG, PITAK/0000-0001-8969-1351; Silva, Gayathri/0000-0002-2687-2144	National Institutes of Health [GM071480]; Wayne State University; Ministere de l'Education Nationale, de la Recherche et de la Technologie and Fondation pour la Recherche Medicale (FRM) graduate fellowships; Universite de Strasbourg, CNRS; Association pour la Recherche sur le Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University; Ministere de l'Education Nationale, de la Recherche et de la Technologie and Fondation pour la Recherche Medicale (FRM) graduate fellowships; Universite de Strasbourg, CNRS; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	work was supported, in whole or in part, by National Institutes of Health Grant GM071480 (to T. L. H.). This work was also supported by Wayne State University (to T. L. H.); Ministere de l'Education Nationale, de la Recherche et de la Technologie and Fondation pour la Recherche Medicale (FRM) graduate fellowships (to F. F.); and the Universite de Strasbourg, CNRS, and the Association pour la Recherche sur le Cancer (to D. K.).	Bailly M, 2007, MOL CELL, V28, P228, DOI 10.1016/j.molcel.2007.08.017; Bhaskaran H, 2011, J MOL BIOL, V411, P854, DOI 10.1016/j.jmb.2011.06.039; Blaise M, 2010, EMBO J, V29, P3118, DOI 10.1038/emboj.2010.192; Cathopoulis T, 2007, MOL BIOSYST, V3, P408, DOI 10.1039/b618899k; Cathopoulis TJT, 2008, BIOCHEMISTRY-US, V47, P7610, DOI 10.1021/bi800369q; Chuawong P, 2006, BIOCHEMISTRY-US, V45, P8079, DOI 10.1021/bi060189c; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Deinert K, 2001, J BIOL CHEM, V276, P6000, DOI 10.1074/jbc.M008682200; Fischer F, 2012, NUCLEIC ACIDS RES, V40, P4965, DOI 10.1093/nar/gks167; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Huot JL, 2011, NUCLEIC ACIDS RES, V39, P9306, DOI 10.1093/nar/gkr619; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Karanasios E, 2010, FEBS LETT, V584, P3842, DOI 10.1016/j.febslet.2010.08.023; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rampias T, 2010, NUCLEIC ACIDS RES, V38, P5774, DOI 10.1093/nar/gkq336; Roy H, 2007, NUCLEIC ACIDS RES, V35, P3420, DOI 10.1093/nar/gkm211; Sheppard K, 2008, METHODS, V44, P139, DOI 10.1016/j.ymeth.2007.06.010; Sheppard K, 2007, J BIOL CHEM, V282, P11866, DOI 10.1074/jbc.M700398200; Skouloubris S, 2003, P NATL ACAD SCI USA, V100, P11297, DOI 10.1073/pnas.1932482100; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Zhao LJ, 2012, BIOCHEMISTRY-US, V51, P273, DOI 10.1021/bi201143x	26	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3816	3822		10.1074/jbc.M112.441394	http://dx.doi.org/10.1074/jbc.M112.441394			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23258533	Green Published, hybrid			2022-12-28	WOS:000314845000013
J	Zhang, SF; Zhou, YJ; Sarkeshik, A; Yates, JR; Thomson, TM; Zhang, ZT; Lee, EYC; Lee, MYWT				Zhang, Sufang; Zhou, Yajing; Sarkeshik, Ali; Yates, John R., III; Thomson, Timothy M.; Zhang, Zhongtao; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.			Identification of RNF8 as a Ubiquitin Ligase Involved in Targeting the p12 Subunit of DNA Polymerase delta for Degradation in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; STRAND BREAK REPAIR; CALF THYMUS; HUMAN-CELLS; PROTEIN; PCNA; RECRUITMENT; TOLERANCE; FAMILY; SITES	DNA polymerase delta consists of four subunits, one of which, p12, is degraded in response to DNA damage through the ubiquitin-proteasome pathway. However, the identities of the ubiquitin ligase(s) that are responsible for the proximal biochemical events in triggering proteasomal degradation of p12 are unknown. We employed a classical approach to identifying a ubiquitin ligase that is involved in p12 degradation. Using UbcH5c as ubiquitin-conjugating enzyme, a ubiquitin ligase activity that polyubiquitinates p12 was purified from HeLa cells. Proteomic analysis revealed that RNF8, a RING finger ubiquitin ligase that plays an important role in the DNA damage response, was the only ubiquitin ligase present in the purified preparation. In vivo, DNA damage-induced p12 degradation was significantly reduced by shRNA knockdown of RNF8 in cultured human cells and in RNF8(-/-) mouse epithelial cells. These studies provide the first identification of a ubiquitin ligase activity that is involved in the DNA damage-induced destruction of p12. The identification of RNF8 allows new insights into the integration of the control of p12 degradation by different DNA damage signaling pathways.	[Zhang, Sufang; Zhou, Yajing; Zhang, Zhongtao; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA; [Sarkeshik, Ali; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Thomson, Timothy M.] CSIC, Dept Cell Biol, Inst Mol Biol Barcelona, Barcelona 08028, Spain	New York Medical College; Scripps Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC)	Lee, MYWT (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	marietta_lee@NYMC.edu	Thomson, Timothy/Z-6271-2019	Thomson, Timothy/0000-0002-4670-9440; zhang, zhongtao/0000-0002-1910-4753; Zhang, Sufang/0000-0003-3883-023X	National Institutes of Health [GM31973, ES14737, P41 GM103533]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031973, P41GM103533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31973 and ES14737 (to M. Y. W. T. L.) and P41 GM103533 (to J. R. Y.).	Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bonner MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020489; Brooks L, 2008, CELL MOL LIFE SCI, V65, P3458, DOI 10.1007/s00018-008-8220-1; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; BYRNES JJ, 1976, BIOCHEMISTRY-US, V15, P2817, DOI 10.1021/bi00658a018; Campbell SJ, 2012, J BIOL CHEM, V287, P23900, DOI 10.1074/jbc.M112.359653; Chea J, 2012, CELL CYCLE, V11, P2885, DOI 10.4161/cc.21280; Chen JJ, 2011, CELL BIOCHEM BIOPHYS, V60, P47, DOI 10.1007/s12013-011-9187-3; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ito K, 2001, EUR J BIOCHEM, V268, P2725, DOI 10.1046/j.1432-1327.2001.02169.x; Kim HT, 2008, MOL CELLS, V25, P457; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Lee MYWT, 2012, ENVIRON MOL MUTAGEN, V53, P683, DOI 10.1002/em.21743; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; LEE MYWT, 1980, BIOCHEMISTRY-US, V19, P2096, DOI 10.1021/bi00551a015; Lehmann AR, 2011, DNA REPAIR, V10, P730, DOI 10.1016/j.dnarep.2011.04.023; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Lorick KL, 2005, METHOD ENZYMOL, V398, P54, DOI 10.1016/S0076-6879(05)98006-3; Luijsterburg MS, 2012, CURR OPIN CELL BIOL, V24, P439, DOI 10.1016/j.ceb.2012.03.008; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Overmeer RM, 2010, MOL CELL BIOL, V30, P4828, DOI 10.1128/MCB.00285-10; Plans V, 2008, ONCOGENE, V27, P1355, DOI 10.1038/sj.onc.1210782; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; PLON SE, 1993, P NATL ACAD SCI USA, V90, P10484, DOI 10.1073/pnas.90.22.10484; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Seki N, 1998, J HUM GENET, V43, P272, DOI 10.1007/s100380050088; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Vrouwe MG, 2011, J CELL SCI, V124, P435, DOI 10.1242/jcs.075325; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wu JX, 2009, MOL CELL BIOL, V29, P849, DOI 10.1128/MCB.01302-08; Xie B, 2002, BIOCHEMISTRY-US, V41, P13133, DOI 10.1021/bi0262707; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595; Zhou YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022224	54	29	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2941	2950		10.1074/jbc.M112.423392	http://dx.doi.org/10.1074/jbc.M112.423392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23233665	Green Published, hybrid			2022-12-28	WOS:000314397900005
J	Iwasaki, T; Takeda, Y; Maruyama, K; Yokosaki, Y; Tsujino, K; Tetsumoto, S; Kuhara, H; Nakanishi, K; Otani, Y; Jin, YJ; Kohmo, S; Hirata, H; Takahashi, R; Suzuki, M; Inoue, K; Nagatomo, I; Goya, S; Kijima, T; Kumagai, T; Tachibana, I; Kawase, I; Kumanogoh, A				Iwasaki, Takeo; Takeda, Yoshito; Maruyama, Kazuichi; Yokosaki, Yasuyuki; Tsujino, Kazuyuki; Tetsumoto, Satoshi; Kuhara, Hanako; Nakanishi, Kaori; Otani, Yasushi; Jin, Yingji; Kohmo, Satoshi; Hirata, Haruhiko; Takahashi, Ryo; Suzuki, Mayumi; Inoue, Koji; Nagatomo, Izumi; Goya, Sho; Kijima, Takashi; Kumagai, Toru; Tachibana, Isao; Kawase, Ichiro; Kumanogoh, Atsushi			Deletion of Tetraspanin CD9 Diminishes Lymphangiogenesis in Vivo and in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHATIC ENDOTHELIAL-CELLS; GROWTH-FACTOR RECEPTOR-3; AIRWAY INFLAMMATION; NODE METASTASIS; FACTOR-C; INTEGRIN; ANGIOGENESIS; CANCER; CD151; MACROPHAGES	Tetraspanins have emerged as key players in malignancy and inflammatory diseases, yet little is known about their roles in angiogenesis, and nothing is known about their involvement in lymphangiogenesis. We found here that tetraspanins are abundantly expressed in human lymphatic endothelial cells (LEC). After intrathoracic tumor implantation, metastasis to lymph nodes was diminished and accompanied by decreased angiogenesis and lymphangiogenesis in tetraspanin CD9-KO mice. Moreover, lymphangiomas induced in CD9-KO mice were less pronounced with decreased lymphangiogenesis compared with those in wildtype mice. Although mouse LEC isolated from CD9-KO mice showed normal adhesion, lymphangiogenesis was markedly impaired in several assays (migration, proliferation, and cable formation) in vitro and in the lymphatic ring assay ex vivo. Consistent with these findings in mouse LEC, knocking down CD9 in human LEC also produced decreased migration, proliferation, and cable formation. Immunoprecipitation analysis demonstrated that deletion of CD9 in LEC diminished formation of functional complexes between VEGF receptor-3 and integrins (alpha 5 and alpha 9). Therefore, knocking down CD9 in LEC attenuated VEGF receptor-3 signaling, as well as downstream signaling such as Erk and p38 upon VEGF-C stimulation. Finally, double deletion of CD9/CD81 in mice caused abnormal development of lymphatic vasculature in the trachea and diaphragm, suggesting that CD9 and a closely related tetraspanin CD81 coordinately play an essential role in physiological lymphangiogenesis. In conclusion, tetraspanin CD9 modulates molecular organization of integrins in LEC, thereby supporting several functions required for lymphangiogenesis.	[Iwasaki, Takeo; Takeda, Yoshito; Tsujino, Kazuyuki; Tetsumoto, Satoshi; Kuhara, Hanako; Nakanishi, Kaori; Otani, Yasushi; Jin, Yingji; Kohmo, Satoshi; Hirata, Haruhiko; Takahashi, Ryo; Suzuki, Mayumi; Inoue, Koji; Nagatomo, Izumi; Kijima, Takashi; Tachibana, Isao; Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan; [Maruyama, Kazuichi] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto 6020841, Japan; [Yokosaki, Yasuyuki] Hiroshima Univ, Biomed Res Unit, Cell Matrix Frontier Lab, Hiroshima 7348551, Japan; [Kumagai, Toru] Osaka Prefectural Med Ctr Resp & Allerg Dis, Osaka 5838588, Japan; [Kawase, Ichiro] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka 5378511, Japan	Osaka University; Kyoto Prefectural University of Medicine; Hiroshima University; Osaka Prefectural Medical Center Respiratory & Allergic Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases	Takeda, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yoshito@imed3.med.osaka-u.ac.jp	Maruyama, Kazuichi/GRX-8129-2022	Maruyama, Kazuichi/0000-0001-6283-5466; Nakanishi, Kaori/0000-0002-4153-5277	Osaka Foundation for Promotion of Clinical Immunology; Ministry of Health, Labour and Welfare; "Kansai Biomedical Cluster" project in Saito; Funding Program for Next Generation World-Leading Researchers (NEXT Program); Special Coordination Funds for Promoting Science and Technology;  [20590922]	Osaka Foundation for Promotion of Clinical Immunology; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); "Kansai Biomedical Cluster" project in Saito; Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by grants from the Osaka Foundation for Promotion of Clinical Immunology (to Y. T.); Grant-in-Aid for Scientific Research (C) 20590922 (to I. K.); a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare and a grant from "Kansai Biomedical Cluster" project in Saito (to I. T.); and the Funding Program for Next Generation World-Leading Researchers (NEXT Program) and Special Coordination Funds for Promoting Science and Technology (to A. K.).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Berditchevski F, 2001, J CELL SCI, V114, P4143; Bruyere F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]; Danussi C, 2008, MOL CELL BIOL, V28, P4026, DOI 10.1128/MCB.02062-07; Dietrich T, 2007, AM J PATHOL, V171, P361, DOI 10.2353/ajpath.2007.060896; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kang S, 2009, BLOOD, V113, P2605, DOI 10.1182/blood-2008-07-166934; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Klosek SK, 2005, BIOCHEM BIOPH RES CO, V336, P408, DOI 10.1016/j.bbrc.2005.08.106; Lammerding J, 2003, P NATL ACAD SCI USA, V100, P7616, DOI 10.1073/pnas.1337546100; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Longo N, 2001, BLOOD, V98, P3717, DOI 10.1182/blood.V98.13.3717; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Nakamura ES, 2004, CANCER SCI, V95, P25, DOI 10.1111/j.1349-7006.2004.tb03166.x; Odintsova E, 2003, J CELL SCI, V116, P4557, DOI 10.1242/jcs.00793; Okazaki T, 2009, AM J PATHOL, V174, P2378, DOI 10.2353/ajpath.2009.080942; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Podgrabinska S, 2002, P NATL ACAD SCI USA, V99, P16069, DOI 10.1073/pnas.242401399; Romanska HM, 2011, J PATHOL, V223, P4, DOI 10.1002/path.2779; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016/S0002-9440(10)61765-8; Somanath PR, 2009, CELL BIOCHEM BIOPHYS, V53, P53, DOI 10.1007/s12013-008-9040-5; Sundar SS, 2007, J CLIN ONCOL, V25, P4298, DOI 10.1200/JCO.2006.07.1092; Takeda Y, 2003, J CELL BIOL, V161, P945, DOI 10.1083/jcb.200212031; Takeda Y, 2008, J BIOL CHEM, V283, P26089, DOI 10.1074/jbc.M801902200; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tobler NE, 2006, J LEUKOCYTE BIOL, V80, P691, DOI 10.1189/jlb.1105653; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; Wang JF, 2001, J BIOL CHEM, V276, P41950, DOI 10.1074/jbc.M101370200; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423; Zhang XF, 2005, J CELL PHYSIOL, V202, P205, DOI 10.1002/jcp.20106; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	45	40	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2118	2131		10.1074/jbc.M112.424291	http://dx.doi.org/10.1074/jbc.M112.424291			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223239	hybrid, Green Published			2022-12-28	WOS:000314211500003
J	Losing, M; Goldbeck, I; Manno, B; Oellerich, T; Schnyder, T; Bohnenberger, H; Stork, B; Urlaub, H; Batista, FD; Wienands, J; Engelke, M				Loesing, Marion; Goldbeck, Ingo; Manno, Birgit; Oellerich, Thomas; Schnyder, Tim; Bohnenberger, Hanibal; Stork, Bjoern; Urlaub, Henning; Batista, Facundo D.; Wienands, Juergen; Engelke, Michael			The Dok-3/Grb2 Protein Signal Module Attenuates Lyn Kinase-dependent Activation of Syk Kinase in B Cell Antigen Receptor Microclusters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLEEN TYROSINE KINASE; ADAPTER MOLECULE; NEGATIVE REGULATION; DEFICIENT MICE; SH2 DOMAIN; GRB2; BLNK; INHIBITION; EXPRESSION; SLP-65	Recruitment of the growth factor receptor-bound protein 2 (Grb2) by the plasma membrane-associated adapter protein downstream of kinase 3 (Dok-3) attenuates signals transduced by the B cell antigen receptor (BCR). Here we describe molecular details of Dok-3/Grb2 signal integration and function, showing that the Lyn-dependent activation of the BCR transducer kinase Syk is attenuated by Dok-3/Grb2 in a site-specific manner. This process is associated with the SH3 domain-dependent translocation of Dok-3/ Grb2 complexes into BCR microsignalosomes and augmented phosphorylation of the inhibitory Lyn target SH2 domain-containing inositol 5' phosphatase. Hence, our findings imply that Dok-3/ Grb2 modulates the balance between activatory and inhibitory Lyn functions with the aim to adjust BCR signaling efficiency.	[Loesing, Marion; Goldbeck, Ingo; Manno, Birgit; Oellerich, Thomas; Bohnenberger, Hanibal; Stork, Bjoern; Wienands, Juergen; Engelke, Michael] Univ Gottingen, Inst Cellular & Mol Immunol, D-37073 Gottingen, Germany; [Schnyder, Tim; Batista, Facundo D.; Wienands, Juergen] Canc Res UK, London Res Inst, Lymphocyte Interact Lab, London WC2A 3LY, England; [Urlaub, Henning] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Bioanalyt Dept Clin Chem, D-37075 Gottingen, Germany	University of Gottingen; Cancer Research UK; Max Planck Society; University of Gottingen	Wienands, J (corresponding author), Univ Gottingen, Inst Cellular & Mol Immunol, Humboldtallee 34, D-37073 Gottingen, Germany.	jwienan@gwdg.de; mengelk@gwdg.de	Bohnenberger, Hanibal/F-2317-2013; Stork, Björn/C-2160-2011	Stork, Björn/0000-0002-4167-7806	Deutsche Forschungsgemeinschaft research group [FOR 521]; State of Lower Saxony; Volkswagen Foundation, Hannover, Germany; Cancer Research UK [15691] Funding Source: researchfish	Deutsche Forschungsgemeinschaft research group(German Research Foundation (DFG)); State of Lower Saxony(European Commission); Volkswagen Foundation, Hannover, Germany(Volkswagen); Cancer Research UK(Cancer Research UK)	This work was supported by the Deutsche Forschungsgemeinschaft research group FOR 521; by the State of Lower Saxony; and by the Volkswagen Foundation, Hannover, Germany.	Ackermann JA, 2011, EMBO J, V30, P1621, DOI 10.1038/emboj.2011.74; Berger AH, 2010, NAT GENET, V42, P216, DOI 10.1038/ng.527; Bohnenberger H, 2011, EUR J IMMUNOL, V41, P1550, DOI 10.1002/eji.201041326; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Depoil D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263pt1; Dong SW, 2011, NEOPLASMA, V58, P89, DOI 10.4149/neo_2011_01_89; Engelke M, 2007, IMMUNOL REV, V218, P235, DOI 10.1111/j.1600-065X.2007.00539.x; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Engels N, 2008, ADV IMMUNOL, V97, P251, DOI 10.1016/S0065-2776(08)00005-9; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Grabbe A, 2006, BLOOD, V108, P3761, DOI 10.1182/blood-2006-02-005397; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Hashimoto S, 1999, BLOOD, V94, P2357, DOI 10.1182/blood.V94.7.2357.419k40_2357_2364; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Jang IK, 2011, P NATL ACAD SCI USA, V108, P7926, DOI 10.1073/pnas.1016451108; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Kurosaki T, 2009, IMMUNOL REV, V228, P132, DOI 10.1111/j.1600-065X.2008.00748.x; Lemay S, 2000, MOL CELL BIOL, V20, P2743, DOI 10.1128/MCB.20.8.2743-2754.2000; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Neumann K, 2011, CELL SIGNAL, V23, P893, DOI 10.1016/j.cellsig.2011.01.015; Neumann K, 2009, IMMUNOL REV, V232, P135, DOI 10.1111/j.1600-065X.2009.00845.x; Ng CH, 2007, BLOOD, V110, P259, DOI 10.1182/blood-2006-10-055194; Niiro H, 2002, J EXP MED, V195, P143, DOI 10.1084/jem.20011524; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Oellerich T, 2011, EMBO J, V30, P3620, DOI 10.1038/emboj.2011.251; Oellerich T, 2009, MOL CELL PROTEOMICS, V8, P1738, DOI 10.1074/mcp.M800567-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Robson JD, 2004, MOL CELL BIOL, V24, P2332, DOI 10.1128/MCB.24.6.2332-2343.2004; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schnyder T, 2011, IMMUNITY, V34, P905, DOI 10.1016/j.immuni.2011.06.001; Stork B, 2004, IMMUNITY, V21, P681, DOI 10.1016/j.immuni.2004.09.007; Stork B, 2007, EMBO J, V26, P1140, DOI 10.1038/sj.emboj.7601557; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Tsang E, 2008, J BIOL CHEM, V283, P32650, DOI 10.1074/jbc.M806340200; Wang L, 2003, CANCER RES, V63, P4724; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316	50	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2303	2313		10.1074/jbc.M112.406546	http://dx.doi.org/10.1074/jbc.M112.406546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23223229	Green Published, hybrid			2022-12-28	WOS:000314211500020
J	Torrens-Spence, MP; Liu, PY; Ding, HZ; Harich, K; Gillaspy, G; Li, JY				Torrens-Spence, Michael P.; Liu, Pingyang; Ding, Haizhen; Harich, Kim; Gillaspy, Glenda; Li, Jianyong			Biochemical Evaluation of the Decarboxylation and Decarboxylation-Deamination Activities of Plant Aromatic Amino Acid Decarboxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SUSPENSION-CULTURES; DOPA DECARBOXYLASE; TYROSINE DECARBOXYLASE; SUBSTRATE-SPECIFICITY; AUXIN BIOSYNTHESIS; SYNTHASE; PURIFICATION; EXPRESSION; ENZYMES; GENES	Plant aromatic amino acid decarboxylase (AAAD) enzymes are capable of catalyzing either decarboxylation or decarboxylation-deamination on various combinations of aromatic amino acid substrates. These two different activities result in the production of arylalkylamines and the formation of aromatic acetaldehydes, respectively. Variations in product formation enable individual enzymes to play different physiological functions. Despite these catalytic variations, arylalkylamine and aldehyde synthesizing AAADs are indistinguishable without protein expression and characterization. In this study, extensive biochemical characterization of plant AAADs was performed to identify residues responsible for differentiating decarboxylation AAADs from aldehyde synthase AAADs. Results demonstrated that a tyrosine residue located on a catalytic loop proximal to the active site of plant AAADs is primarily responsible for dictating typical decarboxylase activity, whereas a phenylalanine at the same position is primarily liable for aldehyde synthase activity. Mutagenesis of the active site phenylalanine to tyrosine in Arabidopsis thaliana and Petroselinum crispum aromatic acetaldehyde synthases primarily converts the enzymes activity from decarboxylation-deamination to decarboxylation. The mutation of the active site tyrosine to phenylalanine in the Catharanthus roseus and Papaver somniferum aromatic amino acid decarboxylases changes the enzymes decarboxylation activity to a primarily decarboxylation-deamination activity. Generation of these mutant enzymes enables the production of unusual AAAD enzyme products including indole-3-acetaldehyde, 4-hydroxyphenylacetaldehyde, and phenylethylamine. Our data indicates that the tyrosine and phenylalanine in the catalytic loop region could serve as a signature residue to reliably distinguish plant arylalkylamine and aldehyde synthesizing AAADs. Additionally, the resulting data enables further insights into the mechanistic roles of active site residues.	[Torrens-Spence, Michael P.; Liu, Pingyang; Ding, Haizhen; Harich, Kim; Gillaspy, Glenda; Li, Jianyong] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Li, JY (corresponding author), Virginia Tech, Dept Biochem, Engel Hall 204, Blacksburg, VA 24061 USA.	lij@vt.edu	Liu, Pingyang/G-7796-2014	Liu, Pingyang/0000-0001-5060-5807	Virginia Tech Department of Biochemistry, College of Agriculture and Life Sciences; Direct For Biological Sciences [1051646] Funding Source: National Science Foundation	Virginia Tech Department of Biochemistry, College of Agriculture and Life Sciences; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Virginia Tech Department of Biochemistry, College of Agriculture and Life Sciences.	BERLIN J, 1994, PLANT CELL TISS ORG, V38, P289, DOI 10.1007/BF00033889; Bertoldi M, 2002, J BIOL CHEM, V277, P36357, DOI 10.1074/jbc.M204867200; Bertoldi M, 1996, J BIOL CHEM, V271, P23954, DOI 10.1074/jbc.271.39.23954; Bertoldi M, 1998, BIOCHEMISTRY-US, V37, P6552, DOI 10.1021/bi9718898; BUTEAU C, 1984, J CHROMATOGR, V284, P201, DOI 10.1016/S0021-9673(01)87816-X; Dai XH, 2013, J BIOL CHEM, V288, P1448, DOI 10.1074/jbc.M112.424077; DeLano W.L, PYMOL MOL GRAPHICS S; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; ELLIS BE, 1983, PHYTOCHEMISTRY, V22, P1941, DOI 10.1016/0031-9422(83)80018-1; Facchini PJ, 2000, PHYTOCHEMISTRY, V54, P121, DOI 10.1016/S0031-9422(00)00050-9; Gutensohn M, 2011, PLANT J, V66, P591, DOI 10.1111/j.1365-313X.2011.04515.x; Han Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008826; Kaminaga Y, 2006, J BIOL CHEM, V281, P23357, DOI 10.1074/jbc.M602708200; KAWALLECK P, 1993, J BIOL CHEM, V268, P2189; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; KOGA J, 1992, J BIOL CHEM, V267, P15823; Komori H, 2012, J BIOL CHEM, V287, P29175, DOI 10.1074/jbc.M112.381897; LEETE E, 1952, CAN J CHEM, V30, P749, DOI 10.1139/v52-090; Lehmann T, 2009, FEBS LETT, V583, P1895, DOI 10.1016/j.febslet.2009.05.017; MARQUES IA, 1988, PLANT PHYSIOL, V88, P46, DOI 10.1104/pp.88.1.46; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; MEIJER AH, 1993, J PLANT RES, P145; NOE W, 1984, PLANT MOL BIOL, V3, P281, DOI 10.1007/BF00017782; Park S, 2009, PLANTA, V230, P1197, DOI 10.1007/s00425-009-1015-2; Rontein D, 2001, J BIOL CHEM, V276, P35523, DOI 10.1074/jbc.M106038200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sekimoto H, 1998, PLANT CELL PHYSIOL, V39, P433, DOI 10.1093/oxfordjournals.pcp.a029387; Seo M, 1998, PLANT PHYSIOL, V116, P687, DOI 10.1104/pp.116.2.687; SRINIVASAN K, 1978, BIOCHIM BIOPHYS ACTA, V526, P597, DOI 10.1016/0005-2744(78)90150-X; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Tieman D, 2006, P NATL ACAD SCI USA, V103, P8287, DOI 10.1073/pnas.0602469103; Torrens-Spence MP, 2012, BIOCHEM BIOPH RES CO, V418, P211, DOI 10.1016/j.bbrc.2011.12.124; TREZZINI GF, 1993, PLANT MOL BIOL, V21, P385, DOI 10.1007/BF00019954; UDENFRIEND S, 1953, J AM CHEM SOC, V75, P501, DOI 10.1021/ja01098a520; Vavricka C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016124; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	37	44	47	8	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2376	2387		10.1074/jbc.M112.401752	http://dx.doi.org/10.1074/jbc.M112.401752			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23204519	Green Published, hybrid			2022-12-28	WOS:000314211500026
J	Hou, TT; Zhang, X; Xu, JJ; Jian, CS; Huang, ZL; Ye, T; Hu, KP; Zheng, M; Gao, F; Wang, XH; Cheng, HP				Hou, Tingting; Zhang, Xing; Xu, Jiejia; Jian, Chongshu; Huang, Zhanglong; Ye, Tao; Hu, Keping; Zheng, Ming; Gao, Feng; Wang, Xianhua; Cheng, Heping			Synergistic Triggering of Superoxide Flashes by Mitochondrial Ca2+ Uniport and Basal Reactive Oxygen Species Elevation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CA-2&-INDUCED MEMBRANE TRANSITION; OXIDATIVE-STRESS; CYCLOPHILIN-D; CA-2+-DEPENDENT PORE; ISOLATED HEPATOCYTES; CELL-DEATH; TRANSIENT; METABOLISM; COMPONENT	Mitochondrial superoxide flashes reflect a quantal, bursting mode of reactive oxygen species (ROS) production that arises from stochastic, transient opening of the mitochondrial permeability transition pore (mPTP) in many types of cells and in living animals. However, the regulatory mechanisms and the exact nature of the flash-coupled mPTP remain poorly understood. Here we demonstrate a profound synergistic effect between mitochondrial Ca2+ uniport and elevated basal ROS production in triggering superoxide flashes in intact cells. Hyperosmotic stress potently augmented the flash activity while simultaneously elevating mitochondrial Ca2+ and ROS. Blocking mitochondrial Ca2+ transport by knockdown of MICU1 or MCU, newly identified components of the mitochondrial Ca2+ uniporter, or scavenging mitochondrial basal ROS markedly diminished the flash response. More importantly, whereas elevating Ca2+ or ROS production alone was inefficacious in triggering the flashes, concurrent physiological Ca2+ and ROS elevation served as the most powerful flash activator, increasing the flash incidence by an order of magnitude. Functionally, superoxide flashes in response to hyperosmotic stress participated in the activation of JNK and p38. Thus, physiological levels of mitochondrial Ca2+ and ROS synergistically regulate stochastic mPTP opening and quantal ROS production in intact cells, marking the flash as a coincidence detector of mitochondrial Ca2+ and ROS signals.	[Hou, Tingting; Xu, Jiejia; Jian, Chongshu; Huang, Zhanglong; Zheng, Ming; Wang, Xianhua; Cheng, Heping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Zhang, Xing; Gao, Feng] Fourth Mil Med Univ, Dept Physiol, Xian 710023, Peoples R China; [Ye, Tao] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Hu, Keping] Chinese Acad Med Sci, Inst Med Plant Dev, Res Ctr Pharmacol & Toxicol, Beijing 100094, Peoples R China; [Hu, Keping] Peking Union Med Coll, Beijing 100094, Peoples R China	Peking University; Air Force Military Medical University; Hong Kong Polytechnic University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, XH (corresponding author), Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.	xianhua@pku.edu.cn	Heping, Cheng/AAE-2680-2019; Ye，PhD，FRSC, Tao/ABB-8698-2020; Zhang, Xing/ACQ-5035-2022; cheng, heping/A-7299-2011; Gao, Feng/X-4385-2019	Heping, Cheng/0000-0002-9604-6702; Ye，PhD，FRSC, Tao/0000-0002-2780-9761; Xu, Jiejia/0000-0003-3885-3546; Hahn, Michael/0000-0003-2136-5191; Knox, John Paul/0000-0002-9231-6891	National Basic Research Program of China [2011CB809102]; National Science Foundation of China [31221002, 31130067, 31123004, 30900264]; BBSRC [BB/E015190/1] Funding Source: UKRI	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Basic Research Program of China Grant 2011CB809102 and National Science Foundation of China Grants 31221002, 31130067, 31123004, and 30900264.	ALNASSER I, 1986, BIOCHEM J, V239, P19, DOI 10.1042/bj2390019; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 2007, NOVART FDN SYMP, V287, P164; Bernardi Paolo, 2007, Novartis Found Symp, V287, P157; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chiong M, 2010, APOPTOSIS, V15, P887, DOI 10.1007/s10495-010-0505-9; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CROMPTON M, 1987, BIOCHEM J, V245, P915, DOI 10.1042/bj2450915; CROMPTON M, 1988, BIOCHEM J, V255, P357; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Huang ZL, 2011, FREE RADICAL BIO MED, V51, P1937, DOI 10.1016/j.freeradbiomed.2011.08.024; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Korge P, 2011, J BIOL CHEM, V286, P34851, DOI 10.1074/jbc.M111.239921; Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Pastor MM, 2009, J BIOL CHEM, V284, P30307, DOI 10.1074/jbc.M109.050682; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; POWIS G, 1981, MOL PHARMACOL, V20, P387; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; THOR H, 1982, J BIOL CHEM, V257, P2419; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang XH, 2012, J MOL CELL CARDIOL, V52, P940, DOI 10.1016/j.yjmcc.2012.02.007; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Wright AR, 1998, PHARMACOL THERAPEUT, V80, P89, DOI 10.1016/S0163-7258(98)00025-4; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	54	80	85	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4602	4612		10.1074/jbc.M112.398297	http://dx.doi.org/10.1074/jbc.M112.398297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	24297170	Green Published, hybrid			2022-12-28	WOS:000315340400010
